<SEC-DOCUMENT>0001564590-21-044462.txt : 20210816
<SEC-HEADER>0001564590-21-044462.hdr.sgml : 20210816
<ACCEPTANCE-DATETIME>20210816083656
ACCESSION NUMBER:		0001564590-21-044462
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		103
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210816
DATE AS OF CHANGE:		20210816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Taysha Gene Therapies, Inc.
		CENTRAL INDEX KEY:			0001806310
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				843199512
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39536
		FILM NUMBER:		211174762

	BUSINESS ADDRESS:	
		STREET 1:		3000 PEGASUS PARK DRIVE
		STREET 2:		SUITE 1430
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
		BUSINESS PHONE:		(214) 612-0000

	MAIL ADDRESS:	
		STREET 1:		3000 PEGASUS PARK DRIVE
		STREET 2:		SUITE 1430
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>tsha-10q_20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-16T11:23:29.1014185+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : 9ce9bc11c38d436e8005d94e4df304b9 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:tsha="http://tayshagtx.com/20210630" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
tsha-10q_20210630.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001806310_20210101_20210630">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0001806310_20210101_20210630">Q2</ix:nonNumeric>
			<ix:nonNumeric id="F_000007" name="dei:EntityCentralIndexKey" contextRef="C_0001806310_20210101_20210630">0001806310</ix:nonNumeric>
			<ix:nonNumeric id="F_000008" name="dei:CurrentFiscalYearEndDate" contextRef="C_0001806310_20210101_20210630">--12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000522" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000314" name="tsha:PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200401_20200430">P2Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000411" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000414" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000422" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000456" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000468" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000425" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630">P6Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000426" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">P6Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000441" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">P9Y9M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_000442" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">P9Y7M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_000443" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">P9Y7M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_000444" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">P9Y3M18D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000054" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001806310_20210630" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000055" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001806310_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000056" name="us-gaap:PreferredStockValue" contextRef="C_0001806310_20210630" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000057" name="us-gaap:PreferredStockValue" contextRef="C_0001806310_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000058" name="us-gaap:CommonStockValue" contextRef="C_0001806310_20210630" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000059" name="us-gaap:CommonStockValue" contextRef="C_0001806310_20201231" xsi:nil="true"></ix:nonFraction>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="tsha-20210630.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001806310_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlishares">
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_20210816">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD">
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_xbrlishares">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>xbrli:shares</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200401_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200101_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200401_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlipure">
				<xbrli:measure>xbrli:pure</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-16</xbrli:startDate>
					<xbrli:endDate>2020-09-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200928_20200928">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-28</xbrli:startDate>
					<xbrli:endDate>2020-09-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-28</xbrli:startDate>
					<xbrli:endDate>2020-09-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200928_20200928">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-28</xbrli:startDate>
					<xbrli:endDate>2020-09-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200928_20200928">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-28</xbrli:startDate>
					<xbrli:endDate>2020-09-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-28</xbrli:startDate>
					<xbrli:endDate>2020-09-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200301_20200731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-01</xbrli:startDate>
					<xbrli:endDate>2020-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200701_20200831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaLaboratoryEquipmentMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:LaboratoryEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaBuildToSuitLeaseMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:BuildToSuitLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_tshaProduct">
				<xbrli:measure>tsha:Product</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-11-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191201_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-12-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_srtRangeAxis_srtMaximumMember_20200221">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-02-21</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200801_20200831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-08-01</xbrli:startDate>
					<xbrli:endDate>2020-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20201001_20201031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-10-01</xbrli:startDate>
					<xbrli:endDate>2020-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_srtRangeAxis_srtMaximumMember_20200831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20201029">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-10-29</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210301_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-01</xbrli:startDate>
					<xbrli:endDate>2021-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200728">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-07-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200928">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200728">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-07-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200728">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-07-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200929_20200929">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-29</xbrli:startDate>
					<xbrli:endDate>2020-09-29</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAPurchaseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-04</xbrli:startDate>
					<xbrli:endDate>2020-03-04</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAPurchaseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementInitialClosingMember_20200304_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-04</xbrli:startDate>
					<xbrli:endDate>2020-03-04</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneOneMember_20200305_20200305">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAAchievementOfSpecificClinicalMilestoneOneMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-05</xbrli:startDate>
					<xbrli:endDate>2020-03-05</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneTwoMember_20200305_20200305">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAAchievementOfSpecificClinicalMilestoneTwoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-05</xbrli:startDate>
					<xbrli:endDate>2020-03-05</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_20200304_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-04</xbrli:startDate>
					<xbrli:endDate>2020-03-04</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-29</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200701_20200702">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-07-02</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaPBMTGTHoldingsLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PBMTGTHoldingsLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-29</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaNolanCapitalLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:NolanCapitalLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-29</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-28</xbrli:startDate>
					<xbrli:endDate>2020-07-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-28</xbrli:startDate>
					<xbrli:endDate>2020-07-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-07-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200701_20200831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-04</xbrli:startDate>
					<xbrli:endDate>2020-03-04</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200629_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-29</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapMeasurementInputTypeAxis_tshaMeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">tsha:MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200702">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-07-02</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_20200629_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-29</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200701">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-07-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-16</xbrli:startDate>
					<xbrli:endDate>2020-09-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-01-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-16</xbrli:startDate>
					<xbrli:endDate>2020-09-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-01-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:CancelledOptionsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:CertainEmployeesAndConsultantsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-07-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-02</xbrli:startDate>
					<xbrli:endDate>2020-09-02</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20200902_20200902">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-02</xbrli:startDate>
					<xbrli:endDate>2020-09-02</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheTwoMember_20200902_20200902">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-02</xbrli:startDate>
					<xbrli:endDate>2020-09-02</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheThreeMember_20200902_20200902">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-02</xbrli:startDate>
					<xbrli:endDate>2020-09-02</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_tshaShareBasedCompensationAwardTrancheFourMember_20200902_20200902">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">tsha:ShareBasedCompensationAwardTrancheFourMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-02</xbrli:startDate>
					<xbrli:endDate>2020-09-02</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-07-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20200701_20200701">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-07-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210401_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_tshaPromissoryNote">
				<xbrli:measure>tsha:PromissoryNote</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_20200101_20200131">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-01-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200131">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:SecuredPromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-01-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200301_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:SecuredPromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-01</xbrli:startDate>
					<xbrli:endDate>2020-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMCapitalGroupLLCMember_20200301_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tsha:PBMCapitalGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tsha:ServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-01</xbrli:startDate>
					<xbrli:endDate>2020-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtTitleOfIndividualAxis_srtDirectorMember_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_20200301_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tsha:ServicesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-03-01</xbrli:startDate>
					<xbrli:endDate>2020-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMTGTHoldingsLLCMember_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tsha:PBMTGTHoldingsLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_utrsqft">
				<xbrli:measure>utr:sqft</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-17</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217_20201217">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-17</xbrli:startDate>
					<xbrli:endDate>2020-12-17</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210101_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-01-11</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-11</xbrli:startDate>
					<xbrli:endDate>2021-01-11</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapLeaseContractualTermAxis_tshaDallasLeaseMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_tshaProgram">
				<xbrli:measure>tsha:Program</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyTwoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughAugustThirteenTwentyTwentyTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyThreeMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughAugustThirteenTwentyTwentyThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-11</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="border-top:Double 2.25pt;padding-top:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, DC 20549</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001806310_20210101_20210630">10-Q</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Mark One)</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Segoe UI Symbol;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000029" name="dei:DocumentQuarterlyReport" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">For the quarterly period ended <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001806310_20210101_20210630" format="ixt:datemonthdayyearen">June 30, <ix:nonNumeric id="F_000003" name="dei:DocumentFiscalYearFocus" contextRef="C_0001806310_20210101_20210630">2021</ix:nonNumeric></ix:nonNumeric></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">OR</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Segoe UI Symbol;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000030" name="dei:DocumentTransitionReport" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">For the transition period from ___________ to ___________</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Commission File Number: <ix:nonNumeric id="F_000015" name="dei:EntityFileNumber" contextRef="C_0001806310_20210101_20210630">001-39536</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityRegistrantName" contextRef="C_0001806310_20210101_20210630">Taysha Gene Therapies, Inc.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Exact Name of Registrant as Specified in its Charter)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000027" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001806310_20210101_20210630">84-3199512</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">( State or other jurisdiction of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer<br />Identification No.)</p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:EntityAddressAddressLine1" contextRef="C_0001806310_20210101_20210630">3000 Pegasus Park Drive</ix:nonNumeric> <ix:nonNumeric id="F_000018" name="dei:EntityAddressAddressLine2" contextRef="C_0001806310_20210101_20210630">Ste 1430</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:EntityAddressCityOrTown" contextRef="C_0001806310_20210101_20210630">Dallas</ix:nonNumeric>, <ix:nonNumeric id="F_000020" name="dei:EntityAddressStateOrProvince" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:stateprovnameen">Texas</ix:nonNumeric> </p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:EntityAddressPostalZipCode" contextRef="C_0001806310_20210101_20210630">75247</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric id="F_000022" name="dei:CityAreaCode" contextRef="C_0001806310_20210101_20210630">214</ix:nonNumeric>) <ix:nonNumeric id="F_000023" name="dei:LocalPhoneNumber" contextRef="C_0001806310_20210101_20210630">612-0000</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.33%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:40%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol(s)</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:40%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:40%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000025" name="dei:Security12bTitle" contextRef="C_0001806310_20210101_20210630">Common stock, par value&#160;$0.00001 per share</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="bottom" style="width:18%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:TradingSymbol" contextRef="C_0001806310_20210101_20210630">TSHA</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="bottom" style="width:40%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000026" name="dei:SecurityExchangeName" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.33%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000009" name="dei:EntityCurrentReportingStatus" contextRef="C_0001806310_20210101_20210630">Yes</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;&#160;</span>&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.33%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000028" name="dei:EntityInteractiveDataCurrent" contextRef="C_0001806310_20210101_20210630">Yes</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;&#160;</span>&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.33%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:10.8pt;">
<td valign="top" style="width:19.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Large&#160;accelerated&#160;filer</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:20.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
</tr>
<tr style="height:3.75pt;">
<td valign="top" style="width:19.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:56.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:21.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:2.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:19.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityFilerCategory" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric></p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:20.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntitySmallBusiness" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:19.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:20.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:2.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:19.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:20.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="width:2.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.33%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000013" name="dei:EntityExTransitionPeriod" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.33%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160;Yes&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000014" name="dei:EntityShellCompany" contextRef="C_0001806310_20210101_20210630" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.33%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of August 16, 2021, the registrant had <ix:nonFraction unitRef="U_xbrlishares" id="F_000024" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_0001806310_20210816" decimals="INF" format="ixt:numdotdecimal">38,391,165</ix:nonFraction> shares of common stock, $0.00001 par value per share, outstanding.</p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Table of Contents</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:82.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART I.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_IFINANCIAL_INFORMATION"><span style="text-decoration:underline;">FINANCIAL INFORMATION</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 1.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_FINANCIAL_STATEMENTS"><span style="text-decoration:underline;">Condensed Consolidated Financial Statements (Unaudited)</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONDENSED_CONSOLIDATED_BALANCE_SHEETS"><span style="text-decoration:underline;"> Balance Sheets</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT"><span style="text-decoration:underline;"> Statements of Operations</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONDENSED_CONSOLIDATED_STATEMENTS_CONVER"><span style="text-decoration:underline;"> Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F"><span style="text-decoration:underline;"> Statements of Cash Flows</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#NOTE_1ORGANIZATION_DESCRIPTION_BUSINESS_"><span style="text-decoration:underline;">Notes to Financial Statements</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 2.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><span style="text-decoration:underline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 3.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU"><span style="text-decoration:underline;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 4.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_CONTROLS_PROCEDURES"><span style="text-decoration:underline;">Controls and Procedures</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART II.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_IIOR_INFORMATION"><span style="text-decoration:underline;">OTHER INFORMATION</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 1.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_LEGAL_PROCEEDINGS"><span style="text-decoration:underline;">Legal Proceedings</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 1A.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1A_RISK_FACTORS"><span style="text-decoration:underline;">Risk Factors</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 2.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT"><span style="text-decoration:underline;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 3.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES"><span style="text-decoration:underline;">Defaults Upon Senior Securities</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 4.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><span style="text-decoration:underline;">Mine Safety Disclosures</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 5.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_5_OR_INFORMATION"><span style="text-decoration:underline;">Other Information</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 6.</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_6_EXHIBITS"><span style="text-decoration:underline;">Exhibits</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p></td>
</tr>
<tr>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:92.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:underline;">Signatures</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IFINANCIAL_INFORMATION">PART I&#8212;FINANCIAL INFORMATION</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_FINANCIAL_STATEMENTS">Item 1. Financial Statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONDENSED_CONSOLIDATED_BALANCE_SHEETS">Condensed Consolidated Balance Sheets</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share data)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ASSETS</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000031" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">197,370</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000032" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">251,253</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000033" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">9,932</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000034" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,626</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000035" name="us-gaap:AssetsCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">207,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000036" name="us-gaap:AssetsCurrent" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">257,879</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred lease asset</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000037" name="us-gaap:DeferredCostsLeasingNetNoncurrent" contextRef="C_0001806310_20210630" decimals="-3" scale="3">691</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000038" name="us-gaap:DeferredCostsLeasingNetNoncurrent" contextRef="C_0001806310_20201231" decimals="-3" scale="3">715</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000039" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">33,867</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000040" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001806310_20201231" decimals="-3" scale="3">287</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000041" name="us-gaap:Assets" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">241,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000042" name="us-gaap:Assets" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">258,881</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">LIABILITIES AND STOCKHOLDERS' EQUITY</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000043" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">6,355</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000044" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,994</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000045" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">22,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000046" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,135</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000047" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">28,391</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000048" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Build-to-suit lease liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000049" name="tsha:BuildToSuitLeaseLiability" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">26,209</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other non-current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000050" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_0001806310_20210630" decimals="-3" scale="3">765</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000051" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_0001806310_20201231" decimals="-3" scale="3">450</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000052" name="us-gaap:Liabilities" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">55,365</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000053" name="us-gaap:Liabilities" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,579</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies - Note 10</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000054">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000055">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stockholders' equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000068" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001806310_20210630" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000069" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001806310_20201231" decimals="INF">0.00001</ix:nonFraction></ix:nonFraction> par value per share&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000070" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001806310_20210630" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000071" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001806310_20201231" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="U_xbrlishares" id="F_000072" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001806310_20210630" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000073" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001806310_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000074" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001806310_20210630" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000075" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001806310_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June 30, 2021 and December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000056">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000057">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000076" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001806310_20210630" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000077" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001806310_20201231" decimals="INF">0.00001</ix:nonFraction></ix:nonFraction> par value per share&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000078" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001806310_20210630" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000079" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001806310_20201231" decimals="INF" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="U_xbrlishares" id="F_000080" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001806310_20210630" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000082" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_20210630" decimals="INF" format="ixt:numdotdecimal">38,391,165</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_000081" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001806310_20201231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000083" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_20201231" decimals="INF" format="ixt:numdotdecimal">37,761,435</ix:nonFraction></ix:nonFraction> issued and outstanding as of June 30, 2021 and December 31, 2020, respectively</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000058">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000059">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000060" name="us-gaap:AdditionalPaidInCapital" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">320,571</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000061" name="us-gaap:AdditionalPaidInCapital" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">312,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000062" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001806310_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">134,076</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000063" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001806310_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">61,126</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000064" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">186,495</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000065" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">251,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders' equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000066" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">241,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000067" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">258,881</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT">Condensed Consolidated Statements of Operations </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share data) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June&#160;30,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June&#160;30,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000084" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001806310_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">30,643</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000085" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001806310_20200401_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,062</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000086" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">54,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000087" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">8,576</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000088" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001806310_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">10,129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000089" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001806310_20200401_20200630" decimals="-3" scale="3">948</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000090" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">18,365</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000091" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,018</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000092" name="us-gaap:OperatingExpenses" contextRef="C_0001806310_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">40,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000093" name="us-gaap:OperatingExpenses" contextRef="C_0001806310_20200401_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">4,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000094" name="us-gaap:OperatingExpenses" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">72,862</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000095" name="us-gaap:OperatingExpenses" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">9,594</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000096" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001806310_20210401_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">40,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000097" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001806310_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000098" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">72,862</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000099" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9,594</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value of preferred stock tranche liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000100" name="tsha:ChangeInFairValueOfPreferredStockTrancheLiability" contextRef="C_0001806310_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,210</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000101" name="tsha:ChangeInFairValueOfPreferredStockTrancheLiability" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,030</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000102" name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="C_0001806310_20210401_20210630" decimals="-3" scale="3">40</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000103" name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="C_0001806310_20210101_20210630" decimals="-3" scale="3">106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000104" name="us-gaap:InterestExpense" contextRef="C_0001806310_20210401_20210630" decimals="-3" scale="3">194</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000105" name="us-gaap:InterestExpense" contextRef="C_0001806310_20210101_20210630" decimals="-3" scale="3">194</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000106" name="us-gaap:InterestExpense" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other expense, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000107" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001806310_20210401_20210630" decimals="-3" sign="-" scale="3">154</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000108" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001806310_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,210</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000109" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" scale="3">88</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000110" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000111" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20210401_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">40,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000112" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000113" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">72,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000114" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">26,651</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per common share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000115" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20210401_20210630" decimals="2" sign="-">1.09</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000116" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20200401_20200630" decimals="2" sign="-">1.95</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000117" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20210101_20210630" decimals="2" sign="-">1.96</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000118" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20200101_20200630" decimals="2" sign="-">2.45</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares outstanding, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000119" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20210401_20210630" decimals="0" format="ixt:numdotdecimal">37,479,164</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000120" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20200401_20200630" decimals="0" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000121" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20210101_20210630" decimals="0" format="ixt:numdotdecimal">37,237,115</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000122" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20200101_20200630" decimals="0" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONDENSED_CONSOLIDATED_STATEMENTS_CONVER">Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share data) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended June 30, 2021</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-in</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders'</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of March 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000123" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210331" decimals="INF" format="ixt:numdotdecimal">37,761,435</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000124" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210331" decimals="-3" format="ixt:numdotdecimal" scale="3">316,022</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000125" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">93,150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000126" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20210331" decimals="-3" format="ixt:numdotdecimal" scale="3">222,872</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000127" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">4,549</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000128" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001806310_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">4,549</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon vesting and settlement of restricted stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000129" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210401_20210630" decimals="INF" format="ixt:numdotdecimal">629,730</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000130" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210401_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">40,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000131" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20210401_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">40,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of June 30, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000132" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210630" decimals="INF" format="ixt:numdotdecimal">38,391,165</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000133" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">320,571</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000134" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">134,076</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000135" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">186,495</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended June 30, 2020</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.74%; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.74%; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders'</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.74%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-in</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.74%; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Deficit)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of March 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000136" name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200331" decimals="INF" format="ixt:numdotdecimal">6,000,000</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000137" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200331" decimals="-3" format="ixt:numdotdecimal" scale="3">16,520</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.74%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000138" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200331" decimals="INF" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000139" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200331" decimals="-3" scale="3">980</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000140" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">6,546</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000141" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,566</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series A convertible preferred stock,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">net of offering costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000153" name="tsha:TemporaryEquityStockOfferingCosts" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000142" name="tsha:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630" decimals="INF" format="ixt:numdotdecimal">200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000143" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630" decimals="-3" scale="3">590</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.74%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of preferred stock tranche liability upon issuance of Series A milestone shares</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000144" name="tsha:ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630" decimals="-3" scale="3">904</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.74%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.74%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000145" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000146" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of June 30, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000147" name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630" decimals="INF" format="ixt:numdotdecimal">6,200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000148" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">18,014</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.74%; border-left:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000149" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200630" decimals="INF" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000150" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630" decimals="-3" scale="3">980</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000151" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">27,766</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000152" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">26,786</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc. </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share data) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended June 30, 2021</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-in</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders'</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000156" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="INF" format="ixt:numdotdecimal">37,761,435</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000157" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">312,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000158" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">61,126</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000159" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">251,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000160" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">8,143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000161" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">8,143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon vesting and settlement of restricted stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000162" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">629,730</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000163" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">72,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000164" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">72,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.86%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of June 30, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000165" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210630" decimals="INF" format="ixt:numdotdecimal">38,391,165</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000166" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">320,571</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000167" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">134,076</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000168" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">186,495</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended June 30, 2020</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Convertible</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders'</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-in</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Deficit)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-left:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000169" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="INF" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000170" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231" decimals="-3" scale="3">980</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000171" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,115</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000172" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20191231" decimals="-3" sign="-" scale="3">135</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series A convertible preferred stock,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">net of offering costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000154" name="tsha:TemporaryEquityStockOfferingCosts" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630" decimals="-3" scale="3">440</ix:nonFraction> and issuance of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">preferred stock tranche liability of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000155" name="tsha:TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,050</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000173" name="tsha:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630" decimals="INF" format="ixt:numdotdecimal">6,200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000174" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">17,110</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of preferred stock tranche liability upon issuance of Series A milestone shares</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000175" name="tsha:ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630" decimals="-3" scale="3">904</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000176" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">26,651</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000177" name="us-gaap:NetIncomeLoss" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">26,651</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of June 30, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000178" name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630" decimals="INF" format="ixt:numdotdecimal">6,200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000179" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">18,014</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-left:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000180" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200630" decimals="INF" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000181" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630" decimals="-3" scale="3">980</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000182" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">27,766</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000183" name="us-gaap:StockholdersEquity" contextRef="C_0001806310_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">26,786</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:2pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:2pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F">Condensed Consolidated Statements of Cash Flows </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June&#160;30,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000184" name="us-gaap:ProfitLoss" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">72,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000185" name="us-gaap:ProfitLoss" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">26,651</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000186" name="us-gaap:Depreciation" contextRef="C_0001806310_20210101_20210630" decimals="-3" scale="3">117</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value of preferred stock tranche liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000187" name="tsha:ChangeInFairValueOfPreferredStockTrancheLiability" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,030</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development license expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000188" name="us-gaap:ResearchAndDevelopmentInProcess" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">5,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000189" name="us-gaap:ResearchAndDevelopmentInProcess" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000190" name="us-gaap:ShareBasedCompensation" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">8,143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000191" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">194</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating assets and liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000192" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,282</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000193" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000194" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">2,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000195" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,237</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000196" name="tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">15,053</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000197" name="tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,214</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to related party</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000198" name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000199" name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000200" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">44,851</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000201" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,165</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of research and development license</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000202" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">5,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000203" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of property, plant and equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000204" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,532</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000205" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9,032</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000206" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuances of Series A convertible preferred stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000207" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">18,600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of Series A convertible preferred stock issuance costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000208" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">263</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from note payable to related party</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000209" name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,673</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of note payable to related party</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000210" name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,645</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000211" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">18,365</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net (decrease) increase in cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000212" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">53,883</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000213" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">11,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash at the beginning of the period</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000214" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">251,253</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash at the end of the period</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000215" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">197,370</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000216" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001806310_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">11,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of cash flow information:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for interest</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000217" name="us-gaap:InterestPaidNet" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of noncash investing and financing activities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment in accounts payable and accrued expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000218" name="tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,308</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000219" name="tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisition of property, plant and equipment funded by landlord</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000220" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" contextRef="C_0001806310_20210101_20210630" decimals="-3" scale="3">606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Build-to-suit lease liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000221" name="us-gaap:CapitalLeaseObligationsIncurred" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">26,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred offering costs not yet paid</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000222" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">90</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of preferred stock tranche liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000223" name="tsha:ReclassificationOfPreferredStockLiability" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">904</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of preferred stock tranche liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000224" name="tsha:AllocationOfPreferredStockTrancheLiability" contextRef="C_0001806310_20200101_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,050</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A convertible preferred stock issuance costs not yet paid</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000225" name="us-gaap:StockIssued1" contextRef="C_0001806310_20200101_20200630" decimals="-3" scale="3">177</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000226" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000226_dcnt_5601f57e-18b5-4981-8eb6-b8b87ab0e13b">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="NOTE_1ORGANIZATION_DESCRIPTION_BUSINESS_">Note 1&#8212;Organization and Description of Business Operations </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc. (the &#8220;Company&#8221; or &#8220;Taysha&#8221;) was originally formed under the laws of the State of Texas on September 20, 2019 (&#8220;Inception&#8221;). Taysha converted to a Delaware corporation on <ix:nonNumeric id="F_000252" name="dei:EntityIncorporationDateOfIncorporation" contextRef="C_0001806310_20210101_20210630" format="ixt:datemonthdayyearen">February 13, 2020</ix:nonNumeric>, which had no impact to the Company&#8217;s par value or issued and authorized capital structure. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Taysha is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Split </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 16, 2020, the Company effected a <ix:nonFraction unitRef="U_xbrlipure" id="F_000253" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916_20200916" decimals="4">1.0895</ix:nonFraction>-for-one stock split of its authorized, issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company&#8217;s convertible preferred stock as discussed in Note 5. Accordingly, all share and per share amounts for the periods presented in the accompanying condensed consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this stock split and adjustment of the convertible preferred stock conversion ratios. On September 16, 2020, the Company also increased the number of shares of common stock authorized for issuance under the 2020 Equity Incentive Plan (the &#8220;Existing Plan&#8221;) to <ix:nonFraction unitRef="U_xbrlishares" id="F_000254" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200916" decimals="INF" format="ixt:numdotdecimal">3,845,294</ix:nonFraction>. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Initial Public Offering </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 23, 2020, the Company&#8217;s registration statement on Form S-1 (File No. 333-248559) related to the initial public offering (&#8220;IPO&#8221;) of its common stock became effective and on September 28, 2020, the IPO closed. Pursuant to the IPO, the Company issued and sold <ix:nonFraction unitRef="U_xbrlishares" id="F_000255" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">9,050,000</ix:nonFraction> shares of common stock at a public offering price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000256" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210630" decimals="INF">20.00</ix:nonFraction> per share, which included <ix:nonFraction unitRef="U_xbrlishares" id="F_000257" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200928_20200928" decimals="INF" format="ixt:numdotdecimal">1,180,434</ix:nonFraction> shares of common stock issued upon the exercise in full of the underwriters&#8217; option to purchase additional shares. The Company received net proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000258" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928" decimals="-5" scale="6">165.9</ix:nonFraction> million after <span style="color:#000000;">deducting underwriting discounts and commissions and other offering costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000259" name="us-gaap:PaymentsForUnderwritingExpense" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928" decimals="-5" scale="6">2.5</ix:nonFraction>&#160;million. The shares began trading on the Nasdaq Global Select Market on September 24, 2020.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 28, 2020, in connection with the closing of the IPO, <ix:nonFraction unitRef="U_xbrlishares" id="F_000260" name="tsha:TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200928_20200928" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction> shares of Series A and <ix:nonFraction unitRef="U_xbrlishares" id="F_000261" name="tsha:TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200928_20200928" decimals="INF" format="ixt:numdotdecimal">5,647,048</ix:nonFraction> shares of Series B convertible preferred stock automatically converted into an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000262" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928" decimals="INF" format="ixt:numdotdecimal">17,047,378</ix:nonFraction> shares of common stock with a conversion ratio of <ix:nonFraction unitRef="U_xbrlipure" id="F_000263" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928" decimals="4">1.0895</ix:nonFraction> shares of common stock for each share of Series A and Series B convertible preferred stock. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the IPO, including the underwriters&#8217; exercise in full of their option to purchase additional shares, and the conversions of the Series A and B convertible preferred stock, the Company&#8217;s total number of outstanding shares increased by <ix:nonFraction unitRef="U_xbrlishares" id="F_000264" name="tsha:CommonStockIncreaseInOutstandingShares" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928" decimals="INF" format="ixt:numdotdecimal">26,097,378</ix:nonFraction> immediately following the closing of the IPO.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon the effectiveness of the Company&#8217;s registration statement related to the IPO, the Company&#8217;s 2020 Stock Incentive Plan (the &#8220;New Plan&#8221;) and 2020 Employee Stock Purchase Plan became effective. At that time, all shares reserved for issuance under the Existing Plan ceased to be available for issuance under such plan and became available for issuance under the New Plan.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Liquidity and Capital Resources </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has incurred operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As of June 30, 2021, the Company had an accumulated deficit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000265" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001806310_20210630" decimals="-5" sign="-" scale="6">134.1</ix:nonFraction> million. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the closing of the Company&#8217;s IPO, between March and July 2020, the Company closed on the sale of an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000266" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200301_20200731" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction> shares of Series A convertible preferred stock for gross proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000268" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200301_20200731" decimals="-5" scale="6">30.0</ix:nonFraction> million. Between July and August 2020, the Company closed on the sale of an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000267" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200701_20200831" decimals="INF" format="ixt:numdotdecimal">5,647,048</ix:nonFraction> shares of Series B convertible preferred stock for gross proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000269" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200701_20200831" decimals="-5" scale="6">96.0</ix:nonFraction> million. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future capital requirements will depend on many factors, including the timing and extent of spending on research and development and the market acceptance of the Company&#8217;s products. The Company will need to obtain additional financing in order to complete clinical studies and launch and commercialize any product candidates for which it receives regulatory approval. There can be no assurance that such financing will be available or will be on terms acceptable to the Company.<span style="color:#000000;"> As of June 30, 2021, the Company had cash of</span> $<ix:nonFraction unitRef="U_iso4217USD" id="F_000270" name="us-gaap:Cash" contextRef="C_0001806310_20210630" decimals="-5" scale="6">197.4</ix:nonFraction> <span style="color:#000000;">million which the Company believes will be sufficient to fund its planned operations for a period of at least twelve months from the date of issuance of these condensed consolidated financial statements.</span></p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000226_dcnt_5601f57e-18b5-4981-8eb6-b8b87ab0e13b">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">novel coronavirus </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that causes the disease </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19 emerged and has subsequently spread worldwide. The World Health Organization has declared</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> COVID-19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> outbreak</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">global </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pandemic</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> resulting in federal, state and local governments and private entities implementing various restrictions</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including travel restrictions, restrictions on public gatherings, stay at home orders, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">advisories and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">quarantines of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">people who may have been exposed to the virus. The Company has been actively monitoring COVID</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and its impact globally. Management believes the financial results for the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">six</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months ended </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> were not significantly impacted by </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> pandemic</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In addition, management believes the remote working arrangements and travel restrictions imposed by various governmental jurisdictions have had limited impact on the Company&#8217;s ability to maintain internal operations during the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">six</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months ended </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30, 2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#8217;s business, results of operations and financial condition will depend on future developments that are highly uncertain, including new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19.</span></p></ix:continuation>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000227" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000227_dcnt_42ff2a6b-78cd-4de9-8827-6c5cd9944484">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 2&#8212;Summary of Significant Accounting Policies </p><ix:nonNumeric id="F_000237" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") as determined by the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission ("SEC") on March 3, 2021 (the &#8220;2020 Annual Report&#8221;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2020 is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#8217;s 2020 Annual Report.</p></ix:nonNumeric><ix:nonNumeric id="F_000238" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Principles of Consolidation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its inactive wholly owned U.S. subsidiaries that were incorporated during 2020, and one inactive foreign subsidiary incorporated in June 2021. All intercompany transactions and balances have been eliminated in consolidation. </p></ix:nonNumeric><ix:nonNumeric id="F_000239" name="us-gaap:UseOfEstimates" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#8217;s financial statements relate to the determination of the fair value of the common stock prior to the IPO (as an input into stock-based compensation), estimating preclinical manufacturing accruals and accrued or prepaid research and development expenses, and the valuation of the preferred stock tranche liability. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected. In response to the ongoing and rapidly evolving COVID-19 pandemic, management considered the impact of the estimated economic implications on the Company&#8217;s critical and significant accounting estimates, including assessment of impairment of long-lived assets.</p></ix:nonNumeric>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Significant Accounting Policies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There have been no changes in the Company&#8217;s significant accounting policies as disclosed in Note 2 to the audited consolidated financial statements included in the 2020 Annual Report, except as described below.</p><ix:nonNumeric id="F_000240" name="tsha:BuildToSuitLeasePolicyTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000240_dcnt_8f6dd23c-ac25-418d-bbe7-90f7814cd2d0">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:2.57%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Build-to-Suit Lease</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:2.57%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the Company&#8217;s recent lease arrangement (as described in Note 10), the Company was involved in the construction of the build-out. To the extent the Company is involved with the structural improvements of the construction project or takes construction risk prior to the commencement of a lease, accounting guidance requires the Company to be considered the owner for accounting purposes of these types of projects during the construction period. In such cases, the Company records an asset in property, plant and equipment </p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000227_dcnt_42ff2a6b-78cd-4de9-8827-6c5cd9944484"><ix:continuation id="F_000240_dcnt_8f6dd23c-ac25-418d-bbe7-90f7814cd2d0">
<p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on its consolidated balance sheet equal to the fair value of the building shell, and a corresponding build-to-suit lease obligation on its consolidated balance sheet representing the amounts paid by the lessor.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Upon completion of&#160;construction, the Company will consider the requirements for sale-leaseback accounting treatment, including evaluating whether all risks of ownership have been transferred back to the landlord.</span></p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000241" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will become effective for the Company for annual reporting periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard requires the use of one of the following two approaches, either (1) retrospectively to each prior reporting period presented in the financial statements with the cumulative effect recognized at the beginning of the earliest comparative period presented, or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company has not yet concluded which approach will be utilized to adopt the new standard and is currently evaluating the impact of this standard on its consolidated financial statements.</p></ix:nonNumeric></ix:continuation><ix:nonNumeric id="F_000228" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000228_dcnt_5b2e3c8b-853f-4722-a59c-de6a30c2656e">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 3&#8212;Balance Sheet Components </p><ix:nonNumeric id="F_000242" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000271" name="tsha:PrepaidResearchAndDevelopmentContracts" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">6,716</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000272" name="tsha:PrepaidResearchAndDevelopmentContracts" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,462</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid bonus</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000273" name="tsha:PrepaidBonus" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,192</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000274" name="tsha:PrepaidBonus" contextRef="C_0001806310_20201231" decimals="-3" scale="3">409</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid insurance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000275" name="us-gaap:PrepaidInsurance" contextRef="C_0001806310_20210630" decimals="-3" scale="3">826</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000276" name="us-gaap:PrepaidInsurance" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,480</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid clinical trial</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000277" name="tsha:PrepaidClinicalTrial" contextRef="C_0001806310_20210630" decimals="-3" scale="3">184</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000278" name="tsha:PrepaidClinicalTrial" contextRef="C_0001806310_20201231" decimals="-3" scale="3">944</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000279" name="us-gaap:OtherAssetsCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,014</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000280" name="us-gaap:OtherAssetsCurrent" contextRef="C_0001806310_20201231" decimals="-3" scale="3">331</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000281" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">9,932</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000282" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,626</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000243" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net consisted of the following (in thousands):<span style="margin-left:36pt;"></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000283" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,863</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000284" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20210630" decimals="-3" scale="3">676</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000285" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20210630" decimals="-3" scale="3">529</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000286" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231" decimals="-3" scale="3">95</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000287" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaLaboratoryEquipmentMember_20210630" decimals="-3" scale="3">460</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000288" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">30,465</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000289" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231" decimals="-3" scale="3">201</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000290" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">33,993</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000291" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001806310_20201231" decimals="-3" scale="3">296</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000292" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001806310_20210630" decimals="-3" scale="3">126</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000293" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001806310_20201231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000294" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">33,867</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000295" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001806310_20201231" decimals="-3" scale="3">287</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in construction in progress at June 30, 2021 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000300" name="us-gaap:ConstructionInProgressGross" contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaBuildToSuitLeaseMember_20210630" decimals="-5" scale="6">30.3</ix:nonFraction> million of costs associated with the Build-to-Suit lease (see Note 10). </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000296" name="us-gaap:Depreciation" contextRef="C_0001806310_20210401_20210630" decimals="0" format="ixt:numdotdecimal">85,000</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000297" name="us-gaap:Depreciation" contextRef="C_0001806310_20210101_20210630" decimals="0" format="ixt:numdotdecimal">117,000</ix:nonFraction> for the three and six months ended June 30, 2021, respectively. There was <ix:nonFraction unitRef="U_iso4217USD" id="F_000298" name="us-gaap:Depreciation" contextRef="C_0001806310_20200401_20200630" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000299" name="us-gaap:Depreciation" contextRef="C_0001806310_20200101_20200630" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> depreciation expense for the three and six months ended June 30, 2020.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000228_dcnt_5b2e3c8b-853f-4722-a59c-de6a30c2656e"><ix:nonNumeric id="F_000244" name="tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities consisted of the following (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000301" name="tsha:AccruedResearchAndDevelopmentCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">14,508</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000302" name="tsha:AccruedResearchAndDevelopmentCurrent" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000303" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,210</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000304" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,766</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and consulting fees</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000305" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,372</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000306" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001806310_20201231" decimals="-3" scale="3">999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued property, plant, and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000307" name="tsha:AccruedPropertyPlantAndEquipmentCurrent" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">1,309</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000308" name="tsha:AccruedPropertyPlantAndEquipmentCurrent" contextRef="C_0001806310_20201231" decimals="-3" scale="3">173</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical trial</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000309" name="tsha:AccruedClinicalTrialCurrent" contextRef="C_0001806310_20210630" decimals="-3" scale="3">959</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000310" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001806310_20210630" decimals="-3" scale="3">678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000311" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001806310_20201231" decimals="-3" scale="3">91</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses and other current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000312" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="C_0001806310_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">22,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000313" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="C_0001806310_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,135</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:nonNumeric id="F_000229" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000229_dcnt_aae06feb-1fed-4616-9b63-a695475d7c2a">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 4&#8212;Research, Collaboration and License Agreements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">UT Southwestern Agreement </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 19, 2019, the Company entered into a research, collaboration and license agreement (&#8220;UT Southwestern Agreement&#8221;) with the Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center (&#8220;UT Southwestern&#8221;). Under the UT Southwestern Agreement, UT Southwestern is primarily responsible for preclinical development activities with respect to licensed products for use in certain specified indications (up to investigational new drug application-enabling studies), and the Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed products. UT Southwestern will conduct such preclinical activities for a <span style="-sec-ix-hidden:F_000314">two-year</span> period under mutually agreed upon sponsored research agreements that were entered into beginning in April 2020. During the initial research phase, the Company has the right to expand the scope of specified indications under the UT Southwestern Agreement. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the UT Southwestern Agreement, the Company obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, the Company obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. The Company is required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least <ix:nonFraction unitRef="U_tshaProduct" id="F_000315" name="tsha:MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200401_20200430" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> licensed product. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 2, 2020, the Company amended the UT Southwestern Agreement to include the addition of another licensed product and certain indications, and a right of first refusal to the Company over certain patient dosing patents. No additional consideration was transferred in connection with this amendment. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, the Company may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2019, as partial consideration for the license rights granted under the UT Southwestern Agreement, the Company issued <ix:nonFraction unitRef="U_xbrlishares" id="F_000316" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130" decimals="INF" format="ixt:numdotdecimal">2,179,000</ix:nonFraction> shares of its common stock, or <ix:nonFraction unitRef="U_xbrlipure" id="F_000317" name="tsha:PercentageOfFullyDilutedCommonStockSharesOutstanding" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130" decimals="2" scale="-2">20</ix:nonFraction>% of its then outstanding fully-diluted common stock, to UT Southwestern. As additional consideration, UT Southwestern was entitled to receive additional shares if their holdings fell below <ix:nonFraction unitRef="U_xbrlipure" id="F_000318" name="tsha:PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130" decimals="2" scale="-2">10</ix:nonFraction>% on a fully-diluted basis before or as a result of the completion of a qualified financing. In March 2020, following the initial closing of the Series A convertible preferred stock agreement, which met the definition of such qualified financing, the anti-dilution feature expired and <ix:nonFraction unitRef="U_xbrlishares" id="F_000319" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200331" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> additional shares were issued. The Company does not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement other than costs related to maintenance of patents. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Queen&#8217;s Agreement </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In late December 2019, the Company entered into a research grant agreement (&#8220;RGA&#8221;) with Queen&#8217;s University at Kingston (&#8220;Queen&#8217;s&#8221;), for certain research and development activities related to the generation of AAV9 vector. The Company committed to fund $<ix:nonFraction unitRef="U_iso4217USD" id="F_000320" name="tsha:ResearchGrantOfCommittedFundAmount" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191201_20191231" decimals="-5" scale="6">3.8</ix:nonFraction> million under the RGA with Queen&#8217;s. The Company issued Queen&#8217;s a promise-to-pay note whereby any amounts paid directly by Queen&#8217;s for the manufacture of the vector for use in the funded research activities, to the extent such amounts had not already been funded by the Company to Queen&#8217;s, would become a loan obligation for the Company (the &#8220;Note&#8221;), subject to an interest </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000229_dcnt_aae06feb-1fed-4616-9b63-a695475d7c2a" continuedAt="F_000229_dcnt_0f34fb9c-7170-4b98-807d-1f3d12dc7596">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rate of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000321" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191231" decimals="INF" scale="-2">6</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any amounts outstanding under the Note were required to be repaid, along with any accrued interest, by or before June 30, 2020. In the event of default, any amount outstanding </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> deemed immediately payable by RA Session II, the Company&#8217;s President and Chief Executive Officer, as a personal guarantor (see Note </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">). For the period from Inception through December 31, 2019, the Company did not incur any expenses associated with the Queen&#8217;s RGA, and no amounts were due or outstanding under the Note as of December 31, 2019. </span><span style="color:#000000;">For the year ended December 31, 2020, the Company paid all expenses associated with the Queen&#8217;s RGA, thus </span><span style="color:#000000;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000322" name="tsha:ResearchGrantOutstandingFundAmount" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;"> amounts were due or outstanding under the Note as of December 31, 2020, and the promise-to-pay has therefore expired.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 21, 2020, the Company entered into a license agreement with Queen&#8217;s (the &#8220;Queen&#8217;s Agreement&#8221;) to obtain the exclusive perpetual, royalty-bearing license, with the right to sublicense through multiple tiers, under certain patent rights and know-how of Queen&#8217;s, including certain improvements to such patent rights and know-how, to develop products in any field which use one or more valid claims of the patents licensed under the Queen&#8217;s Agreement (the &#8220;Licensed Patents&#8221;), or the technology, information and intellectual property related to the patents licensed under the Queen&#8217;s Agreement (together with the Licensed Patents, the &#8220;Licensed Products&#8221;), and to make, have made, use, sell, offer for sale, import and export Licensed Products and otherwise exploit such patents and know-how for use in certain specified indications. In exchange for the rights granted to the Company, the Company made a cash payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000323" name="tsha:PaymentsToAcquireLicenseRight" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20200331" decimals="-5" scale="6">3.0</ix:nonFraction> million in April 2020 which is recorded in research and development expenses in the condensed consolidated statements of operations <span style="color:#000000;">and included as an investing cash outflow in the condensed consolidated statements of cash flows since the acquired license does not have an alternative future use</span> for the six months ended June 30, 2020. The Company is obligated to make aggregate cash payments of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000324" name="tsha:LicenseAgreementRegulatoryMilestonesPayment" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_srtRangeAxis_srtMaximumMember_20200221" decimals="INF" scale="6">10.0</ix:nonFraction> million upon the completion of a combination of regulatory milestones and up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000325" name="tsha:LicenseAgreementCommercialMilestonesPayment" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_srtRangeAxis_srtMaximumMember_20200221" decimals="INF" scale="6">10.0</ix:nonFraction> million upon the completion of a combination of commercial milestones. In further consideration of the rights granted, beginning with the Company&#8217;s first commercial sale of the Licensed Products, the Company will also pay an annual earned royalty in the low single digits on net sales of Licensed Products, subject to certain customary reductions, and a percentage of non-royalty sublicensing revenue ranging in the low double digits. Royalties are payable, on a Licensed Products-by-Licensed Products and a country-by-country basis, until expiration of the last valid claim of a Licensed Patent covering such Licensed Products in such country and the expiration of any regulatory exclusivity for such Licensed Products in such country. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000326" name="tsha:AdditionalMilestonePayments" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20210101_20210630" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction> additional milestone payments were made in connection with the Queen&#8217;s Agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Abeona CLN1 Agreements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the Company entered into license and inventory purchase agreements with Abeona Therapeutics Inc. (&#8220;Abeona&#8221;) for worldwide exclusive rights to certain intellectual property rights and know-how relating to the research, development and manufacture of ABO-202, an AAV-based gene therapy for CLN1 disease (also known as infantile Batten disease). Under the terms of the agreements, the Company made initial cash payments to Abeona of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000327" name="tsha:PaymentOfLicenseFee" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200801_20200831" decimals="-5" scale="6">3.0</ix:nonFraction> million for the license fee and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000328" name="tsha:PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20201001_20201031" decimals="-5" scale="6">4.0</ix:nonFraction> million for purchase of clinical materials and reimbursement for previously incurred development costs in October 2020. In exchange for the license rights, the Company recorded an aggregate of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000329" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200101_20201231" decimals="-5" scale="6">7.0</ix:nonFraction> million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2020 since the acquired license or acquired inventory do not have an alternative future use. The Company is obligated to make up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000330" name="tsha:LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_srtRangeAxis_srtMaximumMember_20200831" decimals="INF" scale="6">26.0</ix:nonFraction> million in regulatory-related milestones and up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000331" name="tsha:LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_srtRangeAxis_srtMaximumMember_20200831" decimals="INF" scale="6">30.0</ix:nonFraction> million in sales-related milestones per licensed CLN1 product. The Company will also pay an annual earned royalty in the high single digits on net sales of any licensed CLN1 products. The license agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the license agreement for convenience upon specified prior written notice to Abeona.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000332" name="tsha:AdditionalMilestonePayments" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20210101_20210630" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction> additional milestone payments were made in connection with this agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Abeona Rett Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 29, 2020, the Company entered into a license agreement (the &#8220;Abeona Rett Agreement&#8221;) with Abeona pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to certain obligations of Abeona, the Company is required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Abeona Rett Agreement, the Company paid Abeona a one-time upfront license fee of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000333" name="tsha:PaymentOfOneTimeUpfrontLicenseFee" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20200101_20201231" decimals="-5" scale="6">3.0</ix:nonFraction> million which is recorded in research and development expenses in the consolidated statements of operations for the year ended December 31, 2020 since the acquired license does not have an alternative future use. The Company is obligated to pay Abeona up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000334" name="tsha:RegulatoryRelatedMilestonesObligationPayable" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20201029" decimals="INF" scale="6">26.5</ix:nonFraction> million in regulatory-related milestones and up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000335" name="tsha:SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20201029" decimals="INF" scale="6">30.0</ix:nonFraction> million in sales-related milestones per licensed Rett product and high single-digit </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000229_dcnt_0f34fb9c-7170-4b98-807d-1f3d12dc7596">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">royalties on net sales of licensed Rett products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the agreement for convenience upon specified prior written notice to Abeona.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000336" name="tsha:AdditionalMilestonePayments" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20210101_20210630" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction> additional milestone payments were made in connection with the Abeona Rett Agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Acquisition of Worldwide Rights for TSHA-120 for the treatment of GAN </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, the Company acquired the exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of Giant Axonal Neuropathy (&#8220;GAN&#8221;). TSHA-120 is an intrathecally dosed AAV9 gene therapy currently being evaluated in a clinical trial for the treatment of GAN. The trial is being conducted by the National Institutes of Health in close collaboration with a leading patient advocacy group focused on finding treatments and cures for GAN. TSHA-120 has received rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration for the treatment of GAN. The worldwide rights were acquired through a license agreement, effective March 29, 2021, between Hannah&#8217;s Hope Fund for Giant Axonal Neuropathy, Inc. (&#8220;HHF&#8221;) and the Company.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the agreement, in exchange for granting the Company the exclusive worldwide rights to TSHA-120, HHF received an upfront payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000337" name="tsha:UpfrontPayment" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210301_20210331" decimals="-5" scale="6">5.5</ix:nonFraction> million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000338" name="tsha:ClinicalRegulatoryAndCommercialMilestonesToBeReceived" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210331" decimals="-5" scale="6">19.3</ix:nonFraction> million, as well as a low, single-digit royalty on net sales upon commercialization of the product. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In exchange for the license rights, the Company recorded an aggregate of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000339" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210301_20210331" decimals="-5" scale="6">5.5</ix:nonFraction> million within research and development expenses in the condensed consolidated statements of operations since the acquired license does not have an alternative future use. This license fee was paid in April 2021 <span style="color:#000000;">and has been classified as an investing outflow in the condensed consolidated statements of cash flows for the six months ended June 30, 2021</span>. <span style="color:#000000;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000340" name="tsha:AdditionalMilestonePayments" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210101_20210630" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span> additional milestone payments were made in connection with this agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000230" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000230_dcnt_64760d74-2efe-4120-9c5c-ee0062a41fa3">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5&#8212;Stockholders&#8217; Equity (Deficit), Convertible Preferred Stock and Tranche Liability </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Authorized Shares</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company amended its certificate of incorporation on March 4, 2020, July 2, 2020 and again on July 28, 2020 such that the total number of shares of common stock authorized to be issued was increased to <ix:nonFraction unitRef="U_xbrlishares" id="F_000341" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001806310_20200728" decimals="INF" format="ixt:numdotdecimal">32,685,000</ix:nonFraction>, and the total number of shares of preferred stock authorized to be issued was increased to <ix:nonFraction unitRef="U_xbrlishares" id="F_000343" name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="C_0001806310_20200728" decimals="INF" format="ixt:numdotdecimal">15,647,052</ix:nonFraction>, of which <ix:nonFraction unitRef="U_xbrlishares" id="F_000344" name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200728" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction> preferred shares were designated Series A convertible preferred stock and <ix:nonFraction unitRef="U_xbrlishares" id="F_000345" name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200728" decimals="INF" format="ixt:numdotdecimal">5,647,052</ix:nonFraction> were designated Series B convertible preferred stock. On September 28, 2020, the Company amended its certificate of incorporation such that the total number of shares of common stock authorized to be issued was increased to <ix:nonFraction unitRef="U_xbrlishares" id="F_000342" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001806310_20200928" decimals="INF" format="ixt:numdotdecimal">200,000,000</ix:nonFraction>, and the total number of shares of new preferred stock authorized to be issued was <ix:nonFraction unitRef="U_xbrlishares" id="F_000346" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001806310_20200928" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction>. As of June 30, 2021 and December 31, 2020, <ix:nonFraction unitRef="U_xbrlishares" id="F_000347" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001806310_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000349" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001806310_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000348" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001806310_20210630" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000350" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001806310_20210630" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of preferred stock were issued or outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">IPO</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 28, 2020, the Company issued an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000351" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928" decimals="INF" format="ixt:numdotdecimal">7,869,566</ix:nonFraction> shares of common stock in the IPO, and on September 29, 2020, the Company issued an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000352" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200929_20200929" decimals="INF" format="ixt:numdotdecimal">1,180,434</ix:nonFraction> shares of common stock upon the underwriters&#8217; exercise in full of their option to purchase additional shares, each at the public offering price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000353" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928" decimals="INF">20.00</ix:nonFraction> per share less underwriting discounts and commissions. In connection with the IPO, the Company received gross proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000354" name="tsha:ProceedsFromIssuanceOfCommonStockGross" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928" decimals="-5" scale="6">181.0</ix:nonFraction> million, which was offset by issuance costs, including underwriters&#8217; discounts and commissions, of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000355" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928" decimals="-5" scale="6">15.1</ix:nonFraction> million.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Series A and B convertible preferred stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 4, 2020, the Company entered into a purchase agreement (the &#8220;Series A Purchase Agreement&#8221;) providing for a private placement of up to <ix:nonFraction unitRef="U_xbrlishares" id="F_000356" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304_20200304" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction> shares of Series A convertible preferred stock at an original issuance price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000357" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304" decimals="INF">3.00</ix:nonFraction> per share, subject to separate closings, including: (1) <ix:nonFraction unitRef="U_xbrlishares" id="F_000358" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementInitialClosingMember_20200304_20200304" decimals="INF" format="ixt:numdotdecimal">6,000,000</ix:nonFraction> shares at the initial closing on March 4, 2020, and (2) <ix:nonFraction unitRef="U_xbrlishares" id="F_000359" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneOneMember_20200305_20200305" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000360" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneTwoMember_20200305_20200305" decimals="INF" format="ixt:numdotdecimal">2,000,000</ix:nonFraction></ix:nonFraction> shares at each of two subsequent closings triggered by the achievement of specific clinical milestones. The Series A Purchase Agreement obligated the </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000230_dcnt_64760d74-2efe-4120-9c5c-ee0062a41fa3">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company to issue and sell and the Series A investors to purchase up to a total of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000361" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_20200304_20200304" decimals="INF" format="ixt:numdotdecimal">4,000,000</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> additional shares of Series A convertible preferred stock (the &#8220;Milestone Shares&#8221;) at the same price per share upon the achievement of certain defined clinical milestones (the &#8220;tranche liability&#8221;). The determination as to whether the milestone events had been met was subject to certification by the Board of Directors. Each Series A investor had the right, but not the obligation, to purchase all or any portion of the Milestone Shares at any time in its sole option and in its sole and absolute discretion, whether or not the Company had achieved the applicable clinical milestone.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 30, 2020, several affiliated Series A investors elected to exercise in full their options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000362" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630" decimals="INF" format="ixt:numdotdecimal">200,000</ix:nonFraction> shares, representing all of their remaining pro-rata portion of the Milestone Shares, prior to the Company&#8217;s achievement of the clinical milestones for gross proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000363" name="us-gaap:ProceedsFromCollaborators" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630" decimals="-5" scale="6">0.6</ix:nonFraction> million. The remainder of the Series A investors exercised in full their options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000364" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200701_20200702" decimals="INF" format="ixt:numdotdecimal">3,800,000</ix:nonFraction> shares, representing all of their remaining pro-rata portion of the Milestone Shares, prior to the Company&#8217;s achievement of the clinical milestones, for gross proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000365" name="us-gaap:ProceedsFromCollaborators" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200701_20200702" decimals="-5" scale="6">11.4</ix:nonFraction> million between July 1, 2020 and July 2, 2020. As part of this issuance, the Company issued and sold <ix:nonFraction unitRef="U_xbrlishares" id="F_000366" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPBMTGTHoldingsLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630" decimals="INF" format="ixt:numdotdecimal">3,266,667</ix:nonFraction> shares to PBM TGT Holdings, LLC and <ix:nonFraction unitRef="U_xbrlishares" id="F_000367" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaNolanCapitalLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630" decimals="INF" format="ixt:numdotdecimal">400,000</ix:nonFraction> shares to Nolan Capital, LLC, which stockholders are controlled by certain members of the Company&#8217;s board of directors.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 2, 2020, the Company entered into a purchase agreement (the &#8220;Series B Purchase Agreement&#8221;), as later amended on July 28, 2020, providing for a private placement of up to <ix:nonFraction unitRef="U_xbrlishares" id="F_000368" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728" decimals="INF" format="ixt:numdotdecimal">5,647,052</ix:nonFraction> shares of Series B convertible preferred stock. The Company sold <ix:nonFraction unitRef="U_xbrlishares" id="F_000369" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728" decimals="INF" format="ixt:numdotdecimal">5,647,048</ix:nonFraction> shares of Series B convertible preferred stock at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000370" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728" decimals="INF">17.00</ix:nonFraction> per share in multiple closings in July and August 2020 for gross proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000371" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200701_20200831" decimals="-5" scale="6">96.0</ix:nonFraction> million. The majority of investors that participated in the Series B Purchase Agreement were new investors.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As described above, in connection with the closing of the IPO, all shares of Series A and Series B convertible preferred stock were automatically converted into an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000372" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928" decimals="INF" format="ixt:numdotdecimal">17,047,378</ix:nonFraction> shares of common stock with a conversion ratio, which was adjusted for the stock split, of <ix:nonFraction unitRef="U_xbrlipure" id="F_000373" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928" decimals="4">1.0895</ix:nonFraction> shares of common stock for each share of Series A and Series B convertible preferred stock then outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Series A convertible preferred stock tranche liability</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company concluded that the tranche liability met the definition of a freestanding financial instrument, as it was legally detachable and separately exercisable from the initial closing of the Series A convertible preferred stock. The estimated fair value of the tranche liability was determined using a Monte Carlo simulation at the initial issuance date. As of March 4, 2020, the simulations occurred based on the implied aggregate equity value of the Company derived from the Series A convertible preferred stock offering price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000374" name="tsha:ConvertiblePreferredStockTrancheLiabilityOfferingPrice" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304" decimals="INF">3.00</ix:nonFraction> per share, along with, in part, the following subjective assumptions: risk-free rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000376" name="tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput" contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304" decimals="4" scale="-2">0.59</ix:nonFraction>%, an expected volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_000378" name="tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput" contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304" decimals="2" scale="-2">80</ix:nonFraction>%, the expected term to a liquidity event of <ix:nonNumeric id="F_000380" name="tsha:ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304_20200304" format="ixt-sec:duryear">1</ix:nonNumeric> year, and a <ix:nonFraction unitRef="U_xbrlipure" id="F_000382" name="tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput" contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_tshaMeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304" decimals="2" scale="-2">60</ix:nonFraction>% probability of achieving the clinical milestones and timing thereof. Subsequently, the estimated fair value of the tranche liability was determined using a backsolve approach at June 30, 2020, immediately prior to the issuance of the Milestone Shares, which was calculated based on the aggregate equity value of the Company derived from the Series B convertible preferred stock offering price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000375" name="tsha:ConvertiblePreferredStockTrancheLiabilityOfferingPrice" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630" decimals="INF">17.00</ix:nonFraction> per share. The subsequent remeasurement also considered, in part, a risk-free rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000377" name="tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput" contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630" decimals="4" scale="-2">0.17</ix:nonFraction>%, an expected volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_000379" name="tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput" contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630" decimals="2" scale="-2">80</ix:nonFraction>%, and the expected term to a liquidity event of <ix:nonNumeric id="F_000381" name="tsha:ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200629_20200630" format="ixt-sec:duryear">0.5</ix:nonNumeric> years.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the analysis, the Company recorded a preferred stock tranche liability of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000383" name="tsha:PreferredStockTrancheLiability" contextRef="C_0001806310_20200304" decimals="-5" scale="6">1.1</ix:nonFraction> million at the issue date to account for the obligation to issue the Milestone Shares at a predetermined fixed price at a future settlement date.&#160; At June 30, 2020, ahead of the anticipated closing of the Series B Purchase Agreement for $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000384" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200702" decimals="INF">17.00</ix:nonFraction> per share that occurred on July 2, 2020, certain investors elected to exercise in full their options to purchase their pro-rata portion of the Milestone Shares prior to the Company&#8217;s achievement of the clinical milestones and purchased <ix:nonFraction unitRef="U_xbrlishares" id="F_000385" name="tsha:IssuanceOfProRataPortionOfMilestoneShares" contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630" decimals="INF" format="ixt:numdotdecimal">200,000</ix:nonFraction> shares of Series A convertible preferred stock. The Company remeasured the fair value of the entire tranche liability at June 30, 2020, and recognized a non-cash expense of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000386" name="tsha:ChangeInFairValueOfPreferredStockTrancheLiability" contextRef="C_0001806310_20200629_20200630" decimals="-5" scale="6">17.0</ix:nonFraction> million in the condensed consolidated statement of operations for the six months ended June 30, 2020. As <ix:nonFraction unitRef="U_xbrlishares" id="F_000387" name="tsha:MileStoneSharesIssued" contextRef="C_0001806310_20200629_20200630" decimals="INF" format="ixt:numdotdecimal">200,000</ix:nonFraction> of the Milestone Shares were also issued to certain investors on June 30, 2020, the related tranche liability was extinguished, and the Company reclassified $<ix:nonFraction unitRef="U_iso4217USD" id="F_000390" name="tsha:AmountReclassifiedToConvertiblePreferredStock" contextRef="C_0001806310_20200630" decimals="-5" scale="6">0.9</ix:nonFraction> million to convertible preferred stock on the condensed consolidated balance sheet as of June 30, 2020. The Company concluded that no beneficial conversion feature (&#8220;BCF&#8221;) existed as the effective conversion price of the Series A convertible preferred stock exceeded the fair value of the Company&#8217;s common stock at each of the commitment dates. Specifically at the commitment date of June 30, 2020, when <ix:nonFraction unitRef="U_xbrlishares" id="F_000388" name="tsha:MileStoneSharesIssued" contextRef="C_0001806310_20200629_20200630" decimals="INF" format="ixt:numdotdecimal">200,000</ix:nonFraction> Milestone Shares were issued, the deemed proceeds were equal to the cash proceeds received for the shares of Series A convertible preferred stock and the fair value of the tranche liability that related to the Milestone Shares, or $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000389" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001806310_20200630" decimals="INF">7.52</ix:nonFraction> per share. As the effective conversion price exceeded the fair value of the Company&#8217;s common stock, no BCF existed.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000231_dcnt_6e8018bf-ba9a-4fe0-83ce-260d4d8e6f05">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 6&#8212;Stock-Based Compensation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 1, 2020, the Company&#8217;s board of directors approved the Existing Plan which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, RSAs, RSUs and other stock-based awards to employees, directors, officers and consultants. On July 1, 2020, <ix:nonFraction unitRef="U_xbrlishares" id="F_000391" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200701" decimals="INF" format="ixt:numdotdecimal">3,529,412</ix:nonFraction> shares of common stock were authorized for issuance under the Existing Plan. On September 16, 2020, the Company increased the number of shares of common stock authorized for issuance under the Existing Plan to <ix:nonFraction unitRef="U_xbrlishares" id="F_000392" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916" decimals="INF" format="ixt:numdotdecimal">3,845,294</ix:nonFraction>. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 16, 2020, the Company&#8217;s stockholders approved the New Plan, which became effective upon the execution of the underwriting agreement in connection with the IPO. The number of shares available for future issuance under the New Plan is the sum of (1) <ix:nonFraction unitRef="U_xbrlishares" id="F_000393" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916" decimals="INF" format="ixt:numdotdecimal">3,390,168</ix:nonFraction> new shares of common stock,&#160;&#160;(2) <ix:nonFraction unitRef="U_xbrlishares" id="F_000394" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200916" decimals="INF" format="ixt:numdotdecimal">209,841</ix:nonFraction> remaining shares of common stock reserved under the Existing Plan that became available for issuance upon the effectiveness of the New Plan and (3) the number of shares of common stock subject to outstanding awards under the Existing Plan when the New Plan became effective that thereafter expire or are forfeited, canceled, withheld to satisfy tax withholding or to purchase or exercise an award, repurchased by the Company or are otherwise terminated. <ix:nonNumeric id="F_000399" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630">At December 31, 2020, there were 2,941,509 shares available for future grant under the New Plan. The number of shares of common stock reserved for issuance under the New Plan will automatically increase on January 1 of each year, for a period of <ix:nonNumeric id="F_000395" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>, from <ix:nonNumeric id="F_000396" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916" format="ixt:datemonthdayyearen">January 1, 2021</ix:nonNumeric> continuing through <ix:nonNumeric id="F_000397" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916" format="ixt:datemonthdayyearen">January 1, 2030</ix:nonNumeric>, by <ix:nonFraction unitRef="U_xbrlipure" id="F_000398" name="tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916" decimals="INF" scale="-2">5</ix:nonFraction>% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#8217;s board of directors.&#160;&#160;On January 1, 2021 the board of directors increased the number of common stock reserved for issuance under the New Plan by <ix:nonFraction unitRef="U_xbrlishares" id="F_000400" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101" decimals="INF" format="ixt:numdotdecimal">1,434,934</ix:nonFraction> shares.</ix:nonNumeric></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, on September 16, 2020, the Company&#8217;s stockholders approved the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which became effective upon the execution of the underwriting agreement in connection with the IPO. The maximum number of shares of common stock that may be issued under the ESPP will not exceed <ix:nonFraction unitRef="U_xbrlishares" id="F_000401" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916" decimals="INF" format="ixt:numdotdecimal">362,000</ix:nonFraction> shares of common stock, plus <ix:nonNumeric id="F_000408" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210630">the number of shares of common stock that are automatically added on January 1st of each year for a period of up to <ix:nonNumeric id="F_000402" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>, commencing on the first January 1 following the IPO date and ending on (and including) <ix:nonNumeric id="F_000403" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916" format="ixt:datemonthdayyearen">January 1, 2030</ix:nonNumeric>, in an amount equal to the lesser of (i) one percent (<ix:nonFraction unitRef="U_xbrlipure" id="F_000404" name="tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916" decimals="INF" scale="-2">1.0</ix:nonFraction>%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) <ix:nonFraction unitRef="U_xbrlishares" id="F_000405" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916" decimals="INF" format="ixt:numdotdecimal">724,000</ix:nonFraction> shares of common stock.</ix:nonNumeric> &#160; <ix:nonFraction unitRef="U_xbrlishares" id="F_000406" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210101" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction> shares were added to the ESPP as of January 1, 2021 and <ix:nonFraction unitRef="U_xbrlishares" id="F_000407" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210630" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> issuances have been made under the ESPP as of June 30, 2021.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Options </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 1, 2020, options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000409" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701" decimals="INF" format="ixt:numdotdecimal">2,896,782</ix:nonFraction> shares of common stock under the Existing Plan were awarded to certain employees and consultants of the Company with an exercise price per share of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000410" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701" decimals="INF">0.80</ix:nonFraction>, which were expected to vest over a <span style="-sec-ix-hidden:F_000411">four-year</span> period, all of which were subsequently cancelled (the &#8220;Cancelled Options&#8221;). The grant date fair value of the Cancelled Options was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000412" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701" decimals="-5" scale="6">13.8</ix:nonFraction> million at the original grant date. In exchange, the Company awarded <ix:nonFraction unitRef="U_xbrlishares" id="F_000413" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902" decimals="INF" format="ixt:numdotdecimal">2,518,932</ix:nonFraction> RSUs on September 2, 2020, which are expected to vest over a <span style="-sec-ix-hidden:F_000414">four-year</span> term. The Company accounted for the changes in award terms as a modification in accordance with ASC 718 Compensation &#8211; Stock Compensation. The modification was accounted for as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus any incremental value measured on the modification date. The Company determined that there was <ix:nonFraction unitRef="U_iso4217USD" id="F_000415" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20210101_20210630" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> incremental value as the fair value of the original award immediately before the modification was greater than the fair value of the new award immediately after the modification. Accordingly, the Company continues to recognize the remaining compensation cost of the Cancelled Options over the vesting period of the RSUs.&#160;&#160; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three months ended June 30, 2021, options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000416" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630" decimals="INF" format="ixt:numdotdecimal">964,750</ix:nonFraction> shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000418" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630" decimals="2">14.73</ix:nonFraction>. For the six months ended June 30, 2021, options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000417" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">2,586,650</ix:nonFraction> shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000419" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630" decimals="2">17.25</ix:nonFraction>. The stock options vest over <ix:nonNumeric id="F_000420" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001806310_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630" format="ixt-sec:durwordsen" continuedAt="C_a7454de5-8cb5-4a7e-8e6c-3dd336be7257">one</ix:nonNumeric> to <ix:nonNumeric id="F_000421" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630" format="ixt-sec:durwordsen">four<ix:continuation id="C_a7454de5-8cb5-4a7e-8e6c-3dd336be7257"> years</ix:continuation></ix:nonNumeric> and have a <span style="-sec-ix-hidden:F_000422">ten-year</span> contractual term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <ix:nonNumeric id="F_000245" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" escape="true" continuedAt="F_000245_cnt_1">The following weighted-average assumptions were used to estimate the fair value of stock options that were granted during the three and six months ended June&#160;30, 2021:</ix:nonNumeric></p><ix:continuation id="F_000245_cnt_1" continuedAt="F_000245_dcnt_5a4e3988-cbc8-435a-8e34-a5a5e88e8ceb">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three months ended June 30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000423" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630" decimals="4" scale="-2">1.07</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000424" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" decimals="4" scale="-2">0.80</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term in years</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000425">6.0</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000426">6.0</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000427" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630" decimals="2" scale="-2">76</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000428" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" decimals="2" scale="-2">75</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p></ix:continuation></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000231_dcnt_6e8018bf-ba9a-4fe0-83ce-260d4d8e6f05" continuedAt="F_000231_dcnt_8eda0f0e-2719-456f-8f79-b8e14b67bd1c"><ix:continuation id="F_000245_dcnt_5a4e3988-cbc8-435a-8e34-a5a5e88e8ceb"></ix:continuation><ix:nonNumeric id="F_000246" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity, during the six months ended June&#160;30, 2021: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000429" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="INF" format="ixt:numdotdecimal">674,842</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000435" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="2">20.68</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000441">9.8</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000445" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,953</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000430" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">2,586,650</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000436" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" decimals="2">26.41</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled or forfeited</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000431" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">47,800</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000437" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" decimals="2">28.61</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000432" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="INF" format="ixt:numdotdecimal">3,213,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000438" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="2">25.18</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000442">9.6</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000446" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="-3" scale="3">786</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at June 30, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000433" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="INF" format="ixt:numdotdecimal">3,213,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000439" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="2">25.18</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000443">9.6</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000447" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="-3" scale="3">786</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable at June 30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000434" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="INF" format="ixt:numdotdecimal">43,054</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000440" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="2">20.50</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000444">9.3</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000448" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="-3" scale="3">37</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value in the above table is calculated as the difference between the fair value of the Company&#8217;s common stock as of June&#160;30, 2021 and the exercise price of the stock options. As of June&#160;30, 2021, the total unrecognized compensation related to unvested stock option awards granted was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000449" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630" decimals="-5" scale="6">47.5</ix:nonFraction>&#160;million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric id="F_000450" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" format="ixt-sec:duryear">3.5</ix:nonNumeric> years.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 2, 2020, the Company issued <ix:nonFraction unitRef="U_xbrlishares" id="F_000451" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902" decimals="INF" format="ixt:numdotdecimal">331,121</ix:nonFraction> RSUs to an employee under the Existing Plan&#59; <ix:nonFraction unitRef="U_xbrlipure" id="F_000452" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20200902_20200902" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000453" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheTwoMember_20200902_20200902" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000454" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheThreeMember_20200902_20200902" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000455" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_tshaShareBasedCompensationAwardTrancheFourMember_20200902_20200902" decimals="2" scale="-2">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the shares of common stock underlying the RSUs vest at each anniversary over a <span style="-sec-ix-hidden:F_000456">four-year</span> period. The RSUs are subject to a service-based vesting condition. The RSUs were also subject to a liquidity-based performance vesting condition that was met upon the closing of the IPO. The Company at any time may accelerate the vesting of the RSUs. Such shares are not accounted for as outstanding until they vest.<span style="color:#000000;"> As of June 30, 2021, the total unrecognized compensation related to unvested RSUs granted, including the remaining compensation cost associated with the RSUs granted on September 2, 2020 in exchange for the Cancelled Options, was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000457" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630" decimals="-5" scale="6">13.3</ix:nonFraction> million which is expected to be amortized on a straight-line basis over the weighted-average remaining vesting period of approximately <ix:nonNumeric id="F_000458" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630" format="ixt-sec:duryear">1.5</ix:nonNumeric> years.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company's default tax withholding&#160;method for RSUs is the&#160;sell-to-cover&#160;method, in which shares with a market value equivalent to the tax withholding obligation are sold on behalf of the holder of the RSUs upon vesting and settlement to cover the tax withholding liability and the cash proceeds from such sales are remitted by the Company to taxing authorities. </p><ix:nonNumeric id="F_000247" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s RSU activity for the six months ended June&#160;30, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at January 1, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000459" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,850,053</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000463" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="2">6.37</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted units granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000460" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">629,730</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000464" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630" decimals="2">5.25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled or forfeited</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000461" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">167,186</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000465" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630" decimals="2">5.25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at June 30, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000462" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630" decimals="INF" format="ixt:numdotdecimal">2,053,137</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000466" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630" decimals="2">6.80</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Awards</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RA Session II, the Company&#8217;s founder, President and Chief Executive Officer, was awarded <ix:nonFraction unitRef="U_xbrlishares" id="F_000467" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701" decimals="INF" format="ixt:numdotdecimal">769,058</ix:nonFraction> RSAs under the Existing Plan on July 1, 2020, which are expected to vest over a <span style="-sec-ix-hidden:F_000468">three-year</span> term, subject to continuous employment. As of June 30, 2021, the total unrecognized compensation related to unvested RSAs granted was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000469" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630" decimals="-5" scale="6">2.6</ix:nonFraction> million which is expected to be amortized on a straight-line basis over the weighted-average remaining vesting period of approximately <ix:nonNumeric id="F_000470" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630" format="ixt-sec:duryear">1.8</ix:nonNumeric> years. The fair value of these RSAs at the grant date of July 1, 2020 was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000471" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20200701_20200701" decimals="INF">5.28</ix:nonFraction> per share. </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000231_dcnt_8eda0f0e-2719-456f-8f79-b8e14b67bd1c"><ix:nonNumeric id="F_000248" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s RSA activity for the six months ended June&#160;30, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000472" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231" decimals="INF" format="ixt:numdotdecimal">769,058</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000475" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231" decimals="2">5.28</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000473" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">298,843</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000476" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630" decimals="2">5.28</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at June 30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000474" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630" decimals="INF" format="ixt:numdotdecimal">470,215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000477" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630" decimals="2">5.28</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p><ix:nonNumeric id="F_000249" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the total stock-based compensation expense for the stock options, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:right;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended June&#160;30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended June&#160;30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000478" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">2,214</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000479" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">3,793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000480" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">2,335</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000481" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">4,350</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000482" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001806310_20210401_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">4,549</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000483" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001806310_20210101_20210630" decimals="-3" format="ixt:numdotdecimal" scale="3">8,143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000232" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 7&#8212;Net Loss Per Common Share </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Since the Company had a net loss in all periods presented, basic and diluted net loss per common share are the same. </p><ix:nonNumeric id="F_000250" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June 30,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June 30,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000484" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001806310_20210401_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">40,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000485" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001806310_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000486" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001806310_20210101_20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">72,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000487" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="C_0001806310_20200101_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">26,651</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares of common stock outstanding used to compute net loss per</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; common share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000488" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20210401_20210630" decimals="0" format="ixt:numdotdecimal">37,479,164</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000489" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20200401_20200630" decimals="0" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000490" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20210101_20210630" decimals="0" format="ixt:numdotdecimal">37,237,115</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000491" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001806310_20200101_20200630" decimals="0" format="ixt:numdotdecimal">10,894,999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per common share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000492" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20210401_20210630" decimals="2" sign="-">1.09</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000493" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20200401_20200630" decimals="2" sign="-">1.95</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000494" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20210101_20210630" decimals="2" sign="-">1.96</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000495" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001806310_20200101_20200630" decimals="2" sign="-">2.45</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000251" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following common stock equivalents outstanding as of June 30, 2021 and 2020 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#8209;dilutive:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested RSUs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000496" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">2,053,137</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested RSAs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000497" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">470,215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000498" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">3,213,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A convertible preferred stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000499" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630" decimals="INF" format="ixt:numdotdecimal">6,200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000500" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001806310_20210101_20210630" decimals="INF" format="ixt:numdotdecimal">5,737,044</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000501" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001806310_20200101_20200630" decimals="INF" format="ixt:numdotdecimal">6,200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000233" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 8&#8212;Related Party Transactions </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RA Session II, founder, President and Chief Executive Officer and a member of the Company&#8217;s board of directors, was a guarantor under the Guaranty and Security Agreement between himself, Queen&#8217;s and the Company, and in the event of the Company&#8217;s failure to fund its obligations under the RGA with Queen&#8217;s, had personally guaranteed payments due by the Company to Queen&#8217;s. In addition, the Company entered into <ix:nonFraction unitRef="U_tshaPromissoryNote" id="F_000502" name="tsha:NumberOfSecuredPromissoryNotes" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_20200101_20200131" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction> secured promissory notes with Mr. Session in January 2020 for an aggregate of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000503" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200131" decimals="-4" scale="6">1.67</ix:nonFraction> million, with <ix:nonFraction unitRef="U_xbrlipure" id="F_000504" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200131" decimals="INF" scale="-2">10</ix:nonFraction>% interest. The Company secured the notes with a first priority security interest in certain assets of the Company. During March 2020, the Company repaid $<ix:nonFraction unitRef="U_iso4217USD" id="F_000505" name="us-gaap:RepaymentsOfDebt" contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200301_20200331" decimals="-4" scale="6">1.65</ix:nonFraction>&#160;million of the notes, and the remaining balance was repaid in July 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the Company entered into a services agreement with PBM Capital Group, LLC (&#8220;PBM&#8221;), an affiliate of PBM TGT Holdings, LLC whereby PBM provides accounting and other administrative and management services related to payroll administration, human resources, bookkeeping, preparation of financial statements and tax returns, accounts payable and receivable, and other similar functions for a fee of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000506" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextRef="C_0001806310_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMCapitalGroupLLCMember_20200301_20200331" decimals="0" format="ixt:numdotdecimal">2,500</ix:nonFraction> per month. Paul B. Manning, a member of the Company&#8217;s board of directors and a holder of more than <ix:nonFraction unitRef="U_xbrlipure" id="F_000507" name="tsha:OwnershipPercentageInExcessOfCapitalStock" contextRef="C_0001806310_srtTitleOfIndividualAxis_srtDirectorMember_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_20200301_20200331" decimals="2" scale="-2">5</ix:nonFraction>% of the Company&#8217;s capital stock, is the Chief Executive Officer of PBM Capital Group, LLC and has sole voting and investment power with respect to the shares held by PBM TGT Holdings, LLC. In September 2020, PBM TGT Holdings, LLC distributed all of the shares of Series A convertible preferred stock it previously held to its beneficial owners, including Mr. Manning and entities controlled by Mr. Manning, for <ix:nonFraction unitRef="U_iso4217USD" id="F_000508" name="tsha:AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" contextRef="C_0001806310_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMTGTHoldingsLLCMember_20200930" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> additional consideration in accordance with the terms of its operating agreement. In April 2021, the PBM services agreement was terminated and all outstanding amounts due have been paid. &#160;&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000234" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 9&#8212;Income Taxes </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. There is <ix:nonFraction unitRef="U_iso4217USD" id="F_000509" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001806310_20210101_20210630" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> provision for income taxes because the Company has incurred operating losses and capitalized certain items for income tax purposes since its inception and maintains a full valuation allowance against its net deferred tax assets. The reported amount of income tax expense for the period differs from the amount that would result from applying the federal statutory tax rate to net loss before taxes primarily because of the change in valuation allowance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2021, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, 2020.</p></ix:nonNumeric><ix:nonNumeric id="F_000235" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000235_dcnt_079b7334-925e-4010-b84d-4416a3a73888">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 10&#8212;Commitments and Contingencies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Litigation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims. From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Commitments </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the normal course of business, the Company enters into contracts that contain a variety of indemnifications with its employees, licensors, suppliers and service providers. The Company&#8217;s maximum exposure under these arrangements is unknown at June 30, 2021. The Company does not anticipate recognizing any significant losses relating to these arrangements. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Durham Lease</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 17, 2020, the Company entered into a lease agreement (the &#8220;Durham Lease&#8221;) with Patriot Park Partners II, LLC, a Delaware limited liability company (the &#8220;Durham Landlord&#8221;), pursuant to which the Company agreed to lease approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000510" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217" decimals="0" format="ixt:numdotdecimal">187,500</ix:nonFraction> square feet of a manufacturing facility located at 5 National Way, Durham, North Carolina (the &#8220;Facility&#8221;). The Durham Lease commenced on <ix:nonNumeric id="F_000511" name="us-gaap:OperationsCommencedDate1" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217_20201217" format="ixt:datemonthdayyearen">April 1, 2021</ix:nonNumeric> and is expected to have a term of approximately <ix:nonNumeric id="F_000512" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217" format="ixt-sec:durwordsen" continuedAt="C_f395fd8f-7a17-4b97-a1ea-02705f2d7ed7">fifteen years</ix:nonNumeric> and<ix:continuation id="C_f395fd8f-7a17-4b97-a1ea-02705f2d7ed7"> six months</ix:continuation>. The Company has two options to extend the term of the Durham Lease, each for a period of an additional <ix:nonNumeric id="F_000513" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company was not required to provide a security deposit in connection with its entry into the Durham Lease. The Company will be responsible for constructing interior improvements within the Facility. The Durham Landlord has the right to </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000235_dcnt_079b7334-925e-4010-b84d-4416a3a73888">
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">terminate the Durham Lease upon specified events of default, including the Company&#8217;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurred initial direct costs to enter into the Durham Lease of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000514" name="tsha:OperatingLeasesInitialDirectCosts" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20200101_20201231" decimals="-5" scale="6">0.8</ix:nonFraction> million in December 2020. The costs have been recorded on the condensed consolidated balance sheets as a deferred lease asset and are being amortized into earnings over the term of the Durham Lease.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC Topic 840,&#160;<span style="font-style:italic;">Leases</span>, the Company is deemed, for accounting purposes only, to be the owner of the entire leased Facility, including the building shell, during the construction period because of the Company&#8217;s expected level of direct financial and operational involvement in the substantial tenant improvements, including structural improvements, required to build out the Facility. As a result, the Company capitalized approximately&#160;$<ix:nonFraction unitRef="U_iso4217USD" id="F_000515" name="tsha:BuildToSuitAsset" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210630" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000516" name="tsha:BuildToSuitLeaseLiability" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210630" decimals="-5" scale="6">26.3</ix:nonFraction></ix:nonFraction> million&#160;as a build-to-suit asset within property, plant and equipment, net and recognized a corresponding build-to-suit lease financing obligation as a liability on its condensed consolidated balance sheets equal to the fair value of the existing building shell using comparable market prices per&#160;square foot for similar space for public real estate transactions in the surrounding area at commencement of construction. Additionally, construction costs incurred as part of the build-out and tenant improvements are also capitalized within property, plant and equipment, net. Costs of approximately&#160;$<ix:nonFraction unitRef="U_iso4217USD" id="F_000517" name="tsha:EquipmentPurchasesAndBuildOutOfLeasedFacility" contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210101_20210630" decimals="-5" scale="6">4.0</ix:nonFraction> million&#160;have been capitalized during the six months ended&#160;June 30, 2021, related to both equipment purchases and the build-out of the leased Facility. Construction is expected to be completed in 2023, upon which time the Company will assess and determine if the build-to-suit asset and corresponding liability should be de-recognized.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dallas Lease</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 11, 2021, the Company entered into a lease agreement (the &#8220;Dallas Lease&#8221;) with Pegasus Park, LLC, a Delaware limited liability company (the &#8220;Dallas Landlord&#8221;), pursuant to which the Company will lease approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000518" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111" decimals="0" format="ixt:numdotdecimal">15,000</ix:nonFraction> square feet of office space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#8220;Office Space&#8221;).</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Dallas Lease commenced on <ix:nonNumeric id="F_000519" name="us-gaap:OperationsCommencedDate1" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111" format="ixt:datemonthdayyearen">May 27, 2021</ix:nonNumeric>, and has a term of approximately <ix:nonNumeric id="F_000520" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>. The <ix:nonNumeric id="F_000521" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111">Company has an option to extend the term of the Dallas Lease for one additional period of <ix:nonNumeric id="F_000523" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.</ix:nonNumeric> The Company&#8217;s obligation for the payment of base rent for the Office Space is initially approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000524" name="tsha:ObligationForPaymentOfInitialBaseRentForOfficeSpace" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111" decimals="-3" format="ixt:numdotdecimal" scale="3">32,500</ix:nonFraction> per month and will increase annually, up to an estimated monthly base rent of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000525" name="tsha:MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111" decimals="INF" format="ixt:numdotdecimal" scale="3">50,000</ix:nonFraction> during the term of the Lease. The Company is obligated to pay operating costs and utilities applicable to the Office Space. The Company was required to provide a security deposit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000526" name="us-gaap:SecurityDeposit" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111" decimals="-3" format="ixt:numdotdecimal" scale="3">32,500</ix:nonFraction> in connection with its entry into the Dallas Lease. <span style="color:#000000;">Total future minimum lease payments under the Dallas Lease over the initial <ix:nonNumeric id="F_000528" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111" format="ixt-sec:duryear">10</ix:nonNumeric> year term are approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000529" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111" decimals="-5" scale="6">4.9</ix:nonFraction> million. </span>The Company is responsible for costs of constructing interior improvements within the Office Space that exceed a construction allowance provided by the Dallas Landlord not to exceed $<ix:nonFraction unitRef="U_utrsqft" id="F_000527" name="tsha:MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111" decimals="2">40.00</ix:nonFraction> per rentable square foot.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has a right of first refusal with respect to certain additional adjacent office space before the Dallas Landlord accepts any offer for such space.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Dallas Landlord has the right to terminate the Lease, or the Company&#8217;s right to possess the Office Space without terminating the Dallas Lease, upon specified events of default, including the Company&#8217;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2021, the Company recognized approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000530" name="us-gaap:LeaseIncentiveReceivable" contextRef="C_0001806310_us-gaapLeaseContractualTermAxis_tshaDallasLeaseMember_20210630" decimals="-5" scale="6">0.6</ix:nonFraction> million of lease construction incentive based on the construction allowance provided. The construction incentive has been recorded on the condensed consolidated balance sheets as a deferred lease incentive obligation and is being amortized into earnings as a deduction of rent expense over the term of the Dallas Lease.&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000236" name="us-gaap:SubsequentEventsTextBlock" contextRef="C_0001806310_20210101_20210630" escape="true" continuedAt="F_000236_dcnt_8e8076a5-2c29-485c-8cf1-95ea20044a69">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 11&#8212;Subsequent Events</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 12, 2021 (the &#8220;Closing Date&#8221;), the Company entered into a Loan and Security Agreement (the &#8220;Term Loan Agreement&#8221;), by and among the Company, the lenders party thereto from time to time (the &#8220;Lenders&#8221;) and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders (&#8220;Agent&#8221;).&#160;&#160;The Term Loan Agreement provides for (i) on the Closing Date, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000531" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812" decimals="-5" scale="6">40.0</ix:nonFraction> million aggregate principal amount of term loans available through <ix:nonNumeric id="F_000532" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">December 31, 2021</ix:nonNumeric>, (ii) from <ix:nonNumeric id="F_000534" name="us-gaap:DebtInstrumentMaturityDateRangeStart1" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">January 1, 2022</ix:nonNumeric> until <ix:nonNumeric id="F_000535" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">September 30, 2022</ix:nonNumeric>, an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000533" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812" decimals="-5" scale="6">20.0</ix:nonFraction> million term loan facility available at the Company&#8217;s option upon having three distinct and active clinical stage programs at the time of draw, (iii) from <ix:nonNumeric id="F_000537" name="us-gaap:DebtInstrumentMaturityDateRangeStart1" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">October 1, 2022</ix:nonNumeric> until <ix:nonNumeric id="F_000538" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">March 31, 2023</ix:nonNumeric>, an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000536" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812" decimals="-5" scale="6">20.0</ix:nonFraction> million term loan facility available at the Company&#8217;s option upon having <ix:nonFraction unitRef="U_tshaProgram" id="F_000539" name="tsha:NumberOfDistinctAndActiveClinicalStage" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" decimals="INF" format="ixt-sec:numwordsen">three</ix:nonFraction> distinct and active clinical stage programs at the time of draw and (iv) from <ix:nonNumeric id="F_000541" name="us-gaap:DebtInstrumentMaturityDateRangeStart1" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">April 1, 2023</ix:nonNumeric> until <ix:nonNumeric id="F_000542" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">December 31, 2023</ix:nonNumeric>, an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000540" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812" decimals="-5" scale="6">20.0</ix:nonFraction> million term loan facility available upon approval by the Agent and the Lenders (collectively, the &#8220;Term Loans&#8221;). The Company drew $<ix:nonFraction unitRef="U_iso4217USD" id="F_000543" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="C_0001806310_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812" decimals="-5" scale="6">30.0</ix:nonFraction> million in term loans on the Closing Date.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000236_dcnt_8e8076a5-2c29-485c-8cf1-95ea20044a69">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The interest rate applicable to the Term Loans is the greater of (a) the WSJ Prime Rate plus <ix:nonFraction unitRef="U_xbrlipure" id="F_000545" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210811_20210812" decimals="4" scale="-2">3.75</ix:nonFraction>% or (b) <ix:nonFraction unitRef="U_xbrlipure" id="F_000544" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812" decimals="INF" scale="-2">7.00</ix:nonFraction>% per annum.&#160;&#160;The Term Loans are interest only from the Closing Date through August 31, 2024, after which the Company is required to pay equal monthly installments of principal through <ix:nonNumeric id="F_000546" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" format="ixt:datemonthdayyearen">August 1, 2026</ix:nonNumeric>, the maturity date.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Term Loans may be prepaid in full through August 12, 2022 with payment of a <ix:nonFraction unitRef="U_xbrlipure" id="F_000547" name="tsha:PercentageOfPrepaymentPremium" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyTwoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" decimals="4" scale="-2">2.00</ix:nonFraction>% prepayment premium, after which they may be prepaid in full through August 12, 2023 with payment of a <ix:nonFraction unitRef="U_xbrlipure" id="F_000548" name="tsha:PercentageOfPrepaymentPremium" contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyThreeMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" decimals="4" scale="-2">1.00</ix:nonFraction>% prepayment premium, after which they may be prepaid in full with no prepayment premium. An additional final payment of <ix:nonFraction unitRef="U_xbrlipure" id="F_000549" name="tsha:PercentageOfPrepaymentOfFacility" contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812" decimals="3" scale="-2">7.5</ix:nonFraction>% of the amount of Terms Loans advanced by the Lenders will be due upon prepayment or repayment of the Term Loans in full.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The obligations under the Term Loan Agreement are secured by a perfected security interest in all of the Company&#8217;s assets except for intellectual property and certain other customarily excluded property pursuant to the terms of the Term Loan Agreement. There are no financial covenants and <ix:nonFraction unitRef="U_iso4217USD" id="F_000550" name="us-gaap:WarrantsAndRightsOutstanding" contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> warrants associated with the Term Loan Agreement.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.<span style="text-transform:uppercase;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited financial statements and notes thereto as of and for the year ended December&#160;31, 2020 and the related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, included in our Annual Report on Form 10-K for the year ended December 31, 2020, or Annual Report, filed with the Securities and Exchange Commission, or the SEC, on March 3, 2021. Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Taysha Gene Therapies, Inc. together with its consolidated subsidiaries.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Forward-Looking Statements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">The information in this discussion contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which are subject to the &#8220;safe harbor&#8221; created by those sections. These forward-looking statements include, but are not limited to, statements concerning our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management. The words &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, &#8220;Risk Factors&#8221; in our Annual Report. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note Regarding Trademarks</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All brand names or trademarks appearing in this report are the property of their respective holders. Unless the context requires otherwise, references in this report to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Taysha Gene Therapies, Inc.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Overview </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a patient-centric gene therapy company focused on developing and commercializing&#160;AAV-based&#160;gene therapies for the treatment of monogenic diseases of the central nervous system, or CNS, in both rare and large patient populations. We were founded in partnership with The University of Texas Southwestern Medical Center, or UT Southwestern, to develop and commercialize transformative gene therapy treatments. Together with UT Southwestern, we are advancing a deep and sustainable product portfolio of 26 gene therapy product candidates, with exclusive options to acquire four additional development programs at no cost. By combining our management team&#8217;s proven experience in gene therapy drug development and commercialization with UT Southwestern&#8217;s world-class gene therapy research capabilities, we believe we have created a powerful engine to develop transformative therapies to dramatically improve patients&#8217; lives. We recently acquired exclusive worldwide rights to a clinical-stage, intrathecally dosed AAV9 gene therapy program, now known as TSHA-120, for the treatment of giant axonal neuropathy, or GAN. A Phase 1/2 clinical trial of TSHA-120 is being conducted by the National Institutes of Health, or NIH under an accepted investigational new drug application, or IND, and we expect to provide a regulatory and clinical update by the end of 2021. A Phase 1/2 clinical trial of TSHA-101 was initiated by Queen&#8217;s University at Kingston, or Queen&#8217;s University, under an accepted Clinical Trial Application, or CTA, in Canada, and Queen&#8217;s University expects to report preliminary safety and biomarker data in the second half of 2021 and preliminary clinical data by the end of 2021. We plan to submit an IND for TSHA-101 for the treatment of GM2 gangliosidosis to the U.S. Food and Drug Administration, or FDA, and initiate a Phase 1/2 clinical trial in the United States, each in the second half of 2021. In addition, we plan to submit INDs / CTAs for each of TSHA-102 in Rett syndrome and TSHA-104 in SURF1-associated Leigh syndrome in the second half of 2021 and one of the following programs in 2021: TSHA-103 in SLC6A1 haploinsufficiency, TSHA-105 in SLC13A5 deficiency, TSHA-111-LAFORIN and TSHA-111-MALIN for two different forms of Lafora disease, TSHA-112 in APBD and TSHA-119 in GM2 AB variant. We are also developing TSHA-118 for the treatment of CLN1 disease (one of the forms of Batten disease) and intend to initiate a Phase 1/2 clinical trial of TSHA-118 in the second half of 2021 under a currently open IND. We anticipate dosing the first patient in that trial in the second half of 2021 and reporting biomarker data in the first half of 2022. Further, we plan to advance four new undisclosed programs focused on neurodevelopmental disorders, genetic epilepsies and neurodegenerative diseases into preclinical development in 2021. In addition to our product pipeline candidates, we are building a platform of next-generation technologies to optimize key components of our&#160;AAV-based&#160;gene therapies, including redosing, transgene regulation and capsid development.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have a limited operating history. Since our inception, our operations have focused on</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> organizing and staffing our company, business planning, raising capital and entering into collaboration agreements for conducting preclinical research and development activities for our product candidates. All of our lead product candidates are still in the clinical </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">preclinical </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">development </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">stage.&#160;We do not have any product candidates approved for sale and have not generated any revenue from product sales. We have funded our operations through the sale of equity, raising an aggregate of $307.0&#160;million of gross proceeds from our initial public offering and private placements of our convertible preferred stock. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since our inception, we have incurred significant operating losses. Our net losses were $73.0 million for the six months ended June 30, 2021 and $26.7 million for the six months ended June 30, 2020. As of June 30, 2021, we had an accumulated deficit of $134.1 million. We expect to continue to incur significant expenses and operating losses for the foreseeable future. We anticipate that our expenses will increase significantly in connection with our ongoing activities, as we: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">continue to advance the preclinical and clinical development of our product candidates and preclinical and discovery programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">conduct our ongoing clinical trials of TSHA-101 and TSHA-120, as well as initiate and complete additional clinical trials of TSHA-101, TSHA-118, TSHA-102, TSHA-104 and any other current and future product candidates that we advance&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">seek regulatory approval for any product candidates that successfully complete clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">continue to develop our gene therapy product candidate pipeline and next-generation platforms&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">scale up our clinical and regulatory capabilities&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">manufacture current Good Manufacturing Practice, or cGMP material for clinical trials or potential commercial sales&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">establish and validate a commercial-scale cGMP manufacturing facility&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">establish a commercialization infrastructure and scale up internal and external manufacturing and distribution capabilities to commercialize any product candidates for which we may obtain regulatory approval&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">adapt our regulatory compliance efforts to incorporate requirements applicable to marketed products&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">maintain, expand and protect our intellectual property portfolio&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">hire additional clinical, manufacturing quality control, regulatory, manufacturing and scientific and administrative personnel&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">add operational, financial and management information systems and personnel, including personnel to support our product development and planned future commercialization efforts&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">incur additional legal, accounting and other expenses in operating as a public company. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Pipeline</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are advancing a deep and sustainable product portfolio of 26 gene therapy product candidates for monogenic diseases of the CNS in both rare and large patient populations, with exclusive options to acquire four additional development programs at no cost. Our portfolio of gene therapy candidates targets broad neurological indications across three distinct therapeutic categories: neurodegenerative diseases, neurodevelopmental disorders and genetic epilepsies. Our current pipeline, including the stage of development of each of our product candidates, is represented in the table below.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000001.jpg" title="" alt="" style="width:719px;height:362px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Developments</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-120 for Giant Axonal Neuropathy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, we acquired the exclusive worldwide rights to a clinical-stage, intrathecally dosed AAV9 gene therapy program, now known as TSHA-120, for the treatment of giant axonal neuropathy, or GAN, pursuant to a license agreement with Hannah&#8217;s Hope Fund for Giant Axonal Neuropathy, Inc., or HHF. Under the terms of the agreement, HHF received an upfront payment of $5.5 million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $19.3 million, as well as a low, single-digit royalty on net sales upon commercialization of TSHA-120.</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GAN is a rare autosomal recessive disease of the central and peripheral nervous systems caused by loss-of-function gigaxonin gene mutations. The estimated prevalence of GAN is 2,400 patients in the United States and European Union.</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Symptoms and features of children with GAN usually develop around the age of five years and include an abnormal, wide based, unsteady gait, weakness and some sensory loss. There is often associated dull, tightly curled, coarse hair, giant axons seen on a nerve biopsy, and spinal cord atrophy and white matter abnormality seen on MRI. Symptoms progress and as the children grow older they develop progressive scoliosis and contractures, their weakness progresses to the point where they will need a wheelchair for mobility, respiratory muscle strength diminishes to the point where the child will need a ventilator (usually in the early to mid-teens) and the children often die during their late teens or early twenties, typically due to respiratory failure. There is an early- and late-onset phenotype associated with the disease, with shared physiology. The late-onset phenotype is often categorized as Charcot-Marie-Tooth Type 2, or CMT2, with a lack of tightly curled hair and CNS symptoms with relatively slow progression of disease. This phenotype represents up to 6% of all CMT2 diagnosis. In the late-onset population, patients have poor quality of life but the disease is not life-limiting. In early-onset disease, symptomatic treatments attempt to maximize physical development and minimize the rate of deterioration. Currently, there are no approved disease-modifying treatments available. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TSHA-120 is an AAV9 self-complementary viral vector encoding the full length human gigaxonin protein. The construct was invented by Dr. Steven Gray and is the first AAV9 gene therapy candidate to deliver a functional copy of the GAN gene</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> under the control of a JeT promoter that drives ubiquitous expression</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000002.jpg" title="" alt="" style="width:632px;height:203px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have received orphan drug designation and rare pediatric disease designation from the FDA for TSHA-120 for the treatment of GAN.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is an ongoing natural history study being led by the NIH, that has already identified and followed a number of patients with GAN for over </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">five</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> years with disease progression characterized by a number of clinical assessments.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The GAN natural history study was initiated in 2013 and included 45 GAN patients, aged 3 to 21 years. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Imaging data from this study has demonstrated that there are distinctive increased T2 signal abnormalities within the cerebellar white matter surrounding the dentate nucleus of the cerebellum, which represents one of the earliest brain imaging findings in individuals with GAN. These findings precede the more widespread periventricular and deep white matter signal abnormalities associated with advanced disease. In addition, cortical and spinal cord atrophy appeared to </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">correlate with</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> more advanced disease severity and older age. Impaired pulmonary function in patients with GAN also was observed, with forced vital capacity correlating well with several functional outcomes such as the MFM32, a validated 32-item scale for motor function measurement developed for neuromuscular diseases. Nocturnal hypoventilation and sleep apnea progressed over time, with sleep apnea worsening as ambulatory function deteriorated. Total MFM32 score also correlated with ambulatory status, where independently ambulant individuals performed better and had higher MFM32 scores than the non-ambulant group, as shown in the graph below. </span></p>
<p style="text-align:center;margin-bottom:18pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000003.jpg" title="" alt="" style="width:350px;height:488px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patients also reported significant autonomic dysfunction based on the COMPASS 31 self-assessment questionnaire. In addition, nerve conduction function demonstrated progressive sensorimotor polyneuropathy with age. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As would be expected for a neurodegenerative disease, younger patients have higher baseline </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MFM32 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">scores. However, the rate of decline in the MFM32 scores demonstrated consistency across </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">p</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">atients of all ages, with most demonstrating an average 8-point decline per year regardless of age and/or baseline MFM32 score, as shown in the natural history plot </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">below</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p>
<p style="text-align:center;margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000004.jpg" title="" alt="" style="width:412px;height:334px;" /></p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A 4-point score change in the MFM32 is considered clinically meaningful, suggesting that GAN patients lose significant function annually.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preclinical Data</p>
<p style="margin-bottom:18pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">TSHA-120 performed well across <span style="font-style:italic;">in vitro</span> and <span style="font-style:italic;">in vivo</span> studies, and demonstrated improved motor function and nerve pathology, and long-term safety across several animal models. Of note, improved dorsal root ganglia, or DRG, pathology was demonstrated in TSHA-120-treated GAN knockout mice. These preclinical results have been published in a number of peer-reviewed journals.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional preclinical data from a GAN knockout rodent model that had received AAV9-mediated GAN gene therapy demonstrated that GAN rodents treated at 16 months performed significantly better than 18-month old untreated GAN rodents and equivalently to controls. These rodents were evaluated using a rotarod performance test which is designed to evaluate endurance, balance, grip strength and motor coordination in rodents. The time to fall off the rotarod, known as latency, was also evaluated and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the data below demonstrate </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the clear difference in latency in treated versus untreated GAN rodents.</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000005.jpg" title="" alt="" style="width:504px;height:315px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A result is considered statistically significant when the probability of the result occurring by random chance, rather than from the efficacy of the treatment, is sufficiently low. The conventional method for determining the statistical significance of a result is known as the &#8220;p-value,&#8221; which represents the probability that random chance caused the result (e.g., a p-value &#61; 0.01 means that there is a 1% probability that the difference between the control group and the treatment group is purely due to random chance). Generally, a p-value less than 0.05 is considered statistically significant.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to dorsal root ganglia, or DRG, inflammation that has been a topic of considerable interest within the gene therapy circles, in GAN and in the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">majority of diseases in our neurodegenerative franchise, the DRG have a significantly abnormal histological appearance and function as a consequence of underlying disease pathophysiology. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treatment with</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TSHA-120</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> resulted in</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> considerable improvements in the pathological appearance of the DRG in the GAN knockout mice. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shown below is </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tissue from a GAN knockout mouse model with numerous abnormal neuronal inclusions containing aggregates of damaged neurofilament in the DRG</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">indicated by the yellow arrows. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> image C, the tissue from the GAN knockout mice treated with an intrathecal injection of TSHA-120 had a notable improvement in the reduction of these neuronal inclusions in the DRG.</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000006.jpg" title="" alt="" style="width:661px;height:249px;" /></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When a quantitative approach to the reduction in inclusions in the DRG was applied, it was observed that TSHA-120 treated mice experienced a statistically significant reduction in the average number of neuronal inclusions versus the GAN knockout mice that received vehicle as illustrated below. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000007.jpg" title="" alt="" style="width:363px;height:365px;" /></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, TSHA-120 demonstrated improved pathology of the sciatic nerve in the GAN knockout mice as shown below.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000008.jpg" title="" alt="" style="width:719px;height:361px;" /></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Results of Ongoing Phase 1/2 Clinical Trial</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A Phase 1/2 clinical trial of TSHA-120 is being conducted by the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NIH</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> under an accepted IND</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">trial</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is a single-site, open-label, non-randomized dose-escalation trial, in which patients are intrathecally dosed with one of 4 dose levels of TSHA-120 &#8211; 3.5x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">13</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg, 1.2x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg, 1.8x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3.5x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg. The primary endpoint is to assess safety, with secondary endpoints measuring efficacy using pathologic, physiologic, functional, and clinical markers.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, 14 patients have been intrathecally dosed and six patients have at least </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">three</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> years</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> worth of long-term follow up data. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he 1.8x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg dose and 1.2x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg cohorts demonstrated dose-related and meaningful slowing of disease progression in the first year post dosing</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as illustrated below</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he 1.8x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg dose effected a statistically significant 8-point improvement versus the historical control</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> over the course of a year</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the 1.2x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg dose effected a statistically significant 6-point improvement</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> over the course of a year</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000009.jpg" title="" alt="" style="width:409px;height:339px;" /></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Six patients in the trial have been followed for more than three years. Patients dosed with 1.8x10<sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup> total vg and 1.2x10<sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup> total vg have shown sustained dose-dependent improvements in MFM32 scores for more than three years, as illustrated below. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000010.jpg" title="" alt="" style="width:719px;height:264px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TSHA-120 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has been</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> well-tolerated at multiple doses with no signs of significant acute or subacute inflammation, no sudden sensory changes and no drug-related or persistent elevation of transaminases.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to report</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> additional data from this </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">trial</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the second half of 2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, including results from the highest dose cohort of 3.5x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg.</span></p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Bayesian Analysis of TSHA-120</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To gain further insight into the impact of TSHA-120 treatment on GAN disease progression and to add more robustness to the data, an additional analysis utilizing Bayesian statistical methodology was performed. Bayesian analysis is a useful method that enables direct probability statements about any unknown quantity of interest to be made, in this case, a statement around the probability of a clinically meaningful improvement in MFM32. Bayesian analysis also enables immediate incorporation into the analysis of data gathered as the trial progresses. It is a particularly appropriate approach for a clinical trial in a rare disease and is a way of statistically increasing the power of a clinical trial in a small patient population when used to incorporate auxiliary information such as historical data, or data that are being accumulated as the trial progresses. Importantly, it has been accepted by regulatory agencies in such cases. Below are the results of the Bayesian analysis of patient data from cohorts treated at 1.8x10<sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup> total vg and 1.2x10<sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup> total vg. As seen in the table, the analysis confirmed both the natural history data of an 8-point decline in the MFM32 total percent score per year, and importantly, that patients treated with 1.8x10<sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup> total vg experienced an arrest of disease progression that was statistically significant. The Bayesian analysis confirms the positive findings that were seen with the frequentist approach.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000011.jpg" title="" alt="" style="width:502px;height:470px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As shown below, t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he Bayesian efficacy analysis confirmed that TSHA-120 halted patients&#8217; pre-treatment rate of decline when compared to individual historical data. As shown on these graphs, the 1.8x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg dose halted patient pre-treatment rate of decline with an average annual slope improvement of 7.78 points while the 1.2x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg dose resulted in a clinically meaningful slowing of disease progression with an average annual slope improvement of 6.09 points. These results are consistent with a dose response relationship.</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000012.jpg" title="" alt="" style="width:697px;height:223px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:18pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further analyses confirmed that there was a nearly 100% probability of clinically meaningful slowing of disease progression. As shown below, t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he 1.8x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg dose confirmed a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">virtually</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 100% probability of clinically meaningful slowing of disease compared to natural history decline of GAN patients while the 1.2x10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">14</sup></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> total vg dose confirmed an approximately 85% probability of clinically meaningful slowing of disease and</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a virtually</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 100% probability of any slowing of disease.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000013.jpg" title="" alt="" style="width:499px;height:631px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We intend to engage with the FDA, European Medicines Agency, Medicines and Healthcare products Regulatory Agency in the United Kingdom and the Pharmaceuticals and Medical Devices Agency in Japan to discuss the regulatory pathway for TSHA-120 and will provide an update by year-end.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Vagus Nerve Redosing</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proof-of-concept research in the preclinical setting has supported that direct injection into the vagus nerve of TSHA-120 following an intrathecal administration of TSHA-120 may ameliorate autonomic nervous system dysfunction. At either four or sixteen weeks after wild-type rats were injected intrathecally with TSHA-120, they received a second dose via direct injection of the AAV9 vector into the vagus nerve. Four weeks after the second injection, tissues were assessed for expression of our re-dosed virus by staining for the green fluorescent protein, GFP, carried by the second AAV9 vector. Examination of the injected vagus nerve and associated nodose ganglia showed a robust expression of GFP (as represented by the brown staining below), indicating that in rats, AAV9 can be re-dosed through a direct nerve injection following intrathecal delivery.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000014.jpg" title="" alt="" style="width:719px;height:325px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consistent with single-dosing studies, re-dosed animals showed expression in the medulla vagus nerve nuclei. As shown </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">below</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, GFP expression was seen in the nucleus ambiguous, which controls motor functions critical for vocalization, swallowing and peristalsis and in the Pre-Botzinger complex, which contains respiratory rhythm generating neurons &#8211; all of which are autonomic functions compromised in GAN and many other neurological diseases.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000015.jpg" title="" alt="" style="width:719px;height:352px;" /><span style="font-size:10pt;margin-left:36pt;"></span>&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">As illustrated below, f</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">urther </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">support</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of how vagus nerve injection permits AAV9 redosing was demonstrated in the brain of a na&#239;ve animal shown on the left compared to an intrathecally AAV9-immunized rat on the right. Efficient GFP transduction was observed in vagal nerve fibers and in brain neurons. In the area postrema, which has a reduced blood-barrier and is a target for vagal afferent fiber trafficking, there was reduced GFP expression in pre-immunized animals, at four and sixteen weeks, as compared to na&#239;ve animals. This suggests that pre-existing neutralization antibodies may dampen the overall transduction of vagal nerve delivered AAV9, but efficient transduction of autonomic relevant neurons can still be achieved.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These results support that the vagus nerve space is immune privileged enough to allow for redosing.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000016.jpg" title="" alt="" style="width:719px;height:335px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-102 for Rett Syndrome</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TSHA-102, a neurodevelopmental disorder product candidate, is being developed for the treatment of Rett syndrome, one of the most common genetic causes of severe intellectual disability, characterized by rapid developmental regression and in many cases caused by heterozygous loss of function mutations in MECP2, a gene essential for neuronal and synaptic function in the brain. We designed TSHA-102 to prevent gene overexpression-related toxicity by inserting microRNA, or miRNA target binding sites into the 3&#8217; untranslated region of viral genomes. This overexpression of MECP2 is seen in the clinic in patients with a condition known as MECP2 duplication syndrome, where elevated levels of MECP2 result in a clinical phenotype similar to Rett syndrome both in terms of symptoms and severity. TSHA-102 is constructed from a neuronal specific promoter, MeP426, coupled with the miniMECP2 transgene, a truncated version of MECP2, and miRNA-Responsive Auto-Regulatory Element, or miRARE, our novel miRNA target panel, packaged in self-complementary AAV9.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recently, preclinical data from the ongoing natural history study for TSHA-102 were published online in Brain, a highly esteemed neurological science peer-reviewed journal. The preclinical study was conducted by the UT Southwestern Medical Center (UT Southwestern) laboratory of Sarah Sinnett, Ph.D., and evaluated the safety and efficacy of regulated miniMECP2 gene transfer, TSHA-102 (AAV9/miniMECP2-miRARE), via intrathecal (IT) administration in adolescent mice between four and five weeks of age. TSHA-102 was compared to unregulated full length MECP2 (AAV9/MECP2) and unregulated miniMECP2 (AAV9/miniMECP2).</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TSHA-102 extended knockout mouse model survival by 56% via IT delivery. In contrast, the unregulated miniMECP2 gene transfer failed to significantly extend knockout mouse model survival at either dose tested. Additionally, the unregulated full-length MECP2 construct did not demonstrate a significant extension in survival and was associated with an unacceptable toxicity profile in wild type mice.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to survival, behavioral side effects were explored. Mice were subjected to phenotypic scoring and a battery of tests including gait, hindlimb clasping, tremor and others to comprise an aggregate behavioral score. miRARE attenuated miniMECP2-mediated aggravation in wild type aggregate phenotype severity scores. Mice were scored on an aggregate severity scale using an established protocol. AAV9/MECP2- and AAV9/miniMECP2-treated wild type mice had a significantly higher mean (worse) aggregate behavioral severity score versus that observed for saline-treated mice (p &#60;0.05&#59; at 6&#8211;30 and 7&#8211;27 weeks of age, </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">respectively). TSHA-102-treated wild type mice had a significantly lower </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(better) </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mean aggregate severity score versus those of AAV9/MECP2- and AAV9/miniMECP2-treated mice at most timepoints from 11&#8211;19 and 9&#8211;20 weeks of age, respectively. No significant difference was observed between saline- and TSHA-102-treated wild type mice.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">miRARE-mediated genotype-dependent gene regulation was demonstrated by analyzing tissue sections from wild type and knockout mice treated with AAV9 vectors given intrathecally. When knockout mice were injected with a vector expressing the mini-MECP2 transgene with and without the miRARE element, miRARE reduced overall miniMECP2 transgene expression compared to unregulated miniMECP2 in wild type mice as shown below.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000017.jpg" title="" alt="" style="width:633px;height:325px;" />&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TSHA-102 demonstrated regulated expression in different regions of the brain. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As shown in the graph and photos below, i</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n the pons and midbrain, miRARE inhibited mean </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MECP2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> gene </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expression in a genotype-dependent manner as indicated by</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">significantly fewer myc(+) cells observed in wild type mice compared to knockout mice (p&#60;0.05), thereby demonstrating that TSHA-102 achieved MECP2 expression levels similar to normal physiological parameters.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000018.jpg" title="" alt="" style="width:543px;height:333px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:18pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000019.jpg" title="" alt="" style="width:558px;height:269px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We plan to submit an IND / CTA for TSHA-102 in the second half of 2021, initiate a Phase 1/2 clinical trial by the end of 2021 and report clinical data by the end of 2022.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-118 for CLN1 Disease</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CLN1 disease (one of the forms of Batten disease), a lysosomal storage disorder, is a progressive, fatal neurodegenerative disease with early childhood onset that has an estimated incidence of approximately 1 in 138,000 live births worldwide. The estimated prevalence of CLN1 disease is 900 patients in the United States and European Union.&#160;&#160;CLN1 disease is caused by loss-of-function mutations in the&#160;<span style="font-style:italic;">CLN1&#160;</span>gene that encodes the enzyme palmitoyl-protein thioesterase-1, or PPT1, a small glycoprotein involved in the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">degradation of certain lipid-modified proteins. Loss of function mutations in the&#160;</span><span style="font-style:italic;">CLN1&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gene causes accumulation of these lipid-modified proteins in cells, eventually leading to aggregation, neuronal cellular dysfunction and, ultimately neuronal cell death.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the infantile-onset form of CLN1 disease, clinical symptoms appear between six to 24&#160;months and include rapid deterioration of speech and motor function, refractory epilepsy, ataxia and visual failure. Infantile-onset CLN1 patients are typically poorly responsive by five years of age and remain noncommunicative until their death, which usually occurs by seven years of age. Late-infantile-onset CLN1 disease begins between two to four years of age with initial visual and cognitive decline followed by the development of ataxia and myoclonus, or quick, involuntary muscle jerks. Juvenile-onset CLN1 disease patients present between the ages of five to ten years old, with vision loss as a first symptom followed by cognitive decline, seizures and motor decline. Approximately 60% of the children diagnosed with CLN1 disease in the United States present with early-onset infantile forms, with the remaining 40% experiencing later-onset childhood forms.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All currently available therapeutic approaches for patients with CLN1 disease are targeted towards the treatment of symptoms, and no disease-modifying therapies have been approved. Gene therapy has shown promise in correcting forms of neuronal ceroid lipofuscinoses, or NCL, diseases that involve mutations in soluble enzymes, in part, due to cross-correction of neighboring non-transduced cells.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that the introduction of a functional&#160;<span style="font-style:italic;">CLN1&#160;</span>gene using an AAV9 vector delivered intrathecally to the CNS offers the potential of a disease-modifying therapeutic approach for this disease.&#160;TSHA-118&#160;is a self-complementary AAV9 viral vector that expresses human codon-optimized&#160;<span style="font-style:italic;">CLN1&#160;</span>complementary deoxyribonucleic acid under control of the chicken &#223;-actin hybrid promoter. We acquired exclusive worldwide rights to&#160;certain intellectual property rights and know-how relating to the research, development and manufacture of TSHA-118&#160;(formerly&#160;ABO-202)&#160;in August 2020 pursuant to a license agreement with Abeona Therapeutics Inc., or Abeona.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TSHA-118&#160;has been granted orphan drug designation, rare pediatric disease designation and fast track designation from the FDA and orphan drug designation from the European Medicines Agency for the treatment of CLN1 disease.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">There are currently two natural history studies ongoing to understand more about the disease. One is an observational study in Hamburg</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Germany</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to assess the natural history of CLN diseases, including CLN1 disease, as part of the international DEM-CHILD database. The second study is a combined retrospective and prospective study being run by the University of Rochester to characterize the age-at-onset of major symptoms and the relationship between age and severity. As shown below, there are three </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">different forms of the disease which are categorized based on the age of onset of first symptom</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">:&#160;&#160;infantile, late infantile, and juvenile. As demonstrated below, symptomatology is closely related to the underlying phenotype.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000020.jpg" title="" alt="" style="width:680px;height:332px;" /></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000021.jpg" title="" alt="" style="width:343px;height:298px;" /></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preclinical Studies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In third-party preclinical studies, evidence of improvements in behavioral outcomes, survival and restoration of PPT1 enzymatic activity was observed, which we believe supports continued development of&#160;TSHA-118.&#160;In these studies,&#160;TSHA-118&#160;was administered at a dose of 7.0 x 10<sup style="font-size:85%;line-height:120%;vertical-align:top">11</sup>&#160;vg/mouse via intrathecal lumbar puncture to a mouse model of CLN1 disease, selected for its ability to recapitulate the severity of the human disease. The results from this study showed that intrathecal treatment with&#160;TSHA-</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118&#160;significantly extended survival of CLN1 knockout mice, with enhanced survival and behavioral outcomes correlating with treatment at younger ages and higher doses.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As illustrated in the figure below, mice treated with TSHA-118 at four weeks or twelve weeks of age had a mean survival of 18.7 or 16.7&#160;months, respectively, compared to approximately 8 months survival for untreated CLN1 knockout mice.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000022.jpg" title="" alt="" style="width:552px;height:264px;" /></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preclinical studies suggested that early intervention is key to better outcomes in CLN1 disease. In CLN1 knockout mice, higher doses of TSHA-118 and earlier intervention mediated stronger rescue of these mice, as demonstrated below.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000023.jpg" title="" alt="" style="width:648px;height:300px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, TSHA-118-treated CLN1 knockout mice had sustained preservation of motor function as demonstrated below.</span></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000024.jpg" title="" alt="" style="width:662px;height:360px;" /></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PPT1 enzyme activity in serum was measured at selected timepoints following&#160;TSHA-118&#160;delivery by intrathecal administration at four, twenty or twenty-six weeks of age. Serum was collected either at four months post-treatment or at the humane endpoint.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As shown in the figure below, heterozygous mice had approximately 50% of normal serum PPT1 activity compared to wild-type mice. In contrast, treatment of CLN1 knockout mice with&#160;TSHA-118&#160;resulted in supraphysiological levels of active PPT1 in the serum in comparison to wild-type and heterozygous mice.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000025.jpg" title="" alt="" style="width:557px;height:212px;" /></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-104 for SURF1-Associated Leigh Syndrome</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing&#160;TSHA-104,&#160;a neurodegenerative product candidate, for the treatment of SURF1-associated Leigh syndrome. The&#160;<span style="font-style:italic;">SURF1</span>&#160;gene encodes the SURF1 protein, which plays a critical role in mitochondrial translation and is involved in the assembly of the cytochrome c oxidase complex. Mutations in&#160;<span style="font-style:italic;">SURF1&#160;</span>lead to SURF1-associated Leigh syndrome, a recessively inherited mitochondrial disease, and are the most frequent cause of Leigh syndrome, a rapidly progressive neurological condition </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">characterized by the degeneration of the CNS. To date over 100&#160;</span><span style="font-style:italic;">SURF1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;mutations, including&#160;non-sense,&#160;frame shift and missense variants have been described in literature. The incidence of SURF1-associated Leigh syndrome is estimated to be approximately 1 in 100,000 live births</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated prevalence of SURF1 deficiency is 300 to 400 patients in the United States and European Union.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SURF1-associated Leigh syndrome can lead to difficulty swallowing in infancy, with subsequent failure to thrive. Severely diseased muscle tone leading to respiratory failure, movement disorders and balance abnormalities are common. According to the literature, only a few patients have been reported to survive beyond 10 years of age. In the majority of SURF1-deficient patients, serum lactate is elevated, and elevated levels of serum lactate have been reported in the CSF as well, indicative of mitochondrial dysfunction. We are pursuing a gene replacement strategy with the goal of restoring mitochondrial function in patients with SURF1-associated Leigh syndrome caused by&#160;loss-of-function&#160;mutations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are constructing&#160;TSHA-104&#160;from a codon-optimized version of the human<span style="font-style:italic;">&#160;SURF1&#160;</span>gene packaged within a self-complementary AAV9 viral vector under the control of a CBh promoter. We plan to submit an IND / CTA for TSHA-104 in the second half of 2021, initiate a Phase 1/2 clinical trial by the end of 2021 and report biomarker data in the first half of 2022.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have received orphan drug designation and rare pediatric disease designation from the FDA for TSHA-104 for the treatment of SURF1-associated Leigh syndrome.</p>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preclinical Studies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Data from preclinical studies suggest that functional gene replacement strategy could restore mitochondrial functions in SURF1-associated Leigh syndrome caused by SURF1 loss-of-function mutations, which we believe support continued development of&#160;TSHA-104.&#160;In these studies,&#160;TSHA-104&#160;was administered at two dose levels via intrathecal lumbar puncture to a knock-out mouse model of SURF1-associated Leigh syndrome. Intrathecal treatment with&#160;TSHA-104&#160;was observed to be well tolerated. TSHA-104 also induced SURF1 expression in the brain and partially rescued COX activity in a tissue specific manner, as shown below.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000026.jpg" title="" alt="" style="width:719px;height:370px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Improvement in MTC01, which is part of the assembled COX1 complex, was dose dependent in the treated mice as demonstrated below.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000027.jpg" title="" alt="" style="width:719px;height:323px;" /></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, there was a correlation between MTCO1 assembly and COX activity</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as demonstrated below.</span></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000028.jpg" title="" alt="" style="width:572px;height:267px;" /></p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When examining long-term rescue, TSHA-104 restored elevation of blood lactate on exhaustive exercise in the SURF1 knock-out mice.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000029.jpg" title="" alt="" style="width:450px;height:423px;" /></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Natural </span><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">H</span><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">istory </span><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">S</span><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">tudy </span><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">D</span><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">ata</span></p>
<p style="margin-bottom:6pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">A detailed retrospective chart review natural history study published in 2013 included 44 cases with SURF1 deficiency. Of the 36 deceased patients with known causes of death, the cause was central respiratory failure in 80% of the patients. Seven patients survived beyond 10 years of age. Of these patients, six had neurological symptoms such as ataxia and motor developmental delay. Of note, gastrointestinal symptoms were not the prominent presenting feature in these cases. Furthermore, these six patients also did not experience developmental regression. Literature searches identified 98 SURF1-deficient cases with available survival data, which were pooled together with the data from the 44 cases. The Kaplan-Meier analysis below compared the survival experience of 142 SURF1-deficient cases to two other groups with Leigh syndrome due to nuclear gene mutations (56 with LRPPRC deficiency and 63 with nuclear-encoded complex I-deficient Leigh syndrome/&#8220;Leigh- like&#8221; disease). As indicated in the survival curve, the disease is progressive with significant morbidity, involves impairment in development and cognition causes seizures and results in a median survival length of 5.4 years.</p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000030.jpg" title="" alt="" style="width:347px;height:360px;" /></p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:6pt;margin-top:6pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Exploratory Study to Examine COX1 Activity and Clinical Phenotype</span></p>
<p style="margin-bottom:6pt;margin-top:6pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The underlying pathophysiology of SURF1 deficiency is linked to the deficiency of mitochondrial activity, which is centered around the formation of a COX complex and the resulting activity of COX1. We completed an exploratory study that examined the fibroblasts from various patients who were categorized as typical or severe Leigh syndrome versus patients who had a milder presentation, of Leigh syndrome to examine the difference in COX activity and the relevance of COX1 as a biomarker for the disease. As demonstrated below, preliminary data indicated that mild patients had slightly higher COX activity than severe patients, which suggests that a small increase in cytochrome oxidase activity could benefit patients.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000031.jpg" title="" alt="" style="width:394px;height:307px;" /></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, a reduction in COX activity correlated with disease worsening, as indicated by patient fibroblast data below.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000032.jpg" title="" alt="" style="width:530px;height:259px;" /></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-113 for Tauopathies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing&#160;TSHA-113&#160;for the treatment of tauopathies. Tau accumulation predicts neurodegeneration in Alzheimer&#8217;s disease, and the propagation of tau aggregates is thought to mediate the progression of several neurodegenerative diseases, including </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">progressive supranuclear palsy, corticobasal degeneration, behavioral variant frontotemporal degeneration, chronic traumatic encephalopathy, frontotemporal dementia and parkinsonism linked to chromosome 17.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result, multiple strategies are currently being tested to reduce tau and ameliorate the effects of these diseases. Preclinical studies testing tau anti-sense oligonucleotides, or ASOs, in the PS19 tauopathy mouse model prevented neuronal loss and showed a reversal of pathological tau deposition and seeding. This treatment in being tested in clinical trials. While promising, ASOs only reduced tau protein levels by approximately 50% in mice, and they required repeated, life-long intrathecal administration to reach this maximum effect.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing&#160;TSHA-113&#160;to utilize&#160;AAV-mediated&#160;gene silencing to deliver life-long reduction of tau protein levels in neurons following administration of a single dose. We are developing&#160;tau-specific&#160;miRNA shuttles that have been designed to target mRNA for all six isoforms of tau found in the human brain and/or mouse brain. Our preliminary data in cells has shown that our tau miRNA selectively reduced some human and mouse tau expression&#160;<span style="font-style:italic;">in vitro</span>&#160;and we have packaged our miRNA shuttles in AAV9 capsids for further evaluation in mouse models of human tauopathies.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preclinical Studies</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In transgenic mouse models carrying human tau, TSHA-113 significantly reduced tau mRNA and protein levels, as shown in the three figures below. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<img src="g3dyckr3udth000033.jpg" title="" alt="" style="width:381px;height:400px;" /><span style="font-size:12pt;"></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<img src="g3dyckr3udth000034.jpg" title="" alt="" style="width:552px;height:343px;" /><span style="font-size:12pt;"></span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000035.jpg" title="" alt="" style="width:503px;height:323px;" /><span style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mice dosed with TSHA-113 demonstrated widespread function and GFP expression in neurons and glia, as illustrated below.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:18pt;border-top:Solid 0.75pt #7F7F7F;padding-top:0pt;border-bottom:Solid 0.75pt #7F7F7F;padding-bottom:0pt;border-left:Solid 0.75pt #7F7F7F;padding-left:0pt;border-right:Solid 0.75pt #7F7F7F;padding-right:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000036.jpg" title="" alt="" style="width:719px;height:357px;" /></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Together with previous <span style="font-style:italic;">in vitro</span> findings, we believe that these data further validate selective reduction of tau mRNA and protein levels and warrant further preclinical development.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-105 for SLC13A5 Deficiency</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing&#160;TSHA-105&#160;for the treatment of SLC13A5 deficiency, a rare autosomal recessive epileptic encephalopathy characterized by the onset of seizures within the first few days of life. The estimated prevalence of SLC13A5 deficiency is 1,900 patients in the United States and European Union. Affected children have impairments in gross motor function and speech production with relative preservation of fine motor skills and receptive speech. SLC13A5 deficiency is caused by&#160;bi-allelic&#160;loss-of&#160;function </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mutations in the&#160;</span><span style="font-style:italic;">SLC13A5</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;gene, which codes for a sodium dependent citrate transporter, or NaCT, that is largely expressed in the brain and liver. To date, all tested mutations result in no or a greatly reduced amount of the citrate in the cells.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diminished NaCT function leads to loss of neuronal uptake of citrate and other metabolites such as succinate that are critical to brain energy metabolism and function. Currently, there are no approved therapies for SLC13A5 deficiency, and treatment is largely to address symptoms.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing TSHA-105 as a gene replacement therapy for SLC13A5 deficiency. TSHA-105 is constructed from a codon-optimized human&#160;<span style="font-style:italic;">SLC13A5</span>&#160;gene packaged in a self-complementary AAV9 capsid. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have received orphan drug designation and rare pediatric disease designation from the FDA for TSHA-105 for the treatment of epilepsy caused by caused by SLC13A5 deficiency.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preclinical Studies</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In preliminary safety studies conducted in wildtype mice, vehicle or TSHA-105 was administered via CSF delivery. Weight and survival in the control and treatment group were the same and no overt toxicities were observed for up to one-year post-treatment.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Studies to evaluate TSHA-105 were conducted using SLC13A5 knockout mice. In comparison to age-matched, wildtype controls, SLC13A5 knockout mice exhibit altered citrate metabolism along with abnormal electroencephalogram, or EEG, activity and increased seizure susceptibility. At 3 months of age, SLC13A5 knockout mice were treated with TSHA-105 via CSF delivery. Administration of TSHA-105 resulted in a significant, sustainable decrease of plasma citrate levels up to 3-months post-injection, as shown below. These results suggest that gene replacement therapy can restore citrate transport and that citrate may be used as a biomarker for the disease and following treatment.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000037.jpg" title="" alt="" style="width:516px;height:260px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:6.67%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, in ongoing EEG studies, TSHA-105 normalized EEG activity and decreased the number of seizures in knockout mice in comparison vehicle-treated controls as shown below.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</span></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000038.jpg" title="" alt="" style="width:402px;height:288px;" /></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000039.jpg" title="" alt="" style="width:402px;height:287px;" /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:6.67%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TSHA-105 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">also reduced seizures and associated deaths </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SLC13A5 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">knockout mice</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as shown below.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</span></p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000040.jpg" title="" alt="" style="width:719px;height:255px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-103 for SLC6A1 Haploinsufficiency Disorder</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SLC6A1 haploinsufficiency disorder is caused by&#160;loss-of-function&#160;mutations in the&#160;<span style="font-style:italic;">SLC6A1</span>&#160;gene. Loss&#160;of-function&#160;mutations in the&#160;<span style="font-style:italic;">SLC6A1</span>&#160;gene have been identified as one of the most common monogenic causes of epilepsy with myoclonic atonic seizures, or brief and abrupt seizures followed by loss of muscle strength, as well as autism spectrum disorder and intellectual disability.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patients diagnosed with SLC6A1 haploinsufficiency disorder typically present with developmental delay, varying degrees of intellectual disability, seizures and abnormal EEG characterized by generalized spike-wave discharges. Most patients are refractory to pharmacological seizure control although a portion of patients become seizure free during the course of disease progression. Importantly, seizure control is not associated with improved cognitive outcomes, which highlights the complexity of the disease as well as the need for novel therapies directed at its underlying pathology.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approximately 81% of patients with SLC6A1 haploinsufficiency disorder have epilepsy, with typical absence seizures, which are abrupt and followed by lack of awareness, being the predominant form observed. In addition, 91% of individuals exhibit developmental delays, with more than 80% characterized as mild or moderate intellectual disability. Ataxia, or tremors, is present in approximately 29% of individuals, while autism or autistic features are observed in approximately 24% of individuals diagnosed with SLC6A1 haploinsufficiency disorder.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The&#160;<span style="font-style:italic;">SLC6A1</span>&#160;gene encodes the gamma-aminobutyric acid, or GABA, transporter 1, or GAT1. GAT1 is a voltage-dependent transporter responsible for the reuptake of GABA, a&#160;non-protein&#160;amino acid that is well characterized for its role as a major inhibitory neurotransmitter within the mammalian CNS. GAT1 plays a critical role in the reuptake of GABA from neuronal synapses and extracellular spaces and as a result, a critical role in balancing neuronal excitations. When GABA transport is disrupted, brain development is negatively impacted resulting in deficits in attention and cognition as well as seizures.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The exact incidence and prevalence of SLC6A1 haploinsufficiency disorder is unknown but we believe the estimated prevalence is 17,000 patients in the United States and European Union. According to recently published data, the incidence of SLC6A1 haploinsufficiency disorder is approximately 1 in 36,000 live births. We believe that SLC6A1 haploinsufficiency disorder is underdiagnosed as the underlying biology was only recently elucidated and the gene had not been part of commercially available genetic epilepsy screening panels. Clinician education and expanded use of genetic screening panels that include SLC6A1 will likely lead to increased identification of individuals with these mutations.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing TSHA-103, a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">genetic epilepsy product candidate, for the treatment of SLC6A1 haploinsufficiency disorder. TSHA-103 is a gene replacement therapy constructed from a codon-optimized version of the human&#160;</span><span style="font-style:italic;">SLC6A1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;gene packaged within a self-complementary AAV9 viral vector. We are currently conducting preclinical studies of&#160;TSHA-103.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have received orphan drug designation and rare pediatric disease designation from the FDA for TSHA-103 for the treatment of epilepsy caused by SLC6A1 haploinsufficiency disorder.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preclinical Studies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently conducting preclinical studies of&#160;TSHA-103. In the SLC6A1 knockout mouse model, TSHA-103 improved nesting and EEG, activity, as shown below.</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000041.jpg" title="" alt="" style="width:657px;height:240px;" /></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In SLC6A1 knockout and heterozygous mouse models, neonatal ICV administration of TSHA-103 rescued abnormal EEG.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3dyckr3udth000042.jpg" title="" alt="" style="width:445px;height:292px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">TSHA-106 for Angelman Syndrome</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing&#160;TSHA-106&#160;for the treatment of Angelman syndrome, a neurodevelopmental disorder caused by a maternal deficiency of the&#160;<span style="font-style:italic;">UBE3A</span>&#160;gene. Angelman syndrome is characterized by profound developmental delay, ataxia and gait disturbance, sleep disorder, seizures, heightened anxiety and aggression and severe speech impairments. Angelman syndrome affects approximately one per 12,000 to 20,000 patients worldwide. The estimated prevalence of Angelman syndrome is 55,000 patients in </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the United States and European Union. There are currently no approved therapies for the treatment of Angelman syndrome. Current treatment focuses on supportive care and managing medical and developmental issues.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Angelman syndrome is an imprinting disorder in which the maternal gene is deficient and the paternal copy of&#160;<span style="font-style:italic;">UBE3A</span>&#160;is intact but silenced by a long&#160;non-coding&#160;RNA,&#160;<span style="font-style:italic;">UBE3A</span>&#160;antisense transcript, or&#160;<span style="font-style:italic;">UBE3A</span>-ATS.&#160;Delivery of an ASO targeting&#160;UBE3A-ATS&#160;showed promising results in ameliorating Angelman syndrome symptoms in a transgenic mouse model.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are two approaches to treat this genetic abnormality. The first is to replace the maternal chromosome, or the maternal allele. The second approach is to use a silencing mechanism, or a small interfering RNA, to silence the noncoding strip of RNA that binds to the paternal allele and causes silencing of the gene. We are examining both approaches. We are developing&#160;TSHA-106&#160;to target the&#160;<span style="font-style:italic;">UBE3A</span>-ATS&#160;transcript through shRNA knock-down with an&#160;AAV-based&#160;strategy to achieve broad distribution of the shRNA expression cassette across the entire CNS following a single intrathecal dose.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">License Agreements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research, Collaboration and License Agreement with The University of Texas Southwestern Medical Center </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2019, we entered into a research, collaboration and license agreement, or the UT Southwestern Agreement with The Board of Regents of the University of Texas System on behalf of UT Southwestern, as amended in April 2020. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the UT Southwestern Agreement, we obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, we obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. We are required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least one licensed product. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the entry into the UT Southwestern Agreement, we issued to UT Southwestern 2,179,000 shares of our common stock. We do not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement, other than costs related to the maintenance of patents. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">License Agreement with Queen&#8217;s University </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2020, we entered into a license agreement, or the Queen&#8217;s University Agreement with Queen&#8217;s University. In connection with the Queen&#8217;s University Agreement, we obtained an exclusive, perpetual, worldwide, royalty-bearing license, with the right to grant sublicenses, under certain patent rights and know-how of Queen&#8217;s University, including certain improvements to the foregoing, to make, have made, use, offer for sale, sell and import licensed products and otherwise exploit such patents and know-how for use in certain specified indications. We also obtained an exclusive right of first negotiation to license certain next generation technology and improvements of Queen&#8217;s University that do not constitute an already-licensed improvement to the licensed technology. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Queen&#8217;s University Agreement, we paid Queen&#8217;s University a one-time fee of $3.0&#160;million as an upfront fee and approximately $0.2 million to reimburse Queen&#8217;s University for certain plasmid production costs. We are obligated to pay Queen&#8217;s University up to $10.0&#160;million in the aggregate upon achievement of certain regulatory milestones and up to $10.0&#160;million in the aggregate upon achievement of certain commercial milestones, a low single digit royalty on net sales of licensed products, subject to certain customary reductions, and a percentage of non-royalty sublicensing revenue ranging in the low double digits. Royalties are payable on a licensed product-by-licensed product basis and country-by-country basis until expiration of the last valid claim of a licensed patent covering such licensed product in such country and the expiration of any regulatory exclusivity for such licensed product in such country. Additionally, we are obligated to pay Queen&#8217;s University a low double-digit portion of any amounts received by us in connection with the sale of a priority review voucher related to a licensed product, not to exceed a low eight-figure amount. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with a separate research grant agreement with Queen&#8217;s University, we reimbursed Queen&#8217;s University for certain manufacturing production costs totaling $3.8 million in fiscal year 2020.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">License Agreement with Abeona </span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(CLN1 Disease)</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, we entered into a license agreement, or the Abeona CLN1 Agreement, with Abeona Therapeutics Inc., or Abeona.&#160;In connection with the Abeona CLN1 Agreement, we obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy for the prevention, treatment, or diagnosis of CLN1 Disease (one of the forms of Batten disease) in humans. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the license grant, we paid Abeona a one-time upfront license fee of $3.0 million during fiscal year 2020. We are obligated to pay Abeona up to $26.0 million in regulatory-related milestones and up to $30.0 million in sales-related milestones per licensed product and high single-digit royalties on net sales of licensed products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country. In addition, concurrent with the Abeona CLN1 Agreement we entered into a purchase and reimbursement agreement with Abeona, pursuant to which we purchased specified inventory from Abeona and reimbursed Abeona for certain research and development costs previously incurred for total consideration of $4.0 million paid in fiscal year 2020. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Abeona CLN1 Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. We may terminate the agreement for convenience upon specified prior written notice to Abeona. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">License Agreement with Abeona (Rett Syndrome)</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2020, we entered into a license agreement, or the Abeona Rett Agreement with Abeona pursuant to which we obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents,&#160;know-how&#160;and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to certain obligations of Abeona, we are required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Abeona Rett Agreement, we paid Abeona a&#160;one-time&#160;upfront license fee of $3.0&#160;million during fiscal year 2020. We are obligated to pay Abeona up to $26.5&#160;million in regulatory-related milestones and up to $30.0&#160;million in sales-related milestones per licensed product and high single-digit royalties on net sales of licensed products. Royalties are payable on a licensed&#160;product-by-licensed&#160;product and&#160;country-by-country&#160;basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Abeona Rett Agreement expires on a&#160;country-by-country&#160;and licensed&#160;product-by-licensed&#160;product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. We may terminate the agreement for convenience.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Impact of COVID-19 on Our Business </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have been actively monitoring the COVID-19 situation and its impact globally. Our financial results for the six months ended June 30, 2021 were not impacted by COVID-19. We believe the remote working arrangements and travel restrictions imposed by various governmental jurisdictions have had limited impact on our ability to maintain internal operations during the six months ended June 30, 2021. The extent to which COVID-19 may impact our business and operations will depend on future developments that are highly uncertain and cannot be predicted with confidence, such as the duration of the outbreak, the effectiveness of actions to contain and treat COVID-19, the efficacy, availability and adoption of vaccines, both domestically and globally, and the impact of new variants or mutations of the coronavirus, such as the Delta variant. Although we have not experienced any material business </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shutdowns or interruptions due to the COVID-19 pandemic, we</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> cannot predict the scope and severity of any potential business shutdowns or disruptions</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the future</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, including to our planned clinical trials and preclinical studies. Any such shutdowns or other business interruptions could result in material and negative effects to our ability to conduct our business in the manner and on the timelines presently planned, which could have a material adverse impact on our business, results of operation and financial condition</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Components of Results of Operations </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have not recognized any revenue from any sources, including from product sales, and we do not expect to generate any revenue from the sale of products, if approved, in the foreseeable future. If our development efforts for our product candidates are successful and result in regulatory approval, or license agreements with third parties, we may generate revenue in the future from product sales. However, there can be no assurance as to when we will generate such revenue, if at all. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Operating Expenses </p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.67%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses primarily consist of preclinical development of our product candidates and discovery efforts, including conducting preclinical studies, manufacturing development efforts, preparing for clinical trials and activities related to regulatory filings for our product candidates. Research and development expenses are recognized as incurred and payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods or services are received. Costs incurred in obtaining technology licenses through asset acquisitions are charged to research and development expense if the licensed technology has not reached technological feasibility and has no alternative future use. Research and development expenses include or could include: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">employee-related expenses, including salaries, bonuses, benefits, stock-based compensation, other related costs for those employees involved in research and development efforts&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">license maintenance fees and milestone fees incurred in connection with various license agreements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">external research and development expenses incurred under agreements with consultants, contract research organizations, or CROs, investigative sites and consultants to conduct our preclinical studies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">costs related to manufacturing material for our preclinical studies and clinical trials, including fees paid to contract manufacturing organizations, or CMOs&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">laboratory supplies and research materials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">costs related to compliance with regulatory requirements&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">facilities, depreciation and other allocated expenses, which include direct and allocated expenses for rent, maintenance of facilities, insurance and equipment. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development activities are central to our business model. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We plan to substantially increase our research and development expenses for the foreseeable future as we continue the development of our product candidates and manufacturing processes and conduct discovery and research activities for our preclinical programs. We cannot determine with certainty the timing of initiation, the duration or the completion costs of current or future preclinical studies and clinical trials of our product candidates due to the inherently unpredictable nature of preclinical and clinical development. Clinical and preclinical development timelines, the probability of success and development costs can differ materially from expectations. We anticipate that we will make determinations as to which product candidates to pursue and how much funding to direct to each product candidate on an ongoing basis in response to the results of ongoing and future preclinical studies and clinical trials, regulatory developments and our ongoing assessments as to each product candidate&#8217;s commercial potential. We will need to raise substantial additional capital in the future. Our clinical development costs are expected to increase significantly as we commence clinical trials. Our future expenses may vary significantly each period based on factors such as: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">expenses incurred to conduct preclinical studies required to advance our product candidates into clinical development&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">per patient trial costs, including based on the number of doses that patients received&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the number of patients who enroll in each trial&#59; </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span><span style="font-family:Times New Roman;">the number of trials required for approval&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the number of sites included in the trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the countries in which the trials are conducted&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the length of time required to enroll eligible patients&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the drop-out or discontinuation rates of patients&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">potential additional safety monitoring requested by regulatory agencies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the duration of patient participation in the trials and follow-up&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the phase of development of the product candidate&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">third-party contractors failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the ability to manufacture of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">regulators or institutional review boards, or IRBs requiring that we or our investigators suspend or terminate clinical development for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the efficacy and safety profile of our product candidates. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:6.67%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">General and Administrative Expenses </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expenses consist or will consist principally of salaries and related costs for personnel in executive and administrative functions, including stock-based compensation, travel expenses and recruiting expenses. Other general and administrative expenses include professional fees for legal, consulting, accounting and&#160;audit and tax-related&#160;services and insurance costs. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support our expanded infrastructure, as well as the initiation and continuation of our preclinical studies and clinical trials for our product candidates. We also anticipate that our general and administrative expenses will increase as a result of payments for accounting, audit, legal, consulting services, as well as costs associated with maintaining compliance with Nasdaq listing rules and SEC requirements, director and officer liability insurance, investor and public relations activities and other expenses associated with operating as a public company. We anticipate the additional costs for these services will substantially increase our general and administrative expenses by between $6.0&#160;million and $7.0&#160;million on an annual basis, including the cost of director and officer liability insurance.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Results of Operations </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Results of Operations for the Three Months Ended June 30, 2021 and for the Three Months Ended June 30, 2020 </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes our results of operations for the three months ended June 30, 2021 and the three months ended June 30, 2020 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June&#160;30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June&#160;30, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,643</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,062</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,129</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,772</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,010</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,772</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,010</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value of preferred stock tranche liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,210</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(194</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other expense, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(154</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,210</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,926</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,220</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses were $30.6&#160;million for the three months ended June 30, 2021, compared to $3.1 million for the <span style="Background-color:#FFFFFF;color:#000000;">three months ended June 30, 2020. </span><span style="color:#000000;">The $27.5 million increase was primarily attributable to an increase of $10.3 million of expenses incurred in research and development manufacturing and other raw material purchases, which included cGMP batches produced by Catalent and UT Southwestern. We incurred an increase in employee compensation expenses of $8.5 million, which included $2.2 million of non-cash stock-based compensation, and $8.7 million in third-party research and development expenses, which includes clinical trial CRO activities, GLP toxicology studies, and consulting for regulatory and clinical studies.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">General and Administrative Expenses </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expenses were $10.1&#160;million for the three months ended June 30, 2021, compared to $0.9 million for the <span style="Background-color:#FFFFFF;color:#000000;">three months ended June 30, 2020. The increase of approximately $9.2 million was</span> primarily attributable to $4.7&#160;million of incremental compensation expense, which included $2.3 million of non-cash stock-based compensation.&#160;&#160;We also incurred an increase of $4.5 million in professional fees related to legal, insurance, investor relations/communications, accounting, personnel recruiting and patient advocacy activities.&#160;&#160; <span style="color:#000000;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Results of Operations for the Six Months Ended June 30, 2021 and for the Six Months Ended June 30, 2020 </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes our results of operations for the six months ended June&#160;30, 2021 and the six months ended June 30, 2020 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June&#160;30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June&#160;30, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,497</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,576</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,365</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,862</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,594</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(72,862</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,594</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value of preferred stock tranche liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,030</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(194</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other expense, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(88</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,057</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(72,950</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.3%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,651</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses  </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses were $54.5&#160;million for the six months ended June 30, 2021, compared to $8.6 million for the <span style="Background-color:#FFFFFF;color:#000000;">six months ended June 30, 2020. </span><span style="color:#000000;">The $45.9 million increase was primarily attributable to an increase of $15.2 million of expenses incurred in research and development manufacturing and other raw material purchases, which included cGMP batches produced by Catalent and UT Southwestern. We also incurred an increase in employee compensation and expenses of $13.8 million, which included $3.8 million of non-cash stock-based compensation. License fees increased by $3.0 million due to the acquisition of exclusive worldwide rights to TSHA-120, for the treatment of GAN.&#160;&#160;We also incurred an increase of $8.0 million of third-party research and development consulting fees, primarily related to GLP toxicology studies and clinical study CRO activities, and $4.7 million in consulting for regulatory and clinical studies.&#160;&#160;Finally, sponsored research agreement expenses increased by $1.2 million.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">General and Administrative Expenses </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expenses were $18.4&#160;million for the six months ended June 30, 2021, compared to $1.0 million for the <span style="Background-color:#FFFFFF;color:#000000;">six months ended June 30, 2020. The increase of approximately $17.4 million was</span> primarily attributable to $8.9&#160;million of incremental compensation expense, which included $4.4 million of non-cash stock-based compensation.&#160;&#160;We also incurred an increase of $7.0 million in professional fees related to legal, insurance, investor relations/communications, accounting, personnel recruiting and patient advocacy activities and an increase is $1.5 million in other expenses. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Other </span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income (</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Expense</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Change in Fair Value of Preferred Stock Tranche Liability </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 4, 2020, the Company entered into a purchase agreement (the &#8220;Series A Purchase Agreement&#8221;) providing for a private placement of up to 10,000,000 shares of Series A convertible preferred stock at an original issuance price of $3.00 per share, subject to separate closings, including: (1) 6,000,000 shares at the initial closing on March 4, 2020, and (2) 2,000,000 shares at each of two subsequent closings triggered by the achievement of specific clinical milestones. The Series A Purchase Agreement obligated the Company to issue and sell and the Series A investors to purchase up to a total of 4,000,000 additional shares of Series A convertible preferred stock (the &#8220;Milestone Shares&#8221;) at the same price per share upon the achievement of certain defined clinical milestones (the &#8220;tranche liability&#8221;). We determined that our obligation to issue, and the investors&#8217; right to purchase, additional shares of Series A convertible preferred stock pursuant to the milestone closings represented a freestanding financial instrument, or the tranche liability. The tranche liability was initially recorded at fair value. We concluded that the tranche liability met the definition of a freestanding financial instrument, as it was legally detachable and separately exercisable from the initial closing of the Series A convertible preferred stock. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 30, 2020, ahead of the anticipated closing of the Series B convertible preferred stock financing at an original issuance price of $17.00 per share on July 2, 2020, certain Series A investors elected to exercise in full their options to purchase their pro-rata portion of the Milestone Shares prior to our achievement of the clinical milestones and purchased 200,000 shares of Series A convertible preferred stock. We remeasured the fair value of the entire tranche liability at June 30, 2020, and recognized a non-cash expense of approximately $17.0 million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Capital Resources </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Overview </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since our inception, we have not generated any revenue and have incurred significant operating losses. As of June 30, 2021, we had cash and cash equivalents of $197.4 million. We have funded our operations through equity financings, raising an aggregate of $307.0 million in gross proceeds from our initial public offering and private placements of convertible preferred stock. Specifically, between March and July 2020, we closed on the sale of an aggregate of 10,000,000 shares of Series A convertible preferred stock for gross proceeds of $30.0 million. In July and August 2020, we closed on the sale of an aggregate of 5,647,048 shares of Series B convertible preferred stock for gross proceeds of $96.0 million. In September 2020, we raised gross proceeds of $181.0 million in our initial public offering.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 12, 2021, or the Closing Date, we entered into a Loan and Security Agreement, or the Term Loan Agreement, with the lenders party thereto from time to time, or the Lenders and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders, or the Agent.&#160;&#160;The Term Loan Agreement provides for (i) on the Closing Date, $40.0 million aggregate principal amount of term loans available through December 31, 2021, (ii) from January 1, 2022 until September 30, 2022, an additional $20.0 million term loan facility available at the Company&#8217;s option upon having three distinct and active clinical stage programs at the time of draw, (iii) from October 1, 2022 until March 31, 2023, an additional $20.0 million term loan facility available at our option upon having three distinct and active clinical stage programs at the time of draw and (iv) from April 1, 2023 until December 31, 2023, an additional $20.0 million term loan facility available upon approval by the Agent and the Lenders, or, collectively, the Term Loans. We drew $30.0 million in term loans on the Closing Date.&#160;&#160;The loan repayment schedule provides for interest only payments until August 31, 2024, followed by consecutive monthly payments of principal and interest.&#160;&#160;All unpaid principal and accrued and unpaid interest with respect to each term loan is due and payable in full on August 1, 2026.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Funding Requirements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have not generated any revenues from the commercial sale of approved drug products, and we do not expect to generate substantial revenue for at least the next few years.&#160;If we fail to complete the development of our product candidates in a timely manner or fail to obtain their regulatory approval, our ability to generate future revenue will be compromised. We do not know when, or if, we will generate any revenue from our product candidates, and we do not expect to generate significant revenue unless and until we obtain regulatory approval of, and commercialize, our product candidates. We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the research and development of, initiate clinical trials of and seek marketing approval for our product candidates, as well as build out of our cGMP manufacturing facility in Durham, North Carolina. In addition, if we obtain approval for any of our product candidates, we expect to incur significant commercialization expenses related to sales, marketing, manufacturing and distribution. Furthermore, we expect to incur additional costs associated with operating as a public company. We anticipate that we will need substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce or eliminate our research and development programs or future commercialization efforts. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assuming full access to the $100.0 million </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in term loans under the Term Loan Agreement</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> we entered into on August </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021, we </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expect we </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will be able to fund our operating expenses and capital requirements into </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the second half of 2023</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We intend to devote our existing cash and cash equivalents to the clinical and preclinical development of our product candidates.&#160;We have based this estimate on assumptions that may prove to be imprecise, and we could utilize our available capital resources sooner than we expect. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of the numerous risks and uncertainties associated with research, development and commercialization of biological products, we are unable to estimate the exact amount of our operating capital requirements. Our future funding requirements will depend on many factors, including, but not limited to: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the scope, progress, costs and results of discovery, preclinical development, laboratory testing and clinical trials for TSHA-101, TSHA-118, TSHA-102, TSHA-104, and TSHA-120 and any current and future product candidates that we advance&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the extent to which we develop, in-license or acquire other product candidates and technologies in our gene therapy product candidate pipeline&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the costs and timing of process development and manufacturing scale-up activities associated with our product candidates and other programs as we advance them through preclinical and clinical development&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the number and development requirements of product candidates that we may pursue&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the costs, timing and outcome of regulatory review of our product candidates&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">our headcount growth and associated costs as we expand our research and development capabilities and establish a commercial infrastructure&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the costs of establishing and maintaining our own commercial-scale cGMP manufacturing facility&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales, and distribution, for any of our product candidates for which we receive marketing approval&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the revenue, if any, received from commercial sales of our product candidates for which we receive marketing approval&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the costs of operating as a public company. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Identifying potential product candidates and conducting preclinical studies and clinical trials is a time-consuming, expensive and uncertain process that takes many years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of product candidates that we do not expect to be commercially available in the near term, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the terms of these equity securities or this debt may restrict our ability to operate. The Term Loan Agreement contains negative covenants, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, prepayment of other indebtedness and dividends and other distributions. Any future additional debt financing and equity financing, if available, may involve agreements that include covenants limiting and restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, entering into profit-sharing or other arrangements or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are continuing to assess the effect that the COVID-19 pandemic may have on our business and operations. The extent to which COVID-19 may impact our business and operations will depend on future developments that are highly uncertain and cannot be predicted with confidence, such as the duration of the outbreak, the duration and effect of business disruptions and the short-term effects and ultimate effectiveness of the travel restrictions, quarantines, social distancing requirements and business closures in the United States and other countries to contain and treat the disease, the efficacy, availability and adoption of vaccines, both domestically and globally, <span style="color:#000000;">and the impact of new variants or mutations of the coronavirus, such as the Delta variant</span>. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic may be difficult to assess or predict, a continued and growing pandemic could result in significant disruption of global financial markets, reducing our ability to access capital, which could in the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">future negatively affect our liquidity. In addition, a recession or market correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash Flows </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table shows a summary of our cash flows for the six months ended June&#160;30, 2021 and 2020 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended June 30, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended June 30, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44,851</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,165</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,032</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,000</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,365</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net change in cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(53,883</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,200</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Operating Activities </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the six months ended June 30, 2021, our net cash used in operating activities of $44.9 million primarily consisted of a net loss of $73.0 million, primarily attributable to our spending on research and development expenses.&#160;The net loss of $73.0 million was partially offset by adjustments for non-cash items, primarily the up-front license fee of $5.5 million to HHF related to the acquisition of TSHA-120 and stock-based compensation of $8.1 million.&#160;&#160;The $73.0 million net loss was also partially offset by a $14.1 million source of cash provided by operating assets and liabilities, primarily resulting from an increase in accounts payable and accrued expenses.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> For the six months ended June 30, 2020, operating activities used $4.2 million of cash. Net cash used in operating activities for the six months ended June 30, 2020 was primarily attributable to a $26.7 million net loss and offset by $20.0 million of non-cash items, primarily driven by a change in fair value of our preferred stock tranche liability of $17.0 million liability related to the issuance of Series A convertible preferred stock and the upfront payment to acquire the license rights pursuant to the Queen&#8217;s University Agreement for $3.0 million, which was recorded as a component of research and development expenses. The $26.7 million net loss was also partially offset by a $2.5 million source of cash provided by operating assets and liabilities, primarily resulting from an increase in accounts payable and accrued expenses.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investing Activities</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2021, investing activities used $9.0 million of cash attributable to the up<span style="color:#000000;">front license fee payment of $5.5 million</span> to acquire exclusive worldwide rights to TSHA-120, for the treatment of GAN, and capital expenditures related to our in-house manufacturing facility and office space.&#160;&#160;During the six months ended June 30, 2020, investing activities used $3.0 million of cash attributable to the upfront payment to acquire the license rights pursuant to the Queen&#8217;s University Agreement of $3.0 million.&#160;&#160;&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Financing Activities </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020, financing activities provided $18.4 million of cash, which was primarily attributable to the issuance of 6,200,000 shares of our Series A convertible preferred stock in exchange for gross proceeds of $18.6 million, net of the payment of issuance costs of approximately $0.3 million. In January 2020, we also entered into two secured promissory notes with a related party, our President and Chief Executive Officer, RA Session II, for an aggregate of $1.67 million. During March 2020, we repaid $1.65 million of the notes. The remaining balance of approximately $28,000 was repaid in July 2020.&#160;&#160;No financing activities took place during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Off-Balance Sheet Arrangements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Critical Accounting Policies and Significant Judgments and Estimates </span></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no material changes to our critical accounting policies that are disclosed in our audited consolidated financial statements for the <span style="Background-color:#FFFFFF;color:#000000;">year ended December&#160;31, 2020 </span>filed with the SEC on March 3, 2021.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note&#160;2 to our unaudited condensed consolidated financial statements located in &#8220;Part I &#8211; Financial Information, Item 1. Financial Statements&#8221; in this Quarterly Report on Form 10-Q for a description of recent accounting pronouncements applicable to our condensed consolidated financial statements. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Emerging Growth Company and Smaller Reporting Company Status </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2012, the Jumpstart Our Business Startups Act of 2012, or JOBS Act, was enacted. Section&#160;107 of the JOBS Act provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B) of the Securities Act of 1933, as amended, for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We elected the extended transition period for complying with new or revised accounting standards, which delays the adoption of these accounting standards until they would apply to private companies. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, as an emerging growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">an exception from compliance with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, as amended&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">exemptions from the requirements of holding non-binding advisory votes on executive compensation or golden parachute arrangements&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">an exemption from compliance with the requirements of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the auditor&#8217;s report on financial statements. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may take advantage of these provisions until we no longer qualify as an emerging growth company. We will cease to qualify as an emerging growth company on the date that is the earliest of: (i)&#160;December&#160;31, 2025, (ii)&#160;the last day of the fiscal year in which we have more than $1.07&#160;billion in total annual gross revenues, (iii)&#160;the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the rules of the SEC, which means the market value of our common stock that is held by non-affiliates exceeds $700&#160;million as of the prior June&#160;30th, or (iv)&#160;the date on which we have issued more than $1.0&#160;billion of non-convertible debt over the prior three-year period. We may choose to take advantage of some but not all of these reduced reporting burdens. We have taken advantage of certain reduced reporting requirements in this Quarterly Report on Form 10-Q and our other filings with the SEC. Accordingly, the information contained herein may be different than you might obtain from other public companies in which you hold equity interests. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are also a &#8220;smaller reporting company,&#8221; meaning that the market value of our shares held by&#160;non-affiliates is less than $700&#160;million and our annual revenue was less than $100&#160;million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i)&#160;the market value of our shares held by&#160;non-affiliates&#160;is less than $250&#160;million or (ii)&#160;our annual revenue was less than $100&#160;million during the most recently completed fiscal year and the market value of our shares held by&#160;non-affiliates&#160;is less than $700&#160;million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on&#160;Form&#160;10-K&#160;and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this Item.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_4_CONTROLS_PROCEDURES">Item 4. Controls and Procedures.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Evaluation of Disclosure Controls and Procedures</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act ), as of the end of the period covered by this Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of&#160;June 30, 2021, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by us in this Form 10-Q was (a) reported<span style="Background-color:#FFFFFF;color:#000000;font-family:Arial;"> </span>within the time periods specified by SEC rules and regulations, and (b) communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding any required disclosure.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Changes in Internal Control Over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no changes in our internal control over financial reporting identified in management&#8217;s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Inherent Limitations on Effectiveness of Internal Controls</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IIOR_INFORMATION">PART II&#8212;OTHER INFORMATION</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_LEGAL_PROCEEDINGS">Item 1. Legal Proceedings.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not subject to any material legal proceedings. From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1A_RISK_FACTORS">Item 1A. Risk Factors.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business is subject to risks and events that, if they occur, could adversely affect our financial condition and results of operations and the trading price of our securities. In addition to the other information set forth in this quarterly report on Form 10-Q, you should carefully consider the factors described in Part I, Item 1A. &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the Securities and Exchange Commission on March 3, 2021. Other than as described below,<span style="font-weight:bold;"> t</span>here have been no material changes to the risk factors described in that report.</p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our existing indebtedness contains restrictions that potentially limit our flexibility in operating our business. In addition, we may be required to make a prepayment or repay our outstanding indebtedness earlier than we expect.</p>
<p style="margin-top:5pt;margin-bottom:0pt;text-indent:4.53%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;12, 2021, we entered into a Loan and Security Agreement, or the Term Loan Agreement, with the lenders party thereto from time to time, or the Lenders, and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders, or the Agent, which provides for term loans of up to $100.0&#160;million in the aggregate available in four tranches. The Term Loan Agreement contains various covenants that limit our ability to engage in specified types of transactions. These covenants limit our ability to, among other things:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">incur or assume certain debt&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">merge or consolidate or acquire all or substantially all of the capital stock or property of another entity&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">change the nature of our business&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">change our organizational structure or type&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">license, transfer, or dispose of certain assets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">grant certain types of liens on our assets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">make certain investments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">pay cash dividends&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-top:5pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">enter into material transactions with affiliates.</span></p></td></tr></table></div>
<p style="margin-top:5pt;margin-bottom:0pt;text-indent:4.53%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A breach of any of these covenants could result in an event of default under the Term Loan Agreement. An event of default will also occur if, among other things, a material adverse change in our business, operations, or condition occurs, which could potentially include a material impairment of the prospect of our repayment of any portion of the amounts we owe under the Term Loan Agreement. In the case of a continuing event of default under the Term Loan Agreement, the lenders could elect to declare all amounts outstanding to be immediately due and payable, proceed against the collateral in which we granted the Lenders a security interest under the Term Loan Agreement, or otherwise exercise the rights of a secured creditor. Amounts outstanding under the Term Loan Agreement are secured by all of our existing and future assets, excluding intellectual property, which is subject to a negative pledge arrangement.</p>
<p style="margin-top:5pt;margin-bottom:0pt;text-indent:4.53%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At closing, we drew on $30.0 million of the $40.0 million available to us as part of the first tranche. The Term Loan Agreement also gives us the ability to access an additional $60.0 million at our option, of which $40.0 million may be drawn in two additional tranches subject to the achievement of certain specified conditions and of which $20.0 million may be drawn in an additional tranche with the approval of the Agent and the Lenders. If we are unable to satisfy these or other required conditions, or if the Agent and Lenders do not consent, as applicable, we would not be able to draw down the remaining tranches of financing and may not be able to obtain alternative financing on commercially reasonable terms or at all, which could adversely impact our business.</p>
<p style="margin-top:5pt;margin-bottom:0pt;text-indent:4.53%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not have enough available cash to repay or refinance our indebtedness at the time any such repayment is required. In such an event, we may be required to delay, limit, reduce, or terminate our preclinical and clinical product development or commercialization efforts or <span style="color:#000000;">build out of our cGMP manufacturing facility </span>or grant others rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. Our business, financial condition, and results of operations could be materially adversely affected as a result.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(a) Recent Sales of Unregistered Equity Securities</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.<span style="font-weight:bold;"> </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(b) Use of Proceeds</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 23, 2020, our Registration Statement on Form S-1, as amended (File No. 333-248559), was declared effective in connection with our initial public offering, pursuant to which we sold an aggregate of 9,050,000 shares of our common stock for aggregate net proceeds of $165.9&#160;million. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There has been no material change in the planned use of proceeds from our initial public offering as described in our prospectus filed pursuant to Rule&#160;424(b)(4) under the Securities Act with the SEC on September 25, 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(c) Issuer Purchases of Equity Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES">Item 3. Defaults Upon Senior Securities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_4_MINE_SAFETY_DISCLOSURES">Item 4. Mine Safety Disclosures.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_5_OR_INFORMATION">Item 5. Other Information.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Term Loan Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 12, 2021, or the Closing Date, the Company entered into a Loan and Security Agreement, or the Term Loan Agreement, by and among the Company, the lenders party thereto from time to time, or the Lenders, and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders, or the Agent.&#160;&#160;The Term Loan Agreement provides for (i) on the Closing Date, $40.0 million aggregate principal amount of term loans available through December 31, 2021, (ii) from January 1, 2022 until September 30, 2022, an additional $20.0 million term loan facility available at the Company&#8217;s option upon having three distinct and active clinical stage programs at the time of draw, (iii) from October 1, 2022 until March 31, 2023, an additional $20.0 million term loan facility available at the Company&#8217;s option upon having three distinct and active clinical stage programs at the time of draw and (iv) from April 1, 2023 until December 31, 2023, an additional $20.0 million term loan facility available upon approval by the Agent and the Lenders, or collectively, the Term Loans. The Company drew $30.0 million in term loans on the Closing Date.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The obligations under the Term Loan Agreement are secured by a perfected security interest in all of the Company&#8217;s assets except for intellectual property and certain other customarily excluded property pursuant to the terms of the Term Loan Agreement.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The interest rate applicable to the Term Loans is the greater of (a) the WSJ Prime Rate plus 3.75% or (b) 7.00% per annum.&#160;&#160;The Term Loans are interest only from the Closing Date through August 31, 2024, after which the Company is required to pay equal monthly installments of principal through August 1, 2026, the maturity date.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Term Loans may be prepaid in full through August 12, 2022 with payment of a 2.00% prepayment premium, after which they may be prepaid in full through August 12, 2023 with payment of a 1.00% prepayment premium, after which they may be prepaid in full with no prepayment premium. An additional final payment of 7.5% of the amount of Terms Loans advanced by the Lenders will be due upon prepayment or repayment of the Term Loans in full.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Term Loan Agreement contains customary representations and warranties and customary affirmative and negative covenants, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, prepayment of other indebtedness and dividends and other distributions.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Term Loan Agreement also includes customary events of default, including failure to pay principal, interest or certain other amounts when due, material inaccuracy of representations and warranties, violation of covenants, specified cross-default and cross-acceleration to other material indebtedness, certain bankruptcy and insolvency events, certain undischarged judgments, material invalidity of guarantees or grant of security interest, material adverse change, involuntary delisting from Nasdaq and change of control, in certain cases subject to certain thresholds and grace periods. If one or more events of default occurs and continues beyond any applicable cure period, the Agent may, with the consent of the Lenders holding a majority of the loans and commitments under the facilities, or will, at the request of such Lenders, terminate the commitments of the Lenders to make further loans and declare all of the obligations of the Company under the Term Loan Agreement to be immediately due and payable.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing description of the Term Loan Agreement is not intended to be complete and is qualified in its entirety by reference to the Term Loan Agreement, a copy of which is filed as Exhibit 10.2 to this Quarterly Report on Form 10-Q.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_6_EXHIBITS"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Item 6. E</span><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">xhibits.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The exhibits listed on the Exhibit Index are either filed or furnished with this report or incorporated herein by reference.&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1806310/000119312520257858/d78879dex31.htm"><span style="text-decoration:underline;">Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-39536), filed with the </span><span style="Background-color:#FFFFFF;text-decoration:underline;">Securities and Exchange Commission on September 29, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1806310/000119312520247565/d938924dex34.htm"><span style="text-decoration:underline;">Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K (File No. 001-39536), filed with the </span><span style="Background-color:#FFFFFF;text-decoration:underline;">Securities and Exchange Commission on September 29, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="tsha-ex101_249.htm"><span style="text-decoration:underline;">Lease Agreement, dated January 11, 2021, by and between Pegasus Place, LLC and the Company.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="tsha-ex102_932.htm"><span style="text-decoration:underline;">Loan and Security Agreement, dated August 12, 2021, by and among the Company, the lenders party thereto from time to time and Silicon Valley Bank, as administrative agent and collateral agent.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">31.1*</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="tsha-ex311_7.htm"><span style="text-decoration:underline;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">31.2*</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="tsha-ex312_6.htm"><span style="text-decoration:underline;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">32.1*#</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="tsha-ex321_9.htm"><span style="text-decoration:underline;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">32.2*#</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="tsha-ex322_8.htm"><span style="text-decoration:underline;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.INS</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.SCH</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Schema Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.CAL</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.DEF</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Definition Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.LAB</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Label Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.PRE</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">104</span></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:77.78%;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Filed herewith.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">#</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section&#160;1350, and are not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.&#160;</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:-4.54%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="SIGNATURES">SIGNATURES</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company Name</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 16, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ RA Session II</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">RA Session II</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 16, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Kamran Alam</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Kamran Alam</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Financial and Accounting Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tsha-ex101_249.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tsha-ex101_249.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>
<div style="width:100%;border-top:Solid 0.75pt #000000;border-bottom:Solid 0.75pt #000000;">
<div style="padding-Top:6.06%;padding-Bottom:6.06%;">

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.1</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_Ref136931945"></a><a name="_Ref136931945"></a>LEASE AGREEMENT BETWEEN</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">PEGASUS PARK, LLC,</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">AS LANDLORD, AND</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">TAYSHA GENE THERAPIES, INC.,</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">AS TENANT</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">DATED January 8, 2021</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">3000 Pegasus park drive<br />dallas, TEXAS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="text-decoration:underline;">BASIC LEASE INFORMATION</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:bold;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:22.97%;"></td>
<td style="width:25.44%;"></td>
<td style="width:12.95%;"></td>
<td style="width:12.72%;"></td>
<td style="width:25.92%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Date:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 8, 2021</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord</a>:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park, LLC, a Delaware limited liability company </p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc., a Delaware corporation</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premises:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Suite No.&#160;1430, containing approximately 15,000 rentable square feet, on the 14<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> floor of the office building commonly known as the Tower (the "<font style="font-weight:bold;text-decoration:underline;">Building</font>"), and whose street address is 3000 Pegasus Park Drive, Dallas, Texas 75247.&nbsp;&nbsp;The Premises are outlined on the plan attached to the Lease as <font style="text-decoration:underline;">Exhibit A</font>.&nbsp;&nbsp;The land on which the Building is located (the "<font style="font-weight:bold;text-decoration:underline;">Land</font>") is described on <font style="text-decoration:underline;">Exhibit B</font>.&nbsp;&nbsp;The term "<font style="font-weight:bold;text-decoration:underline;">Project</font>" shall collectively refer to the Building, the Land and the driveways, parking facilities, and similar improvements and easements associated with the foregoing or the operation thereof. &nbsp;&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120 full calendar months, plus any partial month from the Commencement Date to the end of the month in which the Commencement Date falls, starting on the Commencement Date and ending at 5:00&#160;p.m. local time on the last day of the 120th full calendar month following the Commencement Date, subject to adjustment and earlier termination as provided in the Lease.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commencement Date:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The&nbsp;&nbsp;date on which the Work (as defined in <font style="text-decoration:underline;">Exhibit D</font> hereto) in the Premises is Substantially Completed (as defined in <font style="text-decoration:underline;">Exhibit D</font> hereto) and possession of the Premises is tendered to Tenant in a condition that is ready for occupancy and business operations; provided that may be occupied in two phases during 2021.</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic Rent:</p></td>
<td colspan="4" valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic Rent shall be the following amounts for the following periods of time:</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Month</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Annual Basic Rent Rate Per Rentable Square Foot</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Monthly Basic Rent</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1 - 12</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$26.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$32,500.00</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13 &#8211; 24</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$27.30</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$34,125.00</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25 &#8211; 36</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$28.67</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$35,831.25</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37 &#8211; 48</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$30.10</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$37,622.81</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49 &#8211; 60</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$31.60</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$39,503.95</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61 &#8211; 72</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$33.18</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$41,479.15</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73 &#8211; 84</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$34.84</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$43,553.11</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85 &#8211; 96</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$36.58</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$45,730.76</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97 &#8211; 108</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$38.41</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$48,017.30</p></td>
</tr>
<tr>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109 &#8211; 120</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$40.33</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$50,418.17</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="4" valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As used herein, the term "<font style="font-weight:bold;text-decoration:underline;">Lease Month</font>" means each calendar month during the Term (and if the Commencement Date does not occur on the first day of a calendar month, the period from the Commencement Date to the first day of the next calendar month shall be included in the first Lease Month for purposes of determining the duration of the Term and the monthly Basic Rent rate applicable for such partial month).</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Security Deposit:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$32,500.00.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic Rent, Tenant's Proportionate Share of Taxes and Electrical Costs, Tenant's share of Additional Rent, and all other sums that Tenant may owe to Landlord or otherwise be required to pay under the Lease.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permitted Use:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General office and related ancillary uses.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant's Proportionate Share:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.78%, which is the percentage obtained by dividing (a)&#160;the number of rentable square feet in the Premises as stated above by (b)&#160;the 538,668 rentable square feet in the Building.&nbsp;&nbsp;Landlord and Tenant stipulate that the number of rentable square feet in the Premises and in the Building set forth above were measured in accordance with the Building Owners and Managers Association International Modified Standard Method for Measuring Floor Area in Office Buildings, ANSI/BOMA Z65.1-2010, Method B and are conclusive and shall be binding upon them.</p></td>
</tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies)</p></td>
<td valign="top"  style="width:10%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:22.97%;"></td>
<td style="width:25.44%;"></td>
<td style="width:12.95%;"></td>
<td style="width:12.72%;"></td>
<td style="width:25.92%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expense Stop</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">:</font></p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable (triple net lease).</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Base Tax Year:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable (triple net lease).</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial Liability Insurance Amount:</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2,000,000</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant's Address:</p></td>
<td colspan="2" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all notices:<br />Taysha Gene Therapies, Inc. <br />2280 Inwood Road<br />Dallas, Texas 75235<br />Attention: Kamran Alam, CFO</p></td>
<td colspan="2" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With a copy to:<br />Cooley LLP</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11951 Freedom Drive, 16<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor<br />Reston, Virginia 20190<br />Attention: Peter N. Crain<br />Telephone: 703-456-8189</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord's Address:</p></td>
<td colspan="2" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all Notices:<br />Pegasus Park, LLC</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">P.O. Box 35828</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dallas, Texas 75235</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention:&nbsp;&nbsp;Property Manager <br />Telephone:&nbsp;&nbsp;214-351-6300<br /></p></td>
<td colspan="2" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With a copy to:<br />J. Small Investments<br />P.O. Box 35828</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dallas, Texas 75235</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention:&nbsp;&nbsp;General Counsel<br />Telephone:&nbsp;&nbsp;214-351-6300<br /></p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies)</p></td>
<td valign="top"  style="width:10%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ii</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing Basic Lease Information is incorporated into and made a part of the Lease identified above.&nbsp;&nbsp;If any conflict exists between any Basic Lease Information and the Lease, then the Lease shall control.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD:</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PEGASUS PARK, LLC, </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Delaware limited liability company</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Justin A. Small</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT:</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TAYSHA GENE THERAPIES, INC.,<br />a Delaware corporation</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies)</p></td>
<td valign="top"  style="width:10%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">iii</a></p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a><font style="text-decoration:underline;">LEASE</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Lease Agreement (this "<font style="font-weight:bold;text-decoration:underline;">Lease</font></a>") is entered into as of January 8, 2021, between Pegasus Park, LLC, a Delaware limited liability company ("<font style="font-weight:bold;text-decoration:underline;">Landlord</font>"), and Taysha Gene Therapies, Inc., a Delaware corporation ("<font style="font-weight:bold;text-decoration:underline;">Tenant</font>").</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926661"></a>1.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Definitions and Basic Provisions</font>.&nbsp;&nbsp;The definitions and basic provisions set forth in the Basic Lease Information (the "<font style="font-weight:bold;text-decoration:underline;">Basic Lease Information</font>") executed by Landlord and Tenant contemporaneously herewith are incorporated herein by reference for all purposes.&nbsp;&nbsp;Additionally, the following terms shall have the following meanings when used in this Lease: "<font style="font-weight:bold;text-decoration:underline;">Affiliate</font>" means any person or entity which, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with the party in question; "<font style="font-weight:bold;text-decoration:underline;">Building's Structure</font>" means the Building's exterior walls, roof, elevator shafts, footings, foundations, structural portions of load-bearing walls, structural floors and subfloors, and structural columns and beams; "<font style="font-weight:bold;text-decoration:underline;">Building's Systems</font>" means the Building's HVAC, life-safety, plumbing, electrical, and mechanical systems; "including" means including, without limitation; "<font style="font-weight:bold;text-decoration:underline;">Law</font>s" means all federal, state, and local laws, ordinances, rules and regulations, all court orders, governmental directives, and governmental orders and all interpretations of the foregoing, and all restrictive covenants affecting this Lease or the Project, and "<font style="font-weight:bold;text-decoration:underline;">Law</font>" means any of the foregoing; "<font style="font-weight:bold;text-decoration:underline;">Tenant's Off-Premises Equipment</font>" means any of Tenant's equipment or other property that may be located on or about the Project (other than inside the Premises); and "<font style="font-weight:bold;text-decoration:underline;">Tenant Party</font>" means any of the following persons:&nbsp;&nbsp;Tenant; any assignees claiming by, through, or under Tenant; any subtenants claiming by, through, or under Tenant; and any of their respective agents, contractors, employees, licensees, guests and invitees; and &#8220;<font style="font-weight:bold;text-decoration:underline;">Landlord Party</font>&#8221; means any of the following persons:&nbsp;&nbsp;Landlord and any of their respective agents, contractors, employees, guests, invitees, assignees and licensees.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926662"></a>2.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Lease Grant</font>.&nbsp;&nbsp;Subject to the terms of this Lease, Landlord leases to Tenant, and Tenant leases from Landlord, the Premises together with the right in common with others to use any portions of the Project that are designated by Landlord for the common use of tenants and others, such as, without limitation, sidewalks, common corridors, driveways, parking areas, elevators, stairways, the Amenities (defined herein), vending areas, lobby areas, and, with respect to multi-tenant floors, restrooms and elevator foyers.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506181942"></a><a name="_Toc136926663"></a><a name="_Ref136931968"></a><a name="_Ref136931983"></a>3.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Tender of Possession</font>.&nbsp;&nbsp;Landlord and Tenant presently anticipate that possession of the Premises will be tendered to Tenant in the condition required by this Lease on or about April 15, 2021 (the "<font style="font-weight:bold;text-decoration:underline;">Estimated Delivery Date</font>").&nbsp;&nbsp;If Landlord is unable to tender possession of the Premises in such condition to Tenant by the Estimated Delivery Date, then (a)&#160;the validity of this Lease shall not be affected or impaired thereby, (b)&#160;Landlord shall not be in default hereunder or be liable for damages therefor, and (c)&#160;Tenant shall accept possession of the Premises when Landlord tenders possession thereof to Tenant.&nbsp;&nbsp;Notwithstanding the foregoing, if Landlord does not deliver possession of the Premises in the condition required by May 31, 2021 (subject to extension due to Tenant Delay or Force Majeure), Tenant may terminate this Lease by delivering written notice to Landlord.&nbsp;&nbsp;Upon any such termination pursuant to this <font style="text-decoration:underline;">Section 3</font> Landlord shall return to Tenant the Security Deposit and any prepaid Basic Rent or Additional Rent and shall promptly reimburse Tenant for all hard and soft costs incurred by Tenant related to the design and construction of the tenant improvements (as described in this Lease and Exhibit D) and all costs incurred for furniture purchased for the Premises, and Landlord shall be entitled to retain all such improvements and furniture.&nbsp;&nbsp;By occupying the Premises, Tenant shall be deemed to have accepted the Premises in their condition as of the date of such occupancy, subject to the performance of punch-list items that remain to be performed by Landlord, if any, and any termination right pursuant to this Section shall be considered null and void.&nbsp;&nbsp;Prior to occupying the Premises, Tenant shall execute and deliver to Landlord a letter substantially in the form of <font style="text-decoration:underline;">Exhibit E</font> hereto confirming (1)&#160;the Commencement Date and the expiration date of the initial Term, (2)&#160;that Tenant has accepted the Premises, and (3)&#160;that Landlord has performed all of its obligations with respect to the Premises (except for punch-list items specified in such letter); however, the failure of the parties to execute such letter shall not defer the Commencement Date or otherwise invalidate this Lease.&nbsp;&nbsp;Occupancy of the Premises by Tenant prior to the Commencement Date shall be subject to all of the provisions of this Lease excepting only those requiring the payment of Basic Rent, Additional Rent, Taxes and Electrical Costs (each as defined herein).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926664"></a><a name="_Ref136932032"></a><a name="_Ref136932203"></a><a name="_Ref136932316"></a><a name="_Ref136932436"></a><a name="_Ref136932456"></a><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font><font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Rent</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926665"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Payment</font>.&nbsp;&nbsp;Tenant shall timely pay to Landlord Rent, without notice, demand, deduction or set off (except as otherwise expressly provided herein), by good and sufficient funds at Landlord's address provided for in this Lease or as otherwise specified by Landlord and shall be accompanied by all applicable state and local sales or use taxes.&nbsp;&nbsp;The obligations of Tenant to pay Basic Rent and other sums to Landlord and the obligations of Landlord under this Lease are independent obligations.&nbsp;&nbsp;Basic Rent, adjusted as herein provided, shall be payable monthly in advance.&nbsp;&nbsp;The first monthly installment of Basic Rent shall be payable contemporaneously with the execution of this Lease; thereafter, Basic Rent shall be payable on the first day of each month beginning on the first day of the second full calendar month of the Term.&nbsp;&nbsp;The monthly Basic Rent for any partial month at the beginning of the Term shall equal the product of 1/365 of the annual Basic Rent in effect during the partial month and the number of days in the partial month, and shall be due on the Commencement Date.&nbsp;&nbsp;Payments of Basic Rent for any fractional calendar month at the end of the Term shall be similarly prorated.&nbsp;&nbsp;Tenant shall pay Additional Rent at the same time and in the same manner as Basic Rent.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506102758"></a><a name="_Toc136926666"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Operating Costs; Taxes; Electrical Costs</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)<font style="margin-left:36pt;"></font>Commencing on the Commencement Date, Tenant shall pay to Landlord the amount (per each rentable square foot in the Premises) ("<font style="font-weight:bold;text-decoration:underline;">Additional Rent</font></a>") equal to the annual Operating Costs (defined below) per rentable square foot in the Building (calculated using Tenant's Proportionate Share of Operating Costs).&nbsp;&nbsp;Landlord may make a good faith estimate of the Additional Rent to be due by Tenant for any calendar year or part thereof during the Term.&nbsp;&nbsp;During each calendar year or partial calendar year of the Term, Tenant shall pay to Landlord, in advance concurrently with each monthly installment of Basic Rent, an amount equal to the estimated Additional Rent for such calendar year or part thereof divided by the number of months therein.&nbsp;&nbsp;From time to time, Landlord may estimate and re-estimate the Additional Rent to be due by Tenant and deliver a copy of the estimate or re-estimate to Tenant.&nbsp;&nbsp;Thereafter, the monthly installments of Additional Rent payable by Tenant shall be appropriately adjusted in accordance with the estimations so that, by the end of the calendar year in question, Tenant shall have paid all of the Additional Rent as estimated by Landlord.&nbsp;&nbsp;Any amounts paid based on such an estimate shall be subject to adjustment as herein provided when actual Operating Costs are available for each calendar year.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506184461"></a><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>(2)<font style="margin-left:36pt;"></font>The term "<font style="font-weight:bold;text-decoration:underline;">Operating Costs</font>" means all expenses and disbursements (subject to the limitations set forth below) that Landlord actually incurs in connection with the ownership, operation, and maintenance of the Project, determined in accordance with sound accounting principles consistently applied, including the following costs:  (A)&#160;wages and salaries of all on-site employees at or below the grade of senior building manager engaged in the operation, maintenance or security of the Project (together with Landlord's reasonable allocation of expenses of off-site employees at or below the grade of senior building manager who perform a portion of their services in connection with the operation, maintenance or security of the Project), including taxes, insurance and benefits relating thereto; (B)&#160;all supplies and materials used in the operation, maintenance, repair, replacement, and security of the Project; (C)&#160;costs for improvements made to the Project which, although capital in nature, are expected to reduce the normal operating costs (including all utility costs) of the Project, as amortized using a commercially reasonable interest rate over the time period reasonably estimated by Landlord to recover the costs thereof taking into consideration the anticipated cost savings and the useful economic life of such improvements, as determined by a third&#8209;party engineering or professional consulting firm engaged by Landlord using its good faith, commercially reasonable judgment, as well as capital improvements made in order to comply with any Law hereafter promulgated by any governmental authority or any interpretation hereafter rendered with respect to any existing Law, as amortized using a commercially reasonable interest rate over the useful economic life of such improvements as determined by a third&#8209;party engineering or professional consulting firm engaged by Landlord in its reasonable discretion; (D)&#160;cost of all utilities, except Electrical Costs and the cost of other utilities reimbursable to Landlord by the Project's tenants other than pursuant to a provision similar to this <font style="text-decoration:underline;">Section&#160;4(b)</font>; (E)&#160;insurance expenses for the Project; (F)&#160;repairs, replacements, and general maintenance of the Project; and (G)&#160;&#160;service, maintenance and management contracts with independent contractors for the operation, maintenance, management, repair, replacement, or security of the Project (including alarm service, window cleaning, and elevator maintenance).&nbsp;&nbsp;If the Building is part of a multi-building office complex (the </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 2</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">"</font><font style="font-weight:bold;text-decoration:underline;">Complex</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">"), Operating Costs, Taxes and Electrical Costs for the Complex may be prorated among the Project and the other buildings of the Complex, as reasonably determined by Landlord.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating Costs shall not include costs for (i)&#160;capital improvements made to the Building, other than capital improvements described in <font style="text-decoration:underline;">Section&#160;4(b)(2)(C)</font> and except for items which are generally considered maintenance and repair items, such as painting of common areas, replacement of carpet in elevator lobbies, and the like; (ii)&#160;repair, replacements and general maintenance paid by proceeds of insurance or by Tenant or other third parties; (iii)&#160;interest, amortization or other payments on loans to Landlord; (iv)&#160;depreciation; (v)&#160;leasing commissions; (vi)&#160;legal expenses for services, other than those that benefit the Project tenants generally (e.g., tax disputes); (vii)&#160;renovating or otherwise improving space for occupants of the Project or vacant space in the Project; (viii)&#160;Taxes; (ix)&#160;federal income taxes imposed on or measured by the income of Landlord from the operation of the Project; (x) expenses (including attorneys' fees) incident to Landlord's enforcement of any lease; (xi) ground rental payments; (xii) fines, penalties or damages incurred by Landlord as a result of any violation of law committed by Landlord, or any breach of contract (or breach of lease with other tenants of the Project) committed by Landlord, or Landlord&#8217;s failure to timely pay Taxes or Operating Costs; (xiii) Landlord's advertising, promotional and marketing expenses; (xiv) any costs for which Landlord is reimbursed, including by way of insurance proceeds (or would have been reimbursed if Landlord had maintained the insurance it is required to maintain under this Lease), condemnation awards, warranties, guaranties or otherwise; (xv) costs incurred in connection with the sale, financing, refinancing, mortgaging, selling or change of ownership of the Building, the Land or the Project, including without limitation, brokerage commissions, attorneys' and accountants' fees, closing costs, title insurance premiums, transfer taxes and interest charges; (xvi) costs or expenses of utilities directly metered to tenants of the Building; (xvii) costs associated with any special utilities, services or amenities furnished to any other tenant in the Building which Landlord does not make available to Tenant; (xviii) the cost of any work furnished by Landlord without charge as an inducement for a tenant to lease space (e.g., through improvement allowances); (xix) any compensation paid to clerks, attendants or other persons in commercial concessions operated by Landlord; (xx) costs of any work performed or service provided for which fees are separately charged to Tenant or other compensation received from Tenant (except for fees charged pursuant to provisions similar to this Section 4); costs associated with utilities, services or amenities not available to all tenants and not available to Tenant; and costs associated with utilities, services or amenities provided to any tenant other than Tenant to a materially greater extent or in a materially more favorable manner than generally provided to other tenants (including Tenant), to the extent of the costs associated with such greater extent or more favorable manner of providing such utilities, services or amenities; (xxi) payments for equipment rentals, the cost of which would constitute a capital expenditure if such equipment were purchased; (xxii) costs for sculptures, paintings and other objects of art located in the interior or on the exterior of the Building or immediately adjacent thereto; (xxiii) all amounts that would otherwise be included in Operating Costs which are paid to any affiliate of Landlord, to the extent the costs of such services exceed competitive rates for such services rendered by persons or entities of similar skill, competence and experience; (xxiv) subject to clause (C) above, costs of any repairs, alterations, additions, changes, tools, equipment replacements and the like which under generally accepted accounting principles and practices are properly classified as capital expenditures; (xxv) expenses in connection with repairs or other work occasioned by the exercise of the right of eminent domain; (xxvi) damages incurred due to the negligence or willful misconduct of the Landlord or Landlord&#8217;s agents, employees or contractors; (xxvii) Landlord's general partnership or limited liability company overhead not related to management, operation, maintenance and repair of the Building; (xxviii) bad debt loss, rent loss or reserves for bad debt or rent loss; (xxix) costs of decorating; (xxx) contributions to charitable or political organizations; (xxxi) costs incurred in connection with the operation of any retail operations at the Project that are payable by third parties; (xxxii) any operating costs related to any future expansion of the Building or the Project; (xxxiii) costs which are duplicative, (xxxiv) rent for a management office and rent and expenses for a marketing office, (xxxv) property management fees in excess of five percent (5%) of gross rents for the Project, and (xxxvi) costs incurred to remove any hazardous materials or other toxic material or substances from either the Building or the Premises.&nbsp;&nbsp;In the event there exists a conflict as to an expense which is specified to be included in Operating Costs and is also specified to be excluded from Operating Costs within the above lists, the exclusions listed above shall prevail and the expenses shall be deemed excluded.&nbsp;&nbsp;Landlord shall not recover more than 100% of the Operating Costs actually incurred by Landlord.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall also pay Tenant's Proportionate Share of Taxes for each year and partial year falling within the Term.&nbsp;&nbsp;Tenant shall pay Tenant's Proportionate Share of Taxes in the same manner as provided above for Tenant's Proportionate Share of Operating Costs.&nbsp;&nbsp;"</font><font style="font-weight:bold;text-decoration:underline;">Taxes</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">" means taxes, assessments, and governmental charges or fees whether federal, state, county or municipal, and whether they be by taxing districts or authorities presently taxing or by others, subsequently created or otherwise, and any other taxes and assessments (including non-governmental assessments for common charges under a restrictive covenant or other private agreement that are not treated as part of Operating Costs) now or hereafter attributable to the Project (or its operation), excluding, however, penalties and interest thereon and federal and state taxes on income (if the present method of taxation changes so that in lieu of or in addition to the whole or any part of any Taxes, there is levied on Landlord a capital tax directly on the rents received therefrom or a franchise tax, assessment, or charge based, in whole or in part, upon such rents for the Project, then all such taxes, assessments, or charges, or the part thereof so based, shall be deemed to be included within the term "Taxes</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">" for purposes hereof).&nbsp;&nbsp;Taxes shall include the </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reasonable and actual </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">costs of </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">independent </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">consultants retained in an effort to lower taxes and all </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reasonable and actual </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">costs incurred in disputing any taxes or in seeking to lower the tax valuation of the Project.&nbsp;&nbsp;For property tax purposes, Tenant waives all rights to protest or appeal the appraised value of the Premises, as well as the Project, and all rights to receive notices of reappraisement.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Notwithstanding any of the foregoing, the following shall not be included in Taxes and Tenant shall not be required to pay (i) any municipal, county, state or federal income tax, or (ii) any inheritance, estate, succession, transfer, franchise, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gift, excise, estate, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">corporation, net income or profit tax or capital levy imposed upon Landlord, or (iii) personal income taxes, personal property taxes, or (iv) other tax or assessment levied against Landlord, or penalties or interest on late payments.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall not recover more than 100% of the </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Taxes</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> actually incurred by Landlord</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)<font style="margin-left:36pt;"></font>Tenant shall also pay to Landlord Tenant's Proportionate Share of the cost of all electricity used by the Project ("<font style="font-weight:bold;text-decoration:underline;">Electrical Costs</font></a>").&nbsp;&nbsp;Such amount shall be payable in monthly installments on the Commencement Date and on the first day of each calendar month thereafter.&nbsp;&nbsp;Each installment shall be based on Landlord's estimate of the amount due for each month.&nbsp;&nbsp;From time to time during any calendar year, Landlord may estimate or re-estimate the Electrical Costs to be due by Tenant for that calendar year and deliver a copy of the estimate or re-estimate to Tenant.&nbsp;&nbsp;Thereafter, the monthly installments of Electrical Costs payable by Tenant shall be appropriately adjusted in accordance with the estimations.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)<font style="margin-left:36pt;"></font>By April&#160;1 of each calendar year, or as soon thereafter as practicable, Landlord shall furnish to Tenant a detailed statement of Operating Costs and Electrical Costs for the previous year, in each case adjusted as provided in <font style="text-decoration:underline;">Section&#160;4(b)(6)</font>, and of the Taxes for the previous year (the "<font style="font-weight:bold;text-decoration:underline;">Operating Costs and Tax Statement</font></a>").&nbsp;&nbsp;Landlord shall promptly respond to any inquiries and requests for invoices or other information with respect to Operating Costs, Electrical Costs or Taxes.&nbsp;&nbsp;If Tenant's estimated payments of Operating Costs, Electrical Costs or Taxes under this <font style="text-decoration:underline;">Section&#160;4(b)</font> for the year covered by the Operating Costs and Tax Statement exceed Tenant's Proportionate Share of such items as indicated in the Operating Costs and Tax Statement, then Landlord shall promptly credit or reimburse Tenant for such excess; likewise, if Tenant's estimated payments of Operating Costs, Electrical Costs or Taxes under this <font style="text-decoration:underline;">Section&#160;4(b)</font> for such year are less than Tenant's Proportionate Share of such items as indicated in the Operating Costs and Tax Statement, then Tenant shall promptly pay Landlord such deficiency.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506182257"></a><a name="_Hlk37061112"></a>(6)<font style="margin-left:36pt;"></font><a name="_Hlk37061112"></a>With respect to any calendar year or partial calendar year in which the Building is not occupied to the extent of 95% of the rentable area thereof, or Landlord is not supplying services to 95% of the rentable area thereof, the Operating Costs and Electrical Costs for such period which vary with the occupancy of the Building shall, for the purposes hereof, be increased to the amount which would have been incurred had the Building been occupied to the extent of 95% of the rentable area thereof and Landlord had been supplying services to 95% of the rentable area thereof.&nbsp;&nbsp;<font style="color:#000000;">In no event shall the provisions of this Section be used to enable Landlord to collect from tenants of the Project more than one hundred percent (100%) of Operating Costs actually incurred.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a>(7)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Audit Rights</font>. If Tenant disputes the amount set forth in a given Operating Costs and Tax Statement, Tenant shall have the right, at Tenant&#8217;s sole expense, to cause Landlord&#8217;s books and records with respect to the particular calendar year that is the subject of that particular Operating Costs and Tax Statement to be audited by a certified accountant selected by Tenant from a certified public accounting </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 4</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">firm licensed in the state of Texas, provided (i) there is no Event of Default, and (ii) Tenant delivers written notice (the &#8220;</font><font style="font-weight:bold;text-decoration:underline;">Audit Notice</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) to Landlord on or prior to the date that is ninety (90) days after Landlord delivers the Operating Costs and Tax Statement in question to Tenant (such 90-day period, the &#8220;</font><font style="font-weight:bold;text-decoration:underline;">Response Period</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;). If Tenant fails to timely deliver an Audit Notice with respect to a given Operating Costs and Tax Statement, then Tenant&#8217;s right to undertake an Audit with respect to that Operating Costs and Tax Statement and the calendar year to which that particular Operating Costs and Tax Statement relates shall be automatically waived. If such audit reveals that an error was made in the amounts previously charged to Tenant, then Landlord shall credit such excess to future Basic Rent or other monetary obligations provided that such amount shall be promptly paid to Tenant upon the expiration of the Term. If Tenant&#8217;s audit of the amounts reveals an overcharge of five percent (5.0%) or more, Landlord promptly shall reimburse Tenant for the reasonable costs of the audit. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Tenant retains an agent to review Landlord&#8217;s records, the agent must be with a nationally or regionally recognized licensed CPA firm; the audit may not be conducted by an auditor retained on a contingent fee basis.&nbsp;&nbsp;Tenant shall provide Landlord with a copy of any report prepared in connection with such review or audit within seven (7) business days after Tenant&#8217;s receipt of such report.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event Landlord shall </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fail to invoice Tenant for any A</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dditional </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ent pursuant to this section within </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">two</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) year</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then Landlord shall be deemed to have wa</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ived its right to collect such A</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dditional </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ent.&nbsp;&nbsp;In addition, in the event that Landlord shall fail to invoice Tenant for any </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dditional </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ent pursuant to this section within six (6) months following the expiration or termination of the </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erm of this Lease, then Landlord shall be deemed to have waived its right to collect such </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dditional </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ent</font><font style="color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506184749"></a><a name="_Toc136926667"></a><a name="_Ref136940442"></a>5.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Delinquent Payment; Handling Charges</font>.&nbsp;&nbsp;All past due payments required of Tenant hereunder shall bear interest from the date due until paid at the lesser of ten percent per annum or the maximum lawful rate of interest (such lesser amount is referred to herein as the "<font style="font-weight:bold;text-decoration:underline;">Default Rate</font>"); additionally, Landlord, in addition to all other rights and remedies available to it, may charge Tenant a fee equal to five percent of the delinquent payment to reimburse Landlord for its cost and inconvenience incurred as a consequence of Tenant's delinquency.&nbsp;&nbsp;In no event, however, shall the charges permitted under this <font style="text-decoration:underline;">Section&#160;5</font> or elsewhere in this Lease, to the extent they are considered to be interest under applicable Law, exceed the maximum lawful rate of interest.&nbsp;&nbsp;Notwithstanding the foregoing, the late fee and interest charges referenced above shall not be charged with respect to the first occurrence (but not any subsequent occurrence) during any 12-month period that Tenant fails to make payment when due, until five days after Landlord delivers written notice of such delinquency to Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926668"></a>6.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Security Deposit</font>.&nbsp;&nbsp;Contemporaneously with the execution of this Lease, Tenant shall pay to Landlord the Security Deposit, which shall be held by Landlord to secure Tenant's performance of its obligations under this Lease.&nbsp;&nbsp;The Security Deposit is not an advance payment of Rent or a measure or limit of Landlord's damages upon an Event of Default (as defined herein).&nbsp;&nbsp;Landlord may, from time to time following an Event of Default and without prejudice to any other remedy, use all or a part of the Security Deposit to perform any obligation Tenant fails to perform hereunder.&nbsp;&nbsp;Following any such application of the Security Deposit, Tenant shall pay to Landlord on demand the amount so applied in order to restore the Security Deposit to its original amount.&nbsp;&nbsp;Subject to the requirements of, and conditions imposed by, Laws applicable to security deposits under commercial leases, Landlord shall, within the time required by applicable Law, return to Tenant the portion of the Security Deposit remaining after deducting all damages, charges and other amounts permitted by Law (but in any event not later than sixty (60) days after expiration or termination of this Lease).&nbsp;&nbsp;Landlord and Tenant agree that such deductions shall include, without limitation, all damages and losses that Landlord has suffered as a result of any breach of this Lease by Tenant. The Security Deposit may be commingled with other funds, and no interest shall be paid thereon.&nbsp;&nbsp;If Landlord transfers its interest in the Premises, Landlord shall assign the Security Deposit to the transferee and, upon such transfer and the delivery to Tenant of an acknowledgement of the transferee's responsibility for the Security Deposit as provided by Law, Landlord thereafter shall have no further liability for the return of the Security Deposit.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926669"></a><a name="_Ref136932523"></a><a name="_Ref136932550"></a>7.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Obligations</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506184888"></a><a name="_Toc136926670"></a><a name="_Ref136932524"></a><a name="_Ref136932552"></a><a name="_AEIOULastRenderedPageBreakAEIOU10"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Services</font>.&nbsp;&nbsp;Landlord shall use all reasonable efforts to furnish to Tenant the following services of a quality consistent with that provided in other first class office buildings in Dallas, Texas: (1)&#160;hot and cold water at those points of supply provided for general use of tenants of the Building for lavatory, restroom, and drinking purposes; (2)&#160;heated and refrigerated air conditioning ("<font style="font-weight:bold;text-decoration:underline;">HVAC</font>") as appropriate, at such temperatures and in such amounts as are standard for comparable buildings in the vicinity of the Building; (3)&#160;janitorial service to the Premises on weekdays, other than holidays, for Building-standard installations (including cleaning, trash removal, necessary </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 5</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dusting and vacuuming, maintaining towels, tissue and other restroom supplies and such other work as is customarily performed in connection with nightly janitorial services in office complexes similar in construction, location, u</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">se and occupancy to the Building)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and such window washing as may from time to time be reasonably required; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;elevators for ingress and egress to the floor on which the Premises are located, in common with other tenants, provided that Landlord may reasonably limit the number of operating elevators during non-business hours and holidays</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (provided that at least one elevator shall be available to all floors of the Premises at all times and Tenant shall not be charged any fee for its use of the Building freight or passenger elevators)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; and </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;electrical current for equipment whose electrical energy consumption does not exceed normal office usage.&nbsp;&nbsp;Landlord shall maintain the common areas of the Building in reasonably good order and condition, except for damage caused by a Tenant Party.&nbsp;&nbsp;If Tenant desires any of the services specified in </font><font style="text-decoration:underline;">Section&#160;</font><font style="text-decoration:underline;">7(a)(2)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">:&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(A)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;at any time other than between</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7:00 a.m. and 6:00 p.m.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on weekdays and between </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7:00 a.m. and 1:00 p.m.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on Saturday (in each case other than </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">federal </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">holidays), or </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(B</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;on Sunday or holidays, then such services shall be supplied to Tenant upon the written request of Tenant delivered to Landlord before 3:00 p.m. on the business day preceding such extra usage, and Tenant shall pay to Landlord the cost of such services within 30 days after Landlord has delivered to Tenant an invoice therefor.&nbsp;&nbsp;The </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">current estimate of the </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">costs incurred by Landlord in providing</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> such services is $55.00 per hour</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref136600662"></a><a name="_Toc136926671"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Excess Utility Use</font>.&nbsp;&nbsp;Landlord shall not be required to furnish electrical current for equipment that requires more than 120/208 volts or other equipment whose electrical energy consumption exceeds normal office usage.&nbsp;&nbsp;If Tenant's requirements for or consumption of electricity exceed the electricity to be provided by Landlord as described in <font style="text-decoration:underline;">Section&#160;7(a)</font>, Landlord shall, at Tenant's expense, make reasonable efforts to supply such service through the then-existing feeders and risers serving the Building and the Premises, and Tenant shall pay to Landlord the cost of such service within 30 days after Landlord has delivered to Tenant an invoice therefor.&nbsp;&nbsp;Landlord may determine the amount of such additional consumption and potential consumption by any verifiable method.&nbsp;&nbsp;If Tenant&#8217;s equipment exceeds the electrical energy consumption allowed herein, Landlord may take reasonable action to measure such excess consumption, including installation of a separate meter in the Premises installed, maintained, and read by Landlord, at Tenant's expense.&nbsp;&nbsp;Tenant shall not install any electrical equipment requiring special wiring or requiring voltage in excess of 120/208 volts unless approved in advance by Landlord, which approval shall not be unreasonably withheld.&nbsp;&nbsp;Tenant shall not install any electrical equipment requiring voltage in excess of Building capacity unless approved in advance by Landlord, which approval may be withheld in Landlord's sole discretion.&nbsp;&nbsp;The use of electricity in the Premises shall not exceed the capacity of existing feeders and risers to or wiring in the Premises; provided that Landlord represents and warrants to Tenant that the feeders and risers to and wiring in the Premises are sufficient for normal office usage.&nbsp;&nbsp;Any risers or wiring required to meet Tenant's excess electrical requirements shall, upon Tenant's written request, be installed by Landlord, at Tenant's cost, if, in Landlord's judgment, the same are necessary and shall not cause permanent damage to the Building or the Premises, cause or create a dangerous or hazardous condition, entail excessive or unreasonable alterations, repairs, or expenses, or interfere with or disturb other tenants of the Building.&nbsp;&nbsp;If Tenant uses machines or equipment in the Premises which unreasonably affect the temperature otherwise maintained by the air conditioning system or otherwise overload any utility, Landlord may install supplemental air conditioning units or other supplemental equipment in the Premises, and the cost thereof, including the cost of installation, operation, use, and maintenance, in each case, plus an administrative fee of 10% of such cost, shall be paid by Tenant to Landlord within 30 days after Landlord has delivered to Tenant an invoice therefor.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_C431"></a><a name="_DV_X420"></a><a name="_DV_C432"></a><a name="_DV_X422"></a><a name="_DV_C433"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Access</font>.&nbsp;&nbsp;Tenant shall have access to the Building and the Premises (including, without limitation, the parking areas) on a 24 hours per day, 7 days per week and 365 days per year basis.&nbsp;&nbsp;Tenant shall not be charged any fee for its use of the Building loading docks during the Term of this Lease.&nbsp;&nbsp;In the event that any entry doors or elevators of the Building or Premises are monitored for access<a name="_DV_C431"></a> by a key-card, fingerprint or passcode system, <a name="_DV_X420"></a><a name="_DV_C432"></a>Landlord shall provide Tenant with the initial set of all necessary key-cards, access cards or passcodes <a name="_DV_X422"></a><a name="_DV_C433"></a>at no charge on the Commencement Date; thereafter additional sets and replacements of such items shall be provided by Landlord for a reasonable per-set fee.&nbsp;&nbsp;Notwithstanding the foregoing or anything contained in this Lease to the contrary, Tenant shall be allowed to upgrade the security system(s) serving the Premises and to install security cameras or other security devices within the Premises. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926672"></a><a name="_AEIOULastRenderedPageBreakAEIOU11"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Restoration of Services; Abatemen</font><font style="text-decoration:underline;">t</font>.&nbsp;&nbsp;Landlord shall use commercially reasonable efforts to restore any service required of it that becomes unavailable; however, such unavailability shall not render Landlord liable for any damages caused thereby, be a constructive eviction of Tenant, constitute a breach of any implied warranty, or, except as provided in the next sentence, entitle Tenant to any abatement of Tenant's obligations </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 6</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hereunder.&nbsp;&nbsp;If, however, Tenant is prevented from using the Premises because of the unavailability of any such service for a period of </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ten (10)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> consecutive business days</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> following Landlord&#8217;s receipt from Tenant of a written notice regarding such unavailability</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the restoration of which is within Landlord's </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sole</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> control, and such unavailability was not caused by a Tenant Party or a governmental directive, then Tenant shall, as its exclusive remedy be entitled to abatement of </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and Additional Rent</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for eac</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">h consecutive day (after such 10</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-day period) that Tenant is so prevented from using the Premises.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> If such interruption continues for more than thirty (30) consecutive days,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the casualty provisions of this Lease shall govern</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506185072"></a><a name="_Toc136926673"></a>8.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Improvements; Alterations; Repairs; Maintenance</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506185010"></a><a name="_Toc136926674"></a><a name="_Ref136937355"></a><a name="_Ref136939879"></a><a name="_Ref136942081"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Improvements; Alterations</font>.&nbsp;&nbsp;Except as otherwise provided herein and in Exhibit D attached hereto, improvements to the Premises shall be installed at Tenant's expense only in accordance with plans and specifications which have been previously submitted to and approved in writing by Landlord, which approval shall be governed by the provisions set forth in this <font style="text-decoration:underline;">Section&#160;8(a)</font>.&nbsp;&nbsp;No alterations or physical additions in or to the Premises may be made without Landlord's prior written consent, which shall not be unreasonably withheld or delayed; however, Landlord may withhold its consent to any alteration or addition that would adversely affect (in the reasonable discretion of Landlord) the (1)&#160;Building's Structure or the Building's Systems (including the Building's restrooms or mechanical rooms), (2)&#160;exterior appearance of the Building, (3)&#160;appearance of the Building's common areas or elevator lobby areas, or (4)&#160;provision of services to other occupants of the Building.&nbsp;&nbsp;Except as otherwise provided herein, Tenant shall not paint or install lighting or decorations, signs, window or door lettering, or advertising media of any type visible from the exterior of the Premises without the prior written consent of Landlord, which consent shall not be unreasonably withheld or delayed.&nbsp;&nbsp;All alterations, additions, and improvements shall be constructed, maintained, and used by Tenant, at its risk and expense, in accordance with all Laws; Landlord's consent to or approval of any alterations, additions or improvements (or the plans therefor) shall not constitute a representation or warranty by Landlord, nor Landlord's acceptance, that the same comply with sound architectural and/or engineering practices or with all applicable Laws, and Tenant shall be solely responsible for ensuring all such compliance.&nbsp;&nbsp;Notwithstanding anything in this Lease to the contrary, Tenant shall have the right, without Landlord&#8217;s prior consent or approval, to make interior, non-structural additions, improvements and alterations to the Premises, provided that (i) Tenant shall deliver notice to Landlord prior to commencing such additions, improvements or alterations, (ii) the cost of such alterations do not exceed $30,000.00, and (iii) such alterations are performed in a good and workmanlike manner.&nbsp;&nbsp;Unless Landlord states in writing at the time of their giving of consent to a proposed alteration, addition or improvement that all or any element of such alterations, additions or improvements must be removed by Tenant at the expiration or earlier termination of the Term hereof, such alterations, additions or improvements may remain within or upon the Premises at the expiration or other termination of the Term hereof and Tenant shall have no obligation for removal of such alterations, additions and improvements.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926675"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Repairs; Maintenance</font>.&nbsp;&nbsp;Except for Landlord&#8217;s obligations under this Lease, Tenant shall maintain the Premises in a clean, safe, and operable condition, and shall not permit or allow to remain any waste or damage to any portion of the Premises.&nbsp;&nbsp;Additionally, Tenant, at its sole expense, shall repair, replace and maintain in good condition and in accordance with all Laws and the equipment manufacturer's suggested service programs, all portions of the Premises, Tenant's Off-Premises Equipment and all areas, improvements and systems exclusively serving the Premises.&nbsp;&nbsp;Tenant shall repair or replace, subject to Landlord's direction and supervision, any damage to the Building caused by a Tenant Party.&nbsp;&nbsp;If Tenant fails to make such repairs or replacements within 15 days after the occurrence of such damage, then Landlord may make the same at Tenant's cost.&nbsp;&nbsp;If any such damage occurs outside of the Premises, then Landlord may elect to repair such damage at Tenant's expense, rather than having Tenant repair such damage.&nbsp;&nbsp;The actual cost of all maintenance, repair or replacement work performed by Landlord under this <font style="text-decoration:underline;">Section&#160;8</font> shall be paid by Tenant to Landlord within 30 days after Landlord has invoiced Tenant therefor.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc225232766"></a><a name="_AEIOULastRenderedPageBreakAEIOU12"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Repairs</font>.&nbsp;&nbsp;Notwithstanding anything contained in <font style="text-decoration:underline;">Section&#160;8(b)</font> above to the contrary, Landlord shall repair, maintain and, when necessary, replace (a) all  portions of the Building's Structure, including, but not limited to, the roof, foundation, exterior walls, floors, elevators and windows, (b) the parking facilities, Amenities, lighting facilities, landscaping, drainage areas, driveways, plazas, walkways, courtyards and other common areas, and (c) all portions of the Building's Systems, including, but not limited to the plumbing, heating, ventilating, air conditioning and electrical systems and other mechanical equipment and systems serving the Project, all in a manner consistent with other comparable first-class buildings in Dallas, Texas and in compliance with Laws.&nbsp;&nbsp;Landlord shall not be liable to Tenant for any failure to make any such repairs, or to perform any maintenance </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 7</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hereunder</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> unless such failure shall persist for </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">thirty (30) days</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after written notice of the need of such repairs, maintenance or replacement is given to Landlord by Tenant</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (or within such additional period as may be reasonably required, so long as Landlord commences such repairs or replacement within such period and thereafter diligently proceeds to complete the same)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;If </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a material</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">portion of the Premises becomes untenantable or inaccessible because of the need for Landlord&#8217;s repairs for a period of ten (10) consecutive business days following Landlord's receipt from Tenant of a written notice regarding such unavailability, and such unavailability was not caused by a Tenant Party, then Tenant shall, as its exclusive remedy be entitled to an abatement of Rent with respect to that portion of the Premises which is rendered untenantable for each consecutive day </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(after such ten (10) business day period) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that Tenant is so prevented from using the Premises.&nbsp;&nbsp;If such interruption continues for more than thirty (30) consecutive days, the casualty provisions of this Lease shall govern</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926676"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Performance of Work</font>.&nbsp;&nbsp;All work described in this <font style="text-decoration:underline;">Section&#160;8</font> shall be performed only by Landlord or by contractors and subcontractors reasonably approved in writing by Landlord.&nbsp;&nbsp;Tenant shall cause all contractors and subcontractors to procure and maintain insurance coverage naming Landlord, Landlord's property management company and Landlord's asset management company as additional insureds against such risks, in such amounts, and with such companies as Landlord may reasonably require or approve, which approval shall not be unreasonably withheld, conditioned or delayed. Tenant shall provide Landlord with the identities, mailing addresses and telephone numbers of all persons performing work or supplying materials prior to beginning such construction and Landlord may post on and about the Premises notices of non-responsibility pursuant to applicable Laws.&nbsp;&nbsp;All such work shall be performed in accordance with all Laws and in a good and workmanlike manner so as not to damage the Building (including the Premises, the Building's Structure and the Building's Systems).&nbsp;&nbsp;All such work which may affect the Building's Structure or the Building's Systems must be approved by the Building's engineer of record, at Tenant's expense and, at Landlord's election, must be performed by Landlord's usual contractor for such work.&nbsp;&nbsp;All work affecting the roof of the Building must be performed by Landlord's roofing contractor and no such work will be permitted if it would void or reduce the warranty on the roof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506191804"></a><a name="_Toc136926677"></a><a name="_Ref136934274"></a>(e)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Mechanic's Liens</font>.&nbsp;&nbsp;All work performed, materials furnished, or obligations incurred by or at the request of a Tenant Party shall be deemed authorized and ordered by Tenant only, and Tenant shall not permit any mechanic's liens to be filed against the Premises or the Project in connection therewith.&nbsp;&nbsp;Upon completion of any such work, Tenant shall deliver to Landlord final lien waivers from all contractors, subcontractors and materialmen who performed such work.&nbsp;&nbsp;If such a lien is filed, then Tenant shall, within ten days after Landlord has delivered notice of the filing thereof to Tenant (or such earlier time period as may be necessary to prevent the forfeiture of the Premises, the Project or any interest of Landlord therein or the imposition of a civil or criminal fine with respect thereto), either (1)&#160;pay the amount of the lien and cause the lien to be released of record, or (2)&#160;diligently contest such lien and deliver to Landlord a bond or other security reasonably satisfactory to Landlord.&nbsp;&nbsp;If Tenant fails to timely take either such action, then Landlord may pay the lien claim, and any amounts so paid, including expenses and interest, shall be paid by Tenant to Landlord within ten days after Landlord has invoiced Tenant therefor.&nbsp;&nbsp;Landlord and Tenant acknowledge and agree that their relationship is and shall be solely that of "landlord-tenant" (thereby excluding a relationship of "owner-contractor," "owner-agent" or other similar relationships).&nbsp;&nbsp;Accordingly, all materialmen, contractors, artisans, mechanics, laborers and any other persons now or hereafter contracting with Tenant, any contractor or subcontractor of Tenant or any other Tenant Party for the furnishing of any labor, services, materials, supplies or equipment with respect to any portion of the Premises, at any time from the date hereof until the end of the Term, are hereby charged with notice that they look exclusively to Tenant to obtain payment for same.&nbsp;&nbsp;Nothing herein shall be deemed a consent by Landlord to any liens being placed upon the Premises, the Project or Landlord's interest therein due to any work performed by or for Tenant or deemed to give any contractor or subcontractor or materialman any right or interest in any funds held by Landlord to reimburse Tenant for any portion of the cost of such work.&nbsp;&nbsp;Tenant shall defend, indemnify and hold harmless Landlord and its agents and representatives from and against all claims, demands, causes of action, suits, judgments, damages and expenses (including attorneys' fees) in any way arising from or relating to the failure by any Tenant Party to pay for any work performed, materials furnished, or obligations incurred by or at the request of a Tenant Party.&nbsp;&nbsp;This indemnity provision shall survive termination or expiration of this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926678"></a><a name="_AEIOULastRenderedPageBreakAEIOU13"></a>9.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Use</font>.&nbsp;&nbsp;Tenant shall continuously occupy and use the Premises only for the Permitted Use and shall comply with all Laws relating to this Lease and/or the use, condition, access to, and occupancy of the Premises and will not commit waste, overload the Building's Structure or the Building's Systems or subject the Premises to use that would damage the Premises.&nbsp;&nbsp;The population density within the Premises as a whole shall at no time exceed one person for each 200 rentable square feet in the Premises.&nbsp;&nbsp;Notwithstanding anything in this Lease to the contrary, as between </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 8</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord and Tenant, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall bear the risk of complying with Title III of the Americans With Disabilities Act of 1990, any state laws governing handicapped access or architectural barriers, and all rules, regulations, and guidelines promulgated under such laws, as amended from time to time (the "</font><font style="font-weight:bold;text-decoration:underline;">Disabilities Acts</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">") in the Premises, and </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;Landlord shall bear the risk of complying with the Disabilities Acts in the common areas of the Building, other than compliance that is necessitated by the use of the Premises for other than the Permitted Use or as a result of any alterations or additions, including any initial tenant improvement work, made by or on behalf of a Tenant Party (which risk and responsibility shall be borne by Tenant).&nbsp;&nbsp;The Premises shall not be used for any use which is disreputable, creates extraordinary fire hazards, or results in an increased rate of insurance on the Building or its contents, or for the storage of any Hazardous Materials (other than typical office supplies [e.g., photocopier toner] and then only in compliance with all Laws).&nbsp;&nbsp;Tenant shall not use any substantial portion of the Premises for a "call center," any other telemarketing use, or any credit processing use.&nbsp;&nbsp;If, because of a Tenant Party's acts or because Tenant vacates the Premises, the rate of insurance on the Building or its contents increases, then such acts shall be an Event of Default</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> if Tenant does not cure such act or use within thirty (30) days after notice from Landlord</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Tenant shall pay to Landlord the amount of such increase on demand, and acceptance of such payment shall not waive any of Landlord's other rights.&nbsp;&nbsp;Tenant shall conduct its business and control each other Tenant Party so as not to create any nuisance or unreasonably interfere with other tenants or Landlord in its management of the Building.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506189428"></a><a name="_Toc136926679"></a>10.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Assignment and Subletting</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506185276"></a><a name="_Toc136926680"></a><a name="_Ref136932784"></a><a name="_Ref136932805"></a><a name="_Ref136932855"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Transfers</font>.&nbsp;&nbsp;Except as provided in <font style="text-decoration:underline;">Section&#160;10(h)</font>, Tenant shall not, without the prior written consent of Landlord, (1)&#160;assign, transfer, or encumber this Lease or any estate or interest herein, whether directly or by operation of law, (2)&#160;permit any other entity to become Tenant hereunder by merger, consolidation, or other reorganization, (3)&#160;if Tenant is an entity other than a corporation whose stock is publicly traded, permit the transfer of an ownership interest in Tenant so as to result in a change in the current control of Tenant, (4)&#160;sublet any portion of the Premises, (5)&#160;grant any license, concession, or other right of occupancy of any portion of the Premises, or (6)&#160;permit the use of the Premises by any parties other than Tenant (any of the events listed in <font style="text-decoration:underline;">Section&#160;10(a)(1)</font> through <font style="text-decoration:underline;">10(a)(6)</font> being a "<font style="font-weight:bold;text-decoration:underline;">Transfer</font>").</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926681"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Consent Standards</font>.&nbsp;&nbsp;Landlord shall not unreasonably withhold its consent to any assignment or subletting of the Premises, provided that the proposed transferee (1)&#160;is creditworthy, (2)&#160;has a good reputation in the business community, (3)&#160;will use the Premises for the Permitted Use (thus, excluding, without limitation, uses for credit processing and telemarketing) and will not use the Premises in any manner that would conflict with any exclusive use agreement or other similar agreement entered into by Landlord with any other tenant of the Building or Complex, (4)&#160;will not use the Premises, Building or Project in a manner that would materially increase the pedestrian or vehicular traffic to the Premises, Building or Project, (5)&#160;is not a governmental entity, or subdivision or agency thereof, (6)&#160;is not another occupant of the Building or Complex, (7)&#160;is in compliance with the regulations of the Office of Foreign Asset Control ("<font style="font-weight:bold;text-decoration:underline;">OFAC</font>") of the Department of the Treasury (including those named on OFAC's Specially Designated Nationals and Blocked Persons List) and any statute, executive order (including the September&#160;24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit or Support Terrorism), or other governmental action relating thereto; and (8)&#160;is not a person or entity with whom Landlord is then, or has been within the six-month period prior to the time Tenant seeks to enter into such assignment or subletting, negotiating to lease space in the Building or Complex or any Affiliate of any such person or entity; otherwise, Landlord may withhold its consent in its sole discretion.&nbsp;&nbsp;Additionally, Landlord may withhold its consent in its sole discretion to any proposed Transfer if any Event of Default by Tenant then exists.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926682"></a><a name="_AEIOULastRenderedPageBreakAEIOU14"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Request for Consent</font>.&nbsp;&nbsp;If Tenant requests Landlord's consent to a Transfer, then, at least 15 business days prior to the effective date of the proposed Transfer, Tenant shall provide Landlord with a written description of all terms and conditions of the proposed Transfer, copies of the proposed documentation, and the following information about the proposed transferee: name and address of the proposed transferee and any entities and persons who own, control or direct the proposed transferee; reasonably satisfactory information about its business and business history; its proposed use of the Premises; banking, financial, and other credit information; and general references sufficient to enable Landlord to determine the proposed transferee's creditworthiness and character.&nbsp;&nbsp;Concurrently with Tenant's notice of any request for consent to a Transfer, Tenant shall pay to Landlord a fee of $1,000 to defray Landlord's expenses in reviewing such request, and Tenant shall also reimburse Landlord </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 9</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">immediately upon request for its reasonable attorneys' fees incurred in connection with considering any request for consent to a Transfer</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> up to a maximum amount of $1,500</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926683"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Conditions to Consent</font>.&nbsp;&nbsp;If Landlord consents to a proposed Transfer, then the proposed transferee shall deliver to Landlord a written agreement whereby it expressly assumes Tenant's obligations hereunder; however, any transferee of less than all of the space in the Premises shall be liable only for obligations under this Lease that are properly allocable to the space subject to the Transfer for the period of the Transfer.&nbsp;&nbsp;No Transfer shall release Tenant from its obligations under this Lease, but rather Tenant and its transferee shall be jointly and severally liable therefor.&nbsp;&nbsp;Landlord's consent to any Transfer shall not waive Landlord's rights as to any subsequent Transfers.&nbsp;&nbsp;If an Event of Default occurs while the Premises or any part thereof are subject to a Transfer, then Landlord, in addition to its other remedies, may collect directly from such transferee all rents becoming due to Tenant and apply such rents against Rent.&nbsp;&nbsp;Tenant authorizes its transferees to make payments of rent directly to Landlord upon receipt of notice from Landlord to do so following the occurrence of an Event of Default hereunder.&nbsp;&nbsp;Tenant shall pay for the cost of any demising walls or other improvements necessitated by a proposed subletting or assignment.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506189247"></a><a name="_Toc136926684"></a><a name="_Ref136942120"></a>(e)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Attornment by Subtenants</font>.&nbsp;&nbsp;Each sublease by Tenant hereunder shall be subject and subordinate to this Lease and to the matters to which this Lease is or shall be subordinate, and each subtenant by entering into a sublease is deemed to have agreed that in the event of termination, re-entry or dispossession by Landlord under this Lease, Landlord may, at its option, take over all of the right, title and interest of Tenant, as sublandlord, under such sublease, and such subtenant shall, at Landlord's option, attorn to Landlord pursuant to the then executory provisions of such sublease, except that Landlord shall not be (1)&#160;liable for any previous act or omission of Tenant under such sublease, (2)&#160;subject to any counterclaim, offset or defense that such subtenant might have against Tenant, (3)&#160;bound by any previous modification of such sublease not approved by Landlord in writing or by any rent or additional rent or advance rent which such subtenant might have paid for more than the current month to Tenant, and all such rent shall remain due and owing, notwithstanding such advance payment, (4)&#160;bound by any security or advance rental deposit made by such subtenant which is not delivered or paid over to Landlord and with respect to which such subtenant shall look solely to Tenant for refund or reimbursement, or (5)&#160;obligated to perform any work in the subleased space or to prepare it for occupancy, and in connection with such attornment, the subtenant shall execute and deliver to Landlord any instruments Landlord may reasonably request to evidence and confirm such attornment.&nbsp;&nbsp;Each subtenant or licensee of Tenant shall be deemed, automatically upon and as a condition of its occupying or using the Premises or any part thereof, to have agreed to be bound by the terms and conditions set forth in this <font style="text-decoration:underline;">Section&#160;10(e)</font>.&nbsp;&nbsp;The provisions of this <font style="text-decoration:underline;">Section&#160;10(e)</font> shall be self-operative, and no further instrument shall be required to give effect to this provision.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926685"></a>(f)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Cancellation</font>.&nbsp;&nbsp;Landlord may, within 30 days after submission of Tenant's written request for Landlord's consent to an assignment or subletting, cancel this Lease as to the portion of the Premises proposed to be sublet or assigned as of the date the proposed Transfer is to be effective.&nbsp;&nbsp;If Landlord cancels this Lease as to any portion of the Premises, then this Lease shall cease for such portion of the Premises and Tenant shall pay to Landlord all Rent accrued through the cancellation date relating to the portion of the Premises covered by the proposed Transfer.&nbsp;&nbsp;Thereafter, Landlord may lease such portion of the Premises to the prospective transferee (or to any other person) without liability to Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926686"></a>(g)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Additional Compensation</font>.&nbsp;&nbsp;Tenant shall pay to Landlord, immediately upon receipt thereof, the excess of (t)&#160;all compensation received by Tenant for a Transfer less the actual out-of-pocket costs reasonably incurred by Tenant with unaffiliated third parties (i.e., brokerage commissions and tenant finish work) in connection with such Transfer (such costs shall be amortized on a straight-line basis over the term of the Transfer in question) over (u)&#160;the Rent allocable to the portion of the Premises covered thereby.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506185223"></a><a name="_Toc136926687"></a><a name="_Ref136932755"></a>(h)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Permitted Transfers</font>.&nbsp;&nbsp;Notwithstanding Section&#160;10(a), Tenant may Transfer all or part of its interest in this Lease or all or part of the Premises (a "<font style="font-weight:bold;text-decoration:underline;">Permitted Transfer</font>") to the following types of entities (a "<font style="font-weight:bold;text-decoration:underline;">Permitted Transferee</font>") without the written consent of Landlord:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)<font style="margin-left:36pt;"></font>an Affiliate of Tenant;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU15"></a>(2)<font style="margin-left:36pt;"></font>any corporation, limited partnership, limited liability partnership, limited liability company or other business entity in which or with which Tenant, or its corporate successors, Affiliates or </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 10</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">assigns, is merged or consolidated, in accordance with applicable statutory provisions governing merger and consolidation of business entities, so long as </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(A)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;Tenant's obligations hereunder are assumed by the entity surviving such merger or created by such consolidation; and </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(B)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;the Tangible Net Worth of the surviving or created entity is not less than the Tangible Net Worth of Tenant as of the date hereof; or</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)<font style="margin-left:36pt;"></font>any corporation, limited partnership, limited liability partnership, limited liability company or other business entity acquiring all or substantially all of Tenant's assets if such entity's Tangible Net Worth after such acquisition is not less than the Tangible Net Worth of Tenant as of the date hereof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall promptly notify Landlord of any such Permitted Transfer.&nbsp;&nbsp;Tenant shall remain liable for the performance of all of the obligations of Tenant hereunder, or if Tenant no longer exists because of a merger, consolidation, or acquisition, the surviving or acquiring entity shall expressly assume in writing the obligations of Tenant hereunder.&nbsp;&nbsp;Additionally, the Permitted Transferee shall comply with all of the terms and conditions of this Lease, including the Permitted Use, and the use of the Premises by the Permitted Transferee may not violate any other agreements affecting the Premises, the Building, the Complex, Landlord or other tenants of the Building or the Complex that were enforceable against Tenant prior to the Transfer.&nbsp;&nbsp;No later than 30 days after the effective date of any Permitted Transfer, Tenant agrees to furnish Landlord with (A)&#160;copies of the instrument effecting any of the foregoing Transfers (which instrument may be redacted to remove confidential information unrelated to this Lease &#8211; for example, the terms of a merger contained in a merger agreement), (B)&#160;documentation establishing Tenant's satisfaction of the requirements set forth above applicable to any such Transfer, (C)&#160;evidence of insurance as required under this Lease with respect to the Permitted Transferee, and (D)&#160;evidence or a statement of compliance with the regulations of OFAC and any statute, executive order (including the September&#160;24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism), or other governmental action relating thereto, including the name and address of the Permitted Transferee and any entities and persons who own, control or direct the Permitted Transferee.&nbsp;&nbsp;The occurrence of a Permitted Transfer shall not waive Landlord's rights as to any subsequent Transfers. "<font style="font-weight:bold;text-decoration:underline;">Tangible Net Worth</font></a>" means the excess of total assets over total liabilities, in each case as determined in accordance with generally accepted accounting principles consistently applied ("<font style="font-weight:bold;text-decoration:underline;">GAAP</font>"), excluding, however, from the determination of total assets all assets which would be classified as intangible assets under GAAP including goodwill, licenses, patents, trademarks, trade names, copyrights, and franchises.&nbsp;&nbsp;Any subsequent Transfer by a Permitted Transferee shall be subject to the terms of this <font style="text-decoration:underline;">Section&#160;10</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref7942844"></a><a name="_Toc136926688"></a>11.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Insurance; Waivers; Subrogation; Indemnity</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506189464"></a><a name="_Toc136926689"></a><a name="_Ref136934251"></a><a name="OLE_LINK2"></a><a name="_AEIOULastRenderedPageBreakAEIOU16"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Tenant's Insurance</font>.&nbsp;&nbsp;Effective as of the earlier of (1)&#160;the date Tenant enters or occupies the Premises, or (2)&#160;the Commencement Date, and continuing throughout the Term, Tenant shall maintain the following insurance policies: (A)&#160;commercial general liability insurance in amounts of $2,000,000 per occurrence or, following the expiration of the initial Term, such other amounts as Landlord may from time to time reasonably require (and, if the use and occupancy of the Premises include any activity or matter that is or may be excluded from coverage under a commercial general liability policy [e.g., the sale, service or consumption of alcoholic beverages], Tenant shall obtain such endorsements to the commercial general liability policy or otherwise obtain insurance to insure all liability arising from such activity or matter including liquor liability, if applicable in such amounts as Landlord may reasonably require), insuring Tenant, Landlord, Landlord's property management company, Landlord's asset management company and, if requested in writing by Landlord, Landlord's Mortgagee, against all liability for injury to or death of a person or persons or damage to property arising from the use and occupancy of the Premises and (without implying any consent by Landlord to the installation thereof) the installation, operation, maintenance, repair or removal of Tenant's Off-Premises Equipment, (B)&#160;insurance covering the full value of all alterations and improvements and betterments in the Premises, naming Landlord and Landlord's Mortgagee as additional loss payees as their interests may appear, (C)&#160;insurance covering the full value of all furniture, trade fixtures and personal property (including property of Tenant or others) in the Premises or otherwise placed in the Project by or on behalf of a Tenant Party (including Tenant's Off-Premises Equipment), (D)&#160;contractual liability insurance sufficient to cover Tenant's indemnity obligations hereunder (but only if such contractual liability insurance is not already included in Tenant's commercial general liability insurance policy), (E)&#160;worker's compensation insurance (to the extent required under applicable Laws), and (F)&#160;business interruption insurance in an amount reasonable and standard for a similarly situated tenant in the Dallas, Texas market<a name="OLE_LINK2"></a>.&nbsp;&nbsp;Tenant's insurance shall provide primary coverage to Landlord when any policy issued to Landlord provides duplicate or similar coverage, and in such circumstance Landlord's policy will be excess over Tenant's policy.&nbsp;&nbsp;Tenant&#8217;s insurance may have commercially reasonable deductibles.&nbsp;&nbsp;Tenant shall furnish to </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 11</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord certificates of such insurance and such other evidence satisfactory to Landlord of the maintenance of all insurance coverages required hereunder at least </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">two </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">days prior to the earlier of the Commencement Date or the date Tenant enters or occupies the Premises, and at least 15 days prior to each renewal of said insurance, and Tenant shall obtain a written obligation on the part of each insurance company to notify Landlord at least 30 days before cancellation of any such insurance policies.&nbsp;&nbsp;All such insurance policies shall be in form, and issued by companies with a Best's rating of A:VII or better.&nbsp;&nbsp;If Tenant fails to comply with the foregoing insurance requirements or to deliver to Landlord the certificates or evidence of coverage required herein</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of fifteen (15) days&#8217; notice from Landlord</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Landlord, in addition to any other remedy available pursuant to this Lease or otherwise, may, but shall not be obligated to, obtain such insurance and Tenant shall pay to Landlord on demand the premium costs thereof, plus an administrative fee of 15% of such cost.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926690"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Insurance</font>.&nbsp;&nbsp;Throughout the Term of this Lease, Landlord shall maintain, as a minimum, the following insurance policies:&nbsp;&nbsp;(1)&#160;property insurance for the Building's replacement value (excluding property required to be insured by Tenant), less a commercially-reasonable deductible if Landlord so chooses, (2)&#160;commercial general liability insurance in an amount of not less than $2,000,000, and (3) such other insurance coverage as is customarily carried by prudent landlords of comparable buildings in the Dallas, TX market.&nbsp;&nbsp;Landlord may, but is not obligated to, maintain such other insurance and additional coverages as it may deem necessary.&nbsp;&nbsp;The cost of all insurance carried by Landlord with respect to the Project shall be included in Operating Costs.&nbsp;&nbsp;The foregoing insurance policies and any other insurance carried by Landlord shall be for the sole benefit of Landlord and under Landlord's sole control, and Tenant shall have no right or claim to any proceeds thereof or any other rights thereunder.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506189636"></a><a name="_Ref51471936"></a><a name="_Toc136926691"></a><a name="_Ref136933508"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">No Subrogation; Waiver of Property Claims</font>.&nbsp;&nbsp;Landlord and Tenant each waives any claim it might have against the other for any damage to or theft, destruction, loss, or loss of use of any property, to the extent the same is insured against under any insurance policy of the types described in this <font style="text-decoration:underline;">Section&#160;11</font> that covers the Project, the Premises, Landlord's or Tenant's fixtures, personal property, leasehold improvements, or business, or is required to be insured against under the terms hereof, regardless of whether the negligence of the other party caused such Loss (defined below).&nbsp;&nbsp;Additionally, Tenant waives any claim it may have against Landlord for any Loss to the extent such Loss is caused by a terrorist act.&nbsp;&nbsp;Each party shall cause its insurance carrier to endorse all applicable policies waiving the carrier's rights of recovery under subrogation or otherwise against the other party.&nbsp;&nbsp;Notwithstanding any provision in this Lease to the contrary, Landlord, its agents, employees and contractors shall not be liable to Tenant or to any party claiming by, through or under Tenant for (and Tenant hereby releases Landlord and its servants, agents, contractors, employees and invitees from any claim or responsibility for) any damage to or destruction, loss, or loss of use, or theft of any property of any Tenant Party located in or about the Project, caused by casualty, theft, fire, third parties or any other matter or cause, <font style="font-weight:bold;">regardless of whether the negligence of any party caused such loss in whole or in part</font>.&nbsp;&nbsp;Tenant acknowledges that Landlord shall not carry insurance on, and shall not be responsible for damage to, any property of any Tenant Party located in or about the Project.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506189680"></a><a name="_Toc136926692"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Tenant Indemnity</font>.&nbsp;&nbsp;Subject to <font style="text-decoration:underline;">Section&#160;11(c)</font>, Tenant shall defend, indemnify, and hold harmless Landlord and its representatives and agents from and against all claims, demands, liabilities, causes of action, suits, judgments, damages, and expenses (including reasonable attorneys' fees) (a "<font style="font-weight:bold;text-decoration:underline;">Loss</font>") arising from or related to (i) any use or occupancy of the Project by any Tenant Party, (ii) any default in the performance of Tenant&#8217;s obligations under this Lease, or (iii) any damage to any property occurring in, on or about the Premises arising at any time and from any cause whatsoever (except to the extent arising as a result of the negligence or willful misconduct of Landlord or any Landlord Party).&nbsp;&nbsp;The indemnities set forth in this Lease shall survive termination or expiration of this Lease and shall not terminate or be waived, diminished or affected in any manner by any abatement or apportionment of Rent under any provision of this Lease.&nbsp;&nbsp;If any proceeding is filed for which indemnity is required hereunder, the indemnifying party agrees, upon request therefor, to defend the indemnified party in such proceeding at its sole cost utilizing counsel satisfactory to the indemnified party.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU17"></a>(e)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord Indemnity</font>.&nbsp;&nbsp;Subject to <font style="text-decoration:underline;">Section&#160;11(c)</font>, Landlord shall defend, indemnify, and hold harmless Tenant and its representatives and agents from and against any Loss arising from (i) any act, omission, negligence or willful misconduct of a Landlord Party in connection with such Landlord Party&#8217;s use or occupancy of the Project, (ii) any default in the performance of Landlord&#8217;s obligations under this Lease, or (iii) Landlord&#8217;s ownership, management or control of the Building or the Project.&nbsp;&nbsp;The indemnities set forth in this Lease shall survive termination or expiration of this Lease and shall not terminate or be waived, diminished or affected in any manner by </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 12</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any abatement or apportionment of Rent under any provision of this Lease.&nbsp;&nbsp;If any proceeding is filed for which indemnity is required hereunder, the indemnifying party agrees, upon request therefor, to defend the indemnified party in such proceeding at its sole cost utilizing counsel satisfactory to the indemnified party</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926693"></a>12.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Subordination; Attornment; Notice to Landlord's Mortgagee</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926694"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Subordination</font>.&nbsp;&nbsp;This Lease shall be subordinate to any deed of trust, mortgage, or other security instrument (each, a "<font style="font-weight:bold;text-decoration:underline;">Mortgage</font>"), or any ground lease, master lease, or primary lease (each, a "<font style="font-weight:bold;text-decoration:underline;">Primary Lease</font>"), that now or hereafter covers all or any part of the Premises (the mortgagee under any such Mortgage, beneficiary under any such deed of trust, or the lessor under any such Primary Lease is referred to herein as a "<font style="font-weight:bold;text-decoration:underline;">Landlord's Mortgagee</font>"). The provisions of this Section shall be self-operative and no further instrument of subordination shall be required; provided, however, Landlord shall use commercially reasonable efforts to obtain a subordination, non-disturbance, and attornment agreement in favor of Tenant from Landlord&#8217;s Mortgagee in a commercially reasonable and standard form (&#8220;<font style="font-weight:bold;text-decoration:underline;">SNDA</font>&#8221;).&nbsp;&nbsp;The initial form of SNDA is attached hereto as <font style="text-decoration:underline;">Exhibit J</font>.&nbsp;&nbsp;Any Landlord's Mortgagee may elect, at any time, unilaterally, to make this Lease superior to its Mortgage, Primary Lease, or other interest in the Premises by so notifying Tenant in writing. Tenant shall execute and return to Landlord (or such other party designated by Landlord) within ten days after written request therefor such SNDA, in recordable form if required, or, if the Landlord's Mortgagee so elects, the subordination of such Landlord's Mortgagee's Mortgage or Primary Lease to this Lease. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926695"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Attornment</font>.&nbsp;&nbsp;Tenant shall attorn to any party succeeding to Landlord's interest in the Premises, whether by purchase, foreclosure, deed in lieu of foreclosure, power of sale, termination of lease, or otherwise, upon such party's request, and shall execute such commercially reasonable and standard agreements confirming such attornment as such party may reasonably request.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926696"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Notice to Landlord's Mortgagee</font>.&nbsp;&nbsp;Tenant shall not seek to enforce any remedy it may have for any default on the part of Landlord without first giving written notice by certified mail, return receipt requested, specifying the default in reasonable detail, to any Landlord's Mortgagee whose address has been given to Tenant, and affording such Landlord's Mortgagee a reasonable opportunity to perform Landlord's obligations hereunder.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926697"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Mortgagee's Protection Provisions</font>.&nbsp;&nbsp;If Landlord's Mortgagee shall succeed to the interest of Landlord under this Lease, Landlord's Mortgagee shall not be:  (1)&#160;liable for any act or omission of any prior lessor (including Landlord); (2)&#160;bound by any rent or additional rent or advance rent which Tenant might have paid for more than the current month to any prior lessor (including Landlord), and all such rent shall remain due and owing, notwithstanding such advance payment; (3)&#160;bound by any security or advance rental deposit made by Tenant which is not delivered or paid over to Landlord's Mortgagee and with respect to which Tenant shall look solely to Landlord for refund or reimbursement; (4)&#160;bound by any termination, amendment or modification of this Lease made without Landlord's Mortgagee's consent and written approval, except for those terminations, amendments and modifications permitted to be made by Tenant or Landlord pursuant to the terms of this Lease or by Landlord without Landlord's Mortgagee's consent pursuant to the terms of the loan documents between Landlord and Landlord's Mortgagee; (5)&#160;subject to the defenses which Tenant might have against any prior lessor (including Landlord); and (6)&#160;subject to the offsets which Tenant might have against any prior lessor (including Landlord) except for those offset rights which (A)&#160;are expressly provided in this Lease, (B)&#160;relate to periods of time following the acquisition of the Building by Landlord's Mortgagee, and (C)&#160;Tenant has provided written notice to Landlord's Mortgagee and provided Landlord's Mortgagee a reasonable opportunity to cure the event giving rise to such offset event.&nbsp;&nbsp;Landlord's Mortgagee shall have no liability or responsibility under or pursuant to the terms of this Lease or otherwise after it ceases to own an interest in the Project.&nbsp;&nbsp;Nothing in this Lease shall be construed to require Landlord's Mortgagee to see to the application of the proceeds of any loan, and Tenant's agreements set forth herein shall not be impaired on account of any modification of the documents evidencing and securing any loan.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926698"></a><a name="_AEIOULastRenderedPageBreakAEIOU18"></a>13.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Rules and Regulations</font>.&nbsp;&nbsp;Tenant shall comply with the rules and regulations of the Project which are attached hereto as <font style="text-decoration:underline;">Exhibit C</font>.&nbsp;&nbsp;Landlord may, from time to time, makes reasonable changes to such rules and regulations for the safety, care, or cleanliness of the Project and related facilities, provided Tenant receives written notice of such changes, such changes are applicable to all tenants of the Project, will not unreasonably interfere with </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 13</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant's use of the Premises</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and are enforced by Landlord in a non-discriminatory manner.&nbsp;&nbsp;Tenant shall be responsible for the compliance with such rules and regulations by each Tenant Party.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192310"></a><a name="_Toc136926699"></a>14.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Condemnation</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926700"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Total Taking</font>.&nbsp;&nbsp;If the entire Building or Premises are taken by right of eminent domain or conveyed in lieu thereof (a "<font style="font-weight:bold;text-decoration:underline;">Taking</font>"), this Lease shall terminate as of the date of the Taking.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506191464"></a><a name="_Toc136926701"></a><a name="_Ref136933630"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Partial Taking - Tenant's Rights</font>.&nbsp;&nbsp;If any part of the Building or Project becomes subject to a Taking and such Taking will prevent Tenant from conducting on a permanent basis its business in the Premises in a manner reasonably comparable to that conducted immediately before such Taking, then Tenant may terminate this Lease as of the date of such Taking by giving written notice to Landlord within 30 days after the Taking, and Basic Rent and Additional Rent shall be apportioned as of the date of such Taking.&nbsp;&nbsp;If Tenant does not terminate this Lease, then Rent shall be abated on a reasonable basis as to that portion of the Premises rendered untenantable by the Taking.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926702"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Partial Taking - Landlord's Rights</font>.&nbsp;&nbsp;If any material portion, but less than all, of the Building becomes subject to a Taking, or if Landlord is required to pay any of the proceeds arising from a Taking to a Landlord's Mortgagee, then Landlord may terminate this Lease by delivering written notice thereof to Tenant within 30 days after such Taking, and Basic Rent and Additional Rent shall be apportioned as of the date of such Taking.&nbsp;&nbsp;If Landlord does not so terminate this Lease, then this Lease will continue, but if any portion of the Premises has been taken, Rent shall abate as provided in the last sentence of <font style="text-decoration:underline;">Section&#160;14(b)</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref9926997"></a><a name="_Toc136926703"></a><a name="_Ref136933647"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Temporary Taking</font>.&nbsp;&nbsp;If all or any portion of the Premises becomes subject to a Taking for a period of less than 180 days, this Lease shall remain in full force and effect and Tenant shall continue to perform all of the terms, conditions and covenants of this Lease, including the payment of Basic Rent and all other amounts required hereunder.&nbsp;&nbsp;If any such temporary Taking terminates prior to the expiration of the Term, Tenant shall restore the Premises as nearly as possible to the condition prior to such temporary Taking, at Tenant's sole cost and expense.&nbsp;&nbsp;Landlord shall be entitled to receive the entire award for any such temporary Taking, except that Tenant shall be entitled to receive the portion of such award which (1)&#160;compensates Tenant for its loss of use of the Premises within the Term and (2)&#160;reimburses Tenant for the reasonable out-of-pocket costs actually incurred by Tenant to restore the Premises as required by this <font style="text-decoration:underline;">Section&#160;14(d)</font>.&nbsp;&nbsp;If all or any portion of the Premises becomes subject to a Taking for a period of more than 180 days, the rights related to this Lease shall follow Sections 14(a), 14(b) or 14(c) above.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926704"></a>(e)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Award</font>.&nbsp;&nbsp;If any Taking occurs, then Landlord shall receive the entire award or other compensation for the Land, the Building, and other improvements taken; however, Tenant may separately pursue a claim (to the extent it will not reduce Landlord's award) against the condemnor for the value of Tenant's personal property which Tenant is entitled to remove under this Lease, moving costs, loss of business, and other claims it may have.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192326"></a><a name="_Toc136926705"></a>15.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Fire or Other Casualty</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926706"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Repair Estimate</font>.&nbsp;&nbsp;If the Premises or the Building are damaged by fire or other casualty (a "<font style="font-weight:bold;text-decoration:underline;">Casualty</font>"), Landlord shall, within 90 days after such Casualty, deliver to Tenant a good faith estimate (the "<font style="font-weight:bold;text-decoration:underline;">Damage Notice</font>") of the time needed to repair the damage caused by such Casualty.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926707"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Tenant's Rights</font>.&nbsp;&nbsp;If a material portion of the Premises is damaged by Casualty such that Tenant is prevented from conducting its business in the Premises in a manner reasonably comparable to that conducted immediately before such Casualty and Landlord estimates that the damage caused thereby cannot be repaired within 270 days after the commencement of repairs (the "<font style="font-weight:bold;text-decoration:underline;">Repair Period</font>"), then Tenant may terminate this Lease by delivering written notice to Landlord of its election to terminate within 30 days after the Damage Notice has been delivered to Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926708"></a><a name="_AEIOULastRenderedPageBreakAEIOU19"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Rights</font>.&nbsp;&nbsp;If a Casualty damages the Premises or a material portion of the Building and (1)&#160;Landlord estimates that the damage to the Premises cannot be repaired within the Repair Period, </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 14</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;the damage to the Premises exceeds 50% of the replacement cost thereof (excluding foundations and footings), as estimated by Landlord, and such damage occurs during the last two years of the Term, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;regardless of the extent of damage to the Premises, the damage is not fully covered by Landlord's insurance policies or Landlord makes a good faith determination that restoring the Building would be uneconomical, or </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;Landlord is required to pay any insurance proceeds arising out of the Casualty to a Landlord's Mortgagee, then Landlord may terminate this Lease by giving written notice of its election to terminate within 30 days after the Damage Notice has been delivered to Tenant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926709"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Repair Obligation</font>.&nbsp;&nbsp;If neither party elects to terminate this Lease following a Casualty, then Landlord shall, within a reasonable time after such Casualty, begin to repair the Premises and shall proceed with reasonable diligence to restore the Premises to substantially the same condition as they existed immediately before such Casualty; however, Landlord shall not be required to repair or replace any alterations or betterments within the Premises (which shall be promptly and with due diligence repaired and restored by Tenant at Tenant's sole cost and expense) or any furniture, equipment, trade fixtures or personal property of Tenant or others in the Premises or the Building.&nbsp;&nbsp;If this Lease is terminated under the provisions of this <font style="text-decoration:underline;">Section&#160;15</font>, Landlord shall be entitled to the full proceeds of the insurance policies providing coverage for all alterations, improvements and betterments in the Premises.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926710"></a>(e)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Abatement of Rent</font>.&nbsp;&nbsp;If the Premises are damaged by Casualty, Rent for the portion of the Premises rendered untenantable by the damage shall be abated on a reasonable basis from the date of damage until the completion of Landlord's repairs (or until the date of termination of this Lease by Landlord or Tenant as provided above, as the case may be), unless a Tenant Party caused such damage, in which case, Tenant shall continue to pay Rent without abatement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926711"></a>16.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Personal Property Taxes</font>.&nbsp;&nbsp;Tenant shall be liable for all taxes levied or assessed against personal property, furniture, or fixtures placed by Tenant in the Premises or in or on the Building or Project.&nbsp;&nbsp;If any taxes for which Tenant is liable are levied or assessed against Landlord or Landlord's property and Landlord elects to pay the same, or if the assessed value of Landlord's property is increased by inclusion of such personal property, furniture or fixtures and Landlord elects to pay the taxes based on such increase, then Tenant shall pay to Landlord, within 30 days following written request therefor, the part of such taxes for which Tenant is primarily liable hereunder; however, Landlord shall not pay such amount if Tenant notifies Landlord that it will contest the validity or amount of such taxes before Landlord makes such payment, and thereafter diligently proceeds with such contest in accordance with Law and if the non-payment thereof does not pose a threat of loss or seizure of the Project or interest of Landlord therein or impose any fee or penalty against Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926712"></a><a name="_Ref136942198"></a>17.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Events of Default</font>.&nbsp;&nbsp;Each of the following occurrences shall be an "<font style="font-weight:bold;text-decoration:underline;">Event of Default</font>":</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926713"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Payment Default</font>.&nbsp;&nbsp;Tenant's failure to pay Rent within ten days after Landlord has delivered written notice to Tenant that the same is due; however, an Event of Default shall occur hereunder without any obligation of Landlord to give any notice if Tenant fails to pay Rent when due and, during the 12 month interval preceding such failure, Landlord has given Tenant written notice of failure to pay Rent on more than one occasion;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926714"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Abandonment</font><font style="text-decoration:none;">.&nbsp;&nbsp;Tenant (1) abandons or vacates the entire premises or (2) fails to continuously operate its business in the Premises for a period of more than sixty (60) consecutive days, unless, in each case, such abandonment, vacation or failure to continuously operate is due to a force majeure delay.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926715"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Estoppel</font>.&nbsp;&nbsp;Tenant fails to provide any estoppel certificate after Landlord's written request therefor pursuant to <font style="text-decoration:underline;">Section&#160;25(e)</font> and such failure shall continue for ten days after Landlord's second written notice thereof to Tenant;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926716"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Insurance</font>.&nbsp;&nbsp;Tenant fails to procure, maintain and deliver to Landlord evidence of the insurance policies and coverages as required under <font style="text-decoration:underline;">Section&#160;11(a)</font> and such failure shall continue for ten (10) days after Landlord's written notice thereof to Tenant; provided that to the extent such failure results in a lapse in coverage, Landlord shall not be required to provide Tenant written notice thereof, and such failure shall be an Event of Default immediately upon such lapse;&nbsp;&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 15</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926717"></a><a name="_AEIOULastRenderedPageBreakAEIOU20"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)</font><font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Mechanic's Liens</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Tenant fails to pay and release of record, or diligently contest and bond around, any mechanic's lien filed against the Premises or the Project for any work performed, materials furnished, or obligation incurred by or at the request of Tenant, within the time and in the manner required by </font><font style="text-decoration:underline;">Section&#160;</font><font style="text-decoration:underline;">8(e)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and such failure shall continue for ten days after Landlord's written notice thereof to Tenant;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926718"></a>(f)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Other Defaults</font>.&nbsp;&nbsp;Tenant's failure to perform, comply with, or observe any other agreement or obligation of Tenant under this Lease and the continuance of such failure for a period of more than 30 days after Landlord has delivered to Tenant written notice thereof; provided, however, that if Tenant cannot reasonably cure its breach or failure within a 30-day period, then Tenant's breach or failure is not an Event of Default if Tenant commences to cure its breach or failure within the 30-day period and thereafter diligently and in good faith pursues the cure and effects the cure within 90 days after the expiration of the original 30-day period; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506191823"></a><a name="_Toc136926719"></a><a name="_Ref136942201"></a>(g)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Insolvency</font>.&nbsp;&nbsp;The filing of a petition by or against Tenant (the term "Tenant" shall include, for the purpose of this <font style="text-decoration:underline;">Section&#160;17(g)</font>, any guarantor of Tenant's obligations hereunder) (1)&#160;in any bankruptcy or other insolvency proceeding; (2)&#160;seeking any relief under any state or federal debtor relief law; (3)&#160;for the appointment of a liquidator or receiver for all or substantially all of Tenant's property or for Tenant's interest in this Lease; (4)&#160;for the reorganization or modification of Tenant's capital structure; or (5)&#160;in any assignment for the benefit of creditors proceeding; however, if such a petition is filed against Tenant, then such filing shall not be an Event of Default unless Tenant fails to have the proceedings initiated by such petition dismissed within 90 days after the filing thereof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926720"></a><a name="_Ref136934358"></a><a name="_Ref136934394"></a>18.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Remedies</font>.&nbsp;&nbsp;Upon any Event of Default, Landlord may, in addition to all other rights and remedies afforded Landlord hereunder or by law or equity, take any one or more of the following actions:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192079"></a><a name="_Toc136926721"></a><a name="_Ref136934395"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Termination of Lease</font>.&nbsp;&nbsp;Terminate this Lease by giving Tenant written notice thereof, in which event Tenant shall pay to Landlord the sum of (1)&#160;all Rent accrued hereunder through the date of termination, (2)&#160;all amounts due under <font style="text-decoration:underline;">Section&#160;19(a)</font>, and (3)&#160;an amount equal to (A)&#160;the total Rent that Tenant would have been required to pay for the remainder of the Term discounted to present value at a per annum rate equal to the "Prime Rate" as published on the date this Lease is terminated by The Wall Street Journal, Southwest Edition, in its listing of "Money Rates" minus one percent, minus (B)&#160;the then present fair rental value of the Premises for such period, similarly discounted;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506191887"></a><a name="_Toc136926722"></a><a name="_Ref136934345"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Termination of Possession</font>.&nbsp;&nbsp;Terminate Tenant's right to possess the Premises without terminating this Lease by giving written notice thereof to Tenant, in which event Tenant shall pay to Landlord (1)&#160;all Rent and other amounts accrued hereunder to the date of termination of possession, (2)&#160;all amounts due from time to time under <font style="text-decoration:underline;">Section&#160;19(a)</font>, and (3)&#160;all Rent and other net sums required hereunder to be paid by Tenant during the remainder of the Term, diminished by any net sums thereafter received by Landlord through reletting the Premises during such period, after deducting all costs reasonably incurred by Landlord in reletting the Premises.&nbsp;&nbsp;If Landlord elects to proceed under this <font style="text-decoration:underline;">Section&#160;18(b)</font>, Landlord may remove all of Tenant's property from the Premises and store the same in a public warehouse or elsewhere at the cost of, and for the account of, Tenant, without becoming liable for any loss or damage which may be occasioned thereby.&nbsp;&nbsp;Landlord shall use reasonable efforts to relet the Premises on such terms as Landlord in its sole discretion may determine (including a term different from the Term, rental concessions, and alterations to, and improvement of, the Premises provided that any alterations or improvements and rental concessions or commissions should be normal, reasonable and customary in the market at that time); however, Landlord shall not be obligated to relet the Premises before leasing other portions of the Building or Complex and Landlord shall not be obligated to accept any prospective tenant proposed by Tenant unless such proposed tenant meets all of Landlord's leasing criteria.&nbsp;&nbsp;Landlord shall not be liable for, nor shall Tenant's obligations hereunder be diminished because of, Landlord's failure to relet the Premises or to collect rent due for such reletting.&nbsp;&nbsp;Tenant shall not be entitled to the excess of any consideration obtained by reletting over the Rent due hereunder.&nbsp;&nbsp;Reentry by Landlord in the Premises shall not affect Tenant's obligations hereunder for the unexpired Term; rather, Landlord may, from time to time, bring an action against Tenant to collect amounts due by Tenant, without the necessity of Landlord's waiting until the expiration of the Term.&nbsp;&nbsp;Unless Landlord delivers written notice to Tenant expressly stating that it has elected to terminate this Lease, all actions taken by Landlord to dispossess or exclude Tenant from the Premises shall be deemed to be taken under this <font style="text-decoration:underline;">Section&#160;18(b)</font>.&nbsp;&nbsp;If Landlord elects to proceed under this <font style="text-decoration:underline;">Section&#160;18(b)</font>, it may at any time elect to terminate this Lease under <font style="text-decoration:underline;">Section&#160;18(a)</font>;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 16</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926723"></a><a name="_AEIOULastRenderedPageBreakAEIOU21"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font><font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Perform Acts on Behalf of Tenant</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Perform any act Tenant is obligated to perform under the terms of this Lease (and enter upon the Premises in connection therewith if necessary) in Tenant's name and on Tenant's behalf, without being liable for any claim for damages therefor, and Tenant shall reimburse Landlord on demand for any expenses which Landlord may </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reasonably </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">incur in thus effecting compliance with Tenant's obligations under this Lease (including, but not limited to, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reasonable </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collection costs and legal expenses), plus interest thereon at the Default Rate;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926724"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Suspension of Services</font>.&nbsp;&nbsp;Suspend any services required to be provided by Landlord hereunder without being liable for any claim for damages therefor; or</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926725"></a>(e)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Alteration of Locks</font>.&nbsp;&nbsp;Additionally, with or without notice, and to the extent permitted by Law, Landlord may alter locks or other security devices at the Premises to deprive Tenant of access thereto, and Landlord shall not be required to provide a new key or right of access to Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926726"></a><a name="_Ref136934302"></a>19.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Payment by Tenant; Non-Waiver; Cumulative Remedies</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506191940"></a><a name="_Toc136926727"></a><a name="_Ref136934304"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Payment by Tenant</font>.&nbsp;&nbsp;Upon any Event of Default, Tenant shall pay to Landlord all reasonable costs incurred by Landlord (including court costs and reasonable attorneys' fees and expenses) in (1)&#160;obtaining possession of the Premises, (2)&#160;removing and storing Tenant's or any other occupant's property, (3)&#160;repairing, restoring, altering, remodeling, or otherwise putting the Premises into condition acceptable to a new tenant, (4)&#160;if Tenant is dispossessed of the Premises and this Lease is not terminated, reletting all or any part of the Premises (including brokerage commissions, cost of tenant finish work, and other costs incidental to such reletting), (5)&#160;performing Tenant's obligations which Tenant failed to perform, and (6)&#160;enforcing, or advising Landlord of, its rights, remedies, and recourses arising out of the default.&nbsp;&nbsp;To the full extent permitted by law, Landlord and Tenant agree the federal and state courts of the state in which the Premises are located shall have exclusive jurisdiction over any matter relating to or arising from this Lease and the parties' rights and obligations under this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926728"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">No Waiver</font>.&nbsp;&nbsp;Landlord's acceptance of Rent following an Event of Default shall not waive Landlord's rights regarding such Event of Default.&nbsp;&nbsp;No waiver by Landlord of any violation or breach of any of the terms contained herein shall waive Landlord's rights regarding any future violation of such term.&nbsp;&nbsp;Landlord's acceptance of any partial payment of Rent shall not waive Landlord's rights with regard to the remaining portion of the Rent that is due, regardless of any endorsement or other statement on any instrument delivered in payment of Rent or any writing delivered in connection therewith; accordingly, Landlord's acceptance of a partial payment of Rent shall not constitute an accord and satisfaction of the full amount of the Rent that is due.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926729"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Cumulative Remedies</font>.&nbsp;&nbsp;Any and all remedies set forth in this Lease:&nbsp;&nbsp;(1)&#160;shall be in addition to any and all other remedies Landlord may have at law or in equity, (2)&#160;shall be cumulative, and (3)&#160;may be pursued successively or concurrently as Landlord may elect.&nbsp;&nbsp;The exercise of any remedy by Landlord shall not be deemed an election of remedies or preclude Landlord from exercising any other remedies in the future.&nbsp;&nbsp;Additionally, Tenant shall defend, indemnify and hold harmless Landlord, Landlord's Mortgagee and their respective representatives and agents from and against all claims, demands, liabilities, causes of action, suits, judgments, damages and expenses (including reasonable attorneys' fees) arising from Tenant's failure to perform its obligations under this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192214"></a><a name="_Toc136926730"></a><a name="_Ref136942224"></a>20.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord Default</font>.&nbsp;&nbsp;In the event Landlord fails to cure (or promptly commence and diligently pursue the cure of) any breach or failure by Landlord to comply with any of Landlord&#8217;s obligations under this Lease within a reasonable period (not to exceed thirty (30) days except in the case of an emergency in which case such shorter time as is warranted by the particular circumstances) after Tenant furnishes Landlord with written notice of such failure; provided, however, that if the nature of Landlord&#8217;s obligation is such that more than thirty (30) days are required for performance then Landlord shall not be in default if Landlord commences performance within such 30-day period and thereafter diligently prosecutes the same to completion, then Tenant shall have the right (but not the obligation) to perform such obligation on Landlord&#8217;s account and Landlord shall reimburse Tenant upon demand for the amount expended by Tenant in performing such obligation (including but not limited to reasonable attorneys&#8217; fees and costs of collection). If Landlord fails to make any payment of any sum payable to Tenant hereunder within ten (10) business days of demand, then such payment shall bear interest at ten percent (10%) from the eleventh (11th) business day.&nbsp;&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 17</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192383"></a><a name="_Toc136926731"></a><a name="_Ref136939897"></a><a name="_Ref136942269"></a><a name="_Ref136942379"></a><a name="_AEIOULastRenderedPageBreakAEIOU22"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.</font><font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Surrender of Premises</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;No act by Landlord shall be deemed an acceptance of a surrender of the Premises, and no agreement to accept a surrender of the Premises shall be valid unless it is in writing and signed by Landlord.&nbsp;&nbsp;At the expiration or termination of this Lease, Tenant shall deliver to Landlord the Premises with all improvements located therein in good repair and condition, free of Hazardous Materials placed on the Premises during the Term, broom-clean, reasonable wear and tear (and condemnation and Casualty damage not caused by Tenant, as to which </font><font style="text-decoration:underline;">Sections&#160;</font><font style="text-decoration:underline;">14</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </font><font style="text-decoration:underline;">15</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall control) excepted, and shall deliver to Landlord all keys to the Premises.&nbsp;&nbsp;Provided that Tenant has performed all of its obligations hereunder, Tenant may remove </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">only </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">unattached trade fixtures, furniture, and personal property placed in the Premises or elsewhere in the Building by Tenant (but Tenant may not remove any such item which was paid for, in whole or in part, by Landlord or any wiring or cabling unless Landlord requires such removal).&nbsp;&nbsp;Additionally, at Landlord's option, Tenant shall remove such alterations, additions, improvements, trade fixtures, personal property, equipment, wiring, conduits, cabling, and furniture (including Tenant's Off-Premises Equipment) as Landlord may request; however, Tenant shall not be required to remove any addition or improvement to the Premises or the Project if Landlord has specifically agreed in writing that the improvement or addition in question need not be removed.&nbsp;&nbsp;Tenant shall repair all damage caused by such removal.&nbsp;&nbsp;All items not so removed shall, at Landlord's option, be deemed to have been abandoned by Tenant and may be appropriated, sold, stored, destroyed, or otherwise disposed of by Landlord without notice to Tenant and without any obligation to account for such items.&nbsp;&nbsp;The provisions of this </font><font style="text-decoration:underline;">Section&#160;</font><font style="text-decoration:underline;">21</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall survive the end of the Term.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192434"></a><a name="_Toc136926732"></a><a name="_Ref136936551"></a>22.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Holding Over</font>.&nbsp;&nbsp;If Tenant fails to vacate the Premises at the end of the Term, then Tenant shall be a tenant at sufferance and, in addition to all other damages and remedies to which Landlord may be entitled for such holding over, (a)&#160;Tenant shall pay, in addition to the other Rent, Basic Rent equal to the greater of (1)&#160;150% of the Rent payable during the last month of the Term, or (2)&#160;125% of the prevailing rental rate in the Building for similar space, and (b)&#160;Tenant shall otherwise continue to be subject to all of Tenant's obligations under this Lease.&nbsp;&nbsp;The provisions of this <font style="text-decoration:underline;">Section&#160;22</font> shall not be deemed to limit or constitute a waiver of any other rights or remedies of Landlord provided herein or at law.&nbsp;&nbsp;If Tenant fails to surrender the Premises upon the termination or expiration of this Lease, in addition to any other liabilities to Landlord accruing therefrom, Tenant shall protect, defend, indemnify and hold Landlord harmless from all actual and direct loss, costs (including reasonable attorneys' fees) and liability resulting from such failure, including any claims made by any succeeding tenant founded upon such failure to surrender, and any lost profits to Landlord resulting therefrom.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926733"></a>23.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Certain Rights Reserved by Landlord</font>.&nbsp;&nbsp;Provided that the exercise of such rights does not unreasonably interfere with Tenant's occupancy of the Premises or business operations in the Premises, Landlord shall have the following rights:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926734"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Building Operations</font>.&nbsp;&nbsp;To decorate and to make inspections, repairs, alterations, additions, changes, or improvements, whether structural or otherwise, in and about the Project, or any part thereof; to enter upon the Premises (after giving Tenant reasonable notice thereof, which may be oral notice, except in cases of real or apparent emergency, in which case no notice shall be required) and, during the continuance of any such work, to temporarily close doors, entryways, public space, and corridors in the Building; to interrupt or temporarily suspend Building services and facilities; to change the name of the Building; and to change the arrangement and location of entrances or passageways, doors, and doorways, corridors, elevators, stairs, restrooms, or other public parts of the Building;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926735"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Security</font>.&nbsp;&nbsp;To take such reasonable measures as Landlord deems advisable for the security of the Building and its occupants; evacuating the Building for cause, suspected cause, or for drill purposes; temporarily denying access to the Building; and closing the Building after normal business hours and on Sundays and holidays, subject, however, to Tenant's right to enter when the Building is closed after normal business hours under such reasonable regulations as Landlord may prescribe from time to time;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926736"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Prospective Purchasers and Lenders</font>.&nbsp;&nbsp;To enter the Premises at all reasonable hours (after giving Tenant reasonable notice thereof) to show the Premises to prospective purchasers or lenders; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926737"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Prospective Tenants</font>.&nbsp;&nbsp;At any time during the last 12 months of the Term (or earlier if Tenant has notified Landlord in writing that it does not desire to renew the Term) or at any time following the occurrence of an Event of Default, to enter the Premises at all reasonable hours (after giving Tenant reasonable notice thereof) to show the Premises to prospective tenants.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 18</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926738"></a><a name="_AEIOULastRenderedPageBreakAEIOU23"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24.</font><font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Amenities</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> agrees that Tenant and the Tenant Parties shall have access to certain amenities (collectively, the &#8220;</font><font style="font-weight:bold;text-decoration:underline;">Amenities</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) within the Project that that are provided to tenants of similar first-class office buildings in Dallas, Texas. Such amenities shall include meeting and collaboration spaces, and may include a gym, coffee shop, daycare and on-campus brewery, and community garden.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926739"></a><a name="_Ref136934161"></a><a name="_Ref136936784"></a><a name="_Ref136936866"></a><a name="_Ref136936969"></a>25.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Miscellaneous</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926740"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord Transfer</font>.&nbsp;&nbsp;Landlord may transfer any portion of the Project and any of its rights under this Lease.&nbsp;&nbsp;If Landlord assigns its rights under this Lease, then Landlord shall thereby be released from any further obligations hereunder arising after the date of transfer, provided that the assignee assumes in writing Landlord's obligations hereunder arising from and after the transfer date.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926741"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Liability</font>.&nbsp;&nbsp;The liability of Landlord (and its partners, shareholders or members) to Tenant (or any person or entity claiming by, through or under Tenant) for any default by Landlord under the terms of this Lease or any matter relating to or arising out of the occupancy or use of the Premises and/or other areas of the Building shall be limited to Tenant's actual direct damages therefor, but not any consequential, punitive, special, or incidental damages of any kind, and shall be recoverable only from the interest of Landlord in the Building or Project, and Landlord (and its partners, shareholders or members) shall not be personally liable for any deficiency.&nbsp;&nbsp;The provisions of this Section shall survive any expiration or termination of this Lease.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926742"></a><a name="_cp_text_1_609"></a><a name="_cp_change_67"></a>(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Force Majeure</font>.&nbsp;&nbsp;Other than for Tenant's obligations under this Lease that can be performed by the payment of money (e.g., payment of Rent and maintenance of insurance), whenever a period of time is herein prescribed for action to be taken by either party hereto, such party shall not be liable or responsible for, and there shall be excluded from the computation of any such period of time, any delays due to strikes, riots, acts of God, shortages of labor or materials, war, terrorist acts or activities, governmental laws, regulations, or restrictions, fires, floods, <font style="color:#000000;">unavailability of materials, failure of power, restrictive governmental laws or regulations, civil disturbances, Pandemic Delay (defined herein) </font>or any other causes of any kind whatsoever which are beyond the control of such party.<font style="color:#000000;"><a name="_cp_text_1_609"></a><a name="_cp_change_67"></a>&#160; </font>The term &#8220;<font style="text-decoration:underline;">Pandemic Delay</font>&#8221; shall mean delays resulting from any decree, order, ordinance, statute, moratorium,&#160; or other governmental action or proceeding relating to the COVID-19 outbreak or other pandemic, illness, or communicable disease, which prohibits, restricts or materially delays (a) the occupancy of the Premises, (b) the review, processing or the issuance of permits or other approvals required for the design and construction of improvements and/or occupancy of the Project and/or the Premises, (b) the performance of construction work on, at or for the Project or the Premises, (c) the delivery of materials or supplies required for such construction, or (d) any other non-monetary performance under this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926743"></a>(d)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Brokerage</font>.&nbsp;&nbsp;Neither Landlord nor Tenant has dealt with any broker or agent in connection with the negotiation or execution of this Lease.&nbsp;&nbsp;Tenant and Landlord shall each indemnify the other against all costs, expenses, attorneys' fees, liens and other liability for commissions or other compensation claimed by any broker or agent claiming the same by, through, or under the indemnifying party.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506191741"></a><a name="_Toc136926744"></a><a name="_Ref136934162"></a>(e)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Estoppel Certificates</font>.&nbsp;&nbsp;From time to time, Tenant shall furnish to any party designated by Landlord, within ten days after Landlord has made a request therefor, a commercially reasonable and standard certificate signed by Tenant confirming and containing such factual certifications and representations as to this Lease as Landlord may reasonably request.&nbsp;&nbsp;Unless otherwise required by Landlord's Mortgagee or a prospective purchaser or mortgagee of the Project, the initial form of estoppel certificate to be signed by Tenant is attached hereto as <font style="text-decoration:underline;">Exhibit F</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref7943801"></a><a name="_Toc136926745"></a><a name="_Ref136936787"></a>(f)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Notices</font>.&nbsp;&nbsp;All notices and other communications given pursuant to this Lease shall be in writing and shall be (1)&#160;mailed by first class, United States Mail, postage prepaid, certified, with return receipt requested, and addressed to the parties hereto at the address specified in the Basic Lease Information, (2)&#160;hand delivered to the intended addressee, (3)&#160;sent by a nationally recognized overnight courier service, or (4)&#160;sent by electronic mail transmission during normal business hours followed by a confirmatory letter sent in another manner permitted hereunder.&nbsp;&nbsp;All notices shall be effective upon delivery to the address of the addressee (even if such addressee refuses delivery thereof).&nbsp;&nbsp;The parties hereto may change their addresses by giving notice thereof to the other in conformity with this provision.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 19</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926746"></a><a name="_AEIOULastRenderedPageBreakAEIOU24"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)</font><font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Separability</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If any clause or provision of this Lease is illegal, invalid, or unenforceable under present or future laws, then the remainder of this Lease shall not be affected thereby and in lieu of such clause or provision, there shall be added as a part of this Lease a clause or provision as similar in terms to such illegal, invalid, or unenforceable clause or provision as may be possible and be legal, valid, and enforceable.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926747"></a>(h)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Amendments; Binding Effect; No Electronic Records</font>.&nbsp;&nbsp;This Lease may not be amended except by instrument in writing signed by Landlord and Tenant.&nbsp;&nbsp;No provision of this Lease shall be deemed to have been waived by Landlord unless such waiver is in writing signed by Landlord, and no custom or practice which may evolve between the parties in the administration of the terms hereof shall waive or diminish the right of Landlord to insist upon the performance by Tenant in strict accordance with the terms hereof.&nbsp;&nbsp;&nbsp;&nbsp;The terms and conditions contained in this Lease shall inure to the benefit of and be binding upon the parties hereto, and upon their respective successors in interest and legal representatives, except as otherwise herein expressly provided.&nbsp;&nbsp;This Lease is for the sole benefit of Landlord and Tenant, and, other than Landlord's Mortgagee, no third party shall be deemed a third party beneficiary hereof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926748"></a>(i)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Quiet Enjoyment</font>.&nbsp;&nbsp;Provided Tenant has performed all of its obligations hereunder, Tenant shall peaceably and quietly hold and enjoy the Premises for the Term, without hindrance from Landlord or any party claiming by, through, or under Landlord, but not otherwise, subject to the terms and conditions of this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926749"></a>(j)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">No Merger</font>.&nbsp;&nbsp;There shall be no merger of the leasehold estate hereby created with the fee estate in the Premises or any part thereof if the same person acquires or holds, directly or indirectly, this Lease or any interest in this Lease and the fee estate in the leasehold Premises or any interest in such fee estate.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926750"></a>(k)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">No Offer</font>.&nbsp;&nbsp;The submission of this Lease to Tenant shall not be construed as an offer, and Tenant shall not have any rights under this Lease unless Landlord executes a copy of this Lease and delivers it to Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926751"></a>(l)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Entire Agreement</font>.&nbsp;&nbsp;This Lease constitutes the entire agreement between Landlord and Tenant regarding the subject matter hereof and supersedes all oral statements and prior writings relating thereto.&nbsp;&nbsp;Except for those set forth in this Lease, no representations, warranties, or agreements have been made by Landlord or Tenant to the other with respect to this Lease or the obligations of Landlord or Tenant in connection therewith.&nbsp;&nbsp;The normal rule of construction that any ambiguities be resolved against the drafting party shall not apply to the interpretation of this Lease or any exhibits or amendments hereto.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926752"></a>(m)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Waiver of Jury Trial</font>.&nbsp;&nbsp;TO THE MAXIMUM EXTENT PERMITTED BY LAW, LANDLORD AND TENANT EACH WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY LITIGATION OR TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR WITH RESPECT TO THIS LEASE OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED HERETO.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926753"></a>(n)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Governing Law</font>.&nbsp;&nbsp;This Lease shall be governed by and construed in accordance with the laws of the state in which the Premises are located.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926754"></a>(o)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Recording</font>.&nbsp;&nbsp;Tenant shall not record this Lease or any memorandum of this Lease without the prior written consent of Landlord, which consent may be withheld or denied in the sole and absolute discretion of Landlord, and any recordation by Tenant shall be a material breach of this Lease.&nbsp;&nbsp;Tenant grants to Landlord a power of attorney to execute and record a release releasing any such recorded instrument of record that was recorded without the prior written consent of Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926755"></a>(p)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Water or Mold Notification</font>.&nbsp;&nbsp;To the extent Tenant or its agents or employees discover any water leakage, water damage or mold in or about the Premises or Project, Tenant shall promptly notify Landlord thereof in writing.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926756"></a><a name="_AEIOULastRenderedPageBreakAEIOU25"></a>(q)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Joint and Several Liability</font>.&nbsp;&nbsp;If Tenant is comprised of more than one party, each such party shall be jointly and severally liable for Tenant's obligations under this Lease.&nbsp;&nbsp;All unperformed obligations of </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 20</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant hereunder not fully performed at the end of the Term shall survive the end of the Term, including payment obligations with respect to Rent and all obligations concerning the condition and repair of the Premises.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192733"></a><a name="_Toc136926757"></a><a name="_Ref136936870"></a>(r)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Financial Reports</font>.&nbsp;&nbsp;Within 30 days after Landlord's request, Tenant will furnish Tenant's most recent audited financial statements (including any notes to them) to Landlord, or, if no such audited statements have been prepared, such other financial statements (and notes to them) as may have been prepared by an independent certified public accountant or, failing those, Tenant's internally prepared financial statements.&nbsp;&nbsp;If Tenant is a publicly traded corporation, Tenant may satisfy its obligations hereunder by providing to Landlord Tenant's most recent annual and quarterly reports.&nbsp;&nbsp;Tenant will discuss its financial statements with Landlord.&nbsp;&nbsp;Landlord will not disclose any aspect of Tenant's financial statements that Tenant designates to Landlord as confidential except (1)&#160;to Landlord's Mortgagee or prospective mortgagees or purchasers of the Building, (2)&#160;in litigation between Landlord and Tenant, and/or (3)&#160;if required by court order.&nbsp;&nbsp;Tenant shall not be required to deliver the financial statements required under this <font style="text-decoration:underline;">Section&#160;25(r)</font> more than once in any 12-month period unless requested by Landlord's Mortgagee or a prospective buyer or lender of the Building or an Event of Default occurs.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926758"></a>(s)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Fees</font>.&nbsp;&nbsp;Whenever Tenant requests Landlord to take any action not required of it hereunder or give any consent required or permitted under this Lease, Tenant will reimburse Landlord for Landlord's reasonable, out-of-pocket costs payable to third parties and incurred by Landlord in reviewing the proposed action or consent, including reasonable attorneys', engineers' or architects' fees, within 30 days after Landlord's delivery to Tenant of a statement of such costs.&nbsp;&nbsp;In no event shall such costs exceed $3,000.00, unless Landlord has notified Tenant that such costs will exceed $3,000.00 and Tenant has agreed to reimburse Landlord for such excess costs.&nbsp;&nbsp;Tenant will be obligated to make such reimbursement without regard to whether Landlord consents to any such proposed action.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(t)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Time is of the Essence</font>.&nbsp;&nbsp;Time is of the essence with respect to the performance of every provision of this Lease in which performance is a factor.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926759"></a>(u)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Telecommunications</font>.&nbsp;&nbsp;Tenant and its telecommunications companies, including local exchange telecommunications companies and alternative access vendor services companies, shall have no right of access to and within the Building, for the installation and operation of telecommunications systems, including voice, video, data, Internet, and any other services provided over wire, fiber optic, microwave, wireless, and any other transmission systems ("<font style="font-weight:bold;text-decoration:underline;">Telecommunications Services</font>"), for part or all of Tenant's telecommunications within the Building and from the Building to any other location without Landlord's prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed.&nbsp;&nbsp;All providers of Telecommunications Services shall be required to comply with the rules and regulations of the Building, applicable Laws and Landlord's policies and practices for the Building.&nbsp;&nbsp;Tenant acknowledges that Landlord shall not be required to provide or arrange for any Telecommunications Services and that Landlord shall have no liability to any Tenant Party in connection with the installation, operation or maintenance of Telecommunications Services or any equipment or facilities relating thereto; provided that Landlord acknowledges and agrees that Telecommunications Services are necessary for Tenant&#8217;s business operations and Landlord shall cooperate with Tenant and make necessary accommodations to allow Tenant to obtain Telecommunications Services for the Premises.&nbsp;&nbsp;Tenant, at its cost and for its own account, shall be solely responsible for obtaining all Telecommunications Services.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926760"></a>(v)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Confidentiality</font>.&nbsp;&nbsp;The parties acknowledge that the terms and conditions of this Lease are to remain confidential for the parties' benefit, and may not be disclosed by either party to anyone, by any manner or means, directly or indirectly, without the other party's prior written consent; however, either party may disclose the terms and conditions of this Lease if required by Law or court order, and to its attorneys, accountants, board members, employees and existing or prospective financial partners provided same are advised by such party of the confidential nature of such terms and conditions.&nbsp;&nbsp;Each party shall be liable for any disclosures made in violation of this Section by such party or by any entity or individual to whom the terms of and conditions of this Lease were disclosed or made available by such party.&nbsp;&nbsp;The consent by the other party to any disclosures shall not be deemed to be a waiver on the part of the consenting party of any prohibition against any future disclosure.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926761"></a><a name="_AEIOULastRenderedPageBreakAEIOU26"></a>(w)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Authority</font>.&nbsp;&nbsp;Tenant (if a corporation, partnership or other business entity) hereby represents and warrants to Landlord that Tenant is a duly formed and existing entity qualified to do business in the state in which the Premises are located, that Tenant has full right and authority to execute and deliver this Lease, and that each person </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 21</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">signing on behalf of Tenant is authorized to do so.&nbsp;&nbsp;Landlord hereby represents and warrants to Tenant that Landlord is a duly formed and existing entity qualified to do business in the state in which the Premises are located, that Landlord has full right and authority to execute and deliver this Lease, and that each person signing on behalf of Landlord is authorized to do so.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506192808"></a><a name="_Toc136926762"></a><a name="_Ref136936979"></a>(x)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Hazardous Materials</font>.&nbsp;&nbsp;The term "<font style="font-weight:bold;text-decoration:underline;">Hazardous Materials</font>" means any substance, material, or waste which is now or hereafter classified or considered to be hazardous, toxic, or dangerous under any Law relating to pollution or the protection or regulation of human health, natural resources or the environment, or poses or threatens to pose a hazard to the health or safety of persons on the Premises or in the Project.&nbsp;&nbsp;Tenant shall not use, generate, store, or dispose of, or permit the use, generation, storage or disposal of Hazardous Materials on or about the Premises or the Project except in a manner and quantity necessary for the ordinary performance of Tenant's business, and then in compliance with all Laws.&nbsp;&nbsp;If Tenant breaches its obligations under this <font style="text-decoration:underline;">Section&#160;25(x)</font>, Landlord may immediately take any and all action reasonably appropriate to remedy the same, including taking all appropriate action to clean up or remediate any contamination resulting from Tenant's use, generation, storage or disposal of Hazardous Materials.&nbsp;&nbsp;In no event, however, shall Tenant be responsible for any Hazardous Material which was brought on or in the Premises or the Project, (x) prior to the date Tenant first occupies the Premises, (y) by Landlord or any Landlord Party, or (z) other tenants or parties in the Building, Project or the Complex.&nbsp;&nbsp;Tenant shall defend, indemnify, and hold harmless Landlord and its representatives and agents from and against any and all claims, demands, liabilities, causes of action, suits, judgments, damages and expenses (including reasonable attorneys' fees and cost of clean up and remediation) arising from Tenant's failure to comply with the provisions of this <font style="text-decoration:underline;">Section&#160;25(x)</font>.&nbsp;&nbsp;This indemnity provision shall survive termination or expiration of this Lease.&nbsp;&nbsp;Landlord represents and warrants that to the best of its knowledge and belief there are no Hazardous Materials on, in or under the Premises or Building.&nbsp;&nbsp;Landlord shall indemnify Tenant and hold it harmless against any claims, damages, losses or liabilities (including reasonable attorney&#8217;s fees) incurred by Tenant and arising from any breach of the foregoing representation and warranty and from the presence or removal of the Hazardous Materials.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926763"></a>(y)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">List of Exhibits</font>.&nbsp;&nbsp;All exhibits and attachments attached hereto are incorporated herein by this reference.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit A - Outline of Premises<br />Exhibit B - Description of the Land<br />Exhibit C - Building Rules and Regulations<br />Exhibit D - Tenant Finish-Work<br />Exhibit E - Form of Confirmation of Commencement Date Letter<br />Exhibit F - Form of Tenant Estoppel Certificate<br />Exhibit G &#8211; Parking</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-weight:normal;font-style:normal;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Exhibit H &#8211; Renewal Option</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit I &#8211; Right of First Refusal<br />Exhibit J &#8211; Form of SNDA</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926764"></a><a name="direct"></a>(z)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Determination of Charges</font>.&nbsp;&nbsp;Landlord and Tenant agree that each provision of this Lease for determining charges and amounts payable by Tenant (including provisions regarding Additional Rent and Tenant's Proportionate Share of Taxes and Electrical Costs) is commercially reasonable and, as to each such charge or amount, constitutes a statement of the amount of the charge or a method by which the charge is to be computed for purposes of Section 93.012 of the Texas Property Code.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926765"></a>(aa)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Prohibited Persons and Transactions (Tenant)</font>.&nbsp;&nbsp;Tenant represents and warrants to Landlord that Tenant is currently in compliance with and shall at all times during the Term (including any extension thereof) remain in compliance with the regulations of the OFAC of the Department of the Treasury (including those named on OFAC's Specially Designated Nationals and Blocked Persons List) and any statute, executive order (including the September 24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit or Support Terrorism), or other governmental action relating thereto.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU27"></a>(bb)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Prohibited Persons and Transactions (Landlord)</font>.&nbsp;&nbsp;Landlord represents and warrants to Tenant that Landlord is currently in compliance with and shall at all times during the Term (including any extension thereof) remain in compliance with the regulations of the OFAC of the Department of the Treasury (including those </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 22</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">named on OFAC's Specially Designated Nationals and Blocked Persons List) and any statute, executive order (including the September 24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit or Support Terrorism), or other governmental action relating thereto.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(cc)<font style="margin-left:36pt;"></font>In the event Landlord or Tenant is required or elects to take legal action against the other party to enforce the provisions of this Lease, then the prevailing party in such action shall be entitled to collect from the other party its costs and expenses incurred in connection with the legal action (including, without limitation, reasonable attorneys&#8217; fees and court costs).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926766"></a>26.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Other Provisions</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc136926767"></a>(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Termination Option</font>.&nbsp;&nbsp;Tenant shall have the option to terminate this Lease, effective any time after the end of the 84<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> full Lease Month of the Term, upon six (6) months&#8217; prior written notice to Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Signage</font>.&nbsp;&nbsp;Tenant shall have the right to install, at Tenant&#8217;s sole cost (but subject to reimbursement from the Construction Allowance (as hereinafter defined): (i) suite entry signage on or adjacent to the door to the Premises and (ii) directional signage in the elevator lobby on the 14<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> floor.&nbsp;&nbsp;Landlord shall provide, through the Term, a standard listing on the directory in the lobby of the Building.&nbsp;&nbsp;All such signage rights shall be granted at no additional costs or expense to Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Transition Space</font>.&nbsp;&nbsp;In the event that the Premises are not ready for Tenant occupancy by April 30, 2021, or on such earlier date as Landlord and Tenant may mutually agree, and Tenant does not elect to terminate this Lease in accordance with Section 3 above, Landlord shall make available to Tenant alternative, temporary office space, either within the Complex or at a mutually-acceptable offsite location (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Transition Space</font>&#8221;). Tenant shall be permitted to use all existing furniture and fixtures located within the Transition Space and Landlord shall deliver the Transition Space with minor paint touch-up, patching, and carpet cleaning within the Transition Space having been completed, otherwise, the Transition Space shall be delivered in its AS-IS, WHERE-IS condition.&nbsp;&nbsp;Tenant&#8217;s occupancy of the Transition Space shall be upon the same terms and conditions as those governing this Lease; provided, however, that (a) Basic Rent shall be $13.00 per rentable square foot and (b) the Commencement Date shall not be triggered by Tenant&#8217;s occupancy of the Transition Space.&nbsp;&nbsp;Tenant may continue to occupy the Transition Space until thirty (30) days after Landlord delivers the Premises to Tenant in the condition required by this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD AND TENANT EXPRESSLY DISCLAIM ANY IMPLIED WARRANTY THAT THE PREMISES ARE SUITABLE FOR TENANT'S INTENDED COMMERCIAL PURPOSE, AND TENANT'S OBLIGATION TO PAY RENT HEREUNDER IS NOT DEPENDENT UPON THE CONDITION OF THE PREMISES OR THE PERFORMANCE BY LANDLORD OF ITS OBLIGATIONS HEREUNDER, AND, EXCEPT AS OTHERWISE EXPRESSLY PROVIDED HEREIN, TENANT SHALL CONTINUE TO PAY THE RENT, WITHOUT ABATEMENT, DEMAND, SETOFF OR DEDUCTION, NOTWITHSTANDING ANY BREACH BY LANDLORD OF ITS DUTIES OR OBLIGATIONS HEREUNDER, WHETHER EXPRESS OR IMPLIED.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Lease shall be dated as of the date first above written.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[signatures on the following page]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 23</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD:</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PEGASUS PARK, LLC, </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Delaware limited liability company</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Justin A. Small</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT:</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TAYSHA GENE THERAPIES, INC.,<br />a Delaware corporation</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegasus Park Office Lease (Taysha Gene Therapies, Inc.) &#8211; Page 24</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU28"></a><a name="_Ref136745504"></a><font style="text-decoration:underline;">EXHIBIT A</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136745504"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">OUTLINE OF PREMISES</font><font style="text-decoration:underline;font-family:Times New Roman;"> AND EXPANSION SPACE</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gpujbzzweac5000001.jpg" title="" alt="" style="width:623px;height:361px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT A, Outline of Premises - Page A-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU29"></a><a name="_Ref136745618"></a><font style="text-decoration:underline;">EXHIBIT B</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136745618"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">DESCRIPTION OF THE LAND</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk53738696"></a>BEING a tract of land situated in the Thomas E. Mannin Survey, Abstract No. 958, in the City of Dallas, Dallas County, Texas, said tract being a portion of Lot 1A, Block 1/6368 of Mobil Place Addition No. 2, an addition to the City of Dallas as recorded in Volume 2003041, Page 76 Deed Records of Dallas County, Texas (D.R.D.C.T.).&nbsp;&nbsp;Said tract also being a portion of the property conveyed to Mobil Oil Corporation by deed recorded in Volume 81243, Page 1216 D.R.D.C.T. and being more particularly described as follows:&nbsp;&nbsp;&nbsp;&nbsp; </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BEGINNING at a TxDOT aluminum monument found at the intersection point of the southerly right-of-way line of Stemmons Freeway (Interstate Highway 35E) (a variable width right-of-way) and the westerly right-of-way line of Pegasus Park Drive, said point being the most northerly northeast corner of said Lot 1A;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 08&#176;05'35" East, departing the southerly right-of-way line of said Stemmons Freeway (Interstate Highway 35E), and along the westerly right-of-way line of said Pegasus Park Drive and the easterly line of said Lot 1A, for a distance of 23.47 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the beginning of a tangent curve to the left with a radius of 85.00 feet, a central angle of 49&#176;47'56" and a chord which bears South 32&#176;59'33" East, for a distance of 71.57 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for an arc length of 73.88 feet to a 1/2" iron rod found for a point of tangency for end of said curve;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 57&#176;53'31" East, along the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for a distance of 252.58 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for an angle point in said right-of-way line of Pegasus Park Drive and said line of Lot 1A;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 46&#176;51'08" West, for a distance of 3.07 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for an angle point in said right-of-way line of Pegasus Park Drive and said line of Lot 1A;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 57&#176;55'21" East, along the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for a distance of 27.44 feet to a TxDOT aluminum monument found for the beginning of a tangent curve to the left with a radius of 194.47 feet, a central angle of 13&#176;42'05" and a chord which bears South 64&#176;46'24" East, for a distance of 46.39 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for an arc length of 46.50 feet to a capped iron rod found for a point of tangency for end of said curve;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 71&#176;37'26" East, along the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for a distance of 382.97 feet to a capped iron rod found for the beginning of a tangent curve to the right with a radius of 20.00 feet, a central angle of 51&#176;28'53" and a chord which bears South 45&#176;53'00" East, for a distance of 17.37 feet;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for an arc length of 17.97 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point of tangency for end of said curve, from which a capped iron rod found for reference bears South 77&#176;41'54" West for a distance of 1.45 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;49'16" East, along the westerly right-of-way line of said Pegasus Park Drive and the easterly line of said Lot 1A, for a distance of 43.55 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the beginning of a non-tangent curve to the left from which a capped iron rod found for reference bears South 79&#176;08'12" West for a distance of 1.29 feet, said curve with a radius of 50.00 feet, a central angle of 168&#176;32'16" and a chord which bears South 15&#176;38'12" East, for a distance of 99.50 feet;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT B, Description of the Land - Page B-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU30"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the westerly right-of-way line of said Pegasus Park Drive and the easterly line of said Lot 1A, for an arc length of 147.08 feet to an "X" cut set for a point of tangency for end of said curve;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 80&#176;05'40" West departing said westerly right-of-way line, a distance of 232.11 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;48'02" East a distance of 217.97 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 80&#176;11'58" East a distance of 53.60 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;48'02" East a distance of 14.96 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 80&#176;11'58" East a distance of 15.59 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;48'02" East a distance of 217.04 feet to an iron rod set for corner said corner also being in the north right-of-way line of Irving Boulevard (a variable width public right-of-way);</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 80&#176;11'58" West, along the northerly right-of-way line of said Irving Boulevard a distance of 946.92 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the beginning of a tangent curve to the right with a radius of 2,799.79 feet, a central angle of 07&#176;15'18" and a chord which bears North 83&#176;49'37" East, for a distance of 354.28 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, along the northerly right-of-way line of said Irving Boulevard and the southerly line of said Lot 1A, for an arc length of 354.52 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point of non-tangency for end of said curve, said point also beginning the southerly end of a corner clip at the intersection of the northerly right-of-way line of said Irving Boulevard and the easterly right-of-way line of Lakawana Street a (60' width right-of-way) from which a 1/2" iron rod found for reference bears South 87&#176;37'37" West for a distance of 10.11 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 46&#176;00'18" West, departing the northerly right-of-way line of said Irving Boulevard, and along said corner clip, for a distance of 13.78 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the northerly end of said corner clip, said point also being in the easterly right-of-way line of said Lakawana Street and the westerly line of said Lot 1A;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 00&#176;26'00" East, along the easterly right-of-way line said Lakawana Street and the westerly line of said Lot 1A, for a distance of 112.37 feet to a capped iron rod found for the beginning of a tangent curve to the right with a radius of 98.77 feet, a central angle of 47&#176;31'39" and a chord which bears North 24&#176;17'26" East, for a distance of 79.60 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southeasterly right-of-way line said Lakawana Street and the northwesterly line of said Lot 1A, for an arc length of 81.93 feet to a capped iron rod found for a point of tangency for end of said curve;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 48&#176;02'40" East, along the southeasterly right-of-way line said Lakawana Street and the northwesterly line of said Lot 1A, for a distance of 275.56 feet to a capped iron rod found for an angle point in said Lot 1A and also being the intersection point of said right-of-way line of Lakawana Street and the northeasterly right-of-way line of Iron Ridge Street (a 60' width right-of-way);</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 41&#176;57'30" West, departing the southeasterly right-of-way line of said Lakawana Street, and along the northeasterly right-of-way line of said Iron Ridge Street and the southwesterly line of said Lot 1A, for a distance of 259.91 feet to a 5/8" iron rod found for an angle point in said Lot 1A and also being the southerly corner of Lot 1, Block 1/6368 of Expressway Industrial District, an addition to the City of Dallas, Dallas County, Texas as recorded in Volume 117, Page 2150 of the Plat Records of Dallas County, Texas;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU31"></a>THENCE North 48&#176;02'28" East, departing the northeasterly right-of-way line of said Iron Ridge Street, and along the southeasterly line of said Expressway Industrial District addition and the northwesterly line of said Lot 1A , for a </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT B, Description of the Land - Page B-2</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">distance of 492.28 feet to an "X" cut set for an angle point in said Lot 1A and also being the easterly corner of Lot 5 of said Expressway Industrial District addition;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 41&#176;57'59" West, along the northeasterly line of said Lot 5 and the southwesterly line of said Lot 1A, for a distance of 244.76 feet to a 1/2" iron rod found for the most northerly northwest corner of said Lot 1A and the northerly corner of said Lot 5, said point also being in the southeasterly right-of-way line of Commonwealth Drive (State Highway 356) (a 224' width right-of-way);</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 62&#176;17'34" East, along the southeasterly right-of-way line of said Commonwealth Drive (State Highway 356) and the northwesterly line of said Lot 1A, for a distance of 114.33 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 73&#176;12'35" East, along the southeasterly right-of-way line of said Commonwealth Drive (State Highway 356) and the northwesterly line of said Lot 1A, for a distance of 132.73 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point for corner, said point also being the intersection point of said right-of-way line of Commonwealth Drive (State Highway 356) and the southerly right-of-way line of aforementioned Stemmons Freeway (Interstate Highway 35E);</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 81&#176;59'01" East, departing the southeasterly right-of-way line of said Commonwealth Drive (State Highway 356), and along the southerly right-of-way line of said Stemmons Freeway (Interstate Highway 35E) and the northerly line of said Lot 1A, for a distance of 155.84 feet to the POINT OF BEGINNING and containing 1,011,100 square feet or 23.212 acres of land.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT B, Description of the Land - Page B-3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU32"></a><a name="_Ref136745766"></a><font style="text-decoration:underline;">EXHIBIT C</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136745766"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">BUILDING RULES AND REGULATIONS</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following rules and regulations shall apply to the Premises, the Building, the parking garage associated therewith, and the appurtenances thereto; provided, however, that in the event of a conflict between the terms of the Lease and the rules and regulations (as may be amended in accordance with the terms of the Lease), the terms of the Lease shall prevail:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font>Sidewalks, doorways, vestibules, halls, stairways, and other similar areas shall not be obstructed by tenants or used by any tenant for purposes other than ingress and egress to and from their respective leased premises and for going from one to another part of the Building.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font>Plumbing, fixtures and appliances shall be used only for the purposes for which designed, and no sweepings, rubbish, rags or other unsuitable material shall be thrown or deposited therein.&nbsp;&nbsp;Damage resulting to any such fixtures or appliances from misuse by a tenant or its agents, employees or invitees, shall be paid by such tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font>No signs, advertisements or notices (other than those that are not visible outside the Premises) shall be painted or affixed on or to any windows or doors or other part of the Building without the prior written consent of Landlord.&nbsp;&nbsp;No nails, hooks or screws (other than those which are necessary to hang paintings, prints, pictures, or other similar items on the Premises' interior walls) shall be driven or inserted in any part of the Building except by Building maintenance personnel.&nbsp;&nbsp;No curtains or other window treatments shall be placed between the glass and the Building standard window treatments.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font>Landlord shall provide and maintain an alphabetical directory for all tenants in the main lobby of the Building.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font>Landlord shall provide all door locks in each tenant's leased premises, at the cost of such tenant, and no tenant shall place any additional door locks in its leased premises without Landlord's prior written consent.&nbsp;&nbsp;Landlord shall furnish to each tenant a reasonable number of keys to such tenant's leased premises, at such tenant's cost, and no tenant shall make a duplicate thereof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font>Movement in or out of the Building of furniture or office equipment, or dispatch or receipt by tenants of any bulky material, merchandise or materials which require use of elevators or stairways, or movement through the Building entrances or lobby shall be conducted under Landlord's supervision at such times and in such a manner as Landlord may reasonably require.&nbsp;&nbsp;Each tenant assumes all risks of and shall be liable for all damage to articles moved and injury to persons or public engaged or not engaged in such movement, including equipment, property and personnel of Landlord if damaged or injured as a result of acts in connection with carrying out this service for such tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font>Landlord may prescribe weight limitations and determine the locations for safes and other heavy equipment or items, which shall in all cases be placed in the Building so as to distribute weight in a manner acceptable to Landlord which may include the use of such supporting devices as Landlord may require.&nbsp;&nbsp;All damages to the Building caused by the installation or removal of any property of a tenant, or done by a tenant's property while in the Building, shall be repaired at the expense of such tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.<font style="margin-left:36pt;"></font>Corridor doors, when not in use, shall be kept closed.&nbsp;&nbsp;Nothing shall be swept or thrown into the corridors, halls, elevator shafts or stairways.&nbsp;&nbsp;No birds or animals (other than seeing-eye dogs or other service animals) shall be brought into or kept in, on or about any tenant's leased premises.&nbsp;&nbsp;No portion of any tenant's leased premises shall at any time be used or occupied as sleeping or lodging quarters.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.<font style="margin-left:36pt;"></font>Tenant shall cooperate with Landlord's employees in keeping its leased premises neat and clean.&nbsp;&nbsp;Tenants shall not employ any person for the purpose of such cleaning other than the Building's cleaning and maintenance personnel.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT C, Building Rules and Regulations - Page C-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU33"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To ensure orderly operation of the Building, no ice, mineral or other water, towels, newspapers, etc. shall be delivered to any leased area except by persons approved by Landlord.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.<font style="margin-left:36pt;"></font>Tenant shall not make or permit any vibration or improper, objectionable or unpleasant noises or odors in the Building or otherwise interfere in any way with other tenants or persons having business with them.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font>No machinery of any kind (other than normal office equipment) shall be operated by any tenant on its leased area without Landlord's prior written consent, nor shall any tenant use or keep in the Building any flammable or explosive fluid or substance (other than typical office supplies <font style="font-style:italic;">[e.g., photocopier toner]</font> used in compliance with all Laws).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font>Landlord will not be responsible for lost or stolen personal property, money or jewelry from tenant's leased premises or public or common areas regardless of whether such loss occurs when the area is locked against entry or not.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.<font style="margin-left:36pt;"></font>No vending or dispensing machines of any kind may be maintained in any leased premises without the prior written permission of Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.<font style="margin-left:36pt;"></font>Tenant shall not conduct any activity on or about the Premises or Building which will draw pickets, demonstrators, or the like.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.<font style="margin-left:36pt;"></font>All vehicles are to be currently licensed, in good operating condition, parked for business purposes having to do with Tenant's business operated in the Premises, parked within designated parking spaces, one vehicle to each space.&nbsp;&nbsp;No vehicle shall be parked as a "<font style="font-weight:bold;text-decoration:underline;">billboard</font>" vehicle in the parking lot.&nbsp;&nbsp;Any vehicle parked improperly may be towed away.&nbsp;&nbsp;Tenant, Tenant's agents, employees, vendors and customers who do not operate or park their vehicles as required shall subject the vehicle to being towed at the expense of the owner or driver.&nbsp;&nbsp;Landlord may place a "<font style="font-weight:bold;text-decoration:underline;">boot</font>" on the vehicle to immobilize it and may levy a charge of $50.00 to remove the "<font style="font-weight:bold;text-decoration:underline;">boot</font>."&nbsp;&nbsp;Tenant shall indemnify, hold and save harmless Landlord of any liability arising from the towing or booting of any vehicles belonging to a Tenant Party.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.<font style="margin-left:36pt;"></font>No tenant may enter into phone rooms, electrical rooms, mechanical rooms, or other service areas of the Building unless accompanied by Landlord or the Building manager.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.<font style="margin-left:36pt;"></font>Tenant will not permit any Tenant Party to bring onto the Project any handgun, firearm or other weapons of any kind, illegal drugs or, unless expressly permitted by Landlord in writing, alcoholic beverages.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.<font style="margin-left:36pt;"></font>Tenant shall not permit its employees, invitees or guests to smoke in the Premises or the lobbies, passages, corridors, elevators, vending rooms, rest rooms, stairways or any other area shared in common with other tenants in the Building, or permit its employees, invitees, or guests to loiter at the Building entrances for the purposes of smoking.&nbsp;&nbsp;Landlord may, but shall not be required to, designate an area for smoking outside the Building.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT C, Building Rules and Regulations - Page C-2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU34"></a><a name="_Ref136745677"></a><font style="text-decoration:underline;">EXHIBIT D</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136745677"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">TENANT FINISH-WORK: ALLOWANCE</font><font style="text-decoration:underline;font-family:Times New Roman;"><br />(Landlord Performs the Work)</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord&#8217;s Performance of the Work</font>.&nbsp;&nbsp;Landlord hereby agrees, at Landlord&#8217;s sole cost and expense, to perform the work more particularly described on <font style="text-decoration:underline;">Schedule 1</font> attached hereto (the "<font style="font-weight:bold;text-decoration:underline;">Site and Shell Work</font></a>").&nbsp;&nbsp;The Site and Shell Work shall be performed in accordance with the plans referenced on <font style="text-decoration:underline;">Schedule 1</font> attached hereto and otherwise in a good and workmanlike manner and in compliance with all applicable Laws. The Site and Shell Work shall be deemed to be complete on the date all Site and Shell Work (other than any details of construction, mechanical adjustment or any other similar matter, the non-completion of which does not materially interfere with Tenant&#8217;s use or occupancy of the Premises) has been performed as evidenced by the certificate of substantial completion prepared by the Landlord&#8217;s architect and issuance of the certificate of occupancy for the Building (or its equivalent). Completion shall have occurred even though minor details of construction, decoration, landscaping and mechanical adjustments remain to be completed, provided such items are completed within thirty (30) days after the Commencement Date.&nbsp;&nbsp;As part of the Site and Shell Work, Landlord shall provide an initial test fit for the Premises.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font>Space Plans.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Preparation and Delivery</font>.&nbsp;&nbsp;Within ten (10) business days after Tenant's execution of this Lease, Tenant shall meet with Good Fulton &amp; Farrell or another design consultant selected by Landlord and reasonably acceptable to Tenant (the "<font style="font-weight:bold;text-decoration:underline;">Architect</font></a>") and Pritchard Associates (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Construction Manager</font>&#8221;) to discuss the nature and extent of all improvements that Tenant proposes to install in the Premises and, at such meeting, provide the Architect with all necessary data and information needed by the Architect to prepare initial space plans therefor as required by this paragraph.&nbsp;&nbsp;On or before the tenth day following the meeting, Landlord shall deliver to Tenant a space plan prepared by the Architect depicting improvements to be installed in the Premises (the "<font style="font-weight:bold;text-decoration:underline;">Space Plans</font>").</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Approval Process</font>.&nbsp;&nbsp;Tenant shall notify Landlord whether it approves of the submitted Space Plans within five business days after Landlord's submission thereof.&nbsp;&nbsp;If Tenant disapproves of such Space Plans, then Tenant shall notify Landlord thereof specifying in reasonable detail the reasons for such disapproval, in which case Landlord shall, within three business days after such notice, revise such Space Plans in accordance with Tenant's objections and submit to Tenant for its review and approval.&nbsp;&nbsp;Tenant shall notify Landlord in writing whether it approves of the resubmitted Space Plans within three business day after its receipt thereof.&nbsp;&nbsp;This process shall be repeated until the Space Plans have been finally approved by Tenant and Landlord.&nbsp;&nbsp;If Tenant fails to notify Landlord that it disapproves of the initial Space Plans within three business days (or, in the case of resubmitted Space Plans, within one business day) after the submission thereof, then Tenant shall be deemed to have disapproved the Space Plans in question.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font>Working Drawings.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Preparation and Delivery</font>.&nbsp;&nbsp;On or before the date which is 15 days following the date on which the Space Plans are approved by Tenant and Landlord, Landlord shall cause to be prepared final working drawings of all improvements to be installed in the Premises and deliver the same to Tenant for its review and approval (which approval shall not be unreasonably withheld, delayed or conditioned provided that the working drawings are in substantial conformance with the Space Plans approved by Tenant).<font style="font-weight:bold;font-style:italic;">&nbsp;&nbsp;</font>Such working drawings shall be prepared by the Architect, or another design consultant selected by Landlord (whose fee shall be included in the Total Construction Costs [defined below]).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU35"></a>(b)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Approval Process</font>.&nbsp;&nbsp;Tenant shall notify Landlord whether it approves of the submitted working drawings within five business days after Landlord's submission thereof.&nbsp;&nbsp;If Tenant disapproves of such working drawings, then Tenant shall notify Landlord thereof specifying in reasonable detail the reasons for such disapproval, in which case Landlord shall, within five business days after such notice, revise such working drawings in accordance with Tenant's objections and submit the revised working drawings to Tenant for its review and approval.&nbsp;&nbsp;Tenant shall notify Landlord in writing whether it approves of the resubmitted working drawings within three business day after its receipt thereof.&nbsp;&nbsp;This process shall be repeated until the working drawings have been finally approved by Landlord and Tenant.&nbsp;&nbsp;If Tenant fails to notify Landlord that it disapproves of the initial working drawings within </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT D, Tenant Finish-Work:&nbsp;&nbsp;Allowance - Page D-1</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">three business days (or, in the case of resubmitted working drawings, within one business day) after the submission thereof, then Tenant shall be deemed to have </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dis</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approved the working drawings in question.&nbsp;&nbsp;Any delay caused by Tenant's unreasonable withholding of its consent or delay in giving its written approval as to such working drawings shall constitute a Tenant Delay Day (defined below).&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If </font><font style="font-weight:normal;font-style:normal;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">the working drawings are not in substantial conformance with the Space Plans approved by Tenant, then any withholding of Tenant&#8217;s</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> consent or delay in giving Tenant&#8217;s written approval shall be deemed reasonable and shall not be deemed a Tenant Delay Day</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Landlord's Approval; Performance of Work</font>.&nbsp;&nbsp;If any of Tenant's proposed construction work will affect the Building's Structure or the Building's Systems, then the working drawings pertaining thereto must be approved by the Building's engineer of record.&nbsp;&nbsp;Landlord's approval of such working drawings shall not be unreasonably withheld, provided that (1)&#160;they comply with all Laws, (2)&#160;the improvements depicted thereon do not adversely affect (in the reasonable discretion of Landlord) the Building's Structure or the Building's Systems (including the Building's restrooms or mechanical rooms), the exterior appearance of the Building, or the appearance of the Building's common areas or elevator lobby areas, (3)&#160;such working drawings are sufficiently detailed to allow construction of the improvements in a good and workmanlike manner, and (4)&#160;the improvements depicted thereon conform to the rules and regulations promulgated from time to time by Landlord for the construction of tenant improvements (a copy of which has been delivered to Tenant).&nbsp;&nbsp;As used herein, "<font style="font-weight:bold;text-decoration:underline;">Working Drawings</font></a>" means the final working drawings approved by Landlord and Tenant, as amended from time to time by any approved changes thereto, and "<font style="font-weight:bold;text-decoration:underline;">Work</font>" means all improvements to be constructed in accordance with and as indicated on the Working Drawings, together with any work required by governmental authorities to be made to other areas of the Building as a result of the improvements indicated by the Working Drawings.&nbsp;&nbsp;Landlord's approval of the Working Drawings shall not be a representation or warranty of Landlord that such drawings are adequate for any use or comply with any Law, but shall merely be the consent of Landlord thereto.&nbsp;&nbsp;Tenant shall, at Landlord's request, sign the Working Drawings to evidence its review and approval thereof.&nbsp;&nbsp;After the Working Drawings have been approved, Landlord shall cause the Work to be performed in substantial accordance with the Working Drawings.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Bidding of Work</font>.&nbsp;&nbsp;Prior to commencing the Work, Landlord shall competitively bid the Work to three contractors approved by Landlord and Tenant.&nbsp;&nbsp;If the estimated Total Construction Costs are expected to exceed the Construction Allowance, Tenant shall be allowed to review the submitted bids from such contractors to value engineer any of Tenant's requested alterations.&nbsp;&nbsp;In such case, Tenant shall notify Landlord of any items in the Working Drawings that Tenant desires to change within five business days after Landlord's submission thereof to Tenant.&nbsp;&nbsp;If Tenant fails to notify Landlord of its election within such five business day period, Tenant shall be deemed to have approved the bids.&nbsp;&nbsp;Within five business days following Tenant&#8217;s approval of the construction bids under the foregoing provisions (if applicable), Tenant shall have completed all of the following items: (a)&#160;finalized with Landlord's representative and the proposed contractor, the pricing of any requested revisions to the bids for the Work, and (b)&#160;approved in writing any overage in the Total Construction Costs in excess of the Construction Allowance, failing which each day after such five business day period shall constitute a Tenant Delay Day.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506207076"></a>5.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Change Orders</font>.&nbsp;&nbsp;Tenant may initiate changes in the Work.&nbsp;&nbsp;Each such change must receive the prior written approval of Landlord, such approval not to be unreasonably withheld or delayed; however, (a)&#160;if such requested change would adversely affect (in the reasonable discretion of Landlord) (1)&#160;the Building's Structure or the Building's Systems (including the Building's restrooms or mechanical rooms), (2)&#160;the exterior appearance of the Building, or (3)&#160;the appearance of the Building's common areas or elevator lobby areas, or (b)&#160;if any such requested change might delay the Commencement Date, Landlord may withhold its consent in its sole and absolute discretion.&nbsp;&nbsp;The Architect shall, upon completion of the Work, furnish Landlord with an accurate architectural "as-built" plan of the Work as constructed, which plan shall be incorporated into this <font style="text-decoration:underline;">Exhibit&#160;D</font> by this reference for all purposes.&nbsp;&nbsp;If Tenant requests any changes to the Work described in the approved Space Plans or the approved Working Drawings, then such increased costs and any additional design costs incurred in connection therewith as the result of any such change shall be added to the Total Construction Costs.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU36"></a>6.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Definitions</font>.&nbsp;&nbsp;As used herein, a "<font style="font-weight:bold;text-decoration:underline;">Tenant Delay Day</font>" means each day of delay in the performance of the Work that occurs (a)&#160;because Tenant fails to timely furnish any information or deliver or approve any required documents such as the Space Plans or Working Drawings (whether preliminary, interim revisions or final), pricing estimates, construction bids, and the like, (b)&#160;because of any change by Tenant to the approved Space Plans or Working Drawings, (c)&#160;because Tenant fails to attend any meeting with Landlord, the Architect, Construction Manager, any design professional, or any contractor, or their respective employees or representatives, as may be required or </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT D, Tenant Finish-Work:&nbsp;&nbsp;Allowance - Page D-2</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">scheduled hereunder or otherwise necessary in connection with the preparation or completion of any construction documents, such as the Space Plans or Working Drawings, or in connection with the performance of the Work</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; provided that Landlord shall provide Tenant at least three business days&#8217; written notice prior to any such meeting</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, (d)&#160;because of any specification by Tenant of materials or installations in addition to or other than Landlord's standard finish-out materials, or (e)&#160;because a Tenant Party otherwise delays completion of the Work.&nbsp;&nbsp;As used herein "</font><font style="font-weight:bold;text-decoration:underline;">Substantial Completion</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">," "</font><font style="font-weight:bold;text-decoration:underline;">Substantially Completed</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">," and any derivations thereof mean the Work in the Premises is substantially completed (as reasonably determined by </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Architect</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) in substantial accordance with the Working Drawings.&nbsp;&nbsp;Substantial Completion shall have occurred even though minor details of construction, decoration, landscaping and mechanical adjustments remain to be completed by Landlord.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Walk-Through; Punchlist</font>.&nbsp;&nbsp;When Landlord considers the Work in the Premises to be Substantially Completed, Landlord will notify Tenant and, within three business days thereafter, Landlord's representative and Tenant's representative shall conduct a walk-through of the Premises and identify any necessary touch-up work, repairs and minor completion items that are necessary for final completion of the Work.&nbsp;&nbsp;Neither Landlord's representative nor Tenant's representative shall unreasonably withhold his or her agreement on punchlist items.&nbsp;&nbsp;Landlord shall use reasonable efforts to cause the contractor performing the Work to complete all punchlist items within 30 days after agreement thereon; however, Landlord shall not be obligated to engage overtime labor in order to complete such items.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Excess Costs</font>.&nbsp;&nbsp;The entire cost of performing the Work (including design of and space planning for the Work and preparation of the Working Drawings and the final "as-built" plan of the Work, costs of construction labor and materials, electrical usage during construction, additional janitorial services, general tenant signage, related taxes and insurance costs, licenses, permits, certifications, surveys and other approvals required by Law, and the construction supervision fee referenced in <font style="text-decoration:underline;">Section&#160;10</font> of this Exhibit, all of which costs are herein collectively called the "<font style="font-weight:bold;text-decoration:underline;">Total Construction Costs</font></a>") in excess of the Construction Allowance (hereinafter defined) shall be paid by Tenant; provided that the Total Construction Costs shall not exceed the amount approved by Tenant in accordance with <font style="text-decoration:underline;">Section 4</font> of this Exhibit (unless caused by a change order requested by Tenant).&nbsp;&nbsp;Upon approval of the Working Drawings and selection of a contractor, Tenant shall promptly (a)&#160;execute a work order agreement prepared by Landlord which identifies such drawings and itemizes the Total Construction Costs and sets forth the Construction Allowance, and (b)&#160;pay to Landlord 50% of the amount by which Total Construction Costs exceed the Construction Allowance.&nbsp;&nbsp;Upon Substantial Completion of the Work and before Tenant occupies the Premises to conduct business therein, Tenant shall pay to Landlord an amount equal to the Total Construction Costs (as adjusted for any approved changes to the Work), less (1)&#160;the amount of the advance payment already made by Tenant, and (2)&#160;the amount of the Construction Allowance.&nbsp;&nbsp;In the event of default of payment of such excess costs, Landlord (in addition to all other remedies) shall have the same rights as for an Event of Default under this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Construction Allowance</font>.&nbsp;&nbsp;Landlord shall provide to Tenant a construction allowance not to exceed $40.00 per rentable square foot in the Premises (the "<font style="font-weight:bold;text-decoration:underline;">Construction Allowance</font></a><font style="font-weight:bold;">"</font>) to be applied toward the Total Construction Costs, as adjusted for any changes to the Work.&nbsp;&nbsp;The Construction Allowance shall not be disbursed to Tenant in cash, but shall be applied by Landlord to the payment of the Total Construction Costs, if, as, and when the cost of the Work is actually incurred and paid by Landlord.&nbsp;&nbsp;The Construction Allowance must be used (that is, the Work must be fully complete and the Construction Allowance disbursed) within six (6) months following the Commencement Date (subject to force majeure delays) or shall be deemed forfeited with no further obligation by Landlord with respect thereto, time being of the essence with respect thereto.&nbsp;&nbsp;Tenant shall be entitled to use up to ten percent (10%) of the Construction Allowance for architectural and engineering costs.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506207339"></a>10.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Construction Management</font>.&nbsp;&nbsp;Landlord or its Affiliate or agent shall supervise the Work, make disbursements required to be made to the contractor, and act as a liaison between the contractor and Tenant and coordinate the relationship between the Work, the Building and the Building's Systems.&nbsp;&nbsp;In consideration for Landlord's construction supervision services, Tenant shall pay to Landlord a construction supervision fee equal to five percent of the Total Construction Costs.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref506206922"></a>11.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Construction Representatives</font>.&nbsp;&nbsp;Landlord's and Tenant's representatives for coordination of construction and approval of change orders will be as follows, provided that either party may change its representative upon written notice to the other:</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT D, Tenant Finish-Work:&nbsp;&nbsp;Allowance - Page D-3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:30.77%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord's Representative:</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><a name="_AEIOULastRenderedPageBreakAEIOU37"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pritchard Associates</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2121 North Akard Street</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br />Suite 100</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br />Dallas, TX 75201</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br />Attention: Taylor Wildman</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br />Telephone: </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">214</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">849-0011</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:30.77%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant's Representative:</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Jim Rouse, CIO<br />c/o Taysha Gene Therapies, Inc.<br />2280 Inwood Road<br />Dallas, Texas 75235<br />Attention: Kamran Alam, CFO <br />Telephone: 214-714-6701<br /></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Miscellaneous</font>.&nbsp;&nbsp;To the extent not inconsistent with this Exhibit, <font style="text-decoration:underline;">Sections&#160;8(a)</font> and <font style="text-decoration:underline;">21</font> of this Lease shall govern the performance of the Work and Landlord's and Tenant's respective rights and obligations regarding the improvements installed pursuant thereto.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT D, Tenant Finish-Work:&nbsp;&nbsp;Allowance - Page D-4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU38"></a><a name="_Ref136745727"></a><font style="text-decoration:underline;">EXHIBIT E</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136745727"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">CONFIRMATION OF COMMENCEMENT DATE</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">______________, 20___</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">______________________________<br />______________________________<br />______________________________</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Re:</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Lease Agreement (the "<font style="font-weight:bold;text-decoration:underline;">Lease</font></a>") dated _____________, 20___, between ____________________, a ______________________ ("<font style="font-weight:bold;text-decoration:underline;">Landlord</font>"), and _____________________, a ___________________ ("<font style="font-weight:bold;text-decoration:underline;">Tenant</font>").&nbsp;&nbsp;Capitalized terms used herein but not defined shall be given the meanings assigned to them in the Lease.</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ladies and Gentlemen:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord and Tenant agree as follows:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Condition of Premises</font>.&nbsp;&nbsp;Tenant has accepted possession of the Premises pursuant to the Lease.&nbsp;&nbsp;Any improvements required by the terms of the Lease to be made by Landlord have been completed to the full and complete satisfaction of Tenant in all respects except for the punchlist items described on Exhibit&#160;A hereto (the "Punchlist Items"), and except for such Punchlist Items, Landlord has fulfilled all of its duties under the Lease with respect to such initial tenant improvements.&nbsp;&nbsp;Furthermore, Tenant acknowledges that the Premises are suitable for the Permitted Use.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Commencement Date</font>.&nbsp;&nbsp;The Commencement Date of the Lease is __________, 20___.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Expiration Date</font>.&nbsp;&nbsp;The Term is scheduled to expire on the last day of the ___th full calendar month of the Term, which date is ______________, 20___.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Contact Person</font>.&nbsp;&nbsp;Tenant's contact person in the Premises is:</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:30.77%;text-indent:-30.77%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_____________________________<br />_____________________________<br />_____________________________<br />Attention: ____________________<br />Telephone:&nbsp;&nbsp;____- ___-_____<br />Telecopy:&nbsp;&nbsp;____- ___-_____</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Ratification</font>.&nbsp;&nbsp;Tenant hereby ratifies and confirms its obligations under the Lease, and represents and warrants to Landlord that, as of the date hereof, it has no defenses thereto.&nbsp;&nbsp;Additionally, Tenant further confirms and ratifies that, as of the date hereof, (a)&#160;the Lease is and remains in good standing and in full force and effect, and (b)&#160;Tenant has no claims, counterclaims, set-offs or defenses against Landlord arising out of the Lease or in any way relating thereto or arising out of any other transaction between Landlord and Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;">Binding Effect; Governing Law</font>.&nbsp;&nbsp;Except as modified hereby, the Lease shall remain in full effect and this letter shall be binding upon Landlord and Tenant and their respective successors and assigns.&nbsp;&nbsp;If any inconsistency exists or arises between the terms of this letter and the terms of the Lease, the terms of this letter shall prevail.&nbsp;&nbsp;This letter shall be governed by the laws of the state in which the Premises are located.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please indicate your agreement to the above matters by signing this letter in the space indicated below and returning an executed original to us.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sincerely,</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT E, Form of Confirmation of Commencement Date - Page E-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PEGASUS PARK, LLC, </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Delaware limited liability company</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Justin A. Small</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agreed and accepted:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[TENANT'S SIGNATURE BLOCK]<font style="font-weight:normal;font-style:normal;">, a _______________</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:<font style="margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:<font style="margin-left:36pt;"></font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT E, Form of Confirmation of Commencement Date - Page E-2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU39"></a><font style="text-decoration:underline;">EXHIBIT A</font><font style="text-decoration:underline;"><br /></font><font style="text-decoration:underline;"><br />PUNCHLIST ITEMS</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please insert any punchlist items that remain to be performed by Landlord.&nbsp;&nbsp;If no items are listed below by Tenant, none shall be deemed to exist.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT E, Form of Confirmation of Commencement Date - Page E-3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU40"></a><a name="_Ref136745801"></a><font style="text-decoration:underline;">EXHIBIT F</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136745801"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">FORM OF TENANT ESTOPPEL CERTIFICATE</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned is the Tenant under the Lease (defined below) between _______________________, a ___________________, as Landlord, and the undersigned as Tenant, for the Premises on the __________ floor(s) of the office building located at _____________________, __________ and commonly known as _______________________, and hereby certifies as follows:</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref59334741"></a>1.<font style="margin-left:36pt;"></font>The Lease consists of the original Lease Agreement dated as of ___________, 20____ between Tenant and Landlord<font style="font-weight:bold;font-style:italic;">['s predecessor-in-interest]</font> and the following amendments or modifications thereto (if none, please state "none"):<font style="text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="border-top:Solid 0.75pt;padding-top:1pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The documents listed above are herein collectively referred to as the "Lease" and represent the entire agreement between the parties with respect to the Premises.&nbsp;&nbsp;All capitalized terms used herein but not defined shall be given the meaning assigned to them in the Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font>The Lease is in full force and effect and has not been modified, supplemented or amended in any way except as provided in <font style="text-decoration:underline;">Section&#160;1</font> above.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font>The Term commenced on __________________, 20___ and the Term expires, excluding any renewal options, on _____________________, 20___, and Tenant has no option to purchase all or any part of the Premises or the Building or, except as expressly set forth in the Lease, any option to terminate or cancel the Lease.</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font>Tenant currently occupies the Premises described in the Lease and Tenant has not transferred, assigned, or sublet any portion of the Premises nor entered into any license or concession agreements with respect thereto except as follows (if none, please state "none"): <font style="text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;border-top:Solid 0.75pt;padding-top:1pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:12pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font>All monthly installments of Basic Rent, all Additional Rent and all monthly installments of estimated Additional Rent have been paid when due through ______________.&nbsp;&nbsp;The current monthly installment of Basic Rent is $____________.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font>As of the date hereof, all conditions of the Lease to be performed by Landlord necessary to the enforceability of the Lease have been satisfied and Landlord is not in default thereunder.&nbsp;&nbsp;In addition, Tenant has not delivered any notice to Landlord regarding a default by Landlord thereunder.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font>As of the date hereof, there are no existing defenses or offsets, or, to the undersigned's knowledge, claims or any basis for a claim, that the undersigned has against Landlord and no event has occurred and no condition exists, which, with the giving of notice or the passage of time, or both, will constitute a default under the Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.<font style="margin-left:36pt;"></font>No rental has been paid more than 30 days in advance and no security deposit has been delivered to Landlord except as provided in the Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.<font style="margin-left:36pt;"></font>If Tenant is a corporation, partnership or other business entity, each individual executing this Estoppel Certificate on behalf of Tenant hereby represents and warrants that Tenant is a duly formed and existing entity qualified to do business in the state in which the Premises are located and that Tenant has full right and authority to execute and deliver this Estoppel Certificate and that each person signing on behalf of Tenant is authorized to do so.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.<font style="margin-left:36pt;"></font>There are no actions pending against Tenant under any bankruptcy or similar laws of the United States or any state.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT F, Form of Tenant Estoppel Certificate - Page F-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU41"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other than in compliance with all applicable laws and incidental to the ordinary course of the use of the Premises, the undersigned has not used or stored any hazardous substances in the Premises.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font>Tenant is not itself, and is not directly or indirectly owned, controlled or supported by, a "Specially Designated National" or otherwise designated as a blocked person under any regulation of the Office of Foreign Assets Control, U.S. Department of Treasury (see: www.ustreas.gov/offices/enforcement/OFAC).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font>All tenant improvement work to be performed by Landlord under the Lease has been completed in accordance with the Lease and has been accepted by the undersigned and all reimbursements and allowances due to the undersigned under the Lease in connection with any tenant improvement work have been paid in full.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant acknowledges that this Estoppel Certificate may be delivered to Landlord, Landlord's Mortgagee or to a prospective mortgagee or prospective purchaser, and their respective successors and assigns, and acknowledges that Landlord, Landlord's Mortgagee and/or such prospective mortgagee or prospective purchaser will be relying upon the statements contained herein in disbursing loan advances or making a new loan or acquiring the property of which the Premises are a part and that receipt by it of this certificate is a condition of disbursing loan advances or making such loan or acquiring such property.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executed as of ____________________, 20__.</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:48.85%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.67%;"></td>
<td style="width:4.84%;"></td>
<td style="width:1.97%;"></td>
<td style="width:31.56%;"></td>
<td style="width:1.53%;"></td>
<td style="width:4.88%;"></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TENANT:</p></td>
<td colspan="5" valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="4" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="5" valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="5" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="5" valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT F, Form of Tenant Estoppel Certificate - Page F-2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU42"></a><font style="text-decoration:underline;">EXHIBIT G</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;">PARKING</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant may use all unreserved and visitor parking spaces, and up to 10 reserved parking spaces, in the parking facilities associated with the Building  (the "<font style="font-weight:bold;text-decoration:underline;">Parking Area</font><font style="font-weight:bold;"></font></a>") subject to such terms, conditions and regulations as are from time to time applicable to patrons of the Parking Area during the Term.&nbsp;&nbsp;Tenant shall pay to Landlord, contemporaneously with the payment of Basic Rent, parking rent (plus all applicable taxes) during the initial Term equal to the following rates for each such parking space for the following periods of time:</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:88.5%;">
<tr>
<td style="width:14.43%;"></td>
<td style="width:23.09%;"></td>
<td style="width:19.24%;"></td>
<td style="width:31.74%;"></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Month</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Monthly Rent per Unreserved and Visitor Parking Space</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Monthly Rent per Covered Reserved Parking Space</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Monthly Rent per Uncovered Reserved Parking Space</p></td>
</tr>
<tr>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1 &#8211; 120</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$0.00 </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$100</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$50</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The parking rent during any renewal term shall be determined along with the Basic Rent for such renewal term in accordance with Exhibit H attached to the Lease.&nbsp;&nbsp;Tenant shall at all times comply with all Laws respecting the use of the Parking Area.&nbsp;&nbsp;Landlord reserves the right to adopt, modify, and enforce reasonable rules and regulations governing the use of the Parking Area from time to time including any key-card, sticker, or other identification or entrance systems and hours of operations; provided that Landlord provides Tenant with a sufficient initial set of key-cards, stickers or other identification methods at no additional cost to Tenant; replacements or additional such items shall be made available by Landlord for a reasonable fee.&nbsp;&nbsp;Landlord may refuse to permit any person who violates such rules and regulations to park in the Parking Area, and any violation of the rules and regulations shall subject the car to removal from the Parking Area.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant may validate visitor parking by such method or methods as Landlord may approve, at the validation rate from time to time generally applicable to visitor parking.&nbsp;&nbsp;Unless specified to the contrary above, the parking spaces provided hereunder shall be provided on an unreserved, "first-come, first served" basis.&nbsp;&nbsp;Tenant acknowledges that Landlord has arranged or may arrange for the Parking Area to be operated by an independent contractor, not affiliated with Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There will be a replacement charge payable by Tenant equal to the amount posted from time to time by Landlord for loss of any magnetic parking card or parking sticker issued by Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All motor vehicles (including all contents thereof) shall be parked in the Parking Area at the sole risk of Tenant and each other Tenant Party, it being expressly agreed and understood Landlord has no duty to insure any of said motor vehicles (including the contents thereof), and Landlord is not responsible for the protection and security of such vehicles.&nbsp;&nbsp;<font style="font-weight:bold;">NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THIS LEASE, LANDLORD SHALL HAVE NO LIABILITY WHATSOEVER FOR ANY PROPERTY DAMAGE WHICH MIGHT OCCUR ON THE PARKING AREA OR AS A RESULT OF OR IN CONNECTION WITH THE PARKING OF MOTOR VEHICLES IN ANY OF THE PARKING SPACES.</font></p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If, for any reason, Landlord is unable to provide all or any portion of the parking spaces to which Tenant is entitled hereunder, then Tenant's obligation to pay for such parking spaces shall be abated for so long as Tenant does not have the use thereof; this abatement shall be in full settlement of all claims that Tenant might otherwise have against Landlord because of Landlord's failure or inability to provide Tenant with such parking spaces.&nbsp;&nbsp;Landlord shall not be responsible for enforcing Tenant's parking rights against any third parties.&nbsp;&nbsp;Notwithstanding anything to the contrary contained in the Lease or this Exhibit G, if any event or action or omission by Landlord renders the Parking Area for the Building and/or Tenant&#8217;s parking space allocation (including reserved spaces, if any) for whatever reason inaccessible, unusable, unsafe, or which causes the number of parking spaces for the Building and/or Tenant&#8217;s parking space allocation for the Premises to be reduced below applicable local code requirements (which reasons may include but are not limited to repairs, maintenance, casualty, condemnation, or displacement or dislocation caused by future construction), Landlord shall immediately provide substitute parking areas for Tenant&#8217;s use and its invitees which areas shall (i) cause no net reduction in Tenant&#8217;s parking space allocation, (ii) be similarly convenient in terms of location, quality and safety, and (iii) except in the case of an emergency, be designated by prior written notice to Tenant with the exact location of such substitute parking areas subject to Tenant&#8217;s approval not to be unreasonably withheld, conditioned or delayed.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT G, Parking - Page G-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU43"></a><a name="_Ref136746008"></a><font style="text-decoration:underline;">EXHIBIT H</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136746008"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">RENEWAL OPTION</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provided no Event of Default exists and Tenant is occupying at least 75% of the entire initial Premises at the time of such election, Tenant may renew this Lease for one (1) additional period of five (5) years, by delivering written notice of the exercise thereof to Landlord not earlier than eighteen (18) months nor later than twelve (12) months before the expiration of the Term.&nbsp;&nbsp;The Basic Rent payable for each month during such extended Term shall be the prevailing rental rate (the "<font style="font-weight:bold;text-decoration:underline;">Prevailing Rental Rate</font></a>"), at the commencement of such extended Term, for renewals of space in the Building of equivalent quality, size, utility and location, with the length of the extended Term taken into account.&nbsp;&nbsp;In no event shall the Basic Rent in any renewal term be less than that in effect at the end of the then-current Term.&nbsp;&nbsp;Within 30 days after receipt of Tenant's notice to renew, Landlord shall deliver to Tenant written notice of the Prevailing Rental Rate and shall advise Tenant of the required adjustment to Basic Rent, if any, and the other terms and conditions offered.&nbsp;&nbsp;Tenant shall, within ten days after receipt of Landlord's notice, notify Landlord in writing whether Tenant accepts or rejects Landlord's determination of the Prevailing Rental Rate.&nbsp;&nbsp;If Tenant timely notifies Landlord that Tenant accepts Landlord's determination of the Prevailing Rental Rate, then, on or before the commencement date of the extended Term, Landlord and Tenant shall execute an amendment to this Lease extending the Term on the same terms provided in this Lease, except as follows:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Basic Rent shall be adjusted to the Prevailing Rental Rate;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Tenant shall have no further renewal option unless expressly granted by Landlord in writing; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>Landlord shall lease to Tenant the Premises in their then-current condition, and Landlord shall not provide to Tenant any allowances (e.g., moving allowance, construction allowance, and the like) or other tenant inducements.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font>Tenant shall pay for the parking spaces which it is entitled to use at the rates (if any) from time to time charged to patrons of the Parking Area and/or any other parking area associated with the Building during the extended Term (plus all applicable taxes).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Tenant rejects Landlord's determination of the Prevailing Rental Rate, or fails to timely notify Landlord in writing that Tenant accepts or rejects Landlord's determination of the Prevailing Rental Rate, time being of the essence with respect thereto, the Prevailing Rental Rate shall be determined as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;">Landlord and Tenant shall each designate, by written notice to the other, a commercial real estate broker unaffiliated with the selecting party and willing to act in such determination and having at least ten (10) years&#8217; experience in the leasing or valuation of first class office space in Dallas, Texas (hereinafter called a &#8220;</font><font style="font-weight:bold;">Qualified Appraiser</font>&#8221;). The notice shall set forth the name and address of the Qualified Appraiser selected by the party.&nbsp;&nbsp;If a party shall fail, neglect or refuse within ten (10) business days to designate a Qualified Appraiser, then the sole designated Qualified Appraiser shall alone conduct the determination of the Prevailing Rental Rate for the Premises.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font>If two (2) Qualified Appraisers have been designated as aforesaid, such Qualified Appraisers shall&#160;appoint an additional Qualified Appraiser (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Third Qualified Appraiser&#8221;</font>) who is willing so to act in&#160;such determination, and notice of such designation shall be given to both Landlord and Tenant. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU44"></a>3.<font style="margin-left:36pt;">Landlord&#8217;s designated Qualified Appraiser and Tenant&#8217;s designated Qualified Appraiser shall each submit to the Third Qualified Appraiser within ten (10) business days after the appointment of the Third Qualified Appraiser </font>a complete statement (the &#8220;<font style="font-weight:bold;">Prevailing Rental Rate</font><font style="font-weight:bold;text-decoration:underline;"> Proposal</font><font style="font-weight:bold;">&#8221;</font>) setting forth in reasonable detail all of the relevant economic terms of the party&#8217;s proposed&#160;determination of the Prevailing Rental Rate and the relevant factors used in determining the same.&nbsp;&nbsp;The Third&#160;Qualified Appraiser shall deliver a copy of the Prevailing Rental Rate Proposals to the Qualified Appraisers designated by Landlord and Tenant within two (2) business days after receipt of the same.  The Third Qualified Appraiser shall examine the Prevailing Rental Rate Proposals and any submitted </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT H, Renewal Option - Page H-1</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">supporting documentation and </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">select the </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prevailing Rental Rate of the</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premises</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that the Third Qualified Appraiser believes to most accurately reflect the applicable </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prevailing Rental Rate</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font>Each of Landlord and Tenant shall pay the costs and fees of the Qualified&#160;Appraiser chosen by it, and Landlord and Tenant shall share the costs and fees of the Third Qualified&#160;Appraiser equally. Each of Landlord and Tenant shall pay the legal fees and expenses of their respective&#160;counsel and costs incurred in preparation of its Prevailing Rental Rate Proposal.&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any determination of Prevailing Rental Rate pursuant to this <font style="text-decoration:underline;">Exhibit H</font> shall be binding on both Landlord and Tenant.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant's rights under this Exhibit shall terminate if (1)&#160;this Lease or Tenant's right to possession of the Premises is terminated, (2)&#160;Tenant assigns all of its interest in this Lease or sublets more than 25% of the Premises and such sublease is in effect as of the date Tenant exercised its Renewal Option, or (3)&#160;Tenant fails to timely exercise its option under this Exhibit, time being of the essence with respect to Tenant's exercise thereof.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT H, Renewal Option - Page H-2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU45"></a><a name="_Ref136746010"></a><font style="text-decoration:underline;">EXHIBIT I</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /><a name="_Ref136746010"></a></font><font style="text-decoration:underline;font-family:Times New Roman;">RIGHT OF FIRST </font><font style="text-decoration:underline;font-family:Times New Roman;">REFUSAL</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provided no Event of Default exists and Tenant is occupying the entire Premises, before Landlord accepts any offer for the space in the Building designated on <font style="text-decoration:underline;">Exhibit A</font> (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Expansion Space</font>&#8221;) from any third party, Landlord shall provide Tenant with notice, in writing of the terms and conditions of such offer (the &#8220;<font style="font-weight:bold;text-decoration:underline;">ROFR Notice</font></a>&#8221;).&nbsp;&nbsp;The ROFR Notice must include all material terms and conditions of the offer and the Basic Rent in such offer shall be the same as for the Premises set forth in the Lease.&nbsp;&nbsp;Tenant shall notify Landlord in writing within fifteen (15) business days after receipt of the ROFR Notice (&#8220;<font style="font-weight:bold;text-decoration:underline;">ROFR Deadline</font>&#8221;) whether Tenant elects to exercise its right to lease the Expansion Space pursuant to the terms and conditions of the offer, as set forth in the ROFR Notice.&nbsp;&nbsp;If Tenant fails to notify Landlord of its election on or prior to the ROFR Deadline, Tenant's right of first refusal shall be deemed to have automatically and without further notice expired as to the offer that is the subject of the ROFR Notice and Landlord shall thereafter have the right to lease the Expansion Space to a third party on substantially the same terms and conditions stated in the ROFR Notice (or on terms which are better, but not materially worse, for Landlord in the aggregate considering all economic and non-economic terms of same).&nbsp;&nbsp;If Tenant timely elects to exercise the right of first refusal then Tenant and Landlord shall (within ten [10] business days thereafter) enter into an amendment to this Lease adding the Expansion Space to the Premises and incorporating the terms in the accepted ROFR Notice.&nbsp;&nbsp;If Tenant fails to timely exercise its rights prior to the ROFR Deadline, the right of first refusal shall be deemed to have automatically and without further notice expired and Landlord shall thereafter have the right to lease the Expansion Space to a third party on substantially the same terms and conditions stated in the ROFR Notice (or on terms which are better, but not materially worse, for Landlord in the aggregate considering all economic and non-economic terms of same). If Tenant does not exercise its right hereunder and Landlord does not consummate the lease of the Expansion Space in accordance with the terms of the ROFR Notice within one hundred twenty (120) calendar days after the ROFR Deadline, this right of first refusal shall revive. Notwithstanding anything to the contrary contained herein, Landlord may reduce the Basic Rental rate for the Expansion Space by no more than ten percent (10%) of the Base Rental Rate set forth in the ROFR Notice without reviving the Tenant&#8217;s right of first refusal hereunder. If Landlord consummates the lease of all or a portion of the Expansion Space to a third party within said 120-day period in compliance with this <font style="text-decoration:underline;">Exhibit I</font>, this right of first refusal shall automatically terminate as to that portion of the Expansion Space without further notice.&nbsp;&nbsp; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In no event shall Landlord be obligated to pay a commission with respect to the lease of the Expansion Space pursuant to this <font style="text-decoration:underline;">Exhibit I</font>, and Tenant and Landlord shall each indemnify the other against all costs, expenses attorneys&#8217; fees, and other liability for commissions or other compensation claimed by any broker or agent claiming the same. Tenant's rights under this Exhibit shall terminate if (a)&#160;this Lease or Tenant's right to possession of any of the Premises is terminated, (b)&#160;Tenant assigns any of its interest in this Lease or sublets any portion of the Premises which was not otherwise approved or deemed approved by Landlord, or (c)&#160;less than thirty-six (36) full calendar months remain in the then-current Term of this Lease (unless during the initial Term and Tenant has exercised its renewal right).</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:bold;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT I, Right of First Refusal - Page I-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXECUTION VERSION</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU46"></a><font style="text-decoration:underline;">EXHIBIT J</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;">FORM OF SNDA</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SUBORDINATION, NON-DISTURBANCE AND ATTORNMENT AGREEMENT</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This<font style="font-weight:bold;"> SUBORDINATION, NON-DISTURBANCE AND ATTORNMENT&nbsp;&nbsp;AGREEMENT </font>(&#8220;<font style="font-weight:bold;font-style:italic;">Agreement</font>&#8221;) is entered into as of January ___, 2021 (the &#8220;<font style="font-weight:bold;font-style:italic;">Effective Date</font>&#8221;) by and between <font style="font-weight:bold;">H.I.G. RCF &#8211; PEGASUS DALLAS, LLC</font><font style="font-weight:bold;color:#000000;"> </font>(together with any other holder of the Loan (defined below) and their respective successors and assigns, the &#8220;<font style="font-weight:bold;font-style:italic;">Mortgagee</font>&#8221;) and <font style="font-weight:bold;">TAYSHA GENE THERAPIES, INC.</font>, a Delaware corporation (hereinafter, the &#8220;<font style="font-weight:bold;font-style:italic;">Tenant</font>&#8221;), with reference to the following facts:</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A.<font style="margin-left:36pt;"></font><font style="font-weight:bold;">PEGASUS PARK, LLC</font>, a Delaware limited liability company (formerly known as Pegasus Place, LLC, a Texas limited liability company, the &#8220;<font style="font-weight:bold;font-style:italic;">Landlord</font>&#8221;), owns fee simple title in the real property described in Exhibit &#8220;A&#8221; attached hereto (the &#8220;<font style="font-weight:bold;font-style:italic;">Property</font>&#8221;).</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">B.<font style="margin-left:36pt;">Mortgagee has made or intends to make a loan to Landlord (the &#8220;Loan&#8221;).</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">C.<font style="margin-left:36pt;">To secure the Loan, Landlord has or will encumber the Property by entering into a mortgage or deed of trust in favor of Mortgagee (as amended, increased, renewed, extended, spread, consolidated, severed, restated, or otherwise changed from time to time, the &#8220;</font><font style="font-weight:bold;font-style:italic;">Mortgage</font>&#8221;) to be recorded in land records.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">D.<font style="margin-left:36pt;">Pursuant to the Lease Agreement dated ______________ (as the same may hereafter be modified, amended or extended, the &#8220;</font><font style="font-weight:bold;font-style:italic;">Lease</font>&#8221;) between Landlord (or Landlord&#8217;s predecessor in title) and Tenant, Landlord leased to Tenant a portion of the Property, as said portion is more particularly described in the Lease (the &#8220;<font style="font-weight:bold;font-style:italic;">Leased Premises</font>&#8221;).</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">E.<font style="margin-left:36pt;">Tenant and Mortgagee desire to agree upon the relative priorities of their interests in the Property and their rights and obligations if certain events occur.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, for good and sufficient consideration, Tenant and Mortgagee agree:</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:none;">1.</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;">Definitions.</font><font style="text-decoration:none;font-weight:bold;font-size:10pt;">&nbsp;&nbsp;</font><font style="text-decoration:none;font-size:10pt;">The following terms shall have the following meanings for purposes of this Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Foreclosure Event</font>.&nbsp;&nbsp;A &#8220;<font style="font-weight:bold;font-style:italic;">Foreclosure Event</font>&#8221; means:&nbsp;&nbsp;(i)&#160;foreclosure under the Mortgage; (ii)&#160;any other exercise by Mortgagee of rights and remedies (whether under the Mortgage or under applicable law, including bankruptcy law) as holder of the Loan and/or the Mortgage, as a result of which a Successor Landlord becomes owner of the Property; or (iii)&#160;delivery by Landlord to Mortgagee (or its designee or nominee) of a deed or other conveyance of Landlord&#8217;s interest in the Property in lieu of any of the foregoing.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Former Landlord</font>.&nbsp;&nbsp;A &#8220;<font style="font-weight:bold;font-style:italic;">Former Landlord</font>&#8221; means Landlord and any other party that was landlord under the Lease at any time before the occurrence of any attornment under this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Offset Right</font>.&nbsp;&nbsp;An &#8220;<font style="font-weight:bold;font-style:italic;">Offset Right</font>&#8221; means any right or alleged right of Tenant to any offset, defense (other than one arising from actual payment and performance, which payment and performance would bind a Successor Landlord pursuant to this Agreement), claim, counterclaim, reduction, deduction, or abatement of or against Tenant&#8217;s payment of Rent or performance of Tenant&#8217;s other obligations under the Lease, or any other claim or counterclaim, arising (whether under the Lease or under applicable law) from Landlord&#8217;s breach or default under the Lease or any other act or omission of Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Rent</font>.&nbsp;&nbsp;The &#8220;<font style="font-weight:bold;font-style:italic;">Rent</font>&#8221; means any fixed rent, base rent or additional rent under the Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Successor Landlord</font>.&nbsp;&nbsp;A &#8220;<font style="font-weight:bold;font-style:italic;">Successor Landlord</font>&#8221; means any party that becomes owner of the Property as the result of a Foreclosure Event.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT J, Form of SNDA - Page 2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU47"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Termination Right</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A &#8220;</font><font style="font-weight:bold;font-style:italic;">Termination Right</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means any right of Tenant to cancel or terminate the Lease or to claim a partial or total eviction arising (whether under the Lease or under applicable law) from Landlord&#8217;s breach or default under the Lease.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Other Capitalized Terms</font><font style="font-style:italic;">.</font>&nbsp;&nbsp;If any capitalized term is used in this Agreement and no separate definition is contained in this Agreement, then such term shall have the same respective definition as set forth in the Lease.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:none;">2.</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;">Subordination.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>The Lease (including but not limited to any option to purchase, right of first refusal to purchase or right of first offer to purchase the Property (or any portion thereof)) shall be, and shall at all times remain, subject and subordinate to the lien imposed by the Mortgage, and all advances made under or secured by the Mortgage.&nbsp;&nbsp;Notwithstanding the foregoing, Mortgagee may elect, in its sole and absolute discretion, to subordinate the lien of the Mortgage to the Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Tenant hereby acknowledges and agrees that any option to purchase, right of first refusal to purchase or right of first offer to purchase the Property (or any portion thereof) in the Lease shall not be exercisable in connection with any exercise of remedies pursuant to the Mortgage or any mezzanine loan secured by the membership interests in Landlord, including: (i) a purchase of the Property (or any portion thereof) at a foreclosure sale, (ii) a transfer of the Property (or any portion thereof) to Mortgagee or its designee pursuant to a deed-in-lieu of foreclosure, (iii) a transfer of the membership interests in Landlord pursuant to a foreclosure of any such mezzanine loan, or (iv) any subsequent sale of the Property (or any portion thereof) by Mortgagee or its designee after such foreclosure or deed-in-lieu of foreclosure or by any mezzanine lender or its designee after such foreclosure of such mezzanine loan.&nbsp;&nbsp;The holder of any such mezzanine loan shall be a third party beneficiary of the foregoing sentence.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:none;">3.</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;">Nondisturbance, Recognition and Attornment.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Exercise of Mortgage Remedies Against Tenant</font>.&nbsp;&nbsp;So long as Tenant is not in default under the Lease beyond any applicable notice, grace or cure periods (an &#8220;<font style="font-weight:bold;font-style:italic;">Event of Default</font>&#8221;), Mortgagee (i)&#160;shall not terminate the Lease or disturb Tenant&#8217;s right of quiet possession, use or possession of the Leased Premises under the Lease, except in accordance with the terms of the Lease and this Agreement and (ii)&#160;shall not name or join Tenant as a defendant in any exercise of Mortgagee&#8217;s rights and remedies arising upon a default under the Mortgage unless (a)&#160;applicable law requires Tenant to be made a party thereto as a condition to proceeding against Landlord or prosecuting such rights and remedies, (b) such joinder of Tenant is required for the recovery by Mortgagee of any Rent at any time owing by Tenant under the Lease, whether pursuant to the assignment of rents set forth in the Mortgage or otherwise or (c) such joinder is required in order to enforce any right of Mortgagee to enter the Property for the purpose of making any inspection or assessment, or in order to protect the value of the security provided by the Mortgage, and in any such case, Mortgagee may join Tenant as a defendant in such action only for such purpose(s) and not to terminate the Lease or otherwise adversely affect Tenant&#8217;s rights under the Lease or this Agreement in such action.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU48"></a>(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Recognition and Attornment</font>.&nbsp;&nbsp;Upon Successor Landlord taking title to the Property (i)&#160;Successor Landlord shall be bound to Tenant under all the terms and conditions of the Lease (except as provided in this Agreement); (ii)&#160;Tenant shall recognize and attorn to Successor Landlord as Tenant&#8217;s direct landlord under the Lease as affected by this Agreement; and (iii)&#160;the Lease shall continue in full force and effect as a direct lease, in accordance with its terms (except as provided in this Agreement), between Successor Landlord and Tenant.&nbsp;&nbsp;Tenant hereby acknowledges notice that pursuant to the Mortgage and assignment of rents, leases and profits, Landlord has granted to the Mortgagee an absolute, present assignment of the Lease and Rents which provides that Tenant continue making payments of&nbsp;&nbsp;Rents and other amounts owed by Tenant under the Lease to the Landlord and to&nbsp;&nbsp;recognize the rights of Landlord under the Lease until notified otherwise in writing by the Mortgagee.&nbsp;&nbsp;After receipt of such notice from Mortgagee, Tenant shall thereafter make all such payments directly to the Mortgagee or as the Mortgagee may otherwise direct, without any further inquiry on the part of Tenant.&nbsp;&nbsp;Landlord consents to the foregoing and waives any right, claim or demand which Landlord may have against Tenant by reason of such payments to Mortgagee or as Mortgagee directs.&nbsp;&nbsp;Mortgagee and Landlord agree that any payments made to the Mortgagee shall be credited to </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant under the Lease as if Tenant had made such payments directly to Landlord regardless of whether Mortgagee had the right to make such demand and regardless of any contrary demands which may hereafter be made by Landlord. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Further Documentation</font>.&nbsp;&nbsp;The provisions of this <font style="text-decoration:underline;">Article 3</font> shall be effective and self-operative without any need for Successor Landlord or Tenant to execute any further documents.&nbsp;&nbsp;Tenant and Successor Landlord shall, however, confirm the provisions of this <font style="text-decoration:underline;">Article 3</font> in writing upon request by either of them within ten (10) days of such request.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:none;">4.</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;">Protection of Successor Landlord</font><font style="text-decoration:none;font-size:10pt;">.&nbsp;&nbsp;Notwithstanding anything to the contrary in the Lease or the Mortgage, Successor Landlord shall not be liable for or bound by any of the following matters:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Claims Against Former Landlord</font>.&nbsp;&nbsp;Any Offset Right that Tenant may have against any Former Landlord relating to any event or occurrence before the date of attornment, including any claim for damages of any kind whatsoever as the result of any breach by any Former Landlord that occurred before the date of attornment, except as it relates to Tenant&#8217;s continued right of offset for any default by the Former Landlord that is not personal to such Former Landlord and which remains uncured provided notice of such default has been provided to Mortgagee in accordance with the provisions of this Agreement and/or except to the extent such offset right is expressly provided for under the Lease.&nbsp;&nbsp;The foregoing shall not limit either (i)&#160;Tenant&#8217;s right to exercise against Successor Landlord any Offset Right otherwise available to Tenant because of events occurring after the date of attornment or (ii)&#160;Successor Landlord&#8217;s obligation to correct any conditions that existed as of the date of attornment and violate Successor Landlord&#8217;s obligations as landlord under the Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Prepayments</font>.&nbsp;&nbsp;Any payment of Rent that Tenant may have made to any Former Landlord more than thirty (30) days before the date such Rent was first due and payable under the Lease with respect to any period after the date of attornment other than, and only to the extent that, the Lease expressly required such a prepayment.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Payment; Security Deposit; Work</font>.&nbsp;&nbsp;Any obligation:&nbsp;&nbsp;(i)&#160;to pay Tenant any sum(s) that any Former Landlord owed to Tenant, including without limitation on account of tenant improvements or alterations, tenant improvement allowances, moving costs and other incentives, unless such sums, if any, shall have been actually delivered to Successor Landlord by way of an assumption of escrow accounts or otherwise; (ii)&#160;with respect to any security deposited with any Former Landlord, unless such security was actually delivered to Successor Landlord; (iii)&#160;to commence or complete any initial construction, or any expansion or rehabilitation of the improvements, or any other work required for Tenant&#8217;s occupancy; or (iv)&#160;arising from representations and warranties related to Former Landlord.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Modification, Amendment or Waiver</font>.&nbsp;&nbsp;Any material modification or amendment of the Lease, or any waiver of the terms of the Lease, made without Mortgagee&#8217;s written consent, which consent shall not be unreasonably withheld, conditioned or delayed.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Surrender, Etc.</font>&nbsp;&nbsp;Any consensual or negotiated surrender, cancellation, or termination of the Lease, in whole or in part, agreed upon between Landlord and Tenant, unless effected unilaterally by Tenant pursuant to the express terms of the Lease.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU49"></a><font style="text-decoration:none;">5.</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;">Exculpation of Successor Landlord</font><font style="text-decoration:none;font-size:10pt;">.&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement or the Lease, Successor Landlord&#8217;s obligations and liability under the Lease shall never extend beyond Successor Landlord&#8217;s (or its successors&#8217; or assigns&#8217;) interest, if any, in the Property from time to time, including insurance and condemnation proceeds, security deposits, escrows, Successor Landlord&#8217;s interest in the Lease, and the proceeds from any sale, lease or other disposition of the Property (or any portion thereof) by Successor Landlord (collectively, the &#8220;</font><font style="font-style:italic;text-decoration:none;font-size:10pt;">Successor Landlord&#8217;s Interest</font><font style="text-decoration:none;font-size:10pt;">&#8221;).&nbsp;&nbsp;Tenant shall look exclusively to Successor Landlord&#8217;s Interest (or that of its successors and assigns) for payment or discharge of any obligations of Successor Landlord under the Lease as affected by this Agreement.&nbsp;&nbsp;If Tenant obtains any money judgment against Successor Landlord with respect to the Lease or the relationship between Successor Landlord and Tenant, then Tenant shall look solely to Successor Landlord&#8217;s Interest (or that of its successors and assigns) to collect such judgment.&nbsp;&nbsp;Tenant shall not collect or attempt to collect any such judgment out of any other assets of Successor Landlord.&nbsp;&nbsp;</font><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;">Notwithstanding the </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;">foregoing, this Section 5 shall not limit or modify Tenant&#8217;s right to abate Rent or terminate the Lease in accordance w</font><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;">ith the provisions of the Lease</font><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;"> and this Agreement</font><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;"> and n</font><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;">othing herein shall be a waiver of the obligations of Successor Landlord to restore the Leased Premises </font><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;">after a casualty or condemnation </font><font style="text-decoration:none;Background-color:#FFFFFF;font-size:10pt;">in accordance with the terms of the Lease or a waiver of any of Tenant&#8217;s rights under the Lease in connection with any damage to or condemnation of the Property or the Leased Premises.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:none;">6.</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;">Mortgagee&#8217;s Right to Cure</font><font style="text-decoration:none;font-size:10pt;">.&nbsp;&nbsp;Notwithstanding anything to the contrary in the Lease or this Agreement, before exercising any Offset Right or Termination Right:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Notice to Mortgagee</font>.&nbsp;&nbsp;Tenant shall provide Mortgagee with notice of the breach or default by Landlord giving rise to same (the &#8220;<font style="font-weight:bold;font-style:italic;">Default Notice</font>&#8221;) and, thereafter, the opportunity to cure such breach or default as provided for below.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Mortgagee&#8217;s Cure Period</font>.&nbsp;&nbsp;After Mortgagee receives a Default Notice, Mortgagee shall have a period of thirty (30) days beyond the time available to Landlord under the Lease in which to cure the breach or default by Landlord.&nbsp;&nbsp;Mortgagee shall have no obligation to cure (and shall have no liability or obligation for not curing) any breach or default by Landlord until an attornment occurring pursuant to this Agreement.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:none;">7.</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-weight:bold;text-decoration:underline;font-size:10pt;">Miscellaneous.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Notices</font>.&nbsp;&nbsp;Any notice or request given or demand made under this Agreement by one party to the other shall be in writing, and may be given or be served by hand delivered personal service, by depositing the same with a reliable overnight courier service, by deposit in the United States mail, postpaid, registered or certified mail, and addressed to the party to be notified, with return receipt requested, or by electronic mail (with a copy delivered by one of the other methods provided for in this <font style="text-decoration:underline;">Section&#160;7(a)</font>).&nbsp;&nbsp;A notice shall be deemed to have been given:&nbsp;&nbsp;(i)&#160;in the case of hand delivery, at the time of delivery; (ii)&#160;in the case of registered or certified mail, when delivered or the first attempted delivery on a Business Day; (iii)&#160;in the case of overnight delivery, upon the first attempted delivery on a Business Day; or (iv)&#160;in the case of electronic mail, upon the date of receipt.&nbsp;&nbsp;For purposes of notice, the addresses of the parties shall, until changed as herein provided, be as follows:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to the Mortgagee, at:</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:30.77%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">H.I.G. RCF &#8211; Pegasus Dallas, LLC <br />1271 Avenue of the Americas, 22nd Floor<br />New York, New York 10020 <br />Attention:&nbsp;&nbsp;Jeffrey Wiseman and Michael Mestel<br />Email: jwiseman@higrealty.com and mmestel@higrealty.com</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With a copy to:</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:30.77%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk18514519"></a>King &amp; Spalding LLP</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:30.77%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1185 Avenue of the Americas<br />New York, New York&#160; 10036<br />Attention:&nbsp;&nbsp;Christine O&#8217;Connell, Esq.<br />Email:&nbsp;&nbsp;ckoconnell@kslaw.com</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to Tenant, at:</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:30.77%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TAYSHA GENE THERAPIES, INC. <br />2280 Inwood Road<br />Dallas, Texas 75235<br />Attention: Kamran Alam, CFO</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU50"></a>(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Successors and Assigns</font>.&nbsp;&nbsp;This Agreement shall bind and benefit the parties, their successors and assigns, any Successor Landlord, and its successors and assigns.&nbsp;&nbsp;If Mortgagee assigns the Mortgage, then upon </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delivery to Tenant of written notice thereof accompanied by the assignee&#8217;s written assumption of all obligations under this Agreement, all liability of the assignor thereafter accruing shall terminate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Entire Agreement</font>.&nbsp;&nbsp;This Agreement constitutes the entire agreement between Mortgagee and Tenant regarding the subordination of the Lease to the Mortgage and the rights and obligations of Tenant and Mortgagee as to the subject matter of this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Interaction with Lease and with Mortgage</font>.&nbsp;&nbsp;If this Agreement conflicts with the Lease, then this Agreement shall govern as between the parties and any Successor Landlord, including upon any attornment pursuant to this Agreement.&nbsp;&nbsp;This Agreement supersedes, and constitutes full compliance with, any provisions in the Lease that provide for subordination of the Lease to, or for delivery of nondisturbance agreements by the holder of, the Mortgage.&nbsp;&nbsp;Mortgagee hereby acknowledges that Mortgagee has consented to the Lease. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Mortgagee&#8217;s Rights and Obligations</font>.&nbsp;&nbsp;Except as expressly provided for in this Agreement, Mortgagee shall have no obligations to Tenant with respect to the Lease.&nbsp;&nbsp;If an attornment occurs pursuant to this Agreement, then all rights and obligations of Mortgagee under this Agreement shall terminate, without thereby affecting in any way the rights and obligations of Successor Landlord provided for in this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Interpretation; Governing Law</font>.&nbsp;&nbsp;The interpretation, validity and enforcement of this Agreement shall be governed by and construed under the internal laws of the State in which the Leased Premises are located, excluding such State&#8217;s principles of conflict of laws.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Amendments</font>.&nbsp;&nbsp;This Agreement may be amended, discharged or terminated, or any of its provisions waived, only by a written instrument executed by the party to be charged.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(h)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Due Authorization</font>.&nbsp;&nbsp;Tenant represents to Mortgagee that it has full authority to enter into this Agreement, which has been duly authorized by all necessary actions.&nbsp;&nbsp;Mortgagee represents to Tenant that it has full authority to enter into this Agreement, which has been duly authorized by all necessary actions.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Execution</font>.&nbsp;&nbsp;This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[THIS SPACE INTENTIONALLY LEFT BLANK]</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU51"></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, Mortgagee and Tenant have caused this Agreement to be executed as of the date first above written.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MORTGAGEE:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">H.I.G. RCF &#8211; PEGASUS DALLAS, LLC<font style="font-weight:normal;text-transform:none;"><br />a Delaware limited liability company</font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman Bold;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;">MORTGAGEE&#8217;S ACKNOWLEDGMENT</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">STATE OF _____________<font style="margin-left:36pt;">)</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;">) ss.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COUNTY OF ___________<font style="margin-left:36pt;">)</font></p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:15.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On the ___ day of ___________ in the year 2020 before me, the undersigned, a Notary Public in and for said state, personally appeared ___________________________, proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:55%;">
<tr>
<td valign="top"  style="width:90%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;text-align:left;">&nbsp;</p></td>
<td valign="top"  style="width:10%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;text-align:left;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:90%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature of Notary Public</p></td>
<td valign="top"  style="width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;text-align:left;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Pages Continue on Following Page]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Subordination, Non-Disturbance and Attornment Agreement]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT:</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TAYSHA GENE THERAPIES, INC.,<br />a Delaware corporation</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT&#8217;S ACKNOWLEDGMENT</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">STATE OF _____________<font style="margin-left:36pt;">)</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;">) ss.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COUNTY OF ___________<font style="margin-left:36pt;">)</font></p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:15.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On the ___ day of ___________ in the year 2020 before me, the undersigned, a Notary Public in and for said state, personally appeared ___________________________, proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:55%;">
<tr>
<td valign="top"  style="width:90%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;text-align:left;">&nbsp;</p></td>
<td valign="top"  style="width:10%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;text-align:left;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:90%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature of Notary Public</p></td>
<td valign="top"  style="width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;text-align:left;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU52"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Subordination, Non-Disturbance and Attornment Agreement]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;">LANDLORD&#8217;S CONSENT</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord consents and agrees to the foregoing Agreement, which was entered into at Landlord&#8217;s request.&nbsp;&nbsp;The foregoing Agreement shall not alter, waive or diminish any of Landlord&#8217;s obligations under the Mortgage or the Lease.&nbsp;&nbsp;The above Agreement discharges any obligations of Mortgagee under the Mortgage and related loan documents to enter into a nondisturbance agreement with Tenant.&nbsp;&nbsp;Landlord is not a party to the above Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dated:&nbsp;&nbsp;______________________</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:51.28%;"></td>
<td style="width:5.71%;"></td>
<td style="width:0.71%;"></td>
<td style="width:42.31%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD:</p></td>
<td colspan="3" valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PEGASUS PARK, LLC, </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Delaware limited liability company</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Justin A. Small</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Subordination, Non-Disturbance and Attornment Agreement]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU53"></a><font style="font-size:10pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LIST OF EXHIBITS</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If any exhibit is not attached hereto at the time of execution of this Agreement, it may thereafter be attached by written agreement of the parties, evidenced by initialing said exhibit.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit &#8220;A&#8221;&nbsp;&nbsp;- Legal Description of the Land</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT J, Form of SNDA - Page J-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU54"></a><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT A</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BEING a tract of land situated in the Thomas E. Mannin Survey, Abstract No. 958, in the City of Dallas, Dallas County, Texas, said tract being a portion of Lot 1A, Block 1/6368 of Mobil Place Addition No. 2, an addition to the City of Dallas as recorded in Volume 2003041, Page 76 Deed Records of Dallas County, Texas (D.R.D.C.T.).&nbsp;&nbsp;Said tract also being a portion of the property conveyed to Mobil Oil Corporation by deed recorded in Volume 81243, Page 1216 D.R.D.C.T. and being more particularly described as follows:&nbsp;&nbsp;&nbsp;&nbsp; </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BEGINNING at a TxDOT aluminum monument found at the intersection point of the southerly right-of-way line of Stemmons Freeway (Interstate Highway 35E) (a variable width right-of-way) and the westerly right-of-way line of Pegasus Park Drive, said point being the most northerly northeast corner of said Lot 1A;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 08&#176;05'35" East, departing the southerly right-of-way line of said Stemmons Freeway (Interstate Highway 35E), and along the westerly right-of-way line of said Pegasus Park Drive and the easterly line of said Lot 1A, for a distance of 23.47 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the beginning of a tangent curve to the left with a radius of 85.00 feet, a central angle of 49&#176;47'56" and a chord which bears South 32&#176;59'33" East, for a distance of 71.57 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for an arc length of 73.88 feet to a 1/2" iron rod found for a point of tangency for end of said curve;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 57&#176;53'31" East, along the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for a distance of 252.58 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for an angle point in said right-of-way line of Pegasus Park Drive and said line of Lot 1A;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 46&#176;51'08" West, for a distance of 3.07 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for an angle point in said right-of-way line of Pegasus Park Drive and said line of Lot 1A;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 57&#176;55'21" East, along the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for a distance of 27.44 feet to a TxDOT aluminum monument found for the beginning of a tangent curve to the left with a radius of 194.47 feet, a central angle of 13&#176;42'05" and a chord which bears South 64&#176;46'24" East, for a distance of 46.39 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for an arc length of 46.50 feet to a capped iron rod found for a point of tangency for end of said curve;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 71&#176;37'26" East, along the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for a distance of 382.97 feet to a capped iron rod found for the beginning of a tangent curve to the right with a radius of 20.00 feet, a central angle of 51&#176;28'53" and a chord which bears South 45&#176;53'00" East, for a distance of 17.37 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southwesterly right-of-way line of said Pegasus Park Drive and the northeasterly line of said Lot 1A, for an arc length of 17.97 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point of tangency for end of said curve, from which a capped iron rod found for reference bears South 77&#176;41'54" West for a distance of 1.45 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;49'16" East, along the westerly right-of-way line of said Pegasus Park Drive and the easterly line of said Lot 1A, for a distance of 43.55 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the beginning of a non-tangent curve to the left from which a capped iron rod found for reference bears South 79&#176;08'12" West for a distance of 1.29 feet, said curve with a radius of 50.00 feet, a central angle of 168&#176;32'16" and a chord which bears South 15&#176;38'12" East, for a distance of 99.50 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the westerly right-of-way line of said Pegasus Park Drive and the easterly line of said Lot 1A, for an arc length of 147.08 feet to an "X" cut set for a point of tangency for end of said curve;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT J, Form of SNDA - Page J-2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU55"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 80&#176;05'40" West departing said westerly right-of-way line, a distance of 232.11 feet to an iron rod set for corner;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;48'02" East a distance of 217.97 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 80&#176;11'58" East a distance of 53.60 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;48'02" East a distance of 14.96 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 80&#176;11'58" East a distance of 15.59 feet to an iron rod set for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 09&#176;48'02" East a distance of 217.04 feet to an iron rod set for corner said corner also being in the north right-of-way line of Irving Boulevard (a variable width public right-of-way);</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE South 80&#176;11'58" West, along the northerly right-of-way line of said Irving Boulevard a distance of 946.92 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the beginning of a tangent curve to the right with a radius of 2,799.79 feet, a central angle of 07&#176;15'18" and a chord which bears North 83&#176;49'37" East, for a distance of 354.28 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, along the northerly right-of-way line of said Irving Boulevard and the southerly line of said Lot 1A, for an arc length of 354.52 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point of non-tangency for end of said curve, said point also beginning the southerly end of a corner clip at the intersection of the northerly right-of-way line of said Irving Boulevard and the easterly right-of-way line of Lakawana Street a (60' width right-of-way) from which a 1/2" iron rod found for reference bears South 87&#176;37'37" West for a distance of 10.11 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 46&#176;00'18" West, departing the northerly right-of-way line of said Irving Boulevard, and along said corner clip, for a distance of 13.78 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for the northerly end of said corner clip, said point also being in the easterly right-of-way line of said Lakawana Street and the westerly line of said Lot 1A;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 00&#176;26'00" East, along the easterly right-of-way line said Lakawana Street and the westerly line of said Lot 1A, for a distance of 112.37 feet to a capped iron rod found for the beginning of a tangent curve to the right with a radius of 98.77 feet, a central angle of 47&#176;31'39" and a chord which bears North 24&#176;17'26" East, for a distance of 79.60 feet;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE along said curve, the southeasterly right-of-way line said Lakawana Street and the northwesterly line of said Lot 1A, for an arc length of 81.93 feet to a capped iron rod found for a point of tangency for end of said curve;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 48&#176;02'40" East, along the southeasterly right-of-way line said Lakawana Street and the northwesterly line of said Lot 1A, for a distance of 275.56 feet to a capped iron rod found for an angle point in said Lot 1A and also being the intersection point of said right-of-way line of Lakawana Street and the northeasterly right-of-way line of Iron Ridge Street (a 60' width right-of-way);</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 41&#176;57'30" West, departing the southeasterly right-of-way line of said Lakawana Street, and along the northeasterly right-of-way line of said Iron Ridge Street and the southwesterly line of said Lot 1A, for a distance of 259.91 feet to a 5/8" iron rod found for an angle point in said Lot 1A and also being the southerly corner of Lot 1, Block 1/6368 of Expressway Industrial District, an addition to the City of Dallas, Dallas County, Texas as recorded in Volume 117, Page 2150 of the Plat Records of Dallas County, Texas;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 48&#176;02'28" East, departing the northeasterly right-of-way line of said Iron Ridge Street, and along the southeasterly line of said Expressway Industrial District addition and the northwesterly line of said Lot 1A , for a distance of 492.28 feet to an "X" cut set for an angle point in said Lot 1A and also being the easterly corner of Lot 5 of said Expressway Industrial District addition;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT J, Form of SNDA - Page J-3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU56"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 41&#176;57'59" West, along the northeasterly line of said Lot 5 and the southwesterly line of said Lot 1A, for a distance of 244.76 feet to a 1/2" iron rod found for the most northerly northwest corner of said Lot 1A and the northerly corner of said Lot 5, said point also being in the southeasterly right-of-way line of Commonwealth Drive (State Highway 356) (a 224' width right-of-way);</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 62&#176;17'34" East, along the southeasterly right-of-way line of said Commonwealth Drive (State Highway 356) and the northwesterly line of said Lot 1A, for a distance of 114.33 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point for corner;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 73&#176;12'35" East, along the southeasterly right-of-way line of said Commonwealth Drive (State Highway 356) and the northwesterly line of said Lot 1A, for a distance of 132.73 feet to a 3" aluminum monument stamped "MOBIL PLACE ADDITION NO. 3" set for a point for corner, said point also being the intersection point of said right-of-way line of Commonwealth Drive (State Highway 356) and the southerly right-of-way line of aforementioned Stemmons Freeway (Interstate Highway 35E);</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THENCE North 81&#176;59'01" East, departing the southeasterly right-of-way line of said Commonwealth Drive (State Highway 356), and along the southerly right-of-way line of said Stemmons Freeway (Interstate Highway 35E) and the northerly line of said Lot 1A, for a distance of 155.84 feet to the POINT OF BEGINNING and containing 1,011,100 square feet or 23.212 acres of land.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT J, Form of SNDA - Page J-4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU57"></a><font style="text-decoration:underline;">EXHIBIT K</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;">INTENTIONALLY DELETED</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT K, Intentionally Deleted - Page K-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU58"></a><font style="text-decoration:underline;">EXHIBIT L</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;">INTENTIONALLY DELETED</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT L, Intentionally Deleted - Page L-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref136746016"></a><a name="_AEIOULastRenderedPageBreakAEIOU59"></a><font style="text-decoration:underline;">EXHIBIT M</font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;"><br /></font><font style="text-decoration:underline;font-family:Times New Roman;">INTENTIONALLY DELETED</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT M, Intentionally Deleted - Page M-1</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tsha-ex102_932.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tsha-ex102_932.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.2</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;">LOAN AND SECURITY AGREEMENT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_3"></a><a name="_cp_text_1_5"></a><a name="_Hlk78981383"></a><a name="_cp_text_1_7"></a>This <font style="font-weight:bold;">LOAN AND SECURITY AGREEMENT</font> (this &#8220;<font style="font-weight:bold;">Agreement</font><a name="_cp_text_1_3"></a>&#8221;) dated and effective <a name="_cp_text_1_5"></a>as of August 12, 2021 (the &#8220;<font style="font-weight:bold;">Effective Date</font>&#8221;) among (a) <font style="font-weight:bold;">SILICON VALLEY BANK</font>, a California corporation (&#8220;<font style="font-weight:bold;">SVB</font>&#8221;), in its capacity as administrative agent and collateral agent (&#8220;<font style="font-weight:bold;">Agent</font>&#8221;), (b) SVB, as a lender, (c) <font style="font-weight:bold;">SVB INNOVATION CREDIT FUND VIII, L.P.</font><a name="_Hlk78981383"></a>, a Delaware limited partnership (&#8220;<font style="font-weight:bold;">SVB Capital</font>&#8221;), as a lender (SVB and SVB Capital and each of the other &#8220;Lenders&#8221; from time to time a party hereto are referred to herein collectively as the &#8220;<font style="font-weight:bold;">Lenders</font>&#8221; and each individually as a &#8220;<font style="font-weight:bold;">Lender</font><a name="_cp_text_1_7"></a>&#8221;), and (d) <font style="font-weight:bold;">TAYSHA GENE THERAPIES, INC.</font>, a Delaware corporation (&#8220;<font style="font-weight:bold;">Borrower</font>&#8221;), provides the terms on which Agent and the Lenders shall lend to Borrower and Borrower shall repay Agent and the Lenders.&nbsp;&nbsp;The parties agree as follows:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">ACCOUNTING AND OTHER TERMS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_8"></a>Accounting terms not defined in this Agreement shall be construed following GAAP.&nbsp;&nbsp;Calculations and determinations must be made following GAAP. <a name="_cp_text_2_8"></a>Notwithstanding the foregoing, all financial covenant calculations (if any) shall be computed with respect to Borrower only, and not on a consolidated basis. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in Section&#160;14 of this Agreement.&nbsp;&nbsp;All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code to the extent such terms are defined therein.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">LOAN AND TERMS OF PAYMENT</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Promise to Pay</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower hereby unconditionally promises to pay to Agent, for the ratable benefit of each Lender, the outstanding principal amount of all Credit Extensions advanced to Borrower by such Lender and accrued and unpaid interest thereon, together with any fees as and when due in accordance with this Agreement.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.1.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Term Loan Advances</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_9"></a><a name="_cp_text_4_10"></a><a name="_cp_text_1_11"></a><a name="_cp_text_1_14"></a><a name="_cp_text_1_16"></a><a name="_cp_text_1_18"></a><a name="_cp_text_1_20"></a><a name="_cp_text_1_21"></a><a name="_cp_text_1_23"></a><a name="_Hlk78994280"></a><a name="_cp_text_1_24"></a><a name="_cp_text_1_28"></a><a name="_cp_text_1_29"></a><a name="_cp_text_1_31"></a><a name="_cp_text_1_33"></a><a name="_cp_text_1_34"></a><a name="_cp_text_1_36"></a><a name="_cp_text_1_38"></a><a name="_cp_text_1_39"></a><a name="_cp_text_1_42"></a><a name="_cp_text_1_44"></a><a name="_cp_text_1_45"></a><a name="_cp_text_1_47"></a><a name="_cp_text_1_48"></a><a name="_cp_text_1_49"></a><a name="_cp_text_1_52"></a><a name="_cp_text_1_54"></a><a name="_cp_text_1_55"></a>(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;Background-color:#FFFFFF;">Availability</font><font style="Background-color:#FFFFFF;">.&nbsp;&nbsp;</font><a name="_cp_text_1_9"></a>Subject to the terms and conditions of this Agreement, upon Borrower&#8217;s request, Lenders agree to make term loan advances available to Borrower from time to time in three (3) tranches: &#8220;<font style="font-weight:bold;">Tranche A</font>&#8221;, &#8220;<font style="font-weight:bold;">Tranche B</font>&#8221;, and &#8220;<font style="font-weight:bold;">Tranche C</font><a name="_cp_text_4_10"></a>&#8221;.&nbsp;&nbsp;On <a name="_cp_text_1_11"></a>or about the Effective Date, <a name="_cp_text_1_14"></a>the Lenders, severally and not jointly, shall make one (1) term loan advance to Borrower under Tranche A <a name="_cp_text_1_16"></a>in an original principal amount equal to Thirty Million <a name="_cp_text_1_18"></a>Dollars ($30,000,000<a name="_cp_text_1_20"></a>) according to each Lender&#8217;s Initial Tranche <a name="_cp_text_1_21"></a>A Term <a name="_cp_text_1_23"></a>Loan Advance Commitment as set forth on Schedule 1.1 hereto (the &#8220;<font style="font-weight:bold;">Initial</font><a name="_Hlk78994280"></a> <font style="font-weight:bold;">Tranche <a name="_cp_text_1_24"></a>A Term Loan Advance</font><a name="_cp_text_1_28"></a>&#8221;).&nbsp;&nbsp;Thereafter, from the Effective Date through December 31, 2021, Borrower may request and the Lenders, severally and not jointly, shall make one (1) additional term loan advance available to Borrower under Tranche A in an original principal amount equal to Ten Million Dollars ($10,000,000) according to each Lender&#8217;s Subsequent Tranche A Term Loan Advance Commitment as set forth on Schedule 1.1 hereto (the &#8220;<font style="font-weight:bold;">Subsequent</font> <font style="font-weight:bold;">Tranche A Term Loan Advance</font>&#8221; and together with the Initial Tranche A Term Loan Advance, the &#8220;<font style="font-weight:bold;">Tranche A Term Loan Advances</font>&#8221;).&nbsp;&nbsp;Thereafter<a name="_cp_text_1_29"></a>, during the Tranche B Draw Period, if Borrower can satisfy the Draw Condition on the date of its request for a term loan advance (and the applicable Funding Date), Borrower may request, and <a name="_cp_text_1_31"></a>the Lenders, severally and not jointly, shall make one (1) <a name="_cp_text_1_33"></a>term loan advance <a name="_cp_text_1_34"></a>available to Borrower under Tranche B <a name="_cp_text_1_36"></a>in an original principal amount equal to Twenty Million <a name="_cp_text_1_38"></a>Dollars ($20,000,000<a name="_cp_text_1_39"></a>) according to each Lender&#8217;s Tranche B <a name="_cp_text_1_42"></a>Term Loan Advance Commitment as set forth on Schedule 1.1 hereto (the <a name="_cp_text_1_44"></a>&#8220;<font style="font-weight:bold;">Tranche <a name="_cp_text_1_45"></a>B Term Loan Advance</font><a name="_cp_text_1_47"></a>&#8221;).&nbsp;&nbsp;Thereafter, during the Tranche C Draw Period, if Borrower can satisfy the Draw Condition on the date of its request for a term loan advance (and the applicable Funding Date), Borrower may request, and the Lenders, severally and not jointly, shall make one (1) term loan advance available to Borrower under Tranche C in an original principal amount equal to Twenty Million Dollars ($20,000,000) according to each Lender&#8217;s Tranche C Term Loan Advance Commitment as set forth on Schedule 1.1 hereto (the &#8220;<font style="font-weight:bold;">Tranche C</font> <font style="font-weight:bold;">Term Loan Advance</font>&#8221; and together with the Tranche <a name="_cp_text_1_48"></a>A Term Loan Advances<a name="_cp_text_1_49"></a> and the Tranche B <a name="_cp_text_1_52"></a>Term Loan Advance, each a &#8220;<font style="font-weight:bold;">Term Loan Advance</font><a name="_cp_text_1_54"></a>&#8221; and collectively, the &#8220;<font style="font-weight:bold;">Term Loan Advances</font><a name="_cp_text_1_55"></a>&#8221;).  <font style="color:#000000;">After repayment, no </font>Term Loan Advance<font style="color:#000000;"> (or any portion thereof) may be reborrowed.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_56"></a><a name="_AEIOULastRenderedPageBreakAEIOU2"></a>Additionally, at any time during the term of this Agreement, Borrower may request that Lenders make one (1) additional term loan advance available to Borrower, during the Uncommitted Accordion Draw Period, in an original principal amount equal to Twenty Million Dollars ($20,000,000) (the &#8220;<font style="font-weight:bold;">Uncommitted Accordion</font>&#8221;).&nbsp;&nbsp;Lenders, in their sole and absolute discretion, may grant or deny any such request from Borrower for a term loan advance under </p>
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Uncommitted Accordion.&nbsp;&nbsp;If, and only if, Lenders, in their sole discretion, agree to provide an additional term loan advance to Borrower under the Uncommitted Accordion, the term loan advance shall be considered a &#8220;</font><font style="font-weight:bold;">Term Loan Advance</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; hereunder and added to the definition</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> thereof</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">provided that the terms of the making of any advance under the Uncommitted Accordion shall be outlined in an amendment to this Agreement to be entered into by the parties hereto. </font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_57"></a>(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;"><a name="_cp_text_1_57"></a>Interest Payments</font>.&nbsp;&nbsp;Commencing on the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>) <font style="Background-color:#FFFFFF;">Payment Date of the month following the month in which the Funding Date of the applicable </font>Term Loan Advance occurs, and continuing on the Payment Date of each month thereafter, Borrower shall make monthly payments of interest to Agent, for the account of the Lenders, in arrears, on the principal amount of each Term Loan Advance, at the rate set forth in Section 2.2 (a).</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_58"></a><a name="_cp_text_1_60"></a>(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;"><a name="_cp_text_1_58"></a>Repayment of Principal</font>.&nbsp;&nbsp;The Term Loan Advances shall be &#8220;interest-only&#8221; from the Effective Date through August 31, 2024.&nbsp;&nbsp;<font style="color:#000000;">Commencing on September 1, 2024, and continuing on each Payment Date thereafter, Borrower shall repay the aggregate outstanding </font>Term Loan Advances to Agent, for the account of the Lenders, <font style="color:#000000;">in (i) consecutive equal monthly installments of principal, plus (ii) monthly payments of accrued interest at the rate set forth in Section 2.2(a).&nbsp;&nbsp;All outstanding principal and accrued and unpaid interest with respect to the </font>Term Loan Advances<font style="color:#000000;"><a name="_cp_text_1_60"></a>, the Final Payment, and all other outstanding Obligations under</font><font style="Background-color:#FFFFFF;color:#000000;"> the </font>Term Loan Advances,<font style="Background-color:#FFFFFF;color:#000000;"> are due and payable in full on the </font>Term Loan <font style="color:#000000;">Maturity Date.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_65"></a>(d)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Permitted Prepayment</font><font style="color:#000000;">.&nbsp;&nbsp;Borrower shall have the option to prepay all, but not less than all, of the </font>Term Loan Advances advanced by the Lenders under this Agreement<font style="color:#000000;">, provided Borrower (i) provides written notice to Agent of its election to prepay the </font>Term Loan Advances <font style="color:#000000;">at least ten (10) days prior to such prepayment, and (ii) pays to Agent, for the account of the Lenders in accordance with its respective Pro Rata Share, on the date of such prepayment (A) all outstanding principal plus accrued and unpaid interest</font>, <font style="color:#000000;"><a name="_cp_text_1_65"></a>(B) the Prepayment Premium, (C) the Final Payment, and (D) all other sums, if any, that shall have become due and payable, including Lenders&#8217; Expenses and interest at the Default Rate with respect to any past due amounts.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_66"></a>(e)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Mandatory Prepayment Upon an Acceleration</font>.&nbsp;&nbsp;If the Term Loan Advances are accelerated by Agent, following the occurrence <font style="color:#000000;">and during the continuance </font><a name="_cp_text_1_66"></a>of an Event of Default, Borrower shall immediately pay to Agent, for the account of the Lenders in accordance with its respective Pro Rata Share, an amount equal to the sum of (i) all outstanding principal plus accrued and unpaid interest with respect to the Term Loan Advances, (ii) the Prepayment Premium, (iii) the Final Payment, and (iv) all other sums, if any, that shall have become due and payable, including Lenders&#8217; Expenses and interest at the Default Rate with respect to any past due amounts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_67"></a><a name="_cp_blt_2_69"></a><a name="_cp_blt_2_71"></a>2.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Payment of Interest on the Credit Extensions.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_76"></a>(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Interest Rate</font>.&nbsp;&nbsp;Subject to Section 2.2(b), the outstanding amount of each Term Loan Advance shall accrue interest at a floating per annum rate equal to <font style="font-style:italic;text-decoration:underline;">the greater of</font><a name="_cp_text_1_76"></a> (i) seven percentage points (7.00%), and (ii) three and three quarters percentage points (3.75%) above the Prime Rate, which interest, in each case, shall be payable monthly in accordance with Section 2.2(d) below.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_83"></a><a name="_cp_text_1_84"></a><a name="_cp_text_2_85"></a>(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Default Rate</font><a name="_cp_text_2_83"></a>.&nbsp;&nbsp;Immediately upon the occurrence and during the continuance of an Event of Default, Obligations shall bear interest at a rate per annum which is <a name="_cp_text_1_84"></a>five <a name="_cp_text_2_85"></a>percent (5.00%) above the rate that is otherwise applicable thereto (the &#8220;<font style="font-weight:bold;">Default Rate</font>&#8221;).&nbsp;&nbsp;Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents (including, without limitation, Lenders&#8217; Expenses) but are not paid when due shall bear interest until paid at a rate equal to the highest rate applicable to the Obligations.&nbsp;&nbsp;<font style="color:#000000;">Payment or acceptance of the increased interest rate provided in this Section&#160;2.2(b) is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Agent or any Lender.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Adjustment to Interest Rate</font>.&nbsp;&nbsp;Changes to the interest rate of any Credit Extension based on changes to the Prime Rate shall be effective on the effective date of any change to the Prime Rate and to the extent of any such change. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_87"></a><a name="_cp_text_1_89"></a><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><a name="_cp_text_1_91"></a>(d)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Payment; Interest Computation</font><a name="_cp_text_1_87"></a>.&nbsp;&nbsp;Interest is payable monthly on the Payment Date and shall be computed on the basis of a three-hundred-sixty (<a name="_cp_text_1_89"></a>360) day year for the actual number of days elapsed.&nbsp;&nbsp;In computing interest, (i)&#160;all </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-2-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_91"></a>payments received after 12:00 p.m. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pacific </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">time on any day shall be deemed received at the opening of business on the next Business Day, and (ii)&#160;the date of the making of any Credit Extension shall be included and the date of payment shall be excluded; </font><font style="text-decoration:underline;">provided</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><font style="text-decoration:underline;">however</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, that if any Credit Extension is repaid on the same day on which it is made, such day shall be included in computing interest on such Credit Extension.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_93"></a>2.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Fees</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower shall pay to Agent:&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_95"></a><a name="_cp_blt_2_97"></a><a name="_cp_blt_1_100"></a><a name="_cp_blt_2_99"></a>(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Final Payment</font>.&nbsp;&nbsp;The Final Payment, when due hereunder, to be shared between the Lenders pursuant to their respective Term Loan Commitment Percentages;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_101"></a><a name="_cp_blt_2_103"></a><a name="_cp_blt_1_109"></a><a name="_cp_blt_2_108"></a><a name="_cp_text_1_105"></a><a name="_cp_text_1_107"></a>(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Prepayment Premium</font><a name="_cp_text_1_105"></a>.&nbsp;&nbsp;The Prepayment Premium, if and <a name="_cp_text_1_107"></a>when due hereunder, to be shared between the Lenders pursuant to their respective Term Loan Commitment Percentages; provided, however, if Borrower refinances the Term Loan Advances with another credit facility from or led by SVB, the Lenders shall waive the Prepayment Premium; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_111"></a><a name="_cp_blt_2_110"></a>(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Lenders&#8217; Expenses</font>.&nbsp;&nbsp;All Lenders&#8217; Expenses (including reasonable and documented out-of-pocket attorneys&#8217; fees and expenses for documentation and negotiation of this Agreement) incurred through and after the Effective Date, when due (or, if no stated due date, upon demand by Agent).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_113"></a><a name="_cp_text_1_113"></a>Unless otherwise provided in this Agreement or in a separate writing by Agent, Borrower shall not be entitled to any credit, rebate, or repayment of any fees earned by Agent or any Lender pursuant to this Agreement notwithstanding any termination of this Agreement or the suspension or termination of any Lender&#8217;s obligation to make loans and advances hereunder.&nbsp;&nbsp;Agent may deduct amounts owing by Borrower under the clauses of this Section 2.3 pursuant to the terms of Section 2.4(e).&nbsp;&nbsp;Agent shall provide Borrower written notice of deductions made from the Designated Deposit Account pursuant to the terms of the clauses of this Section 2.3.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Payments; Pro Rata Treatment; Application of Payments; Debit of Accounts.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_115"></a><a name="_cp_text_1_117"></a>(a)<font style="margin-left:36pt;"></font><a name="_cp_text_1_115"></a>All payments (including prepayments) to be made by Borrower under any Loan Document shall be made to Agent for the account of Lenders, in immediately available funds in Dollars, without setoff or counterclaim, before 12:00 p.m. Pacific <a name="_cp_text_1_117"></a>time on the date when due.&nbsp;&nbsp; Agent shall distribute such payments to Lenders in like funds as set forth in Section 2.5.&nbsp;&nbsp;Payments of principal and/or interest received after 12:00 p.m. Pacific time are considered received at the opening of business on the next Business Day. When a payment is due on a day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall continue to accrue until paid.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Each borrowing by Borrower from Lenders hereunder shall be made according to the respective Term Loan Commitment Percentages of the relevant Lenders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>Except as otherwise provided herein, each payment (including each prepayment) by Borrower on account of principal or interest on the Term Loan Advances shall be applied according to each Lender&#8217;s Pro Rata Share of the outstanding principal amount of the Term Loan Advances.&nbsp;&nbsp;The amount of each principal prepayment of the Term Loan Advances shall be applied to reduce the then remaining installments of the Term Loan Advances based upon each Pro Rata Share of Term Loan Advances.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font>Agent has the exclusive right to determine the order and manner in which all payments with respect to the Obligations may be applied.&nbsp;&nbsp;Borrower shall have no right to specify the order or the accounts to which Agent shall allocate or apply any payments required to be made by Borrower to Agent or otherwise received by Agent or any Lender under this Agreement when any such allocation or application is not specified elsewhere in this Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:36pt;"></font>Agent may debit any of Borrower&#8217;s deposit accounts, including the Designated Deposit Account, for principal and interest payments or any other amounts Borrower owes Agent or any Lender when due. These debits shall not constitute a set-off.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-3</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unless Agent shall have been notified in writing by Borrower prior to the date of any payment due to be made by Borrower hereunder that Borrower will not make such payment to Agent, Agent may assume that Borrower is making such payment, and Agent may, but shall not be required to, in reliance upon such assumption, make available to Lenders their respective Pro Rata Share of a corresponding payment amount.&nbsp;&nbsp;If such payment is not made to Agent by Borrower within three (3) Business Days after such due date, Agent shall be entitled to recover, on demand, from each Lender to which any amount which was made available pursuant to the preceding sentence, such amount with interest thereon at the rate per annum equal to the daily average Federal Funds Effective Rate.&nbsp;&nbsp;Nothing herein shall be deemed to limit the rights of Agent or any Lender against Borrower.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref240295045"></a><a name="_Ref103138290"></a><a name="_cp_text_1_119"></a><a name="_cp_text_1_121"></a>2.5<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Settlement Procedures</font><font style="font-family:Times New Roman;font-weight:normal;">.<a name="_cp_text_1_119"></a>&nbsp;&nbsp;If Agent receives any payment for the account of Lenders on or prior to 12:00 p.m. (Pacific <a name="_cp_text_1_121"></a>time) on any Business Day, Agent shall pay to each applicable Lender such Lender&#8217;s Pro Rata Share of such payment on such Business Day. If Agent receives any payment for the account of Lenders after 12:00 p.m. (Pacific time) on any Business Day, Agent shall pay to each applicable Lender such Lender&#8217;s Pro Rata Share of such payment on the next Business Day.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Withholding by Borrower.</font><font style="font-family:Times New Roman;font-weight:normal;">&nbsp;&nbsp;Payments received by Agent or any Lender from Borrower under this Agreement will be made free and clear of and without deduction for any and all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges imposed by any Governmental Authority (including any interest, additions to tax or penalties applicable thereto), other than Excluded Taxes.&nbsp;&nbsp;Specifically, however, if at any time any Governmental Authority, applicable law, regulation or international agreement requires Borrower to make any withholding or deduction from any such payment or other sum payable hereunder to Agent or any Lender, other than Excluded Taxes, Borrower hereby covenants and agrees that the amount due from Borrower with respect to such payment or other sum payable hereunder will be increased to the extent necessary to ensure that, after the making of such required withholding or deduction, Agent or any Lender, as appropriate receives a net sum equal to the sum which it would have received had no withholding or deduction been required, and Borrower shall pay the full amount withheld or deducted to the relevant Governmental Authority.&nbsp;&nbsp;Borrower will, upon request, furnish Agent and the Lenders with proof reasonably satisfactory to Agent and the Lenders indicating that Borrower has made such withholding payment; provided, however, that Borrower need not make any withholding payment if the amount or validity of such withholding payment is contested in good faith by appropriate and timely proceedings and as to which payment in full is bonded or reserved against by Borrower.&nbsp;&nbsp;The agreements and obligations of Borrower contained in this Section 2.6 shall survive the termination of this Agreement.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">CONDITIONS OF LOANS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Conditions Precedent to Initial Credit Extension</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Each Lender&#8217;s obligation to make the initial Credit Extension hereunder is subject to the condition precedent that Agent shall have received, in form and substance satisfactory to Agent and the Lenders, such documents, and completion of such other matters, as Agent may reasonably deem necessary or appropriate, including, without limitation:</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>duly executed signatures to the Loan Documents;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_122"></a><a name="_cp_blt_2_125"></a><a name="_cp_blt_1_128"></a><a name="_cp_blt_2_127"></a><a name="_cp_blt_1_132"></a><a name="_cp_blt_2_131"></a><a name="_cp_text_1_130"></a>(b)<font style="margin-left:36pt;"></font><a name="_cp_text_1_130"></a>the Operating Documents and long-form good standing certificates of Borrower certified by the Secretary of State of the State of Delaware and the Secretary of State of Texas, each dated as of a date no earlier than thirty (30) days prior to the Effective Date; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_133"></a><a name="_cp_text_1_134"></a>(c)<font style="margin-left:36pt;"></font>a secretary&#8217;s certificate of Borrower with respect to such Borrower&#8217;s Operating Documents, incumbency, specimen signatures and resolutions authorizing the execution and delivery of this Agreement and the other Loan Documents to which it is a party;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_136"></a><a name="_cp_blt_2_135"></a>(d)<font style="margin-left:36pt;"></font>duly executed signatures to the completed Borrowing Resolutions for Borrower;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_142"></a><a name="_cp_text_1_143"></a>(e)<font style="margin-left:36pt;"></font>duly executed signatures to a completed Payment/Advance Form in connection with the Initial Tranche A Term Loan Advance;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_144"></a><a name="_cp_text_1_145"></a><a name="_AEIOULastRenderedPageBreakAEIOU5"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">uly executed signatures to a completed Disbursement Letter in connection with the </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tranche A </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan Advance;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_147"></a><a name="_cp_blt_2_146"></a>(g)<font style="margin-left:36pt;"></font>certified copies, dated as of a recent date, of Lien searches (including without limitation, UCC searches), as Agent may request, accompanied by written evidence (including any UCC termination statements and other Lien releases) that the Liens indicated in any such financing statements or other filings either constitute Permitted Liens or have been or, in connection with the initial Credit Extension hereunder, will be terminated or released;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_149"></a><a name="_cp_blt_2_148"></a>(h)<font style="margin-left:36pt;"></font>the Perfection Certificate of Borrower, together with the duly executed signatures thereto;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_154"></a><a name="_cp_blt_2_153"></a><a name="_cp_text_1_156"></a>(i)<font style="margin-left:36pt;"></font><a name="_cp_text_1_156"></a>evidence satisfactory to Agent that the insurance policies and endorsements required by Section 6.5 hereof are in full force and effect with respect to Borrower, together with appropriate evidence showing lender loss payable and/or additional insured clauses or endorsements in favor of Agent;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)<font style="margin-left:36pt;"></font>a Control Agreement in favor of Agent for the benefit of the Lenders covering Borrower&#8217;s accounts nos. xxxxx2355 and xxxxxx1402 at JPMorgan Chase Bank, N.A.; and </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_158"></a><a name="_cp_blt_2_157"></a>(k)<font style="margin-left:36pt;"></font>payment of the fees and Lenders&#8217; Expenses then due as specified in Section 2.3 hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Conditions Precedent to all Credit Extensions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Each Lender&#8217;s obligation to make each Credit Extension, including the initial Credit Extension, is subject to the following conditions precedent:</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>timely receipt by the Lenders of (i) an executed Disbursement Letter and (ii) an executed Payment/Advance Form;&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>the representations and warranties in this Agreement shall be true, accurate, and complete in all material respects on the date of the Disbursement Letter (and the Payment/Advance Form) and on the Funding Date of each Credit Extension; <font style="text-decoration:underline;">provided</font>, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and <font style="text-decoration:underline;">provided</font>, <font style="text-decoration:underline;">further</font> <font style="color:#000000;">that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date,</font> and no Event of Default shall have occurred and be continuing or result from the Credit Extension.&nbsp;&nbsp;Each Credit Extension is Borrower&#8217;s representation and warranty on that date that the representations and warranties in this Agreement remain true, accurate, and complete in all material respects; <font style="text-decoration:underline;">provided</font>, <font style="text-decoration:underline;">however</font>, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and <font style="text-decoration:underline;">provided</font>, <font style="text-decoration:underline;">further</font> <font style="color:#000000;">that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date; and</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk49353090"></a>(c)<font style="margin-left:36pt;"></font><font style="color:#000000;">Agent </font>and each Lender <font style="color:#000000;"><a name="_Hlk49353090"></a>determine to its satisfaction that there has not been a Material Adverse Change.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_169"></a>3.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-weight:normal;"> </font><font style="font-family:Times New Roman;">Covenant to Deliver</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower agrees to deliver to Agent and each Lender each item required to be delivered to Agent and each Lender under this Agreement as a condition precedent to any Credit Extension.&nbsp;&nbsp;Borrower expressly agrees that a Credit Extension made prior to the receipt by Agent and each Lender of any such item shall not constitute a waiver by Agent or Lenders of Borrower&#8217;s obligation to deliver such item, and the making of any Credit Extension in the absence of a required item shall be in each Lender&#8217;s sole discretion.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Procedures for Borrowing</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_173"></a><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Term Loan Advances</font><a name="_cp_text_1_173"></a>.&nbsp;&nbsp;Subject to the prior satisfaction of all other applicable conditions to the making of a Credit Extension set forth in this Agreement, to obtain a Credit Extension, Borrower shall notify Agent (which notice shall be irrevocable) by electronic mail, facsimile, or telephone by 12:00 p.m. Pacific time at least five (5) Business Days before the proposed Funding Date of such Credit Extension (other than the Initial Tranche A Term Loan Advance to be made on the Effective Date).&nbsp;&nbsp;Together with any such electronic or facsimile notification, Borrower shall deliver to Agent by electronic mail or facsimile a completed Disbursement Letter (and Payment/Advance Form) executed by an Authorized Signer.&nbsp;&nbsp;Agent may rely on any telephone notice given by a person whom Agent believes is an </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signer.&nbsp;&nbsp;On the Funding Date, Agent shall credit the Credit Extensions to the Designated Deposit Account.&nbsp;&nbsp;Agent may make Credit Extensions under this Agreement based on instructions from an Authorized Signer or without instructions if the Credit Extensions are necessary to meet Obligations which have become due</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Funding</font>.&nbsp;&nbsp;In determining compliance with any condition hereunder to the making of a Credit Extension that, by its terms, must be fulfilled to the satisfaction of a Lender, Agent may presume that such condition is satisfactory to such Lender unless Agent shall have received notice to the contrary from such Lender prior to the making of such Credit Extension.&nbsp;&nbsp;Unless Agent shall have been notified in writing by any Lender prior to the date of any Credit Extension, that such Lender will not make the amount that would constitute its share of such borrowing available to Agent, Agent may assume that such Lender is making such amount available to Agent, and Agent may, in reliance upon such assumption, make available to Borrower a corresponding amount.&nbsp;&nbsp;If such amount is not made available to Agent by the required time on the Funding Date therefor, such Lender shall pay to Agent, on demand, such amount with interest thereon, at a rate equal to the greater of (i) the Federal Funds Effective Rate or (ii) a rate determined by Agent in accordance with banking industry rules on interbank compensation, for the period until such Lender makes such amount immediately available to Agent.&nbsp;&nbsp;If such Lender&#8217;s share of such Credit Extension is not made available to Agent by such Lender within three (3) Business Days after such Funding Date, Agent shall also be entitled to recover such amount with interest thereon at the rate per annum applicable to the Term Loan Advances, on demand, from Borrower.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">CREATION OF SECURITY INTEREST</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Grant of Security Interest.</font><font style="font-family:Times New Roman;font-weight:normal;">&nbsp;&nbsp;Borrower hereby grants Agent, for the ratable benefit of the Lenders, to secure the payment and performance in full of all of the Obligations, a continuing security interest in, and pledges to Agent, for the ratable benefit of the Lenders, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and all proceeds and products thereof.&nbsp;&nbsp;For clarity, any reference to &#8220;Agent&#8217;s Lien&#8221; or any granting of collateral to Agent in this Agreement or any Loan Document means the Lien granted to Agent for the ratable benefit of the Lenders.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Borrower acknowledges that it previously has entered, and/or may in the future enter, into Bank Services Agreements with SVB.&nbsp;&nbsp;Regardless of the terms of any Bank Services Agreement, Borrower agrees that any amounts Borrower owes SVB thereunder shall be deemed to be Obligations hereunder and that it is the intent of Borrower and SVB to have all such Obligations secured by the first priority perfected security interest in the Collateral granted herein (subject only to Permitted Liens that are permitted pursuant to the terms of this Agreement to have superior priority to Agent&#8217;s Lien in this Agreement), and by any and all other security agreements, mortgages or other collateral granted to Agent by Borrower as security for the Obligations, now or in the future.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If this Agreement is terminated, Agent&#8217;s Lien in the Collateral shall continue until the Obligations (other than inchoate indemnity obligations) are repaid in full in cash.&nbsp;&nbsp;Upon payment in full in cash of the Obligations (other than inchoate indemnity obligations) and at such time as the Lenders&#8217; obligation to make Credit Extensions has terminated, Agent shall, at the sole cost and expense of Borrower, release its Liens in the Collateral and all rights therein shall revert to Borrower.&nbsp;&nbsp;In the event (x) all Obligations (other than inchoate indemnity obligations), except for Bank Services, are satisfied in full, and (y) this Agreement is terminated, Agent shall terminate the security interest granted herein upon Borrower providing to SVB cash collateral acceptable to SVB in its good faith business judgment for Bank Services, if any. In the event such Bank Services consist of outstanding Letters of Credit, Borrower shall provide to SVB cash collateral in an amount equal to (x) if such Letters of Credit are denominated in Dollars, then at least one hundred five percent (105.0%); and (y) if such Letters of Credit are denominated in a Foreign Currency, then&nbsp;&nbsp;at least one hundred ten percent (110.0%), of the Dollar Equivalent of the face amount of all such Letters of Credit plus, in each case, all interest, fees, and costs due or to become due in connection therewith (as estimated by SVB in its business judgment), to secure all of the Obligations relating to such Letters of Credit.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>4.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Priority of Security Interest</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower represents, warrants, and covenants that the security interests granted herein are and shall at all times continue to be a first priority perfected security interests in the Collateral (subject only to Permitted Liens that are permitted pursuant to the terms of this Agreement to have superior priority to Agent&#8217;s Lien under this Agreement).&nbsp;&nbsp;If Borrower shall acquire a commercial tort claim, Borrower shall promptly notify Agent in a writing signed by Borrower of the general details thereof and grant to Agent, for the ratable benefit </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-weight:normal;">of the Lenders, in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to Agent.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Authorization to File Financing Statements</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower hereby authorizes Agent, on behalf of the Lenders, to file financing statements and other similar forms, without notice to Borrower, with all appropriate jurisdictions to perfect or protect Agent&#8217;s and Lenders&#8217; interest or rights hereunder, including a notice that any disposition of the Collateral, by Borrower or any other Person, shall be deemed to violate the rights of Agent under the Code.&nbsp;&nbsp;Such financing statements and other similar forms may indicate the Collateral as &#8220;all assets of the Debtor&#8221; or words of similar effect, or as being of an equal or lesser scope, or with greater detail, all in Agent&#8217;s discretion.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">REPRESENTATIONS AND WARRANTIES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Borrower represents and warrants as follows: </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Due Organization, Authorization; Power and Authority</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower is duly organized, validly existing and in good standing as a Registered Organization in its jurisdiction of formation and is qualified and licensed to do business and is in good standing in any other jurisdiction in which the conduct of its business or its ownership of property and other assets or business which it is engaged in requires that it be qualified except where the failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#8217;s business. In connection with this Agreement, Borrower has delivered to Agent and each Lender a completed certificate signed by Borrower, entitled &#8220;</font><font style="font-family:Times New Roman;">Perfection Certificate</font><font style="font-family:Times New Roman;font-weight:normal;">&#8221; (collectively, the &#8220;</font><font style="font-family:Times New Roman;">Perfection Certificate</font><font style="font-family:Times New Roman;font-weight:normal;">&#8221;).&nbsp;&nbsp;Borrower represents and warrants to Agent and each Lender that: (a) Borrower&#8217;s exact legal name is that indicated on the Perfection Certificate and on the signature page hereof; (b) Borrower is an organization of the type and is organized or is incorporated in the jurisdiction set forth in the Perfection Certificate; (c) the Perfection Certificate accurately sets forth Borrower&#8217;s organizational identification number or accurately states that Borrower has none; (d) the Perfection Certificate accurately sets forth Borrower&#8217;s place of business, or, if more than one, its chief executive office as well as Borrower&#8217;s mailing address (if different than its chief executive office); (e) except as indicated on the Perfection Certificate, Borrower (and each of its predecessors) has not, in the past five (5) years, changed its jurisdiction of formation, organizational structure or type, or any organizational number assigned by its jurisdiction; and (f) all other information set forth on the Perfection Certificate pertaining to Borrower and each of its Subsidiaries is accurate and complete in all material respects (it being understood and agreed that Borrower may from time to time update certain information in the Perfection Certificate after the Effective Date to the extent permitted by one or more specific provisions in this Agreement).&nbsp;&nbsp;If Borrower is not now a Registered Organization but later becomes one, Borrower shall promptly notify Agent of such occurrence and provide Agent with Borrower&#8217;s organizational identification number.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The execution, delivery and performance by Borrower of the Loan Documents to which it is a party have been duly authorized, and do not (i) conflict with any of Borrower&#8217;s organizational documents, (ii) contravene, conflict with, constitute a default under or violate any material Requirement of Law, (iii) contravene, conflict or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its Subsidiaries or any of their property or assets may be bound or affected, (iv) require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are in full force and effect), filings and registrations contemplated by this Agreement, or (v) conflict with, contravene, constitute a default or breach under, or result in or permit the termination or acceleration of, any material agreement by which Borrower is bound.&nbsp;&nbsp;Borrower is not in default under any agreement to which it is a party or by which it is bound in which the default could reasonably be expected to have a material adverse effect on Borrower&#8217;s business.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Collateral</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower has good title to, rights in, and the power to transfer each item of the Collateral upon which it purports to grant a Lien under this Agreement and other Loan Documents, free and clear of any and all Liens except Permitted Liens.&nbsp;&nbsp;Borrower has no Collateral Accounts at or with any bank or financial institution other than SVB or SVB&#8217;s Affiliates except for the Collateral Accounts described in the Perfection Certificate delivered to Agent and each Lender in connection herewith and Collateral Accounts for which Borrower has given Agent notice and taken such actions as are necessary to give Agent, for the ratable benefit of the Lenders, a perfected security interest therein.&nbsp;&nbsp;The Accounts are bona fide, existing obligations of the Account Debtors.&nbsp;&nbsp;</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Collateral is not in the possession of any third party bailee (such as a warehouse) except as otherwise provided in the Perfection Certificate</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or as permitted by the terms of Section 7.2</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;None of the components of the Collateral </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(other than portable Equipment in the possession of employees) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shall be maintained at locations other than as provided in the Perfection Certificate or as permitted pursuant to Section 7.2.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Inventory is in all material respects of good and marketable quality, free from material defects.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_183"></a>Borrower is the sole owner of the Intellectual Property with any material value which it owns or purports to own except for (a) (i) non-exclusive licenses granted to its customers or strategic partners in the ordinary course of business and (ii) exclusive licenses to the extent permitted by Section 7.1 hereof or otherwise permitted by the Lenders in advance, in writing, in their sole discretion, (b) over-the-counter software that is commercially available to the public, and (c) material Intellectual Property licensed to Borrower and noted on the Perfection Certificate.&nbsp;&nbsp;To Borrower&#8217;s knowledge, e<a name="_cp_text_1_183"></a>ach Patent which it owns or purports to own and which is material to Borrower&#8217;s business is valid and enforceable, and no part of the Intellectual Property which Borrower owns or purports to own and which is material to Borrower&#8217;s business has been judged invalid or unenforceable, in whole or in part.&nbsp;&nbsp;To the best of Borrower&#8217;s knowledge, no claim has been made that any part of the Intellectual Property violates the rights of any third party except to the extent such claim would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as noted on the Perfection Certificate or as to which Borrower has provided the Lenders with notice in accordance with Section 6.8(b) hereof, Borrower is not a party to, nor is it bound by, any Restricted License.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_187"></a>5.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Litigation</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;There are no actions or proceedings pending or, to the knowledge of any Responsible Officer, threatened in writing by or against Borrower or any of its Subsidiaries that could reasonably be expected to result in liability or costs to Borrower in excess of One Million <a name="_cp_text_1_187"></a>Dollars ($1,000,000) individually or in the aggregate. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_188"></a><a name="_cp_text_1_189"></a>5.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Financial Statements; Financial Condition</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_188"></a>.&nbsp;&nbsp;All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Agent and the Lenders by submission to the Financial Statement Repository or otherwise submitted <a name="_cp_text_1_189"></a>to Agent and the Lenders fairly present in all material respects Borrower&#8217;s consolidated financial condition and Borrower&#8217;s consolidated results of operations.&nbsp;&nbsp;There has not been any material deterioration in Borrower&#8217;s consolidated financial condition since the date of the most recent financial statements submitted to the Financial Statement Repository or otherwise submitted to Agent and the Lenders.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.5<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Solvency</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;The fair salable value of Borrower&#8217;s consolidated assets (including goodwill minus disposition costs) exceeds the fair value of Borrower&#8217;s liabilities; Borrower is not left with unreasonably small capital after the transactions in this Agreement; and Borrower is able to pay its debts (including trade debts) as they mature.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Regulatory Compliance</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower is not an &#8220;investment company&#8221; or a company &#8220;controlled&#8221; by an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.&nbsp;&nbsp;Borrower is not engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors).&nbsp;&nbsp;Borrower (a) has complied in all material respects with all Requirements of Law, and (b)&#160;has not violated any Requirements of Law the violation of which could reasonably be expected to have a material adverse effect on its business.&nbsp;&nbsp;None of Borrower&#8217;s or any of its Subsidiaries&#8217; properties or assets has been used by Borrower or any Subsidiary or, to the best of Borrower&#8217;s knowledge, by previous Persons, in disposing, producing, storing, treating, or transporting any hazardous substance other than legally.&nbsp;&nbsp;Borrower and each of its Subsidiaries have obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.7<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Subsidiaries; Investments</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower does not own any stock, partnership, or other ownership interest or other equity securities except for Permitted Investments.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_190"></a><a name="_cp_text_1_191"></a><a name="_AEIOULastRenderedPageBreakAEIOU9"></a>5.8<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Tax Returns and Payments; Pension Contributions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;</font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_190"></a>Borrower has timely filed  <a name="_cp_text_1_191"></a>all required tax returns and reports, and Borrower has timely  paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except (a) to the extent such taxes are being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as such reserve or other appropriate provision, if </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">any, as shall be required in conformity with GAAP shall have been made therefor, or (b) if such taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed </font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">Five Hundred </font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">Thousand Dollars ($</font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">500</font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">,000</font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">).&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent Borrower defers payment of any contested tax in an amount greater than Five Hundred Thousand Dollars ($500,000) individually or in the aggregate, Borrower shall (i) notify Agent in writing of the commencement of, and any material development in, the proceedings and (ii) post bonds or take any other steps required to prevent the Governmental Authority levying such contested taxes from obtaining a Lien upon any of the Collateral that is other than a &#8220;Permitted Lien.&#8221;&nbsp;&nbsp;Borrower is unaware of any claims or adjustments proposed for any of Borrower&#8217;s prior tax years which could result in additional taxes becoming due and payable by Borrower in excess of Five Hundred Thousand Dollars ($500,000).&nbsp;&nbsp;Borrower has paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and Borrower has not withdrawn from participation in, and has not permitted partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any liability of Borrower, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency<font style="color:#000000;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.9<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Use of Proceeds</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower shall use the proceeds of the Credit Extensions as working capital and to fund its general business requirements and not for personal, family, household or agricultural purposes.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_201"></a><a name="_cp_text_1_202"></a><a name="_cp_text_1_204"></a><a name="_cp_text_1_205"></a><a name="_cp_text_1_207"></a><a name="_cp_text_1_208"></a><a name="_cp_text_1_209"></a><a name="_cp_text_1_210"></a>5.10<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Full Disclosure</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_201"></a>.&nbsp;&nbsp;No written representation, warranty or other statement of Borrower in any report, <a name="_cp_text_1_202"></a>certificate, <a name="_cp_text_1_204"></a>or written statement submitted to the Financial Statement Repository or otherwise submitted <a name="_cp_text_1_205"></a>to Agent or any Lender in connection with the Loan Documents, or the transactions contemplated thereby, as of the date such representation, warranty, or other statement was made, taken together with all such written reports, written <a name="_cp_text_1_207"></a>certificates and written statements submitted to the Financial Statement Repository or otherwise submitted <a name="_cp_text_1_208"></a>to Agent or any Lender, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the reports, <a name="_cp_text_1_209"></a>certificates, <a name="_cp_text_1_210"></a>or written statements not misleading (it being recognized by Agent and each Lender that the projections and forecasts provided by Borrower in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results).</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.11<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Definition of &#8220;Knowledge</font><font style="font-family:Times New Roman;font-weight:normal;">.</font><font style="font-family:Times New Roman;">&#8221;</font><font style="font-family:Times New Roman;font-weight:normal;">&nbsp;&nbsp;For purposes of the Loan Documents, whenever a representation or warranty is made to Borrower&#8217;s knowledge or awareness, to the &#8220;best of&#8221; Borrower&#8217;s knowledge, or with a similar qualification, knowledge or awareness means the actual knowledge, after reasonable investigation, of any Responsible Officer.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.12<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Healthcare Permits</font><font style="font-family:Times New Roman;font-weight:normal;">. (a) Borrower and each of its Subsidiaries have obtained all Healthcare Permits and other rights from, and have made all declarations and filings with, all applicable Governmental Authorities, all self-regulatory authorities and all courts and other tribunals necessary to engage in the management and/or operation of their respective businesses; (b) each such Healthcare Permit is valid and in full force and effect, and Borrower and each of its Subsidiaries are in compliance with the terms and conditions of all such Healthcare Permits; and (c) neither Borrower nor any of its Subsidiaries has received notice from any Governmental Authority with respect to the revocation, suspension, restriction, limitation or termination of any Healthcare Permit nor, to the knowledge of Borrower or any of its Subsidiaries, is any such action proposed or threatened in writing.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.13<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Compliance with Healthcare Laws</font><font style="font-family:Times New Roman;font-weight:normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Borrower is in compliance with all applicable Healthcare Laws. Without limiting the generality of the foregoing, Borrower has not received written notice by a governmental authority of any violation (or of any investigation, audit, or other proceeding involving allegations of any violation) of any Healthcare Laws, and no investigation, inspection, audit or other proceeding involving allegations of any violation is, to the knowledge of Borrower, threatened in writing or contemplated.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>To the knowledge of Borrower, Borrower is not in default or violation of any law which is applicable to Borrower or its respective assets or the conduct of its respective businesses and Borrower has not been debarred or excluded from participation under a state or federal health care program, including any state or federal workers compensation program.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU10"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Borrower is not a party to any corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders or similar agreements with or imposed by any governmental authority.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">AFFIRMATIVE COVENANTS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Borrower shall do all of the following:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Government Compliance</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Maintain its and all its Subsidiaries&#8217; legal existence and good standing in their respective jurisdictions of formation and maintain qualification in each jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.&nbsp;&nbsp;Borrower shall comply, and have each Subsidiary comply, in all material respects, with all laws, ordinances and regulations to which it is subject.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Obtain all of the Governmental Approvals necessary for the performance by Borrower of its obligations under the Loan Documents to which it is a party and the grant of a security interest to Agent, for the ratable benefit of the Lenders, in all of its property.&nbsp;&nbsp;Borrower shall promptly provide copies of any such obtained Governmental Approvals to Agent.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>Cause the operations and property of Borrower, each of its Subsidiaries to comply with all applicable Healthcare Laws. Without limiting the foregoing, the operations and property of Borrower and each of its Subsidiaries shall comply with HIPAA in all material respects. Borrower established and maintains a corporate compliance program that (i) addresses the material Requirements of Law, including all applicable Healthcare Laws, of Governmental Authorities having jurisdiction over its business and operations, and (ii) has been structured to account for the guidance issued by the U.S. Department of Health and Human Services regarding characteristics of effective corporate compliance programs applicable to Borrower. As of the Effective Date, Borrower has delivered to the Lenders an accurate and complete copy of each material report, study, survey or other document of which Borrower has knowledge that addresses or otherwise relates to the compliance by Borrower and each of its Subsidiaries, with applicable Healthcare Laws.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_212"></a>6.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Financial Statements, Reports.</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_212"></a>&nbsp;&nbsp;Provide Agent and each Lender with the following by submitting to the Financial Statement Repository or otherwise submitting to Agent and each Lender:</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_213"></a><a name="_cp_blt_2_215"></a><a name="_cp_blt_1_234"></a><a name="_cp_blt_2_233"></a><a name="_cp_text_1_218"></a><a name="_cp_text_1_220"></a><a name="_cp_text_1_222"></a><a name="_cp_text_1_226"></a><a name="_cp_text_2_228"></a>(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Quarterly Financial Statements</font><font style="color:#000000;">.&nbsp;&nbsp;A</font><a name="_cp_text_1_220"></a>s soon as available, but no later than (i) forty-five <a name="_cp_text_1_222"></a>(45) days after the last day of the first three calendar quarters of each fiscal year, and (ii) ninety (90) days after the last day of the last fiscal quarter of each fiscal year, a company-<a name="_cp_text_1_226"></a>prepared consolidated and consolidating (if applicable) <a name="_cp_text_2_228"></a>balance sheet, cash flow statement, and income statement covering Borrower&#8217;s and each of its Subsidiary&#8217;s operations for such calendar quarter in a form acceptable to Agent (the &#8220;<font style="font-weight:bold;">Quarterly Financial Statements</font>&#8221;)<font style="color:#000000;">;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_248"></a><a name="_cp_blt_2_247"></a><a name="_cp_text_1_236"></a><a name="_cp_text_1_238"></a><a name="_cp_text_1_246"></a>(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Quarterly <a name="_cp_text_1_238"></a>Compliance Statement</font><font style="color:#000000;">. </font> Together with the Quarterly Financial Statements, <a name="_cp_text_1_246"></a>a completed Compliance Statement confirming<font style="color:#000000;"> that as of the end of such calendar quarter, Borrower was in full compliance with all of the terms and conditions of this Agreement, and setting forth calculations showing compliance with the financial covenants (if any) set forth in this Agreement and such other information as Agent or the Lenders may reasonably request;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_257"></a><a name="_cp_blt_2_256"></a><a name="_cp_text_1_253"></a><a name="_cp_text_1_254"></a>(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Annual Operating Budget and Financial Projections</font><font style="color:#000000;">.&nbsp;&nbsp;Within sixty (60<a name="_cp_text_1_253"></a>) days after the last day of each <a name="_cp_text_1_254"></a>fiscal year of Borrower, and within ten (10) days of any updates or amendments thereto, (i) annual operating budgets (including income statements, balance sheets and cash flow statements, by month) for the then-current fiscal year of Borrower, and (ii) annual financial projections for the then-current fiscal year (on a quarterly basis) as approved by the Board, together with any related business forecasts used in the preparation of such annual financial projections;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_266"></a><a name="_cp_blt_2_265"></a><a name="_cp_blt_1_274"></a><a name="_cp_blt_2_273"></a>(d)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Bank Statements</font>.&nbsp;&nbsp;<font style="color:#000000;">A</font>s soon as available, but no later than thirty (30) days after the last day of each month, bank statements for the prior month, covering each of Borrower&#8217;s Deposit Accounts and Securities Accounts maintained at financial institutions other than SVB;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU11"></a><a name="_cp_text_1_270"></a><a name="_cp_text_1_272"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Other Statements</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_270"></a>.&nbsp;&nbsp;Within </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ten </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_272"></a>(</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) days of delivery, copies of all statements, reports and notices made available to Borrower&#8217;s security holders or to any holders of Subordinated Debt;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_280"></a><a name="_cp_blt_2_279"></a><a name="_cp_text_2_275"></a><a name="_cp_text_1_276"></a><a name="_cp_text_2_277"></a>(f)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">SEC Filings</font>.&nbsp;&nbsp;W<a name="_cp_text_2_275"></a>ithin <a name="_cp_text_1_276"></a>five <a name="_cp_text_2_277"></a>(5) days of filing, copies of all periodic and other reports, proxy statements and other materials filed by Borrower and/or any Guarantor with the SEC, any Governmental Authority succeeding to any or all of the functions of the SEC or with any national securities exchange, or distributed to its shareholders, as the case may be.&nbsp;&nbsp;Documents required to be delivered pursuant to the terms hereof (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#8217;s website on the internet at Borrower&#8217;s website address;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_287"></a><a name="_cp_blt_2_286"></a>(g)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Legal Action Notice</font>.&nbsp;&nbsp;A prompt report of any legal actions pending or threatened in writing against Borrower or any of its Subsidiaries that could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries of, individually or in the aggregate, One Million Dollars ($1,000,000) or more;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_291"></a><a name="_cp_blt_2_290"></a>(h)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Additional Reporting Requirement</font>. At any time that Borrower is not a public company or an issuer of securities that are registered with the SEC under Section 12 of the Exchange Act (or that is required to file reports under Section 15(d) of the Exchange Act), written notice of any changes to the beneficial ownership information set out in Section 13 of the Perfection Certificate.&nbsp;&nbsp;Borrower understands and acknowledges that each Lender relies on such true, accurate and up-to-date beneficial ownership information to meet such Lender&#8217;s regulatory obligations to obtain, verify and record information about the beneficial owners of its legal entity customers; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_293"></a><a name="_cp_blt_2_292"></a>(i)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Other Financial Information</font>.&nbsp;&nbsp;Other financial information reasonably requested by Agent or any Lender.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_294"></a><a name="_cp_text_4_295"></a><a name="_cp_text_1_296"></a><a name="_cp_text_4_297"></a><a name="_cp_text_1_298"></a><a name="_cp_text_4_299"></a><a name="_cp_text_4_300"></a><a name="_cp_text_1_301"></a><a name="_cp_text_1_302"></a><a name="_cp_text_4_303"></a><a name="_cp_text_1_304"></a><a name="_cp_text_4_295"></a>Any submission by Borrower of a Compliance Statement, or any other financial statement submitted to the Financial Statement Repository pursuant to this Section 6.2 or otherwise submitted to Agent and Lenders <a name="_cp_text_1_296"></a>shall be deemed to be a representation by Borrower that (a) as of the date of such Compliance Statement, or other financial statement, the information and calculations set forth therein are true, accurate and correct in all material respects<a name="_cp_text_4_297"></a>, (b) as of the end of the compliance period set forth in such submission, Borrower is in complete compliance with all required covenants except as noted in such Compliance Statement, or other financial statement, as applicable; (c) as of the date of such submission, no Events of Default have occurred or are continuing; (d) all representations and warranties other than any representations or warranties that are made as of a specific date in Article 5 remain <a name="_cp_text_1_298"></a>true and correct in all material respects <a name="_cp_text_4_299"></a>as of the date of such submission except as noted in such Compliance Statement, or other financial statement, as applicable; (e) as of the date of such submission, Borrower <a name="_cp_text_4_300"></a>and each of its Subsidiaries <a name="_cp_text_1_301"></a>has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section <a name="_cp_text_1_302"></a>5.9<a name="_cp_text_4_303"></a>; and (f) as of the date of such submission, <a name="_cp_text_1_304"></a>no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Agent and Lenders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Taxes; Pensions</font><font style="font-family:Times New Roman;font-weight:normal;">. Timely file, and require each of its Subsidiaries to timely file, all required tax returns and reports and timely pay, and require each of its Subsidiaries to timely pay, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Subsidiaries, except pursuant to the terms of Section 5.8 hereof, and shall deliver to Agent, on demand, appropriate certificates attesting to such payments, and pay all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Inventory; Returns</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Keep all Inventory in good and marketable condition, free from material defects.&nbsp;&nbsp;Returns and allowances between Borrower and its Account Debtors shall follow Borrower&#8217;s customary practices as they exist at the Effective Date.&nbsp;&nbsp;Borrower must promptly notify Agent and the Lenders of all returns, recoveries, disputes and claims that involve more than Five Hundred Thousand Dollars ($500,000).</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-11</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU12"></a><font style="font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6.5</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Insurance.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_313"></a>(a)<font style="margin-left:36pt;"></font>Keep its business and the insurable<a name="_cp_text_2_313"></a> Collateral insured for risks and in amounts standard for companies in Borrower&#8217;s industry and location.&nbsp;&nbsp;Insurance policies shall be in a form, with financially sound and reputable insurance companies that are not Affiliates of Borrower, and in amounts that are satisfactory to Agent.&nbsp;&nbsp;All property policies shall have a lender&#8217;s loss payable endorsement showing Agent as the sole lender loss payee.&nbsp;&nbsp;All general liability policies shall show, or have endorsements showing, Agent as an additional insured.&nbsp;&nbsp;Agent shall be named as lender loss payee and/or additional insured with respect to any such insurance providing coverage in respect of any Collateral. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Ensure that<font style="font-weight:bold;"> </font>proceeds payable under any property policy are, at Agent&#8217;s option, payable to Agent for the ratable benefit of the Lenders on account of the Obligations.  Notwithstanding the foregoing, (i) so long as no Event of Default has occurred and is continuing, Borrower shall have the option of reinvesting the proceeds of any casualty policy in an aggregate amount not to exceed One Million Dollars ($1,000,000) in any fiscal year in other assets useful to the business of Borrower; provided that any such assets shall be deemed Collateral in which Agent has been granted a first priority security interest, and (ii) after the occurrence and during the continuance of an Event of Default, all proceeds payable under such casualty policy shall, at the option of Agent, be payable to Agent on account of the Obligations.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_314"></a><a name="_cp_text_1_315"></a><a name="_cp_text_2_316"></a>(c)<font style="margin-left:36pt;"></font><a name="_cp_text_2_314"></a>At Agent&#8217;s request, Borrower shall deliver certified copies of insurance policies and evidence of all premium payments.&nbsp;&nbsp;Each provider of any such insurance required under this Section 6.5 shall agree, by endorsement upon the policy or policies issued by it or by independent instruments furnished to Agent, that it will give Agent <a name="_cp_text_1_315"></a>thirty <a name="_cp_text_2_316"></a>(30) days prior written notice before any such policy or policies shall be materially altered or canceled.&nbsp;&nbsp;If Borrower fails to obtain insurance as required under this Section 6.5 or to pay any amount or furnish any required proof of payment to third persons and Agent, Agent may make all or part of such payment or obtain such insurance policies required in this Section 6.5, and take any action under the policies Agent deems prudent. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_320"></a>6.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;"><a name="_cp_blt_2_320"></a>Operating Accounts.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Maintain the Designated Deposit Account with SVB.&nbsp;&nbsp;Borrower shall not, without the prior written consent of the Lenders, transfer any proceeds of the Term Loan Advances to any Collateral Account maintained by Borrower at a financial institution other than SVB.  For the avoidance of doubt, Borrower may use the proceeds of the Term Loan Advances as working capital in the ordinary course of business so long as Borrower does not at any time, violate the terms of the preceding sentence.  </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>In addition, Borrower shall provide Agent five (5) days prior written notice before establishing any Collateral Account at or with any bank or financial institution other than SVB or SVB&#8217;s Affiliates. For each Collateral Account that Borrower at any time maintains, Borrower shall cause the applicable bank or financial institution (other than SVB) at or with which any Collateral Account is maintained to execute and deliver a Control Agreement or other appropriate instrument with respect to such Collateral Account to perfect Agent&#8217;s Lien in such Collateral Account in accordance with the terms hereunder, which Control Agreement may not be terminated without the prior written consent of the Lenders.&nbsp;&nbsp;The provisions of the previous sentence shall not apply to (i) deposit accounts exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of Borrower&#8217;s employees and identified to Agent and the Lenders by Borrower as such, or (ii) Borrower&#8217;s deposit accounts located in countries other than the United States or Canada so long as the aggregate value of assets contained in all such accounts does not, at any time, exceed Two Hundred Fifty Thousand Dollars ($250,000).  </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_330"></a><a name="_cp_blt_1_335"></a><a name="_cp_blt_2_334"></a><a name="_cp_blt_2_336"></a><a name="_cp_blt_2_338"></a><a name="_cp_blt_2_340"></a><a name="_cp_blt_2_344"></a><a name="_cp_blt_2_346"></a><a name="_cp_blt_2_348"></a><a name="_cp_blt_2_350"></a><a name="_cp_blt_2_352"></a><a name="_cp_blt_2_354"></a><a name="_cp_blt_2_357"></a><a name="_cp_blt_2_359"></a><a name="_cp_blt_2_361"></a><a name="_cp_blt_2_363"></a><a name="_cp_blt_1_374"></a><a name="_cp_blt_2_373"></a>6.7<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Reserved.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_375"></a><a name="_cp_blt_2_377"></a><a name="_cp_blt_2_381"></a>6.8<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Protection of Intellectual Property Rights.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_386"></a><a name="_cp_text_1_389"></a><a name="_cp_text_2_390"></a><a name="_cp_text_1_391"></a>(a)<font style="margin-left:36pt;"></font><a name="_cp_text_2_386"></a>(i) Protect, defend and maintain the validity and enforceability of any Intellectual Property with any material value; (ii)&#160;promptly advise Agent in writing of material alleged infringements or any other event that could reasonably be expected to materially and adversely affect the value of its Intellectual Property with any material value<a name="_cp_text_1_389"></a>; and (iii) not allow any Intellectual Property  <a name="_cp_text_2_390"></a>material <a name="_cp_text_1_391"></a>to Borrower&#8217;s business to be abandoned, forfeited or dedicated to the public without Agent&#8217;s written consent.&nbsp;&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-12</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_392"></a><a name="_cp_blt_1_400"></a><a name="_cp_blt_2_399"></a><a name="_AEIOULastRenderedPageBreakAEIOU13"></a><a name="_cp_text_2_394"></a><a name="_cp_text_1_395"></a><a name="_cp_text_2_396"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_394"></a>Provide written notice to Agent within </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_395"></a>ten</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_396"></a>(</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) days of entering or becoming bound by any Restricted License (other than over-the-counter software that is commercially available to the public</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or available as a free or open source</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">).&nbsp;&nbsp;Borrower shall take such </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">commercially reasonable </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">steps as Agent requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (i)&#160;any Restricted License to be deemed &#8220;Collateral&#8221; and for Agent to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such Restricted License, whether now existing or entered into in the future, and (ii)&#160;Agent to have the ability in the event of a liquidation of any Collateral to dispose of such Collateral in accordance with Agent&#8217;s and the Lenders&#8217; rights and remedies under this Agreement and the other Loan Documents.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6.9<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Litigation Cooperation</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;From the date hereof and continuing through the termination of this Agreement, make available to Agent, without expense to Agent or any Lender, Borrower and its officers, employees and agents and Borrower&#8217;s books and records, to the extent that Agent and/or the Lenders may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or against Agent and/or any Lender with respect to any Collateral or relating to Borrower.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_402"></a><a name="_cp_text_1_403"></a><a name="_cp_text_2_404"></a><a name="_cp_text_2_406"></a><a name="_cp_text_1_407"></a><a name="_cp_text_2_408"></a><a name="_cp_text_1_411"></a><a name="_cp_text_1_413"></a>6.10<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Access to Collateral; Books and Records</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_2_402"></a>.&nbsp;&nbsp;Allow Agent or its agents, at reasonable times, on <a name="_cp_text_1_403"></a>five <a name="_cp_text_2_404"></a>(5<a name="_cp_text_2_406"></a>) Business Days&#8217; notice (provided no notice is required if an Event of Default has occurred and is continuing), to inspect the Collateral and audit and copy Borrower&#8217;s Books.&nbsp;&nbsp;Such inspections or audits shall be conducted no more often than once every <a name="_cp_text_1_407"></a>twelve <a name="_cp_text_2_408"></a>(12<a name="_cp_text_1_411"></a>) months unless an Event of Default has occurred and is continuing in which case such inspections and audits shall occur as often as Agent shall determine is necessary.&nbsp;&nbsp;The foregoing inspections and audits shall be at Borrower&#8217;s expense and the charge therefor shall be One Thousand Dollars ($1,000<a name="_cp_text_1_413"></a>) per person per day (or such higher amount as shall represent Agent&#8217;s then-current standard charge for the same), plus reasonable out-of-pocket expenses.&nbsp;&nbsp;In the event Borrower and Agent schedule an audit more than eight (8) days in advance, and Borrower cancels or reschedules the audit with less than eight (8) days written notice to Agent, then (without limiting any of Agent&#8217;s or any Lender&#8217;s rights or remedies) Borrower shall pay Agent a fee of Two Thousand Dollars ($2,000) plus any out-of-pocket expenses incurred by Agent to compensate Agent for the costs and expenses of the cancellation or rescheduling.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_2_415"></a><a name="_cp_blt_1_427"></a><a name="_cp_blt_2_426"></a><a name="_cp_text_1_418"></a><a name="_cp_text_1_425"></a>6.11<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Formation or Acquisition of Subsidiaries</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_418"></a>.&nbsp;&nbsp;Notwithstanding and without limiting the negative covenants contained in Sections 7.3 and 7.7 hereof, at the time that Borrower or any Guarantor forms any direct or indirect Subsidiary or acquires any direct or indirect Subsidiary after the Effective Date (including, without limitation, pursuant to a Division), Borrower and such Guarantor shall (a) cause such new Domestic Subsidiary to provide to Lenders a joinder to this Agreement to become a co-borrower hereunder or a Guaranty to become a Guarantor hereunder, together with such appropriate financing statements and/or Control Agreements, all in form and substance satisfactory to Agent and Lenders (including being sufficient to grant Lenders a first priority Lien (subject to Permitted Liens) in and to the assets of such newly formed or acquired Subsidiary), (b) provide to Lenders appropriate certificates and powers and financing statements, pledging all of the direct or beneficial ownership interest in such new Subsidiary (provided that if Borrower can demonstrate to Agent and the Lenders&#8217; satisfaction that pledging in excess of sixty-five percent (65%) of the stock of any new Foreign Subsidiary would cause an adverse tax consequence for Borrower or such newly created/acquired Foreign Subsidiary, Borrower shall be required to pledge only sixty-five percent (65%) of the stock of such Foreign Subsidiary), in form and substance reasonably satisfactory to Agent and Lenders<a name="_cp_text_1_425"></a>; and (c) provide to Lenders all other documentation in form and substance satisfactory to Agent and Lenders, including one or more opinions of counsel satisfactory to Lenders, which in its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above.&nbsp;&nbsp;Any document, agreement, or instrument executed or issued pursuant to this Section 6.11 shall be a Loan Document.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_429"></a><a name="_cp_blt_2_428"></a>6.12<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Further Assurances</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Execute any further instruments and take further action as Agent and the Lenders reasonably request to perfect or continue Agent&#8217;s Lien in the Collateral or to effect the purposes of this Agreement.&nbsp;&nbsp;Deliver to Agent and the Lenders,</font><font style="font-family:Times New Roman;"> </font><font style="font-family:Times New Roman;font-weight:normal;">within five (5) days after the same are sent or received, copies of all correspondence, reports, documents and other filings with any Governmental Authority regarding compliance with or maintenance of Governmental Approvals or Requirements of Law or that could reasonably be expected to have a material adverse effect on any of the Governmental Approvals or otherwise on the operations of Borrower or any of its Subsidiaries.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU14"></a><font style="font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6.13</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Post-Closing Item</font><font style="font-family:Times New Roman;">s</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>As soon as possible, but in any event not later than the date that is thirty (30) days after the Effective Date, Borrower shall deliver to Agent and the Lenders, a landlord&#8217;s consent in favor of SVB for each of Borrower&#8217;s leased locations at (a) 3000 Pegasus Park Drive, Suite 1430, Dallas, TX 75247, and (b) 5 National Way, Durham, NC 27703, each by the respective landlord thereof, together with the duly executed signatures thereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>As soon as possible, but in any event not later than the date that is thirty (30) days after the Effective Date, Borrower shall deliver to the Lenders a joinder to this Agreement pursuant to which each of Borrower&#8217;s Domestic Subsidiaries shall become a co-borrower hereunder, together with such appropriate financing statements and/or Control Agreements, and any other documentation required by the Lenders all in form and substance satisfactory to Agent and Lenders (including being sufficient to grant Lenders a first priority Lien (subject to Permitted Liens) in and to the assets of such Person. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_cp_blt_2_430"></a><font style="text-decoration:none;">7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">NEGATIVE COVENANTS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Borrower shall not do any of the following without the prior written consent of the Lenders:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_433"></a><a name="_cp_text_1_441"></a>7.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Dispositions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Convey, sell, lease, transfer, assign, or otherwise dispose of (including, without limitation, pursuant to a Division) (collectively a &#8220;</font><font style="font-family:Times New Roman;">Transfer</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_433"></a>&#8221;), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, except for Transfers (a) of Inventory in the ordinary course of business; (b) of worn-out <a name="_cp_text_1_441"></a>or obsolete Equipment that is, in the reasonable judgment of Borrower, no longer economically practicable to maintain or useful in the ordinary course of business of Borrower; (c) consisting of Permitted Liens and Permitted Investments; (d) consisting of the sale or issuance of any stock of Borrower permitted under Section 7.2 of this Agreement; (e) consisting of Borrower&#8217;s use or transfer of money or Cash Equivalents in a manner that is not prohibited by the terms of this Agreement or the other Loan Documents; (f) of non-exclusive licenses for the use of the property of Borrower or its Subsidiaries in the ordinary course of business and licenses that could not result in a legal transfer of title of the licensed property but that may be exclusive in respects other than territory and that may be exclusive as to territory only as to discrete geographical areas outside of the United States; and (g) of other assets not to exceed Five Hundred Thousand Dollars ($500,000) in the aggregate per year.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Changes in Business, Management, Control, or Business Locations</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;(a) Engage in or permit any of its Subsidiaries to engage in any business other than the businesses currently engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto; (b) liquidate or dissolve; (c) fail to provide notice to Agent and Lenders of any Key Person departing from or ceasing to be employed by Borrower within ten (10) Business Days after such Key Person&#8217;s departure from Borrower; or (d) permit or suffer any Change in Control.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_442"></a><a name="_cp_text_1_443"></a><a name="_cp_text_2_444"></a><a name="_Hlk49438531"></a><a name="_cp_text_2_448"></a><a name="_cp_text_2_442"></a>Borrower shall not, without at least <a name="_cp_text_1_443"></a>thirty <a name="_cp_text_2_444"></a>(30<a name="_Hlk49438531"></a>) days prior written notice to Agent: (1) add any new offices or business locations, including warehouses (unless such new offices or business locations contain less than One Million <a name="_cp_text_2_448"></a>Dollars ($1,000,000) in Borrower&#8217;s assets or property) or deliver any portion of the Collateral valued, individually or in the aggregate, in excess of One Million Dollars ($1,000,000) to a bailee at a location other than to a bailee and at a location already disclosed in the Perfection Certificate, (2) change its jurisdiction of organization, (3) change its organizational structure or type, (4) change its legal name, or (5) change any organizational number (if any) assigned by its jurisdiction of organization.&nbsp;&nbsp;If Borrower intends to add any new offices or business locations, including warehouses, containing in excess of One Million Dollars ($1,000,000) of Borrower&#8217;s assets or property, then Borrower shall use commercially reasonable best efforts (as determined by Agent and the Lenders) to cause the landlord of any such new offices or business locations, including warehouses, to execute and deliver a landlord consent in form and substance satisfactory to Agent.&nbsp;&nbsp; If Borrower intends to deliver any portion of the Collateral valued, individually or in the aggregate, in excess of One Million Dollars ($1,000,000) to a bailee, and Agent and such bailee are not already parties to a bailee agreement governing both the Collateral and the location to which Borrower intends to deliver the Collateral, then Borrower shall use commercially reasonable efforts to cause such bailee to execute and deliver a bailee agreement in form and substance satisfactory to Agent. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU15"></a>7.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Mergers or Acquisitions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Merge or consolidate, or permit any of its Subsidiaries to merge or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the capital </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-14-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-weight:normal;">stock or property of another Person (including, without limitation, by the formation of any Subsidiary or pursuant to a Division).&nbsp;&nbsp;A Subsidiary may merge or consolidate into another Subsidiary or into Borrower.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Indebtedness</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than Permitted Indebtedness.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.5<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Encumbrance</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Create, incur, allow, or suffer any Lien on any of its property, or assign or convey any right to receive income, including the sale of any Accounts, or permit any of its Subsidiaries to do so, except for Permitted Liens, permit any Collateral not to be subject to the first priority security interest granted herein, or enter into any agreement, document, instrument or other arrangement (except with or in favor of Agent, for the ratable benefit of the Lenders) with any Person which directly or indirectly prohibits or has the effect of prohibiting Borrower or any Subsidiary from assigning, mortgaging, pledging, granting a security interest in or upon, or encumbering any of Borrower&#8217;s or any Subsidiary&#8217;s Intellectual Property, except as is otherwise permitted in Section 7.1 hereof and the definition of &#8220;Permitted Liens&#8221; herein.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Maintenance of Collateral Accounts</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Maintain any Collateral Account except pursuant to the terms of Section 6.6 hereof.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_468"></a><a name="_cp_text_1_470"></a><a name="_cp_text_2_471"></a><a name="_cp_text_1_472"></a><a name="_cp_text_1_474"></a>7.7<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Distributions; Investments</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_468"></a>.&nbsp;&nbsp;(a) Pay any dividends or make any distribution or payment or redeem, retire or purchase any capital stock, provided that Borrower may (i) convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof and paying cash in lieu of fractional shares in connection with any such conversion<a name="_cp_text_1_470"></a>, (ii) pay dividends solely in common stock, (iii) repurchase the stock of current or <a name="_cp_text_2_471"></a>former employees or consultants pursuant to stock repurchase agreements so long as an Event of Default does not exist at the time of any such repurchase and would not exist after giving effect to any such repurchase, provided that the aggregate amount of all such repurchases does not <a name="_cp_text_1_472"></a>exceed One Hundred <a name="_cp_text_1_474"></a>Thousand Dollars ($100,000) per fiscal year; or (b) directly or indirectly make any Investment (including, without limitation, by the formation of any Subsidiary) other than Permitted Investments, or permit any of its Subsidiaries to do so.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.8<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Transactions with Affiliates</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Directly or indirectly enter into or permit to exist any material transaction with any Affiliate of Borrower, except for (a) transactions that are in the ordinary course of Borrower&#8217;s business, upon fair and reasonable terms that are no less favorable to Borrower than would be obtained in an arm&#8217;s length transaction with a non-affiliated Person, (b) sales of equity securities to its investors in bona fide equity financings so long as a Change in Control does not occur, (c) transactions between Borrower and its Subsidiaries permitted under Section 7.7, (d) reasonable and customary compensation arrangements and benefit plans for officers and other employees of Borrower entered into or maintained in the ordinary course of business and approved by the Board, and (e) reasonable and customary fees paid to independent members of the Board in the ordinary course of business. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.9<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Subordinated Debt</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;(a) Make or permit any payment on any Subordinated Debt, except under the terms of the subordination, intercreditor, or other similar agreement to which such Subordinated Debt is subject, or (b) amend any provision in any document relating to the Subordinated Debt which would increase the amount thereof, provide for earlier or greater principal, interest, or other payments thereon, or adversely affect the subordination thereof to Obligations owed to Agent and the Lenders.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.10<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Compliance</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Become an &#8220;investment company&#8221; or a company controlled by an &#8220;investment company&#8221;, under the Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Credit Extension for that purpose; fail to (a) meet the minimum funding requirements of ERISA, (b) prevent a Reportable Event or Prohibited Transaction, as defined in ERISA, from occurring, or (c) comply with the Federal Fair Labor Standards Act, or violate any other law or regulation, if the violation could reasonably be expected to have a material adverse effect on Borrower&#8217;s business, or permit any of its Subsidiaries to do so; withdraw or permit any Subsidiary to withdraw from participation in, permit partial or complete termination of, or permit the occurrence of any other event with respect to, any present pension, profit sharing and deferred compensation plan which could reasonably be expected to result in any liability of Borrower, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency</font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-15</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_480"></a><a name="_AEIOULastRenderedPageBreakAEIOU16"></a><font style="font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.11</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Subsidiary Assets</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Permit the aggregate value of (a) cash and Cash Equivalents held by Borrower&#8217;s Subsidiaries</font><font style="font-family:Times New Roman;font-weight:normal;"> that are no</font><font style="font-family:Times New Roman;font-weight:normal;">t </font><font style="font-family:Times New Roman;font-weight:normal;">co-Borrowers or secured Guarantors hereunder</font><font style="font-family:Times New Roman;font-weight:normal;">, collectively, to exceed </font><font style="font-family:Times New Roman;font-weight:normal;">Five Hundred Thousand </font><font style="font-family:Times New Roman;font-weight:normal;">Dollars ($</font><font style="font-family:Times New Roman;font-weight:normal;">500</font><font style="font-family:Times New Roman;font-weight:normal;">,000)</font><font style="font-family:Times New Roman;font-weight:normal;"> (or equivalent)</font><font style="font-family:Times New Roman;font-weight:normal;"> for more than </font><font style="font-family:Times New Roman;font-weight:normal;">five </font><font style="font-family:Times New Roman;font-weight:normal;">(</font><font style="font-family:Times New Roman;font-weight:normal;">5</font><font style="font-family:Times New Roman;font-weight:normal;">) </font><font style="font-family:Times New Roman;font-weight:normal;">Business D</font><font style="font-family:Times New Roman;font-weight:normal;">ays in any calendar month</font><font style="font-family:Times New Roman;font-weight:normal;">, or (b) all assets held by Borrower&#8217;s Subsidiaries </font><font style="font-family:Times New Roman;font-weight:normal;">that are not co-Borrowers or secured Guarantors hereunder </font><font style="font-family:Times New Roman;font-weight:normal;">collectively, to </font><font style="font-family:Times New Roman;font-weight:normal;">exceed </font><font style="font-family:Times New Roman;font-weight:normal;">One Million Dollars ($1,000,000)</font><font style="font-family:Times New Roman;font-weight:normal;"> (or equivalent)</font><font style="font-family:Times New Roman;font-weight:normal;"> for more than</font><font style="font-family:Times New Roman;font-weight:normal;"> five </font><font style="font-family:Times New Roman;font-weight:normal;">(</font><font style="font-family:Times New Roman;font-weight:normal;">5</font><font style="font-family:Times New Roman;font-weight:normal;">) </font><font style="font-family:Times New Roman;font-weight:normal;">Business D</font><font style="font-family:Times New Roman;font-weight:normal;">ays in any calendar month</font><font style="font-family:Times New Roman;font-weight:normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">EVENTS OF DEFAULT</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any one of the following shall constitute an event of default (an &#8220;<font style="font-weight:bold;">Event of Default</font>&#8221;) under this Agreement:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Payment Default</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower fails to (a)&#160;make any payment of principal or interest on any Credit Extension when due, or (b)&#160;pay any other Obligations within three (3) Business Days after such Obligations are due and payable (which three (3) Business Day cure period shall not apply to payments due on the Term Loan Maturity Date).&nbsp;&nbsp;During the cure period, the failure to make or pay any payment specified under clause (b) hereunder is not an Event of Default (but no Credit Extension will be made during the cure period);</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Covenant Default.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Borrower fails or neglects to perform any obligation in Sections 6.2, 6.3, 6.5, 6.6, 6.7, 6.8(b), 6.9, 6.10, 6.11, 6.12, or 6.13 or violates any covenant in Section 7; or</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_487"></a>(b)<font style="margin-left:36pt;"></font>(b) Borrower fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section 8) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within ten (10) Business Days after the occurrence thereof; <font style="text-decoration:underline;">provided</font>, <font style="text-decoration:underline;">however</font>, that if the default cannot by its nature be cured within the ten (10) Business Day period or cannot after diligent attempts by Borrower be cured within such ten (10) Business Day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30) days) to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not be deemed an Event of Default (but no Credit Extensions shall be made during such cure period).&nbsp;&nbsp;Cure periods provided under this section shall not apply, among other things, to financial covenants (if any) or any other covenants set forth in clause (a) above;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Material Adverse Change</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;A Material Adverse Change occurs;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Attachment; Levy; Restraint on Business.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>(i) The service of process seeking to attach, by trustee or similar process, any funds of Borrower or of any entity under the control of Borrower (including a Subsidiary), or (ii) a notice of lien or levy is filed against any of Borrower&#8217;s assets by any Governmental Authority, and the same under subclauses (i) and (ii) hereof are not, within ten (10) days after the occurrence thereof, discharged or stayed (whether through the posting of a bond or otherwise); <font style="text-decoration:underline;">provided</font>, <font style="text-decoration:underline;">however</font>, no Credit Extensions shall be made during any ten (10) day cure period; or </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font> (i) any material portion of Borrower&#8217;s assets is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii)&#160;any court order enjoins, restrains, or prevents Borrower from conducting all or any material part of its business;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_490"></a><a name="_cp_text_1_492"></a>8.5<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Insolvency</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_490"></a>.&nbsp;&nbsp;(a) Borrower and <a name="_cp_text_1_492"></a>any of its Subsidiaries is unable to pay its debts (including trade debts) as they become due or otherwise becomes insolvent; (b) Borrower or any of its Subsidiaries begins an Insolvency Proceeding; or (c) an Insolvency Proceeding is begun against Borrower or any of its Subsidiaries and is not dismissed or stayed within thirty (30) days (but no Credit Extensions shall be made while any of the conditions described in clause (a) exist and/or until any Insolvency Proceeding is dismissed);</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU17"></a><a name="_cp_text_1_504"></a><a name="_cp_text_1_510"></a>8.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Other Agreements</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;There is, under any agreement to which Borrower or any Guarantor is a party with a third party or parties, (a) any default resulting in a right by such third party or parties, whether or not exercised, to </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-16-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-weight:normal;">accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of </font><font style="font-family:Times New Roman;font-weight:normal;">One Million </font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_504"></a>Dollars ($</font><font style="font-family:Times New Roman;font-weight:normal;">1,000</font><font style="font-family:Times New Roman;font-weight:normal;">,000</font><font style="font-family:Times New Roman;font-weight:normal;">); or (b) any breach or default by Borrower or Guarantor, the result of which could </font><font style="font-family:Times New Roman;font-weight:normal;">reasonably be expected to </font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_510"></a>have a material adverse effect on Borrower&#8217;s or any Guarantor&#8217;s business</font><font style="font-family:Times New Roman;font-weight:normal;">;</font><font style="font-family:Times New Roman;font-weight:normal;"> </font><font style="font-family:Times New Roman;font-weight:normal;">provided, however, that the Event of Default under this Section 8.6 caused by the occurrence of a breach or default under such other agreement shall be cured or waived for purposes of this Agreement upon </font><font style="font-family:Times New Roman;font-weight:normal;">Agent</font><font style="font-family:Times New Roman;font-weight:normal;"> receiving written notice from the party asserting such breach or default of such cure or waiver of the breach or default under such other agreement, if at the time of such cure or waiver under such other agreement (x) </font><font style="font-family:Times New Roman;font-weight:normal;">neither Lender has</font><font style="font-family:Times New Roman;font-weight:normal;"> declared an Event of Default under this Agreement and/or exercised any rights with respect thereto; (y) any such cure or waiver does not result in an Event of Default under any other provision of this Agreement or any Loan Document; and (z) in connection with any such cure or waiver under such other agreement, the terms of any agreement with such third party are not modified or amended in any manner which could reasonably be expected to have a material adverse effect on Borrower&#8217;s or any Guarantor&#8217;s business;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.7<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Judgments; Penalties</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;One or more fines, penalties, or final judgments, orders or decrees for the payment of money in an amount, individually or in the aggregate, of at least One Million Dollars ($1,000,000) (not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower by any Governmental Authority, and the same are not, within ten (10) days after the entry, assessment or issuance thereof, discharged, satisfied, or paid, or after execution thereof, stayed or bonded pending appeal, or such judgments are not discharged prior to the expiration of any such stay (provided that no Credit Extensions will be made prior to the satisfaction, payment, discharge, stay, or bonding of such fine, penalty, judgment, order or decree);</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.8<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Misrepresentations</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower or any Person acting for Borrower makes any representation, warranty, or other statement now or later in this Agreement, any Loan Document or in any writing delivered to Agent or any Lender or to induce Agent or any Lender to enter this Agreement or any Loan Document, and such representation, warranty, or other statement is incorrect in any material respect when made;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.9<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Subordinated Debt</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Any document, instrument, or agreement evidencing the subordination of any Subordinated Debt shall for any reason be revoked or invalidated or otherwise cease to be in full force and effect, any Person shall be in breach thereof or contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder, or the Obligations shall for any reason be subordinated or shall not have the priority contemplated by this Agreement or any applicable subordination or intercreditor agreement;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.10<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Guaranty.</font><font style="font-family:Times New Roman;font-weight:normal;">&nbsp;&nbsp;(a) Any guaranty of any Obligations terminates or ceases for any reason to be in full force and effect; (b) any Guarantor does not perform any obligation or covenant under any guaranty of the Obligations; (c) any circumstance described in Sections 8.3, 8.4, 8.5, 8.6, 8.7, or 8.8 of this Agreement occurs with respect to any Guarantor, or (d) the liquidation, winding up, or termination of existence of any Guarantor; </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_515"></a><a name="_cp_text_1_516"></a>8.11<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Lien Priority.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-weight:normal;">There is a material impairment in the priority of Agent&#8217;s security interest in the Collateral; </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_519"></a><a name="_cp_blt_2_518"></a>8.12<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Governmental Approvals</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Any Governmental Approval shall have been&#160;revoked, rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a full term and such decision or such revocation, rescission, suspension, modification or non-renewal (a) causes, or could reasonably be expected to cause a material adverse change or (b) adversely affect the legal qualifications of Borrower or any of its Subsidiaries to hold such Governmental Approval in any applicable jurisdiction. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.13<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Delisting</font><font style="font-family:Times New Roman;font-weight:normal;">. Borrower&#8217;s common stock is delisted from the NASDAQ stock exchange because of Borrower&#8217;s failure to comply with continued listing standards thereof. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">RIGHTS AND REMEDIES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU18"></a>9.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Rights and Remedies</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;</font><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">Upon the occurrence and during the continuance of an Event of Default, Agent, as directed by Lenders in accordance with the Lender Intercreditor Agreement or, if such rights and remedies are not </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-17-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-weight:normal;">addressed in the Lender Intercreditor Agreement, as directed by Lenders having a majority of the Obligations, may, without notice or demand, do any or all of the following:</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>declare all Obligations immediately due and payable (but if an Event of Default described in Section 8.5 occurs all Obligations are immediately due and payable without any action by Agent or any Lender);</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>stop advancing money or extending credit for Borrower&#8217;s benefit under this Agreement or under any other agreement among Borrower, Agent and/or any Lenders;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>demand that Borrower (i) deposit cash with SVB in an amount equal to at least (x) one hundred five percent (105.0%) of the Dollar Equivalent of the aggregate face amount of all Letters of Credit denominated in Dollars remaining undrawn, and (y) one hundred ten percent (110.0%) of the Dollar Equivalent of the aggregate face amount of all Letters of Credit denominated in a Foreign Currency remaining undrawn (plus, in each case, all interest, fees, and costs due or to become due in connection therewith (as estimated by SVB in its good faith business judgment)), to secure all of the Obligations relating to such Letters of Credit, as collateral security for the repayment of any future drawings under such Letters of Credit, and Borrower shall forthwith deposit and pay such amounts, and (ii) pay in advance all letter of credit fees scheduled to be paid or payable over the remaining term of any Letters of Credit;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font>terminate any FX Contracts;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:36pt;"></font>verify the amount of, demand payment of and performance under, and collect any Accounts and General Intangibles, settle or adjust disputes and claims directly with Account Debtors for amounts on terms and in any order that Agent and/or the Lenders consider advisable, and notify any Person owing Borrower money of Agent&#8217;s security interest in such funds. Borrower shall collect all payments in trust for Lenders and, if requested by Agent, immediately deliver the payments to Lenders in the form received from the Account Debtor, with proper endorsements for deposit;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:36pt;"></font>make any payments and do any acts Agent or any Lender considers necessary or reasonable to protect the Collateral and/or its security interest in the Collateral.&nbsp;&nbsp;Borrower shall assemble the Collateral if Agent requests and make it available as Agent designates.&nbsp;&nbsp;Agent may enter premises where the Collateral is located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or compromise any Lien which appears to be prior or superior to its security interest or charges and pay all expenses incurred. Borrower grants Agent a license to enter and occupy any of its premises, without charge, to exercise any of Agent&#8217;s rights or remedies;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)<font style="margin-left:36pt;"></font>apply to the Obligations (i) any balances and deposits of Borrower it holds, or (ii) any amount held by Agent owing to or for the credit or the account of Borrower;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(h)<font style="margin-left:36pt;"></font>ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell the Collateral.&nbsp;&nbsp;Agent, for the benefit of the Lenders, is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, Borrower&#8217;s labels, Patents, Copyrights, mask works, rights of use of any name, trade secrets, trade names, Trademarks, and advertising matter, or any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Agent&#8217;s exercise of its rights under this Section, Borrower&#8217;s rights under all licenses and all franchise agreements inure to Agent, for the ratable benefit of the Lenders;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:36pt;"></font>place a &#8220;hold&#8221; on any account maintained with Agent or Lenders and/or deliver a notice of exclusive control, any entitlement order, or other directions or instructions pursuant to any Control Agreement or similar agreements providing control of any Collateral;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)<font style="margin-left:36pt;"></font>demand and receive possession of Borrower&#8217;s Books; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)<font style="margin-left:36pt;"></font>exercise all rights and remedies available to Agent and the Lenders under the Loan Documents or at law or equity, including all remedies provided under the Code (including disposal of the Collateral pursuant to the terms thereof).</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-18</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU19"></a><a name="_cp_text_2_525"></a><a name="_cp_text_1_526"></a><font style="font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9.2</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Power of Attorney</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_2_525"></a>.&nbsp;&nbsp;Borrower hereby irrevocably appoints Agent, for the benefit of the Lenders, as its lawful attorney-in-fact, exercisable </font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_526"></a>following</font><font style="font-family:Times New Roman;font-weight:normal;"> </font><font style="font-family:Times New Roman;font-weight:normal;">the occurrence of an Event of Default, to: (a) endorse Borrower&#8217;s name on any checks, payment instruments, or other forms of payment or security; (b) sign Borrower&#8217;s name on any invoice or bill of lading for any Account or drafts against Account Debtors; (c) demand, collect, sue, and give releases to any Account Debtor for monies due, settle and adjust disputes and claims about the Accounts directly with Account Debtors, and compromise, prosecute, or defend any action, claim, case, or proceeding about any Collateral (including filing a claim or voting a claim in any bankruptcy case in Agent&#8217;s or Borrower&#8217;s name, as Agent chooses) for amounts and on terms Agent determines reasonable; (d) make, settle, and adjust all claims under Borrower&#8217;s insurance policies; (e) pay, contest or settle any Lien, charge, encumbrance, security interest, and adverse claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or discharge the same; and (f) transfer the Collateral into the name of Agent or a third party as the Code permits. Borrower hereby appoints Agent as its lawful attorney-in-fact to sign Borrower&#8217;s name on any documents necessary to perfect or continue the perfection of Agent&#8217;s security interest in the Collateral regardless of whether an Event of Default has occurred until all Obligations have been satisfied in full and the Loan Documents have been terminated. Agent&#8217;s foregoing appointment as Borrower&#8217;s attorney in fact, and all of Agent&#8217;s rights and powers, coupled with an interest, are irrevocable until all Obligations have been fully repaid and performed and the Loan Documents have been terminated.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Protective Payments</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;If Borrower fails to obtain the insurance called for by Section 6.5 or fails to pay any premium thereon or fails to pay any other amount which Borrower is obligated to pay under this Agreement or any other Loan Document or which may be required to preserve the Collateral, Agent may obtain such insurance or make such payment, and all amounts so paid by Agent are Lenders&#8217; Expenses and immediately due and payable, bearing interest at the then highest rate applicable to the Obligations, and secured by the Collateral. Agent will make reasonable efforts to provide Borrower with notice of Agent obtaining such insurance at the time it is obtained or within a reasonable time thereafter. No payments by Agent are deemed an agreement to make similar payments in the future or Agent&#8217;s or and Lenders&#8217; waiver of any Event of Default.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_528"></a>9.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;"><a name="_cp_text_2_528"></a>Application of Payments and Proceeds</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent shall have the right to apply in any order any funds in its possession, whether from Borrower account balances, payments, proceeds realized as the result of any collection of Accounts or other disposition of the Collateral, or otherwise, to the Obligations. Agent shall pay any surplus to Borrower by credit to the Designated Deposit Account or to other Persons legally entitled thereto; Borrower shall remain liable to Agent and the Lenders for any deficiency. If Agent, directly or indirectly, enters into a deferred payment or other credit transaction with any purchaser at any sale of Collateral, Agent shall have the option, exercisable at any time, of either reducing the Obligations by the principal amount of the purchase price or deferring the reduction of the Obligations until the actual receipt by Agent of cash therefor.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9.5<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Liability for Collateral</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;So long as Agent and Lenders comply with reasonable banking practices regarding the safekeeping of the Collateral in their possession or under the control of Agent and/or Lenders, Agent and Lenders shall not be liable or responsible for: (a) the safekeeping of the Collateral; (b) any loss or damage to the Collateral; (c) any diminution in the value of the Collateral; or (d) any act or default of any carrier, warehouseman, bailee, or other Person. Borrower bears all risk of loss, damage or destruction of the Collateral.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">No Waiver; Remedies Cumulative</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent&#8217;s and any Lender&#8217;s failure, at any time or times, to require strict performance by Borrower of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Agent or any Lender thereafter to demand strict performance and compliance herewith or therewith. No waiver hereunder shall be effective unless signed by the party granting the waiver and then is only effective for the specific instance and purpose for which it is given. Agent&#8217;s and each Lender&#8217;s rights and remedies under this Agreement and the other Loan Documents are cumulative. Agent and each Lender have all rights and remedies provided under the Code, by law, or in equity. Agent&#8217;s or any Lender&#8217;s exercise of one right or remedy is not an election and shall not preclude Agent or any Lender from exercising any other remedy under this Agreement or any other Loan Document or other remedy available at law or in equity, and Agent&#8217;s or any Lender&#8217;s waiver of any Event of Default is not a continuing waiver. Agent&#8217;s or any Lender&#8217;s delay in exercising any remedy is not a waiver, election, or acquiescence.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9.7<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Demand Waiver</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by Agent on which Borrower is liable.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-19</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU20"></a><font style="text-decoration:none;">10</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">Agent </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Appointment and Authority.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M798"></a><a name="_DV_M800"></a><a name="_DV_M801"></a><a name="_DV_M802"></a>(a)<font style="margin-left:36pt;"></font><a name="_DV_M802"></a>Each Lender hereby irrevocably appoints SVB to act on its behalf as Agent hereunder and under the other Loan Documents and authorizes Agent to take such actions on its behalf and to exercise such powers as are delegated to Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>The provisions of this Section 10 are solely for the benefit of Agent and Lenders, and Borrower shall not have rights as a third party beneficiary of any of such provisions.&nbsp;&nbsp;Notwithstanding any provision to the contrary elsewhere in this Agreement, Agent shall not have any duties or responsibilities to any Lender or any other Person, except those expressly set forth herein, or any fiduciary relationship with any Lender, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or any other Loan Document or otherwise exist against Agent.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Delegation of Duties</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by Agent.&nbsp;&nbsp;Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Indemnified Persons.&nbsp;&nbsp;The exculpatory provisions of this Section 10.2 shall apply to any such sub-agent and to the Indemnified Persons of Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Agent.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-weight:normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;">Exculpatory Provisions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent shall have no duties or obligations except those expressly set forth herein and in the other Loan Documents.&nbsp;&nbsp;Without limiting the generality of the foregoing, Agent shall not:</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M803"></a><a name="_DV_M804"></a><a name="_DV_M805"></a><a name="_DV_M806"></a><a name="_DV_M807"></a><a name="_DV_M808"></a>(a)<font style="margin-left:36pt;"></font><a name="_DV_M808"></a>be subject to any fiduciary, trust, agency or other similar duties, regardless of whether any Event of Default has occurred and is continuing;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M809"></a>(b)<font style="margin-left:36pt;"></font>have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that Agent is required to exercise as directed in writing by the Lenders, as applicable; <font style="text-decoration:underline;">provided</font> <font style="text-decoration:underline;">that</font><a name="_DV_M809"></a> Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose Agent to liability or that is contrary to any Loan Document or applicable law; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and Agent shall not be liable for the failure to disclose, any information relating to Borrower or any of its Affiliates that is communicated to or obtained by any Person serving as Agent or any of its Affiliates in any capacity.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M810"></a><a name="_DV_M811"></a><a name="_DV_M811"></a>Agent shall not be liable for any action taken or not taken by it (i) with the consent or at the request of the Lenders (or as Agent shall believe in good faith shall be necessary, under the circumstances as provided in Section 13.7) or (ii) in the absence of its own gross negligence or willful misconduct.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Event of Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in Section 3 or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to Agent.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU21"></a>10.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-weight:normal;"> </font><font style="font-family:Times New Roman;">Reliance by Agent</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person.&nbsp;&nbsp;Agent also may rely upon any statement made to it orally or by </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-20-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-weight:normal;">telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon.&nbsp;&nbsp;Agent may consult with legal counsel (who may be counsel for Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.&nbsp;&nbsp;In determining compliance with any condition hereunder to the making of a Credit Extension that, by its terms, must be fulfilled to the satisfaction of a Lender, Agent may presume that such condition is satisfactory to such Lender unless Agent shall have received notice to the contrary from such Lender prior to the making of such Credit Extension.&nbsp;&nbsp;Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement and the other Loan Documents in accordance with a request of the Lenders, and such request and any action taken or failure to act pursuant thereto shall be binding upon Lenders and all future holders of the Credit Extensions.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10.5<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;"> Notice of Default</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent shall not be deemed to have knowledge or notice of the occurrence of any Event of Default (except with respect to defaults in the payment of principal, interest or fees required to be paid to Agent for the account of Lenders), unless Agent has received notice from a Lender or Borrower referring to this Agreement, describing such Event of Default and stating that such notice is a &#8220;notice of default&#8221;.&nbsp;&nbsp;In the event that Agent receives such a notice, Agent shall give notice thereof to Lenders.&nbsp;&nbsp;Agent shall take such action with respect to such Event of Default as shall be reasonably directed by the Lenders.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M812"></a><a name="_DV_M813"></a><a name="_DV_M814"></a><a name="_DV_M816"></a>10.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;"> Non-Reliance on Agent and Other Lenders</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Each Lender expressly acknowledges that neither Agent nor any of its officers, directors, employees, agents, attorneys in fact or affiliates has made any representations or warranties to it and that no act by Agent hereafter taken, including any review of the affairs of a Group Member or any Affiliate of a Group Member, shall be deemed to constitute any representation or warranty by Agent to any Lender.&nbsp;&nbsp;Each Lender represents to Agent that it has, independently and without reliance upon Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own appraisal of, and investigation into, the business, operations, property, financial and other condition and creditworthiness of the Group Members and their Affiliates and made its own decision to make its Credit Extensions hereunder and enter into this Agreement.&nbsp;&nbsp;Each Lender also represents that it will, independently and without reliance upon Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make such investigation as it deems necessary to inform itself as to the business, operations, property, financial and other condition and creditworthiness of the Group Members and their Affiliates.&nbsp;&nbsp;Except for notices, reports and other documents expressly required to be furnished to Lenders by Agent hereunder, Agent shall have no duty or responsibility to provide any Lender with any credit or other information concerning the business, operations, property, condition (financial or otherwise), prospects or creditworthiness of any Group Member or any Affiliate of a Group Member that may come into the possession of Agent or any of its officers, directors, employees, agents, attorneys in fact or Affiliates.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M817"></a><a name="_DV_M818"></a><a name="_Ref247951211"></a>10.7<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Indemnification</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Each Lender agrees to indemnify Agent in its capacity as such (to the extent not reimbursed by Borrower and without limiting the obligation of Borrower to do so in accordance with the terms hereof, according to its Term Loan Commitment Percentage in effect on the date on which indemnification is sought under this Section 10.7 (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Obligations shall have been paid in full, in accordance with its Term Loan Commitment Percentage immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Credit Extensions) be imposed on, incurred by or asserted against Agent in any way relating to or arising out of, the Commitments, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by Agent under or in connection with any of the foregoing; </font><font style="text-decoration:underline;font-family:Times New Roman;font-weight:normal;">provided</font><font style="font-family:Times New Roman;font-weight:normal;"> </font><font style="text-decoration:underline;font-family:Times New Roman;font-weight:normal;">that</font><font style="font-family:Times New Roman;font-weight:normal;"> no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted primarily from Agent&#8217;s gross negligence or willful misconduct.&nbsp;&nbsp;The agreements in this Section shall survive the payment of the Credit Extensions and all other amounts payable hereunder.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M819"></a><a name="_DV_M820"></a><a name="_AEIOULastRenderedPageBreakAEIOU22"></a>10.8<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Agent in Its Individual Capacity</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;The Person serving as Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not Agent and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall, unless otherwise expressly indicated or unless the context otherwise requires, </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-21-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-weight:normal;">include each such Person serving as Agent hereunder in its individual capacity.&nbsp;&nbsp;Such Person and its Affiliates may accept deposits from, lend money to, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with Borrower, any Guarantor or any Subsidiary or other Affiliate thereof as if such Person were not Agent hereunder and without any duty to account therefor to Lenders.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M821"></a><a name="_DV_M822"></a><a name="_Ref238621672"></a>10.9<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_Ref238621672"></a>&nbsp;&nbsp;</font><font style="font-family:Times New Roman;">Successor Agent</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent may at any time give notice of its resignation to Lenders and Borrower, which resignation shall not be effective until the time at which the majority of the Lenders have delivered to Agent their written consent to such resignation.&nbsp;&nbsp;Upon receipt of any such notice of resignation, the Lenders shall have the right, in consultation with Borrower, to appoint a successor, which shall be a financial institution with an office in the State of California, or an Affiliate of any such bank with an office in the State of California.&nbsp;&nbsp;If no such successor shall have been so appointed by the Lenders and shall have accepted such appointment within thirty (30) days after the retiring Agent has received the written consent of the majority of the Lenders to such resignation, then the retiring Agent may on behalf of Lenders, appoint a successor Agent meeting the qualifications set forth above; provided that in no event shall any such successor Agent be a Defaulting Lender and provided further that if the retiring Agent shall notify Borrower and Lenders that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and (1) the retiring Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents (except that in the case of any collateral security held by Agent on behalf of the Lenders under any of the Loan Documents, the retiring Agent shall continue to hold such collateral security until such time as a successor Agent is appointed and such collateral security is assigned to such successor Agent) and (2) all payments, communications and determinations provided to be made by, to or through Agent shall instead be made by or to each Lender directly, until such time as the Lenders appoint a successor Agent as provided for above in this Section 10.9.&nbsp;&nbsp;Upon the acceptance of a successor&#8217;s appointment as Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Agent, and the retiring Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section 10.9).&nbsp;&nbsp;The fees payable by Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between Borrower and such successor.&nbsp;&nbsp;After the retiring Agent&#8217;s resignation hereunder and under the other Loan Documents, the provisions of this Section 10 shall continue in effect for the benefit of such retiring Agent, its sub-agents and their respective Indemnified Persons in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting as Agent.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref116123417"></a>10.10<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Defaulting Lender.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Defaulting Lender Adjustments</font>.&nbsp;&nbsp;Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as such Lender is no longer a Defaulting Lender, to the extent permitted by applicable law:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:15.38%;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Waivers and Amendments</font>.&nbsp;&nbsp;Such Defaulting Lender&#8217;s right to approve or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as long as said Lender is a Defaulting Lender.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:15.38%;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU23"></a>(ii)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Defaulting Lender Waterfall</font>.&nbsp;&nbsp;Any payment of principal, interest, fees or other amounts received by the Agent for the account of such Defaulting Lender (whether voluntary or mandatory, at maturity, pursuant to Section&#160;8 or otherwise, and including any amounts made available to the Agent by such Defaulting Lender pursuant to Section&#160;13.10), shall be applied at such time or times as may be determined by the Agent as follows: <font style="text-decoration:underline;">first</font>, to the payment of any amounts owing by such Defaulting Lender to the Agent hereunder; <font style="text-decoration:underline;">second</font>, as Borrower may request (so long as no Event of Default exists), to the funding of any Term Loan Advance in respect of which such Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Agent; <font style="text-decoration:underline;">third</font>, if so determined by the Agent and Borrower, to be held in a Deposit Account and released pro rata to satisfy such Defaulting Lender&#8217;s potential future funding obligations with respect to Term Loan Advances under this Agreement; <font style="text-decoration:underline;">fourth</font>, so long as no Event of Default has occurred and is continuing, to the payment of any amounts owing to Borrower as a result of any judgment of a court of competent jurisdiction obtained by Borrower against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement; and <font style="text-decoration:underline;">fifth</font>, to such Defaulting Lender or as otherwise directed by a court of competent </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-22-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">jurisdiction; </font><font style="text-decoration:underline;">provided</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that if (A)&#160;such payment is a payment of the principal amount of any Term Loan Advances in respect of which such Defaulting Lender has not fully funded its appropriate share and (B)&#160;such Term Loan Advances were made at a time when the conditions set forth in Section&#160;3.1 were satisfied or waived, such payment shall be applied solely to pay the Term Loan Advance of all non-Defaulting Lenders on a </font><font style="font-style:italic;">pro rata</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> basis prior to being applied to the payment of any Term Loan Advances of such Defaulting Lender until such time as all Term Loan Advances are held by the Lenders pro rata in accordance with the Term Loan Commitments under this Agreement.&nbsp;&nbsp;Any payments, prepayments or other amounts paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender pursuant to this Section&#160;10.10(a)(ii) shall be deemed paid to and redirected by such Defaulting Lender, and each Lender irrevocably consents hereto.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:15.38%;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Certain Fees</font>.&nbsp;&nbsp;No Defaulting Lender shall be entitled to receive any fee pursuant to Section&#160;2.3(b) or Section 2.3(c) for any period during which such Lender is a Defaulting Lender (and Borrower shall not be required to pay any such fee that otherwise would have been required to have been paid to such Defaulting Lender).&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Defaulting Lender Cure</font>.&nbsp;&nbsp;If Borrower and Agent agree in writing that a Lender is no longer a Defaulting Lender, Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein, such Lender will, to the extent applicable, purchase at par that portion of outstanding Term Loan Advances of the other Lenders or take such other actions as Agent may determine to be necessary to cause the Term Loan Advances to be held on a <font style="font-style:italic;">pro rata</font> basis by the Lenders in accordance with their respective Term Loan Commitment Percentages, whereupon such Lender will cease to be a Defaulting Lender; <font style="text-decoration:underline;">provided</font> that no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of Borrower while such Lender was a Defaulting Lender; and <font style="text-decoration:underline;">provided</font> <font style="text-decoration:underline;">further</font> that, except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from such Lender having been a Defaulting Lender. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Termination of Defaulting Lender</font>.&nbsp;&nbsp;Borrower may terminate the unused amount of the Term Loan Commitment of any Lender that is a Defaulting Lender upon not less than ten (10) Business Days&#8217; prior notice to Agent (which shall promptly notify the Lenders thereof), and in such event the provisions of Section<font style="text-decoration:underline;"> </font>10.10(a)(ii) will apply to all amounts thereafter paid by Borrower for the account of such Defaulting Lender under this Agreement (whether on account of principal, interest, fees, indemnity or other amounts); <font style="text-decoration:underline;">provided</font> that (i)&#160;no Event of Default shall have occurred and be continuing, and (ii)&#160;such termination shall not be deemed to be a waiver or release of any claim Borrower, Agent or any Lender may have against such Defaulting Lender.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font>If the Person serving as Agent is a Defaulting Lender pursuant to clause (d) of the definition thereof, the non-Defaulting Lenders may, to the extent permitted by applicable law, by notice in writing to Borrower and such Person, remove such Person as Agent and, in consultation with Borrower, appoint a successor.&nbsp;&nbsp;If no such successor shall have been so appointed by the non-Defaulting Lenders and shall have accepted such appointment within thirty (30) days (or such earlier day as shall be agreed by the non-Defaulting Lenders) (the &#8220;<font style="font-weight:bold;">Removal Effective Date</font>&#8221;), then such removal shall nonetheless become effective in accordance with such notice on the Removal Effective Date.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">11</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">NOTICES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU24"></a>All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be in writing and shall be deemed to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission, when sent by electronic mail or facsimile transmission; (c) one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address, facsimile number, or email address indicated below. Agent or Borrower may </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-23-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">change its mailing or electronic mail address or facsimile number by giving the other party written notice thereof in accordance with the terms of this Section 11. </font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:15.38%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="_Hlk79075723"></a>&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:15.38%;width:64.62%;">
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to Borrower:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_536"></a>Taysha Gene Therapies, Inc.</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3000 Pegasus Park Drive, Suite 1430</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dallas, TX 75247</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_541"></a><a name="_cp_text_1_541"></a>Attn:  RA Session II, CEO</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Email:  rsession@tayshagtx.com</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With a copy (which</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_543"></a>shall not constitute</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_545"></a>notice) to:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_548"></a>Cooley LLP</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 Embarcadero Center, 20th Floor</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">San Francisco, CA 94111</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Telephone: (415) 693-2148</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_549"></a>Attn:  Gian-Michele a Marca</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Email:  gmamarca@cooley.com</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to Agent or SVB:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Silicon Valley Bank</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk79075676"></a>4370 La Jolla Village Drive, Suite 1050</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk79075683"></a>San Diego, CA 92122</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk79075691"></a><a name="_Hlk79075691"></a>Attn:&nbsp;&nbsp;Kristine Rohmer, Vice President</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk79075701"></a><a name="_Hlk79075701"></a>Email:&nbsp;&nbsp;krohmer@svb.com</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with a copy to:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_565"></a>DLA Piper LLP (US)</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk79075633"></a>401 B Street, Suite 1700</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_568"></a>San Diego, CA 92101</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_570"></a><a name="_cp_text_1_570"></a>Attn:  Laurie Hutchins</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk79075663"></a><a name="_Hlk79075663"></a>Email:  Laurie.Hutchins@us.dlapiper.com</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to SVB Capital:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SVB Innovation Credit Fund VIII, L.P.</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c/o SVB Capital</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2770 Sand Hill Road</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Menlo Park, CA 94025</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attn:  SVB Capital Finance and Operations</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Email:  svbcapitalcredit@svbank.com;</p></td>
</tr>
<tr>
<td valign="top"  style="width:18%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:61%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SVBCapCreditFinance@svb.com</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:15.38%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">Choice of Law, Venue AND Jury Trial Waiver AND JUDICIAL REFERENCE</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as otherwise expressly provided in any of the Loan Documents, California law governs the Loan Documents without regard to principles of conflicts of law.&nbsp;&nbsp;Except to the extent otherwise set forth in the Loan Documents, Borrower, Agent and Lenders each submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California; <font style="text-decoration:underline;">provided</font>, <font style="text-decoration:underline;">however</font>, that nothing in this Agreement shall be deemed to operate to preclude Agent or Lenders from bringing suit or taking other legal action in any other jurisdiction to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of Agent or any Lender.&nbsp;&nbsp;Borrower expressly submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby waives any objection that it may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable relief as is deemed appropriate by such court.&nbsp;&nbsp;Borrower hereby waives personal service of the summons, complaints, and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in accordance with, Section 11 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower&#8217;s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-24</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU25"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER, AGENT AND EACH LENDER EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR ALL PARTIES TO ENTER INTO THIS AGREEMENT.&nbsp;&nbsp;EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL</font><font style="font-weight:normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES&#8217; AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature between them arising at any time shall be decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara County, California Superior Court) appointed in accordance with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in Santa Clara County, California; and the parties hereby submit to the jurisdiction of such court.&nbsp;&nbsp;The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure Sections 638 through 645.1, inclusive.&nbsp;&nbsp;The private judge shall have the power, among others, to grant provisional relief, including without limitation, entering temporary restraining orders, issuing preliminary and permanent injunctions and appointing receivers.&nbsp;&nbsp;All such proceedings shall be closed to the public and confidential and all records relating thereto shall be permanently sealed.&nbsp;&nbsp;If during the course of any dispute, a party desires to seek provisional relief, but a judge has not been appointed at that point pursuant to the judicial reference procedures, then such party may apply to the Santa Clara County, California Superior Court for such relief.&nbsp;&nbsp;The proceeding before the private judge shall be conducted in the same manner as it would be before a court under the rules of evidence applicable to judicial proceedings.&nbsp;&nbsp;The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under the rules of discovery applicable to judicial proceedings.&nbsp;&nbsp;The private judge shall oversee discovery and may enforce all discovery rules and orders applicable to judicial proceedings in the same manner as a trial court judge.&nbsp;&nbsp;The parties agree that the selected or appointed private judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to California Code of Civil Procedure Section 644(a).&nbsp;&nbsp;Nothing in this paragraph shall limit the right of any party at any time to exercise self-help remedies, foreclose against collateral, or obtain provisional remedies.&nbsp;&nbsp;The private judge shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Section 12 shall survive the termination of this Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">GENERAL PROVISIONS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_583"></a><a name="_cp_text_1_584"></a><a name="_cp_text_1_585"></a><a name="_cp_text_1_586"></a><a name="_cp_text_1_587"></a><a name="_cp_text_4_588"></a><a name="_cp_text_1_589"></a>13.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;"><a name="_cp_text_1_583"></a>Termination Prior to Term Loan Maturity Date; Survival</font><font style="font-family:Times New Roman;font-weight:normal;"><a name="_cp_text_1_584"></a>.&nbsp;&nbsp;All covenants, representations and warranties made in this Agreement shall <a name="_cp_text_1_585"></a>continue in full force until this Agreement has terminated pursuant to its terms and all Obligations have been satisfied.&nbsp;&nbsp;So long as Borrower has satisfied the Obligations (other than inchoate indemnity obligations, and <a name="_cp_text_1_586"></a>any other obligations which, by their terms, are to survive the termination of this Agreement, and any Obligations under Bank Services Agreements that are cash collateralized in accordance with Section 4.1 of this Agreement), this Agreement may be terminated prior to the Term Loan <a name="_cp_text_1_587"></a>Maturity Date by Borrower<a name="_cp_text_4_588"></a> pursuant <a name="_cp_text_1_589"></a>to the terms and conditions set forth in Section 2.1.1(d), effective three (3) Business Days after written notice of termination is given to Agent.&nbsp;&nbsp;Those obligations that are expressly specified in this Agreement as surviving this Agreement&#8217;s termination shall continue to survive notwithstanding this Agreement&#8217;s termination.&nbsp;&nbsp;No termination of this Agreement shall in any way affect or impair any right or remedy of Agent or any Lender, nor shall any such termination relieve Borrower of any Obligation to any Lender, until all of the Obligations have been paid and performed in full. Those Obligations that are expressly specified in this Agreement as surviving this Agreement&#8217;s termination shall continue to survive notwithstanding this Agreement&#8217;s termination and payment in full of the Obligations then outstanding. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU26"></a>13.2<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Successors and Assigns</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;This Agreement binds and is for the benefit of the successors and permitted assigns of each party. Borrower may not assign this Agreement or any rights or obligations under it without Agent and Lenders&#8217; prior written consent (which may be granted or withheld in Agent&#8217;s and Lenders&#8217; sole discretion). Agent and each Lender has the right, without the consent of or notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, such Lender&#8217;s obligations, rights, and benefits under this Agreement and the other Loan Documents (other than the Warrant, as to which assignment, transfer and other such </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-25-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-weight:normal;">actions are governed by the terms thereof).</font><font style="font-family:Times New Roman;font-weight:normal;">&nbsp;&nbsp;Notwithstanding the foregoing, so long as no Event of Default has occurred, no Lender shall assign its interest in the Loan Documents to any Person who, in the reasonable estimation of the Lenders, if (a) a direct competitor or Borrower, or (b) a vulture fund or distressed debt fund. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.3<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Indemnification</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Borrower agrees to indemnify, defend and hold Agent, each Lender and their respective directors, officers, employees, agents, attorneys, or any other Person affiliated with or representing Agent or any Lender (each, an &#8220;</font><font style="font-family:Times New Roman;">Indemnified Person</font><font style="font-family:Times New Roman;font-weight:normal;">&#8221;) harmless against: (i) all obligations, demands, claims, and liabilities (collectively, &#8220;</font><font style="font-family:Times New Roman;">Claims</font><font style="font-family:Times New Roman;font-weight:normal;">&#8221;) claimed or asserted by any other party in connection with the transactions contemplated by the Loan Documents; and (ii) all losses or expenses (including Lenders&#8217; Expenses) in any way suffered, incurred, or paid by such Indemnified Person as a result of, following from, consequential to, or arising from transactions between Agent, Lenders and Borrower (including&nbsp;&nbsp;reasonable attorneys&#8217; fees and expenses),&nbsp;&nbsp;except for Claims and/or losses directly caused by such Indemnified Person&#8217;s gross negligence or willful misconduct.&nbsp;&nbsp;This Section 13.3 shall survive until all statutes of limitation with respect to the Claims, losses, and expenses for which indemnity is given shall have run.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.4<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Time of Essence</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Time is of the essence for the performance of all Obligations in this Agreement.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.5<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Severability of Provisions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.6<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Correction of Loan Documents</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent may correct patent errors and fill in any blanks in the Loan Documents consistent with the agreement of the parties.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.7<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Amendments in Writing; Waiver; Integration</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;No purported amendment or modification of any Loan Document, or waiver, discharge or termination of any obligation under any Loan Document, or release, or subordinate Lenders&#8217; security interest in, or consent to the transfer of, any Collateral shall be enforceable or admissible unless, and only to the extent, expressly set forth in a writing signed by Agent, with the consent of the Lenders in accordance with the Lender Intercreditor Agreement or, if such item is not addressed in the Lender Intercreditor Agreement, as consented to by a majority of the Lenders, and Borrower.&nbsp;&nbsp;Without limiting the generality of the foregoing, no oral promise or statement, nor any action, inaction, delay, failure to require performance or course of conduct shall operate as, or evidence, an amendment, supplement or waiver or have any other effect on any Loan Document.&nbsp;&nbsp;Any waiver granted shall be limited to the specific circumstance expressly described in it, and shall not apply to any subsequent or other circumstance, whether similar or dissimilar, or give rise to, or evidence, any obligation or commitment to grant any further waiver.&nbsp;&nbsp;The Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements.&nbsp;&nbsp;All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of the Loan Documents merge into the Loan Documents.&nbsp;&nbsp;In the event any provision of any other Loan Document is inconsistent with the provisions of this Agreement, the provisions of this Agreement shall exclusively control.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.8<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Counterparts</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU27"></a>13.9<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Confidentiality</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Agent and each Lender agrees to maintain the confidentiality of Information (as defined below), except that Information may be disclosed (a) to Agent and/or any Lender&#8217;s subsidiaries or Affiliates, and their respective employees, directors, investors, potential investors, agents, attorneys, accountants and other professional advisors (collectively, &#8220;</font><font style="font-family:Times New Roman;">Representatives</font><font style="font-family:Times New Roman;font-weight:normal;">&#8221; and, together with Agent and the Lenders, collectively, &#8220;</font><font style="font-family:Times New Roman;">Lender Entities</font><font style="font-family:Times New Roman;font-weight:normal;">&#8221;); (b) to prospective transferees, assignees, credit providers or purchasers of any of Agent&#8217;s or Lenders&#8217; interests under or in connection with this Agreement and their Representatives (provided, however, Agent and the Lenders shall use their best efforts to obtain any such prospective transferee&#8217;s, assignee&#8217;s, credit provider&#8217;s, or purchaser&#8217;s or their Representatives&#8217; agreement to the terms of this provision); (c)&#160;as required by law, regulation, subpoena, or other order; (d)&#160;to Agent&#8217;s or any Lender&#8217;s regulators or as otherwise required in connection with Agent&#8217;s or any Lender&#8217;s examination or audit; (e)&#160;as Agent or any Lender considers appropriate in exercising remedies under the Loan Documents; and (f) to third-party service providers of Agent and/or any Lender so long as such service providers have executed a confidentiality agreement with Agent or the Lenders, as applicable, with terms no less restrictive than those contained herein.&#160; The term &#8220;</font><font style="font-family:Times New Roman;">Information</font><font style="font-family:Times New Roman;font-weight:normal;">&#8221; means all information received from Borrower regarding Borrower or its </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-26-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-weight:normal;">business, in each case other than information that is either: (i)&#160;in the public domain or in Agent&#8217;s or any Lender&#8217;s possession when disclosed to Agent or such Lender, or becomes part of the public domain (other than as a result of its disclosure by Agent or a Lender in violation of this Agreement) after disclosure to Agent and/or the Lenders; or (ii)&#160;disclosed to Agent and/or a Lender by a third party, if Agent or such Lender, as applicable, does not know that the third party is prohibited from disclosing the information.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_591"></a>Lender Entities may use anonymous forms of confidential information for aggregate datasets, for analyses or reporting, and for any other uses not expressly prohibited in writing by Borrower. The provisions of the immediately preceding sentence shall survive termination of this Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.10<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Attorneys&#8217; Fees, Costs and Expenses.</font><font style="font-family:Times New Roman;font-weight:normal;">&nbsp;&nbsp;In any action or proceeding among Borrower, Lender, and/or Agent arising out of or relating to the Loan Documents, the prevailing party shall be entitled to recover its reasonable attorneys&#8217; fees and other costs and expenses incurred, in addition to any other relief to which it may be entitled.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.11<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Right of Setoff</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp; Borrower hereby grants to Agent, for the ratable benefit of the Lenders, a Lien, security interest, and a right of setoff as security for all Obligations to Agent and the Lenders, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Agent or any entity under the control of Agent (including a subsidiary of Agent) or in transit to any of them.&nbsp;&nbsp;At any time after the occurrence and during the continuance of an Event of Default, without demand or notice, Agent or any Lender may setoff the same or any part thereof and apply the same to any Obligation of Borrower then due regardless of the adequacy of any other collateral securing the Obligations.&nbsp;&nbsp;ANY AND ALL RIGHTS TO REQUIRE AGENT OR ANY LENDER TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER, ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.12<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Electronic Execution of Documents</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature&#8221; and words of like import in any Loan Document shall be deemed to include electronic signatures, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.13<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Captions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;The headings used in this Agreement are for convenience only and shall not affect the interpretation of this Agreement.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.14<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Construction of Agreement</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;The parties mutually acknowledge that they and their attorneys have participated in the preparation and negotiation of this Agreement.&nbsp;&nbsp;In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty to exist.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.15<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Relationship</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement.&nbsp;&nbsp;The parties do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those of parties to an arm&#8217;s-length contract.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.16<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Third Parties</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Nothing in this Agreement, whether express or implied, is intended to: (a)&#160;confer any benefits, rights or remedies under or by reason of this Agreement on any persons other than the express parties to it and their respective permitted successors and assigns; (b) relieve or discharge the obligation or liability of any person not an express party to this Agreement; or (c) give any person not an express party to this Agreement any right of subrogation or action against any party to this Agreement.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.17<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Patriot Act</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;Each Lender hereby notifies Borrower that pursuant to the requirements of the USA PATRIOT Act, it is required to obtain, verify and record information that identifies Borrower and each of its Subsidiaries, which information includes the names and addresses of Borrower and each of its Subsidiaries and other information that will allow Lender, as applicable, to identify Borrower and each of its Subsidiaries in accordance with the USA PATRIOT Act.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-27</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU28"></a><font style="text-decoration:none;">14</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="font-family:Times New Roman;text-decoration:underline;text-transform:uppercase;">DEFINITIONS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">14.1<font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;">Definitions</font><font style="font-family:Times New Roman;font-weight:normal;">.&nbsp;&nbsp;As used in the Loan Documents, the word &#8220;shall&#8221; is mandatory, the word &#8220;may&#8221; is permissive, the word &#8220;or&#8221; is not exclusive, the words &#8220;includes&#8221; and &#8220;including&#8221; are not limiting, the singular includes the plural, and numbers denoting amounts that are set off in brackets are negative.&nbsp;&nbsp;As used in this Agreement, the following capitalized terms have the following meanings:</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Account</font>&#8221; is any &#8220;account&#8221; as defined in the Code with such additions to such term as may hereafter be made, and includes, without limitation, all accounts receivable and other sums owing to Borrower.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Account Debtor</font>&#8221; is any &#8220;account debtor&#8221; as defined in the Code with such additions to such term as may hereafter be made.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Affiliate</font>&#8221; is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any Person that controls or is controlled by or is under common control with the Person, and each of that Person&#8217;s senior executive officers, directors, partners and, for any Person that is a limited liability company, that Person&#8217;s managers and members.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Agent</font>&#8221; is defined in the preamble hereof. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Agreement</font>&#8221; is defined in the preamble hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Authorized Signer</font>&#8221; is any individual listed in Borrower&#8217;s Borrowing Resolution who is authorized to execute the Loan Documents, including any Credit Extension request, on behalf of Borrower.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Bank Services</font>&#8221;&#160; are any products, credit services, and/or financial accommodations previously, now, or hereafter provided to Borrower or any of its Subsidiaries by SVB or any SVB Affiliate, including, without limitation, any Letters of Credit, cash management services (including, without limitation, merchant services, direct deposit of payroll, business credit cards, and check cashing services), interest rate swap arrangements, and foreign exchange services as any such products or services may be identified in SVB&#8217;s various agreements related thereto (each, a &#8220;<font style="font-weight:bold;">Bank Services Agreement</font>&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Bank Services Agreement</font>&#8221; is defined in the definition of Bank Services.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Board</font>&#8221; means Borrower&#8217;s board of directors.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Borrower</font>&#8221; is defined in the preamble hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Borrower&#8217;s Books</font>&#8221; are all Borrower&#8217;s books and records including ledgers, federal and state tax returns, records regarding Borrower&#8217;s assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment containing such information.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Borrowing Resolutions</font>&#8221; are, with respect to any Person, those resolutions adopted by such Person&#8217;s board of directors (and, if required under the terms of such Person&#8217;s Operating Documents, stockholders) and delivered by such Person to Agent approving the Loan Documents to which such Person is a party and the transactions contemplated thereby, together with a certificate executed by its secretary on behalf of such Person certifying (a)&#160;such Person has the authority to execute, deliver, and perform its obligations under each of the Loan Documents to which it is a party, (b)&#160;that set forth as a part of or attached as an exhibit to such certificate is a true, correct, and complete copy of the resolutions then in full force and effect authorizing and ratifying the execution, delivery, and performance by such Person of the Loan Documents to which it is a party, (c) the name(s) of the Person(s) authorized to execute the Loan Documents, including any Credit Extension request, on behalf of such Person, together with a sample of the true signature(s) of such Person(s), and (d)&#160;that Agent and Lenders may conclusively rely on such certificate unless and until such Person shall have delivered to Agent and Lenders a further certificate canceling or amending such prior certificate.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-28</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU29"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;">Business Day</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; is any day that is not a Saturday, Sunday or a day on which Agent is closed.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Cash Equivalents</font>&#8221; <font style="color:#000000;">means (a)&#160;</font>marketable direct obligations issued or unconditionally guaranteed by the United States or any agency or any State thereof having maturities of not more than one (1) year from the date of acquisition; (b)&#160;commercial paper maturing no more than one (1) year after its creation and having the highest rating from either Standard &amp; Poor&#8217;s Ratings Group or Moody&#8217;s Investors Service, Inc.; (c) SVB&#8217;s certificates of deposit issued maturing no more than one (1) year after issue; (d) money market funds at least ninety-five percent (95%) of the assets of which constitute Cash Equivalents of the kinds described in clauses (a) through (c) of this definition, and (e) other highly liquid investments consistent with Borrower&#8217;s investment policy as in effect on the Effective Date.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_614"></a>&#8220;<font style="font-weight:bold;">Change in Control</font>&#8221; means (a) at any time, any &#8220;person&#8221; or &#8220;group&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act), shall become, or obtain rights (whether by means of warrants, options or otherwise) to become, the &#8220;beneficial owner&#8221; (as defined in Rules 13(d)-3 and 13(d)<a name="_cp_text_1_614"></a>&#8209;5 under the Exchange Act), directly or indirectly, of forty-nine percent (49%) or more of the ordinary voting power for the election of directors of Borrower (determined on a fully diluted basis) other than by the sale of Borrower&#8217;s equity securities in a public offering or to venture capital or private equity investors so long as Borrower identifies to the Agent and the Lenders the venture capital or private equity investors at least seven (7) Business Days prior to the closing of the transaction and provides to Agent and the Lenders a description of the material terms of the transaction; (b) during any period of twelve (12)<font style="font-style:italic;"> </font>consecutive months, a majority of the members of the board of directors or other equivalent governing body of Borrower cease to be composed of individuals (i)&#160;who were members of that board or equivalent governing body on the first day of such period, (ii)&#160;whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i)&#160;above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii)&#160;whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i)&#160;and (ii)&#160;above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body; or (c)&#160;except as permitted by Section 7.3, at any time, Borrower shall cease to own and control, of record and beneficially, directly or indirectly, one hundred percent (100%) of each class of outstanding capital stock of each Subsidiary of Borrower (other than, with respect to Foreign Subsidiaries, nominal qualifying directors shares where required by law) free and clear of all Liens (except Liens created by this Agreement).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Claims</font>&#8221; is defined in Section 13.3.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Clinical Stage Program</font>&#8221; means (a) a Clinical Trial Application (in Canada, the European Union, the United Kingdom, Japan, Australia or Israel) and/or Investigational New Drug Application (U.S.) has been accepted by the relevant Governmental Authority, (b) the asset is in phase 1, phase 2, or phase 3 clinical trials, or (c) a &#8221;Biologics License Application&#8221; seeking permission to introduce, or deliver for introduction, a biologic product into interstate commerce has been submitted to the United States Food and Drug Administration. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Code</font>&#8221; is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of California; <font style="text-decoration:underline;">provided</font>, <font style="text-decoration:underline;">that</font>, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern; <font style="text-decoration:underline;">provided</font> <font style="text-decoration:underline;">further</font>, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies with respect to, Agent&#8217;s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the State of California, the term &#8220;<font style="font-weight:bold;">Code</font>&#8221; shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions relating to such provisions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Collateral</font>&#8221; is any and all properties, rights and assets of Borrower described on <font style="text-decoration:underline;">Exhibit A</font>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Collateral Account</font>&#8221; is any Deposit Account, Securities Account, or Commodity Account.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Commitment</font>&#8221; and &#8220;<font style="font-weight:bold;">Commitments</font>&#8221; means the Term Loan Commitment(s).</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-29</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU30"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;">Commodity Account</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; is any &#8220;commodity account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_623"></a><a name="_cp_text_4_624"></a><a name="_cp_text_1_625"></a>&#8220;<font style="font-weight:bold;">Compliance Statement</font><a name="_cp_text_4_624"></a>&#8221; is that certain statement in the form attached hereto as <font style="text-decoration:underline;"><a name="_cp_text_1_625"></a>Exhibit B</font>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Contingent Obligation</font>&#8221; is, for any Person, any direct or indirect liability, contingent or not, of that Person for (a) any indebtedness, lease, dividend, letter of credit or other obligation of another such as an obligation, in each case, directly or indirectly guaranteed, endorsed, co&#8209;made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable; (b) any obligations for undrawn Letters of Credit for the account of that Person; and (c) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices; but &#8220;Contingent Obligation&#8221; does not include endorsements in the ordinary course of business.&nbsp;&nbsp;The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Control Agreement</font>&#8221; is any control agreement entered into among the depository institution at which Borrower maintains a Deposit Account or the securities intermediary or commodity intermediary at which Borrower maintains a Securities Account or a Commodity Account, Borrower, and Agent pursuant to which Agent obtains control (within the meaning of the Code) for the benefit of the Lenders over such Deposit Account, Securities Account, or Commodity Account.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Copyrights</font>&#8221; are any and all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Credit Extension</font>&#8221; is any Term Loan Advance, or any other extension of credit by any Lender for Borrower&#8217;s benefit.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;color:#000000;">Default Rate</font><font style="color:#000000;">&#8221; is defined in Section 2.2(b).</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU31"></a>&#8220;<font style="font-weight:bold;">Defaulting Lender</font>&#8221; is, subject to Section 10.10(b), any Lender that (a) has failed to (i) fund all or any portion of its Term Loan Advances within two (2) Business Days of the date such Term Loan Advances were required to be funded hereunder unless such Lender notifies Agent and Borrower in writing that such failure is the result of such Lender&#8217;s reasonable determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, or (ii) pay to Agent or any other Lender any other amount required to be paid by it hereunder within two (2) Business Days of the date when due, (b) has notified Borrower or Agent in writing that it does not intend to comply with its funding obligations hereunder, or has made a public statement to that effect (unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Term Loan Advance hereunder and states that such position is based on such Lender&#8217;s reasonable determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has failed, within three (3) Business Days after written request by Agent or Borrower, to confirm in writing to Agent and Borrower that it will comply with its prospective funding obligations hereunder (<font style="text-decoration:underline;">provided</font> that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation by Agent and Borrower), or (d) has, or has a direct or indirect parent company that has, (i) become the subject of an Insolvency Proceeding, or (ii) had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity; <font style="text-decoration:underline;">provided</font> that a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any equity interest in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender.&nbsp;&nbsp;Any determination by Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-30-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">through (d) above shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting Lender (subject to Section 10.10(b)) upon delivery of written notice of such determination to Borrower and each Lender.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Deposit Account</font>&#8221; is any &#8220;deposit account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_628"></a>&#8220;<font style="font-weight:bold;">Designated Deposit Account</font><a name="_cp_text_1_628"></a>&#8221; is the multicurrency account denominated in Dollars, account number xxxxxxx3564, maintained by Borrower with SVB.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_633"></a>&#8220;<font style="font-weight:bold;">Disbursement Letter</font><a name="_cp_text_1_633"></a>&#8221; is that certain form attached hereto as Exhibit D. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Division</font>&#8221; means, in reference to any Person which is an entity, the division of such Person into two (2) or more separate Persons, with the dividing Person either continuing or terminating its existence as part of such division, including, without limitation, as contemplated under Section 18 217 of the Delaware Limited Liability Company Act for limited liability companies formed under Delaware law, or any analogous action taken pursuant to any other applicable law with respect to any corporation, limited liability company, partnership or other entity.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Dollar Equivalent</font>&#8221; is, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in a Foreign Currency, the equivalent amount therefor in Dollars as determined by Agent at such time on the basis of the then-prevailing rate of exchange in San Francisco, California, for sales of the Foreign Currency for transfer to the country issuing such Foreign Currency.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_4_638"></a>&#8220;<font style="font-weight:bold;">Dollars</font><font style="font-style:italic;">,</font>&#8221;<font style="font-style:italic;"> </font>&#8220;<font style="font-weight:bold;">dollars</font>&#8221; or use of the sign &#8220;<font style="font-weight:bold;">$</font>&#8221; means only lawful money of the United States and not any other currency, regardless of whether that currency uses the &#8220;$&#8221; sign to denote its currency or may be readily converted into lawful money of the United States.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Domestic Subsidiary</font>&#8221; means a Subsidiary organized under the laws of the United States or any state or territory thereof or the District of Columbia. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Draw Condition</font>&#8221; means Borrower has provided the Lenders with evidence, satisfactory to the Lenders in their sole discretion, confirming that Borrower has at least three (3) distinct and active Clinical Stage Programs. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;color:#000000;">Effective Date</font><font style="color:#000000;">&#8221; is defined in the preamble hereof.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Equipment</font>&#8221; is all &#8220;equipment&#8221; as defined in the Code with such additions to such term as may hereafter be made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">ERISA</font>&#8221; is the Employee Retirement Income Security Act of 1974, and its regulations.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Event of Default</font>&#8221; is defined in Section 8.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Exchange Act</font>&#8221; is the Securities Exchange Act of 1934, as amended.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU32"></a>&#8220;<font style="font-weight:bold;">Excluded Taxes</font>&#8221; means any of the following taxes imposed on or with respect to Agent or the Lenders or required to be withheld or deducted from a payment to Agent or the Lenders, (a) taxes imposed on or measured by net income (however denominated), franchise taxes, and branch profits taxes, (b) taxes imposed as a result of a present or former connection between Agent or any Lender (as applicable) and the jurisdiction imposing such tax (other than connections arising from Agent/the applicable Lender having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document), and (c) U.S. federal withholding taxes imposed on amounts payable to or for the account of Agent/the applicable Lender or its successor or assign with respect to an applicable interest in a Term Loan Advance pursuant to a law in effect on the date on which Agent/the applicable Lender or such successor or assign, as applicable, (i) acquires such interest in the Term Loan Advance or (ii) changes its lending </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-31-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">office, except in each case to the extent that amounts with respect to such taxes were payable either to such predecessor or assignor immediately before such successor or assign became a party hereto or to </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agent/the applicable Lender</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or such successor or assign immediately before it changed its lending office. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Federal Funds Effective Rate</font>&#8221; means, for any day, the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day of such transactions received by SVB from three federal funds brokers of recognized standing selected by it.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_670"></a><a name="_cp_text_4_671"></a><a name="_cp_text_4_672"></a>&#8220;<font style="font-weight:bold;">Financial Statement Repository</font>&#8221; is (a) SWLSReporting@svb.com, and (b<a name="_cp_text_4_671"></a>) any such other means of collecting information approved and designated by Agent or a Lender after providing notice thereof to Borrower <a name="_cp_text_4_672"></a>from time to time.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_677"></a><a name="_cp_text_1_679"></a><a name="_cp_text_1_681"></a><a name="_cp_text_1_682"></a><a name="_cp_text_1_683"></a><a name="_cp_text_4_684"></a><a name="_cp_text_1_685"></a>&#8220;<font style="font-weight:bold;">Final Payment</font><a name="_cp_text_1_677"></a>&#8221; is a payment (in addition to and not in substitution for the regular monthly payments of principal plus accrued interest) due on the earliest to occur of (a) the Term Loan Maturity Date, (b) the payment in full of the <a name="_cp_text_1_679"></a>Term Loan Advances<a name="_cp_text_1_681"></a>, (c) as required by Section 2.1.1(d) or 2.1.1(e), <a name="_cp_text_1_682"></a>(d) acceleration of the Term Loan Advances after an Event of Default has occurred and is continuing, or (e) <a name="_cp_text_1_683"></a>the termination of this Agreement<a name="_cp_text_4_684"></a>, and equal to the aggregate original principal amount of the Term Loan Advances made <a name="_cp_text_1_685"></a>by the Lenders to Borrower <font style="font-style:italic;">multiplied by</font> seven and one half percentage points (7.50%).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Foreign Currency</font>&#8221; means lawful money of a country other than the United States.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Foreign Subsidiary</font>&#8221; means any Subsidiary which is not a Domestic Subsidiary. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Funding Date</font>&#8221; is any date on which a Credit Extension is made to or for the account of Borrower which shall be a Business Day.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">FX Contract</font>&#8221; is any foreign exchange contract by and between Borrower and SVB under which Borrower commits to purchase from or sell to SVB a specific amount of Foreign Currency on a specified date.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">GAAP</font>&#8221; is generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other Person as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination without giving effect to Accounting Standards Codification 842, Leases (or any other Accounting Standards Codification having similar result or effect) (and related interpretations) to the extent any lease (or similar arrangement) would be required to be treated as a capital lease thereunder where such lease (or arrangement) would have been treated as an operating lease prior to the effectiveness of such Accounting Standards Codification.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">General Intangibles</font>&#8221; is all &#8220;general intangibles&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation, all Intellectual Property, claims, income and other tax refunds, security and other deposits, payment intangibles, contract rights, options to purchase or sell real or personal property, rights in all litigation presently or hereafter pending (whether in contract, tort or otherwise), insurance policies (including without limitation key man, property damage, and business interruption insurance), payments of insurance and rights to payment of any kind.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_C1286"></a>&#8220;<font style="font-weight:bold;">Governmental Approval</font>&#8221; is any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority, including, without limitation, Healthcare Permits.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_C1287"></a><a name="_AEIOULastRenderedPageBreakAEIOU33"></a>&#8220;<font style="font-weight:bold;">Governmental Authority</font>&#8221; is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-32-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any self-regulatory organization</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Group Member</font>&#8221; means Borrower and its Subsidiaries.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Guarantor</font>&#8221; is any Person providing a Guaranty in favor of Lenders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Guaranty</font>&#8221; is any guarantee of all or any part of the Obligations, as the same may from time to time be amended, restated, modified or otherwise supplemented.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Healthcare Laws</font>&#8221; means all applicable laws relating to the operation or management of hospitalist practices, the provision of hospitalist services, proper billing and collection practices relating to the payment for healthcare services, insurance law (including law related to payment for &#8220;no-fault&#8221; claims) and workers compensation law as they relate to the provision of, and billing and payment for, healthcare services, patient healthcare, patient healthcare information, patient abuse, the quality and adequacy of rehabilitative care, rate setting, equipment, personnel, operating policies, fee splitting, including, without limitation, (a) all federal and state fraud and abuse laws, including, without limitation, the federal Anti-Kickback Statute (42 U.S.C. &#167;1320a-7b(b)), the Stark Law (42 U.S.C. &#167;1395nn), the civil False Claims Act (31 U.S.C. &#167;3729 et seq.), the administrative False Claims Law (42 U.S.C. &#167; 1320a-7b(a)), the Anti-Inducement Law (42 U.S.C. &#167; 1320a-7a(a)(5)), the exclusion laws (42 U.S.C. &#167; 1320a-7); (b) the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009; (c) the Medicare Regulations and the Medicaid Program (Title XIX of the Social Security Act); (d) quality, safety and accreditation standards and requirements of all applicable state laws or regulatory bodies; (e) all laws, policies, procedures, requirements and regulations pursuant to which Healthcare Permits are issued; (f) any laws, regulations or administrative guidance with respect to fee splitting by healthcare professionals and the corporate practice of medicine in any jurisdiction in which any Borrower or any Guarantor operates; and (g) any and all comparable state or local laws and other applicable health care laws, regulations, manual provisions, policies and administrative guidance, each of (a) through (g) as may be amended from time to time and the regulations promulgated pursuant to each such law.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Healthcare Permit</font>&#8221; means, with respect to any Person, a permit issued or required under Healthcare Laws applicable to the business of Borrower or any Guarantor, or necessary in the possession, ownership, warehousing, marketing, promoting, sale, labeling, furnishing, distribution or delivery of goods or services under Healthcare Laws applicable to the business of Borrower or any Guarantor.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">HIPAA</font>&#8221; means, collectively, the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic Clinical Health (HITECKH) Act and the implementing regulations thereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Indebtedness</font>&#8221; is (a) indebtedness for borrowed money or the deferred price of property or services, such as reimbursement and other obligations for surety bonds and Letters of Credit, (b) obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease obligations, and (d) Contingent Obligations.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Indemnified Person</font>&#8221; is defined in Section 13.3.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Information</font>&#8221; is defined in Section 13.9.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Initial</font> <font style="font-weight:bold;">Tranche A Term Loan Advance</font>&#8221; is defined in Section 2.1.1(a).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Insolvency Proceeding</font>&#8221; is any proceeding by or against any Person under the United States Bankruptcy Code, or any other bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, or other relief.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-33</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU34"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;">Intellectual Property</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means, with respect to any Person, all of such Person&#8217;s right, title, and interest in and to the following:</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>its Copyrights, Trademarks and Patents; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how and operating manuals;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>any and all source code;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font>any and all design rights which may be available to such Person;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:36pt;"></font>any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:36pt;"></font>all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Inventory</font>&#8221; is all &#8220;inventory&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is temporarily out of Borrower&#8217;s custody or possession or in transit and including any returned goods and any documents of title representing any of the above.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Investment</font>&#8221; is any beneficial ownership interest in any Person (including stock, partnership interest or other securities), and any loan, advance or capital contribution to any Person.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_696"></a>&#8220;<font style="font-weight:bold;">Key Person</font><a name="_cp_text_1_696"></a>&#8221; is Borrower&#8217;s Chief Executive Officer, who is RA Session II as of the Effective Date.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Lender</font>&#8221; and &#8220;<font style="font-weight:bold;">Lenders</font>&#8221; is defined in the preamble.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Lender Entities</font>&#8221; is defined in Section 13.9. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Lender Intercreditor Agreement</font>&#8221; is, collectively, any and all intercreditor agreement, master arrangement agreement or similar agreement by and between SVB Capital and SVB, as each may be amended from time to time in accordance with the provisions thereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Lenders&#8217; Expenses</font>&#8221; are all of Agent&#8217;s and the Lenders&#8217; audit fees and expenses, costs, and expenses (including reasonable and documented out-of-pocket attorneys&#8217; fees and expenses) for preparing, amending, negotiating, administering, defending and enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred with respect to Borrower.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Letter of Credit</font>&#8221; is a standby or commercial letter of credit issued by SVB upon request of Borrower based upon an application, guarantee, indemnity, or similar agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Lien</font>&#8221; is a claim, mortgage, deed of trust, levy, charge, pledge, security interest or other encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_705"></a><a name="_cp_text_1_706"></a>&#8220;<font style="font-weight:bold;">Loan Documents</font>&#8221; are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, the Perfection Certificate, each Disbursement Letter, the Lender Intercreditor Agreement, any Bank Services Agreement, any Control Agreement, any pledge agreement,<a name="_cp_text_1_705"></a> any subordination agreement, any note, or notes or guaranties executed by Borrower or any Guarantor<a name="_cp_text_1_706"></a>, and any other present or future agreement by Borrower or any Guarantor with or for the benefit of Agent and the Lenders in connection with this Agreement or Bank Services, all as amended, restated, or otherwise modified.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-34</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU35"></a><a name="_cp_text_2_708"></a><a name="_cp_text_1_711"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;">Material Adverse Change</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_708"></a>&#8221; is: (a) a material impairment in the perfection or priority of Agent&#8217;s, for the ratable benefit of the Lenders, Lien in the Collateral or in the value of such Collateral; (b) a material adverse change in the business, operations, or condition </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(financial or otherwise) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of Borrower; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_711"></a>(c) a material impairment of the prospect of repayment of any portion of the Obligations</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Obligations</font>&#8221; are Borrower&#8217;s obligations to pay when due any debts, principal, interest, fees, Lenders&#8217; Expenses, the Final Payment, the Prepayment Premium, and other amounts Borrower owes Agent or any Lender now or later, whether under this Agreement, the other Loan Documents (other than the Warrant), or otherwise, including, without limitation, all obligations relating to Bank Services, if any, and including interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower assigned to Agent and/or the Lenders, and to perform Borrower&#8217;s duties under the Loan Documents (other than the Warrant).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Operating Documents</font>&#8221; are, for any Person, such Person&#8217;s formation documents, as certified by the Secretary of State (or equivalent agency) of such Person&#8217;s jurisdiction of organization on a date that is no earlier than thirty (30) days prior to the Effective Date, and, (a)&#160;if such Person is a corporation, its bylaws in current form, (b)&#160;if such Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c)&#160;if such Person is a partnership, its partnership agreement (or similar agreement), each of the foregoing with all current amendments or modifications thereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Patents</font>&#8221; means all patents, patent applications and like protections including without limitation improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of the same.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Payment/Advance Form</font>&#8221; is that certain form attached hereto as Exhibit C.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Payment Date</font>&#8221; is the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>) calendar day of each month.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Perfection Certificate</font>&#8221; is defined in Section 5.1.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Permitted Indebtedness</font>&#8221; is:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Borrower&#8217;s Indebtedness to Agent and the Lenders under this Agreement and the other Loan Documents;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Indebtedness existing on the Effective Date which is shown on the Perfection Certificate;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>Subordinated Debt;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font>unsecured Indebtedness to trade creditors incurred in the ordinary course of business; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:36pt;"></font>Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:36pt;"></font>Indebtedness secured by Liens permitted under clauses (a) and (c) of the definition of &#8220;Permitted Liens&#8221; hereunder; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_721"></a><a name="_cp_text_1_722"></a>(g)<font style="margin-left:36pt;"></font>Intercompany Indebtedness that qualifies as a Permitted Investment; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_726"></a><a name="_cp_blt_2_725"></a>(h)<font style="margin-left:36pt;"></font>Indebtedness incurred in connection with insurance premium financings in the ordinary course of business; provided that any Lien securing such Indebtedness is limited to the unearned premium of such insurance; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:36pt;"></font>other unsecured Indebtedness not otherwise permitted hereunder in an aggregate outstanding principal amount not to exceed Two Hundred Fifty Thousand Dollars ($250,000); </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-35</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU36"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indebtedness in resp</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ect </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of performance bonds, bid bonds, appeal bonds, surety bonds and similar obligations in an aggregate amount not to exceed One Hundred Thousand Dollars ($100,000) incurred in the ordinary course of business; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)<font style="margin-left:36pt;"></font>extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a) through (j) above; <font style="text-decoration:underline;">provided</font> <font style="text-decoration:underline;">that</font> the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or its Subsidiary, as the case may be.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Permitted Investments</font>&#8221; are:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Investments (including, without limitation, Subsidiaries) existing on the Effective Date which are shown on the Perfection Certificate; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_732"></a>(b)<font style="margin-left:36pt;"></font>Investments consisting of (i) <a name="_cp_text_1_732"></a>Cash Equivalents, and (ii) any Investments permitted by Borrower&#8217;s investment policy, as amended from time to time, provided that such investment policy (and any such amendment thereto) has been approved in advance, in writing, by Agent in its good faith business judgment; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_734"></a><a name="_cp_text_1_735"></a>(c)<font style="margin-left:36pt;"></font>Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of Borrower;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_736"></a><a name="_cp_text_1_737"></a>(d)<font style="margin-left:36pt;"></font>Investments consisting of deposit accounts in which Agent has a perfected security interest to the extent required by the terms of this Agreement (including, but not limited to Sections 3.1 and 6.6(b)); </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_738"></a><a name="_cp_text_1_739"></a>(e)<font style="margin-left:36pt;"></font>Investments accepted in connection with Transfers permitted by Section 7.1;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_740"></a><a name="_cp_text_1_741"></a>(f)<font style="margin-left:36pt;"></font>Investments (i) by Borrower in Subsidiaries to fund the ongoing day-to-day operations of such Subsidiaries in the ordinary course of business so long as such Investments are made on a cost-plus basis or otherwise in accordance with transfer pricing (or similar) arrangements approved in advance, in writing by the Lenders, provided that if the Lenders do not provide Borrower with any comments/objections to any specific cost-plus/transfer pricing agreement within ten (10) Business Day of receipt by the Lenders of a copy of the same from Borrower, the Lenders shall be deemed to consent to the applicable cost-plus or transfer pricing agreement, (ii) by Borrower or any Subsidiary that is a co-Borrower or Secured Guarantor hereunder in Borrower or any other Subsidiary that is a co-Borrower or secured Guarantor hereunder, (iii) by Borrower in Subsidiaries that are not co-Borrowers or secured Guarantors hereunder not to exceed Five Hundred Thousand Dollars ($500,000) in the aggregate in any fiscal year, and (iv) by Subsidiaries that are not co-Borrowers or secured Guarantors hereunder, in other Subsidiaries that are not co-Borrowers or secured Guarantors hereunder or in Borrower; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_742"></a><a name="_cp_text_1_743"></a>(g)<font style="margin-left:36pt;"></font>Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course of business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee stock purchase plans or agreements approved by the Board;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_744"></a><a name="_cp_text_1_745"></a>(h)<font style="margin-left:36pt;"></font>Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_746"></a><a name="_cp_text_1_747"></a>(i)<font style="margin-left:36pt;"></font>Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the ordinary course of business; provided that this paragraph (i) shall not apply to Investments of Borrower in any Subsidiary; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)<font style="margin-left:36pt;"></font>Investments consisting of deposits to secure the performance of bids, trade contracts, statutory obligations, surety and appeal bonds (other than bonds related to judgments or litigation) or performance bonds, in each case in the ordinary course of business; </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-36</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU37"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments in joint ventures or strategic alliances in the ordinary course of Borrower&#8217;s business consisting of the non-exclusive licensing of technology, the development of technology or the providing of technical support, or cash in an amount not to exceed Five Hundred Thousand Dollars ($500,000) in any fiscal year; a</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nd </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(l)<font style="margin-left:36pt;"></font>other Investments not otherwise prohibited by the terms of this Agreement in an aggregate amount not to exceed Five Hundred Thousand Dollars ($500,000) in each fiscal year. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Permitted Liens</font>&#8221; are:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Liens existing on the Effective Date which are shown on the Perfection Certificate or arising under this Agreement and the other Loan Documents;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Liens for taxes, fees, assessments or other government charges or levies, either (i) not due and payable or (ii) being contested in good faith and for which Borrower maintains adequate reserves on its Books, provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code of 1986, as amended, and the Treasury Regulations adopted thereunder;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>purchase money Liens (i) on Equipment acquired or held by Borrower incurred for financing the acquisition of the Equipment securing no more than Ten Million Dollars ($10,000,000) in the aggregate amount outstanding, or (ii) existing on Equipment when acquired, if the Lien is confined to the property and improvements and the proceeds of the Equipment; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_758"></a><a name="_cp_text_1_759"></a>(d)<font style="margin-left:36pt;"></font>Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising in the ordinary course of business so long as such Liens attach only to Inventory and which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_762"></a><a name="_cp_text_1_760"></a><a name="_cp_text_4_761"></a><a name="_cp_text_1_763"></a>(e)<font style="margin-left:36pt;"></font>L<a name="_cp_text_4_761"></a>iens to secure payment of workers&#8217; compensation, employment insurance, old-age pensions, social security and other like obligations incurred <a name="_cp_text_1_763"></a>in the ordinary course of business (other than Liens imposed by ERISA);</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_766"></a>(f)<font style="margin-left:36pt;"></font><a name="_cp_text_1_766"></a>Liens incurred in the extension, renewal or refinancing of the indebtedness secured by Liens described in (a) through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the indebtedness may not increase;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_772"></a><a name="_cp_text_1_768"></a><a name="_cp_text_4_769"></a><a name="_cp_text_1_770"></a><a name="_cp_text_4_771"></a><a name="_cp_text_1_773"></a>(g)<font style="margin-left:36pt;"></font>l<a name="_cp_text_4_769"></a>eases or subleases of real property granted <a name="_cp_text_1_770"></a>in the ordinary course of Borrower&#8217;s business <a name="_cp_text_4_771"></a>(or, if referring to another Person, in the ordinary course of such Person&#8217;s business), and leases, subleases, non-exclusive licenses or sublicenses of personal property (other than Intellectual Property) granted <a name="_cp_text_1_773"></a>in the ordinary course of Borrower&#8217;s business (or, if referring to another Person, in the ordinary course of such Person&#8217;s business), if the leases, subleases, licenses and sublicenses do not prohibit granting Agent a security interest therein;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_775"></a>(h)<font style="margin-left:36pt;"></font>of non-exclusive licenses for the use of the property of Borrower or its Subsidiaries in the ordinary course of business and licenses that could not result in a legal transfer of title f the licensed property but that may be exclusive in respects other than territory and that may be exclusive as to territory only as to discrete geographical areas outside of the United States; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_778"></a><a name="_cp_text_1_776"></a>(i)<font style="margin-left:36pt;"></font>Liens incurred to secure the performance of bids, trade contracts (other than for borrowed money), statutory obligations, surety and appeal bonds and performance bonds incurred in the ordinary course of business; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)<font style="margin-left:36pt;"></font>Liens on Borrower&#8217;s cash Collateral incurred in connection with security deposits posted to any of Borrower&#8217;s landlords to secure the performance of operating leases incurred in the ordinary course of business, but only if, after request by Borrower, any such landlord refuses to accept a letter of credit in lieu of any such cash security deposit; </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-37</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU38"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)</font><font style="margin-left:36pt;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liens on insurance policies and the proceeds thereof securing Indebtedness described in clause (h) of Permitted Indebtedness; </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_4_777"></a><a name="_cp_text_1_779"></a>(l)<font style="margin-left:36pt;"></font>L<a name="_cp_text_4_777"></a>iens arising from attachments or judgments, orders, or decrees in circumstances not constituting <a name="_cp_text_1_779"></a>an Event of Default under Sections 8.4 and 8.7; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_780"></a><a name="_cp_text_1_781"></a>(m)<font style="margin-left:36pt;"></font>without duplication with items (a) (l) above, Liens on up to Two Million Six Hundred Thousand Dollars ($2,600,000) of the cash Collateral to secure Borrower&#8217;s obligations under its lease for the real property located at 5 National Way, Durham, NC 27703; <a name="_cp_blt_1_780"></a><a name="_cp_text_1_781"></a>and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(n)<font style="margin-left:36pt;"></font>Liens in favor of other financial institutions arising in connection with Borrower&#8217;s or its Subsidiaries&#8217; deposit and/or securities accounts held at such institutions, provided that Agent has, to the extent required pursuant to this Agreement, including Section 6.6(b) hereof, for the benefit of the Lenders, a perfected security interest in the amounts held in such deposit and/or securities accounts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Person</font>&#8221; is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Prepayment Premium</font>&#8221; shall be an additional fee, payable to Agent, for the ratable benefit of the Lenders based on their Pro Rata Share, with respect to the Term Loan Advances, in an amount equal to:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_blt_1_788"></a><a name="_cp_blt_2_787"></a><a name="_cp_text_1_784"></a><a name="_cp_text_1_786"></a>(a)<font style="margin-left:36pt;"></font>for a prepayment of the Term Loan Advances made on or prior to the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup><a name="_cp_text_1_784"></a>) anniversary of the Effective Date, two <a name="_cp_text_1_786"></a>percent (2.00%) of the then outstanding principal amount of the Term Loan Advances immediately prior to the date of such prepayment; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_790"></a><a name="_cp_text_1_792"></a>(b)<font style="margin-left:36pt;"></font>for a prepayment of the Term Loan Advances made after the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>) anniversary of the Effective Date, but on or prior to the second (2<sup style="font-size:85%;line-height:120%;vertical-align:top">nd</sup><a name="_cp_text_1_790"></a>) anniversary of the Effective Date, one <a name="_cp_text_1_792"></a>percent (1.00%) of the then outstanding principal amount of the Term Loan Advances immediately prior to the date of such prepayment; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:15.38%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_794"></a><a name="_cp_text_1_796"></a>(c)<font style="margin-left:36pt;"></font>for a prepayment of the Term Loan Advances made after the second (2<sup style="font-size:85%;line-height:120%;vertical-align:top">nd</sup><a name="_cp_text_1_794"></a>) anniversary of the Effective Date, but prior to the Term Loan Maturity Date, zero <a name="_cp_text_1_796"></a>percent (0%) of the then outstanding principal amount of the Term Loan Advances immediately prior to the date of such prepayment.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Prime Rate</font>&#8221; is the rate of interest per annum from time to time published in the money rates section of The Wall Street Journal or any successor publication thereto as the &#8220;prime rate&#8221; then in effect; <font style="text-decoration:underline;">provided</font> <font style="text-decoration:underline;">that</font>, in the event such rate of interest is less than zero, such rate shall be deemed to be zero for purposes of this Agreement; and <font style="text-decoration:underline;">provided</font> <font style="text-decoration:underline;">further</font> that if such rate of interest, as set forth from time to time in the money rates section of The Wall Street Journal, becomes unavailable for any reason as determined by Agent, the &#8220;Prime Rate&#8221; shall mean the rate of interest per annum announced by SVB as its prime rate in effect at its principal office in the State of California (such SVB announced Prime Rate not being intended to be the lowest rate of interest charged by SVB in connection with extensions of credit to debtors); provided that, in the event such rate of interest is less than zero, such rate shall be deemed to be zero for purposes of this Agreement.</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Pro Rata Share</font>&#8221; is, as of any date of determination,, with respect to each Lender, a percentage (expressed as a decimal, rounded to the ninth decimal place) determined by <font style="font-style:italic;">dividing</font> the outstanding principal amount of Term Loan Advances held by such Lender <font style="font-style:italic;">by</font> the aggregate outstanding principal amount of all Term Loan Advances.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_797"></a><a name="_cp_text_4_798"></a><a name="_cp_text_4_799"></a>&#8220;<font style="font-weight:bold;"><a name="_cp_text_4_798"></a>Quarterly Financial Statements</font><a name="_cp_text_4_799"></a>&#8221; is defined in Section 6.2(a).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Registered Organization</font>&#8221; is any &#8220;registered organization&#8221; as defined in the Code with such additions to such term as may hereafter be made.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_C1523"></a>&#8220;<font style="font-weight:bold;">Removal Effective Date</font>&#8221; is defined in Section 10.10(d).</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-38</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU39"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;">Representatives</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; is defined in Section 13.9.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Requirement of Law</font>&#8221; is as to any Person, the organizational or governing documents of such Person, and any law (statutory or common), treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_804"></a>&#8220;<font style="font-weight:bold;">Responsible Officer</font>&#8221; is any of the Chief Executive Officer, President, and<a name="_cp_text_1_804"></a> Chief Financial Officer of Borrower.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_2_805"></a><a name="_cp_text_1_806"></a><a name="_cp_text_2_807"></a>&#8220;<font style="font-weight:bold;">Restricted License</font>&#8221; is any material license or similar <a name="_cp_text_2_805"></a>agreement with respect to <a name="_cp_text_1_806"></a>which Borrower is the licensee of third Person Intellectual Property<a name="_cp_text_2_807"></a> (a)&#160;that prohibits or otherwise restricts Borrower from granting a security interest in, or a fixed or floating charge over, Borrower&#8217;s interest in such license or agreement or any other property, or (b)&#160;for which a default under or termination of could interfere with the Agent&#8217;s right to sell any Collateral.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">SEC</font>&#8221; shall mean the Securities and Exchange Commission, any successor thereto, and any analogous Governmental Authority.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Securities Account</font>&#8221; is any &#8220;securities account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Subordinated Debt</font>&#8221; is indebtedness incurred by Borrower subordinated to all of Borrower&#8217;s now or hereafter indebtedness to Agent and the Lenders (pursuant to a subordination, intercreditor, or other similar agreement in form and substance satisfactory to Agent and the Lenders, entered into between Agent, the Lenders and the other creditor), on terms acceptable to Agent and the Lenders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Subsequent</font> <font style="font-weight:bold;">Tranche A Term Loan Advance</font>&#8221; is defined in Section 2.1.1(a).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Subsidiary</font>&#8221; is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person.&nbsp;&nbsp;Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">SVB</font>&#8221; is defined in the preamble hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">SVB Capital</font>&#8221; is defined in the preamble hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Term Loan Advance</font>&#8221; and &#8220;<font style="font-weight:bold;">Term Loan Advances</font>&#8221; are each defined in Section 2.1.1(a).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Term Loan Commitment</font>&#8221; means, for any Lender, the obligation of such Lender to make a Term Loan Advance as and when available, up to the principal amount shown on <font style="text-decoration:underline;">Schedule 1</font>.&nbsp;&nbsp;&#8220;<font style="font-weight:bold;">Term Loan Commitments</font>&#8221; means the aggregate amount of such commitments of all Lenders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_824"></a>&#8220;<font style="font-weight:bold;">Term Loan Commitment Percentage</font>&#8221; means, as to any Lender at any time, the percentage (carried out to the fourth decimal place) of the Term Loan Commitments represented by such Lender&#8217;s Term Loan Commitment at such time.&nbsp;&nbsp;The initial Term Loan Commitment Percentage of each Lender is set forth opposite the name of such Lender on <font style="text-decoration:underline;">Schedule 1</font><a name="_cp_text_1_824"></a>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_826"></a>&#8220;<font style="font-weight:bold;">Term Loan Maturity Date</font><a name="_cp_text_1_826"></a>&#8221; is August 1, 2026.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-39</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU40"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;">Trademarks</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means any trademark and servicemark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of Borrower connected with and symbolized by such trademarks.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_828"></a><a name="_cp_text_1_830"></a><a name="_cp_text_1_828"></a>&#8220;<font style="font-weight:bold;">Tranche A</font><a name="_cp_text_1_830"></a>&#8221; is defined in Section 2.1.1(a) hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_832"></a><a name="_cp_text_1_834"></a><a name="_cp_text_1_836"></a><a name="_cp_text_1_832"></a>&#8220;<font style="font-weight:bold;">Tranche A Term Loan Advances</font><a name="_cp_text_1_834"></a>&#8221; is defined in Section 2.1.1<a name="_cp_text_1_836"></a>(a).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_841"></a>&#8220;<font style="font-weight:bold;">Tranche B</font>&#8221; is defined in Section 2.1.1(a) hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_842"></a>&#8220;<font style="font-weight:bold;">Tranche B Draw Period</font>&#8221; is the period of time beginning January 1, 2022 and continuing through September 30, 2022.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_843"></a>&#8220;<font style="font-weight:bold;">Tranche B Term Loan Advance</font>&#8221; is defined in Section 2.1.1(a). </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_844"></a>&#8220;<font style="font-weight:bold;">Tranche C</font>&#8221; is defined in Section 2.1.1(a) hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_846"></a><a name="_cp_text_4_847"></a><a name="_cp_text_1_848"></a>&#8220;<font style="font-weight:bold;"><a name="_cp_text_4_847"></a>Tranche C Draw Period</font><a name="_cp_text_1_848"></a>&#8221; is the period of time beginning on October 1, 2022 and continuing through March 31, 2023.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_849"></a>&#8220;<font style="font-weight:bold;">Tranche C Term Loan Advance</font>&#8221; is defined in Section 2.1.1(a).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_850"></a>&#8220;<font style="font-weight:bold;">Transfer</font>&#8221; is defined in Section 7.1.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_851"></a>&#8220;<font style="font-weight:bold;">Uncommitted Accordion</font>&#8221; is defined in Section 2.1.1(a) hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_852"></a>&#8220;<font style="font-weight:bold;">Uncommitted Accordion Draw Period</font>&#8221; is, if the Lenders, in their sole and absolute discretion, agree to accept a request from Borrower to make the Uncommitted Accordion available to Borrower, the period of time beginning on April 1, 2023 and continuing through December 31, 2023.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature page follows.]</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-40</a>-</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU41"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the Effective Date.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:50%;">
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BORROWER:</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TAYSHA GENE THERAPIES, INC.</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Kamran Alam</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Kamran Alam</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AGENT:</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SILICON VALLEY BANK<font style="font-weight:normal;">, as Agent</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_856"></a><a name="_cp_text_1_856"></a>By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael White</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael White</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Head of Business Development</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SILICON VALLEY BANK<font style="font-weight:normal;">, as Lender</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael White</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael White</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Head of Business Development</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SVB INNOVATION CREDIT FUND VIII, L.P.<font style="font-weight:normal;">, as Lender</font></p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: SVB Innovation Credit Partners VIII, LLC, a</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delaware limited liability company, its General Partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Ryan Grammer</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ryan Grammer</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Managing Director</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">Signature Page to Loan and Security Agreement</font>]</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU42"></a><font style="text-decoration:underline;">SCHEDULE 1</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">LENDERS AND COMMITMENTS</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Lender</font></p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_860"></a><font style="text-decoration:underline;">Initial</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Tranche A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Initial</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Tranche A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Percentage</font></p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Subsequent</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Tranche A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_862"></a><font style="text-decoration:underline;">Subsequent</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Tranche A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Percentage</font></p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_table_18_864"></a><font style="text-decoration:underline;">Tranche B</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Tranche B</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Percentage</font></p></td>
<td valign="top"  style="width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Tranche C Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Tranche C Term Loan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Advance</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Commitment</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Percentage</font></p></td>
</tr>
<tr style="height:31.9pt;">
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Silicon Valley Bank</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_869"></a><a name="_cp_text_1_869"></a>$18,750,000</p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.5000%</p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$6,250,000</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.5000%</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$12,500,000</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.5000%</p></td>
<td valign="top"  style="width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$12,500,000</p></td>
<td valign="top"  style="width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.5000%</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SVB Innovation Credit Fund VIII, L.P.</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_873"></a><a name="_cp_text_1_873"></a>$11,250,000</p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.5000%</p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,750,000</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.5000%</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7,500,000</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.5000%</p></td>
<td valign="top"  style="width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7,500,000</p></td>
<td valign="top"  style="width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.5000%</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">TOTAL</font></p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_877"></a><a name="_cp_text_1_877"></a>$30,000,000</p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">100.0000%</p></td>
<td valign="top"  style="width:10.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$10,000,000</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">100.0000%</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_table_18_878"></a>$20,000,000</p></td>
<td valign="top"  style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">100.0000%</p></td>
<td valign="top"  style="width:11%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$20,000,000</p></td>
<td valign="top"  style="width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">100.0000%</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:5.56%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.56%;">&nbsp;</p>
<p style="text-align:left;margin-top:12pt; clear:both;margin-bottom:0pt;text-indent:0%;font-size:5pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></a></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU43"></a><font style="text-decoration:underline;">EXHIBIT A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_881"></a><font style="text-decoration:underline;">COLLATERAL DESCRIPTION</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Collateral consists of all of Borrower&#8217;s right, title and interest in and to the following personal property:</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All goods, Accounts (including health-care receivables), Equipment, Inventory, contract rights or rights to payment of money, leases, license agreements, franchise agreements, General Intangibles (except as provided below), commercial tort claims, documents, instruments (including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts, certificates of deposit, fixtures, letters of credit rights (whether or not the letter of credit is evidenced by a writing), securities, and all other investment property, supporting obligations, and financial assets, whether now owned or hereafter acquired, wherever located; and </p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Borrower&#8217;s Books relating to the foregoing and any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds of any or all of the foregoing.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, the Collateral does not include (a) with respect to stock in Foreign Subsidiaries, more than sixty-five percent (65.0%) of the presently existing and hereafter arising issued and outstanding shares of capital stock owned by Borrower of any Foreign Subsidiary which shares entitle the holder thereof to vote for directors or any other matter, but only if Borrower can demonstrate to Agent and the Lenders&#8217; satisfaction that pledging in excess of sixty-five percent (65%) of such stock would cause an adverse tax consequence for Borrower or any such Foreign Subsidiary, or (b) any Intellectual Property; provided, however, the Collateral shall include all Accounts<font style="text-decoration:none;color:#auto;font-weight:bold;letter-spacing:0pt;"> </font><font style="text-decoration:none;color:#auto;letter-spacing:0pt;">and all proceeds of Intellectual Property</font>.&nbsp;&nbsp;If a judicial authority (including a U.S. Bankruptcy Court) would hold that a security interest in the underlying Intellectual Property is necessary to have a security interest in such Accounts and such property that are proceeds of Intellectual Property, then the Collateral shall automatically, and effective as of the Effective Date, include the Intellectual Property to the extent necessary to permit perfection of Agent&#8217;s, for the ratable benefit of the Lenders, security interest in such Accounts and such other property of Borrower that are proceeds of the Intellectual Property.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms of a certain negative pledge arrangement with Agent and the Lenders, Borrower has agreed not to encumber any of its Intellectual Property without Agent and the Lenders&#8217; prior written consent.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:5pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU44"></a><font style="text-decoration:underline;">EXHIBIT B</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_cp_text_1_883"></a><a name="_cp_text_1_883"></a>COMPLIANCE STATEMENT</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:30%;">
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:26%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TO:</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;">SILICON VALLEY BANK (&#8220;SVB&#8221;), as Agent, SVB, and SVB INNOVATION CREDIT FUND VIII, L.P., as Lenders</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_885"></a><a name="_cp_text_1_885"></a>FROM:&nbsp;&nbsp;<font style="font-weight:bold;">TAYSHA GENE THERAPIES, INC.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_887"></a><a name="_cp_text_1_890"></a><a name="_cp_text_1_892"></a><a name="_cp_text_1_903"></a>Under <a name="_cp_text_1_890"></a>the terms and conditions of the Loan and Security Agreement among Borrower, Lenders, and Agent (the &#8220;<font style="font-weight:bold;">Agreement</font><a name="_cp_text_1_892"></a>&#8221;), <a name="_cp_text_1_903"></a>Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below.&nbsp;&nbsp;Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes.&nbsp;&nbsp;Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:99.89%;">
<tr>
<td style="width:46.15%;"></td>
<td style="width:35.13%;"></td>
<td style="width:18.61%;"></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:-5.4pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Please indicate compliance status by circling Yes/No under &#8220;Complies&#8221; column.</p></td>
</tr>
<tr style="height:9.9pt;">
<td colspan="3" valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-18pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:-18pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reporting Covenants</font></p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:-18pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Required</font></p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:-18pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Complies</font></p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-18pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-18pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-18pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_906"></a><a name="_cp_text_1_908"></a>Quarterly Financial Statements with <br /><a name="_cp_text_1_908"></a>Compliance Statement</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_910"></a><a name="_cp_text_1_912"></a>Quarterly <a name="_cp_text_1_912"></a>within (i) 45 days for the first 3 fiscal quarters of each fiscal year and (ii) 90 days for the final fiscal quarter of each fiscal year</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yes&nbsp;&nbsp; No</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10&#8209;Q, 10&#8209;K and 8-K</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_916"></a><a name="_cp_text_1_916"></a>Within 10 days after filing with SEC</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yes&nbsp;&nbsp; No</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_918"></a><a name="_cp_text_1_918"></a>Board approved projections</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_920"></a><a name="_cp_text_1_922"></a><a name="_cp_text_1_924"></a>Within 60 days after FYE, <a name="_cp_text_1_922"></a>and within 10 <a name="_cp_text_1_924"></a>days of any updates/amendments</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yes&nbsp;&nbsp; No</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_table_15_925"></a>Monthly bank statements </p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Monthly within 30 days </p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yes&nbsp;&nbsp; No</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><a name="_cp_table_15_926"></a>&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Other Matters</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:74.04%;"></td>
<td style="width:12.99%;"></td>
<td style="width:12.97%;"></td>
</tr>
<tr style="height:29.35pt;">
<td valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_929"></a><a name="_cp_text_1_929"></a>Have there been any amendments of or other changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries?&nbsp;&nbsp;If yes, provide copies of any such amendments or changes with this Compliance Statement.</p></td>
<td valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yes</p></td>
<td valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_933"></a><a name="_cp_text_1_933"></a>The following are the exceptions with respect to the statements above: (If no exceptions exist, state &#8220;No exceptions to note.&#8221;)</p>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:normal;font-family:Times New Roman;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU45"></a><font style="text-decoration:underline;">EXHIBIT C</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">LOAN PAYMENT/ADVANCE REQUEST FORM</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100.22%;">
<tr>
<td valign="top"  style="width:35%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fax To:</p></td>
<td valign="top"  style="width:35%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:26%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;">Loan Payment<font style="font-variant: normal;">:</font></p></td>
<td colspan="4" valign="top"  style="width:39.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_948"></a>TAYSHA GENE THERAPIES, INC.</p></td>
<td colspan="3" valign="top"  style="width:43.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.6%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:35.32%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:43.46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From Account #</p></td>
<td colspan="3" valign="top"  style="width:35.32%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To Account #</p></td>
<td valign="top"  style="width:22.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.7%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.6%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:35.32%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Deposit Account #)</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.22%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:28.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Loan Account #)</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal $</p></td>
<td colspan="4" valign="top"  style="width:35.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.22%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and/or Interest $</p></td>
<td colspan="2" valign="top"  style="width:28.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr style="height:15.1pt;">
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.6%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.86%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:26.06%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.22%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:28.24%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:20.48%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signature:</p></td>
<td colspan="2" valign="top"  style="width:30.44%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phone Number:</p></td>
<td colspan="2" valign="top"  style="width:28.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Print Name/Title:</p></td>
<td valign="top"  style="width:4.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:26.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:28.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:26.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:28.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;">Loan Advance:</p></td>
<td colspan="4" valign="top"  style="width:39.74%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:43.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="9" valign="top"  style="width:98.78%; border-left:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="9" valign="top"  style="width:98.78%; border-left:solid 0.75pt #000000;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Complete <font style="font-style:italic;">Outgoing Wire Request</font> section below if all or a portion of the funds from this loan advance are for an outgoing wire.</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.6%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:35.34%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:43.42%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From Account #</p></td>
<td colspan="3" valign="top"  style="width:35.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To Account #</p></td>
<td valign="top"  style="width:23.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.6%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:35.34%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Loan Account #)</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:29.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Deposit Account #)</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:15.1pt;">
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.6%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:9.88%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:22.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:29.42%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr style="height:15.1pt;">
<td colspan="4" valign="top"  style="width:28.48%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amount of Term Loan Advance $</p></td>
<td valign="top"  style="width:22.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:29.42%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr style="height:15.1pt;">
<td valign="top"  style="width:15.02%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.6%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.98%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:9.88%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:22.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:29.42%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="9" valign="top"  style="width:98.78%; border-left:solid 0.75pt #000000;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Borrower&#8217;s representations and warranties in the Loan and Security Agreement are true, correct and complete on the date of the request for an advance:</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:18.6%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:32.36%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:29.42%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:18.6%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signature:</p></td>
<td colspan="2" valign="top"  style="width:32.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phone Number:</p></td>
<td colspan="2" valign="top"  style="width:29.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Print Name/Title:</p></td>
<td valign="top"  style="width:2.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:9.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:22.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:29.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:15.62%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:9.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:22.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:29.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.22%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="5" valign="top"  style="width:47.12%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;">Outgoing Wire Request:</p></td>
<td valign="top"  style="width:15.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="9" valign="top"  style="width:98.8%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Complete only if all or a portion of funds from the loan advance above is to be wired.</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="6" valign="top"  style="width:62.84%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_950"></a><a name="_cp_text_1_950"></a>Deadline for same day processing is noon, Pacific Time</p></td>
<td valign="top"  style="width:1.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:18.04%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beneficiary Name:</p></td>
<td valign="top"  style="width:7.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amount of Wire:</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top"  style="width:11.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:18.04%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beneficiary Bank:</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Account Number:</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:18.04%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">City and State:</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:25.6%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beneficiary Bank Transit (ABA) #:</p></td>
<td valign="top"  style="width:17.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:28.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beneficiary Bank Code (Swift, Sort, Chip, etc.):</p></td>
<td valign="top"  style="width:23.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="4" valign="top"  style="width:51.68%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:18pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(For International Wire Only)</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:18pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr></table></div>
<p style="margin-bottom:12pt;margin-top:12pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU46"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intermediary Bank:</font></p></td>
<td valign="top"  style="width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transit (ABA) #:</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:18.04%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For Further Credit to:</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Special Instruction:</p></td>
<td valign="top"  style="width:0.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="9" valign="top"  style="width:98.8%; border-left:solid 0.75pt #000000;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">By signing below, I (we) acknowledge and agree that my (our) funds transfer request shall be processed in accordance with and subject to the terms and conditions set forth in the agreements(s) covering funds transfer service(s), which agreements(s) were previously received and executed by me (us).</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:18.04%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signature:</p></td>
<td colspan="3" valign="top"  style="width:25.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:28.54%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2<sup style="font-size:85%;line-height:120%;vertical-align:top">nd</sup> Signature (if required):</p></td>
<td valign="top"  style="width:23.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Print Name/Title:</p></td>
<td valign="top"  style="width:0.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Print Name/Title:</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Telephone #:</p></td>
<td valign="top"  style="width:0.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Telephone #:</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:17.16%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:0.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:17.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.28%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:15.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.28%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:11.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:23.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.2%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:normal;font-family:Times New Roman;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU47"></a><font style="text-decoration:underline;">EXHIBIT D</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Form of Disbursement Letter</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_954"></a>[see attached]</p>
<p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;"><a name="_iDocIDField_EOD"></a><a name="_AEIOULastRenderedPageBreakAEIOU48"></a><font style="font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;">DISBURSEMENT LETTER </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-weight:normal;font-family:Times New Roman;text-transform:uppercase;font-size:10pt;font-style:normal;font-variant: normal;">[DATE]</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_956"></a><a name="_cp_text_1_959"></a><a name="_cp_text_1_961"></a><a name="_cp_text_1_956"></a>The undersigned, being an Authorized Signer of <font style="font-weight:bold;">TAYSHA GENE THERAPIES, INC.</font>, a Delaware corporation (&#8220;<font style="font-weight:bold;">Borrower</font>&#8221;), does hereby certify to (a) <font style="font-weight:bold;">SILICON VALLEY BANK</font>, a California corporation (&#8220;<font style="font-weight:bold;">SVB</font>&#8221;), in its capacity as administrative agent and collateral agent (&#8220;<font style="font-weight:bold;">Agent</font>&#8221;), (b) <font style="font-weight:bold;">SVB</font>, as a lender, (c) <font style="font-weight:bold;">SVB INNOVATION CREDIT FUND VIII, L.P.</font>, a Delaware limited partnership (&#8220;<font style="font-weight:bold;">SVB Capital</font>&#8221;), as a lender (SVB and SVB Capital and each of the other &#8220;Lenders&#8221; from time to time a party hereto are referred to herein collectively as the &#8220;<font style="font-weight:bold;">Lenders</font>&#8221; and each individually as a &#8220;<font style="font-weight:bold;">Lender</font><a name="_cp_text_1_959"></a>&#8221;) in connection with that certain Loan and Security Agreement dated as of August 12, 2021, by and among Borrower, Agent and the Lenders from time to time party thereto (the &#8220;<font style="font-weight:bold;">Loan Agreement</font><a name="_cp_text_1_961"></a>&#8221;; with other capitalized terms used herein having the meanings ascribed thereto in the Loan Agreement) that:</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;">The representations and warranties made by Borrower in Section&#160;5 of the Loan Agreement and in the other Loan Documents are true and correct in all material respects as of the date hereof.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;">No event or condition has occurred that would constitute an Event of Default under the Loan Agreement or any other Loan Document.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;">Borrower is in compliance with the covenants and requirements contained in Sections 4, 6 and 7 of the Loan Agreement.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;">All conditions referred to in Section&#160;3 of the Loan Agreement to the making of a Credit Extension to be made on or about the date hereof have been satisfied or waived by Agent.</font></p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_965"></a>5.<font style="margin-left:36pt;"><a name="_cp_text_1_965"></a></font>No Material Adverse Change has occurred.</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;">The undersigned is an Authorized Signer.</font></p>
<p style="margin-top:12pt;text-align:left;margin-bottom:0pt;text-indent:3.85%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;;font-style:normal;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">Balance of Page Intentionally Left Blank</font>]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FF8C00;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SVB Conidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU49"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7A.</font><font style="margin-left:36pt;">The proceeds of the Term&#160;Loan Advance shall be disbursed as follows:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;">
<tr>
<td style="width:50.07%;"></td>
<td style="width:15.15%;"></td>
<td style="width:24.78%;"></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Disbursement from SVB:</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:12.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loan Amount</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$_______________</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:24.6pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Plus<font style="font-style:normal;">:</font></p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:24.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;&#8209;Deposit Received</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$__________</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:24.6pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Less<font style="font-style:normal;">:</font></p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:24.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;&#8209;Lenders&#8217; Legal Fees</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">($_________)</p></td>
</tr>
<tr style="height:12.05pt;">
<td colspan="2" valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net Proceeds due from SVB:</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$_______________ </p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Disbursement from SVB Capital:</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:12.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loan Amount</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$_______________</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:24.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:11.3pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:12.05pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net Proceeds due from SVB Capital:</p></td>
<td colspan="2" valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$_______________ </p></td>
</tr>
</table></div>
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.77%;width:90%;">
<tr>
<td style="width:73.99%;"></td>
<td style="width:16.01%;"></td>
</tr>
<tr style="height:24.1pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TOTAL TERM&#160;LOAN ADVANCE</p>
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NET PROCEEDS FROM LENDERS</p></td>
<td valign="middle"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;margin-left:-62pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$_______________</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;text-indent:3.85%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FF8C00;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SVB Conidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU50"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8A.</font><font style="margin-left:36pt;">The aggregate net proceeds of the Term Loan Advance shall be transferred to the Borrower&#8217;s Designated Deposit Account as follows:</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:15.38%;width:84.62%;">
<tr>
<td style="width:25.64%;"></td>
<td style="width:58.97%;"></td>
</tr>
<tr style="height:7.45pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Account Name:</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_992"></a>Taysha Gene Therapies, Inc.</p></td>
</tr>
<tr style="height:14.95pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bank Name:</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Silicon Valley Bank</p></td>
</tr>
<tr style="height:10.85pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bank Address:</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3003 Tasman Drive<br />Santa Clara, California&#160;95054</p></td>
</tr>
<tr style="height:10.85pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Account Number:</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_994"></a>xxxxxxx3564</p></td>
</tr>
<tr style="height:14.55pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ABA Number:</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_996"></a>121140399</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">Balance of Page Intentionally Left Blank</font>]</p>
<p style="text-align:center;margin-top:12pt; clear:both;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FF8C00;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SVB Conidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU51"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dated as of the date first set forth above.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:50%;">
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">BORROWER:</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_1006"></a>TAYSHA GENE THERAPIES, INC.</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AGENT:</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SILICON VALLEY BANK</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">LENDER:</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SILICON VALLEY BANK</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">LENDER<font style="font-weight:normal;">:</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SVB INNOVATION CREDIT FUND VIII, L.P.</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: SVB Innovation Credit Partners VIII, LLC, a</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delaware limited liability company, its General Partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_cp_text_1_1009"></a>[<font style="font-style:italic;">Signature Page to Disbursement Letter</font>]</p>
<p style="text-align:left;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></a></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>tsha-ex311_7.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tsha-ex311_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, RA Session II, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">I have reviewed this Quarterly Report on Form 10-Q of Taysha Gene Therapies, Inc.;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 16, 2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;RA Session II</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">RA Session II</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>tsha-ex312_6.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tsha-ex312_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Kamran Alam, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">I have reviewed this Quarterly Report on Form 10-Q of Taysha Gene Therapies, Inc.;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 16, 2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Kamran Alam</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Kamran Alam</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Financial Officer and Principal Accounting Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>tsha-ex321_9.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tsha-ex321_9.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Quarterly Report of Taysha Gene Therapies, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ending June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 16, 2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;RA Session II</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">RA Session II</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>tsha-ex322_8.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tsha-ex322_8.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.2</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Quarterly Report of Taysha Gene Therapies, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ending June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 16, 2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Kamran Alam</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Kamran Alam</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Financial Officer and Principal Accounting Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g3dyckr3udth000008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %J M # 2(  A$! Q$!_\0
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MGY2P@215;_9; 4^Q-6?#NN0^(?C7#J$2-$Y\*M'/ _WH95O"KHWN&!'OU[T
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M1N)QVK;U_P .6?B/^R_MDDZ?V;J$6H0^2P&Z2/.T-D'*\G(&#[UL44 <=?\
MPTT"_P!.\161^T0+X@N([B\D@**X9&# *2IXW DYSR[>M3#X?:-_96K:>\EX
MT>IZF^JO)YVV2&X8J0T;* 5VE01U/J375T4 <O%X!T6+PM_8!-V\)G^U-=-<
M-]I:XW;O.,@P=^X9R*TO#^@IX?L3;+J.IZ@S-N:?4;MIY#^)X ]@!6M10 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO?$6CZ:NZ]U*VMQZR. * -.BN=_X3WPE_P!#%IO_ ($+1_PGOA+_ *&+3?\
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M6@#H/ G_ "4/PS_V%;7_ -&K7V_7Q!X$_P"2A^&?^PK:_P#HU:^WZ "BBB@
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MB$7>3DG%1NDIB9BP9AR">/TH \)E\%3K"07DWXZ[/E_&N<N=)N],G_?(5(.
MR]/SKZ/2-)('5XT7<,,1P*Y_6M!M=8MI(959%3_EX6+!##U!Y]/K0!XU;:I?
M*I07DX3T\P\U6E7S)2 &+-SUSFNID^'>IF];[-?03QL"0""NT#V]:ZS1/ MO
MI=K)>W&9KM%4JS#:$[G@_P!: *WA311I.GP7,D:EYOF.3S^5=3+<Q0>7;Y2+
M<"Q+/R?<9]>E%N$GB8S/ND0?*OI[XK,O!_I 3:LF/W?[T?='4=J )/MEY>$L
MR0QH@YC<9<'MGZ^U,FE$,6)8\RHV6"Y&/<]JS#) URWFVQM;>V4B6>V^?)[
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M\E#\,_\ 85M?_1JU]OU\6^&-+N=(^)_ANVN4PPU6U*L.C#S5Y%?:5 !1110
M4444 %%%% 'RUXX:4>*-7LUD&Q;^XE [!F<D_IBH++P/J&L0+>P8C1@2HD;&
M[TQ[4>.)%?QYK4;*I47TF<YR/F(S7J^G6IM=+M($8CRXE VXSVH \:-CK/A^
MY\N2*:W;J6!)!(Z<]*OVGBO4H1$[E)G&0"R_>)]?6O8&B4[@4#^Q'%9D_AG3
M;R=GDM452>5V[><=0: .3TKQ7IFJ3?9-:MC C,0'CY12?4'D5UD.AZ+I"-=:
M9:0S;U(60#<V[!Z5P7BOPLV@R+>6I+63$@9X:-NP/K75_#+51=Z3>:6__'Q
M-\1;DD8Q^?\ C0!Y_!')IWB%I]J@VTI?:3SZ\?A7ML,R20Q2*25=01QUR.M>
M->,X!'JT82)XSY0+ANN>?RKU;PXK#P_8EG+!K=#D]N* -($?*!G_ .N:IZG9
M6VH6;6EQ!OAD&#C^'WS5]5^4Y QVP:4Q@1D8Y;T/ZT > R"[T#7G2)QFUG8!
MP,$CL"?I6[XGB:+48M6BDREW&MTK@=&[C'U!I_B_[.=<GB7YF0C)V@&4]R?I
MS7>:/H5MK'@,6$J8E5=ZL_\  3R"#VXXH D\.Z]!KEC'(KJ+E %FA[J0.WJ#
MUJ#Q'XRTK0"(YMT\V<-%$ =I[9["N(NO"&KV%QYD(8J"0'1L'-)9>"I+JZ!O
MS+N(+-$H+,?J: .FTCQW#J%[Y5X([>%FS'*_ /H.?YUC^.CI=U=BY@NO,N<@
M'80RE,=./3^M,O/ L.^,VMR4XQY<SCC\<\?C1'X*>#/VB_B9/[D39.?2@#1\
M-2O)H*AVVQQ.P5_;M_7BM"^%C<:>\-Q)!;P,H W2[<G/4=\^]7+*%8XE"0".
MVM@3&AY!('?U[]:XC2=.?Q1K=TUQ=>6P!DW$9Z' &/0>U &J^F7]Q:Q^7K\#
M[6PDLL>73'8X.&^N.U4[^:PM[BUFU;4#J-[;'$5O!'MC49SN8>OH3FB_^'MY
M J1#4D620D#$;;0/<BM/PYX MM/F-S?SF[8<%!D+^74T 11^/[N/RU_L](X$
M $:QL<JF??K73PC^V2M[;2;T?#, 3G&><>GTK(\>75G8:5'9""(2E\Q^4N&1
M .<_4\53T;4;RRT.PTO3H@VH3,SD-P(E///K0!V-Q9VFGZ)?7D\:DPQ[RI;J
M!V->+QFYU/49(X6 EN/DVGKD] *[F_U348[74-&U1$CN98"8V0_*XSG!KD="
MNWT[5X)GAW(LX=FVDLF.H% '6V/PSWV\!O[[[OWHXDY/MN_^M79Z/HVG:-;&
M*R@\L=V/+,?<]ZN6UU;WT(GMI4EB;HR'(^GUJ8* 2I.?:@!&'RC/K],^]9VL
M6B7^D7EO(N5EB91]>U:+*I')S_LBF;3M(P3G^5 'SWY,]K>[4AS);,-Y X+#
MG\*ZJY;P_KUJJW,@AG_A#\-&3Z'H1[5UGB/P3%JC++:MY<RG.QF(1A[XY[5P
M5]X7U71HIFN;8^1G<DD:[@1Z9[4 9VH:9>Z*BP.^ZT<Y2=1E&X[&K>E^+M4T
MV(0Q2B2+=D+(?NCVIFG:U<:.\F EQIC.(Y;:7Y@<C.0#R.G45TMKX3TK6[5+
MFV'E+(>'1B,#^5 #HOB(YMXC)8J9">2KG:/3_P#56;KGCC4KNS>U@E:*SDY=
M(S@$$]"?\*VW^%<B0LPU"0A<;$P"?8YJ]I_PNM+9A+J,SRH.?++\#N?;\* .
M"L;&[\0.KE#';H-F\J H [*.YK936KJ"-;31)$M+*(;1.4WM*WOZ#<.O6N@\
M3-!I>AV]HJ?9KJ[!B1,J?+!![CC.!^M<>I&EV(LF86Y<!5()/ER'A<8Z\T :
M=MXGN?[#^U:Q/.;O>5CCB8E'(/WLGH*ELO&EW8R%I4N8(6);<W(S^/6J]K:K
M>^,[&Q)$EO;1#(Z[MN22?7)KT2XMH+F,I/#'(GHZ@B@#+TSQY#*B*S+.N3N(
M;:_/L>M= NHZ5J.&81LX7.V1>4'H:XW4_ VG719[8&TF/(VG*?E_A7.V4]SI
M.IMI6HNP9C^ZDW\CTP>X- 'ITNCZ1&P;[#"H"[E./T'O4FEP6TE]8M HACCN
M495[?>' K%LM3>2P$$F;AH_NX R?0BLJ752/%'AVSB.T/J-OO4G)_P!8N<_C
MQ^% %;XJVT$WQ#GFO'+6\-K&2@/3CO7#VCR:EK<%SI]@;2&(@@J2,_CZ^U=U
M\97@?Q/-;@[+B2&+_@:^_P!,?K7+:WJ1L&%O:JJR-&H.WC8,<8]Z /1Y[ZTM
M[&&#4[R-KA0I<DC/O]:HWMOI>O6LB7<UI-M8M$&QDKGN1^%><Z=X<O\ 6B)3
M-L##.9#DGGK4TNA:_H$C2VK&:(@Y,7S<>Z]J ->Y\&VAB_XES-;/S@$\ ^QK
M!DTJZT^6)KTSLR@JA)R@]ZMV'C&\@G6&Y2W$:AF_?!@,^@ Z$UUVEZ]I6N/"
M%C,0(W&-CN*L/;O0!2T6]6#1_,O=XC#D0HI^<C'3GMGOVJMJE_/K,A'DK#%M
M^54;..W6J5X3JMZ)Y@ \;DICY0GX=N*2!\3 )@@@ ;>IH R=7TFY>S15=I&1
MMP,F!\I&.?7%7;2%PL$5E$TT[*%_U94R>Q/:NHMM(2-)IM9<VZID+$3RQ[ U
M2@U Z:RK;P+("3N##&/QH BE\.7C-))>200QC&]<&0CVX'%.MX;>SU&.97,\
MB8SO/) Z#'I4LUU<7D\KA-[.00H!.VFKI6I21X2TVY&<D@$_UH WY=2,]MYJ
MJR1^9N!!&#[[<^O%6'UUKQ@P=XY@ 5*=$/?WKDKG3KZ 9EAE"*,C;R!^--CU
M"5 @9=VT ;EX./ZT >C_ -H*)([.\1'+J,R(<@D],^G:M/& %^5<G 5L9)^M
M</87D<<D/E'SLL,JQP6QGD9Z?C75BY$R1B)@2K@XP2=N.2?4T 6VF4-A3AS\
MS.P^4#O1<3010,]S+Y:!>?FQ4>^"Y19%Q(  203QCVKRK7)+BYU-AJ'FG',9
M#':2,]OIT_&@#MH-4\.K=935!YW(5GD)V^WICVKHK9X[AA(DT<J%0"4P03Z_
M_6KQRYMXYHSY,*;3Q@J,GZ5-87UYHEW$\1D2-GVL-V0#VQ['^M 'K8L[=-[Q
MQ(KL3DGO3+Q6%N$1HL.V/WF<$>@-26MU'=6,<\)WJX&,]OK4NU5<,P''W30!
MRYLYX9%8+N!./E4C'KG-.O;7.(9&64NHP!R?Q^M=&S2F0[1CCAB>@^E5I]/A
MDF\]@Q<XS@]<>E ')3Z>$N'AA4KL0E%4?*#W8CN:C>T\HP_9_P!X!%M*D8!'
M7'US747%HTMSN.0@'3&/R/;BJ<R);W2*%/E8X<MP.>N10!D64;Q8#0(L<F=X
M!X*^YJZLJP6<GG "-1\O4E?3'>DN)#&!#]G*L/F4#]3[U,\,J'SW?,4H'F#;
M\W/0?K0!B'4+N'YXDD;9@O,8]A'_ 'T<'-5;CQ%:[6FNH2)QRCPMQ)Z#.,5K
MWFCQK()WF:8'A5*D#CGIT)K*O(GNXDMS FUB,Y8 @9[8/RY]: %M?%"W<J(L
MWE@ EA*V!CZ]ZZ* I=V$,L97[VYBC]P<<5SH\,Z9=1._S0R1'. V0P[#FM+3
M8'M)HK>VE;RBC,8W7*  <8/7J>E $>H^>8Y)FMU+H2-P&-_I6*+QIVB BV*?
ME.X'.1UKLI)5G@EA91(R#[H_G6)/IDGR2Q7$L;2'_5OT_(T 9S/;^9, ) (Q
MRJ#D_2LZ&-)&CV$LJG)9ACO_ #K<$$VV2XB7;VW$#@C^=58O,5,/)O.WDLH
M'TH :PDW))Y84 X.3ST_K6;+ JP*MUAHD?"+&N&<]ADU9GD!2:W_ '@D\O*$
M*2.N0,CWIT<-R^R6=!YFW*JAR#[YH T].FN)8%@F B*$*0G.1TP3]*J(D.E7
M4ME=IYL3DR6Y(R?=?PJ[;6<BV[-(-JR@#);!%3SPPBW5H09;B(8C:0>OUH S
M;+1H[SQ=H5S/"0\>HP31N.JXD4X_2OH:O&O#TLO]KZ<DT2B07$63N'/SC->R
MT %%%% !1110 4444 ?*GB?_ $?X@:Z\Z[HQJ,S;2,Y!<X_GFO6[*836D+(0
MT;1*RS#H_M[5Q/Q L--U+7=1GTF\C-_'<2)=6[L%)8,>1ZGVZURND:_K&C7
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MRS0#!'=LC^5*WQ)LPL<<>BPL^0=S\?CC_P"O7+IX#UQB]S)8E^ (HE=0P/\
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MZLWM^O- 'F'C#PK#HTWVE( ]O.2(U0\HY['VJ7X<Z@MMJC64V?L\J''7(9<
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MM_%@<?E7G%^LEM)!J42GSK4["H7D@=Q[<UW.CZS:ZQIZ3V\B[QCS$)Y4]P:
M+V"<GEL=.*Y_Q1H,6LV8D "7,"[HY .W7%=#O&W:.Y/3UKG-:\56VGPS1PAI
MKH$JJ@C ;'4^U &%X<UM(HO.N3F6$F,XXW<<'Z\5F^'&&K?$S3)YI,%M120*
M1]W:P8#\<5<\-Z+*4WW%ONFE;S"A7D#/0U/;:0UAX_T6YA0^4^HP!@ <*3(
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M\0A@N]0:6>\EEV,1C+;G'OR?\\5K>#PVC>/M'2WN//M;JZA523D,I<#=['-
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M2.O=0#PW'':NTEGU3Q%K1T^RF\A,$E6.!@>OJ: .\U*ST[Q/"64PK/&,.K.
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M*#R>5]>Q&*YVZ.HKIE]X=N52YN=/AWP7*G):W/4''<#&*OS6EAJ\)295=8P
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MY_E3K_Q);C=%YACF*YVALLA/3 '!^E5O[0U"4I?1W\T.8PK6\B*V/]KIW]*
M.EDM+6V4EF(; "AG S_A3+FUA0*VPA0>YY/TK'FNAJ7A^ZM+B3=>-&P&U-H<
M]1W[^E3:5'/>Z='=7#RB18PFSIV]* //?&NOQPR316(>(NVQI"WH.0*\Y.HW
M=NXD@N)5(Y+;B*]'\<^'+FX\^\AA/RL6\L [F 'WL5YK&ROL24KM4@-DG./2
M@""*WO=4OO*MTDN+F1A@ 9/U->HZ)X6.DZ.]I<1++-.-T[J?N@\?D/YU#X<\
M5^'+*P\N:WBL93\I=,MNX_,5NIXK\.7(8C4H@_ )((8@'/7&<>U '">+]%QH
M4%[ KKY!VNKG.5)(S]>.OO7+:+<O:ZC&"Y1),*2O5<]#7:^+O%-I?VATZU02
M0R29>1>"5'1?KGO7&Z9IESJNM106<+2,S;BD8QM Z_04 >S0V<MQ9) 69D1
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MTSN^N:H37:VM_'J5HS'RIRDB'J3_ ($=/I6GI\D-_!*IB\JX3,<BL=PR#_\
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MQAR )&. .OL*Y;4M8%_=2WVHMYDA;$,'\*#U^GMWK5TWP3K>M6T=S-=_9(V
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MY&@B"H._!KF+S37T1K:WN"(YY8RSR;"=O/W1ZFO4_B-9-#XAN]2MD$EXT$:
M'^%1Z>]<AIUK>ZLB?VS S0')C=N"#[=Z *_A_5;FYL;R"YQ/# /DDP <>F<<
M^V:S==\'?:@;BR4139!VXP&]B/6N^@L[?3[4VUK J(#DK_>]_K4C11?:$D.3
M( 5Z\4 >0:9=SZ<YB<%!NPZ'J#TKI],T_2[9OM%E;(DCIMWJ#D@U=\9^'_.M
M3JEK&/-C&9L#&Y?6N;T2\*L;20Y#?=Y_2@#IG0S/L4%CC@ =?\XKJO"5_<7L
M#Q2%6,(^8[NH%<FC0P/OW%23A3N_3Z5<T6>6TU2-H0 &#*<+U]/QZT >B7Z7
M$6G@V\S*4&2<=17/C[5 +::":4;Y]LBLQ88(^]CZUWUC:$)$\Y&Y\80]<T)I
M,4=_]H"?(,DH1DAO:@#$O[B.SD7E T:99\Y(8CD#_"LN'6&GO(YC:23F-@P8
MD#V'/I_A727OA^QU*Z$C0J2G]Y.,^OUYK.N)].TLB*X4$1_ZI$;&1Z8^M &M
M_9UO>1^9(#%(Y&"#TI([2QTX2/+<ICKER!A?>O,_$OQ$OWF^SZ9^X"\,Y.>/
M0#H#7 :CJNJ:DJQ7%[(Z8^[G@T >RZCXAT>VE9=/OM*!X5(_E# ]SNJ@Z?VC
M*IBGC:$#.^*3+9/TX_.O([?0+Z;_ %5I)*N ?W:YJ"2TU"RF+1/<6<R'(P2I
MS[T >X6Q>RG1VE# G 8GD-@D>W:KAU.X5_-+.S.0"%P,#U_"N8^'OC9]7E?2
M-2MX_M44>\3!1B8=.?0\]:]"&EV;(V+7'8",G@_C0 VS*&W16D:>)QM:1SSG
M^Z:X7Q=\,%NI6NM$"I*1EX#PK'MCTKT:SLHHH/+&[KEB3@@BK;N%QOR!D?-V
MH ^:+SP=K]O.RSV,D:@9WXPOYU WA[5+:4L;.7*_W1TKZ;E[XQC.<8J,I"[$
ME%.2,Y [4 ?.UKX+UV\N8XS8O%O;EY!C;[FO6O#7@ZU\.P0E3YET3^]D+;0W
M^S_];O6W(UC>,4ME63#[G*CY1ZDGMQ4VI72V4,?"E@_RC'*C\: (+AX;F1XV
ME1I%Y"D%-H[\CO7+ZQJ_V&+S(MTHS]Y!N^@)[5C7FM:MKFMW&EZ"Z01KS<W9
M7[N>H]Z+/P##) [ZI?WKSEB 5DP#Z$#W]Z %M_%9NICF.4+SN4QY_P#UBM&Q
MU:*\?8C@.#DY!R!Z8[5@:GX,U+386ETB]>]A7YFL[@9W#T!]?RK+T[4(]1B9
MB9H)[?=OB3B2/UYZL!_=- 'H9D62+<4#9;"CL?>L>:\60!9$\S;G>R\8^E7[
M*2.6V**6,*+PP/\ K!]!ZU*T<4T*CRPOFC!4KR!CN: .:>[D=6\V215')#MQ
M[<]*QX9[PS>8D3,()<!F;E@><$'BMZ]"6EWB.,,%&1Y@)P>WM68]G*JO=0GR
MR7.YF^ZQ/8^O?Z4 0PWDPG?[2S*N[Y(F3@>OS=.:Z?2XV\B0.A4.V=IZ?A7.
MVIFEN_*GD"+UVH.6SP#]*UX]52RG%JX9W1.).,;<XQ]: -"*V\Q2DKLY5RRE
M_?UKGM2L1J%K/#=0A6<D/R?F/8C_ #VK9@NHHK(7$C>2K,2KR#)].35&\U"*
M9QY+!XU(+'IEAZ4 <K;SZUH4:07%D]]:@?NY8S\X7W%6K+Q-97,_E2B6VES\
MJ3+C/T-;DT-U<6@,-P8]PZYYZ]\]1]*YJ]M%:1K?4;))1_%) 3D>G% &R4FD
MOXRSA;/822G)+=A]*7G&7 '/0URY@-J\D=CK5U;*OW8[A,@_C4L>F75\X,OB
M R#'S%&"*/\ &@#L]"3;XCTOVO(<8_WQ7NU?-'A[14C\7Z"S:V;ADOX&6(RD
M]) ?Z5]+T %%%% !1110 4444 ?/6GW\EG\5?$-I<(76[OY@C-R<AR5_0X_*
MO0,,P9$RKD'!*]#[UY;X\L3I_C+4+^(2*'NY'.U\?-N)_"NQT/QCIE[I\;7M
MW%;72@>8DAVY/J/4&@#ITC;RP".@Y([UP/C[2;"RT?[=! J3-<8X)&XMUKHM
M2\5Z796?F6MY%<.3]U7R!]:Y8:G8>)])N6;3I-6URW#2)93W3Q0S(,EC"%ZL
M!V)R0"1Z4 46TMH?ABFHWA!1Y/\ 1XD7+A3G:WJ Q#@?2J.A:>-9UFSLYX%C
M5D,TG][9@?+[9KGM.^(>K7/BR>;^RH+V'4(HK)=*4L(PB$>4J8.001P?<^M>
MD)>>']$\2VO^CFVU2>,I?!;OS8+9NT88CEAW[#IS0!V=E91VUMY$4$4<8R D
M8XQ_^JK2QA4"J/E P!V%-7G&""&P00>!4HW$8W?>Z'MF@#C_ !UX>%[ICZC:
M+B[M0)#@?ZQ>XQW-97@;6O[(U-8P#):SVXD,>.5_O #V_6N\O,G3[F,C ,#@
M_0+U]J\H\*N8=5L4,@Q^\4XYRO7CVH ['7_"=[#JDNK:%'_H]RH9E8X4\9&0
M!FLG[/;Z=8;M00*^\RE5C_B[[0<9KIU^(VE:08K*;[3<2*N)2J@>6?[HK-\7
MSQ:E/INO6%PEW;1GYX)2!LYW#(]* *=KXKT^TA99=.O4$@YF;N#TX_\ KUKV
M=REQY4L4N8I  ''0_7T/L:V=/BTW4=-,\,7FVUZ@RK<@>O7H:X?3KE]"\0ZA
M8(5>"!]NQQD2+GH?P/7VH ZF6)1,(E9I.ZKUYST/ZT\*L$D@>+*KCY7Y('MV
MJAK&M:)I<^V"=GP-V$;.SVS7'W_BB^U"Y*6@>-V.57[S'W]!]: .XEN889U9
MWV)&X=7DE POT)YXS^=84FE>'=1U(S6[1G<X=UB=6 SST'\JYFS\.:[JLK7;
MVT^TGEI7QO'MNYK'OK'4M!U1RSI#-D20B)^&6@#8,UCIOC*47TB?8TG*XP3\
M@^ZV/PYKUVTOHKV%7BD!C/W'0\,/8]Q7E[Z;;ZIIZLZJ&D3S%8+EE)&2/?FI
M/AU?7$<]WI<VY8HQO@7N,'##D]>?TH ]:1@P.03Z<=!7#>/]=MUL_P"QXI=U
MP[K(X3G8HZ9]\UT.H:U#H=C->WC[((_NAN"YQT ]Z\\\)6$NO^*;K4(;..1)
MSOEEF.0A[8^E &!J]A/I\=GY\;9G4L 1R><UZW\/G4^#[4H5.'?=@8YSWK,^
M(GAUO[+L3 C/):(V\_WLGG]:Y[P7XD.BRM;S^8+&0@NS_P#+-P<$CVQ0!ZS&
MWFQ*ZY ;YN010Z@C;GJ#C(I4FCFA26*2.2-N58-D$=L4X$$9R"/7';VH Y7Q
M3X6@UW2V22-#/$I:,@9.?;O7F/AR6.PUB.WC:3RYLQL&Z!NWY5[C?W*VEM).
MY^5%SMXR?0#WKP*ZGGCU99RB^=%*9  ,$#K@T >JZO\ V/8W:W>KSH0H^6(-
MS)QP:YMO'VEVTX-CHSR@*0K2SDM@]>/ZUF:!X9N_%U_->:C=,D*D%V3J2><+
MV Q7HUCX9T>RA6".QB*D'YI%W$_4T >87^H>%==N?-N;>YLY'^]+"<G\NAIU
MKH-O*4_LSQ-  ,;DD)C8<^G>N_N? OAZX#'[ (B>K1-CFN3\0^ K?1M/?4+2
M\+A6 :*7&3GT/K0!%J/A>UTG2;C5+^]-Q-N C@5.')YZGZ5Y[J4U[?7J-+#Y
MC3,!'$@.0.P'XUT]W=W-YH5HMX^8H974-G[P &!]>:U/ &A+>:\U]<#!BBW1
MJ>0,G /\Z .I\%:9+I6E-;/%M8.&<Y^8D@9R:ZM@H!7&#[BA(Q$HVD9)QG&:
M) I &6!]^] $>1N[,"<'C@UY#XTT632M6\N&():73,XD ZGK@GVKU\,I9P'!
M*$!@.V:IZCI\&H6K6MPN58@@J>5/J#VH \<>^BOK;[-J, BFC7RX9U/RMCL?
M\:Q5TNZ:Y9;!&FN!R$7KCW!_IZUT7B'0YM'F7[7&SPL[%78Y#^F".AQVI_AG
M56M;][6X_>!TW0S #+*.WX?TH X2ZAD@NO(F8)?\J[-\GX$GIZ5O_#VY@D\:
M:*94DEN#?0#*MA5_>KR<<GM63?$RWTS.H:1I"\<V>1SQ^'M7:^!X]!O;_P .
M+;2_9M6MKZ!I1)@></,!(![^U 'K'C!O^*B90>=B<8^M8"N6;C'<'FMWQESX
M@D*GGRU5L?3-<]GT*M0!,>1DD<\4APLJD9 /M49)*8&<&GLP;!(RIY],4 *^
MUX65^0?7@8KRC7;,Z3K\\$8 56\R,KTVGFO4Y&C"88J% QS7F_BRX@N-6/V9
MLK&@0YY.?\* +?G27$,4L4!E+#MR!GV')KMO"NFO+JD$GEY2+!W8/R$]C^M8
M?@O2YKNU2-6"R!2RJ1RV3T'O7I6D6\6@V<?G2,;B3EXU.0!GG/O[T ;40O9=
M3.[B"-N#ZC';ZUHB01,QD8#<..>/_K562\MFM?/C4LJC!P#QS7F'Q'\836LY
MT_3Y6#O$"Q VX% '0^(O%UM:%K*.\2#:N/E?! ^O7/TKD_.TZXADW7*3!S\S
M&3D>I.3FO/;33=1U R301274BC<=IRQ]\=:E/ACQ,T,<C:3*8YN4:)PW'OW4
M_6@"6_\ )6XD$;@QY(R.E-TG2[K7=26TLQA1S)*1P@_QK1TSX=:K.<ZA(MK$
M/X%.YR?Y"O1/#VC6>CZ>D5M&8V;!?><L6]S0!=TV**TL(8;2!EM@-JNPRK$=
M>?7K7(^.M%5=&_M"U=I&ADS,3U*GC)^AKL5M@HV"601YRL(QMSUW?J>].=%N
M/,AE12C HZ$<$'^= 'BOAC57TS64O(WV%_E\S'2OHC0M7ANK*',Y=WYY^][Y
MKYS\1:2^A:W+;*^Z(ONB/^R?\.E>A_#C46ED*3EF8KLC.[&?;- 'L D5R"%(
M/J1UI)&S\H&[/3%9\T\D%U &A?,P &UCA3Z5<F+;2%P&)PNT?K0 ES((86D<
M_)W55W$CZ5FRPS7,,ANY6A@(SY22 -T[FM!8O+509BSJ,%B!EA[UB:MJ5E!:
MRIYT<D[H0D:G)/\ A^- &"5U1-8B?1)G6W.-T,K\8!YSGKQ6IXIO66P\H*@#
M\L">0,<_2LFWO)X(?M7RQ2QMS&#N5EQSS5^_>36=!\W:DBN,#8#GIP?Y\>U
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M#%YBD8/F*3N/I6T= FGB=/M$6QSRWEY;@_7K6A#HMI&$:1 \P&"R_*/J!VH
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MI_@7P9:7-L;9KVSO-/GCFBU!I?,:9E8$[H_N@<=%Y^M5O&'AZWN-2O;[1_\
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M?H*U[>);>$H',BH?EWC)% 'F:?#N !/.215/)02DC([&MK2[6RT^S>VM#L4
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MU\2Z3'XHT?3;.1KF2348$1APJYD7./PS0!Z+XD(_MM@7R!&"4Q7EVOZPKO+
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M1JSQH&W$H>3SG%(OF!#(ZGY5.0#FK$C\\C@<>]0^=^^\HJ=VP.#V(/;/K[4
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MR$J.>/2@"E87MUX>U=[.[A5(PVV2,$\'^\/?O7;ZUXV%MMB2%G,<(E'(50.
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MN2\+Z?8S:3<&YC1KJ-A\I3?@'V_G4=QXPU2XMGM-0M89U(.#)&593V/\ZU?
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M<CGK7F,'Q+NK>%HKJWBGD3@N6(ST'( YYJCJ/CW6+B"-+$);E@2509*CMR:
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M$'ZCH: /(].\2VT($0LG0(I&9"&  [8],^N:UK*$7MH#+ J&3<)!(V8SN).
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MRV<PVI(3Y:I@8SQ^)K8\N*6W?R(41W[E<9]B:X+1M>L+^T<6T?DRQJ6>+/(
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MB=83)NECBSOV*3V^ASUK9T'4KB&5M(O)"UM<@HGS<H3TY[BN>E,;(TGF Q1
ML<GD>O':KFGS-?S6]P-C1Y&"J_>/0=?3^M '+7]K=:)X@'EAEDBF#1K[@UZ[
MH^IP:QIL5Y "1(.C<8/I63XZ\-2ZI:KJ.G0.UY'RZ@XWJ.<CWXKS[2_$>IZ/
M;26\;;E$H86\G!!SZ]J /:5(PHR03SCT]J<.$(Y*Y[5XPWBGQ3<;I/MOE^8Y
MQ%; G;STR:DB\9>(;/Y9[MRXZ>:F1_\ 7H [;XC-&GAF)6*F8S# ;O@<US_@
M6X,-A>M)-LARI=B, 8!Z_G6#-+K7BZ_2,^9=2$87:N%0?T'O6C'ILYO;+PR7
M6*-V\R9D8X;_ !P* .^A\>Z-;1_9WN/.XVC8N%'XUG^*_#OAK7_#$VJ2V,%Q
M<?ZNWN+$>7(7/"AL<'!/?/%:,7AO0XH?)2QMC'MQDKEF_&N*O8'T/5+[2K&=
MDM+J'S%!YP1G^1!H QYO.LAI_EWXGNK5!$9=A .T\$$\$CH?I736WC@96/5(
M)3O&V4A<#/J,56L+3?I]J1)$&"K@<8&1T/YFH;FPAM[B*-O*>V/R2*Y.-W9@
M>QS0 V^-CJ'B6VDTI2OF.A;REPOF=\#KBK7Q&EQKBVJM^YC0@*>?:M?P[HL2
MZI!#;)L^?+'.25X.?:L_XCV!_M"2\5!M27:YSG(;G^>: -GX=:=;#0#>-&DD
MLDS?,PY7'2NU4C:0?EYZ]\5YG\-M8$5Q<:7(-JR?O8@3Q[@?A_*O1S@  <KC
MH: 'EVV./E)P0H;I2QE@@W@!\<X/!I@.U<X  ["F2%DB)4!I#R 6P* )_,*$
M!E)4C&1P!]:;NYRQZ9 /K36(6(2,XVCDD\ 4UB6 !(V[3P.N?6@#G_%^EQZE
MI\C#EHDR&)YW9Z#TKSWP]JQT;Q!:7<;NOS[958<;3P?K7IM_#-/#Y;L%Q@NY
M_B'8?GBO);^YWW<HV(K1N55L8)&>* /HNWN$G@66-LHXR!ZTES+&(\,RD'C:
MW0^V*R-'O))-!M9.1LA^<D=<<#^5>7Z]XQ:6>:.!F9/-XSP#GK^O\J /2&U;
M3HRSI&N0V&52=RCU JM+XEN?+8V\)DRQV]CCMUYS7CP\0ZPS"""[,&7V!5 P
M?^!5-'XBU6PG07;+.BDDHQVD$<<X[T >J'Q5>9*SV1^5<AN,&L&Z^)1M[K8(
MD#QC:!&JD9Y_B]O:N.U;QA<7UJMI;Q/;J3^\)Y8C'3CH*S-*L);L8$$DBQY:
M1U4MCCI^5 'I^E>/M*U!52Y1[.<?(H,AP0>I-=;##<JL$T%SYJ,06&3C'MZB
MO!+J!H'2%F^8?,"!DD9KOO 7B$QQR6=PS-@[4+9.[T'M0!M_$FS+^'7ND&=G
MR/@=LYKROPK(MIXBA97CW%&8(?X@.OY5[U<6HU#3;BVN4)$RE2KXXR.E?/%U
M!+H.LW,;JJWEMNC#,.BYZK[_ .- 'NJRB9$?<0&'3UII_B]N !S6'X:UZUU'
M2X"F5*($8D'&?_K^M;F#G) YXZ_E0 GRY4G@'J#W%-F7S4*B1T)((9>O%.;=
MN."#^%*5*H>N>] #.YW<KCGT%>2>.]/@_M]Y%7B8!8P@P%(QU_ _I7K1QL8.
M0 1C / KQOQ??6]UK5ZB79:13L5$/R #'ZF@#<^'@'G1JY/F"Y:,$#Y1A17?
M6UX=)URQ65#B>]C@P.!EG 'Y9KAOAW;N;*SW"3:\LDSD*>03@9]N*[V[$.I:
MKI"*^3;ZA!(%QTQ(M &#\293'X[D.[;B&/#CJO%9NF:Y_I!BNF^;&TG/&.Q/
M^-:GQ/T]Y?%[7,9)'DH&51DC@\X[CVKS[?\ 9I68 '<<$ _RH ]-BN8KB/Y7
M60]<IR*AN_,BMPWF$L!EB!\N/IZ5Q^GWS6F#"0C-U'\+'T/I]:Z73M02ZR@!
MCES\T)/ ^A]#0!G2VPDG$MLTA;DO$H^X#WY]J[/P[(]QI3))N5T&WGIMQP1C
M^=48(HXY&9U!.,!^A'/7/TK6T^XMLRK'+$6)RS*.' X!]_PH \V\7:*]_MNH
M@#,,J57JQ'7-8O@WQ ^E7PL;AO\ 0YSC#'[C^OT]:]?N]-AW22MMVR+M**>I
M/7\?Y5Y-XD\(WMI=37,$):'.XCTR: /1KF$2B$I(ZD.#E?XO8^U0I/)';7-Q
M=0)$L3$@!]WRC^1->6Z?XFU?1R(?,,D2\>3,,@>WJ*TM2\=3ZAILUJ+2.+S!
MM+!B<?2@"'5O&VJ:A.T=@6M;?/RK'RWY_P"%8]CX?U/6K[!24EF!DDD]/4DU
MJ>"[":XU1ITB8QQJ?WA'RJ?4GZ9K8\0>*H[*-K#3X/*F!*M*PY(]?Q]* .YT
MVYT_0=&AMKN:**.,<*3D'W_.N.\5R:?JVI1ZEHNIQ?;HR%,>=I;T*YKG[/PW
MKFMQK=32>7"V-KSMC(]AZ5'K>AMHQ3=*)%?@2*, G'- &E>:;XDU&%;>ZM88
MU#$[Y<$DGJ>]7?#_ (#EAO([B_E23R_FCBS\I(/2K?A&YDO=+",7>:/(R><B
MNB'FVK_O-XSV7N/;- '"ZOKNJ:WJ%Q:6$OD6L;, $^7@<9/^%8-WH8L5%[JU
MS)<2,VU85/+'ZGM[UT]_X4NS?27&F7*KYCDA&.",^XJF?"=^KF?4G9RK<J 6
M_6@"?1M<M1IMQ;6]DMO<QQ,\2 ;@^/U)KG9;QC&;B2]=I3SDMG_(]JGM+]-/
MUF6XNDY<%!A>$Y]/PK;LI/#)N?M,[6JR@YW$$G/TQC]* ,6:.;2+^QO=AB^T
M1"0H..#PP_SZUU1=@H*R K$  QP<#J#GZ5@ZY?#Q+K%O;V2%HHQY:''+<\GV
MKL9K*!F#+&[':%(C)^< 8Q@=: -;3]0G$.(4SN0-D+DC-:Z6OVE6DDCVF1 L
MD1'IU_$\5B>'H+<7CR274;3*@ @48$9!SU[GZ5HR:TD-\RD;HR?E8-P: ()_
M#MG-,KR1#S <8/(8<9S3K/PWI]H@)@564GD@?-6I%<QLTK[@B84[B>N?Y5RO
MB/QA:Z;!*C -(/D4*V<GUH WYFLK2(2OL;RC[?NS4;:C:X#VQB9L'82<#->+
MZIXHU/4U\M7\F$G[D?5CZD^M9_F7]L@E,D_J<@F@#WJUU:VFB),L2M&,LJ')
M_*G-?V\F=^Y57Y@Q!'/I7A%GXTG@<@P1.W_/0 JWZ5</B_4OO1-M!R>7+9^H
M- 'IMWH-K>NTEO.JR$XVEN,^E06:W]O$+6Z0K"%Q@-G;VSFO.[3QGJMN=TC!
MUY.!Q@^N.G%=;HWBNRU5UA+J)=@7##;^F>F: -'4]L8$KL H');EL8KRG7MQ
MU+YP-P4<CO[UZGJ]U$B) RA@P(/(./0UPGBG2S(/M]NI,8'S@=0/7VYH G\,
M_N](R#\WFD@@XP:U@@4*JY&<GGO7$Z1K#::[HZ&2!^2H/(/J*ZFTU2UOU_=2
M98]4;A@* )Y76,L3\JK][U/OCVHR&V\9R ?K3^B;L#;C&*86"XR<;1GGB@"M
M/IMI=_ZZ%"W/S8P?S%<GKVFQ:?<(L6=K+NY.<<UNW?B6S@?$>92!_!TSZ5R]
M_?RW]R9I>,\!1T H [KX4SLWB+3XP266[A!.>-NX&OJFOESX3V#KKMG<R*R[
M[N%D.>H#C-?4= !1110 4444 %%%% 'F>K_9[K5;ZVDP_P"\DW*1VW&O&KNP
MD\->()4#NL22@HQ&0ZGD5ZA/XBTVYU_5K4W"0SP7DT;K(<<AR,@_A7"^-[NV
MN-46."17,<(W$=">WMG% &E$EI=!961&9SE04QGW^M:VCP?:]7A@,3(B?O"X
M/&!5#0K2:\MK6%%43! =[= *VM3U*U\*:7<.A#S)]]R?O9& /K_DT 7=8U:*
MQBDEO[Z**(<HN[DCM@5P%YXNT"2^,[V$MR0,;BH&3WSZUR5Q)?ZYJ*22AIKB
MX<! .0 >WL*Z2/X;7\\)F>X2!L<*WS'IUX[?G0!OV'BSPK,PA2U-MN&2"Q0!
MA].*WTO_  W#:B6]MX&; ;EU=?;DGK7G=WX+U"&:,R$3P[.6C7DG''%98\+Z
MM)<9CTZ8Q'E2$S@]\]* /7+;QMX7M@D5O)#;AW"L%0*%'J<=:I>(M BU5X]?
M\/ZA$)8!DA6XQ[$?UKSU_".J06VZZL')0%F>-@<?A5*UFU+1[CSK"9U"\-@D
M*WJI!ZT >CZ%X@O+C4I=-U(1K<*N4$8Z^O/?UXJMJ[Q2^/M-AF7,93]X?4'.
M:P(=4=Y[77H85S VR>('.T?X5?U'4K;7?$>E3:0LDEP,*XV8P"?U[T :=]X.
MUS39V.F*+ZR/W0K8<>V3Z>M3:?X:U^]EB>ZL%MXXSE5E;<0WN?3O]:WM7\=V
M>BM+91AKBYBPF5 VJ>_?FJEA\3+>=EAGMB)]V.ORD]AQ0!U&E:*-.D,[S%Y6
M7#X''T%<_P"*]/AGO)DD08NHOD8#./7]1FNAT_7[34)V@#%+A0"5;T]O4U#X
MCTZ6_P!.!M]QGC;*A3R<]?Y4 >(6NH7.C:JC.?G@EQTX&/\ '^M>VV=W'?64
M-U$W[N50RGZUX_XHL MQ#=!E59?W<A_VAZUU7P^UE#$=(>;>8UW1#!_$"@#O
M688&,8I!G<0^!MYIIS\I*Y)XQZ4H8GC/S>F* !V#(5VAD/4=>*5_]7\NW<1C
M:QXHZ_>'S \BGJ.,\9[C/&: *.I;8[*6=B-L:%@2<<UX?;NUSJZ@Y)>7)YSG
MFO1?'7B>-;,:;:2(9).';/3M_P#6KEO!GA^35]:!3(2 Y9STS0!WFM:C<:7X
M(N(T$D<ZK&OF$\ $Y Q]#7E]MI3Z@;9H;D>:K$>0&RTC?AVKT[XC"9_#\D.[
M"QN&7"\.!ZUYYX>OX;+6;2XV9*$DG@YP,=: .WTSP-I]M;YO 3<R+D^6Q4(2
M.@]3[U2U#P%+))(EO<K-!)SF?(>,CN#WKM8IH;M([E<%6&5;%2Y&,$'OB@#S
MRS^&EP=OV^_C\M3@>2/G9?3/I^==E::;#I4*P:9!&L9QYFXDD^_N:O%@.&W9
M(R/3BFB5<#WQU&#0!Y[XTL[:'41*\11)EVLR=!@<_J:Q?#&V*ZG"NP8(KQEO
MXB#_ "KOO%.E?VGHS 'YX6\P<=1WS[5Y78W4VG:E!/@K"7V'GC'0XH ^A-)O
M/MVG0SLQ+E<, W.<=ZY/QWX+CUV#[? Z1:B@QER )<#@'WJQX.N&+S .6C )
MY'WO0\?6KNKZNFE;DU)X1&[?(TO1L>F/2@#Q6UO;[0;XC:R7*(8Y89@0HSCK
M^5=7!XYAU"V^S[IQ.&0G<^U,#J,_>)SZ5O:L_@KQDZ"6_P#*N<8$P0IGCWKF
M+SX?M!=C^RM9@EP/D#OM(8]: .AMO'FF1Q"*^:..<,051\@8]Z%\>>'XEV-?
ML0. [ G(]2<5Q%]\-O$&?-^QK*3SNB??GW_&J2^!O$$NU/[,E*X* 9X% '1>
M(?B/%<V$T6DI(<K@S8P<>PKB=,M)M3E@A$9-S.>G4C/<UT]G\-=?=,SI#;(!
M]Z5^3]:ZG2--T_P_'*\2FXN6B(:9OE(_W?2@#I/#^BIHVF6MJ)<S;%1S&.",
M=/YYJ>&W4>(;&-;;"+=1LK8/]X<_2KUK/:B%=B[">H/45;L+F.;4;>,$DB5?
MQY% &;XVMHYM<<GA_*7#5YYJ6CI*?GVQS$<..C?6O8-?36CJ;&QBD>'8,%44
M\]^M8MWINMW]OY-S:2R)G.-BCG\* /%Y/.LY1',-K*.1V;Z5>CNE')+IL(VD
M'E?_ *U=CJ7@;5;E3&VF32*?NLH&5_6N</@7Q5!)Y:Z'=.B\*PV]/SH W-%U
M4W8\F<H95Y7 XD7U'O[5U-C]FNH874KYL3$]@5/?\*XFW\(>)XI4=-%N48#Y
M3@?*?7K7::+INM#'VK2KB/@*P<+@'U% %Z1U6>-Y 2I/R8'&??W]*;<B-QB>
M))(W&/F _*KJZ7J$:LHMI#D'!/IZ=:SG\/ZKYTC>3-Y.0T:X!(XH Y>[TC0[
MO=%<6;(0>3U/T!ZBF6_P\\/M(L@,K(YX4M747.@:EJ -Q_9\L,V<%7(^8=CQ
MTJM!I&OVDP*Z?.RALD  _ES0!DZ];QZ/H#Q:=$L<:#A1CT/)]S7FGA2SM]4U
M[?>,'*@R!'/#M[U[==Z%J5WIDL4UDQF89!1,<]0>OZ5Y;J'PO\2"0W&GZ;<C
MG/EY"D?0YH [0(7CV_. !T../PKS?QIJJ7=]!I]ORMKD.R]&<]A6S'I/Q+^R
M&U;1;PKC E8*7'XYJ3PY\,_$'VQ;C4-*F0#G:^/Q/7K0!M^ =-DLM/\ ,E/W
MAG _G^?\JZ6^N[*VAD2YD7KD[^WTH30]2LK.41Z=<,3@!(EQP.F.:XJ\\/\
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MC=0!Z!@>E)@>@KB-'\2_8OAM=:Y>ZK!<,MW>+'>@;H78W<D<14-)@1DE  9
MH7&7 &X8_ACXC:CK4I-Q=Z&%BBNI)$C9<$1-(%:5TG<VRD*I+%)(\8Q(2ZJ
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M4HC^9C]H.%9AR#\X! 4 ZR#2=-M;B*XM]/M(9XK<6L<D<*JR0@Y$8(&0@/\
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MI8D[B.N>:Y=_'<T%KJUQ<:5&J6MOJ-Q:B.Z+&=;*7RI ^4'EEF*[<;^"<XP
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M5P+;[ T^I06MJ?,#17.IS:;'(_R[3]IC!(8#<!$?OAF;_EG6'K/BW4F\/:Q
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M?-TJQD_L_'V+=;H?LV,8\OCY,;5Z8^Z/2I$TG38T1$T^T5$2)%40J JQ-NB
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M+JUW?9YGC!>+<,-M8\KD<''6K%% %.+2=-A>!XM/M(WMT1(62%08U1650O'
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M-9PZLNHQILD2*2*.- %1/,D$DK  #+.RH23G[O&"6W:%% &7_P (UH.^Y?\
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%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g3dyckr3udth000025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000025.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #5 BX# 2(  A$! Q$!_\0
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MBTA:18Q(PP<@LWMTH T-#\%P:)X6U'0DO[BXCOGG=IY@#(#*.<XX)]ZK:/X
MMM(O]+NDOY9&T_2#I:JT:@.I8-O/OQTK9UKQ3H/AUH%UC5;6R:<_NA-( 6]_
MI[]*P#\3-%N;_P 0:987%NVH:3"SK]HF"13E4+-AAG 7&&..* *EM\+O[,M=
M'.D>(;RPO].M7LC=I#&YFA9RY4JP(&">#6]IWA"VL=5UZ]EN9;H:U'!'/'*
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M** "BBB@ HHHH **** "BBB@ HJ"\O+?3[.6[NI!'!$-SN03@?A4] !1110
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MFZGW- #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHOJRMJ>IV<\5N(YPQ6YB<X4\ ,"3TK0BU2RFD6..<,[' &#7 5?T;_D+6_\
MOBOGZ6=5YSC%Q6K7?_,]2>74XQ<DWH=Y1117TQXX4444 %%%% !1110 445E
M:]JCZ79*\2AI9&VKNZ#WH U:*YSP]KUQJ%R]M=!6;;O5U&.G4&K7BS5;O0O"
MNI:M8VR7,]G"9Q$Y(#*O+=/]G- &S17FU]\49(=2UZUM+&.9+6"%M.D+'%U*
MQC5E_!IHQQ[UH6/B?Q GBS4M.UAM"MM/TR*.>YN1)(I\N3?MP6X!!3G/'/%
M'<T5Q\GC1FO_ !!'9I;7%KIVDQZA;SQR;EF+"0XR.-OR#D>M5K7XF6!2T2[L
M+X2-%9M=30Q!H+=KE5*98MG&YL=": .YHK@K/XFK)#,UWX?U..7^U9-,MXH0
MDC3.NX_WA@X0YSP,CDC)JS;?$_P_=Z]<Z/#]I:YA$V,!")&B!+JHW;@1@X+
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M:DUYD:D=36(S9C2=E96(&. =Y)&>N*A_X5YHOFZCB6]%KJ"S":S$V(LR@[V
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MB#_D#3?5?YBM.LSQ!_R!IOJO\Q7-C?\ =JGH_P C;#_QH^J.'J_HW_(6M_\
M?%4*OZ-_R%K?_?%?%8?^-#U7YGT5;^'+T9WE%%%??'RX4444 %%%% !1110
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M&?>N5US7K:#XC^$_*\1J+6]6;?:K=((F4Q'RVP/O;F/!).2!BN>\ ^(;V_\
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MNLB6T:LI)R"%&161X@\1Z+=WJ/!J4#J(P"03ZGVKT&B@#R?^V=,_Y_H?S/\
MA72>'_%.A6EG(L^J6Z,7R 2?\*[2BG<5C"_X33PW_P!!BV_[Z-'_  FGAO\
MZ#%M_P!]&MVBD,\D\8:UIE]K7G6M[%+'Y8&Y<D9_*N?^W6O_ #W7\C_A7O=%
M<%3 0G)R;W,94$W>YYYX*\2:-I^FSQW>HPQ.TN0&)&1CZ5TW_":>&_\ H,6W
M_?1K=HKKI4U3@H+H:1CRJQA?\)IX;_Z#%M_WT:H7?Q(\-6D_E&[EFXSNAA9U
M_,"NLHK5-)ZEHXS_ (6CX9_YZW?_ ("O_A5VS\?^&KR$R#45APVW;.A1OK@C
MI7344VXVT0-HXOQ1XHT._P##-_:VNJ6\D\L>$0-U.16O_P )IX;_ .@Q;?\
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MX33PW_T&+;_OHUNT5[)YYA?\)IX;_P"@Q;?]]&C_ (33PW_T&+;_ +Z-;M%
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MUR+[9<O=S?Z&YW2OC<>3QT'% '745@?\)2G_ $!=;_\  %J/^$I3_H"ZW_X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g3dyckr3udth000037.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000037.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $% @4# 2(  A$! Q$!_\0
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M3EMYMK#&YG#$%L>@49YQ5;5/ NKZYX%OO#.J>)DG$Z0QPW"V 4QK&ZMEAO\
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M/A2XTJYU"UAOI)TN(;RRL1"L,B,K(PCWG)!7NW.:ZNB@#C)O $3^$](TF.^
MO=+F%S'=R6ZNLLQW>8SQD\JY=\C.>>N1FB]\#W&IV.CQ76HV<<VG:S#JA:TT
M_P E)!&#B/;O.,Y^\2?I79T4 <K:^$)E\;+XDN[VVDEBBDAB6WLQ"[JY'$S[
MCYFW:,<#')J'7? O]M^(=3U;^T?)^W>'Y=$\KR-VS>Y;S<[AG&<;<#ZUV%%
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M2+W2UG-]<:?/))M"FRL/LH &>OSL6/XC'I6U10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 445D>*=7DT#PIJNK0QK)+9VLDR(_0L%)&?;- &O17):!J&K6_BV\T
M#5+_ /M #3X;^.=H%B92[R(R87C:-@QGGKDFL36/%6KVGCB335OQ BWMK%;Q
M>0K6TD4@7>)I<$I+P^U<KG*<-NS0!Z114%U>VMD@>[N8;=&. TL@0$^G-5?[
M?T;_ *"]A_X$I_C0!HT5#:W=M?6XGM)XIX2S*)(G#*2I*D9'H01^%34 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6^MHHK@BVN3/&T<AD5?F9$.[,3Y&W&-O)R0-B@ HHHH **** "BBB@ HHHH
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M"!1R2XQD\&F?$=]<)I<6GZ;:2WFHV\MY&DM]MB6!&09,L:."Y$L9PH*_>PY
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M7IOUD_\ 9:\_KZ+ ?[O'Y_F?!9W_ +]/Y?DC5\-?\C+IW_7=:ZWXE?ZC3O\
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MX_/\SX+._P#?I_+\D:OAG_D9=._Z[K76_$K_ %&G?[TG\EKDO#/_ ",VG?\
M7=:ZWXE?ZC3O]Z3^2UE6_P![I^G^9OA?^156]5^AY[6GX=_Y&33?^OA/YUF5
MI^'?^1DTW_KX3^==M7^'+T/)PW\:'JOS.I^)?^LTWZ2?^RUP==Y\2_\ 6:;]
M)/\ V6N#KGP/^[Q_KJ=N=?[]4^7Y(V?"?_(TZ?\ ]=/Z&O9*\;\)_P#(TZ?_
M -=/Z&O9*\_,_P"*O0][AS_=Y?XOT05S_B7_ (__  W_ -A4?^B)JH>*O^0I
M%_UQ'_H35AU\EB,Y]C5E3Y+V\_\ @'V=++_:04^;?R_X)Z717":'_P AFV_W
MC_(UW==V!QGUNFY\MK.V]SFQ.']A)1O<****[3F"BBB@ HHHH **** "N.\=
MS:M;3Z!<Z-81:C>17S,MC)/##YP\F0':TG(8 DY7)P#D8S78UY?X[MK.]U6+
M59]/\;R2:?=?9A%HZOB3,1/F( PPO[S:7&"2"O2@#=\"W$YN=6M;KP?8^&IT
M:.=XK:]AG:8OO^9Q& 5^[P6ZY..AKLZX3X=?V<[ZG+:Z)XHL;DB(37'B%'\R
M<#?M",S-D+SD#&-P]:[B::*V@DGGD2*&)2[R.<*J@9))[ "@!]%9>D>(M*UX
MS+IUWYKPX\Q&C:-@#G:VU@"5.#AAP<<&H;KQ9H5EK4.D7.H)%>S2"*-&1MID
M.,)OQMWG(PN<G/2@#:HHHH Y[P6<^'I"3G_B8W__ *5S5T-<]X+.?#TA)S_Q
M,;__ -*YJZ&@!DO^I?\ W37G%>CR_P"J?_=-><4T)A1113)/24^XOTKS3XC?
M\ARV_P"O8?\ H35Z6GW%^E>:?$;_ )#EM_U[#_T)J[,O_CH\G/O]R?JCCJ**
M*]\^%.^^&G_,4_[9?^SUW]<!\-/^8I_VR_\ 9Z[^OG<?_O$OE^2/OLE_W&'S
M_-A1117(>J%%%% !1110 4444 %%%% !1110 4444 %%%% !7DY;P5J^EM8W
MGBJ31F@N+RUN+2XU&&*1XGF)>)@?^69(&TCD*< \FO4+Z2YBL9Y+*W2XNE0F
M*%Y-BNV. 6P<#WQ7D</AGQ)JFE7$=Q\/_"\&I7,L_P#Q,[E8&>,F5MK&/R2&
MP, $_>P">IH ]C    Z"EI!G SU[XI: "BBB@ KG_$F?[6\+8&?^)L>W_3K<
M5T%<]XD_Y"WA;_L+'_TEN* ,/XE_ZO3?K)_[+7G]>@?$O_5Z;]9/_9:\_KZ+
M ?[O'Y_F?!9W_OT_E^2-7PS_ ,C-IW_7=:ZWXE?ZC3O]Z3^2UR7AG_D9=._Z
M[K76_$K_ %&G?[TG\EK*M_O=/T_S-\+_ ,BJMZK]#SVM/P[_ ,C)IO\ U\)_
M.LRM/P[_ ,C)IO\ U\)_.NVK_#EZ'DX;^-#U7YG4_$O_ %FF_23_ -EK@Z[S
MXE_ZS3?I)_[+7!USX'_=X_UU.W.O]^J?+\D;/A/_ )&G3_\ KI_0U[)7C?A/
M_D:=/_ZZ?T->R5Y^9_Q5Z'O<.?[O+_%^B.0\5?\ (4B_ZXC_ -":L.MSQ5_R
M%(O^N(_]":L.OS;,?]ZGZGZ+A/X$30T/_D-6W^\?Y&N[KA-#_P"0U;?[Q_D:
M[NO=R+^!+U_1'F9G_%7H%%%%>T><%%1RW$,&/.FCCW=-[ 9_.H_M]G_S]P?]
M_!0!8HJ.*X@G)$,T<F.NQ@<5)0 4444 %<!-XOM/"GC76HO%%[<VEO>-"VFS
M2AVMC&(\,JD957WAR<X)RO)XQW](RJXPRAAZ$4 <9X*UM_$>N:_JMC)>2>'Y
M3;K9/<!U5Y K>:T2L 53[@],ACW-:WC;3[K5O ^N:?91^9=7%E+'$F0-S%3@
M9/KTK>Z# HH \^TS4)7\2ZAXG32-76Q73;2P$)LG2:27S7+;8V )""1<MC'W
ML'@U'X@O3K7CVQTW4=&U==*TBYBNH9H]/ED2ZNB"$.]5*K&@8Y)/)/8*<^BT
M4 9^IPZS*8O[*O["U SYGVJR>?=TQC;*F._K^%9_V/QA_P!!W0__  33?_)5
M=!10!S?@43#POBXD2287]]YCHA16;[7+DA26('MDX]:Z2N?\%Y_X1^3)R?[1
MO^__ $]S5T% #)?]2_\ NFO.*]'E_P!2_P#NFO.*:$PHHHIDGI*?<7Z5YI\1
MO^0Y;?\ 7L/_ $)J]+3[B_2O-/B-_P ARV_Z]A_Z$U=F7_QT>3GW^Y/U1QU%
M%%>^?"G??#3_ )BG_;+_ -GKOZX#X:?\Q3_ME_[/7?U\[C_]XE\OR1]]DO\
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M?I)_[+7!UWGQ+_UFF_23_P!EK@ZY\#_N\?ZZG;G7^_5/E^2-GPG_ ,C3I_\
MUT_H:]DKQOPG_P C3I__ %T_H:]DKS\S_BKT/>X<_P!WE_B_1'(>*O\ D*1?
M]<1_Z$U8=;GBK_D*1?\ 7$?^A-6'7YMF/^]3]3]%PG\")H:'_P AJV_WC_(U
M/XE_Y##?[BU!H?\ R&K;_>/\C4_B7_D,-_N+6L?^1>_\7Z$/_>U_A_4R*U?#
MN/[:A^C?R-95:OAW_D-0_1OY&N?!?[S3]5^9KB/X,O1C->_Y#=S]5_\ 016;
M6EKW_(;N?JO_ *"*S:G%_P"\3]7^8Z'\*/HC:\,?\A8_]<C_ #%=C7'>&/\
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M@ HHHH **** "BBB@ HHHH **** "O&V\4:X'8?VE/P?6O9*\Y/PWNRQ(OX
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M1110 4444 %%%% !1110 52.CZ8R!&TVS*"X^UA3 N!/G/F]/OYYW=<U=HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g3dyckr3udth000040.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000040.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $  M # 2(  A$! Q$!_\0
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M7W_@PG_^+H_L&R_YZ7W_ (,)_P#XNM.B@#,_L&R_YZ7W_@PG_P#BZ/[!LO\
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MMJG_ ($#_"C^PC_T%M4_\"!_A6O10!D?V$?^@MJG_@0/\*/["/\ T%M4_P#
M@?X5KT4 9']A'_H+:I_X$#_"C^PC_P!!;5/_  ('^%:]% &1_81_Z"VJ?^!
M_P */["/_06U3_P('^%:]% &1_81_P"@MJG_ ($#_"C^PC_T%M4_\"!_A6O1
M0!D?V$?^@MJG_@0/\*/["/\ T%M4_P# @?X5KT4 9']A'_H+:I_X$#_"C^PC
M_P!!;5/_  ('^%:]% &1_81_Z"VJ?^! _P */["/_06U3_P('^%:]% &1_81
M_P"@MJG_ ($#_"H%MYM.U[3XEU"\FBG24.D\@8?* 01QP:WJR;__ )&/2/\
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MG1;.TFD&UI(H@&(],]A["BP\'>'-+ENY+'1;*W>\4I.T<0!=3U7V!]!3>O\
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MI)F098+GC\ZR]1\4"RUYM%2*-KR6.(VJN^T.SE\[CCY5 3ZG. ,UT 15)*J
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MB@ HHHH **** "BBB@!#T-9OAW_D6=*_Z](O_0!6D>AK-\._\BSI7_7I%_Z
M* &>&_\ D")_UVF_]&O6M63X;_Y B?\ 7:;_ -&O6M0 4444 %%%% !1110
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M%_Z *TCT-9OAW_D6=*_Z](O_ $ 4 ,\-_P#($3_KM-_Z->M:LGPW_P @1/\
MKM-_Z->M:@ HHJM_:%EYMS%]K@\RU4-<+Y@S$",@M_=& 3S0!9HK-_X2#1?[
M*_M3^UK'^S\[?M7VA?*SG&-V<9S6A')'-$DL3J\;J&5U.0P/0@]Q0!0TO5XM
M5FU*.*)T-A=M:.7Q\S!%;(QVPX_*M&N7\'?\?OBK_L-R?^B8:ZB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *R;_\ Y&/2/]V?_P!!6M:LF_\ ^1CTC_=G_P#05H UJ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH RI?^1KM/^O&;_P!#BK5K*E_Y&NT_
MZ\9O_0XJU: "N<\=^(9_"W@K4M9MHUDGMT41AAD;F8*"1WQNSCVKHZJ:IIEG
MK6EW&FZA L]I<(4EC;N/Z'WH Y#0_&,UKHNJR:V+^YO--NQ!-!%8@S(&52OR
MQ,P88.<CMUZ5!H/B*V\1_$XSVMK?VZPZ,R,M[;- Q)F4Y ;J/>NMT3P_8>'X
M)H[,2L]Q)YL\T\K222M@#+,W)P !^%9+?\E8B_[ ;_\ H]: .JHHHH ****
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MM!%=>"M6MY_MGDRVY27[%%YDVP\-M7OQG\,T :]I?V=_&TEG=P7**=K-#('
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M_P#OV*/[(T[_ )\;?_OV*OVF(\OZ^1A]5POG_7S..^S>.?\ H,Z'_P!_9?\
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MO^P&_P#Z/6KGA/Q98^,=.N;_ $Z.9;>"[>V!E7!?;@[@/0Y'7FJ;?\E8B_[
M;_\ H]: .JHHHH **** "BBB@ HHHH **IB6[^V^2?)V!=^<'.,XJY3:L3&2
MD%0SW45L 9=X![A"?Y5-69K>HVEA9C[5,L>]AM'4G!!/ IPCS22(KU%3IN;:
M5NYHHXD0,H(!]00?UK(GOI]2G>RTM]J(=L]YC(3U5/5OT%,,\^OL8[1WATSI
M)<#AIO54]!ZG\JV(+>*U@2""-8XD&%51P*NRAOO^1AS2Q&D7:/?OZ>7G]W<A
MM;""RM/L]L#&.I?JQ/<DGJ:=;VQMRW[Z1PQ)PV.I.3T%6"0!D\4@96Z,#]#6
M;DWN=,:48VLK6(KFTM[V$PW,*2QGJKC-9GV+4=,YT^;[5;C_ )=KAN0/]E_Z
M&MFBJC-K3H14H0F^;9]UO_7D]#E)_&-E%JD4<UM<QM&K)*&491CCC&>>E:?V
MC5]0_P"/:%;" _\ +6<;I"/9!P/Q-5[WP]I=SKT5U*IWL"[KNPK,,8R*Z"M9
MSII+D6OF<6'HXJ4IJO/2^EM&_5_=L9MMH=I#*)Y]]W<C_EM<'<1]!T'X"K-^
MZI83[F"YC;&3CM5FH9S;@+]H,0&>/,Q_6L>=MWD=JHQA!QIJUR2-E= 58,/4
M'-.J.$PF/]P8RF?^6>,9_"I*DU5[:B$!E*GH1@U!#96\$F^*,*QZG)J<G )Q
MG'I44=P)7*A)!@X)9< 4<UM+[A[-2]ZVQ-1110,0]#6;X=_Y%G2O^O2+_P!
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M^-=A7+^#O^/WQ5_V&Y/_ $3#744 %%%% !1110 4444 %%%% !1110 4444
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M@D,-JAN9QU5#POU;H*X;XD:GIVD:/#/K^JQ6]Q-(JP01QEL@.I; ')P.2?\
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MI9PRL,@CS7X-4(_A]X5@M(;2#1X8K:*Z%X(8RP5I0, L,_,!G@'CVK0\-_\
M($3_ *[3?^C7K6H *J:G=7%GIMQ<6EE)>W$:9CMHW"F1NPRW ^IJW6?KEG>Z
MCHEW9Z??FPNIHRD=T(]YBSU(&1SC..: .,O/B9/8Z5=/-I4/]HVVJ)IDD<=P
MTD&]DWE@ZQEB%7J-F01BNIL/$EA-HUC?WNH:;!]KC\Q"EV#&P_V&8*6'3L*Q
M=(\'ZUH?ANWTO3]=M+66VF$B20Z?\DHP0PE5I"7))W;@RG(%7+'P!H$.@:=I
M6HZ?;:J+%7"2WD".<NVYR!CC)/0>U $?@B>&YG\3S02QRQ/K4A62-@RL/)AZ
M$=:ZRN0\!65KIQ\2V=E;Q6]M#K,BQPQ*%5!Y,)P .E=?0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9-__
M ,C'I'^[/_Z"M:U9-_\ \C'I'^[/_P"@K0!K4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!E2_\C7:?]>,W_H<5:M94O_(UVG_7C-_Z'%6K
M0 4444 <?H_@.TB\&2>'-=6._MY+J6X949D!W2F1>00>,BL[0?"^B^%?B<;;
M1+(6D,^C-)(HD9]S"90#\Q/:O0:Y5O\ DK$7_8#?_P!'K0!U5%%% !1110 U
MUW+C<R^Z]:9#"(%VAW8=@QZ5+12LKW'=VL%%%%,1#]F3S?,W2;O]\U-11222
MV&VWN%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'H:S?#
MO_(LZ5_UZ1?^@"M(]#6;X=_Y%G2O^O2+_P! % #/#?\ R!$_Z[3?^C7K6K)\
M-_\ ($3_ *[3?^C7K6H **** "BBB@#E_!W_ !^^*O\ L-R?^B8:ZBN7\'?\
M?OBK_L-R?^B8:ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *R;_\ Y&/2/]V?_P!!6M:LF_\ ^1CTC_=G
M_P#05H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH RI?^
M1KM/^O&;_P!#BK5K*E_Y&NT_Z\9O_0XJU: "N:\?ZS>:!X(U'4;!@MU&$2-V
M7<$+NJ;L'KC=G\*Z6J]]8VNI6,UE>P)/:SH4EB<9#*>QH X[0/$%_8/XDL;\
MW^KKI%['##)% 'GD1XU;!5  =I8\XZ52/B.8^.TUC_A&O$?V1=,:U)_LYMV\
MRJW3/3 /-=MI&B:=H-HUMIEJL$3N9'^8LSL>K,Q))/ ZGM6A0!RO_"<)_P!"
MWXE_\%C?XU#<_$2SLQ$;G0O$40ED6*/?IK#<[=%'N:["L;Q%I+:M'INV>.$6
MFH07;%Q]X(?NCW.: ,[_ (3A/^A;\2_^"QO\:/\ A.$_Z%OQ+_X+&_QKJJ*
M.5_X3A/^A;\2_P#@L;_&J]C\2+#5+..\L-$\07-K)G9+%IS%6P2#@Y[$$?A7
M9$X&37.^!=!?PSX/LM(DNHKIH#*?.B&%;=(S\?3=C\* *_\ PG"?]"WXE_\
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M:<Q,;X!VGG@X(/XUV5<]X:T)M'U#Q!<-=13C4=1:Z"H.8\HJ[3[_ "T 5O\
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M;\#'55U4W7BKQ8/LNI3VL>W5G&40@#/J?>@#U6BN%_X5A;?]#9XO_P#!P_\
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M%% !1110!E2_\C7:?]>,W_H<5:M94O\ R-=I_P!>,W_H<5:M !1110 4444
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MC[MP);D*0O3J,CGU /:**AM9OM%G!.1CS(U?'ID9J:@ HHHH **** "BBB@
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M2&X$D:@H53Y@  .<8QQBN,O?AOJUWI.O1R65I)=7.BV%I:,[J2LL2X?!_AY
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MW%. "J    , #M67_P )/X?_ .@YIG_@7'_C1_PD_A__ *#FF?\ @7'_ (T
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M0!JT5E?\)/X?_P"@YIG_ (%Q_P"-'_"3^'_^@YIG_@7'_C0!JT5E?\)/X?\
M^@YIG_@7'_C1_P )/X?_ .@YIG_@7'_C0!J'H:S?#O\ R+.E?]>D7_H II\3
MZ!C_ )#FF?\ @7'_ (T[PX0?#&E$'(-G%@C_ '!0 SPW_P @1/\ KM-_Z->M
M:N9T/7]&M-,\BYU>PAF2>8/')<HK*?-?@@GBM'_A)_#_ /T'-,_\"X_\: -6
MBLK_ (2?P_\ ]!S3/_ N/_&C_A)_#_\ T'-,_P# N/\ QH U:*RO^$G\/_\
M0<TS_P "X_\ &C_A)_#_ /T'-,_\"X_\: -6BLK_ (2?P_\ ]!S3/_ N/_&C
M_A)_#_\ T'-,_P# N/\ QH U:*RO^$G\/_\ 0<TS_P "X_\ &C_A)_#_ /T'
M-,_\"X_\: -6BLK_ (2?P_\ ]!S3/_ N/_&C_A)_#_\ T'-,_P# N/\ QH U
M:*RO^$G\/_\ 0<TS_P "X_\ &C_A)_#_ /T'-,_\"X_\: -6BLK_ (2?P_\
M]!S3/_ N/_&C_A)_#_\ T'-,_P# N/\ QH U:*RO^$G\/_\ 0<TS_P "X_\
M&C_A)_#_ /T'-,_\"X_\: -6BLK_ (2?P_\ ]!S3/_ N/_&C_A)_#_\ T'-,
M_P# N/\ QH U>G2BLK_A)_#_ /T'-,_\"X_\:/\ A)_#_P#T'-,_\"X_\: -
M6BLK_A)_#_\ T'-,_P# N/\ QH_X2?P__P!!S3/_  +C_P : -6BLK_A)_#_
M /T'-,_\"X_\:/\ A)_#_P#T'-,_\"X_\: -6BLK_A)_#_\ T'-,_P# N/\
MQH_X2?P__P!!S3/_  +C_P : -6BLK_A)_#_ /T'-,_\"X_\:/\ A)_#_P#T
M'-,_\"X_\: -6BLK_A)_#_\ T'-,_P# N/\ QH_X2?P__P!!S3/_  +C_P :
M -6BLK_A)_#_ /T'-,_\"X_\:/\ A)_#_P#T'-,_\"X_\: -6LF__P"1CTC_
M '9__05I?^$G\/\ _0<TS_P+C_QJDVK:;J/B;2DL=0M+ID2<LL$RN5&%Y(!H
H Z*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g3dyckr3udth000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %K M # 2(  A$! Q$!_\0
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MT'=1_P# EO\ &C_A*O$7_0=U'_P);_&IO^$3U#_GO9?]_O\ ZU'_  B>H?\
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MJ'_/>R_[_?\ UJ/^$3U#_GO9?]_O_K4>PJ_RO[@^NX;_ )^1^]$/_"5>(O\
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M:F_X1/4/^>]E_P!_O_K4?\(GJ'_/>R_[_?\ UJ/85?Y7]P?7<-_S\C]Z(?\
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M%N" 'QC=TZT>PJ_RO[@^NX;_ )^1^]%_;XW\HR/K-[&H>)&,EVZA3(!C)/
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M #TM?^^S_A2_\*\UC_GK:?\ ?9_PK3ZW0_F1S_V7C/\ GVSDJ*ZW_A7FK_\
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M_P!__P#ZU'MZ?</J5?\ E_(R**U_["'_ $%=-_[_ /\ ]:C^PA_T%=-_[_\
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M;_W_ /\ ZU']A#_H*Z;_ -__ /ZU'MZ?</J5?^7\C(HK7_L(?]!73?\ O_\
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MG_A M6_YZVO_ 'V?\*/^$"U;_GK:_P#?9_PH^MT/YD']EXS_ )]LY:M?PO\
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M_"C_ (0N_P#^>\'_ (]_A47]M^(O6?\ [\?_ %J/[;\1>L__ 'X_^M1_M?\
M-'^OD'_"7_S[G_7S)?\ A"[_ /Y[P?\ CW^%'_"%W_\ SW@_\>_PJ+^V_$7K
M/_WX_P#K4?VWXB]9_P#OQ_\ 6H_VO^:/]?(/^$O_ )]S_KYDO_"%W_\ SW@_
M\>_PI?\ A"K_  #Y\'/^]_A4/]M^(O6?_OQ_]:C^W/$>!S/[?N/_ *U'^U_S
M1_KY!_PE_P#/N?\ 7S)?^$+O_P#GO!_X]_A1_P (7?\ _/>#_P >_P *B_MO
MQ%ZS_P#?C_ZU']M^(O6?_OQ_]:C_ &O^:/\ 7R#_ (2_^?<_Z^9+_P (7?\
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MA7[A_8."[/[SDK3P?=Q7<4DMRJHK DQ9W?AQ71:O82:C82VJ,$+NIW.FX8#
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MY>PYZ]JU+.[M]0M([NTG$L$HRCKT(K)/A/1 @5K0[-V0K3O@-@ $<]0  /3
MQ6S;PK;0)#&&V(,#<Y8_F>30!)CW-&/<T9/I^M&3Z?K0 8]S1CW-&3Z?K1D^
MGZT &/<T8]S1D^GZT9/I^M !CW-&/<T9/I^M&3Z?K0!P#^,=-#L#'/P2/N?_
M %Z3_A,M-_YYS_\ ?'_UZCDT3PV)7#W*AMQR#<#@TW^Q?#7_ #]+_P"! KT.
M7"_RR/!=7,[_ !P^\F_X3+3?^><__?'_ ->C_A,M-_YYS_\ ?'_UZA_L7PU_
MS]+_ .! H_L7PU_S]+_X$"GR87^60>US/^>'WDW_  F6F_\ /.?_ +X_^O1_
MPF6F_P#/.?\ [X_^O4/]B^&O^?I?_ @4?V+X:_Y^E_\  @4<F%_ED'M<S_GA
M]Y-_PF6F_P#/.?\ [X_^O1_PF6F_\\Y_^^/_ *]0_P!B^&O^?I?_  (%']B^
M&O\ GZ7_ ,"!1R87^60>US/^>'WDW_"9:;_SSG_[X_\ KT?\)EIO_/.?_OC_
M .O4/]B^&O\ GZ7_ ,"!1_8OAK_GZ7_P(%')A?Y9![7,_P">'WDW_"9:;_SS
MG_[X_P#KTH\9Z: ?W<_(_N?_ %Z@_L7PU_S]+_X$"E&B>&<'-VO3_GX%')A?
MY9![7,_YX?>2_P#"9:;_ ,\Y_P#OC_Z]'_"9:;_SSG_[X_\ KU#_ &+X:_Y^
ME_\  @4?V+X:_P"?I?\ P(%')A?Y9![7,_YX?>3?\)EIO_/.?_OC_P"O1_PF
M6F_\\Y_^^/\ Z]0_V+X:_P"?I?\ P(%']B^&O^?I?_ @4<F%_ED'M<S_ )X?
M>3?\)EIO_/.?_OC_ .O1_P )EIO_ #SG_P"^/_KU#_8OAK_GZ7_P(%']B^&O
M^?I?_ @4<F%_ED'M<S_GA]Y-_P )EIO_ #SG_P"^/_KT?\)EIO\ SSG_ .^/
M_KU#_8OAK_GZ7_P(%']B^&O^?I?_  (%')A?Y9![7,_YX?>3?\)EIO\ SSG_
M .^/_KT?\)EIO_/.?_OC_P"O4/\ 8OAK_GZ7_P "!1_8OAK_ )^E_P# @4<F
M%_ED'M<S_GA]Y-_PF6F_\\Y_^^/_ *]*?&>F[5'ES\?['_UZ@_L7PU_S]+_X
M$"K/_"*:,45@LQ##.1(>:36#6ZD5&6:R^&4&,'C'3<_<G'_ /_KUMQ7$<\2R
MQ%7C<95@3@UC_P#"*:/_ '9O^^S6O'%%#&L<>$11A5"\ 5SUO867LK_,[L']
M=3?UEJW2Q)O_ -D?F:-_^R/S-)A?[Q_*C"_WC^5<YW7%W_[(_,TFX?W%_6C"
M_P!X_E1A?[Q_*@ W#^XOZT;A_<7]:,+_ 'C^5&%_O'\J #</[B_K1N']Q?UH
MPO\ >/Y487^\?RH  PR/D7K[U%>7B6<;2M$SG>%5$^\S$X '..OK4H"Y'S'\
MJCN[6"[C>&;<4)SP2I!!R""#D$'N* *S:U9(J^=((W+;#&P8L&R 5P,\@L.G
MK4/_  D^CAMAOH@QC\W;ALE?7&._YFGIHFFI<_:!&YEX(+.QP>.<$XR<#)[]
MZ7^Q=.$F\1$'8L9 9L$+C;D9Y(P.>O% $?\ PD.FN2@<LHQO8QN% *D\D^RG
M(ZCO4KZSIL06-YH@C@X&UBN 2#GL!P1SUQQ1_9%@&9E0@MG/)(S\W.,XS\[?
MG47_  C^F_9(;?;)MA@$"'<?N@$ D9PQ&202#@F@!'\4Z+"J&2_AC$F=H<,I
MP/8C([8SU[47/B.QMK5;C;)+&PS^[C.>'5""#@Y!8<?6D7PYI0C1#'(VU2A9
MI'+.#U#'/(X[]*M'3+%G#M'E@YDSS]XL&)Z_W@#^% %:+Q!:S7"QQP2M&SB/
MSP!L#%F50><\E3SC'(K4W#^XOZUG6^@Z7:21-!"8Q$<H@=M@.20=N<9!9L'M
MFM'"_P!X_E0 ;A_<7]:-P_N+^M&%_O'\J,+_ 'C^5 "AAN'R+U]ZUJR0%W#Y
MCU]*UJ "BBB@ HHHH **** "BBB@ IR?ZQ?K3:<G^L7ZT 6Z:QPRYIU-/WEH
M Y_7O#<6LWZW+"W;%G-;%9%(+%V0@[AR,;#T]:Q%\":@B&5=:'VPD8DV$*/]
M',).P8&X9R#CM6QX@DUN/4E_LVZEB@-E,Y_T<21K*"@3.%+<AFX&>G0X(.+'
MKOB]4^T/ID[0@C$1BS*Q^SDXX4#!EQ\W'I@4= ZEQ?"%[!X:_L:*_M988IT>
MU66#:L2K()!]WO\ PC' %,F\%S75\T\DUM$IU+[8IA!R%/EDK@C&XF(?-P1D
M_B]-6\0Q^%U-U:WD>IV]PD4LHM5<3CS0&(1"< ISD# YP:IKJ_C)KN,+97#6
M_P!NB$S?9U4HAD*LB@X++MVG>,XYY]'U_KR#H=]N'K1N'K2T4@$W#UHW#UI:
M* *.K6KZAI<]K%*L;R  %@2#R#@X['H?8UA6OA+9=VUU<30N\!)6(*2B@ER1
M[X)3!_V:WM6GN;;2YYK2,O.H&T!=Q'(!.T=<#)QWQBN<M+CQ)/=6FZ6=+0%A
M+(T*[G!+[3@QCLH[+@L,[J Z'1Z580Z7I=O9QB,>6@#%%"AF[G'N:N;AZU1T
M5;Q=)MVOYY)KIU#N9$52I/\ #A0!Q5^A@)N'K1N'K2T4 )N'K1N'K2T4 <MJ
MWAF;4KR[Q/;"UNU82[X@9"#'LV9Q]WC/!'4]<U"OA6ZCE+M<6ETTLT3SM-&0
MVV,ML"D9P0-@S['UJU>:CJEKK4ZJ)Y;-9(V/EVQ(CCX#?PY8G).5)X!X&.:+
M7OBE_,*),F^ ",F%<!S@]-I(/)Y.1P1C-"V&/U'PE=7DU]+]MAE^URK(\4B%
M -I(4;EYX4XJ_<>'Y99K)TNXU\FW$4P,?^L9 ?+;&>-K$G%207NHP7]S!*DM
MT(H86/[LJH.&W[6V@.>%.!Z]JR4U_P 26]M&EQIC?:"TA;S(&/! 9/\ 5Y
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MX_YES_A"+C_G\C_[]FC_ (0BX_Y_(_\ OV:I_:_$_P#T^_\ ?K_ZU'VOQ/\
M]/O_ 'Z_^M1_M/\ S\C_ %\@MEW_ #XG^/\ F7/^$(N/^?R/_OV:/^$(N/\
MG\C_ ._9JG]K\3_]/O\ WZ_^M1]K\3_]/O\ WZ_^M1_M/_/R/]?(+9=_SXG^
M/^9<_P"$(N/^?R/_ +]FC_A"+C_G\C_[]FJ?VOQ/_P!/O_?K_P"M1]K\3_\
M3[_WZ_\ K4?[3_S\C_7R"V7?\^)_C_F7/^$(N/\ G\C_ ._9H_X0BX_Y_(_^
M_9JG]K\3_P#3[_WZ_P#K4?:_$_\ T^_]^O\ ZU'^T_\ /R/]?(+9=_SXG^/^
M9<_X0BX_Y_(_^_9KI["P-AIT%L'>38#EF_IZ"N-^U^)\_P#+Y_WZ_P#K5VEJ
M;AK&W-TJK.5^<*> :X\8ZW*E4DFO(]7*HX7VDG1IRB[=;_YLFV-_=-&QO[II
MM%<![@[8W]TT;&_NFFT4 .V-_=-&QO[IIM% #MC?W31L;^Z:;10 [8W]TT;&
M_NFFT4 ."-D?*:5D;>WRGK31U'UJOJ#S1V[M;@F3>H  SQN&?TS0!9V-_=-&
MQO[IKD5O]=&V*\-S"@VLUQ#:!B0QD(&-IY&%!X]#WJTEYJ<QA>9YK>,E8I3!
M!YA60)D\8. 6.">VW&1UH!Z'2;&_NFC8W]TUS:W.LVUQ:H5N;J+[0_VAVB08
MCW[% P!V^;@$\>E.EUO4HOM7_$N:3RY'CB\N&0AN/DY[Y[G  ]30!T6QO[IH
MV-_=-<Q;:IK\MK%BSA,@VAWE@D3)^0$;>.06;)Z';Q4;Z]K4:\Z: Q7=M,,C
M8/'' Z=<=23P<=: .KV-_=-&QO[IKF8=8UJ226,:=@[]J>;"XPI*X<D<8^8_
M*.1MZTMSJ.JL8?(25+DVY9X6MSY1;=@8;!(/!.,\#L30!TNQO[IHV-_=-<_=
MWFJ100C#)=M<R*$BA,D3(#P&;;D C !XR3Z"JUOJ&I,8EDN+Q<I(Q>2Q."H7
MC@+]X-G XR%[Y% '4A&W#Y3UK7KGM-EDGTZTEE#"5XT+[D*G=@9R#TYS70]Z
M "BBB@ HHHH **** "BBB@ IR?ZQ?K3:<G^L7ZT 6Z:WWEIU-;.Y<4 8FL>(
M6TB^%M_9US<@VLESNA8$X0J"-O4GYE_7TJA%X]TF24(?-'&XR*0T87R3,6WC
MC& 1ZY[5KZ@VC-=A+^:S6Z$+JHDF".(S@MCD$#Y0<^U5ETCPU-;B!+?3WA=@
M0BL"&;R\#OR=F?J*.@$4'BVSN/#T.K1PS-O=$DMPZ&2(M)Y9W<XP#Z9]JD?Q
M*B.R_8;D[-1%@PW+G<0I# 9Y&&!XY !/:GR:5X=FTUF,%@+*ZE64NC!4D<D;
M3N!YR<8]Z8NC^'/MJSJEK]I^U,RL)SN\_;\PZ_>VCD>@IAT-[;[G\Z-ON?SJ
M"6]MH5D:6Y@C6)@LA>0 (3C /H3D?F*B?5M/B$IDU"T00OLD+3*-C>AYX/L:
M0%S;[G\Z-ON?SJF=6T]7D0ZA:!HCB13,N4/OSQ5B*XBN%W0RQR#@Y1@>HR.G
MJ"#^- #+RZAL+22ZN'98HQEB 6/IP!R36--XNTY;%[F%;B79_P LS&R,>F,!
MAZL!6[+"D\?ERHKID'!]0<C]16?+9Z18JDL\=I L9#*\C!0,;0#D^F%_(4 4
M;?Q99RNJRPS6^8EE+2,-H4J68YST50"?9A6KI5_%JVFQ7L2NB29PK$$C!([$
MCM50:?H4_EXALI/+)*<AL;E!_557\!6A9Q6\5LHLTA6!\NOE?=.XYR,<<YS0
M!/M]S^=&WW/YT?-[4?-[4 &WW/YT;?<_G1\WM1\WM0!@ZEXHL]-N[JU96>6W
MB21OWBJ#N8+C)/&-RDD\8-01^+HYII(8M/N3*-@C5V"[V;9QD],;Q6LVEZ;/
M<M,;6V>X60.SX&X-@$9/7H%_(5"^CZ1>SW4A@AEE=@LQ60Y5AM/8_*>%/&#P
M* +EA=K?V27"I)'N)#(YY5@2"#CC@@U9V^Y_.H$6WTVR"CRK>UA7N=JH!ZFG
M074-RBO!/%*K#<K1N&!'3(Q0!+M]S^=&WW/YT?-[4?-[4 &WW/YT;?<_G1\W
MM1\WM0 @C5<[1MR<G'&32[1[T?-[4?-[4 &WW/YT;?<_G1\WM1\WM0 ;?<_G
M1M]S^='S>U'S>U 'FK^-D61A_9_0D?ZP?X4W_A-T_P"@?_Y$'^%7F7PMO;)L
M\Y.>:;M\*^MG^=>E_L__ #ZE^/\ F?/MX_\ Z"8?A_D4_P#A-T_Z!_\ Y$'^
M%'_";I_T#_\ R(/\*N;?"OK9_G1M\*^MG^='^S_\^I?C_F*^/_Z"8?A_D4_^
M$W3_ *!__D0?X4?\)NG_ $#_ /R(/\*N;?"OK9_G1M\*^MG^='^S_P#/J7X_
MYA?'_P#03#\/\BG_ ,)NG_0/_P#(@_PH_P"$W3_H'_\ D0?X5<V^%?6S_.C;
MX5];/\Z/]G_Y]2_'_,+X_P#Z"8?A_D4_^$W3_H'_ /D0?X4?\)NG_0/_ /(@
M_P *N;?"OK9_G1M\*^MG^='^S_\ /J7X_P"87Q__ $$P_#_(I_\ ";I_T#__
M "(/\*4>.$ /_$O/(_YZ#_"K>WPKZV?YTH7PIALFSZ<<T?[/_P ^I?C_ )A?
M'_\ 03#\/\BE_P )NG_0/_\ (@_PH_X3=/\ H'_^1!_A5S;X5];/\Z-OA7UL
M_P Z/]G_ .?4OQ_S"^/_ .@F'X?Y%/\ X3=/^@?_ .1!_A1_PFZ?] __ ,B#
M_"KFWPKZV?YT;?"OK9_G1_L__/J7X_YA?'_]!,/P_P BG_PFZ?\ 0/\ _(@_
MPK:TK5X]5MC+''L93AT(Z'Z]ZH[?"OK9_G6M9BR%JGV+;Y'.WR\8K&O['E]R
M#3\SLP7UKVG[VM&:[*U_PL3[SZ+^5&\^B_E1\GJWY4?)ZM^5<9ZH;SZ+^5&\
M^B_E1\GJWY4?)ZM^5 !O/HOY4I;Y%X7OVI/D]6_*G'9L7EN_:@!N[_97\J-W
M^ROY4?)ZM^5'R>K?E0 ;O]E?RHW?[*_E1\GJWY4?)ZM^5 !N_P!E?RHW?[*_
ME1\GJWY4?)ZM^5 !N_V5_*C=_LK^5'R>K?E1\GJWY4 &[_97\J-W^ROY4?)Z
MM^5'R>K?E0 !N1\J_E2LWSMPO7TI!LR.6Z^E*VS>W+=?2@!-Y]%_*C=_LK^5
M'R>K?E1\GJWY4 &\^B_E1O/HOY4?)ZM^5'R>K?E0 ;SZ+^5&\^B_E1\GJWY4
M?)ZM^5 !O/HOY4;SZ+^5'R>K?E1\GJWY4 &\^B_E1O/HOY4?)ZM^5'R>K?E0
M H;YAPO7TK6K)&S<.6Z^E:U '->,%UNWTNZU/2M:%DEG:R2M ;59?-903]X]
M/2JFEZEJ6D>$9/$NO:R+Z!K%+E8%M5BV,1G:"/O9) K>\16_VOPSJMMYBQ^;
M:2)O8$A<J1DXKD]3T:/5]#\-:#/J(33X ANO*#*\YCC^4*<<#(SSZ"BW]?C^
M1+G%.S?]/1?B6/"VK^(+J:]T/Q#.EOJTEJE[:31Q !8W&",="4;@U03QCKES
M!%X8BB2/Q@)S;W$ACS%%$O)N<=-I7&!ZFI9/#%I:ZUIVKZ1K%\U]92_O/[0N
M'F5X"")$&>A.,_45KPQ0)\0+K6?M*&.?3(X%BV'>,.6W$],5"J0>S\_D/F6F
MNYA:KXAOX?$]YIFH^*!X=M[58Q:226:L+W*_-(SL-N,\;1BK^L>*+C09?";7
M^L63V=Y)*M]=Q1@12J$RI7KM&<=#2ZYJNM0W%PUO?:)<:=*VU(;^UDW0\<C*
MY##C/..M8VD:/I]K)X:MHM2CN7TN>YN[F/[.RAO,0DJBXP ,\"K3OL-.^QMP
M^-;35O'>D:9HNJ6]W8RVUP]TL0R0R@;.2,CO53Q!XNU:S\07-QI^QM!T1X8]
M5_=Y:1I#\VT]M@*D_6GZG>Z<WBO3M:M+N"(V%G<(T30,"6< *3@= <9K&L?#
MGAF'2I8-4U_5)[FX\R2_:UN)$AED)^?Y<8QVYZXH ]45E=0Z,&5AE6'0@]#3
MT_UB_6N<\%1RVWAJ&PGO$NWLG:W655()0?<# ]PI _"NC3_6+]: +=-;[RTZ
MFG[RT 8NL^'XM8NUGD="!:2VQCDC+*V]D.200>-G8@\]1BL/_A7[;6D_MF<W
MC=;AD)./(,)XW8)P<ACSZYK3\0:9J=WJ2S65Q>PP_8ID8V]QC$I*;"$+ $XW
M^GU!P:Q8[/QQ&GG[LL"-MKYX(S]G*YWLQ./,()!R<\Y-'0?4TAX.D@\/MI$&
MI[H%G66!9K92L*B028 7;SGC.0,=J?\ \(M<_;//%Y:K_P 3/^T!MM3E<Q["
MH.[KWSZ]JJK:^*8?"PLI5FEO+:X01SPW@:2=!(#EBP7C9P<G)/:GB#7UO@RQ
M:@8UU<R@-<)M-L8\8/S?=#\A>W7%/K_7D+I_7F.U+P9)JC7<,^JM]CNI4FE_
MT=?-9EBV#)^[C(#?=Z@4U?!<R6R?\37S;H3S3,\T&Z,F5"K?)NX/.<Y_G5'4
M]/\ &LFMW$UM(ZV4LL,QCBNQ\OEA,HF<?*Y+YSC[GO4<=GXWBBNHYEGD>:"=
MHGANU81RR!2JG)& C!@,9P#QFIZ#)/\ A64"*RPZDX5F);S(=YZ$+C)XX)SC
MKQZ5TWA_0DT".[BCG,L4TH>-=F/+0(JA.O.-OY8':L[PW9>(;35&&J2RRVAA
MD=6>8-AVER%QGLHX/8-CM7556PBAJU@NJV)M&E:-&92V ?F .<<$<'BL3_A#
M(#;+:M>S?9P=VP;@<\8(.[(.54Y]<^M=!J0O#82+8,JW+8",P!"Y(R<'K@9-
M<X]GXIN+/[/-=;7D('GIM1HP=F?ND9QE_?CMQ2 D/A >:S1W[0K)&4F6*$#=
MT *YR 0@*]#P:W=+LQINF6]EYIE$*; Y7;D=N!Q^5<W%9^)K:2)HVDF!C"E9
MKD81U3ACR25+.<]3A!UK?T.&^M])BAU%B]TC.&<R;]PW'!S@9XQV% &AN'^1
M1N'^12T4 )N'^11N'^12T4 <UK'ANXU07D:7Z017$RSC$+;T8($^\&'H",8Y
M]13)/"2^=O@NQ$&>21V$1W!F.2RD,,$]"2#D#M3]6?Q%']N72X)#(9U>"1C&
MR;/+ *@,<_?!STZY&>E1>3XEMIW\F26;S99)!YA1D7)X4Y.0H4#;M[YS0##_
M (1%DN+J2*^VI-:BW2,Q$J"-N"1NYP5/O\QYHN?"D]P%;[>B3&4S/MA(0,6S
ME5W8_P"^L\\]:26/Q0[WL#EY+<V@$;H41S+\N=K @@GY^O3 YYIC1^);>.,V
M<<Y0R$K'-*CN$W<*S,2!QW^8XX]Z.H="J/ <JB+;JTA*%B2WF9?(P<G?D9[X
MX],5J>&O#3Z#/<2R7K7+3#&=K*!SG&W<5P.@P,XK-$GCD"+<$)RWF;88L#CL
M-_.#R#D9Z$=SI^&F\2--<'7,+'C]TFQ..>#N4\G&,C P>E,&=%N'^11N'^12
MT4@$W#_(HW#_ "*6B@!-P_R*-P_R*6B@!-P_R*,C_(I:* /,G\$EI&;[=U8G
M_5C_ !IO_"$'_G^_\AC_ !JE)%XG\Q\?;<;CCY__ *]-\KQ/_P!/O_??_P!>
MO9O7_P"?J_ ^1<<'?_=9_C_F7_\ A"#_ ,_W_D,?XT?\(0?^?[_R&/\ &J'E
M>)_^GW_OO_Z]'E>)_P#I]_[[_P#KT[U_^?R_ 7+@_P#H%G^/^9?_ .$(/_/]
M_P"0Q_C1_P (0?\ G^_\AC_&J'E>)_\ I]_[[_\ KT>5XG_Z??\ OO\ ^O1>
MO_S^7X!RX/\ Z!9_C_F7_P#A"#_S_?\ D,?XT?\ "$'_ )_O_(8_QJAY7B?_
M *??^^__ *]'E>)_^GW_ +[_ /KT7K_\_E^ <N#_ .@6?X_YE_\ X0@_\_W_
M )#'^-'_  A!_P"?[_R&/\:H>5XG_P"GW_OO_P"O1Y7B?_I]_P"^_P#Z]%Z_
M_/Y?@'+@_P#H%G^/^9?_ .$(/_/]_P"0Q_C2CP.2#_I_0?\ /,?XUG^5XG_Z
M??\ OO\ ^O0(?%&#C[=TY^?_ .O1>O\ \_E^ <N#_P"@6?X_YE__ (0@_P#/
M]_Y#'^-'_"$'_G^_\AC_ !JAY7B?_I]_[[_^O1Y7B?\ Z??^^_\ Z]%Z_P#S
M^7X!RX/_ *!9_C_F7_\ A"#_ ,_W_D,?XT?\(0?^?[_R&/\ &J'E>)_^GW_O
MO_Z]'E>)_P#I]_[[_P#KT7K_ //Y?@'+@_\ H%G^/^9?_P"$(/\ S_?^0Q_C
M6YI.CKI-J84D,C,VYF)P/P&>*Y3RO$__ $^_]]__ %ZZ70QJ*V&-2/[S/R;O
MOX_VJYL4ZOL_>J)KLCT,MCAO;?NZ$H.V[O\ JS5V-Z#\Q1L;T'YBFT5YQ[X[
M8WH/S%&QO0?F*;10 [8WH/S%.*-L7IW[BHZ<?N)^- !L;T'YBC8WH/S%-HH
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M /K5I->^&-[9%KG)S^Z_^QI/MOA?^[:_]^O_ +&O3M1_Y\O\3YQO%7_WN/\
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M!<?_ "4SO^$XF_Y\8_\ OO\ ^M6KHGB,ZM-+"]OY3JFX%?F&/?CBH_MOA?\
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M)Z-^= !O;V_(4;V]OR%'R>C?G1\GHWYT &]O;\A1O;V_(4?)Z-^='R>C?G0
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M;OXD.T,2VVFF"5@6D,K!RHV,PV+QNZ#/89]ZUSXIN203;09'0\\4?\)3<_\
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M\8ZJLC@&# 8C[G_UZ;_PF6J^L'_?'_UZWS?0DY_L^VY_V1_A2?;8?^@?;?\
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M5^WXG245S?\ PDEQ_P ^\7YFC_A)+C_GWB_,T?VQA.[^YA]0K]OQ.DHKF_\
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M2FG4X3N^5_F7 ./N?*!@<].*?;:SHMWX>AU2'3(GE:1(YK59D+PEI/+))!Y
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M[?F* &6\%O;11P0)Y<48"HBC 4>@K:K)"-N'3KZBM:@ HHHH **** "BBB@
MHHHH *<G^L7ZTVG)_K%^M %NFG[RTZFL,LM '-^(;#5;C4UEL+J]AA^PS!C
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M;V]?TH ;13M[>OZ4;V]?TH 0?>'UK8[UDAVW#GOZ5K4 %%%% !1110 4444
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M ,K_ '/UHRO]S]:-H_OK^M&T?WU_6@ RO]S]:,K_ '/UHVC^^OZT;1_?7]:
M#*_W/UIQ*[%^3U[TW:/[Z_K3BHV+\X[T -RO]S]:,K_<_6C:/[Z_K1M']]?U
MH ,K_<_6C*_W/UHVC^^OZT;1_?7]: #*_P!S]:,K_<_6C:/[Z_K1M']]?UH
M,K_<_6C*_P!S]:-H_OK^M&T?WU_6@ RO]S]:,K_<_6C:/[Z_K1M']]?UH  5
MR/D[^M*Q7>WR=_6D"C(^=>OO2LHWM\Z]: $RO]S]:,K_ '/UHVC^^OZT;1_?
M7]: #*_W/UHRO]S]:-H_OK^M&T?WU_6@ RO]S]:,K_<_6C:/[Z_K1M']]?UH
M ,K_ '/UHRO]S]:-H_OK^M&T?WU_6@ RO]S]:,K_ '/UHVC^^OZT;1_?7]:
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M>( 4\K5PFSC=]HD*GKABF,<# "@A>,G/2IF\2:@U_/:+9HFW<$E,;L"0O"Y
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M.V_[X/\ C1_PEFH?\\[;_O@_XU@Y'J*,CU%'UJM_,P]I/N;W_"6:A_SSMO\
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M #[0?]^E_P */LUO_P ^T'_?I?\ "I\IZ-^=&4]&_.CDCV"R(/LUO_S[0?\
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M'L%D0?9K?_GV@_[]+_A1]FM_^?:#_OTO^%3Y3T;\Z,IZ-^=')'L%D0?9K?\
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M(;;_ //[)_WR*!X-M^<WTG S]T5B_8M=_P">5[_WT?\ &MSP[!JL33_;/,6
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M,;[_ )X0_FW^-'_"8WW_ #PA_-O\:[K_ (1?2?\ GTB_[X%'_"+Z3_SZ1?\
M? H]AB?YPY*G\QPO_"8WW_/"'\V_QH_X3&^_YX0_FW^-=U_PB^D_\^D7_? H
M_P"$7TG_ )](O^^!1[#$_P X<E3^8X7_ (3&^_YX0_FW^-'_  F-]_SPA_-O
M\:[K_A%])_Y](O\ O@4?\(OI/_/I%_WP*/88G^<.2I_,<+_PF-]_SPA_-O\
M&M;0]?EU.2:&6(JZKN#)DKCW]*Z3_A%])_Y](O\ O@5/!H=E;*RP1B)6ZA !
MFKITJ\9)RG=%1C-/5F;O;^\?SHWM_>/YUK?V5!_>?\Z/[*@_O/\ G78:F3O;
M^\?SHWM_>/YUK?V5!_>?\Z/[*@_O/^= &3O;^\?SHWM_>/YUK?V5!_>?\Z/[
M*@_O/^= &3O;^\?SHWM_>/YUK?V5!_>?\Z/[*@_O/^= &3O;^\?SHWM_>/YU
MK?V5!_>?\Z/[*@_O/^= &3O;^\?SI2[;%^8]^]:O]E0?WG_.C^RX< ;GX]Z
M,G>W]X_G1O;^\?SK6_LJ#^\_YT?V5!_>?\Z ,G>W]X_G1O;^\?SK6_LJ#^\_
MYT?V5!_>?\Z ,G>W]X_G1O;^\?SK6_LJ#^\_YT?V5!_>?\Z ,G>W]X_G1O;^
M\?SK6_LJ#^\_YT?V5!_>?\Z ,G>W]X_G1O;^\?SK6_LJ#^\_YT?V5!_>?\Z
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M<?WC0!!14_V<?WC1]G']XT 04Y/]8OUJ7[./[QI1  P.X\&@"6BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g3dyckr3udth000012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #@ KH# 2(  A$! Q$!_\0
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MI&"/ZT?V/9^7Y>QO+W[MN[C.W;_*K]%+F8<J,[^R(4W/&[^?M90[G/48Y^@
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MLNZ)MR#=P#C'2GRZ=#-?1WC%_.BX0AN@[C\:GGD,,+R!"^T9VCO3;:?[1")
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M9%*1D8-5K(E4> ]8FVCZ=1^E+9@6:***H HHHH **** "BBB@ HHHH ****
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M@_A;]XGX]?U_G5JJMY^[,=P/^6;?-_NG@T2[@6J***H HHHH **** "BBB@
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M8C(!/8X[5I5C0: L#Q*+ES CI*8RH^9U  .?3@<5LTW;H3&_4****104444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MINQDXJY#K\LEX4DM!'#'#(\I\P%E9#@@ =142^(Y_M,3/9@6SQ([$2J2FYL
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ML0@@J#D8/%,@MX;6(101)'&#G:HP*EHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g3dyckr3udth000032.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000032.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $$ A,# 2(  A$! Q$!_\0
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M["V^S-Y1+GDKN. 2>M9<%CXOT?0UGM[S61<W/AEY+E[ZX8K%=!TP 7XC?87
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPHV-_P ]6_(?X4 /HIFQO^>K?D/\*-C?\]6_(?X4 /HIFQO^>K?D/\*-C?\
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MCCA2-E9-QW GO6Y28!ZBL,32G5I\M.7*^YI2G&$KR5T<C_PE-]_SQA_[Y/\
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M"2BH_*']]_\ OJCRA_??_OJ@"2BH_*']^3_OJCRA_??_ +ZH DHJ/RA_??\
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MY3_S%>E7,*"TFX/^K;N?2O0S#^.O1'A9%_N3]6<)\-?^/O4/]Q/YFNO\2_\
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M/]Q/YFNO\2_\BUJ/_7!JX[X;HKW>H;@#\B=?J:Z[Q)%&/#>H$( ?(;M1BO\
M>_FOT#+?^14_27ZF'\-_^03=_P#7?_V45J^-?^13O/\ @'_H0K(^'*(^DW>Y
M0?W_ '_W16IXSB1?"MX50 _)V_VA2J_[[\U^@\/_ ,BA_P"&7ZD'P_\ ^19_
M[;O_ $J'XB?\@"'_ *^!_(T_P#&C>&LLH)\]^OX5%\0HT3082J@?Z0.GT--?
M[[\Q2_Y$_P#VZ;'A/_D5M/\ ^N?]37/?$K_CTT__ 'W_ )"M[PI%&WA?3R4!
M/E^GN:P/B0BI:6&U0/G?I]!2H?[Y\W^H\9_R*?\ MV/Z'6:)_P @+3_^O>/_
M -!%</\ $3_D-6'_ %R_]FKM=%BC.A6!*#_CW3M_LBN)^(2*NLV(50!Y7;_>
MIX/_ 'K[Q9K_ ,BY?]NGHZ?<7Z5YOXK_ .1]L_K#_P"A5Z(L,>Q?D7IZ5YSX
MJ51X[LU  &8>/^!5. _BOT9IG?\ NT?\2/2ZXMO^1L_[>1_.NP\B+.?+7\JX
MYE'_  E6W V_:1Q^-?,YOM2_Q(^HP'V_0[6O,O#7_(]G_KI-_(UZ5Y,?]Q?R
MKS3PVJGQR5(!'F3<?@:ZL7_$I^O^1Y57XHGI%W_QY3_]<V_E7G/@#_D/O_U[
MM_,5Z'=PQBSG.Q?]6W;VKSOP$JMKSA@"/L[?S%+$_P >F%3XXGHM](\5A<2(
M<.L9(/H<5D^'+^ZO6N!<2E]@7' &.M:.I11C3+DA!GRV[>U8?A1%=[K<H/"]
M?QK'$5)K'THIZ-/3[STZ48O#3DUKH;6LW$MKI<LL+[9%(P<>]5?#U[<7MO,U
MQ)O*N #@#'%.U^)%T:8J@!RO;W%5/"R(]K<;E!_>#K]*52I-9E"%].7;IU'"
M$?JDI6UO_D=%16;JURNG68G2!')<+@\4NE3KJ%BMP\"(2Q&!STKO^L4_;>QO
M[UKG+[*7L_:=#1HJK<26=J%,[1Q[NF[C-21"WFC62((Z-T8=#6JG%RY4]2.5
MVO;0FHJ/R8O[B_E1Y,7]Q?RJA$E%1^3%_<7\J/)B_N+^5 $E%1^3%_<7\J/)
MB_N+^5 $E%1^3%_<7\J/)B_N+^5 $E%1^3%_<7\J/)B_N+^5 $E%1^3%_<7\
MJ/)B_N+^5 $E%1^3%_<7\J/)B_N+^5 $E%1^3%_<7\J/)B_N+^5 $E%1^3%_
M<7\J> %& , 4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4C?=/TI:1ONGZ4 SR[P'_ ,C4_P#URD_F*]-NO^/2;_KFW\J\R\!_
M\C4__7*3^8KTVZ_X])O^N;?RKT,P_CKT1X61?[D_5G ?#7_C[U#_ '$_F:Z_
MQ+_R+6H_]<&KD/AK_P ?>H?[B?S-=?XE_P"1:U'_ *X-1BO][^:_066_\BI^
MDOU,#X;_ /()N_\ KO\ ^RBM7QK_ ,BG>?\  /\ T(5E?#?_ )!-W_UW_P#9
M16KXU_Y%.\_X!_Z$*57_ 'WYK]"L/_R*'_AE^I5^'_\ R+/_ &W?^E0_$3_D
M 0_]? _D:F^'_P#R+/\ VW?^E0_$3_D 0_\ 7P/Y&FO]]^8I?\B?_MTUO"?_
M "*VG_\ 7/\ J:Y[XE?\>FG_ .^_\A70^$_^16T__KG_ %-<]\2O^/33_P#?
M?^0I4/\ ?/F_U'C/^13_ -NQ_0ZO1/\ D!:?_P!>\?\ Z"*X?XB?\AJP_P"N
M7_LU=QHG_("T_P#Z]X__ $$5P_Q$_P"0U8?]<O\ V:G@_P#>OO%FO_(N7_;I
MZ,GW%^E>;^*_^1]L_K#_ .A5Z0GW%^E>;^*_^1]L_K#_ .A5. _BOT9IG?\
MNT?\2/2:XMO^1L_[>1_.NTKBV_Y&S_MY'\Z^9S?:E_B1]1@/M^AVE>9>&O\
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MP:C%?[W\U^@LM_Y%3])?J8'PW_Y!-W_UW_\ 916KXU_Y%.\_X!_Z$*ROAO\
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M1F7\9^ARW@._O+RXO1=74TP5%VB1R<=:ZC6I'BTB=XW9' &&4X(Y%<?\.O\
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MT8RQR3]:=10!G/HEG(TC-YVZ0\D3,,#G*CGA3D\>]7PBB/8HVJ!@ <8%.HH
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DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g3dyckr3udth000011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '7 ?<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **S-9\0Z1
MX?ABEU>_ALXY6*HTIP&/7%3Z9JMAK-DM[IMY#=VS$@20N&&1U'U]J!76Q<HH
MHH&%%%4M1U6TTH6INVD47-PEM%LB9\NV< [0<#@\GB@"[1110 44R61(8GED
M8+&BEF8]@.IJGI.N:7KUFUWI5]#=VZN4:2)L@, "0?0X(_.@+E^BL[2-?TG7
MXY9-)OX+R.%]DC0MN"GTJY<7$%I;R7%S-'#!$I:265@JH!U))X H"Y+16;=Z
M]I]CJVF:9/,1=:GYGV554D/L4,W(X'!'6M*@+A116=_;=C_PD?\ 8/F-_:'V
M3[9Y>PX\K?LSGI][M0!HT45G:3KEAK;7RV,K2&QNGLY\H5VRIC<.>O7J* -&
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH X7QZ\Z>(/"+6UW;6DPO9ML]RF^-/W#]1N7/IU'6N<T#5+;1?#_ (OBGGN)
M6BU</-J&ENJBZFF93MCW$B/'"-SQG(.>GJ.HZ1IFKQ)%J>G6E[&C;D6Y@60*
M?4!@<&E&EZ>--.G"PM18E-AMA"HC*^FW&,>U5?0AQ=[GEB_VV!XPT[2M4OA/
MIL5I?6L,E^UTR2#<SQ[\[BKA "I./F]Z?=^+]2U30O$?BK2;N>*P M+*TY.V
M,$J9I<'@,/-V[L<;.>F*],MM'L-.@D33+*TLF:(1AH8%7 &=H(&,@%B<>Y]:
MI>%O#%KX8\*VNA1E;B*%")'9,"5F)+$J2>I)XR:+HGD9SFGV6MVO]LQ6FJI#
M8S:>3;276IF[>WN>0'W,"0AR#UP".!S7+7>N7FG1Z5I$=QJEKJ46O:?'?;]2
M>Z65)%D/RR$YVL4Y4XZ=*]6LO#^BZ=!/!8Z18VT,XQ-'#;HBR#T8 <CZTD/A
MS0[:VBMH='T^."&87$<:VR!4E'1P,<,,GGK1=#Y&>=>/M78+XBNM/U#5K>[T
M?RB)?[0$,,<A"D(L0_U@/?<#G<0#V$6KW6JZAK?Q!']N:E;PZ/807=I#;S>6
MJR?9]^3@9QE>F<')R*],NM T:^NVN[S2;&XN&C,32S6Z.Q0_PDD=/:I3I.FE
M[QSI]J6O4$=TWDKF=0-H5^/F '&#GCBBX<CN8^G7\VJ_#:VU"Y(,]SI*RR$#
MJS19)_.O,-/OKKPQH]CI]B)%?Q5HUJMD4&1'=A4B=L=OD9&)_P!FO;8[6WAM
M%M(K>)+9$\M850! F,;0O3&.,5&-,L%6T5;&V"V?_'L!$N(.,?)Q\O''':A,
M;BV>2J\OA'1?'$6BGR!:7EG;)(.L49CB1GR<\A23DYP>34_B'2M23POXF1K^
M<Z/_ &89TC;5GN9A.N<Y8C/EL",C.,CIR:]56PLT:X9;2!3<G,Y$8'FG&,M_
M>X '/:JUEH&C:9#-#8:38VL4XQ*D-NB+(/1@!R*.8GV;/--9TR%_$_PWL;75
M;YHW%Z?M0NO,EP8D8@.<\=O8'C'%5[37M571YM'EU>YBM8O%<FD2:@\A,R6H
MY"^9G*L3\N_MFO5+?0='M!:?9M*LH?L9<VWEVZCR=_WMF!\N>^.M/_L;2_LU
MU;_V;9^1=NTES'Y"[9G;[S.,?,3W)HN/D9Y?JVKZCH=GXML=)UJZELK1;/RK
MR>0W#6;2OMD <G)PN&P3QFJKRC0?B'K4NB:I/JTUGX2DDB:XG^TM&XE#!2W4
M]FP23\W'& /6K72--L;!K"TT^U@LV!#6\4*K&0>N5 P<TVRT32M-V?8=,L[;
MRT:-/)@5-JL0648'0D D=R*+AR,X#2;B2QUCPC)8^(;S4Y=7C<W\4MR94<>5
MN,BH21%AL# P.<5@V%_=6B:Y;0WKV%M?^-Y[:[NXSM:.(\D!OX"Q 7=VS7KM
MCH>DZ9<37%AIEG:S3',LD$"HS_4@9-._L;2_LUU;_P!FV?D7;M)<Q^0NV9V^
M\SC'S$]R:+AR,\RU'6KO0(?%-EI^LW%Q86GV+RII[DN\+RR8DC$S9P2N""QP
MN>2!4L>G:W)X;\2:EIFHZI#/')'/IUM<:HUTZ+$%9D;$C#YR'&-W1AGTKM-6
M\(V-YX=.CZ:L.EQ"5)D%O;KY>Y6# ,@P&4D<CC/K4>A^%'TF\U#4);V&74+V
M%(6:"T$,*!-VTB,$Y/S<Y8YQVHNA<KN9_@K6Y?%>KZMKT,\W]D[(;6TA+$)N
M"[Y'V],[G"Y_V:[6L7PGX<@\)^&;/1K>3S5MU.Z7;M\QB26;&3C)/3/%;5)E
MQ32U"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%<X_B2^WZ@\.D":UL96CD<7 #G:,DA2/3
MWK6AU:QF@@E%S$HF5&178!CN^Z,>IJN5DJ:>A=HJNE_:2W3VT=U"]PGWHE<%
MA^%1:MJ<&D:=+>W!^6,9"Y +'T&>]*S'=%VBJ::MI[6ZS_;;<1D$[C(,<=?R
MS3_[1LOM*6WVN#SW *Q^8-QSTXHLPYD6:*K/J-E'*L3W<"R,^P(9 "6],>M+
M)?V<5TEK)=0I</\ =B9P&/X468718HK$M?$*WNM7-G L!M[8D2S-. V0,DA>
MX'0G-:46HV4\#3Q7<#PH<,ZR @'W-#BT)23+-%10W$-RK-!*DJJQ5BC @$=1
M]:EI%!1110 4444 %%%% "%E#*I8 MT!/6EJ&40?:+<R[?-!/E9ZYQSC\,U-
M0 4444 %%%% !1110 445E:UJTVF?8T@M1<374WDHK2; #@GK@^E-*[L)NRN
MS5HK(T_6FN+RYLKZU^QW5N@E8&0.A0_Q!N/3O5^"_L[F%YH+J&6-/O.D@(7Z
MGM0TT"DF6**R[SQ!IUII4VH+<Q3Q1\8CD!W-Z#WJ];74%W )K>5)(S_$C BB
MS#F3=B:BLJR\0Z=?37<27$2FW<J29!\P !+#VY_2K3ZI81QO(][;JD;;78R#
M"GKCZT68*29;HJNU]:+$DK74(C<$HY<88#DD&D.HV0LQ=F[@%L>DOF#:?QHL
MPNBS16)JWB.WL([06[V\\MVV(MTX1,8Y8MSQV^M:":A;>=';2W$"7;*"8!*"
MW3MZT<KM<7,KV+=%0"]M6G$"W,1F)($8<;N.O'M4](H**** "BBB@ HHHH *
M*** "BBB@ HHHH **** *UWJ%G8*K7=S%"&.%WL!GZ42:A9PVBW<EU"MNV-L
MI<;3GT/>N>\0/Y?B"TD:<V 2W<+>&+S%;)&4QT![YJAI^VTCT:[NH'2P@,Z;
MV0D;B?EE(QD!N?IFM%!-7,G4:E8[6&>*YA6:"1)(W&5=#D'\:DK T*&62UU*
M2!GMH+FZ:2V.SD+@?,%/8D$_C4T\6HV9@E;5'F4S(C(T" $%@#R!FI<=;%*6
MES9HHHJ2PHHHH **** .2L?#S7MUK'VR:_@@EO'(A1]B2I@<],D'IP:MVVE*
MOBB]E^QA8DM84MI&3Y5(S]T^HXKHJ*KG9'LT<%H>F3)>:?!=1WZ7-I*SN1:H
ML>><DR]6!SZDUM:OHMT^@ZG%]KGOY)8R8HI57Y2.?EP.M='13<VW<4::2L<F
MMM%J>J:+*-+E2UB282+-;[ K87!(]ST^E9VJQ7;WUP4TV6)8;Z.8K!:;C*BD
M?/O[G'\*^E=[134[.XG2NK?UM8XB]TA[C3?$4O\ 9S-<RW0>W8Q?.1A,%>_K
MTI=1MKF/6IFM[.XEDFFB=HIK82128Q\PDZICW[CWKMJ*%4:_K^NP.DF<5>:/
M=2V7B)8+1EDENE:/" &2,!2P7/7.#]:K2:?)=:7J\UO!J#RRP1Q;)+180^&S
MPJ\D@=\5WU%"J- Z29#:V\-K;K%!"D2 ?=1<"IJ**S-4K!1110 4444 %%%%
M $$MNLMQ;S%B&A)*@=\C%3U6GMWEO+296 6%F+ ]\J15F@2"BBB@84444 %%
M%% !7/\ B:QGOIM(2$3J%O 7EA^]&-I^;/:N@HIIV=Q25U8Y?5O#GDZ/=FT^
MT7EU*\;3&:3=)-&K E,\#&,\51GLQJ4VHW%MI=W!9-9"%XUB$3RONR-JGKM'
MY]*[:BJ4VB'33.%^QWE]HNLQ"S,VZ)/)F>T$$DK#J-O? X!]ZW[2W;4(K:YM
M9KS3X8^&MC"L8<@\D@C//2MNBASN"II'%26KP)XCLETR;S[CS9+>2.#*E2@
M 8=\YXJQ?6IL;'1X[?3%&!^\E2U\UH6V 9V>IZ9/2NMHHYP]F<+IFG32KHUM
M<V$Q6UO+CSA-#\H!#%3Z8Y'3C-.DTV2"VN/]%NX4BU5Y8&@@#A%*\-L/WEZ]
M*[BBG[1WN+V2L<9:V-S<?V(]QIJJ$NYB^VWV#85;#,O\.3SCUJFNES_VC-:W
M:7_F/?\ GH\-JC*1NRK>:>0 .",^U=_11[1W!TDU8PM T\07>JW,UJ$FDO9"
MDC)AF3C&#Z=:W:**ANYI%6"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "J&J_ZB#_KYB_\ 0Q5^J&J_ZB#_ *^8O_0Q36XI;%^BBBD,**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M/Y_VRT\O
M=Y6YO-QTQM.,_CBK-5I[AXKRUA505F9@Q/;"D_TJS3$@HHHI#"BBB@ HHHH
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M_P!1!_U\Q?\ H8IIML322+]%%%24%%%% !1110 4444 %%%% !1110 4444
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MVIH44R*19HDD0Y5U##Z&GT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M68AHB2H]<C%356GMVEN[68, L+,2/7*D?UJS2!!1110,**** "BBB@ HHHH
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MZQBC4.9]OR-:BLC^SM2_Z";'\*/L&IC_ )?L_P# B/Z4:AS/L:]%9/V+4O\
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M%Q_I#?,%&1CT_"MG2([C4O!LUL;J;SLRQ1S;SO&UB%YZ]A72!%&,*!MZ<=*
M HP  /:B4[A&G8X,:GJ-]HNH:K#),C06\=J "?E<$>:^/49Z^U,%S<0:=J#6
MFIQR6F81)]FN'F:%2V'8,PXR.W:N_"J!@  'T%-2*.-2J1JJGJ N :?.NQ/L
MGW.'U6'3)O#E\;&_N;JW@GB<YG9UCY&[#=QCD\G!]*DN9].:^$,^J31:6EIO
MM)$NF D?<=QWYRQ'&!FNT6*-(_+6-0G]T#BD\B$HJ&)-J\J-HP/I1SC]F<AI
M2W>J:E81ZC<72D:<DSQK(4WL)#@L![8S4_B."R3Q)I-S?3R0PLLJ-)Y[(H(
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M<,IP1M/!_*D_M6R_Y[?^.'_"L6Z_X_KC_KH:BKC>(FG8R<V;_P#:ME_SV_\
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MMO\ GI_XZ:HW?B72;%KP7-R\:V<+SS/Y$A0*@+-A@N&8 $E5)8>E3:7K5IK
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MX/G+"']Z")"I4&(CDAL$_*>^Q;^$$_LW3+.[U/4'BLK".S,4,WE!RFP^9YB
M2AB47HX''3DYW?,NO^?:/_O[_P#6H\RZ_P"?:/\ [^__ %J.9!<Y3Q'X0M9[
M'PW$FD+K$&D70WPW1265X3$Z$;I3@_,8V()'W..0!1!X=NI=?9KRSC=&N+AK
MN\DCB9;VUD$@CMB,EL)O3.X ?)QG<:ZOS+K_ )]H_P#O[_\ 6H\RZ_Y]H_\
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MVFH77VB>-ANWDR>8_P IRN!N.,'IG V/,NO^?:/_ +^__6H\RZ_Y]H_^_O\
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MK'\.:+_8.G26OE:5%OE,F-,T_P"QQ\@#E-[Y;C[V>F!CBMB@ HHHH *KW_\
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M[## =^&4;3N/[M^#M&%//:FIXB9]02-;5'LYIY;6WE2<&26>(.7380 !^Z<
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MN0JP(/R+_A111R(+#_(G_P"?R3_OA?\ "CR)_P#G\D_[X7_"BBCE06#R)_\
MG\D_[X7_  H\B?\ Y_)/^^%_PHHHY4%@\B?_ )_)/^^%_P */(G_ .?R3_OA
M?\***.5!8/(G_P"?R3_OA?\ "CR)_P#G\D_[X7_"BBCE06#R)_\ G\D_[X7_
M  I@M)1*T@NY-S  _(O;/M[T44<B"P_R)_\ G\D_[X7_  H\B?\ Y_)/^^%_
MPHHHY4%@\B?_ )_)/^^%_P */(G_ .?R3_OA?\***.5!8/(G_P"?R3_OA?\
M"CR)_P#G\D_[X7_"BBCE06#R)_\ G\D_[X7_  ID=I+%&L:W<FU1@?(O^%%%
M'(@L/\B?_G\D_P"^%_PH\B?_ )_)/^^%_P ***.5!8/(G_Y_)/\ OA?\*/(G
M_P"?R3_OA?\ "BBCE06#R)_^?R3_ +X7_"CR)_\ G\D_[X7_  HHHY4%AD=I
M+&I"W<F"Q;[B]2<^E/\ (G_Y_)/^^%_PHHHY$%D'D3_\_DG_ 'PO^%'D3_\
M/Y)_WPO^%%%'*@L'D3_\_DG_ 'PO^%'D3_\ /Y)_WPO^%%%'*@L'D3_\_DG_
M 'PO^%'D3_\ /Y)_WPO^%%%'*@L,%I*)6D^UR;BH4_(O09]O>G^1/_S^2?\
M?"_X444<B"P>1/\ \_DG_?"_X4>1/_S^2?\ ?"_X444<J"P>1/\ \_DG_?"_
MX4>1/_S^2?\ ?"_X444<J"P>1/\ \_DG_?"_X4>1/_S^2?\ ?"_X444<J"P@
9MG,L;R7#N(VW!2H'.".P]Z***:26P['_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g3dyckr3udth000031.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000031.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $T 8L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **1MVQMN-V.,],UX-:ZWXCTO5H)/$_B#7]'U;[7B3[7:B32I4+8"H5^[D
M8^;/%"U=@>USWJBO(O$/B+4K2Y^)A^WWODZ?#9-:I#/L,.Y 6V'!VY/7BMV]
M\>ZG!J\FEZ-X??5?[.LH[G496NEC9 Z[@J@CYFQSVH';^ON_S/0**\?N/'6O
M:IJG@74M*LY'?5+6[=],2YV12,HPI=B.B]<XIFO?$GQ)>^%M.N]*TV.RO/[<
M&F7T37 .)%88C5L?=;D%NV/>C^OQL+^OU/8Z*X/X@ZIJEAI/AB6*:2RN;C6;
M.*Y2"3@AL[TSW7/YXK,U;XH:S83^(7M?"Z75AH5UY5U<_; A*<?=4C);GZ=*
M/Z_+_,#T^BN U/X@ZHVL2Z?X:\.-JS6EI%=WFZX$3(L@W*BC!W,5YITWCS5S
MXQ;1+70$\F&TAO;N>XN=AMXF^^"H!RP[ 'G!H [VBO+?#?QD@UWQ%8V+Z?!%
M::C(\=H\=XLDR$9QYL8Y3=CCFKNG_$NXE\866AW^FV<1OO.$<=O?K/<6_E@D
M><BC:I8#@!C0!Z+17FGA3XJGQ)JT<#6-G%;2+,SJEYFXM?+_ .>L3*IY _@+
M8[U7\._&6#7/$5C9/I\$5GJ,K16KQWBR3H1T,L0Y0-CBA:@]#U.BN/\ B+J<
MVE:+ITL$US$TFJVT)-O-Y9(9\$$X.5]1WK"UCXFZU87OB-++PPEW9Z#*HNK@
MW@3]V5!X4C);K[8%%_Z_KU ]-HKD_%WBR31OAM=^)K&+,GV5)8%D&<&3:%)'
MMN!_"L[0O"7B2VFTS57\;ZC=.X62^MKF-'@E4C)6-1C9ST/-'6P=+G>T5Y1H
M]OXB^(4FLZNOBJ_TB&VOI;2PM;+:$7R_XI<CY\GM5&?Q9K]U\,=/\;+J'DW^
MCW+1WMN)-D%\JOL8$=-QX(]\X[47T"Q[+17G/@BZ\2ZOX.O/$T5_#=ZGJTGF
M6EK/,3;6<>[:%P.X&2<<D@#WJY\*M1U/4O#5])J]\][=QZI<0F5NF%8#"CLO
MH.U'6P7ZG=45Y5\4M;U2;6K7P]H>M_V5<PV4VHSS"81E]HVQQY)_B;/%:S_$
M<OX0\-ZAIM@-0U37"L-O:B41J) /WFYCT"D&A:JX=;'?T5Y-XL\:^-;?2-#>
M'01IEY/K"V=Q%+<*1*<Y54;'W'YRW&,>]3S^-=0T/5?&%[+;3W4>FRV'VBW>
MYW)#'(G[PQ#;Q@G)]<9XH_K^OO ]2HKS+Q;XXGFT7QBFGQRQVFCPP!;ZVN-D
MCRN58JIVD# (R>>M4KGQEXQM?'>JVMIIT%Y8V.D+=);O<A2RXSYF0N2Y(VX[
M4!_7]?>>M45QVD>.EUW7M'L-/M%>&\TO^TKF4O\ ZA20%7&.26R.W2JOQ-D\
M1QV&G'1?[2^Q>>?[1.E!3=B/''E[O?KCVH>@+4[NBO%[7Q1-%\//%DD/B;5+
M]K%$>*.ZC^S:A:!B,AWP0<]B!ZUU%YX]U.'5FTK1M ?53I]C%=:C(UTL;('7
M(5<CYFQD]J&!Z!17F2?$_5+NR\+-IWAZ.[O-?@GD2#[5L$1C/=B.F.3]*KWG
MCVZUCPUIMT]M=:9>Q>)(=,NX;>Y &X-AANVG<A[C SZT6UM_6]@/5:*\0O?$
M/B&:Z^(&H7<NI6\.DH8;=+;4%1(>%P H4Y8C+;N<=*ZR[\>:Q'?C2M \//K$
M]C8PW-^SW0C9=ZY55X^=R.: /0Z*\^\7_$6]\,1+<OI-K';K;).Z7U^L4TA;
MK'%& Q9E[DX'H33=4^(6L+K[:5H7AQ=0<Z7'J0>2Z$6U&)R&R#[8QW- 'H=%
M>17GQ"\1:OJG@6XT.PC2QU@2O)!).%,CH"&0G'"K]X$?>Z58T+QKJ.FWE\;X
MO>V,_BN?3#-+*<VJG'E #'W<Y';&:/Z_)?J'2_\ 77_(]5HKGO"_B23Q+)J\
MJVJQ6=G?/9V\H?)GV<,V,<#/ ^E=#0 4444 %%%% !1110 4444 ,EC2:)XI
M%#(ZE64]P>M><_\ "IG:T71I/%6IR>&4E$BZ4R)T#;@AE^\5SVKTFBCK<#B-
M5^'4.J'Q7G4GB'B".WC8"('R!$ !CGYLX]JY+QMI.IZ=XHGFTJR\3!+S3TMK
MB?28HY4NMJ[5#;N8B.A89XZ5[)12:'?^OZ]#SOP?X#N;33_!=[J,S6][HEI-
M&]J%#!C*.06SP1[9J2Y^%\<^A7FGQZS/#--K)UB&Y6%289<Y"[2<,!7H%%-Z
MN_\ 7<2.;\0>%&\0Z=HUM<ZBXETZ\@O&F\H9G:/U' &2<\=*S[GX?17.E^*[
M$ZBZCQ#/YSOY0_<< 8 S\W3VKM**/Z_K[@."U3X;2W-[]KTKQ)?:1-/9QV=Z
MUO&I^T(@PIYY1L<9%:VG>#(+#Q'=ZL][-<BYT^*P>*<;F*I_$SYRQ/?BL73?
MB?9PZ;?7OB(I:11:U-I<#01.^[9RI8#)R>>E6(_B]X-D$/\ Q,)E:2;R75[:
M0&!LX'F<?)D],_T-&_\ 7?\ X<-OZ[?\,'A_X=S:#.D">)M2ET: 2"VT[:J*
M@?/#./F<#/&>AJAHGPF71K_1IUUMY(M(DF:WB%HD999%(;>R\LW/WO;I6OK'
MQ/\ "^A:M=Z9?7-RMW:;3,D=J[A590V[(!&T C)]ZFU'XC>&],O+&UDN9YI;
M^W6YM1;6[R^:C' (V@_7Z4;Z@S-M/AE&OB&RU34M7DU'["SM 9+:-)GW C$L
MHYD !XX%3>&_A]/X;OH1#XEU"71[5G:UTPJBJF[/#./F<#/ -6+KXF^%+/6W
MTJ;46$T<HAEE$+F&.0_P-(!M!_&KEQXXT*UM=;N)[AXUT601W@:,[E+8VX'\
M0.1@CK0GU![DWBKPTGBC3[2T>Z:W%O>PW894W;C&V=O7OZUEW'@&*XM?%L!U
M!U_X2)@SGRA^X^3;QS\WZ5)J/Q)\,Z5J*6-Y>2QS;8VF/D.5M]_W?-8#"$Y[
MU'XF^)&@>';BXL)+LOJ$=N9MBPNZ1_+E/,91A03C\Z3T7]?UT&M7_7]=3:E\
M.V5WX3'AV^!N+,VJVLA^Z6 4#/L>,USND^ -3L+VQ^U>--7O-.T]@UM9X6+H
M, 2.O+@#L:V?#'B)M6\#6/B'4%CA,UI]IF$8.U0 2<9R>@KE=-\8>/-=LH=?
MTGPWIDNB3R?N;:2Z9+N2/=C?G[@]<&JUYB5\)<O?AM<+J6H3Z!XHU#1;74I#
M+>6L$:.K.?O,A/*$^HJ67X8Z:]OH&FI=2+H>D/YQT\H"+J7)(>1N_))QC')I
MFJ>.+ZQU?Q79B&TCCT?38KR*257.68$D/M/(&.PS5F\^)>@:.EG!JMQ(+Z>Q
MCO1';VTCAU;^[@$]B>>@'-);?UYC?]?U\R]X9\(1^%M1U9[&\?\ LV_F^T)8
M%!MMY#]XH<]#Z8XXJ?PGX93PKIUU:)=-<BXO);LLR;=ID.=O7MZUG2>-K>[O
M?"K:3<VLUAK<DJ[Y$?>P1<X7'"D$<[J?:_$CPO>^(1HL%^S732M!&YA8122#
MJBOC:3^-'D'G\R%OAOHU_P")=5UO78H=7EO2@BCN8 5MD48"KZY[FLU/A3!;
M:5]BLM9N+1[;4GU#3)HHES9%NL8!.&3V.*W++X@>']0UF'3()Y_,N))(K>9[
M=UAG=/OJDA&UB/:G^"?$=UXFTJ]NKN&&)[?4)[51%G!6-L G)/-"\OZV QKO
MX;3WOAR&PN/%&HS:E%J*ZDFH3*KE)1G 6,_*%Y^[Z_E6G:>"((KSQ'/>7C7B
MZ[#%%<(\87&R+RR>.N<Y[8KB#\2/&R^']0\3#3O#[Z-8W4D,D1EE2X8(^TXR
M2N?\XK;N/BO9:;XFNK35$\G3UT^"\@,4+R3,9!ELA<C"CJ<#%&Z]?\O^ /6_
M]=RU:?#"UL_AK>>#TU*5C>,7FO6B!=F+ YVY[!0O7M5J\\*2:;XG/BRTO[Q_
M)L!;W.GPP)(;M4!*JN>0<XX'4BK6I?$3PUI=C87<MZ\R7\7G6ZVT+RN\>.7V
MJ,@#U--U'XC^&-,ATZ::_:2+4H6FM&@A>3S0N,@;1G//2AW$K&'\)/"TVB6.
MJZE=6-Q9/J%TQMK6Y_UD%LI)1".W+,<?2NC\5^$E\2/8W=OJ5SIFJ:>[/:WE
MN Q3<,,"IX8$=JB7XB>&&\+?\)'_ &CC3S)Y()C;S#)_<V8SN]L5EZK\5M$M
MO!VH:[IHENY;-A$UH\3QNDC?=W@C*KQUZ4/\@7YC#\+UN-'UZ'4=>NK[5-:B
M2&XU"6)1M1#E0L:X 'XUS?C72-3TWQ/)-I5EXF"W>GI;7$^D11RI=;5VJ&#<
MQ$=-PSQT[UW&A_$'1=:M;A]\]O+:6:WEPD\#1XC(.67=U&0:@O/BEX8L5L?/
MFNP]]:"\MHUM)&>2,D@8 '7@G'IS0UT_KK_P03_K[O\ @&=X-\!W-GIO@R]U
M&5K>]T2UGC>U"A@QE[%L\$>V:L?\*SA^QR6_]J28?7QK>[R1PV<^7UZ>_P"E
M:<_Q$\,P:#8ZR+]IK:^8I;+!$SR2L/O (!G([\<5LZ+K>G^(=*BU+2[@3VLN
M<, 001P00>00>QIZWO\ UW%TM_78YJZ^'D5U9>+;8ZE(H\12"1V\H?N, # Y
M^;I[5!JWPXEN[\WNE>([[2)KBTCL[TV\:G[0B# //*-CC(KO**0SSC6/A-%J
M=WJ$L6NW,2ZA9QVEP9X$GE(C7 *R-RN<#<!U]NV[I_@M+'76U4W[2.VD1Z84
M\H 83^/KW]/UKJJ*/Z_K[P_K^ON//H_A?]FTGPQ:V>O7%O=:!)*T-TL"MYBR
M'Y@5)P..,UG>+?"TFC^"?$&GV5EJ&LW6NZE)=0BUA -K*Q#*6.>%4J/FKU*B
MA@M#$\(:'_PC?A/3=))#2P0CSFSG=(?F<_BQ-;=%%-N[N)*R"BBBD,**** "
MBBB@ HHHH **** "BLN;Q'HT$\D,NI6ZR1L5==_*D=0?>F?\)3H?_04M_P#O
MJ@#7HK(_X2G0_P#H*6__ 'U1_P )3H?_ $%+?_OJ@#7HK(_X2G0_^@I;_P#?
M5'_"4Z'_ -!2W_[ZH \ZA\!:^BV@:VA_=^+WU9OWR_\ 'N>C?7VZTNL> M>O
M-$\;6T%M"9M6U6*ZM<RJ-T:LI))[=#P:]$_X2G0_^@I;_P#?5'_"4Z'_ -!2
MW_[ZH_K\O\@ZW_KK_F>7./$;?$KQY;^'M/L+UY[>TMYQ=3>68]T) 8<?,!SE
M>_%=!X8\":CX>\5Z!,QCGLM.T(V,DX89,QDW'"]<<GFNKCUWPU#<S7,5Y8I/
M-CS95 #28Z;CC)Q[U-_PE.A_]!2W_P"^J%I_7K_F']?E_D>:W/@7Q>FCZOX.
MMK?3)-%U.]:X_M224^9$CN'(,>/F<8P#G_ZVGXC^'=]J'C?3+FS=?[%G6 :N
MK, 9#;G=$<=3G@'Z5V__  E.A_\ 04M_^^J/^$IT/_H*6_\ WU0M+>0/6YYM
MKWPZUB7Q;K4UOI=GJFGZS+'*7N=1G@6W(&&#QQL/,'&1Z5=U+PKXKTK6O$7_
M  C]CIU[8Z]:QQ,]S.4:U9(C'C&"6&.GZ^_>?\)3H?\ T%+?_OJC_A*=#_Z"
MEO\ ]]4K:6'?6YG^%/#\]E\.;#P_JB!)5L?LUPJ,&QD$'!_&N7T73?B-X:TB
MV\,Z?9Z/-:VK;(-6GG; BW9^:(<EL<<''\Z[C_A*=#_Z"EO_ -]4?\)3H?\
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M6W,%!Z\KRV.>E>I>%$GC\*:8ETU\TZP*)&OQB<MWWC)P?Q-<!XUFN8?B"O\
M9&L:S;WDUM%#<)86L3QQ@F0Q[R_5F(< ?7FN_P#"EXNH^%-,O$OI;Y9H%?[3
M-&$>3/=E' /8@>E $EYX9T'4+TWEYHUA<71QF:6W5G..G)&>*M+I6G)J3ZBE
MA;+?2+L>Y$2B1E]"V,XJW10!4L=*T[3/.^P6%M:><^^7R(E3>WJ<#DUQ]G_R
M7/5/^P%#_P"C6KNZX2S_ .2YZI_V H?_ $:U '=T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/X?\
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MMJ="=2+E'H<F(QM+#U(4YWO+8]!HHHK$ZPHHHH **** "BBB@ HHHH ****
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M7_80F_G0!L4444 %%%% !1110 4444 %%%% !1110!D^'_\ CTN_^O\ N?\
MT:U:U9/A_P#X]+O_ *_[G_T:U:U '@WBBUNM'\19U;0?!L#7,2O-J=YH\TEO
M+*6;/SC(0XQDD#)ZFO9O#A<^';#S'T]V\E?FTX8MR.WEC^[CI7FWB?6=+UV_
MB?5H_&4FDRP C2[73Y(XF.Y@?-*_,V<?=R!C'K7I/A[[%_PC]C_9ME)967E
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M]97AMHW\.V31X*[.2!@$Y.3^)R:U:\V<>63CV/H*4^>G&?=)A1114F@4444
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M/A__ (]+O_K_ +G_ -&M6M0!R'BJ]\$QZBNG^(Q:/>7UN8_*>(NSPJ=_.!P
M5)&>XXKH]);3VT>S;2?)_L\PJ;;R1\GEX^7'MBO+OB+;SV?B]-4%UJ>C6K1P
MF;4XK%;RWS&7VE@#NC*[VYP5.?:O1/"=KIMCX3TNUT>Y%SI\5NJP3AL^8O\
M>S[G- &S117#67Q%BO/%.IZ68[.&WT^29'9[D^=((DW,R1[<$ \?>SP30!W-
M<)9_\ESU3_L!0_\ HUJN^%?&S^(+U+6[TTV+W%@FI6A\\2"2W<X!; &UAQD<
M]>M4+%E;XY:H58$?V%#T/_35J .]HHHH \N^(?\ R,<?_7LO\VKDZZSXA_\
M(QQ_]>R_S:N3KZ7"_P &/H?G>9_[Y4]2:TE2&[BDD&55LG_&KD=O):;KN:19
M(65AE6SYN1C^?/-482BSQM*-T88%AZC/-:2"X2[^T3S!K4GYF\P%77T _IVK
M2>YC1U7S^[S?D9-%%%:',>Q>#_\ D5-/_P!P_P#H1K;K$\'_ /(J:?\ [A_]
M"-;=?+U_XLO5GZ5@_P#=J?\ A7Y!2,VQ&8]AFEKFIO&^AYEB$\K@$H7CC)4X
MX.#WKGG4A#63L;RDDM20>,]):[^S S^:9/+QY1ZYQ_.MZ6:*!=TLB1J3C+L
M*\BU+3/"^JN?M&K:HB&;SL01F-LYSC<#GO7/>+?#OAY/#=_<:9K.N27,$+2H
M+V]D*Y"D\#N>E<=+%-I\[5^G]7,HU=-3WV*XAG!,,L<@'78P./RJ(ZC9#[UY
M #Z&0"O"O#?ACPZNC0S:CK.M12SQ1R8L;Z3G*9.X8QU-6;;0+#3YIVL[_?',
M5;_2KAY&&![CCO1/&J,;K5C=:RT/=:*YD>.=$4;?,G..,B(X-=*#D CO79"K
M"?PNYHI)["T45#=3"WMWD/8<54I**NRTFW9$U07EW%96YFF.%! XK'T+6#=W
M,UO*^23NBR><>G]:JZ_J&CW-V+.?Q%IMK)"?G@EG0,&]P6&.*XGC/:X=U:"N
M]EZG1[#DJ\E71'4*0RAE.01D&EKFM.\3^'K.S2"7Q-I4I3A6%T@X]/O5;_X2
M_P -;=W_  D&EXZ9^V1_XUTTZJE%.6C[7,90:DTM3:HK.CUS3+JTFN+*_MKM
M(5RYMY5DQGIG!XS5+P_JDEU)/!<$^86,B9]#U'X5$\53A5C2>\BHT92@YK9&
M]111709!6/X?^YJ7_80F_G6Q6/X?^YJ7_80F_G0!L4444 %%%% !1110 444
M4 %%%% !1110!D^'_P#CTN_^O^Y_]&M6M63X?_X]+O\ Z_[G_P!&M6M0!Y+X
MCN[?6M5@NM6\)>-=0MC"I&FI&!;QD,PRZ*XW,<9YR,8KTK0I(9=#LW@TZ338
M3$-EG)&(VA']TJ.!7BOC#2-2L/'U_'H=YK<[W*VZW#/J_P!G6-I3)Y<8.TDK
M\K 9Z9QWKU;X?F$^ -#,"JD7V5=JJY<+[;CR3[T =)7$WG@[5M8UR&35]3M9
MM+M9IYK=8;;RYSYL90(S9QA0QY R>,UVU% '#^&? EQIMQOUFZM;Z.'2ET>"
M..$JKVX)),@).6;@$#CCWK.\/:/INB?&C5;32[&"SMSHD+F.! JEC*V3@=^!
M7I-<)9_\ESU3_L!0_P#HUJ .[HHHH \N^(?_ ",<?_7LO\VKDZZSXA_\C''_
M ->R_P VKDZ^EPO\&/H?G>9_[Y4]0HHHKH. **** /8O!_\ R*FG_P"X?_0C
M6W6)X/\ ^14T_P#W#_Z$:VZ^7K_Q9>K/TK!_[M3_ ,*_(*\&M_\ 5'_KI)_Z
M&U>\UX-;_P"J/_723_T-J\C,O@CZCQ&R*VHS:G#Y?]G6,%UG._S9_+V^F..:
MR;]_$M]IUS:'1K)!/$T987N<9&,]*Z2K5N42TGF,,<C*Z*/,!( .[/?V%>9"
M:71?C_F<Z9R=I-XFM;*"V&C63>3&L>[[;C.!C/2MFQDO);4-?6\=O/N.8XY-
MXQV.:U)626P$H@BC<3;,Q@C(VYYYJI1.2?1?B#85[E'_ *M?H*\-KW*/_5K]
M!7H99]KY?J;X?J.JCJ\LL.GN\.T-D EUR ,\Y_"KU9?B!]FCR':K?,HPW0\U
MVXN7+0F_)G=05ZL5YF ^M7(VS6Z0( =I_=#(/_UQ_6N6U.#PEK$DESJ$/AN6
M]E?,LLC0K(<<?,2<Y_PK7-P=C((HE##!*J<_SK&3PCX;+27,N@Z=(V?XH =S
M'U_4U\I3Q<FVISE9]CW)T$E>,5?S.6\:V'A.*TT0V%KX>C<:E;K+]G\HY3=A
MM^T\J>^:Z8Z-X%^W>?\ 8?"_DYV@;X-OUQG\:63P3X9,RK'H.G;9,%,PCO\
MX58_X03PZTS)_P (WIXC(VJQA7@CH?\ /K75]:4THWGHS#V#B[VCJ:&@2V6G
M/,/#UKI-NLS!99+&% K[<XR5ZXR3^-=1H>K/<7<MO.6.[YHBP].H_K7&:?86
MFD0^3IUM':1[BVR!=HR>">/I78>%9'D^U;W9\;<;B3CK2P&)JU,5&/.]WOKI
M8>)HPA1;Y5\CHZ***^J/$"L?P_\ <U+_ +"$W\ZV*Q_#_P!S4O\ L(3?SH V
M**** "BBB@ HHHH **** "BBB@ HHHH R?#_ /QZ7?\ U_W/_HUJUJR?#_\
MQZ7?_7_<_P#HUJUJ /&O%6JZE+>M:>(O"/AO[1?P>2$GUC:\L2L7[+D $$@]
MN<&O3_#&!X7TT+:VMJ@MUV06DHDB1<<!6'WAC'->:^)7TG7O%5YJ>@>,](M;
MJQCC_M!+R 2K&(BP#*QQQF0@@9!.,UZ%X*AT^W\%:1#I5R]S8);*L,[J5,BC
M^+!Z9ZXH WJ*** "N$L_^2YZI_V H?\ T:U=W7"6?_)<]4_[ 4/_ *-:@#NZ
M*** /+OB'_R,<?\ U[+_ #:N3KK/B'_R,<?_ %[+_-JY.OI<+_!CZ'YWF?\
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MF_G6Q6/X?^YJ7_80F_G0!L4444 %%%% !1110 4444 %%%% !1110!D^'_\
MCTN_^O\ N?\ T:U:U9/A_P#X]+O_ *_[G_T:U:U 'B"?#+QHB:)!+:>$;NWT
M8S>0EP9B)?,;=F0!?F(/([9KV/25OETJV74DM4O1&!,MIGR@WHF><?6KE% !
M5/5K[^R]&OM0*;_LMO)-M_O;5)Q^E7*CG@BNK:6WF0/%*A1U/\2D8(H \_\
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MM+NP^KQ/G'_A-?#G_04C_P"_;_X5ZPOQA\ !%!\1P\#_ )XR_P#Q-=MY$/\
MSR3_ +Y%'D0_\\D_[Y%=%##1H7Y7N7"FH;'%?\+B\ ?]#'#_ -^9?_B:IZK\
M4_!&I6#VUMXBMC*Q! =70<'/5E KT'R(?^>2?]\BCR(?^>4?_?(K2M356G*F
M^JL;TYN$U)=#Q[_A+_#?_0>T_P#[_K1_PE_AO_H/:?\ ]_UKV'[/#_SQC_[Y
M%'V>'_GC'_WR*\;^PJ7\[_ ]#^TY_P J/'O^$O\ #?\ T'M._P# A:/^$O\
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M4 %%%% !1110 4444 %%%% !1110!D^'_P#CTN_^O^Y_]&M6M63X?_X]+O\
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M4 9/_"3Z%_T%[/\ [_"C_A)]"_Z"]G_W^%:U% &3_P )/H7_ $%[/_O\*/\
MA)]"_P"@O9_]_A6M10!D_P#"3Z%_T%[/_O\ "C_A)]"_Z"]G_P!_A6M10!D_
M\)/H7_07L_\ O\*/^$GT+_H+V?\ W^%:U% &3_PD^A?]!>S_ ._PH_X2?0O^
M@O9_]_A6M10!D_\ "3Z%_P!!>S_[_"C_ (2?0O\ H+V?_?X5K44 9/\ PD^A
M?]!>S_[_  H_X2?0O^@O9_\ ?X5K44 9/_"3Z%_T%[/_ +_"C_A)]"_Z"]G_
M -_A6M10!D_\)/H7_07L_P#O\*/^$GT+_H+V?_?X5K44 9/_  D^A?\ 07L_
M^_PH_P"$GT+_ *"]G_W^%:U% &3_ ,)/H7_07L_^_P */^$GT+_H+V?_ '^%
M:U% &3_PD^A?]!>S_P"_PH_X2?0O^@O9_P#?X5K44 9/_"3Z%_T%[/\ [_"C
M_A)]"_Z"]G_W^%:U% &3_P )/H7_ $%[/_O\*B\,S1W%K?3PN'BDOIF1UZ,,
M]1ZBMNB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g3dyckr3udth000007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %N 6P# 2(  A$! Q$!_\0
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M22<9]:RY/AUKV@Z+X<GTO5KS4[O0YX9([#9;QH5)Q,%8A3RI;[S?CGFO6:*
M,<:&MMK%QK,5YJDT[H<6;7KF G'18R=JGCK[UR_@R/Q';>*O$%UJ7AF>QMM4
MG6X25[N!_+VQJFTA&)R2/3%>@44 >9^%X_%C>*9-9\2>$KC[?<MY"3B]MVAL
M+?/W44.6/JQQDGVK.U#P?XCN=#UCP3_9N_3M2U8W:ZLDZ*D5NTJRL&4G<9 5
M(&%P<CWKUVB@#.UIKF+2)19Z7'J;8"M9O(J"1#PP!;Y<XSP< ],CK7DFI^ -
M:NO!_C&#2-!.F1:JUJ;/1OM49P\<BF23[WEID#H#_"/85[910!XEJ\R0Z[XM
MOKXW$FBV=W;2W=K:W<48F>**(_,DB[BP*K]Q@&P!U!SVXT74+CXPP>)!:G^R
MCX?^R^<S+D2F8OMVYW?=/7&/>NFFT'1[G4DU*?2;"6_C "74ELC2KCT<C(ZG
MO6A0!XWX1\#>)-,'PX^VZ?Y?]C/J1OOW\;>2)<^7T8[L_P"SG'?%:&M>#]>N
M_@YKN@P6._4[K4)9H8/.0;D-X) =Q;:/DYY/MUKU2B@#A+.QU[P]XQUF>VT4
M:C::R\$BW*W"1_9RD8C99 QR1QD;0?3%8^J:+XQU6_6*\M+JX\C7H+I)OM<2
M6PM%E# (@.XL%&3N&>N"> ?4Z* /-+SPGK,VM_$ZY6R#1ZUIL4&GMYJ?OG%L
MR$=?E^8@?-@4_3=$U_1[CP/=?V2US]ATC^SKV-+B,-;LPB^8Y.&4;#G:3[9K
MTBB@#S72? ]U<>&_'FE:U;K!%K&KW=S;,SHX\ML&.3@G&" <'!&*F^$/V[5/
M#]SXJU4#^T-8="3M(_=1*(UQGL2';_@5>A.B2QM'(JNC JRL,@@]0145I%:V
M]LEM91PQ00#RUBA4*L8'\( X&/2@#R[5/AU>7?\ PD^LV^G0)XA75?MND7#E
M&,B*D>$/.-K$.N&Q@G-:FKZ1K7_"5Q>)(])OKB.[TN.UGM+.]CBFMY Q8@DL
M%9?F(.&ZCN.:]$HH \XN/#%[H4_A'4=#T)[J'1XKB%M.>[5IHA,!RLCMM.T@
M@\]#@<5A+X(\3IH5S<R:=#_:$/C$>(([.*X5A-%A245S@ Y+#Y@/N].17L3R
M)$A>1U11U9C@"G4 >8V7A3Q!JUW\0;C4K*/3#XCL[>*U7[0LVPK#)&0Y7N/E
M)QQ\W!.,U-?Z5XD\2^ 'T*?0UTRYM([?RS)=(R3O$Z-M79DJA"<$X(R..*](
MI,C=MR,XSB@#SU?#$^NV&OR2Z3J6F:G?:7)IRS:A?K.&5@<#:CL, GJ>>3CK
M5'3M%\37WBKP/>W?AV/3++0(;BVGQ=1N3N@V!E5?^6>54#G/S?= &3ZC10!Q
M_C/PS-XCUGPT/*F:QM;J62[>&X,+QJ86"D,K!OO$#Y?Y53\2>"!!HVD1>&[,
M_P#$LU);][=)RDEQ\K*Q$C'_ %GS9RQYQR17>44 >4^)/"%_K/P[\3QZ;H5_
M;ZQJTELS07M^DCR^7(GS9WE%^4'N"<#VKHO$FEZK;>(?#NOZ9IHU%=-BFMYK
M-)$C<+(JC>A8A<C;R,C@UVE% 'G.J:1KH\5)XD_L>[G6ZTU+2>SL+Y(Y8'61
MF&68JKJ0W.#P1W'--;P;=6WB+X>OIFF20Z7HRWGVE);E9&MO,0;%)+9;YLCY
M<@8[#%>D44 >3+X0\10>'?%,:Z<'N)_%)U6T@\]!Y\(EC<$'.%)"GAL>];7B
M"+Q;J5\/*T^]&GW6FE$M8;N*+R+DYSY[9R5Q@?)N'7@\5W]% 'CMY8ZKI\W@
M+2(Y)++5+/194N#!<Q1R1@+$K#<ZO&PW#&.O0@X!S/9Z<VHZ9X6UOPWIU[)8
MZ,EU8/91W:).1N"%TD)"M\T9[C(/'I7INI:-I6LQ)'JFF6=]&AW(MU LH4^H
M# X-6XHHX8EBBC6.-!A408 'H!0!B>$M*BTK2)!'875BUU<27,L%U<^>X=S\
MQ)#$#/7 .,D^IKAKKPQXBBT/Q)X3M]%CGAUF^GN$U7SXUC1)6!)D4G>74# P
M#G"\CMZO10!R^F:->VGCW4M0>(_8I=-M;>*8LOSNC2;AC.1PR]1WKJ*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#Q+J&IZ-\3-5\0VLLTEEI$
M%DU[:B0[6MI!*LC!>064A&[<*>:]?K)3P[8KK.J:F_F2R:G;QV]Q%(08]B!@
M !C/.\YR30!YEX?\9W&FZ9K\EM*MU/J'C&ZL[.6X+R11(55@Q"_,5"@X5<9R
M.G6M35?B'KFD^!_$NHO:6TNH:/- L-PUI-%;722.@W!6.<C<P(#'! /0XK9T
MWX7:!I'ATZ-92WT<:WW]H07 F'G038"AD;;C@#&"#D9SG-:L_A&WU#PS>Z%K
M&H7VJP7@Q))=,F\<@C;M50,$ CCJ* (/^$DO/^%I_P#"+^7!]A_L3^T/,VGS
M/,\_R\9SC;CMC.>]<AI'Q'\3:MX=TG54T[3%;6KI;"QCR_[N4%M\LG/W %;Y
M0=QVCGG Z_1/ UEHNO#7#J6J7^I&S-F\U[.'W1EU8<  +@KQMP.23DG-06OP
MYT:S\'V/AN&>^$-A.;BTN_-43PR[F8.&"@9!8CIC'7- %,>+]:TVW\5VFK0V
M,VHZ)IWV^&:V5DBG0H[*"I8E2"A!Y.>V*IZ+X[URXUOPK'JMII\5EXEM))K9
M;9G9X&2,2?.S8!#!AP!P>YZUT%OX'L(],UFUN+R^N[C68#;WE]/(IF9"A0 8
M4*H 8X 7'KFD7P'I2R^&9/.NV_X1V"2WM%+KB17C$9\SY>3A1TQS0!AZ?XWU
M9_%FCV,UUHE]8ZG)-"?[/67-O(B%N)6.V4?*RG 4]..HI?A5_P ?'CC_ +&B
M\_FM:FE_#S3]+NM*E34M3FBTB1WL+>65/+A5T92F H+##<%B6X'/7.MX?\-6
M7AQ]5:SDG<ZG?RZA-YS [9),9"X PO'&<GWH X6X\57?A3P_\0-<BC%U)8ZV
MJQQ3,=NUA I ]/OD_6KY\?:IHNNZK8>(K2S(M]%.M0BQ+<(K%3$2WWFR.&P!
M["MG4_ &E:MHFO:5/<7JP:W=K=W+1NH9''EX"94@#]VO4'J:LWG@O2M0\12:
MS=>=+)+I;:5) S#RFA+%CD8SNY(SG&.U '!?$:X\17GP5UJ[US^S0ES%:S0Q
MV:N&BW3QG8Q8D-@8^88YSQ79P>)+S_A9<?A?RX/L/]A#4/,VGS/,\[R\9SC;
MCMC.>]5I_AK8WGAB[\/7FM:U<V$Z1Q();A"8$1U=53Y,=5 RP)QQFM#6O!5C
MK.KVNJ"]U"QO((#:M+8S"-IH"<F-C@G&><K@C)P10!QMC\2-=OO!GAO69AIN
MG+J1N3=W\EK++;6YCD*HI57!7<!]YFP,'UXN:MXJM=)^(DEY+86=P;?PFVH-
M>P%C)(HE/[M#G;L."1QGD<UO6_@"TL?#EKH.G:OJMEI\ E0I%)&?-21V=E;<
MA_O$ C!QW/6GI\/M"34H[L1S&./1O[%%JS@Q&VSGG(W%NV=WZ\T 9VG>)_$M
MOJ?A\:[;Z;]DUX$1):*XDM'\LR*KDL1(, @D <^U86H?$SQ#;:9XBUJ/3]-&
MF:!K#6$ZEG,UP@D"97H%(#J<DG// QSU^D>!++2]0L[N74M2U#^SU9+"*\F5
MDM5(VG;A02=O&6)./QJO<_#;1KKP]X@T5[F^%MKE^VH7+K(F])"ZN0AVX"Y0
M=03UYH B?Q9?KX_?1[B>PT^R#QK;)=6\GF7X9 28Y=P0$$[=N">#Z\=M7.7W
M@^WU+4X+F\U+49K6WGCN8K!I$\E94QM;[N_@C.-V/:NCH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!&SM.T MC@&N;AU?4+;5OL]Y
M-;3*L+RSQPQE?(P,C#'[V>E=(PW*5R1D8R#R*Q8M E-W!+?:A)=I;JZQ(\8!
M^88.YA][BJC;6Y,KZ6*L&KZG''I]_=& VE](J>2BD-%O^Z=V>??CO6S<ZMI]
MG-Y5S>P128SM=P#BL^V\.F%[6.6^DFL[1]\$#(!M(Z9;^+':MAX(I&W/$C'U
M*@TY./0F*E;4;;7=M>Q&6UGCFC!P61LC/I4U9^F*J3:@JJ%'VGH!C^!:T*EE
MIW04444AA1110 4444 %%17,Z6MM).^=L:ECBLY[S4;:$7=S%!]GX+QH3OC4
M]\]#CO5*+9$IJ.YK4445)84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %#3O^/C4
M?^OG_P!D6K]4-._X^-1_Z^?_ &1:OTWN*.P4444AA1110 4444 1SPI<020R
M#*.I5A[&L\Z==2HMM<7JR6JXR!'AW Z!CG^0YJW?O+'I]P\ )E6,E<#OBL>>
M"QM]-CN[.3-V=ICD#Y>5B1P?7/<5K33L8U&KZK^OU.AHH[45D;!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&H_]?/\ [(M7ZH:=_P ?&H_]?/\ [(M7Z;W%'8****0PHHHH **** "BBB@
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M8>-=JL,=0.PK23?+J8P24W8L4445F;!1110!0T[_ (^-1_Z^?_9%J_5#3O\
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M5!K,GFEO; 6"6,T<S!58LN$CQW![].,5MT5<9V(E#F#M1114%A1110 4444
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M6EX>M9[6RF$L;0QO,SPPN<F-#T'_ -:G2G-RM+M]VWE^HDV:]%%%=)84444
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M8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*;("T; =2"*=39.(G(_NFA@<\(M1;1K?3CISJR&,&0R+M^5@2>N>U='7&I-9
M?V1;3)J4K7Y:/*?:F))+#(VY],UV5<]!I_<B8A111704%%%% !1110 4444
M%%%% !1110!Q^K6UW:ZY-<VL>'=ED23[6(T"A<,"I/4^N/Y5<\(V\L-O*_E&
M.!UCVG?N$CX^9Q['BJVI:/#J6KW[+]D>YC,;*MU&>/E((SW4CTZ&NDT^![73
MK>"219'CC"EE& <#M6C?N6,5'W[EFBBBLS8**** *&G?\?&H_P#7S_[(M7ZH
M:=_Q\:C_ -?/_LBU?IO<4=@HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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M:X35)FO6:/*?:B<DL,C;GZUV%94ZG.).X4445J,**** "BBB@ HHHH ****
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M'_/&/_OD5)10%B/[/!_SQC_[Y%48+>+^V;S,*;?*BQ\@]7K2HIW%8C^SP?\
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M^SP?\\8_^^11]G@_YXQ_]\BI** L1_9X/^>,?_?(IX 4 *  .@%+10 4444
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>BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g3dyckr3udth000013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )X ?0# 2(  A$! Q$!_\0
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MLAF>/).2<'*\G@+]:WOA9;W+^%YM;O0XN];NY+]U=MVQ6.$ /IM (^M1^,_
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M,<B!E)[@C(K!U+P+X<U?4WU"^T_SII"IE4S.(Y2H !>,':Q  ZCL/2NA "@
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MXDU4Z-'?7ES+'%:QSS;HW@,4*R'R]ZJ3E#PQ4MM W <TNC^&M;M;+P_!<VR
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M"3@X.6W<=^@ZXZU=OX'NM-NK="H>6%T4D\ D$466@7EJ9,FNW'V> Q)#YO\
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M3^-#Y?F>IT54_LZ'^_<?]_W_ ,:/[.A_OW'_ '_?_&N&\NQZ&I;HJI_9T/\
M?N/^_P"_^-']G0_W[C_O^_\ C1>78-2W154V$)_CG_[_ +_XTG]G0_W[C_O^
M_P#C1>78!UU;17UE<VI;:LR-&[)C(R,'\:HRZ!'<6;6DUU<- (XTC4$#RF3H
MZG'7I^543X>MK;4VDMYKEKJ=S)S,P5%[DXY/XGFMAH[V!?,2?[1MY:)D"[A[
M$=#]<U,*D^J)M?=$&GZ,+2YFNY[N:[NI4$1EEP-J#G    YYJSI>GQZ5IL-E
M$[.D0(#-U/)/]:L0S)/"DL9RC#(I]:\UQJ*6P4444AA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7):Q<?Z7J[7%Y+!/:Q(UBB2%<DC.0O\1+?+W]*ZVHW@BDD21XD9T.49E!
M*_3TIQ=F3)71SFMWD$L%M%)<.+UXV ACNO*1'P,L[9XVD]/?I5*[G94OS=ZE
M(+JTMHC9M'(5$C%,[P!P^Y^._I76O9VLIS);0N2<_-&#S3C;0$QDP1DQ?ZLE
M!\GT]*I21+@VR W%XL,)%F9':,&3$@7:W<<U%I#.ZWC21^6QN6RN0<<#N*T:
MHZ;]^^_Z^F_DM*^A5M47J***DH**** "BBB@ HHHH **** "BBB@ J&[+"U?
M;&)"< J5R,$\\=\#G'>IJJ7^GP:A$%FBB9E.49XP^WD$]>QQ@TUOJ)WMH<]K
M#2MX)N#+;);<1[8TC*8X3/!Z?-N'T KF_!?_ ",T'^X_\JZCQ!8K8^$KY%$0
MWNKD11"-0<J.!^'<FN7\%_\ (S0?[C_RKKA_"E8X*M_;1OY?F>H4445QGH!1
M110 4456OY&2S<(<228C3ZL<?_7I-V5P&6/[YIKL_P#+5L)_N+P/SY/XU<ID
M4:Q1)&@PJ*%'T%/HBK("G#_HU_)!TCF'FI['^(?R/XFKE5-0!6%;A1E[=O,X
M[C^(?EFK2D,H93D$9!I1T=A"T4450PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"J.F_?OO^OIOY+5ZJ.F_?OO^OIOY+36PGN7J***0PHHHH **** "BBB@ HHH
MH **** "JNH.T=C(RQF0Y VA68\D<X7DXZ\>G:K54=6GC@T]B]RMOO955F<I
MDDCC(Y&1GD=!D]J<=Q2V,'7!)_PB-V6NKB;E0?.A,>#N'0, V/J3]:YOP7_R
M,T'^X_\ *NCUA]_@Z^(G25?,&W9,TH497C>W+<Y/XX[5SG@O_D9H/]Q_Y5V0
M_A2."I_&A\OS/4****XCT HHHH *IS?OM2@B_AB4RM]>B_U_*KE4[']ZT]U_
MSU?"_P"ZO _J?QJ9:V0BY1115# @$8(R#5/3SLCDM6/S6[;1_N]5_3C\*N52
MFS!J<$W_ "SE7R7^O53_ #'XU,M&F!=HHHJ@"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@D
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M>.R7_EH=TGL@Z_F<#\Z4G9 .T]#Y#3N,27#>8P/;/0?@,5;HHH2LK %%%%,
MHHHH IWW[EH;L?\ +)L/_N-P?RX/X5<IKHLD;(XRK#!'J*K6#L(VMY#F6 ["
M3_$/X3^(_7-3M+U$6Z***H84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !113#+&)1$9$$A&0F[DCZ4
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M6@S@J>Y7_"K$%U#<@^6^6'WD(PR_4'D4E+H]P)J***H HHHH **** "BBB@
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M<M93JL,20I.PBDBA\I95P/FV_7(]\5LT44-W8)65@HHHI#"D8!E*GH1@TM%
M'$1VT-K,BW<#?V5%?W.]60LH/&PL.X^]SZD5T'AM)(])PRND1FD-ND@(98BQ
MVCGIQ^F*UZ*IRNK$1A9W"N7\>JKZ!"CC*M>0JP]06KJ*AN;6WO(Q'<PI*@8,
M%=<@$=#2B[-,<E>+1YG=VMW+!=Z%.&^R:+'-/O)_U@(_=#\,G\JLB.ZFO/"*
M65PD%P;%MDCIO XYXKT.2TMY1,)((V\Y=LN5'SCT/KUJ-=.LDDMW2UA5[==D
M+!!F,>@]!6GM#+V/F<?XETZXNO\ A']/U.X2>6:XD1Y8TV Y4XX]N*YW4C>:
MIHUQ<7ZE3I")9C)^]+O 9O\ OD#\Z]6FM;>XEADFA21X6W1LRY*'U'I3)M/L
MYX)(9;6)XI6WNC("&;U/J>!1&I8)4;WU)8/^/>+_ '!_*I*0    8 Z"EK)F
MRV"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 <[K=_<1WTT*7,]O%!:B;]Q$'9G+
M$#.0?E&/UZUM6$TEQIUM-*8VD>)68QG*DD<X/I65<VFH/XEDN+200K]C6/?)
M%O1CO;CJ.1U_&EL2VF75KH]N\4L,4>),_?7@G<>W)["KLFC.[4KLW****@T"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "HS;PF;SC#'YH_CVC=^=2
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(\'?\C/:?1__ $$UTTE:$T<E9WJ0;/5****Y#N"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HIC1J94DYW*"!R<<^WX4^@ HK%TB:[;6]5@NI_-,(@P%
M&%7*DG HUDRQS1?9;F;[=,ZK!%O^10#\Q*CJ,9SG/;&*OEUL1S^[<VJ*ANY9
M(+626*'SF09V;L$COCWQ4&GZ@NHB26%/]&!"QR;OOGOQV Z?G4V=KE75[%VB
MN=N;V]M-=O/,FWQQ:=)<)&HPH(?C/J< <_6FZ7--->0V;W$Y6YTZ.Z=C(20Y
M;#8/\((/;&.V#S5<CM<CVBO8Z2BN;D2^&FZ5&+.Y>.&.W9EC*@EPR9# D'@
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M% !7.'6[W:=0 A^P"[^S>3M._&_9OW9Z[NV.E='69_8-G]L\_,VSS?/\C?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*HZ1_P @\?\ 763_ -#:KU4=(_Y!X_ZZR?\ H;4^@NI>HHHI#"BBB@ HHHH
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M7?M?P2^;$(IX)6AE0-D!AW!]""#^-59=!1I9+B*YDBN3<FXCD !V$J%(QW!
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M_OW%_P#$4?:=1_Z"EQ_W[B_^(H^M1[/\/\P]HCJ:*Y;[3J/_ $%+C_OW%_\
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M?X?YA[1'3>4@F,NT>85"EN^!GC]33ZY;[3J/_04N/^_<7_Q%'VG4?^@I<?\
M?N+_ .(H^M1[/\/\P]HCJ:*Y;[3J/_04N/\ OW%_\11]IU'_ *"EQ_W[B_\
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M_P#GPM_^^!1_8>E_\^%O_P!\"M"BCV<.R#E78S_[#TO_ )\+?_O@4?V'I?\
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M[.D_Z"5[^:?_ !-5S/L.[[%ZFR(LL;1MG:P*G#$'!]QR*I_V=)_T$KW\T_\
MB:/[.D_Z"5[^:?\ Q-',^P7?8CAT*PM]/FLHEN%CGYED^U2^<YP!DR[O,S@
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M;M,F.XVJZ']:YW_A!XD@^S0W8%O<0&VOUEAWM<1F1Y"%.X;/FE?LP ;&.AH
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M]^6_^*HHHY%W"P;=5_Y[67_?EO\ XJC;JO\ SVLO^_+?_%444<B[A8-NJ_\
M/:R_[\M_\51MU7_GM9?]^6_^*HHHY%W"P;=5_P">UE_WY;_XJC;JO_/:R_[\
MM_\ %444<B[A8-NJ_P#/:R_[\M_\51MU7_GM9?\ ?EO_ (JBBCD7<+!MU7_G
MM9?]^6_^*HVZK_SVLO\ ORW_ ,5111R+N%@VZK_SVLO^_+?_ !5&W5?^>UE_
MWY;_ .*HHHY%W"P;=5_Y[67_ 'Y;_P"*HVZK_P ]K+_ORW_Q5%%'(NX6#;JO
M_/:R_P"_+?\ Q5&W5?\ GM9?]^6_^*HHHY%W"P;=5_Y[67_?EO\ XJC;JO\
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MO_BJ-NJ_\]K+_ORW_P 5111R+N%@VZK_ ,]K+_ORW_Q5&W5?^>UE_P!^6_\
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G+?\ Q5%%'(NX6':=;3VT$BW#QM(\KR9C! ^8Y[T44525E9#2L?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g3dyckr3udth000036.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000036.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %F M # 2(  A$! Q$!_\0
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M5@MQ:6$\\189 =8V89'?D5P7AOQYJT7@749M7F%YK4%I;7-J2BQ_:/M4:F$
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MC[UG]9K7M?\  U]A2Y;V'_V_J&W/_"0^(,\9&+'_ .1JM6VHZE<*S'Q%X@1
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M+>VLML9 ,E ZE<X[XS7)K\-+?^TO"=V^H,PT*TCMIHQ#@7OE*/*9OF^7:^7
M.[KVZUW=%;&)P!^&:X7&K$'_ (2K_A(SFWZG_GC][Z?-^E:VD^%;[1M3NUM]
M84Z)<W$MR;![8%U>3)91)N^YN).-N??%=37+:7XX@UK6KS3[#1M6ECLKU[&X
MO-D0A21/O=9-V.G(7O0!!X:\%W'AN:W@2^L9],M0P@1M.47(!SM#3!L';GJ%
M!.!D]<FM>#=0O?&T'BC2M=33[E+#[!)')9"<-'YA?(^=<')]ZZSSXMK-YJ;5
M;:3N'!]/K39+JWB;;)<1(=P7#.!R>@^M '+?\*_L_P#A%+S1FU"Z>YO+K[=+
MJ+[3*;D.'$F  O!50%QC Q4<7@W4VOKW6+[6+.ZUJXM5LHY6TX"!( Q<H8RY
M+;B<D[AV].>O>X@CE2)YHUD?[B,P!;Z#O67%XEL+N#53I[&\GTQGCE@C(5F=
M5#;06('.X<YQSUH YR/X;10^&;338KZ-+NTOWU""46H,"2,6R@A)P(L,1MW9
M'KFK=UX-O+S2;16U*SM]6L[T7MO=6E@(XE8*5VF/>2RD$@_-GGM720ZC$=/M
MKJZVV9GC5O+FD7*D@';D'!(Z<$BIY;JWA!,L\48 W$NX&!ZT 8WASP]/H=QJ
MUS=:FU_/J5RMR[M"(]A$:IM !QCY>.^, Y/)PK_X:PWVO:]J+:K,D&J6LD26
MHB&VWF=(U:8'/)Q$G'UYYKN@05W @@C.:BBO+:='>*XAD6/[Y1P0OU]* .+_
M .%<G^P/#^G/J[R3Z7K*:Q/=/;C-W('=V! 8;<E^O. !UJU+X*N6/BJWCU9$
MT_Q!#+NA-KN>&:2-8RX?<-R@+]W Y/45U<=Q!+(T<<T;NH!958$@'ID5FZCX
MAM=/O]-LQB:2]O/LGR./W3>6\F6'T0_G0!FZ=X.^P77A>?[?YG]A::UACR<>
M?E8UW_>^7_5].>O7BK/BKPS_ ,)-_8O^F?9O[,U6#4O]5O\ -\O=\G48SNZ\
MXQT-3^(/$MGX=AMOM$5S<W-W)Y-K:6L>^6=\9(4=  !DDD =S65>>/K?2?#^
MI:QK&AZQI\>GB-GBFA0M(';8NPJY0G/4;@1WZC( GB;P=J'BKSM.O];0^'YY
M$DELQ9CSOE(;:LN[@$J.=I/49]+^E>%UTSQEX@\0B[,AUA;<& QX\HQ(4^]G
MG/'88]ZK7OCBWTKPM?\ B#5='U6PM;/9NCG2(R2;F"C:%D(ZL!R15C1/%]GK
M.JSZ4]G>Z=J4,*W!M+U4#O$3@2+L9@5SQUR#VH YS2?A-96VD:#I.KWB:KI^
MDQ7 %O);[%EEEDWB0C><;1E0.>I.1TK6TCX>Z/H]QK$,<%M-HFHM%(-*FME>
M*&1!@L,YSNPIP1P1UIUSX[A3Q)J.A66A:QJ5WIPB-RUHD.Q/,7<O+R*3Q[5U
M!N(5#EIHP$.')8?+]?2@#E?%7@Z[UVPL-/TO4K32;&SEBF2 :?Y@#1L&0+AU
M"J,8QC\J3Q1X4UKQ)IVG6G]OVML;:2*XF?\ LXOYLT;!@P'FC:N1]WGZUU1N
MK<2+&9X@[$JJ[QDD=0!ZT&X@641--&)"=H0L,DXSC'TYH YK7_#FOZYI;:;_
M ,)%;06UU:&VO1_9VXR;@0[1GS/DR#C!W8_G??PS:_\ "$2>%H)9([5M/:P6
M0_,RJ8RF?<X.:UHKF"??Y,\<FPX?8X.T^^.E)'=VTL32QW$3QID,ZN"!CKDT
M <5I/P^O(+;1;/6?$+:A8:,T;VMK#9K C-&N$,GS,6V]1R!GKFK5AX(FTO69
MIK.]L3ILUXUXT%QIRR3(S-N94EW#"DY(RI(SUZ8Z"35A_:&GV]O;M<P7@D)N
MHI$\N+:,C.6R<]/E!]\5<6ZMWG:!9XFF49:,."P^HZT <9%\._+TS5;/^U,_
M;_$']M[_ +/_ *O]XC^5C=S]S&[CKTI]_P##N#4-2\3WCZC+&VMFSD3RXP&M
M9+8?(P).&R<'! Z'UXZ_[5;B18S<1;V8JJ[QDD=0!ZU7U+4)+ V8CLI;G[1<
MI WENB^4&S\YW$9 QT&3Z"@#EV\"7=^-;NM9U>*ZU74M+?2DN(;/RDMX6W=$
MWDL=S;C\PS@#CK5RQ\&FQG\,RC4"S:'ICV Q#CSBR1KOZG;CR\XYZ]>.>D^U
M6XD6,W$6]F*JN\9)'4 >M8OB_P 8:;X*TJ'4=3CN9(IKE;9%MHP[EV!(X)'&
M%- &$WPW^UKX@>_U"W\_6;,6CM960MT !)$C+N.^3)Y.1P,5HGPC>W>N>%=8
MU'5XIKO0Q="3RK3RUN/.38,#>=FT >N?:M.+Q-I]QJVF6%N7F_M&S>]MYTP8
MS&I3OG/.\8XK42Y@DF>%)HVE3[Z*X++]1VH X&7X8-/JD5R^K1&*#6DUB,FR
M!G9P^XQR2[LLN#M7@8 '7%7+[X?/?2:]"VJ[-/U6=;Q8A; R072^7APY;#+^
M['RE><GFNS$\3*C+*A5SA2&&&/MZTB7-O(2(YXG*KN(5P<#U^G!H Y.;P5<Z
MCX?O=.U*_LEGF:)X+C3M.%OY+QL&5L%VW'< >2!VJ[H?AN_T_7[S6M2U@7]U
M=VL-NZK;")(_+9S\N"3@[^AR<YYP0!O17=M/$TL5Q%)&N=SHX(&.N32I<P2.
MR1SQNZ@%E5P2 >F: .7\1>!H]?\ %FDZW]N-NMF%6YMQ%N^U*DBRQJ6R-H5U
MST/4].<MTGP*FE^/-3\2_P!H-)'=[S#9>2%6!Y!&)'W9RQ;RE[#'/6NKAN(+
ME"\$T<J@X)1@P!].*075N;G[.)XO/ SY6\;L?3K0!PZ?#B2"WOGM=8\N_DU^
M77+6X^S9$+N-IC9=WSKC()R,Y[8I9OAS+<+=W$^M>?J4NI)J4-Q+9J41UB$1
M1H\X9" 1C((!')(W'MOM5N)%C-Q%O9BJKO&21U 'K5+7M<MM!T>^OYR'-K;2
M7/D!P'=4!)P#]* *,&AZC%X?GLC>:8+R9]QDCTP+ 1Q\K1;\L/?=GG\*X6?X
M?ZOI'B'P9'HUQM6TFU*XGO$MAY%LTR JHBW<1DY4*#G&>0>:],O=8L],T.76
M+^46]G##YTKD$[5QGMR3[#K65I/BV75+RWB?PWKEE!<Y\FZN8$"'@L-P5BR9
M XW =AP2!0!CCX:I_96E6YU3-U;:^NO7=Q]G'^E3 L6&W=\@.0 <G 4=:MWG
M@F?_ (2&^U33;ZRB34&1[J&\T\7)#*H7=&VY=I( R#N&1G'7-CPUXU7Q/I>B
M:C:Z7<I;:IY^7:2/%OY3,OS#.3N*\;0??%=)'=6\TKQ13Q/(GWT5P2OU':@#
M@?$_PO;Q'+K:_P!JPPV^JB(L7LA+- T>W:$DW#$?RYVX[GD9JYK?@*[U*?7U
ML=>:PL]=AVW<(M5D(D"!-RL2, @ ,,<XX*GFNWHH CMXO(MHH<[O+0+G&,X&
M*DHHH **** .5\:KNF\/KNVYOIQN]/\ 0+KFN;TZ]>73V:Y;"QC!F!^\170^
M.1DZ$/6]G'_DA=UY[?VW]FZ='OD,EO,3Y:C.%;U^M>=C6U),[L+%.+1T5P;3
M5=._X^-D0.[( _(U6N;>ZDTYH8'<' *J._XUD6E\J6\:NQW./E4'@GZ>M;"W
MLMI$DTF0N,,NW)/T':N+F3W.GE<=BCI4921"]N&GAR$!/*YZY]:Z1"V%9U"L
M.P.:R+2PD?5SJ1</$Z?*#ZGN!VXK41"H6,%G&?F+'FJ@K(F;NRE+I$$^J&YD
MB'RC  X!/8\59L(Q"K1&,HP;<H;D$]S2[KI [11^< >%8[<_C5N,R2PEFC:-
MCQM/:KBD2V[#TD#,R9P%YS3U9 <@$^@IJ0K&NYN_<TCOQD'"#N:TUZF8KRDD
MKS[5$+==Q+8#$<L>M$SB),[@I/0UFW5]*P*Q$*#W:HE)+<J,6]BXDEK;NT2O
MND'+*QY_+M5>YU;RID2-5"@YD=^@7V]ZPVW6K$KEI93\SGD#'0?2LW43J$M[
M!!)%YD<@QMB['/7/^-9>T?0V5)=3KI-54GB1<#^Z:I2:O=1WFT(ODM&2-_'(
M[YKFI$N[>6..W1VPV" .1[FM=;2]DCD%Q L\8!^93T!ZXJ>>3*Y(HM-JC36,
M5XF7/3&>]3VFJ7;P9N%C67)X'IVK/TVW1+06ULD@7:6$C'*GZ&HE@GBNU<VT
MS2LH4D= /_KT7EN+ECL:Z:K)L._"G.0!4:ZVIG\ET<'&27X %4-1O/[-@AN3
M;RN),D@+C:/Q]Z8(SK5K(;:-UE&,L1R*+R#EB;*ZDZL=Z@Q_WMV*L+J:,^U#
MG S@'/%9%S"EO:'[0_E(N%+$<>E5);B"PANKB)P[(G"#]*?/)"Y(M:'2?VM
MB;F)4^A%6X+])DS$X=3VS7$KJC/8+=3PX[%/7WHM;F_>VCEDMC%'NR&C;;@?
M3O5*JQ.BCOUW/EDB9L<';VIH?:Y#GR^>X(KEK;Q"T=WY0D8E^4!7 &.N:WX-
M>9C^_5)<C'S"M8U(LRE3E$T>2H!567UZ\5E3:;;6]R)X,JS-G:3Q^%:"W5A.
M=T8>!_\ 9.1GZ>E/W*_$FWI5M*1";3.8U71+VYN8[J!O,4D&2/=TQ_2F3VK6
MUFLS1;%08V 9(S753>8(@8!Y@_NYP:8$^4>:,GN#WJ'25]#1578Y6YLC%!]O
M1@RE!O\ EYV^M)9W$6IQ2+;IDXX=ACD=JZ*XL8[BWEBC(.Y2"O:L_3[,:='<
M1M'M8-E@.3[5FZ=F6IIHPO.FBC94D,;CDJ\@&?H:GF@,D<4MTAV%< GK^=5+
MW1I]1O!(C,BL?F9N .<\58U#^V+.!#+-%)"BX ]>.IK.QK?:Q/'9-I]N+[Y1
MCYR2?NCL*I2:U!J-^OF2(+5E'E;A@Y[U/<W)U?PVZ_*GW=I4\,?2N=M8C 5$
MN79V V;>!@^U$G9:!%7U>YHP0!=2EO6$B0(^T^K#'%6-1UV6**&;2(XPI8J_
MF  D]C]*M-=310S0%$/\0#K@@^WK7,37\-M/LD"/(3GID#WI7ML-+FW.TLI4
MG\$ZG,;>.&>26T:0(,9_?#!_G7J=>4Z<9)/ ^ISRQ[&>6T'/4@3#&:]6KV,+
M_!1Y>(_BL****Z# *\S\ >%]2MO$7BC4;N[U>QC;Q!=2Q6?RI!<QM@K(04W,
M#GJ& ^7V->F44 >,_8-5L+?Q'HIT74II[SQ:FII-#;EHA;-/"P??T.-A! R1
MU(P"0[7_  BVK:[\4+N[T&2[=K*W.E2R6I?=)]F(;R3CEMRH#MYX KV2B@#R
M[2M.BA\97,WB3PW=:A>W1M)-/OC9&9856- 5WXQ"5<,QY&<Y&358:#'8Q?$J
MRA\/2IJ-Y;W<EG<0V!Q+"\" 1I(%P29,G8#DD$XKUJB@#QRVTF.R.@W'BCPS
M>:I8+X:M+6"$6#7)MKA1^\5HL$HY^7YL#[N,\53\*^!;YO$6CV?BK2&OK>V\
M*>6S7$&^&.;[2Y2//*^8D;X'.<<U[?10!P_AV#4;7X,6EM/I+75]'I)C.G7*
M;3(0A C93ZC P:X9--U6XO-?FL])N8[*\\&SVX2'27LT>Z4D+&L1R=P#$+W(
MZ9QFO<:* /*O#'A>32-6\&75EI#65Q-H,J:G.+8J?.*PL/../O[]WWN>#Z5F
M>&M#-M<>#HQX5OK?5[&_<:MJ#6I =O*E^9I.L@8D$-R!G!() /M%% '%>+K:
M_L?%7A_Q-:Z?<:C;6*3V]U!;+NE1)0N)$7JV"N"!S@\"N'\40:]XA\&>-+>Q
MMM?O+!XK(6$5];.LSR+,&EV(RAB,!>W:O;:* /,_'WA?4D^$&MZ;:7>KZW>3
M^0Z)<;991MEC)50B+P "<8)KJ-!\)QZ7JDNLWE_=:EJTUNML;FY6-2D0.[8H
M15 &>3W/%=)10!Y%+9'3OB[XHU34K+Q,MK<?8GLY=*AN6CF*1 ,'\D88 C&&
M]_6I?$>E:B_Q ?6K33+QM$ANK--2M4@8F^D7<5G10N6$1:/)&0=O^Q7K%% '
MSVFG'6(O%EC8:/<2^('\73"PU1;7>MH%GC=CYG2/ W$@XSN&,]NLN_"M[J7C
M'XD7D>FNMZ]I;KH]Y+&5 D:U*.8G/ .0JDJ>.,UZ;8:78Z7]J^PVL<'VJX>Y
MGV#'F2MC<Y]S@5;H \GT;0K*^M+C_1M8L&31GL+FWM](:U(5MO 8C$LBD'&W
M=U/7/+[*PN=0\#:QI^HP7D%E%<0BTO[32&AN+A4"-O>V();##:?EPPS@ 5ZK
M10!Y!96FOZAXI\"7MQHYMA;3:LKSP6+P1A&B"Q2R(<^47_NL<YJEHGAZ7?X2
ML[7P]=6'B33=16?5]3DLB/-B <2YN",2>9N&,$GGV->V44 >(CPC.VE^)]3?
M0)FUE?%_G6,[6K&86_VB-MT9(SY>&D.1QU/:NV^)-A>7W_"(_8[2>X\CQ+9S
MS>3&7\N-=^YVQT49&2>!7<44 >(CPC.VE^)]3?0)FUE?%_G6,[6K&86_VB-M
MT9(SY>&D.1QU/:NV^)6FW>I)X3%K9RW*V_B2SGG$<9?9$-X9F _A&1DUW%%
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M[_67_P D4 =!17/_ /"0ZI_T)FN?]_K+_P"2*/[?U=ON>#]64_\ 36XM /\
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MD'H1T%:49:*%I&&58<KGO44<$AU3S/D,9&6^7YAZ5;M;26!IS<77F>:?EP
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M2HM[V]Z'".%;KANN1DC%<OJ'B:[CD>*UVQ@G*LXS^%8;:M/.?-=II9$^\=V
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M,@&ND8_L.<;LG)B=<?I5Q='NY8_-N].G:0\!1&2/RJ?^S=1_Z WBK_P?K_\
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MLQ<@AX6)]C5R"Y$BM&W#?P9_E6L97T9G*/81PDF >&)XYJO)$R'D&KS0Y^Z
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MA '3YE(.>>>F.0#JZ*** "BBB@ HHHH @OB1I]R0<$1-@CZ&L[PD /!FA #
M&GV^ /\ KFM:%_\ \@ZY_P"N3?R-9_A/_D3=#_[!\'_HM: -BL+Q5_R#HO\
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MP_\ 0FKTRO,_B-_R'+;_ *]A_P"A-7;E_P#'1X^??[D_5''4445[Y\*%%%%
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M+2K_ ,),OW?#7AT?35I/_D6BBCE78.9CL^)\Y_X1OP]G_L+2_P#R+1N\3_\
M0M^'O_!M+_\ (M%%'*@NPSXG_P"A;\/?^#:7_P"1:-WBC_H6_#W_ (-I?_D6
MBBCE078F?$__ $+7AW_P;2?_ "+1GQ./^9:\._\ @VD_^1:**.5=@NRMJ%CX
MFU2S6Q?1]#LX7G@DDEBU.1V"I*KG"_9U!/RD=1UKKZ**8@HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g3dyckr3udth000026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000026.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %S M # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /PE7_4!US_P#_\ KT?\)5_U =<_\ __ *] '045S_\ PE7_ % =<_\  /\
M^O1_PE7_ % =<_\  /\ ^O0!T%%<_P#\)5_U =<_\ __ *]'_"5?]0'7/_ /
M_P"O0!T%%<__ ,)5_P!0'7/_  #_ /KT?\)5_P!0'7/_  #_ /KT =!17/\
M_"5?]0'7/_ /_P"O1_PE7_4!US_P#_\ KT =!17/_P#"5?\ 4!US_P  _P#Z
M]'_"5?\ 4!US_P  _P#Z] '045S_ /PE7_4!US_P#_\ KT?\)5_U =<_\ __
M *] '045S_\ PE7_ % =<_\  /\ ^O1_PE7_ % =<_\  /\ ^O0!T%%<_P#\
M)5_U =<_\ __ *]'_"5?]0'7/_ /_P"O0!T%%<__ ,)5_P!0'7/_  #_ /KT
M?\)5_P!0'7/_  #_ /KT =!17/\ _"5?]0'7/_ /_P"O1_PE7_4!US_P#_\
MKT =!17/_P#"5?\ 4!US_P  _P#Z]'_"5?\ 4!US_P  _P#Z] '045S_ /PE
M7_4!US_P#_\ KT?\)5_U =<_\ __ *] '045S_\ PE7_ % =<_\  /\ ^O1_
MPE7_ % =<_\  /\ ^O0!T%%<_P#\)5_U =<_\ __ *]'_"5?]0'7/_ /_P"O
M0!T%%<__ ,)5_P!0'7/_  #_ /KT?\)5_P!0'7/_  #_ /KT =!17/\ _"5?
M]0'7/_ /_P"O1_PE7_4!US_P#_\ KT =!17/_P#"5?\ 4!US_P  _P#Z]'_"
M5?\ 4!US_P  _P#Z] '045S_ /PE7_4!US_P#_\ KT?\)5_U =<_\ __ *]
M'045S_\ PE7_ % =<_\  /\ ^O1_PE7_ % =<_\  /\ ^O0!T%%<_P#\)5_U
M =<_\ __ *]'_"5?]0'7/_ /_P"O0!T%%<__ ,)5_P!0'7/_  #_ /KT?\)5
M_P!0'7/_  #_ /KT =!17/\ _"5?]0'7/_ /_P"O1_PE7_4!US_P#_\ KT =
M!17/_P#"5?\ 4!US_P  _P#Z]'_"5?\ 4!US_P  _P#Z] '045S_ /PE7_4!
MUS_P#_\ KT?\)5_U =<_\ __ *] '045S_\ PE7_ % =<_\  /\ ^O1_PE7_
M % =<_\  /\ ^O0!T%%<_P#\)5_U =<_\ __ *]'_"5?]0'7/_ /_P"O0!T%
M%<__ ,)5_P!0'7/_  #_ /KT?\)5_P!0'7/_  #_ /KT =!17/\ _"5?]0'7
M/_ /_P"O1_PE7_4!US_P#_\ KT =!17/_P#"5?\ 4!US_P  _P#Z]'_"5?\
M4!US_P  _P#Z] '045S_ /PE7_4!US_P#_\ KT?\)5_U =<_\ __ *] '045
MS_\ PE7_ % =<_\  /\ ^O1_PE7_ % =<_\  /\ ^O0!T%%<_P#\)5_U =<_
M\ __ *]'_"5?]0'7/_ /_P"O0!T%%<__ ,)5_P!0'7/_  #_ /KT?\)5_P!0
M'7/_  #_ /KT =!17/\ _"5?]0'7/_ /_P"O1_PE7_4!US_P#_\ KT =!17/
M_P#"5?\ 4!US_P  _P#Z]'_"5?\ 4!US_P  _P#Z] '045S_ /PE7_4!US_P
M#_\ KT?\)5_U =<_\ __ *] '045S_\ PE7_ % =<_\  /\ ^O1_PE7_ % =
M<_\  /\ ^O0!T%%<_P#\)5_U =<_\ __ *]'_"5?]0'7/_ /_P"O0!T%%<__
M ,)5_P!0'7/_  #_ /KTG_"6PI)"MQI.KVZ2S1P"6:UPBL[A%R<\99@/QH 7
MP)_R3SPS_P!@JU_]%+705S_@3_DGGAG_ +!5K_Z*6N@H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLP89978L.,  <8(S7I4FBZ5-#9PRZ99O%8E6M$:!2MN5X4H,?*1@8QC%,O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-JEOIYNKE?[#O5@N2KO_ *2TC#R=S<;_ -R0S Y&YQSQ0!Z-17FVG_$&_O\
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M=<_\$-[_ /&:Z"B@#G_^$RTO_GUUS_P0WO\ \9H_X3+2_P#GUUS_ ,$-[_\
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M?]#1_P"4^/\ QH Z"BLGPU>7-_X?M;B\D62X;>KNJ[0Q5RN<=NE:U !1110
M4444 %%%% !1110 4444 8WBO2!KOA?4=-,;2-- P6-96CWMC@$J1P3P1G!Z
M'BJ'A;3H[+4]2D@T^[M89(H%#W]T\]P[ R$@EY'(0;ACD<L_'<Z7B'2[W5]-
M6VL-4DT^02!G= ?WB8(*$J59<Y^\K @@>X.=X.T&30DU!)].M8)YIMYN89FF
M:X3)VAW<;R5']XGKP3S0!T]%5-0U&WTR"*:YWA))XK=2JD_/(ZQKGT&Y@,^]
M67D2)=TCJB^K' H Q/!7_(CZ%_UX0_\ H J6^UR>SNW@30=5NE7&)K=8BC9&
M>-T@/MTJ+P5_R(VA?]>$/_H K=H8EL<UIWB]M4MK:YMO#NM&WN &25DA P>Y
M_>9Q72US_@;_ )$;1?\ KT3^5=!0,**** "BN8BN/$NI:AJ8LM1TFUMK6Z-N
MB3Z;),YPB-DL)T'5O2I_L?C#_H.Z'_X)IO\ Y*H Z"BN?^Q^,/\ H.Z'_P""
M:;_Y*H^Q^,/^@[H?_@FF_P#DJ@"QH^BSZ9J.J74NHSW2WTOFK%+)*RP<M\J!
MW8*N"O  ^;<?NE$38KG_ +'XP_Z#NA_^":;_ .2J/L?C#_H.Z'_X)IO_ )*H
M Z"BN?\ L?C#_H.Z'_X)IO\ Y*H^Q^,/^@[H?_@FF_\ DJ@#H**Y_1KW6/\
MA(=2TG5KFQN?L]I;7,<MI:O!_K'F4J0TCYQY0.01U-=!0 4453U*\GL;=9+?
M3+O4'+;3%:M$K 8//[QT&/QSSTH N45RX\7W;:B]@/".N?:DB69D\RSX1B0#
MG[1CJI_*M^PNIKRU6:>PN+&0D@P7#1EQ[_NV9>?K0!9HHHH *P_%G_('M_\
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M7:C'\*W:S]0T][V^TFX5U46-VT[ C[P,,L>!^,@/X4 :%%%% !1110 4444
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M1^9VY!+FQC?]U_FCI:BN+>*[MI;:>,20S(8Y$/1E(P1^52T5X1]H( %4 #
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MX:9S]7<EC^)-.S#F1:KS+5TO'FF%C/!#+YQRT\!E7&3Q@.O/3G->FUYU=_\
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M^.XUZ5\.O]3J'^]'_P"S5P5=[\.O]3J'^]'_ .S56#=Z\?G^0Z+]]&'\;O\
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MZ(WP%6<ZC4G?0P/B-_R'+;_KV'_H35QU=C\1O^0Y;?\ 7L/_ $)JXZO9P?\
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MM:;_ ,A2S_Z[I_Z$*]67PL^:I_&O4]SKSJ[_ ./R?_KHW\Z]%KSJ[_X_)_\
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M5U_PY_Y&&X_Z]6_]#2N0KK_AS_R,-Q_UZM_Z&E;XO^!(X\K_ -\I^IWNO?\
M($N?HO\ Z$*X6NZU[_D"7/T7_P!"%<+7YAGG^\1]/U9^O99_"?K_ )!6KX=_
MY#47^ZW\C656KX=_Y#47^ZW\C7GX+_>:?JOS.O$?P9>C.VHHHK[H^9"BBB@
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M6WT->"5>5_;^7ZF?$N]+Y_H%6M-_Y"EG_P!=T_\ 0A56K6F_\A2S_P"NZ?\
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M=3,Q[<DO4?\ PJSP7_T!5_\  B7_ .+KV(XA))6.&IE\Y3<K[GSC7TC\,_\
MDG>D_P"[)_Z,>F?\*L\%_P#0%7_P(E_^+J];^!] M(%@M[>ZAB3[J1W\ZJ._
M #U%6LIJQMA<)*C-R;N<K\1O^0Y;?]>P_P#0FKCJ]8G\ ^'+IP]Q9SRL!@%[
MV<D#\7J+_A7'A7_H&O\ ^!<W_P 7791S"-.FH-;'DXS(JF(KRJJ:5SRRO3/A
MS_R [G_KY/\ Z"M3_P#"N/"O_0-?_P "YO\ XNK$'@;0+5"EO;7,2DY(2^G
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MBS_D#V__ &$[#_TKAH C\"?\D\\,_P#8*M?_ $4M=!7/^!/^2>>&?^P5:_\
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M=I/#'G.[G:0  =9IU_;ZKIMKJ%H^^VNHEFB;U5AD?SJS2(BQHJ(H55&%51@
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M&&9<F,L#C(K4\'^%)-)M;&;4'\R6UMQ#9PO$F^S0@[D,B_ZPG(!;@':#C/-
M'46LYN;.&=H98&EC5S%* '3(SM;&1D=#4U%(2%!)( '))H 6N.\;^,U\/1)8
M6F6U6ZPD*\90MD(X5L"0!PH*@Y^8>U.\3>(GBU'2['1[S_B9W&9K6 J&@OD
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MKZ@=*TJ>]%NUP8@"(5=59\D#"EB!GG@9Y.!WKAX]6O?'.HV?V,3V&GC>[Q3
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M;5W$DX7@=>K&NNHHH *XGQ+XC%TIMM.N+S[%;3Q'4[K3L/(MNXD :,KDX$B
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\
M"-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z
M_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6
M'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_
M (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\
M:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY11
M0 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_
M .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\
M"-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z
M_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6
M'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_
M (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\
M:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY11
M0 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_
M .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\
M"-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z
M_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6
M'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_
M (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\
M:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY11
M0 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_
M .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\
M"-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z
M_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6
M'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_
M (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE'_  C5A_S\
M:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\ "-6'_/QJO_@VNO\ XY11
M0 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z_P#CE%% !_PC5A_S\:K_
M .#:Z_\ CE'_  C5A_S\:K_X-KK_ ..444 '_"-6'_/QJO\ X-KK_P".4?\
M"-6'_/QJO_@VNO\ XY110 ?\(U8?\_&J_P#@VNO_ (Y1_P (U8?\_&J_^#:Z
M_P#CE%% !_PC5A_S\:K_ .#:Z_\ CE(?"VF.T32-J$HBE295EU*Y==Z,'4E6
,D(.&4'!':BB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g3dyckr3udth000017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %& GH# 2(  A$! Q$!_\0
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M$*7EMK0T^+PUY*;I8O,"Y_OEB"6W#CBN@^&]A(/%GC6_N+E;B8:J]OO:! ^
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MYYL-2N=4\46WC$V[R-IVB7%W8VL@/$,*")"1_MR-(WT45?@\6^,9?".OW_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8=0> >X%<)X5UNXL?!?A?3AXLDTZQOKJZ%_?LT9:S=>4@W,,)O\ O9;GGTH
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MT3$4+.P48ZENYSTJU\)K+1+O7+W6]!:UM;&.T6RALHYE>XE4.3]HN #P[$$
M'G%/K85]+GHFF:+X=L[F2YTG3-+@GC)A>6T@C5E/=25&1VR*OW5M:3K')=PP
M2"W?SD:9 ?+8?Q GH1SS7CW]IZLKSVNF:F=/DO/&\]F\T,4>?+*$D$$8)XZG
MG.*['P!>7^H6GB/2M6OGU$:?J<UBD\RJ'>+:IPV  3\Q[4M6K_UT_P RFK/^
MO/\ R.FVZ(58XT\KJ9^8X3%WQCG^_P <=^*IO:^$M/BEMW@T2VCRD<L;)$@R
MOS(K#U'4 ].HKPJTLM1U"TN+1%E\SP!'*\)!_P!9,+G>/J/*C(KNO#6E:=XD
M^'OB'Q%JFG6]R=5NKN_MQ<Q*YB4*4CQGH0%Z^]*^E_Z\@ZV/18%T'5FO'MQI
MMXTRJET8Q'(749VA\9R.N :QM7T+1M:\*RZ?I6I6NF64,F]WLDA:$$<E9$(*
M%>Y!]!5?X7Z5IUA\/='NK.QMK>>[L8GN)8H@K3-MZL1]X\GKZUXOX8CN8="@
M\/0AC;^+\MN4\(89Y!-^<:J*<M'82VN>V^%_"^AZ7IEQ92WUMK+:K(;B9IEB
M*3[0%^6-1MVJ !@#BNECTO3XA:B.QM4%IG[,%A4>3D8.SCY>..*\/\(:C=:=
MH/A":QB2:XBT#5)HH_+!+R*^5 .,\GL#S5I?&>I67@W4-1TWQJ-;U-],AN9+
M1K=6-D[.JR.&484*&/R-DC&>E-_U^/\ D"_K^OF>Q3:'I%Q:/:3:58R6SR&5
MX7MT*,YY+%2,$^_6KL<:11K'&BI&@VJJC  ] *X+X9:KJNH#58KW6+75;6%X
M_L\T=TEQ(A9265W154]B,<C.#7?T-6"]PHHHI %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GW.@Z/
M>SM/=:38SS-]Z26W1F/U)&:T** *8TC35BEB&G6@CE14D40KAU7[H(QR!V%9
M>F^$-.T[6=3U,HL\M]<)<*LL:D0,J!!LXXX%=!10!$EK;QR32)!$KS',K*@!
MD.,?,>_'K4,>F:?#:26D5C;1VTF=\*PJ$;/7*XP:MT4 4_[)TTV'V Z?:_8_
M^??R5\O_ +YQBI5L;1# 5M8%-N"(<1@>4",$+Z<>E3T4 5XK"R@N9;F&T@CG
MF_ULJ1@,_P!2!D_C2)IUC&L"I9VZK;DF$+$H$9/4KQQU/2K-% $5S;6]Y T%
MU!%/"WWHY4#*?J#3%L;-++[$MK MKMV^0(QLQZ;>F*L44 5ETZQ2"&!;*W6&
M%@\48B4+&PZ%1C /N*/[.L?^?*W_ -=Y_P#JE_UO]_I][WZU9HH P/#WA+3_
M  \DQC N)I+J:Y6>6-=Z>:VYE!QD"M-=)TU;EKE=/M!.S^891"NXMC&[.,YP
M3S5RB@"J=-L6L18M96QM ," Q+Y?K]W&*673K*XMH[::SMY((R"D3Q*57'3
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M9VMA (+.VAMX0<B.&,(N?H*GHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,/3)-:U'2;.]-]8QFY@28H+-CMW*#C/F>]6OL^L_P#01LO_  ";_P".
MTWPU_P BKI'_ %Y0_P#H K4H S?L^L_]!&R_\ F_^.T?9]9_Z"-E_P" 3?\
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MPG2!XKVV=;@D0E95/F8Z[>>?PJU0!F^?K7_0/L?_  -?_P"-4>?K7_0/L?\
MP-?_ .-5I44 9OGZU_T#['_P-?\ ^-4>?K7_ $#['_P-?_XU6E10!F^?K7_0
M/L?_  -?_P"-4>?K7_0/L?\ P-?_ .-5I44 9OGZU_T#['_P-?\ ^-4>?K7_
M $#['_P-?_XU6E10!F^?K7_0/L?_  -?_P"-4>?K7_0/L?\ P-?_ .-5I44
M9OGZU_T#['_P-?\ ^-4>?K7_ $#['_P-?_XU6E10!F^?K7_0/L?_  -?_P"-
M4>?K7_0/L?\ P-?_ .-5I44 9OGZU_T#['_P-?\ ^-4>?K7_ $#['_P-?_XU
M6E10!F^?K7_0/L?_  -?_P"-4>?K7_0/L?\ P-?_ .-5I44 9OGZU_T#['_P
M-?\ ^-4>?K7_ $#['_P-?_XU6E10!F^?K7_0/L?_  -?_P"-4>?K7_0/L?\
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M@#*T+_57W_7]/_Z%1XD_Y 4_^_'_ .C%HT+_ %5]_P!?T_\ Z%1XD_Y 4_\
MOQ_^C%H U:**XCQ9XYN] NYK2'34CV!-MY?.R0.6('R;0=V,\Y*]#0!V]%5[
M%Y)+"W>6:&>1HU+2P#$;G'5>3QZ<FK% !1110 4444 %9NN_\@O_ +;P?^C4
MK2K-UW_D%_\ ;>#_ -&I0!I4444 %%%% !1110 4444 %%%% !1110 4444
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M#.#L X_,U)&Y>-6*,A(^ZW44 .HHHH **** "BBJ]U/+ BM'!YN3@_.%QZ4
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MF4?O2/F8#M76?#T8TF['I<?^RBO*P]>I+$.+>FIS0G)SLV=?1117JG2%%%%
M!69?7MOYBJFJ1PL&VNH=,CZYZ5IUX[JZ%M?U,A"?WTG0>]<N*Q#H132O<SJ3
MY$>NP3Q3Q[H9DF4<%D8$9_"I:Y7P ,>'I.,?Z0W\A755M1G[2"GW*B^:-PKY
MT\2_\C5J_P#U^S?^AFOHNOG3Q+_R-6K_ /7[-_Z&:T*/=_#7_(JZ1_UY0_\
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MEO?R7+S$L/G ;A5!##C/)ZT =S7$:GJVI:=<>*8X+R6:=8HGL8W4'82C,X0
M?-@*6QR>*[>C ]* /+K_ %FZB4Q6.MSSZ5]NA1+V6Z$6=T,C.AFVG@$(>G!.
M/IT.JZQ?Q: GV:.>.S_<*^JK,DO[IF4.ZXY)"D_,5]ZZ_:N,;1CTQ2X&,8XH
M X*QU"_>ZT\P:I=3Z>-9:UAD;!%S 82V6;&6"N" P/..];^MRZB;;8]I +?[
M3"/,%P2V/-7G;M_3-;H      Z"L[7?^07_VW@_]&I0!I4444 8WBS_D5M0_
MZY?U%>0)MWQ@-DAAQCWKU_Q9_P BKJ'_ %R_J*\>B_UT?^\/YU[>6?PI>I\=
MQ%_O,/3]6=+XS_Y&FY_W(_\ T$5M_#G_ )B/UC_]FK$\:?\ (U7/^Y'_ .@B
MMOX<_P#,1^L?_LU?%TO]]?J_U/IH?Q3NJ***]DZPJKJ-_#IEA+>7&[RH@"VT
M9/7']:M5A>,?^13OO]U?_0A5THJ4U%]68XFHZ=&<X[I-_@9EKXVTP7.'N;V4
M.0J*T2XY^GO7*^+?^1IOO]Y?_016):N6O+<''^M7M[UM^+?^1IOO]Y?_ $$5
MEG^'A1IPY.K/$R['UL93DZMM&MOF=+\.O^/._P#^NJ_RKM:XKX=?\>=__P!=
M5_E7:USX/^!'^NI[M+X$%%%%=1H%%5-3U*#2;![RYW^4A .P9/)Q7.67C73W
MNUC>YN9?-8)&I@ ZD#)(K2%&I-<T5='/5Q="E+DJ229QOB3_ )&74?\ KL?Y
M"NQ^'O\ R"+K_KX_]E%<=XD_Y&74?^NQ_D*['X>_\@BZ_P"OC_V45X.%_P!Z
M?S(I_P 0Z^BBBO:.L*0G R>U+6)XKU2YTC1&N[0J)1(J_,N1@U4(.<E%=3.M
M5C2INI+9:FI!>0W+,L18E>N49?YBO(=<_P"0_J'_ %\/_.MK2?&6KW&KVEL[
M0>7/,H?$?/)P:Q=<_P"1@U'_ *^'_G7%G.'G1C%2ZGGTL=2QD.:E?1]3N_ '
M_(O2?]?#?R%=57*^ /\ D7I/^OAOY"NJJ\+_  8^AZ-/X$%?.GB7_D:M7_Z_
M9O\ T,U]%U\Z>)?^1JU?_K]F_P#0S706>[^&O^15TC_KRA_] %>:7-CIC^-)
MY+73+R*W^UDW;:E:SRI(V>3 %!9>>Y(7VKTOPU_R*ND?]>4/_H KD?$%HL?B
M1;=8V@MTC21)6AO;CS&9V+#]TX5<'USU]!0!TWBO*Z%<O++"+01LLT4EMYWF
M%L!0%W+SN([]^HK.\"1+:VM_:O#Y%W',IGB:#8XRHVEF\Q]^1T.[C&.U7_%P
MD&@SR&ZCAME4B='L_M/G*> H7<.22*H^!84M;.]M#$T,\<P,L4EKY+KE0020
M[[\CH=W;':@#K**** "BBB@ K-?_ )&:#_KSD_\ 0TK2K-?_ )&:#_KSD_\
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MHHH \4\0?\C%J/\ U\/_ #K5F_Y$#3_^OQ_Y&LG7_P#D8M1_Z^'_ )UK3?\
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M6&<!<=J /0:S7_Y&:#_KSD_]#2N<\(3RW<^I3VMS=JCHOE6U^978-EOWCE@
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M45!<W(ME#&*5P3C]VN<4 9?B[_D5-0_ZYC_T(5Y#!_Q\Q?[Z_P Z]<\5MO\
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M *&E:59K_P#(S0?]><G_ *&E &E1110!YM\2/^0K9?\ 7 _^A50\(_ZG7/\
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MA]:*C7+DMGJ.G^Z*[BN%UW_D-7/U'\A7BY[_ +O'U_1GHY;_ !7Z?Y$4N/\
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M>/DJ'RM8>X6X\FV&1G9]LDQGZ;,5MUG:]JRZ'H=WJ;1>:MNFXINVYY Z]NM
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MH_MA_P#H%:C_ -^E_P#BJ -.BLS^V'_Z!6H_]^E_^*H_MA_^@5J/_?I?_BJ
M-.L5O#%BVHS77FW2QSN9)K19B()'*[2S+WR.HS@]2,U/_;#_ /0*U'_OTO\
M\51_;#_] K4?^_2__%4 -TC0H-&W"*[O9UV".-;B<N(D'15']3D].:U:S/[8
M?_H%:C_WZ7_XJC^V'_Z!6H_]^E_^*H TZ*S/[8?_ *!6H_\ ?I?_ (JC^V'_
M .@5J/\ WZ7_ .*H TZ*S/[8?_H%:C_WZ7_XJC^V'_Z!6H_]^E_^*H FN=*M
M;N^CNYT+ND$D&TGY2C[=P([_ '15?2-!@T8D0W5[,H011I<3EUB0=%4?U.3P
M.:=_;#_] K4?^_2__%4?VP__ $"M1_[]+_\ %4 :=%9G]L/_ - K4?\ OTO_
M ,51_;#_ /0*U'_OTO\ \50!IT5F?VP__0*U'_OTO_Q5']L/_P! K4?^_2__
M !5 &G6+>^&;._U&>\EGN@+B$07%NL@$4R#< &&/]H]"*G_MA_\ H%:C_P!^
ME_\ BJ/[8?\ Z!6H_P#?I?\ XJ@!=*T>/25D"WE[=%PJAKJ8N55>@'8=>O4]
MR:TJS/[8?_H%:C_WZ7_XJC^V'_Z!6H_]^E_^*H TZ*Y[6?$TNFZ+>WR:3>E[
M>%I )4 7(&>2#P*WT;=&K>H!H S-"_U5]_U_3_\ H5'B3_D!3_[\?_HQ:-"_
MU5]_U_3_ /H5'B3_ ) 4_P#OQ_\ HQ: -6BBB@ HHHH **** "BBB@ HHJ"\
MO+?3[5[F[E6*%" SMT&2 /U(H GHHHH \WE\(Z^UY>O!B(F2\:&5KK( F8D>
M6 N8VZ9.3T/K5N^\.Z__ &Q=&P/EV30F"(F\<DC"%6.XGD%6Z?WL\Y-=[10!
MS6AZ+J6GZP]U<3N\<T<WFJUPS@L9BT>%/ Q&<<8]*Z6BB@ HHHH *Q/$FG75
M]!8S6<<4\ME=I<_9Y6VK* &&,X."-V03W K;HH XQM*UB/47U%=$TR5KRU-O
M):M-A(/WC-DG;\P8-\V!R5'6NR0;44$ 8&,#I2T4 %%%% !1110!E>)=/FU7
MPWJ%C;A#-/ R1[S@9(]:RIM)U&VUZ]GM].L;VVU 0;GGDV_9_+&""N#N'\0Q
M_$3]:ZJB@ HHHH **** "L3Q-97MW;V$EA D\UK>QW!B>39N5<YP<'GFMNB@
M#DM.TW5K;5)VFTJQEAO;Q;UYY9MSP':H*8V_,R[?E((&#VQSUM%% !114$UY
M;V\UO#-*$DN',<*G^-@I8@?@I/X4 3U\Z>)?^1JU?_K]F_\ 0S7T77SIXE_Y
M&K5_^OV;_P!#- 'N_AK_ )%72/\ KRA_] %:E9?AK_D5=(_Z\H?_ $ 5J4 %
M%%% !1110 4444 %%%% "!57.U0,G)P.II:** "BBB@ HHHH **** "BBB@
MHHHH J7VJ:?IGE_;[VWM?-)">=*$W$=<9IS:C9(9@UY #"JM*#(/D#?=)] >
MWK6-XBT_4+C4]-O+&RMKP0)/')%<2[%_>*H!/RG(XY%<S+X U.*SD%K/;M=>
M1;6I=B0)H5 #J?3!&5Z],=S0!Z$EU;RW,UM'/&\\(4RQJX+)NZ9';/:IJX_1
MO#VL6'BJ76;B:V=;TS"YB489%W Q?-_'@+CH,;CUKL* "BBB@ HHHH ****
M"BBB@ HHHH 1E5U*L RG@@C@TM%% &5H7^JOO^OZ?_T*CQ)_R I_]^/_ -&+
M1H7^JOO^OZ?_ -"H\2?\@*?_ 'X__1BT :M%%% !1110 4444 %%%% !5#6M
M*AUS2)].N'9(IMNXIUX8-_2K]% &7_PCNC_\^$/Y&C_A'-'_ .@?#^1K4HH
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M /0/A_(T?\(YH_\ T#X?R-:E% &7_P (YH__ $#X?R-'_".:/_T#X?R-:E%
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MRXDY(/WESFNA\*7<M]X<MKB>\^US,7$DNW;\P8@KC Z=.G:@#:HHHH ****
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M9T'_ )]-2_[]I_\ %T?\+9T'_GTU+_OVG_Q=%% !_P +9T'_ )]-2_[]I_\
M%T?\+9T'_GTU+_OVG_Q=%% !_P +9T'_ )]-2_[]I_\ %T?\+9T'_GTU+_OV
MG_Q=%% !_P +9T'_ )]-2_[]I_\ %T?\+9T'_GTU+_OVG_Q=%% !_P +9T'_
M )]-2_[]I_\ %T?\+9T'_GTU+_OVG_Q=%% !_P +9T'_ )]-2_[]I_\ %T?\
M+9T'_GTU+_OVG_Q=%% !_P +9T'_ )]-2_[]I_\ %T?\+9T'_GTU+_OVG_Q=
M%% !_P +9T'_ )]-2_[]I_\ %T?\+9T'_GTU+_OVG_Q=%% !_P +9T'_ )]-
M2_[]I_\ %T?\+9T'_GTU+_OVG_Q=%% !_P +9T'_ )]-2_[]I_\ %T?\+9T'
M_GTU+_OVG_Q=%% !_P +9T'_ )]-2_[]I_\ %T?\+9T'_GTU+_OVG_Q=%% !
M_P +9T'_ )]-2_[]I_\ %T?\+9T'_GTU+_OVG_Q=%% &YX/U"'5M&FU"W5UA
MN+N9T$@ 8#>1S@GTJ;Q;.EKX7O;F0,4A"R,%'. ZDX]^*** .=_X6SH/_/IJ
M7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+HHH /^%LZ#_SZ:E_W[3_XNC_A;.@_\^FI
M?]^T_P#BZ** #_A;.@_\^FI?]^T_^+H_X6SH/_/IJ7_?M/\ XNBB@ _X6SH/
M_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+HHH /^%LZ#_SZ:E_W[3_XNC_A;.@_
M\^FI?]^T_P#BZ** #_A;.@_\^FI?]^T_^+H_X6SH/_/IJ7_?M/\ XNBB@ _X
M6SH/_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+HHH /^%LZ#_SZ:E_W[3_XNC_A
M;.@_\^FI?]^T_P#BZ** #_A;.@_\^FI?]^T_^+H_X6SH/_/IJ7_?M/\ XNBB
M@ _X6SH/_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+HHH /^%LZ#_SZ:E_W[3_X
MNC_A;.@_\^FI?]^T_P#BZ** #_A;.@_\^FI?]^T_^+H_X6SH/_/IJ7_?M/\
MXNBB@ _X6SH/_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+HHH /^%LZ#_SZ:E_W
M[3_XNC_A;.@_\^FI?]^T_P#BZ** #_A;.@_\^FI?]^T_^+H_X6SH/_/IJ7_?
MM/\ XNBB@ _X6SH/_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+HHH /^%LZ#_SZ
M:E_W[3_XNC_A;.@_\^FI?]^T_P#BZ** #_A;.@_\^FI?]^T_^+H_X6SH/_/I
MJ7_?M/\ XNBB@ _X6SH/_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+HHH /^%LZ
F#_SZ:E_W[3_XNO&-;\2V-UK^I7"1W 26ZE=0RKD L3ZT44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g3dyckr3udth000039.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000039.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $@ 9,# 2(  A$! Q$!_\0
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M6N_]]P?_ !J@#H:*Y[_A&+K_ *&K7?\ ON#_ .-4?\(Q=?\ 0U:[_P!]P?\
MQJ@#H:*Y[_A&+K_H:M=_[[@_^-4?\(Q=?]#5KO\ WW!_\:H Z&BN>_X1BZ_Z
M&K7?^^X/_C59^NZ-?Z9X>U*_@\4ZV9K6TEFCWM 1N5"1D>5TR* .QHJ*U=I+
M2&1^6:-2?J110!B>!/\ DGGAG_L%6O\ Z*6N@KG_  )_R3SPS_V"K7_T4M=!
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10 4444 %%%% !1110 4444 %%<'K'_(8NO]^J-.PKGI5%8OA@$:4Q+$YE)
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MM([%1O1"0,!MBYS@5N44 %8WBW_D3-=_[!]Q_P"BVK9K&\6_\B9KO_8/N/\
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M2AZS_P!@JP_]&W= '04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU9@/[+UT9.,G2I^/_':Z"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;/LN[<WX UB77CC1&ECGD\5LOVMRZ+%?70"Y/=1+\@]CC% KGG/A_6M<\/\
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M?WL$%VMS#,\6+NW=9(1^[0?>![$<XZ?G7=E\XPJWD[:'C9Y1J5L,HTU=WO\
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ML X)4D9P1Q[BKE=IS!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%8WBW_D3-=_[!]Q_Z+:MFL;Q;_R)FN_]@^X_]%M0!I6/_(/MO^N2_P A118_
M\@^V_P"N2_R%% &-X$_Y)YX9_P"P5:_^BEKH*Y_P)_R3SPS_ -@JU_\ 12UT
M% !1110 5SGB7P[=:KJ&DZKIM[%:ZEICRF%IHC)&RR+M<$ CG&"#[>]='10!
MSNE^#-'LO">G^'KVTMM3M;-01]L@60-)R2^UL@$EF^@.*=_P@G@__H5-#_\
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M*>4JB2M&-YQ@.K D\;N#VXKV"B@#RV#]G_P1"MT'34)O/&$,ES_J.>J8 _\
M'MU:WASX/>#?#D=PHTQ-3:9L[]3CCG* =ERH 'X9]37>44 4]-TG3=&MVM]+
MT^TL8&?>T=K"L2EL 9(4 9P!S["KE%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %8WBW_D3-=_[!]Q_Z+:MFL;Q;_P B9KO_ &#[C_T6U &E
M8_\ (/MO^N2_R%%%C_R#[;_KDO\ (44 8W@3_DGGAG_L%6O_ **6N@KCO"6M
M0:=X+T*RN[/5XKFVTZWAEC.DW1*NL:@CB/L:V/\ A)]/_P"??5O_  47?_QN
M@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X
M2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GW
MU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W
M_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\
MA*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"?
M?5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W
M?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9H
MK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_
M /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\
M\$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&
MZ/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/
M_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__
M  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN
M@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X
M2C3_ /GWU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GW
MU?\ \$]W_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W
M_P#&Z/\ A*-/_P"??5__  3W?_QN@#9HK&_X2C3_ /GWU?\ \$]W_P#&Z/\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g3dyckr3udth000016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %0 M # 2(  A$! Q$!_\0
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MBC_P$B_^.UG;".A^4=A2T_9H+FC_ ,+9M?\ H4O%/_@)%_\ ':3_ (6U:?\
M0I^*/_ 2+_X[6<6../SJ'=)YP7;^[(^_GH:/9A<U_P#A;5I_T*?BC_P$B_\
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M!=&:7SV=BQ')(QNKH]I[Q@Z;M>QG>),?\(EKFX@L;*;D*!_ :]DTG_D#6/\
MU[Q_^@BO%?$-Q%_PBNKQL<3RV,[X/4@(:]JTG_D#6/\ U[Q_^@BHEJ[D25F7
M*\(\(&[7P?I9@5"NUMQ8_P"V:]WKP/PS"C^"=->6Y>*$(P8*.OSG%53W(D=!
M?Q&\A2U4NJLP,C]@!SC'?/3Z51N-,E-@(Y;@E8]JC]Z1N52>N0<$C'8],58%
MP#M126)(7:,G ]<U/*453;*K,X_A'I]:VLR-C+@2475M<VUOYB+'M9R^6;"E
M2#Q@G.#GCZ59GCEA83R$EFDW>7NVJ%.W(R!D?='Y5;>5K=XTCBRIZD=J>KQ7
M6Z.3:XQRGJ*-&,RY;"^N/,A@N P:$*YDD8@GC&#C\SR?UIZ6-U([V\UU\S$Y
M\N4C:-N!R0<'.>W?-:]G<>8'18&B"G"@CJ*?^Z-UL*#<!D-[TK*XKO8S;G3V
MEN-OGL@0/L42L,$[=O3CC#?G2:.S1SSPB;<N P&2><G/4=QCUZ4^XFEEN$DC
MMLN) JC?U&>2?I6E&+>.4QQE!(W) ZYI>3*V1'<PH\8F&%D0$H6Z"GVD$+9G
MA&3*OWNQIK1W+6LXF*SD@[4Z9]JEA<>0A6(Q, ,Q$_=IWLK$ZCTABB;=L!?&
MW)Z_G44&Z!&2:?SI-Y.[&,#L*9<P1WD)?.\(IVKGC<#D&B,7$T"/(JK*P_>%
M>*3N-(6X:!I-LH(4CY<C@TUEC^UQSI]X)L8@Y!';-.C B@+R/YA7._')J2&.
M.;;<*I&X<#H"/I2U0]")VEA087S(P,[F;D5'/ T\D<LAWJR@.C<KM'/3UJ=D
M2=71@R>7]XL./PJ6W6-H=ZG '3'>G>P$,\?[F,!GB+. I5<@>WTJLUB@9GN6
M4R%B58CD#T%6/.$\S1P/D* 6X.5J0@!O/DD.S&%1EZ&@+M%.-9G"S6TH977F
M/&5)]:M21RE=RQ)YF.=IZ&FW4\]N/,M[??;(OS[<#::6Z8?9@99_*0D,S#C<
M/2E<8B3F&*2>;>"& *YR/PJNG[S59,H2LL7# ],=OQJ:-)BL?*I&"<J1NW#M
MSVJO/(I9E\PG(P#'U![&I=UIU+BDQTMS$)S;!&1U7!8=?_U51E#2QAFF:,PD
M@J1DS*>WL:N3W=NJQ1-N6\F&%'\1QVS4+2SR(%#()2I ^7HU9RDK-;FD$]R6
MT?;:LRM)R"?+<?,.V,U-:P"&'=$[HAYQNSBL[8_V;?//\RN5F" K\WJ/:F6%
MM-#-=,)99"_)5SA?P-1&6J5AR@K-W-<W=YMB\JY4*)!YA=<G;[>]7)IK:6#S
M+HE5'WMIX(K+9':T:"3E&7AB"2#5>V26WM5@FNXPQ;$C.<[E[ "M%-1U,W3N
M;T45NUN&MFW1>H[5&[1H =ZX/>JI;['#Q$K1-G?&N>1[5.JV$WEJ#Y)8<(_T
MK526[,G&Q762Y^U$-$B0KT;=RU-FNYH)LO;,;<@8=3DY]QZ5)J"75F8_+B,T
M3\>8I^[]?:EMI=ZD/N5AU#4E/6S*MI="+&BL\BC!DP2?6FI-$)C#SOQDC%*\
MT<C,A!79U9A@'\:A7?"&.6=2?EZ$C/OZ4V[ E<M8[XXK"E\):=+9:5;.TW_$
ML9#!(&&XA2#AN,$$J,C':MG+8(SS_#[4UH#.=D^1M(*[3@D^]%T)Q*MUH]O=
M:E!?2M)YL,3Q(%.!AB"3TSGY1WJI!X>,>HM>2ZC<W,WDF)&FVY120<#:!W Z
M\^];8!7.3QZ^M&.1C&*=Q%6V MK4"9MK$\EVJP0%7<>0!GBFR(LRD,BM@?*"
M.]16GG>0!<@"3/(7I1YAYCEF6:,, 5!]12@#9ZU%J 0VKEMZJO)V=33XQNC4
MINP5&,]: T%8@X7IFM7X5<6?B4?]1N3_ -$0UCW(Q&"(C*V<;0<&MCX5 "S\
M2@# &MR8_P"_$-9S&CS[P1=0CPKI\#0LS8DYQD?ZQNE;^HZ.FV.257"/@$(2
M P[9-<YX(:*Q\*VMU+YT@D#JL:<X/F-R!VKH;BY3[*?D+,XP(PV2!ZXS6L$M
M+&NMAO\ Q-K.(F 1/$S?=1B-J>],>#4T::=PJ;D^2*0< ^AJYI\ O-*906DD
MDXE4C;GVQ3&LM0+2)<!C%TC78> /4FE/5.VXXO42W0>7YVH")_+(=&4[3']3
MW%6888[Z:2\M[AL,#$(FX#8[C/6JJWM]8VS^9 88U; )PY<'MS52\U26YC>>
M"Y!CB;;*IBP5/;;G'%5K:SW$TV[K8LVQC.J3:1*05\O>(RA! ]<]_P *L?8K
MS2K9PDA$+OM79'N\H'N:;;:O=16*".-&G1<;F3.P=@>_-07%WJ>I691XA]_:
M<MM4_P"UQ_*IC)= :E?4MRPVNG1>=$T<R-DRD Y)QUQ4$6I0VJK/]D8H<*,#
M@CM5:31KE;R.2*X-R(5PBD8&._UJ"=9HX[B62!XP?X$;.?4@=C4/?N6DFC0D
MN_[0\PQ,\60=LB '\JHZE:"+36O-3FDAQC85EY<#CI5>U;[)/+<[6>WC9=YW
M;@>...M.OEM[IA=?9HXT+\AP?E],9[548KFLT#NK<K'?84NK!KJV5G+ ( B
M8'UJS9V0BF0S6:3;. SN6/2HY/-NPKV),;I]Y"P 8>N.U6;/4M1CNR+>"1T<
MY8[]V#TP!V%3))1L.[>Q2ND^SJT5Q&I9CP'!13Z 5KZ-HM[%J$,TD:P6*Q9(
M<]_0=ZGU*ZUBTD5Y%61'P!$-I<'U'H*K-++J,"PSZFL;.,%BP_("G?R(U:W#
M5KV.RNI1;HCQ[<EE;G-8GG"XE#.ZIO)'RL#O^O\ A5AXXH].S?!FW.5.\Y+#
ML<?2EA&G-LQ;G9"F4P<!<]C[U-I1E?\ (T7+RD3(;<,LDL87D1Y7(_*K%IJ,
M:3Q62B*.3;SY:< ^E6(HT=HF>Y7:%.Q"!N/XTZ.YM=,5IY3;SW#C[X7B/_@7
M\5-Q3=V]2>;2R12N;RY=9!%<K*23N0_*5'M5:?4-4:U6UD9%C9<!<Y'L*UU.
MG:C922W)>V<MA'((#?E4&K'1[:X40IYT[1[51C\I&.34RLG;_AQQ=]+&#<M!
M::>)MI-S*0)$W<N >F>U/CMDM-]Y=0QJV5VI#(2R?[V?:B6*UAAD\V6*; W,
MD)("# Q@=2?:I8B+BUM9&(B$N"AD7#$Y/6HO)>Y$TT>K*&KNES.;R' D9MH5
MN1CI4_V.2WD2"XMXF>2 %0.D8[9'8TMI!)'?S0QD2Q2,6>1#_JQVXK.N([F7
M5)+AY=[QN!\W*L/7U_"I:=O>W*5MD:#"8.D*>7)-"I+=0&[<"JTWFK<)Y*#:
MH.^-^1GT]16E82A=2BE@"YC_ -;E.H/4#-)'9S7$MS=72@1!R(.</BI4')/E
MU&Y6>IEQI<Q,LD2E5099)6R"?3-:-E;;8/M$[$OC *_, ,]*DNTM/)$=S;NP
MD88QQCT.:9;V^UU5HR(5. G(&/4TN5JTF%[Z#8]1NIY)+6&"&-=V'N"OS$#L
M#_#5F%"(6\T.S*V00<\>]3FW6&W:5=N>JB0$#VZ5)-*4*FU"*SC]\">,>HK5
MW:5R-$]"E+<P&$QM 9",?( 2#^5/,BO%&T<Z6T2XRNP$_3D\4+)<A9)[<,!D
MC;NVJP_VAVJL]F5&Z:W12Y#'G.WTQ234=;CM?0TT@BVM*S%L#CW^OO3(EN.7
M\T E\Y)R /051NGD"M!:.2'VY0]3CFI;A[A+4YB8<?=Z_E4/57';4D>ZN?MB
M+Y"E /GDS]T_UI]_),\220HA&\!R#SCVJJ9MLD>Q@V5R\>.14KZJ0\-I' [,
M6RS[>!]<UI&ZM(EI/0=-:RB2.2.WQ"3DC. /?ZU.)1!'O;:$;(*#J<U,E[&Z
MI;J'9RQSCT]?I32T<F0N(WSC>>1FG-62?<47?0@@M8S8^2@,22G=('ZG\.U-
MS;VZ?;+UG5P=J[0?E'0<?UJRA0S!9"/.R06;C(]0*M)9EXG9U0R.,8;E134W
M*5V2THHQM=-O+X+U*>WE:;?:7&XR'YE^0\?2O;=)_P"0-8_]>\?_ *"*\5\1
MVAA\+ZP8Y (H[&93&%P,[#7M6D_\@:Q_Z]X__011+1F,K7T+E>(^" A\%Z=N
M4ME&X/3[[5[=7AG@RZ2+P=IB8+,58$+U^^:=/<SEL=$I7>RKM5O85'/$94*1
MMM<#D@TL\^RX6(0,$?K,.B_6D2+;>^:9G<.,*@'RUMJ0566[@DYVR1GC'>I+
M6W996DD #$\8ZX]ZL7"N\T*C>H#;F8 8P.Q^M+(ZJS.2JD?>). !3Z!<=%NA
M\QI9-RDY!/\ #38)%GG9FA"LOW9.QI2LDR[D=#&1V[TPQ>3;(DT_)/#'BD"%
MN)98)42")65C\Q/:HT*O<87RC.#D]>!3HBR,5=BU3HB%BRJ-WKBC8!9(;B1F
M"RJL93C'7=1LN5E0KL>(+AO[Q-$UM,[!EFV1[2OEC^(U'I+PM!^ZB\O!(/.3
MFE<?2Y8DN_)3,L6S+84(I/YXJ%7F"3S2HX91E4!R/PJQ'.TTYVM&T8.#CDBD
MN&65GABYF4 @$$#\Z8MB".T!5)0S0R#YG"'AO8U>0^82%!X'<55626.4NX_=
MGY=JKSN]?I4UO;F$N?.9RQS\W:AC*LP22595G(=?D&T[A^(I?.^RH%*/,?XC
MC;BI6T^V>=;G[.GF@_?.<U));Q+()F4<C;DGC%38=T1Q2"89BQM.>@Y%1+*D
MR.D3EW3[Q88JP4>&)5MXT!SP!P*;+9Q7D?E3>Q;RS@Y'/6BP[K<H0BUN'+QN
M$EZMD'Y@.V*CGF_>.B.[9^]D @?2K4MU%]IVL=N&V*JKDN<55N)8FLW22"XR
M9-A*H0?P]O>IDG?0TB^XS3C)<66R24RHLI#!R=Q]JO-MC4*,*\A^4'KBL^6X
MEBC6"22*#S#^Y(/[P =R#U-9VI7QMKBWN K3LL15Y6&W:,CM[FL9SY$]310<
MV:DMKY$PG\HFX<G9)MS@BH;JY7=',S;,_>4KCYO6KK7S7>G6UJ@=9QF:0CHO
MHON<5G26LEY,K,@D5U.T[\!2/7WK*E4G.'-R\KNU\KV3^95E>TB'9%<SRC[2
MT;LP610>/R/:KV60"$LJQX # G./Z5%8B::X%HT:MM4MY[+C!]/0U5-O*MY(
M+O:4(P$!^\/<GO2U2N7HW8UWED11L4GD;>>M1*B.7G:(DJQ7#C)/T]!4<5[$
M6%M;9/RY8MP*M0KMBC&<J!G"<;OPK925S)JR$:^C2#S6B*@?Q=<>W'>I5:.5
M6DWJR8QFG02-!$T=M;QR6[DEB6^;/M50P,A$?E(BR#+*^3S[$5<M+/H0M;HA
M@O[F.Y:..[<%0"(W&0WJ#4Z>)HIKLP&VC 5?G+9'/IFH+BQ#WBS$L,CYE R,
M_P!*BA6%0?\ 1?*G7@9. X'2L+R3T=C9QA)7:-BXU#2_L;&YC?RBP4J%+<D^
MU2"R,46(5!CZJ*SH/LL^_P U%$@()5<G'UJU]J^S@;=V <=1@UNINWO,P<+/
MW1PQ),80L@<#.2O!_&D:.56^8$#UJ!M2D2\EBEMUBC"[EDW=?PJY#>3*%5I!
M)D9^[_G%/FBW85I)7,UH_M-Q$)HRQB;*LKX_,5I KY?!R :59]LV7M44'^/-
M2YM 6.-JMU/;-::;&<FWT*+,TX9(7"''#]1GTH42K)AR"NW[W?-3/80-(LB@
M94'"[O7O0ZNI153>AZMG!%,+C&4'CUJ-]ZR+M&5/4YZ5(&1I&C# NOWA2.OR
M%@,C'W?6@"/>/.*$-D#)XX_.M?X6?\>GB;_L.2?^B8:PK26:[MW:X@: ;OE4
MGDCL:W?A7_QY^)?^PY)_Z(AK.925CS#P;/&GAFV$MVT)^=(D;YE8EV[=JZ-]
M(,5C# 1^^63?N7@'Z9[5C>"K:V'A*RN6C#RKYAQZ_O&KHTOCJEN\<N[$1/[N
M3GIZ=ZU57W4D:J+W*6V2TEENUMS%AN2"1G/4U>L=>U+]](!*(E)VI,N=P]15
MC3))KJWN$CN/,@.'594X3 P5SUJI;J%B=!.96ZKO(&?8&LG:*TW*OS.TBQJ-
MQ<:DL;31;H1RX*;5Z<8-9^F/YENTCF-H2^T;1T'I4UW-=K9NCP^8K84Q;^F:
M;;236NEM;6T2I*#D0ALY]C]:6CCKN-*VB'SRP1 ;6Q(V=I) W#TJO8W/D6[L
M=\4!8XC*DMFK>D6#7M[--?6WE)LX1QPCCJ0:K2::\,LI@;?$QR6W9.>V*'!6
MM?4:DKV&W,L\*^=Y3+)$_P K";@KZD=:N)JJBUWW6)[=CAQC)&?0UE/$+=&A
MCD5KV0;I/,7/RU%%=!EAB16$.XJXVX(^GK2E[L4QJ*D6[VVL=,=F2$(20H1_
MX@W2JD5M+ [&)1MWA0SN3E>^*OM:07SQ+,TC1*3@D[?QIVH+817D:1WC' $:
M*8V*EO\ >Z4<SDFX@O==F2S/;0*LYE8!B(R8U)/U..U2WMOJEE TMLB+NQM9
M"#N7ZUE/YFFVK!HY"^<Y)X-64=WA$L;L%P/E#<#V -*,XK6P.#[D\KRO=6\2
M77E32\.AY9B>QK/OXWT!2LT=N]R/N,1@K5>Q,\5Y-.4,TKG"@N-R#Z^E:OV^
M::.-=22V<K(&4/&'+CN,]C6W-RZ7T)<=2E#:7-S9QN0-ZN'P1A6/UJZ"CB:W
ME ##YV7:2N?ZU%K-\U[<V_V.(16<:Y$2]3ZU5%U.=021HV^<85=_;Z5,?>N^
MJ&[^@.!#)',5D*H0-[R*H3Z#^E6KK2;J01WLLD:1L,*K=/8@>M0Q"._U7R%#
M>2HWRAQE4^IHU^\DO_*73V:.&(;%FE!PI']T"HE-63&D[V,J2UN]T5K>R-(I
M8R(J=6]!CL*([4/>I=1SR1R0##B3@%CT7';O5JVM7DFFEE5Y?+0?OLE?,/<8
M/05G3W/EW327\8D20YC1'X &!D@=ZS3;:9IY&IIU@'FN+H&.,R?,-G/MQV[4
MYIXC?;I(0(8W^64G(+8]*S/MPAF<+.[(<,T1QC;_ $KHHIK670;V6-(WW-''
M#NX.<[B1[ =_PK*MBO91NEU2^]I7_KH')KJ9'VD*\TMKY<)D7RR.ZCOCTJ,+
M)Y2.L<<BNQ!"DD'_ (%VJ]#IR0SLR1P,K)D"60X;WI\[O<7<44,1C@B7+.B?
M(?PZDUNDYJ\A747:)3A1KJYCGBB1U"^6IC7*IQ^M:<#6R6\INBTC*1L[8;N,
M4-L1G,%MB$ 9PI4YS^M*T/VN-^H !(['GWH]V+TW)>JUV(XEFNQ%&L"+L8@'
MM&OKS_.JD=I>1N=D7D[GW/N;?Y@^O:K42O 9T*M*F,2O*QP1_='K36G7<6:/
M8L)X82<!<<<54/A?<'>_D26QWQ-&\OFNDF#A>GM]*BDE:.[5'LAY&[:K(#DG
MW]J99S&2,H@,8<_-N^Z/]VEU&(H8LSMP< 9X)]Z7M$W=ARVT%F6,NW[I2!U0
M=&JNT6$W01,6<\J6^Z*=>)!%"ZAMT@ )93]WGTI&$68?WP&0"P().*P=S56L
M2I;J\2;MC.N2W/(^E220326L=VL<JVP'W\Y/7KMZ_C2_;(L[8RAD/W5QD'_"
MG6KW^H7+QV\$BR0(2[A@%5?\]JVBN;?4SDVO(6TMHT$>R)HYI.?,D7&1[U%-
M-LNC&LL+88DG&,BF-(0LLQ$A\P N&)-$86%0JIGNNX<8]*4[VN$=R:WGBGN"
MLCAY "$VCY5 ]Z62SEB\N[N-0@CM6.%BZL?KZ5'#,GFB*>W$2.O8U66&VNKQ
MU-N)H5;&XM]T_P"-5%75Y*Z$]'9,TT:*X266V7=-$-H\P<'WS3+57EC7S;C8
M5.YY(3P3Z4R2\M8;?['! ^Q!AV7[H'^]2V[0;(+:*W @!R&)W;F_I6CG%*\2
M.5O<;XM D\+:G)N;Y;*?@' /[L]17L>D_P#(&L?^O>/_ -!%>,>*)%3POJD3
M$;FL9]H'LAKV?2?^0-8_]>\?_H(J)-NUS*2LRY7A'@MY%\*Z8WV-V1%9A*I'
M7<U>[UXEX+8IX$T]]I<+&Y*CJ?G:G3W,Y;&M'?K)YV(L1J,E@<@GWJU;!GMT
M;Y!QG"YJ"W%K]F22)?L^\[MC<$GT(J2-O-E\DD(=N<!_FK9OH38DFG%NC';N
M(&=@^\WTJ&ZM;.Y4O<Y&.3\V./>I(F1;HPMO+XR&9?ZU'=R+#+L$6991MW!<
MC\::O?05@^T6TD4D-OCY4SM / J NLL4:- Y11DD]!5D+%]F6/*QN_&X+][\
M*=;[&B9%1U52<EQC-&FX%=E65E<,1CTJ5,[O]9CVQ4AC0#/ %-^17';-(!!=
MNLC1B-FQPI')SZTR)DE'V=V42MEU"<$X//2IGM4EY5]A)SD=ZE2.VM5V!8TY
M[=233TL,K)<1V\,4QMVME>4IL*99CV/':K%Q,T">:2/Q;%,%W' ZQ2_:'+.0
M&:+"KBK$"6MW;C8I\OG -+=W&]"LD\0WL\QWN #L'Y8]ZFMD6-&12V\<_O&I
M;FWA2W0F#>8CE%VY.?6HQ.ER=ZPF:6+C(Z$TK+H&Y899)I4ECN5\H?>15!S^
M-.NL/ 65%EVC<%8]:2*1/+&]=F?X1V-#&&/)P Q&-WK[4N85M2O#.+VV1_FB
M+<J.]22M+$/-V8'.4&,OZ<U%<7L<$_DK'([-T 4D _T%5+H>?(2LH+*0K 'I
M_P#7K.52VQI&%WJ2Q7,>H6QG$)1HS]TD9SZU#%)=O'#))*$82;3N7[ZGTJE<
M/- XE^VBW5/OPY SGN<58\I;NX\N+S 2H(4]'_W?>H]I:/,^AK[-+3H2/;I)
M<[#,)50\N>=A]C4[VVGZ=$L]XZR2,F(TD/+>Y'I532H8M(N;B 0JIBR3YK J
M'//2FPK>WL]Q-J$R_,/E55R5KAJ.IB+0AI![M/?R6NB[O?MW-%%1=VPN+.6[
M@5@[8D7!,+;/SJ&#39;<)Y>_;&NWYY-Q7U.*L7%M'';'_27C=?\ 5R*<[3]*
M6*>=X0D@C^T;=I&[.2/6NIQ38DVD9H6:![C[-.S;NK_>//8#UIJZ>%N7)FWR
M&+'EN26'<GZ\UNFWVQP>=)#$JK\YV]/I61=6%Y;W =2]Q&0?G7 _'--PVTN.
M-1/K8MI]G18XD4*Y7G<,D@>M16]O!%=M.-X8KM))+?D*58WGDBN9%&[.P$CH
M#[5:68R0-/:-'-)%E&4# )'O0DYNX-\JL5)KQ?.BM\*\329"H/N=\FI3)YDG
MF2YD$9^4QD@K_C3KF48BN(5/FL 72(K@GW)J0VJWJF5P$< A&5N1ZU2NOA=V
M3I;56(C)%<0JZ2\HWS%B0Q]L55DNDGD6V +*<D.<EL=\?C3-6L1,8X?/P,8P
M$SN;MD]15*UBDM+N$P1L=ORMF09QZ#/:L9RE?4UA&-M"[,\\(8B!+J IAI#\
MI(/; ZTBQBWTTO\ -+(O)51@J.R__7K'U"YN(O-C4&-&.0T2ECS^F:5+Q+6%
M/,MV=9$W.LC$L3G^=9N:-/9NQK-=6V(Y$60[R$DWC/![9K21$0[H-Z@ J-IR
M,_T-<Q]K1(Q<P(8U5\/&Y.=OJ1[5HQ_NDVVUPD:RG<J %@Q/./K6D9HSE3)-
MU\R2&&4^<6P5=./Q-7[+4=\GD7&Q&&$/^]4%G]_,LC))C[N>/PIHBGC=KIH&
M64':B(WRO[G-5&][HB23T9NH\1."2#V([TDD!=E9)?D'5<=:Q?MD:E4+E+A<
M;P3D FD&JR)<&-(YI%08=A@+N]*Z'5BCG]C)[&CB[A:)-J2@L?,DQM('; J=
MB?NA<$_Q>E16=\+J),H58CD=<?C4Y\S;]WO5J2DKHAIQ=F4X8KV/'G3I(.^%
MQFMCX5Y^R>)<]?[<DS_WXAJ@R?:("&#1[QR <$5>^%2".S\2H,D+K<@&3S_J
M(:F8T<+X D6#PA92O )H\N&![?O&KHIY; $20+*A/!#8.#]:X_PLT\?@O3GC
M\LC,F%+XS^\:MI+I6M79K8Q GD.P&X^V:23L;I*UR^;J:"-UCE7;)UVKC]:K
M6]U&@E*V<,P+<1S/\F?PZ57CF,:20Q!H(W&6P./KFJD1LDCV17#A2</WW_X4
M*_-I<OE5M3=N]2,]W# +=4W+G*-\H_$UFW,I@NVOTF5A)A&R,YQZ"GKY7V1%
MMI'4$D#+ G]>:CL25N9BZ&1H,%EVDJ3_ (T)OFT7J'*DC5O=VHVT=R7>$QH?
MW2''F9Z;JP](:2V/V_S7>16)&<A"/3!]*T[^&;4$-]=-';N<*MN9<*?J5Z53
M2PDGM0L5RLK!ONP2 !?;FG*U[)DP^'4J:C=2-J9E>_/ER_O#@<+VP*NB[A73
MP2$>.'+;I%^;Z@]S5:YT_4+21M^GI$'/[HRDO@@9^GXU.\9NK<R+*A? \Q)2
M%"GO4N+LD6G'H0&RE69I5F3<X!"*V>O/!Z?A39TFT^SE9)51F<$B0=![5+!#
M(T@9@J*,C$<F=WH:GDB,D>/]:VW:2_):DY6T;':X+-=289SN7;@EERAR*S%E
ME*3021%TD8A6' 'H,?UK7MKR_M[1[:Y,7ER-D87IZ#-0K;3ZA=) HGC>,AED
M7Y%4^A-33?*VD#[LI6KPVB['A:(!=K28ROT'K6@-/N?LUNL$>]Y7PK2(<@=S
MGH,>]7IM,9"WFR$*Q^[D$,?8U2\_4))A%'=3)"ARSX'S^PK6ZY=2-WH-U*S,
M%VME;W@W*@<L>&XZUFWEU*S,UNS>6GRR2JF"*OVL4T^N.98V120S[^K>@!^E
M.O!=7%_(UU&;6QCY4*H*R_CZ4E)[6L/3J[F18-8K+','E"2-LEG=CC"]015R
MZU07UR\<4:6UM!&4MX$7@CKN)[FLYH8KATGW>='_ ,LT5<1E?\:8S02S>7"D
MBHWRM%R=F.]<TI=$;*-W=DEC>A$*-!=.LG)GF(Q^7;Z5;MK&$!HH!"V$PSQX
M."3G&/ZT^TAA;9(S,K2MC:\1^4=L^F<59;3\WT2K*L<;$F:2-/NI_LYZFG)<
ML.9BYM2:*TAO68MY20P@/<SNN!&G^/'2H+B>WG65H?,)SF!'0(WE=LUH_:;5
MTCT^U39IL)P[D[R_?+-W)K.N;BX?4EGMK**)Y#M<2-PBCH<>N*QP_M)-U*NE
M]H]O-^?X+\1.]]"QI4:2I+&56(*N_P J10&^M6H&96SY$A0_?STYY'U'TK-6
M.:*8W<4?S%\-YOS;AZC'2MPM))$6BS@C@%MJJ*[H<M]#*=S,>T:;<Z22,UR?
MF&,X&?N@=J:(PEVP!E58DV'#C XYXK1MED20N[Q1R.OWR" QQQS5:9##D3L&
MESG,1RHYXSZTI75P3N[&1+=,(Y%$$GDYVEE;YA_^NG2VUDD9DE5 S\NK2!1C
MMQZUI2H7MU>1)2V=Q/?\?:JCZ;Y]O+YD:E.@#=_3BH32=M32]T12?:G>.6&/
M-J5 #;NGJ?>G11R3/(QC8A.0&!.1VZ5<6&9IQ&;I&"H,Q#C8/I2/;6T4Q>#<
MC%<97K[BA*+6HN9IZ"36XNE:*;Y5P,,!@'VS3 [?\><3QJY )VIDD4Z:65"L
M$/F.SC(8CY5]B>U)+#+]F2X2-7N%XPO5OSIJ+>B%=+<:MO<0;I&E&,8'R@<T
MEM/<6T@D^T*C 8;;R''X5/927+3EKFS1$ Y5I<Y..OX4Y]0M[0;S;JTF["L1
ME1[#U-)QY=&PO?H-&K0,!YVDF>9SM W[<X[FJLT[B0)]F"CHD88D(?K3Q=)-
M,4D9XP/FRF%SGMFHHHKI[R3:1M48"Y[>Y]:4FVM1Q23+,%F=[2F9F8+@1]0*
M4PK!$1&D<98Y; ZGW]:;!$R74DDLNZ$K@;?[P[5%YWFSNL46Q>[,:5O=#J3O
M;02I'YV %'WAP#[5:PT*J(5B"]?2L]8$N$"[MN22IP1S4,]@PC5MTDC9^?)P
M!Z&M*;5E<4DQ-=FEE\(:P;B,>;]CG 8#C&QJ]LTG_D#6/_7O'_Z"*\8\07FN
MWW@?4OM%K!!9PV4P=T7F3]V0/ISBO9])_P"0-8_]>\?_ *"*JHK,YF[LN5X9
MX$ABB\*V,L4@$TRG>N[KAB!Q7N=>$^!6@_X1O3\F#S$1NGWQ\QZT0W)>QNQ6
M^Z)_,CE0-(0 W)__ %5=%K#YBR^6HF"X#8YQ3E $K/DY;'&[BF2.T GFFD#1
M\>6%3E?\:V,W=B6UPMRS"W*OY9*MDXP1US2Z@7:,P03+#=./W189%,@MY)K1
M?WK(6.6=5VDT]X;M9#MF1U)X$@Y ]J:7<.N@L%M-',LK^6S% ) #GYO4"I)%
M,O#L %^\ ?YU$]L;1S<6\;.Q7#+N)R!Z>]6HTWJ'$90L,L#U_&DP((5A: >2
MP=?3-0L\<I\F1&1FZ*X^]5FZM;1;-HYMD,1.2=VWFFJOER1Q1*@B"<R2$EAZ
M8-&@(AFCC$<4;31Q,O(4U8>6/&Y C2;<@%@,T-#;RR[GC21T&-X.?SIF^1)F
M'DCRU7(?&<^V*!DC7J1P*]Q#)\P^8 ;]I_"G3%4A<PHX9P/F0@$?2HA,8<7;
MB385_P!6%Y^N.M02:G:M$X=5='^7 .-Q/:HE-1W*4&]D6[=OLML9)7D8D[CY
MK [:A:]COK1O(#&-\@F,[2?H:KPR^;$^,F,<",G. !TS5>VA-O"?LVT*3E$!
MY/N:S=3JC14UUW';UQ%<V-VPCB!1H%&X,?KZBJ]Y<)%?(S3*O&61R<ACTP*I
M+/J<,ZB9XA$Q.P$CY#G\SFJ%]]JO=2=;F62:.+$B 184X[,:YZE1M6MJ=,*6
MM[FY]N%N_F^;L0@Y9SR<=JIK=2>9]HDFY<AFC7 QZ$UJZ3I\E["TSF)I=O\
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MH[Z*&2ZF1I,2R#?D,<EO4^E1)IRP/Y5NLV[;\TBL67=^/?FLYX:I4LZK_P#
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M-XX(TDD!=E&\CH3Z"K3HT^5,B HO(QDYI$MV0)YA9R.<CO4J#:;N-RU. O\
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M*T5V[[BD152"%##/2BVDF9@\D13'91Q5D(J*?*4;D'W5^Z*9$DV_S!)'N?D
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MS!"<'MD=?QK7NY[UKRSFEM3<F,;1+,?G+ Y''?N:<=9U6]O;B">^@LXXW5D
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M(R=QS5GR%C\L%E\K'5CSFJ\MM?WICC,OE1I\TCJ<;SZ?2I9+>W<Q27;QLR<
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M!^1J]:TG_D#6/_7O'_Z"*\I\7 ?\(;K9R,_89<C/^R:]6TG_ ) UC_U[Q_\
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M&>XJM%HT5M([K/)N;D' .*V5Y (Z'I41,HN540@Q8RSYZ'TQ24$'M);7&M"
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MMI(Z=*0"XY!/3VJ&XN(;9-\L@1<XRQISS)&K;CC:-S>PJN9;75+;RP5EC(Z
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MC0D"U3(,8[^^1TK9M5B56AC0J8SM((Q^/N/>JVFVL5I$<QE)IVW.-V[G_"M
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M >6,PECT?U/\OH33VB=TDY7YW5OE/IC/\J0[NUBR/H*0$;CBE!QWY%([,0Y
M!<CCZTQ"]B::/G7Y@/IG-0QO.%598\R;,L4^[GT%%N\K%C)$8P>@)YIV"PY[
MB.,X)R?[HZU#'!+-(LUSLW)GRP@.0#ZU9'E%R%*[UZXZBE) /7K25QE:ZMY)
MWA>.9HC"VXCLX]#4OVB$; 95W/PHSR33R-ZE>F:A6RMUF27R_G48!/:F'0L
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MM_A5)#6IJ'=QSGFHI1-O3RMNW/SY/;VJ.6/?Y<[NX\D9VKT/X=ZD@G6XB65
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M^,^U-#(A"-)ECT!/)IB(+.Z\]2DD3I,@&_<, _2K)&00<T<<YZ4A/R_+^!-
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E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g3dyckr3udth000038.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000038.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $A 9,# 2(  A$! Q$!_\0
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M$MI-#&VG:Q;ZA)YI(#)'NW 8!Y^;CM74T4 <]XGMO%%PL(\/3Z/Y; I<0:I
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M ("6W_QNC^Q=;_Z&V^_\!+;_ .-UOT4 8']BZW_T-M]_X"6W_P ;H_L76_\
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MUK>M$N4M8UO)H9K@#]Y)#$8T8^REF(_,U/10!YY% O\ PDS^#"BBW34/[:5
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MH 2BEHH 2BEHH 2BEHH 2BEHH 2D/WU_&G4A^^OXT %%+10 E%+10 E%+10
ME%+10 E%+10 E(O\7^\:=2+_ !?[QH **6B@!**6B@!**6B@!**6B@!**6B@
M#%\)_P#(&G_["5__ .E<U%'A/_D#3_\ 82O_ /TKFHH C\/?\ASQ9_V%4_\
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MBSM59&6WB!0;5P@&!D''Y@5-11SR[@5CIMB<_P"AP<H4.(P/E.,CZ<#\J?\
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M?^AG_P#)"/\ QH WZ*P/[(\0_P#0S_\ DA'_ (T?V1XA_P"AG_\ )"/_ !H
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M?^-']D>(?^AG_P#)"/\ QH WZ*P/[(\0_P#0S_\ DA'_ (T?V1XA_P"AG_\
M)"/_ !H E\)_\@:?_L)7_P#Z5S45;T33&TC3!:/<M<R&::9Y60+N:21I&X'
MY<T4 :-%<A::1#KGB#Q(][=ZK_HU^D$*6^J7,"(GV6W? 6.15^\['.,\U:G\
M'::D3R+>:Z-J$X_MV]P>/^NM '2T5Q:^"790PU;5,$9_Y#-]_P#'J7_A")/^
M@MJ?_@YOO_CU9>T?\K_#_,Q]K+^1_A_F=G17#Q>$/.DF1-6U7=$VQ\ZO?CG
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M!;4__!S??_'J/:/^5_A_F'MI?R/\/\SLZ*XS_A")/^@MJ?\ X.;[_P"/4?\
M"$2?]!;4_P#P<WW_ ,>H]H_Y7^'^8>VE_(_P_P SLZ*X63PFL=W#;-J^J^;,
M&* :O?D<=>?.XJ?_ (0B3_H+:G_X.;[_ ./4>TE_*_P_S#VTOY'^'^9V=%>>
M7>@VUC.89]7U@.%#';JFH, #[B:M*+P5B16EU/5GC[A-:O@2/^_U/GEUB_P_
MS!56W;E?X?YG8T5YZG@O4!.T1UG4"P3*AM6OSD9ZDB8<]>*L/X(NOM#,FK:K
MY1880ZS>Y SZ^;SQ5<WD;'=45QLO@HEW:/5-55,DJK:S?$@>_P"^IA\%.J%C
MJVJ8 R?^)Q??_'JCVC_E?X?YF+JM/X'^'^9VM%<4G@MI(U==6U3:P!&=8OAP
M?^VU._X0B3_H+:G_ .#F^_\ CU'M'_*_P_S#VTOY'^'^9V=%<9_PA$G_ $%M
M3_\ !S??_'J/^$(D_P"@MJ?_ (.;[_X]1[1_RO\ #_,/;2_D?X?YG9T5QG_"
M$2?]!;4__!S??_'J;)X,:*-Y&U;5-J*6.-8OCP/^VU'M'_*_P_S#VTOY'^'^
M9VM%<6/!+D C5M4P>?\ D,7W_P >I?\ A")/^@MJ?_@YOO\ X]1[1_RO\/\
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MG17&?\(1)_T%M3_\'-]_\>H_X0B3_H+:G_X.;[_X]2]H_P"5_A_F'MI?R/\
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M_P"PE?\ _I7-10!'X>_Y#GBS_L*I_P"D5K6Q>2QI Z,P#/&VT'O@<UC^'O\
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MK?0T#H/I0 ZBDHH 6BDHH 6BDHH 6BDHH 6BDHH 1NJ_7^E.IC=5^O\ 2G4
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MPB-K_P!!37/_  :S_P#Q5;'V^S_Y^X/^_@H^WV?_ #]P?]_!0!C_ /"(VO\
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M&D<LQR3D[<?ATIH"A_PB?AS_ *%_2O\ P#C_ ,*/^$3\.?\ 0OZ5_P" <?\
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MXY"X8<$C=6GJ]Y+JOQ*M_"WVN[MK6/1Y-0D-M,T1=S,L:?,I#?+ACCH<\YH
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MA?TK_P  X_\ "MFB@#&_X1/PY_T+^E?^ <?^%'_")^'/^A?TK_P#C_PK9HH
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M0 E%+10 E%+10 E%+10 E(?OCZ&G4T_?'T- "T4M% "44M% "44M% "44M%
M"44M% #6_A_WJ6D;^'ZTZ@!**6B@!**6B@!**6B@!**6B@#$\)_\@:X_["5_
M_P"E<U%'A/\ Y ]Q_P!A._\ _2N:B@"OH"R_V]XM9) !_:D8VLN0/]#MN:?X
M@NM6M[">6UBC$R2%8,$EBA&,@=VR> >*7P]_R'/%G_853_TBM:V)O^/FV_WF
M_P#036E.?+-2:O83V.6L+SQA+-*S6=N9!]])V:.)"<<(0I+8QU^M6TN_&9+9
MTG2 -N1NO''..G"'//TKI:*WEBHMW]G'\?\ ,7+YG+PW7C3SV5]-TTKN;E[D
MA<<8P0I/KU';DBGM>>- R@:1I#+N(8_;7'&>OW/\_P ^EHI/$Q;_ (<?Q_S"
MWF<N][XU4L1I&E,,\*+MB>W<J/\ :_*J\5WX[^W+NTW2O+\L;D%PP3.[DAMI
M.1Z$ <UV%-3[OXG^=-8J*7\./X_YAR^9A_:/%?GMC3]+,>,#-RXQUYSMY[#&
M/6JHN_&[1RXTS2%<-B,O<N 1CKP#WKJ**E8B*_Y=Q_'_ #';S.:N[WQ=#832
MIIFE^8D;,-MQ(_(_V=HS^>:J&Y\;^?<F+3;#=L4#?<'8#AC\HQUY /;..>I'
M8454<5&*M[./X_YBY?,Y%[OQHLJJEC9GRX064R[@YP>2=HR<C[HQCU.:L?:_
M&87)TO2B25 "W+>V2<@8[],UTU%#Q47_ ,NX_C_F'+YG*7EYXSCB,MOIUB^2
M#L#DD+QGJ1\W7U'(JM;:CXK&XM9LRB)W3>HW')')''/7 ]^1TKM**:Q<4K>S
MC^/^8<OF<7::AXW(4#3;.6)F_P!=-(4?H?X!T' _.I;V_P#&T?D!=+LQD99K
M:7S/FSPI# 8!ZY[8]ZZ^BG];CS7]E'\?\PY?,YV>X\6AI?(L-+R#\F;ACGCC
M/ QFJ=K?^.\M]IT;2MH5BI6Y;)[#/'7J?Q XZUU@^\WX4ZH6)BE;V<?Q_P P
MMYG*M=^-7*C^S=-C (.X3%L\=".W/^>]65N?%P:,'3=*96/S'[6XV\G_ &.P
MQTST-=#10\3%_P#+N/X_YA;S.92Y\9H53^S=,D&<M))=,O&X^BGM3;B\\;(@
M\C2=(=MO.ZZ<?-G']WICFNHHH^LQO?V<?Q_S"WF<M#>>-S:PE](TD2E07#7C
M<''/12.OH:EEN_&(53%I6DEMWS*UVX!'UV_TKI**'B8MW]G'\?\ ,+>9S*W?
MC3C_ (E6D8R<AKQQQVZ(:2.\\:R)DZ3I"'<1\]VXP!CL%.>_.1TZ5T]%'UF/
M_/N/X_YA;S.5FO?&8GM@NEZ>%9R)-DY90.V20"![@'KTXY9J5SXS*Q"WTZR5
MB<9AN=V#ZL64?*.^ 3TKK::?OCZ&FL5%-/V<=/7_ ##E\SFI[[QBJ6^S2-/^
M;_6%;@L5.>!C &/4YXP?:JKZEXO2^G(T^W<I&6$!8[,9X(8<L<#&/Y5V-%$<
M5%?\NX_C_F'+YG*P7WC%YRC:;8*"I8&25L+AN1E1@\8QWZGM3;V^\:K'((-+
MT\, V-DS/QV() Y[8(]^G%=911]:C>_LX_C_ )AR^9P\U]XTE6Z6*Q7"G;R=
MA5@PP4_O#KGU['UUIKKQ@EO,8],TB64-^['VMP",#K\GKG\JZ*BG+%1=OW<?
MQ_S#E\SFFNO&@6/;I6C,V<./MD@'3J/D]<_F*J0W?CU@6DTO2U?:VU#<'8>3
M@DCD'&. "/<5V%%)8J*5O9Q_'_,.7S.::[\9K%)MTK2'D )3-VZ@GC ^Z?\
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MX_["=_\ ^E<U%,\&S17&@2302)+%)J-^R.C!E8&[EP01U%% &_1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g3dyckr3udth000033.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000033.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &1 7X# 2(  A$! Q$!_\0
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MQN4.'"L#M/OZ413PSH7AECD4'!9&! _*@##_ .$$\'_]"IH?_@NA_P#B:/\
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MHK:012F[N%CD/\+;0 ?PKR99=.;2TT.6U$?BW^U/+/B$W68A\V<^;GTXQ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KQ_\ :._Y)YI__85C_P#14M>P5X_^T=_R3S3_ /L*Q_\ HJ6@
M#T#P)_R3SPS_ -@JU_\ 12UT%<_X$_Y)YX9_[!5K_P"BEKH* "BBB@ HHHH
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MPGXKT_QCH@U/3EE1 [1213+M>-QU!%>9_$/_ (3?PUJ5C/;>,I?L^J:B+:*
M6RCR%8\<]\5U?PHT/4]"T358-3LWM9)M3FFC5R#N0XP>#4?Q3T+5-<_X1K^S
M+.2Y^RZK'--L(&Q!U)R:II<T7Z?C:X+9KU_"]B7^V+_P!I,-OKU[J'B74KR<
MBV6TM!O(QTP. !ZTL7Q8T-O#5]K,UIJ$'V"Y6UNK62("6-V.!QG&/Q[52^*-
MGXDNKS1AIUOJ5UHH9OM]OIDXBF<X^7YO2N%M_ 'B0^"_&-A%H4UK+=7D%W9P
M23K(71225WYY8#U[TD[W;_K5?I<=K62_K<]DG\6Z?;^)M)T!XY_M>IP// P4
M; J@D[CG@\4WQ;XRTSP9:6ESJ:7#1W,X@3R(]Y#'U&?Y5PNFV_B77/B9X7UR
M[\-76FZ?86<MO(TTB%@Q1AD@'(!) %;GQ1T/4];3PX-.LWN?LVK13S[2/DC!
MY8Y/2AK5>OZ_Y!T^7Z?YE?\ X7'I?FWEK_86NC4;8;VLC:?O#'C.\\\#'K7/
M>-?']SJG_"'W/A[Q =&T[5VE6:YF10(]I ^;=P,'(ZUT,?A_51\4_$^J&Q?[
M%=:4L$$V1AWP/E'.:XG3/A]K4UAX!L]3T)Y+>RNKIM0BEVE8T:3(W#/((]*4
M=;?UW!Z7_KI?_@&MX9\5:[9_$C3M _X2RU\56%["[S2P1K_HY )!W+D=OUJ/
MX=?$S4[KQ=J6A>(+AI([BXF73KAU &Y&(,>?IC%:VE>$M2\!?$AI-!TLW'AG
M5EQ.L87=9OZ@DYV^WIGTK'M/AKJFI> ]8MKBU>RUF#5IK[39"PW9SD8(/ ;_
M  HOI?R?Y_IT[BMK;S7Y/^F:OAGQY?V_P:U'Q+J]V;B\AEGCB=P 2V<(./<U
M+\)O%6O7UYJ6@>*Y6?5H$CNXBX )B=0<<>F1^=<9I_@3Q=J7A#P_X2NM/N=/
MMVOY;K4+IBC>6/X.,\]S^5=#/X#\3>%O'.A^)++4;WQ"V_[->B1$1T@(QZ\@
M9/Y"K7Q:]=/P_P Q2VT]?Q_R/9:***D84444 %%%% !1110 4444 %>/_M'?
M\D\T_P#["L?_ **EKV"O'_VCO^2>:?\ ]A6/_P!%2T >@>!/^2>>&?\ L%6O
M_HI:Z"N?\"?\D\\,_P#8*M?_ $4M=!0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>/_M'?\D\T_P#["L?_ **EKV"O'_VC
MO^2>:?\ ]A6/_P!%2T >@>!/^2>>&?\ L%6O_HI:Z"N?\"?\D\\,_P#8*M?_
M $4M=!0 4444 %%%% !1110 4455GU.PM9?*N+ZVAD R4DE53^1- %JJFJ:E
M;Z/IEQJ%V7$%NA=]BEFQ[ =32P:E874GEV][;328SMCE5CCZ U:H8(Y3P'XO
ME\9:?J%W+8-9"VO7MDB?._: ""P[-STK%\1?$74=/\;/X<TK3]/N)(XXF=KJ
M^6 EGZ*H/WCCL*MZ!HOB'PWIOB22VM+2XOKS5I;NUBDG*HT;%?O$#@X!XK \
M9^"?$.O:GJ$4&C:'-#J(AVZD_P EQ9E<;NQ+=.,8HZKY?D'?Y_F>I-=P186>
M>*.3 )5G (I\4\-PI:&5)%!P2C X/X5SNH?#_P ,ZS)#<:OI4-]=QPI"9Y2V
MY@HXS@UA?"^PM=+O/%MC8PB&U@U=EBB4DA1L7@9IO<2V/0Z***0PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "O'_VCO^2>:?\ ]A6/_P!%2U[!7C_[1W_)/-/_ .PK'_Z*EH ] \"?
M\D\\,_\ 8*M?_12UT%<_X$_Y)YX9_P"P5:_^BEKH* "BBB@ HHHH **** "O
M%/C"_P /A_:RZBJ_\)3]D'D']YG./DZ?+7M=>:^)K[Q!KOCF;PWX;33+1[.V
M2XN[Z\MQ*WS?=500:EJ^A2=M3.^%S_#<W]H/#J*->^Q#SB/,ST7?][CK7K=>
M<>%+[7='\:GPSXD33;F>:T:ZM;ZRMQ$2H8!E8 "O1ZT;OJ0E;0****D85POP
M_P#^0WXT_P"PRW_H"UW5<+\/_P#D-^-/^PRW_H"T =U1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7C_[1W_)/-/\ ^PK'_P"BI:]@KQ_]H[_DGFG_ /85C_\ 14M 'H'@3_DG
MGAG_ +!5K_Z*6N@KG_ G_)//#/\ V"K7_P!%+704 %%%% !1110 4444 %>(
M_$G_ (1_3O',]W+KWB.TU":U1KE-(C#+%$O 9SV%>W5Y5XJ\,^,_^$OUS4]!
MM]*EL]4L4M93>2E2H"D''YU+WN4NO]=34\&^!+2RU6U\4Q>)=3UCS+0I UVX
M8>6^#QQGM7H->1_#/7]:L]6L_!M_=Z%/#:6;8^P3F60;<8W'IWKURM)6Z;&<
M?/<****DH*X7X?\ _(;\:?\ 89;_ - 6NZKA?A__ ,AOQI_V&6_] 6@#NJ**
MCGE\F"27RWDV*6V1C+-CL!ZT 8VO>,_#OAB:&'6M6M[.6?\ U:/DDCUP <#W
M/%;,$\-U;QW%O*DL,BADD1LJP/0@^E?,GQ8\)^(_$/C4ZO8Z-J36]X(X8UN$
M5&5\?< W'C@FO9?A9;WVC^#M/T+4+#4(;FUB9GDN(P(P2Q.Q2"<XS0!W5%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7C_P"T=_R3S3_^PK'_ .BI:]@KQ_\ :._Y)YI__85C_P#14M 'H'@3
M_DGGAG_L%6O_ **6N@KG_ G_ "3SPS_V"K7_ -%+704 %%%% !1110 4444
M%>4?$GPEXLUC7$O;9Y-4T!%7S-&BO#;,Y Y.0.<_G7J]>97T^J:W\4-:TI=6
MDM8M/TP?8[-7VK</*A!=O7:2.G3BI8U_7WF5\&Y]/TF_U70Y]'N-)U2:YDN(
M;>X@8,(!C"^81SC/K7L5>->!]*O_  E\0],T>XU2:_GN])>6_BEF\X6\BL,%
M2>0#7LM:/9?UMI^A*W?];ZA12!E;.T@X.#@]*0NH8*6 8] 3R:D8ZN%^'_\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'_VCO\
MDGFG_P#85C_]%2U[!7C_ .T=_P D\T__ +"L?_HJ6@#T#P)_R3SPS_V"K7_T
M4M=!7/\ @3_DGGAG_L%6O_HI:Z"@ HHHH **** "BBB@ KSGXA::UFTFNS^,
M-;TVW<I#'96"AR[G@!%ZEC7HU>6?%7Q/HJS0:',^IQ:A:/'?K>V, D%B0<*[
M@]1R>*3Z#74B^'5]#/XAB5_$_B*ZFEM7D2RU2(*K -M8@C^)2.1VS7K%>*?#
M>."3Q]Y8UJY\0O903$7<5N([6W:1@S#/\3,3^%>UU3V1*W84444AA7"_#_\
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M $K9?QGXJ>-E_P"%=:GR"/\ C\@_QKDOAX_C#P5HUW8S^!;^Y:>[>X#1W4(
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M-@^$>^\LPIN(LV_R;AE>>AR/2N7\9^!;CQ)YMWIWPXU+2]0* *8KN 0DCNR
M_P L4 >[^'=:B\1>';#6((VCCO(5E"-U7/4?G6G7F'AK7O%>@>&=-TEOA[J,
MC6ENL1=+N$!B!U'-:P\:>*2P!^'>I@$]?MD/'ZT =S12 DJ"1@D=*6@ HHHH
M **** "BBB@ KQ_]H[_DGFG_ /85C_\ 14M>P5X_^T=_R3S3_P#L*Q_^BI:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'_P!H
M[_DGFG_]A6/_ -%2U[!7C_[1W_)/-/\ ^PK'_P"BI: /F*3_ %C?4TVBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *FMO
(]8?I110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g3dyckr3udth000027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000027.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %$ M # 2(  A$! Q$!_\0
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M,Y/- 'MU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CW_A;1
MM3U&YO[RS\RZNM/;3)G\UQNMF)+)@' R2>1S[U7_ .$)\._] _\ YA7]C?ZZ
M3_CS_P">?WO_ ![[WO7044 >>WOPNTW4O&=K=7MC9W'AZUT*/3(+21W,D;I+
MN4@^@3C.[/)]:ZUO#6CF]TB\%BB3:.CI8>6Q18%=0C *"%(V@#D'':M6B@#
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M2K_J ZY_X!__ %Z/^$J_Z@.N?^ ?_P!>@#H**Y__ (2K_J ZY_X!_P#UZ/\
MA*O^H#KG_@'_ /7H Z"BN?\ ^$J_Z@.N?^ ?_P!>C_A*O^H#KG_@'_\ 7H Z
M"BN?_P"$J_Z@.N?^ ?\ ]>C_ (2K_J ZY_X!_P#UZ .@HKG_ /A*O^H#KG_@
M'_\ 7H_X2K_J ZY_X!__ %Z .@HKG_\ A*O^H#KG_@'_ /7H_P"$J_Z@.N?^
M ?\ ]>@#H**Y_P#X2K_J ZY_X!__ %Z/^$J_Z@.N?^ ?_P!>@#H**Y__ (2K
M_J ZY_X!_P#UZ/\ A*O^H#KG_@'_ /7H Z"BN?\ ^$J_Z@.N?^ ?_P!>C_A*
MO^H#KG_@'_\ 7H Z"BN?_P"$J_Z@.N?^ ?\ ]>C_ (2K_J ZY_X!_P#UZ .@
MHKG_ /A*O^H#KG_@'_\ 7H_X2K_J ZY_X!__ %Z .@HKG_\ A*O^H#KG_@'_
M /7H_P"$J_Z@.N?^ ?\ ]>@#H**Y_P#X2K_J ZY_X!__ %Z/^$J_Z@.N?^ ?
M_P!>@#H**Y__ (2K_J ZY_X!_P#UZ/\ A*O^H#KG_@'_ /7H Z"BN?\ ^$J_
MZ@.N?^ ?_P!>C_A*O^H#KG_@'_\ 7H Z"BN=;Q?;Q-%]ITK5[:.26.'S9K7"
M*SL$7)SQEF _&K-YXKT.PO9;.YOU6XA($B*C,4) 8 X!P<$''H10!LT5S_\
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M -!#_P @R?\ Q- '045S_P#PF_AW_H(?^09/_B:/^$W\._\ 00_\@R?_ !-
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M_P")H_X3?P[_ -!#_P @R?\ Q- '045S_P#PF_AW_H(?^09/_B:/^$W\._\
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M/#W_ "'/%G_853_TBM:/&?\ R+Z?]A"Q_P#2N*CP]_R'/%G_ &%4_P#2*UH
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MJBK8K'\2_P#(*@_["%E_Z514 5_ G_)//#/_ &"K7_T4M=!7/^!/^2>>&?\
ML%6O_HI:Z"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MIC.<[4Y;^5#,<[$^]W/I2JH08'XD]Z !$"CU)ZD]Z5F"C). *&8*N37G>L>)
M-9@\0WDL-PRZ;97EO \@B0V\0;;YBS$_O"_S#!3@;ESWH ]!"ER&<8 ^ZOI[
MFI**:'4L5!Y':@!O,73F/T_N_P#UJDZC(HJ/!B.5&4[@=OI0 KID[E.&'0^M
M*C[N,88=1Z4H((R#D&D=-W(.&'0T .HIJ/NR",,.HIU !1110 4444 %%%%
M!1110 4444 %%%% '/\ C/\ Y%]/^PA8_P#I7%1X>_Y#GBS_ +"J?^D5K1XS
M_P"1?3_L(6/_ *5Q4>'O^0YXL_["J?\ I%:T =!1110 4444 %4=:_Y 6H?]
M>TG_ *":O51UK_D!:A_U[2?^@F@"Y'_JU^@IU-C_ -6OT%.H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,W2/O:A_U^/_):TJS=
M(^]J'_7X_P#):TJ "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_R"H/\
ML(67_I5%6Q6/XE_Y!4'_ &$++_TJBH K^!/^2>>&?^P5:_\ HI:Z"N?\"?\
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M.UAAAU%.5@PR#D&D= P]".A':@!U%,5R3M888?K]*?0 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "HRQ<E4. /O-_04$F0[5.%'5OZ"G@!0
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MC->FUQ'A#S3K-PT(NOL!$OE,1<"(_/\ PB1ROKT4>W%=O0 51UK_ ) 6H?\
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MM:_<**Y'PWJ/B^Z\5:W;ZYI<%MI4+@6<J-G<.V#_ ! CDGC!X^G74B@HHHH
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MRE?M7BC5&+'&(YUB'_CH%+_PK@3\WE_?7+$<^;J$C9_2NHMM0^W)_HNHZ?=
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MLEW;2JT;#*N.A%9GEQ72_P!F6*K;Z9;?),T0V@X_Y9KC_P >/X=<XUHXUVJ
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M$A)WY(] >*ZVO/O!\MB_BB:YCDBEGO(I'22&\0J4#CK#&B@'D?,V6]^M>@T
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MH5< <4COM'3+'H/6AWVX &6/04B)@[F.6/4T "H0=S'+']/I3Z*XGQ!\1(-
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M5W8?_>E_70\_&?\ (KEZ?J8GP_\ ^1F_[8/_ #%=YXG_ .19U#_KD:X/X?\
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M(R/J.1^%6** ,G2_#>FZ/<//9)<*[@[O,NY9 <\DX9B,\=>M:U%% !5'6O\
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M_F:Q_P ^MC_X$O\ _&ZY:XT'5_MBH?L.Z=F(_>OQW_NUCF^%K8A05)7M<]C
M5J=)RYW:YUND_P#((M/^N2_RKPOXM?\ (^3?]>\7\C7M5HFL6UI#!]FL6\M
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M^SY\WR=XW[<<YQZ<XSCFH-!.JKI#XC9Q]JD^S"]D99!!N.S<2"V?3=SC&>:
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M["%E_P"E45;%8_B7_D%0?]A"R_\ 2J*@"OX$_P"2>>&?^P5:_P#HI:Z"N?\
M G_)//#/_8*M?_12UT% !1110 4444 %%%% %2[FN8D?RH-RA"=^\#!^E8.C
MZMJ5S>%),S#83L(">G?%=,TT2-M>1%8]BP!K)TGQ1I.M7%]#9W*EK*;RI-Q
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MCH1VH =U&#4?,77F/U_N_P#UJ57).UAAA^OTI] !3&0D[E.&'Z_6DYB]X_\
MT'_ZU24 -1]PZ88=1Z4ZF.F?F!PPZ&F^8S?*%P_?/04 .9R#M498_I]:5$"C
MKDGJ3WH5 @XY)ZD]Z4D*"2< 4 !( R3@"F &0Y883LOK]: "YW., =%_J:DH
M *8S$ML3KW/I0S%B43MU;T_^O3E4*N .* !5"# __72T44 %%%% !1110 44
M44 %%%% !1110!S_ (S_ .1?3_L(6/\ Z5Q4>'O^0YXL_P"PJG_I%:T>,_\
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MN&!VYXR/3)_.K><=:P/"5HL>D1W;PLEQ.NUF<Y=T4D1[C@;OEQAB 2,9K/\
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M$0RR3!8U"JS.&#;ACD88X':MBB@#/T71K70=,2PL_,,2,S;I6W,23GD]_3Z
M57\2_P#(*@_["%E_Z515L5C^)?\ D%0?]A"R_P#2J*@"MIWA>?2],M=/M/$>
MK);6L*01*4MB0B@*!DP\\ 59_L:__P"AFU7_ +]VO_QFBB@ _L:__P"AFU7_
M +]VO_QFC^QK_P#Z&;5?^_=K_P#&:** #^QK_P#Z&;5?^_=K_P#&:/[&O_\
MH9M5_P"_=K_\9HHH /[&O_\ H9M5_P"_=K_\9H_L:_\ ^AFU7_OW:_\ QFBB
M@ _L:_\ ^AFU7_OW:_\ QFC^QK__ *&;5?\ OW:__&:** #^QK__ *&;5?\
MOW:__&:/[&O_ /H9M5_[]VO_ ,9HHH /[&O_ /H9M5_[]VO_ ,9H_L:__P"A
MFU7_ +]VO_QFBB@ _L:__P"AFU7_ +]VO_QFC^QK_P#Z&;5?^_=K_P#&:**
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MO_\ H9M5_P"_=K_\9HHH /[&O_\ H9M5_P"_=K_\9H_L:_\ ^AFU7_OW:_\
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M +]VO_QFC^QK_P#Z&;5?^_=K_P#&:** #^QK_P#Z&;5?^_=K_P#&:/[&O_\
MH9M5_P"_=K_\9HHH /[&O_\ H9M5_P"_=K_\9H_L:_\ ^AFU7_OW:_\ QFBB
M@ _L:_\ ^AFU7_OW:_\ QFC^QK__ *&;5?\ OW:__&:** #^QK__ *&;5?\
MOW:__&:/[&O_ /H9M5_[]VO_ ,9HHH /[&O_ /H9M5_[]VO_ ,9H_L:__P"A
MFU7_ +]VO_QFBB@ _L:__P"AFU7_ +]VO_QFC^QK_P#Z&;5?^_=K_P#&:**
M#^QK_P#Z&;5?^_=K_P#&:/[&O_\ H9M5_P"_=K_\9HHH /[&O_\ H9M5_P"_
M=K_\9H_L:_\ ^AFU7_OW:_\ QFBB@ _L:_\ ^AFU7_OW:_\ QFHY?#T]QY2W
;.OZG/%'/%/Y3);@,8W5U!*Q XRHZ$444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g3dyckr3udth000041.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000041.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #Q I(# 2(  A$! Q$!_\0
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M^7\*NBTMENS=K;Q"Y:,1&8(-Y0$D+NZX!)..G)J:B@"I8:5IVEH4T^PM;1"
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M<+MFN%@422#T9L9/XU>HH HZ=HNE:/YW]F:;9V7G-NE^S0+'O/J< 9J]110
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MCVNOV?AO2;Y2UM=:TD;A20>8)^01Z'FN^J&>TMKIH6N+>*5H)!+$9$#>6X!
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MS)IG,@4D>9=K&^..-RG&.W;% &A<V>MV=K-=7/BQ(H(4:221[&,*B@9))ST
M%2#3/$+ $>*,@C(_T"/_ !KG]=U*&^\#^+%EU(MJ$=CJ$<MEN ,:JKA<IC(&
MW:0W\08'D$5H+J5\^L7%L+VVMY(;F!(8IY_+WQ%(R<)L._=EP&!ZC'!4T :!
MTOQ%D#_A)^O_ $X1_P"-+_97B+_H9_\ R0C_ ,:WC]Y:6@# _LKQ%_T,_P#Y
M(1_XT?V5XB_Z&?\ \D(_\:WZ* ,#^RO$7_0S_P#DA'_C1_97B+_H9_\ R0C_
M ,:WZ* ,#^RO$7_0S_\ DA'_ (T?V5XB_P"AG_\ )"/_ !K?HH P/[*\1?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI,&L3ZJ%V#!:4$%/H,]: .QHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3&>,#[WO^E=112]M0O\ P_Q86?<R/"?_ ")NA_\ 8/@_]%K11X3_ .1-T/\
M[!\'_HM:*Y2C8HHHH ***S=9U=-&M[:9X6E$]U%; *0,&1@H/T&: -*BBB@
MHHHH **** "BBN>NO''AVR.HB?440Z>ZQW/!^1FZ"@#H:*YZX\<>';5K]9=1
MC4V,2RS\'Y5;I_GWK<MKB*[MHKF!P\,JAT8=P>0: ):*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#GO
MHS\._#0R1G2;7D=OW2UK6J-%)*C2-(RA06;J>*Y[2-'\5:-HMCI=OJ6C20V5
MO';QO)92[F5%"@G$N,X%61:^+A([_;]$RV,_Z'+V_P"VM,#HLTT?>:L'R/%_
M_/\ :'_X!R__ !VC[/XOR3]NT/G_ *<Y?_CM(#H,T9KG_(\7_P#/]H?_ (!R
M_P#QVCR/%_\ S_:'_P" <O\ \=H Z#-&:Y_R/%__ #_:'_X!R_\ QVCR/%__
M #_:'_X!R_\ QV@#H,T9KG_(\7_\_P!H?_@'+_\ ':/(\7_\_P!H?_@'+_\
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M9/+4HA*J<$_,>@Z'W]J *'_"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\
M\&,/_P 55^]D$,L&Z>6,3/Y2[,8!VLV3GZ5ERZN#:Q26DE[<RW.\VL42H6G5
M<9==Q"A?0L5'(]1E7?8EM]B7_A._!_\ T->A_P#@QA_^*H_X3OP?_P!#7H?_
M (,8?_BJLZ?.+])<3W<4L+^7+#)M#Q-@'!QD'@@Y!(YZU-&HFEF2+4'=H7\N
M158$QMM# -Z'#*<>A'K2N^PN:78H?\)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\
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M+CF[FS^'^%-M]AMM;(S/^$[\'_\ 0UZ'_P"#&'_XJC_A._!__0UZ'_X,8?\
MXJM/[-+WNYOT_P *7[-)CBZGZ#'(_P *5WV%S2[&7_PG?@__ *&O0_\ P8P_
M_%4?\)WX/_Z&O0__  8P_P#Q5:+6MP5.R]D#=B0#Z?\ UZ>;:3C%U..><D?X
M47?87-+L9?\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5J_
M9V_Y^9_^^A_A3# X=5^US9;) X[?A1=]@YI=C-_X3OP?_P!#7H?_ (,8?_BJ
M/^$[\'_]#7H?_@QA_P#BJTS;2\8NYAZYQ_A2?9IB3MNYASWP:+OL'-+L9O\
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M:W49&<&I:Y3H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4N,A77ID=Q6!\*OAD_P^@OY;J^2ZO+PJK>4I"(JYP.>2<DT >C4444 %%%%
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .6^''_).?#_ /V#X/\
MT6M=0RAE*L 5(P01UKB?"TGB#0/"^F:3/X7NI9;.VCA=X[NWVL54 D9<''%:
M_P#;FM_]"E??^!=M_P#'*;W U6A7%Q%&JH&3' P.<U+$GEPQIUV*%S]!6"-8
MUSS&;_A$KWD ?\?=OVS_ --*=_;6M_\ 0I7W_@7;_P#QRB_0#?HK _MK6_\
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M2OO_  +M_P#XY0!OTG\0^E8/]M:W_P!"E??^!=O_ /'*3^V=;SG_ (1*^_\
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M^$IUW_OJ#_XU0!T=%<Y_PC=W_P!#3KG_ 'U!_P#&J!X<NCT\5:X>WWH/_C5
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MLX+5G2^0*QC0+N&1G!QFM7^U_$7_ $*__E0C_P *; UQ"L5PI5G.X-G<Q/\
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M]J^(O^A8_P#)^/\ PH_M7Q%_T+'_ )/Q_P"% &_FC-8']J^(O^A8_P#)^/\
MPH_M7Q%_T+'_ )/Q_P"% &_FD)Z?6L'^U?$7_0L?^3\?^%!U3Q%Q_P 4Q_Y/
MQ_X4 ;^:,U@?VKXB_P"A8_\ )^/_  H_M7Q%_P!"Q_Y/Q_X4 ;^:,U@?VKXB
M_P"A8_\ )^/_  H_M7Q%_P!"Q_Y/Q_X4 ;^:1C\I^E8/]J^(O^A8_P#)^/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g3dyckr3udth000009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %4 9H# 2(  A$! Q$!_\0
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M^+X;KQ+=:<P80JR1P'R7W,_\6[T&>A.*ZBDXM;A&2EL%%%%(H**** "BBB@
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M8&99+5HR>6 /(8UWU%+G=[C=--6N>=7FEZVFFZUI$6DO*EQ=&X2X$BA2I8'
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M;ZC'E+AKF<RQ;EE<XQ\N>@]#1S*VX<KOL.\&M(=3U(64]S/HB[1;R7#$Y?\
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M6[FM4><8^;)&<=,CH<>]6H+:&V\SR8PGFR&1\?Q,>IJ6BB["R"BBBD,****
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M7<%P66.12Z_?3/S+[$=J46T*W!N%B42L-I<#!(]_6N?U'2KN"".*S0,G5[@
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M[TM8MAH]W9VL*+J#QNH^9%0,F?3![?E6UVIQ=UJC5-]0HHHIC"BBB@ HHHH
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MUCQ'+OYFZC!'I[U82.2UMF6,R7##E1(XS],_XU)!-YT0<QR1G."L@P14RC<
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M** "BBB@ HHHH *A@G$SSJ%QY4FP\]?E!S^M35#!.LSSJJ[3%)L/N=H.?UH
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M((%8VFPS3:EI\HL);-+.U:&7S% W$[<*N.H&"<]*I*Z)DVFCHJ***DH****
M"BBB@ HHHH **** "H(;BVFFF6"6)Y$($H1@2I[ U/6586K0:YJDHA\N&41%
M& P&(!S30FS5HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC &G5)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%(1D$'H1BEHH STT:T2PM;)0_DVKK)&-W.5.1D]Z(=&M(&MV0/FWDDDCRW\3
MYW9_,UH44[L7*C(/ARR$<*Q27,!B0QAX9BK,I.XJ3W&34VI::UW':M!(([BU
ME66%FR1QP0>^""16C11S,7*C"MO#J?;;BYNY9'#W9N$A60^7VVEE]01_*K;Z
M'9M8_9?WJJ)C.KJY#HY8MD'MR36E11S,.5%(:9;G37L)C+/#("',TA9FSUY_
MPJLGAZR6-UD>XF=WC9I992SG8<J,^@/:M:BB['RHS-9TQ]3%DJ2F,0W E=E8
MJV K#Y2._(IG_".V0MXXT>X22.1I1<+*1*6;[Q+=\UK447=K"Y4W<R)/#EC)
M:QVRM<11(C1LL<Q'F*QRP;UR>_7FK,.DV]OJ+7L+2HSH%:-7.QL# )7U XJ]
M11S,.5%'^R+(ZE-J!BS/-%Y+Y/!7Z>O;\*KQ^'K-+6:U>2YFMY$$8CEF9@BC
MH%],<<]>*UJ*+L?*C)/A^U:T:!Y[MV,JR^>TY,@9>A![8I3X>LC="8M.1O61
MXC*=DCKC#L.YX'Y5JT4<S%RQ[%>SLX;&)XX0VUY&D.XY^9B2?U-4TT"SCD+!
MI]OV@7*QF0[$<$G(';))S6I11=CLC)E\.V<EV]SON$9YEN-J2D*)!QN ^@Q4
MJ:)91I;H%?;;O(Z#>>KYW?\ H1K1HHNQ<J,A/#EDJMO>XE9O+^:64LP"-N50
M?3-3?V-;C4&O$EN(V9Q(\22E8W8#&2OKP/KBM&BCF8<J*]E9PZ?:);0!A&A)
M&XY/))/ZFK%%%(HS&T*R:R-J/-5?/-PKK(0Z2$DY![=34<GAVSF$/F2W3M&C
MQES.2SJ_W@Q]/IBM>BGS,GE1G6VBVEJDBJ96\R!8'+R')5<@<^O)YJE/X:C>
MW>".XE9;AD%S),Y=VC3D(#^GXFMZBGS.]PY5:P 8&!1114E!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
; 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g3dyckr3udth000030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000030.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %I 5P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBO/OB3+KB7&F+:7.JVFCG?]MN-)B\R=&XV
M<==O7.*38'H-%>6:7XQOM(\$S7JZM!K_ )>HQVT4DP:.9(W8#$JD AQD_6NA
MU?QE=:=J_B"SCM8733-+6^1F8Y=B3\I]N*;TU_K:X+7^O.QV5%<%;^,/$$%O
MH>HZMIVGP:;JD\<1,,SM)#YBY4MD ?>P/QJG?^,;O4;>VNXHVBLSXACL+9X9
MVC,J D,S8ZC=GY>AQ3MK;^NG^8KZ7_KK_D>DT5P)\?7HMOLGV*W_ +;_ +8_
MLP6^YMF,Y\SUQLY^M5=<^)5WHWB*2U^RZ?-9PW26\B1SL\X#$#>=J[$Y/W6.
M>*2U_K^NXWI_7]=CTBBO/O#^IZA/X0\73RWL\DUO>WB02,Y+1JJ_*%/8#M7
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MV[OFV],T(#4N==TRSG>&XNTCD3[P(/'Z5>AFCN($FA</%(H9&4\$'H:;<?\
M'K-_N'^54O#_ /R+NG?]>R?^@B@#(?XC^%(Y&1M5 925(\F3@C_@-;.D:WIV
MNV?VO3;E9X0Y3< 1R.HP>>]6_L\'_/&/_OD5YMXK\.+X2N8_$VA71LW\X)/$
MPWK(9' )Y.!U]*M*,M$<\Y5*:YG9K^O,].HID<L<T8DB=71NC*<@_C3Z@Z H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BN?^/6;_ '#_ "JEX?\
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M]D_]!%7;G_CUF_W#_*J7A_\ Y%W3O^O9/_010!I4444 %%%% !1110 4444
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M*.=B]A#^FSC_ /A#-4_Z'/6OS7_"C_A#-4_Z'/6OS7_"NPHHYV'L(?TV<?\
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M(YHW_0-MO^^!0!I;E_O#\Z-R_P!X?G6;_P (YHW_ $#;;_O@4?\ ".:-_P!
MRV_[]B@#2W+_ 'A^=5[6TL[(S&VABB,\AEEV #>YZL?>L/2?#^FL^H^=IL/%
MXX3?'_#A<8]NM:7_  CNC?\ 0,MO^_8H"QH[U_O#\Z-Z_P!X?G6=_P ([HW_
M $#+;_OV*/\ A'=&_P"@9:_]^Q0!H[T_O+^=&]/[R_G6=_PCNC?] RU_[]BC
M_A'=&_Z!EK_W[% &D"#T(/TI:QM-L(K#7+];:V$%N\,)&Q<*6R^?QZ5LT %%
M%% !1110 4444 %%%% !1110 5F:SK,>D1VX\B6YNKJ7R;>WBQND;!/4\
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M' (S@=ZZ*N0E\'W,^H6+R7%D+>UEAF$D=KMN2T:@;=^?NG'IG'%=?3 ****
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<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g3dyckr3udth000019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000019.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $. B\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HK
MS59/$P^*X\-'Q=>M9#2/[2.;.UW%O/\ +V9\O[N/Q]ZT3\3+0?VQ+_8^H&ST
MJZDLIKD%-KW"R"-8D&[)+%@<X  (R1S@ [FBN7M?&)NCJ=LFCW+ZE8)%(;.*
M:%C*DA(5E?>%P,-G)&-IZ\9Q-:^(T\/ACQ-/I^G%=7T38)H7D21%#KN63(8;
MEQG@<\'B@#T.BN0O_'$NFOH=I/X>U!M5UA9S!8QR0E@8L$@MOV %6W9W< '/
M/%4K3XGV\[Z6T^A:E:VM_??V8;B7R]L=UN91'@,2PRI^8#'OU  .\HKCS\0K
M$7K*+.<V"ZA_9IO-Z >=NV9"9W%-_P N['7G&.:KZS\2(M*U/7+*'0M1OO[#
M2.6_E@,86*-XPX;YF!/!/ &?E/2@#N**XRY\6ZFGQ"TW1;32GN=-N[ W)F1X
MP0-Z#S.7'RJ&Y&"3D8S6WJ'B*UTS7K'2[I'0WL$TL4Q(V9B ++]=I)^BGTH
MV**X_1?B%I^NVFB26UI=1S:M//"D$@4/#Y6[>SC/ &!^+J.]<UIGQ U-M(\'
M2Z78ZAJ\&K2W*22730)<2;/,^7AE0$;<YZ;1CK0!ZK17ETWCG4]#\<^.A/8W
M^IZ7IB6<HC@:,"TC,):1OF(SD\X&3P>F*] OX+C5M,C_ +.U6?3VDVR+<01Q
MNQ7'3$BL,'([4 :-%>1>'M>\:7OP=;Q5%J=QJ>K7"-LMA90D1!9RC.BHJEV"
M*3M).34VM^+Y[3X1ZYK>@>*[C4KJVEB1)[FVB2:V8RHC(R;%'0G[RYYX)XH
M]7HKS3_A88U?XA^$-*T>ZNEL[H7?V^*>R>+S"L.Z/!D0'@@GY3]>U(GB_6!\
M08;J2ZC7PK<ZC)HD43*JG[0B9$@;&3ND62/&0. 1G- 'IE%5FO(7DEMK>YMV
MO%4XB+@D'W YQTKD_!6L:Q/)XIBUN^CO9=-U!HD:* 1*$$2MA5R3C)/4D^]
M':T5YAHWB'Q K^$=9OM6-Q;^(YFCEL/(01VX:-GC\M@ V1M )8G.3P.,7;*[
M\2Z=\2[#19M=_MBVGLY+C4$:VCB%ICB,IM&0&;@!B3@$Y/6@#T*BO._B-XEO
MM%\2^%K"'6VT?3[\W;7MTD,<C*L:*R_?5@!DG/%.\/\ C>]@\*0WNL(]]+=Z
MF]EI<B1K$U]%SLF8'"H"JLQ/ P,CJ!0!Z%17&/\ $:PCM%,EK)'>G4?[,-N\
MT843%-X_>9V[2N"#U.<8SQ6I<>*H;/7?#^CW-G/'=:TLYC 966(Q('8,0><@
M\8S0!OT5YSXH\7W,]GX;N=*EGM%E\61:7< XS(BO(CK_ +I*5)8_$2]A/B6;
M6=&GBM-,O3;0/$T9+L?+"0XWDEV,F=V H!Y((H ]"HKCI?B'96=KJC7UE<0W
M6GB%C;1NDIF\YML>QE."2WRG.,'VYIOAW7=3U3QSJ=M?65WIT<.FVT@LKAT;
M:[22@L"A((("]^U '9T5QFL>*H-&\::A!--J$BV7AV35'M4$?DE$D()'\7F<
M8Z[<>]2Z#X[CUO5;*S?1KZQCU"S:\L;BX:/;<1KMR0%8D<." 0#CTH ZZBO.
M_&OB'4-*\5VUM>ZQ=Z#X?DM08]1M[-)5-R7QLE=E8(N-I&5&<GYN*T+WQ7::
M5XRN(+N_O9(;;P\=3D2-(S;LBR8+C WESCIG;CWH [2BN-7QZ4.IB[T.\M_[
M.TO^U)298G_=D,57AOO'8WL,=>F:$OQ'BN],N3)I>JZ9%<://J5E=DPEIHXT
M!+(-QPV&! 8?4"@#T&BO,=<\0:G=6/@6WTY-6EM]75)99H9XH9YAY!?:QR &
MZ,<8'! Z@5?T_P <06MIJI4:KJ=T/$$VEV]LXB#M*H!V(1@", $Y<YX.3TH
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M[I@<Y;)R37=W=[:V*1O=W$<"R2+$AD8*&=CA5'N3P*I_V_8?\)3_ ,(YN?\
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ME43DY\P 'AO?K6QX0ADL=?\ !=RE[?S2:UH4EQ?"XNY)5DD"PL&"L2%P7(&
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MUZ;28&<X&?6@#R+P)/->:CHC2Z[%'KD;2G5+.6YE:YG)#;U>(_*@5L%2!@
M#@\^O4F!DG R>II: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,=NN I(89:1PX!]%X!JS!\4=TFGWDMC-)975I9K]GM4#R_:[G>RH"2. J?\
MCPH ]+HK@(?BA9W]O,L>FZE9.;6ZEBFN(49/,MQ^\3 ?DKQZ ],US^K?$?6+
M:\O!;:C8HT-M:R6EI+ILDCWLDL0?8&5\(2> .>O?% 'K]%><>(/B!J&D:[HT
M#06EO:+;PW&M+,^9+<3.(U5>>JMDG@\#-9.K_$76[/Q-KEC;WECYEE=I;V.F
MM82/)>EE5M@D5L*QR>WO0!Z[17FA\7ZW<>-M4TM=0BM+>SNXH$C71IKHN&1&
M.Z5&VKRQ&2..M>ET %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5RVO:/X6US5K>?7)[.Z-FCQI:7,J
M&)2Q!+%#_%\H&>PS74U\=?$1+=OBAXC$^0/M;8('? I2=E<F4N57/H&V\">
M(+E'FGM+JUB\W[/8W-Q&]O;F1@S;$[<CN3@4Z'P7X'A&DK_:$;QZ3=/<V:/>
M(1'O8-L]T# $ ]^]?)A1=QX!_"D*KG[H_*ES"YS["U/1?#VJZHU]<>(Y?O>;
M';_;T,44NPH)$4YP0&.!G;GG&:9-X<\(SV4EHVJQK#)I\&G$+>("(H6+)C_:
MR3DU\@;5_NC\J3:O]T?E1S!SGV')H/A274'O6U:/SGOFOSB[3'F-#Y)_#;V]
M:HS>#/!<^GQ6+ZO^YBTW^S%Q>QY\GS%D_P"^LJ.?3M7R:8U^7 4D]@*66V>!
M]LD>UO0BESH.='W(-:TD #^T[+C_ *>$_P :/[;TG_H)V7_@0G^-?"^U<?=%
M)M7T'Y4^8.8^Z?[;TK_H)V7_ ($)_C1?WMAY,UI<:C%:O)&5SYRHZ@C&X9[^
MAKX755W#Y1U':O3OCHJGXC\@'_0(.H_WJ.;0?-I<]DC\!^ K6VL5L+JVL+JS
M!"WMM<QK/("A1M[$'=D,<\5;T[PCX%TJYTV?2WL;2YL1M66"= \ZE"I64_Q@
M@Y.>_-?)45N9R5CCW$#)P*6'?;2I/%A71L@X[U+J=B'5[;GUII7ACPMH?AR?
M0]+UN2TCEN/M)GCOU$RN,8YZ;0% VD$$<'-,3PGX/33KNR_M5"EW:R6TTAO$
MWMYC[Y'S_>9L9XQP,"OF"/6Y(KV:]-G;,\T?EL"O'UQ64GE*&S$I)Z<=*F-2
M3W1,:LW\43Z\'A_PF+^:\_M9/-FN+.X;_3$QNMAB/\,#GU]J%\/^$UC=!JR8
M>VN[8_Z8GW+F3S)/QST]!ZU\A>4 N2@_*F[5_NC\JOG+]H?9/A_3O#/AN6XD
ML=5A+7$-O"_FW:-\L,?EICWVCGWK<_MO2O\ H)V7_@0G^-?#6Q?[H_*DV+_=
M'Y4<X<Y]S?VUI7_03LO_  (3_&L[Q'9:%K]A:VNKWD/V(S)<"(SJJ7&TY ;/
MWDS@X]A7Q447'W1^5>F?$X ^#?AV,#_D$>GM'3YAJ9[++X%\ 273/'/:06DD
ML4LUA#<QK;3-'NVED[_?.1G!XI+GP)X"N++4[%+JWMK/47BDDM[>Z1$CDCZ/
M&/X21P?6OD_:F/NC\J0*O]T?E1S!SGV)K&C>&M9MK>TDUQK>QB@%L]I;WZI%
M-%Q\C+SZ 9&#C(S@TZVTCPQ;7=M=?VO&\]O<W-RK-=)R\X(?(] #@>F!7QZL
M092=J\>U,V+_ '1^5+G%SGUI<>#/!ESID=@^K?N4T]=.&+U,^4LJRCG^]N4<
M^E6I/#GA*2UO(?[517N=3.JB=;Q!)!<''S1GL.,8.>":^0E12/NK^5)L7/W1
M^5'./G/K6;P9X$N%N))KBT?4)[DW1U(W$?VE)-^X%7_A (  QC Q5N70/"DM
MK'%_:Z+)%J3:I%.EX@DCG9BS8/3:<D;<=#7Q_M7^Z/RHV+_='Y4<P<Y]@Z;H
MVB:1=R367BNYCADNGNGM/MD)B9W;<PQMS@D],UJ^(+?1O$?AV?3[W4433[DB
M.22&Y5=V"&*;O?'(],U\4[%/11^5>A3(&^ -B-HQ_P )!(>G_3(T^8.<]QN?
M _@*:9VMI[2PAFB$%Q;V5Q'''<('5\.._*CD8."1WJ=O"'@51J"6LME8P:A9
MFSN8+6>..-QG(?;_ 'QDX;WKY.LY((&D,MLLNY"JY_A/K3HX%>,YVC'M4.I;
MH0ZMGJCZUDT+P[_PC^GZ+:^(9;.UL8S$IM[Y TB,,,'SD-D$\XR#R,4Q/#7@
M^*.VCBU""..VOH+Z)4NT^5X8Q'&ONH4=.O7FODAXE0E0%/X5/:::][(R1*GR
M\DFAU4E=@ZT8KF>Q]7+X6\(K!'"-5&U!> ?Z8F?]*_UG_P!;T]Z=)X:\'S:=
MJ-A+J$4D&H1012AKQ,KY*A8V4]F& <^HKY,N)&EEPZ("GR_*/2BY@*"&0Q(J
MNN5QWH53N"J[7/JNZ\$>![T7S:O<6^H7=ZBJUW>7$;3( @0;&XVX S]>:>OA
M3PC_ &;?V4NLF;[;+%,\\EZGFI+$H5)$88VL-H.?K7RW#IPO-+NKUKF(- !B
M)S\S#VK,"+GA1^5$:J=_((5E*Z['U_'HVBP:K=:C;>+KJWEO)$EN$BO(0DCJ
MH7)!4]0HS@UU]M=VUXK-;7$4RJ<$Q.& /X5\(F,8SM&/I7T9^SB /"^LX&/]
M.'_H"U:E<T4KGM%%5--N7O-.@N) H>1<D+TJW5%!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\<_$:4P_%'
MQ$X4'_3&ZCV%?8U?&WQ-&/B9XA_Z_&_D*F:NK$32:LSEY6WR,^ -W84SM4J1
M>:,!@&]#3[>1;:YW/&L@7JIZ5E>RT,;V6A6I5&YL9Q3I6#RLZJ$#'(4=J95%
M="QYB"(1E!E3PXZT"0RW"-)NE53R,\D5"*=""9E&2,GJ#4V)LAUVL27#"'=Y
M?4!NU0"I9@?-;&2H. 348'/--;%1^$%^\OU%>F?'0X^)'_;A!_[-7F8^\/J*
M].^.*AOB3M"DL;&  #_@55T*^RSSGS'BDW(VTXZJ:C)).?7FK4<,5K<F/4(G
M("\*#CFH<>9(R1)D$_*.^*S31BFN@QHY$17*D*W2FA23P,TYBV-I8D#L>U(&
M(Z=13U*UL+R<*3CUIS1A1US21H9I .23Z=35^WL7N7>!  R#)W\5,I*.Y$YJ
M.YFX/7TI"<GI5@H\*/G!1CBHEDVQLFT'=W/452=]BT[[#*]*^)W_ ")WP[_[
M!'](Z\UKTOXFD#P?\/,_] C^D=6MBULSS+-*:0]:<.G-(0Y::1@T9 H;D<4A
M#D /4X_"FD<TZ/!R"2*3OB@.HVE6@C'- H&3VT22SA'D\L'^+%>CI,]I\"H4
MA591)KLL9+#MY?4?E7F95EP2",],BO0)G*_ .Q8''_%02?\ HHTG&Z9+CS)G
M D^7)E1C'8U/#,-Z>8@*AP3[CN*@8;B,<DU*8C"%+C#YY1A@U+LR79HVO$FH
M:=?+;"PM!"47YR$VY]JQ5N61!L)0]"RGK5FSGEM+M+T6RR+&V2LB93Z&EU6[
MCU+4)+N"UCMT8#,<8P :QIQY+4TM.]S"E!4TJ25TNM^O8H[E"MP22>#5B9WN
M+.-R%"P_+QU-,M5@:8B=)&!4A53KN[5$J-YHA9MN3@^U;:7]#9V;]"4>0(-X
M<B4=%(X-1*J'<22./E&.IJ:]M!9R!!*LC=]O2H@\8A:-HOWA/RMGI0G=70XN
MZNM;BK&PM6E.X#.!QP:^A/V<O^17UG_K^'_H"U\^.UQ'&+>4,J_>"D8KZ$_9
MS_Y%C6?^OX?^BUK2G>YI2O<]6T+_ ) EI_N?UK1K.T+_ ) EI_N?UK1K4W"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBN(\4>.SX>O=7M7%G ]IIZ75H+N0J;V0ELQQ@=<;0.,G+#C% ';U\;?$
MS_DIGB+_ *_&_D*^PK.=KJQM[AHGA:6)7,;]4)&<'W%?(_Q M%NOBAXD5ITB
M NG;+?0<5$VDKLSJ248W9Q0-31F+8RLN6/0U#QNJ<*L;!B-Z]QG%0S.1$H <
M;NG>E=2Q9E1MF>N.!2?>)(_"O0=,\9:!:>&X[&:Q=I$BV/$(P1(<<G/O6&(J
MSII.$.8YL56J44I4X.=^W3S//\+'*,D.H(/'>M&739+JRDU.")8K<-C;NZ5G
M/AF9D4*I.0/05/!'+(&@:5HUQNVL3@_A6D[Z-.QM.^C3M_D0Q2F'E"<GUJ(_
M>S4C1L$W@':#@FHZT5MS16O<E,818W$BMN/('45Z1\<6*?$H,"018P$$=OO5
MYHI7 !4[MPP<UZ5\=/\ DHW_ &X0?^S4^@U\+N>?2R_:"\DSLTF.":LZ='8O
M'+]KFEBD ^0H.*SXW"$Y4-QWJ_I6G2ZSJ,=G%*D3R9PSGBL9I1@[NR,*B48.
M[LD9[#YCR3SP:FCC\N7]X <#M4UWIES::A-8RH3<QN5*H-V?I5:&*::<0Q*6
MD)QM/%5S*2NGH7S*4;IZ$T$WDW7GIC*-E>*Z+5-!FLXH=4N;Z+;=Q[D,0^7=
MC.W\N]8LVC74&GK=N4^:4Q>6#E@11?W\4UC:P0P21M$I$FYR58^P[5A).<DZ
M;\F<TTZDXND]-GM_6Y&TR?8C"8E#AC\U4V1@%;;UZ5+Y:FU,OF#<&QL/I217
M!B1QL#%A@,>U;)6V.B*M?E(*]*^)Y_XH[X=_]@C^D=>;/UR*]*^)W_(F_#O_
M +!'](ZU6QM'8\SZTY: ..M'2D2!QM]Z0'BG*NX^U-8;7(I +2XI!S4F5V X
MY%#$QI/&*:IPW/:EH')YH LWE])>LADP-@P *[>;_D@5C_V,$G_HHUY^0,<5
MZ#+G_A0=CC_H8)/_ $4:(I)6012C&R.%AD:&6.9 -T;!AD<<5?O]2EUF\2:X
M6./"[<(.,5!YZ21+%Y()'3%5AE3TZ'D&L>5-\S6J,.52ES-:HWH-7U.V\,W=
ME#%$]@TFQY2OSC-8&&D'RC..:MWEW%(H2VB:"(@;TW9#,.]3Z=J%O;V%S!):
MK)+*/ED/\-1&/)%RC'5LSC'V<7*,=6_ZN4X[@16X58\3*^X2=Q[5#<7#W,S2
MR$&1NI Q3[B VTJCS%D5E#;E-5BA9CBMHJ/Q(Z(J-^9#B21TY]:7DC?GY@:(
MB4?D9S2,"C_6J\BBW>W\]^4:8+\@QE17T!^SH0?"^L8'_+\/_0%KYW9R(=@R
M 3DBOH;]G'_D5M9_Z_A_Z+6G2BEHBJ,5'1(]7T+_ ) EI_N?UK1K.T+_ ) E
MI_N?UK1K8W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "O//&MKKLOB"&7PY!=&^CC0^=>-%]@3D\X<%M_J8\'IDUZ
M'7CWCD6$OQ#NX[^W\.S!=/@*#7[\Q*,M)GR@ ?3YL^@H ](\-76M7.DD:_:P
M6^H0RM$[6Y)BF Z2)GD CL?0U\K?%%(H_B3KQ#;R]RQ/^R<"OKNR"BPMP@C"
M^4N!$<H!@?=/<>E?'OQ-_P"2E^(O^OQOY"IDB)JYR-2AOW97/X4S!QG'%"'#
M@U#(>HHZXJS9RP)*%NDW0G[Q YJNH+S *,DG %2-;RBX\G83(?X1S4RLU9D2
MLU9B "2X(C!VEN![5>U1HQ=19B=2$&X$]15&2%X9=I(W=MIJ6Y^T1C%S$0S
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MD_PH.@:U_P! ;4?_  %D_P *Z5?BEXZ89'B.[..N$3_XFF?\+4\=?]#+=_\
M?*?_ !-5[%[G->)S?_"/ZUG_ ) VH_\ @))_A3_[ UK'_('U'_P$D_PKI?\
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M2F*74[U8Y'>E%TGNF_\ *Q6MM"WL@\E SMY\9^93T_"DFF^TWJ;]D0.%9D'
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M+3_<_K6C7$=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !115/5O+_L:^\VZ:TC^SR;[A#@Q#:<N/<=?PH \;NKJ$?%BXM9
MO#FF?;VOXS;1MIC&611(F9O.Z9*%WST79CK7JWB>#0/[(EO_ !%96ES9V2&4
MFXMQ-L'? (/)XZ5XEX>GOE\7:<EEXEU3Q)IK7* W1U*2S"?,."DC$2CU"CGI
MWKT_XHP/+X9+"/7IT!*O;Z0R@R _\],@G:,=0,YH G\&:EX5OKB[7PYHATYU
M13*_]FFU$@R<<[1NKYW^(_VBS^)/B%Q.T327#%<=U('%>^^!O[175;U)T\4&
MR%NFR77I(\^9N.0BJ/3')/X5\[_$S+_$GQ#R3B\;KVX%;X=-RT,JRNK') <C
M+8SZ=JM9+V9'#<YSGI5.I8F5G56!VYY [UUT)1NXVWT^\RDKZ@KN1M7/TJQ8
MVT%W+Y$DGERL?E<_='UJOD+.<9"YXI9 HX .[-0XW3;>W]:":;5EH!7;*T>X
M$!MN[U]ZT[T1V5W&;6=!YB ,5'W:S%,UI/NV%7'9A5B\N%NR9I@5F*JJA1Q@
M5-.+46UNOP(G%N2[%EK=65HVNX?)Y8L!\W%9R0-<3B.'YB>F3BA87CC6Y9,Q
M!NN,\U8U'4Y=4F6:2.*'8NU5B7%*;E)JZW"*DG9:K]?0IE2DFTCE6P?SKU3X
MVP";Q_A3\_V*$G/ QAJ\NVNJ)N7",<@^M>D_')-_Q#. <BQ@).>,?-2AHVNZ
M-GK'<\T9"IK0T?4+G3=1CNK218YDS@L,C\:BCG M)8VA1V8<.W5?I4 !VAU7
M('.[%)TE*-^AE)*<7&2TV-?^THYO$@U'4HH[M97WW$4?R@YX./>J]Y+:VNMS
M7&DH_P!D5LQ"<9('I5))GB8L@&<8Q5I;AGTV96A+%B-S[?N>E0J7-?EV2_ R
M]DHM-;6M;I;T+$.LW5X([.Y>)K596E$;@ !C[U7>SCBNS%/.GE$;V9.0/:J3
M)Y:X=2&/(^E2W$(DM8IXHW"#Y)'/3=Z?E6L'R:-;?(I4XQ?NZ)_U<;)*?FC2
M4M"><=*<PM38*5+BZ#_,#T*U=T2+3KA+FUNU<32)^Y=5)(8?2J4]A=VR@S6[
MQY7>-PQD>M.?-+W^]RE*//R;-?C_ )D 92 'S]1UKTKXD?\ (H?#L@@#^R>_
MTCKS5(]S[6.,C->F_$:$R>#/A_M(RND<#UXCJZ<:LY0Y8W=W;OI_7J;723/-
M7=<L$SC/'-,=2,$]ZEC81[HV P>I/:EN2"5 )( [BJE&-2$JDGKVVLV_\O\
M(A/6PR"0I)R <\"FW"%93D'/?(I$#$G Z<U+(3*NXD9'&.]1&\Z3B]]U^H;2
MN0"I%8CH3FF *$SN^;/2E'!K%IQ:?S&R4JIB#,^9">:BY!P#4YMIO)^T%,1D
MXSF@_P#'KP%)SR>XKHE3E.3NN5I7];?Y]?O)31!STKT"3/\ PH6QZ_\ (P2?
M^BC7 HQ5M_7M7H,S.WP(L">#_P )!(/_ "$:QY8Z7;OZ=/4OHSAHW5)$<IN
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M_K6C6=H7_($M/]S^M:-<ITA1110 4444 %%%% !1110 4444 %%%% !1110
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MR)DKH^85&"1FFXR>M?1W_#.OA_.3K.JGZ^7_ /$TG_#.?A[_ *#6J_\ D/\
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M5-J'*SY9+$-N7@'TIC-M;,;?E7T;_P ,\^']NTZQJA]/]7Q_X[3?^&=/#_\
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MVX<C/F_OFIV7" [ASZ5]$_\ #.OA[_H-:K_Y#_\ B:4?L[^'Q_S&=4_\A_\
MQ-.$X+1@X29\Y%LGGFA/OXS@&OHS_AG7P]_T&=5_\A__ !-'_#.OA[_H,ZK_
M .0__B:7M/>N]0]FSYZF@:'!)RK=#ZUV]R/^+"6(_P"IAD_]%&O47_9ZT*0
M/K>K''3)C_\ B:UW^#6D/X-A\-?VIJ MHKUKT2C9O+%=N/NXQCVJJ]2DZK=)
M6CYA"$DO>/F*#"@.2!CG![T^21'+,3D]L=*^@S^SUH+  ZUJF ,<>7_\30/V
M>= &/^)SJG'_ %S_ /B:T6)C;EMN1*AK='SZ9<JD0.%)ZD4LL'^E?9X7$O.%
M([U] G]GG0"03K.J<=!^[_\ B:<G[/F@HP9-9U0,.A_=\?\ CM.>(C-VOIM\
MO0GV,EL> /8O%:^8S!7+;2IJ.ROGM;V&48'EG&0,\=Z^A&_9_P!#9"K:UJAR
M<DGR_P#XFHA^SOX?'_,9U3_R'_\ $U<\132BJ?;6_?\ X<2H2<6IZGBS:%>:
ME'?7NGJ)[2,F1CP#Z\"L==0N4MA S;H?X%;G'TKZ0L_@C86%K/;6OB/5XH9Q
MB1!Y6#_X[5 _L[>'S_S&M5QZ?N__ (FL?K%Y-O165OZ[&=+#U;M5+-=._P _
M/T/G+.:^B?V=/^17UC_K^'_H"T__ (9V\/YS_;6J_P#D/_XFNZ\#^!K'P+87
M5G8W5Q<)<S"5C/MR#@#C 'I64IQ<;'7"+3-C0O\ D"6G^Y_6M&F111PQ+'$@
C1%& H' I]8FH4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g3dyckr3udth000034.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000034.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %8 BD# 2(  A$! Q$!_\0
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M ,31X$_Y)YX9_P"P5:_^BEKH* .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
MT*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@
MNA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)K9N
MKZTL45[NZ@MU8X#32! 3^-5X]=TB:18XM5L7D8X55N$))] ,T 9W_"">#_\
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M_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\
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M]9URX-M#!.Y\J-U.'8D<E<D>G6LG2I=<D_:#LU\06]G%>QZ4Z[[)V:*5><,
MW(],'TKHO$7@#6=5TG0;FUU"PA\0:-.;B-U@\NV<D@E=J\@<#GZ^M&D>"_$_
M_"R;;Q=KM_ILK"S>"2WM%=5B)Z!-P^8=R20>>E5IS7\W^6G]?\ 3^&WI^?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3'\+-(3X?2>#VNKN2T:4S+.Q7S$?.01@8X^E+^;SM^95UIZ_H<-X+\6:XOQ
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M4 %%%% !1110 5\ 5]_U\ 4 ?;_@3_DGGAG_ +!5K_Z*6N@KG_ G_)//#/\
MV"K7_P!%+704 %%%% !1110 4444 %%%% !1110 4444 %%%% !116?;:U8W
M%Y]C,HAO,%A;3?+(5#$;@O<<'F@#0HHHH **0$'H0<'!Q2T %%%)D9QD9':@
M!:*** "BD) (!(&>GO2T %%%4+[6+/3) +YS;PE03<2#$0). "W8T 7Z*165
MT#HP96&00<@BEH **3(SC(R>U+0 444A( R2!]: %HHHH **.@R: 01D'(-
M!115:\O$LHUDE21D+89D7(08R6;T QUH LT57LKZUU&TCNK*XBN+>0962)@R
MG\15B@ HI"0.I ^M+0 444$@#)X H ** 01D<@T4 %%%("#G!!P<'% "T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7P!7W_7P!0!]O^!/^2>>&
M?^P5:_\ HI:Z"N?\"?\ )//#/_8*M?\ T4M=!0 4444 %%%% !1110 4444
M%%%% !1110 444V21(8GED8)&BEF8G@ =30!'=W4-E:2W,\L<44:[F>5PBCZ
ML>!7FM[*GB#5K2..*Y:>YN%,NGWL1D2-.\T%PGW, 9RK<^@J7_A((_$,6S5I
MWTTS7GVK3$OK<"">(+B,;NA)/SX//(XK;\!^')M"M)WGM#9&0(@M5N3*GRCY
MI./E!8Y/ ],T ==&@CC5 20H !)R>/>JFL7DVGZ->7D%M)<S0PLZ0QC+.0.
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MBN1D4 >@6OVC[+%]K,1N-H\PQ9V[N^,\XJ6BB@ HHHH **** "BBB@ HHHH
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MRC'4J.<?3-<MI-W=>)M+M(K_ $K2-4T6[ !^Q-C['QPKH_ITRI!![4 3> -
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MO^O@"@#[?\"?\D\\,_\ 8*M?_12UT%<_X$_Y)YX9_P"P5:_^BEKH* "BBB@
MHHHH **** "BBB@ HHHH *HZSJ2Z/HUYJ+1-*+:)I/+4X+8'3-7JPO&?_(EZ
MQ_UZO_*@!HU7Q"0#_P ([%S_ -/Z_P#Q-5;]M5U2U>VOO"MO/"XPR-?KR,YQ
M]WI72#[J_044 8<>HZ]%&L<?AN%$4855OE  ]!\M._M3Q#_T+L7_ ('K_P#$
MUM9I: ,"XN];N[=X+GPO;30N,/')>JRL/<%:CL)-7TNRCL[+PO##;QC"1C4
M0OTRM='2T 8G]J>(?^A=B_\  ]?_ (FD.I^(2,'P[%_X'K_\36Y24 <OI\6H
M:5)</8>$K6V-R^^417RA6;UQMP#]*O?VIXA_Z%V+_P #U_\ B:VJ* ,7^U/$
M/_0NQ?\ @>O_ ,35#RM0&KC51X1M5OPA0SK?*&93V.%Y_&NIHH Q/[4\0_\
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M9M2\(VMS%G($E\N5/J#MR#[BKBZEX@10J^'8@ ,#_3U_^)K<HH Q/[4\0_\
M0NQ?^!Z__$U%/>:W=0/!<>&+>6%QAXY+U65AZ$%:Z"B@#FM/;5M*LDL['PM!
M!;1YV1KJ PN>>,K5K^U/$/\ T+L7_@>O_P 36W10!S\OB#5;.6U^W:$L,$\Z
M0&1+Q7*EC@'&!D9KHZY_Q3_QYV'_ &$;?_T.N@H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "O@"OO^O@"@#[?\"?\ )//#/_8*M?\ T4M=!7/^!/\
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M.?\ A,]%_P#!>W_QVNR\J#_GC%_WP*3RX/\ GC%_WP* .1_X2";_ *'31?\
MP7-_\=H_X2";_H=-%_\ !>W_ ,=KKQ%!_P \8O\ O@4&*#_GC%_WP* .0_X2
M";_H=-%_\%[?_':/^$@F_P"ATT7_ ,%[?_':Z[RX/^>,7_? I1%!_P \8O\
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M !1110 4444 %%%% !6)XQ1Y?!6MI&C.[6,P55&23L/ %;=% '.+XOT':O\
MIW8?\L)/_B:7_A+M _Y_O_($G_Q-=#@>@HP/04 <]_PE^@X_X_\ _P @R?\
MQ-'_  EV@_\ /_\ ^0)/_B:Z' ]!1@>@H Y[_A+M!S_Q_P#_ ) D_P#B:/\
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M#SSMJ$#!%A?H&R3R.@%=G28'I2T %%%% !1110 4444 %%%% !1110 4444
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M!L/^-']LZ]_T*LW_ (&P_P"-;>:7- &'_;.O?]"K-_X&P_XT?VSKW_0JS?\
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M &JN:)K$=U=NJR!LGC!KY-ET[7(Y2VRXR#U!->B_""^U23Q*\-VTA15_C[4
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M_P# J[_^*KNU/RK]!2YH X+_ (0W4_\ GTT;_P "KO\ ^*H_X0W4O^?31O\
MP*N__BJ[W/%)D4 <'_PAFI?\^FC?^!-W_P#%4?\ "&ZE_P ^FC?^!5W_ /%5
MWF1FER* ."_X0W4_^?31O_ J[_\ BJ/^$,U+_GTT;_P)N_\ XJN\W"C<* .#
M_P"$-U+_ )]-&_\  J[_ /BJ/^$-U(];31O_  )N_P#XJN\W"D+@#K0!P?\
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M %\ 4 ?;_@3_ ))YX9_[!5K_ .BEKH*Y_P "?\D\\,_]@JU_]%+704 %%%%
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M#WH 7Q5_QYV'_81M_P#T,5OUSZ^$;3[1!+-J&JW(@E65(Y[QW3<O0D=\5T%
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M!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\
MX,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@
M_P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T
M->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\
MBJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\
MT->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?
M_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$
M[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_
M^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^
M$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A
M_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ*
M* #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_
M /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'
M_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'
M_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@
MQA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_
M (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0U
MZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*
MH_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0
MUZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^
M*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3O
MP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X
M,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3
MOP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_
G .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JOB+RW_N-^5%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g3dyckr3udth000015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %A M # 2(  A$! Q$!_\0
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M35;: ']PQ8=V&&&T\=^V><+;^-?MGBK3=-L]-N9["_TX7T=VH48!*X)!8':
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M6VH:A_95U?6@OIH+5;,1@B*+",[EW4<N'P <XQQUI;OXA:;!8I>6UC?WUO\
M8DOYG@6-?)A?(4MYCKR2K<#.,'..,EF+F1UU%<[=^,K"RL]<N)[:[ T4(;E
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MM;C[=Y_V?2(-,V^5MW>4S'?U.,[NG;'4U>N]#^U>*-,UK[1M^PP3Q>3LSO\
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M.W;UX&.N*ZVBBY7*F<1;?#T0>)(=7:]MI'AOWO%D-D/M+AU<&-YMV64;QMX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH Q&\7Z K%3J4>0<'Y6_PI/\ A,-
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MRQF-P<ML&#GW_P *GZM)+W395T]SSFR>;3[N":&8HRMC<.37KVD73ZAI,,C
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M4YZBGR:!;7ES%=:BSW4R(HV,Q$08#E@G;/XUK44 %%%% '%>(21XO7 !_P!
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M 0UV[/(X&!D8R3ZGI5*3B9N-RX.$)N!N4C&=O/\ ^NH+JZ6TLV>*(SE0'BC
MR6/U_I6E(ZH,+@LV1US]:;<1V]M&-L1V\9'H/6NAW:T,TTGJ8VAZC-J=H;NX
MMW@)<J(I@$X!ZC_&M.623)=(R=I !..?4U(4M900ZQO(?XM_Y54,$B*D:W$(
M3^ZC?-GU%*$;1L4W=]B'7/[12W4Z5!%-+O*N))-JJ#U(/Y5'HG]HS[H-61(0
MBY1HV#*Q^IYJ:*_ABN5TV21A+*A:)BGW\<X)]:M""&\LE4-(K#T/.<<C%39\
MU[CO:-K#FW;A#YHG(Y.>/Q!I4CCD<%0=V< 'IFH?L"(8FAD.XG)R01GZU,T*
M.R98(P]1G)]ZT=K:$$$MR/,^2*/<N5#8Z4L#%BJ,"LA!.VG&/#G:59L_*!4F
MY%C*HZ^:3U;%9\KN7=6T L!DAPN!NW%N:A/G-A@%$?7+'K3I$#1DNL88#C;_
M #J%(55R&5D&>,-N!(]:V25B25I> C@,S<JPXZ'UHW*QVED8GAL'^E0M&1@A
M@6(R0#TP<_G4RF/Y7 !QG9N/3/7ZT60;!G 5<9!X/KUK,\07DUII):)<FXD\
MJ1L9VI@\?_7K7@*;6);#+U)JCJJQ_8+C@',3'CITXI728G=G>:;_ ,@JS_ZX
M)_Z"*M55TW_D%6?_ %P3_P!!%6J# **** "BBB@#C==*CQ?AQD'3U'_D1JKX
M5@^WID\>_:K&NKN\8+[6"D>_[QJ@DCD?;MVAB>%8XW>N!WJX[%(1@>JDE2 6
M]O:F(H53R0#U)X^GXTX29!EPJEC@@>GJ*=(H4 <D9SQV_&EL4B)OF#$#K_>;
M'/\ G^=,6)##O.>A!S\N ./QIY59-H<;@,'I69J\EX$.S_5$?/W*@4UJ[(M*
MXES)%/ T'G$H1L<=G'H:OK"\5O"L:1*"O,:C 'Y5QDVVW<[@VXIP"<+CU^M=
M+I1N%T.VCGD+2[,>8?0G/?VQ6U2/)%:E2CU1B^-=8_L'P_<7A;;(9$@M5)R7
M<]S[ <UX)(2\\AWERQ)+$Y)YZUV/Q,UI-5\2+:12,UM9KM'<&0]3^6*Y6& N
MNX?=7&[->74DN9R/3PU-J-F7= ODT[40\NTQ_P"T,_\ ZLUV^F:U9MJBWC7"
MQQJI5XT^;?QC"KZY_E7GC0, %)PI.<^GO3K2=]/O$N$^;9SBLXSE%MP>YO.D
MI+4^@=$\56>NHPM&FCN(ERR2J 9%Z9&#CKUK>M5-QM4H W/RMP4^M>&>'=>M
M-/UB*]$J001Y=@YYY!R,=QS7KVC^(+#6(#<6,Z3<89%.'0^X//M7>JU)VC%_
M>>36P\XZV-*/]UJL#R8VQL5...O\7ZUTH*[RH/.-V/:N=C4 /F,%F.USZ8[&
MH[S5'TY([F/#L&V*K'[P[BK?O.R.64'(Z8US95D:1"0&#E1Z'GI]:J_\)_:^
M4/\ 0;D3$9P<;?S]*FC92/M D9Q.-ZEA@=>AH<6M)#A3E'5CBHW Y<;SSQV'
MUIRL$8E<;<<#')-/#B5&8D,P&T^A]J%V*<MN4D<9)(_&I5NA;OU(4+'6=+W
MC%ZHY'L:]"K@ 1_:6D  _P#'XN25QG@]*[^B6YC+<Y3PJP'AFT+N  9, \8_
M>-6HUW&/NY;Z"N<\.'_B16_U?_T-JU#T[C/0XKJA37*F>56K2YVD6S>>D?YF
MHS=R'H%7Z"LB'3KF.;S&U>Y(+AWB"#:_'(YR1G'8UKQV[. 3\H]Z:26Z(<IM
MVB[C"[R'#$MGH*GBM>AD_P"^:G2-(AP,>YZU*D;R %5('JPQ4RJ=C6%%MW>H
MW@=![  59BB$0,DA ./7A12!(K5&FE?[HY9N@^E,"/>D-(I2W'(C8<O[MZ#V
M_/TK!NYV1AR^HD6;V59W!\A#F)2,;C_?/]/S]*;/,)#G.$7I[^]27$V28E/3
M[Q_I63=W*X/.(UZD#J?ZU=.',S*O54%8S;[7M/@O6ANKI(2J;BS?=7G&">QY
M!K:M)%:VCDC(8<,,=^]9JIF1I7BC5V&/N MCW/?H./85;BBG4[E4BMG%VLSC
MA42ES),T3!<RR,\6I2*A/"")#CVY&:C?2WDOHKR26)YX00CM -P![9!J+[3@
MXEBP?44];F#KEE_.L7"1V*O!_P##EP"\[O ??81_6@QWC#FXC7_<B_Q-5A=)
MG(G8>W7^=.^VC_GM_P".U/)+L:>UI]R5(;Q ,W@D_P!^(?T(IVV]Q_K8,Y_Y
MYG_XJJ_VT?\ /8_]\TANT)YF8_I1R2#VM-=?Q)GM[Q_^7XI_N1+_ %S0T#1K
ME[^<=,DE!_[+522XA*\%C47VC<?W<63ZU2IR,W7@O^'+,TBL[OSMP!S[5FJ2
M#D$@CI4S1SR'+#\,U#)&X^4DHW4$#/\ ^L5O!**L<E:3D[V-&"8LH=3AUZC_
M #VJS(GVE5EA;;-']TG]5/L?_KUAPW#)+@@+(!DCLP]1[?RK7AF Q(G(/WA_
MGO6-2%G='3AZRDN5D\<BW<3*RLDBG#(>J'_/>H65D;:X^C=C4TL(F*S0OLE4
M?*XY!'H1W%-CN$E;[/<($GQG8>0WNI[_ ,ZR3ML=$HWT96>%9!R,'U%5)(7C
MY/(]16J]LPYC;/LQ_K43 QC#J5'J>E:QJ'-4H7,X2.OW78?C5'5-6GMDAMH'
M1[NY?9$CC(Q_$2/0"MB2W1AE?E/Z5S7]BI?:K=7>HVV8]P2%&;Y6 4#?P>^!
MC'I5MJ2T,8Q<'>3T-RUE2U@6&&.)8TX"H, '//ZU:%W&PPX*UGVMI'!"EM:Q
M+'&@PJ+T JQ]FES]S]13<8]254G?343P9_R*-A]'_P#0VK>K!\&?\BC8?1__
M $-JWJY#U@HHHH \OM].M'O_ +=) IFCN)=LA)X^=A_6MD?=.?D(& :JZ>0$
MN#M7/GR@$_\ 70U8P<!"V,\8(X/XUFVV]3=;$<D$>[=\Q.,]>1].Q%8YUB!)
MS;,)2HX$QZ=?\:W'PRXW8?\  _E7.2^'7>YR'54SDM[9Y_&M:<HM-3+BD22O
M/!XAMM@?RIX6$I'3>".<?2M4*V1G(QV[&J]]8226V(R%ECP8V]".E-TR_DO+
M7]\FV>,[95/'/K7&])6[FCU5T3>2D;B15&,\XI;R-8C%<_>0'DXZ#UJ9FRI4
M#-+:*SL\<IW*W&#W%#5]!7MJ(K-&S*"#G'7H:NB',#2O+^[';TJG)"T "CYU
M P#W %2V5PHF,3X*-@@'IGM5IV>I,E=70@C,BE48$ 9Z=/6J=_/::?:&\OG\
MN+(#-R=IZ9QV!IFK)>69CO;$.Y#$20]F'J/YU!):?VO&1J2>9%-'N9"W &.1
M1*K).Q48JU^A:N=8TBP^QK-@?;1B';&.>>_H.15P6,>&D5@&0[0N/6O+;BY'
MB+XB6%DI>WL;#"LQ/R*J<\>@)P/P%=T;R]L3>M?!(K6WF(69VX=" <^V/ZTH
MUIIZ@Z2Z&I+9M#*KLL8D3@,O 'M[5'Y31R97?&2<G;P#3DOUCM25E64N05;J
M *C^TREMP<;6YQVK;VR)49$A.XA-SY!X)X JRMO'G#2G=MP&(R,4R!XW8+,H
M]!VP?6GF6))-I!.T'\*I.^Q+OL9FI7JZ7%$&Q)+(" J_*#CJ3[53T_5([FY$
M,T:QN_(V<C([?6E\6:9-J%I!+ ,O&&4H>Z'^1_QK.\.:3.NH"XN(RB*Q8)G)
M)P!T]L5JG!QWU*BO=.HCAA:)561I"O+<=?;%(3&!YC*1G@!5W?Y-*&B$OF#A
M0<+VP<>G>HI[V"VC4S%=F RDM@_4]LU+=M2-6R4QPC"# ;DY=<XXZ8J6$916
M92N1D)M _6LNRU"WNG=+:Z281@G;$VXJ.W':M..39M1E8,0 V3G:<=/UI.5U
MHP::W$V1@#,?WN3GK5>^P=,NMO:)^OTJQ+(V[/&#^=17BK_9-Z&!+"%\'/48
MK)O4;^$[?3?^059_]<$_]!%6JJZ;_P @JS_ZX)_Z"*M5H<P4444 %%%% '&Z
MZ1_PF2#&=U@H'_?QJS-0MWFM%ED4RR*^ @'3C[PSSVK2UX9\9)C&?L"XR/\
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MNR+L5I/,8/QGG XZ\?3WK4%L_:%1]2*D,=\PQ]J@4^H@/]6I$MKO'[R_)/\
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M>HHAYE3M;3L>CZ;_ ,@JS_ZX)_Z"*M55TW_D%6?_ %P3_P!!%6JZ#A"BBB@
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M:]N[RZE;2[BZV/#+91VTXQ^YCC(2,9(R7Z,#C/ [U-=)=P6]Q%8M_I#J&B+
M?>SANOY_CWK.O-&;4999[::YC66,(P650&QGKP><TEE8-IMZ\PF9PO[LF6;*
MC+<\ <<X_&L[,UNEJ3V-QX@GN(IKBW@BMY&^://S1C'N,DY'_CWM5,Z&T$09
M;V>%Q*S2(%.Q\ONQZ#AB,^_MBMVXN+F(Q)Y49,K[ 5;)'?H<9X![U3OKV.RM
M(YY%N[D/*(G53AER"<E1_GH:$K;C;OHC*6SAO->O'>2=KN I&[*8U#97 (!S
MGC//8CCFK\VA6SQVT,UFURJ?ZR:8AG(SWQSGG@BG:?<Z?J.FL[)- BE5=97(
M*MA6&#GGJ.?7-6X-1$2$7C%$"[DG="@<8SR#T8 =/RIQ;6L2)I/W9['.:IX5
ML;EH[?2[GRII&'F1M-NVQ]&8*>3CCN*I2Z/KGAP&6SED:WZLUMD@>[1G/YC-
M=+IEI%>W$NN1SR%KM5\DLFTQQC^''<$\_E5N\N;^,0I:P1M-N^=6? *]RI[D
M>G%;0Q51/WO>7GJ<M7+Z,E:'N/HXZ'+6GC6\6-1=6L%RN/OQML)]\<BKH\96
M.S<=,GW^F4Q^>:S=7T:X735UAK:.WD;+75O$#A03P^.Q_O#\>QKG9'G# 1(A
M&Y>21]WG=WZ_=Q7H0HX:K#VD8OY'AU\9C\)5]E.2?9M;G22^*[F>[21K*#[/
M&<I 9#UZ9)Q@\9XQW[UT.D-I.M6YN4T^*.1&VR1NBY5OPX(]#7GD32ECYJHO
MH%.<<GC/?@ Y_P!KVKN_!EH8M+DNV4@W3[ES_<'"G\>3^-9XNC2A2YHJS-LJ
MQF)KXATZC4E:_30G\&?\BC8?1_\ T-JWJP?!G_(HV'T?_P!#:MZO*/I@HHHH
M \^L&01RACC-Q+GCI\YYJRSA-QVY7/52./>LZUC:0S=-HGFZC/\ &:LI%)%A
MB53VSD&H:5S>*T)8U61'&[Y3D8Z9%5]/TB+3H%CAE>3)+$N^3S_*K MYD9G;
M#9Z8&,5(2(\-(<9. 1WJ&E>Y=WLB, )*53Y21P<Y'--+R#;NW88]?I_2IEC\
M_JOW3S\W2FSAEXP&P. 16A(V!FB 9DRSMNX_SR*;<6,<J-N&8V.=C?YXJ+$X
MD4(JE2>6!S5P'<H4'J>,=:4DNHU=:HPK;PUI]E<?:A$A95Z8^7/TJC:WJ:1?
M7UW?/F>9@$0<@1C("^W/-=3#$&2X#'#H<UY;KUS'=:[,5D+8!4C=C'/ZURU+
M1LXG13]^Z9KZ]K=MJMHL4;[ #N//((_QKGFD21M[$A@.O8U48C< $8^G/:B-
M@3ESA>WO[5B[O5FZ22LCO]#M[6_\.[$)6;=LFV-@GKT/;M4FH>&U_LVWCT5(
M[>02QM+*?O%%/.3W-<YX6UE=.N9B^\1OM/R+DELXZ=Q@FNR_MB**4@PY@R58
M@_,!ZXKIHP4XM6U1A-RC+0T9!AC@XII3(P.O0>U+*NR1!DE?+!!]:ANRWV8E
M>@X8UJHW=C(9;7=K<R./,4M&QBVN0"6']/YU))C:VTXZC)8?I7.W"F81Q1H#
M([A4QQR>]7_&331^%[B*W11,PVALXSSSD]JJ5X*]RN5<UBY8_9EB(BNHI!NP
MVV0$D_W3[U=$BI'B%@<_PL*\N\.Z1K?A<V:1E':[99)(U.Y2,X'/L,DFO4O,
M20@$#@]3WK.G4OH$XVU&EC+CSHU8C@A.U,+[025R1SCIBD#7(NXL,AA"L)%_
MB)SQC]:L$AQG@@=#[5HG?0C8\S^)WAY[Z"*[L;5IIW(4)&,GGO7,Z3\)=6FO
M8_[2G@@@"AFVMN8G^Z/>O9Y=JW"Q[ $;G<.G/^%4O[0T^:_FL(;U&O(#S"I
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MG#CL#3Q<5&?39G)Z7X6NKV4'4%-K:]61F DD]L#[H]3U_G7?((XT5$VJJC
MZ >E.'6EJ*^(G6=Y&V#P5+"0Y::WW?5F#X,_Y%&P^C_^AM6]6#X,_P"11L/H
M_P#Z&U;U8'6%%,DECA4-+(D:D@ LP R>@K-35Y+G46M+2PN&C1F26YD79&A&
M>F>6Y]* .2L(]Z3E<[A<2@_3>:>[ 2;2N .-RCI4&EF2*&3S)-SM-(K!1A<[
MCT]LU?VN':17B)]!G\ZB^IO'8ACF,0*!\J<@G.?T/2EDEBG5 R'(]6QGWI61
M,?O%& .W:F^3NVF-E)7ID8./3WHO%E$D%RD)D5LE2203]/6B2Z\P<,RLN&!
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MS;E[;CG'T%;OV:II+<UE)21H1J$/F A]P*@XP1[U*UNTW\+L#@\# ..U-4G
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MJN[)8Y)S[<D\]*8C35@RAE.01D&FR1I(NUQD=?H?6L>SU,-J$]M$J[D>021
M\@KMR1_WWWZ]J?K&LS:=!#/;VGVB$AVE8MM$:J,\\=?;\.M T[[D&JP7WGP0
M6<TOD/*KW3JPWQ(O.!@YYQZ&MBW.]YI,$?/M'N!_DUS>@W%T=<O)9K1Y5O7#
M)>*K!-@3*@ C@#I]370P1BUE:$%BDC%TSS@]Q[#T_&@5K,M45DZYJ=YI:PR6
MUBUU&21(%SD= O(Z<GT-/TN[U&YFN%O;00(N#&0#\V2W'7L OY^E(HFM[:".
MYF41)N7&UMO(4\X_/-5KQ72RNRA4%)UE&1Z%6_QK1'_'U)_N+V]S5"^/^BZ@
M!U)4?B0M6MS)_#]Y7-IX@-U-B^MA!)(> IW(N,#;QP>^/7O5S3HM4C>3^T+B
M"9?^6?E+MQ]?\_XE\NJ645X+0SHUTP)6!3ES@$]/\:I02ZQJL,XD@_LN%U B
M?<&F!SU(Z#C/N*@U*/AO4;33/!-A/>3K%'AP">I.]N .I-7Y;S5-1MK=])B2
MWCE#;Y;M2&3!P,)WSU%4O!-E;IX8M9O+R\C-(Q8Y^8,0",]./2NFH RSH-G/
M>1WEZINKE$4 R$[ 0.2J=!GK6I110!Y[8G"R \9N)N?3YS5HN$CW' '\ZH07
M5O#%,C,WG>?,0H!.1O-3SRO)#%&V00N=N.16$I:NQTP3LB!G(R3@ 'IFG17J
M*>3GU-4[MQM4;L9Y_*HMY5=SCM@Y!XIPIN6IJTK'20S0W,)5E'(X_K562W5L
M)&P)Y8'&>!679W94AD^Z3C!_E6S%<0LI3:JEAUQ0VXLAQL567).5!X^7Z>]+
M$DB.PV%2QW#'/X?C3;NZ@6Y2&>[@A8\ %@"?IFG1)) /FE:12>Z[3BJ51[6"
MV@JA(KI9B@\Q28V/J.V?\]JIZL]K(GV66S>9749R/EZXZ^M:@Y^9\%LY QU7
MM^54[BV6X+"0;44\#TSWI2BVM!Q:O=GGVO\ AJZTZ=7LXVE@DXRHW$'L*U]#
M\'1>5]IO+W?,5X1%!$)([^XK;U_39-4T.\T^WO&MI)$.R5,@ ]L]ZJ>&;/4-
M/TN'3[UHI'ACV&9!\K'/7]>_I6#I\LE=&WM&XZ&+KK0^!/!%Y+'<SSW4S"&*
M9Y,MN8=NPP,FO+?A_<,GC*S9C*6=FR4/.2.IKN/'=M?>-(!%I.Z:/3I"&A5<
M*[D=CZ@"D^&OA9]+N7O+Z&2.[9&B*L!^[4C[V/4\BJ;CR:=2;2YKOH=#I=G'
MH$%O;1*+EGF8SOG 12<X_7-=8UG%-L$@&Q1PJ\ T0Z?;0N[1Q*"YW-QG)QBK
M/&TD#..U6HKE2L*4KO09&H*L< MNR6QCD51NFM-6BELUE;S$P7VY#)QP:N7$
MDD &R,NS@#;G'-1V0>0227)C21V^X,96E)W=A+3WB+3[?['9QP[F<(,9;K5P
MX"D]*:$VL0748/K4:EG8Y'RKV[@?XU:BTK(&[ZDJG#*2"V*(7DEG\O:0A!SN
M['_.*:7&U3G*_E5>]MWNDC:&5X)(7#!D?#>_U!HE%I70E9F1JXGN/&.EVT3.
MJQ1.TA4_*<]C^0K6O]-_M$0$SRPK#('(0X+X' -)J-W8Z;(+R9B7D&/N?,V.
MPK(T?QK:WNH+:SP&%I9 BLK;E)/;-.-%N+DUHQ\STMT.H=@\<:A=F#^+&L$J
MK1ZI=FR\B1T:/><_O!@\X/2M]V*\&,\-P>M5M2MU_LRZ>,D[8FR?7@TK)M>1
M%[)G<:;_ ,@JS_ZX)_Z"*M55TW_D%6?_ %P3_P!!%6JU.0**** "BBB@#B_$
M&?\ A+ACK_9Z]3C'[QJB5 \$14;#@C+#OBI]=&[QBJ\DG3UP,X_Y:-4*8,S,
M6+< '?TSVJUL:1V'C.WA0#MR5/7CK[TR4#RVD0D <[0.G/\ +FE/FJ-G4. .
M1C\O>E24NQ&T@DX!)SG%)HM::DH+;092",\<=/;%-"+*G!P&;H<D#V]OI3!)
M&BE0LD;YX&/T]Z<")/,\LJ"<\=,FBS ,XA:-3E<?-@<*/:F37";4CW<C@*O0
MTQ742 'A\\'&:?Y@9R,*"IRQ'7)]Z8[$)G(D?Y!RHW'.:\'\?6)LO%UY#!@H
MY690&^YN&2N/7->];,S[@I4H3\QY/K7B_CO9-XGNL#Y6=%>0C/8#\/\ Z]<N
M,:C%,[<#?G.H^%-J$T.XD92)KBY&Z3&?E"\#/XUZ/N/EL6SO)* @=!ZXKC/!
M,$UMX:MFC4"25F9<# QG )]^*ZN-_+5BV\MZ<UIAT_9I]S'$:U&6L+'%EF;<
M>"3R??%0-96K3+)LW.PY\P\9]ZDA02J-S!6SCKBG%25'5 ,YSQGWK5>AA\QJ
M,(@P!9G/"\_*/6H.7&&.<=,$]*=@G80#R#SC%13B/8_G,?+/!'>HU;-$DA1Q
M]X @D  ]J/,D^9%+%AR>V:H3ZM!;H3\J1\8:0YS]*GAOENE7:  1\K!L@_\
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M/.?M$7'_ (]63BVS>,XI")&V>058'KWI#NQCJ=V./_K4XV&NG_F#./I/'_\
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M)%LU31B<,!=J%;OC!KNZF3N8RW.?\&J3X5LSN8<R=,?\]&K>"G^\QK#\&?\
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M33\R79Z%])G69O+/VV\'R,X^6.(9Z$\X]P,D_P K<-AF5+B[<3SJ<KQA(_\
M=7^IR:P[;3_$\*) +VRAABB 7;"&#MWR.,?A^0K3N3X@25?LJ:=+$$7=YA=6
M+=R,9&*'+L-0[FKL7^Z/RHP/0?E69-?ZI%J'E)HYEM=P N%N5!P<9)4\\<_E
M0NLM_:1LVTO4%'F%!/Y.8S[YSP*DLTL#=T'3TI<#T'Y5E6_B+3KF]^R*\J3G
M.%DA=<XR3SC'0&I[76]+O2PM[^WD*J78!QD*.IQZ4 4/!G_(HV'T?_T-JWJY
M_P %.A\*6*AE+*'R >1\[5T% !1110 4444 %%%% !7.>,O%]OX+TJWO[FQO
M+T3W(MUBM$#/DHSYP2. $-='7.>*]*N]4NO#C6L ECM-72XN,LHVQ"*52>3S
MRRC R>: )H?%FF3ZG):K,HMTTQ-4-XSJ(?)=F .[/HA)/3%:@U"R,\< O+<S
M21&=(_-&YHQC+@9Y7D<].17FUGX!U:TNO%6F1QQC3+G2);#2[EI<E4D+L(F7
M.0$:1@#C[I [5'/X>\5Z^ZM+I(TEO^$9N-,5I+M'*W#%, [,X4[3AAGC.0.
M0#LKSQGIRR:6-,N+34DO-373I'M[A6$+&-WR<9Y^3IQUK6&M:4VK'2EU*T.H
MA=YM!,OF@>NW.:XY]-U;4HO#6/#ATTZ;JL+S@S0G,20RJ7&UN5#. !UY/ K-
MTWPAJT7B)8M3369K>+6)-2@G@N+46PR[,I;*B?.#M*C(.<9VT >BQ:MILZ6C
MQ:A:2+>Y^RLDRD3X!)V<_-P">,\"DL-9TS57G33M1M+MK=]DPMYE<QMZ-@\&
MO-M#\.>)85\':?=Z(([;0)KB.>X-W&1,IAD1'10<[6W#K@@GIC)KHO >FZOI
M7VJTGM+NTT:*.-+&WOWA>>+!;<H:(D&,#:%W$MUH OWWC2PL/&5GX;D@G::Y
M"@W"@>5$[K(R(W.<L(GQ@&M2YU_1K.Y%M<ZM8PW!E6 127"*WF, 53!.=Q!!
M ]"/6O/]0\&^)=0T?7-2\Y8=6N-1.HVUB4C.7@8"W'F;N,I&F>?XCT[&O>#-
M1UC3O'DK:+$U[JZ6QL@[1%F*01@C=GY=KANI'3(]: .NUGQCI]AH-WJ>GSVN
MI?9;J&VE2&X4['>5(R&(S@C?G'M5BZ\3Z?\ V5<WNF7=A?\ V>=() M[&BH[
M.%VLY. ?FZ'DG '6N-\6>#-1OI/$J:7I-N\-];Z8D,9=(XY3#<,T@8=@$QU'
M(X&>E0:CX7US5CXAO8=#73_M;:;##:>=%ND$%P'>0[3M VGC)R=IX'&0#T$^
M)-"&K?V2=9T\:EN"_9#=)YN<9QLSG..<8J>+5M-G2T>+4+21;W/V5DF4B? )
M.SGYN 3QG@5Y7X5O;==?TZ2\:>19M<U);*.!XBJR/),2SK_K,!0W7@;@3VQ:
MT3PWXGB7P=IUQI(MH-!FN(YKS[5&V]3#(B2(H.=IW#@X()Z8R: /1[;6])O-
M1FT^VU.SFO8/];;QSJTB?50<BGQ:MILZ6CQ:A:2+>Y^RLDRD3X!)V<_-P">,
M\"O/O#WAG64?PG97FD"S;P^[//?^;&ZW1,;)^[VG?\Q;<=P7IWJMH?ASQ+"O
M@[3[O1!';:!-<1SW!NXR)E,,B(Z*#G:VX=<$$],9- 'I-AK.F:J\Z:=J-I=M
M;OLF%O,KF-O1L'@U=KB_ >FZOI7VJTGM+NTT:*.-+&WOWA>>+!;<H:(D&,#:
M%W$MUKM* "BBB@ HHHH **** "BBB@ HHHH XS7B!XP&2!_Q+UZ_]=&J-)&B
M^9!O8C[W3/U%2:^57Q@NX @Z>HY_ZZ-4)CS]W SW9J+:&U/8K7VOV=HZ).^R
M;@E=M2_:DDCBD@R8V.T%.WN?:F3Z?%>6[17$2E2<\?,?P-):64-I;F"$MM!R
M%)Z?X53C'E\S5<O0NVLZI)YAPJXXIMS/)J,T:J(S;D\A3DM]?\*H:F9DM@L?
M"]&7.2:J:=(Z1RL)=LB-U*\5/(TKC44_>.Q@C58 $"H!Z"N;\0WHL-1CV LT
MB@J21U']:T!J>Q,LC#(X(&1_^JL^YV74J-<P[@6(Y/ S51:3O(SA%J5V<])J
MMY+<K&%<R$] >0#_ #KA/'KW&J:Q#;0@RQVB;)6 QA\Y(_"O6DTY8GWHJ"3.
M$&!QFO%=5>2YU&Z!:1IIIV",P W'?M'_ (\*XL;)JW+U/2PK3=^QZAX&M$T[
MPE:Q1AB'S,2>>6;H/PKHE<*GREC\V" >U06&GMI^DQ6)E+M$ "Q]ATX'2KK
MJAC1R#MX(_SQ731C:FDSCJ2O-M#6\M\J@VKU'3-(((T);>5'!!]?J:8JD*(D
MP?,Y,A'4^GX5.F%4KY>%QZ<FM+F8((R3&Q(PV<YSCZ&AV4R #DGH2,8Q38T&
MS& ,GC'Z@T]@Q7#!@"-PR<9/I4JX/<B^ZWF?-M)QN)QBG.8TD(8)DCA64'\:
MJ/=+#JFFQ[@L<SNCY'\6W(_D:OW<01?- VDN"VWJ:>J5T-[V8*L88_NP@/RY
MP*4_NV_<X0=,'OVJ%9'<-N8?=R?\*1,DKOVE0N'QWQTJKDV$DP=4T<[<'[8G
M?V;M7=UP<BD:MI);K]M7OTX.17>5+,)[F#X,_P"14L_K)_Z,:MZL#P:P'A6S
M'/63M_TT:M[</0_E2)&Q8\L;1@4^HT8!0,-^5*9 /X6_[YH ?2'JOUI-X]&_
M*FF0;@-K=?[IH DIDL4<\;1RHKHW56&0:7>/1ORI/,_V6_*@"A]FNK#'V1C<
M0#K!*WS+_NN?Y-^8J2*ZM+Y_+8;)UZQ2#:ZX]OZCBK1EQ_RS<_056GB@O8BE
MQ:M(N3C<HR/H<Y!^E5>^Y/+;8;=/'IUJT\MY+'#&O)8;_P"F3T_G5$:I9W$Z
M0"XFD=B H=MBG.<9QV((QGJ,4^ZT^::$P!I)[9OO07.3GG/#@[OSSFJJ6NGV
M<@>YTR:.2/&PL=\9]/FZ<?[6,=J:78ENVY=!+R[8(XYIE'+$8AC_ !_BZ$<<
M_2FRR1PEI#(;B8 D22?=4=RJCV.#BIC:2W2[H[N-()"2Z(@D5OQ/YUGZ)-;Z
MD\GE#4%*J#YDVT!@20""/H?P%.Z)Y7T'JZR3!YUN7C/+8A<YQTR0,>G3L.:M
M.\U\/(A0Q6^/F(.#],@_*/8<_2LS7[>Z2\@-M<0G]V=L4BM+,7/&Y1R ,?A]
M*U#:W-\?]-79;=K2(C!_WV[_ $''UIW6XDGL8[6G]K64L%I=/%)"#$CQ<,R!
MB0Z= PYQSQD=>,U!%ILS31O->W DC96\J-6P2I_ND[AGD^F6/45U$EK'.H5H
MV4HV49&VE/IC^72H)#)$FW4(%N80>)ECR5_WE_J/R%*ZDQ\KBBBD[P[HY(9-
MCC)BFB.#W()QC/ODYZ =JMQYP?LS[@3N:WG.0>I^4]CG'7H!T%0:@T=G913:
M?;RW"2R;6$$KD*N"=V!GICTJA8"]NK_RS9W5G&"RK.K!@"!DG#KD9R.?P[&A
MR0*,C1GO;>UM6FE)\N$X:.8'>@) &#UQQGOD57BURT:X2 _VA%E@-S<A20Q&
M3UY'(_"IKF:&%6M9]FI;CEXE3=+]<#CC\*(],9Y(Y8+"WLB@PCNH>11[#[H/
MXFAH$_O-)X[6U0RSNN!UDF?/\_I4!N[J]XLH_*CSS<3*1Q_LKU/U.!]:?%I\
M<<WGO&TTXX$LS[B/IV'X 5;#-O<;>F.]3=%V?H0VMC%:LT@+23/]^60Y9OQ[
M#V&!5JF!G[IC\:7+?W?UJ6[E));"O]P_2EIC%MC<8X]:=EO0?G0,6BFY?T'Y
MT OW4?G0 O\ %^%0&QM#OS:P_.I1SY8^93U!]C4NYM^ HZ>M+E_[H_.@#E/"
M6C:?<>%(7DME+W*,LS!BI<!SCD'V%:T?AZU@M)K:UN+VW64J2T=PVY<>A.<5
M!X,_Y%&P^C_^AM6]0!D'2;Z*Q\BUUJY67S-XGF196QC&W!P,=Z'@UZ*TB2&]
MLYKA68R23PE0P[#"GBM>B@#(FN->@@MRMC:74I4^<(YB@!SQMW#T]:+G5[VU
M\G?HMU+NB5Y/(97V,>J]LX]:UZ* ,FY\06UG=?9Y[>\0D+\_V=BG(SU%2?V_
MI0U V)O8Q=!Q'Y9!!W'MTK2IK1HY!9%8J<@D9Q0!!'J%E-,88KRW>525*+*"
MP(ZC&:L @C(.0>XJH-*T];L72V-NMP"6$JQ -D]3FJMMX:TJSG:>UMVAD92I
M9)&[C!XSC- &M161;Z%]D6<0:GJ/[R,HHEGWB,G^)01UHBT_5H+:=!K)FD;;
MY336Z_N\'G..N1Q0!KT5D(OB"*R?<]A<7(<;.&12N.<]>:&OM9ALED?2$FN"
MY#1PW  "X^]ENO/:@#7HK(EUR2VM8)I])U#=+NW1PQ"0QX/\6#W[43^)=,M$
MA:[EDM_.0.HDA;(&<<X'!^M &O15%M9TR-T22_MXV= ZK)(%)!Z'FK8EC,AC
M$BEQU4-R* 'T444 0K:VR3M.EO$LS?>D" ,?J:FHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** .(\1L5\7)@-S8J#MZXWMTJ$2R##*"6+''.<BK6O%
M1XQ4,<;K!1G_ +:-52X=X-S!&60@,J?[/3KT%7%)HV@]"R7?;G:!@C  YZTW
MS(OND;9,\FF)<+(?EWN%.[);@9'3ZBI##'<!HY$RRDX;/44))/4HCVMY.T*I
M4]AR 14/F%'W+M!4\ 4L,?D@(CLW)(D[CV(]*EW(')< ,PW$YP!3>FA2$!7R
M_G*?-VQP!36A1]X'#]<D>WO3=DBJ),+LQA><,:EEWB(%&!7&[(_S^%1?J,YW
M7O$_]C%6\LN^<(I/+$=?:O+8;M/^$B_M)U9564W!X! .<X]NM>G>)O#S>(;.
M+[/+Y5U!D)Y@^5P>H->3:I8'3-0&EW4<<4D/#1K)]XD^OM6.*A3=#F;U.S#R
MULD>W7^KBRT];HKN,X7RXV'\1&>W;O6;9>(!+*$O% !(^<#!'.!GGD5/K6G-
M?Z7'"#YAAV; HYY'0>_2L73- OVOT+Q.L)8%FD7H!V![]/UKKP\8NE>6Y@U'
M4[..T$$\LX,F\D95FR,#CCTJP&!8,Z[2W3U]ZC8J8U4*Q()#=MQ'<>HJ4-A?
M+.XJ%!'.2/QK)N[,A&)B&R94"MT=1U&*CW 188EMHZYQD#VISX=0#@@@;6P>
MOM1L$AV,7,@'! !X^G?%&PB"Y@6YAV%,J2&0.0,,.A]O_KU;D'F6P5^&&/E'
M)!]*Y75_%J:<Z^= 7.2%C Y(&><^E7?#?B*QU^-VCADBEC8!X7ZC/0Y].U/E
MDX\S6A;BTC06ZVKY3QLKN3UX;C]*FMW(8/\ +MZYSQD?UJ6Y0A_,C'0X8'G=
M[#WJ&62-)2K,X0Y)W#[OUHYD]";7"52FL:2"Q8&]4ACWX-=W7GR;CJ>E$G(-
MZF,@9'!XKT&D]SGG\1QGAGQ)I&G>'[>TN[U8IXVDWH5;(R['T]#6O_PF&@?]
M!)/^^&_PK<HI$&$OB_0 N/[23_OAO\*7_A,- _Z"2?\ ?#?X5N44 8?_  F&
M@?\ 023_ +X;_"D/C#0,C_B8IP?[C?X5NT4 8?\ PF&@?]!)/^^&_P */^$P
MT#_H))_WPW^%;E% &'_PF&@?]!)/^^&_PI!XP\/C/_$Q3K_<;_"MVB@##_X3
M#0/^@DG_ 'PW^%'_  F&@?\ 023_ +X;_"MRB@#EGUSPJ7,B7J12-U>$.A/U
MP!FC^WO#V-O]MSA?0,P_4+G]:Z=W2-"\CJBCJS' %(98UB\UI%$>,[B>,?6G
MS,GE1SMMXB\+698P7D2,YRS;'+-]21DU9_X3#0/^@DG_ 'PW^%;:L&4,I!4C
M(([U%=WEM86DEW>7$5O;Q+NDEE<*J#U)/ %)NXTDMC('B_0 3_Q,DY.?N-_A
M2_\ "8:!_P!!)/\ OAO\*W <C(Z52EU?38/M/G7]M']E=(Y]TJCRF?&Q6]"V
MY< ]<CUH&8KZ]X6:5I5ODCE;[SQ!T)^N!S^-,;7/##QE9-4DE'I))*1^5=51
M3YF3RQ['/0>*/#-M'Y<%Y!$G7:D3 ?H*E_X3#0/^@DG_ 'PW^%;E%(HP_P#A
M,- _Z"2?]\-_A2#Q?H 8G^TDY_V&_P *W:* ,/\ X3#0/^@DG_?#?X4?\)AH
M'_023_OAO\*W** ,(^,- ((_M%/^^&_PI?\ A,- _P"@BG_?#?X5N44 8?\
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M;GFIH->TJXMFN([^#R58*SLVT GH#G% &C1445S!.@>&:.1"<!D<$$^G%2T
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M<#/. .36E10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/ %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g3dyckr3udth000042.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000042.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $E ;X# 2(  A$! Q$!_\0
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M>+)9[+_24C6+3&4C:&5LI$3C*+\PZA<@4 >M:KK>G:)]B_M&X\G[==QV5O\
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MW7R_,"Y)82Y'4X3'H:GL/ T.F7>HR6FMZHEKJ-])?7=D5MVBE>0C>N6B+A2
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M;RNDH5A&SIEHG964[?X6[$<$'#K[X9:!JUU++JK7E^C1R1QQ7$H;RA(06PX
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M+9,T>QQCS6(Q\Q4X[XQ[C2\'N)/#%K(&N&5]S!KB^%VY&X\^:"0P],'CIVH
MW:*** "N?\0_\ASPG_V%7_\ 2*ZKH*Y_Q#_R'/"?_85?_P!(KJ@#H**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O.OB-?:7)J6FV
M%W>:?<"-)7FTRXU4V6XG9LD+CIMYP#C.[(Z5Z+7G7Q"866I6,X:>6XG#!%6&
MSQ'&&B0C?-&2!N=3U[L3@+P =-H6HPV?@;3+Z]U'[7&MI#ONT5W\XD  @8W,
M22,<9.>F326WC"QGNEAEL-7M [A(Y;K3I8XV). -Q7"_\"QUJWX9NC>^%M*N
MBQ8RVL;DG;GE1_="K^0 ]*\_^'6L7-YXJGL9-;CO1!%+([)<SS"Z+"%=X#H%
M4!D<X!X\S X!- 'I=YJ5AIYA%[>VUL9W\N(32JGF-_=7)Y/L*6WU"RO)[B"V
MO+>>:V;;/'%*K-$WHP!^4\'KZ5R7CCPSJFM:C87>F[&,4$L!624*B,SQLKNI
M4B1!Y9!7OD=>S=!\+:K9:]>W$\BVT7D74,5S X:20S7+3+)M92 4! PP89)Z
MCJ ;%G_R4/6?^P58?^C;NN@KD]"LY['QUK<5QJ=WJ#G3+%A+=+$K >;=_*/+
M1!CC/3/)YZ5UE !1110!%=75O96LMU=3QP6\2EY)9&"JBCJ23T%5-&UW2O$-
MC]MTB_@O+8.4,D39 8=0?0\CKZBJWBSPY;^+?"]_H5U+)#%=H!YD?5&#!E/O
M@J.._2L/X<?#NW^'FEW5K'?O?3W4@>68Q^6,#(4!<G'4]^: .UHHHH ****
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M61LL[(V,C(Z')" 5/X/UNVF\)M<W5^6:S:;[5+/=I.4".X+%U"@IA20<#@4
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MC$@ Y%>P5RJ^+;F\\36UAI>G_:K$@"YG)=)(&);(92GR%0H^5RK'<,#BNJH
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M_P#0UZ'_ .#&'_XJN:\=7_@+QCX8FTZ^\5:45C;[1&+?4X0QD53@=3G.<8H
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MU6Z<C@ XKOX(8[:WC@A79%$@1%'8 8 H DHHHH **** "BBB@ HHHH ****
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M&1_S]A4>EZ58Z+8+8:;;1VMHCNZ0QC"J7<NV!V&YCP.!T&!0!<HHHH ****
M"O/]=N[^Q\0R3N-5$YU6QBLWB>06B6<CP1R;QD1,Q=YUP0THW*P 559?0*RY
MO#VF7&J#49()#/O61D$\@BD=<;7>(-L=QM7#,I(V)@_*N #4HHHH **** "O
M/_'UW?Z?_:M\HU7;:Z5Y^EM9/(L:7*>:TK3;2$*JH@;;-D, P0,2RGT"LO4O
M#VF:M<+/>02,X3RW"3R1K,@)(2558"5.6^5PP^9N/F.0#4HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g3dyckr3udth000023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000023.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $M HD# 2(  A$! Q$!_\0
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M@DJ<;0* /7M<\0Z9X<M[:?5)Y(DN;A;6 1P22M)*P)5 J*22<'M4^FZM9:O
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M/) X%>3?9[K_ (55_P (7]I_XJW^T<^7M'FY^W>9]HV_W-OS;NG;-=3\;?\
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MYQG#@[=_&XX!;:.P&!C?HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#R>"*ZCPWH]WIOC^^N;Z#4Y7O+.W=;LN?(9U0B0.H8@-G&!R!DXH [^BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X#XE:-8
MW3:)>3)+Y\NIVMH[).Z;HF<[EPI YSUZUD7'B/7-%TC4&L[BVCT^TU?^R+=3
M$#]FC!'[UY';!.,+\Q R<DUZJRJV-R@X.1D=Z:8HV1D:-2K_ 'E(X/UH \BO
MOB/K5G9Z7++>V G\M9ITC1&CFC,_E[_,W]-H)PF[!R2<4P>*-9T.'7$76H;B
MX.N>0XEC4&TB;D3?,V K8"KG"YYS7KQMX& #0QD!=@!4<+Z?2E:W@;?NAC.\
M8?*CYAZ'UH \8\1^--:O/#+6M[J5A8>=H\LXDA&_[<^]DVQ,&PIV@$XS@MZ5
MM>,K2XU/Q3X;LH;/[<TFF7#>0UZ]LNX>7ARR\Y&?UKTTP0L%#1(0@PN5'R]N
M*?M7<&VC<!@''2@#R_\ M?Q7X=MK^Q:^AOY-"T>&>56A+O<RL)!][.=HV@],
MG'O6IX3\3^(=2L)7-M::PJW:Q">VNHDVQE 26"EER">@.<8[UWFU=Q;:-Q&"
M<=:;'%'"FR*-47^ZHP* /%M%N9(_%?DZ??17VK73WJQ7D=Q*)HW 8J+JV?C8
M" H(P.!BMFQ\:^(M:LK&YM9K>T2^U&+3D\VVW%&$#-,V,C.)!@?[M>ES6<,T
M<Z@&)YD*-+$=LF",9##D'T-0Z5I%EHNF0:?90[+>#)0,2S$DDEB3R2222?>A
M >6+X_\ $\.B/?3W5C(TNE/=Q!;8J(GCN%B)/S?,&!)[8[4W4/$NKWCVLC>)
MK06%EKD<']J06X6&4/"6^;YL81OEQG!)&>17JFJ:/8ZQIDVGWD.;>4!6"':<
M AN".G(%6_L\/E>5Y,?EYSLVC'KTH \L;Q_K:WU[MN;1W47ZMIX@_>62P(QC
ME<YY#$#J #O&*(O%_BJ*??/?V$L,4VG-)&MH5+I=<% =QQMZ@]Z]4\F+>S^6
MFYQAFVC)'H:/*C_YYKV[>G2@#S/Q3+H\GC?4(/&%]+:Z=%I\;Z8#.\2,Q+>8
MR[2-T@.W Y..@K,C\6^+=/T"W:2ZB26QT>VOITNK?=+-NF9,,<C:2@4GC.:]
M?DABEV^9&C[3E=R@X/K2M&C$ED4Y&#D=10@/*[[X@:W9:GXBB1[>X:TBG:VM
MXH@ZH$9 &<AMZD!B2&4 ]C5.3Q'K=\NAWEWXAL[6TBU=[<WD0C>-P825,FQR
MH.25VYQR#U%>OB&(2-((T#N,,P49;ZFF_9H!"(A#'Y8.0FP8'X4("6BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHK%NM:EM[J6$0H0C8!)--*Y,I*.Y
MM45S_P#PD$__ #PC_,T?\)!/_P \(_S-/E9/M8G045S_ /PD$_\ SPC_ #-'
M_"03_P#/"/\ ,T<K#VL3H**SM,U&2^:0/&J[ ",'UK1J6K%IIJZ"BBB@8444
M4 %%4]6O7TW2+N^CMS<-;Q-)Y0<+N &3R>G%8#^-XX8VNYK%UT\/)$)ED!8R
M)&9"-F.GRL <]1T .: .KHK&T[7O/>[BU&!+&:U6-W!F#IMD!VG=@<Y!!'J.
M]3_\)!I.]E&H0,5^]L;=C\JF<XP5YNR'&+D[15S2HK-_M_2_^?Q/R/\ A1_;
M^E_\_B?D?\*R^M4/YU]Z+]C4_E?W%RXM+:\14N;>*=5<.JRH& 8=",]QZU-6
M;_;^E_\ /XGY'_"C^W]+_P"?Q/R/^%'UJA_.OO0>QJ?RO[B\\$4DD<CQ(TD1
M)C9E!*$C!P>W%25F_P!OZ7_S^)^1_P */[?TO_G\3\C_ (4?6J'\Z^]![&I_
M*_N-*BLW^W]+_P"?Q/R/^%']OZ7_ ,_B?D?\*/K5#^=?>@]C4_E?W&E16=_;
MVE_\_:_]\G_"@:]I9_Y?$_(_X4?6J'\Z^]#]C5_E?W&C16=_;NE_\_D?ZT?V
M[IG_ #^1_K1]:H?SK[T'L*O\K^XT:*SO[=TS_G\C_6E_MS3/^?R/]:/K5#^=
M?>@]A5_E?W&A16?_ &YIG_/Y'^M78I4GB66)@R,,J1W%7"M3J.T))^C)E3G'
M62:'T445H0%%%% !1110 4444 %%%% '+2ZG>K-(!<-@,0.!Z_2F_P!JWW_/
MPWY#_"JTW^OD_P!\_P ZY35=>OK*[UN&*&>5;>V1X7CC4K"Q4DELGI^?2ME&
MYPSJ..K9VG]JWW_/PWY#_"C^U;[_ )^&_(?X5R2>)S]NCLDLI)WQ&CR*<#S&
M0-TQPO(R<\9Z56M_%-W!HUE=7UBK-<%_WHE"IA3W.,*>P!],YI\C(^L+N=M_
M:M]_S\-^0_PK<TB>6XLV>9R[;R,D?2N7!R 1T(S71Z#_ ,@]O^NA_D*B2T.F
MDVY&I11169T!1110 54OM2M=.$!NG9!/,L,>$9LNQP <#CGN>*MU2U/3UU.V
MC@:0H$GBFR!G.QP^/QQB@"BOBS1G65A<OB, K^Y?]Z"VP&/CY\MQ\N>2/6M*
MPO[?4K47%LY9-Q0AE*LK X*L#R"",8-<XO@D!(5.IR,;)533SY0_T<*X<;O[
M_P!U1VX'KS6M9:!!;V+07$CW$DD[W$L@8Q[I&.20%/ [ >U &MD4F1ZURMGX
M5TR]:[FF%P6^TR*/](?@!L =:L_\(3HW]RX_[_M_C63E5OI%??\ \ F\NQT.
M1ZT9'J*Y[_A"=&_N7'_?]O\ &C_A"=&_N7'_ '_;_&ES5OY5]_\ P O+L=#D
M>HHR/45SW_"$Z-_<N/\ O^W^-'_"$Z+_ ,\[C_O^W^-'-6_E7W_\ +R['0Y'
MJ*,CU%<]_P (3HO_ #SN/^_[?XT?\(3HO_/.X_[_ +?XT<U;^5??_P  +R['
M0Y'J*,CU%<]_PA.B_P#/.?\ [_M_C7%^(_#NJ:+_ &O>V<5C=VD$1N88)I90
MZQJGS#*]6+ XSQBIE4JQWBOO_P" -*;Z'JNX>HHW#U%<5X>T;PSXCT:'4;%I
M98W^5]LL@VN/O+SSP>*U/^$)T7_GG/\ ]_V_QJN:M_*OO_X KR['0[AZBC</
M45S%QX-T>,P[8YAOD"G]\W3GWJ;_ (0G1?\ GE/_ -_V_P :E5*K;7*OO_X
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M3@ 8 [57MH(9-:U,R11N<Q<LH/\ #6K6=9?\AG4_K%_Z#2:3W!:;%O[';?\
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MI><OE-#<R(A!SN4X/X=JRP_\-1[:?<$'9)=BY/:PW.WS5)V].2,5R-Q$L/Q
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M "BBB@"CJ,$(T^X811[O+)SM%71T%1W,/VBUEA#;=ZE<XZ9J'9?X_P!?;_\
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MDJQ/*R*6$:$9;'89('YF@#-MFU6>:Z0WMJ/(E\L$6IY^16S]_P#VJL>1JO\
MT$+;_P !#_\ %UEZ?XICO+_3H%T^:)=1@$\4C.F?N!B2H.<#A=WKQ71T 4/(
MU7_H(6W_ ("'_P"+H\C5?^@A;?\ @(?_ (NK]17,KP6TDJ0O.Z*2L4>-SGT&
M2!^= &7 ^K37EW ;VU @*@'[*><KG^_5KR-5_P"@A;?^ A_^+KGE\>6?F0I]
MB99Y9&64>=& H5PF0^</DGC'H>E=A0!0^SZK_P!!"V_\!#_\75:^TBXU.U:U
MOY;"ZMV(+13V.]21TX+UL5#=S/;VLDT<#W#HN5BC(#.?09('YT <GX=\--H>
MLZX-,GM+9)Y(7>*.SVQJ1'CY5#<?XUT7V?5?^@A;?^ A_P#BZYY?']BOE2/9
M.@<_OG$J$ >9Y09#G]X,C^'H/RKL: ,_[/JO_00MO_ 0_P#Q='V?5?\ H(6W
M_@(?_BZT*KWUTMCI]S>.K.L$32%5ZD*,X'OQ0!GQMJTFH7%K]NM@(D1]WV4\
M[MW^W_LU8^SZK_T$+;_P$/\ \76,?&")IT.HG36>.27RI3#<1N4.0 O!RS?-
M]T<\'\>IH S9+35)(V0ZA;X8$'_1#_\ %T1VFJ1QJ@U&WPH '^B'_P"+K2J&
M[NHK*RGNYR1#!&TCD#HJC)_E2LKW'=VL9@;5CJ;VGVZVPL*R[OLISR2,??\
M:K/V?5?^@A;_ /@(?_BZY]?'=LUO%<?80KR2F(E[F(*BA0V6;.!]X<'^7-=@
M#D9]:8C/^SZK_P!!"W_\!#_\71]GU7_H(6__ ("'_P"+K0J.=Y(X)'BB,LBJ
M2L88+N/ID\"@#*#:L=4:S^W6V%A$N[[*<\L1C[_M5G[/JO\ T$+?_P !#_\
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M)%KB6L4\\T<,$PF9(F*ER 0!N'( )SQZ5QY\ 7AOC:-.LFFFW%OYSL=X41%
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M-EE.(R'!#GG@>O0_E4M !1110 4457^WV?VI[;[7!]HC7>\7F#<J^I'4#WH
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M4 X)&<#G!K4H **** "BBB@ HHHH **** "BBB@ HJB^EQ/(SFXNP6).!<,
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MV<'=MJ&Q\0:Q?7-J2\J1:D\<$*^5@Q/"1YYZ?Q#S ,_W!BN@?Q7:*S,MK=/
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M0!)1110 4444 %5Y;&VFD,DD*LQZDU/D#J>O2@$'H<TTVMA.*EHT5?[,LO\
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MKK=K=J0%X8($"CC[N!TK8J*"XANH1-;RK+&20'0Y!P<']14M !1110 4444
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M"1%H9 I0C_EGN*8/7UYJUX=T3S-09TTJ?2[!+2W26&10IEN8WW;L<YP!@O\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g3dyckr3udth000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %/ 9T# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y3Q#XGN=$\16=OY:
M/8-$)+@[260;MN[/H.*ZNN>OM'EO?%D=Q+ 'L&L'MY6+#J6Z8Z]*J%KZD5+V
MT%7Q!Y?B#4H+F6%-/M;6.<28]>I)[BGIXMTN:TNIXGE+6\8D:-H6#%3P"!C)
M!/>N=L/#_B#3FU@1HDK_ &98+.60JP=5;C(/?;ZU8T;2=7CUJ2YNK6<)=61A
M:6>X5V1AZXZ ]@.E6XQL9J<[[&CI'C"TN]'ANKUC%,S)'(%B;;O8D* >_2M.
MYU_3K22\CFF*M9HLDXV$[5;I]:Y1=)UM_",&F-IH2?3IXY(R9E(N-K$G'IVZ
MTZ]T?6]277KB33EADOK6)(8A,K<J>03QSBFXQN"G-):'0-XNT<6XF6=W5I3%
M&$B8M(0 3M&,D8/6H+OQ('?1)--DCEMKZZ\EV93D#!R/8Y%1:W::P4TJ.QA<
MP1KMN!;R+'*#@ 88]!ZXK*TW0=6AATF"6SV_8M2>5W\U2&0Y.X=SUQZTE&.X
M.4]C>UG77TO7M*M7DABM+D2><\O&,#CG/'-4I/$\LVJ:Q#9W-HUM:V0GBFP7
M ;OD@\@>@JSKFCRZEXCT>=K5)[.#S//WX(&1QP>O-9]SX<N8]4UUK*RCCM;G
M3_)@$950S]QCM]:2Y;#?/S:;&I_PE-C965H;^XWW$ENLTA@A=E"G^(C'RK]:
MKS>,;:+Q(FG@%K4PAC(L3L2Y(QC'5<'K61J&AZJL=FUM83BY6P2#S[6Z"$.!
M]V0'AE'M6E-9ZS::]INI+9B]860MKC9($VMD$MSVJN6-_O)YIV^XTI/%>C1:
MB;%[O$@?RRVP[ _]TMC&:?-XFTN#4&L&G<W2OL,:QL2.,YZ=,=ZY>30=9&FW
M/A];%&@GO#,+\RC 0L&Y7KNXQ70Z1IUQ::_K=U/$%AN&C\IRP.X!<'Z?C4N,
M4BE*;=OZZEJ+Q%IDT5C+'.66^<I;X0Y8CKQCC'O6=K>J:K%XAL=+TU[6,W$+
MR%IT) V_0UC^%[ /XJNUCD26PTQY#;,AR-TI!(S[#(K5USP^VL>*-.EGMS)I
M\<#K*PDVX;MT.?RIVBI!S2E%E%_%NI)IMX)([87EG>Q6TCQY,;ACU'O6[?>*
M=(TZ]-I<W)$BX\PJC,L>>FX@8%4=;\.(GA^.PT:R1<74<K(K 9 ;)))//%9U
M]I.L02:Y96NGI<PZM)O2X,H419&"&!YX[8HM%_UZ"O./]>O_  #2N/%\$'B<
M::0QMQ%EI%B9B9"1@#'5<'KTK7U36;'1XXWO)2ID.V-$4LSGV YK!DTW4]+U
MS3+NUM/MT45BMG(1($*D$?-SVJUKME?IKFG:S96HO/LJ/&]OO"G##[P)XS2:
MCH-2G9W*^M^,8(-'MKG2Y5D>ZE\M7:-F$>/O$CKD>G4U-K.LZAIGA&&_A>&:
M[<QC<8BJMN/]TG(K+7P]JAL(I'MU6XGU=;V2%7&(4^O<_2MSQ9I]UJ6C+!9Q
M^9*+B)\;@. P)/-.T4TO,5YM-^1F:AXQDB\)VE_;(AO[@[/*(R%9?O\ 'M@_
MF*@N?$VJL=$C@GL+=KVU,TDER"$##WSQ3Y_"4XU+6;F(!X9+>3['%N&!+(/G
M^G3]:2'PU<S7OAX7UBDEM:V317"N58*^.!COSZ52Y/Z]&2_:?UZH;K'B36='
MT[3YO,L+R2>63>UNI*,BX/'/7K4WB?QA+IR6(TL1R-.@F=G7(6,X []R?TJ]
MJFAEM1T-;*SC%E:RR&5%PJJK+CIWR?2L"3P9?P:)J$,:_:+A[B-( 7'$"-D<
MGIU/'M2CR.UQR]HKI&SKNIZ]:27$T!L+2R@0,CW)W-<'&2  >/2I#J'B'4;#
M3Y+"S@M&N(O,GEN<D1'^Z%Z\]:K:_!K%S+/;/HUOJ5FZC[*X<(T#XP2<_P Q
M5*^TOQ&--TO36AEOK:*'-V([H1F5LG"ECS@#'UI)*RV&VTWN:>B^*Q-8!M4V
MK-]L-FKP*621NQ'H*ZBN<TZ34[33[:"'P[%:HMP(S$MPI"1XY?/<Y_&NCJ9V
MOH:4[VU"BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ JO+?6D#E)KJ"-AU#R ']:L5Q7C_2K#^RVU#[+']L:>)&FQ\Q&<8_*
MJBDW9DS;C%M'8Q3PSJ6AE210<$HP(_2GEE! + $] 3UKC2+FUUFYT;PXEIIT
M=O +F9FBW>8QZ#&>!@#FLVXU#4]<N?#-[%/#;O,\BHIBW!)%!#-UY!'0=JI4
M[D.K9;'HM,$L9E,0D4R 9*9Y ]<5Q6O^(=4TNXG$>H6K-;)&3;QV[.7SC<7;
MI'[#-7[!O,^(-])C!;3HC^M+D=KC]HKV.D-S;BX%N9XA,1D1EQN(^G6G>;'Y
MOE>8GF ;MF[G'KBN*UC0Y+"]N=5N);46BW2WAN"#]H7&,1+VP3P/K3M)U:VT
MV\N;K4X9SJ%TZ&ZF6/,=J&_U<1;M@$9]S3Y+JZ%[1IV9V<LL<$9DED2-!U9V
MP!^-)#/#<1^9!*DJ'^)&##\Q7-^,+">^.F^0MO<&*8N;*>4()^.V>N*R+/5K
M71+77;BWTF2POX51I+-I,Q9/"LN.G7FDH75QRJ6E9['?T5R5QJ>OZ'I-W?:A
M+9W:"%6A,:E"LC'&".Z\]:C_ +9UK3+QK/4)[:X>:QDN89(XMOELHS@C/(HY
M&'M$=C2,H92K#((P0>]<._B'7+?0+2^FEMWEU%HTMUB@+>4""68CJQ/H*VO#
M.I:C>F\AU"*0^2X\JX>W:'S5/^R>A%#@T"J)M(U+"&PM8FM]/2WC1&^:.' P
M?<#O4Z3PR2M$DJ-(GWE# E?J*\ST^_;P]K&HZPP+6D]U<6\J@='7YD_/D5-X
M=6[TO5-9N)I(5O6L4N'>X;:BNYW?,?09JG3ZW(57I8]*HKCM"UO4]0U&ZT]K
MV.;_ $030W/V4QA6)QP#]Y??O4GAC7M2US4'BF>WCCLDV7 3!,TF2,KZ+Q4N
M#1:J)G6T5SFKZS>V>HO#!?:'%&%!"7<S+)SZ@=JT+%WU;1B+N:VE,H9&>QD.
MS'3ANN:7*[7*YE>QH)+'(S*DBLR'# ')4^],AN[:X=DAN(I&3[RHX)'UQ7FC
M[])T+Q5#9,\:K?)#OW$LJ'@\]?Q]ZU]4TVRT*]\.3Z3$L,SW"PL8^#,A'.[U
M^OO5^S1G[5VV_J]CM);NVMW5)KB*-G^ZKN 3],U-7!Z5IUEKC>(KO5HDFN%N
M)(@9.3"BCC;Z?_6JYHFI7:_#9KQV9IH8)!&YZD+D*?\ /I4N%D4IW?W_ ('3
M+J-DRR,+N#;$_ENWF#"MZ$^M317$,X)AFCD ZE&!Q^5>>:G9QV_PVTE$19#+
M<0R.#_RT9LDY/OG%3Z<B:-XKDFN-.72V:R=HK6W<.DVWDDD=",=,57LUJ2JK
MNM.WXGH%%<-HWB76KR]L99(7GMKLMOC2S=%@_ND2=&'K3M*U[6+[4/LEQ>0V
MMU,D@%M/:,OEL/N[&Z/[YJ73:&JL6=A/>6UK!Y\]Q''$#M+LP S]:G!R,BN%
M\*V%Q>^$[R*[GBDLIA,HB\O#!]QRV[/KSTK;\%W4MWX3L7F8LZJ8]Q[A20/T
M%$H6N.,[VTW-^BBBH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *HZKI5MK-E]DNM_E[U?Y&P<@Y%7J*$[":NK,Q]4\-6.JW*W,
MCW$$^SRVDMY2A=/[K>HI+OPOIMWI]I9A9;=+0Y@:"0JR>O/O6S13YF+DCV.>
MG\&Z9<27#227>+A%65!.0KD# 8CNWUJ_9:):V-[]LC>9Y_LZVY:1]V57IGW]
MZTJ*?,P4(K6Q2U#2K;4WMC<[V2WE$JQAL*S#IN'?%4[OPQI]Y?M=RF<>8RO+
M"DI$<K+]TLO?%;-%)2:V!Q3W,W5]#LM:CB6Z$BO"VZ*6)]KH?8U7M?"VF6UI
M=V[++<?;!B>2>0N[CMS[5M44<SM8.5-WL8-KX1TNVAN(G^T7(N(A"QN)2Y"#
MHH]!2V?A33[3SSON9Y)83!YD\I=DC/\ "OI6[13YI=PY(]C*F\.V$^BP:4ZR
M>1;A?*</AT*]"&]:FTO28=*CD6*:XF:5MSR7$I=B<8[U?HI<S#E2,@>&M-^R
MW%L\;R13W/VIP[9^?(/'MQTHNO#>GWMQ?33K(S7L*PRC?QM7ICT-:]%',PY8
M]CGX_"%C%()4NK\3>28&D^T$LRGL?IVQTJS:^&]/L;NUN;59(9+>'R $; =/
M]H=^><UKT4^:7<.2/8K3:=8W$ADGL[>60\%GB5C^9%2PP0V\8C@B2*,=%10H
M_(5)14W'9&9%H&GQKJ*F-I$U!R\Z2-D$^WI5;3O"FG:==QW*M<SR0KMA^T2E
MQ$/]D=JW**?,Q<D>QA7_ (2TW4+R6Y9KF%IP!.L$Q19O]X=ZU/L%L-.-@L2I
M;>68A&O0+C&*LT4-MJPU%)W.8M/"[2^'ET759"\-O-NMY('*L5&=N>.",U=L
M/"VG6%V;H?:+B<H4$ES,9"JGJ!FMJBFYMDJ$48=CX5T_3[I)H9;LI'N\N!YR
M8H]W7"TMCX6L+"\AN8Y+J3R-WD12S%DBW==HK;HHYGW'R1['-R^&386=^NBR
MR)-=J4"33'RHMQ^9E&.O6MC2=.CTG2K:PB.4A0+D]SW/XFKE%)R;5@44G=!1
M112*"BBB@ HHHH **** "BBB@ HHHH *8TT2ARTJ 1_?)8?+]?2GUR=WIS0Z
MG=2K8NUF+R&:6-(\^8OED$@?Q88@D>U-*Y,FT=.;F!8//::,0D9\PN-OYU("
M&4$$$$9!'>N1CM)(KF*[EL93IOVN:1;?RBQ0,H"L4ZXR&XQQNK6TBUO(=%6-
M"+5C*[QI*F[RXRQ*KC(QP1WXIN*2$I-LV:*HVLEVM]);W,T4H$2NK)$4QDD>
MI]*O5+*3N%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HI&954LQ 4<DD\"H[>ZM[N(2VT\4T9. \;AA^8H E
MHHHH **C^T0_:?LWG1^?L\SRMPW;<XW8ZXSQFI* "BBH_M$/VG[-YT?G[/,\
MK<-VW.-V.N,\9H DHHJ.>XAM86FN)HX8E^\\C!5';DF@"2BHTN(9)I84FC:6
M+'F(K LF>1D=LU)0 4444 %%%% !1110 4444 %%%% !1110!27_ )#4G_7N
MG_H35=JDO_(:D_Z]T_\ 0FJ[38D%%%%(84444 %%%% !1110 44A( R2 !W-
M5+V_^RF-(XC+(X+ ;@H"C&22>G4?G2;25V!<HJ"UNH[NWCE3*[P?E;J,'!'Y
MU/0FFKH HHHI@%%%% !1110 4444 %%%% !1110 4444 8WBPQCPMJ!E25T\
MKI&<'J,?AGK[9JKH3M#JFO&Y)DF22)GE@C;RV'E# 5<D[AWQDG(KHB RE6 (
M(P0>]1V]M!:0B&V@CAB!R$C0*!^ JE+2Q#C[USEM4UV[75KE;6Y:&WCTE[M(
MY8-I,BN1T<!AD#\NGK4VI:W?*J>7_HN-+>_.5!W.NW]WSVYYQSR,&M.71(KC
MQ!_:DQ21/LHM_(>,$9#[PV3[^U:,MO#/M\Z&.38<KO4'!]1FGS1TT%RRUU.3
MO=3NEU>XG1$AE'A]KD9B4NC[LXW8S@>F<>U02:QJ,UG-;O=N#)H OQ(BJK+)
MW P.A_,=L<8[&2SMI9&DDMH7D>,Q,S("60]5)_N^W2D2SM8Y%DCMH4=8A"K+
M& 1&/X1_L^W2GS+L+DEW,W2YIK?P=:W&9+F9+%91NQECLR!QCZ>OKD\U@6-]
M</XA34'87$Y\/B?:H ^8ONV\>_%=K##%;Q+%#&D<:C"HB@ #V J..RM(9O.B
MM88Y=NS>L8#;<YQGTSSBDI+4;@W8YS1]:U.6WEEN(VF!L!=H&:(,7Y^550YV
M'C!89X.36?KUU-=>!;B:?4(YGN+:WG-OM4-&6=<XQSM[<@G(/-=7YFDZ6\J[
M[*T=AYTHRD9()QN/3OQD]ZE_LRP\J6+[#;>7,VZ5/*7#G.<D8Y.?6GS).]A<
MC:M<Y+5M5O+";Q9-:O'%+;_8_+=84W?-@')Q\W7OG':KEWKU_9?\)(BXG;3U
MA:$E1QO7)SCJ!U^E=%)I]E-YWFVEN_G[?.W1 ^9M^[NXYQVSTJ1;:!99I5@C
M$DP E<(,O@8&X]\#UI<R[?UH/DEW_K4S-"N[V>2\@O-S>2R^6\CQ&0AESAA&
M2 <].F01[UL5%;VMO:1>5;0101@YV1(%'Y"I:EN[+BK(****0PHHHH ****
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M]1M+F,O',N%&6#?*5QUR#TJ:&>*XC$D,J2(>C(P(_2NI23V+)****8!1110
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MLD-.Y9HHHK884444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ)!1115C"BBB@ HHHH **** "BBB@ HHHH **** "DP/04M% !1110 4444
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M.VNEG3S3Y;,T43.2D1;J5';.3^9JDU;4AJ5]#1HHHJ2PHHHH **** "BBB@
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MR%:=-M=!13ZA1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(<9-LDHHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@"*:W@N4"3PQRJ#D"10P_6I%4*H50 H&  .E+10 A /49I:** "BBB@ P#
MU'2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g3dyckr3udth000028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000028.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $, CT# 2(  A$! Q$!_\0
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M]WH .?Y9K N?AQK.JV-\=3U'3?MDMI;6$(M;=HXA#%,LF7!))8XQ@<"KNJ^
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MI$&U%7T&*6@$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK1HH SOM.K?] VV_\"S_ /$4?:=6_P"@;;?^!9_^(K1HH SOM.K?] VV_P#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &=8?\A35O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOY-6A65ITS3:KJ#-!+"=L0VR8ST/H36K0 4444 %%%% !1110 4444 %%%%
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MUZ]JF4E!<TMA-I*[-2BJ>EZC%JNG0WL(94D'W6Z@@X(JY334E=#3OJ%%%%,
MIKNJ#+L%&<<GO4;3Y?RX1YC X8CHO3.3Z\YQ1'!AA)*V^7'7L.F0!Z9&><F@
M!H,LY!&8HN",CYFZ'OT[@@\U+'&D2!$7"@8%/HH **** /./#?@[Q)IOQ NM
M6O;\263F0EO-),P;[H*]L<?3'%>CT454I.3NS.G2C35HA1114FAG6'_(4U;_
M *[)_P"BDI9_^0_9?]>T_P#Z%%26'_(4U;_KLG_HI*6?_D/V7_7M/_Z%%0!H
M45RR:[=GQ&]E)J>G+$+GREC6TE)(QG89=VP2>WZ5U- !3%BC1W=(T5G.68*
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M/<^M=/1T#J%%%<OI6C:K;>(-2N9Y0(Y_,VS[PS'+Y3"]MJ\'.>V.] &Q:_\
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MH!G X[5Z%6-"M&M'FB1":FKH@\J9OOSX'HBX]?7/J/RI?LL)^^ID/JYW>G^
MI)KZTMWV374$3XSM>0 X_&IE974,I#*1D$'@BM;HL H484 #V%+113 ****
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M0[2)4F153 6>-8W')ZJO _"M&A@%9VN?\@F3_?C_ /0UK1K.US_D$R?[\?\
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M[$QMRXQ+-(W'(4[1T'ISVSU[T]((D.5C4$DG..>3G^?-245H4%%%% !1110
M4444 %%%% !1110 4444 9UA_P A35O^NR?^BDI9_P#D/V7_ %[3_P#H45)8
M?\A35O\ KLG_ **2EG_Y#]E_U[3_ /H45 '+ZU-9Q_$&R6=+=Y-D6WS%8,I+
MX&,, QY!Y!VXSFNXKE7T_6GU=5:!&5;[[0FH-."4ASS$$QD<?+CI_%G-=50M
M@ZA1110!GVO_ "&=0_W8OY-6A6?:_P#(9U#_ '8OY-6A0 4444 %%%% &!K^
MEW=_<PR6Z*P1""2V.<U=TUGM]-AMPGF3(F#M/R@\_P 7X8XS6@Z+(A1QE3U%
M*%"C"@ >@%<M/"4X5I5UO(VE7E*FJ;V1@^*["\U#PKJ=O!NEN)(&6**,[<GG
M'Z'N<<5YKX2L?$'@:VU[7-2TR0)!I[/&DLHP[!@<<$XKVFJU_86NJ6$]C>PB
M:UG0I+&20&4]1Q7:IM1<3CG0C*HJC>J. ^'7Q/N/'&LW=A-I<5HL%OYP=)B^
M?F QC ]:T/B1X]G\"6FGS06$=X;N1T(>4IMV@'L#5Q/!NA^%M/U*\\/Z8+.]
M>U9-\+.6(Z@#)/<"N;T;13XLOFM?%5I<7UK#&9(ENMX"OD#(/';-:0HN=-SO
ML8UL8J5>%%Q;YNO0ZKP%XIE\8^%X]7FM$M7:5X_+1RP^4XSG KIJS]&T33?#
MVGK8:5:K:VJL7$:DD9/4\DUH5@=@4444 %%%% !1110 4444 %%%% !1110
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MU;_KLG_HI*6?_D/V7_7M/_Z%%26'_(4U;_KLG_HI*6?_ )#]E_U[3_\ H45
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M0 4444 %,F\HPNLP5HV!#*PR"/3'>GTQH4>0.PW$= 3D#WQZ^] &?IVFVEA
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MN<G&.*]"'04 4?L^I_\ 00A_\!O_ +*C[/J?_00A_P# ;_[*K]% %#[/J?\
MT$(?_ ;_ .RH^SZG_P!!"'_P&_\ LJOUR_B6'6I+^(Z?]I*>3B P2!52?>/F
MDYY3;GU'7C)% &G,NJ1SV\8O8F$K%6/V;[N%)_O>U3?9]3_Z"$/_ (#?_95R
M]]%XEN+V[DL5O(IG+M$SR 1"'RL*H7.!)OYSCW)QQ33;ZWOMC!%JZQ_;5:!9
M9\E(<IO$OS=2=Y&[=QQP2, ,ZK[/J?\ T$(?_ ;_ .RH^SZG_P!!"'_P&_\
MLJOT4 4/L^I_]!"'_P !O_LJ/L^I_P#00A_\!O\ [*K]% %#[/J?_00A_P#
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M77_04N/^_<?_ ,35ZB@"C]BNO^@I<?\ ?N/_ .)H^Q77_04N/^_<?_Q-7J*
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M!2X_[]Q__$U#=6VH16[/!J-P\@(POE1GN,_P^E:E% %'[%=?]!2X_P"_<?\
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M'_;;_P!DH [7P]_R+6E?]></_H K2K-\/?\ (M:5_P!></\ Z *TJ "BBB@
MHHHH **** "BBB@ HHHH **** "BH+V]M=.M)+N\G2"WC&7D<X I+&_M-2M(
M[NRN$G@DSM=#D'!P?R- %BBH;FZM[.!I[F9(HE(!=C@#)P/U(%34 %%%9]SK
MFEV>I0Z=<7\$5Y/CRX6;#'/3Z9[>O:@#0HK(@\4:%<LZP:K;2%)5B;:_\3'"
MC\2, ],\5H6EY;WULES:S)+"^=CH<AL'''Y4 3T5!<7MM:;?M$\<98,5#-RV
MT9.!WP!FFM?VJ003M,HBG*K$QZ,6Z?G0!9HJ.">&Y@2>"5)(I%#(Z'(8'H0:
MDH **** "BBB@ HHHH **** "BBB@#.L/^0IJW_79/\ T4E+/_R'[+_KVG_]
M"BI+#_D*:M_UV3_T4E+/_P A^R_Z]I__ $**@#0HHHH **** "BBB@ HHHH
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MH3@$\&MV*6.>&.:)@\<BAD8="#R#0 ^BBB@ HHHH **** "BBB@ KSCXK?\
M,(_[;?\ LE>CUYQ\5O\ F$?]MO\ V2@#M?#W_(M:5_UYP_\ H K2KQS2_B1K
M%OI%E"EM8%8X$09C?. H']ZKG_"SM:_Y]=/_ ._;_P#Q= 'J]%>4?\+.UK_G
MUT__ +]O_P#%T?\ "SM:_P"?73_^_;__ != 'J]%>4?\+.UK_GUT_P#[]O\
M_%T?\+.UK_GUT_\ []O_ /%T >KT5Y1_PL[6O^?73_\ OV__ ,71_P +.UK_
M )]=/_[]O_\ %T >KT5Y1_PL[6O^?73_ /OV_P#\71_PL[6O^?73_P#OV_\
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MY%*_NVR ,CU!P>1UKC?^%G:U_P ^NG_]^W_^+H_X6=K7_/KI_P#W[?\ ^+H
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M_P /]"M9&:".9%/ED('X!3;R#C/.Q<\X-<C_ ,+.UK_GUT__ +]O_P#%T?\
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:+QMXWU+5/L/GV]H/+\S;L1AUV_[7M0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g3dyckr3udth000020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000020.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %- JD# 2(  A$! Q$!_\0
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M98E+8)P"Q S@'CV-7*\[^+9F6W\'M;QQR3CQ19&-)'**S8? + $@9[X./0T
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M'-_?>-/#:6]Y-<Z1KIO4"7$4<90VX/S(JJ'12RGAV8X],5ZC0 4444 %%%%
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M!W%2_7;GG&<=Z\;\6:]K.CR_$5[35KX#0Y=+FL4:=B$:;;Y@//S*<GY3P,\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K UOPI:^("T5_>WK6$KH\]AN0PS%"I7.Y2P&5!PK*#W!R<[]%
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MU2CTA^+%_:>+2NZRWMLNU_Z\R=/'OC"2&29+72FBBQYCK;3%4SP,G?QFFO\
M$'Q;&VU[?2%) 8!K>4<$9!^_W!!J(:K9R6MPV/);][LCVC<-\:I\FQ53DCYM
MP'RXV_-DU0U'BUTM#PZVOS*>HS+(PS]58'Z$'O3C@Z+=G'\63/-L6HWC5O\
M)=_33_@>>FE_PL3Q5_SRT;_OQ+_\<H_X6)XJ_P">6C?]^)?_ (Y7.T5K]0P_
M\OXLYO[;QW\_X+_(Z+_A8GBK_GEHW_?B7_XY73^!?%.J^(KO58=3CLE^R+"8
MS;(RYW[\YW,?[H_6O-J[+X6?\A7Q!_N6O_M6N3&X6E2I<T%J>IE&98G$XGV=
M65U9]$>EUY//\1?$PO[^*&'2?*M[VXMTWPR;BL<K("</U(6O6*\!?_D)ZO\
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M!S__  BO_4>US_P,_P#K4?\ "*_]1[7/_ S_ .M7044 <_\ \(K_ -1[7/\
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M_P"H]KG_ (&?_6KH** .?_X17_J/:Y_X&?\ UJ/^$5_ZCVN?^!G_ -:N@HH
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MWL4-QN9-V&65U (X4C/WF5>215BY\+>%;;Q!'HAF\0/>R/&D864[7+!F/S'
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M_P "S_A7;T4>VJ?S/[P^J8?^1?<CB/\ A5FA_P#/YJO_ (%G_"C_ (59H?\
MS^:K_P"!9_PKMZ*/;5/YG]X?5,/_ "+[D<1_PJS0_P#G\U7_ ,"S_A1_PJS0
M_P#G\U7_ ,"S_A7;T4>VJ?S/[P^J8?\ D7W(XC_A5FA_\_FJ_P#@6?\ "C_A
M5FA_\_FJ_P#@6?\ "NWHH]M4_F?WA]4P_P#(ON1Q'_"K-#_Y_-5_\"S_ (4_
MPCH-KX>\5^(+.TEN)(S;VCYGDWG)\[O7:5S^G?\ (\Z]_P!>EG_.:E*I.2LV
MV7"A2@[PBD_)'05X[<:+X;L-&NM<UF\U%)+K6K^!(XKQ(5=Q=3\!I"J+\J,<
MLPSC R2 ?8JXO1]*FU+0HYK2YCM[RQUW4KBW>6(RQ[C<W49#H&4L-LC8PPYP
M>0""HRE%WB[%3IPJ*TTFO,R-2\&>%=+T9=3N;[65B=-T4;W!CD<E2VW:X7:0
MH).[:%"L6*A6(P[2Q\(7>AVNKA?$B6MQ%+=#-Y"Y2VBV^;.VQR-J%U!0$R9R
M AP:[O5_"@'A?2-,L1)<1:0FQ87\LO/']FDMR,N/+W[9"P#+L8J%.T,2*=YX
M"O+^>XN)]9@$VH17-OJ6RR(62.9+>,^2#(?+8);)@L9!N8G&,**]M4_F?WF7
MU3#_ ,B^Y&)<^%O"MMX@CT0S>('O9'C2,+*=KE@S'YC@ *B.V3@-L=4WLC*N
MA9_#[P[>7%U;"ZUF*YMGQ)#+=8;:2=CC&048 D$>A!PRLHZ/Q#X<N-;U'3;J
M'5Y[$6.\A(D#;G8IA^>C*JR <<^80P9"\;V-/L;@^(=3U>XC\A9XH;2*$L&8
MI"\I\PD<#<93A><*JDD%BJGMJG\S^\/JF'_D7W(P/^%6:'_S^:K_ .!9_P *
M/^%6:'_S^:K_ .!9_P *[>BCVU3^9_>'U3#_ ,B^Y'$?\*LT/_G\U7_P+/\
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M_H<]<_[\V7_R/1_PCVJ?]#GKG_?FR_\ D>@#H**Y_P#X1[5/^ASUS_OS9?\
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MKOP=I5QJDEV^H26ZM=&[M_(D$O\ &I3:N &R!QR #DYR;'B7_D5=7_Z\IO\
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M7+WQU&[NYH;HW**KR6:0R,#M$,+>6LQC :2)65I& .V0%_0* "BBB@ HHHH
M*Y_1O^1J\2_]=;?_ -$K705S^C?\C5XE_P"NMO\ ^B5H Z"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_P)_R3SPS_ -@J
MU_\ 12UT%<7X9U#6='\*:/IEQX/UEIK.QAMY&CFL]I9$"DC-P#C([@5J?\)#
MJG_0F:Y_W^LO_DB@#H**Y_\ X2'5/^A,US_O]9?_ "11_P )#JG_ $)FN?\
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M :P_^$AU3_H3-<_[_67_ ,D4?\)#JG_0F:Y_W^LO_DB@#H*R_$O_ "*NK_\
M7E-_Z :I_P#"0ZI_T)FN?]_K+_Y(JEK&KZO?:)?V<7@[6A)/;21*6FLL LI
MSBXZ<T =#I/_ "!K'_KWC_\ 016'X?\ MG]BZJ+#R!='5;L(T^=BYG8%B!RV
M!D[<C=C&Y<[AO:9')%I-G'+&8Y$@170D$J0HR.,C\JY&W6^@L]3TR]\(ZK>0
M3:A<3I+;SVJ@JTQ='4M.KJPX8' ((!&"* +G]N3:EX:L89;6TEN]7N)M.59H
MR8#M$NYY(R=P!2%R82=P8B-BIW,*<?Q/TP6?V^^TG5;#35M(+V2\G6%DCAG+
M"%BL<C.=S*1@*2.X YHN/M?]G6EO8>#M<M)K&4W%I,9;.3;*0P9G!N<R;A)(
M').YM['<&PPC:PM)+ 6$GP[UF2T^SVUJ89+FT96BMW+PH0;GD*Q/7[V<-D4
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M/^A,US_O]9?_ "10!T%%<_\ \)#JG_0F:Y_W^LO_ )(H_P"$AU3_ *$S7/\
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M_P!H^*?^A=L?_!H?_C5']H^*?^A=L?\ P:'_ .-5T%% '/\ ]H^*?^A=L?\
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M2_X5A";6VQ=6%M=V^IVVI(UAI4=M#NAR A13N8$,W5R03D8'RUZ!69_9]_\
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M##)< 6\;6WEQ+^[8^;NQN/SM\J<?[0X];<+SOXG<S1)&OV3Y,2;B1O\ XN
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M'_HP5IUF:W_Q[VO_ %^0?^C!6G0 4444 %%%% !1110 4444 %%%% !1110
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M445L9A69H7_(/E_Z_+K_ -'R5IUF:%_R#Y?^ORZ_]'R4 4O!?_(M)_U]W?\
MZ425T%<_X+_Y%I/^ON[_ /2B2N@H PO%QVZ#N!82+<P&,JJD!Q*NW.XA<9QG
M)^G.*9X6M+V""ZN+NX5S<SM*8U1!M8X!.48CH!_,\FG^,(5F\-S[Y+:-8Y(I
M=URRB,;75N=_RGIT/'N.M1^$]2M;FQ^SQH\4RYD,367V;*DXRH&58?[2DCD>
MM $FNOJR:GIGV R?9=Q\\1IDL=\> 3CY1M,I)/''J01-I'G?VCJWVCR_,\],
M^7G&/+7'7VI-9U>33+W3XAY?E7$FU\[2Y^9% 4%U/\1R1N(QT-+I$CRZCJSO
M!)"QG0;)"I(_=K_=)'ZT :]%8'BK7+G0[*&6V@5VD?:7<':G'MW-<U_PGVJ%
M)RNGPDJH(P&_=^[>WY5DJT765%?$S"KB(4HN4NAZ)169X?U&?5=&AO+F#R97
MSE0#@X/49[&M.MY1<9.+Z&E.I&I!3CL]0K+U_5_[$TMKOR3*V\(JYP,GU/I6
MI4<\4,\+1W"(\1'S*X!!^N:SFI.+479E.]M"GHFJ#6-*AO1$8M^05)S@@X.#
MW%:%,BCCBB6.%%2-1A508 'M3Z(IJ*4MP5[:A39-_EMY>-^#MSTS3J*H9YA+
MJ/BZW$T#2S^<T@RF S_\!']W_P"M7HFEM=OI=LU\H6Z,8,H'K55M#A;5QJ'F
MOD,&\O'&1[UJUCAI5%2]E4CLW9[MKS,OJT:=7VD)MW2NGLGY!1116QJ%%8^N
M:M/IGDB&)6WYRSYQQVK%B\7W\GB2#3VT\1Q2.$*L#OP?XO3'?Z5RO&4E4=)O
M56Z=RJD73A&<MGL=E111742%<3XRUG5-,U6S2UN%AA9=PZ?,V>=V>W3]:[:O
M/?B'"'U*Q86TC$QD%USA^?NCW_QJ)^RM^^DXQ[K<Y<9*K&BW15Y'H"$LBDXR
M1GCI3JBM@%M(5$9C 10$/5>.E2U9TK;4****!A1110 4444 %%%% &9K?_'O
M:_\ 7Y!_Z,%:=9FM_P#'O:_]?D'_ *,%:= !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 <MH-O9W7PQT6&_M/M=L=,M2\'E
M^9OPB$?+WY /X4>%XM%BG5]+\/2Z7)/;^8[26WDG&5.WGDG)YQP,<]15SP:,
M^ _#XR1G3+?I_P!<EK+\(^'M(TK4IIM+U*PN-L'DR):QQJY/R@M(5//,9(&!
M@L_KP ='JVJV^C:=)>7).U <(I&YSC.!GO@$_0$]JK17$4_BB01/N,=IM; Z
M'?5K59-/CL'&I^6;9\JRNN[/!SQ],GV )[5 NT^)%*8V_8N,=,;Z -2BBB@
MHHHH **** "BBB@ HHJKJ%_!IMF]S<.JHO R<;CV'XTFTE=@W8M45F?VB]I=
MP07\ULHN0?**$CYACY>>O7KQ]*TZ49)["3N%%%%4,**** "F>3%YWG>6GF8Q
MOVC/YT^BDTGN.[04444Q!69H7_(/E_Z_+K_T?)6G69H7_(/E_P"ORZ_]'R4
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M#Y:YSCGIG\>QZ4SPMIUY9ZGJ,FIP78NY7WK,\B-$Z[5S@(%7=NW<E Q&,YH
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M7,[?J<U;VG/#DBFKZM]/0[:BLS^WK#^]<?\ @++_ /$T?V]8?WKC_P !9?\
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M:/[>L/[UQ_X"R_\ Q-5.<IN\G=F=*E"E'EIJR-.D(RI'/(QQ6;_;UA_>N/\
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M#U;P9<7-G;VL-EH<\T=I]D@U22W$%UIX4L(Y(MB,&90RD*IB 9"05#@)W%%
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MJMW%-#M5850=,9_IM'N03[G=KEO%MOK.HRVUII"%7MU:\\UY&C0RKQ$A(!W
ML22OHHSUK(NO%&NLPELK>Y%Q,THCL)K-@JJ+9I$R^,[]VW*YS_#@$'(!Z!4%
M[%)/87$,1Q))$RH<XP2"!7-Z=J?B,:-=W%S91SB'S3&ZL_GNHC!7$9AC#L6W
M#'R#@=>M9VDZAX@N=1@>=[R18I9DC#1-'%.##$R&0^2,#=Y@#;>,8Y/4 OZE
M8^)KZ%(+:1;6'[(\,@$_S%S&ZA@0,CYC&?P/3O8BT[Q!)!JL5Y>1NLQ_T0 X
M*#>QY(']W8/<@_4YVK+/)=7[:O:7OVEK9?[/73VFE1'PV=C*H DW<EF"\8[
MTDEYXLALVDD=S.QFB*):$I'MV[7&%+'/S<X88QA3CD L/HWB(F"=[X33PVX
MW. !*WEB0C"C^$28Z'GJ,YI4TGQ-):6WVO4=\R&(RK'(%5BODY(PO0XF..^X
M#Z9T&M>*Y[K3XT@D6!M@:66%@9<SNKGB$CB,(P)\O.[."/E%Y?M[>"M&%T=2
MFQ)&-1S&XN&09# @ ,1NVYP,E<]0<D FT/2_$MC=V:W=[ UF@D,T:]26:0\<
M?[4?I@*1QWZNN U'4K_3+<)H%KJ,=L&FFB5[=W$@41X4 HS(I)?"X7."0P&
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M  >0#H**\[&J:R_B#5[:VN=9T^SV72PFXTV>ZV2 -^\C'V<#&X%T!GD!7"!
M64)<^'D.EV?VZQTB+0Y[6&*#_B9:-;^7',?G'E.=\A>1 H8DN3B89 ZL =Q1
M7F[ZMXJN=:T725U+[%]GNWTS4;@012&[E\B642*N,1MY<44H W*#<A2&\ME.
MA;>(I8O&EY!>^((/LL7FL]KA +>) 26EC*K+!_"1*SR1.-Q^3S(A0!W%%%%
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>48  %BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g3dyckr3udth000005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $\ ?D# 2(  A$! Q$!_\0
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M%>5?!:ZU_7-.O/$.MS:E(MX!Y$D]\LEO)AW#>5  ##MV@').[J*]5H ****
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MB.F>*YOPMX;^(VB:PUU>OX4NC>7*OJ%X6N&N7BW<JAP%&U<A5P%'?N:]0HH
M\[U;P1XA-QK=AH=_I=OH7B"6274!/"YGA9T"2&+:0IW8R=W0GO7>V5I#I]C;
MV5L@2"WB6*- ,!548 _(5G:CXDL],\1Z+H<T<[76K^?]G=%!1?*0.VXDY&0>
M, _A5S5M2AT;1K[5+A9&@LK>2XD6, L512Q R0,X'J* /._^%<:Q_P *)_X0
M?[38_P!I_P#/7>_D_P#'SYO7;N^[Q]WK^=;6K^&?$5IXGO=;\)WFEPR:K'#%
M?IJ$3MCRPP61"AY8*<8/!P.:ZG2M3@U?1++58 Z6]Y;QW*"4 ,JNH8;L$@'!
MYYKDYOBKH@;S;/3M=U#3U+"34K+3GDMDV\$[^,C(/*@CB@"&[^'DD'ACP?HF
ME3PB/0M6MKZ9YB5\Q4+F0J #\Q9R0#@>]:__  CEY_PM/_A*/,@^P_V)_9_E
M[CYGF>?YF<8QMQWSG/:M"X\3Z7!X3F\2I/\ :--CMFN@\."74#.%SCD],''/
M7%.\-^(;3Q1HD6J64<\4;LZ-#<)LDC=6*LK+DX((]: .%T_X<:Q:>!/!FAR7
M-B;K1-;CU"Y=7?8\:RRN0AVY+8<<$ =>:D\7?#;4?$?B>]O5N-*FL;^V6W?^
MT+9I9K'"E2;;!"@MDDD]"!75>#?&FD^.-'.I:2951)#')#. )(R/4 D<CD<U
M:\+>)+/Q=X<M-<L(YX[6ZW[$G4!QM=D.0"1U4]Z .:\,>"M4T?Q1I&J7<UF8
M;+PQ%HTBQ2,6,J2!MPRH^4@?7/;O6$G@'QG8?#G0/"^GW.A2"UDF?4H[J2;R
MKE3*71,JH8I\QW XS@#D9!]:HH X#5/"/B#Q9X-6P\1G08]4M+Z.ZLA9Q226
MN$ PLB/@L#F12.F".*BM/AQ-<^#-=TC55T2TNM751MTBP6&"WV %,<!Y,/EO
MF/? Q7HE8_A;Q)9^+O#EIKEA'/':W6_8DZ@.-KLAR 2.JGO0!R=OX5\9WWC;
MPUKNOW^BR1:1]J5HK*.5&(DCV!OFSN)X)'R@8XS2?%U)I+3PA';RB&9O$]D(
MY"NX(Q$F#CO@]J]%JOJ%];Z9IMUJ%V_EVUK"\\S[2=J*"S' Y/ /2@#CM/\
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M_?$'_P =H_X26Z_Z%?7/^^(/_CM=!10!S_\ PDMU_P!"OKG_ 'Q!_P#':/\
MA);K_H5]<_[X@_\ CM=!10!S_P#PDMU_T*^N?]\0?_':/^$ENO\ H5]<_P"^
M(/\ X[7044 <_P#\)+=?]"OKG_?$'_QVC_A);K_H5]<_[X@_^.UT%% '/_\
M"2W7_0KZY_WQ!_\ ':/^$ENO^A7US_OB#_X[7044 <__ ,)+=?\ 0KZY_P!\
M0?\ QVC_ (26Z_Z%?7/^^(/_ ([7044 <S=^,'L;.>\NO#>MQ6\$;2RR&.$A
M549)XE[ 5TU8?C/_ )$7Q#_V#+G_ -%-6Y0!S_@3_DGGAG_L%6O_ **6N@KG
M_ G_ "3SPS_V"K7_ -%+704 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 8?C/_D1?$/\ V#+G_P!%-6Y6'XS_ .1%\0_]@RY_]%-6Y0!S_@3_ ))Y
MX9_[!5K_ .BEKH*Y_P "?\D\\,_]@JU_]%+704 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1137D2)"\CJB+R68X H =14%O>VEWN^S74,VWKY
M<@;'Y5/233U0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M##\9_P#(B^(?^P9<_P#HIJW*P_&?_(B^(?\ L&7/_HIJW* .?\"?\D\\,_\
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M\"0>%;N:\?4KO4KI[>.TCEN0H,4$?W4&T#\^^*I^'_\ DKOC+_KUL?\ T%Z
M.YHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +!ES_Z*:MR@#G_ G_)//#/_ &"K7_T4M=!7/^!/^2>>&?\ L%6O_HI:Z"@
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MSX*'.^15^:)0!$=F#+L(!Z)17/\ @SCP^\0XCAU"^@B0=(XTNY41%'95554
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M-M?BUN;7STW>1<Q[)$]F7L: +M%>=W.J^)+?XO6%G>W$,>D36ET]O:VY)+A
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M1110 4444 %%%% !1110 4444 8?C/\ Y$7Q#_V#+G_T4U;E8?C/_D1?$/\
MV#+G_P!%-6Y0!S_@3_DGGAG_ +!5K_Z*6N@KG_ G_)//#/\ V"K7_P!%+704
M %175NEY:36TN?+FC:-L'!P1@U+10!YB/@EX3MFA(U#68F0>7$?M^T@'^%>/
MT%>@:/I<.B:1;:;;R3R0VZ;%>=][D9SR>]>/>.K6SG^(&L-XAT+5M=MA9PC3
M5TQV86C;3N#JI^1BW(8]J]*^'WVW_A -$_M&<3W?V9=\@D$F>N 6'4@8!]Q0
M!TM%%% !7#>'_P#DKOC+_KUL?_07KN:X;P__ ,E=\9?]>MC_ .@O0!W-%%%
M!1110 444V12Z%0[(3_$N,BA[ .HK/\ )E^V^5]LN-OE[NJ]<X]*NQ(8TVF1
MY.>KXS^E9PJ.3VL7**74?1152[O1 ?+CVM-C)W'"H/[S'L/U-7*2BKL@DN+E
M;?:H4R3/]R->K?X#U-,AMRCFYNG5I\=?X8QZ+_4]3^0$%LKC<\*&25_OW,PV
M@_0=<#L.![U8%HK$-<.9V'(#?='T7I_,UDI.6J5_R_X)7);XCG?%%](S6OV8
M.8\-\ZL5#'CIZ_7WK&T:XO(M1A C=\REMHDZYYKL=5TPZBT654K&#C,A7KCV
M/I5.TT![6X2<+&71LC]Z?_B:\7$83$2Q?M%M=:Z]+'H4ZM)4;-ZZ]NIK?;/6
MVN!_VSS_ "H^W1=X[@?]N[G^0JS17N<M3^;\#@O'L5OM]OW9Q_O1,/Z4?VA:
M=YT'UXJS11:IW7W?\$+P[?C_ , K#4+)C@7=N3[2#_&L'Q%JTB.MO#!:7-O(
MN6\P[@3GTKIB PP0#]:Y[Q!8QS7$+?:K.WPIXFDV$\UR8V.)=%JEJ_+_ (<U
MHNCS_O'9>=O\C(\.ZE<64L5H+:TC@9F,C@[2>IY..<?_ %J[#SYIO^/>+"_\
M])00/P'4_I7+Z1;P6U]#=2ZC8!5SE//&[H1TKL:SRZ&(]C^^NM=/2R'7=",^
M6D[V_KH5A9JQ#3L9V'(W_='T7I_6K-%%>C&"CL<[DWN%%%%4(IZC;FXA4+"9
M6#?=\]HOU7K7.V6F7#:KJ4AM-Z!TC"?;I 4(16//4@[L_G775DZ-=PW5YK!A
M<-MO,''M&B_S4_E5)2:;3:L<M:%-U(\R5V_T9HVRLEM&K)L*KC;O+X_$\FI:
M**DZDK*P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% &'XS_Y$7Q#_P!@RY_]%-6Y6'XS_P"1%\0_]@RY_P#135N4 <_X$_Y)
MYX9_[!5K_P"BEKH*Y_P)_P D\\,_]@JU_P#12UT% !2,H92I&01@TM% 'F2?
M!+1$U2^O!K&N*MUM_=QWA4K@="W5AZ9Z5WNAZ-9^'M$M-)T]66UM4V1AVR<9
MSR?7)->6^.KC4HO&EV/!T_B$:^JQ-<HI3^SPNT8+^9P..I'O77>"M;\57-_=
MZ1XKTZVBN[>".=+NS),4JL2,>FX8[&@#M**** "N&\/_ /)7?&7_ %ZV/_H+
MUW-<-X?_ .2N^,O^O6Q_]!>@#N:*** "BBB@ JM?W8L;-[DQ-($QE5(SU]ZL
MUF^('$>@W;G.%3)Q]165:3C2E*.Z3*@DY)2V,;_A+(?MY?[%<<1 8ROK]?:N
MBBNU:T2XF7R PR%=AGVZ5Y*NJ-]I+M&-I ! Z@<_XUZ59H+N&(VVX)L >Y;E
MNG*IGI[GH.W/3R\#B<14E)3L:3EAY*].3?\ 6A8-]/=S-!91E=O#SR#A/H.Y
M]C^/:I;;38+<[SNEE)W&20Y)/K5F**.")8XE"HO0"GUZBI7=YZO^OZ[F?,^F
M@4445J2%%%% !1110 4444 %4K\F&*2YDFMHX(UW,982Q ^NX4Z>^"2FWMT,
M]SWC4X"^['^$?KZ UCZ]H-_J]AY7VJ(S,P+;LA$7T4#//N>>O3.*N-*,FE-V
M1SUJ\HPDZ4>9HJ^'M6LYM)CEEN[& "1PT<R@/RQ/4L.Q]/SK=_MJQ/\ JWEF
M_P"N,#R?^@@USO@S0K[2Y9IWG@>WD+QE!G<&1BN1Q['\Z[*KJTZ-*;C"[7K_
M )F&#J8FM1C.K92]/QT:W,_^TY&_U6FWLGU14_\ 0V%'VG4W_P!7IT2?]=KG
M'_H*M6A14<R['5[.?63_  _R,_;J[_\ +6RA^D;R?U6C[%?/_K-5E7_KC"B_
M^A!JT**.=_T@]BNK?WLP]5TZXCTR=[:6_NKK;B-?M)3D]_E*CCK7+^#;'6=,
MUR42V;BW8^5<'<#L; 93U_VA_P!]5Z)6?I__ !_:M_U]+_Z)BK>GB)*G*#5[
MG#7P,)8BG53::?Z-_CMZ&A1117*>F%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!A^,_^1%\0_\ 8,N?_135N5A^,_\ D1?$
M/_8,N?\ T4U;E '/^!/^2>>&?^P5:_\ HI:Z"N?\"?\ )//#/_8*M?\ T4M=
M!0 4444 >4>*M-UW3O&&N7T7AI?$-EK5BEH@-Z(?LZ@89"#_  L?FR/SKM_
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M!>@#N:*** "BBB@ J&[@BNK2:WG_ -5*A1N<<&IJKWD<LL(6)('.>1,"5_\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8?C/\
MY$7Q#_V#+G_T4U;E8?C/_D1?$/\ V#+G_P!%-6Y0!S_@3_DGGAG_ +!5K_Z*
M6N@KG_ G_)//#/\ V"K7_P!%+704 %%%(0""",@\$4 >&?$(:G)\19I&LM6U
M6WMVMS#%ID^1;1E&$BN@^X[$@ACVKTWX>-=O\/M$:^NA<W/V8;Y1*),\G +#
MJ0, GU%>1>(M%\#Z!XTO]/BT'Q+JEQ*T:NEG<,(XW9"X0'<"Q*@G!STXKV/P
M+)82^!])DTNR:RL6@S#;N^]D7)ZGN>_XT =#1110 5PWA_\ Y*[XR_Z];'_T
M%Z[FN&\/_P#)7?&7_7K8_P#H+T =S1110 4444 %%%% !1110 445!<7MK:
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M&%FEF#91BIZ9[@T >I45PGG?%3_GT\)_]_I_\*/.^*G_ #Z>$_\ O]/_ (4
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M2UT%<_X$_P"2>>&?^P5:_P#HI:Z"@ HHHH **** "D95=2K*&5A@@C((I:*
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MO2$T^T6\7R@LCL&(0 [2P&Y< '=W)- 'J5%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 8?C/_D1?$/_ &#+G_T4U;E8
M?C/_ )$7Q#_V#+G_ -%-6Y0!S_@3_DGGAG_L%6O_ **6N@KG_ G_ "3SPS_V
M"K7_ -%+704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMKI]IXCU9+:UA2")2EL<(H"@9,.3P!5G^QK_ /Z&;5?^_=K_ /&: -BBL?\
ML:__ .AFU7_OW:__ !FC^QK_ /Z&;5?^_=K_ /&: -BBL?\ L:__ .AFU7_O
MW:__ !FC^QK_ /Z&;5?^_=K_ /&: -BBL?\ L:__ .AFU7_OW:__ !FC^QK_
M /Z&;5?^_=K_ /&: -BBL?\ L:__ .AFU7_OW:__ !FC^QK_ /Z&;5?^_=K_
M /&: -BBL?\ L:__ .AFU7_OW:__ !FC^QK_ /Z&;5?^_=K_ /&: -BBL?\
ML:__ .AFU7_OW:__ !FC^QK_ /Z&;5?^_=K_ /&: -BBL?\ L:__ .AFU7_O
MW:__ !FC^QK_ /Z&;5?^_=K_ /&: -BBL?\ L:__ .AFU7_OW:__ !FC^QK_
M /Z&;5?^_=K_ /&: -BBL?\ L:__ .AFU7_OW:__ !FC^QK_ /Z&;5?^_=K_
M /&: -BBL?\ L:__ .AFU7_OW:__ !FC^QK_ /Z&;5?^_=K_ /&: -BJ6L:7
M;ZYHUYI=V7%O=PM#)Y9PVUA@X/K53^QK_P#Z&;5?^_=K_P#&:/[&O_\ H9M5
M_P"_=K_\9H D&@68UJTU4&7[3:VC6D?S?+L8J3D>ORCFN93X4:%#;75K;WNJ
MV]K>1^7=PQ7.%GQG!;C.0#C@@' SFNB_L:__ .AFU7_OW:__ !FC^QK_ /Z&
M;5?^_=K_ /&: 'Z%H%GX>MIX+-IF6>8S.96W'<55?0=E%:M8_P#8U_\ ]#-J
MO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']
MC7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\
M?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8
M_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-J
MO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']
MC7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\
M?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8
M_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-J
MO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']
MC7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\
M?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8
M_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-J
MO_?NU_\ C-']C7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']
MC7__ $,VJ_\ ?NU_^,T ;%%8_P#8U_\ ]#-JO_?NU_\ C-']C7__ $,VJ_\
M?NU_^,T 1^,_^1%\0_\ 8,N?_135N5S]]X9N-2T^YL;GQ)JS6]S$T,JA+895
+@01D0\<&N@H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g3dyckr3udth000021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000021.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $K 5@# 2(  A$! Q$!_\0
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M@;=H/09SDTKC2/1**\F\'^.+;3= U_5+GQ6^NZ78(LD<<\)2]A)XV." &RV
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M&5/(X'K]*L6>M:Y=WL22::(%\B1F0JQW, NP[B  "2>.O'- '445QSZUKEI
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M"SDE\QXQRW;KT'M6A11"A&,N?=@H)._4****V+"BBB@ HHHH **** "BBB@
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M3%=+7-A\0ZW-[MK.WJ;5:7L[:WNBE?\ _'QI_P#U\_\ M-ZNU2O_ /CXT_\
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M-*45*:3V)=&@:+3UDD_ULY,K_4UH4@    P!TI:JE35."@N@IS<Y.3ZE*_\
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MU'U?Y?\ #DM%%%=)B%%%% %*_P#^/C3_ /KY_P#:;U=JE?\ _'QI_P#U\_\
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MEP_O2G4[NWW:?G<VJZ*,?+\PHHHKJ,0HHHH I7__ !\:?_U\_P#M-ZNU2O\
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MD8(/6NRN)B^LV49AE4*TGSL!M;Y3TYH TZ*** "BBB@ HHHH *P?#'[]-0U
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M;?\ [^"D&K:<1D7UN1[2BK6Q?[H_*FQP10QB..-54= !0!!_:NG_ //[;_\
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MIW_/];\]/WHJT51020H Y)(K$&N^'[N-KZ/5+5H;%LR,'&%W J,^QSQCKVH
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M/+<7T;6ZGRR@\E5&Y@V>C8P.N37H%AH>DZ7-)-I^F6=I++P[P0*A;OR0*OT
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FGU- #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g3dyckr3udth000014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %& M # 2(  A$! Q$!_\0
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M:BB[#E04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW7=';GK&FQ5QS@D\L2!D\"H/^%>Z=*)'OM0U.]NGABA^U33*)%$4GF1E=J@
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MB,W7S $++N$?!VKNY"5VE !1110 4444 %%%% !1110 4444 %%%% !1110
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MG_#7_']XC_["K?\ HF&N@H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!S'(G!1QU_ UT/PG_P"1)/\ V$+S_P!'O4U.C'%E7XS_ /(@?]O]M_Z,%>-
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M.V\#^(+@:[K\ABTVX?9+J+LC8C8X8=P>XKT.L#QT"?A[XE &2=*NL ?]<FH
MK?\ "$Q?]##XC_\ !F]'_"$Q?]##XC_\&;UU%% '+_\ "$Q?]##XC_\ !F]'
M_"$Q?]##XC_\&;UU%% '+_\ "$Q?]##XC_\ !F]'_"$Q?]##XC_\&;UU%% '
MGGA_PA'->:\IUW7T\K4BF4U%P6_=1'+>IYZ^PK;_ .$)B_Z&'Q'_ .#-ZN>'
MH98;SQ 98G02:F70LI&Y?)B&1ZC(//M6Y0!R_P#PA,7_ $,/B/\ \&;T?\(3
M%_T,/B/_ ,&;UU%% '+_ /"$Q?\ 0P^(_P#P9O1_PA,7_0P^(_\ P9O7444
M<O\ \(3%_P!##XC_ /!F]'_"$Q?]##XC_P#!F]=110!R_P#PA,7_ $,/B/\
M\&;T?\(3%_T,/B/_ ,&;UU%% '+_ /"$Q?\ 0P^(_P#P9O1_PA,7_0P^(_\
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M"&2!B>&3NOU!/ZT7NBJ^FO8DL[64PNK,K]X;3NV<_E2WC/K&FP:E:,/+W+(
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M-S_]>JCMN)9V!9CR2:LP:/+=N[2?(L W,>N[Z 5$(M[%MI;C_"^AR^)=<CM
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M.WO%FXVNDQDVX]QY9S]15>U\7Z5-8F[N9?LB&]FL8Q,>9)(F92% ZYV,0.M
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M* "BBB@#A/B[_P B&W_7]:?^CDK(MM/&IZ3K.F;5B:Z.]'(R,E1@_@16Q\7
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MIYD5;AX_O 8&8U/8\_SJU<^?I5B+&SC4SLNU3C*PH.I/J?;N3]:OS-=+)+"
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MDMK.5IH)D6\:SNI(R-N3D(PP3]X^7QG^/VJ&YU?4/L*WBLT<+Q33PO%;-,&
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MXB"L@7&S!R ?4Y)JI*VHGM<2[,D4$$F)6:*0F7R@#CW(ZX^G2KWPG_Y$D_\
M80O/_1[TPR!;N9596W#=D'D?_7Z_E3_A/_R))_["%Y_Z/>LIC14^-(S\/6'K
M?6W_ *,%>#@7%KH$2W'F12+*%QG!R.A_*O>_C(I?P&J#'S:A:CG_ *ZBO#_%
MVG7&GW5K;:@D8FADDRT394\X_I6;3MS&M-ZV.?D_>2&63+MV)ZFMJPT;YUN[
MW"P@;UCZDTS3M-CO;:8XA5P!LDDDV@?_ %ZW--\.WVFR++>989WD\Y?CCKT
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ML;>348;]H\W4,4D,;[C\J.4+#'3DQI^7N:L444 %%%% !1110 4444 %%%%
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M;4]#.G6T4RW(X,&U5#GKD8^]QQ5RJ)*T2E!MWD-UK6AN^QVK+]E8YRBX//\
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MRQ7:S:Y9$C'_ $V2LZGP,J&Z/8:***X#I"BBB@ HHHH **** "BBB@ HHHH
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M!+&FTC'45)\)_P#D23_V$+S_ -'O60)VM]425&4I(I>3'7KS^7\C6O\ "?\
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MN3G@G&3[^U=G:V]KHNE%21'#"ADE<G\236/X>MI&O#<"$BW6/B5S]YL\!1Z
M=_<5D_%V[NK7P*ZV[%5GN$BE8'!V\G'XD5;?)#F(E[\^4\\\2?$B[U2ZNX8<
M?97<K'Q]V/I@>YZU8\(6_GZ,=3AN'>2P:0Q6CJ-OGD?NW+>@SG'^S7G,9+-C
M).>OM7;:<LFD^%/LKOMGOI?-=%^\L>,#/UKE562=V=:BFK(6ZU"YF@73WNY'
ML2,3G'SW#%LLVX^_2NRT?4-2N;;;?JBZ?Y8AM&1,RLHX);^M<+:6\]S>QV\(
M#-(X5%7OFO3[BUCT:QWW-P(OL2*&D4X''4#/N<>]7"4W>[T%-15NY$FFW,KK
M<60>]DCE+)#YOE1@D]S_ '5';VJPUKI5MK5U<+;_ &F^=MK7,N65, <#T'\Z
MQ[+Q0WB&9[&QG&FN7*PY7<LB'J<?WNM6[F&YEGV\0VL4BJ\F<-*0,X ]ZV51
M2C=;&;BT]0O].M]3LKVV*2%E("LXPHSSN'J>V.V:K7NG,=2TFQ2Y*)+(S[4)
MW%1R3["MDS6RHJR, _EM*4/H.-Q]LTDGDQPVVH$;[BXC"I+WV$YP.P'?\JTC
M#5$.;)VE$EUY2#Y47+?Y[FNNM0!:0@*5&P8![5R^E:5+YTCA07+?,Q/&,\8K
MK:T;N<\Q:S==CCFT2ZAE!,<B;64=6'I6@S!5)9@ .YKR_P >^-Y;:>2TL"?+
M1 &E0\Y/4#\,<]JB<E%78Z4'*6AS=_/#I\=P+-9%:4^7([\[3V13Z*,Y]2:Y
MF5!N4#"@#''<UTER8=5\+63Q310+$Q9O-;!;/7'?.?SJ#PUIIU76K>TL TK[
MMTD[C C4'D@>ON:X:DN::Y3THV4=3M?!/A6*#3(]4N(A]H<?(S#E![>A]ZVC
MIUO'^XMX0D;S&>51_&_4?KBMZZ:.TLPL8Q'&-J#UJOI<!>YDE?GR^/JQKT*<
M5"-D>?*HY.[-*)$M[94X54'.?UJE:2[[V;]YN!^Z/:I[NY1 T13S'88V#O4D
M2!44F-48CD#M0S/H2$!A@@$'M6!XF_X^/#G_ &'++_T<E;]8'B?_ (^/#G_8
M=LO_ $<E9U/@8X?$CUJBBBN$ZPHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#A?BY_R(C?]?UI_Z/2HK&5K2],$V?WK85CWZXJ7XNC/
M@1AG&;ZTY_[;)6=;)J$4$,6J""XF@.?-3(W _P#UJN F7-3MEM+Q=2"!H6^2
MY7H<'C>/<5#=6*VY#P3$D#Y&R,@]C[BM2WO8+M2A0J<?ZN0=1Z^XJG?Z*)E\
MRS=H95&0N?E;VJT).VY1O(K/Q/8S:)K,2QS-GRF'<X^\OOUXKR:0SZ!KTN@O
M''+&MP$6-F*E5(Y(/?UQ7HX6:[W('>&X4;PR\,C*?>N=^*EG-=#2]61=L A8
MSLI ;<.16=:&AT4I6=NC.=DU\QV6H:;%Y,UJF4DMWC^1SU# CE6&>M7+?2FU
MRRALFU;[)J1VO!8W@*;>.J/T8XKCX]$@N[3SGF5+LD%,-]XD]"/QKUS7O[$U
MSP"-3AGC^V6%LOES$J)5*XRIS6,8W-9R<7IU.$CMKK2KU+36M)>*1<B-M@7S
M /T8'TI#%I<UPK:>\8F9L>7O.W/IM/<>HI(O'.K1WL.G^(;>/4]%N5 :()\R
M*?XE/52*TY?!%I:SP2V%V;G3;DBYBN&8!5BSR#W)QUJ7%->Z6JEG:1%I-XMM
MJ$1B8"_MYL131*%/(_B'<=16D;QHM:B:[G5IF4R [<;5)P2?S Q7)V\,UQXC
MN[B*-5:-V,)C/11W/U  K;N(+D74%Q]ED>/[+*CN>=H/)&/7N*<79I,IJZ;-
MC4K1UN+C]^HCWF4D?>5,C:1]#P:;JFJR75G((D,B^8R3!.#$X!P1^(J'50\M
MKI4UN6:\7;PG<8!VGW)Q^M:LOA[R=)O=22:1YS*3=Q.,$ ]#QZ UU2VYD8)I
M-)F5I&KSPB#4(TC:Z*\KR"RCL1Z]:]1BDCU73DD4[=ZAL'G:?0UX[;*MFR;H
MPDKSEB6.5P3@D'T/!KT7P;>126[6J% T:@LJ'(!J*<FUJ3B(*UT1W\#65A)-
MO9)K>0&13R "<;Q_LD=:W_A/_P B2?\ L(7G_H]ZBUV"*;3I2_#A& ..H/4'
MVJ7X3_\ (DG_ +"%Y_Z/>KJ:I'.G=%;XS$+X"W$9 O[4G_OX*\!U+6%U&[=_
ML?D1H?\ 1U$FYE]<GI7OGQI_Y)\?^OZV_P#1@KYO8EI&&T*,]!6$F[6-J1>@
M\ER[Q(XE52R@D$&JEO;O?7\4,7,DC  4ZT:1KE!%$\KA@ B\\GBO6_!G@2'3
M5BU+5+4)J08E8@V40=CCUITJ<IO0JK4C!:G3:/IRZ'H$%@SAV1#N/JQZC^E>
M>(ZV"WNFZ=;+/? -.T6_(#*5^4_@2:W/&7Q!C\/WYLXK2.Y:+!E+MSDC[H_3
MFN9?3#KVGZGK.BH(%U!8Y(4W8*R<"0$GMD'@5V*4'*RZ:'+",DKRZZGK.FRQ
MSZ;!)$-J%<8]".H_.N&^,HD/@R#;C8+M2^3['&*W_#&JR227>DW,#)-8A,S#
ME9-PR<?2L3Q[?6\FHV5M=H9--MD>>[V\G./E&.]55_ALSI1:JGDWA7P]<Z]?
M(=CI9I\TDVWCCMGUK4U+_7S7$H:.+HK%<  < #UK#UO6Y;J_EEM9YX+1F)@@
M1]HC7TP..E5=0FN[IK5[R5GS"NS<>%7Z"O.=FCT$[,[#0=>@L6/]CV^Z[<'S
M+VX 'E(!D[%]2!UI^H^)KO7=.59Y!AADQCI@'CZGO5;PWX=MY;"ZU>]DVVT4
M#B%!U;CYGQW'8>YH3PGJA2"2SC9XIE&Y)&"M"W]UN>H&/SK2T_9Z+<F\>:[W
M)="TN>:^@O$XBMG#2D'!4 ]?_K5V^H>2]DTMO)Y[*\?"$,<EO0=..M9,L4NG
M>'KC2]18/$3&!)8??)8XPQ([=ZZ6UL+72=/2.RME144.0PRS<<[JZ*=*T;/J
M95*FMSF/$MS"^L?9K>>2"00F"ZG !"1[2[8'J!751QVM_H.GR:1B9[2&-5@E
M8!]F <D>I'/XUS5_I*2:W9QVCRQ>?,U]+=2)N6-0,%<^F..?6KOV_2M5U"*[
MLIDV6Q>.+R%)(RN"3ZXQ[CFNEZ>ADU>UCM+3Q#9R1)]H/V>3=L8,, 'ZUL<5
MYKXBOFM[>>5L.Y58H>@\R1C@$?S_  KJ/#FNV<^FP6LUT@N84"/O<<GT^OM3
M9A*&ET8OQ&UK4-,AMX;-_+6568L.IQ7C]O!?:_/.<!8XE,EQ,W"QIGEC[]@.
MYKZ!\3^'[?Q%I)MI44RH=T+$X"M[^WK7DNIZ+%I-K<Z1:ZG'<2EPURQQ'N;^
MZ!_='7K7%B(._,V=>'FG'E6YS.U6=8X<[!PF[O[GTKVGP+HB:+X<BN6CQ>WP
MW$D<[/X1[#'-<7X-\*)=W#7&H7$"6UO^\F7(.Y0,]?3'Z5Z;=ZBL<*R#B6Y7
M%M&1@A/[V.W;]*TP]/[;W)Q-2_N(S;J]>\ORD(+Q0R>5$@./-E[GZ#_&MRV>
M"TA$,EQ$9NLF&ZL>O%85G 7GG6'Y)$ A0CLS<L?KBMNVTBQMX%B%O&Q'5RO)
MKK9RRL201H7:8LK2,>QS@58ID=O%#GRT"Y]*23<?E0[21U]*DG<?6!XG_P"/
MCPY_V';+_P!')5]+N=9)+=RDDJ'AE4_,/IZUC^(#<F^\.F8X4ZW98&,?\MTK
M.I\#+@O>1['1161X@UEM&M[5E2(M<W"P"29]D<>03ECZ<?G7'"+G+E1O.:A%
MREL:]%8$_B5=-GTVUU*(">]+@M;!Y44#)4@A><@#Z9]!FK\^MZ=;)?O-<;5L
M-OVD[&/E[@&'0<\$=,U3I373?_AB57IN^NW^5_R-"BN9\2>+K32;"^6UG1[^
M"(.%:-F0$XP&8< D=LYK3&OZ<MM/-)<A1;2+%,-C95VQ@ 8R<[ATS3]C4Y5*
MV_\ 7ZB6(I.3CS+0TZ*I:E)J,<"_V9;P33,V#Y\I15&#SP"3VX]ZK>&]8?7=
M&2]D@6%S(\;*K[ERK$9!QTXJ?9ODY^A7M8\_)U-:BBBH- HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*8=F<;2,,Q/4UZ16-?>&=(U&^DGN(YB\H!GACNY8XI\ +^]B5@DF5 4[U.5
M4Y  H V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=GV*"<[MZX'7:"3Z2_\ "1W):U@^PR13S+,[;X92 (W"@A0N[#;@02!@>O%
M'145P\'B"Y/CKR3#+%+?:58M';W!94A8R7)?/'WMJ], MM'0 D=!:ZI=W,MW
M!Y$*7<3,$MI69"4#8#[L88%<'*@@$XZT ;%%%% !7/\ _-0_^X5_[5KH*Y__
M )J'_P!PK_VK0!T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 <_J/_ "/.@_\ 7I>?SAKH*Y_4?^1YT'_KTO/YPUT%
M !1110 4444 9^O?\B]J?_7I+_Z :-!_Y%[3/^O2+_T 4:]_R+VI_P#7I+_Z
M :-!_P"1>TS_ *](O_0!0!H4444 <-\6_P#D1C_U_P!I_P"CTK/O[FXM_P![
M>A)$#[O)7!"#' SW)K0^+?/@8C_I_M/_ $>E9DFH6D\[PM"Y!D;:C1XWD'!P
M:T@'4IOXJ@N'5EMT)R%4@G#'/W>*LP:C::M<LMO$8[B),M"5_P!8O<J3P<5%
M!X3T\RR;"]KYC[S%O#9/K]:CCT*32KN]GM]2D\H?O%0C.P@?KQ51\RWR/X2Y
M#'"8X_*DE>V/)C#E0#[>GTJTMW?1%C&(WA4#"2-COS@COBHM,CM;J-)YX!%=
M,02 W#>C+Z@U?DM%B=KA0V5!Z,<8^E#9#?0MQ2QW4"R(=T;C(S7"_$/2GFT^
M:1VQ!D2@CC!'8^QK=\.:D9+<QRJ!&92$8'.#GH?3-6?$5L]QI<P8KY*@.Y_B
M4 Y)'OBDUT'"\)GDWAPZB8;VS#Q6]O$3@7'\+$#&X==O>N8U[2DT[5(;"WG2
M><RF7<JX4 \]_P"5:_BBWOM,U9H(+-WAN26=8W.90,,S'N!G%9MG$GG^="WG
MS>85*2G.WC=G/H.@-<DM-#M6NIU^B6\-](MZ^%NRK%HPV6 /"[O3/7%8'BS7
MV<SZ1IJ>9'.RBYE"\SR+TVCLHY'OS5M;F>WTN^NM/D-PLI0"0J<C/W\=SCIG
MWH5([W4KY8X5@O;A<P.O(V+C*D>_/(IK5**0VNHVUU.WNI$B$#6L-LN9&3_E
MJ<XX_P ?>I(YQ/=74[[E8C<4;@1Y.?\ #\Z;<0+9Z#B(+/(\FV5]F"@SG&.V
M*B:ZMY995AF61)WXSZ$<_CCI]:N$TM!N+)+B[DL]-^WLI68-Y*,1T4< _K73
M10IY-I [%I5 S(.IQUKE4O8YDGMIE807)S%O^;8ZG.#[5K0:@EY%!+<G[+/;
MR[0 3D,>![$&MJ52+E=F<XRV/6;*\2\L4FASAA@<<C''-)\)_P#D23_V$+S_
M -'O5/P_;R0VDCR,-LK[D53P!5SX3_\ (DG_ +"%Y_Z/>E,XK6;*GQJ_Y)ZW
M_7];?^C!7SIX6\,2ZKK91P3:0,&G)X..P_&OHOXT_P#)/6_Z_K;_ -&"O%O!
M]^Z+?D2[4C5"2YP, TH).23+UY6T:M[!):M)JLR06VFZ>S"VA&=TC#@$]@":
M\^&KW+WLM[-*99)&W2@]_IZ5Z[<VL&M^&A$0?W\9< =1^'M7GJ^$UBN8K>YN
M8XU9OG+G:Q [ >]%=24E$JE)--FAH-@GB*;[?<W(@T^U7,LDW R.P]:M:EK,
M'B#7_L4,GFK&<63=$5@O&%]<]S^%5O$LUBWAR'2;!H8YX9!(;>$$Y7'0MW/.
M<>U4;!#H%G%?6Z*=3G=5@:5<^4I^\^WVZ#-/FDFH/9!9.\NIU/BS55\.:=I^
M@:9-MN(R)+IU/W>/N^Y).37&V]]>/=[H[B1G8C+$\FJUW,]U=W$]PSF1W)9F
MZDU>T+2-3U>]\O34550%I9W.U(Q_>)J)2=61<8JG$[.TMI;1[J\O1]JFN0J"
M!1N38 ,<=%]Q5W5]5@N]#FL[8&&_78B)"VS82<#)[ 5-IMO'%I)MC??;(CD/
M/'QO_'OS5SPQX;C:Z.IWD2.J-F!#DC</XSZD=!75!3C-6V.:4HV;>Y(G@:RU
M&UA.JHK2_*[O&,.[ =2>PJ.\N8X[_P"R:8BF*!UC8)T [_4UH>)_$\&BR0VC
M2*LUP"-Q_AST_'-<U>7%Y:RK_9MI%*&0.S22;58^F1S6K;YK(RC>2O+Y$K:I
M/=>(%@M8(YH]S"YD_P">8! '3OUK2N699I'3*PX,2#N?\#Q7'V4O]@:_>VT
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M^S;,<8W;LT 7J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Y_4?^1YT'_KTO/YPUT%49]-2?6;+4C(P>UBEC5 .&\S9
MDGZ;/UJ]0 4444 %%%% &?KW_(O:G_UZ2_\ H!HT'_D7M,_Z](O_ $ 59O;8
M7MA<6K,56>)HRPZC<,9_6BRMA96%O:JQ98(EC#'J=HQG]* )Z*** .&^+?\
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M*9#B3&-VX>O3C&>:T3H]@?L7[C'V)R]N [ (2".F>1ST.0, ]0,+-IL,LS7
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ME%M"T@B09:0@<*H[DG 'N:Q++QE&-/MSJEJ\.I/>R:>]I:YG(G56? ([%%#
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M6D4GEX!"&/>6"!R2K'(W;>^W- '2T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g3dyckr3udth000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'I 5\# 2(  A$! Q$!_\0
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MAV+#\PRRD;G&.%*^M;GB+XBZ3X<U*6QEL]5O9+:-9;Q[&T,J6D;9(>5L@*,
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MQ]W@CIG'?%)KOQ$TS0M>31CI^K7][+8B^B33K7S_ #$+E<#!SG@G) &.^>*
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M<=&4JI'('7-8VH^ M33X):MX?TW1;:UU&]N%G33[:[9U0>=&<&25R"P1.2"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6W_QNN@HH Y_^P];_P"AMOO_  $MO_C=']AZW_T-M]_X"6W_ ,;KH** .?\
M[#UO_H;;[_P$MO\ XW1_8>M_]#;??^ EM_\ &ZZ"B@#G_P"P];_Z&V^_\!+;
M_P"-T?V'K?\ T-M]_P" EM_\;KH** .?_L/6_P#H;;[_ ,!+;_XW1_8>M_\
M0VWW_@);?_&ZZ"B@#G_[#UO_ *&V^_\  2V_^-T?V'K?_0VWW_@);?\ QNN@
MHH Y_P#L/6_^AMOO_ 2V_P#C=']AZW_T-M]_X"6W_P ;KH** ,3PK=W=YH\A
MOK@W$\-[=6YF**I=8YG120H SA1T%;=<_P"#_P#D%7O_ &%;_P#]*I*Z"@ H
MHHH **** "BBB@ HHHH **** "N?\9_\B^G_ &$+'_TKBKH*Y_QG_P B^G_8
M0L?_ $KBH Z"BBB@ HHHH *P?^$E!.I 6,X-FT:(K_*9B_ P.PSW/UK>K&N-
M"\^?49/M#(UYY10JO^K:/H??F@"N/$5RTWV)-.5M2#LKP>?A % ;._'.0PQQ
M6?XTUJQE^'&H323I ;VQD$,<K ,S;?NCU-7_ /A'KI9?MJ7Z+J;.S/-Y.4(8
M!2 N>,!1CGK53Q?I\%G\--5M@HD%OI\@1W )SM//UH Z/3?^059_]<$_]!%6
MJJZ;_P @JS_ZX)_Z"*M4 %%%% !117&_$">6*QM$CF=%>1MRKQNP!U/M_7VK
M.M4]G!S[$SERJYV5%8WA:5Y_#5E))(TCE2"S=>&(_3&*DO-2FM_$>F:>BH8;
MJ*=W)'(*;,8_[Z-5"7-%2[C3NKFK1115#"BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH Y_P?\ \@J]_P"PK?\ _I5)705S_@__ )!5[_V%;_\ ]*I*Z"@
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M -*I*Z"N?\'_ /(*O?\ L*W_ /Z525T% !1110 4444 %%%% !1110 4444
M%<_XS_Y%]/\ L(6/_I7%705S_C/_ )%]/^PA8_\ I7%0!T%%%% !12$@ DG
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M[_P(7_&E_P"$P\-_]!W3O_ A?\:W)-JBL7_A,/#?_0=T[_P(7_&C_A,/#?\
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M "N>\>?\B#KW_7C+_P"@FNAKGO'G_(@Z]_UXR_\ H)H U]-_Y!5G_P!<$_\
M015JJNF_\@JS_P"N"?\ H(JU0!SGC?\ Y%L_]?-O_P"C5KHZYSQO_P BV?\
MKYM__1JUT= !1110 'I7"^(,_P#"5V_WL_)C]Z >O;^[^-=U5.;3;&>4RS6L
M,DAZLR@FN/&X9XBFH)VU3^XZ,-75&;DU?1HMCH*6DX'%+78<X4444 8&E_\
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MZ "BBB@ HHHH **** "BBB@#G_!__(*O?^PK?_\ I5)705S_ (/_ .05>_\
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MM6%66\=A!TI:**R.H**** "BBB@ HHHH **** "BBB@#G_!__(*O?^PK?_\
MI5)705S_ (/_ .05>_\ 85O_ /TJDKH* "BBB@ HHHH **** "BBB@ HHHH
M*Y_QG_R+Z?\ 80L?_2N*N@KG_&?_ "+Z?]A"Q_\ 2N*@#H**** "BBB@ K-U
MV:TM](FEOHFF@7!,2@DN<C Q]<5I44 <)Y5DUG#<R78A5KB64K;VWFPQN5 "
M8(]/;DYJ3QA'J5U\,[N7SQ9.M@[7$ A!WC;]WG[OX5V]<]X[_P"1!U[_ *\9
M?_030!KZ;_R"K/\ ZX)_Z"*M55TW_D%6?_7!/_015J@ HHHH **** "N>U+_
M )'?0?\ KWN_Y1UT-<]J7_(\:#_U[W?\HZ .AHJ*XG6VMI9W!*QH7;'7 &:Q
M-'\76&MWWV2VAN4D"%\R*H&!CT8^M7&G*47)+1&,\12ISC"3LWMYG04445!L
M%%%% !1110 4444 %%%% !1110!S_@__ )!5[_V%;_\ ]*I*Z"N?\'_\@J]_
M["M__P"E4E=!0 4444 %%%% !1110 4444 %%%% !7/^,_\ D7T_["%C_P"E
M<5=!7/\ C/\ Y%]/^PA8_P#I7%0!T%%%% !1110 4444 %<]X\_Y$'7O^O&7
M_P!!-=#7/>//^1!U[_KQE_\ 030!KZ;_ ,@JS_ZX)_Z"*M55TW_D%6?_ %P3
M_P!!%6J "BBB@ HHHH *:44L&(&X=#CD4ZB@".>%;BWDA?.R1"C8]",&L;2/
M">GZ+>FZMGG:0H4_>,",'Z >E;M%4IRBFD]&9RHTYR4Y13:V\@HHHJ30****
M "BBB@ HHHH **** "BBB@#G_!__ ""KW_L*W_\ Z525T%<_X/\ ^05>_P#8
M5O\ _P!*I*Z"@ HHHH **** "BBB@ HHHH **** "N?\9_\ (OI_V$+'_P!*
MXJZ"N?\ &?\ R+Z?]A"Q_P#2N*@#H**** "BBB@ HHHH *Y[QY_R(.O?]>,O
M_H)KH:Y[QY_R(.O?]>,O_H)H U]-_P"059_]<$_]!%6JJZ;_ ,@JS_ZX)_Z"
M*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/^
M#_\ D%7O_85O_P#TJDKH*Y_P?_R"KW_L*W__ *525T% !1110 4444 %%%%
M!1110 4444 %<_XS_P"1?3_L(6/_ *5Q5T%<_P",_P#D7T_["%C_ .E<5 '0
M4444 %%%% !1110 5SWCS_D0=>_Z\9?_ $$UT-<]X\_Y$'7O^O&7_P!!- &O
MIO\ R"K/_K@G_H(JU573?^059_\ 7!/_ $$5:H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .?\ !_\ R"KW_L*W_P#Z525T%<_X
M/_Y!5[_V%;__ -*I*Z"@ HHHH **** "BBB@ HHHH **** "N?\ &?\ R+Z?
M]A"Q_P#2N*N@KG_&?_(OI_V$+'_TKBH Z"BBB@ HHHH **** "N>\>?\B#KW
M_7C+_P"@FM6_U.VTT(;AGS(2%6-"[' R>!S@"L;QI-'<_#O6IH7#QR:?(R,.
MA!7K0!MZ;_R"K/\ ZX)_Z"*M55TW_D%6?_7!/_015J@ HHHH **** "BBB@
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ML?\ C6Q10!C_ /"6>&_^A@TK_P #8_\ &C_A+/#?_0P:5_X&Q_XUL44 8_\
MPEGAO_H8-*_\#8_\:/\ A+/#?_0P:5_X&Q_XUL44 8__  EGAO\ Z&#2O_ V
M/_&C_A+/#?\ T,&E?^!L?^-;%% &/_PEGAO_ *&#2O\ P-C_ ,:/^$L\-_\
M0P:5_P"!L?\ C6Q10!C_ /"6>&_^A@TK_P #8_\ &C_A+/#?_0P:5_X&Q_XU
ML44 8_\ PEGAO_H8-*_\#8_\:/\ A+/#?_0P:5_X&Q_XUL44 8__  EGAO\
MZ&#2O_ V/_&C_A+/#?\ T,&E?^!L?^-;%% &/_PEGAO_ *&#2O\ P-C_ ,:/
M^$L\-_\ 0P:5_P"!L?\ C6Q10!C_ /"6>&_^A@TK_P #8_\ &C_A+/#?_0P:
M5_X&Q_XUL44 8_\ PEGAO_H8-*_\#8_\:/\ A+/#?_0P:5_X&Q_XUL44 <YX
F)FBN-$NIX)$EADU.^9)$8,K W,F"".HKHZ** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g3dyckr3udth000018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %. B # 2(  A$! Q$!_\0
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MDYY '))P*T;WQ[9:AI&D7MK=ZCIS2:]%ID]N+:-Y1-D[H) QPJ]RRG.,8ZT
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MLUMN6.-D#[RQ(& IZ9SP< X)KHGUBW_L./5[:.>\MYHXY85M8S(\BOC;@?\
M @<G  Y) !- &A16#H'BJ#7KV_L&T^_T^_L/+,]M>HH;:X)5@59E(.".#P0<
MUO4 %%%% !1110 4444 %%%% !7*Z_X9O-5\<^$];@E@6VT<W1N%<G>WFQJJ
M[1@@\CG)'XUU5% 'G ^'^JCPYXDT[[19>=J?B,ZM"V]MJQ>=$^UOER'PAX (
MZ<T:Q\/]5U"]\?SQ7%DJ^(;>UBM [ME#''M;S/EX&>F,UZ/6!K7C;PUX>O%L
M]5U>WM[I@#Y/+N!_>*J"0N 3DX  S0!A:QX/UJ#7+K4O"TUC:&_TN2SNXY6,
M:B<#]U.H5#N89(.<< =>E4+KX5+8:/I!T"^NCJFDSP30?;=0F\@["-XV_,%#
M#</E7OCH37HEE>VNI64-Y93QW%M,N^.6-LJP]0:GH \\U'X>W=]IGB8+/;0Z
MG>:G_:.EW:$[K=PD87+;<KRA!QGAC5S5M#\4R^)-*U_3X]%DNH=->TNH;J>5
M4WNR,2A6,DC*D<@?2NWJ*YN8+.VDN;J>."WB4O)+*X544=22> * *;V]]>>'
M9+:[%M'?36S1N(68Q*Y4C@D9QGOC\*Y#PSX&U/1O%6BZI<SV;06/AJ+2)%C9
MBQF5]Q894#9COD'VKOP0RAE(((R".]+0!Y7X9^&FLZ+_ ,()]INK!_\ A'WO
MVNO+=SO\_.S9E1G'?./;-*_PTUEO,_TJPPWC/^W_ /6/_P >_/R_=_UG/3I_
MM5ZG10!Y5+\/?%'V'Q)I$-[I(TWQ#JDUW/(1)YUO&[@X7C#L5 &#M"G/+9XT
MKCX?7T]_X[=;JVCM_$%G;VUIRS-&8X3&2XQZ],$\5TFJ^-_#.A:C]@U36K2T
MNL!O+F?!P>A^E;-K=6]]:Q75I/'/;RJ'CEB<,K@]P1P10!PVI>$]=U1-!U2X
M@TB35M,BE@DLWFD^S3(X49#[-RL-H/W3U(]Z:_@W5K.YT?6=$LM#L=3M'N#<
MV2LXMYA,%#-Y@3=O&Q>=O/X5Z#10!RG@7PSJ'AFVUI=3N;:XGU'5IM0WVRLJ
M_O%3(VMDCY@W&3QCFL%/A[J=IX=TQK&6QB\0Z;J<MY%.'*I+%),[-$[["VUD
M;!&#R!VKTFB@#SF'P#<VFH7ML^EZ%JFDWE])=M)>NXEC#MN*E A5\'H<C]*Y
M77[JWM/&_B:\GBMKJZCN89+729Y)XI;PQQIMVQ1DI*-P^5F4D%3G@#'KU[KN
MGZ?K>EZ1<2LM[J?F_94"$A_+7<^3T& >]:5 'F^K^"O$-UK'B:YTJXT^&U\4
M6,4%Y]L#F2V9(FCPBKPV0W4D8/.#C!CMOAYKD&H6=S%J5M;/!X130Q-$S%TN
M5.?,4;1\@]<@^U>F5##=VUQ)-'!<12O _ES*CAC&V =K =#@@X/8B@#@= \$
MZO::_;ZE>IIMNB:3+82+!/+/(\C,A\QG=1NSM.>X]3GBM_P@GB*Y\)^%M%NI
M-+5]!U>VN/,BEDQ-;PAAG!3ASD?+TXZUW+^(]&CU]-"?48%U5UWI:EL.PP3D
M#OP"?PI;KQ%H]CK-MH]SJ-O%J5T-T-LS_.XYY _ _D: .*NO!'B+^S]:\.6E
MUIW]AZM=2W#W4I?[1 LK;I$"!=K'KABPQGD<58D\":@=0\?313V@B\0:?%:6
M09VRC);M%F3Y>!DCIGC\J] HH XRX\&7-Y\+[#PP]W'#?6EM;*LZ@O&)8=I!
MP<$KE?8XHL_#^OZAX@;7-?;3H)X;"2RMK>QD>1/G(+.S,JG^$  #@=S79T4
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M7<Z@L8HY1OP.IV]<>]5Y?'.AQ:-8ZJ)+N2"^G-O;)'92M+*XW9 CV[OX6[4
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M9<XRVX@%B0!DD#I6Q10!PGA/1/%WAQ!I\D&@RZ<+FXE$RW$OG8D=G QY>.K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&G_"C_A%!_T'M=_\#?\ ZU=#10!SW_"*#_H/:[_X&G_"C_A%!_T'M=_\#?\
MZU=#10!SW_"*#_H/:[_X&G_"C_A%!_T'M=_\#?\ ZU=#10!SW_"*#_H/:[_X
M&G_"C_A%!_T'M=_\#?\ ZU=#10!SW_"*#_H/:[_X&G_"C_A%!_T'M=_\#3_A
M70T4 <]_PB@_Z#VN_P#@;_\ 6H_X10?]![7?_ T_X5T-% '/?\(H/^@]KO\
MX&__ %J/^$4'_0>UW_P-/^%=#10!SW_"*#_H/:[_ .!O_P!:C_A%!_T'M=_\
M#3_A70T4 <]_PB@_Z#VN_P#@;_\ 6H_X10?]![7?_ T_X5T-% '/?\(H/^@]
MKO\ X&G_  H_X10?]![7?_ W_P"M70TC,$1G8X51DF@#G_\ A%!_T'M=_P#
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M):KODA\G<91$_'S _P 97MC\,UO:5#=1&]-TBJ9+DNFW;RNU>>/<'KS6C10
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M0 4444 %%%% !1110 4444 %%%(S!$9CT49- "T5X3X;\56-Y96WBWQ1%XF
MO+\LM]'<NEC9@2%8X]JNH*#: 6*$$GD\FNB:";QKX\\:V%YJ.H6]OHT%O#8I
M9W<D C>2-F:0[3AFR.,@C':@#U2N?\%_\B\__80O_P#TKFJE\,=<N_$?PXT;
M5+]R]U)$Z2.3RY1V3<?<[<GZU=\%_P#(O/\ ]A"__P#2N:@#H**** "BBB@
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MFNGH **** "BBB@ KG_!?_(O/_V$+_\ ]*YJZ"N?\%_\B\__ &$+_P#]*YJ
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M_P#Z5S5?T'1;7P[H-CH]EN^SVD0B0MC<V.K''&2<D^YJAX+_ .1>?_L(7_\
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M_P"O7_VG76:!_P ARV_X%_Z":Y#Q_H^F7'C&[FGTZTEE=8RSO K,WR <DCT
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MRW,MTZ##33!0[^YV*JY^@%8MM_R4/5/^P39_^C;FN@H **** "BBB@ HHHH
M**** "N>\=?\B+K7_7H_\JZ&N>\=?\B+K7_7H_\ *@#H:*** "BBB@ HHHH
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MU\OG,U"$)6OJ?6Y=%RE)>18\#:E]MO;N/[#>P;8P=T\6T'GH.>M=O7+>$_\
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MJZ&N>\=?\B+K7_7H_P#*@#H:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BBB@ HHHH *Y[QU_R(NM?]>C_ ,JZ&N>\=?\ (BZU_P!>C_RH Z&BBB@
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M %%%% !1110 45C#Q;X=;6?['&MV!U+?L^S"X7?N_NXSU]NM;- !7/\ @O\
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M@'&$X\WQ)K[SV</'V-13WL<M7H&E_P#(*M,_\\5_E6-_P@/A?_H%)_W]D_\
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M?]>C_P J/^$'\.?] T?]_I/_ (J@^!O#9&&TM&'HTCD'\,T =#1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<SXJ\:VGA.[T^&[M+F9+M9)'EAV[8(XR@=VR0<#S >,G -=-7)^)?#L
MNN>*='>2V\W2UL;^VO&W ;?.6(*,$Y.=K=!QB@"?7_&EIH&N:5I4EG<W$E_)
M&ADA"[( \BQH7)(ZLW&,GY6]*UAK>E-JQTD:E9G457<;03KYH'KMSFO.-/\
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MJ]7#0:5K%KX^^U:?97<%C<2!]2DGEA>WGQ%M#QC)E63(1>@7 /U/<T %%%%
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M)4DX)Z]373T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !37
MC20J716*-N7<,[3ZCWIU% #7C20J716*-N7<,[3ZCWIU%% !1110 4444 %%
9%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g3dyckr3udth000010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $) M # 2(  A$! Q$!_\0
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M?[19SK-%DKN7U':K-3L4G?8**** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9\JY>5MR@'=P&4\ XZ8KM**3GY#5*UM0HHHK,U"BBB@ HHHH **** "BBB@
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MHJ"REFFM(Y;A$21QNVH<@ ].:GJ'H4G=7"BBB@84444 %%%% !1110 4444
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M,TL@(<-N;KN&#P/I4MKHD%L8#YLKM"Y=2Q'IC!Q[5IT4^9ARH****DH****
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M_O(=II14HJVX:D]%9U[)>V5JTD<B2@$#+K@KDXSQZ4NGW,DLLL33+.J!2)%
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M%(84444 %%%% %:>_MK>7RY),-C)PI.T>IQT_&K'!'J#6?=Z=)/)-Y<P2.<
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M3YA_C4L<T4RYC=6'L::DF!)13(Y8Y0?+D5\'!VG.*?3 **** "BBB@ HHHH
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M/43LXN(E$>58-N;^[Z4"9+1110,*0@,,$ @]C2T4 (  ,   =A2T44 %%%%
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MNPR,#P1W/MC-)HVHRZAYS2F,;2-JJ.1UZTN1VYN@_:+FY7N:M%%%0:!1110
M5#"Y:68&+9M; /\ >XZU-440F\R7S"-N[Y,>F* ):*** "HI+>&9U:2)'9>A
M9<XJ6BBX-7(+JV2[A\M^.05;'0BHK?3HHG>20)+(^ 3L   [ 5<HIJ32L2XI
MNXP0Q+TB0?113@ .@ I:*15B*:WBN% E7.#D$$@C\14?V*- /L_[EATV=#]1
MWJS13NQ.*9B+?WGGC)1Y#+Y?D#CCU]<]_2M/_2V_YY(/Q;_"IMB;]^U=V,;L
M<TZJE)/9$1@UNROY$S'Y[EOHB@?XT?8XS]\R/_O.:L45/,R^5$2VT"?=B0>^
MVI<#&,<444KA9(CBMX8"QBB1-W7:,9J2BB@:5@HHHH **** *NI?\@^;_=JP
MG^K7Z"J^I?\ (/F_W:L)_JU^@I]!=1U%%%(84444 %%%% !1110 4444 %%%
M% !1110 5!*8A=P!E)D(;8?3IFIZB=G%Q$HCW*0VYO[OI^= F2T444#"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH CDMX)6#20QNR]"R@D4JQ1H[.L:*[_>8+@GZT^B@"I/_P A*T^C
M_P JMU4G_P"0E:?1_P"56Z;$@HHHI#"BBB@ HHHH **** #J,&HH;>&W!\F)
M$SUVC&:EHHN%@HHHH **** "H84"RS$2[]S9(_N\=*FJ" P^=<>6"&W_ #Y]
M<4")Z***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M7/:O->IJ#+&\ZD(IM5C'RNV?FW?A32N["D[*YKZE_P @^;_=JPG^K7Z"L[5!
M>_9)BC0"/:,A@<^]3*-0V+AK?IZ&BV@KZEVBJ>-0_O6WY&C&H?WK;\C18=RY
M15/&H?WK;\C1C4/[UM^1HL%RY16=)+J$<T,9-N?,)&>>,"I<:A_>MOR-%@N7
M**IXU#^];?D:,:A_>MOR-%@N7**IXU#^];?D:1O[05&;=;\#/0T6"Y=HJA!)
MJ$\"2@VPWC..:?C4/[UM^1HL%RY15/&H?WK;\C1C4/[UM^1HL%RY43B4SQ%6
M C&=X]?2H,:A_>MOR-02M>B[@1OLY9@VT_-QTHL)LTZ*IXU#^];?D:,:A_>M
MOR-%AW+E%4\:A_>MOR-&-0_O6WY&BP7+E%4\:A_>M_R-1P2ZA/&7!MAABO?L
M<46"YH453QJ']ZV_(T8U#^];?D:+!<N453QJ']ZV_(T8U#^];?D:+!<N45G3
MS:A J$FV.YPG?O4N-0_O6WY&BP7+E%4\:A_>MOR-&-0_O6WY&BP7+E%4\:A_
M>MOR-&-0_O6WY&BP7+E%5;::=KB6&?R\H%(*9[Y_PJU2&@HHHH **** "BBB
M@ HHHH **** "BBB@ HH)P,UBV&L3W-U$)(X_*N%D:-4/S)L./F^M-*XFTB_
M/_R$K3Z/_*K=9$MZ[7]J?L5P,!^JCTJW]M?_ )\[C_OD4VA)HN453^VO_P ^
M=Q_WR*/MK_\ /G<?]\BE9CNBY15/[:__ #YW'_?(H^VO_P ^=Q_WR*+,+HN4
M51742SNBVEQN3&X;:=]M?_GSN/\ OD46871<HJG]M?\ Y\[C_OD4?;7_ .?.
MX_[Y%%F%T7**I_;7_P"?.X_[Y%-?43'MW6EP-S!1\O<T6871>HJG]M?_ )\[
MC_OD4?;7_P"?.X_[Y%%F%T7**I_;7_Y\[C_OD4?;7_Y\[C_OD46871<J&%RT
MLP,6P*V ?[W'6H?MK_\ /G<?]\BHX[]VDE'V>X;:V,; -O'3WHL%T:%%4_MK
M_P#/G<?]\BC[:_\ SYW'_?(HLPNBY15/[:__ #YW'_?(H^VO_P ^=Q_WR*+,
M+HN451DU$Q1EWL[@*.ORT[[:_P#SYW'_ 'R*+,+HN453^VO_ ,^=Q_WR*/MK
M_P#/G<?]\BBS"Z+E%4_MK_\ /G<?]\BC[:__ #YW'_?(HLPNBY15'^T3YOE?
M9+C?MW8V]J=]M?\ Y\[C_OD46871<HJG]M?_ )\[C_OD4?;7_P"?.X_[Y%%F
M%T7**I_;7_Y\[C_OD4?;7_Y\[C_OD46871<HJ.WF6X@250P##HPP14E(8444
M4 %%%% #9 IC;> 5QR"*K66HP7K2)$'5H\;E="IP>AJ2XM(KDHS[@R'*E6(P
M?PZU7T_37LY[B:2X,LDQ&[Y HX[X]?>FK6)=[Z%^BBBD4%%%% %6^NH+-%FF
MC=\$XV(6(XY/Y5/#*D\*2QMN1U#*?4&L^^T<7(80W#P;WW2@Y82>Q!/3Z5H1
M)Y<2(2#M ' P/RIZ6$KW'T444AA00",'H:*BN+:.ZB\N4,5SGAB/Y4 1V=W;
MW(E2WR! _EL"N,$59JM:V:VLMPX<MYS[\'MP!C]*LTV)7ZA1112&%4)M2LX[
MY8)"?,4A=^TE4+= 3V)J_67/HPFO'E\]EADD662+;]YEZ<]N@_*FK7U%*]M#
M4HHHI#"BBB@ JM975O=1R-;Y"I(R,"N/F'6K-5K2T%J9R'+>=*TAR.F>U,6M
MRS1112&%%%% %2_O;>RB5[A'9>6^5"VW'))] *M(ZR(KJ<JPR#ZBJ.IZ?)J"
MQ*MSY2(V60IN63TSSTJ\HVH <<#' Q3TL+6XM%%%(84444 4H=0MI=0>V576
M;!.60@, <'![XS5VL^+37356O9+DO\I55V <$YP3WQVK0INPE?J%%%%(8444
M4 %%%% !1110 4444 %%%% !4$5E;03O-% B2/\ >8#DU/10!#,L0D2XE<)Y
M><$G YJ4$, 000>A%9NHVMS-')\J7*$_+"5"E/<$\$CWJ?2K>2TTJWMY0HDC
M3!"G(%.VA-];%RBBBD4%%%-D#M&PC?8Y'#8SC\* (D$,5U)^\'FRX)0L,\>U
M3UA'3[J36899X$DCB(87";59FP>HZX'H*W:;)3"BBBD4%13QHZHTC;1&P?.<
M=*EJE?VDUW%+&)$,+QE3"R?>...:!,N @C(.0>AI:@LHF@L;>)\;TB56QZ@8
MJ>AC04444 %00+"))FBD#EFRX!S@XJ252\+HK;692 ?2L?1]-N+6Y626%(52
M 0ML;/FMG.\__7YYIK8EO5&W1112*"BBB@"*X2.2!DE;:AZG.*EZC(JIJEJ;
MW3+BW"JS.A"ANF>U3VZ-';1(WWE0 _7%/H+J24444AA1110! !#]M+>8OG%-
MNS<,XSZ5/6+]BGD\0"YDM$6&,YCE1AECC&6[_A6U38DPHHHI#"D)"@DD #J3
M2U#=H9+61%B64E>$8X#>U !:K$MNJPN'C'0@YJ:LS1+.:SMIEFB6+S)F=4!!
M(!]<<?E6G3>XH[!1112&%%%% !1110 4444 %%%% !1110!GZQ?SZ;9FYAMA
M.J_?!<+@=*A76TAWB_5+=E"Y57WG+ D#CZ5>OK-+^RDM9&95D R5Z]<_TJL^
MCPO?"Z,CAPR-CM\H('\ZI6MJ0^:^@T>(=+:)Y5NE*ICL><],>M-O-<A@2R:
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5** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g3dyckr3udth000029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000029.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &H <,# 2(  A$! Q$!_\0
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M %%%% %:;4;&WG6">\MXIGQMC>558YZ8!.:LUY3KTOAF+XHZY_PDXL3;OHD
MC6Y569CODR(P>2V/[O/2N>&N>+]+TK0=*N+]M,==&\^&6ZN8X-\_F,%61I$;
M?M39F,88Y- 'N$5Y;3W$]O%<1236Y FC5P6C)&1N';(YYJ>O"/$J7$\_B6ZN
M+J6T>/5-'ENI+5]J+F--S9(^ZI.03TP,UMZIXQN[?QWI=AINJ7DD2W]K:3+/
M+"4GBD0$NL83<P.0?,W 9X H ]9\Z+SA#YB>:5W!-PW8Z9QZ4^O/=5U+3]*^
M-5E<:C>6]I$^@21K)/($#,9U(4$]^#Q7.OXYUAO&<\>DSW=PIBU!?L-T\;$R
M0H6CQ$BAHP6'&YB6!H ]DHKQ'5;N+4_#7AC47\8WUSC5;.34)1)&BV;.K;B<
M)\F#P V<=^M:<_BV]G^)-KI=EJ5\MO)?2:?<132Q?=$1(=(PFY1G!60GYN>,
M4 >MTA( ))P!U)KP?1]8U/1/A]I5O9:I<?O=5GM]2>6X2-K(!I"J[V0B+>0"
M2P/7C&:]$TJX34/ANTGBZ\L+BW.]9;C[0#%(@?";G&U2?N@XX)^M '7&]M5M
M/M9N81;8SYQD&S'3KTJ5'61%=&#(PRK*<@CUKPS0KW3IO!'P[^V3VTFC6MY*
MFI"0AHHI-DAB$HZ#D@C=QR*VK&]U#1/@?K%_ITLEKY=S<2::X3[D!G^0J&'W
M<'CCH: /6Z*\@U'5O$6DZEK@7Q'>SQ:5J.G)$DL46)%N-GF*^%&1\QP!C'O4
MMKXHUJ;Q1 @U69]0?6Y[.YT;RU"0V2AL2XV[A@!6WYP=V* /6J@:\MDO([-K
MB);F5"Z0EQO91C) ZD#(_.O&++5O$.I:!817.M7MT=:\/WLTB!$!22(C9Y>U
M<@D'!SG/M46G))<Q>$&L-=NQ)'X;NG-S&R.Z.HBS'DK@!6&,8SQC- 'M=]8V
MVI6,UE>0K-;3H4DC;HRGM7-:;\-O#6F7MM=1V]S,UH=ULES=22I >Q56.!7(
MZ/XPU:Y\0>&)K_4S-%J=I:C[%9/&KQRO&6=Y8BI9HSP=RL N*];HN)I,****
M!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 TQHS!BBEAT)'(I656
MQN4'!R,CI2T4 (44[LJ/FZ\=:38F<[%R. <4ZB@!C1QN0716QTR,T[8N[=M&
M[UQS2T4 -\M-I78N&.2,=:-B;MVU=WKBG44 -\M,,-BX;J,=:"BE-A4%>F,<
M4ZB@!@BC"E1&H4]1MX-.*@KM(!'IBEHH :44YRHYZ\=:7:N[=M&XC&<<TM%
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M=^48;SS]Y\@Y!^48Q30I'I5%%%(H**** "BBB@ HHHH **** "BBB@ HHHH
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M_MG_ .S5P==Y\.ON:A_VS_\ 9JZ\%_'C\_R-:/QH[BBBBO?.T**** "BBB@
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MQ\?@.>/2]/LO^$CU)C:79N3*7;=+DYV-\W3KTYY^N0#LZ*** "BBB@ HHHH
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MW/4P>'C7;4NAV7]N:;_S\C_OAO\ "C^W--_Y^1_WPW^%<+17D?VYB/Y5^/\
MF=_]F4N[_KY'=?VYIO\ S\C_ +X;_"C^W--_Y^1_WPW^%<+11_;F(_E7X_YA
M_9E+N_Z^1W7]N:;_ ,_(_P"^&_PJQ;:A:WC%;>7>5&2-I'\Z\]KH?"G_ !\S
M_P"Y_45TX3-JU:O&G)*S]?\ ,QQ& ITZ;FF]#JJ***^A/*"BBB@ KR'Q9K7A
MB^\6W:'Q!JFDWEDT2S-:VS2+,Z;\8&PX9=S#=T.[OBO7J\\\:6/B*75;B\TZ
MZU2&U@2#,6EB/S)5)<.<'EF7Y, D#&::)GL=AX<6%/#.F+;VTUK"+6,)#/\
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M:/QH[BBBBO?.T^1[O_C\F_WS_.H:FN_^/R;_ 'S_ #J&O6/EF%%%% @HHHH
M]3^"/_(9U3_KW7_T*O:Z\4^"/_(9U3_KW7_T*O:Z\_$?Q&>]@/X"^85YY?\
M_(0N/^NK?SKT.O/+_P#Y"%Q_UU;^=?-9]\$/5GT&5_%(KT445\T>P%%%% !7
M0^%/^/F?_<_J*YZNA\*?\?,_^Y_45WY9_O</ZZ'-C?X$CJJ***^U/G HHHH
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MLYU"W$0?,!X7#')%-"DSN]<_Y &H_P#7M)_Z":\2/4U[;KG_ " -1_Z]I/\
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M&,5Z77'>)O\ DH?@C_KK>?\ H@T(4CH=<_Y &H_]>TG_ *":\2/4U[;KG_(
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M*/\ A5_B/_H:K/\ \%?_ -LKA_LZMW7]?(Q]C,Y^BN@_X5?XC_Z&JS_\%?\
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M?_0VZ=_X*?\ [97+5DIRNCU,+3E2IJ,EJ=A7GE__ ,A"X_ZZM_.M/^Q_'?\
MT-NG?^"G_P"V5ER^!_%TLKR-XKL-SL6/_$J]?^VE>/FF"J8J,53:T[GJX+$Q
MHR;DGJ045)_P@?BS_H:[#_P5?_;*/^$#\6?]#78?^"K_ .V5XW]B8GNOO?\
MD>A_:5'L_P"OF1T5)_P@?BS_ *&NP_\ !5_]LH_X0/Q9_P!#78?^"K_[91_8
MF)[K[W_D']I4>S_KYD==#X4_X^9_]S^HK"_X0/Q9_P!#78?^"K_[95JR\)^,
M[!V:'Q9IX+#!SI/_ -LKJP>4UZ->-235E_78PQ&/IU*3A%.[.]HKE;72O&D=
MW"]UXHL)K=7!DC72]I=<\@'?QD=ZZJOHCR4PHHHH&%%%% !1110 4444 %%%
M% !1110 4444 %-\Q-H;>N"< Y[TZO!M=M;UKK5O"EBTB2:/>W.NQ!1QY819
M(E_[[D8?A32N3*5CW9YHHSAY$4^A8"E21)%W(ZL.F5.:\=NXK'Q/X#\:>+IK
M6.;[8&^Q--&"8DBC" KGH=V_I7J/AZQL]/T*TBLK6"VC:)'988P@+%1DX'?W
MH:!.YIT444B@HHHH ***1ON-]* $WH0#N7#' .>M,-S "09HP1U&X<5XCHK:
MF?"OP]\X67]F_P!MIY#1NYF)W2_>!&W'7H?2MSX<V.EWZ7<-[9>';@R7-UD.
M%>\;]\WWU(^[_3%.Q"G<]426.0D)(C$=0K T^N$^$VGV-OX,ANK>TMX[B6:X
M625(P&<"9P 2.2!7=TF4G=7"BBB@8TN@W99?E&6YZ4&1%*@NH+?=R>OTKQGQ
M,Y7XAZ]]MR?#GVC3QJXC/S;#&WE[O^F>[&[OTJW='099_&S^)6MO[0BD*V F
M8;UM_+'DF =1DY^YWJK$<YZ[17F5OJWC&UN/!5K)9B1YK5_M"RW90SN(03YG
MR':5//?)]*V/'?B:^\(S:=JID)TMEF@N(0@;]Z4+1'.,_>4K^-*P^96N=K4<
M4\-P&,,L<@1BC%&!VL.H..X]*\EOO%'B^RO(=-DO(XKZ#3[>?=.]O"EQ,^2^
M[?@E1]W$>".I[4_P[J6HZ9JL<D-X!:W_ (HN[2>S\M2HR&8MNQNW KZXQVHL
M+G/5H+B"ZB\VWFCFCR1OC8,,@X(R/>EBGAG#F&6.0(Q1MC [6'4''<>E>4:'
MXCO&72[&75K?1+.87TYND@A199$N"JQC*[1\OS' R?6J<7B#4-(62UL9C!;W
MNOZCY]U&\*$%<%5#2_(I8DGGDXP*+!SH]GHK'\+7>H7WAFPN=4:W:]>/]ZUL
MX>-B"1D%>.0 >..:V*1:$+ $ D GH,]:0R(%9BZA5."<\"O._B?_ &K_ &GX
M9_L3R_[4\VZ^S[^F[[.W3W],\9Q6)92>'YKGPA%,0OAI[6X9UO6&UKX$;A/G
M@O\ >/S=^E.Q#EK8]@!! (((/0BF33PVT+33RI%$@RSR,%4?4FO(O[0U72_!
MWB^X\-)G2H[U_L,RS%1"F%W&$;3N7?N  P.N*ZGQY+=S?"?6)-1MHK:X, W1
MI-YJCYQCYMH_E18?-H=QU&117E]QXMU:/7IDCU)(YH-9AT^+1O+0F:W8+F7I
MOR06;<#M&WI65+\1M=TBY/VZ0S6^C23VNJOY*@R2,9/L[# X&$7I_>HLQ<Z/
M9:*S/#O]H?\ ".:<=5F\W4&MT:X?:%^<C)&!QQG'X5ITBPI-R@D;AD#)&>U+
M7CGQ >X3QWJ##?\ V8-*MO[5$)/G?9?/??LQ^&[_ &<TTKBD[(]@,L856,B@
M-]TD]?I3Z\K0^&9O%6NCQ$UC_9L5C;?V0MPP\H6IC.YH<\9W=UYZ8J'3]5\7
MV/A?P3&MLSM-<JCO-=%'F0B4K'(-AP-H4[LGD#BBQ/,>K23PPM&LLL<;2MLC
M#, 7;K@>IXI&N($N$MVFC69P62,L-S =2!U(%<9X[2XN+GP@@E^R7#ZLF70"
M3RSY4F<9&#[$C\*Y8^*]62&VOI9;::^M+#5@+B2V3<S0.JHW R,CJ%P#18;E
M8]=EGAMPIFECC#L$4NP&6/0#/<^E25XF^JZCK^D0SS:V]Q"=<T^.T\Y8#+ <
M_,S+&,?>SM!/(%>C>"M3OM0M-6@O[G[5+I^ISV:SE%5G1<$%@H S\V. .E#0
M*5V=-1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J/R(O-:7RD\Q
MEVLVT9(]"?2I** (A;P+!Y AC$.,>6%&W'TZ5(    , = *6B@ HHHH ****
M "BBB@"(6T 2-!#&%C.Y%"#"GU'I3(["SAG,\5I DQSF18P&.?>K%% #8XXX
MDV1HJ+G.U1@4ZBB@ HHHH C:W@;S-T,9\T8DRH^<>A]::UI;/)'(]O$SQ?ZM
MB@)3Z>E344 %,EABG39-&DBYSM=01FGT4 12VT$[QO-!'(T9RA= 2I]1GI1]
MF@!!\F/(<N/D'#'O]?>I:* (&L[5HUC:VA**V]5,8P&]0/6E>TMI8FBDMX7C
M=MS(R @GU(]:FHH 155%"J J@8  X I:** &-%&[H[HK,ARI(R5^GI3&L[9X
MGB>VA:-VW,A0$,?4CN:FHH 1$6-%1%"JHP% P *22-)8S'(BNC=589!IU% $
M7V> SB?R8_. VB3:-P'IGKBD:TMG$@>WB;S""^4!W$="?6IJ* "BBB@ IAAB
M9V<Q(69=C,5&2OH?:GT4 0/96LBQ*]M"RQ?ZL&,$)]/2IZ** &O''(5+HK%#
MN4D9VGU%4=2T/3M6TVXT^[M4:WG1D<)\IPW)P1R.>:T** ,72?"^G:1-<7"F
M>ZNKC9YEQ=R&5R$SL'/ QDXP*V$CCCW;$5=S;FVC&3ZGWIU% 6"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN)D\1Z[+X3O?$L7V&&R
M^S2S6T!B=Y0HSL9FW8).,E0O?&: .VHKGXO%EO);73C3]1$]JZ)+;-$JR ,,
MJW+;0I'<D>G7BJTGCW2DBAF2"^FADM4O'EC@RL,3,5W/SQ@J<@9/'>@#J:*Y
MV7QGIT.IM:20W8B0S!KLQCR085W2<YSQTZ=<U8TGQ-9:T+E;=98IH(UE:.91
MG8X)5N">#M/&01CD"@#:HKE+;QQ9>3;">*ZE9H;:2>YBM]L,8GX0G+$@$]N2
M._'-:.J:K/8Z[IUNJE[>:WN9941-SL8PFT+_ -]&@#:HKFD\:V,MNK16=])=
M&X:V%DB*9=ZJ'/\ %MP%(.=W<#KQ2VGBJ6XU/6+:32+U(M/6-E<*I,FY VW&
M>#S], Y(H Z2BN4C\;)=:EI-O9:;=RQWLTT$S':#;O'C(/S8/7.03QTSTJ]I
M7BW3-8U 6=J9=SH\D+N!MF5&"L5P2>"1U SG(S0!NT5R=IXPQ96\\UK=7<M_
M+<M:06<(9O*B;'.2!G&#DGOCTJ=O'.D[8I8H[N>U:.*66YCBS';K)]SS,D$>
M^ <#KB@#I:*Y74/&B0:7=7MAIEW=K;WB6AP$ 9C*(VQ\V1@^H&<CL<UJZGK]
MMI,%HUQ%,9[L[8K==N\D+N(Y8*, <\XH U:*YNW\:Z5>SVMO:F=YKN-)+=?+
M^^C DOU^ZI4AO0X'<9K>'?&:ZEI$#75G>B]^PI=$"WVBX' 8QC/0,1UQU!Z<
MT =;16#8>+=.U!H$C2X225IU*.@RC18W@D$C^(8P2#44?C&TNDD^PVEW<2)9
M+>E0JC"NA9 <L#DX[9&>,T ='17)6OC1&L+&_OH);1)].^UM;&'?(6+1JNTJ
MQSDN !C)R.G2K!\:68"QG3M2%X;C[-]B\D&4/Y9D&<-MP5!.<X^E '2T5SUY
MXA\[P]8:KIIPEU=6\?[U,$*\JHP([$9(]C22>,].@GO8;F"\@DM8Q)M>(9F4
MN$&P DY+%0 <'YA0!T5%<V/%$[:]ING_ -B7\:7<,TCO*J Q%&4<@,<CYLY&
M>HQGG%74?'45M9WC6^EWLEW:R0*UM(JJQ2638''S?7@X.<9 SF@#KJ*Y^3QC
MID.II83":.0R1PR,P7;%*Z@JC<YSR.0"!D9-+J'B[3[&2..&*YU!GADG'V%!
M* B$!B3G'&X<?E0!OT5S;>-]*4W;JET]M:PQRR72Q?NOWBJT:@YR68,, #ZX
MJWIWB?3-123]^MM-%*87AN'0.& #8&"0>&!X)ZT ;-%<M%X_T62-Y?\ 2$A6
M-)_,9!@PL^WS>#D("03G! .<8JK-XYC@U02FUO)-+;3Q=[DM_F1?,93*W/W-
MH! ZD<XH [.BL.Y\565IJOV">"Z1C&[QRE!LDV)O8+SG[H/) !P>:CN?&&FV
ML"2NMP1);P7" (!D3-L09) !SUR0!ZT =!17*7GBV>"^U.U.FW-O':::M[]I
ME17520_#*'!/W,8!Y.>1P:MKXMLO[02S:&Z*F9;5KL1?N!.0#Y><YSR!TQDX
MSF@#H**P=#\66.O3I%;V]Y#YL'VB%KB+8)H\@$KR>A(ZXZC&16]0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<R/!L*V%UIL>J
M7R:7.LBK9CR]L6_.=K%=V 2< D@?2NFKG==U2;3=>T\B4"W^R7<LL;2!$<IY
M>W+'@8R>?>@ U'P?9ZC>S7;7,\<TDL4O 1U!C1D'RLI!&'/4'G!&,5%'X'T^
M+2IM.%S=&*6P6P+$KNV!G;/3&[+GVZ<56M?&\M\L=O:Z6DNI/=26XA^U8B(1
M%D9_,*9QAU'W>I].:?#XEU2+4/$ O;.TCM+ 1>46N@IW.BG:Q(QU8\_@ : ,
MVT\%WX\2W]Q=>2]G?27(N27#!X9 0%0;=R-]W)W$?+],=/HOA^/1K6:W%W)<
M+(H4,\42%5 P!\B+D^YS6#:>,=1U35=&CLK"W6"XGN8+L-.3M,6.4.WD8.>0
M,]..M02^-Y-:TC4#IT,MLRV4MY:W*L6_U1!Q(-N%+<8&3D9Z$4 ;*>"[!--F
ML1<7/ERPVL).5R! 05[=3CG^E7-<\.6FOA1=2SH!;S0?NF ^63;D].HVC]<Y
MJ*^\0R0Q:7'967VJ\U)2\,+R^6H4)N8LV#C (' /)%8NF:[J'B#QA8&..2VT
MY+%YI(1< 'S1(T;!@%^<!E('('?VH O0^"+>V'FV^I7<-Z+EKA+J-(E*%HUC
M90FS9M*J.,=1G-37GA"WO6OO,O[S9>QPB9/D(:2(C;)]WD_* 5^Z1GBJDWC&
M^&HO;6VA&:/[>^GQRF[5-TH3?DC'"8!YY.1T-0)XV,CQ3QVD[2W$$"16;2H$
M\YYI(R-VW/!0Y;D8 P,]0#0L_!EM8FTD@OKI9K>[DNA(%C&[S!AT*A=H4@=@
M".QJQH?A:VT"=VM;B1H,%8H6BB'E G. P4.?0;B>*S=1\;R:7=+:7.EDW<<*
M3W,,4Q<J&<J!'A?G.%)P=O'O2^)-2U&U\4:='$'_ +/@L[B^G$=QY;2&/9A2
M-IR/FZ9&<^W(!7B\(ZFDNFPQ7[6<-A)>".>W92_ERL&0892#@9!^@-7/^$#T
MZ-!;V]U>06+Q117-HC*4N!'PNXE2P.!@[2,BHAXPU!X(/*T$-=269OW@-X!Y
M<'&WYMN"YY^7IP?FJ.3QW,\P-CHDES:--;PK,;E4+-/&KI\I'3YP"<\=L]*
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M[B%SG.>V.:R+OQYJ<GAZYN[;2$MKE].-_9^;<!PR!E5MP X(W @<Y]J -A?
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M7WG'R\A-N"><BI]"\1W5YX;U6XN+F*74+*-FD\M%,2MY>\;&5B'7T.<^H!H
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M?3VJ155$5$4*JC  & !2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+C(V>O.>U '4T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g3dyckr3udth000024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000024.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %I I<# 2(  A$! Q$!_\0
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M<NZEL2-O!C3H 5!.5;TQ0![!17FWQ=NFO?@=J5V\$D#SPVLC0RJ5>,M-$=K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB9Y R0E2A3<&R1M)')..U=/10!SNI>!/#&KZ5I^FZAI$-Q:Z<BQVBNS;HE4
M!0V=Q&%&03SCG-76\-Z.U]I%X+%$FT='2P\LE%@5U", H(4C: .0<=L5JT4
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M_A7H58MWX6TJ]GOIIHI"]])!).1(1EH2#'CTP0/K0!E1_$726UG^RGMKU+H
MJR%%)641^88L!B=V.^-N>,YJFWQ(6Y?3UTW1[N<S:A]BN$)C+1GRC(,$/M)(
MP>O&&SS@5MW'@S2+F_O;MUN5^VJRW$*7#K%(6386*@XW;>,_UJK#\/M$MX/*
MB:^0B:*X61;MPZR1J4# YX)4[3ZB@"HGQ1T!WO55;IOLRDIM16^T8D$>$ ;(
M)<@ -MSG/2J]SXXU&/P=XAUD64=M<:=??9HH;E3\JYC&9 K')&\]#C@5K_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWXSAMM2^S?9)#&I D=OE93_ND=J:BWL3*I&.YT]%%%(L**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH IZLTBZ1=F*&>:01-MCMWV2.<=%;L?>N+M['7$>P> :@\H+8CN"XBARY)
MRWF9.T8QN#;L=L\>@44 <MX:MM6C6X\T7, -O"I^W.92UP-WFN/F^Z?EZ$#/
M05J:8LZZIJ0N)(W?,?,:%1C;Z$G^=:M9]G_R&-2_[9?^@T :%%%% &)>ZY=+
MJ4MAI>F-?S6ZJUPQF6)(]W*KDYRQ'. . 1DC(J[I.J1:O8BYBCDB8.T<L,H
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ME21?53G%2U)H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ;B9?#]H^H:W:BY"*BR7BR!^6.#\K8V+G'3UKE-<\3Z>=,O9(KFV@EB*RP/
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M/0X_0]JK2UC-J?-S=.QH45!:W4=W$64%64[7C;[R-Z&IZDU3N%%%% !1110
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M_''--#*%N)8/(@C59)B)65<(Q)VX R1G')KN8QB)!NW84?-Z^]+@9!P,CH:
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MQPLBC^%OZ'M6?I?BJRU2]%K''+&[#*%P,-@9/2G:^J)YTG:1NT444BPHHHH
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M]9?M,<,V+:"Y4V0+;1)N^0C)RPVYSQD'H*T-,G^T:GJ,@CECYC&V1-I^[Z4
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MD<L<R[HI%=?53FGU0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=S#=:GJ4D+[DS&,X(YV^]6['3+'35D6RM(;<2-N<1H!DU%:?\AC4O^V7_H-
M&A1110 4444 %%%% !1110 V2-)HGBD4,CJ593T(/45B>$9'&@I8RL6FTZ1[
M)R>_EG"G\4VG\:W:XNVU+48=3UG6-,THW>D2R#?^_"2N\0*2/$F,,,*H&2I)
M0XZB@#KKJW6ZMWA+LFX<.APRGU!]:R#))))'<A4%Y"_E3HF6^;&1D] "#UQ_
M%[5KVMS#>V<-U;OOAFC62-O52,@_E5+58EC_ -+8;HMOEW"DL1LZ[@HZL#C\
M,T-.2LM]UZ_\'8RG:+YGMU]._P MRM?:8US*NK:4($O60*ZW"'RYU[!\#(9>
MQZCD=*MZ5I,6FI)(6$UY.0UQ<%0I<]@ .BCH!V]SDFG)JUOH=K)<ZA)Y=N20
M3LP3+Z*O4[NH !R<^M:UE>VVHV<5W:3++!*NY'7H?_K^U"::4ELS1-[/=$]%
M%% PHHHH **** ('M()'WF,!_P"\ORGMW'T'Y4P0W,6!'<>8HP-LPR>W<?0^
MO6K5%+E0K''^*_%\^C+'IUO:O_:MQ&71EC:5(D& 7.!SR< ?G@5%X,\73:A.
MNC:H)C?K&9(9W@9//08R2"  PR,XX.<CTKJ-2TY-0B0B1H+F%M\%PGWHV_J#
MT(/!%,TW36LR]Q<S_:;Z8#S9RNT8'15'.U1V'XG).:GEES7N%G>]S0HHHJQA
M1110 4444 %%%% !1110 4444 %%%% !116/'XBMY-6^PB"?89FMEN"!L:95
MWLG7/0'G&,@B@"S<?\ANQ_ZY3?\ LE7ZPIM9TM];L]FI6;;8I@V)U./N=>:T
M?[7TW_H(6G_?Y?\ &@"Y15/^U]-_Z"%I_P!_E_QI/[7TP#)U&T_[_K_C0!=H
MJG_:^F_]!&T_[_K_ (T?VOIO_00M/^_R_P"- %RBJ?\ :^F_]!"T_P"_R_XT
MG]KZ9_T$;3C_ *;K_C0!=HJG_:^F_P#00M/^_P O^-']KZ;_ -!"T_[_ "_X
MT 4;G2=0CU"YN]*U&*V^UA?/2>W\T!@ H=,,,'  P<@X'OF_IFGQ:7IL%E"S
M,D2XW.<LQZEC[DDG\:;_ &OIG_01M.?^FZ_XTO\ :^F_]!"T_P"_R_XT 7**
MI_VOIO\ T$+3_O\ +_C1_:^F_P#00M/^_P O^- %RBJ7]KZ81D:C:?\ ?]?\
M:7^U]-_Z"-I_W^7_ !H N453_M?3?^@C:?\ ?]?\:3^V-,SC^T;3/_7=?\:
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M_P"@A:_]_5H O451_MG3/^@A:_\ ?T4@UO2B,C4;4CU$J_XT 7Z*H_VUI?\
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MY4RR],YQVJQ7&>(==O;;5;F&WN[V.*VC#,+2RCD .TN=[2-_=4G  X&,DG%
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M<VT@8CRH[: Q)&,<\$DG)YZUH444 9VNPR7&@WT$5N]PTL+1^5&X1F#<'!/
M.">M<[I&GW%AKL%Q;:-?P0M&87CE-ND,6[:7D4(Q()*+\H&,DGCFNSHH ***
M* .#U;1)+V]U-VT?4DFN)?ENK9K=MT>T(1EF!*LH&5/0C(KM+*6>>RAENK<V
MT[KEX2P;8?3(X-6** "N=\5VT5VMC'<Z9=WUNLK.RVZ*^/E*X96(X(8X(Y!
MKHJ* .>\,@0/>6\.EWEI \AGW7$:1C<W&Q57L HY[]>I-=#110!%<)));2QP
MR>5*R$))MSM)'!QWQ7.VV@ZK;&$12Z);['#,]MIQ1^<;\?.0"P7&<5T]% !1
M110!RNK:9J,WB!KZ#3DF"QA(I%OS"?NLOS)M(R-[X/O6UHD5U!I4,%U;Q6[1
M#RXXHI#(%C'"@L0,G &>*T** "L;Q/&9M)$7V6[N,S(?]$"F2,J=P<!N#@@<
M'UK9HH Y#PE;OI]PUN+'4SYD2J]S=PQPJJQC"(%3J?F//7CD]*Z^BB@ K@K
M2::/M$6D^(4NO-EFEAA""*9F9FPP+$=P-P )Q7>T4 (A+(I9=K$9(STI:**
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M3&RLG7!4Q@^G)X XJ*]\#)$E\^F&,R7,'D(DQ*B(%44D, >,(.,=>] &]?\
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M2-< "(AB['[JJ!U)R,?6N;\-?#_P[H5_>W5JJW<K.8U$N'^SJ1S&/?GDGG!
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MUO;77LTFCT:YN&AM7FBA>X9?NQQD98_4D ?B:PH_%]K)$)ULY_+0 W,@*$0
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M0%D!#@26BV3?O3S&O_LW3)ZG JRNCZ?"JA2RQPW1ND3S/EC<@Y '8?,3CWH
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M!@8_N]L56D\':)*(%:VD$<4,<!C69PLL<?W%D .' [;LUO44 %<KJO@FTN;
M6NG>7:HU\U]*CAV620@C.0P*X)R #CCI7544 <_8>&/+ANDU2]?46N+1+-G=
M=K>6 =PR#U)8G/T],U;?PYI4DC/);;RTHE8,Q(+"+RAD9Z;.,5JT4 <^G@S1
MDM_*"7.X2)(LWVJ3S4V A KYR  6&,XP3ZTO_"&:'BW1K5WAMX_+C@>9VC V
ME<[2<9PS#/O6_10!2TS2K?2;8P6[W#J3G,\[2GI@#+$X  Z5=HHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g3dyckr3udth000006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #Z I8# 2(  A$! Q$!_\0
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MHN ><(V6/3C@]BP*:.MHKS;1O%]Q<:A>R6*&>35]1MTLTN9"$A1K*.8D]3P
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M9)4C('J1S18.='H5%<99>,;_ %>33X--M+/S;];BXC,TS;8X8F"?. N?,+,
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MA/LGMU/9_P#B<?\ 3C_X_1_Q./\ IQ_\?KSG5!=6OA)[<ZPUO?R6XB6?<?\
M6>M7_#$US::181WNJ"]E*&-YP_WVQ4..ERG0=[';_P#$X_Z<?_'Z/^)Q_P!.
M/_C]<K)>[8,B*6<S,4QN(_"HY08+J&&WNA##"GS1;B/PI6*6'=]SKO\ B<?]
M./\ X_1_Q./^G'_Q^O/]8N+@^&[UHED0(5)V.<@9Y:N$M;RZEBE*7DQ"(9&(
ME8@1@<G\JTA2YE>Y+H-.S9[W_P 3C_IQ_P#'Z/\ B<?]./\ X_7BMCK%WJVE
MZ;<SSSH4B+1JKE<J3QGUXJS]OU(S*$ED,+J0[>:<@]@!1[)]QQH72=]SV'_B
M<?\ 3C_X_1_Q./\ IQ_\?KDO"VHF\DDCE9_,MCY8!8G/&<UT>I,182_,<D8&
M#WK)Z.QE*%I<I:_XG'_3C_X_34N;^*_MX+I;8I,&P8BV00,]ZCM Z6D2LQR%
M&<FGS_\ (3TOZ2?^@T$/>QIT444 9B7VHW#2FVLK5HDE:,-)=,K':<$X$9QT
M]:?YVL?\^-C_ .!K_P#QJFZ7_P >UU_U]3?^AFL'5?&1TO4[RU^P/-%9K&TT
MHG13\XR-JDY;\* .@\[6/^?&Q_\  U__ (U1YVL?\^-C_P"!K_\ QJIU<LH8
M$\C/-&YO[Q_.@"#SM8_Y\;'_ ,#7_P#C5'G:Q_SXV/\ X&O_ /&JFWM_>/YT
M;W]30.Q#YVL?\^-C_P"!K_\ QJCSM8_Y\;'_ ,#7_P#C53[F_O'\Z-S?WC0(
M@\[6/^?&Q_\  U__ (U1YVL?\^-C_P"!K_\ QJI][>IHW-ZG\Z (/.UC_GQL
M?_ U_P#XU1YVL?\ /C8_^!K_ /QJI]S>II=S?WC^= %?SM8_Y\;'_P #7_\
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M<R!NF,#VKN6U*Z95"3LK[<G@8IRBUN6J39J>=K'_ #XV/_@:_P#\:H\[6/\
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M^:6&(%8\]![TXP<M$)TFE=L]#\[6/^?&Q_\  U__ (U1YVL?\^-C_P"!K_\
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M^@U7T^(QVWS=6.:L3_\ (3TOZ2?^@TD9224G8TZ***9)FZ7_ ,>MU_U]3?\
MH9KE-9\+75_K6J7*V&FSQWL421SW#'S("JD9  ]3D<UUFE_\>MU_U]3?^AFI
MZ (+*![6PM[>29IGBC5&D;JY QDU,U+3&YXI#0W#$\'ZU+2*,"EH!L*6DHH$
M%%%% !12U#/<1V\9>1@H% TF]$/8D#-<UXDU*>W18H'&]OH0!WJM?^*(IV=;
M19) G!8< 5Y9XH\: WAALG"Y;:\F<Y]A6E.FYL[*=-4USS-:_P!)QI-['!J4
M$.I7AW/(<8_W0>H%<]IGAC4_#L]C;RP136]Y+MGE7]XCCJ%^E)IUPMRC(\:
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MLK(#@C(S]177>#C)_;,"ECN#[LCD$$$']*4XJQ,_>@[GHTG_ "&;;_KWF_\
M0HZ*)/\ D,VW_7O-_P"A1T5B>:5]/./#>G_]>T7_ *"*DIFF_P#(NZ?_ ->T
M7_H(I](3&L0OS$X &37,WFJRWLTXMK>6>.'C9&.7.>V?2MS4N;-UW!2:X>U\
M56TVM7NFVT0C-BJAI<X#.1D@'VJHJYT48]>I>O9K>;48+CS&$GV8Q+'C@#/)
M/OFH'!;/!('&.@JC'K5O>MO$(+@G>Z-DJ?;V-/T[7(=12])BEC6S!:0E#R!R
M<>OX5IRR.M)11;.V%@V JC&,CI5FZN[B'3)Y[:!IYEC+1Q+UD;' %9.B^(=#
M\20N;6[$C*3^Z<;')'H#6CIVK>;8^?/I\ME(S,$CF8;BH. Q Z9]*336Z$Y*
M6QDZ'XCU271!<ZQIRQ:A)*4AM"=I.._/:KT[07ME]GO'^S32N'5&;.TCMGWJ
MD\@EU+[8R[WQM60\;?8"J^HP_:XI'\I?-081AR<U=E?30I0:6I5^(MOH]EH\
M&H:K;7%S+YH6(1S%2Q[DUI:)J<EOH>GP7%O+;S7GR6\4),GEKU^9NW'K6M>I
M&^C+>:K9QS6L$'F%2,EG X"CWK+\&^)9?$-A>1II$FG!7 9)N0X/]T\47O3V
MV,5I-ZG._$+2YO\ A*%N79F@N(45& )8$<5U?A+PV^@6OGR."\R9=CQ@=E _
MG6Q;,)6BCFMHY(8V.UP,^6!VYIVK:D)YH8+2V>4EMK,.-H_&B55RBH#4&G8=
MITTL]^Q>'Y8E)#G]*ET.T2VU'4-0G+-<2JJX/147)P/J3FHF9K"R6!6VR/F1
MU+8PHZ5/I5[:Y@'G*S3*QQG[WN*R"K'FBVD<]X8N?MZ+=%)!&]S,ZAQ]Q=YJ
M7P]K4FKVMX)-/>V,5X\,8EXW*.C?C6A+?&TNO+@MLI*[-'(!@#'4$56N+:X^
MQSM:?-<NA6+)_CP:MM-OS'&+45?HBSK-^FF:#<7]]'YD,"EV6+DX'7%<O<FR
MU/34\0VR!YHK)S;3Y(*(_<J>]6-*L-7B\#26>KWP34K@.H>5=X7/MT-4['0$
MU7P78VPU.YF6.;#WD*[%PAP01_=X_2JBE'KU)3[K0X$&2)%VNQ#@<9_2NQU.
MTOD>UABMI6DGMHAA>H 7G/\ *MO1_!>F6E]:ZK#*]["P\R')&S'8^XI-8\:7
M46HO::<8%\L[7G9-S$]PO; Z5K*IS2]U#BY;(9X<U&ZDOM"DU#2YM.ACEN+=
M!/Q\Y4;3^(S7?:5Q',O<2'-<,E[J?B3PGJ4%WY<UQ Z21?+@\$'/UKN--(::
MZ//WA7-4,)J2YN8T*;/_ ,A/2_I)_P"@TZFS_P#(3TOZ2?\ H-08&G1110!F
MZ7_QZW7_ %]3?^AFK%5]+_X];K_KZF_]#-6* $)H HQ2TABTE+24""BBF22+
M&I9CC H#<<3CM6+J'B&"UD>"+;+,!_JPW-<WX@\0WK3.L5R(+-?ERO5V] :X
M!-:6W?S=.VQR;MSS7#>9)*??/0>PJU3E)-H[J6%ZR/1[[6/L$:W5^6 N&"1P
MQKR#ZUE:GJNIR:[:V6E/$UN &N';D!3U_2O/SXJU6.6:\NIUO;=Y?GCD7@#V
M]!7<ZOJ]IHWAFUOA:D_:#NCCBPN<#/)->?0R94L2L75UJ.^VWRZZ+J]S92C8
MFU34;2)GL-(>*.XCP]Q'$,%>>35&/Q&L%JR7D'GH020QYQ[5P>C^,IEURXN!
MI-L8[@YEP3NV]?O9KLK_ $";6;-;ZQOH8K*=,HSC<0>ZD"O8=-1=I!2DI1*N
MB:'X8EDN+2RU*8P:ER;:=^5<<@CW%$W@U=,2ZO;^_(M8%SL1?G;'N>!5_P -
M^$&T/6Q=W.RX5$5H0A^8^K8/85I>(2GB6QO+*VC^T6\I =]P5%(]#U-#F^:R
M>A"IZ6BC T_1+7Q,Z:G-:S6-O"RK"4;?YO/\0Z'-=5K.F)?VAT])988R</Y)
MVY7TSVKSVVG\0Z5J-IIVFW,I$;B-;7'R[?\ #WKT37M(FUK1YK*VOA:W$RC#
M[N<]P%ZX]Z4[J2N]!I**=UK^9Q<W@6VT^^W6-A#>0>4QCBFE)9Y1]W/M5^'P
M?>:_/IH\00V=A]G?S5ALAA6QV;WK8T#PZ="T>WL9+YIYX7=WD;CD\^O:MNQ:
M"\N?.FN-WRXQNQC%*5:7?YDJA!*]OD6I)51)F2,;(@%4=,GU^E9PF\^;<[>3
MQDCKS5V421P7#;-LCX'E[]Y _O8K&NI1!YDZ*&=0,NXX 'I[UX^"P%.A6JSC
M!*[T]++];FT+)-F'<SM91W)\)P6$LKR9G:1L!W[_ (\UT%K>12.MG(\']HNF
M6A#@D-CTK$TFXTN^TR1RD?F^:P9<#[V>PKE[S1(+3Q%<:M!>,LH;Y%_NR$8S
MGO\ 2O8Y%)V>Y-Y12<=CT$S7>G\WD&W;R&2/:%'UKKO#EW<WC227&,% 4*G(
M(KR'1M9U%1/'J%Z]W9E2CQ7 W!@?Y&O3_ UE)IUO-;&97@ #6Z ',49Z*2>N
M*BI#EW(KN].]C?T'_D7M,_Z](O\ T 5H5GZ#_P B]IG_ %Z1?^@"M"LCSC/N
M?^0[8?\ 7*;_ -DKS'XAP2-*8U+&%9F9FSPI)KTZY_Y#MA_URF_]DKS3QK>)
M?V^J+8B6YFM+G;+;1 EBW8>]:4OB1O0:3=SE[+4([4?9 S2/(=T2@9)/I46M
MX4V[ZA$;<3GY(DYED]@.WUK>\$6#2:>]^Z2-?1RLLD4T'EO$>/E /;'>MB^T
MJRNM<AU&XB_TF%2L63P!W./7FMG-1D=7-*<-.HL"N;6&W"^4L405$3L,=">Y
MI\<$\;98OMQ@[F) J?(4@'.6.!CO4,C2;T!;.#T4\FL35#%!MR98G=22?ER=
MI_"KVCVFE2W3WALH8KV,89E7K[BJL3$J_F@+DXP#TJQIBA&N9F0^5E45B:'L
M3-)HM3^89A))MW8^7VI_S22*RQ%]O.=V*D7[+D7,TJ1H3A0[<8]:AFU&WTZ9
M%NVC0R-B(E@ WL#4D<W1&#J.I:O;>)-JZ:ITIE'F7!FQL]:UHKRTE"FVNT:4
M\^66#$CZ5BWFOV$FMR:9?Q6J6EPFU//DVL[YPPP>WH12P60TG7[6UL=)@2QF
M7:LX&7C?N&/H>U:..G9DJ3N;MW%!>6DMG=C,<J%6 [^U9UWK$.@V5O PGD+$
M)###&7=L=!6VUE*UR_S *% "XP#ZGZU!.D4%G,]O.$O_ "6$+RC(1L<$U$6M
MF-M<MX[F#KNG_P!L:UING-)K%L$/F&2U3;&#UP[5N:G=MI5I)>2POY<:A?W<
M>^0GH.G6N>\*75R]B;/4M=^U:@6)(W'#=_ER,5T1>24($9XXP2-VW)Z=3Z54
MM'9]!1C+=[L?%.DMFF-RF0A@&ZCZU6OH-;G9(](O+.T7_EK-(N_CVHN[O1K.
MW#:K=B%'0H)I,J"?\^E8>BQZ1H$5S-X?+:U]H8"2*&ZW;!]&/%**ZBF]>5&S
M+I=PUHHU.6WOE)ZQH=I]\'/-2BW1()(K>-MK+L0@<+GTJ]]G9-/,MK$L8124
M60X"MZ'\:P](U+6RLJZW:Q+Y9W1RVP^5N>!BC5JY497]U:EK1M-GTJP^S37D
MUY,K%C)-@GGL/:K@0SX:$E6 .YPV!^-21S-,I_<!">N?\*HZ@;]=/E33S 9\
M?+O!* ^^*6K8]4C+T_PI]BN-0,&I7,T5R?,^SL/D5CW^M9=S;RVUT(ID94#<
MG;P!]?\ /6NIT<ZM#IJG63;FX1LJUL"%8>X/>K4D,>I1,ER"RXXV'!^F*IS=
M]14Y<JTV.#E4J"T:,78X5 N22:[GPCHMQIDL4ER5:>5BS ?\LP>BUDZUJMMH
M+0R6EBD]XZGRP> GN3WIW@7Q)=7VL2V>HLOGEM\97HP/7'THES.-^@ZCE*+L
M>@R?\AFV_P"O>;_T*.BB3_D,VO\ U[S?^A1T5D><0:;_ ,BYI_\ U[1?^@BG
MTS3CCPYIY_Z=HO\ T$5%?2&.QF<'!"$\4!:[L<V=<@U2\OK:.X7SK)MKQ#L2
M.,UY[_9$8O+F5'01/(S_ "MP3Z^^:@U.XA\.ZPLT*Q[KQC->,"3YA.1M7GCB
MM3P[X,M+*Q>[TV]GGM[T[U20C$9_SP:ZHI05[[G=%6:BT)';HBD1$1L3DX':
MI;R2X%MMM)C!<#!#8Z\]/>M6'2GA $H08ST'%6]/@C-THD:-Y5Y50<XQW-0Y
MJ]S=VL5TTG1;"\TW5+JSLXM8D78I/RECC)"KTSBJ[SS3F:ZFD^9VS\PQM'91
M5G5-0LYKZ(I:+=7-L25E;I'GJ<^OTI@N+>[</+']X;<KT'X4KO=D0@ET*[$O
MY;9! Z8/2I(83<RQP0C<KM\Q'0>]/^Q6GFJ%U(1Y. C+R:T-2GM?#GAO4=1:
M90((<&11D@GC&/6B_1%2FHHQ_$GB6U^>RB966/$:^Q'I2:%XELK:T(N&6W8.
ML,)E'^LE;H!ZUS&GP/=Z6+L(TT3+YT3Q+R_X5U?A+3(=3L(9]9TP13"X-S;P
MR#E2.%8^AZFKE&$8D-M1LC;O)ID#JJ(+@<,H/RDU/]G;9A6V7+==O0#T^M->
M1+!VEN[B.,.X$;,P^<]P*HIJ]S;7<O\ :.F7-C;2!YHKJ1E*,%&2#C[N1ZUB
MDWL$JD8]2>*>TU>QN84N/M)BD:&9MI!3 Y4'O4/]D0&ZT^Y$(C%G&3&<D; >
M,4F@:]#JMDM]:Q$6TA8@LN,\_P!:L7/B'3K*]MK'4)Q')>2*J(!DN?[N/RIZ
MIV0:I7982:*6=X/M"NT"!I(Q_#GD'\:=&&B:-58$<NW]*Y6SU>PNO%NNP+))
M'=S2"-0T95=L8QP>];\ N/,!DP6V$OCICVHE'E=@IOFC<M/+-(8W1%:-#U(S
M6'K%Y<6&AW)TF&.2>9A'#;2L%5\GGCV'85>U :A':Q)IJPEO-#2F5\;(^Y'J
M:C/ANTOM9CU*^B>>ZMT"VT1;:B9/+X]?>B-EJQ3^%I&/#,;;P-&+,36<5L',
ML4H(.<]!GD+GI7+K%<>;%(LD8M^L@*\GCC!KK_'L6HVVC1VFGJ[W%Q<()6('
MW,Y/X5B3+9P$F.(29PK!V) ^@]*W@]+]QP2::70ZGP5:/#'>37#*J7( A7N0
M.IKJ-%W&2Z<]"PKD_">I/>>?%.@9X$^69> 0>P';%=9X>EBGTTSPOOCDD8JW
MK@X_I7-._,[F5;1,UJ;-_P A/2_I)_Z#3J;/_P A/2_I)_Z#4G&:=%%% &;I
M?_'K=?\ 7U-_Z&:L57TO_CUNO^OJ;_T,U8H *2EII)[4AH=D#OUHI@4YR>?2
MG$D#- 6!F5%+,P '))-<9K?BBSN[.=+5W:) 1(Y4@<=<'O6?XVU)M0O+;1;*
M^BBO9WVHK-^)..^!FL/4$^Q6R1[PZJO+$<L1Q6D87W.W#T5>[W./CUW4O%M\
M]KI%J196T,A9WXR<$#'O_P#7J6P\.W-Q;PX&PL/GW#O[>U=CX/M"FF_;IH@B
MR3LH4+C(Q@$>M:$=JT2Y:(HZDX)[#VK=U>5VB;PB_M.[.3718]-M':>%967.
M 5R*Z.SD@\3>$GCN;'=)9G$0W;,D#CGMQ5'4KN%K65I90D2#+NS */K5VV^Q
M7W@EK+2;U94FW;KI3QO/44G)NS?<)Q7PK<Y"Q'A?[4EBUK>074[%9(4Q(,@]
M-U;6H^))K&_TW1;+3"D#,%6(#A5SUSZU'X?\-2:/&J>0K7&3_I$G'!KJ[31M
MNV>]O(T /[L;<;OH33G./-W(A&:@KNS*FH^*(-$O%BGMQ<2NOSC/W4QR!18P
MPW.G,?#=[$87&1!/D/&3V^E<EXJT;5IM7-P+9YP[;5\H$\5I^#],N-/\1S+<
MSB"-(E,<1;F9V'7W Z5S8RK'#8:5;>RO;>XW-\QHW/A+618*UEJ*6FH3/^_N
MBF[C^ZOH/YU!IWA^V\-SW&I:AJ,UU?R$*;B9L;0>, 5L>*_#T^M1VC0ZO=V%
MQ!("ODG*O]12:GH5IXADMX-3MKB:.'GS4F\L9QR6]?I6&7XWZWAH59:7W5OZ
MT[>1%FVY6V^XL2+&\6\N&+YW!1VHMH;=!$($6,?JOU[5@>*=8N=!AM_[/L);
MIW<1HRJ6C5!QCCJ:VM/DN+BV26[4PNR9*C@$^P-=3BU&YTJ49-I=#G[[P[H&
MG>(K:[OKRXEO;IF>'?.VU]O.#V'TKH;:]AUF.9S:^61)Y2*WRJQ'\0]J+BQM
M+F-()UCG56W?.N<'V]*JWR72V[+I4D-M<#'EB5=P..OR]:;ES+S(5/D3LBW8
M^'K*VC\U+=!+G*5@1:*+C4KE[N&>R9LC#J"C#LRGUKLX[AULQ+*$,GRKE1@%
MN_'UK$UMM0OK&1+*81W0.4<@,%/T]*\?*J^-G6K+$;7TUVT6GI:WSN+EOTT,
M^S\&0P7,=S+J+W,2MO\ *"!0Q[9-=YX<=9=3NG1 B^6HQZG-<7HT.N)"_P#:
M_P!FD4'"&UC9>>Y.:[+PL2UW='S0Z[%  7&*]>;;>I%6*]DV;&@_\B]IG_7I
M%_Z *T*S]!_Y%[3/^O2+_P! %:%9GFF?<_\ (=L/^N4W_LE><:EX<^Q_$.Z\
M0+JMP-V<6BMM4MC'XBO1[G_D.V'_ %RF_P#9*XWQ-;27&HR0,X!>0F)P<$'^
M[5P;1O0BI2U,OP]J^I:AJUY'JELEO'C]SY3;G//.X].E='<V)*;W/FH.A)^9
M:\RM-+\5Z#XGCN(;.6>T+;9 KAEV]R?0BO3))EN+;;;NC3$_,H<556-I76QM
M%W>A0EA 8YPP!IA"[MP3YO6L[6FUV.T\S1X(9)XSF6"0'<W^[5O29+^]TV*>
MZM?LLK+EXFZK2LTKFZDKV)6QLR0./O5E>)-=_P"$=\+^>;1IW9L)".,@]V]!
M6IJ%Y80VUP)9(9OLRAG0'YMW\(..G-<7<";5)6GN)Y&ED&YANPJKZ*.]53C=
MW>P6<EH5].\7W'CO3+W1Y;*.VE6#]TT8.,>Y[5W)T&VO?!]C8ZI"]S' BY93
M\VX=\UQ[07&CQ>?9SJH)Y 0#(KL--U^ZB\+07DMC/-))((]D0R03W^E5.^G)
ML92I<L5S:LGN-)TB^CA:YL(+Q80!&\JY9?QJ2\NI[>UE-M%YCV\;-'$> _'3
M^E23S7$$7GPV<D[?\M(T(!QZBG6LXNHHIPK1N<X64 ,#65W;4JRNR#1]2OM4
MTBV-Y";*60[9(LYV_C4>MPS)ID\5H@9MI7..2/2M"")K+@*55F9F?=NW$\TY
M\RV\,C*Q4-DA3RWUHNE*Z".AYMIL%X]VMO%;RK."K%@I^4BEM?B'J]UXDFT>
M+1I)<R[4PQC/'5B#4_B#Q-=0:C=6]I.T2K(8P(AM[=2>]7/!>N/J$KK<,))T
M&T7#J,CVSUKHE\/-)!4<IM).QV<5O;L09UA8*""'CW,#Z@]JBALX(\JL00-G
M:5();\J>\D<40#G (^^HZFI&A*-LZ9&0:YKL+:W&F=FCV2@K@_*!DY]S222Q
MP(\C2NBJ-Q5EPHQWJ!([A'D+A6A8#8<_-^5+'<0W7FPQ3K(Q4JX3#<G_ #WH
ML-I="EIWB/3=625;&[^U/'Q)Y2DC)]ZF:_L8KL:<]T8)IH_E(SD^P/0&F:'I
M2Z/;RVL5P)G>3=O:%5V#_@/6KTRP")WNPB'.$93G=^%4^5/0B+;C[VC$2,P6
ML0@B+2 ;>6+9^M.:"7S8Y1@2!N@X[=#31$UI;K%'O\LC_6YYYK-O7O;*"\O5
M:6XC2',=N@'4>_7)J;7>A?F87B,3PZC++*XD8@[0>@'I6+X(EF;QYI;EOOR,
M&'_ 379VEW%K_@Y;Q;+;>,"&@<?,C^AS63X5L8K?QI9>?"8;I6(VL>O!Z5NI
M>ZTR9WJ1O%['K,G_ "&;;_KWF_\ 0HZ*)/\ D,VW_7O-_P"A1T5S'GE?3N?#
MFG_]>T7_ *"*Y/QEXJM=&LFAEO$M6D/EJ[KD$]ZZW3?^1=T__KVB_P#017 >
M,M$TS6(S'J$6]1)A&!P0Q]ZJ%N9<VQK2BY-VW/(+JWENYV2[9MR.77>>H)R"
M#[UZ)#*^B>';"P>_%K>>8)F+)N14)Z-Z<5'9Z7HME=V"2V^Y(!MA#G(XZ ^M
M8?B&>_36I[65_,=OF8+SP>Y]!7:Y*HTD=/)R?$=]K<K3ND$1*Q@9\Q3P:P]-
MU.TTO4VTK,CW]S#)(CXXP!TSV-33W:6/A:WEU&X2".. 8G##!] /4]*RM'GM
M[G5[:_D<3[4_=2A,91N#6$8^Z[FKV26YIL[B+>@(8+QSUXI+<7#(K3!5<'((
M.:FGC-O<FWD( .3$W0,/0>]3:?I]S<3+!#;2>3_%(XPJ^O-'0NZ6K8_3;9KZ
M;B6/RXCNGE/\*C^M4?&$3:O=VMK;V5Q=Z3=;DN%A(\L/QY;N>O8\BNDU%K2U
MLFTX1 VS*490<-*3US6+HEV=$MTTFRM6.G[B099"Q3_9^E3%Z\R,9*4^FAS^
MG:;K\FI1V1A^P:3 O+1^@Z!?K7I%J%D9I4B*11P<2N><CC%16]Q!<6,TL%L2
MT9^:-NA_^M4D*PMIYNF0IYHVF(=,>U3.?,]K#Z&-=:3:ZU>:?)/%OEM6+QN3
MPK>X[U7-RVN:_?Z%J6I>;;6]L56V$6Q'WC'+Y^8@>F*Z>SC?S5NK90(U&QHG
M%<=-X/V>(+G6ENY$M1<>='92+G]X1@E&[#VJH/N]MB)I2E9(WM+T2+3+.UTR
MR5OLL$?!)SFLF?PYN\80:U,RR;(O+MPP^XV3N?ZXP!736UX%C1>@1<'/4T7,
ML<JPL0![>@ZU*D[OS*UNDUH8J'3M8O1.\?[Z-V$;2?*X(X.!W%:EO(BNL4GS
M!_D!'I67)<>';&6WN;V2-+QI3%:F3._+=E ZUH3V<L,MM(%(&>2.V:&5=-N+
M)%,-N\QGB\Y",&/&3C-6)YH&U:2&6,R%D "@8 '7 JK<1B.Y6+&Y>C>X[T7T
M<\QNK:.Y$,EQ&8K>55RRY'!'X5*)DOM>15UJ:+5+*6&.=89F&V,DYVD=J\YU
M>WOXD:W4B&X'\;#.1ZU)L3PS9IIL-R7DR=TDK9WMGDUO6RKK>G1VETVRX=#Y
M<Q'W3VS73%>SUZ%)>[RD7P\>47=W',=S+$H9AWR>M=UX0MI--LKC3I1CRIW:
M/GJC'(_G7G>@V>JZ#<7T?V2X\U[R&WDD*_(8\DL0?3%>JZ>IN+I[W 1"/+11
MWQWK*O\ %ZG/-J4;FE39_P#D)Z7])/\ T&G4V?\ Y">E_23_ -!K$Y33HHHH
M S=+_P"/6Z_Z^IO_ $,U8JOI?_'K=?\ 7U-_Z&:GH *0 ]<TO%<MXN\3R:1%
M;VM@\1OKJ41H&^;;ZG%"5W8I)O8V=4UBUTF(R7!;'HHR:R;OQ7"EH7,3Q-TQ
M+P/SKC[S4YH]1\VXE%]<DA5.W$<?_ ?6N3\2^(Y%O9C*AE6(C<SD[0?8=JTA
M2<F=BI4Z:O,V;C44NM6:X2W'G'Y?-4X8CK@'TJSJ>O"U73K5-.DU*[N9=J1*
MV!L[DL*YW2+MM6S%';%=PRK*.O(S74^)+G^Q/"T-I8'RIY93#YF,,5_B(]JU
M<4I)&LI<T+P9)J/CF&SOA9:;:K%Y&$\QF!7/<#Z>M8NHZ_J&H*S"\, QG 08
M)[=<UP5U%,M\N_=\IRH]:Z'1+*ZU2YM]/C4^;,WRY[#U_"M?91BKD4ZJ;::.
M^TBPA\5> EGU"RA4N6BN8]NT2[3P0>W/-84U];>&"UE96\/DP(!;6D3YW,>K
M,?7]:ZCQIJ4'A7P?#I%J?GD7R@P^GS'ZUXY"I=MC2$?W2#WJ*4>9-O8E5+/F
MZ_H=?=:[>:YI\-G=VPA6.[B:X2W<[I8"?F'7/'<>E>IZMHUOJL%I/9S(B1*%
M49PI4=!7F/A[38YK[SI'VFVC,C2$=" >?ISFM7P[::M$L]Q>ZV+^WD?=:LI^
M4+ZU%1+IT-%&:JJ47J=<T:F1U:5(U4 $N,B1<<C%<Y=VTVD-I<.BVXNU^TXE
M$[9\J,GG'TJS'I\USK:ZF=;%S;I\D=M"!MSCDL>^/2MPZ>?LY8Y\P<GCI6,U
M[KC?=%V3W=CD];\3WFD:G-;S64D\]U/Y5HD;DH%'0MZ'KP*FTK53?QO%=0SQ
MSQ#]X&C94SGL3UK3;3;2Y:)W+2-"XD5GXY'O3M.U2#5H)IU62WD65HUBF^5B
M!WP>U*E!4Z,::^RDK^@TW&=FSE/%VI:]I,L4UJT)TN3"3)G9)C/\)Z_E5R_\
M4:A-?63Z78?;]"$>)94):5"!\Q(_SFNCNM.BUBV*75NJ^5SEQNS2VNFVMK U
MK:JEI XR7MSTXZUKSPLKHSE"7,Y)D=H9-2L8Y[>TVJP#+N7:R^Q'8T^%(+4R
M37$<8G!P7*%F ]!5'P9INH>&$O;*\O1=P2SF6"XW9.#V8'I6NT4FH2M+'*GF
MY.%QR0/6IEHVD7";E'WE9%;? 86@D1D@DPXED;JY/3':IIM-$=H)Y59V0\B,
MX(]*Y[Q+;>(IY+2/0[N"W1/^/CSDR6.>,5U4+3162/.'>1L"5B<9&,'%91I1
MIW<?M.[]=OT#GDG9%>TNYY-T32K(K<+GG;6SX<$\=[=0RQQ*BJNUD&"WN:\M
M\+P:K;Z_-'::Q;ZEI*RN26?$J>V/K7J?AE72>[5KCSP3N!/5<]OI6LX\KL95
M)J=-M*QIZ#_R+VF?]>D7_H K0K/T'_D7M,_Z](O_ $ 5H5F>>9]S_P AVP_Z
MY3?^R5RJW]IJ6N7L-T@MYK>9PN]L;D4XWBNJN?\ D.V'_7*;_P!DK@]=U70H
M]>N&O@WGP.R<KV/7ZBJBKFU%-MV,+6M8>XMKZ*R&_P R5D$V2%D08^8#Z\9]
MJY3[/=Q$.0V\\Y0D8^E>FZMI>DZE8P72W;6V(OD>)=P"_2N?AC\/VOR_Z5?N
MO!DE; /X5O&:MHCLBTTKW-76M>N-$\&V%_Y8EN6C"NSCOZFL+PWXFU+5=2CC
MDPML%WR8'"UT46KZ3JRIIEY:!K?I&6'R_2L'Q59Q:)>6^FV=N8K>0;RZG)?V
M/H*F*BURM:A&ZE9FI>0^'8;+4?-?;#=-YUU-NR=PZ$'MBL72[:+56,VC7L5W
M! ,.SY5AGID&LQ_*2#RMJ^6?X2V=PK4\#;[#Q9%;VN$L[I&\R)0-N0,@U5FH
MO4;?)K#YFY:^'?.FBNKV;?&.D:G ''?UJKK^M6%^T7A2&>*WFN<1LYRHB[[E
M/=O09IWB;Q1+I6I7-C#&CF)QS(<#D9Q3[;Q/H6MZ=;V-W:Q1SNP!21> X.05
M;UJ4I+WF14;FM.ITEM"EK80+;W3W(BC$3.Y^9R.,FHKJ&2: BT\N.0#(\U<\
M_3CBG6L:Q QB,*'R<#UJ6*'G&U2S'D,<G'M6/4=N4AMOW<(68OYA'*J/E)]J
MH3W:///;:??P)J$0#-&[>8$_WE%:;(/M+Q0D$*<8)XJE:Z18Z?<7$T=DEO<7
M#9DEV\N?<U2MN#W,^YT.TUJW235[)(=0'WY;%B$8^N#5S1?#MOIYF-M#C;QO
MD;.<]ZMZI9#5;":UEF*QNNT@-M;\"*9HFG'0M'-FKO=V_<SODM^--R;CN3JE
MH7V:,3^5(I)VC;NQL_\ UUCVVCZI%K4MQ/JEU/9R L(#&N(?H_7'MBF/<&/6
M4:59[BQE4)'% FY8V[L6ZULRW7VB0QIE$VXY%+5!9WT*[J-S0Q2@QL#N=^6-
M9&B>#]+\/WLUS:VTL3SC#N)B>#SC;6N0REHGE5F] O:I$1XW4*V5_C5QVQV-
M',TK(J26XZU9<E48+@\#'6FRQB20*X5W+85<X"UC-XDTRVU5=-E<F^?C%NA?
M'UQP*U4DDV2/,Q@C7C<XY)]:&F@33;:+$<O[UX#;F-(^A9N&-8NL^(]*TF6.
MWUBXCC,[_NT16.?R]ZV+2UBCW+)(T^1D$]S6%J%C!K%L8+J#RF#'9(H =<'@
M@]J(VOKL*S=^7<VX9,E')V"0#Y=N#CUS4-A)96WBR"VCVW%VYRY./W*X..?7
MVI$Q!;", .54*)&;+#%9?AQ-GBF'</F,A8D]2<&B*W*<?=9Z))_R&;7_ *]Y
MO_0HZ*)/^0S;?]>\W_H4=%0>:5K!MGAFQ;^[:QG_ ,=%>;>+-19M.CGB<".5
MV(D'8]J]'M)%B\+63M]U;6,G_OD5Y%?:[I4OVW1DMIY9C*7ABBC+*V3DC/89
MK2DKRN=%%J-VRMX<MVU;4Q&K,\=N0\DC=!CFNHL[^]O-2NA-HUO' [;8YBX9
MG ]1BH[>^CLK<V%O8I:NT*F=AU)/49]JR%O+NTU!G@;<JL#M)P-O2M9>^V=*
M3W8M_:WUS%?6?B&VMKK3Y9LV5GMP(D7OE<')K1T6WTNUV6RV@L]H'ED E!],
MU=UF-F:UN@C'"'DGH",BN3CUX3ZNUHETWG18=XMN 1Z4E>4= BHQUZFGJWB/
M58O$/V*V\'3W]A$X4W.#U[L.,"NIO-3CT_0KC4 ))$MHS(T0X90!DC'2GV.M
MF&(PJQ4LN[E<@\=JP-&\4Z3XCBU.'3_,:>)6#1W*!1(PSQZ5#UZ:(SLXMJ3]
M"AIVJP^)-.L=6:!X#*'*QL<[0"1G--O8[R:XMS9W!BB5B9@5SO'I]:L>$(=7
MO_#D;:I91VEQ&[)&L:A08QTX%/F2:%RLD3C!SPA(-7L[(WIM2BKEC3[RXAU"
M$0L09'"[<'FMB:;55\72I>M;IHJ1@)"BYDD8CJ3_  @56T;2[F)VN;IO*+#]
MTG=0>YK5OTCAC0!?-E&U=[')Y[UFVKD32E-'-:7IFH1ZK?:CK-[+Y\KE((8W
M/E0Q9^4*/4CJ:V/[?L9-7;2'N!+?+ )%0CYE&<9S6/;2:SI^M"SNV;58;B8O
M$ZIM%K'C[K5=M_#%K_PF,FOO(XF:,)AB , 8JI6O>1,;**2Z&@C(2W#XSU'K
M4BI'O#3(^ H^7^]Q4BJ(I99L*8HT*@*V<GU]JC22.XL;9FW(\9(?/?TK,T;O
ML5QIUA)<P7"V:O- 2Z^:-S1_[M:33B2V\^;)C##J<5FC]QJV8)""'_>!CU!'
M.!5NZ9KBSABBXCB.3D?>:FQ-7:()+Q#,T\;$,AP1CU[5I-N81[ %Q&N37):=
MI\UC%J5W=7;2">8S*AZ1*!T%;5WJ[Q:*+ZTS*@MQ+'C_ ):<9 'UH<==!26B
M.:U+P_%<W33K$)TWY0-U5JR-1L?%TFL0:?HL*6\6P/->2D;$_P!@'U_6MGPI
MXT&NPS6E[#+97*,KLLRXVY)XR?6K5UJYTFYD>[&Z4D[+<?H:V3FG9H&U->Z[
M":#KNK:Q_:T>HW$,L-G<".!H0.55>3QU.<UU7AS6K*^LTCMY0X!(!'KZ$=C7
M :7JMCX2TV6"P02:C?3M=3YQA,\XS_2NXLI8KQM.U".!(FN$5I-HQR?6LZD4
MM4C'D?)RR_IG34V;_D)Z7])/_0:=39_^0GI?TD_]!K(Y#3HHHH S=+_X];K_
M *^IO_0S4XJ#3/\ CTNO^OJ;_P!#-39VKEC@4AC9BHB;<<#'6O/(-/L9=0O;
MV2>(7$9=$GD0DX]CVQ5GQ)XV1+B:STQXI6B^5GZ@O_='N.]<'//?7\Z"<@P=
MHP<*/4^^:VA!^AUTH\L=2Y;Z9=HSI92I?A#D?9Y-Q.3SGOFK\WA&+5;(RZF8
M+5>KEY0,?7'6LV)?[/N(=1T\>5/ PX08RN>1[\5U7B%-/N-8CTN[B5(;F 3V
M]QZ/[^W-3B*TJ,>=)NV]M[=7;RW-Y?RLY^TU/1="'V+38KF>->MXB@C/H,GD
M5S5P+S5?%)DO=3?^RFD8HLH(V+V&WL?>NJE\/W5M;SEHE"0#.['OVKE;V-XI
M':4[0IR><@UKAZ]&LG*E)2\]_,)06AU%CX4D>X+7DR+91C(,8/F/Z#G@5T5@
M-!\+":YMHY8[J8!!+<2;\#V]!3'N[R#P(NIR0@7,5MN$9'5>QQ]*\P/B.XN&
M,MW.)RQ/R_W?PIQC.I?L#E3>DCK_ !BUQ=:K!#.F81#O!+95]QY(K-T32O,O
M!"J@2,W!"95?3FME+#5=3\%1F]M-UW:S^9#%NQ(8/3_]=;>@26K6Y$"112B+
M,H#ABOL:B=6-*G>3T1<6OF5- OWO;>^MYM'EM)(I3"Y=0?/4=_I5^ZT_3[O3
M6L77;#T\J-RG'IQVJRUS) %^:(F4$*H/)JO<.+.R$IA)DSR$&2_YU%];HI12
MC[VHQ=/AL].2"S@%K H_=[!A0?7U)JCIFB3P7IO6UC4;EW'*R2D*!]*Z2$S:
MAIBRO"T#[>%E8<?@*YS4M;;1@7>VN[R0<;+>/(IIR>B)O"UWT-)[:224;HV6
M/N[OP/H*KZKHNDZ['&MZ5N/('"[B.?4[>:?>32ZKI)C2:2PN)HB!\OS)D< U
MG>%(UT*0Z/>:A%=ZD%W#=PX0_7K0KI73U"<K^[):&%J6JMX2A73;?1KV_M;A
MCO<OUW?P]ZW]5BMM,\$F4"YM[0(&"0<R0GK@U6UC4+*WU+^T)=83[-9,L5Q9
M#!'G,3M+?Y[5SL5Y:^$_&5Q]JU1[R&]!$L4BDQY/(YZ<>U;)<VOS]3GDVG:Z
ML].FAN:-K>I:S$^GW]LL4;V:R0ZA$2&=&& 2.@;V'I71:#:QZ+IAA2\FNK@*
M5,]P/FQUZU<@2W!1K=(BC(,#)P!VQ2:S.;#3XX4LOM5Y,V%2,=?Q[5BWS.R-
MDE%6>ICZFU@MLJWUS<I*7RLEN>?I["F2:AJTDNFP6-I)/:$YD>;(VKZG/-:7
M^F0*GV^UMK:,?>6-]YS5\7)6T"QE9 #\K#J:&[%-7U74P(?".F:9J7]LZ<9(
M9>=T#-E,GJ1W_"NA\'1ZD-;U*2>:U-@Z*;>*-2'4YYW9JD+N25)H<QEPO0]#
MS_.KW@F_FU&^U!SI[VL$($:/(,&0]21[4-R:;9A6C&%/E6AT>@_\B]IG_7I%
M_P"@"M"L_0?^1>TS_KTB_P#0!6A69P&?<_\ (=L/^N4W_LE>->*%E?Q5J4H!
M8)<,H0J"N/KVKV6Y_P"0[8?]<IO_ &2O%_&23#Q%J&QG0_:#M0'AB>AK:CN=
M&'W9T?AUUD\'7,IQ_$HSR,#M7+I;K<Q^9N8(3\P%=KX*VCP^=.GA"RY+]<A@
M:P+VXT.SU*:%=06!5;YL1EAFG%^\TCKA)7:D$-N/LS\'Y3\NT\_A6[J%C_;&
MCV-R[@R*F Q]?0UR^I:Y8P:0MU92->1>9Y6"NS#8STJKX>\>R6T[07JF2W8?
MZO Z^U-PG\2'.<6U9ZF=JNARC48Y)Y&@5,[1T5_<5TO@%575[C42DBV=K;'=
M*Z\%O05TOB77+/1K:UA%FMS/<@O$CH"$'J<]*P[7Q3J$TH$AAC@#X*1H.5H<
MY2CL9QASI\JW.#UJ_EUK6;K4<$+)*=JYZ#M^E+I.G2ZA=);;PTN]6=F. B@Y
MW>U>J36>C:S:.OEV\TF=R@C%4-3\*Z9?V7V"Z@$:%ED+VYV;@.Q(YQ5>V5K;
M"4.JW.AW6DK*!/B1DW =OSJ!HFDB=E)9D&5.?ZUS.G1:3X3M9+51<SQ-(7)D
MER4^F>@]JVK"_L-:Q)I-PT;1M\\;#GZ^]8.-O0T5XVOH,T2'^S9]3N;AI)1>
MW(DC8_PC:!M]L$<5HQS.\C122*20?]8_S"J6D:7>Z?)<)<R&6TGE+*KG/ED]
M?PJM=Z+IR>(;?5+MI?M,/[J(F3:.>.G0TY6;9,4DM#9,3)'^_(+#@!1D8]ZJ
MO>6ED\4%S=01-/Q%&[X)^E6%C82M(S!(\88DUF>(/#%CXDTXV\LS+L(<2J/F
M'TI1M?4)-I:&E++9HRJQF@(X4KT-5]?EUG3+&UE\/6D5\6DWW D?!9/8^M.T
MZU:TTN& RM(+=1&KA,%@.YS4\813)(%W;CQR !^%":3[BG'F5KV$2>:Z"O-$
ML$Q R%?('MFH96G2-OLSQM,.%WJ2I/UJR]Q.BO&D:&/&"% !I0T8C6=249%(
M6-^-S4BMD5+.UN8$2XO?*6:11N$2  'V/6M=5=VE\Z&$)D>2X?<7'N.U<]HU
M]J][]H;5K$6S!SL"G(8>M:4.V6<LJJCX^]D_RIRO?4AKF298E\DS"9[DKL.!
M"H'ZU6FNP;@J;<].'5>O_P!>G6ZI&DJ!5C+<M(>2YIUG>"X62.%DEC3AF5P2
M3Z<=Z15DC$U/6K?3;GR9K6\EFE7*QPQYS^/:K>EVI3Q%IUT8V@5R/ED^]DCI
M6C<(?) 5FB#-V&2:R8]<O(O'NF:0L($#'+O(,L>#TJUJM!2;Y6SOI/\ D,VW
M_7O-_P"A1T42?\AFV_Z]YO\ T*.BLCSS.4J/!]IOZ&UB'_CHKF1%!9QNT<,:
M.PSN P:Z&;_D3+'_ *X0_P#H(KRS2-5U":W,-_,7E66148C!*AN/TJXQ;5SL
MPVUC8FA">=<*6=C]XD\8]JSYF5HE>$!LD;HP,DY/%6+V7?H<EPEQ]F,4RQLR
MH'W_ .SCWI@\116D*R0Z7"& ^:0\$^YK5)G2WND=C?6IEA:$;E 4*#C@'%<6
ML-D;F5Q;2F5&VL%CY8_7TJ:ZUS7->T%TT%DCN_-4S*QSM^A]ZFU&5M1CM;.2
M:ZM+LNDDQMTX8KU!/8&E&+CN91;6C+^GVSS3K/,C1QQ<_-QGT K,NI]&A\2P
MZ1))';W=X28XE7EL@YR0.,\UK7FH&XM9[.TO+9-5 S'"6SSVS[U0TG1'DN+?
M5]:M(VUQ(]AF7^'Z>E2M%=EN3OH2:>B>#]'MM'6Y>XN/G*,XZ+G_ .OBF)K6
MJ"Z2$7< #L!L\H<?K5C7[1YK=;E""\:%<YZ9KAK.UU :N=X#Q%AY6T$OFKC%
M23;",5&*5KGK-I$M[#YLT9;<W][L.]*T=LH(WDRJO<]!Z5'9W)@(5T=7"ACQ
MQFJVQ1NDDS^\SC';FL">5\SUT+WGVS2"2/"JRY(%4[TR/(K+&S(7Z]@.U49$
M*WLD0(12N!D]*LI<Q[557Q&#PQ]:9HH<MFBAH5EKT7B#4)+Z[@?39/N6R18*
M>AW>M;5]:B"S1\<L_8=:PO#&IW]^]\]Y9/:M'*4&XY$@!ZBNEEO5OC);!,"(
M@ ^M5*_-J8IM-..W]=S"U3P^-5U6TNKH;'M6$D,L<FUNG0XZCVK;LIXT@\B1
M"SG@X'>L'Q?=3Z6)+RRL9;RZ1%"PJW7WJU;322V44TL9AED"LRD]"1R*'=I%
M)*2L1M;O)87=O=/\SM)&"/X58$#\LU;TK3(]+T2SL97,I@MTBWXX.T?UITD\
M4V]U7Y>X]ZE@BFOFQY_EQL>5!Z<<TFV#C97>AYQJ%C-!XT@75;)9]/NR\\WS
M9&V)=R\CISCBJ][JSZAJ,DUS:".>0'9*C;E'ID5Z+-:B6#4+5\E98'19/H.U
M>3O<*DJP-,$E)^4#DL!733?/\@7NMLIS+<S:B@# Q$@%<<[AU->T>',2Z):B
M)MQCA#*WJ1UKRYH$C(D8NT[J-P/"C^M=[\/]2:YL8XI$2)H':(HG0CM2Q&L4
MT*4;1?<[V*02QJZ]Q2S_ /(3TOZ2?^@U4_X]+C@GRW/3TJW,<ZEI9'I)_P"@
MUR'#)6V-.BBB@DS=+_X];K_KZF_]#-<K\1M8GTG0$2V5C-=R>2I&<+GN:ZK2
M_P#CUNO^OJ;_ -#-97B78UAL=8V)8%0XS@^M.+2=V:4DW))'C=\/['U?3-)=
M3M@MR6.W_6,W);W/K6U:61N OV4&5'.X;!GBJ^LW-]8:M!*3:7-Q$FZ,R+N"
MGID'J.*FNEU/Q=8VXTZ=-,U.TD#O;JV$E]SCJ/:NEWLF=J]Q.RN:PT"6XB:)
MW2"0GA=P9@/7 _K6=JMNSZEIEC?LY6U A6</\\JX&:S)O"'BO4=9DU"ZNK*&
MXCA$2M:H0R9[C^=:T.G:?%KEE+?ZQ]IFT^'RXY1*2V[^(L.]2TK;].A*E*3V
ML=J8A<VDL 1EC\HH,] ,>M<3':Z'I 6\U2Z.I7<!W_9K9?W8^I/6JD.I^(=7
M&LV]P(6LVV"T2W?#$!^<]SE>36A;6MGL,;(NP J5/K]*\[ 993R]S5.3M)WM
M>_XFL%SKL6HOB'IE]>#[5!+!#(-C%U!4#L" :M-X:\*V-W%JEK;*UQ<OLMU/
MS*9#S\HKSG6M'AC9[2*0"%GW1LA^8'.=I]JZBQTC6'E\/7-EJR6[VY9OL[@L
MK@]P/7&:]&IR4X\_-9=3%\_;8N?;]>T>UNKSQ$;1H<M$J0<N^[C!].#T%1^
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MIO$6E7\5U:>1<03&)Q*/O@=".YK1JU[;'/%K3FWU,JT\!I!XAU3SHX)M)O\
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MJ>A'K5/7+IDT:XN+?+2K&SICMQ6)\/K"YL+:^N+V3+Z@4G"=U)'.:TLG#F[
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M&*%LD \"NV\76UCJ M;87"6^I.=UJS\;\=0#W-<FOAW6$N7AN42. Y:1BW
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M,I>W>8]GRKQ4%G#I%I9Q6O\ PE*2I&,9>YCR?J<UJ6FHZ):;MFKV1!];A/\
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M+_A)=$_M0Z9_:=M]L#F,Q;QG>!N*^FX#G;UQ3;+Q5H.HS>59:M:W#^29P(Y
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M0 4444 %%%% !1110 4444 %%%% !2,P52S'  R2>U+39(UEB>-QE74J?H:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>gpujbzzweac5000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gpujbzzweac5000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %J G # 2(  A$! Q$!_\0
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MU%0Z1 L=DDQ9WEE4,[N<DT :%%%% !1110 4444 9+ZI/N>2..,PH3\I)WL
M<$CM6JK!E##H1D5CSV,;:RD6^00R(9'B#85CFMGH,"@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,__F8?^W7_ -GK0K/_ .9A_P"W7_V>IVU&
MQ7=NO+<;3ALRKP?SH LT57^WV>,_:X/^_@I!J%DPRMY;D'N)5_QH LT56&H6
M1Z7=N<?]-!_C1_:%EG'VNWS_ -=!_C0!9JO??\@^Y_ZY-_(TG]H660/M=OD]
M/W@_QJO>ZA9-8706\MR1$P($H]#[T 6;'_D'VW_7)?Y"K%9UEJ%DNGVH:\MP
M3$@&95ZX'O5C^T;(L5%Y;Y'4>:O'ZT 6:*K?VA99 ^UV^3T_>#_&@ZA9#K=V
MXS_TT'^- %FBJYO[,#)NX/\ OX*/M]G_ ,_<'_?P4 6*S_\ F8?^W7_V>ICJ
M5B%W&]MP/7S5_P :I?;K3_A(,_:H,?9>OF#^]0!KT56&HV)!(O;<@'!_>KQ^
MM+]OL_\ G[@_[^"@"Q158:A9$9%W;D?]=!_C0-1LFSMO+<X.#B5>#^= %FBJ
MW]H66<?:[?/IY@_QH_M&R#!3>6^3T'FK_C0 M]_R#[G_ *Y-_(T6'_(.MO\
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MN+B>;+R6HBZ(V 1QG<?45NU%+;03,&EB1V7H2* &V<KSV<4L@PS+DU/1THH
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M444 %%%% $=Q_P >TO\ N'^51V/_ !XP_P"X*DN/^/:7_</\JCL?^/&'_<%
M%BBBB@ HHHH *" 1@BBB@"B\:?VM%\B_ZH]O>HM12(7E@2B#]YQD#KQ4[_\
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M_P#;O_[-0!<HHHH **** "BBB@"&[_X\Y_\ KFW\J+3_ (\H/^N:_P J+O\
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M'_WQ0!<HJGY5_P#\_$?_ 'Q1Y5__ ,_$?_?% %RBJ?E7_P#S\1_]\4>5?_\
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MG_MW_P#9JN4 %%%% !1110 5#=_\><__ %S;^535#=_\><__ %S;^5 !:?\
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M5,(+%<]2,XZ^M6[:]OKN>ZC1-. MWV,3:CGC-26\5Y$F88],"2-D;;8'D]Z
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M!_US7^534 %%%% !1110 53_ .8S_P!N_P#[-5RJ?_,9_P"W?_V:@"Y1110
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M3_WP?\*/[4L_^>I_[X/^%7** *?]J6?_ #U/_?!_PH_M2S_YZG_O@_X5<HH
MI_VI9_\ /4_]\'_"N,O?B-8V?C9=,-I,Y91#YH( R3G..M=_6/)I.GR^(A<R
M6<+3B'<)"O.=W6@"Y_:EG_SU/_?!_P */[4L_P#GJ?\ O@_X5<HH I_VI9_\
M]3_WP?\ "LFWU&U'B>];S#@P(!\I_P *Z*LV[T*RO;LW4HE$K*%)20KP/I0
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MP/X8_M01_P!BVNSR=V-IZYK;TO0M+T42#3;&*V\S[_EC&: )?[4L_P#GJ?\
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M=N2=X&?UJ?PY%+<>&G2WG,+F>3#@9Q\U9MSKUUH][+:75Y-<%2%W"/ Y],4
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MO120,A^!P.G%7+'4+34/%+3VLZ2QD8# ^BX-;)_Y&!?^O7_V:EN]&L;R+8\
M3G=NB^0Y^HH O;AZC\ZQO$]G=WVD".QA6:=)DD"%PN0#D\FN:;P_?^=EA>L-
MK!L-D _PXY^E=7HVEK80)(S2F=T D#N2,T 9]Q>ZY=V[P3^%E>)QAE-^G/Z5
M1%GJ!D!C\*)!(7!\XWZG:?[V.Y KLJ* .3\1Z-?O<:7+I5FDZVKEG4RB,G\3
MZT^_OM;GLY1-X6C8!&P6O8SCCZ5U-07G_'C<?]<V_E0!Q.N>$YM1\%65OIEM
M!]L$L,[[B%+ <D;OQK8CTFXM-"T]ETZ&YU"V0*T9=1D=QN/%;FG_ /(-MO\
MKFO\JLT <P]UKGV::&'PM'%YB%25O8QU&.PJ+29_$>FZ5;V3>'5D,*;2XOD
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MZ&B@#FKKQ/'+:31KI.K[GC91FU/4CZUH>&XI(/#EA%-&T<BQ ,C#!'UK5HH
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MRRK_ &@@VCL.* -F*/Q')XAN--/B,!(H%E#_ &%,DDXQUK2_LGQ!_P!#.?\
MP C_ ,:Y@:C<OK=[ ES ERVGQI]H%W'][/6ETP:Q::A%/<:Q#+&IRR?V@A##
MTP: -30X_$>JZ>;F3Q&$;S73"V*=CCUI^K+X@T>S6\.OBX5945HVLT4,"P!Y
M!KG+.XU"^T2%+&_@M EQ*7'VQ%WY8T7<FHVFCS1W5[%>&2>+8@O4<@[AT[T
M=EXGU""UM!&]ZD#,&!7S I(QWJ'PIJ<5U%)"+Y)MB1B-?-W'&VO)OBA;)K7B
M2^M+J*^MKF)(I@;4>9\NPC!(Z#-4/AWI(T3Q;ITEN-2N99^ MROEJ.,\$T >
MPV U[6)M0ECUP6L4-Y)!'$MHCX5<8Y)I=5M?$6GZ5=7B>)-[0QEPIL8\''XU
M@17%_<66HV]K<Q6,RZG,S[KM%)'''K3))-1L=&U(WFI0W*/;LH0WR-SZT =1
M::=XAN+."<^)<&2-7(%C'QD9]:IZC'XCLK_3;=?$89;N4HQ-BGRX&>.:R+EM
M4OH[66UU6&WA^SQKY0OD7& /2EFU"YM9M"AN;F"XF2X<^:;Q#C*\<^WO0!U'
M]D^(/^AG/_@!'_C2:#>7HNM5M=3ODN!:2*%F,8CX*YYQQ7)&WUTS[_[=A^]D
M?\3!/7TJ/5-1F_L7Q=.;9985,1DD2=6X &>G6@#:\0WEE+XRT(_:;=XP3N.\
M$#ZUTN@NCZ+;F-E9?FP5.1]XU\OW7A2TO-4DF2?6TCES*JK;GY<G@#VKW?X<
MW%U'X-M4M]/=XD9E4O*%/!QR#TH WM<GLHKI1.+OS# Q/V?O&.H-4M6TBZUW
M2A%8201VMQ%&5,P.Y0!QP/:EUW1&\0>4;NPN4,8(!@O0A(/4'CFM2U>]M+6*
MVBTP^7$@1=UPI.!0!G^#8C;V^J0DY,>H2(2.^ HKH9T:6WEC4[6="H/H2*Y;
MPU=7P?6=NG;LZE,3^_48/'%;WVO4/^@9_P"3"T <T_@='/S6NGGY,$'S.6_O
M=>O>NCN)[>STMK>>ZA61+?:0S@$_+[T[[7J'_0,_\F%KQ+XH6Z:UXDO+2[BO
M;:XC2*53:CS/EVD8..@S0!WMA-:20>%?*DA:;SB&VL"V,&N_KYO^'FCIHGBS
M39;==1N99FPJW*>6J\9.":^@?M>H?] S_P F%H OUS_B+19-5FA=8S($0@!9
M A5CW]ZT?M>H?] S_P F%H^UZA_T#/\ R86@#,\.:$^DW$LAC,8DC"OF3?N;
M/7VKHJH?:]0_Z!G_ ),+1]KU#_H&?^3"T 77=8T+NP51R2QP!7D?C"]M6U3P
M_<>;!(1=DR-D'C)&3]*['QI?7D?@[4WFTXK$L67(F!XR,\5\]77A2SO-2>:.
M?6HXYLRJJVY^7)Z#VH ^G?#90^'K/8X=0IPP[\FLKQ':RWGBC0HH;N6U;$Y\
MR+&?NCCFLWX<7%U'X.@2WL)'B21E5I)0K<<<@]*LZ[?7,?B71C/;+;YCN%5F
MN5')3U- &I_PC^H?]#%?_DM8>C:'?/K6MJ->O5*SH"P"Y;Y>]9T.F3Q7"2_V
MC'E6W;O[17/7ZXI_VEM2N];@2>&$M<1MN6]1<X7IGO\ A0!MZUH-\FA:@S>(
M+YPMO(2I"X/RGBM_1/\ D :=_P!>L7_H(K@A#)IFGZE,UU#('LY$V?;U8'*G
MG!-=?HUU?C0M/ TW(^S1X/GKS\HH X[XFW%L([ZWD>-)3:[U)QN.,\"NR\+7
MEJ_AO2HDN86D^RQC:'!/W1VKR#XHVT>M^(KNRO(;VWG2..53;#S/EVD8..V:
MR?A[I"Z)XJTR6W&I7$LSA0MPGEH,#/!- 'OQ\.Z23G[$F<$?>/0]>]4=918]
M<\.QH,*LSJH] $K2^UZA_P! S_R86L'6KJ^.O:"3IV")I,#SUY^6@#K:ANK9
M+NV>"3=L<8.TX-5OM>H?] S_ ,F%H^UZA_T#/_)A: (SHD3'Y[J[<$@E6EX.
M.F>*=KMW-8Z'>75N0)HH]R$C(S3OM>H?] S_ ,F%K%\6ZA>0>$]2EFTXK&D)
M+,)E.!]* *ZP^(Y=1M93JEFK26^X9@Z ]JQ=&MO$_BR:6XO-<MTMK*_DA,,5
ML 752,_-[UYS\3_$6H^*-.T:'1-/U6&6W3+E$9=PVCT[5Z+\(++6]&\ V\=Y
M8.\L\KSYDF"MACW!YS0!Z915#[7J'_0,_P#)A:SY+NXEGG^TR/:-'C9&LHX&
M/O?[7TH WZ*@LY'ELXI)!AV7)XJ>@ HHHH **** "BBB@ HHHH **** "BBB
M@#/_ .9A_P"W7_V>L&X^'>D75G/:3/</!-(961I"<$G/%;^T_P!O[L';]EQG
M''WJOT <6?A?X;*;?LB],9Q38OA9X:AC5!:AMHQN89/YUVU% '%+\+O#:;L6
MH.3GD4#X6^&E<N+1>>V.*[6B@#B_^%7^'/,206H#(<C J:;P1I]M'?W<<UQY
MTT9WL7.3@' ^E==4%Z";"X &28FP/P- ',Q>"[&ZM+&62>YW1*LB$2'@XJ&7
MX9>'Y[V:[FB:6:7&XN<]*ZRQ!%A; C!$2Y'X"IZ .*;X7>&F96-HORYXQP?K
M0WPN\-MM_P!% VG/ KM:* .+?X7>&G7!M%^H'(I1\,/#8 'V1>/:NSHH XU/
MAKH<=E):1+)'#(09%1L;\>OK4@\*VJZV(A/.%%KD8<_WOK7750VG^W]V#M^R
MXSCC[U &"?A[I+V<MI(\[P2.79'<D9/I4(^&'AL #[(O'M79T4 <4GPM\-1J
M +13CN1S38OA9X:BWXMMV]RYW<XSV'M7;T4 <4/A;X:#EA:+R,8QQ0/A=X<6
MZBN%MRKQ?=V\#/K7:T4 <C/X(T^W2_NTFN/.EB.]BYR0 <#Z4L7@NQN[.QDD
MGN=T021")#P<5TUZ";"X &28FP/P-%B"+"V!&"(ER#]!0!R3_#'P]+>374L)
MDEEP7+'.3Z_6F-\*_#3S)(;7[H(V]CGU%=O10!Q$OPK\-2A,VVW8P8;>,X['
MVI9OA9X:FB9&M0,]U&"/I7;44 <7_P *O\-[-OV1>F,XYIT7PUT2#36L(O.2
MW<@NJN1OY[^M=E10!R(\*VJZTL2SSA1;<8<\?-]:EC\"Z?%;RPQW-VBRN7.V
M4@@GKCTK:*M_;RM@[?LV,XX^]5^@#G_^$2M=FW[3<],9\P_XTR'P?:0Q+&+N
MZ8+W:4D_SKHZ* .9M_!-A:F8Q7%R/.D,KYD/WCU[U+_PB-KYF_[5<YQC'F''
M\ZZ&B@#GCX1M2ZM]JN?ESP)#@_K5.7P1I]N+V\2:X\Z6,[V+GH <#Z5UM0W8
M)LIP!DF-OY4 <O!X+L;NRL9)9[G=%MD0B0\'%6U\'VBSM+]KNR6 &#*<#\,U
MM6 (T^W!!!$:Y!^E6: .<;P?:-,DOVN[!0$ "4X.?49HE\'6DP3-W=KM8,-L
MI&<>O/2NCHH YV7PA:S1-&;JZ4,,960@_P Z<OA.U50/M-R<#',A_P :Z"B@
M#E[GP-I]W9-:3W%T\3?>!D//.>:A_P"$5M4UF*)9YPHMSC#GCGZUUU4&5O[=
MC;!V_9R,XXZT 8\'@BPMHY4BN+I5E=G/[P\$]<4VZ\!:3?)&MV'N!']WS26Q
M74T4 <4GPN\-H@46H..Y&338_A7X:CDD<6N3(<D'H/I7;T4 <1_PJOPU]H\[
M[-SLV;?X>N>GK6F?!EEF';<W2+%]U5D('3&,9KI** .3D\$:? UY>)-<>?+'
MAF+GH!P/I3+?P78WEA9/+/<[HMLB$2'@BNJN03:3 ==C?RJ+3@5TZW!!!"#(
M- &1_P (C:^9O^U7.<8QYAQ_.HIO!-A//!,]Q<EX&+)^\/4C'K7344 <Y-X.
MM)H]AN[M1D'*RD'^=.?PC:R1LANKD!@1D2$$?K70T4 <]'X1M8XU075R0H R
M9"2?UJI<^ -.N].EL9[N]:&7[W[XYZYZUUE% &6D*VVJ6<"9V1VVQ<^@P*U*
MH2*?[;A;!VB%AG'O5^@ J-X(I6#21(Y'0LH.*DHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **:Z[T9
M<D9&,@\UR^-9AMK40K<2,C&28N_+#. OY<T =517,3KJODW+--.$CD58@J\L
MIY.<?E5=)_$()E$;>2KQ'8V2Y&#NQ^E '7T5BZ/)JJ6\Z7L+-*#OC+,.0>V?
M:J^K7=_%->Q11SY>W4PE%R _?F@#HJ*Y:WDU7[);F/SF>4^5)D'Y#UW<_C56
MTN=6@0-.+EV2X7> I)*;CGVZ8Z4[ =G167?O=O\ 8YK,28\S+QXQD8[U2A35
M)M"O!<^<ET)6,>UN<<8Q[4@.AHKDD.IQ:E<1,]SY8C'EG!)SMY]NM2VT>H3P
M6Y=[I=MRH9MQ&Y._!H ZBBN=O(=5:_U"2)W$*(@A 8Y)QS@=*NZ3!<1W%TT\
MD[ E=@D;(QCG'XT :M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_(H^SZE_S_1_]^16A10!G_9]2_Y_H_\ OR*/L^I?\_T?_?D5H44 9_V?4O\
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M_P!'_P!^11]GU+_G^C_[\BM"B@#/^SZE_P _T?\ WY%'V?4O^?Z/_OR*T**
M,_[/J7_/]'_WY%'V?4O^?Z/_ +\BM"B@#/\ L^I?\_T?_?D4?9]2_P"?Z/\
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M*** "BBB@ HHHH **** "C'.:** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9-((8))3T12U/J*X
MB\ZVEB_OJ5H \9U_Q%"MVUS?S[?,)VCK@"N*_P"$MGGU'R[>X18GN1$F8B<+
MZ_C6GXWTB_\ [3BB2WD;R0P^49R?0^QJ2PT H+>XF8)*)O/:,#@$C&V@#V'P
M5J4MW8/;3,6>'&"?2KLWBW1;>Z6WEO LC2/$ 1_$@RPK.\#V,D%I-=2*0)2
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MK_='Y4O2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** ,S5-!LM6&9TQ(!Q(O!K,L_!5A;S>9+(\^#D*W KIJ* &HB
MQH$10J@8 ':HVM;=V+-!&2>I*BIJ* &"*,!0$4!?N@#I2?9X3G,2<]?E'-24
J4 1K!"ARL2*1W"TIAC9=K1J5)S@C-/HH C2WAB.8XD4^H7%2444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g3dyckr3udth000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #, GD# 2(  A$! Q$!_\0
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M1A2Z>W41I$J6\@B<<9B9ARN0#DU)I=Q?ZAJGA5M M=(TIT@U6--MLSVDJ++
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MJSXB_P"$6/Q,NU\2QV,C'1;;[*MPBM*6$UQGRA][=T^[STH ])I&944L[!5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ****  C(P>E%%% !1110 4=:** "DP,=!
M2T4 %&.<]Z** "BBB@ HHHH 3 .,CITI<?K110!DKX<TU=0:]$<QD,_VG8;B
M0QB7&-X3.T''MUYZUK444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %(S*BEF("@9)/:EJO)''>*H+DQJ_S*.C$=C^- #&\R:[VI
M<ND?E!AL"G/)[D&G_9Y?^?V?_OE/_B:!_P A%O\ KD/YFK% %?[/+_S^S_\
M?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y
M3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L
M_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#O
ME/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\
M?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y
M3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L
M_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#O
ME/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\
M?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y
M3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L
M_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#O
ME/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\
M?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y
M3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#OE/\ XFK%% %?[/+_ ,_L
M_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\ ?*?_ !-'V>7_ )_9_P#O
ME/\ XFK%% %?[/+_ ,_L_P#WRG_Q-'V>7_G]G_[Y3_XFK%% %?[/+_S^S_\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFR.(HVD;)"C)P,F@
M9U0J&."QVCW-1PVZPM(^2TDC99CU]A]!1;-,\6^=0K,<A1_".P/O4U !1110
M!7'_ "$6_P"N0_F:L57'_(1;_KD/YFK% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% &7_ &9*=;O+TR[8YK:*%%5C
MG*F3)(_X&,<^M5+;2=0,D<ERUN&2/R\)(S#A&7/*CKD'_'OOT4 95Q87)M+"
M.-89C  )(Y)&16^7&00#R.H!'Y5F7&CZCYROB-U$H!5)G_?YD#!I/E^7 !&!
MN&">W%=110!S@TK4(CI<9E)!9UN@C$JJ;O,4 X!." @Z9#&K.H:7=W>H!T:(
M0DQDR&0AT"G+(%Q@AAP3D=>_%;5% &);Z//;>&M-L(S +FS2$G.?+=TQGWP2
M#SCT..U5Y-&U6_A(N[M(659/+$;^;M9L;3N91]W'!Q_$:Z.B@#G+S0+NZN(;
ME9H(I?M<,MP.2'1&1L XZAD./9CZU+=VMQ/X@5_+DV+C9("1L^1AGI@@$],C
MG!QQ6]10!ST6@3F*))W!"$EE\XE6/EE<X"KWY.<^O6K$>EW8O[>>2?>L<<8)
M$F""H(;JIR#GU&?P%;-% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %5[W_CW'_72/_P!#%6*KWO\ Q[C_ *Z1_P#H8H L4444 %%%% !1110
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M%)3_ ($O5?Y5F7'B*Q/B&&]03/:0Q/$\Z1DH&)'>B*J-M^0JDJ,8I;:K??\
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MW$<%G$&:.QFEVW4J]57(_GS^59.I66CV6H:=%IMUY2W#B.X6*X.&CR.2<_\
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M6US_ *!D_P"0J_;4_P"9?>9?5,1_(_N9D45K_P#"+:Y_T#)_R%'_  BVN?\
M0,G_ "%'MJ?\R^\/JF(_D?W,R**U_P#A%M<_Z!D_Y"C_ (1;7/\ H&3_ )"C
MVU/^9?>'U3$?R/[F9%%:_P#PBVN?] R?\A1_PBVN?] R?\A1[:G_ #+[P^J8
MC^1_<RGIEF=0U2UM.<32JK$=0,\G\LUNCPFL=P7FG:2UD8"V%L59YMVX@9.
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MS,BBM?\ X1;7/^@9/^0H_P"$6US_ *!D_P"0H]M3_F7WA]4Q'\C^YF14MO\
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MZ#K3UL?%*+M6UFVXD&#&I!$F-^?7.!2C&-K.#^[T_P""))6U13\+?\C-8_\
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M% !1110 4444 4KS2K._N(I[B-VDB5D4K*Z JV-RD*0&!VC@YZ5*+&V5=HB
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *KWO_'N/^ND?_H8JQ5>]_X]Q_UTC_\ 0Q0!8HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&2V260.6=6 QE'(
MX_"F_9%_YZS_ /?UO\:L44 5_LB_\]9_^_K?XT?9%_YZS_\ ?UO\:L44 5_L
MB_\ /6?_ +^M_C1]D7_GK/\ ]_6_QJQ10!7^R+_SUG_[^M_C1]D7_GK/_P!_
M6_QJQ10!7^R+_P ]9_\ OZW^-'V1?^>L_P#W];_&K%% %?[(O_/6?_OZW^-'
MV1?^>L__ '];_&K%% %?[(O_ #UG_P"_K?XT?9%_YZS_ /?UO\:L44 5_LB_
M\]9_^_K?XT?9%_YZS_\ ?UO\:L44 5_LB_\ /6?_ +^M_C1]D7_GK/\ ]_6_
MQJQ10!7^R+_SUG_[^M_C1]D7_GK/_P!_6_QJQ10!7^R+_P ]9_\ OZW^-'V1
M?^>L_P#W];_&K%% %?[(O_/6?_OZW^-'V1?^>L__ '];_&K%% %?[(O_ #UG
M_P"_K?XT?9%_YZS_ /?UO\:L44 5_LB_\]9_^_K?XT?9%_YZS_\ ?UO\:L44
M 5_LB_\ /6?_ +^M_C1]D7_GK/\ ]_6_QJQ10!7^R+_SUG_[^M_C1]D7_GK/
M_P!_6_QJQ10!7^R+_P ]9_\ OZW^-'V1?^>L_P#W];_&K%% %?[(O_/6?_OZ
MW^-'V1?^>L__ '];_&K%% %?[(O_ #UG_P"_K?XT?9%_YZS_ /?UO\:L44 5
M_LB_\]9_^_K?XT?9%_YZS_\ ?UO\:L44 5_LB_\ /6?_ +^M_C1]D7_GK/\
M]_6_QJQ10!7^R+_SUG_[^M_C1]D7_GK/_P!_6_QJQ10!7^R+_P ]9_\ OZW^
M-'V1?^>L_P#W];_&K%% %?[(O_/6?_OZW^-'V1?^>L__ '];_&K%% %?[(O_
M #UG_P"_K?XT?9%_YZS_ /?UO\:L44 5_LB_\]9_^_K?XT?9%_YZS_\ ?UO\
M:L44 5_LB_\ /6?_ +^M_C1]D7_GK/\ ]_6_QJQ10!7^R+_SUG_[^M_C1]CC
5)&YYF (.&D)&0<BK%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g3dyckr3udth000035.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000035.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %$ ?@# 2(  A$! Q$!_\0
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MXDU_XG)XU\3Z1'I L;0VMG:+<K,Q)W98LO&,2/U]>G&:U?AGX<U7P]_PDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG_"_/!7][4?_  %/^-%T!ZA17F'_  OSP5_>U'_P%/\ C2CX]>"L$[]1&/\
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M56 ?(5.TJ221SFE7/W:AS3U//'6AH"5,^E:.GV$EW((XU9F;@!1GFJ2S@0[
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M5>1C[$U<CN71P0Y'H:\_ZK*%[O4CEL;ES>W0MCIJ"-8@_F$MCJ!ZU@W%PC8
MX8=3GK4]Q=QFW^8L9,\>F*YZZN&$A4'BNC#T;CBC4N%$5BDZ72F1V(:/G('K
M52W:4LRC^+@UF^:^1DDXK4LKF-=N5P0>3ZUTN#A'N5:Q??2+LQ?-"54IO!;C
M(]:QY+!V?"8!)Z&NEN=9FNPI9FQ&FU 3G ]*P[B5I%VX QDY Y-949U/M"3?
M4R7C,;E6Z@XI\$9>50*T+2*,MAP#GU[5.\2QD%0 1T(KHE5Z%7(!!OD\L=>E
M:<UH^E-/!<VT4I:$8(8$+N'!X[UF^:?-W$Y;O237>Z0@>G2LFI-^1.K*;6K#
MD5 \3(>:T/M<BQ-$$7#');'--,3/%DBMU-K<JYG\UHZ7?36,WF0R,C8QE3@U
M5:WD*LZH2J]2!TJU96YD!/9>314<7%I@]CL?#5Q:'4(I+EHT YS(A8$^]?2O
MA81CPKI@B96C^SIM*C (QVKY:L1#';2DH3)@;#G&,]\=Z^G?! (\#:(#U^QQ
M_P#H-<^"@E6E)=B8+WCR3]H[_CX\.?[MQ_[3KQ_2M/;4+CR59%8\@,<9KV[X
M_P"GF\_L682(ODI.2&;!.=G3\J\;?3/L^DP:A%>PNTC%3$C?O$^H]*Z*]17<
M4]2FS,O[<V]T\1(.TXX.15,=>*U?*C99&DDPP&1G^(^E4!M#DE0<TX2TL"(]
MVT^M1=34DBD<U'6JV&**FA"M(H<[5)Y..@HM+=[J=(4QN<X&:'0QR,GH<'%2
MVM@);U+>.Z=+61I(1]UF&":@4$'ZU)%M\Q2_W<\BIM0FMI;G=:0F&/: %+9Y
MI+^414;K4BMQ4?)H)IV&*9.U*,]149S3U.!BG8"3S6(VD\>E"@%>G/K3  ><
MTY,]JFP#I6)5?:H))'D(W,3M&!]*LR0E8U<L#N[ \BH,8YQUHC8!H0D9H*X'
M-6(K@I!)",;7ZY'-0GG\*J[N!'3D9D8,IP:0]*<.!C% "C)-3)T [D\'-0 X
M%2;C@<YI,"2564XS^M)]FE*;PAV^N*?$0>6YJ^FK;+(VQ16[*QZJ*R<I+X4(
MQL%32JA8D]<=:D='/[S:=I/7'%(O>M;C&X /%/4NZB,'(SP,U'VH+;6X- 'U
M%\"E9/AK$K#!%Y."/^!44? @Y^&<)/\ S]S_ /H5%="V*/2Z^'-7_P"0WJ/_
M %]2_P#H9K[CKX@UJ%X];U'>"#]JE."/]LU%1Z"9GT4NTFD(Q68@HHHH ***
M* "BBE"DG % !_#258C@S]ZK::87"'(PQQUJ'4BMQ71FBI8HRS"NM7P+=-H]
MUJ<<\#06R@M\_)KG+20)=HV =IZ'I64,1"HG[-WL+F3V-S3O#[WEG+<Q9+1<
MF)5)..[?2LN68JQ&>!QBMF?7ITR]J_V=GB,<GE<;Q7/^6SL#SR:PI<\FW4%&
M_4LVVV[N8XY)A&I."[=%JEJ$ AO)$202HIP)%Z-[ULVNBSW*.T,;/L7>V.P'
M>F):1,H#<GO5QJQ4KIA?L<_M8=C5W3[9IY0.0.];%Q;6IMXXXH=LBY+-GK5W
M0K>8,[0VPF$:DL"N0!ZT5,2N1M Y"_V86ME6##R'/ Z_B*I:AI-W8JOVFW>+
M(R-RD9KK- T=[R&ZNX;J.+R5RP9L9%5KN[GNV,<C-+'T.XYKSHXEJ;BM;;F?
M,[G#HQ,N!6Q)H]]%I\-_+"RVTQ*QN>C8JW9>'WU+55M;90K2-A<G K;U"RN;
M*+^SM0NBRV?^KB4[EYZ\UM5Q4>91B]?T*<NQQK:>\DB)&1N=L#FM#2_"[ZEJ
M,=BKJDK-MW,>*KZA<QI.?(#)%Q][KGZUM^$M0L+C6K>._E6*('!8''YFJK5*
ML:3E'L#;M<QM2TB73;Z6REVEXV*DKSDU1.%5E/RG''%=EXYCTNUU7=ITZNI7
M+A7W 'ZUS=C<Z?\ ;H#?0O);*V9 IPQ'H*6'K2J4E4:81E>-S-0':1DX/44\
MP%(=ZMSG!%3>9;R:B[("EN7R%[A<UT'B>ST*W@MI-&OGGWK^\C<<I6LJMI1B
MUO\ UJ._0Y^WN'0YSVKZM\"L7\!Z$QZFRC/_ ([7RO,EK'8P/#.SSL#YJ%<!
M?3GO7U-X!.?A_H)_Z<8O_0177A;<S9<=SRO]HO>)?#Q7IMN ?_(=>)0N ?FS
MQTQ7M/[1[$7'AS']VX_]IUX:DC<@=#UK:HKL;-1IH94VD8)JM#:FXG6*,$LQ
MQ]*@4X&"#FM#1M:ET6^6\A16E3[H<9%8.,HQ?)JQ/1:#-8TXZ=<&#S!)MX)'
M%9K[2?E&![U:U+4Y]3OI;JX.9)&RU5AM[BM*?,HKFW! C%#E3@^U*V0,G/-*
M@R<9Z\4YDZCTJKZC&^9F+;@=>N.::0> :3!!'M3WD:63>YRQ[T (#M!! YII
MQGBE?KS48&330$T;1C.\$\<8]:?+()"NU O&.*9A"JJ%.\'EL\5-;I&)U$Y(
M3N5ZU+LM0)1:86/<I3<,[CT-$:0KOWL1@<8'4U.K/<2+")?W:9V;NU496(D8
M9SSC-9J[=F(1V)%0')&*GC."<@'(Z&A@@AR"=^>?3%:)V&0+3CP<4C?+@8HR
M6.>M4 X %220,?K2%L=>>*1<[NE*5S0 S)-/7I3=I!J14+(6&>.M# 4'C-20
MP-<R!%^\?6FGR_+ &=W\6>E(C%3D$@U/H!<74)X;*33\(T3-G!7)!]C5,<<D
M<^E&\J^X'D=#3A*1)OSD^II*-MA$6"3BFX);%67,/D1[=WF_Q>E0_-G--,9]
M3?!*TDL_AM;)+C+7$KC![%N**C^!CN_PT@+L6(NIAD_[U%=$+\JN-;'I-?#^
MKR,=<U#))_TJ7K_OFON"OAS5_P#D-ZC_ -?4O_H9J:FP,CCYX]:6>/RSM888
M=12VPC,;!@3)QMQ2RP,R[L'CK7/>S)*F.:7%7[&Q-Q.%(.*Z2_\ #$EC9_Z1
M9R1LX_=NW%9U,33A)1;U8G)(XNBK$]L\+$,,5#M]JW335RAO>I(Y-C=*CQ13
M OPW4>X!ER,^M;5N8VE4[!M/85S K3TZ9F<+R<>E<U:GI=$M'HFNZ!96?@I;
MN/429Y "8E?@^V/:O,H(\R9.<>U=#>ZE+J$<-IL4>4NT%5P3]?4U#?:6UAY9
M:*:)7 (\Q<9KCPBE1BXU)7;9$=-""-83$WF-@@< #K5B&W :-(]K%N<>GM6?
M=/!'+_H\C.N/XA@YJ6WOY(762+AEY!(SS6\H2:T*LS4EDOK*66)-T9"[7"GL
M:BT^*>XF:-(][E21[8J+[7+/)YDS?,QY-:,-P+>$[&PSJ0Q(SGZ>E8-.*M;4
MEZ$4<:"Z2.9\1DC<X&<#O4=[=);7=PNGRR&$956!P6%5VFDEEV)G<>*6_L+J
MT>+SHO++J& ]0:<8JZYF-+7433K^^5I3%O*[27Q_=]ZW8+])I(PJI$I'S[CP
M:YJ>9K6W/E'9OX8*>H]*KC4R(L9R>E5/#JIJD'+<Z^QU2!M7&P_9D=\!R?N>
M])>.6FF5IO, 8_.#][WKB'OW)R.*M'5&6W"AN<5#P34DT+D)-7>,@!6'''!K
M'61T.5.*'E+GGUJ/->C3ARQL:)6)S<2,?F8FM2&YMO[/9#"7F/\ $3C;6)6U
MINGB>*25G 5!ZU-514;L'89!'YC #C/O6F-,G73VNW&(0VP'^\?:H?LJPSJ
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MG*>:SYMRJ1Y/^T4VVX\.D==MQ_[3KQ:ZO9[N&))9"PC7:H/85[1^T5G[3X=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g3dyckr3udth000022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3dyckr3udth000022.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $) BD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .,^(FO\
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M%S>:C_:D6I37+Q(IE,<;1I'M4 !0K=J )[KXCZ19WK6\UGJ2QPM#'=W/V?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445EZC=SP:QH\$;[8[B:195P/F B9A^H%
M &I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M6?JNMZ;H<4,FI72P+/*L,>5)W.QP!@ ]R.:IS^,?#]MJ<^G3ZG%'<VZLTH=6
M"+M3>PWXV[@OS%<Y YQ0!N5BZM_R'_#_ /U\2_\ HEZLZ/KNFZ];R3Z;<&5(
MG\N0-&T;(V <%6 (X((R.0:S]=O;6VUW0FFN(HPEQ+NW..,P/B@#H:*I?VM8
M_P#/ROY&C^UK'_GX7\C18+EVBJ7]K6/_ #\+^1H_M:Q_Y^%_(T6"Y=HJE_:U
MC_S\+^1H_M:Q_P"?A?R-%@N7:*I?VM8_\_"_D:/[6L?^?A?R-%@N7:*I?VM8
M_P#/POY&C^UK'_GX7\C18+EVBJ7]K6/_ #\+^1H_M:Q_Y^%_(T6"Y=HJE_:U
MC_S\+^1H_M:Q_P"?A?R-%@N7:*I?VM8_\_"_D:7^U;+_ )[C\C0!<HJG_:EE
M_P ]Q^1H_M2R_P">X_(T 7**I_VI9?\ /<?D:/[4LO\ GN/R- %RBJ?]J67_
M #W'Y&C^U++_ )[C\C0!<HJD=6L 0#<J">@(/-+_ &I9?\]Q^1HL*Z+E%4_[
M4LO^>X_(T?VI9?\ /<?D:!ERBJ?]J67_ #W'Y&C^U++_ )[C\C0!<HJG_:EE
M_P ]Q^1H_M2R_P">X_(T 7**I_VI9?\ /<?D:/[4LO\ GN/R- %RBJ?]J67_
M #W'Y&C^U++_ )[C\C0!<HJG_:EE_P ]Q^1JS%+'/&)(F#*>A% #Z*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH Y[QEHVIZ]HJV&FSVD),\4LC7*LPQ&ZR #:1U*@'VS7,:E\,[
MS5Y+ZWNM4@CL+F>>] BA)D6XEA\H\DX* DL!C)Z&O2** ,#PUH=[IDVIWVIW
M,$U_J,R22_9HRD:!(UC4*&)/1<DGN?:JWB+1M,O]>T3[5I]M*9;B3S&:)2S8
MA?&3C)KJ*Q=6_P"0_P"'_P#KXE_]$O2:35F--IW18&@:8!@6V .@WM_C1_8.
MF_\ /O\ ^/M_C6E16'U3#_R+[D:>WJ_S/[S-_L'3?^??_P ?;_&C^P=-_P"?
M?_Q]O\:TJ*/JF'_D7W(/;U?YG]YF_P!@Z;_S[_\ C[?XT?V#IO\ S[_^/M_C
M6E11]4P_\B^Y![>K_,_O,W^P=-_Y]_\ Q]O\:/[!TW_GW_\ 'V_QK2HH^J8?
M^1?<@]O5_F?WF;_8.F_\^_\ X^W^-07F@6AM7%M;XFXV_.?7W-;-%-86@G=0
M7W(/;5?YG]YD)HMB9FC:Q8*!Q)YAP>GO[_I4O]@Z;_S[_P#C[?XU9OX9I[*2
M*!]DK8VMG&.15@,#G!!P<'':E]4P_P#(ON0>WJ_S/[S._L'3?^??_P ?;_&C
M^P=-_P"??_Q]O\:TJ*/JF'_D7W(/;U?YG]YDW&B:?';2NL&&5"0=[=<?6K>G
MJK:=;DJ"3&O)'M4MUS9S@?\ /-OY53L+^TCL+=&N$#", @GIQ6-J-"NK6BFO
M)=46W.I3UN]30\M/[B_E1Y:?W%_*HXKNWG;;%,CMC. :FKLC.,E>+N8--:,;
MY:?W%_*CRT_N+^5.HJA#?+3^XOY4>6G]Q?RIU% &#JR*/$>@_*O+S=O^F=;G
MEI_<7\JQ=6_Y&/0?^NDW_HNMRM:GPP]/U9S4/XE7_$O_ $F(WRT_N+^5'EI_
M<7\J=161TC?+3^XOY4>6G]Q?RIU% #?+3^XOY4>6G]Q?RIU% #?+3^XOY4>6
MG]Q?RIU% #?+3^XOY4>6G]Q?RIU% #?+3^XOY4H  P!@4M% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
MC,%4LQ 4#))/ J);NV=@JW$3,>  XR: )J*** "BH[B4P6TLJQ23%$+".,#<
M^!T&2!D^Y%<?)\2],BB)ETW4HIA>FQ\F00JWFB/S",F3;PN/XNIQ0!VE8NK?
M\A_P_P#]?$O_ *)>ME&WHK8*Y&<'J*Y[6[^SA\1:$DMY;QM'<2EU>505S"^,
M@F@#HJ*0$$ @Y!Z$4M !1110 4444 %%%% !1110 5!;6PMC,0^[S9#)TZ9[
M5/5:UAEB:X,K[M\I9.<X'I0!9HHHH *C^SPG_EC'_P!\BI**32>XTVMC.EC1
M-9M-B*N4?H,=JT:IWED]Q+'+%<-!)&" P4-P?8U%]BU#_H*M_P!^%KECSTIR
MM!M-WTMV7=HV:C-*\K??_D:-%9WV+4/^@JW_ 'X6C[%J'_05;_OPM7[:?_/M
M_P#DO_R1/LX_SK\?\C1HK&O5U"QM'N?[1,GED'885 /(%;-53J\\G%Q::MO;
MK?LWV%.'*DT[W,/5O^1CT'_KI-_Z+K<K(UBQO9[S3[RR$+26K.=DI(!W+CJ*
M;:ZEJ*ZM%9:A;6\?G1LZ-"Y;D8ZYKM<>>$7'HOU;/-C45*K-33]YJSMILEOZ
MFS1116!W!1110 4444 %%%% !1110 4444 %%%% !1145Q))% SPPF9QT0,!
MG\30!+16(UUJYOHYAIL@A5"K1>>O))&#6E9SW$X<W%HUN0> 7#;ORH LT5SG
MCN>_M?!]W<::UPMQ%)#(3;@EQ&)4,F .3\F[..V:Y8>(];OM;N7T2\S8:AJ0
M@M;FYMGDC2-+,NY1<KQYBXSG!)- 'IE%>1Q^,/%32S78N8XY;NQTR:VLI+)B
MD;32!)F!!!(4GD$]QTQS9F\<^*+/7-;M)[6!H-/@FVJMNQF?8@*S*F?F5B3Q
MD #OD&@#U.BO(M/\:>*;R73+Z212OE:C']DBM#MO)8MK1 -GY2P)P1Q\IQG/
M#(_'GB>[\/127365NMQ</$U[%:R2B/\ <EQ&44Y#E_E!S^&: /8**\PCOO$<
M&E>!H]-+/-+HLK7,=U(ZJS+%#@N0I.\$G&>Y-4M$\7^+);S0=)VQ(DVG6S//
M=HQEF9X<O(OJ5;M[')&10!ZY17,_#Z_OM3\#Z9=:E=FZOFCQ.[0^4RN."K#U
M!X)[XKIJ "BBB@ HHHH **** "BBB@ HHHH AN[2WO[.:TNX4FMYD*21.,JZ
MGJ"/2O'H-"N--\>6,EMX6TRVL_[1:* 6^BDNB))C>9\X7Y,.#C'4#D5[!>74
M5C93W<^_R8(VD?8A<[0,G &23["O)[7RI/B;]H@OY](5[[+6UE97A%]D]9F8
M")<]R!^- 'K]%%% ","5(4X8C@XSBN/F\!+)X2CT"/4W5',K7EQ);1RO<M(2
M9&.X':Q+'!'3\*[&B@""RM(K"PM[.'=Y5O$L2;CD[5  R>YP*Q-;T^RG\1:$
M\MG;R-)<2AV>)26Q"^,DBNBK%U;_ )#_ (?_ .OB7_T2] &R    , = *6BB
M@ HHHH **** "BBB@ HHHH *KQB<7DY<_N2%\OGVYJQ5>*29KV>-EQ$H78<=
M<CGF@"Q1110 4444 %%%% !1110!G:[_ ,@:X_X#_P"A"KGVJW_Y[Q?]]BGN
MB2(4=0RL,$$9!JO_ &=9?\^L7_?(KGE"HJCG"VJ2U\K_ .9JI0<%&7];?Y$O
MVJW_ .>\7_?8K*NB#XKTT@Y!@EP?RJ^^G681B+6+I_=%8\6G7ES%IU[9W,<4
MD,;IB1-P()K7#U9JMR5+*Z??T[>9S8RG>CS4TW:4=-.]^_D='16-]F\0?]!"
MT_[\'_&J]Q=:QIES8FYN;:>*XND@95B*D;L\Y_"NE4;Z*2_'_(P>*<=90DE\
MO\SH:***Q.L**** "BBB@ HHHH **** "BBB@ HHIKR)$A>1U11U+' H =15
M5]1MDFAC\P$2AB'!!4;>N3^-3QRQS+NBD5USC*G(H ?165XBUM/#VBR:E) T
MZI+%'L5@"?,D5,\^F[/X5F77CG3=/U/4+*]BN4:UN4MH_*B:9IW:'SL*J GA
M<_E0!U%%<>/B3H/VB[#"\%K;P6TXNUM7:.59SB/;@9))(XQSSZ'%I/'WAU]1
MFT\7<GVN&)I'B,#[OE4,R 8Y=01E1R/P- '345R$/Q'T*YO+*&#[4\-S%<2M
M<^0PC@\D@.)"?NXS]!QZBC_A97AN73&N[2ZEG?>8D@2WD,A8)YGW N=NWYMV
M,8H Z^BN(N?B-!8:1X<N[JP=I];L_/AAA<',VV,K$N>I9I  >.F34C^/FCED
MEDT:<:9;WJ:?=7JS(1%.65" G5D5V"EN.^ 10!V=%%% !1110 4444 %%%%
M!1110 4444 %>::99ZKJ/CJZO]*U1-,TVVU&2*[M3?27#7;*?F'E. L6>N5]
M:]+KQRXET]/BA +2VT&]O6U4+,L6C3"ZA&3ES,6V$K@9;\1Z4 >QT444 %%(
MS*B,[L%51DDG  JFNKZ8]L;E-1M&MP_EF43J5#?W<YQGVH NUBZM_P A_P /
M_P#7Q+_Z)>MJL75O^0_X?_Z^)?\ T2] &U1110 4444 %%%% !1110 4444
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MI!S^-7_[)U3_ *&.\_\  >#_ .(J*;QGH5O<V<$EV^^[CBDC*P.RJLIVQEV
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MM)>W%O\ :$"(2H3&1EN@)'..N*J[M8AQ3:DUJB2'3=3CGC>37KB5%8%HS;Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!6?3[*2]2\DL[=KI!A)VB4NH]FQD59HHH 8D,4;R.D:*TAW.54
M L<8R?4X 'X4^BB@ HHHH *8L,2222)&BO(078* 6P,#)[\4^B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>51
<FILENAME>tsha-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-14T14:11:23.8924016+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : 9ce9bc11c38d436e8005d94e4df304b9 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:tsha="http://tayshagtx.com/20210630" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://tayshagtx.com/20210630" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://tayshagtx.com/20210630/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited" id="Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" id="Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited">
        <link:definition>100030 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited">
        <link:definition>100040 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&apos; Equity (Deficit) (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited">
        <link:definition>100050 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&apos; Equity (Deficit) (Parenthetical) (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperations" id="Role_DisclosureOrganizationAndDescriptionOfBusinessOperations">
        <link:definition>100070 - Disclosure - Organization and Description of Business Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponents" id="Role_DisclosureBalanceSheetComponents">
        <link:definition>100090 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreements" id="Role_DisclosureResearchCollaborationAndLicenseAgreements">
        <link:definition>100100 - Disclosure - Research, Collaboration and License Agreements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability" id="Role_DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability">
        <link:definition>100110 - Disclosure - Stockholders&apos; Equity (Deficit), Convertible Preferred Stock and Tranche Liability</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100120 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShare" id="Role_DisclosureNetLossPerCommonShare">
        <link:definition>100130 - Disclosure - Net Loss Per Common Share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactions" id="Role_DisclosureRelatedPartyTransactions">
        <link:definition>100140 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100150 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100160 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100170 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100180 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables" id="Role_DisclosureBalanceSheetComponentsTables">
        <link:definition>100190 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100200 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareTables" id="Role_DisclosureNetLossPerCommonShareTables">
        <link:definition>100210 - Disclosure - Net Loss Per Common Share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" id="Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails">
        <link:definition>100220 - Disclosure - Organization and Description of Business Operations - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" id="Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail">
        <link:definition>100230 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" id="Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail">
        <link:definition>100240 - Disclosure - Balance Sheet Components - Schedule of Property Plant and Equipment, Net (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" id="Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails">
        <link:definition>100250 - Disclosure - Balance Sheet Components - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>100260 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" id="Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails">
        <link:definition>100270 - Disclosure - Research, Collaboration and License Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails" id="Role_DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails">
        <link:definition>100280 - Disclosure - Stockholders&apos; Equity (Deficit), Convertible Preferred Stock and Tranche Liability - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100290 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails" id="Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails">
        <link:definition>100300 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" id="Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails">
        <link:definition>100310 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" id="Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails">
        <link:definition>100320 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" id="Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails">
        <link:definition>100330 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails" id="Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails">
        <link:definition>100340 - Disclosure - Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" id="Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails">
        <link:definition>100350 - Disclosure - Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" id="Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
        <link:definition>100360 - Disclosure - Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" id="Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>100370 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100380 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100390 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="Role_DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>100400 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="tsha_BuildToSuitLeaseLiability" name="BuildToSuitLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" name="ChangeInFairValueOfPreferredStockTrancheLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" name="IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" name="ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_TemporaryEquityStockOfferingCosts" name="TemporaryEquityStockOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" name="TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" name="IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" name="PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_ReclassificationOfPreferredStockLiability" name="ReclassificationOfPreferredStockLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_AllocationOfPreferredStockTrancheLiability" name="AllocationOfPreferredStockTrancheLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" name="ResearchCollaborationAndLicenseAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_BuildToSuitLeasePolicyTextBlock" name="BuildToSuitLeasePolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" name="ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" name="OrganizationAndDescriptionOfBusinessOperationsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" name="OrganizationAndDescriptionOfBusinessOperationsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TwoThousandTwentyEquityIncentivePlanMember" name="TwoThousandTwentyEquityIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" name="TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_CommonStockIncreaseInOutstandingShares" name="CommonStockIncreaseInOutstandingShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_PrepaidResearchAndDevelopmentContracts" name="PrepaidResearchAndDevelopmentContracts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_PrepaidBonus" name="PrepaidBonus" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_PrepaidClinicalTrial" name="PrepaidClinicalTrial" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_BuildToSuitLeaseMember" name="BuildToSuitLeaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_AccruedResearchAndDevelopmentCurrent" name="AccruedResearchAndDevelopmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_AccruedPropertyPlantAndEquipmentCurrent" name="AccruedPropertyPlantAndEquipmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_AccruedClinicalTrialCurrent" name="AccruedClinicalTrialCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" name="PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" name="MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_UTSouthwesternAgreementMember" name="UTSouthwesternAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_QueensAgreementMember" name="QueensAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_AbeonaCLN1AgreementsMember" name="AbeonaCLN1AgreementsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_AbeonaRettAgreementMember" name="AbeonaRettAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_AbeonaTherapeuticsIncMember" name="AbeonaTherapeuticsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" name="AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" name="PercentageOfFullyDilutedCommonStockSharesOutstanding" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" name="PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="tsha_ResearchGrantOfCommittedFundAmount" name="ResearchGrantOfCommittedFundAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_ResearchGrantOutstandingFundAmount" name="ResearchGrantOutstandingFundAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_LicenseAgreementRegulatoryMilestonesPayment" name="LicenseAgreementRegulatoryMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_LicenseAgreementCommercialMilestonesPayment" name="LicenseAgreementCommercialMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_PaymentsToAcquireLicenseRight" name="PaymentsToAcquireLicenseRight" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_AdditionalMilestonePayments" name="AdditionalMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_PaymentOfLicenseFee" name="PaymentOfLicenseFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" name="PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" name="LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" name="LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_RegulatoryRelatedMilestonesObligationPayable" name="RegulatoryRelatedMilestonesObligationPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" name="SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_PaymentOfOneTimeUpfrontLicenseFee" name="PaymentOfOneTimeUpfrontLicenseFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_UpfrontPayment" name="UpfrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" name="ClinicalRegulatoryAndCommercialMilestonesToBeReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_SeriesAPurchaseAgreementMember" name="SeriesAPurchaseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_SeriesAPurchaseAgreementInitialClosingMember" name="SeriesAPurchaseAgreementInitialClosingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" name="SeriesAAchievementOfSpecificClinicalMilestoneOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" name="SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" name="SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" name="PBMTGTHoldingsLimitedLiabilityCompanyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_NolanCapitalLimitedLiabilityCompanyMember" name="NolanCapitalLimitedLiabilityCompanyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_SeriesBPurchaseAgreementMember" name="SeriesBPurchaseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" name="MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_ProceedsFromIssuanceOfCommonStockGross" name="ProceedsFromIssuanceOfCommonStockGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" name="ConvertiblePreferredStockTrancheLiabilityOfferingPrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" name="ConvertiblePreferredStockTrancheLiabilityMeasurementInput" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" name="ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_PreferredStockTrancheLiability" name="PreferredStockTrancheLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_IssuanceOfProRataPortionOfMilestoneShares" name="IssuanceOfProRataPortionOfMilestoneShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_MileStoneSharesIssued" name="MileStoneSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_AmountReclassifiedToConvertiblePreferredStock" name="AmountReclassifiedToConvertiblePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_TwoThousandTwentyStockIncentivePlanMember" name="TwoThousandTwentyStockIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_CancelledOptionsMember" name="CancelledOptionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_CertainEmployeesAndConsultantsMember" name="CertainEmployeesAndConsultantsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_ShareBasedCompensationAwardTrancheFourMember" name="ShareBasedCompensationAwardTrancheFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_FounderPresidentAndChiefExecutiveOfficerMember" name="FounderPresidentAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" name="PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_NumberOfSecuredPromissoryNotes" name="NumberOfSecuredPromissoryNotes" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_SecuredPromissoryNotesMember" name="SecuredPromissoryNotesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_PBMCapitalGroupLLCMember" name="PBMCapitalGroupLLCMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_PBMTGTHoldingsLLCMember" name="PBMTGTHoldingsLLCMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_ServicesAgreementMember" name="ServicesAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_OwnershipPercentageInExcessOfCapitalStock" name="OwnershipPercentageInExcessOfCapitalStock" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" name="AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_DurhamLeaseMember" name="DurhamLeaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_DallasLeaseMember" name="DallasLeaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_PegasusParkLLCMember" name="PegasusParkLLCMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_OperatingLeasesInitialDirectCosts" name="OperatingLeasesInitialDirectCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_BuildToSuitAsset" name="BuildToSuitAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" name="EquipmentPurchasesAndBuildOutOfLeasedFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" name="ObligationForPaymentOfInitialBaseRentForOfficeSpace" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" name="MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" name="MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_NumberOfDistinctAndActiveClinicalStage" name="NumberOfDistinctAndActiveClinicalStage" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" name="TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" name="TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" name="TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" name="TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TermLoanFacilityMember" name="TermLoanFacilityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" name="TermLoanThroughAugustThirteenTwentyTwentyTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" name="TermLoanThroughAugustThirteenTwentyTwentyThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="tsha_PercentageOfPrepaymentPremium" name="PercentageOfPrepaymentPremium" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="tsha_PercentageOfPrepaymentOfFacility" name="PercentageOfPrepaymentOfFacility" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>52
<FILENAME>tsha-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-14T14:11:23.8924016+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : 9ce9bc11c38d436e8005d94e4df304b9 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="tsha-20210630.xsd#TemplateLink" roleURI="http://tayshagtx.com/20210630/role/TemplateLink" />
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsLeasingNetNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredCostsLeasingNetNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseLiability" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="tsha_BuildToSuitLeaseLiability" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredCostsLeasingNetNoncurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10170.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:type="locator" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="10070.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="10080.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" order="10120.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10150.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10160.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" order="10190.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidClinicalTrial" xlink:type="locator" xlink:label="tsha_PrepaidClinicalTrial" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance" xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidBonus" xlink:type="locator" xlink:label="tsha_PrepaidBonus" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidResearchAndDevelopmentContracts" xlink:type="locator" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="tsha_PrepaidResearchAndDevelopmentContracts" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="tsha_PrepaidBonus" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="tsha_PrepaidClinicalTrial" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="10050.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedClinicalTrialCurrent" xlink:type="locator" xlink:label="tsha_AccruedClinicalTrialCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:type="locator" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedResearchAndDevelopmentCurrent" xlink:type="locator" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_AccruedResearchAndDevelopmentCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_AccruedPropertyPlantAndEquipmentCurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_AccruedClinicalTrialCurrent" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>53
<FILENAME>tsha-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-14T14:11:23.8924016+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : 9ce9bc11c38d436e8005d94e4df304b9 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef xlink:type="simple" xlink:href="tsha-20210630.xsd#TemplateLink" roleURI="http://tayshagtx.com/20210630/role/TemplateLink" />
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" xlink:type="locator" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" xlink:type="locator" xlink:label="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="10800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="10820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="10940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" order="11260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11580.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockOfferingCosts" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockOfferingCosts" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_TemporaryEquityStockOfferingCosts" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" order="10160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10470.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:type="locator" xlink:label="us-gaap_Cash" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CommonStockIncreaseInOutstandingShares" xlink:type="locator" xlink:label="tsha_CommonStockIncreaseInOutstandingShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" xlink:type="locator" xlink:label="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:type="locator" xlink:label="us-gaap_PaymentsForUnderwritingExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesBConvertiblePreferredStockMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:type="locator" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:type="locator" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_PlanNameAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesBConvertiblePreferredStockMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_PaymentsForUnderwritingExpense" order="10900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_CommonStockIncreaseInOutstandingShares" order="11080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="11180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="11220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_Cash" order="11290.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="tsha_LaboratoryEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_LaboratoryEquipmentMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10500.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseMember" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_BuildToSuitLeaseMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ConstructionInProgressGross" order="10200.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:type="locator" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_UpfrontPayment" xlink:type="locator" xlink:label="tsha_UpfrontPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:type="locator" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:type="locator" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:type="locator" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:type="locator" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentOfLicenseFee" xlink:type="locator" xlink:label="tsha_PaymentOfLicenseFee" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AdditionalMilestonePayments" xlink:type="locator" xlink:label="tsha_AdditionalMilestonePayments" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAgreementCommercialMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentsToAcquireLicenseRight" xlink:type="locator" xlink:label="tsha_PaymentsToAcquireLicenseRight" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchGrantOutstandingFundAmount" xlink:type="locator" xlink:label="tsha_ResearchGrantOutstandingFundAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchGrantOfCommittedFundAmount" xlink:type="locator" xlink:label="tsha_ResearchGrantOfCommittedFundAmount" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:type="locator" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:type="locator" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:type="locator" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:type="locator" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:type="locator" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaTherapeuticsIncMember" xlink:type="locator" xlink:label="tsha_AbeonaTherapeuticsIncMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaRettAgreementMember" xlink:type="locator" xlink:label="tsha_AbeonaRettAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaCLN1AgreementsMember" xlink:type="locator" xlink:label="tsha_AbeonaCLN1AgreementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_QueensAgreementMember" xlink:type="locator" xlink:label="tsha_QueensAgreementMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_UTSouthwesternAgreementMember" xlink:type="locator" xlink:label="tsha_UTSouthwesternAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_UTSouthwesternAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_QueensAgreementMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaCLN1AgreementsMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaTherapeuticsIncMember" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" order="11070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" order="11160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" order="11180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" order="11270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" order="11310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ResearchGrantOfCommittedFundAmount" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ResearchGrantOutstandingFundAmount" order="11500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentsToAcquireLicenseRight" order="11570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementRegulatoryMilestonesPayment" order="11610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementCommercialMilestonesPayment" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_AdditionalMilestonePayments" order="11720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfLicenseFee" order="11790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="11870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" order="11910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" order="11950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfOneTimeUpfrontLicenseFee" order="12060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_RegulatoryRelatedMilestonesObligationPayable" order="12080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" order="12100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_UpfrontPayment" order="12200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" order="12220.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AmountReclassifiedToConvertiblePreferredStock" xlink:type="locator" xlink:label="tsha_AmountReclassifiedToConvertiblePreferredStock" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MileStoneSharesIssued" xlink:type="locator" xlink:label="tsha_MileStoneSharesIssued" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IssuanceOfProRataPortionOfMilestoneShares" xlink:type="locator" xlink:label="tsha_IssuanceOfProRataPortionOfMilestoneShares" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_PreferredStockTrancheLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCollaborators" xlink:type="locator" xlink:label="us-gaap_ProceedsFromCollaborators" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ProceedsFromIssuanceOfCommonStockGross" xlink:type="locator" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" xlink:type="locator" xlink:label="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBPurchaseAgreementMember" xlink:type="locator" xlink:label="tsha_SeriesBPurchaseAgreementMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NolanCapitalLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="tsha_NolanCapitalLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" xlink:type="locator" xlink:label="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" xlink:type="locator" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" xlink:type="locator" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAPurchaseAgreementInitialClosingMember" xlink:type="locator" xlink:label="tsha_SeriesAPurchaseAgreementInitialClosingMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAPurchaseAgreementMember" xlink:type="locator" xlink:label="tsha_SeriesAPurchaseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesBConvertiblePreferredStockMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesBConvertiblePreferredStockMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAPurchaseAgreementMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAPurchaseAgreementInitialClosingMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_NolanCapitalLimitedLiabilityCompanyMember" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesBPurchaseAgreementMember" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_2" order="11150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="11170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="11440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="11560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="11640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="11770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockGross" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="11890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromCollaborators" order="12170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="12460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="12530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" order="12580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" order="12620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" order="12700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_PreferredStockTrancheLiability" order="12810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_IssuanceOfProRataPortionOfMilestoneShares" order="12930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" order="12990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_MileStoneSharesIssued" order="13050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_AmountReclassifiedToConvertiblePreferredStock" order="13170.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_FounderPresidentAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CertainEmployeesAndConsultantsMember" xlink:type="locator" xlink:label="tsha_CertainEmployeesAndConsultantsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CancelledOptionsMember" xlink:type="locator" xlink:label="tsha_CancelledOptionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="tsha_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_EmployeeStockPurchasePlanMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_CancelledOptionsMember" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_CertainEmployeesAndConsultantsMember" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="11820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_2" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="11850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="11870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" order="11890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" order="11910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="tsha_ShareBasedCompensationAwardTrancheFourMember" order="11930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_FounderPresidentAndChiefExecutiveOfficerMember" order="12070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="12150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="12260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="12330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="12410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" order="12450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" order="12490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" order="12530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="12570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="12870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="12980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="13020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" order="13060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" order="13100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" order="13180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="13290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="13500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="13570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="13610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="13810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" order="13960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="14080.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="10300.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="11330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="11730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="11960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="12160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="12260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="12390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" order="12490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" order="12590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="12790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12890.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="10690.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="10570.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10140.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" xlink:type="locator" xlink:label="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OwnershipPercentageInExcessOfCapitalStock" xlink:type="locator" xlink:label="tsha_OwnershipPercentageInExcessOfCapitalStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NumberOfSecuredPromissoryNotes" xlink:type="locator" xlink:label="tsha_NumberOfSecuredPromissoryNotes" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:type="locator" xlink:label="srt_DirectorMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ServicesAgreementMember" xlink:type="locator" xlink:label="tsha_ServicesAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMTGTHoldingsLLCMember" xlink:type="locator" xlink:label="tsha_PBMTGTHoldingsLLCMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMCapitalGroupLLCMember" xlink:type="locator" xlink:label="tsha_PBMCapitalGroupLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_FounderPresidentAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SecuredPromissoryNotesMember" xlink:type="locator" xlink:label="tsha_SecuredPromissoryNotesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_SecuredPromissoryNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_FounderPresidentAndChiefExecutiveOfficerMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_2" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="tsha_PBMCapitalGroupLLCMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="tsha_PBMTGTHoldingsLLCMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_2" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="tsha_ServicesAgreementMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="tsha_NumberOfSecuredPromissoryNotes" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="tsha_OwnershipPercentageInExcessOfCapitalStock" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" order="10690.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseIncentiveReceivable" xlink:type="locator" xlink:label="us-gaap_LeaseIncentiveReceivable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:type="locator" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" xlink:type="locator" xlink:label="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" xlink:type="locator" xlink:label="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" xlink:type="locator" xlink:label="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseLiability" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitAsset" xlink:type="locator" xlink:label="tsha_BuildToSuitAsset" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OperatingLeasesInitialDirectCosts" xlink:type="locator" xlink:label="tsha_OperatingLeasesInitialDirectCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperationsCommencedDate1" xlink:type="locator" xlink:label="us-gaap_OperationsCommencedDate1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PegasusParkLLCMember" xlink:type="locator" xlink:label="tsha_PegasusParkLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_DallasLeaseMember" xlink:type="locator" xlink:label="tsha_DallasLeaseMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_DurhamLeaseMember" xlink:type="locator" xlink:label="tsha_DurhamLeaseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DurhamLeaseMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DallasLeaseMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_CounterpartyNameAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_PegasusParkLLCMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_2" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="10950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="tsha_DallasLeaseMember" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" order="11000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperationsCommencedDate1" order="11020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="11040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_OperatingLeasesInitialDirectCosts" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_BuildToSuitAsset" order="11160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_BuildToSuitLeaseLiability" order="11180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="11340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="11360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" order="11400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" order="11440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="11500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseIncentiveReceivable" order="11550.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfPrepaymentOfFacility" xlink:type="locator" xlink:label="tsha_PercentageOfPrepaymentOfFacility" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfPrepaymentPremium" xlink:type="locator" xlink:label="tsha_PercentageOfPrepaymentPremium" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NumberOfDistinctAndActiveClinicalStage" xlink:type="locator" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember" xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFacilityMember" xlink:type="locator" xlink:label="tsha_TermLoanFacilityMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:type="locator" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_2" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_TermLoanFacilityMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_2" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="11080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeStart1" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeEnd1" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_NumberOfDistinctAndActiveClinicalStage" order="11220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="11300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfPrepaymentPremium" order="11440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfPrepaymentOfFacility" order="11480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="11500.00" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>54
<FILENAME>tsha-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-14T14:11:23.8924016+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : 9ce9bc11c38d436e8005d94e4df304b9 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Quarterly Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Quarterly Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseLiability" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Build-to-suit lease liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_BuildToSuitLeaseLiability" xlink:to="tsha_BuildToSuitLeaseLiability_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsLeasingNetNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredCostsLeasingNetNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredCostsLeasingNetNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred lease asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsLeasingNetNoncurrent" xlink:to="us-gaap_DeferredCostsLeasingNetNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredCostsLeasingNetNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs Leasing Net Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS&apos; EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities And Other Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Build-to-suit lease liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Build To Suit Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies - Note 10</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&apos; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of June 30, 2021 and December 31, 2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 38,391,165 and 37,761,435 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&apos; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" />
    <link:label xml:lang="en-US" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value preferred stock tranche liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:to="tsha_ChangeInFairValueOfPreferredStockTrancheLiability_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Preferred Stock Tranche Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income Expense Nonoperating Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other expense, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per common share, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average common shares outstanding, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" xlink:type="locator" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" />
    <link:label xml:lang="en-US" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon vesting and settlement of restricted stock units value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" xlink:to="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" xlink:type="locator" xlink:label="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" />
    <link:label xml:lang="en-US" xlink:label="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of Temporary Equity preferred stock tranche liability upon issuance of milestone shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" xlink:to="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Class Of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A Convertible preferred stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesAConvertiblePreferredStockMember" xlink:to="tsha_SeriesAConvertiblePreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Convertible preferred stock balance, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Convertible preferred stock balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Carrying Amount Attributable To Parent</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance, shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of convertible preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Value New Issues</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issued during period shares new issues.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of convertible preferred stock, shares</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of preferred stock tranche liability upon issuance of Series A milestone shares</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Temporary Equity Preferred Stock Tranche Liability Upon Issuance Of Milestone Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting and settlement of restricted stock units</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Vesting And Settlement Of Restricted Stock Units Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting and settlement of restricted stock units, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Convertible preferred stock balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Convertible preferred stock balance</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockOfferingCosts" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockOfferingCosts" />
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock offering costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TemporaryEquityStockOfferingCosts" xlink:to="tsha_TemporaryEquityStockOfferingCosts_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" />
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issuance of preferred stock tranche liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" xlink:to="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of convertible preferred stock, offering costs</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issuance Of Preferred Stock Tranche Liability</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:type="locator" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" />
    <link:label xml:lang="en-US" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in accrued expense and other liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" xlink:type="locator" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" />
    <link:label xml:lang="en-US" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Property and equipment in accounts payable and accrued expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" xlink:to="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ReclassificationOfPreferredStockLiability" xlink:type="locator" xlink:label="tsha_ReclassificationOfPreferredStockLiability" />
    <link:label xml:lang="en-US" xlink:label="tsha_ReclassificationOfPreferredStockLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of preferred stock liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ReclassificationOfPreferredStockLiability" xlink:to="tsha_ReclassificationOfPreferredStockLiability_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AllocationOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_AllocationOfPreferredStockTrancheLiability" />
    <link:label xml:lang="en-US" xlink:label="tsha_AllocationOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Allocation of preferred stock tranche liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AllocationOfPreferredStockTrancheLiability" xlink:to="tsha_AllocationOfPreferredStockTrancheLiability_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of preferred stock tranche liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development license expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentInProcess" xlink:to="us-gaap_ResearchAndDevelopmentInProcess_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development In Process</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Expense And Other Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Due To Related Parties</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of research and development license</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire In Process Research And Development</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of property, plant and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of Series A convertible preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Convertible Preferred Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of Series A convertible preferred stock issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from note payable to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Related Party Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of note payable to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Related Party Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash at the beginning of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash at the end of the period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment in accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property And Equipment In Accounts Payable And Accrued Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition of property, plant and equipment funded by landlord</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Or Part Noncash Acquisition Fixed Assets Acquired1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:type="locator" xlink:label="us-gaap_CapitalLeaseObligationsIncurred" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalLeaseObligationsIncurred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Build-to-suit lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsIncurred" xlink:to="us-gaap_CapitalLeaseObligationsIncurred_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalLeaseObligationsIncurred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Capital Lease Obligations Incurred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs not yet paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred But Not Yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ReclassificationOfPreferredStockLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ReclassificationOfPreferredStockLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Preferred Stock Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AllocationOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allocation of preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AllocationOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocation Of Preferred Stock Tranche Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" xlink:label="us-gaap_StockIssued1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A convertible preferred stock issuance costs not yet paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Description of Business Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:type="locator" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research, collaboration and license agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:to="tsha_ResearchCollaborationAndLicenseAgreementsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research Collaboration And License Agreements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research, Collaboration and License Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&apos; Equity (Deficit), Convertible Preferred Stock and Tranche Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeasePolicyTextBlock" xlink:type="locator" xlink:label="tsha_BuildToSuitLeasePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeasePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Build-to-suit lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_BuildToSuitLeasePolicyTextBlock" xlink:to="tsha_BuildToSuitLeasePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeasePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Build-to-Suit Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeasePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Build To Suit Lease Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Issued Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" xlink:type="locator" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of accrued expense and other current labilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" xlink:to="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expense and Other Current Labilities</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Expense And Other Current Labilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock Option Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Activity Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Restricted Stock Units Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Restricted Stock Awards Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonvested Restricted Stock Shares Activity Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Detail)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Calculation of Basic and Diluted Net Loss Per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:type="locator" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" />
    <link:label xml:lang="en-US" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization and description of business operations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:type="locator" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" />
    <link:label xml:lang="en-US" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization and description of business operations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization And Description Of Business Operations [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization And Description Of Business Operations [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2020 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IPOMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">IPO</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IPOMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">I P O [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriters&#8217; Option to Purchase Additional Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Over Allotment Option [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesBConvertiblePreferredStockMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesBConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B convertible preferred stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesBConvertiblePreferredStockMember" xlink:to="tsha_SeriesBConvertiblePreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesBConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesBConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series B Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IPOMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Description of Business Operations [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization And Description Of Business Operations [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation Date Of Incorporation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Stock Split Conversion Ratio1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of common stock authorized for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel">Issuance of shares of common stock, shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share issue price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued Price Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from issuance of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:type="locator" xlink:label="us-gaap_PaymentsForUnderwritingExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts and commissions and other offering costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments For Underwriting Expense</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" xlink:type="locator" xlink:label="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" />
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity conversion shares of convertible preferred stock to common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" xlink:to="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of convertible preferred stock to common stock, shares</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Conversion Shares Of Convertible Preferred Stock To Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CommonStockIncreaseInOutstandingShares" xlink:type="locator" xlink:label="tsha_CommonStockIncreaseInOutstandingShares" />
    <link:label xml:lang="en-US" xlink:label="tsha_CommonStockIncreaseInOutstandingShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock increase in outstanding shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_CommonStockIncreaseInOutstandingShares" xlink:to="tsha_CommonStockIncreaseInOutstandingShares_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_CommonStockIncreaseInOutstandingShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Increase in outstanding shares</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_CommonStockIncreaseInOutstandingShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Increase In Outstanding Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accumulated deficit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate shares sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Number Of Shares Issued In Transaction</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gross proceeds from sale of convertible preferred stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:type="locator" xlink:label="us-gaap_Cash" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Cash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Cash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidResearchAndDevelopmentContracts" xlink:type="locator" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts" />
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid research and development contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PrepaidResearchAndDevelopmentContracts" xlink:to="tsha_PrepaidResearchAndDevelopmentContracts_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidBonus" xlink:type="locator" xlink:label="tsha_PrepaidBonus" />
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidBonus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid bonus.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PrepaidBonus" xlink:to="tsha_PrepaidBonus_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidClinicalTrial" xlink:type="locator" xlink:label="tsha_PrepaidClinicalTrial" />
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidClinicalTrial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical trial.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PrepaidClinicalTrial" xlink:to="tsha_PrepaidClinicalTrial_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid research and development</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Research And Development Contracts</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidBonus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid bonus</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidBonus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Bonus</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance" xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid insurance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidClinicalTrial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical trial</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PrepaidClinicalTrial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Trial</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid expenses and other current assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Fixtures [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="tsha_LaboratoryEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LaboratoryEquipmentMember" xlink:to="tsha_LaboratoryEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in Progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, plant and equipment, net</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseMember" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Build-to-suit lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_BuildToSuitLeaseMember" xlink:to="tsha_BuildToSuitLeaseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Build-to-Suit Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Build To Suit Lease [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressGross" xlink:to="us-gaap_ConstructionInProgressGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress Gross</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedResearchAndDevelopmentCurrent" xlink:type="locator" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent" />
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedResearchAndDevelopmentCurrent" xlink:to="tsha_AccruedResearchAndDevelopmentCurrent_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:type="locator" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent" />
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued property, plant, and equipment current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:to="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedClinicalTrialCurrent" xlink:type="locator" xlink:label="tsha_AccruedClinicalTrialCurrent" />
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedClinicalTrialCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued clinical trial current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedClinicalTrialCurrent" xlink:to="tsha_AccruedClinicalTrialCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional and consulting fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued property, plant, and equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Property Plant And Equipment Current</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedClinicalTrialCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical trial</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AccruedClinicalTrialCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Trial Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses and other current liabilities</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:type="locator" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" />
    <link:label xml:lang="en-US" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preclinical activities period under sponsored research agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:to="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:type="locator" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" />
    <link:label xml:lang="en-US" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum licensed product to develop obtain regulatory approval for and commercialize.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:to="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repurchase Agreement Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_UTSouthwesternAgreementMember" xlink:type="locator" xlink:label="tsha_UTSouthwesternAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_UTSouthwesternAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">UT southwestern agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_UTSouthwesternAgreementMember" xlink:to="tsha_UTSouthwesternAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_UTSouthwesternAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">UT Southwestern Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_UTSouthwesternAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U T Southwestern Agreement [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_QueensAgreementMember" xlink:type="locator" xlink:label="tsha_QueensAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_QueensAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Queen&apos;s agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_QueensAgreementMember" xlink:to="tsha_QueensAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_QueensAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Queen&apos;s Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_QueensAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Queens Agreement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaCLN1AgreementsMember" xlink:type="locator" xlink:label="tsha_AbeonaCLN1AgreementsMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaCLN1AgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Abeona CLN1 agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AbeonaCLN1AgreementsMember" xlink:to="tsha_AbeonaCLN1AgreementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaCLN1AgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Abeona CLN1 Agreements</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaCLN1AgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Abeona C L N1 Agreements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaRettAgreementMember" xlink:type="locator" xlink:label="tsha_AbeonaRettAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaRettAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Abeona Rett agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AbeonaRettAgreementMember" xlink:to="tsha_AbeonaRettAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaRettAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Abeona Rett Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaRettAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Abeona Rett Agreement [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaTherapeuticsIncMember" xlink:type="locator" xlink:label="tsha_AbeonaTherapeuticsIncMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaTherapeuticsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Abeona Therapeutics Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AbeonaTherapeuticsIncMember" xlink:to="tsha_AbeonaTherapeuticsIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaTherapeuticsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Abeona</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AbeonaTherapeuticsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Abeona Therapeutics Inc [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:type="locator" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Acquisition of worldwide rights for TSHA 120 for treatment of giant axonal neuropathy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">TSHA-120</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Acquisition Of Worldwide Rights For T S H A120 For Treatment Of Giant Axonal Neuropathy [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preclinical activities period under sponsored research agreements</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preclinical Activities Period Under Sponsored Research Agreements</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum licensed product to develop obtain regulatory approval for and commercialize</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Licensed Product To Develop Obtain Regulatory Approval For And Commercialize</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:type="locator" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of fully diluted common stock shares outstanding.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:to="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:type="locator" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" />
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of common stock shares entitled to receive additional shares on fully diluted basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:to="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of fully diluted common stock shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Fully Diluted Common Stock Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of entitled to receive additional shares on fully diluted basis</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Common Stock Shares Entitled To Receive Additional Shares On Fully Diluted Basis</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchGrantOfCommittedFundAmount" xlink:type="locator" xlink:label="tsha_ResearchGrantOfCommittedFundAmount" />
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchGrantOfCommittedFundAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research grant of committed fund amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ResearchGrantOfCommittedFundAmount" xlink:to="tsha_ResearchGrantOfCommittedFundAmount_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchGrantOutstandingFundAmount" xlink:type="locator" xlink:label="tsha_ResearchGrantOutstandingFundAmount" />
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchGrantOutstandingFundAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research grant outstanding fund amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ResearchGrantOutstandingFundAmount" xlink:to="tsha_ResearchGrantOutstandingFundAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchGrantOfCommittedFundAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research grant of committed fund amount</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchGrantOfCommittedFundAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research Grant Of Committed Fund Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchGrantOutstandingFundAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research grant outstanding fund amount</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ResearchGrantOutstandingFundAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research Grant Outstanding Fund Amount</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment" />
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement regulatory milestones payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:to="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAgreementCommercialMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment" />
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement commercial milestones payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAgreementCommercialMilestonesPayment" xlink:to="tsha_LicenseAgreementCommercialMilestonesPayment_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentsToAcquireLicenseRight" xlink:type="locator" xlink:label="tsha_PaymentsToAcquireLicenseRight" />
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentsToAcquireLicenseRight_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to acquire license right.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentsToAcquireLicenseRight" xlink:to="tsha_PaymentsToAcquireLicenseRight_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentsToAcquireLicenseRight_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash payment to acquire license agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentsToAcquireLicenseRight_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire License Right</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement regulatory milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Regulatory Milestones Payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement commercial milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Commercial Milestones Payment</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AdditionalMilestonePayments" xlink:type="locator" xlink:label="tsha_AdditionalMilestonePayments" />
    <link:label xml:lang="en-US" xlink:label="tsha_AdditionalMilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional Milestone payments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AdditionalMilestonePayments" xlink:to="tsha_AdditionalMilestonePayments_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_AdditionalMilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AdditionalMilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Milestone Payments</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentOfLicenseFee" xlink:type="locator" xlink:label="tsha_PaymentOfLicenseFee" />
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentOfLicenseFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of license fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentOfLicenseFee" xlink:to="tsha_PaymentOfLicenseFee_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:type="locator" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" />
    <link:label xml:lang="en-US" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase of clinical materials and reimbursement incurred development costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:to="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" />
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License and inventory purchase agreement regulatory related milestones payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" />
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License and inventory purchase agreement sales related milestones payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentOfLicenseFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License fee payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentOfLicenseFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of License Fee</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of clinical materials and reimbursement incurred development costs</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Of Clinical Materials And Reimbursement Incurred Development Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and inventory purchase agreement regulatory related milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License And Inventory Purchase Agreement Regulatory Related Milestones Payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and inventory purchase agreement sales related milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License And Inventory Purchase Agreement Sales Related Milestones Payment</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:type="locator" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable" />
    <link:label xml:lang="en-US" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory related milestones obligation payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:to="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:type="locator" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" />
    <link:label xml:lang="en-US" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale-related milestones per licensed product and royalties on net sales of licensed products payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:to="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:type="locator" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee" />
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of one-time upfront license fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:to="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of one-time upfront license fee</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of One Time Upfront License Fee</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory related milestones obligation payable</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Related Milestones Obligation Payable</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale-related milestones per licensed product and royalties on net sales of licensed products payable</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Related Milestones Per Licensed Product And Royalties On Net Sales Of Licensed Products Payable</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_UpfrontPayment" xlink:type="locator" xlink:label="tsha_UpfrontPayment" />
    <link:label xml:lang="en-US" xlink:label="tsha_UpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_UpfrontPayment" xlink:to="tsha_UpfrontPayment_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:type="locator" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" />
    <link:label xml:lang="en-US" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical, regulatory and commercial milestones to be received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:to="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_UpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_UpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical, regulatory and commercial milestones to be received</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Regulatory And Commercial Milestones To Be Received</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock By Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Underwriters&apos; Option to Purchase Additional Shares</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAPurchaseAgreementMember" xlink:type="locator" xlink:label="tsha_SeriesAPurchaseAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A purchase agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesAPurchaseAgreementMember" xlink:to="tsha_SeriesAPurchaseAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Purchase Agreement [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAPurchaseAgreementInitialClosingMember" xlink:type="locator" xlink:label="tsha_SeriesAPurchaseAgreementInitialClosingMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAPurchaseAgreementInitialClosingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A purchase agreement initial closing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesAPurchaseAgreementInitialClosingMember" xlink:to="tsha_SeriesAPurchaseAgreementInitialClosingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAPurchaseAgreementInitialClosingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Closing</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAPurchaseAgreementInitialClosingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Purchase Agreement Initial Closing [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" xlink:type="locator" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A achievement of specific clinical milestone one.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" xlink:to="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement of Specific Clinical Milestone One</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Achievement Of Specific Clinical Milestone One [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" xlink:type="locator" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A achievement of specific clinical milestone two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" xlink:to="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement of Specific Clinical Milestone Two</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Achievement Of Specific Clinical Milestone Two [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" xlink:type="locator" xlink:label="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A upon achievement of certain defined clinical milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" xlink:to="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upon Achievement of Certain Defined Clinical Milestones</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Upon Achievement Of Certain Defined Clinical Milestones [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">PBM TGT holdings, limited liability company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" xlink:to="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PBM TGT Holdings, LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">P B M T G T Holdings Limited Liability Company [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NolanCapitalLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="tsha_NolanCapitalLimitedLiabilityCompanyMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_NolanCapitalLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Nolan capital, limited liability company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_NolanCapitalLimitedLiabilityCompanyMember" xlink:to="tsha_NolanCapitalLimitedLiabilityCompanyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_NolanCapitalLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nolan Capital, LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_NolanCapitalLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nolan Capital Limited Liability Company [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBPurchaseAgreementMember" xlink:type="locator" xlink:label="tsha_SeriesBPurchaseAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesBPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B purchase agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeriesBPurchaseAgreementMember" xlink:to="tsha_SeriesBPurchaseAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesBPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SeriesBPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series B Purchase Agreement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk Free Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected Volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Price Volatility [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" xlink:type="locator" xlink:label="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Measurement input probability of achieving clinical milestones and timing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" xlink:to="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Probability of Achieving Clinical Milestones and Timing</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Probability Of Achieving Clinical Milestones And Timing [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, shares authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, shares outstanding</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ProceedsFromIssuanceOfCommonStockGross" xlink:type="locator" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockGross" />
    <link:label xml:lang="en-US" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock, gross.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ProceedsFromIssuanceOfCommonStockGross" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued during period</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock Gross</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issuance costs, including underwriters&#8217; discounts and commissions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of share options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCollaborators" xlink:type="locator" xlink:label="us-gaap_ProceedsFromCollaborators" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromCollaborators_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Clinical milestones for gross proceeds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCollaborators" xlink:to="us-gaap_ProceedsFromCollaborators_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromCollaborators_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Collaborators</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" />
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock tranche liability offering price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" />
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock tranche liability measurement input.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" />
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock tranche liability liquidity term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock tranche liability, offering price</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Tranche Liability Offering Price</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock tranche liability, measurement input</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Tranche Liability Measurement Input</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock tranche liability, term</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Tranche Liability Liquidity Term</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_PreferredStockTrancheLiability" />
    <link:label xml:lang="en-US" xlink:label="tsha_PreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred Stock Tranche Liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PreferredStockTrancheLiability" xlink:to="tsha_PreferredStockTrancheLiability_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IssuanceOfProRataPortionOfMilestoneShares" xlink:type="locator" xlink:label="tsha_IssuanceOfProRataPortionOfMilestoneShares" />
    <link:label xml:lang="en-US" xlink:label="tsha_IssuanceOfProRataPortionOfMilestoneShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of pro-rata portion of milestone shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IssuanceOfProRataPortionOfMilestoneShares" xlink:to="tsha_IssuanceOfProRataPortionOfMilestoneShares_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MileStoneSharesIssued" xlink:type="locator" xlink:label="tsha_MileStoneSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="tsha_MileStoneSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Mile stone shares issued.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MileStoneSharesIssued" xlink:to="tsha_MileStoneSharesIssued_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AmountReclassifiedToConvertiblePreferredStock" xlink:type="locator" xlink:label="tsha_AmountReclassifiedToConvertiblePreferredStock" />
    <link:label xml:lang="en-US" xlink:label="tsha_AmountReclassifiedToConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount reclassified to convertible preferred stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AmountReclassifiedToConvertiblePreferredStock" xlink:to="tsha_AmountReclassifiedToConvertiblePreferredStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_IssuanceOfProRataPortionOfMilestoneShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Milestone pro-rate shares issued during the period</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_IssuanceOfProRataPortionOfMilestoneShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Pro Rata Portion Of Milestone Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non cash expenses due to remeasured fair value of tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MileStoneSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Mile stone shares issued during the period</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MileStoneSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Mile Stone Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AmountReclassifiedToConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche liability amount reclassified to convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AmountReclassifiedToConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amount Reclassified To Convertible Preferred Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Equity Incentive Plan</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty stock incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="tsha_EmployeeStockPurchasePlanMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_EmployeeStockPurchasePlanMember" xlink:to="tsha_EmployeeStockPurchasePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CancelledOptionsMember" xlink:type="locator" xlink:label="tsha_CancelledOptionsMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_CancelledOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cancelled options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_CancelledOptionsMember" xlink:to="tsha_CancelledOptionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_CancelledOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cancelled Options</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_CancelledOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cancelled Options [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CertainEmployeesAndConsultantsMember" xlink:type="locator" xlink:label="tsha_CertainEmployeesAndConsultantsMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_CertainEmployeesAndConsultantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Certain employees and consultants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_CertainEmployeesAndConsultantsMember" xlink:to="tsha_CertainEmployeesAndConsultantsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_CertainEmployeesAndConsultantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certain Employees and Consultants</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_CertainEmployeesAndConsultantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Certain Employees And Consultants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Award Tranche One [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Award Tranche Two [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Award Tranche Three [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation award tranche four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:to="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche Four</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Award Tranche Four [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_FounderPresidentAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Founder, president and chief executive officer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_FounderPresidentAndChiefExecutiveOfficerMember" xlink:to="tsha_FounderPresidentAndChiefExecutiveOfficerMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RA Session II</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Founder President And Chief Executive Officer [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares authorized for issuance</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award commencement date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of automatic increase every year in common stock shares reserved for future issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:to="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock reserved for future issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, expiration period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, commencement date</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Commencement Date</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, expiration date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of automatic increase every year in common stock shares reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Automatic Increase Every Year In Common Stock Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, terms of award issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares of common stock issued under ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Employee Stock Purchase Plans</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options grants in period grant date fair value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options replacement units grants in period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, options granted, exercise price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, options grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares awarded</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Units Grants In Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, plan modification, incremental cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, options, weighted-average grant date fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term in years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding. Stock Options, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted, Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options cancelled or forfeited, Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding. Stock Options, Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at June 30, 2021, Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at June 30, 2021, Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Weighted Average Exercise Price, Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options cancelled or forfeited, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Weighted Average Exercise Price, Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at June 30, 2021, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at June 30, 2021, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement By share based payment award options granted weighted average remaining contractual term1.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding, Weighted Average Remaining Contractual Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at June 30, 2021, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at June 30, 2021, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options grants in period intrinsic value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options cancelled or forfeited in period intrinsic value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Aggregate Intrinsic Value, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options cancelled or forfeited, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Forfeited In Period Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Aggregate Intrinsic Value, Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at June 30, 2021, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at June 30, 2021, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, options, compensation cost not yet recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, RSU/RSA granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, vesting rights percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Nonvested, Number of Shares, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted units/stock granted, Number of Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested, Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled or forfeited, Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Nonvested, Number of Shares, Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested, Weighted Average Grant Date Fair Value per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award requisite service vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, RSU/RSA granted, weighted average grant date fair value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss Available To Common Stockholders Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested RSUs</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested RSAs</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive securities excluded from computation of diluted net loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NumberOfSecuredPromissoryNotes" xlink:type="locator" xlink:label="tsha_NumberOfSecuredPromissoryNotes" />
    <link:label xml:lang="en-US" xlink:label="tsha_NumberOfSecuredPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of secured promissory notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_NumberOfSecuredPromissoryNotes" xlink:to="tsha_NumberOfSecuredPromissoryNotes_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Longterm Debt Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Longterm Debt Type [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SecuredPromissoryNotesMember" xlink:type="locator" xlink:label="tsha_SecuredPromissoryNotesMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_SecuredPromissoryNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Secured promissory notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SecuredPromissoryNotesMember" xlink:to="tsha_SecuredPromissoryNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_SecuredPromissoryNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Secured Promissory Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_SecuredPromissoryNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Secured Promissory Notes [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions By Related Party [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMCapitalGroupLLCMember" xlink:type="locator" xlink:label="tsha_PBMCapitalGroupLLCMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_PBMCapitalGroupLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">PBM Capital Group, LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PBMCapitalGroupLLCMember" xlink:to="tsha_PBMCapitalGroupLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PBMCapitalGroupLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PBM Capital Group, LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PBMCapitalGroupLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">P B M Capital Group L L C [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMTGTHoldingsLLCMember" xlink:type="locator" xlink:label="tsha_PBMTGTHoldingsLLCMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_PBMTGTHoldingsLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">PBM TGT Holdings, LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PBMTGTHoldingsLLCMember" xlink:to="tsha_PBMTGTHoldingsLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PBMTGTHoldingsLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PBM TGT Holdings, LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PBMTGTHoldingsLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">P B M T G T Holdings L L C [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ServicesAgreementMember" xlink:type="locator" xlink:label="tsha_ServicesAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_ServicesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Services agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ServicesAgreementMember" xlink:to="tsha_ServicesAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_ServicesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Services Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ServicesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Services Agreement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:type="locator" xlink:label="srt_DirectorMember" />
    <link:label xml:lang="en-US" xlink:label="srt_DirectorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Paul B. Manning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_DirectorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_NumberOfSecuredPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of secured promissory notes</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_NumberOfSecuredPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Secured Promissory Notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate amount, related party transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayments of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Debt</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OwnershipPercentageInExcessOfCapitalStock" xlink:type="locator" xlink:label="tsha_OwnershipPercentageInExcessOfCapitalStock" />
    <link:label xml:lang="en-US" xlink:label="tsha_OwnershipPercentageInExcessOfCapitalStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership percentage in excess of capital stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_OwnershipPercentageInExcessOfCapitalStock" xlink:to="tsha_OwnershipPercentageInExcessOfCapitalStock_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" xlink:type="locator" xlink:label="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" />
    <link:label xml:lang="en-US" xlink:label="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional consideration to related party under operating agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" xlink:to="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting and other administrative and management services fee per month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Expenses From Transactions With Related Party</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_OwnershipPercentageInExcessOfCapitalStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership percentage more than capital stock</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_OwnershipPercentageInExcessOfCapitalStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ownership Percentage In Excess Of Capital Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional consideration payable under operating agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Consideration To Related Party Under Operating Agreement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_DurhamLeaseMember" xlink:type="locator" xlink:label="tsha_DurhamLeaseMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_DurhamLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Durham lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DurhamLeaseMember" xlink:to="tsha_DurhamLeaseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_DurhamLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Durham Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_DurhamLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Durham Lease [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_DallasLeaseMember" xlink:type="locator" xlink:label="tsha_DallasLeaseMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_DallasLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Dallas lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DallasLeaseMember" xlink:to="tsha_DallasLeaseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_DallasLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dallas Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_DallasLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Dallas Lease [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PegasusParkLLCMember" xlink:type="locator" xlink:label="tsha_PegasusParkLLCMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_PegasusParkLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Pegasus Park, LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PegasusParkLLCMember" xlink:to="tsha_PegasusParkLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PegasusParkLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pegasus Park L L C</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PegasusParkLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pegasus Park L L C [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating lease landlord square feet manufacturing facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Subject To Or Available For Operating Lease Number Of Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperationsCommencedDate1" xlink:type="locator" xlink:label="us-gaap_OperationsCommencedDate1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease commencement date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperationsCommencedDate1" xlink:to="us-gaap_OperationsCommencedDate1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operations Commenced Date1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease term of contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Term Of Contract</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease extend term of contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Renewal Term</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OperatingLeasesInitialDirectCosts" xlink:type="locator" xlink:label="tsha_OperatingLeasesInitialDirectCosts" />
    <link:label xml:lang="en-US" xlink:label="tsha_OperatingLeasesInitialDirectCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating leases initial direct costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_OperatingLeasesInitialDirectCosts" xlink:to="tsha_OperatingLeasesInitialDirectCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_OperatingLeasesInitialDirectCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases initial direct costs</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_OperatingLeasesInitialDirectCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Initial Direct Costs</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitAsset" xlink:type="locator" xlink:label="tsha_BuildToSuitAsset" />
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Build-to-suit asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_BuildToSuitAsset" xlink:to="tsha_BuildToSuitAsset_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" xlink:type="locator" xlink:label="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" />
    <link:label xml:lang="en-US" xlink:label="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equipment purchases and build-out of leased facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" xlink:to="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Build-to-suit asset</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_BuildToSuitAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Build To Suit Asset</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equipment purchases and build-out of leased Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equipment Purchases And Build Out Of Leased Facility</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" xlink:type="locator" xlink:label="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" />
    <link:label xml:lang="en-US" xlink:label="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Obligation for payment of initial base rent for office space.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" xlink:to="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" xlink:type="locator" xlink:label="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" />
    <link:label xml:lang="en-US" xlink:label="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum estimated monthly base rent increase annually during term of lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" xlink:to="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:type="locator" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" />
    <link:label xml:lang="en-US" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum construction allowance provided by landlord per rentable square foot.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:to="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, option to extend description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Option To Extend</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, option to extend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Existence Of Option To Extend</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Obligation for payment of initial base rent for office space</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Obligation For Payment Of Initial Base Rent For Office Space</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum estimated monthly base rent increase annually during term of lease</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Estimated Monthly Base Rent Increase Annually During Term Of Lease</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Deposit</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum construction allowance provided by landlord per rentable square foot</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Construction Allowance Provided By Landlord Per Rentable Square Foot</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseIncentiveReceivable" xlink:type="locator" xlink:label="us-gaap_LeaseIncentiveReceivable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseIncentiveReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease construction incentive</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseIncentiveReceivable" xlink:to="us-gaap_LeaseIncentiveReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseIncentiveReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Incentive Receivable</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NumberOfDistinctAndActiveClinicalStage" xlink:type="locator" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage" />
    <link:label xml:lang="en-US" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of distinct and active clinical stage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_NumberOfDistinctAndActiveClinicalStage" xlink:to="tsha_NumberOfDistinctAndActiveClinicalStage_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan through december thirty one twenty twenty one.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:to="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Through December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Through December Thirty One Twenty Twenty One [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:type="locator" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan from january one twenty twenty two until september thirty twenty twenty two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 1, 2022 until September 30, 2022</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan From January One Twenty Twenty Two Until September Thirty Twenty Twenty Two [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan from october one twenty twenty two until march thirty one twenty twenty three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:to="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">October 1, 2022 until March 31, 2023</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan From October One Twenty Twenty Two Until March Thirty One Twenty Twenty Three [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan from april one twenty twenty three until december thirty one twenty twenty three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:to="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">April 1, 2023 until December 31, 2023</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan From April One Twenty Twenty Three Until December Thirty One Twenty Twenty Three [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFacilityMember" xlink:type="locator" xlink:label="tsha_TermLoanFacilityMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFacilityMember" xlink:to="tsha_TermLoanFacilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember" xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan through august thirteen twenty twenty two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Through August 13, 2022</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Through August Thirteen Twenty Twenty Two [Member]</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan through august thirteen twenty twenty three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Through August 13, 2023</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Through August Thirteen Twenty Twenty Three [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum borrowing capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Date</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity start date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeStart1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Date Range Start1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity end date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeEnd1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Date Range End1</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of distinct and active clinical stage</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Distinct And Active Clinical Stage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current borrowing capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Current Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, basis spread on variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Basis Spread On Variable Rate1</link:label>
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfPrepaymentPremium" xlink:type="locator" xlink:label="tsha_PercentageOfPrepaymentPremium" />
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfPrepaymentPremium_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of prepayment premium</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfPrepaymentPremium" xlink:to="tsha_PercentageOfPrepaymentPremium_lbl" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfPrepaymentOfFacility" xlink:type="locator" xlink:label="tsha_PercentageOfPrepaymentOfFacility" />
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfPrepaymentOfFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of prepayment of facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfPrepaymentOfFacility" xlink:to="tsha_PercentageOfPrepaymentOfFacility_lbl" />
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfPrepaymentPremium_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of prepayment premium</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfPrepaymentPremium_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Prepayment Premium</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfPrepaymentOfFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of prepayment of facility</link:label>
    <link:label xml:lang="en-US" xlink:label="tsha_PercentageOfPrepaymentOfFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Prepayment Of Facility</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants associated with loan facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrants And Rights Outstanding</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>55
<FILENAME>tsha-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-08-14T14:11:23.8934033+00:00 -->
<!-- Version            : 5.0.1.648 -->
<!-- Package ID         : 9ce9bc11c38d436e8005d94e4df304b9 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://tayshagtx.com/20210630/role/TemplateLink" xlink:href="tsha-20210630.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tsha-20210630.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentQuarterlyReport" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseLiability" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsLeasingNetNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredCostsLeasingNetNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DeferredCostsLeasingNetNoncurrent" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="tsha_BuildToSuitLeaseLiability" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" xlink:type="locator" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" xlink:type="locator" xlink:label="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_li0l2" order="11790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_li0l2" order="12580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_li0l2" order="12600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityStockOfferingCosts" xlink:type="locator" xlink:label="tsha_TemporaryEquityStockOfferingCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_TemporaryEquityStockOfferingCosts" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="tsha-20210630.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" xlink:label="us-gaap_StockIssued1" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AllocationOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_AllocationOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ReclassificationOfPreferredStockLiability" xlink:type="locator" xlink:label="tsha_ReclassificationOfPreferredStockLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:type="locator" xlink:label="us-gaap_CapitalLeaseObligationsIncurred" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" xlink:type="locator" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:type="locator" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalLeaseObligationsIncurred" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="11800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_ReclassificationOfPreferredStockLiability" order="11840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_AllocationOfPreferredStockTrancheLiability" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_StockIssued1" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperations" xlink:href="tsha-20210630.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessOperations" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperations">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="tsha-20210630.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponents" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponents" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponents">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreements" xlink:href="tsha-20210630.xsd#Role_DisclosureResearchCollaborationAndLicenseAgreements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreements">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:type="locator" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability" xlink:href="tsha-20210630.xsd#Role_DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensation" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensation">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShare" xlink:href="tsha-20210630.xsd#Role_DisclosureNetLossPerCommonShare" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShare">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactions" xlink:href="tsha-20210630.xsd#Role_DisclosureRelatedPartyTransactions" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactions">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxes" xlink:href="tsha-20210630.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxes">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="tsha-20210630.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEvents" xlink:href="tsha-20210630.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEvents">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="tsha-20210630.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeasePolicyTextBlock" xlink:type="locator" xlink:label="tsha_BuildToSuitLeasePolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tsha_BuildToSuitLeasePolicyTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" xlink:type="locator" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareTables" xlink:href="tsha-20210630.xsd#Role_DisclosureNetLossPerCommonShareTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:type="locator" xlink:label="us-gaap_Cash" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CommonStockIncreaseInOutstandingShares" xlink:type="locator" xlink:label="tsha_CommonStockIncreaseInOutstandingShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" xlink:type="locator" xlink:label="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:type="locator" xlink:label="us-gaap_PaymentsForUnderwritingExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:type="locator" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember_li0l2" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesBConvertiblePreferredStockMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:type="locator" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_PlanNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesBConvertiblePreferredStockMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember_li0l2" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_PaymentsForUnderwritingExpense" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_CommonStockIncreaseInOutstandingShares" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_Cash" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidClinicalTrial" xlink:type="locator" xlink:label="tsha_PrepaidClinicalTrial" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance" xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidBonus" xlink:type="locator" xlink:label="tsha_PrepaidBonus" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PrepaidResearchAndDevelopmentContracts" xlink:type="locator" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_PrepaidResearchAndDevelopmentContracts" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_PrepaidBonus" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidInsurance" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_PrepaidClinicalTrial" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="tsha_LaboratoryEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_LaboratoryEquipmentMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseMember" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_BuildToSuitLeaseMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ConstructionInProgressGross" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedClinicalTrialCurrent" xlink:type="locator" xlink:label="tsha_AccruedClinicalTrialCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:type="locator" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AccruedResearchAndDevelopmentCurrent" xlink:type="locator" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_AccruedResearchAndDevelopmentCurrent" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_AccruedPropertyPlantAndEquipmentCurrent" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_AccruedClinicalTrialCurrent" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:type="locator" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_UpfrontPayment" xlink:type="locator" xlink:label="tsha_UpfrontPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:type="locator" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:type="locator" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:type="locator" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:type="locator" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentOfLicenseFee" xlink:type="locator" xlink:label="tsha_PaymentOfLicenseFee" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AdditionalMilestonePayments" xlink:type="locator" xlink:label="tsha_AdditionalMilestonePayments" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAgreementCommercialMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:type="locator" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PaymentsToAcquireLicenseRight" xlink:type="locator" xlink:label="tsha_PaymentsToAcquireLicenseRight" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchGrantOutstandingFundAmount" xlink:type="locator" xlink:label="tsha_ResearchGrantOutstandingFundAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchGrantOfCommittedFundAmount" xlink:type="locator" xlink:label="tsha_ResearchGrantOfCommittedFundAmount" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:type="locator" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:type="locator" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:type="locator" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:type="locator" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:type="locator" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaTherapeuticsIncMember" xlink:type="locator" xlink:label="tsha_AbeonaTherapeuticsIncMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaRettAgreementMember" xlink:type="locator" xlink:label="tsha_AbeonaRettAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AbeonaCLN1AgreementsMember" xlink:type="locator" xlink:label="tsha_AbeonaCLN1AgreementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_QueensAgreementMember" xlink:type="locator" xlink:label="tsha_QueensAgreementMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_UTSouthwesternAgreementMember" xlink:type="locator" xlink:label="tsha_UTSouthwesternAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:type="locator" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_UTSouthwesternAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_QueensAgreementMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaCLN1AgreementsMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaTherapeuticsIncMember" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ResearchGrantOfCommittedFundAmount" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ResearchGrantOutstandingFundAmount" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentsToAcquireLicenseRight" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementRegulatoryMilestonesPayment" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementCommercialMilestonesPayment" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_AdditionalMilestonePayments" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfLicenseFee" order="11780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="11860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfOneTimeUpfrontLicenseFee" order="12050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_RegulatoryRelatedMilestonesObligationPayable" order="12070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_UpfrontPayment" order="12190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AmountReclassifiedToConvertiblePreferredStock" xlink:type="locator" xlink:label="tsha_AmountReclassifiedToConvertiblePreferredStock" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MileStoneSharesIssued" xlink:type="locator" xlink:label="tsha_MileStoneSharesIssued" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ChangeInFairValueOfPreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_IssuanceOfProRataPortionOfMilestoneShares" xlink:type="locator" xlink:label="tsha_IssuanceOfProRataPortionOfMilestoneShares" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PreferredStockTrancheLiability" xlink:type="locator" xlink:label="tsha_PreferredStockTrancheLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" xlink:type="locator" xlink:label="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCollaborators" xlink:type="locator" xlink:label="us-gaap_ProceedsFromCollaborators" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ProceedsFromIssuanceOfCommonStockGross" xlink:type="locator" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" xlink:type="locator" xlink:label="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBPurchaseAgreementMember" xlink:type="locator" xlink:label="tsha_SeriesBPurchaseAgreementMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NolanCapitalLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="tsha_NolanCapitalLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" xlink:type="locator" xlink:label="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" xlink:type="locator" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" xlink:type="locator" xlink:label="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAPurchaseAgreementInitialClosingMember" xlink:type="locator" xlink:label="tsha_SeriesAPurchaseAgreementInitialClosingMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAPurchaseAgreementMember" xlink:type="locator" xlink:label="tsha_SeriesAPurchaseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesBConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesBConvertiblePreferredStockMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tsha_SeriesBConvertiblePreferredStockMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAPurchaseAgreementMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAPurchaseAgreementInitialClosingMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_NolanCapitalLimitedLiabilityCompanyMember" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SeriesBPurchaseAgreementMember" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockGross" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromCollaborators" order="12160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="12450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="12520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput" order="12610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm" order="12690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_PreferredStockTrancheLiability" order="12800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_IssuanceOfProRataPortionOfMilestoneShares" order="12920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_ChangeInFairValueOfPreferredStockTrancheLiability" order="12980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_MileStoneSharesIssued" order="13040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tsha_AmountReclassifiedToConvertiblePreferredStock" order="13160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_FounderPresidentAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CertainEmployeesAndConsultantsMember" xlink:type="locator" xlink:label="tsha_CertainEmployeesAndConsultantsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_CancelledOptionsMember" xlink:type="locator" xlink:label="tsha_CancelledOptionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="tsha_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_EmployeeStockPurchasePlanMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_CancelledOptionsMember" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_CertainEmployeesAndConsultantsMember" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember_li0l2" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="11840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="11860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="tsha_ShareBasedCompensationAwardTrancheFourMember" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_FounderPresidentAndChiefExecutiveOfficerMember" order="12060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="12140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="12320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="12400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" order="12440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" order="12480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" order="12520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="12560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="12860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="12970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="13010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" order="13090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" order="13170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="13280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="13490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="13560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="13600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="13800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" order="13950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="14070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_li0l2" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:type="locator" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="11620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="11950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="12380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" order="12480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" order="12580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_li0l2" order="12680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="12780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SeriesAConvertiblePreferredStockMember" xlink:type="locator" xlink:label="tsha_SeriesAConvertiblePreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="tsha_SeriesAConvertiblePreferredStockMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:href="tsha-20210630.xsd#tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" xlink:type="locator" xlink:label="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OwnershipPercentageInExcessOfCapitalStock" xlink:type="locator" xlink:label="tsha_OwnershipPercentageInExcessOfCapitalStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NumberOfSecuredPromissoryNotes" xlink:type="locator" xlink:label="tsha_NumberOfSecuredPromissoryNotes" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:type="locator" xlink:label="srt_DirectorMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ServicesAgreementMember" xlink:type="locator" xlink:label="tsha_ServicesAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMTGTHoldingsLLCMember" xlink:type="locator" xlink:label="tsha_PBMTGTHoldingsLLCMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PBMCapitalGroupLLCMember" xlink:type="locator" xlink:label="tsha_PBMCapitalGroupLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_FounderPresidentAndChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="tsha_FounderPresidentAndChiefExecutiveOfficerMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_SecuredPromissoryNotesMember" xlink:type="locator" xlink:label="tsha_SecuredPromissoryNotesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_SecuredPromissoryNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_FounderPresidentAndChiefExecutiveOfficerMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="tsha_PBMCapitalGroupLLCMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="tsha_PBMTGTHoldingsLLCMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="tsha_ServicesAgreementMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="tsha_NumberOfSecuredPromissoryNotes" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="tsha_OwnershipPercentageInExcessOfCapitalStock" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseIncentiveReceivable" xlink:type="locator" xlink:label="us-gaap_LeaseIncentiveReceivable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:type="locator" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" xlink:type="locator" xlink:label="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" xlink:type="locator" xlink:label="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" xlink:type="locator" xlink:label="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitLeaseLiability" xlink:type="locator" xlink:label="tsha_BuildToSuitLeaseLiability" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_BuildToSuitAsset" xlink:type="locator" xlink:label="tsha_BuildToSuitAsset" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_OperatingLeasesInitialDirectCosts" xlink:type="locator" xlink:label="tsha_OperatingLeasesInitialDirectCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperationsCommencedDate1" xlink:type="locator" xlink:label="us-gaap_OperationsCommencedDate1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PegasusParkLLCMember" xlink:type="locator" xlink:label="tsha_PegasusParkLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_DallasLeaseMember" xlink:type="locator" xlink:label="tsha_DallasLeaseMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_DurhamLeaseMember" xlink:type="locator" xlink:label="tsha_DurhamLeaseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DurhamLeaseMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DallasLeaseMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_CounterpartyNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_PegasusParkLLCMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="tsha_DallasLeaseMember" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperationsCommencedDate1" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_OperatingLeasesInitialDirectCosts" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_BuildToSuitAsset" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_BuildToSuitLeaseLiability" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseIncentiveReceivable" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="tsha-20210630.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfPrepaymentOfFacility" xlink:type="locator" xlink:label="tsha_PercentageOfPrepaymentOfFacility" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_PercentageOfPrepaymentPremium" xlink:type="locator" xlink:label="tsha_PercentageOfPrepaymentPremium" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_NumberOfDistinctAndActiveClinicalStage" xlink:type="locator" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember" xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFacilityMember" xlink:type="locator" xlink:label="tsha_TermLoanFacilityMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:type="locator" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:type="locator" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" />
    <link:loc xlink:href="tsha-20210630.xsd#tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:type="locator" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_TermLoanFacilityMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeStart1" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeEnd1" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_NumberOfDistinctAndActiveClinicalStage" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfPrepaymentPremium" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfPrepaymentOfFacility" order="11470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>tsha-10q_20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:tsha="http://tayshagtx.com/20210630"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="tsha-20210630.xsd" xlink:type="simple"/>
    <context id="C_0001806310_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_20210816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2021-08-16</instant>
        </period>
    </context>
    <context id="C_0001806310_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_20200401_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_20200101_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200401_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-16</startDate>
            <endDate>2020-09-16</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200928_20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200928_20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200928_20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200301_20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200701_20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaLaboratoryEquipmentMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaBuildToSuitLeaseMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:BuildToSuitLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191201_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_srtRangeAxis_srtMaximumMember_20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-21</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:QueensAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200801_20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20201001_20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_srtRangeAxis_srtMaximumMember_20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20201029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-29</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210301_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2020-07-28</instant>
        </period>
    </context>
    <context id="C_0001806310_20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-28</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-28</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200929_20200929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-09-29</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-04</startDate>
            <endDate>2020-03-04</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-04</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementInitialClosingMember_20200304_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-04</startDate>
            <endDate>2020-03-04</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneOneMember_20200305_20200305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAAchievementOfSpecificClinicalMilestoneOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-05</startDate>
            <endDate>2020-03-05</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneTwoMember_20200305_20200305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAAchievementOfSpecificClinicalMilestoneTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-05</startDate>
            <endDate>2020-03-05</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_20200304_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-04</startDate>
            <endDate>2020-03-04</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200701_20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaPBMTGTHoldingsLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PBMTGTHoldingsLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaNolanCapitalLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:NolanCapitalLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-28</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200701_20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-04</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-04</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-04</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-04</startDate>
            <endDate>2020-03-04</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200629_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapMeasurementInputTypeAxis_tshaMeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">tsha:MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-04</instant>
        </period>
    </context>
    <context id="C_0001806310_20200304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2020-03-04</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tsha:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SeriesBPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="C_0001806310_20200629_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-16</startDate>
            <endDate>2020-09-16</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-16</startDate>
            <endDate>2020-09-16</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:CertainEmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:CancelledOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-02</startDate>
            <endDate>2020-09-02</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20200902_20200902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-02</startDate>
            <endDate>2020-09-02</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheTwoMember_20200902_20200902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-02</startDate>
            <endDate>2020-09-02</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheThreeMember_20200902_20200902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-02</startDate>
            <endDate>2020-09-02</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_tshaShareBasedCompensationAwardTrancheFourMember_20200902_20200902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">tsha:ShareBasedCompensationAwardTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-02</startDate>
            <endDate>2020-09-02</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20200701_20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210401_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">tsha:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_20200101_20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200301_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:FounderPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMCapitalGroupLLCMember_20200301_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tsha:ServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tsha:PBMCapitalGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtTitleOfIndividualAxis_srtDirectorMember_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_20200301_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tsha:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMTGTHoldingsLLCMember_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tsha:PBMTGTHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217_20201217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-17</startDate>
            <endDate>2020-12-17</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210101_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapLeaseContractualTermAxis_tshaDallasLeaseMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyTwoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughAugustThirteenTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyThreeMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughAugustThirteenTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <unit id="U_xbrlishares">
        <measure>shares</measure>
    </unit>
    <unit id="U_iso4217USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_iso4217USD_xbrlishares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_xbrlipure">
        <measure>pure</measure>
    </unit>
    <unit id="U_tshaProduct">
        <measure>tsha:Product</measure>
    </unit>
    <unit id="U_tshaPromissoryNote">
        <measure>tsha:PromissoryNote</measure>
    </unit>
    <unit id="U_utrsqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_tshaProgram">
        <measure>tsha:Program</measure>
    </unit>
    <dei:AmendmentFlag contextRef="C_0001806310_20210101_20210630" id="F_000001">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_0001806310_20210101_20210630" id="F_000004">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_0001806310_20210101_20210630" id="F_000007">0001806310</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_0001806310_20210101_20210630" id="F_000008">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111"
      id="F_000522">true</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <tsha:PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200401_20200430"
      id="F_000314">P2Y</tsha:PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701"
      id="F_000411">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902"
      id="F_000414">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630"
      id="F_000422">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902"
      id="F_000456">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701"
      id="F_000468">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630"
      id="F_000425">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      id="F_000426">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      id="F_000441">P9Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      id="F_000442">P9Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      id="F_000443">P9Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      id="F_000444">P9Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001806310_20210630"
      id="F_000054"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001806310_20201231"
      id="F_000055"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001806310_20210630"
      id="F_000056"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001806310_20201231"
      id="F_000057"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="C_0001806310_20210630"
      id="F_000058"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="C_0001806310_20201231"
      id="F_000059"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="C_0001806310_20210101_20210630" id="F_000000">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="C_0001806310_20210101_20210630" id="F_000029">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="C_0001806310_20210101_20210630" id="F_000002">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_0001806310_20210101_20210630" id="F_000003">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_0001806310_20210101_20210630" id="F_000030">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_0001806310_20210101_20210630" id="F_000015">001-39536</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_0001806310_20210101_20210630" id="F_000006">Taysha Gene Therapies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001806310_20210101_20210630" id="F_000027">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001806310_20210101_20210630" id="F_000016">84-3199512</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001806310_20210101_20210630" id="F_000017">3000 Pegasus Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001806310_20210101_20210630" id="F_000018">Ste 1430</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001806310_20210101_20210630" id="F_000019">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001806310_20210101_20210630" id="F_000020">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001806310_20210101_20210630" id="F_000021">75247</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001806310_20210101_20210630" id="F_000022">214</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001806310_20210101_20210630" id="F_000023">612-0000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="C_0001806310_20210101_20210630" id="F_000025">Common stock, par value&#160;$0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001806310_20210101_20210630" id="F_000005">TSHA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001806310_20210101_20210630" id="F_000026">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="C_0001806310_20210101_20210630" id="F_000009">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_0001806310_20210101_20210630" id="F_000028">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_0001806310_20210101_20210630" id="F_000010">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_0001806310_20210101_20210630" id="F_000011">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001806310_20210101_20210630" id="F_000012">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001806310_20210101_20210630" id="F_000013">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="C_0001806310_20210101_20210630" id="F_000014">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0001806310_20210816"
      decimals="INF"
      id="F_000024"
      unitRef="U_xbrlishares">38391165</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000031"
      unitRef="U_iso4217USD">197370000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000032"
      unitRef="U_iso4217USD">251253000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000033"
      unitRef="U_iso4217USD">9932000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000034"
      unitRef="U_iso4217USD">6626000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000035"
      unitRef="U_iso4217USD">207302000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000036"
      unitRef="U_iso4217USD">257879000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCostsLeasingNetNoncurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000037"
      unitRef="U_iso4217USD">691000</us-gaap:DeferredCostsLeasingNetNoncurrent>
    <us-gaap:DeferredCostsLeasingNetNoncurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000038"
      unitRef="U_iso4217USD">715000</us-gaap:DeferredCostsLeasingNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000039"
      unitRef="U_iso4217USD">33867000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000040"
      unitRef="U_iso4217USD">287000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000041"
      unitRef="U_iso4217USD">241860000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000042"
      unitRef="U_iso4217USD">258881000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000043"
      unitRef="U_iso4217USD">6355000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000044"
      unitRef="U_iso4217USD">1994000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000045"
      unitRef="U_iso4217USD">22036000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000046"
      unitRef="U_iso4217USD">5135000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000047"
      unitRef="U_iso4217USD">28391000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000048"
      unitRef="U_iso4217USD">7129000</us-gaap:LiabilitiesCurrent>
    <tsha:BuildToSuitLeaseLiability
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000049"
      unitRef="U_iso4217USD">26209000</tsha:BuildToSuitLeaseLiability>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000050"
      unitRef="U_iso4217USD">765000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000051"
      unitRef="U_iso4217USD">450000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000052"
      unitRef="U_iso4217USD">55365000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000053"
      unitRef="U_iso4217USD">7579000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000068"
      unitRef="U_iso4217USD_xbrlishares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000069"
      unitRef="U_iso4217USD_xbrlishares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000070"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000071"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000072"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000073"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000074"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000075"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000076"
      unitRef="U_iso4217USD_xbrlishares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000077"
      unitRef="U_iso4217USD_xbrlishares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000078"
      unitRef="U_xbrlishares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000079"
      unitRef="U_xbrlishares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000080"
      unitRef="U_xbrlishares">38391165</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000082"
      unitRef="U_xbrlishares">38391165</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000081"
      unitRef="U_xbrlishares">37761435</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000083"
      unitRef="U_xbrlishares">37761435</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000060"
      unitRef="U_iso4217USD">320571000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000061"
      unitRef="U_iso4217USD">312428000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000062"
      unitRef="U_iso4217USD">-134076000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000063"
      unitRef="U_iso4217USD">-61126000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000064"
      unitRef="U_iso4217USD">186495000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000065"
      unitRef="U_iso4217USD">251302000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000066"
      unitRef="U_iso4217USD">241860000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000067"
      unitRef="U_iso4217USD">258881000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000084"
      unitRef="U_iso4217USD">30643000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000085"
      unitRef="U_iso4217USD">3062000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000086"
      unitRef="U_iso4217USD">54497000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000087"
      unitRef="U_iso4217USD">8576000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000088"
      unitRef="U_iso4217USD">10129000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000089"
      unitRef="U_iso4217USD">948000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000090"
      unitRef="U_iso4217USD">18365000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000091"
      unitRef="U_iso4217USD">1018000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000092"
      unitRef="U_iso4217USD">40772000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000093"
      unitRef="U_iso4217USD">4010000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000094"
      unitRef="U_iso4217USD">72862000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000095"
      unitRef="U_iso4217USD">9594000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000096"
      unitRef="U_iso4217USD">-40772000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000097"
      unitRef="U_iso4217USD">-4010000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000098"
      unitRef="U_iso4217USD">-72862000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000099"
      unitRef="U_iso4217USD">-9594000</us-gaap:OperatingIncomeLoss>
    <tsha:ChangeInFairValueOfPreferredStockTrancheLiability
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000100"
      unitRef="U_iso4217USD">-17210000</tsha:ChangeInFairValueOfPreferredStockTrancheLiability>
    <tsha:ChangeInFairValueOfPreferredStockTrancheLiability
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000101"
      unitRef="U_iso4217USD">-17030000</tsha:ChangeInFairValueOfPreferredStockTrancheLiability>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000102"
      unitRef="U_iso4217USD">40000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000103"
      unitRef="U_iso4217USD">106000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestExpense
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000104"
      unitRef="U_iso4217USD">194000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000105"
      unitRef="U_iso4217USD">194000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000106"
      unitRef="U_iso4217USD">27000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000107"
      unitRef="U_iso4217USD">-154000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000108"
      unitRef="U_iso4217USD">-17210000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000109"
      unitRef="U_iso4217USD">-88000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000110"
      unitRef="U_iso4217USD">-17057000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000111"
      unitRef="U_iso4217USD">-40926000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000112"
      unitRef="U_iso4217USD">-21220000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000113"
      unitRef="U_iso4217USD">-72950000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000114"
      unitRef="U_iso4217USD">-26651000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20210401_20210630"
      decimals="2"
      id="F_000115"
      unitRef="U_iso4217USD_xbrlishares">-1.09</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20200401_20200630"
      decimals="2"
      id="F_000116"
      unitRef="U_iso4217USD_xbrlishares">-1.95</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20210101_20210630"
      decimals="2"
      id="F_000117"
      unitRef="U_iso4217USD_xbrlishares">-1.96</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20200101_20200630"
      decimals="2"
      id="F_000118"
      unitRef="U_iso4217USD_xbrlishares">-2.45</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20210401_20210630"
      decimals="0"
      id="F_000119"
      unitRef="U_xbrlishares">37479164</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20200401_20200630"
      decimals="0"
      id="F_000120"
      unitRef="U_xbrlishares">10894999</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20210101_20210630"
      decimals="0"
      id="F_000121"
      unitRef="U_xbrlishares">37237115</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20200101_20200630"
      decimals="0"
      id="F_000122"
      unitRef="U_xbrlishares">10894999</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210331"
      decimals="INF"
      id="F_000123"
      unitRef="U_xbrlishares">37761435</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210331"
      decimals="-3"
      id="F_000124"
      unitRef="U_iso4217USD">316022000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210331"
      decimals="-3"
      id="F_000125"
      unitRef="U_iso4217USD">-93150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20210331"
      decimals="-3"
      id="F_000126"
      unitRef="U_iso4217USD">222872000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210401_20210630"
      decimals="-3"
      id="F_000127"
      unitRef="U_iso4217USD">4549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000128"
      unitRef="U_iso4217USD">4549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210401_20210630"
      decimals="INF"
      id="F_000129"
      unitRef="U_xbrlishares">629730</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210401_20210630"
      decimals="-3"
      id="F_000130"
      unitRef="U_iso4217USD">-40926000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000131"
      unitRef="U_iso4217USD">-40926000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210630"
      decimals="INF"
      id="F_000132"
      unitRef="U_xbrlishares">38391165</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210630"
      decimals="-3"
      id="F_000133"
      unitRef="U_iso4217USD">320571000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210630"
      decimals="-3"
      id="F_000134"
      unitRef="U_iso4217USD">-134076000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000135"
      unitRef="U_iso4217USD">186495000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200331"
      decimals="INF"
      id="F_000136"
      unitRef="U_xbrlishares">6000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200331"
      decimals="-3"
      id="F_000137"
      unitRef="U_iso4217USD">16520000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200331"
      decimals="INF"
      id="F_000138"
      unitRef="U_xbrlishares">10894999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200331"
      decimals="-3"
      id="F_000139"
      unitRef="U_iso4217USD">980000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200331"
      decimals="-3"
      id="F_000140"
      unitRef="U_iso4217USD">-6546000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20200331"
      decimals="-3"
      id="F_000141"
      unitRef="U_iso4217USD">-5566000</us-gaap:StockholdersEquity>
    <tsha:TemporaryEquityStockOfferingCosts
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630"
      decimals="-3"
      id="F_000153"
      unitRef="U_iso4217USD">10000</tsha:TemporaryEquityStockOfferingCosts>
    <tsha:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630"
      decimals="INF"
      id="F_000142"
      unitRef="U_xbrlishares">200000</tsha:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630"
      decimals="-3"
      id="F_000143"
      unitRef="U_iso4217USD">590000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <tsha:ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200401_20200630"
      decimals="-3"
      id="F_000144"
      unitRef="U_iso4217USD">904000</tsha:ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200401_20200630"
      decimals="-3"
      id="F_000145"
      unitRef="U_iso4217USD">-21220000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000146"
      unitRef="U_iso4217USD">-21220000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630"
      decimals="INF"
      id="F_000147"
      unitRef="U_xbrlishares">6200000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630"
      decimals="-3"
      id="F_000148"
      unitRef="U_iso4217USD">18014000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200630"
      decimals="INF"
      id="F_000149"
      unitRef="U_xbrlishares">10894999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630"
      decimals="-3"
      id="F_000150"
      unitRef="U_iso4217USD">980000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630"
      decimals="-3"
      id="F_000151"
      unitRef="U_iso4217USD">-27766000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20200630"
      decimals="-3"
      id="F_000152"
      unitRef="U_iso4217USD">-26786000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="INF"
      id="F_000156"
      unitRef="U_xbrlishares">37761435</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231"
      decimals="-3"
      id="F_000157"
      unitRef="U_iso4217USD">312428000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231"
      decimals="-3"
      id="F_000158"
      unitRef="U_iso4217USD">-61126000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000159"
      unitRef="U_iso4217USD">251302000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20210630"
      decimals="-3"
      id="F_000160"
      unitRef="U_iso4217USD">8143000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000161"
      unitRef="U_iso4217USD">8143000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20210630"
      decimals="INF"
      id="F_000162"
      unitRef="U_xbrlishares">629730</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20210630"
      decimals="-3"
      id="F_000163"
      unitRef="U_iso4217USD">-72950000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000164"
      unitRef="U_iso4217USD">-72950000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210630"
      decimals="INF"
      id="F_000165"
      unitRef="U_xbrlishares">38391165</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210630"
      decimals="-3"
      id="F_000166"
      unitRef="U_iso4217USD">320571000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210630"
      decimals="-3"
      id="F_000167"
      unitRef="U_iso4217USD">-134076000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000168"
      unitRef="U_iso4217USD">186495000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="INF"
      id="F_000169"
      unitRef="U_xbrlishares">10894999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231"
      decimals="-3"
      id="F_000170"
      unitRef="U_iso4217USD">980000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000171"
      unitRef="U_iso4217USD">-1115000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20191231"
      decimals="-3"
      id="F_000172"
      unitRef="U_iso4217USD">-135000</us-gaap:StockholdersEquity>
    <tsha:TemporaryEquityStockOfferingCosts
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630"
      decimals="-3"
      id="F_000154"
      unitRef="U_iso4217USD">440000</tsha:TemporaryEquityStockOfferingCosts>
    <tsha:TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000155"
      unitRef="U_iso4217USD">1050000</tsha:TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability>
    <tsha:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630"
      decimals="INF"
      id="F_000173"
      unitRef="U_xbrlishares">6200000</tsha:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630"
      decimals="-3"
      id="F_000174"
      unitRef="U_iso4217USD">17110000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <tsha:ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630"
      decimals="-3"
      id="F_000175"
      unitRef="U_iso4217USD">904000</tsha:ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20200630"
      decimals="-3"
      id="F_000176"
      unitRef="U_iso4217USD">-26651000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000177"
      unitRef="U_iso4217USD">-26651000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630"
      decimals="INF"
      id="F_000178"
      unitRef="U_xbrlishares">6200000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200630"
      decimals="-3"
      id="F_000179"
      unitRef="U_iso4217USD">18014000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200630"
      decimals="INF"
      id="F_000180"
      unitRef="U_xbrlishares">10894999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200630"
      decimals="-3"
      id="F_000181"
      unitRef="U_iso4217USD">980000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200630"
      decimals="-3"
      id="F_000182"
      unitRef="U_iso4217USD">-27766000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001806310_20200630"
      decimals="-3"
      id="F_000183"
      unitRef="U_iso4217USD">-26786000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000184"
      unitRef="U_iso4217USD">-72950000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000185"
      unitRef="U_iso4217USD">-26651000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000186"
      unitRef="U_iso4217USD">117000</us-gaap:Depreciation>
    <tsha:ChangeInFairValueOfPreferredStockTrancheLiability
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000187"
      unitRef="U_iso4217USD">-17030000</tsha:ChangeInFairValueOfPreferredStockTrancheLiability>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000188"
      unitRef="U_iso4217USD">5500000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000189"
      unitRef="U_iso4217USD">3000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000190"
      unitRef="U_iso4217USD">8143000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000191"
      unitRef="U_iso4217USD">-194000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000192"
      unitRef="U_iso4217USD">3282000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000193"
      unitRef="U_iso4217USD">9000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000194"
      unitRef="U_iso4217USD">2382000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000195"
      unitRef="U_iso4217USD">1237000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000196"
      unitRef="U_iso4217USD">15053000</tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities>
    <tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000197"
      unitRef="U_iso4217USD">1214000</tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000198"
      unitRef="U_iso4217USD">-8000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000199"
      unitRef="U_iso4217USD">14000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000200"
      unitRef="U_iso4217USD">-44851000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000201"
      unitRef="U_iso4217USD">-4165000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000202"
      unitRef="U_iso4217USD">5500000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000203"
      unitRef="U_iso4217USD">3000000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000204"
      unitRef="U_iso4217USD">3532000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000205"
      unitRef="U_iso4217USD">-9032000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000206"
      unitRef="U_iso4217USD">-3000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000207"
      unitRef="U_iso4217USD">18600000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000208"
      unitRef="U_iso4217USD">263000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000209"
      unitRef="U_iso4217USD">1673000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000210"
      unitRef="U_iso4217USD">1645000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000211"
      unitRef="U_iso4217USD">18365000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000212"
      unitRef="U_iso4217USD">-53883000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000213"
      unitRef="U_iso4217USD">11200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000214"
      unitRef="U_iso4217USD">251253000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000215"
      unitRef="U_iso4217USD">197370000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001806310_20200630"
      decimals="-3"
      id="F_000216"
      unitRef="U_iso4217USD">11200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000217"
      unitRef="U_iso4217USD">27000</us-gaap:InterestPaidNet>
    <tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000218"
      unitRef="U_iso4217USD">3308000</tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses>
    <tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000219"
      unitRef="U_iso4217USD">19000</tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000220"
      unitRef="U_iso4217USD">606000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000221"
      unitRef="U_iso4217USD">26250000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000222"
      unitRef="U_iso4217USD">90000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <tsha:ReclassificationOfPreferredStockLiability
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000223"
      unitRef="U_iso4217USD">904000</tsha:ReclassificationOfPreferredStockLiability>
    <tsha:AllocationOfPreferredStockTrancheLiability
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000224"
      unitRef="U_iso4217USD">1050000</tsha:AllocationOfPreferredStockTrancheLiability>
    <us-gaap:StockIssued1
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000225"
      unitRef="U_iso4217USD">177000</us-gaap:StockIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000226">
&lt;p id="NOTE_1ORGANIZATION_DESCRIPTION_BUSINESS_" style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 1&#x2014;Organization and Description of Business Operations &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Taysha Gene Therapies, Inc. (the &#x201c;Company&#x201d; or &#x201c;Taysha&#x201d;) was originally formed under the laws of the State of Texas on September 20, 2019 (&#x201c;Inception&#x201d;). Taysha converted to a Delaware corporation on February 13, 2020, which had no impact to the Company&#x2019;s par value or issued and authorized capital structure. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Taysha is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock Split &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 16, 2020, the Company effected a 1.0895-for-one stock split of its authorized, issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company&#x2019;s convertible preferred stock as discussed in Note 5. Accordingly, all share and per share amounts for the periods presented in the accompanying condensed consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this stock split and adjustment of the convertible preferred stock conversion ratios. On September 16, 2020, the Company also increased the number of shares of common stock authorized for issuance under the 2020 Equity Incentive Plan (the &#x201c;Existing Plan&#x201d;) to 3,845,294. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Initial Public Offering &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 23, 2020, the Company&#x2019;s registration statement on Form S-1 (File No. 333-248559) related to the initial public offering (&#x201c;IPO&#x201d;) of its common stock became effective and on September 28, 2020, the IPO closed. Pursuant to the IPO, the Company issued and sold 9,050,000 shares of common stock at a public offering price of $20.00 per share, which included 1,180,434 shares of common stock issued upon the exercise in full of the underwriters&#x2019; option to purchase additional shares. The Company received net proceeds of $165.9 million after &lt;span style="color:#000000;"&gt;deducting underwriting discounts and commissions and other offering costs of $2.5&#160;million. The shares began trading on the Nasdaq Global Select Market on September 24, 2020.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 28, 2020, in connection with the closing of the IPO, 10,000,000 shares of Series A and 5,647,048 shares of Series B convertible preferred stock automatically converted into an aggregate of 17,047,378 shares of common stock with a conversion ratio of 1.0895 shares of common stock for each share of Series A and Series B convertible preferred stock. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As a result of the IPO, including the underwriters&#x2019; exercise in full of their option to purchase additional shares, and the conversions of the Series A and B convertible preferred stock, the Company&#x2019;s total number of outstanding shares increased by 26,097,378 immediately following the closing of the IPO.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon the effectiveness of the Company&#x2019;s registration statement related to the IPO, the Company&#x2019;s 2020 Stock Incentive Plan (the &#x201c;New Plan&#x201d;) and 2020 Employee Stock Purchase Plan became effective. At that time, all shares reserved for issuance under the Existing Plan ceased to be available for issuance under such plan and became available for issuance under the New Plan.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Liquidity and Capital Resources &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has incurred operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As of June 30, 2021, the Company had an accumulated deficit of $134.1 million. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to the closing of the Company&#x2019;s IPO, between March and July 2020, the Company closed on the sale of an aggregate of 10,000,000 shares of Series A convertible preferred stock for gross proceeds of $30.0 million. Between July and August 2020, the Company closed on the sale of an aggregate of 5,647,048 shares of Series B convertible preferred stock for gross proceeds of $96.0 million. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:10pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future capital requirements will depend on many factors, including the timing and extent of spending on research and development and the market acceptance of the Company&#x2019;s products. The Company will need to obtain additional financing in order to complete clinical studies and launch and commercialize any product candidates for which it receives regulatory approval. There can be no assurance that such financing will be available or will be on terms acceptable to the Company.&lt;span style="color:#000000;"&gt; As of June 30, 2021, the Company had cash of&lt;/span&gt; $197.4 &lt;span style="color:#000000;"&gt;million which the Company believes will be sufficient to fund its planned operations for a period of at least twelve months from the date of issuance of these condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;novel coronavirus &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;that causes the disease &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;COVID-19 emerged and has subsequently spread worldwide. The World Health Organization has declared&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; COVID-19&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; outbreak&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; a &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;global &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;pandemic&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; resulting in federal, state and local governments and private entities implementing various restrictions&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;including travel restrictions, restrictions on public gatherings, stay at home orders, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;other &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;advisories and &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;quarantines of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;people who may have been exposed to the virus. The Company has been actively monitoring COVID&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and its impact globally. Management believes the financial results for the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;six&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months ended &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; were not significantly impacted by &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;COVID-19&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; pandemic&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. In addition, management believes the remote working arrangements and travel restrictions imposed by various governmental jurisdictions have had limited impact on the Company&#x2019;s ability to maintain internal operations during the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;six&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months ended &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30, 2021&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#x2019;s business, results of operations and financial condition will depend on future developments that are highly uncertain, including new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="C_0001806310_20210101_20210630" id="F_000252">2020-02-13</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916_20200916"
      decimals="4"
      id="F_000253"
      unitRef="U_xbrlipure">1.0895</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200916"
      decimals="INF"
      id="F_000254"
      unitRef="U_xbrlishares">3845294</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210101_20210630"
      decimals="INF"
      id="F_000255"
      unitRef="U_xbrlishares">9050000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20210630"
      decimals="INF"
      id="F_000256"
      unitRef="U_iso4217USD_xbrlishares">20.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200928_20200928"
      decimals="INF"
      id="F_000257"
      unitRef="U_xbrlishares">1180434</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928"
      decimals="-5"
      id="F_000258"
      unitRef="U_iso4217USD">165900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928"
      decimals="-5"
      id="F_000259"
      unitRef="U_iso4217USD">2500000</us-gaap:PaymentsForUnderwritingExpense>
    <tsha:TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200928_20200928"
      decimals="INF"
      id="F_000260"
      unitRef="U_xbrlishares">10000000</tsha:TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock>
    <tsha:TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200928_20200928"
      decimals="INF"
      id="F_000261"
      unitRef="U_xbrlishares">5647048</tsha:TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928"
      decimals="INF"
      id="F_000262"
      unitRef="U_xbrlishares">17047378</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928"
      decimals="4"
      id="F_000263"
      unitRef="U_xbrlipure">1.0895</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <tsha:CommonStockIncreaseInOutstandingShares
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928"
      decimals="INF"
      id="F_000264"
      unitRef="U_xbrlishares">26097378</tsha:CommonStockIncreaseInOutstandingShares>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001806310_20210630"
      decimals="-5"
      id="F_000265"
      unitRef="U_iso4217USD">-134100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200301_20200731"
      decimals="INF"
      id="F_000266"
      unitRef="U_xbrlishares">10000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200301_20200731"
      decimals="-5"
      id="F_000268"
      unitRef="U_iso4217USD">30000000.0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200701_20200831"
      decimals="INF"
      id="F_000267"
      unitRef="U_xbrlishares">5647048</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200701_20200831"
      decimals="-5"
      id="F_000269"
      unitRef="U_iso4217USD">96000000.0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:Cash
      contextRef="C_0001806310_20210630"
      decimals="-5"
      id="F_000270"
      unitRef="U_iso4217USD">197400000</us-gaap:Cash>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000227">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 2&#x2014;Summary of Significant Accounting Policies &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission ("SEC") on March 3, 2021 (the &#x201c;2020 Annual Report&#x201d;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2020 is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#x2019;s 2020 Annual Report.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its inactive wholly owned U.S. subsidiaries that were incorporated during 2020, and one inactive foreign subsidiary incorporated in June 2021. All intercompany transactions and balances have been eliminated in consolidation. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#x2019;s financial statements relate to the determination of the fair value of the common stock prior to the IPO (as an input into stock-based compensation), estimating preclinical manufacturing accruals and accrued or prepaid research and development expenses, and the valuation of the preferred stock tranche liability. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected. In response to the ongoing and rapidly evolving COVID-19 pandemic, management considered the impact of the estimated economic implications on the Company&#x2019;s critical and significant accounting estimates, including assessment of impairment of long-lived assets.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant Accounting Policies &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There have been no changes in the Company&#x2019;s significant accounting policies as disclosed in Note 2 to the audited consolidated financial statements included in the 2020 Annual Report, except as described below.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:2.57%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Build-to-Suit Lease&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:2.57%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In the Company&#x2019;s recent lease arrangement (as described in Note 10), the Company was involved in the construction of the build-out. To the extent the Company is involved with the structural improvements of the construction project or takes construction risk prior to the commencement of a lease, accounting guidance requires the Company to be considered the owner for accounting purposes of these types of projects during the construction period. In such cases, the Company records an asset in property, plant and equipment &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;on its consolidated balance sheet equal to the fair value of the building shell, and a corresponding build-to-suit lease obligation on its consolidated balance sheet representing the amounts paid by the lessor.&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Upon completion of&#160;construction, the Company will consider the requirements for sale-leaseback accounting treatment, including evaluating whether all risks of ownership have been transferred back to the landlord.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Recently Issued Accounting Pronouncements &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will become effective for the Company for annual reporting periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard requires the use of one of the following two approaches, either (1) retrospectively to each prior reporting period presented in the financial statements with the cumulative effect recognized at the beginning of the earliest comparative period presented, or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company has not yet concluded which approach will be utilized to adopt the new standard and is currently evaluating the impact of this standard on its consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000237">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission ("SEC") on March 3, 2021 (the &#x201c;2020 Annual Report&#x201d;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2020 is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#x2019;s 2020 Annual Report.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000238">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its inactive wholly owned U.S. subsidiaries that were incorporated during 2020, and one inactive foreign subsidiary incorporated in June 2021. All intercompany transactions and balances have been eliminated in consolidation. &lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="C_0001806310_20210101_20210630" id="F_000239">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#x2019;s financial statements relate to the determination of the fair value of the common stock prior to the IPO (as an input into stock-based compensation), estimating preclinical manufacturing accruals and accrued or prepaid research and development expenses, and the valuation of the preferred stock tranche liability. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected. In response to the ongoing and rapidly evolving COVID-19 pandemic, management considered the impact of the estimated economic implications on the Company&#x2019;s critical and significant accounting estimates, including assessment of impairment of long-lived assets.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <tsha:BuildToSuitLeasePolicyTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000240">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:2.57%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Build-to-Suit Lease&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:2.57%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In the Company&#x2019;s recent lease arrangement (as described in Note 10), the Company was involved in the construction of the build-out. To the extent the Company is involved with the structural improvements of the construction project or takes construction risk prior to the commencement of a lease, accounting guidance requires the Company to be considered the owner for accounting purposes of these types of projects during the construction period. In such cases, the Company records an asset in property, plant and equipment &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;on its consolidated balance sheet equal to the fair value of the building shell, and a corresponding build-to-suit lease obligation on its consolidated balance sheet representing the amounts paid by the lessor.&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Upon completion of&#160;construction, the Company will consider the requirements for sale-leaseback accounting treatment, including evaluating whether all risks of ownership have been transferred back to the landlord.&lt;/span&gt;&lt;/p&gt;</tsha:BuildToSuitLeasePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000241">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Recently Issued Accounting Pronouncements &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will become effective for the Company for annual reporting periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard requires the use of one of the following two approaches, either (1) retrospectively to each prior reporting period presented in the financial statements with the cumulative effect recognized at the beginning of the earliest comparative period presented, or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company has not yet concluded which approach will be utilized to adopt the new standard and is currently evaluating the impact of this standard on its consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000228">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 3&#x2014;Balance Sheet Components &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid expenses and other current assets consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,716&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,462&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid bonus&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,192&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;409&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid insurance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,480&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid clinical trial&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;184&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;944&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,014&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total prepaid expenses and other current assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,932&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,626&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property, plant and equipment, net consisted of the following (in thousands):&lt;span style="margin-left:36pt;"/&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,863&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;676&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;529&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;460&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,465&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,993&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(126&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property, plant and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,867&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;287&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Included in construction in progress at June 30, 2021 was $30.3 million of costs associated with the Build-to-Suit lease (see Note 10). &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation expense was $85,000 and $117,000 for the three and six months ended June 30, 2021, respectively. There was no depreciation expense for the three and six months ended June 30, 2020.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,106&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional and consulting fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,372&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued property, plant, and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,309&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued clinical trial&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;959&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;678&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued expenses and other current liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,135&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000242">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid expenses and other current assets consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,716&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,462&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid bonus&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,192&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;409&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid insurance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,480&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid clinical trial&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;184&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;944&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,014&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total prepaid expenses and other current assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,932&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,626&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <tsha:PrepaidResearchAndDevelopmentContracts
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000271"
      unitRef="U_iso4217USD">6716000</tsha:PrepaidResearchAndDevelopmentContracts>
    <tsha:PrepaidResearchAndDevelopmentContracts
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000272"
      unitRef="U_iso4217USD">2462000</tsha:PrepaidResearchAndDevelopmentContracts>
    <tsha:PrepaidBonus
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000273"
      unitRef="U_iso4217USD">1192000</tsha:PrepaidBonus>
    <tsha:PrepaidBonus
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000274"
      unitRef="U_iso4217USD">409000</tsha:PrepaidBonus>
    <us-gaap:PrepaidInsurance
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000275"
      unitRef="U_iso4217USD">826000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000276"
      unitRef="U_iso4217USD">2480000</us-gaap:PrepaidInsurance>
    <tsha:PrepaidClinicalTrial
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000277"
      unitRef="U_iso4217USD">184000</tsha:PrepaidClinicalTrial>
    <tsha:PrepaidClinicalTrial
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000278"
      unitRef="U_iso4217USD">944000</tsha:PrepaidClinicalTrial>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000279"
      unitRef="U_iso4217USD">1014000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000280"
      unitRef="U_iso4217USD">331000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000281"
      unitRef="U_iso4217USD">9932000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000282"
      unitRef="U_iso4217USD">6626000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000243">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property, plant and equipment, net consisted of the following (in thousands):&lt;span style="margin-left:36pt;"/&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,863&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;676&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;529&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;460&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,465&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,993&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(126&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property, plant and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,867&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;287&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210630"
      decimals="-3"
      id="F_000283"
      unitRef="U_iso4217USD">1863000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20210630"
      decimals="-3"
      id="F_000284"
      unitRef="U_iso4217USD">676000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20210630"
      decimals="-3"
      id="F_000285"
      unitRef="U_iso4217USD">529000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231"
      decimals="-3"
      id="F_000286"
      unitRef="U_iso4217USD">95000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaLaboratoryEquipmentMember_20210630"
      decimals="-3"
      id="F_000287"
      unitRef="U_iso4217USD">460000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20210630"
      decimals="-3"
      id="F_000288"
      unitRef="U_iso4217USD">30465000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231"
      decimals="-3"
      id="F_000289"
      unitRef="U_iso4217USD">201000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000290"
      unitRef="U_iso4217USD">33993000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000291"
      unitRef="U_iso4217USD">296000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000292"
      unitRef="U_iso4217USD">126000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000293"
      unitRef="U_iso4217USD">9000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000294"
      unitRef="U_iso4217USD">33867000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000295"
      unitRef="U_iso4217USD">287000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ConstructionInProgressGross
      contextRef="C_0001806310_us-gaapPropertyPlantAndEquipmentByTypeAxis_tshaBuildToSuitLeaseMember_20210630"
      decimals="-5"
      id="F_000300"
      unitRef="U_iso4217USD">30300000</us-gaap:ConstructionInProgressGross>
    <us-gaap:Depreciation
      contextRef="C_0001806310_20210401_20210630"
      decimals="0"
      id="F_000296"
      unitRef="U_iso4217USD">85000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001806310_20210101_20210630"
      decimals="0"
      id="F_000297"
      unitRef="U_iso4217USD">117000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001806310_20200401_20200630"
      decimals="INF"
      id="F_000298"
      unitRef="U_iso4217USD">0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001806310_20200101_20200630"
      decimals="INF"
      id="F_000299"
      unitRef="U_iso4217USD">0</us-gaap:Depreciation>
    <tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000244">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,106&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional and consulting fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,372&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued property, plant, and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,309&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued clinical trial&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;959&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;678&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued expenses and other current liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,135&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock>
    <tsha:AccruedResearchAndDevelopmentCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000301"
      unitRef="U_iso4217USD">14508000</tsha:AccruedResearchAndDevelopmentCurrent>
    <tsha:AccruedResearchAndDevelopmentCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000302"
      unitRef="U_iso4217USD">2106000</tsha:AccruedResearchAndDevelopmentCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000303"
      unitRef="U_iso4217USD">3210000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000304"
      unitRef="U_iso4217USD">1766000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000305"
      unitRef="U_iso4217USD">1372000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000306"
      unitRef="U_iso4217USD">999000</us-gaap:AccruedProfessionalFeesCurrent>
    <tsha:AccruedPropertyPlantAndEquipmentCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000307"
      unitRef="U_iso4217USD">1309000</tsha:AccruedPropertyPlantAndEquipmentCurrent>
    <tsha:AccruedPropertyPlantAndEquipmentCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000308"
      unitRef="U_iso4217USD">173000</tsha:AccruedPropertyPlantAndEquipmentCurrent>
    <tsha:AccruedClinicalTrialCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000309"
      unitRef="U_iso4217USD">959000</tsha:AccruedClinicalTrialCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000310"
      unitRef="U_iso4217USD">678000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000311"
      unitRef="U_iso4217USD">91000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0001806310_20210630"
      decimals="-3"
      id="F_000312"
      unitRef="U_iso4217USD">22036000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0001806310_20201231"
      decimals="-3"
      id="F_000313"
      unitRef="U_iso4217USD">5135000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000229">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 4&#x2014;Research, Collaboration and License Agreements &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;UT Southwestern Agreement &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On November 19, 2019, the Company entered into a research, collaboration and license agreement (&#x201c;UT Southwestern Agreement&#x201d;) with the Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center (&#x201c;UT Southwestern&#x201d;). Under the UT Southwestern Agreement, UT Southwestern is primarily responsible for preclinical development activities with respect to licensed products for use in certain specified indications (up to investigational new drug application-enabling studies), and the Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed products. UT Southwestern will conduct such preclinical activities for a &lt;span style="-sec-ix-hidden:F_000314"&gt;two-year&lt;/span&gt; period under mutually agreed upon sponsored research agreements that were entered into beginning in April 2020. During the initial research phase, the Company has the right to expand the scope of specified indications under the UT Southwestern Agreement. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the UT Southwestern Agreement, the Company obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, the Company obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. The Company is required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least one licensed product. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On April 2, 2020, the Company amended the UT Southwestern Agreement to include the addition of another licensed product and certain indications, and a right of first refusal to the Company over certain patient dosing patents. No additional consideration was transferred in connection with this amendment. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, the Company may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November 2019, as partial consideration for the license rights granted under the UT Southwestern Agreement, the Company issued 2,179,000 shares of its common stock, or 20% of its then outstanding fully-diluted common stock, to UT Southwestern. As additional consideration, UT Southwestern was entitled to receive additional shares if their holdings fell below 10% on a fully-diluted basis before or as a result of the completion of a qualified financing. In March 2020, following the initial closing of the Series A convertible preferred stock agreement, which met the definition of such qualified financing, the anti-dilution feature expired and no additional shares were issued. The Company does not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement other than costs related to maintenance of patents. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Queen&#x2019;s Agreement &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In late December 2019, the Company entered into a research grant agreement (&#x201c;RGA&#x201d;) with Queen&#x2019;s University at Kingston (&#x201c;Queen&#x2019;s&#x201d;), for certain research and development activities related to the generation of AAV9 vector. The Company committed to fund $3.8 million under the RGA with Queen&#x2019;s. The Company issued Queen&#x2019;s a promise-to-pay note whereby any amounts paid directly by Queen&#x2019;s for the manufacture of the vector for use in the funded research activities, to the extent such amounts had not already been funded by the Company to Queen&#x2019;s, would become a loan obligation for the Company (the &#x201c;Note&#x201d;), subject to an interest &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;rate of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%. &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Any amounts outstanding under the Note were required to be repaid, along with any accrued interest, by or before June 30, 2020. In the event of default, any amount outstanding &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;was&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; deemed immediately payable by RA Session II, the Company&#x2019;s President and Chief Executive Officer, as a personal guarantor (see Note &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;). For the period from Inception through December 31, 2019, the Company did not incur any expenses associated with the Queen&#x2019;s RGA, and no amounts were due or outstanding under the Note as of December 31, 2019. &lt;/span&gt;&lt;span style="color:#000000;"&gt;For the year ended December 31, 2020, the Company paid all expenses associated with the Queen&#x2019;s RGA, thus &lt;/span&gt;&lt;span style="color:#000000;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;"&gt; amounts were due or outstanding under the Note as of December 31, 2020, and the promise-to-pay has therefore expired.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On February 21, 2020, the Company entered into a license agreement with Queen&#x2019;s (the &#x201c;Queen&#x2019;s Agreement&#x201d;) to obtain the exclusive perpetual, royalty-bearing license, with the right to sublicense through multiple tiers, under certain patent rights and know-how of Queen&#x2019;s, including certain improvements to such patent rights and know-how, to develop products in any field which use one or more valid claims of the patents licensed under the Queen&#x2019;s Agreement (the &#x201c;Licensed Patents&#x201d;), or the technology, information and intellectual property related to the patents licensed under the Queen&#x2019;s Agreement (together with the Licensed Patents, the &#x201c;Licensed Products&#x201d;), and to make, have made, use, sell, offer for sale, import and export Licensed Products and otherwise exploit such patents and know-how for use in certain specified indications. In exchange for the rights granted to the Company, the Company made a cash payment of $3.0 million in April 2020 which is recorded in research and development expenses in the condensed consolidated statements of operations &lt;span style="color:#000000;"&gt;and included as an investing cash outflow in the condensed consolidated statements of cash flows since the acquired license does not have an alternative future use&lt;/span&gt; for the six months ended June 30, 2020. The Company is obligated to make aggregate cash payments of up to $10.0 million upon the completion of a combination of regulatory milestones and up to $10.0 million upon the completion of a combination of commercial milestones. In further consideration of the rights granted, beginning with the Company&#x2019;s first commercial sale of the Licensed Products, the Company will also pay an annual earned royalty in the low single digits on net sales of Licensed Products, subject to certain customary reductions, and a percentage of non-royalty sublicensing revenue ranging in the low double digits. Royalties are payable, on a Licensed Products-by-Licensed Products and a country-by-country basis, until expiration of the last valid claim of a Licensed Patent covering such Licensed Products in such country and the expiration of any regulatory exclusivity for such Licensed Products in such country. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;No additional milestone payments were made in connection with the Queen&#x2019;s Agreement during the six months ended June 30, 2021.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Abeona CLN1 Agreements &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2020, the Company entered into license and inventory purchase agreements with Abeona Therapeutics Inc. (&#x201c;Abeona&#x201d;) for worldwide exclusive rights to certain intellectual property rights and know-how relating to the research, development and manufacture of ABO-202, an AAV-based gene therapy for CLN1 disease (also known as infantile Batten disease). Under the terms of the agreements, the Company made initial cash payments to Abeona of $3.0 million for the license fee and $4.0 million for purchase of clinical materials and reimbursement for previously incurred development costs in October 2020. In exchange for the license rights, the Company recorded an aggregate of $7.0 million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2020 since the acquired license or acquired inventory do not have an alternative future use. The Company is obligated to make up to $26.0 million in regulatory-related milestones and up to $30.0 million in sales-related milestones per licensed CLN1 product. The Company will also pay an annual earned royalty in the high single digits on net sales of any licensed CLN1 products. The license agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the license agreement for convenience upon specified prior written notice to Abeona.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;No additional milestone payments were made in connection with this agreement during the six months ended June 30, 2021.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Abeona Rett Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On October 29, 2020, the Company entered into a license agreement (the &#x201c;Abeona Rett Agreement&#x201d;) with Abeona pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Subject to certain obligations of Abeona, the Company is required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the Abeona Rett Agreement, the Company paid Abeona a one-time upfront license fee of $3.0 million which is recorded in research and development expenses in the consolidated statements of operations for the year ended December 31, 2020 since the acquired license does not have an alternative future use. The Company is obligated to pay Abeona up to $26.5 million in regulatory-related milestones and up to $30.0 million in sales-related milestones per licensed Rett product and high single-digit &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;royalties on net sales of licensed Rett products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the agreement for convenience upon specified prior written notice to Abeona.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;No additional milestone payments were made in connection with the Abeona Rett Agreement during the six months ended June 30, 2021.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Acquisition of Worldwide Rights for TSHA-120 for the treatment of GAN &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2021, the Company acquired the exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of Giant Axonal Neuropathy (&#x201c;GAN&#x201d;). TSHA-120 is an intrathecally dosed AAV9 gene therapy currently being evaluated in a clinical trial for the treatment of GAN. The trial is being conducted by the National Institutes of Health in close collaboration with a leading patient advocacy group focused on finding treatments and cures for GAN. TSHA-120 has received rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration for the treatment of GAN. The worldwide rights were acquired through a license agreement, effective March 29, 2021, between Hannah&#x2019;s Hope Fund for Giant Axonal Neuropathy, Inc. (&#x201c;HHF&#x201d;) and the Company.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms of the agreement, in exchange for granting the Company the exclusive worldwide rights to TSHA-120, HHF received an upfront payment of $5.5 million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $19.3 million, as well as a low, single-digit royalty on net sales upon commercialization of the product. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In exchange for the license rights, the Company recorded an aggregate of $5.5 million within research and development expenses in the condensed consolidated statements of operations since the acquired license does not have an alternative future use. This license fee was paid in April 2021 &lt;span style="color:#000000;"&gt;and has been classified as an investing outflow in the condensed consolidated statements of cash flows for the six months ended June 30, 2021&lt;/span&gt;. &lt;span style="color:#000000;"&gt;No&lt;/span&gt; additional milestone payments were made in connection with this agreement during the six months ended June 30, 2021.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <tsha:MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200401_20200430"
      decimals="INF"
      id="F_000315"
      unitRef="U_tshaProduct">1</tsha:MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130"
      decimals="INF"
      id="F_000316"
      unitRef="U_xbrlishares">2179000</us-gaap:CommonStockSharesIssued>
    <tsha:PercentageOfFullyDilutedCommonStockSharesOutstanding
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130"
      decimals="2"
      id="F_000317"
      unitRef="U_xbrlipure">0.20</tsha:PercentageOfFullyDilutedCommonStockSharesOutstanding>
    <tsha:PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20191130"
      decimals="2"
      id="F_000318"
      unitRef="U_xbrlipure">0.10</tsha:PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaUTSouthwesternAgreementMember_20200331"
      decimals="INF"
      id="F_000319"
      unitRef="U_xbrlishares">0</us-gaap:CommonStockSharesIssued>
    <tsha:ResearchGrantOfCommittedFundAmount
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191201_20191231"
      decimals="-5"
      id="F_000320"
      unitRef="U_iso4217USD">3800000</tsha:ResearchGrantOfCommittedFundAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20191231"
      decimals="INF"
      id="F_000321"
      unitRef="U_xbrlipure">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <tsha:ResearchGrantOutstandingFundAmount
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20201231"
      decimals="INF"
      id="F_000322"
      unitRef="U_iso4217USD">0</tsha:ResearchGrantOutstandingFundAmount>
    <tsha:PaymentsToAcquireLicenseRight
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20200331"
      decimals="-5"
      id="F_000323"
      unitRef="U_iso4217USD">3000000.0</tsha:PaymentsToAcquireLicenseRight>
    <tsha:LicenseAgreementRegulatoryMilestonesPayment
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_srtRangeAxis_srtMaximumMember_20200221"
      decimals="INF"
      id="F_000324"
      unitRef="U_iso4217USD">10000000.0</tsha:LicenseAgreementRegulatoryMilestonesPayment>
    <tsha:LicenseAgreementCommercialMilestonesPayment
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_srtRangeAxis_srtMaximumMember_20200221"
      decimals="INF"
      id="F_000325"
      unitRef="U_iso4217USD">10000000.0</tsha:LicenseAgreementCommercialMilestonesPayment>
    <tsha:AdditionalMilestonePayments
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaQueensAgreementMember_20210101_20210630"
      decimals="INF"
      id="F_000326"
      unitRef="U_iso4217USD">0</tsha:AdditionalMilestonePayments>
    <tsha:PaymentOfLicenseFee
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200801_20200831"
      decimals="-5"
      id="F_000327"
      unitRef="U_iso4217USD">3000000.0</tsha:PaymentOfLicenseFee>
    <tsha:PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20201001_20201031"
      decimals="-5"
      id="F_000328"
      unitRef="U_iso4217USD">4000000.0</tsha:PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20200101_20201231"
      decimals="-5"
      id="F_000329"
      unitRef="U_iso4217USD">7000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <tsha:LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_srtRangeAxis_srtMaximumMember_20200831"
      decimals="INF"
      id="F_000330"
      unitRef="U_iso4217USD">26000000.0</tsha:LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment>
    <tsha:LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_srtRangeAxis_srtMaximumMember_20200831"
      decimals="INF"
      id="F_000331"
      unitRef="U_iso4217USD">30000000.0</tsha:LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment>
    <tsha:AdditionalMilestonePayments
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaCLN1AgreementsMember_20210101_20210630"
      decimals="INF"
      id="F_000332"
      unitRef="U_iso4217USD">0</tsha:AdditionalMilestonePayments>
    <tsha:PaymentOfOneTimeUpfrontLicenseFee
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000333"
      unitRef="U_iso4217USD">3000000.0</tsha:PaymentOfOneTimeUpfrontLicenseFee>
    <tsha:RegulatoryRelatedMilestonesObligationPayable
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20201029"
      decimals="INF"
      id="F_000334"
      unitRef="U_iso4217USD">26500000</tsha:RegulatoryRelatedMilestonesObligationPayable>
    <tsha:SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20201029"
      decimals="INF"
      id="F_000335"
      unitRef="U_iso4217USD">30000000.0</tsha:SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable>
    <tsha:AdditionalMilestonePayments
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaAbeonaTherapeuticsIncMember_us-gaapTypeOfArrangementAxis_tshaAbeonaRettAgreementMember_20210101_20210630"
      decimals="INF"
      id="F_000336"
      unitRef="U_iso4217USD">0</tsha:AdditionalMilestonePayments>
    <tsha:UpfrontPayment
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210301_20210331"
      decimals="-5"
      id="F_000337"
      unitRef="U_iso4217USD">5500000</tsha:UpfrontPayment>
    <tsha:ClinicalRegulatoryAndCommercialMilestonesToBeReceived
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210331"
      decimals="-5"
      id="F_000338"
      unitRef="U_iso4217USD">19300000</tsha:ClinicalRegulatoryAndCommercialMilestonesToBeReceived>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210301_20210331"
      decimals="-5"
      id="F_000339"
      unitRef="U_iso4217USD">5500000</us-gaap:ResearchAndDevelopmentExpense>
    <tsha:AdditionalMilestonePayments
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210101_20210630"
      decimals="INF"
      id="F_000340"
      unitRef="U_iso4217USD">0</tsha:AdditionalMilestonePayments>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000230">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 5&#x2014;Stockholders&#x2019; Equity (Deficit), Convertible Preferred Stock and Tranche Liability &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Authorized Shares&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company amended its certificate of incorporation on March 4, 2020, July 2, 2020 and again on July 28, 2020 such that the total number of shares of common stock authorized to be issued was increased to 32,685,000, and the total number of shares of preferred stock authorized to be issued was increased to 15,647,052, of which 10,000,000 preferred shares were designated Series A convertible preferred stock and 5,647,052 were designated Series B convertible preferred stock. On September 28, 2020, the Company amended its certificate of incorporation such that the total number of shares of common stock authorized to be issued was increased to 200,000,000, and the total number of shares of new preferred stock authorized to be issued was 10,000,000. As of June 30, 2021 and December 31, 2020, no shares of preferred stock were issued or outstanding.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;IPO&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 28, 2020, the Company issued an aggregate of 7,869,566 shares of common stock in the IPO, and on September 29, 2020, the Company issued an aggregate of 1,180,434 shares of common stock upon the underwriters&#x2019; exercise in full of their option to purchase additional shares, each at the public offering price of $20.00 per share less underwriting discounts and commissions. In connection with the IPO, the Company received gross proceeds of $181.0 million, which was offset by issuance costs, including underwriters&#x2019; discounts and commissions, of approximately $15.1 million.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Series A and B convertible preferred stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On March 4, 2020, the Company entered into a purchase agreement (the &#x201c;Series A Purchase Agreement&#x201d;) providing for a private placement of up to 10,000,000 shares of Series A convertible preferred stock at an original issuance price of $3.00 per share, subject to separate closings, including: (1) 6,000,000 shares at the initial closing on March 4, 2020, and (2) 2,000,000 shares at each of two subsequent closings triggered by the achievement of specific clinical milestones. The Series A Purchase Agreement obligated the &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Company to issue and sell and the Series A investors to purchase up to a total of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,000,000&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; additional shares of Series A convertible preferred stock (the &#x201c;Milestone Shares&#x201d;) at the same price per share upon the achievement of certain defined clinical milestones (the &#x201c;tranche liability&#x201d;). The determination as to whether the milestone events had been met was subject to certification by the Board of Directors. Each Series A investor had the right, but not the obligation, to purchase all or any portion of the Milestone Shares at any time in its sole option and in its sole and absolute discretion, whether or not the Company had achieved the applicable clinical milestone.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On June 30, 2020, several affiliated Series A investors elected to exercise in full their options to purchase 200,000 shares, representing all of their remaining pro-rata portion of the Milestone Shares, prior to the Company&#x2019;s achievement of the clinical milestones for gross proceeds of $0.6 million. The remainder of the Series A investors exercised in full their options to purchase 3,800,000 shares, representing all of their remaining pro-rata portion of the Milestone Shares, prior to the Company&#x2019;s achievement of the clinical milestones, for gross proceeds of $11.4 million between July 1, 2020 and July 2, 2020. As part of this issuance, the Company issued and sold 3,266,667 shares to PBM TGT Holdings, LLC and 400,000 shares to Nolan Capital, LLC, which stockholders are controlled by certain members of the Company&#x2019;s board of directors.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On July 2, 2020, the Company entered into a purchase agreement (the &#x201c;Series B Purchase Agreement&#x201d;), as later amended on July 28, 2020, providing for a private placement of up to 5,647,052 shares of Series B convertible preferred stock. The Company sold 5,647,048 shares of Series B convertible preferred stock at a price of $17.00 per share in multiple closings in July and August 2020 for gross proceeds of $96.0 million. The majority of investors that participated in the Series B Purchase Agreement were new investors.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As described above, in connection with the closing of the IPO, all shares of Series A and Series B convertible preferred stock were automatically converted into an aggregate of 17,047,378 shares of common stock with a conversion ratio, which was adjusted for the stock split, of 1.0895 shares of common stock for each share of Series A and Series B convertible preferred stock then outstanding.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Series A convertible preferred stock tranche liability&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company concluded that the tranche liability met the definition of a freestanding financial instrument, as it was legally detachable and separately exercisable from the initial closing of the Series A convertible preferred stock. The estimated fair value of the tranche liability was determined using a Monte Carlo simulation at the initial issuance date. As of March 4, 2020, the simulations occurred based on the implied aggregate equity value of the Company derived from the Series A convertible preferred stock offering price of $3.00 per share, along with, in part, the following subjective assumptions: risk-free rate of 0.59%, an expected volatility of 80%, the expected term to a liquidity event of 1 year, and a 60% probability of achieving the clinical milestones and timing thereof. Subsequently, the estimated fair value of the tranche liability was determined using a backsolve approach at June 30, 2020, immediately prior to the issuance of the Milestone Shares, which was calculated based on the aggregate equity value of the Company derived from the Series B convertible preferred stock offering price of $17.00 per share. The subsequent remeasurement also considered, in part, a risk-free rate of 0.17%, an expected volatility of 80%, and the expected term to a liquidity event of 0.5 years.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Based on the analysis, the Company recorded a preferred stock tranche liability of $1.1 million at the issue date to account for the obligation to issue the Milestone Shares at a predetermined fixed price at a future settlement date.&#160; At June 30, 2020, ahead of the anticipated closing of the Series B Purchase Agreement for $17.00 per share that occurred on July 2, 2020, certain investors elected to exercise in full their options to purchase their pro-rata portion of the Milestone Shares prior to the Company&#x2019;s achievement of the clinical milestones and purchased 200,000 shares of Series A convertible preferred stock. The Company remeasured the fair value of the entire tranche liability at June 30, 2020, and recognized a non-cash expense of $17.0 million in the condensed consolidated statement of operations for the six months ended June 30, 2020. As 200,000 of the Milestone Shares were also issued to certain investors on June 30, 2020, the related tranche liability was extinguished, and the Company reclassified $0.9 million to convertible preferred stock on the condensed consolidated balance sheet as of June 30, 2020. The Company concluded that no beneficial conversion feature (&#x201c;BCF&#x201d;) existed as the effective conversion price of the Series A convertible preferred stock exceeded the fair value of the Company&#x2019;s common stock at each of the commitment dates. Specifically at the commitment date of June 30, 2020, when 200,000 Milestone Shares were issued, the deemed proceeds were equal to the cash proceeds received for the shares of Series A convertible preferred stock and the fair value of the tranche liability that related to the Milestone Shares, or $7.52 per share. As the effective conversion price exceeded the fair value of the Company&#x2019;s common stock, no BCF existed.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001806310_20200728"
      decimals="INF"
      id="F_000341"
      unitRef="U_xbrlishares">32685000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0001806310_20200728"
      decimals="INF"
      id="F_000343"
      unitRef="U_xbrlishares">15647052</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200728"
      decimals="INF"
      id="F_000344"
      unitRef="U_xbrlishares">10000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200728"
      decimals="INF"
      id="F_000345"
      unitRef="U_xbrlishares">5647052</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001806310_20200928"
      decimals="INF"
      id="F_000342"
      unitRef="U_xbrlishares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001806310_20200928"
      decimals="INF"
      id="F_000346"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000347"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001806310_20201231"
      decimals="INF"
      id="F_000349"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000348"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001806310_20210630"
      decimals="INF"
      id="F_000350"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928"
      decimals="INF"
      id="F_000351"
      unitRef="U_xbrlishares">7869566</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200929_20200929"
      decimals="INF"
      id="F_000352"
      unitRef="U_xbrlishares">1180434</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928"
      decimals="INF"
      id="F_000353"
      unitRef="U_iso4217USD_xbrlishares">20.00</us-gaap:SharesIssuedPricePerShare>
    <tsha:ProceedsFromIssuanceOfCommonStockGross
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928"
      decimals="-5"
      id="F_000354"
      unitRef="U_iso4217USD">181000000.0</tsha:ProceedsFromIssuanceOfCommonStockGross>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0001806310_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200928_20200928"
      decimals="-5"
      id="F_000355"
      unitRef="U_iso4217USD">15100000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304_20200304"
      decimals="INF"
      id="F_000356"
      unitRef="U_xbrlishares">10000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementMember_20200304"
      decimals="INF"
      id="F_000357"
      unitRef="U_iso4217USD_xbrlishares">3.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAPurchaseAgreementInitialClosingMember_20200304_20200304"
      decimals="INF"
      id="F_000358"
      unitRef="U_xbrlishares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneOneMember_20200305_20200305"
      decimals="INF"
      id="F_000359"
      unitRef="U_xbrlishares">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAAchievementOfSpecificClinicalMilestoneTwoMember_20200305_20200305"
      decimals="INF"
      id="F_000360"
      unitRef="U_xbrlishares">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember_20200304_20200304"
      decimals="INF"
      id="F_000361"
      unitRef="U_xbrlishares">4000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630"
      decimals="INF"
      id="F_000362"
      unitRef="U_xbrlishares">200000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ProceedsFromCollaborators
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630"
      decimals="-5"
      id="F_000363"
      unitRef="U_iso4217USD">600000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200701_20200702"
      decimals="INF"
      id="F_000364"
      unitRef="U_xbrlishares">3800000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ProceedsFromCollaborators
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200701_20200702"
      decimals="-5"
      id="F_000365"
      unitRef="U_iso4217USD">11400000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPBMTGTHoldingsLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630"
      decimals="INF"
      id="F_000366"
      unitRef="U_xbrlishares">3266667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaNolanCapitalLimitedLiabilityCompanyMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630"
      decimals="INF"
      id="F_000367"
      unitRef="U_xbrlishares">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728"
      decimals="INF"
      id="F_000368"
      unitRef="U_xbrlishares">5647052</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728_20200728"
      decimals="INF"
      id="F_000369"
      unitRef="U_xbrlishares">5647048</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200728"
      decimals="INF"
      id="F_000370"
      unitRef="U_iso4217USD_xbrlishares">17.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200701_20200831"
      decimals="-5"
      id="F_000371"
      unitRef="U_iso4217USD">96000000.0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928"
      decimals="INF"
      id="F_000372"
      unitRef="U_xbrlishares">17047378</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_0001806310_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200928_20200928"
      decimals="4"
      id="F_000373"
      unitRef="U_xbrlipure">1.0895</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <tsha:ConvertiblePreferredStockTrancheLiabilityOfferingPrice
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304"
      decimals="INF"
      id="F_000374"
      unitRef="U_iso4217USD_xbrlishares">3.00</tsha:ConvertiblePreferredStockTrancheLiabilityOfferingPrice>
    <tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput
      contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304"
      decimals="4"
      id="F_000376"
      unitRef="U_xbrlipure">0.0059</tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput>
    <tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput
      contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304"
      decimals="2"
      id="F_000378"
      unitRef="U_xbrlipure">0.80</tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput>
    <tsha:ConvertiblePreferredStockTrancheLiabilityLiquidityTerm
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304_20200304"
      id="F_000380">P1Y</tsha:ConvertiblePreferredStockTrancheLiabilityLiquidityTerm>
    <tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput
      contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_tshaMeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200304"
      decimals="2"
      id="F_000382"
      unitRef="U_xbrlipure">0.60</tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput>
    <tsha:ConvertiblePreferredStockTrancheLiabilityOfferingPrice
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630"
      decimals="INF"
      id="F_000375"
      unitRef="U_iso4217USD_xbrlishares">17.00</tsha:ConvertiblePreferredStockTrancheLiabilityOfferingPrice>
    <tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput
      contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630"
      decimals="4"
      id="F_000377"
      unitRef="U_xbrlipure">0.0017</tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput>
    <tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput
      contextRef="C_0001806310_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200630"
      decimals="2"
      id="F_000379"
      unitRef="U_xbrlipure">0.80</tsha:ConvertiblePreferredStockTrancheLiabilityMeasurementInput>
    <tsha:ConvertiblePreferredStockTrancheLiabilityLiquidityTerm
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_20200629_20200630"
      id="F_000381">P0Y6M</tsha:ConvertiblePreferredStockTrancheLiabilityLiquidityTerm>
    <tsha:PreferredStockTrancheLiability
      contextRef="C_0001806310_20200304"
      decimals="-5"
      id="F_000383"
      unitRef="U_iso4217USD">1100000</tsha:PreferredStockTrancheLiability>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesBConvertiblePreferredStockMember_us-gaapTypeOfArrangementAxis_tshaSeriesBPurchaseAgreementMember_20200702"
      decimals="INF"
      id="F_000384"
      unitRef="U_iso4217USD_xbrlishares">17.00</us-gaap:SharesIssuedPricePerShare>
    <tsha:IssuanceOfProRataPortionOfMilestoneShares
      contextRef="C_0001806310_us-gaapStatementClassOfStockAxis_tshaSeriesAConvertiblePreferredStockMember_20200629_20200630"
      decimals="INF"
      id="F_000385"
      unitRef="U_xbrlishares">200000</tsha:IssuanceOfProRataPortionOfMilestoneShares>
    <tsha:ChangeInFairValueOfPreferredStockTrancheLiability
      contextRef="C_0001806310_20200629_20200630"
      decimals="-5"
      id="F_000386"
      unitRef="U_iso4217USD">17000000.0</tsha:ChangeInFairValueOfPreferredStockTrancheLiability>
    <tsha:MileStoneSharesIssued
      contextRef="C_0001806310_20200629_20200630"
      decimals="INF"
      id="F_000387"
      unitRef="U_xbrlishares">200000</tsha:MileStoneSharesIssued>
    <tsha:AmountReclassifiedToConvertiblePreferredStock
      contextRef="C_0001806310_20200630"
      decimals="-5"
      id="F_000390"
      unitRef="U_iso4217USD">900000</tsha:AmountReclassifiedToConvertiblePreferredStock>
    <tsha:MileStoneSharesIssued
      contextRef="C_0001806310_20200629_20200630"
      decimals="INF"
      id="F_000388"
      unitRef="U_xbrlishares">200000</tsha:MileStoneSharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001806310_20200630"
      decimals="INF"
      id="F_000389"
      unitRef="U_iso4217USD_xbrlishares">7.52</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000231">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 6&#x2014;Stock-Based Compensation &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On July 1, 2020, the Company&#x2019;s board of directors approved the Existing Plan which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, RSAs, RSUs and other stock-based awards to employees, directors, officers and consultants. On July 1, 2020, 3,529,412 shares of common stock were authorized for issuance under the Existing Plan. On September 16, 2020, the Company increased the number of shares of common stock authorized for issuance under the Existing Plan to 3,845,294. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 16, 2020, the Company&#x2019;s stockholders approved the New Plan, which became effective upon the execution of the underwriting agreement in connection with the IPO. The number of shares available for future issuance under the New Plan is the sum of (1) 3,390,168 new shares of common stock,&#160;&#160;(2) 209,841 remaining shares of common stock reserved under the Existing Plan that became available for issuance upon the effectiveness of the New Plan and (3) the number of shares of common stock subject to outstanding awards under the Existing Plan when the New Plan became effective that thereafter expire or are forfeited, canceled, withheld to satisfy tax withholding or to purchase or exercise an award, repurchased by the Company or are otherwise terminated. At December 31, 2020, there were 2,941,509 shares available for future grant under the New Plan. The number of shares of common stock reserved for issuance under the New Plan will automatically increase on January 1 of each year, for a period of ten years, from January 1, 2021 continuing through January 1, 2030, by 5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#x2019;s board of directors.&#160;&#160;On January 1, 2021 the board of directors increased the number of common stock reserved for issuance under the New Plan by 1,434,934 shares.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furthermore, on September 16, 2020, the Company&#x2019;s stockholders approved the Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which became effective upon the execution of the underwriting agreement in connection with the IPO. The maximum number of shares of common stock that may be issued under the ESPP will not exceed 362,000 shares of common stock, plus the number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO date and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock. &#160; No shares were added to the ESPP as of January 1, 2021 and no issuances have been made under the ESPP as of June 30, 2021.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock Options &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On July 1, 2020, options to purchase 2,896,782 shares of common stock under the Existing Plan were awarded to certain employees and consultants of the Company with an exercise price per share of $0.80, which were expected to vest over a &lt;span style="-sec-ix-hidden:F_000411"&gt;four-year&lt;/span&gt; period, all of which were subsequently cancelled (the &#x201c;Cancelled Options&#x201d;). The grant date fair value of the Cancelled Options was $13.8 million at the original grant date. In exchange, the Company awarded 2,518,932 RSUs on September 2, 2020, which are expected to vest over a &lt;span style="-sec-ix-hidden:F_000414"&gt;four-year&lt;/span&gt; term. The Company accounted for the changes in award terms as a modification in accordance with ASC 718 Compensation &#x2013; Stock Compensation. The modification was accounted for as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus any incremental value measured on the modification date. The Company determined that there was no incremental value as the fair value of the original award immediately before the modification was greater than the fair value of the new award immediately after the modification. Accordingly, the Company continues to recognize the remaining compensation cost of the Cancelled Options over the vesting period of the RSUs.&#160;&#160; &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the three months ended June 30, 2021, options to purchase 964,750 shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $14.73. For the six months ended June 30, 2021, options to purchase 2,586,650 shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $17.25. The stock options vest over one to four years and have a &lt;span style="-sec-ix-hidden:F_000422"&gt;ten-year&lt;/span&gt; contractual term.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; The following weighted-average assumptions were used to estimate the fair value of stock options that were granted during the three and six months ended June&#160;30, 2021:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71.9%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Three months ended June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Six months ended June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.80&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term in years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000425"&gt;6.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000426"&gt;6.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes stock option activity, during the six months ended June&#160;30, 2021: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;674,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.68&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000441"&gt;9.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,953&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,586,650&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26.41&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled or forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47,800&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28.61&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000442"&gt;9.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and expected to vest at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000443"&gt;9.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercisable at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,054&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000444"&gt;9.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The aggregate intrinsic value in the above table is calculated as the difference between the fair value of the Company&#x2019;s common stock as of June&#160;30, 2021 and the exercise price of the stock options. As of June&#160;30, 2021, the total unrecognized compensation related to unvested stock option awards granted was $47.5&#160;million, which the Company expects to recognize over a weighted-average period of approximately 3.5 years.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Restricted Stock Units&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 2, 2020, the Company issued 331,121 RSUs to an employee under the Existing Plan; 25% of the shares of common stock underlying the RSUs vest at each anniversary over a &lt;span style="-sec-ix-hidden:F_000456"&gt;four-year&lt;/span&gt; period. The RSUs are subject to a service-based vesting condition. The RSUs were also subject to a liquidity-based performance vesting condition that was met upon the closing of the IPO. The Company at any time may accelerate the vesting of the RSUs. Such shares are not accounted for as outstanding until they vest.&lt;span style="color:#000000;"&gt; As of June 30, 2021, the total unrecognized compensation related to unvested RSUs granted, including the remaining compensation cost associated with the RSUs granted on September 2, 2020 in exchange for the Cancelled Options, was $13.3 million which is expected to be amortized on a straight-line basis over the weighted-average remaining vesting period of approximately 1.5 years.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company's default tax withholding&#160;method for RSUs is the&#160;sell-to-cover&#160;method, in which shares with a market value equivalent to the tax withholding obligation are sold on behalf of the holder of the RSUs upon vesting and settlement to cover the tax withholding liability and the cash proceeds from such sales are remitted by the Company to taxing authorities. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s RSU activity for the six months ended June&#160;30, 2021 was as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;of Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at January 1, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,850,053&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(629,730&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.25&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled or forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(167,186&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.25&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,053,137&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.80&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Restricted Stock Awards&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;RA Session II, the Company&#x2019;s founder, President and Chief Executive Officer, was awarded 769,058 RSAs under the Existing Plan on July 1, 2020, which are expected to vest over a &lt;span style="-sec-ix-hidden:F_000468"&gt;three-year&lt;/span&gt; term, subject to continuous employment. As of June 30, 2021, the total unrecognized compensation related to unvested RSAs granted was $2.6 million which is expected to be amortized on a straight-line basis over the weighted-average remaining vesting period of approximately 1.8 years. The fair value of these RSAs at the grant date of July 1, 2020 was $5.28 per share. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s RSA activity for the six months ended June&#160;30, 2021 was as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;of Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;769,058&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(298,843&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the total stock-based compensation expense for the stock options, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:right;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Three Months Ended June&#160;30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Six Months Ended June&#160;30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,214&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,335&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,350&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,549&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,143&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200701"
      decimals="INF"
      id="F_000391"
      unitRef="U_xbrlishares">3529412</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200916"
      decimals="INF"
      id="F_000392"
      unitRef="U_xbrlishares">3845294</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916"
      decimals="INF"
      id="F_000393"
      unitRef="U_xbrlishares">3390168</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200916"
      decimals="INF"
      id="F_000394"
      unitRef="U_xbrlishares">209841</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630"
      id="F_000399">At December 31, 2020, there were 2,941,509 shares available for future grant under the New Plan. The number of shares of common stock reserved for issuance under the New Plan will automatically increase on January 1 of each year, for a period of ten years, from January 1, 2021 continuing through January 1, 2030, by 5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#x2019;s board of directors.&#160;&#160;On January 1, 2021 the board of directors increased the number of common stock reserved for issuance under the New Plan by 1,434,934 shares.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916"
      id="F_000395">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916"
      id="F_000396">2021-01-01</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916"
      id="F_000397">2030-01-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20200916_20200916"
      decimals="INF"
      id="F_000398"
      unitRef="U_xbrlipure">0.05</tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101"
      decimals="INF"
      id="F_000400"
      unitRef="U_xbrlishares">1434934</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916"
      decimals="INF"
      id="F_000401"
      unitRef="U_xbrlishares">362000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210630"
      id="F_000408">the number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO date and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916"
      id="F_000402">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916"
      id="F_000403">2030-01-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance
      contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916_20200916"
      decimals="INF"
      id="F_000404"
      unitRef="U_xbrlipure">0.010</tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916"
      decimals="INF"
      id="F_000405"
      unitRef="U_xbrlishares">724000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210101"
      decimals="INF"
      id="F_000406"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20210101_20210630"
      decimals="INF"
      id="F_000407"
      unitRef="U_xbrlishares">0</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701"
      decimals="INF"
      id="F_000409"
      unitRef="U_xbrlishares">2896782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701"
      decimals="INF"
      id="F_000410"
      unitRef="U_iso4217USD_xbrlishares">0.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaCertainEmployeesAndConsultantsMember_us-gaapAwardTypeAxis_tshaCancelledOptionsMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701"
      decimals="-5"
      id="F_000412"
      unitRef="U_iso4217USD">13800000</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902"
      decimals="INF"
      id="F_000413"
      unitRef="U_xbrlishares">2518932</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="C_0001806310_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20210101_20210630"
      decimals="INF"
      id="F_000415"
      unitRef="U_iso4217USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630"
      decimals="INF"
      id="F_000416"
      unitRef="U_xbrlishares">964750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630"
      decimals="2"
      id="F_000418"
      unitRef="U_iso4217USD_xbrlishares">14.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630"
      decimals="INF"
      id="F_000417"
      unitRef="U_xbrlishares">2586650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210101_20210630"
      decimals="2"
      id="F_000419"
      unitRef="U_iso4217USD_xbrlishares">17.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001806310_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630"
      id="F_000420">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001806310_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyStockIncentivePlanMember_20210401_20210630"
      id="F_000421">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      id="F_000245">The following weighted-average assumptions were used to estimate the fair value of stock options that were granted during the three and six months ended June&#160;30, 2021:
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71.9%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Three months ended June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Six months ended June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.80&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term in years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000425"&gt;6.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000426"&gt;6.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630"
      decimals="4"
      id="F_000423"
      unitRef="U_xbrlipure">0.0107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      decimals="4"
      id="F_000424"
      unitRef="U_xbrlipure">0.0080</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630"
      decimals="2"
      id="F_000427"
      unitRef="U_xbrlipure">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      decimals="2"
      id="F_000428"
      unitRef="U_xbrlipure">0.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      id="F_000246">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes stock option activity, during the six months ended June&#160;30, 2021: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;674,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.68&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000441"&gt;9.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,953&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,586,650&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26.41&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled or forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47,800&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28.61&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000442"&gt;9.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and expected to vest at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25.18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000443"&gt;9.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercisable at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,054&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000444"&gt;9.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="INF"
      id="F_000429"
      unitRef="U_xbrlishares">674842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="2"
      id="F_000435"
      unitRef="U_iso4217USD_xbrlishares">20.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="-3"
      id="F_000445"
      unitRef="U_iso4217USD">3953000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      decimals="INF"
      id="F_000430"
      unitRef="U_xbrlishares">2586650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      decimals="2"
      id="F_000436"
      unitRef="U_iso4217USD_xbrlishares">26.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      decimals="INF"
      id="F_000431"
      unitRef="U_xbrlishares">47800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      decimals="2"
      id="F_000437"
      unitRef="U_iso4217USD_xbrlishares">28.61</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="INF"
      id="F_000432"
      unitRef="U_xbrlishares">3213692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="2"
      id="F_000438"
      unitRef="U_iso4217USD_xbrlishares">25.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="-3"
      id="F_000446"
      unitRef="U_iso4217USD">786000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="INF"
      id="F_000433"
      unitRef="U_xbrlishares">3213692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="2"
      id="F_000439"
      unitRef="U_iso4217USD_xbrlishares">25.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="-3"
      id="F_000447"
      unitRef="U_iso4217USD">786000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="INF"
      id="F_000434"
      unitRef="U_xbrlishares">43054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="2"
      id="F_000440"
      unitRef="U_iso4217USD_xbrlishares">20.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="-3"
      id="F_000448"
      unitRef="U_iso4217USD">37000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210630"
      decimals="-5"
      id="F_000449"
      unitRef="U_iso4217USD">47500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      id="F_000450">P3Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200902_20200902"
      decimals="INF"
      id="F_000451"
      unitRef="U_xbrlishares">331121</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20200902_20200902"
      decimals="2"
      id="F_000452"
      unitRef="U_xbrlipure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheTwoMember_20200902_20200902"
      decimals="2"
      id="F_000453"
      unitRef="U_xbrlipure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheThreeMember_20200902_20200902"
      decimals="2"
      id="F_000454"
      unitRef="U_xbrlipure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_us-gaapVestingAxis_tshaShareBasedCompensationAwardTrancheFourMember_20200902_20200902"
      decimals="2"
      id="F_000455"
      unitRef="U_xbrlipure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630"
      decimals="-5"
      id="F_000457"
      unitRef="U_iso4217USD">13300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630"
      id="F_000458">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000247">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s RSU activity for the six months ended June&#160;30, 2021 was as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;of Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at January 1, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,850,053&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted units granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(629,730&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.25&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled or forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(167,186&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.25&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,053,137&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.80&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="INF"
      id="F_000459"
      unitRef="U_xbrlishares">2850053</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="2"
      id="F_000463"
      unitRef="U_iso4217USD_xbrlishares">6.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630"
      decimals="INF"
      id="F_000460"
      unitRef="U_xbrlishares">629730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630"
      decimals="2"
      id="F_000464"
      unitRef="U_iso4217USD_xbrlishares">5.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630"
      decimals="INF"
      id="F_000461"
      unitRef="U_xbrlishares">167186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630"
      decimals="2"
      id="F_000465"
      unitRef="U_iso4217USD_xbrlishares">5.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630"
      decimals="INF"
      id="F_000462"
      unitRef="U_xbrlishares">2053137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210630"
      decimals="2"
      id="F_000466"
      unitRef="U_iso4217USD_xbrlishares">6.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapPlanNameAxis_tshaTwoThousandTwentyEquityIncentivePlanMember_20200701_20200701"
      decimals="INF"
      id="F_000467"
      unitRef="U_xbrlishares">769058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630"
      decimals="-5"
      id="F_000469"
      unitRef="U_iso4217USD">2600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630"
      id="F_000470">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20200701_20200701"
      decimals="INF"
      id="F_000471"
      unitRef="U_iso4217USD_xbrlishares">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000248">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s RSA activity for the six months ended June&#160;30, 2021 was as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;of Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;769,058&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(298,843&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Nonvested at June 30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231"
      decimals="INF"
      id="F_000472"
      unitRef="U_xbrlishares">769058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231"
      decimals="2"
      id="F_000475"
      unitRef="U_iso4217USD_xbrlishares">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630"
      decimals="INF"
      id="F_000473"
      unitRef="U_xbrlishares">298843</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210101_20210630"
      decimals="2"
      id="F_000476"
      unitRef="U_iso4217USD_xbrlishares">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630"
      decimals="INF"
      id="F_000474"
      unitRef="U_xbrlishares">470215</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210630"
      decimals="2"
      id="F_000477"
      unitRef="U_iso4217USD_xbrlishares">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000249">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the total stock-based compensation expense for the stock options, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:right;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Three Months Ended June&#160;30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Six Months Ended June&#160;30, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,214&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,335&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,350&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,549&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,143&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210401_20210630"
      decimals="-3"
      id="F_000478"
      unitRef="U_iso4217USD">2214000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20210630"
      decimals="-3"
      id="F_000479"
      unitRef="U_iso4217USD">3793000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210401_20210630"
      decimals="-3"
      id="F_000480"
      unitRef="U_iso4217USD">2335000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001806310_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20210630"
      decimals="-3"
      id="F_000481"
      unitRef="U_iso4217USD">4350000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000482"
      unitRef="U_iso4217USD">4549000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000483"
      unitRef="U_iso4217USD">8143000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000232">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 7&#x2014;Net Loss Per Common Share &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Since the Company had a net loss in all periods presented, basic and diluted net loss per common share are the same. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.64%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Three Months&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ended June 30,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Six Months&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ended June 30,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(40,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(72,950&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26,651&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average shares of common stock outstanding used to compute net loss per&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; common share, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,479,164&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,894,999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,237,115&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,894,999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per common share, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.09&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.96&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following common stock equivalents outstanding as of June 30, 2021 and 2020 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#x2011;dilutive:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,053,137&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested RSAs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Series A convertible preferred stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,200,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,737,044&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,200,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000250">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.64%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Three Months&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ended June 30,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Six Months&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ended June 30,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(40,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(72,950&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26,651&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average shares of common stock outstanding used to compute net loss per&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; common share, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,479,164&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,894,999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,237,115&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,894,999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per common share, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.09&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.96&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001806310_20210401_20210630"
      decimals="-3"
      id="F_000484"
      unitRef="U_iso4217USD">-40926000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001806310_20200401_20200630"
      decimals="-3"
      id="F_000485"
      unitRef="U_iso4217USD">-21220000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001806310_20210101_20210630"
      decimals="-3"
      id="F_000486"
      unitRef="U_iso4217USD">-72950000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0001806310_20200101_20200630"
      decimals="-3"
      id="F_000487"
      unitRef="U_iso4217USD">-26651000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20210401_20210630"
      decimals="0"
      id="F_000488"
      unitRef="U_xbrlishares">37479164</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20200401_20200630"
      decimals="0"
      id="F_000489"
      unitRef="U_xbrlishares">10894999</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20210101_20210630"
      decimals="0"
      id="F_000490"
      unitRef="U_xbrlishares">37237115</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001806310_20200101_20200630"
      decimals="0"
      id="F_000491"
      unitRef="U_xbrlishares">10894999</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20210401_20210630"
      decimals="2"
      id="F_000492"
      unitRef="U_iso4217USD_xbrlishares">-1.09</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20200401_20200630"
      decimals="2"
      id="F_000493"
      unitRef="U_iso4217USD_xbrlishares">-1.95</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20210101_20210630"
      decimals="2"
      id="F_000494"
      unitRef="U_iso4217USD_xbrlishares">-1.96</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001806310_20200101_20200630"
      decimals="2"
      id="F_000495"
      unitRef="U_iso4217USD_xbrlishares">-2.45</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000251">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following common stock equivalents outstanding as of June 30, 2021 and 2020 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#x2011;dilutive:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;June&#160;30,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,053,137&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested RSAs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Series A convertible preferred stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,200,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,737,044&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,200,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20210630"
      decimals="INF"
      id="F_000496"
      unitRef="U_xbrlishares">2053137</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockMember_20210101_20210630"
      decimals="INF"
      id="F_000497"
      unitRef="U_xbrlishares">470215</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20210630"
      decimals="INF"
      id="F_000498"
      unitRef="U_xbrlishares">3213692</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001806310_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_tshaSeriesAConvertiblePreferredStockMember_20200101_20200630"
      decimals="INF"
      id="F_000499"
      unitRef="U_xbrlishares">6200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001806310_20210101_20210630"
      decimals="INF"
      id="F_000500"
      unitRef="U_xbrlishares">5737044</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001806310_20200101_20200630"
      decimals="INF"
      id="F_000501"
      unitRef="U_xbrlishares">6200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000233">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 8&#x2014;Related Party Transactions &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;RA Session II, founder, President and Chief Executive Officer and a member of the Company&#x2019;s board of directors, was a guarantor under the Guaranty and Security Agreement between himself, Queen&#x2019;s and the Company, and in the event of the Company&#x2019;s failure to fund its obligations under the RGA with Queen&#x2019;s, had personally guaranteed payments due by the Company to Queen&#x2019;s. In addition, the Company entered into two secured promissory notes with Mr. Session in January 2020 for an aggregate of $1.67 million, with 10% interest. The Company secured the notes with a first priority security interest in certain assets of the Company. During March 2020, the Company repaid $1.65&#160;million of the notes, and the remaining balance was repaid in July 2020.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2020, the Company entered into a services agreement with PBM Capital Group, LLC (&#x201c;PBM&#x201d;), an affiliate of PBM TGT Holdings, LLC whereby PBM provides accounting and other administrative and management services related to payroll administration, human resources, bookkeeping, preparation of financial statements and tax returns, accounts payable and receivable, and other similar functions for a fee of $2,500 per month. Paul B. Manning, a member of the Company&#x2019;s board of directors and a holder of more than 5% of the Company&#x2019;s capital stock, is the Chief Executive Officer of PBM Capital Group, LLC and has sole voting and investment power with respect to the shares held by PBM TGT Holdings, LLC. In September 2020, PBM TGT Holdings, LLC distributed all of the shares of Series A convertible preferred stock it previously held to its beneficial owners, including Mr. Manning and entities controlled by Mr. Manning, for no additional consideration in accordance with the terms of its operating agreement. In April 2021, the PBM services agreement was terminated and all outstanding amounts due have been paid. &#160;&#160; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <tsha:NumberOfSecuredPromissoryNotes
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_20200101_20200131"
      decimals="INF"
      id="F_000502"
      unitRef="U_tshaPromissoryNote">2</tsha:NumberOfSecuredPromissoryNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200131"
      decimals="-4"
      id="F_000503"
      unitRef="U_iso4217USD">1670000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200131"
      decimals="INF"
      id="F_000504"
      unitRef="U_xbrlipure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_0001806310_srtTitleOfIndividualAxis_tshaFounderPresidentAndChiefExecutiveOfficerMember_us-gaapLongtermDebtTypeAxis_tshaSecuredPromissoryNotesMember_20200301_20200331"
      decimals="-4"
      id="F_000505"
      unitRef="U_iso4217USD">1650000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="C_0001806310_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMCapitalGroupLLCMember_20200301_20200331"
      decimals="0"
      id="F_000506"
      unitRef="U_iso4217USD">2500</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <tsha:OwnershipPercentageInExcessOfCapitalStock
      contextRef="C_0001806310_srtTitleOfIndividualAxis_srtDirectorMember_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_20200301_20200331"
      decimals="2"
      id="F_000507"
      unitRef="U_xbrlipure">0.05</tsha:OwnershipPercentageInExcessOfCapitalStock>
    <tsha:AdditionalConsiderationToRelatedPartyUnderOperatingAgreement
      contextRef="C_0001806310_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMTGTHoldingsLLCMember_20200930"
      decimals="INF"
      id="F_000508"
      unitRef="U_iso4217USD">0</tsha:AdditionalConsiderationToRelatedPartyUnderOperatingAgreement>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000234">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 9&#x2014;Income Taxes &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. There is no provision for income taxes because the Company has incurred operating losses and capitalized certain items for income tax purposes since its inception and maintains a full valuation allowance against its net deferred tax assets. The reported amount of income tax expense for the period differs from the amount that would result from applying the federal statutory tax rate to net loss before taxes primarily because of the change in valuation allowance.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of June 30, 2021, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, 2020.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001806310_20210101_20210630"
      decimals="INF"
      id="F_000509"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000235">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 10&#x2014;Commitments and Contingencies &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Litigation &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims. From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Commitments &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In the normal course of business, the Company enters into contracts that contain a variety of indemnifications with its employees, licensors, suppliers and service providers. The Company&#x2019;s maximum exposure under these arrangements is unknown at June 30, 2021. The Company does not anticipate recognizing any significant losses relating to these arrangements. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Durham Lease&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On December 17, 2020, the Company entered into a lease agreement (the &#x201c;Durham Lease&#x201d;) with Patriot Park Partners II, LLC, a Delaware limited liability company (the &#x201c;Durham Landlord&#x201d;), pursuant to which the Company agreed to lease approximately 187,500 square feet of a manufacturing facility located at 5 National Way, Durham, North Carolina (the &#x201c;Facility&#x201d;). The Durham Lease commenced on April 1, 2021 and is expected to have a term of approximately fifteen years and six months. The Company has two options to extend the term of the Durham Lease, each for a period of an additional five years.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company was not required to provide a security deposit in connection with its entry into the Durham Lease. The Company will be responsible for constructing interior improvements within the Facility. The Durham Landlord has the right to &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;terminate the Durham Lease upon specified events of default, including the Company&#x2019;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company incurred initial direct costs to enter into the Durham Lease of approximately $0.8 million in December 2020. The costs have been recorded on the condensed consolidated balance sheets as a deferred lease asset and are being amortized into earnings over the term of the Durham Lease.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accordance with ASC Topic 840,&#160;&lt;span style="font-style:italic;"&gt;Leases&lt;/span&gt;, the Company is deemed, for accounting purposes only, to be the owner of the entire leased Facility, including the building shell, during the construction period because of the Company&#x2019;s expected level of direct financial and operational involvement in the substantial tenant improvements, including structural improvements, required to build out the Facility. As a result, the Company capitalized approximately&#160;$26.3 million&#160;as a build-to-suit asset within property, plant and equipment, net and recognized a corresponding build-to-suit lease financing obligation as a liability on its condensed consolidated balance sheets equal to the fair value of the existing building shell using comparable market prices per&#160;square foot for similar space for public real estate transactions in the surrounding area at commencement of construction. Additionally, construction costs incurred as part of the build-out and tenant improvements are also capitalized within property, plant and equipment, net. Costs of approximately&#160;$4.0 million&#160;have been capitalized during the six months ended&#160;June 30, 2021, related to both equipment purchases and the build-out of the leased Facility. Construction is expected to be completed in 2023, upon which time the Company will assess and determine if the build-to-suit asset and corresponding liability should be de-recognized.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dallas Lease&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January 11, 2021, the Company entered into a lease agreement (the &#x201c;Dallas Lease&#x201d;) with Pegasus Park, LLC, a Delaware limited liability company (the &#x201c;Dallas Landlord&#x201d;), pursuant to which the Company will lease approximately 15,000 square feet of office space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#x201c;Office Space&#x201d;).&lt;/p&gt;
&lt;p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:10pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Dallas Lease commenced on May 27, 2021, and has a term of approximately ten years. The Company has an option to extend the term of the Dallas Lease for one additional period of five years. The Company&#x2019;s obligation for the payment of base rent for the Office Space is initially approximately $32,500 per month and will increase annually, up to an estimated monthly base rent of $50,000 during the term of the Lease. The Company is obligated to pay operating costs and utilities applicable to the Office Space. The Company was required to provide a security deposit of $32,500 in connection with its entry into the Dallas Lease. &lt;span style="color:#000000;"&gt;Total future minimum lease payments under the Dallas Lease over the initial 10 year term are approximately $4.9 million. &lt;/span&gt;The Company is responsible for costs of constructing interior improvements within the Office Space that exceed a construction allowance provided by the Dallas Landlord not to exceed $40.00 per rentable square foot.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has a right of first refusal with respect to certain additional adjacent office space before the Dallas Landlord accepts any offer for such space.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Dallas Landlord has the right to terminate the Lease, or the Company&#x2019;s right to possess the Office Space without terminating the Dallas Lease, upon specified events of default, including the Company&#x2019;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of June 30, 2021, the Company recognized approximately $0.6 million of lease construction incentive based on the construction allowance provided. The construction incentive has been recorded on the condensed consolidated balance sheets as a deferred lease incentive obligation and is being amortized into earnings as a deduction of rent expense over the term of the Dallas Lease.&#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217"
      decimals="0"
      id="F_000510"
      unitRef="U_utrsqft">187500</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits>
    <us-gaap:OperationsCommencedDate1
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217_20201217"
      id="F_000511">2021-04-01</us-gaap:OperationsCommencedDate1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217"
      id="F_000512">P15Y6M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20201217"
      id="F_000513">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <tsha:OperatingLeasesInitialDirectCosts
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20200101_20201231"
      decimals="-5"
      id="F_000514"
      unitRef="U_iso4217USD">800000</tsha:OperatingLeasesInitialDirectCosts>
    <tsha:BuildToSuitAsset
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210630"
      decimals="-5"
      id="F_000515"
      unitRef="U_iso4217USD">26300000</tsha:BuildToSuitAsset>
    <tsha:BuildToSuitLeaseLiability
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210630"
      decimals="-5"
      id="F_000516"
      unitRef="U_iso4217USD">26300000</tsha:BuildToSuitLeaseLiability>
    <tsha:EquipmentPurchasesAndBuildOutOfLeasedFacility
      contextRef="C_0001806310_us-gaapTypeOfArrangementAxis_tshaDurhamLeaseMember_20210101_20210630"
      decimals="-5"
      id="F_000517"
      unitRef="U_iso4217USD">4000000.0</tsha:EquipmentPurchasesAndBuildOutOfLeasedFacility>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111"
      decimals="0"
      id="F_000518"
      unitRef="U_utrsqft">15000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits>
    <us-gaap:OperationsCommencedDate1
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111"
      id="F_000519">2021-05-27</us-gaap:OperationsCommencedDate1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111"
      id="F_000520">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111"
      id="F_000521">Company has an option to extend the term of the Dallas Lease for one additional period of five years.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111"
      id="F_000523">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <tsha:ObligationForPaymentOfInitialBaseRentForOfficeSpace
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111"
      decimals="-3"
      id="F_000524"
      unitRef="U_iso4217USD">32500000</tsha:ObligationForPaymentOfInitialBaseRentForOfficeSpace>
    <tsha:MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111"
      decimals="INF"
      id="F_000525"
      unitRef="U_iso4217USD">50000000</tsha:MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease>
    <us-gaap:SecurityDeposit
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111"
      decimals="-3"
      id="F_000526"
      unitRef="U_iso4217USD">32500000</us-gaap:SecurityDeposit>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111"
      id="F_000528">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111"
      decimals="-5"
      id="F_000529"
      unitRef="U_iso4217USD">4900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <tsha:MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot
      contextRef="C_0001806310_srtCounterpartyNameAxis_tshaPegasusParkLLCMember_us-gaapTypeOfArrangementAxis_tshaDallasLeaseMember_20210111_20210111"
      decimals="2"
      id="F_000527"
      unitRef="U_utrsqft">40.00</tsha:MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot>
    <us-gaap:LeaseIncentiveReceivable
      contextRef="C_0001806310_us-gaapLeaseContractualTermAxis_tshaDallasLeaseMember_20210630"
      decimals="-5"
      id="F_000530"
      unitRef="U_iso4217USD">600000</us-gaap:LeaseIncentiveReceivable>
    <us-gaap:SubsequentEventsTextBlock contextRef="C_0001806310_20210101_20210630" id="F_000236">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note 11&#x2014;Subsequent Events&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On August 12, 2021 (the &#x201c;Closing Date&#x201d;), the Company entered into a Loan and Security Agreement (the &#x201c;Term Loan Agreement&#x201d;), by and among the Company, the lenders party thereto from time to time (the &#x201c;Lenders&#x201d;) and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders (&#x201c;Agent&#x201d;).&#160;&#160;The Term Loan Agreement provides for (i) on the Closing Date, $40.0 million aggregate principal amount of term loans available through December 31, 2021, (ii) from January 1, 2022 until September 30, 2022, an additional $20.0 million term loan facility available at the Company&#x2019;s option upon having three distinct and active clinical stage programs at the time of draw, (iii) from October 1, 2022 until March 31, 2023, an additional $20.0 million term loan facility available at the Company&#x2019;s option upon having three distinct and active clinical stage programs at the time of draw and (iv) from April 1, 2023 until December 31, 2023, an additional $20.0 million term loan facility available upon approval by the Agent and the Lenders (collectively, the &#x201c;Term Loans&#x201d;). The Company drew $30.0 million in term loans on the Closing Date.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The interest rate applicable to the Term Loans is the greater of (a) the WSJ Prime Rate plus 3.75% or (b) 7.00% per annum.&#160;&#160;The Term Loans are interest only from the Closing Date through August 31, 2024, after which the Company is required to pay equal monthly installments of principal through August 1, 2026, the maturity date.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Term Loans may be prepaid in full through August 12, 2022 with payment of a 2.00% prepayment premium, after which they may be prepaid in full through August 12, 2023 with payment of a 1.00% prepayment premium, after which they may be prepaid in full with no prepayment premium. An additional final payment of 7.5% of the amount of Terms Loans advanced by the Lenders will be due upon prepayment or repayment of the Term Loans in full.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The obligations under the Term Loan Agreement are secured by a perfected security interest in all of the Company&#x2019;s assets except for intellectual property and certain other customarily excluded property pursuant to the terms of the Term Loan Agreement. There are no financial covenants and no warrants associated with the Term Loan Agreement.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812"
      decimals="-5"
      id="F_000531"
      unitRef="U_iso4217USD">40000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000532">2021-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000534">2022-01-01</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000535">2022-09-30</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812"
      decimals="-5"
      id="F_000533"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000537">2022-10-01</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000538">2023-03-31</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812"
      decimals="-5"
      id="F_000536"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <tsha:NumberOfDistinctAndActiveClinicalStage
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      decimals="INF"
      id="F_000539"
      unitRef="U_tshaProgram">3</tsha:NumberOfDistinctAndActiveClinicalStage>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000541">2023-04-01</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000542">2023-12-31</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812"
      decimals="-5"
      id="F_000540"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="C_0001806310_us-gaapLongtermDebtTypeAxis_tshaTermLoanFacilityMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812"
      decimals="-5"
      id="F_000543"
      unitRef="U_iso4217USD">30000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210811_20210812"
      decimals="4"
      id="F_000545"
      unitRef="U_xbrlipure">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812"
      decimals="INF"
      id="F_000544"
      unitRef="U_xbrlipure">0.0700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      id="F_000546">2026-08-01</us-gaap:DebtInstrumentMaturityDate>
    <tsha:PercentageOfPrepaymentPremium
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyTwoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      decimals="4"
      id="F_000547"
      unitRef="U_xbrlipure">0.0200</tsha:PercentageOfPrepaymentPremium>
    <tsha:PercentageOfPrepaymentPremium
      contextRef="C_0001806310_us-gaapDebtInstrumentAxis_tshaTermLoanThroughAugustThirteenTwentyTwentyThreeMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      decimals="4"
      id="F_000548"
      unitRef="U_xbrlipure">0.0100</tsha:PercentageOfPrepaymentPremium>
    <tsha:PercentageOfPrepaymentOfFacility
      contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812"
      decimals="3"
      id="F_000549"
      unitRef="U_xbrlipure">0.075</tsha:PercentageOfPrepaymentOfFacility>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210812"
      decimals="INF"
      id="F_000550"
      unitRef="U_iso4217USD">0</us-gaap:WarrantsAndRightsOutstanding>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844057561320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Aug. 16, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TSHA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Taysha Gene Therapies, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001806310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-3199512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3000 Pegasus Park Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste 1430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">612-0000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,391,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value&#160;$0.00001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844067483176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 197,370<span></span>
</td>
<td class="nump">$ 251,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">9,932<span></span>
</td>
<td class="nump">6,626<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">207,302<span></span>
</td>
<td class="nump">257,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsLeasingNetNoncurrent', window );">Deferred lease asset</a></td>
<td class="nump">691<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">33,867<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">241,860<span></span>
</td>
<td class="nump">258,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,355<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">22,036<span></span>
</td>
<td class="nump">5,135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">28,391<span></span>
</td>
<td class="nump">7,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_BuildToSuitLeaseLiability', window );">Build-to-suit lease liability</a></td>
<td class="nump">26,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">765<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">55,365<span></span>
</td>
<td class="nump">7,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Note 10</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of June 30, 2021 and December 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 38,391,165 and 37,761,435 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">320,571<span></span>
</td>
<td class="nump">312,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(134,076)<span></span>
</td>
<td class="num">(61,126)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">186,495<span></span>
</td>
<td class="nump">251,302<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 241,860<span></span>
</td>
<td class="nump">$ 258,881<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_BuildToSuitLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Build-to-suit lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_BuildToSuitLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsLeasingNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents costs incurred by the lessor that are (a) costs to originate a lease incurred in transactions with independent third parties that (i) result directly from and are essential to acquire that lease and (ii) would not have been incurred had that leasing transaction not occurred and (b) certain costs directly related to specified activities performed by the lessor for that lease. Those activities are: evaluating the prospective lessee's financial condition; evaluating and recording guarantees, collateral, and other security arrangements; negotiating lease terms; preparing and processing lease documents; and closing the transaction. The costs represented by this element are those costs not expected to be recognized in (amortized to) earnings within one year from the date of the statement of financial position or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121585684&amp;loc=d3e40246-112709<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsLeasingNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844068048600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">38,391,165<span></span>
</td>
<td class="nump">37,761,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">38,391,165<span></span>
</td>
<td class="nump">37,761,435<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844067984408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 30,643<span></span>
</td>
<td class="nump">$ 3,062<span></span>
</td>
<td class="nump">$ 54,497<span></span>
</td>
<td class="nump">$ 8,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,129<span></span>
</td>
<td class="nump">948<span></span>
</td>
<td class="nump">18,365<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">40,772<span></span>
</td>
<td class="nump">4,010<span></span>
</td>
<td class="nump">72,862<span></span>
</td>
<td class="nump">9,594<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(40,772)<span></span>
</td>
<td class="num">(4,010)<span></span>
</td>
<td class="num">(72,862)<span></span>
</td>
<td class="num">(9,594)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ChangeInFairValueOfPreferredStockTrancheLiability', window );">Change in fair value of preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,030)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(194)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(194)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(154)<span></span>
</td>
<td class="num">(17,210)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
<td class="num">(17,057)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (40,926)<span></span>
</td>
<td class="num">$ (21,220)<span></span>
</td>
<td class="num">$ (72,950)<span></span>
</td>
<td class="num">$ (26,651)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share, basic and diluted</a></td>
<td class="num">$ (1.09)<span></span>
</td>
<td class="num">$ (1.95)<span></span>
</td>
<td class="num">$ (1.96)<span></span>
</td>
<td class="num">$ (2.45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding, basic and diluted</a></td>
<td class="nump">37,479,164<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
<td class="nump">37,237,115<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ChangeInFairValueOfPreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ChangeInFairValueOfPreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844061807112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="num">$ (135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 980<span></span>
</td>
<td class="num">$ (1,115)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares', window );">Reclassification of preferred stock tranche liability upon issuance of Series A milestone shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,651)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="num">(26,786)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980<span></span>
</td>
<td class="num">(27,766)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock balance at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="num">(5,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980<span></span>
</td>
<td class="num">(6,546)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares', window );">Reclassification of preferred stock tranche liability upon issuance of Series A milestone shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(21,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,220)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="num">(26,786)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980<span></span>
</td>
<td class="num">(27,766)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock balance at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 251,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,428<span></span>
</td>
<td class="num">(61,126)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">37,761,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,761,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 8,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon vesting and settlement of restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(72,950)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,950)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 186,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,571<span></span>
</td>
<td class="num">(134,076)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="nump">38,391,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,391,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">$ 222,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,022<span></span>
</td>
<td class="num">(93,150)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,761,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon vesting and settlement of restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(40,926)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,926)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 186,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,571<span></span>
</td>
<td class="num">$ (134,076)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="nump">38,391,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,391,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity preferred stock tranche liability upon issuance of milestone shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844068976808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability', window );">Issuance of preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_TemporaryEquityStockOfferingCosts', window );">Issuance of convertible preferred stock, offering costs</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 440<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issuance of preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_TemporaryEquityStockOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_TemporaryEquityStockOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844056980872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (72,950,000)<span></span>
</td>
<td class="num">$ (26,651,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">117,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ChangeInFairValueOfPreferredStockTrancheLiability', window );">Change in fair value of preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,030,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Research and development license expense</a></td>
<td class="nump">5,500,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">8,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">194,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(3,282,000)<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,382,000<span></span>
</td>
<td class="nump">1,237,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">15,053,000<span></span>
</td>
<td class="nump">1,214,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Due to related party</a></td>
<td class="num">(8,000)<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(44,851,000)<span></span>
</td>
<td class="num">(4,165,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Purchase of research and development license</a></td>
<td class="num">(5,500,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(3,532,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(9,032,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuances of Series A convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of Series A convertible preferred stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(263,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from note payable to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,673,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of note payable to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,645,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,365,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(53,883,000)<span></span>
</td>
<td class="nump">11,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at the beginning of the period</a></td>
<td class="nump">251,253,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at the end of the period</a></td>
<td class="nump">197,370,000<span></span>
</td>
<td class="nump">11,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses', window );">Property, plant and equipment in accounts payable and accrued expenses</a></td>
<td class="nump">3,308,000<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisition of property, plant and equipment funded by landlord</a></td>
<td class="nump">606,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsIncurred', window );">Build-to-suit lease liability</a></td>
<td class="nump">$ 26,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Deferred offering costs not yet paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ReclassificationOfPreferredStockLiability', window );">Reclassification of preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">904,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AllocationOfPreferredStockTrancheLiability', window );">Allocation of preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Series A convertible preferred stock issuance costs not yet paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AllocationOfPreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allocation of preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AllocationOfPreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ChangeInFairValueOfPreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ChangeInFairValueOfPreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued expense and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property and equipment in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ReclassificationOfPreferredStockLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of preferred stock liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ReclassificationOfPreferredStockLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in lease obligation from new lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844054486680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Description of Business Operations</a></td>
<td class="text">
<p id="NOTE_1ORGANIZATION_DESCRIPTION_BUSINESS_" style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 1&#8212;Organization and Description of Business Operations </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Taysha Gene Therapies, Inc. (the &#8220;Company&#8221; or &#8220;Taysha&#8221;) was originally formed under the laws of the State of Texas on September 20, 2019 (&#8220;Inception&#8221;). Taysha converted to a Delaware corporation on February 13, 2020, which had no impact to the Company&#8217;s par value or issued and authorized capital structure. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Taysha is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Split </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 16, 2020, the Company effected a 1.0895-for-one stock split of its authorized, issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company&#8217;s convertible preferred stock as discussed in Note 5. Accordingly, all share and per share amounts for the periods presented in the accompanying condensed consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this stock split and adjustment of the convertible preferred stock conversion ratios. On September 16, 2020, the Company also increased the number of shares of common stock authorized for issuance under the 2020 Equity Incentive Plan (the &#8220;Existing Plan&#8221;) to 3,845,294. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Initial Public Offering </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 23, 2020, the Company&#8217;s registration statement on Form S-1 (File No. 333-248559) related to the initial public offering (&#8220;IPO&#8221;) of its common stock became effective and on September 28, 2020, the IPO closed. Pursuant to the IPO, the Company issued and sold 9,050,000 shares of common stock at a public offering price of $20.00 per share, which included 1,180,434 shares of common stock issued upon the exercise in full of the underwriters&#8217; option to purchase additional shares. The Company received net proceeds of $165.9 million after <span style="color:#000000;">deducting underwriting discounts and commissions and other offering costs of $2.5&#160;million. The shares began trading on the Nasdaq Global Select Market on September 24, 2020.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 28, 2020, in connection with the closing of the IPO, 10,000,000 shares of Series A and 5,647,048 shares of Series B convertible preferred stock automatically converted into an aggregate of 17,047,378 shares of common stock with a conversion ratio of 1.0895 shares of common stock for each share of Series A and Series B convertible preferred stock. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the IPO, including the underwriters&#8217; exercise in full of their option to purchase additional shares, and the conversions of the Series A and B convertible preferred stock, the Company&#8217;s total number of outstanding shares increased by 26,097,378 immediately following the closing of the IPO.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon the effectiveness of the Company&#8217;s registration statement related to the IPO, the Company&#8217;s 2020 Stock Incentive Plan (the &#8220;New Plan&#8221;) and 2020 Employee Stock Purchase Plan became effective. At that time, all shares reserved for issuance under the Existing Plan ceased to be available for issuance under such plan and became available for issuance under the New Plan.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Liquidity and Capital Resources </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has incurred operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As of June 30, 2021, the Company had an accumulated deficit of $134.1 million. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the closing of the Company&#8217;s IPO, between March and July 2020, the Company closed on the sale of an aggregate of 10,000,000 shares of Series A convertible preferred stock for gross proceeds of $30.0 million. Between July and August 2020, the Company closed on the sale of an aggregate of 5,647,048 shares of Series B convertible preferred stock for gross proceeds of $96.0 million. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future capital requirements will depend on many factors, including the timing and extent of spending on research and development and the market acceptance of the Company&#8217;s products. The Company will need to obtain additional financing in order to complete clinical studies and launch and commercialize any product candidates for which it receives regulatory approval. There can be no assurance that such financing will be available or will be on terms acceptable to the Company.<span style="color:#000000;"> As of June 30, 2021, the Company had cash of</span> $197.4 <span style="color:#000000;">million which the Company believes will be sufficient to fund its planned operations for a period of at least twelve months from the date of issuance of these condensed consolidated financial statements.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">novel coronavirus </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that causes the disease </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19 emerged and has subsequently spread worldwide. The World Health Organization has declared</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> COVID-19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> outbreak</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">global </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pandemic</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> resulting in federal, state and local governments and private entities implementing various restrictions</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including travel restrictions, restrictions on public gatherings, stay at home orders, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">advisories and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">quarantines of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">people who may have been exposed to the virus. The Company has been actively monitoring COVID</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and its impact globally. Management believes the financial results for the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">six</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months ended </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> were not significantly impacted by </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> pandemic</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In addition, management believes the remote working arrangements and travel restrictions imposed by various governmental jurisdictions have had limited impact on the Company&#8217;s ability to maintain internal operations during the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">six</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months ended </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30, 2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#8217;s business, results of operations and financial condition will depend on future developments that are highly uncertain, including new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844054531544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 2&#8212;Summary of Significant Accounting Policies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") as determined by the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission ("SEC") on March 3, 2021 (the &#8220;2020 Annual Report&#8221;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2020 is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#8217;s 2020 Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Principles of Consolidation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its inactive wholly owned U.S. subsidiaries that were incorporated during 2020, and one inactive foreign subsidiary incorporated in June 2021. All intercompany transactions and balances have been eliminated in consolidation. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#8217;s financial statements relate to the determination of the fair value of the common stock prior to the IPO (as an input into stock-based compensation), estimating preclinical manufacturing accruals and accrued or prepaid research and development expenses, and the valuation of the preferred stock tranche liability. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected. In response to the ongoing and rapidly evolving COVID-19 pandemic, management considered the impact of the estimated economic implications on the Company&#8217;s critical and significant accounting estimates, including assessment of impairment of long-lived assets.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Significant Accounting Policies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There have been no changes in the Company&#8217;s significant accounting policies as disclosed in Note 2 to the audited consolidated financial statements included in the 2020 Annual Report, except as described below.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:2.57%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Build-to-Suit Lease</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:2.57%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the Company&#8217;s recent lease arrangement (as described in Note 10), the Company was involved in the construction of the build-out. To the extent the Company is involved with the structural improvements of the construction project or takes construction risk prior to the commencement of a lease, accounting guidance requires the Company to be considered the owner for accounting purposes of these types of projects during the construction period. In such cases, the Company records an asset in property, plant and equipment </p>
<p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on its consolidated balance sheet equal to the fair value of the building shell, and a corresponding build-to-suit lease obligation on its consolidated balance sheet representing the amounts paid by the lessor.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Upon completion of&#160;construction, the Company will consider the requirements for sale-leaseback accounting treatment, including evaluating whether all risks of ownership have been transferred back to the landlord.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will become effective for the Company for annual reporting periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard requires the use of one of the following two approaches, either (1) retrospectively to each prior reporting period presented in the financial statements with the cumulative effect recognized at the beginning of the earliest comparative period presented, or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company has not yet concluded which approach will be utilized to adopt the new standard and is currently evaluating the impact of this standard on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844065104296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 3&#8212;Balance Sheet Components </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,716</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,462</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid bonus</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,192</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">409</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid insurance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">826</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,480</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid clinical trial</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">944</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,014</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid expenses and other current assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,932</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,626</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net consisted of the following (in thousands):<span style="margin-left:36pt;"/></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,863</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">676</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">529</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,465</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,993</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">296</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(126</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,867</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">287</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in construction in progress at June 30, 2021 was $30.3 million of costs associated with the Build-to-Suit lease (see Note 10). </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense was $85,000 and $117,000 for the three and six months ended June 30, 2021, respectively. There was no depreciation expense for the three and six months ended June 30, 2020.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities consisted of the following (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,106</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,210</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and consulting fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,372</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">999</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued property, plant, and equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,309</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical trial</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">959</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">678</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses and other current liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,135</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844055971064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research, Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ResearchCollaborationAndLicenseAgreementsAbstract', window );"><strong>Research Collaboration And License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Research, Collaboration and License Agreements</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 4&#8212;Research, Collaboration and License Agreements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">UT Southwestern Agreement </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 19, 2019, the Company entered into a research, collaboration and license agreement (&#8220;UT Southwestern Agreement&#8221;) with the Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center (&#8220;UT Southwestern&#8221;). Under the UT Southwestern Agreement, UT Southwestern is primarily responsible for preclinical development activities with respect to licensed products for use in certain specified indications (up to investigational new drug application-enabling studies), and the Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed products. UT Southwestern will conduct such preclinical activities for a <span style="-sec-ix-hidden:F_000314">two-year</span> period under mutually agreed upon sponsored research agreements that were entered into beginning in April 2020. During the initial research phase, the Company has the right to expand the scope of specified indications under the UT Southwestern Agreement. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the UT Southwestern Agreement, the Company obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, the Company obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. The Company is required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least one licensed product. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 2, 2020, the Company amended the UT Southwestern Agreement to include the addition of another licensed product and certain indications, and a right of first refusal to the Company over certain patient dosing patents. No additional consideration was transferred in connection with this amendment. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, the Company may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2019, as partial consideration for the license rights granted under the UT Southwestern Agreement, the Company issued 2,179,000 shares of its common stock, or 20% of its then outstanding fully-diluted common stock, to UT Southwestern. As additional consideration, UT Southwestern was entitled to receive additional shares if their holdings fell below 10% on a fully-diluted basis before or as a result of the completion of a qualified financing. In March 2020, following the initial closing of the Series A convertible preferred stock agreement, which met the definition of such qualified financing, the anti-dilution feature expired and no additional shares were issued. The Company does not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement other than costs related to maintenance of patents. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Queen&#8217;s Agreement </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In late December 2019, the Company entered into a research grant agreement (&#8220;RGA&#8221;) with Queen&#8217;s University at Kingston (&#8220;Queen&#8217;s&#8221;), for certain research and development activities related to the generation of AAV9 vector. The Company committed to fund $3.8 million under the RGA with Queen&#8217;s. The Company issued Queen&#8217;s a promise-to-pay note whereby any amounts paid directly by Queen&#8217;s for the manufacture of the vector for use in the funded research activities, to the extent such amounts had not already been funded by the Company to Queen&#8217;s, would become a loan obligation for the Company (the &#8220;Note&#8221;), subject to an interest </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rate of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any amounts outstanding under the Note were required to be repaid, along with any accrued interest, by or before June 30, 2020. In the event of default, any amount outstanding </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> deemed immediately payable by RA Session II, the Company&#8217;s President and Chief Executive Officer, as a personal guarantor (see Note </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">). For the period from Inception through December 31, 2019, the Company did not incur any expenses associated with the Queen&#8217;s RGA, and no amounts were due or outstanding under the Note as of December 31, 2019. </span><span style="color:#000000;">For the year ended December 31, 2020, the Company paid all expenses associated with the Queen&#8217;s RGA, thus </span><span style="color:#000000;">no</span><span style="color:#000000;"> amounts were due or outstanding under the Note as of December 31, 2020, and the promise-to-pay has therefore expired.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 21, 2020, the Company entered into a license agreement with Queen&#8217;s (the &#8220;Queen&#8217;s Agreement&#8221;) to obtain the exclusive perpetual, royalty-bearing license, with the right to sublicense through multiple tiers, under certain patent rights and know-how of Queen&#8217;s, including certain improvements to such patent rights and know-how, to develop products in any field which use one or more valid claims of the patents licensed under the Queen&#8217;s Agreement (the &#8220;Licensed Patents&#8221;), or the technology, information and intellectual property related to the patents licensed under the Queen&#8217;s Agreement (together with the Licensed Patents, the &#8220;Licensed Products&#8221;), and to make, have made, use, sell, offer for sale, import and export Licensed Products and otherwise exploit such patents and know-how for use in certain specified indications. In exchange for the rights granted to the Company, the Company made a cash payment of $3.0 million in April 2020 which is recorded in research and development expenses in the condensed consolidated statements of operations <span style="color:#000000;">and included as an investing cash outflow in the condensed consolidated statements of cash flows since the acquired license does not have an alternative future use</span> for the six months ended June 30, 2020. The Company is obligated to make aggregate cash payments of up to $10.0 million upon the completion of a combination of regulatory milestones and up to $10.0 million upon the completion of a combination of commercial milestones. In further consideration of the rights granted, beginning with the Company&#8217;s first commercial sale of the Licensed Products, the Company will also pay an annual earned royalty in the low single digits on net sales of Licensed Products, subject to certain customary reductions, and a percentage of non-royalty sublicensing revenue ranging in the low double digits. Royalties are payable, on a Licensed Products-by-Licensed Products and a country-by-country basis, until expiration of the last valid claim of a Licensed Patent covering such Licensed Products in such country and the expiration of any regulatory exclusivity for such Licensed Products in such country. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No additional milestone payments were made in connection with the Queen&#8217;s Agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Abeona CLN1 Agreements </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the Company entered into license and inventory purchase agreements with Abeona Therapeutics Inc. (&#8220;Abeona&#8221;) for worldwide exclusive rights to certain intellectual property rights and know-how relating to the research, development and manufacture of ABO-202, an AAV-based gene therapy for CLN1 disease (also known as infantile Batten disease). Under the terms of the agreements, the Company made initial cash payments to Abeona of $3.0 million for the license fee and $4.0 million for purchase of clinical materials and reimbursement for previously incurred development costs in October 2020. In exchange for the license rights, the Company recorded an aggregate of $7.0 million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2020 since the acquired license or acquired inventory do not have an alternative future use. The Company is obligated to make up to $26.0 million in regulatory-related milestones and up to $30.0 million in sales-related milestones per licensed CLN1 product. The Company will also pay an annual earned royalty in the high single digits on net sales of any licensed CLN1 products. The license agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the license agreement for convenience upon specified prior written notice to Abeona.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No additional milestone payments were made in connection with this agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Abeona Rett Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 29, 2020, the Company entered into a license agreement (the &#8220;Abeona Rett Agreement&#8221;) with Abeona pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to certain obligations of Abeona, the Company is required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Abeona Rett Agreement, the Company paid Abeona a one-time upfront license fee of $3.0 million which is recorded in research and development expenses in the consolidated statements of operations for the year ended December 31, 2020 since the acquired license does not have an alternative future use. The Company is obligated to pay Abeona up to $26.5 million in regulatory-related milestones and up to $30.0 million in sales-related milestones per licensed Rett product and high single-digit </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">royalties on net sales of licensed Rett products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the agreement for convenience upon specified prior written notice to Abeona.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No additional milestone payments were made in connection with the Abeona Rett Agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Acquisition of Worldwide Rights for TSHA-120 for the treatment of GAN </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, the Company acquired the exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of Giant Axonal Neuropathy (&#8220;GAN&#8221;). TSHA-120 is an intrathecally dosed AAV9 gene therapy currently being evaluated in a clinical trial for the treatment of GAN. The trial is being conducted by the National Institutes of Health in close collaboration with a leading patient advocacy group focused on finding treatments and cures for GAN. TSHA-120 has received rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration for the treatment of GAN. The worldwide rights were acquired through a license agreement, effective March 29, 2021, between Hannah&#8217;s Hope Fund for Giant Axonal Neuropathy, Inc. (&#8220;HHF&#8221;) and the Company.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the agreement, in exchange for granting the Company the exclusive worldwide rights to TSHA-120, HHF received an upfront payment of $5.5 million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $19.3 million, as well as a low, single-digit royalty on net sales upon commercialization of the product. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In exchange for the license rights, the Company recorded an aggregate of $5.5 million within research and development expenses in the condensed consolidated statements of operations since the acquired license does not have an alternative future use. This license fee was paid in April 2021 <span style="color:#000000;">and has been classified as an investing outflow in the condensed consolidated statements of cash flows for the six months ended June 30, 2021</span>. <span style="color:#000000;">No</span> additional milestone payments were made in connection with this agreement during the six months ended June 30, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ResearchCollaborationAndLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research, collaboration and license agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ResearchCollaborationAndLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844055972824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5&#8212;Stockholders&#8217; Equity (Deficit), Convertible Preferred Stock and Tranche Liability </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Authorized Shares</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company amended its certificate of incorporation on March 4, 2020, July 2, 2020 and again on July 28, 2020 such that the total number of shares of common stock authorized to be issued was increased to 32,685,000, and the total number of shares of preferred stock authorized to be issued was increased to 15,647,052, of which 10,000,000 preferred shares were designated Series A convertible preferred stock and 5,647,052 were designated Series B convertible preferred stock. On September 28, 2020, the Company amended its certificate of incorporation such that the total number of shares of common stock authorized to be issued was increased to 200,000,000, and the total number of shares of new preferred stock authorized to be issued was 10,000,000. As of June 30, 2021 and December 31, 2020, no shares of preferred stock were issued or outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">IPO</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 28, 2020, the Company issued an aggregate of 7,869,566 shares of common stock in the IPO, and on September 29, 2020, the Company issued an aggregate of 1,180,434 shares of common stock upon the underwriters&#8217; exercise in full of their option to purchase additional shares, each at the public offering price of $20.00 per share less underwriting discounts and commissions. In connection with the IPO, the Company received gross proceeds of $181.0 million, which was offset by issuance costs, including underwriters&#8217; discounts and commissions, of approximately $15.1 million.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Series A and B convertible preferred stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 4, 2020, the Company entered into a purchase agreement (the &#8220;Series A Purchase Agreement&#8221;) providing for a private placement of up to 10,000,000 shares of Series A convertible preferred stock at an original issuance price of $3.00 per share, subject to separate closings, including: (1) 6,000,000 shares at the initial closing on March 4, 2020, and (2) 2,000,000 shares at each of two subsequent closings triggered by the achievement of specific clinical milestones. The Series A Purchase Agreement obligated the </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company to issue and sell and the Series A investors to purchase up to a total of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000,000</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> additional shares of Series A convertible preferred stock (the &#8220;Milestone Shares&#8221;) at the same price per share upon the achievement of certain defined clinical milestones (the &#8220;tranche liability&#8221;). The determination as to whether the milestone events had been met was subject to certification by the Board of Directors. Each Series A investor had the right, but not the obligation, to purchase all or any portion of the Milestone Shares at any time in its sole option and in its sole and absolute discretion, whether or not the Company had achieved the applicable clinical milestone.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 30, 2020, several affiliated Series A investors elected to exercise in full their options to purchase 200,000 shares, representing all of their remaining pro-rata portion of the Milestone Shares, prior to the Company&#8217;s achievement of the clinical milestones for gross proceeds of $0.6 million. The remainder of the Series A investors exercised in full their options to purchase 3,800,000 shares, representing all of their remaining pro-rata portion of the Milestone Shares, prior to the Company&#8217;s achievement of the clinical milestones, for gross proceeds of $11.4 million between July 1, 2020 and July 2, 2020. As part of this issuance, the Company issued and sold 3,266,667 shares to PBM TGT Holdings, LLC and 400,000 shares to Nolan Capital, LLC, which stockholders are controlled by certain members of the Company&#8217;s board of directors.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 2, 2020, the Company entered into a purchase agreement (the &#8220;Series B Purchase Agreement&#8221;), as later amended on July 28, 2020, providing for a private placement of up to 5,647,052 shares of Series B convertible preferred stock. The Company sold 5,647,048 shares of Series B convertible preferred stock at a price of $17.00 per share in multiple closings in July and August 2020 for gross proceeds of $96.0 million. The majority of investors that participated in the Series B Purchase Agreement were new investors.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As described above, in connection with the closing of the IPO, all shares of Series A and Series B convertible preferred stock were automatically converted into an aggregate of 17,047,378 shares of common stock with a conversion ratio, which was adjusted for the stock split, of 1.0895 shares of common stock for each share of Series A and Series B convertible preferred stock then outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Series A convertible preferred stock tranche liability</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company concluded that the tranche liability met the definition of a freestanding financial instrument, as it was legally detachable and separately exercisable from the initial closing of the Series A convertible preferred stock. The estimated fair value of the tranche liability was determined using a Monte Carlo simulation at the initial issuance date. As of March 4, 2020, the simulations occurred based on the implied aggregate equity value of the Company derived from the Series A convertible preferred stock offering price of $3.00 per share, along with, in part, the following subjective assumptions: risk-free rate of 0.59%, an expected volatility of 80%, the expected term to a liquidity event of 1 year, and a 60% probability of achieving the clinical milestones and timing thereof. Subsequently, the estimated fair value of the tranche liability was determined using a backsolve approach at June 30, 2020, immediately prior to the issuance of the Milestone Shares, which was calculated based on the aggregate equity value of the Company derived from the Series B convertible preferred stock offering price of $17.00 per share. The subsequent remeasurement also considered, in part, a risk-free rate of 0.17%, an expected volatility of 80%, and the expected term to a liquidity event of 0.5 years.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the analysis, the Company recorded a preferred stock tranche liability of $1.1 million at the issue date to account for the obligation to issue the Milestone Shares at a predetermined fixed price at a future settlement date.&#160; At June 30, 2020, ahead of the anticipated closing of the Series B Purchase Agreement for $17.00 per share that occurred on July 2, 2020, certain investors elected to exercise in full their options to purchase their pro-rata portion of the Milestone Shares prior to the Company&#8217;s achievement of the clinical milestones and purchased 200,000 shares of Series A convertible preferred stock. The Company remeasured the fair value of the entire tranche liability at June 30, 2020, and recognized a non-cash expense of $17.0 million in the condensed consolidated statement of operations for the six months ended June 30, 2020. As 200,000 of the Milestone Shares were also issued to certain investors on June 30, 2020, the related tranche liability was extinguished, and the Company reclassified $0.9 million to convertible preferred stock on the condensed consolidated balance sheet as of June 30, 2020. The Company concluded that no beneficial conversion feature (&#8220;BCF&#8221;) existed as the effective conversion price of the Series A convertible preferred stock exceeded the fair value of the Company&#8217;s common stock at each of the commitment dates. Specifically at the commitment date of June 30, 2020, when 200,000 Milestone Shares were issued, the deemed proceeds were equal to the cash proceeds received for the shares of Series A convertible preferred stock and the fair value of the tranche liability that related to the Milestone Shares, or $7.52 per share. As the effective conversion price exceeded the fair value of the Company&#8217;s common stock, no BCF existed.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844056153800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 6&#8212;Stock-Based Compensation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 1, 2020, the Company&#8217;s board of directors approved the Existing Plan which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, RSAs, RSUs and other stock-based awards to employees, directors, officers and consultants. On July 1, 2020, 3,529,412 shares of common stock were authorized for issuance under the Existing Plan. On September 16, 2020, the Company increased the number of shares of common stock authorized for issuance under the Existing Plan to 3,845,294. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 16, 2020, the Company&#8217;s stockholders approved the New Plan, which became effective upon the execution of the underwriting agreement in connection with the IPO. The number of shares available for future issuance under the New Plan is the sum of (1) 3,390,168 new shares of common stock,&#160;&#160;(2) 209,841 remaining shares of common stock reserved under the Existing Plan that became available for issuance upon the effectiveness of the New Plan and (3) the number of shares of common stock subject to outstanding awards under the Existing Plan when the New Plan became effective that thereafter expire or are forfeited, canceled, withheld to satisfy tax withholding or to purchase or exercise an award, repurchased by the Company or are otherwise terminated. At December 31, 2020, there were 2,941,509 shares available for future grant under the New Plan. The number of shares of common stock reserved for issuance under the New Plan will automatically increase on January 1 of each year, for a period of ten years, from January 1, 2021 continuing through January 1, 2030, by 5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#8217;s board of directors.&#160;&#160;On January 1, 2021 the board of directors increased the number of common stock reserved for issuance under the New Plan by 1,434,934 shares.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, on September 16, 2020, the Company&#8217;s stockholders approved the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which became effective upon the execution of the underwriting agreement in connection with the IPO. The maximum number of shares of common stock that may be issued under the ESPP will not exceed 362,000 shares of common stock, plus the number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO date and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock. &#160; No shares were added to the ESPP as of January 1, 2021 and no issuances have been made under the ESPP as of June 30, 2021.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Options </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 1, 2020, options to purchase 2,896,782 shares of common stock under the Existing Plan were awarded to certain employees and consultants of the Company with an exercise price per share of $0.80, which were expected to vest over a <span style="-sec-ix-hidden:F_000411">four-year</span> period, all of which were subsequently cancelled (the &#8220;Cancelled Options&#8221;). The grant date fair value of the Cancelled Options was $13.8 million at the original grant date. In exchange, the Company awarded 2,518,932 RSUs on September 2, 2020, which are expected to vest over a <span style="-sec-ix-hidden:F_000414">four-year</span> term. The Company accounted for the changes in award terms as a modification in accordance with ASC 718 Compensation &#8211; Stock Compensation. The modification was accounted for as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus any incremental value measured on the modification date. The Company determined that there was no incremental value as the fair value of the original award immediately before the modification was greater than the fair value of the new award immediately after the modification. Accordingly, the Company continues to recognize the remaining compensation cost of the Cancelled Options over the vesting period of the RSUs.&#160;&#160; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three months ended June 30, 2021, options to purchase 964,750 shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $14.73. For the six months ended June 30, 2021, options to purchase 2,586,650 shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $17.25. The stock options vest over one to four years and have a <span style="-sec-ix-hidden:F_000422">ten-year</span> contractual term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The following weighted-average assumptions were used to estimate the fair value of stock options that were granted during the three and six months ended June&#160;30, 2021:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71.9%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three months ended June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.07</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.80</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term in years</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000425">6.0</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000426">6.0</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity, during the six months ended June&#160;30, 2021: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">674,842</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.68</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000441">9.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,953</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,586,650</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26.41</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled or forfeited</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,800</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28.61</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,213,692</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.18</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000442">9.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at June 30, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,213,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.18</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000443">9.6</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable at June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,054</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000444">9.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value in the above table is calculated as the difference between the fair value of the Company&#8217;s common stock as of June&#160;30, 2021 and the exercise price of the stock options. As of June&#160;30, 2021, the total unrecognized compensation related to unvested stock option awards granted was $47.5&#160;million, which the Company expects to recognize over a weighted-average period of approximately 3.5 years.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 2, 2020, the Company issued 331,121 RSUs to an employee under the Existing Plan; 25% of the shares of common stock underlying the RSUs vest at each anniversary over a <span style="-sec-ix-hidden:F_000456">four-year</span> period. The RSUs are subject to a service-based vesting condition. The RSUs were also subject to a liquidity-based performance vesting condition that was met upon the closing of the IPO. The Company at any time may accelerate the vesting of the RSUs. Such shares are not accounted for as outstanding until they vest.<span style="color:#000000;"> As of June 30, 2021, the total unrecognized compensation related to unvested RSUs granted, including the remaining compensation cost associated with the RSUs granted on September 2, 2020 in exchange for the Cancelled Options, was $13.3 million which is expected to be amortized on a straight-line basis over the weighted-average remaining vesting period of approximately 1.5 years.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company's default tax withholding&#160;method for RSUs is the&#160;sell-to-cover&#160;method, in which shares with a market value equivalent to the tax withholding obligation are sold on behalf of the holder of the RSUs upon vesting and settlement to cover the tax withholding liability and the cash proceeds from such sales are remitted by the Company to taxing authorities. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s RSU activity for the six months ended June&#160;30, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at January 1, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,850,053</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted units granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(629,730</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.25</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled or forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(167,186</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.25</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at June 30, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,053,137</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.80</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Awards</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RA Session II, the Company&#8217;s founder, President and Chief Executive Officer, was awarded 769,058 RSAs under the Existing Plan on July 1, 2020, which are expected to vest over a <span style="-sec-ix-hidden:F_000468">three-year</span> term, subject to continuous employment. As of June 30, 2021, the total unrecognized compensation related to unvested RSAs granted was $2.6 million which is expected to be amortized on a straight-line basis over the weighted-average remaining vesting period of approximately 1.8 years. The fair value of these RSAs at the grant date of July 1, 2020 was $5.28 per share. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s RSA activity for the six months ended June&#160;30, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">769,058</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.28</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(298,843</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.28</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">470,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.28</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the total stock-based compensation expense for the stock options, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:right;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended June&#160;30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended June&#160;30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,214</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,793</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,335</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,350</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,549</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,143</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844058438296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Common Share</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 7&#8212;Net Loss Per Common Share </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Since the Company had a net loss in all periods presented, basic and diluted net loss per common share are the same. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.64%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June 30,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June 30,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,926</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,220</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(72,950</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,651</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares of common stock outstanding used to compute net loss per</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; common share, basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,479,164</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,894,999</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,237,115</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,894,999</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per common share, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.09</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.95</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.96</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.45</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following common stock equivalents outstanding as of June 30, 2021 and 2020 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#8209;dilutive:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.36%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested RSUs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,053,137</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested RSAs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">470,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,213,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A convertible preferred stock</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,200,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,737,044</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,200,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844055914600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 8&#8212;Related Party Transactions </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RA Session II, founder, President and Chief Executive Officer and a member of the Company&#8217;s board of directors, was a guarantor under the Guaranty and Security Agreement between himself, Queen&#8217;s and the Company, and in the event of the Company&#8217;s failure to fund its obligations under the RGA with Queen&#8217;s, had personally guaranteed payments due by the Company to Queen&#8217;s. In addition, the Company entered into two secured promissory notes with Mr. Session in January 2020 for an aggregate of $1.67 million, with 10% interest. The Company secured the notes with a first priority security interest in certain assets of the Company. During March 2020, the Company repaid $1.65&#160;million of the notes, and the remaining balance was repaid in July 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the Company entered into a services agreement with PBM Capital Group, LLC (&#8220;PBM&#8221;), an affiliate of PBM TGT Holdings, LLC whereby PBM provides accounting and other administrative and management services related to payroll administration, human resources, bookkeeping, preparation of financial statements and tax returns, accounts payable and receivable, and other similar functions for a fee of $2,500 per month. Paul B. Manning, a member of the Company&#8217;s board of directors and a holder of more than 5% of the Company&#8217;s capital stock, is the Chief Executive Officer of PBM Capital Group, LLC and has sole voting and investment power with respect to the shares held by PBM TGT Holdings, LLC. In September 2020, PBM TGT Holdings, LLC distributed all of the shares of Series A convertible preferred stock it previously held to its beneficial owners, including Mr. Manning and entities controlled by Mr. Manning, for no additional consideration in accordance with the terms of its operating agreement. In April 2021, the PBM services agreement was terminated and all outstanding amounts due have been paid. &#160;&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844054591256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 9&#8212;Income Taxes </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. There is no provision for income taxes because the Company has incurred operating losses and capitalized certain items for income tax purposes since its inception and maintains a full valuation allowance against its net deferred tax assets. The reported amount of income tax expense for the period differs from the amount that would result from applying the federal statutory tax rate to net loss before taxes primarily because of the change in valuation allowance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2021, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, 2020.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844056117432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 10&#8212;Commitments and Contingencies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Litigation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims. From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Commitments </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the normal course of business, the Company enters into contracts that contain a variety of indemnifications with its employees, licensors, suppliers and service providers. The Company&#8217;s maximum exposure under these arrangements is unknown at June 30, 2021. The Company does not anticipate recognizing any significant losses relating to these arrangements. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Durham Lease</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 17, 2020, the Company entered into a lease agreement (the &#8220;Durham Lease&#8221;) with Patriot Park Partners II, LLC, a Delaware limited liability company (the &#8220;Durham Landlord&#8221;), pursuant to which the Company agreed to lease approximately 187,500 square feet of a manufacturing facility located at 5 National Way, Durham, North Carolina (the &#8220;Facility&#8221;). The Durham Lease commenced on April 1, 2021 and is expected to have a term of approximately fifteen years and six months. The Company has two options to extend the term of the Durham Lease, each for a period of an additional five years.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company was not required to provide a security deposit in connection with its entry into the Durham Lease. The Company will be responsible for constructing interior improvements within the Facility. The Durham Landlord has the right to </p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">terminate the Durham Lease upon specified events of default, including the Company&#8217;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurred initial direct costs to enter into the Durham Lease of approximately $0.8 million in December 2020. The costs have been recorded on the condensed consolidated balance sheets as a deferred lease asset and are being amortized into earnings over the term of the Durham Lease.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC Topic 840,&#160;<span style="font-style:italic;">Leases</span>, the Company is deemed, for accounting purposes only, to be the owner of the entire leased Facility, including the building shell, during the construction period because of the Company&#8217;s expected level of direct financial and operational involvement in the substantial tenant improvements, including structural improvements, required to build out the Facility. As a result, the Company capitalized approximately&#160;$26.3 million&#160;as a build-to-suit asset within property, plant and equipment, net and recognized a corresponding build-to-suit lease financing obligation as a liability on its condensed consolidated balance sheets equal to the fair value of the existing building shell using comparable market prices per&#160;square foot for similar space for public real estate transactions in the surrounding area at commencement of construction. Additionally, construction costs incurred as part of the build-out and tenant improvements are also capitalized within property, plant and equipment, net. Costs of approximately&#160;$4.0 million&#160;have been capitalized during the six months ended&#160;June 30, 2021, related to both equipment purchases and the build-out of the leased Facility. Construction is expected to be completed in 2023, upon which time the Company will assess and determine if the build-to-suit asset and corresponding liability should be de-recognized.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dallas Lease</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 11, 2021, the Company entered into a lease agreement (the &#8220;Dallas Lease&#8221;) with Pegasus Park, LLC, a Delaware limited liability company (the &#8220;Dallas Landlord&#8221;), pursuant to which the Company will lease approximately 15,000 square feet of office space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#8220;Office Space&#8221;).</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Dallas Lease commenced on May 27, 2021, and has a term of approximately ten years. The Company has an option to extend the term of the Dallas Lease for one additional period of five years. The Company&#8217;s obligation for the payment of base rent for the Office Space is initially approximately $32,500 per month and will increase annually, up to an estimated monthly base rent of $50,000 during the term of the Lease. The Company is obligated to pay operating costs and utilities applicable to the Office Space. The Company was required to provide a security deposit of $32,500 in connection with its entry into the Dallas Lease. <span style="color:#000000;">Total future minimum lease payments under the Dallas Lease over the initial 10 year term are approximately $4.9 million. </span>The Company is responsible for costs of constructing interior improvements within the Office Space that exceed a construction allowance provided by the Dallas Landlord not to exceed $40.00 per rentable square foot.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has a right of first refusal with respect to certain additional adjacent office space before the Dallas Landlord accepts any offer for such space.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Dallas Landlord has the right to terminate the Lease, or the Company&#8217;s right to possess the Office Space without terminating the Dallas Lease, upon specified events of default, including the Company&#8217;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2021, the Company recognized approximately $0.6 million of lease construction incentive based on the construction allowance provided. The construction incentive has been recorded on the condensed consolidated balance sheets as a deferred lease incentive obligation and is being amortized into earnings as a deduction of rent expense over the term of the Dallas Lease.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844068154920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 11&#8212;Subsequent Events</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 12, 2021 (the &#8220;Closing Date&#8221;), the Company entered into a Loan and Security Agreement (the &#8220;Term Loan Agreement&#8221;), by and among the Company, the lenders party thereto from time to time (the &#8220;Lenders&#8221;) and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders (&#8220;Agent&#8221;).&#160;&#160;The Term Loan Agreement provides for (i) on the Closing Date, $40.0 million aggregate principal amount of term loans available through December 31, 2021, (ii) from January 1, 2022 until September 30, 2022, an additional $20.0 million term loan facility available at the Company&#8217;s option upon having three distinct and active clinical stage programs at the time of draw, (iii) from October 1, 2022 until March 31, 2023, an additional $20.0 million term loan facility available at the Company&#8217;s option upon having three distinct and active clinical stage programs at the time of draw and (iv) from April 1, 2023 until December 31, 2023, an additional $20.0 million term loan facility available upon approval by the Agent and the Lenders (collectively, the &#8220;Term Loans&#8221;). The Company drew $30.0 million in term loans on the Closing Date.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The interest rate applicable to the Term Loans is the greater of (a) the WSJ Prime Rate plus 3.75% or (b) 7.00% per annum.&#160;&#160;The Term Loans are interest only from the Closing Date through August 31, 2024, after which the Company is required to pay equal monthly installments of principal through August 1, 2026, the maturity date.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Term Loans may be prepaid in full through August 12, 2022 with payment of a 2.00% prepayment premium, after which they may be prepaid in full through August 12, 2023 with payment of a 1.00% prepayment premium, after which they may be prepaid in full with no prepayment premium. An additional final payment of 7.5% of the amount of Terms Loans advanced by the Lenders will be due upon prepayment or repayment of the Term Loans in full.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The obligations under the Term Loan Agreement are secured by a perfected security interest in all of the Company&#8217;s assets except for intellectual property and certain other customarily excluded property pursuant to the terms of the Term Loan Agreement. There are no financial covenants and no warrants associated with the Term Loan Agreement.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844059194024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") as determined by the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission ("SEC") on March 3, 2021 (the &#8220;2020 Annual Report&#8221;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2020 is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#8217;s 2020 Annual Report.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Principles of Consolidation </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its inactive wholly owned U.S. subsidiaries that were incorporated during 2020, and one inactive foreign subsidiary incorporated in June 2021. All intercompany transactions and balances have been eliminated in consolidation. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#8217;s financial statements relate to the determination of the fair value of the common stock prior to the IPO (as an input into stock-based compensation), estimating preclinical manufacturing accruals and accrued or prepaid research and development expenses, and the valuation of the preferred stock tranche liability. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected. In response to the ongoing and rapidly evolving COVID-19 pandemic, management considered the impact of the estimated economic implications on the Company&#8217;s critical and significant accounting estimates, including assessment of impairment of long-lived assets.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_BuildToSuitLeasePolicyTextBlock', window );">Build-to-Suit Lease</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:2.57%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Build-to-Suit Lease</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:2.57%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the Company&#8217;s recent lease arrangement (as described in Note 10), the Company was involved in the construction of the build-out. To the extent the Company is involved with the structural improvements of the construction project or takes construction risk prior to the commencement of a lease, accounting guidance requires the Company to be considered the owner for accounting purposes of these types of projects during the construction period. In such cases, the Company records an asset in property, plant and equipment </p>
<p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on its consolidated balance sheet equal to the fair value of the building shell, and a corresponding build-to-suit lease obligation on its consolidated balance sheet representing the amounts paid by the lessor.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Upon completion of&#160;construction, the Company will consider the requirements for sale-leaseback accounting treatment, including evaluating whether all risks of ownership have been transferred back to the landlord.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will become effective for the Company for annual reporting periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard requires the use of one of the following two approaches, either (1) retrospectively to each prior reporting period presented in the financial statements with the cumulative effect recognized at the beginning of the earliest comparative period presented, or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company has not yet concluded which approach will be utilized to adopt the new standard and is currently evaluating the impact of this standard on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_BuildToSuitLeasePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Build-to-suit lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_BuildToSuitLeasePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844056032984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,716</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,462</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid bonus</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,192</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">409</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid insurance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">826</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,480</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid clinical trial</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">944</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,014</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid expenses and other current assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,932</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,626</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment, Net</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net consisted of the following (in thousands):<span style="margin-left:36pt;"/></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,863</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">676</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">529</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,465</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,993</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">296</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(126</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,867</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">287</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock', window );">Schedule of Accrued Expense and Other Current Labilities</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities consisted of the following (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,106</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,210</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and consulting fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,372</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">999</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued property, plant, and equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,309</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical trial</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">959</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">678</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses and other current liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,135</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of accrued expense and other current labilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844052555272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s RSU activity for the six months ended June&#160;30, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at January 1, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,850,053</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted units granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(629,730</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.25</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled or forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(167,186</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.25</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at June 30, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,053,137</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.80</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock Awards Activity</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s RSA activity for the six months ended June&#160;30, 2021 was as follows: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">769,058</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.28</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(298,843</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.28</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nonvested at June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">470,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.28</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Detail)</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the total stock-based compensation expense for the stock options, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:right;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended June&#160;30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended June&#160;30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,214</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,793</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,335</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,350</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.54%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,549</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,143</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options</a></td>
<td class="text">The following weighted-average assumptions were used to estimate the fair value of stock options that were granted during the three and six months ended June&#160;30, 2021:
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71.9%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three months ended June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.07</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.80</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term in years</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000425">6.0</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000426">6.0</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.66%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity, during the six months ended June&#160;30, 2021: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">674,842</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.68</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000441">9.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,953</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,586,650</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26.41</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled or forfeited</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,800</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28.61</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,213,692</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.18</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000442">9.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at June 30, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,213,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.18</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000443">9.6</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable at June 30, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,054</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000444">9.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844057256552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Loss Per Common Share</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.64%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June 30,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="5" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended June 30,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,926</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,220</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(72,950</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,651</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares of common stock outstanding used to compute net loss per</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; common share, basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,479,164</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,894,999</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,237,115</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,894,999</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per common share, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.09</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.95</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.96</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.45</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following common stock equivalents outstanding as of June 30, 2021 and 2020 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#8209;dilutive:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.36%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested RSUs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,053,137</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested RSAs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">470,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,213,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A convertible preferred stock</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,200,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:68.18%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,737,044</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,200,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:68.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.36%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844057524920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 29, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 16, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 13,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (134,076)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (134,076)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (61,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Gross proceeds from sale of convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock', window );">Conversion of convertible preferred stock to common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Aggregate shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Gross proceeds from sale of convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock', window );">Conversion of convertible preferred stock to common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,647,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Aggregate shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,647,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Gross proceeds from sale of convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Underwriters&#8217; Option to Purchase Additional Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock, shares</a></td>
<td class="nump">1,180,434<span></span>
</td>
<td class="nump">1,180,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,869,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Underwriting discounts and commissions and other offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_CommonStockIncreaseInOutstandingShares', window );">Increase in outstanding shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,097,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of common stock authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,845,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0895<span></span>
</td>
<td class="nump">1.0895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,047,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | 2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of common stock authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,845,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,529,412<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_CommonStockIncreaseInOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock increase in outstanding shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_CommonStockIncreaseInOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization and description of business operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity conversion shares of convertible preferred stock to common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844057271304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PrepaidResearchAndDevelopmentContracts', window );">Prepaid research and development</a></td>
<td class="nump">$ 6,716<span></span>
</td>
<td class="nump">$ 2,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PrepaidBonus', window );">Prepaid bonus</a></td>
<td class="nump">1,192<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PrepaidClinicalTrial', window );">Prepaid clinical trial</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">1,014<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 9,932<span></span>
</td>
<td class="nump">$ 6,626<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PrepaidBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid bonus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PrepaidBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PrepaidClinicalTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical trial.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PrepaidClinicalTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PrepaidResearchAndDevelopmentContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid research and development contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PrepaidResearchAndDevelopmentContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844061494712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property Plant and Equipment, Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 33,993<span></span>
</td>
<td class="nump">$ 296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">33,867<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 30,465<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844068154728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 117,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_BuildToSuitLeaseMember', window );">Build-to-Suit Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">$ 30,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_BuildToSuitLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_BuildToSuitLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844064794968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development</a></td>
<td class="nump">$ 14,508<span></span>
</td>
<td class="nump">$ 2,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">3,210<span></span>
</td>
<td class="nump">1,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and consulting fees</a></td>
<td class="nump">1,372<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AccruedPropertyPlantAndEquipmentCurrent', window );">Accrued property, plant, and equipment</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AccruedClinicalTrialCurrent', window );">Accrued clinical trial</a></td>
<td class="nump">959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">678<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 22,036<span></span>
</td>
<td class="nump">$ 5,135<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedClinicalTrialCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical trial current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedClinicalTrialCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued property, plant, and equipment current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139843978491416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research, Collaboration and License Agreements - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>Product</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,391,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,391,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,761,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,643,000<span></span>
</td>
<td class="nump">$ 3,062,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,497,000<span></span>
</td>
<td class="nump">$ 8,576,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember', window );">TSHA-120</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AdditionalMilestonePayments', window );">Additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_UpfrontPayment', window );">Upfront payment</a></td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived', window );">Clinical, regulatory and commercial milestones to be received</a></td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_UTSouthwesternAgreementMember', window );">UT Southwestern Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements', window );">Preclinical activities period under sponsored research agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize', window );">Minimum licensed product to develop obtain regulatory approval for and commercialize | Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,179,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding', window );">Percentage of fully diluted common stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis', window );">Percentage of entitled to receive additional shares on fully diluted basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_QueensAgreementMember', window );">Queen's Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ResearchGrantOfCommittedFundAmount', window );">Research grant of committed fund amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ResearchGrantOutstandingFundAmount', window );">Research grant outstanding fund amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AdditionalMilestonePayments', window );">Additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_QueensAgreementMember', window );">Queen's Agreement | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PaymentsToAcquireLicenseRight', window );">Cash payment to acquire license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_QueensAgreementMember', window );">Queen's Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_LicenseAgreementRegulatoryMilestonesPayment', window );">License agreement regulatory milestones payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_LicenseAgreementCommercialMilestonesPayment', window );">License agreement commercial milestones payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember', window );">Abeona CLN1 Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AdditionalMilestonePayments', window );">Additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PaymentOfLicenseFee', window );">License fee payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts', window );">Purchase of clinical materials and reimbursement incurred development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember', window );">Abeona CLN1 Agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment', window );">License and inventory purchase agreement regulatory related milestones payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment', window );">License and inventory purchase agreement sales related milestones payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember', window );">Abeona | Abeona Rett Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AdditionalMilestonePayments', window );">Additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PaymentOfOneTimeUpfrontLicenseFee', window );">Payment of one-time upfront license fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember', window );">Abeona | Maximum | Abeona Rett Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_RegulatoryRelatedMilestonesObligationPayable', window );">Regulatory related milestones obligation payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable', window );">Sale-related milestones per licensed product and royalties on net sales of licensed products payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AdditionalMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Milestone payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AdditionalMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Clinical, regulatory and commercial milestones to be received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAgreementCommercialMilestonesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement commercial milestones payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAgreementCommercialMilestonesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAgreementRegulatoryMilestonesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement regulatory milestones payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAgreementRegulatoryMilestonesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License and inventory purchase agreement regulatory related milestones payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License and inventory purchase agreement sales related milestones payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum licensed product to develop obtain regulatory approval for and commercialize.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentOfLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of license fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentOfLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentOfOneTimeUpfrontLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of one-time upfront license fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentOfOneTimeUpfrontLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentsToAcquireLicenseRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire license right.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentsToAcquireLicenseRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock shares entitled to receive additional shares on fully diluted basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fully diluted common stock shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preclinical activities period under sponsored research agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of clinical materials and reimbursement incurred development costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_RegulatoryRelatedMilestonesObligationPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Regulatory related milestones obligation payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_RegulatoryRelatedMilestonesObligationPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ResearchGrantOfCommittedFundAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research grant of committed fund amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ResearchGrantOfCommittedFundAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ResearchGrantOutstandingFundAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research grant outstanding fund amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ResearchGrantOutstandingFundAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale-related milestones per licensed product and royalties on net sales of licensed products payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_UpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_UpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_UTSouthwesternAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_UTSouthwesternAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_QueensAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_QueensAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139843972892664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 29, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Sep. 16, 2020</div></th>
<th class="th">
<div>Jul. 28, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 02, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 05, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 04, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,647,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs, including underwriters&#8217; discounts and commissions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuances of Series A convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PreferredStockTrancheLiability', window );">Preferred stock tranche liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ChangeInFairValueOfPreferredStockTrancheLiability', window );">Non cash expenses due to remeasured fair value of tranche liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,030)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_MileStoneSharesIssued', window );">Mile stone shares issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AmountReclassifiedToConvertiblePreferredStock', window );">Tranche liability amount reclassified to convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,047,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0895<span></span>
</td>
<td class="nump">1.0895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,869,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ProceedsFromIssuanceOfCommonStockGross', window );">Gross proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs, including underwriters&#8217; discounts and commissions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Underwriters' Option to Purchase Additional Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="nump">1,180,434<span></span>
</td>
<td class="nump">1,180,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of share options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Clinical milestones for gross proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuances of Series A convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice', window );">Convertible preferred stock tranche liability, offering price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm', window );">Convertible preferred stock tranche liability, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_IssuanceOfProRataPortionOfMilestoneShares', window );">Milestone pro-rate shares issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Risk Free Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput', window );">Convertible preferred stock tranche liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Expected Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput', window );">Convertible preferred stock tranche liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Probability of Achieving Clinical Milestones and Timing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput', window );">Convertible preferred stock tranche liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | PBM TGT Holdings, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,266,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Nolan Capital, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Private Placement | Series A Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Private Placement | Series A Purchase Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Private Placement | Initial Closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Private Placement | Achievement of Specific Clinical Milestone One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Private Placement | Achievement of Specific Clinical Milestone Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Private Placement | Upon Achievement of Certain Defined Clinical Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,647,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuances of Series A convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice', window );">Convertible preferred stock tranche liability, offering price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm', window );">Convertible preferred stock tranche liability, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Risk Free Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput', window );">Convertible preferred stock tranche liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Expected Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput', window );">Convertible preferred stock tranche liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Series B Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Private Placement | Series B Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,647,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuances of Series A convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock | Private Placement | Series B Purchase Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,647,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AmountReclassifiedToConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount reclassified to convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AmountReclassifiedToConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ChangeInFairValueOfPreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ChangeInFairValueOfPreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible preferred stock tranche liability liquidity term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible preferred stock tranche liability measurement input.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible preferred stock tranche liability offering price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IssuanceOfProRataPortionOfMilestoneShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of pro-rata portion of milestone shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IssuanceOfProRataPortionOfMilestoneShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_MileStoneSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mile stone shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_MileStoneSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock Tranche Liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ProceedsFromIssuanceOfCommonStockGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock, gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ProceedsFromIssuanceOfCommonStockGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tsha_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_NolanCapitalLimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_NolanCapitalLimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SeriesAPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SeriesAPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SeriesAPurchaseAgreementInitialClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SeriesAPurchaseAgreementInitialClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tsha_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SeriesBPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SeriesBPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139843978761880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Sep. 16, 2020</div></th>
<th class="th"><div>Sep. 02, 2020</div></th>
<th class="th"><div>Jul. 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-based payment award, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance', window );">Percentage of automatic increase every year in common stock shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Share-based payment award, terms of award issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO date and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Number of shares of common stock issued under ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan (&#8220;ESPP&#8221;) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,586,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based payment award, options granted, exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Share-based payment award, options, compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,500,000<span></span>
</td>
<td class="nump">$ 47,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based payment award, RSU/RSA granted, weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,845,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Share-based payment award, plan modification, incremental cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Cancelled Options | Certain Employees and Consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,896,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based payment award, options granted, exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue', window );">Share-based payment award, options grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod', window );">Number of shares awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,518,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based payment award, RSU/RSA granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Restricted Stock Units | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based payment award, vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Restricted Stock Units | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based payment award, vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Restricted Stock Units | Share-based Payment Arrangement, Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based payment award, vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Restricted Stock Units | Share-based Payment Arrangement, Tranche Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based payment award, vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Restricted Stock Awards | RA Session II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based payment award, RSU/RSA granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,845,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,529,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">1,434,934<span></span>
</td>
<td class="nump">3,390,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate', window );">Share-based payment award, commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-based payment award, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance', window );">Percentage of automatic increase every year in common stock shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Share-based payment award, terms of award issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">At December 31, 2020, there were 2,941,509 shares available for future grant under the New Plan. The number of shares of common stock reserved for issuance under the New Plan will automatically increase on January 1 of each year, for a period of ten years, from January 1, 2021 continuing through January 1, 2030, by 5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#8217;s board of directors.&#160;&#160;On January 1, 2021 the board of directors increased the number of common stock reserved for issuance under the New Plan by 1,434,934 shares.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">964,750<span></span>
</td>
<td class="nump">2,586,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based payment award, options, weighted-average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.73<span></span>
</td>
<td class="nump">$ 17.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of automatic increase every year in common stock shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options replacement units grants in period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options grants in period grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tsha_CancelledOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tsha_CancelledOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=tsha_CertainEmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=tsha_CertainEmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=tsha_ShareBasedCompensationAwardTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=tsha_ShareBasedCompensationAwardTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=tsha_FounderPresidentAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=tsha_FounderPresidentAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844059243336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options (Details) - Stock Options<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.07%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844064920280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock Option Activity (Details) - Stock Options<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding. Stock Options, Beginning Balance | shares</a></td>
<td class="nump">674,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted, Stock Options | shares</a></td>
<td class="nump">2,586,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled or forfeited, Stock Options | shares</a></td>
<td class="num">(47,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding. Stock Options, Ending Balance | shares</a></td>
<td class="nump">3,213,692<span></span>
</td>
<td class="nump">674,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at June 30, 2021, Stock Options | shares</a></td>
<td class="nump">3,213,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options exercisable at June 30, 2021, Stock Options | shares</a></td>
<td class="nump">43,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares</a></td>
<td class="nump">$ 20.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">26.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled or forfeited, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">28.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares</a></td>
<td class="nump">25.18<span></span>
</td>
<td class="nump">$ 20.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and expected to vest at June 30, 2021, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">25.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at June 30, 2021, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 20.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted Average Remaining Contractual Life</a></td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest at June 30, 2021, Weighted Average Exercise Price</a></td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at June 30, 2021, Weighted Average Exercise Price</a></td>
<td class="text">9 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value, Beginning Balance | $</a></td>
<td class="nump">$ 3,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value, Ending Balance | $</a></td>
<td class="nump">786<span></span>
</td>
<td class="nump">$ 3,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at June 30, 2021, Aggregate Intrinsic Value | $</a></td>
<td class="nump">786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at June 30, 2021, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844058155112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Number of Shares, Beginning Balance | shares</a></td>
<td class="nump">2,850,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Number of Shares | shares</a></td>
<td class="num">(629,730)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled or forfeited, Number of Shares | shares</a></td>
<td class="num">(167,186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Number of Shares, Ending Balance | shares</a></td>
<td class="nump">2,053,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 6.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">5.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">5.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance | $ / shares</a></td>
<td class="nump">$ 6.80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844058379400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details) - Restricted Stock Awards - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Number of Shares, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(298,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Number of Shares, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share</a></td>
<td class="nump">$ 5.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844068016632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 4,549<span></span>
</td>
<td class="nump">$ 8,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">2,214<span></span>
</td>
<td class="nump">3,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,335<span></span>
</td>
<td class="nump">$ 4,350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844052580568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (40,926)<span></span>
</td>
<td class="num">$ (21,220)<span></span>
</td>
<td class="num">$ (72,950)<span></span>
</td>
<td class="num">$ (26,651)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding, basic and diluted</a></td>
<td class="nump">37,479,164<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
<td class="nump">37,237,115<span></span>
</td>
<td class="nump">10,894,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share, basic and diluted</a></td>
<td class="num">$ (1.09)<span></span>
</td>
<td class="num">$ (1.95)<span></span>
</td>
<td class="num">$ (1.96)<span></span>
</td>
<td class="num">$ (2.45)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844060496472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">5,737,044<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">2,053,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">470,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">3,213,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tsha_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tsha_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tsha_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844065090472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($) </div>
<div>PromissoryNote</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tsha_PBMCapitalGroupLLCMember', window );">PBM Capital Group, LLC | Services Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Accounting and other administrative and management services fee per month</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tsha_PBMTGTHoldingsLLCMember', window );">PBM TGT Holdings, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement', window );">Additional consideration payable under operating agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=tsha_FounderPresidentAndChiefExecutiveOfficerMember', window );">RA Session II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_NumberOfSecuredPromissoryNotes', window );">Number of secured promissory notes | PromissoryNote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Paul B. Manning | Services Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OwnershipPercentageInExcessOfCapitalStock', window );">Ownership percentage more than capital stock</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=tsha_SecuredPromissoryNotesMember', window );">Secured Promissory Notes | RA Session II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount, related party transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 1,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional consideration to related party under operating agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_NumberOfSecuredPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of secured promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_NumberOfSecuredPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_OwnershipPercentageInExcessOfCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership percentage in excess of capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_OwnershipPercentageInExcessOfCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tsha_PBMCapitalGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tsha_PBMCapitalGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=tsha_ServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=tsha_ServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tsha_PBMTGTHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tsha_PBMTGTHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=tsha_FounderPresidentAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=tsha_FounderPresidentAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=tsha_SecuredPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=tsha_SecuredPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844068076824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844060486120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 11, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 17, 2020 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_BuildToSuitLeaseLiability', window );">Build-to-suit lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,209,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=tsha_DallasLeaseMember', window );">Dallas Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseIncentiveReceivable', window );">Lease construction incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_DurhamLeaseMember', window );">Durham Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits', window );">Number of operating lease landlord square feet manufacturing facility | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperationsCommencedDate1', window );">Operating lease commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease extend term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_OperatingLeasesInitialDirectCosts', window );">Operating leases initial direct costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_BuildToSuitAsset', window );">Build-to-suit asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_BuildToSuitLeaseLiability', window );">Build-to-suit lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility', window );">Equipment purchases and build-out of leased Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_DallasLeaseMember', window );">Dallas Lease | Pegasus Park L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits', window );">Number of operating lease landlord square feet manufacturing facility | ft&#178;</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperationsCommencedDate1', window );">Operating lease commencement date</a></td>
<td class="text">May 27,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term of contract</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease extend term of contract</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease, option to extend description</a></td>
<td class="text">Company has an option to extend the term of the Dallas Lease for one additional period of five years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend', window );">Lease, option to extend</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace', window );">Obligation for payment of initial base rent for office space</a></td>
<td class="nump">$ 32,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease', window );">Maximum estimated monthly base rent increase annually during term of lease</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="nump">$ 32,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot', window );">Maximum construction allowance provided by landlord per rentable square foot | ft&#178;</a></td>
<td class="nump">40.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future minimum lease payments</a></td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_BuildToSuitAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Build-to-suit asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_BuildToSuitAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_BuildToSuitLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Build-to-suit lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_BuildToSuitLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equipment purchases and build-out of leased facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum construction allowance provided by landlord per rentable square foot.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum estimated monthly base rent increase annually during term of lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligation for payment of initial base rent for office space.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_OperatingLeasesInitialDirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating leases initial direct costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_OperatingLeasesInitialDirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseIncentiveReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents a receivable for an incentive or inducement contractually stipulated between parties to a lease whereby the lessor has committed to provide the entity (lessee) with a cash payment as inducement to enter the lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121549951&amp;loc=d3e40019-112707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121549951&amp;loc=d3e40010-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseIncentiveReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether lessee has option to extend operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperationsCommencedDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the operations of the entity commenced, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperationsCommencedDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of units (items of property) under operating lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=tsha_DallasLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=tsha_DallasLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_DurhamLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_DurhamLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_DallasLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_DallasLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_PegasusParkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_PegasusParkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844056556392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - Subsequent Event<br></strong></div></th>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($) </div>
<div>Program</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Aug.  01,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest rate</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentOfFacility', window );">Percentage of prepayment of facility</a></td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants associated with loan facility</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing capacity</a></td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember', window );">Through December 31, 2021 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember', window );">January 1, 2022 until September 30, 2022 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeStart1', window );">Debt instrument, maturity start date</a></td>
<td class="text">Jan.  01,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1', window );">Debt instrument, maturity end date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember', window );">October 1, 2022 until March 31, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeStart1', window );">Debt instrument, maturity start date</a></td>
<td class="text">Oct.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1', window );">Debt instrument, maturity end date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_NumberOfDistinctAndActiveClinicalStage', window );">Number of distinct and active clinical stage | Program</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember', window );">April 1, 2023 until December 31, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeStart1', window );">Debt instrument, maturity start date</a></td>
<td class="text">Apr.  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1', window );">Debt instrument, maturity end date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember', window );">Through August 13, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentPremium', window );">Percentage of prepayment premium</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember', window );">Through August 13, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentPremium', window );">Percentage of prepayment premium</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_NumberOfDistinctAndActiveClinicalStage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of distinct and active clinical stage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_NumberOfDistinctAndActiveClinicalStage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfPrepaymentOfFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment of facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfPrepaymentOfFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfPrepaymentPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment premium</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfPrepaymentPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Latest date the outstanding debt instruments are required to be repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateRangeEnd1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateRangeStart1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earliest date the outstanding debt instruments are required to be repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateRangeStart1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=tsha_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=tsha_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>98
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#YOF/M$A5T*/'0-OLS&.7R%?E\CL"/*(?)*I"36@!B+X-MX!EC55MJ=ZS5#
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M9L+H-G; </U&Z2ZWLI4N#KDP@M"!A]D5:SR!G>0)-;^9/9.*+.4V;>6&P]V
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M7KANF.,[$2AK@/L+*<W+Q-ZZS5O6^!]02P,$%     @ F$004WZ;EKAN!
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MWFSN*4EI61NHWW><R^>=^BU9]Z)V_2]02P,$%     @ F$004PH\P'>& @
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MQ \>%CDP2^]:HR6Y4 @S;C-:&V),_@A"=Z?2J *M^P W3XVD%SB^QJ7,)9W
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MK.#*&L#O&PD=7'MC)^@^85W]!U!+ P04    " "81!!3>2RG#.X*   ['
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M6.NZ!SK,?S,)X$.RN^&#TB"B(Q0\E2@@^Q9M'ZOZ4.8!NTU.X$#I\4XMP%;
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M!X!>_N*2+J*K^2O'PL7H*OZYQIB@/"W <WI=U5[0 =UGK\O? %!+ P04
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M-=[J0#L!_+]6V!*[A3,PW!,7_P)02P,$%     @ F$004X_V>G2L#P  JC0
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M@<ZR0%1VRHM^"?+5?<"?D*5O6,$?S\B4\H**FKQ\_T_,RVS ML>T$NR($VQ
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M[Y]X3ZB^.+/A7Z,LC',FXX]K(*HJZ '<7QKCJB^T0?WSI.?_!E!+ P04
M" "81!!30/?SSOD*  !I(P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6S-6FMS&[L-_2L<-6F3&4669%MV7IZQG=S7)#>>F[3]T.D':I>2F.PN-R37
MLOOK>P!R'WI&;M)I9^YU)"T)@, !<$#IU=+8+VZAE!=W>5:XU[V%]^6+HR.7
M+%0NW<"4JL"3F;&Y]'AKYT>NM$JFO"G/CL;#X>0HE[KH7;SBSV[LQ2M3^4P7
MZL8*5^6YM/=7*C/+U[U1K_[@#SU?>/K@Z.)5*>?JH_)_+6\LWATU4E*=J\)I
M4PBK9J][EZ,75R>TGA?\3:NEZ[P6=)*I,5_HS:_IZ]Z0#%*92CQ)D/CG5EVK
M+"-!,.-KE-EK5-+&[NM:^D]\=IQE*IVZ-MG?=>H7KWOG/9&JF:PR_X=9_J+B
M>4Y)7F(RQW_%,JX=]D12.6_RN!D6Y+H(_\J[Z(=#-HSCAC';'12QE6^DEQ>O
MK%D*2ZLAC5[P47DWC-,%!>6CMWBJL<]??/0F^;(P6:JL^XMX^[72_EX\>:-F
M.M'^:5]<F^)66:^GF1(W<)BR5J6"=PE9I.*3E06 (MYI.=49-K\Z\C"+A!\E
MT82K8,)XAPD3\=X4?N'$VR)5Z>K^(QRG.=.X/M/5>*_ WZIB((Z'?3$>CD=[
MY!TW/CIF><<[Y$6O_.-RZKP%C/ZY1^9)(_.$99[\+_V^UP1*]Q>NE(EZW4,^
M.V5O5>_B=^.5./WSG\['H_'+KI'\T=G+'V&JN*S\PEC]+UJVD- M/N'YM<E+
M6=P+B9P'$(3V3B0D&(HDK#(SH8O$V-)8R1F-_]Y+FRS$"8<: ?^MRN[%.+QC
MW7*.ND0+PY/S^,A5V.47TN./$MYXF8FBRJ?*DA87;,*KQ.0Y-KMPEM9J;\14
M">U<A3=+Z<@PE$07'AV/^Y/ST_YP"(O(B/TZRL9E#U0S.NU/3L[ZPU,<&'*6
M"XU#C8:L%_]W!0=E2V45*I;3\P+^A.^5U?CX$L=L([AA#@[0*-HEXFJ?B('X
M4&!AZ14?O@Y"G_WRX*#_=T,W'C;^.R1V!;K.0^+71F<@+ED":I5J:A5K?*.2
MX*CC4>VHPNS!"X<DZC"PK_+.0XXNY@/QZ\V'0YP?=TLTR?G<JGET_%G_?/*\
M?SJ9['(K4HO$0$MPEEE1]?P!JD;]T?FP?W)\LDM559J@K ),[-)JWZE)ZD[9
M1#M%!LVJ+*/=6*OAC9)!@T"4%2H%PBQDFFKZ$"$-NOI"26 J(JJLIIE.( %.
MA@_A;IVPB8_&PP%E%8[&^T2FG&O-H;6I=HFI"D"8O$'VX[A0Y1")@E*DB%QD
MJ?VB=5W7/Q;1!TU)Q=P:B"^M291*V1^/1N>CP1 D(,L@HQ\3GF %8QWXVS2X
M%]5609GS.!G G56$A:U^VVDO%Q190ON=!O-1J)V/1J>#4:U\T-8.VKDW_0F
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M1)1^'E<;IQT$C"W3]?JX)#.#YY0>G.-4/L()9N@O9DF;(X6%?L3:57E@""_
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MCTR/%2[N[.4 WI<. [5?B(/A7X&S?P%02P,$%     @ F$004T 06VW] P
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M@X\2]F* ][5#9QT7XF#ZS-G^ U!+ P04    " "81!!30R>]B*@'  "[%
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MXZG!OGA]ZZK*1&0Y!J7K4MVZ.IIZ275A*%R.(USPPG&1S;U.YF9/F'NAWL/
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M(X4MV3)MD?Z&T2.(Z 3!@#@].?HGK[CV41=&X0&EXY.:-R9MGQS]FQ<@F)P
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M%Z((/8Z[.PX[<&3'&"($HN"R+YG>=%GKQLFC-$WG)JJWPGNP^^(K,2H:(DG
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M(W"J(2-SIE(N5"VQ.+_O5TI+/*%_SH0+VW"A#1>]$^Y0>G0,5*:Y+7T&6[R
M%5XGW5?/O<?8>C3W>#N-AWX\=K?'5>L:!5$<M$9O8*,6-KH(=B7*NG>G]_+!
M45#?'P4G9%VCR!OU@PU:L,%%8*S$+3+;UP<WZ,1-@M.J=6V"*/'ZX>(6+KX(
M+L4%EE).M&24]Q'&W?(ET0EAUV841?V PQ9P>!;0WO0^GF&7Q_-/@;I&8>CW
M R4M4'(6Z$EH+%/5U V.NY*P72EMNA*U7:D//>D<_]$H/#V)7:,X/CH2>W;W
MJ/V:I^\[E1L\9X3#&F7>[1!3E_OG9#_1HK(=>24T]G<[S/$%!FD,<'TMA#Y,
M3)-OW_3I?U!+ P04    " "81!!3]\CR#EL#  #Y#   &0   'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6RU5]&.FS@4_14+]:&5I@,V"0E5$FDFTU%G-;N*
MFK;[L.J#!VX2JV!3VTQF_GYMAP$F(6RU%2_!AGON/?=@GYC97L@?:@>@T5.>
M<37W=EH7'WQ?)3O(J;H4!7#S9"-D3K69RJVO"@DT=: \\TD01'Y.&?<6,W=O
M)1<S4>J,<5A)I,H\I_+Y&C*QGWO8>[GQF6UWVM[P%[.";F$-^FNQDF;FUUE2
ME@-73' D83/WKO"')0DLP$5\8[!7K3&RK3P(\<-.[M*Y%UA&D$&B;0IJ+H^P
MA"RSF0R/GU52KZYI@>WQ2_9;U[QIYH$J6(KL;Y;JW=R;>BB%#2TS_5GL/T'5
MT-CF2T2FW"_:5[&!AY)2:9%78,,@9_QPI4^5$"T 'IT!D I ?A405H#0-7I@
MYMJZH9HN9E+LD;31)IL=.&T<VG3#N'V-:RW-4V9P>G%-,\H30&NW9I8B+P0'
MKA5ZC]9FR:1E!DALT$J:A2/U,UJ9<(TH3]''GR4KS O5%^@O WU[ YJR[)T!
M?EW?H+=OWJ$WB''T92=*9>+5S->&KZWJ)Q6WZP,W<H;;'R6_1&%P@4A < =\
MV0^_@<3 L8,'K^&^4:F6BM12$9<O/)/O2(.KM@;HGWL3C>XTY.I[3ZVPKA6Z
M6J/_J'6!BEIP: 3?2J$Z!3UDC5Q6NX,?%V$8Q^',?VSK=AI%XJB.>45X5!,>
M]1*^2I(R+S.J(36[R#A*PJC=IUTD#YG&K?+O,8F..'8$Q=T4QS7%\>]HRD%W
MD1V?\ C#:30Y8GL:1::3;KI133?JI7L/QIUV(DO175Y(\0B6INI96Y,Z\63P
M=3RM:TT'6<?3$SWQ- J[!8UK+G$OE]M2<J9+"8[%+7NRXSY!<="8:#"XI+AE
MV7@04:NT;56CR9E]CQM7Q*27C?W/*#7(IN.^)AL#Q.'PDC;NA?OMZW]+>FI3
M8Q(?F4-'4#P^(WMC9KC?S>[I@Y!4"_G\:\(WMH.CX85OO A/AA%^<J+I* K.
MB-JX%>ZWJZ7@2LOR<,(TAQ?#;FL\HM<D&OO!\>#"DL:22#"(L%7:5T>(8!2-
MC]9T1Q@)\)'^?NM<:C\*_J1RR[A"&6P,*KB<F-<G#^?LPT2+PAU5'X0V!U\W
MW)EO$Y VP#S?"*%?)O;T6W_M+/X%4$L#!!0    ( )A$$%/(IZ&MO@(  !$(
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;+56;6_:,!#^*U:T#ZVT
M-B$!4E6 !(1IG5H)%77[,.V#FQQ@U;%3^U+HOY_MA(SR)K1I7XA?[GF>N_/I
MCMY*JA>]!$"RSKG0?6^)6-SZODZ7D%-]+0L0YF8N54[1;-7"UX4"FCE0SOTP
M"+I^3IGP!CUW-E6#GBR1,P%31729YU2]CX#+5=]K>9N#1[98HCWP![V"+F &
M^%1,E=GY#4O&<A":24$4S/O>L'4[B:V],_C.8*6WUL1&\BSEB]W<97TOL X!
MAQ0M S6?-Q@#YY;(N/%:<WJ-I 5NKS?L7USL)I9GJF$L^0^6X;+OW7@D@SDM
M.3[*U5>HX^E8OE1R[7[)JK*- X^DI4:9UV#C0<Y$]:7K.@]; ,-S&!#6@' 7
MT#X"B&I =*Y"NP:TSU7HU  7NE_%[A*74*2#GI(KHJRU8;,+EWV'-OEBPM;)
M#)6Y90:'@Q'E5*1 9JXHQS(OI "!FER1898Q^YB4DSM15:1]VHL$D#*N+XW)
MTRPA%Y\N>SX:5RRAG]:RHTHV/"(;D0<I<*G)1&20'< GI_'=$WC?I*#)0[C)
MPR@\2?BM%-<D"CZ3, A;!_P9GP\/#H7S;^J3OU;_D(RH*8K(\45'^*;*]"&%
M[V1JB@/)4&1D\EJRPO0')#_OC36Y0\CUKQ-:[4:K[;3:1[02,/TM955MP=KT
M/PV'ZJEBZ3H6V_S>!C>=(##1OFV_TK[5CD6R;]%JQ7M$DU-$'^+L-'%V3L8Y
M*AG/KE!>S4J&Y![H;I@?6+L-:_>_OU3<:,4G(QA+H5&558-G@A1*+A1H?>BU
MXKWT14$4!'MY3LXPK)SUMWI<#FKAAHLFJ2P%5I7=G#;S:^C:]L[YJ'4[;ATX
M3\R\J\;3'_IJ6#Y0M6!"$PYS(Q5<Q^:E536 J@W*PG789XFF7[OETLQL4-;
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M@E4@-)."*-C,O.OP[2*S]L[@.X.=/A@3F\E:RM]V\K&8>8$% @ZYL1XH_CW
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MTMI1M'8ZT?H'*BX>F)2='F4<16UGNZCMU,[7/YC:A;X.3;FCJ.V8J7U?]'W
M3)A^5_HA0TEQ8!@HHNM0Y+R3Y(XBN6,F>946!7I^)D$4?9WM.KUV%)$=,Y$?
MC*2)9X&_R'^+AZ2ALT 7I)MBBN$:=$Q'NXYBN6,^>G@$ENSJ4,+XYE%<5GWC
M5QID1XM@<\1*&D'JO1TNC"YMGI0W\*A?>TT".M1%]E:2@!(/3[WY#V'5W>K-
MI^/L_8\W]T_P_CG6W+_ ^U>Z^]=X_W/^OI.:-G_]ZH;RA0_)$K YF&#MC6 3
M\?R-IOR#C%?9RQNS6,HXS"Z7C'J,IP/@^WD<R_)#.D'U7MG1_U!+ P04
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MY5]O]C#?N&]9G?JBCM%H%_72LP:IP^A)'0I S +]F69?T'E*"/K,+) Y!E*
MX0V S"8@ORDOO/?<*=7D(B*L6Z;Q:IUW;9MJR7J7H!UIFN4)INR01DQY&E$,
MP]G7%0ER]L&?2<@Z'JZYS%>0*,PAGKN8@.AFWY.7 6)1+LF';K5@")I*L_;
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M!!B--X#G\R1AFR_\Y<;JA=SS_P-02P,$%     @ F$004^OV]R*M @  <@<
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M&#'9YVN,Z<V"BX@I:HJE)M<"F9\*1:%FZKJC12R(>Y-QVG<K)F.^46$0XZT
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MZ_UWM\72.8*66(ZU9G*&5,P6)G>P.>Z4W?GN\8KI KY](9=P;+$TWW< '31
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MQ,C<-;N9--@ZW3#%UPTH:X#[<RG-9F(/J-Y+_;]02P,$%     @ F$004]4
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MG8V<&P>E9(T+IA_$_@.I],2&;R68LK]H7\5Z#EH52HN\ L,.<LK+?_Q:^=
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M9O#=0J0)@/FU$/K0,0O47T+CWU!+ P04    " "81!!38ZR8!5,#  "V#
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MUSV;4Y4K=$_E([J%O[%KGM;6C=_+NW%MWOA_=^\1;K#O8.\HD-J]R=N[]^@
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M"T8C)DT#>&\D6M^8ST'5!\;A?U!+ P04    " "81!!3R_ I%9@$  #,%0
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MZK ^L6I1O:Z;*&M57AW.82,MM&L UZ=*V><3]P:P?8$[_A]02P,$%     @
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MH),!  #B&   &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=E-CH)
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M1[WS=^H=XK7RX=GS6./]WTEUO%WKG[>_+Q^;O8=PQ]G!+XW5+U!+ P04
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M79-:E<W1GW7_2>:?4$L! A0#%     @ F$004P=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "81!!3
M+>N6PNX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " "81!!3F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )A$$%,UL%7M=P4
M +T6   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    " "81!!3]E[)@1(%   6$P  &               @(&Z
M#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ F$004R*H
M]%'8 @  <0D  !@              ("! A,  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    ( )A$$%-^FY:X;@0  !P0   8
M  " @1 6  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "8
M1!!3<9><?]\%  "T'0  &               @(&T&@  >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @ F$004PH\P'>& @  3@8  !@
M         ("!R2   'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   ( )A$$%/.PN=\B 8  ,X:   8              " @84C  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "81!!3>2RG#.X*   ['
M&               @(%#*@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @ F$004S#,<\=7"@   AL  !@              ("!9S4  'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( )A$$%.I/&- 2@0
M #,*   9              " @?0_  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @ F$004X_V>G2L#P  JC0  !D              ("!
M=40  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "81!!3
M0/?SSOD*  !I(P  &0              @(%85   >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    ( )A$$%/8'MT <@L  .L@   9
M      " @8A?  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @ F$004S %.$,&!   CPD  !D              ("!,6L  'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "81!!3G*>?IU<%   6#
M&0              @(%N;P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    ( )A$$%- $%MM_0,  /((   9              " @?QT  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ F$004T,GO8BH
M!P  NQ0  !D              ("!,'D  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    " "81!!3(KU3QDT%  "0#0  &0
M@($/@0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( )A$
M$%.L?/B[;0H  !0<   9              " @9.&  !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @ F$004R"31RD&!   -@H  !D
M         ("!-Y$  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    " "81!!3S8V*@H<%   P#P  &0              @(%TE0  >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( )A$$%,$.D3:]0,  &\)
M   9              " @3*;  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @ F$004UG>;(3V!0  _AP  !D              ("!7I\
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "81!!3JI%Y
MY-@"  #?!P  &0              @(&+I0  >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    ( )A$$%/WR/(.6P,  /D,   9
M  " @9JH  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
MF$004\BGH:V^ @  $0@  !D              ("!+*P  'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    " "81!!34(@+C0X#  "7"   &0
M            @($AKP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    ( )A$$%-8,#,W@@<  &,F   9              " @6:R  !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ F$004QD^T0E""@
MZC\  !D              ("!'[H  'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    " "81!!3O$X'GBH*  "<.P  &0              @(&8
MQ   >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( )A$$%/K
M]O<BK0(  '('   9              " @?G.  !X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @ F$004[<*3MZ1!   ,1,  !D
M     ("!W=$  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
M" "81!!3IX7SV!T#  "Q"0  &0              @(&EU@  >&PO=V]R:W-H
M965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( )A$$%. X=JQVP(  *@(   9
M              " @?G9  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L!
M A0#%     @ F$004XCIMY#Z @  .PD  !D              ("!"]T  'AL
M+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "81!!3U0#F;!8#
M   5"0  &0              @($\X   >&PO=V]R:W-H965T<R]S:&5E=#,V
M+GAM;%!+ 0(4 Q0    ( )A$$%-CK)@%4P,  +8,   9              "
M@8GC  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ F$00
M4V'R'D+F P  YPP  !D              ("!$^<  'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    " "81!!3-D+A*Q("  !A!   &0
M        @($PZP  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   ( )A$$%/<V&1E) 4  &P4   9              " @7GM  !X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ F$004\OP*168!   S!4
M !D              ("!U/(  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q0
M2P$"% ,4    " "81!!39CJ7QQ\#   8$@  #0              @ &C]P
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( )A$$%.7BKL<P    !,"   +
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4!08     ,0 Q $X-  !3 P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>183</ContextCount>
  <ElementCount>332</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Organization and Description of Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperations</Role>
      <ShortName>Organization and Description of Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Research, Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreements</Role>
      <ShortName>Research, Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability</Role>
      <ShortName>Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Net Loss Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShare</Role>
      <ShortName>Net Loss Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponents</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Net Loss Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareTables</Role>
      <ShortName>Net Loss Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShare</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Organization and Description of Business Operations - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails</Role>
      <ShortName>Organization and Description of Business Operations - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Balance Sheet Components - Schedule of Property Plant and Equipment, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail</Role>
      <ShortName>Balance Sheet Components - Schedule of Property Plant and Equipment, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Balance Sheet Components - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails</Role>
      <ShortName>Balance Sheet Components - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Research, Collaboration and License Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails</Role>
      <ShortName>Research, Collaboration and License Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails</Role>
      <ShortName>Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="tsha-10q_20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="tsha-10q_20210630.htm">tsha-10q_20210630.htm</File>
    <File>tsha-20210630.xsd</File>
    <File>tsha-20210630_cal.xml</File>
    <File>tsha-20210630_def.xml</File>
    <File>tsha-20210630_lab.xml</File>
    <File>tsha-20210630_pre.xml</File>
    <File>tsha-ex101_249.htm</File>
    <File>tsha-ex102_932.htm</File>
    <File>tsha-ex311_7.htm</File>
    <File>tsha-ex312_6.htm</File>
    <File>tsha-ex321_9.htm</File>
    <File>tsha-ex322_8.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g3dyckr3udth000001.jpg</File>
    <File>g3dyckr3udth000002.jpg</File>
    <File>g3dyckr3udth000003.jpg</File>
    <File>g3dyckr3udth000004.jpg</File>
    <File>g3dyckr3udth000005.jpg</File>
    <File>g3dyckr3udth000006.jpg</File>
    <File>g3dyckr3udth000007.jpg</File>
    <File>g3dyckr3udth000008.jpg</File>
    <File>g3dyckr3udth000009.jpg</File>
    <File>g3dyckr3udth000010.jpg</File>
    <File>g3dyckr3udth000011.jpg</File>
    <File>g3dyckr3udth000012.jpg</File>
    <File>g3dyckr3udth000013.jpg</File>
    <File>g3dyckr3udth000014.jpg</File>
    <File>g3dyckr3udth000015.jpg</File>
    <File>g3dyckr3udth000016.jpg</File>
    <File>g3dyckr3udth000017.jpg</File>
    <File>g3dyckr3udth000018.jpg</File>
    <File>g3dyckr3udth000019.jpg</File>
    <File>g3dyckr3udth000020.jpg</File>
    <File>g3dyckr3udth000021.jpg</File>
    <File>g3dyckr3udth000022.jpg</File>
    <File>g3dyckr3udth000023.jpg</File>
    <File>g3dyckr3udth000024.jpg</File>
    <File>g3dyckr3udth000025.jpg</File>
    <File>g3dyckr3udth000026.jpg</File>
    <File>g3dyckr3udth000027.jpg</File>
    <File>g3dyckr3udth000028.jpg</File>
    <File>g3dyckr3udth000029.jpg</File>
    <File>g3dyckr3udth000030.jpg</File>
    <File>g3dyckr3udth000031.jpg</File>
    <File>g3dyckr3udth000032.jpg</File>
    <File>g3dyckr3udth000033.jpg</File>
    <File>g3dyckr3udth000034.jpg</File>
    <File>g3dyckr3udth000035.jpg</File>
    <File>g3dyckr3udth000036.jpg</File>
    <File>g3dyckr3udth000037.jpg</File>
    <File>g3dyckr3udth000038.jpg</File>
    <File>g3dyckr3udth000039.jpg</File>
    <File>g3dyckr3udth000040.jpg</File>
    <File>g3dyckr3udth000041.jpg</File>
    <File>g3dyckr3udth000042.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>104
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tsha-10q_20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 183,
   "dts": {
    "calculationLink": {
     "local": [
      "tsha-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tsha-20210630_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tsha-10q_20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tsha-20210630_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tsha-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "tsha-20210630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 430,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 18,
    "http://tayshagtx.com/20210630": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 23
   },
   "keyCustom": 63,
   "keyStandard": 269,
   "memberCustom": 40,
   "memberStandard": 25,
   "nsprefix": "tsha",
   "nsuri": "http://tayshagtx.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Balance Sheet Components",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Research, Collaboration and License Agreements",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreements",
     "shortName": "Research, Collaboration and License Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability",
     "shortName": "Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Stock-Based Compensation",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Net Loss Per Common Share",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShare",
     "shortName": "Net Loss Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Related Party Transactions",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Income Taxes",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Commitments and Contingencies",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Subsequent Events",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Balance Sheet Components (Tables)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Net Loss Per Common Share (Tables)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareTables",
     "shortName": "Net Loss Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Organization and Description of Business Operations - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
     "shortName": "Organization and Description of Business Operations - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "tsha:PrepaidResearchAndDevelopmentContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail",
     "shortName": "Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "tsha:PrepaidResearchAndDevelopmentContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Balance Sheet Components - Schedule of Property Plant and Equipment, Net (Detail)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail",
     "shortName": "Balance Sheet Components - Schedule of Property Plant and Equipment, Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210401_20210630",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Balance Sheet Components - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
     "shortName": "Balance Sheet Components - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "tsha:AccruedResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "tsha:AccruedResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Research, Collaboration and License Agreements - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
     "shortName": "Research, Collaboration and License Agreements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapTypeOfArrangementAxis_tshaAcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_20210101_20210630",
      "decimals": "INF",
      "lang": null,
      "name": "tsha:AdditionalMilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20200928",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20200928",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_tshaEmployeeStockPurchasePlanMember_20200916",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210401_20210630",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
     "shortName": "Stock-Based Compensation - Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20210630",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
     "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
     "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210401_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails",
     "shortName": "Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210401_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210401_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
     "shortName": "Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210401_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
     "shortName": "Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMCapitalGroupLLCMember_20200301_20200331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapRelatedPartyTransactionAxis_tshaServicesAgreementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_tshaPBMCapitalGroupLLCMember_20200301_20200331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210401_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210401_20210630",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "tsha:BuildToSuitLeaseLiability",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapLeaseContractualTermAxis_tshaDallasLeaseMember_20210630",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:LeaseIncentiveReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Subsequent Events - Additional Information (Details)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210811_20210812",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited",
     "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20200101_20200630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "tsha:TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) (Unaudited)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited",
     "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) (Unaudited)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20200101_20200630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "tsha:TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100070 - Disclosure - Organization and Description of Business Operations",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperations",
     "shortName": "Organization and Description of Business Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tsha-10q_20210630.htm",
      "contextRef": "C_0001806310_20210101_20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "verboseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation Date Of Incorporation",
        "terseLabel": "Date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r47",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "verboseLabel": "Paul B. Manning"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r173",
      "r174",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r173",
      "r174",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r171",
      "r173",
      "r174",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r171",
      "r173",
      "r174",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase Agreement Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r133",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_AbeonaCLN1AgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abeona CLN1 agreements.",
        "label": "Abeona C L N1 Agreements [Member]",
        "verboseLabel": "Abeona CLN1 Agreements"
       }
      }
     },
     "localname": "AbeonaCLN1AgreementsMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_AbeonaRettAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abeona Rett agreement.",
        "label": "Abeona Rett Agreement [Member]",
        "terseLabel": "Abeona Rett Agreement"
       }
      }
     },
     "localname": "AbeonaRettAgreementMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_AbeonaTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abeona Therapeutics Inc.",
        "label": "Abeona Therapeutics Inc [Member]",
        "terseLabel": "Abeona"
       }
      }
     },
     "localname": "AbeonaTherapeuticsIncMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_AccruedClinicalTrialCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued clinical trial current.",
        "label": "Accrued Clinical Trial Current",
        "terseLabel": "Accrued clinical trial"
       }
      }
     },
     "localname": "AccruedClinicalTrialCurrent",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_AccruedPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued property, plant, and equipment current.",
        "label": "Accrued Property Plant And Equipment Current",
        "terseLabel": "Accrued property, plant, and equipment"
       }
      }
     },
     "localname": "AccruedPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_AccruedResearchAndDevelopmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development current.",
        "label": "Accrued Research And Development Current",
        "terseLabel": "Accrued research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of worldwide rights for TSHA 120 for treatment of giant axonal neuropathy.",
        "label": "Acquisition Of Worldwide Rights For T S H A120 For Treatment Of Giant Axonal Neuropathy [Member]",
        "terseLabel": "TSHA-120"
       }
      }
     },
     "localname": "AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_AdditionalConsiderationToRelatedPartyUnderOperatingAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional consideration to related party under operating agreement.",
        "label": "Additional Consideration To Related Party Under Operating Agreement",
        "terseLabel": "Additional consideration payable under operating agreement"
       }
      }
     },
     "localname": "AdditionalConsiderationToRelatedPartyUnderOperatingAgreement",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_AdditionalMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Milestone payments.",
        "label": "Additional Milestone Payments",
        "terseLabel": "Additional milestone payments"
       }
      }
     },
     "localname": "AdditionalMilestonePayments",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_AllocationOfPreferredStockTrancheLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of preferred stock tranche liability.",
        "label": "Allocation Of Preferred Stock Tranche Liability",
        "terseLabel": "Allocation of preferred stock tranche liability"
       }
      }
     },
     "localname": "AllocationOfPreferredStockTrancheLiability",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_AmountReclassifiedToConvertiblePreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount reclassified to convertible preferred stock.",
        "label": "Amount Reclassified To Convertible Preferred Stock",
        "terseLabel": "Tranche liability amount reclassified to convertible preferred stock"
       }
      }
     },
     "localname": "AmountReclassifiedToConvertiblePreferredStock",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_BuildToSuitAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Build-to-suit asset.",
        "label": "Build To Suit Asset",
        "terseLabel": "Build-to-suit asset"
       }
      }
     },
     "localname": "BuildToSuitAsset",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_BuildToSuitLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10090.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Build-to-suit lease liability.",
        "label": "Build To Suit Lease Liability",
        "terseLabel": "Build-to-suit lease liability"
       }
      }
     },
     "localname": "BuildToSuitLeaseLiability",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_BuildToSuitLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Build-to-suit lease.",
        "label": "Build To Suit Lease [Member]",
        "terseLabel": "Build-to-Suit Lease"
       }
      }
     },
     "localname": "BuildToSuitLeaseMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_BuildToSuitLeasePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Build-to-suit lease.",
        "label": "Build To Suit Lease Policy [Text Block]",
        "terseLabel": "Build-to-Suit Lease"
       }
      }
     },
     "localname": "BuildToSuitLeasePolicyTextBlock",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tsha_CancelledOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cancelled options.",
        "label": "Cancelled Options [Member]",
        "terseLabel": "Cancelled Options"
       }
      }
     },
     "localname": "CancelledOptionsMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_CertainEmployeesAndConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain employees and consultants.",
        "label": "Certain Employees And Consultants [Member]",
        "terseLabel": "Certain Employees and Consultants"
       }
      }
     },
     "localname": "CertainEmployeesAndConsultantsMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_ChangeInFairValueOfPreferredStockTrancheLiability": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10120.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10030.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value preferred stock tranche liability.",
        "label": "Change In Fair Value Of Preferred Stock Tranche Liability",
        "negatedLabel": "Change in fair value of preferred stock tranche liability",
        "terseLabel": "Change in fair value of preferred stock tranche liability",
        "verboseLabel": "Non cash expenses due to remeasured fair value of tranche liability"
       }
      }
     },
     "localname": "ChangeInFairValueOfPreferredStockTrancheLiability",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical, regulatory and commercial milestones to be received.",
        "label": "Clinical Regulatory And Commercial Milestones To Be Received",
        "terseLabel": "Clinical, regulatory and commercial milestones to be received"
       }
      }
     },
     "localname": "ClinicalRegulatoryAndCommercialMilestonesToBeReceived",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_CommonStockIncreaseInOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock increase in outstanding shares.",
        "label": "Common Stock Increase In Outstanding Shares",
        "positiveLabel": "Increase in outstanding shares"
       }
      }
     },
     "localname": "CommonStockIncreaseInOutstandingShares",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "tsha_ConvertiblePreferredStockTrancheLiabilityLiquidityTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred stock tranche liability liquidity term.",
        "label": "Convertible Preferred Stock Tranche Liability Liquidity Term",
        "terseLabel": "Convertible preferred stock tranche liability, term"
       }
      }
     },
     "localname": "ConvertiblePreferredStockTrancheLiabilityLiquidityTerm",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "tsha_ConvertiblePreferredStockTrancheLiabilityMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred stock tranche liability measurement input.",
        "label": "Convertible Preferred Stock Tranche Liability Measurement Input",
        "terseLabel": "Convertible preferred stock tranche liability, measurement input"
       }
      }
     },
     "localname": "ConvertiblePreferredStockTrancheLiabilityMeasurementInput",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "tsha_ConvertiblePreferredStockTrancheLiabilityOfferingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred stock tranche liability offering price.",
        "label": "Convertible Preferred Stock Tranche Liability Offering Price",
        "terseLabel": "Convertible preferred stock tranche liability, offering price"
       }
      }
     },
     "localname": "ConvertiblePreferredStockTrancheLiabilityOfferingPrice",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "tsha_DallasLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dallas lease.",
        "label": "Dallas Lease [Member]",
        "terseLabel": "Dallas Lease"
       }
      }
     },
     "localname": "DallasLeaseMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_DurhamLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Durham lease.",
        "label": "Durham Lease [Member]",
        "terseLabel": "Durham Lease"
       }
      }
     },
     "localname": "DurhamLeaseMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan (\u201cESPP\u201d)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_EquipmentPurchasesAndBuildOutOfLeasedFacility": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment purchases and build-out of leased facility.",
        "label": "Equipment Purchases And Build Out Of Leased Facility",
        "terseLabel": "Equipment purchases and build-out of leased Facility"
       }
      }
     },
     "localname": "EquipmentPurchasesAndBuildOutOfLeasedFacility",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_FounderPresidentAndChiefExecutiveOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Founder, president and chief executive officer.",
        "label": "Founder President And Chief Executive Officer [Member]",
        "terseLabel": "RA Session II"
       }
      }
     },
     "localname": "FounderPresidentAndChiefExecutiveOfficerMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10180.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in accrued expense and other liabilities.",
        "label": "Increase Decrease In Accrued Expense And Other Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedExpenseAndOtherLiabilities",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon vesting and settlement of restricted stock units value.",
        "label": "Issuance Of Common Stock Upon Vesting And Settlement Of Restricted Stock Units Value",
        "terseLabel": "Issuance of common stock upon vesting and settlement of restricted stock units"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitsValue",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_IssuanceOfProRataPortionOfMilestoneShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of pro-rata portion of milestone shares.",
        "label": "Issuance Of Pro Rata Portion Of Milestone Shares",
        "verboseLabel": "Milestone pro-rate shares issued during the period"
       }
      }
     },
     "localname": "IssuanceOfProRataPortionOfMilestoneShares",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "tsha_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory Equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_LicenseAgreementCommercialMilestonesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement commercial milestones payment.",
        "label": "License Agreement Commercial Milestones Payment",
        "terseLabel": "License agreement commercial milestones payment"
       }
      }
     },
     "localname": "LicenseAgreementCommercialMilestonesPayment",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_LicenseAgreementRegulatoryMilestonesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement regulatory milestones payment.",
        "label": "License Agreement Regulatory Milestones Payment",
        "terseLabel": "License agreement regulatory milestones payment"
       }
      }
     },
     "localname": "LicenseAgreementRegulatoryMilestonesPayment",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and inventory purchase agreement regulatory related milestones payment.",
        "label": "License And Inventory Purchase Agreement Regulatory Related Milestones Payment",
        "terseLabel": "License and inventory purchase agreement regulatory related milestones payment"
       }
      }
     },
     "localname": "LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and inventory purchase agreement sales related milestones payment.",
        "label": "License And Inventory Purchase Agreement Sales Related Milestones Payment",
        "terseLabel": "License and inventory purchase agreement sales related milestones payment"
       }
      }
     },
     "localname": "LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum construction allowance provided by landlord per rentable square foot.",
        "label": "Maximum Construction Allowance Provided By Landlord Per Rentable Square Foot",
        "terseLabel": "Maximum construction allowance provided by landlord per rentable square foot"
       }
      }
     },
     "localname": "MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "tsha_MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum estimated monthly base rent increase annually during term of lease.",
        "label": "Maximum Estimated Monthly Base Rent Increase Annually During Term Of Lease",
        "terseLabel": "Maximum estimated monthly base rent increase annually during term of lease"
       }
      }
     },
     "localname": "MaximumEstimatedMonthlyBaseRentIncreaseAnnuallyDuringTermOfLease",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input probability of achieving clinical milestones and timing.",
        "label": "Measurement Input Probability Of Achieving Clinical Milestones And Timing [Member]",
        "terseLabel": "Probability of Achieving Clinical Milestones and Timing"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfAchievingClinicalMilestonesAndTimingMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_MileStoneSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mile stone shares issued.",
        "label": "Mile Stone Shares Issued",
        "verboseLabel": "Mile stone shares issued during the period"
       }
      }
     },
     "localname": "MileStoneSharesIssued",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum licensed product to develop obtain regulatory approval for and commercialize.",
        "label": "Minimum Licensed Product To Develop Obtain Regulatory Approval For And Commercialize",
        "terseLabel": "Minimum licensed product to develop obtain regulatory approval for and commercialize"
       }
      }
     },
     "localname": "MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "tsha_NolanCapitalLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nolan capital, limited liability company.",
        "label": "Nolan Capital Limited Liability Company [Member]",
        "terseLabel": "Nolan Capital, LLC"
       }
      }
     },
     "localname": "NolanCapitalLimitedLiabilityCompanyMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_NumberOfDistinctAndActiveClinicalStage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of distinct and active clinical stage.",
        "label": "Number Of Distinct And Active Clinical Stage",
        "terseLabel": "Number of distinct and active clinical stage"
       }
      }
     },
     "localname": "NumberOfDistinctAndActiveClinicalStage",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "tsha_NumberOfSecuredPromissoryNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of secured promissory notes.",
        "label": "Number Of Secured Promissory Notes",
        "terseLabel": "Number of secured promissory notes"
       }
      }
     },
     "localname": "NumberOfSecuredPromissoryNotes",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "tsha_ObligationForPaymentOfInitialBaseRentForOfficeSpace": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligation for payment of initial base rent for office space.",
        "label": "Obligation For Payment Of Initial Base Rent For Office Space",
        "terseLabel": "Obligation for payment of initial base rent for office space"
       }
      }
     },
     "localname": "ObligationForPaymentOfInitialBaseRentForOfficeSpace",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_OperatingLeasesInitialDirectCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating leases initial direct costs.",
        "label": "Operating Leases Initial Direct Costs",
        "terseLabel": "Operating leases initial direct costs"
       }
      }
     },
     "localname": "OperatingLeasesInitialDirectCosts",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization and description of business operations.",
        "label": "Organization And Description Of Business Operations [Line Items]",
        "terseLabel": "Organization and Description of Business Operations [Line Items]"
       }
      }
     },
     "localname": "OrganizationAndDescriptionOfBusinessOperationsLineItems",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "tsha_OrganizationAndDescriptionOfBusinessOperationsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization and description of business operations.",
        "label": "Organization And Description Of Business Operations [Table]",
        "terseLabel": "Organization And Description Of Business Operations [Table]"
       }
      }
     },
     "localname": "OrganizationAndDescriptionOfBusinessOperationsTable",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "tsha_OwnershipPercentageInExcessOfCapitalStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership percentage in excess of capital stock.",
        "label": "Ownership Percentage In Excess Of Capital Stock",
        "terseLabel": "Ownership percentage more than capital stock"
       }
      }
     },
     "localname": "OwnershipPercentageInExcessOfCapitalStock",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tsha_PBMCapitalGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PBM Capital Group, LLC.",
        "label": "P B M Capital Group L L C [Member]",
        "terseLabel": "PBM Capital Group, LLC"
       }
      }
     },
     "localname": "PBMCapitalGroupLLCMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_PBMTGTHoldingsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PBM TGT Holdings, LLC.",
        "label": "P B M T G T Holdings L L C [Member]",
        "terseLabel": "PBM TGT Holdings, LLC"
       }
      }
     },
     "localname": "PBMTGTHoldingsLLCMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_PBMTGTHoldingsLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PBM TGT holdings, limited liability company.",
        "label": "P B M T G T Holdings Limited Liability Company [Member]",
        "terseLabel": "PBM TGT Holdings, LLC"
       }
      }
     },
     "localname": "PBMTGTHoldingsLimitedLiabilityCompanyMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_PaymentOfLicenseFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of license fee.",
        "label": "Payment Of License Fee",
        "terseLabel": "License fee payment"
       }
      }
     },
     "localname": "PaymentOfLicenseFee",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PaymentOfOneTimeUpfrontLicenseFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of one-time upfront license fee.",
        "label": "Payment Of One Time Upfront License Fee",
        "terseLabel": "Payment of one-time upfront license fee"
       }
      }
     },
     "localname": "PaymentOfOneTimeUpfrontLicenseFee",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PaymentsToAcquireLicenseRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to acquire license right.",
        "label": "Payments To Acquire License Right",
        "terseLabel": "Cash payment to acquire license agreement"
       }
      }
     },
     "localname": "PaymentsToAcquireLicenseRight",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PegasusParkLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pegasus Park, LLC.",
        "label": "Pegasus Park L L C [Member]",
        "terseLabel": "Pegasus Park L L C"
       }
      }
     },
     "localname": "PegasusParkLLCMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of automatic increase every year in common stock shares reserved for future issuance.",
        "label": "Percentage Of Automatic Increase Every Year In Common Stock Shares Reserved For Future Issuance",
        "terseLabel": "Percentage of automatic increase every year in common stock shares reserved for future issuance"
       }
      }
     },
     "localname": "PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of common stock shares entitled to receive additional shares on fully diluted basis.",
        "label": "Percentage Of Common Stock Shares Entitled To Receive Additional Shares On Fully Diluted Basis",
        "terseLabel": "Percentage of entitled to receive additional shares on fully diluted basis"
       }
      }
     },
     "localname": "PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fully diluted common stock shares outstanding.",
        "label": "Percentage Of Fully Diluted Common Stock Shares Outstanding",
        "terseLabel": "Percentage of fully diluted common stock shares outstanding"
       }
      }
     },
     "localname": "PercentageOfFullyDilutedCommonStockSharesOutstanding",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tsha_PercentageOfPrepaymentOfFacility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of prepayment of facility.",
        "label": "Percentage Of Prepayment Of Facility",
        "terseLabel": "Percentage of prepayment of facility"
       }
      }
     },
     "localname": "PercentageOfPrepaymentOfFacility",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tsha_PercentageOfPrepaymentPremium": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of prepayment premium",
        "label": "Percentage Of Prepayment Premium",
        "terseLabel": "Percentage of prepayment premium"
       }
      }
     },
     "localname": "PercentageOfPrepaymentPremium",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preclinical activities period under sponsored research agreements.",
        "label": "Preclinical Activities Period Under Sponsored Research Agreements",
        "terseLabel": "Preclinical activities period under sponsored research agreements"
       }
      }
     },
     "localname": "PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "tsha_PreferredStockTrancheLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock Tranche Liability.",
        "label": "Preferred Stock Tranche Liability",
        "terseLabel": "Preferred stock tranche liability"
       }
      }
     },
     "localname": "PreferredStockTrancheLiability",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PrepaidBonus": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid bonus.",
        "label": "Prepaid Bonus",
        "terseLabel": "Prepaid bonus"
       }
      }
     },
     "localname": "PrepaidBonus",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PrepaidClinicalTrial": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid clinical trial.",
        "label": "Prepaid Clinical Trial",
        "terseLabel": "Prepaid clinical trial"
       }
      }
     },
     "localname": "PrepaidClinicalTrial",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PrepaidResearchAndDevelopmentContracts": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid research and development contracts.",
        "label": "Prepaid Research And Development Contracts",
        "terseLabel": "Prepaid research and development"
       }
      }
     },
     "localname": "PrepaidResearchAndDevelopmentContracts",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ProceedsFromIssuanceOfCommonStockGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common stock, gross.",
        "label": "Proceeds From Issuance Of Common Stock Gross",
        "terseLabel": "Gross proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockGross",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property and equipment in accounts payable and accrued expenses.",
        "label": "Property And Equipment In Accounts Payable And Accrued Expenses",
        "terseLabel": "Property, plant and equipment in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "PropertyAndEquipmentInAccountsPayableAndAccruedExpenses",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of clinical materials and reimbursement incurred development costs.",
        "label": "Purchase Of Clinical Materials And Reimbursement Incurred Development Costs",
        "terseLabel": "Purchase of clinical materials and reimbursement incurred development costs"
       }
      }
     },
     "localname": "PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_QueensAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Queen's agreement.",
        "label": "Queens Agreement [Member]",
        "terseLabel": "Queen's Agreement"
       }
      }
     },
     "localname": "QueensAgreementMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_ReclassificationOfPreferredStockLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of preferred stock liability.",
        "label": "Reclassification Of Preferred Stock Liability",
        "terseLabel": "Reclassification of preferred stock tranche liability"
       }
      }
     },
     "localname": "ReclassificationOfPreferredStockLiability",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity preferred stock tranche liability upon issuance of milestone shares.",
        "label": "Reclassification Of Temporary Equity Preferred Stock Tranche Liability Upon Issuance Of Milestone Shares",
        "terseLabel": "Reclassification of preferred stock tranche liability upon issuance of Series A milestone shares"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityPreferredStockTrancheLiabilityUponIssuanceOfMilestoneShares",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_RegulatoryRelatedMilestonesObligationPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory related milestones obligation payable.",
        "label": "Regulatory Related Milestones Obligation Payable",
        "terseLabel": "Regulatory related milestones obligation payable"
       }
      }
     },
     "localname": "RegulatoryRelatedMilestonesObligationPayable",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ResearchCollaborationAndLicenseAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research, collaboration and license agreements.",
        "label": "Research Collaboration And License Agreements [Abstract]"
       }
      }
     },
     "localname": "ResearchCollaborationAndLicenseAgreementsAbstract",
     "nsuri": "http://tayshagtx.com/20210630",
     "xbrltype": "stringItemType"
    },
    "tsha_ResearchGrantOfCommittedFundAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research grant of committed fund amount.",
        "label": "Research Grant Of Committed Fund Amount",
        "terseLabel": "Research grant of committed fund amount"
       }
      }
     },
     "localname": "ResearchGrantOfCommittedFundAmount",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ResearchGrantOutstandingFundAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research grant outstanding fund amount.",
        "label": "Research Grant Outstanding Fund Amount",
        "terseLabel": "Research grant outstanding fund amount"
       }
      }
     },
     "localname": "ResearchGrantOutstandingFundAmount",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale-related milestones per licensed product and royalties on net sales of licensed products payable.",
        "label": "Sale Related Milestones Per Licensed Product And Royalties On Net Sales Of Licensed Products Payable",
        "terseLabel": "Sale-related milestones per licensed product and royalties on net sales of licensed products payable"
       }
      }
     },
     "localname": "SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of accrued expense and other current labilities.",
        "label": "Schedule Of Accrued Expense And Other Current Labilities Table [Text Block]",
        "terseLabel": "Schedule of Accrued Expense and Other Current Labilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tsha_SecuredPromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured promissory notes.",
        "label": "Secured Promissory Notes [Member]",
        "terseLabel": "Secured Promissory Notes"
       }
      }
     },
     "localname": "SecuredPromissoryNotesMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesAAchievementOfSpecificClinicalMilestoneOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A achievement of specific clinical milestone one.",
        "label": "Series A Achievement Of Specific Clinical Milestone One [Member]",
        "terseLabel": "Achievement of Specific Clinical Milestone One"
       }
      }
     },
     "localname": "SeriesAAchievementOfSpecificClinicalMilestoneOneMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesAAchievementOfSpecificClinicalMilestoneTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A achievement of specific clinical milestone two.",
        "label": "Series A Achievement Of Specific Clinical Milestone Two [Member]",
        "terseLabel": "Achievement of Specific Clinical Milestone Two"
       }
      }
     },
     "localname": "SeriesAAchievementOfSpecificClinicalMilestoneTwoMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesAConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Convertible preferred stock.",
        "label": "Series A Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesAConvertiblePreferredStockMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesAPurchaseAgreementInitialClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A purchase agreement initial closing.",
        "label": "Series A Purchase Agreement Initial Closing [Member]",
        "terseLabel": "Initial Closing"
       }
      }
     },
     "localname": "SeriesAPurchaseAgreementInitialClosingMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesAPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A purchase agreement.",
        "label": "Series A Purchase Agreement [Member]",
        "terseLabel": "Series A Purchase Agreement"
       }
      }
     },
     "localname": "SeriesAPurchaseAgreementMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A upon achievement of certain defined clinical milestones.",
        "label": "Series A Upon Achievement Of Certain Defined Clinical Milestones [Member]",
        "terseLabel": "Upon Achievement of Certain Defined Clinical Milestones"
       }
      }
     },
     "localname": "SeriesAUponAchievementOfCertainDefinedClinicalMilestonesMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesBConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B convertible preferred stock.",
        "label": "Series B Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBConvertiblePreferredStockMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_SeriesBPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B purchase agreement.",
        "label": "Series B Purchase Agreement [Member]",
        "terseLabel": "Series B Purchase Agreement"
       }
      }
     },
     "localname": "SeriesBPurchaseAgreementMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_ServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services agreement.",
        "label": "Services Agreement [Member]",
        "terseLabel": "Services Agreement"
       }
      }
     },
     "localname": "ServicesAgreementMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award commencement date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Commencement Date",
        "terseLabel": "Share-based payment award, commencement date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options replacement units grants in period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Units Grants In Period",
        "verboseLabel": "Number of shares awarded"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options cancelled or forfeited in period intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Forfeited In Period Intrinsic Value",
        "terseLabel": "Options cancelled or forfeited, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options grants in period grant date fair value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value",
        "terseLabel": "Share-based payment award, options grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options grants in period intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value",
        "terseLabel": "Options granted, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_ShareBasedCompensationAwardTrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation award tranche four.",
        "label": "Share Based Compensation Award Tranche Four [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Four"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheFourMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity conversion shares of convertible preferred stock to common stock.",
        "label": "Temporary Equity Conversion Shares Of Convertible Preferred Stock To Common Stock",
        "verboseLabel": "Conversion of convertible preferred stock to common stock, shares"
       }
      }
     },
     "localname": "TemporaryEquityConversionSharesOfConvertiblePreferredStockToCommonStock",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "tsha_TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock issuance of preferred stock tranche liability.",
        "label": "Temporary Equity Stock Issuance Of Preferred Stock Tranche Liability",
        "terseLabel": "Issuance of preferred stock tranche liability"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuanceOfPreferredStockTrancheLiability",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock issued during period shares new issues.",
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of convertible preferred stock, shares"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "tsha_TemporaryEquityStockOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock offering costs.",
        "label": "Temporary Equity Stock Offering Costs",
        "terseLabel": "Issuance of convertible preferred stock, offering costs"
       }
      }
     },
     "localname": "TemporaryEquityStockOfferingCosts",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tsha_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan facility.",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan from april one twenty twenty three until december thirty one twenty twenty three.",
        "label": "Term Loan From April One Twenty Twenty Three Until December Thirty One Twenty Twenty Three [Member]",
        "terseLabel": "April 1, 2023 until December 31, 2023"
       }
      }
     },
     "localname": "TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan from january one twenty twenty two until september thirty twenty twenty two.",
        "label": "Term Loan From January One Twenty Twenty Two Until September Thirty Twenty Twenty Two [Member]",
        "terseLabel": "January 1, 2022 until September 30, 2022"
       }
      }
     },
     "localname": "TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan from october one twenty twenty two until march thirty one twenty twenty three.",
        "label": "Term Loan From October One Twenty Twenty Two Until March Thirty One Twenty Twenty Three [Member]",
        "terseLabel": "October 1, 2022 until March 31, 2023"
       }
      }
     },
     "localname": "TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan through august thirteen twenty twenty three.",
        "label": "Term Loan Through August Thirteen Twenty Twenty Three [Member]",
        "terseLabel": "Through August 13, 2023"
       }
      }
     },
     "localname": "TermLoanThroughAugustThirteenTwentyTwentyThreeMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TermLoanThroughAugustThirteenTwentyTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan through august thirteen twenty twenty two.",
        "label": "Term Loan Through August Thirteen Twenty Twenty Two [Member]",
        "terseLabel": "Through August 13, 2022"
       }
      }
     },
     "localname": "TermLoanThroughAugustThirteenTwentyTwentyTwoMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan through december thirty one twenty twenty one.",
        "label": "Term Loan Through December Thirty One Twenty Twenty One [Member]",
        "terseLabel": "Through December 31, 2021"
       }
      }
     },
     "localname": "TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TwoThousandTwentyEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty equity incentive plan.",
        "label": "Two Thousand Twenty Equity Incentive Plan [Member]",
        "terseLabel": "2020 Equity Incentive Plan",
        "verboseLabel": "2020 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_TwoThousandTwentyStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty stock incentive plan.",
        "label": "Two Thousand Twenty Stock Incentive Plan [Member]",
        "terseLabel": "New Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyStockIncentivePlanMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_UTSouthwesternAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UT southwestern agreement.",
        "label": "U T Southwestern Agreement [Member]",
        "terseLabel": "UT Southwestern Agreement"
       }
      }
     },
     "localname": "UTSouthwesternAgreementMember",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tsha_UpfrontPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment.",
        "label": "Upfront Payment",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "UpfrontPayment",
     "nsuri": "http://tayshagtx.com/20210630",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10110.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10120.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities And Other Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r33"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Accrued professional and consulting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r28",
      "r141"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r214"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10060.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid In Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r86",
      "r87",
      "r88",
      "r211",
      "r212",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r175",
      "r177",
      "r217",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r177",
      "r207",
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "positiveLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Anti-dilutive securities excluded from computation of diluted net loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r81",
      "r125",
      "r127",
      "r131",
      "r135",
      "r239",
      "r244",
      "r251",
      "r302",
      "r311"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r6",
      "r46",
      "r81",
      "r135",
      "r239",
      "r244",
      "r251"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10130.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r178",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis Of Accounting Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred But Not Yet Paid",
        "terseLabel": "Deferred offering costs not yet paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsIncurred": {
     "auth_ref": [
      "r74",
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in lease obligation from new lease.",
        "label": "Capital Lease Obligations Incurred",
        "terseLabel": "Build-to-suit lease liability"
       }
      }
     },
     "localname": "CapitalLeaseObligationsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r26",
      "r325",
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r26",
      "r72"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10160.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r64",
      "r72",
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "periodEndLabel": "Cash at the end of the period",
        "periodStartLabel": "Cash at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r64",
      "r252"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r79",
      "r81",
      "r100",
      "r101",
      "r102",
      "r105",
      "r107",
      "r113",
      "r114",
      "r115",
      "r135",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class Of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class Of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r234",
      "r235",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Research, Collaboration and License Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]",
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r39",
      "r147",
      "r306",
      "r315"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies - Note 10"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Common stock reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r86",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock, par value per share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "verboseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10050.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "terseLabel": "Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 38,391,165 and 37,761,435 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r78",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation Policy [Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r303",
      "r304",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument Basis Spread On Variable Rate1",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r261",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument Face Amount",
        "terseLabel": "Aggregate amount, related party transaction"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument Interest Rate Stated Percentage",
        "terseLabel": "Percentage of interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r36",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument Maturity Date",
        "terseLabel": "Debt instrument, maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateRangeEnd1": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latest date the outstanding debt instruments are required to be repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument Maturity Date Range End1",
        "terseLabel": "Debt instrument, maturity end date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateRangeEnd1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateRangeStart1": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earliest date the outstanding debt instruments are required to be repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument Maturity Date Range Start1",
        "terseLabel": "Debt instrument, maturity start date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateRangeStart1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCostsLeasingNetNoncurrent": {
     "auth_ref": [
      "r29",
      "r264"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10140.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents costs incurred by the lessor that are (a) costs to originate a lease incurred in transactions with independent third parties that (i) result directly from and are essential to acquire that lease and (ii) would not have been incurred had that leasing transaction not occurred and (b) certain costs directly related to specified activities performed by the lessor for that lease. Those activities are: evaluating the prospective lessee's financial condition; evaluating and recording guarantees, collateral, and other security arrangements; negotiating lease terms; preparing and processing lease documents; and closing the transaction. The costs represented by this element are those costs not expected to be recognized in (amortized to) earnings within one year from the date of the statement of financial position or operating cycle, if longer.",
        "label": "Deferred Costs Leasing Net Noncurrent",
        "terseLabel": "Deferred lease asset"
       }
      }
     },
     "localname": "DeferredCostsLeasingNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r70",
      "r139"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10110.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "terseLabel": "Net loss per common share, basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options",
        "terseLabel": "Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
        "terseLabel": "Share-based payment award, options, compensation cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r86",
      "r87",
      "r88",
      "r90",
      "r95",
      "r97",
      "r112",
      "r136",
      "r161",
      "r168",
      "r211",
      "r212",
      "r213",
      "r225",
      "r226",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r320",
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture And Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10080.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General And Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "I P O [Member]",
        "terseLabel": "IPO",
        "verboseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r227",
      "r229",
      "r231",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r82",
      "r96",
      "r97",
      "r124",
      "r221",
      "r228",
      "r230",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense Benefit",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10170.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase Decrease In Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10190.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.",
        "label": "Increase Decrease In Due To Related Parties",
        "terseLabel": "Due to related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10160.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r51",
      "r123",
      "r260",
      "r262",
      "r308"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10050.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10040.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income Expense Nonoperating Net",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r62",
      "r66",
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid Net",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseIncentiveReceivable": {
     "auth_ref": [
      "r265",
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents a receivable for an incentive or inducement contractually stipulated between parties to a lease whereby the lessor has committed to provide the entity (lessee) with a cash payment as inducement to enter the lease.",
        "label": "Lease Incentive Receivable",
        "terseLabel": "Lease construction incentive"
       }
      }
     },
     "localname": "LeaseIncentiveReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether lessee has option to extend operating lease.",
        "label": "Lessee Operating Lease Existence Of Option To Extend",
        "terseLabel": "Lease, option to extend"
       }
      }
     },
     "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee Operating Lease Liability Payments Due",
        "terseLabel": "Future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee Operating Lease Option To Extend",
        "terseLabel": "Lease, option to extend description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Renewal Term",
        "terseLabel": "Operating lease extend term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Term Of Contract",
        "terseLabel": "Operating lease term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r32",
      "r81",
      "r128",
      "r135",
      "r240",
      "r244",
      "r245",
      "r251"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r81",
      "r135",
      "r251",
      "r305",
      "r313"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r81",
      "r135",
      "r240",
      "r244",
      "r245",
      "r251"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10080.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line Of Credit Facility Current Borrowing Capacity",
        "terseLabel": "Current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line Of Credit Facility Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Longterm Debt Type [Axis]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r37",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Longterm Debt Type [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input Price Volatility [Member]",
        "terseLabel": "Expected Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input Risk Free Interest Rate [Member]",
        "terseLabel": "Risk Free Rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10030.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10020.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r64",
      "r68",
      "r71"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10010.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r49",
      "r50",
      "r52",
      "r71",
      "r81",
      "r89",
      "r91",
      "r92",
      "r93",
      "r94",
      "r96",
      "r97",
      "r103",
      "r125",
      "r126",
      "r129",
      "r130",
      "r132",
      "r135",
      "r251",
      "r307",
      "r316"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r94",
      "r98",
      "r99",
      "r104",
      "r107",
      "r125",
      "r126",
      "r129",
      "r130",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income Loss Available To Common Stockholders Basic",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing And Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash Or Part Noncash Acquisition Fixed Assets Acquired1",
        "terseLabel": "Acquisition of property, plant and equipment funded by landlord"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10020.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income Expense",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income Expense [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity Table [Text Block]",
        "terseLabel": "Schedule of Restricted Stock Awards Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10060.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r125",
      "r126",
      "r129",
      "r130",
      "r132"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10010.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperationsCommencedDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the operations of the entity commenced, in CCYY-MM-DD format.",
        "label": "Operations Commenced Date1",
        "terseLabel": "Operating lease commencement date"
       }
      }
     },
     "localname": "OperationsCommencedDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Description of Business Operations"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r33"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10100.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10150.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income Expense",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over Allotment Option [Member]",
        "terseLabel": "Underwriters\u2019 Option to Purchase Additional Shares",
        "verboseLabel": "Underwriters' Option to Purchase Additional Shares"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForUnderwritingExpense": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.",
        "label": "Payments For Underwriting Expense",
        "terseLabel": "Underwriting discounts and commissions and other offering costs"
       }
      }
     },
     "localname": "PaymentsForUnderwritingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments Of Stock Issuance Costs",
        "negatedLabel": "Payment of Series A convertible preferred stock issuance costs",
        "terseLabel": "Stock issuance costs, including underwriters\u2019 discounts and commissions"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10080.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.",
        "label": "Payments To Acquire In Process Research And Development",
        "negatedLabel": "Purchase of research and development license"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10090.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r178",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value per share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "verboseLabel": "Convertible preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "verboseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10040.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "terseLabel": "Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of June 30, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r24",
      "r25"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10170.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r3",
      "r5",
      "r137",
      "r138"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromCollaborators": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from collaborators during the current period.",
        "label": "Proceeds From Collaborators",
        "verboseLabel": "Clinical milestones for gross proceeds"
       }
      }
     },
     "localname": "ProceedsFromCollaborators",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds From Issuance Of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10040.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds From Issuance Of Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuances of Series A convertible preferred stock",
        "verboseLabel": "Gross proceeds from sale of convertible preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds From Related Party Debt",
        "terseLabel": "Proceeds from note payable to related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r0",
      "r49",
      "r50",
      "r63",
      "r81",
      "r89",
      "r96",
      "r97",
      "r125",
      "r126",
      "r129",
      "r130",
      "r132",
      "r135",
      "r238",
      "r242",
      "r243",
      "r246",
      "r247",
      "r251",
      "r309"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10100.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r28",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r27",
      "r140"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Plant And Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r142",
      "r314"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10150.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r10",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property Plant And Equipment [Text Block]",
        "terseLabel": "Schedule of Property Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of units (items of property) under operating lease arrangements.",
        "label": "Property Subject To Or Available For Operating Lease Number Of Units",
        "terseLabel": "Number of operating lease landlord square feet manufacturing facility"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r172",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r172",
      "r272",
      "r273",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction Expenses From Transactions With Related Party",
        "terseLabel": "Accounting and other administrative and management services fee per month"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r172",
      "r272",
      "r276",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party Transactions By Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r270",
      "r271",
      "r273",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments Of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10070.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments Of Related Party Debt",
        "negatedLabel": "Repayment of note payable to related party"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r220",
      "r327"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "order": 10070.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10130.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research And Development In Process",
        "terseLabel": "Research and development license expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards",
        "verboseLabel": "Unvested RSAs"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units R S U [Member]",
        "terseLabel": "Restricted Stock Units",
        "verboseLabel": "Unvested RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r168",
      "r214",
      "r312",
      "r323",
      "r324"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10070.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r86",
      "r87",
      "r88",
      "r90",
      "r95",
      "r97",
      "r136",
      "r211",
      "r212",
      "r213",
      "r225",
      "r226",
      "r320",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale Of Stock Number Of Shares Issued In Transaction",
        "terseLabel": "Aggregate shares sold"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]",
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Schedule of Calculation of Basic and Diluted Net Loss Per Common Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r177",
      "r206",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsRsasAndRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r177",
      "r206",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Schedule of Total Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Detail)"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r28",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule Of Property Plant And Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r83",
      "r274",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule Of Related Party Transactions By Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r190",
      "r195",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Activity Table [Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r178",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
        "terseLabel": "Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r40",
      "r79",
      "r113",
      "r114",
      "r158",
      "r159",
      "r160",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule Of Stock By Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10140.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1",
        "terseLabel": "Award requisite service vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period",
        "negatedLabel": "Cancelled or forfeited, Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period",
        "terseLabel": "Restricted units/stock granted, Number of Shares",
        "verboseLabel": "Share-based payment award, RSU/RSA granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share",
        "verboseLabel": "Share-based payment award, RSU/RSA granted, weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number",
        "periodEndLabel": "Nonvested, Number of Shares, Ending Balance",
        "periodStartLabel": "Nonvested, Number of Shares, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance",
        "periodStartLabel": "Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period",
        "negatedLabel": "Vested, Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, Weighted Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the equity-based award expires, in CCYY-MM-DD format.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Expiration Date",
        "terseLabel": "Share-based payment award, expiration date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance",
        "verboseLabel": "Number of common stock authorized for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price",
        "terseLabel": "Options exercisable at June 30, 2021, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period",
        "negatedLabel": "Options cancelled or forfeited, Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Options granted, Stock Options",
        "verboseLabel": "Share-based payment award, options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based payment award, options, weighted-average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "periodEndLabel": "Outstanding, Aggregate Intrinsic Value, Ending Balance",
        "periodStartLabel": "Outstanding, Aggregate Intrinsic Value, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r186",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Outstanding. Stock Options, Ending Balance",
        "periodStartLabel": "Outstanding. Stock Options, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, Weighted Average Exercise Price, Ending balance",
        "periodStartLabel": "Outstanding, Weighted Average Exercise Price, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number",
        "terseLabel": "Options exercisable at June 30, 2021, Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest at June 30, 2021, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest at June 30, 2021, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number",
        "terseLabel": "Vested and expected to vest at June 30, 2021, Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost",
        "terseLabel": "Share-based payment award, plan modification, incremental cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award",
        "terseLabel": "Share-based payment award, terms of award issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r176",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price",
        "terseLabel": "Options cancelled or forfeited, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Options granted, Weighted Average Exercise Price",
        "verboseLabel": "Share-based payment award, options granted, exercise price per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share Based Compensation Award Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share Based Compensation Award Tranche Three [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Three"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share Based Compensation Award Tranche Two [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage",
        "terseLabel": "Share-based payment award, vesting rights percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r201",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
        "terseLabel": "Expected term in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsAndCancelledOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1",
        "terseLabel": "Options exercisable at June 30, 2021, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1",
        "terseLabel": "Options exercisable at June 30, 2021, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Outstanding, Weighted Average Remaining Contractual Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1",
        "terseLabel": "Vested and expected to vest at June 30, 2021, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued Price Per Share",
        "terseLabel": "Share issue price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r79",
      "r81",
      "r100",
      "r101",
      "r102",
      "r105",
      "r107",
      "r113",
      "r114",
      "r115",
      "r135",
      "r161",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Statement Class Of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r43",
      "r86",
      "r87",
      "r88",
      "r90",
      "r95",
      "r97",
      "r112",
      "r136",
      "r161",
      "r168",
      "r211",
      "r212",
      "r213",
      "r225",
      "r226",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r320",
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r86",
      "r87",
      "r88",
      "r112",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationTables",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParentheticalUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued1",
        "terseLabel": "Series A convertible preferred stock issuance costs not yet paid"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r42",
      "r161",
      "r162",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period Shares Conversion Of Convertible Securities",
        "verboseLabel": "Conversion of stock, shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r17",
      "r18",
      "r161",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period Shares Employee Stock Purchase Plans",
        "terseLabel": "Number of shares of common stock issued under ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r161",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "positiveTerseLabel": "Issuance of shares of common stock, shares",
        "terseLabel": "Issuance of common stock upon vesting and settlement of restricted stock units, shares",
        "verboseLabel": "Shares issued during period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r161",
      "r168",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "terseLabel": "Number of share options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r21",
      "r22",
      "r81",
      "r134",
      "r135",
      "r251"
     ],
     "calculation": {
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 10030.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r80",
      "r168",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiability"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders Equity Note Stock Split Conversion Ratio1",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r259",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r259",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r259",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r259",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r279",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Subsidiary Sale Of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureBalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Carrying Amount Attributable To Parent",
        "periodEndLabel": "Convertible preferred stock balance",
        "periodStartLabel": "Convertible preferred stock balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Shares Authorized",
        "verboseLabel": "Convertible preferred stock, shares authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Shares Outstanding",
        "periodEndLabel": "Convertible preferred stock balance, shares",
        "periodStartLabel": "Convertible preferred stock balance, shares"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockholdersEquityDeficitConvertiblePreferredStockAndTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants And Rights Outstanding",
        "terseLabel": "Warrants associated with loan facility"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Weighted average common shares outstanding, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://tayshagtx.com/20210630/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://tayshagtx.com/20210630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121585684&loc=d3e40246-112709"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549951&loc=d3e40010-112707"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549951&loc=d3e40019-112707"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r328": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r329": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r331": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r332": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r333": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r334": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>105
<FILENAME>0001564590-21-044462-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-044462-xbrl.zip
M4$L#!!0    ( )A$$%,Q&?4?QXT  !RX   6    9S-D>6-K<C-U9'1H,# P
M,# Q+FIP9]R\!5A47=<W?@@)01H!B4%!*0%!)!084"D#Q  %) 1%ND,$!D1
M&D1 &D4) >F.D2XIZ8X!1KICF/J?\;Z?^P;?YWV^-__7=WWCG(NS:^VUUEY[
M_=;:YXSX(?P40'=#64T9("(B @S!?P!^%+@&4)"1D9,=HR G)Z>DI#A.S72"
MFHJ*FHV!D9:)\Q2$B_,4!P<WKP@?]YGS/!P<_%("YR^(24A(0/ADY*3%944N
M2H@3B!!14E)24U&SGCC!*GZ:X[3X?_J#_P;04Q!9$'>3$)T!B.F)2.B)\ T
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MW?BGF +6F4DG0:]KS$B>4)7!SPH5IF\BZ%D>O.8UF_N"3?6JL@LVYJ!M2SB
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M_/_*IE9M-\#+J7N[!8%U(>#$,CT8M%I)_<*F+]AJ^7G8W5P,/"),R1)F&'9
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M["3C,&"LAAO;@$A?1.,0!(Q'&VRI'*#(,2#[76!>8R!N<&@9" C\F(# /GB
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M+\,$=?C_G6J2CLE:K14>2$EK*]]JH,;^56$\@-S50,]JZ<49O G^JC(B5H8
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MJ16H21*=U2NC"0\#[)0$NKEH0K-^\[&+[!2HCK>YAM+?B/;ER,(;4,,MDI>
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M*V.4]$)U=$@H3Y 1$Z416[I_?Y)J;.#[&RFC81F6CVBP;9=SDL \8N2UO['
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M220UL?MO[\R;>^_[9^;-G37SK_?>FNJUU^HZIVJ?^G;M77OOJD)/H[\!5U7
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MEG93SWJ92]("1[2</=^;-9<:A-[TK[4FJ==_V-LI+SXN<:2G=;.<KVA1Q9,
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MQ)/#DKPH4SA  .&5@[>VW71,-<_/M,ZVUI-M9*8SHE?F*Q6*YN)8J4^_F^(
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MTGP5(=/:N#D)H6U]!M2UOA@,%<.18MCL\X<'ZQ>K$>M;MC],4;0SE]\8-B*
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MVCK;MRZT[)F'-^AY-BW9[XE48;Z^9S!##4U8:L&P3+(6+H?9?KNCEEJ2XD]
MN,WQ&(SF[DJN@^7<DQ5X7"_0\RRM4?.':C>:$HE"(24>>T$K2E8\?(&JP";'
MGB59G&R2]'88-7&QV<[<2$H^V5Z3=QC1P7X;K/N::0)\OA<)TWJ#W.M,SV[X
MS:2*K+5T/Z2]X0!R@_LG)P''-/*1$@$[XITS3YL2U^IEFT1Y\M9>S5XH])-
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M#<]U+KO87R_ET[R_HP=8W$S22>?#\W@3.ESS#?4$U2O6RR=O[[S\@8F.U3J
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M9L#]KCE40*EP*9HE2/GI1<RCEWVM<[W^6-L<V7_H)!#3_P]02P,$%     @
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M(&Q2H-!VB)6@2;S[!H1,%X1O:<,U*;I%PJTRI0#;NF%]ZY8!Y5_ZW [FU9X
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MJJQ]*%L!)"$HQL7*J9HC@2KMAVP<A8JK6AX>5]G$"C5'*GFF>"I?0$P5 4<
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MOQ/2"]5_O$+D%&0J4/"Z""S<>Y5)*7E/4.65)*>DK(=)VOT%4Q3(;*&+<C.
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M(%_,HMR.Z<Y4_E?05,1 Q\5DP)7;B?\("I)3<*/$RYR0"4WD>*6H0L4JNW1
MO#QG[&# -EZUD8("^JI8C^!YK:?*]R!G;P&S)C,E&RFQL&9CTXF9_>F-B,&O
MW7'OSQGI3K<EZ8&&!U^74]9%>@^'I ;7G@OJX,SZXG+**?/TI@0F:7.\\6')
MR+NPYO/:4$E,>_1S]:",?W%,:\8.CZ*K&[V;W7X!2A=J8+M)EW=6E=W\=B:[
M9V83""0W-K7Z)^'SW\&_%VI-"2J&7=^^C=[=<W?IQ'[TG F:J_6EKU3LO<X;
MD(?761CFJP"J8_'X;]E/WN8,/QWY,,..:,XPM#I:FF^VB D0%CFZ])B4TZ8
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MC+YEG9\PM8)Q6T>3,H%P9<SX,A-7*;JPA"+?_/>!'=F%=]167#9>IS]O2A*
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M?%;!)TWD]/3OV"R3I-J$>Q-D%_I*V&3IC>M2>39V)^D"*6S^Z4<D3XD5-(
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M/\9]+*?LY/A?NB3$F/+^-^;%N/WR?P!02P,$%     @ F$004P@"I^ @0
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M$9"0$!$?K_H\7@<0<9'PJ-E$D?&5C5!>.!"P^\=FHM*\*_]%J#)V0LOQT3$
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MT#<&:T_2E&OQ?(&P=_VB"2 .^&+LYR.A/2[@?6Y-FA"_1D&DCWXT/%1-B+=
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M&-@PH=+)\N/%4FT7>GYJ_EFCH]-<-%JMJB5JKU>[BS:A3H2U@F:EC"]6>C>
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MLVO:79A%5E3H2A9]1R_A/GX3W7EFI<-0\!92\5=A^K\@T)_#[7^W!1*1^;6
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M   6    9S-D>6-K<C-U9'1H,# P,# V+FIP9ZR[!51<39LUVKB[.\$]N$N
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MZ?W"#5(V!E_B=M^.!%1'1]FCPB1+P@IH(ZP\ B0]^ P>]:2WQB]U3?Y4"(%
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M2%9:E4P,^8!U@#,3%M,C9-NY+4A$RMQ[.\9GP&SII77W%? [.^N'V#:7]2M
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MZ$4[9C6"-L B. J1BI6HUHE[\$ ^@G&!44@ZV[E)4UVI2ZE,D2*]AX8LJV:
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M\5!YB8%1.$ID \J.T!SA8A1\,.($=CTS^=K7$Z<\A3=VX")4ZT4Q*L6QLJB
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M.MZ/S.-/DQ:U8C_-L('USJ(&5CZC-"'#6%XM>\Y,4H]L4B.3.1:*N$+VD:!
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MXC#FEBI(MD/IES*X'P0ZJ,\*#JVDOV=_/8B. B<?LY;V)2UD+S P^U_ZQF9
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M@,U6]!45G ,PO"-'GN\]O$+; #;1(2[C'W!^/\3D2;G='"5^NSBFO*N6;S*
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M YF5Z+ Z5&;??FYXUG63:MLH_Z.'(4V3V^=1?$>H]$AD?V]K2#*@:=OA+6G
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M+Z.[8G^\(4-:6YMK+)0BP@W$&O'5Q2V+I=J6L.M3>U/MCZ7"S1<J%O)]K*8
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M_WH(" 4%!>TQ&AXZ.AX[.1$Y^[\][EL!+&20-<@2'D0!P&&!X+% ]YT *0"
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M="7)'C0&T3E+7A;/<QE5'<:B8-74%F4?"(ONEI]"JB'TU.K]?N/*7;C"RYG
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ME+NC*X2QK%''/0Y+RK[IQT_2HF60O+?4BW>#)C-5@Z)'%:JQ.J(Z^*&4DZC
MC1FSHW;G6&[C*$MFS;42J6FPQOLN0T1X#$D,.EU]Q9TK\4K8Y-5=ZJH$<R%3
MC1]5K?9%J37':H^ ."@IB84DDTN&B^'B/4-A!]<H=^8;+0YN1$6QXDO2D:+2
MCTHSHB9<0XFF\8H.C):?V8UM,3#Q!$;ZE_"4%GH,Z&>TY[4#84Q97HL'<QX\
M7?R=3(+"I3OI2CO."U-8;9PY@K+S^WBY##>F ZP=4P&G)>U?N&S0F;,=C!R(
M>V*X&F@^BZW*%H@"Q]L,'W+DN=*5E!4?XI8>_?_U%S',^ZG_!5!+ P04
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MKKZAL:.SJ[NGMZ]_8&)R:GIF=FY^86U]8W-K>V=W;__L_.+RZOKF]N[^/[A
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M<DNW"',%#P&81*%@<@"XHO/%^I1=3\)&:JD>GFN1O3)F-6D9IZDO65,K02K
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MY=66WACV?S,QK36E>;YA).JP4;/&;H(Z%3V3N-X\XWHP7264IA]W?)*EK;I
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MLB'L&!;S ><]B9_36N4L-XCB>)ORR+#/>W?TCD?QN&=^BN GO2G1S64)?[*
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MYJNVP*=/=F)\S/#0U8ODFMP#E)M31+/0WZ2==<B$>P&S%%K )>*472E8B61
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M- #R':<OO4QZ[3O%Q [6Z!8"MQ;C#.6)PUZL_DP(YO^G5* S99H\\S,J%T!
M*T)=F(&>B)"$^Z1\,M]<&1U6-LYPQIF(J1=A+ PPEWR\&RSO"T%Z7GQ:\ :;
MB7V[CFN&!@DZBIFS2OG>^663#=%(2MM: +W_FJ+')?9@)5--QZ6->&%?Z)E
MAD5MT6!SJGTN-/Q8P5"A["W=+Q>AI\[TN91B^47W"9%/K^[E)^$W9PQA%=B?
M2)_R)?NE"H7J8""OF;;NI*EDK-*[!H'3\?QR(![IJ]5"OKU!?'V/:V&LEV__
MW#LF"GTVF=%V#V)$^&!U$/)*C]/BR]7Q:OC YP>!(B0CQ0^A4@U)*4H=T_Y;
M*L*)+(+CQSE'KWET?XJB<F'YMQ,8$VYVKBLI&R>9"]\!57.J,C]?E^9BJKI9
MAD+&SZN:HZ&4<"43[8!G<+4G[=2R<F<& G7L(I6G2UGHCR;U:SE^]E@D'31,
M_>[FF- .+F\]]6E.>K>W.6S/WB[)KR#>&X';2C%"W71*HP607V06YHX(>BV-
M]9269!8UD9:4P,%S89,^GA>+=HG6R3>4^+@4O\MR3_!T.^'X,$W.5?]YLY$B
M$@6D-;C_Q3_NVB4',XU9 %2Y,CXB&!E73+ 1R7R@S!U:+V<N1\3K\&\-1'_4
M[+F#/VX?$9G/U)OX(YX]]C^2')_O0%VP90)'+K9IKZ3$@FV;*[4N%P(A7OQP
M7Y12G90NC!GKN)^%7VUN&RDUUEGE?FFR/&<4/TJ54#?B<!4X-2@/="=C7D4Z
MY$%SD)A(B%))N)(()79IX;FB7Z)O1TX(_RT:75.LT4RLB[8>(I]I+*3-0RHL
M70GU H[@+,?&EO1;L_+6?PL#/5083P6O)^,:?FKRL(<B]_<Y\(U0S98_^[QB
MU\WR[N_ ;<14]=S?-N^P31Y>7D0R#W"]@84/VFS=HI8NQ>V%H7YJ^3F"*Z:(
MMR_=R$P]TBU^:G@:\MF];3A/O+">1Q7I&@?,H8E$/&,?[*^JO.K[<O=*7!'<
M;]=<!Y[,^$^JS[24R8M_DUG^7G:^ ^6DHB<J=?8**#$,S&DL/RO)P,TY&.;G
MN\ZV7#(X4E3\]F<3L@,AGCW<?^+8D;YTFMAHD-B);C=6BFGI;O/TP!.0&% C
M-M:;"&:45CHC7PTY-J>?5PO&5/H6 .+HN]VNSW)L%1?Q7Q41*\=FTHYNFE8&
M8_EP,):6/7QPQI=3"UJOBF(I;I<#DR> 5WH]056&(MP*@K7/X3S]JSND6L!D
MQ,JH2GPKKSI#P>NK9=9LN62NI0"W<K IE3#UOF#8.R!89H):_+<&#XL[OKRW
M;)#-FY=3\EHYPI1$#C%*FL'CUW_MVJ'A^D0+VQR^+V%#R_^Y&2S,HV^O5MZF
M\,M1.(DF>5GGI81M1UA<.T'<V=X,C1M!L*?"_61#4&JZN6Q%PIQPXWN-C!14
M!H:7)$,984@F_U]D;7#MH@SM$..B-ZU[OP[,A+A.L]]R6]SBB;K:\#\7_J!!
MX2@YDE1GK\V1;5BR@='O 33_VQ@YO:%:V19D7KXB!K]"]<[T.=P\):1?]'-J
M+4VVXM\0-"+S;V))C_3E_N^]P(26]TNR+XZ7N+E=\/SYFT'D:D;H%U_QF.%V
M6+2N.+8*T2[ZR>>%Y(>KWJ,WMEGF;2P:SV;B,R^OE? 7^NK)%W"AWA&T_FQ5
M;4$6\4\\J%DH;Y80.)KFNNJDS-F-ONU\>):IJIEZ6X-#2>#LYZ&R89QO893K
M\]!-RDZU=,?I2;A7O4*<;S8L673+EFDVF<F?JQ^QF_Z2>*^$S4XV!$;2*T<T
M<A"A\E"&QYU>)@VA+5[_^'WW'9 *QV/"/K#T\.OE(97-RS7?T9RW.CWP!ZN)
M<V2O+_E?/9LTG_%ODT <MX?VWX8#[D!B-.4ILBK=+&%2B26!L:+$I(XG>K$I
M6:13 G*6;]'6]3([M%ZX%V,!2ZV2^-$:KO]S30-E)B6ZS*]_4Y8@!I-1@2-]
MGTJG^W$^%#^*=(*".=W[D<BK1!']5:)ZP:[KAYXF?CSO ,C-3>\HIGB9B>E,
M)';3MUQO!S3VRXU(ZVUP=IX%+;EV)1S-;<^W#;A[M6QK&YHY!U,"G9NO'V[O
M*FDNR_XX:V.SH?E %7F';W>6_?A!OMVN5<?QQ\O8OH?W= 1)T=C0N%@$2^K3
MNR?GD#/1#QW7M*HQ#ZUGB 05F3Z4YEJB$<.V=:O29>&RQ22:;X?_X>T$;H%0
M>J6&SI>U.M.# !6$<5>T&%F@R'*[76@:5]/I9!8+P\1F\^9_^_U:=ZZT]GMR
MV,T1(H#]Y*LW9C4D4XB1^_N,_&7?_HI>SG CF<?MH67H3(6^&!0CUR!8#XG4
M9H  B\F#M//V+@>C4"-1GD+-G+_T]D 0\T0)I4J&S*VF+";ID<S3I92PO_ZO
MN>-9@(L7^J+D^(35 JGO]N\SL=V"'+>U:%6?:U)?T?]DVK;V'\-,S0TCR:VY
MW40TYLDLMXD##15S/="L,R5GJZ0KCZM&I@;:]:0OW;[5"V_%<4W]RHI279:6
M>C_TK#5MH*-ZM@[T?81/G.M;;%AVB!:PR*YQU,&6J"^=#989WH%["3QO$,:P
M7+!F_ML>K$<+$_DZ(-Z#"5Y53^E(MRTU/QXO)?QVC1.PEQ@7+_A8(@32UY$2
M7$_AVHM@[8 _9['K25C(GO83-,=GX85[LI]41]]Y=5FS>@>JMU.<>UH&MW@7
M\PJ]KW4Q<B'BN8MCGF[/9#'G(9O- R*")Q,"7PR9_FVG0\2(>'9EQA]__=DE
M/XLI  PL[CX?09<>H0VF*IV?A@XX3WPQ,Y4"SV1Q>%S7_*,=UVN%*-R<_]6<
MRB--?/G+=?UZFN6K=="&MRW^=WC^^C&@7PRU]AT8X4:$B[%21BSO7[>2/8DE
MVM_])%Y,:>,1&!GQ,XTW5\8HGI?21C70^-,*]J8HP2#E JB]&#8)JA2<L^#4
M($,I+B"KQ8:@Z-VZ\.?!0>.4,^QLQUR@N98(X9"H<4]OQ]>A(7E:\6!/8GR=
MS1NXK_S0DN5V^ROC[^.4K#& ]I%O<Q*Q]/@=6+SCMG0M&P^B>31"'\VPLTRW
M)35WF0D$YPGDT*),C\L9W.X\S9OX;Z7_P],?<R]>8Q/+QS,^ECE 7413S]-X
M,)6J"3:([J?()TV36%6:G43\HW],@K-@X[62[IG.2WHAASSTTD+H7!%H2ZMT
M.O%9!.C?C?VSZ'BTWOJ<_>'!8Y/U&0C+@GP&I^V^B&_2>Q,I>8M-7S:IP?Q-
M(>"]^4_6X.9M>>I2RS3-,5\H]*[X1<,K$F=Y9!>XGQ=PGMT><U0]1K'#$$MC
MB)PB[N@*KJV-[0>;-<;\R4V:Y?*Y! R\W2%*@)F<>R7G;6=7!.-4R2Y:!NS+
M(6S)I5HJ4U(!9VU??6"(8_:?> 0'RS*#')Q^S*9<RD\TRY(R_?9I5"@B! ;>
MSY-P[D2M+-2(T>CNF%$<FAP0[9$0LN04^7$JV)*3 .^RA1Y:4Y@N&A$#?I.2
M8SXOPN RK54FU3"RDCVE8L%BV &2)_H3VUH+%J3"**\FTQ]7#?RDT'+5Z?.T
MO>0N0DO_08F3&#O?(HB3'OGD_M2^?GW_!"H_C@LOYE$ '[%+T8.IJJ7V?7W3
MZZ;3&EHG6DWT1NA-#@;6,0%9R]57@Y27LEJO;'_JH@+;%\'F "5"L\*?\=J!
MWO_1 XZO1UN&@Z>: I1M0WX\-]\<=8#+G1CZX*ENN>EV0[3R#F PUOTSF8-4
MYIA_^T-B=PU#1O(V"W-"PF+[4)PJ>F!D'P,QH$^V85TEL73MUWD($"O*9E2M
MOAES7+JAFX5AW36.F\ .1:6+B\6LEY2A]<\@]&2QPF(KRI97_M"Q$)STB+C@
M'W$5Y3)ZQ/=R*0FHVK*QM7-E6<[NFG4;1@3#$B^D/]1LHT9IO*;65.>(9RGZ
M=OLQ/D[KB&-7B_QBX'= \ []VFJ+<E3)5 *7I:?" %H4)A>,.='P09W>;ZV7
MG@L8Q*XI(6Y0$KW02\K7[LM9&CB0[M]6U./D!4PSGI\G$6;%[G3ES[>15@*/
M65=.M"A$/[/&^:WR',2\U:O)C9C47^^H#.<A M Q]]!>7WP%2]Z9FT<-_E[4
MCUR;RHCBV\QXVEJX-=%0LN6F1WTXS$J=5_J$Z[J3,.,UAP1$878"7I+\W?VV
MNQF%66=8JDF)+[,1W* B!F_H?($0/I1=G#@J?QB<GFB6P4WR.OMJ]D'['?AB
M0_6IB74W,CIQC5JN9<'Y2UTM_O?1^+AN3"@$Q+XU7\8[GDNQW"OLKWA _8AR
MHX1I-N\AE!6G+0DVZ?(^8-!>G81?XZ*!,)"'3"-H&W"550U7@]QO3W1BHNM4
M=8F>Q>:6)4/D1Y54BB*S<ROZK .B C3AW(>[61L%77V*VGFG; 0&?TG0=.;E
M$G_TS03<*D,XU6<X$]NB[O >O4:=*O]R,.H1E=$X\KKZN#^O/U9FO$CD=P1#
M1JPJ6RB>_PJ?9E\>Z85>[GPW-Z;E-3%JI>2OSK::1*Q"QADDEQ;*=\Z/J[WR
M;Q5DU;Q6HL)31@B^9@&LP<%"20Y&*](Z"-2H=3YU0 H;DJ$Y\4OFG+H]Y9%F
M30_G*!M1LQ8^TD1B/+#&GS:IT5:O;,)PS*+AGTQR&UYFH::L-9SEY*!X*"99
M1/4.A.Z(X']Q_C9/X8UEJNT8-3G\8D#BF-6F5A1AJVDED%,,>]69)3(@+#O4
MV):%Y#-WU<=@/6IPKJ;C.*;_SYTS$W%L.9X^$MWOH CQ$7HF0IS=,X\U5JZS
M&\.W"==Y,R&N.\Y_G;#X5M_M1JJLS2\7]:FMJ9Y'-]+'EL0H(4OXDVZ@$DYE
M"NIZ;TX\*_U+7WNXL!;@(;<O$$4<1+<'(D B:A>]J62!HAU90S%XK2?/61$R
MJ*&!"SQW?1[?[KF&0>M/G_8J]A\'@,#(=X#O&L0U=G$;)?Z]4;TU>IE,H)NU
MO?&_@@.<?(C:XG&;L!(7,8?;40*D46]QYK(^4/0%]ROR>ZJYQ!0:4J[Z->FS
M*?0\Q AGF@]^$R'  $ * -@"]_L80?87 B5)+V.,^O$-BS UFJ_QS#2LJ('#
MK][M)Z4=-0H2*KR;FA0'1*'B)YKV#T9S5&@'7@)Q1%\ (Z%<6[0P@3VFP#W
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M_DW%[F)(5QQMF);"?P=0V@67W82Z.""@T12V358C=@+AOC?HS1VV68W&(?N
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M?&ENQ,!2*^%4<N.&&&%&U!<<=MO'43JP'8I+J'T[[#L2Y\4WFJB7;,(4+U\
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MIW]\_CGXQ'CX+R".K]=&/1TB]QO[@W^DL25C.?"NI@Q.LFHRFKV&Q%A_#AL
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M9^@7>UZ_M;+\%VU4F("+0OAY@B/M[TWH--1VI4/C82DH]D5DIS9HD,@^967
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M1@AW[('&V$1T_*/,4?9%5'\((S+Y,MM#:XYNN.&X7UGT/,6<6'>O4%?0HM\
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MU0;=V&?/AVYK4:,Q?X'+L+4R\J^4_/\(E-3[+S;V^)T=JOT(<KC\>RIE$4@
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M(F<U&D+Z?I+60VZ-L*$JH"0&"HU$F_ /0I0!=RG.QC?$_"=Z>"I(?K<$L6\
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M:<1?L4 #=P'[$QITMXS;P$\$,(J># D=+55;49OU7<IC%=1O&.B@E#WKQCJ
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M2XD48?7TC ZA*VB:ELTO'^(8XP]W9./_B/*F%4!5E',?6B"=%KE5UU63%RV
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M'H8I.SJ2-DORBB4H:$%PI.5SK]RK;(.ZS(+(6;$<DK$%,MKBXA=N:U8*1NX
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M)7L!T_!$789/867<,&K-YML9K0#M.+>GU]1(;RJNLYKPSVQ14X EXVY7$I>
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M7]4H.(A&>/N=<#6PI4V!__MG6)V'C$\_5;A]@]GP+#:\6WEKR-=5)MB5A)_
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M,GC3,D7XTT<8HHWH?:)DK23J[12?4S$[!62R'R4T.#9?4O8F;0FP[25VI,?
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M'W\XEA=!$BE8X@$W@XJB"!X^[0OWQ6ECJD<VSH;+I'O#5M+94KGO/PBB#68
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M2\(BSA+/B+"24JWT->;M59HZ;I0OK68-\K:1!/62&QX*$-?]_ ''4O^@!F
ME*?ZII1.A_=M' @[_(E\AD]A'KR"#,;U8L$L*7OB.$81)FW/F WO0W\IB4#]
M!NX-.8 [7D9A[4O<O*A&DI)ZH)'?^BQ JUS&M@P^),*9>+^P? QMW(K'(LD\
MZ1VSJ8N@$#&1CL.=6B9'<U[U7QV:_8+9"=;E4:/I/IX!=]4&5,^F<[&ZMJ1;
M^+6,JT*+JO<!W1N(Z((/G74R#]3TQJ:J,0B))PL"TV7\T? ;\'ED(0B141M
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M]#1#85"KAKOX&F6@,]HPQXDDK-UI5;_OR%C4E+"EHF;Z P!V?5MN;4T=)/]
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M\SGRGR7L&7^P.%R8=.3<TJR:QAKR-$?G#S_O)QZ! 0.#**RPYC)X8R$:VL.
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MDK1I90R&\ V]4W8I'Y[$BEZ(KDOB!ISV9\LO= ).K*KJP&.0;HMV$.!;#9J
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M69PCDU6D#C6 7Z!^R6;_#[]^@))[*$TS#==9Y)RIY@*\P=2,+%.4'8GJ"=E
M< T<S+P!4D0-L $PLKO15E@$O'?*#NN;([98>HTG/P_ON )UV ZCFG%%R#/K
MW@$U)Q$02JV]:9@8(?IO7-PN0%S]YR8D6Q;Y>BKU!4Y.[2$%*441DKAP7[)3
M<1%5Q?LI<;QO"8)2[7[SXNQ-6OX@5-UB2[1/SH4J0P$6'38) ./Z!]BHV@R'
M%FDH-#;WZ',,3O=[7F(/KU2.1GV]0A$)I>>AL&=?>Z$STHZ^J*.BCMV=RQ<
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M&"WY,^,$_?^]S#_O7H2W=N25_SER8SU1TF&88N3[NLR>937F8ODK+-'\LW(
M;26>+, 5$0(:]TA*3/W4GF@2-79L8]>QCQ00<SV(&8-"O_$SG]DAQQHK)B=1
M5)1PN(\]X*>J[%:3UIYEA>"^<<OS6G-K8RQ?&!79\A?9.SH43!*(Y6<?^L+I
M_%1;MCG=@"^9E!8X)\*CW/CT7V1/>E-I<O*^_>YE:TYC?*?=19F*K)HIA:&=
M?8%U9D>3K9S*U#%3=F-=;4K>&L$GHY@$$279S/2X\,M0H%Z*;+\4@0Q\0H1H
ML7$/LHJ3GZIBA;MT0FZ0=GVDWY6W9PIC7L(%]A9D1']UW$]U'VC*:4YIAIV&
MJ/'4>:]QS.$A'$0+![L4:I+0"F7G(U>U?TCJ,3]M8)EGR=5ZXO'IIF7$)1BW
M^*N(;KE A@+?+\@OZBU:YGJ2Q\1CA<=^FB:'SM([23X&^I0M@FH$ZMJGP6NP
M0-LR-'"/;_C,:QC=>@OW4M.QT02SW1W"6-G0=T[&KNG3C?S>J3N] /3SG)?N
MC]QJ?\FM_K@QJ)I$D,G'%*D/\A#E;3W7]:U -M;.UR&DI9"WUZ3,@5.0#\*#
MO4/<W'ERUFDN8S_0\<U M10//[CHI>@3Z#<:>FR]YNVO,Z EV'G"C%D?S(F3
MC^4Y?@R"/$4OBA_(#]@*X8_1N6;43L!V=?CC9P6T$7A\N=6! S(JWA:AN15=
M5)-,_2D,WL86T-0T3F G?!KR5Z<O -CG,-246/I/@7Q?,,]$,:^/XP*RO/(J
MWN6;%.94N7S.J9V]IN<#XBQ)?FL,;S+"KS_^;K% V]]FJV*BL/<ZB]@_<.9*
M@8CR879%>X+PR>0O9F-*%U+3H542 -4TF>D3BTC/LO58K>_P(_[1,+)-$ACO
M0P?_H5#]M:6FOOW38', 510O:)/_?N;ZB^M&&]O8Z=&T3YY,:P%42[3T823O
M(VW>:I<M97%.JFTH!4UB],=/@CH?<?3""7PD*#.3C IK.//SE&K.>K$AHQ3S
MN:;5ZMN2AC^-KFS#^7JD^*I^/WA[/E4Q<3HC(W&$H:Q>65E^=:C1V.14%0@#
MB)7Y 8!1 6)HY^0T9-C93IEJJCM&$\I^NP^:RO_[,G.:Z@,OH -W*!*I#B+9
MD+"Q64#"YHW14GC1",3. ?>IB?YT$@5:W:^<QAJ-0G%',MOWT,_[<%Q'VJ44
ME@ET0L^CLEZ3@@G@ORY-0%_N)NQ1XO>7X_I0)Z!+D.IN7$WY5V^6KJXN[=^4
M.SL]F.B] :.(^PYXDY<*J)*0L'5(TMA_2U_2./ F6,M'9%]E DS"8N60*]%=
MT9XZ>9R RI.+ZI01QOGZB/:X5)M.NR.C49]%BRO0?<OBHI>/U9GL^)6&F/'6
MEB*$U36GCN%2ZQE+"BL2TOSB)0V)U#%L-*'D._WR<(O#T"9U\AG#.)4TQ;NY
M#0XTHQ (VI/"QG&,:6.@*U5#0\@45. J12CE0U$00*WV'ZD-A&D$941NC!AY
M8%F>@TC)VF(B%2\*2%1%7&M%%I&M4M@G6#?'OTI_:FBNBYAN"G9=U$D4T?1^
M]M7":-_^$RJG =WHM_'U[ 7P]$'F!9 S:C^%"1DH3.&RF<]Q=$)+7TK@_MGN
MA*QE;H[OBQ)E.$.:7D1>TY877J6GZ>3*P<VAG]]VMW&#I>#4(MKC\N[9_E1+
M8*AS @P_061MBUJL;*0D,J%5_%&96*&[F^?QT_%L;^>#0BYA*0*-:;VG'1%I
M8X5V/,W=F#?>\KE !X@C@OGX39]BG7#99 L)133<)O&G?)<(#/L&%\LEWQ,U
MQZM"%/PB&()+Q2SUKPG<YFG+VXCH7'6E=^S++5J=Z+IBNZPJS]J=Y$+<FVHN
MPWD/&JDVKOAA*;N!DC.HV^8@-PL*XD8Q!];0$P<P"K"XF6D-FLF4!$PYGPT8
M@W(F'YBC:Q[YMXLG;X)V#-:(CV$IL(GWD2ZA<'&N'NDMI",W5<YLYOH.[/G8
M>@F6QL[K/NM[W6!.02J'T^![.4[Y@X<# #<YJHV2&9&(5EX1-V%%5M\&V3BP
MSD'^<'=ZJ#OM I)>#ZI0HSUX;E_G4M.==,Q1J1<KB,R#Y8P6V-^P\;E5/-(%
M^ -@)E15:#95BO%*,K\R@16.M: ?93E_FC6:ICK;/J_J:&IN"/1(WW%SC8II
M05HVB1OLO"IFLIA._2DF6,RAHZ-C7QO#E Q'[+CLOLL@A8-;,6D<07XQQPGW
M-,&3=T%*4V0L7SH4D0NQ+\7SE#( E',OL=) />#&EI5,C^.W)I4_HN!A@*EG
M5_T9B4!Q3A7G[,,?W35,QY'I318( +$A0S[7S?ZP6PE(-^&(PI-FV2L#&\,Q
M3Q)L(*ZYM7$<&DILOLEW=/\@47O1CQ.J>D$+<1*9LEN\KYVK[%'[Y(3#- 1F
MC_&-[CU'KV<WRFZES6;HE7Q8(%<X42XA,! VA!4-$2D7_JV7JJJHRYJD8T,8
M4X9KB4YWL9X$_D+>CDP>D(OW _H!&*'C=+E2<K=G02O%\&=7!,?D2CRM=F/V
MJN9GF.Q*<5!>K)H3B\>QO%:.^$),3A$O@ 8\6*7+I7+F1QV<G:9FF_\!+9"Q
MI2_1UV?$_^C[%@W,R.  [ZC=WD3=6$N)GJ(C7YIU3DS_3D98O-YCV_UM14!.
M1,;[&#GF%6->C!\ "G]HKX>IW:E>.J_EW2M#Y"_\PC4 4S8)?^_^FJCN<F-=
MD-YB>\.-!1M7''Z_H;]I_P[2[H'P#Q_Z:EM!B.**KQ",W\/[9--A]!O)V_G4
MH[^B"0,R"PDM=QZ#XBZ?.RK)_6M:'P3RM[L.,LTZ%AKD">N&AVF<A-<2<<0&
M(?V"Q3FQPQ3G20./^B"5AL'SI]]I,H:0CNLO]F/NR2'*XC!80OC\P'"^SD,1
M9_T<;6B+HSP]50IBZGF@7MYTW4M2L/8(OJPUQJ6P+&SU2%DBW]7<TW+3SYQU
M&6+B? $@#>/$2]]4<V3:KRVH^9Q^V#RO2-F(5(*,*?5WXD;<^!JE&,@H:7V&
M6T&I%)R\:Q79/>&>5UB0Z[)RQ:@L@9E2].^D><K7]-);ID"'(0?)Z<['8J$Z
MFX[=AF<>OZXJNX[-^\WG9KS0QE4RX,+@:-H+ %1O<+GT B 06I>Z*4]ZO'D!
M]"/_U(#":*\2(O66M'\!6"WZC=L_.KP @HG_WE8+0_GZRQU,K?D+X.^]E)]*
MS5X  AWGW<^8 1+$6EG1_\\-H$*H,X"8<N_W;6U=BV/0;Z9C8N*<_0+9<BSL
M06/XV=MO\],CS?-L]0L@<^WG^@L _GM.5)GB@$ N]PO@OZP<=:S+?'?\ H@D
M/JLPO[F95ZCU;EE*+B_?[+LS<RAIXL&E7@Z0KYIAN.8S<C9RAYJ!C*8($3Z0
M/F"CN>]Y0,[(D/HS?=K^Y516UJ7>GB210&4B]XL-#?X6PW3D#^!^\*E19>_^
MY?K*X"N1GC)Z5WKSN)4&'6T;QK\08$4Y#"SSF7I-7G_Y5&NA^/<%8/C]W8R&
M:MC8B3?5NOW\)5&.U DH0GT+U!!GD,\8/L9&Q[C3?O_<X)@([W7SE]W*Z1"^
MJ&>04^^8Z9D&[+$)L4K-41%-9C#_!VXDF2V3'LAZ'=7^K S/U. @:5]JSF+K
M=1#L_Z5@&N!JR:LH?4H$)7R=88-9?#>\X\3ML[Q;*"0[D7N(?B3H]N<C(X#8
M_?Y% !74E##M&I;PQ05(S5'_H@+R/U_!*.-LB[Y SE#(*\7A-WP<RHN&(_H8
M=(<7YW6ZV&C7Y[:;_JO+Q/ZYRYS1UA8[/>TM.&=8EY?M+HPLP+9 ;&Z1A>!E
MRK]T^Y>:C[Y_+V(&Y)P="<- R?8D;*8+B)67CJP(/7 J8T,N>E7^]>'X],]U
MVZFP*S_:0%L>BI'45F)/1QH15KZF"/@Y,_.7*.GX%Z&E_%<[_ DT^1C[BASC
M3O06Z8S2]1(TN>UQ97J,YV-&&+T 2.GM;U][BEC1YX0OSR[F48#>OJ7)J:/9
M^2_DRV]^ 40=1MWO6=%=4K;PKJZ_9JLH?X:HJI0O )47@)AB@=QS_G-(W +,
MY+M5O]VTYWA[H<O1%X L$S1,)%FF/?Q(_;DB19BSU8/AYX$?C#TVTDIP/(#,
MC-*T"&85^DW.R$+&C)L""FS9FJ41M>^"%I$,/& S)#CZ/;?4$[=9=SLO@'S\
M\<=+OZEBA:'N=Y=I,A]D,'0((Y8;NGST032%##V<-5V]^79-4)L\ R=@IYI7
M6M=B&[B9%X?*H?OF39>YEM26^@0-"55?+D0@C/ E3V#Y=UJH0K";(K?+Q131
MJBF");>1POV](0+NX),\7WUD?Z_JBN),Y),?84QS5;2)5[9/E/_PD"(X$;+M
M.W9G$:EO@G_&>LL>K@XI2)+(.YJ'-UK+GA]7S;[,U\L-@DG/SMO]R)^ #XM+
M8-XF]M?QE%M? ./<3S0WF2(CSL\$D:>*>"NOEVQC0:MG3W''B!=\4MOD'\H6
M&;BQ3CPWZYR], L_VW"6(BG<RJ$RY<3E3X9H)*H#X5*%6&SP19V"XB*^:^;\
M:F-%]E@N0:FI)!Z]RW(F1F_%;S5-'G5I@X43>;$GN!9)SGK,254BO!?+@4\L
MBM2QM!P/MBKRQOU<]T'[9X=PC"T*-572$:4A%,.7P:N*JR<^O5Z"ER\ _K6K
MW%\M<1,PXJ ]9]$QQQ'2T1$BP$6[PK0IF; VOD- E]X4X1[NNBY]K$QV<"%B
M34"M7E7_ '61,J&G(&87-1QGDR5X9$=7N$,0\/Y(J1NQ1@ZS2(;:\**Z"&H
M *[H[ ^SKG+Z5R4$<A!2B##9,N!9&=![ZY:9,RC*QIK6.[POPZ]!*V]=RDO,
M?[<H-6XW^J@"B>=BW[]%FHW=A[H[_'SZ \A:5>[?ADS&=Q^,T=UGSXY]R;\.
MD?/#^:U;EF\[W3GF6O+94MN(&>K7%\#[,,MYNMU,6/+('W-H(*LS#W81[R^N
M;NS-@F7:NYXSGN\ H(_2T&<I"$'++P L'^3?N97NKM]YF+-AMLPE;+^"V;4
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M8=[G_;G%Q0BOWNNS7BONT>&_<>?Z,W=LBVPLYQ-[.NX.D\E1@M=?#_3=-\Q
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M5%=G2\*0;S(EM55W:\=3.D!2]T,4HD>^(K>[RO7X"5^$1?H8*>\79)1:KU;
MR1E%2&;1*>8'*+JS,PRPI;EF"AFJ@7RYL+DRW?YP]_[:A<N;9)G436$W6=C
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MG8Y/O5OIYI-6K#)]:<> F2$20Z,M/4I'?-[RNV;SA@]7E+SDF'*W&9VL^MJ
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M.-9YVV>/K[X"4:GO$ 4:AU$?E36N?][!&\H_R^J#U5G:7*^IO#86PS)51:J
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M#>5WRE#\EU#A?QBBKW/G!#-WU+^$7F7'%F&L^/(VDBTWN:,2,_U?4$L#!!0
M   ( )A$$%,&B"CW(S(  $4X   6    9S-D>6-K<C-U9'1H,# P,#$R+FIP
M9\5[952<RYIN$UP"@= X-.X07(*'X!"<X!!<@CL$MZ0AN+L[!&UHW%V"!G=W
M=[EDSYFS]SDS9^Y<6[=Z/3]ZU==5]?KS?K7Z:?II&?!*6EQ*'  # P/0?_X
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M5=!1R#@; WE'C<":.E.8W50;9TX6)CPF<34!&RF6X$#>!8SA[.UGN,%":V!
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MA-12(""%3\*#3/QM;<@%VFIARXU >J4R8H#W4S]98#)#?7]B8U>TH4FP=A&
M+E50HL" @%DMHLU%BKI#(=+UV[&'I"57;W*!Y<.7Y::"-=)R.A3-EL[A@1%D
M5AW\H5LD:1=OGHTZ\!@!-0S$XQ6X5=XP.B,_ (HSZ?8;OZ-&;7(!="""UA7J
M:PH997VHL8L=XH8]G XD&$!LA[I9&4&GB\Y.8(6-9X?PIQ"PR)@J'1P,&;10
MP4=N77\=>:/8WY%(H*(*4S)=%8@5A1+TLGIY?5G98,IJ<:W?>V'=B)47Y!KJ
M%7.C#LV>'\TJD"J>R6NMM#$%T2IX(N.?;YL/%,WLSY_11R0G./7@[\G$AB?B
MFA48UONI$QA%X/WB2S@)=2KJ4/4]S/ CZC6FB>R>1SL32]#!W2Y2M(@[79 "
M4+KI;\S!N/((#2>Z%?68F)"H1+E)ELP)C&#;EV^*!P*53J\U<NPYC+,-L"/F
M_=SU70I)3A?Y8FO=A!,?=_771TV(>M/ P\EJZOEI(/)WHU:P_(A,X\#7>^ "
MHG?.D*%$ 1<BT #VC7K*ZG<+^I+9[]6XU,C:Q0%+5Q]84[R<0)=-<4:#=>JM
MC',?>)\ %TH;AIMBN_0IFC%8A/ZI%1W5\?LB^ @QNVH6*VA[47/B,'LIBL\[
MUHHI02<R('5A"+PN^NA"/B2;,180R@Q<U'@>1?_HQ=\Y RHF8N-FXZ@N0@_5
MK<OCRC:+:I1[&RQ[B,BO;Q+"4L^DJ/($J&%L5C %U J+/'C2%19K80;;5F+9
M-KD3>4OSJCLP;^PR",ZIUZ3!12[U,W);67<L+<VF.'G A,ZC"PLY7N&?/X?W
M<S/P;.-"N6(-84+'UEB=.Q4LR<N++":EF2L;IW>EH:__\ *=K&();TM&)2FB
M_CZ\@7011:Y2TXU#*5%6N*)E/UOVG2Z<3X,A$ZIO#K18 M.,=8JA]2E> K<3
MD%IS1V,4)-;F,8QMLRIT(_4L,!T:;1880)M5+%>@J35/U5B5)?T$<)*_6?6!
MFF2G >O\)/7X=*132+HSK<2'F!_[?R%1PU+)CPNX.^9K+FGI%G-6#Y J^X=-
M['<Y2C GVS J4N/S9P;2VMJ*8VS2@_;Y6#9\[*)X7K8"#(&Y8D2#VL45Z3C?
M+9&$,Q]EU](Z#4&QW'?H(]8CBY^[N0[7>+J]ZDKIZ<X$5_I(NK1"\,H^A7$Q
M-NLM&/-0A'K3ESG*L&&_NE;*/W)'0QG+BF='Q+YB'Y> O&=(1*)RK[UR5Q8J
M/W"V6F"60)F[41R!/>/,%Q,T(:K8-WD"&&BD(=G7W>76[80^QK1,0_+M#"G8
MT=AQ-J"(MRBC66'F+NB2E_0+ZEW.*KWJ0'C[?'S$@EN"("LF]'2F$C1#+)XO
M:7:]0F/5M#G)HAMBJ)ZL3&44C@X5K\J0UJ/<^K*69"6S C6FJ_DZ/^?CO7RP
M>,!V8+7/RB%P?*6=. &UQUC\?.J>WH,MDB]JX\8TAGMF_ 10E[%=3(]]NWNT
MWR#D/(RW1E&CCDA*9,AQV#Y@$++#-6SO\G#I<.;4UP>2]?T(*7-'%R@TRW7N
M,0H]R]:,-Z&69<<::/!C;P#)GLD2$!<X6HW=!V\0UN$-"R66OJ4[8[7OJ9 [
M'S!GRJAU,HA@,=I*HT<58"T]RDE-P>N/?8_?"K=9O9T[V!&+7YPU1];?F!E/
M2.A-BV"+N&F>+U)!PZ>N#ZBS3MBV5 )_&3LDBMQ7!?<9?%]%7U2F;DU<=NJ[
M39E %*OI01#CF8N87X.QN_;5Y%#:--P0=[EDRF.!]1V!J3?R?X!_<RE0)M)Q
M['#5,LMT/V2F*)\8$B< QMS!&:WG6=1DX\):<@0(@S[(<9A!?-\]G@$ @C;"
MP@_(I01T#BP;.J%MF9H!Q@MOAE)[7!2$$<]?I%.'F&RJS;;E&-L[_/PAJQ:(
M?9,[STLQG6F7AVQ8 ^9%,X<U#<O1#]^3N!1(C]_8MWGC==!0-[S0TO]C5"8Q
MF)Z]I9),;H2P);TFAB_E F]K&U <=QSB89:I'$D0B+BC-"IJ=<B)#?EG[H72
MWHW!MM)O-')U=MYS6K0T[1S O$8!)%VOY2%&_*D6BWV3D*+,KOR^6@*-.SW>
MAFG"(7R XRQ'"ZLD3\Q1555_WB<C?%U.+RN='9=^7PU2[C=**:D2^,7H]3:K
MZKA8C;8#63?71CT "?:",UN,V410Q:0K2[/=D-:($(EG8<(_\G;LV7]GCQ82
M6=,376R76*V]7VMR*&\:K(<;<CK*J&Z/;842+R @]:S+(;ZOIE<XF@G#=0&L
MX=^N5A=D)P8S>@#CNN%KD]!>$PUJM DX3&7[R_@A3]GJY&K?#\Z,X#VJ.H,_
M/EM.VJP+;<PM8X"B JY,A8Z7@J31J1@C+Z=RI*G%B5\Z--N_2_</"6B'<KL$
M!I4;*P^_U9(NM/+T2'^I=V37DW#MNM^N>T>8<2A$D.:&QM+HBWJ /\LW;I5_
M]YY<.%!$8+L!5<* [GR;F3)*8I&X/32HFRO%C]XL(PQ/B5*Q1AS!0I-.)ZS_
MBEY[Y^>"++7][C( !<+J'^$%+3K(G(TEQ<?E&28LW(H^ZBM]2[MI8"=;B)!L
M8X,=F6%02:N&YM"*]\QY7HK.Y3;<V'9C<TD]9W]Q3TL#L,6'*T2X2;#RCMH5
M+H+I4A]\##>:<.O(EB(Q^JC?T1F>'[J,O3 >[(ZFBM*F_FKZN^_-\<!,O:J&
M##1DP 5HX5:1.=J2(^P4@6^Z@K A$MSTG,)XU;I=+CD+^PPI^# 20^SG_4?6
MZ;PK#AS2T\N\KIJ]$TM1Z,Y8-L(-^>ZPQ@F]W6IA&1K\)$0O-E,<DPWL7;8
MGD=B<_=%SQGBMXN/[#/(S0RFNY@1UMLBGA<BA)LW<^L/]@ZVQNVJZV_^&)5@
M?\Y+[./20:CX!\M47R;H41W">')"Q'TQ7:H:TS3$/1?L634Y%'\'<OZS\57^
MS?@G40+7Q5R0YO>U6#CSXX)'&=V XN?X_,RK].S;D2)BV HPZK]F^6NY'3CL
MLSKL7P_-0XVG76<]]TS YM-R--!@M^R%75SZ\2$4<6#PX<3ANB%)>KAF6H],
M$FZ2UK<8*4K+5Z?B/X'NH%*+T>>8CM7=(-1CX[M989<BAU,C'+:UN% *>7QW
M!;H8\B[5R>GV ]/FL&2!:0'_!%AN-2Q,W#B[OGW)![Y;-1LP)VH3WX=:#P^_
MZ-=!9!+\:G&Y1"\IO8S;WW62R"N'2W>?-!_M%WO!Z-S7KF@I20W37?'N00K[
MRGJD3 ZH8M"W&$?]Y N[Y%7WA=9!5D\ [5\WJN!^K>0>(VQ%,;) ;$5A^-]@
MW013BT6)J3G4B/!77.9/\LT)50]9D@<LH&6>2O"T]6)/_BA(/<CDA?IHHSK0
MW^084;L56M(Y[@5-1EV*OFI=9W9=PWL"[(V7[EN33^;7NP$S(UY5' K1M*Q]
M&(#RCU0X'$#J1M))4/>'CU;/,VVL4B=Q5!D'^Q$+B2WIY;"TWW8:J)IK^X:!
MI[=V6349\N9*^[4!BP98(O-V([IT-:\^Z(0(^__T#Z-%0^HE#=?L>"OP,TZ4
MJ*AHC-T/[WM.A(NG71>7 ,$EC0]E0>'KPU[#WGFID0D"WH^VF_&&SKQ8ZE.2
MTVPLO129^6HRYO&@&6?(R0>*)&;\(%N5XX[3@A+2NG#UB/*(SJ+EAM=GQD%"
M9!+TVQV)%^(+V(H*ZHIBV(#?4/6X2-UGQIF!#!N2LZ<%$ZD^VRJE!JQ^4!8Q
MLXAJ#GS7KK4YCSCL?K6VYZ\2-Z!XQVCQ<SZZ(A#RJR?NKA(_R!6OYX?T/FWQ
M%D5$K@/G1J,<J;H&I@@OY>N]CQ9EV4\ TITGP#RGF6,AG?4_F.8O !ZY>()U
MH NUH6J&2W*YVU$ZE24-A $;PB0S!YH?]_"K'2B*:+<<SA'*:R:^\S.QE33;
M8IQ6GB-RYC#NISL:JU8GZR36Y"ZF2L@%[>=UD [/;Q%-]O<=C]R'3'D?IF]:
M:L:^CTD24[9JXYY^)D!^?^9[>D)HVN*81O;7_MZ<@&%VX=>*&K_>1K?EBGE
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M=0+E,B7@F&6!,_[G5_34Q)\VFM4'44BC/@9Q+9Q9RVY1C/NKAG\UG2'#^4H
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M+G4P)TX15&T<>LVG#=@R&W[GQ*GBNOEZI=!)U*S=,;X?9PY*4RN8L%E=\D6
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MGUS3$=U/4[:>:7'VK!KSH9M)_:2V/B^YWDBU1LWRI;8/ 'A[XJ^Q\U N-$;
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M.'X- H6$A(2*@DJ(AD;(045*Q?$_/AY; "Q$:#>H,Q@H:@ :"PH&"^JQ Z
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M>JCWDZ0)PA]<B^GVZ[9@3[,J69@_[I,%J7I"':IHM^V0N[><KJ\'74J;W(F
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MK9/B]U\*_CZ-<UP]9A/X"<CU?O.X]4E724./4"_A[>*D2%S>(S"\7O, D_K
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MDT9#"@H(%TD<IE[GMV.+QY6&RJ2=)*C_\4ZA8UTN%0G7M_'Q_K]JI9EOB>3
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M?8X;%%^?V7DX"[&/O%9Y_X4K,C T4+[!W,"X!@OD#!F"RL,:>XE!PI2WU>>
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MI+<^N#< 0Z$^M57UU+D6:\[I*VI4.$+UOE@[AJE798,$LS:FMTY#!;"Z#Y+
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M7':'ZB021GPM:T=\17(.-:(1^[]V3]/"<<BF!W\XH2[;(OHP*/P=W#>V/7G
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MOAVO3\EY<?2> SYFVD-7*YESL:\PJC$_OQ;=DL>$QQM6QD:M$>ED5,_4@#,
M0^&* (4ULUZ=1PB+@.C XX*@Z;=#3VI00!R(Y;/8WF2KL;#2*2\OZSL&VVNM
MW:5*$CL/9TFBZ=>E,=U11ICL^Q/<M_/*6R:6AZ]B*0IN,\_-%-?#/#]D]1WC
MR-Y\M5NX@[MJZRA%[Q0TUM>,.M!$K-JX3G[!I9LZ:E##G"VN(EJ,S_Q2PO;N
MU) %DIST=4M&13!T&@F:<0<=.#HS)?>::RJP>7>AH._,$J18@"7J9WY*^YZ0
M,_MRWN2CGG%X6V\/3$G/9?=1M: OSN.MU,1KK9E^^GHU5@);;^KYC_[:&(68
M"#3QF=D- W3+^!G[P8L-#4W04#4P3 %,0BP<W9/W 1$!#NA]K6!$P3"-&EP;
M*?9(>]LGH]-5#JOYF^+3SZD6*1\^8>/#)MNGI]07G2?J5+UP.OE$B4=.A%).
MVO&#<[^354%2P)KA*^I4%>A\JU#@REX$KK\V.>;=LX:0NS-:7ZG !4E%&;B9
MRZ?>!.#*^M0[5(!EV2.O8P5"SW&HA=9 -,3SR:NDHP^3G.#.-PT TU:#J?9.
MOA:\EH:[X2F6RFO-4%A2BL6R\KJ+UW4K_T:% :,M&]:\>.E\6C DZV7KR,?:
M>I6!9FZ;[>?Z]8R2F7(W].=V)*2'VQHNVRA?!(+TP@@6/ZHX$P.1,M/CO.!>
M)>ZP-X(CY64G)6G]6R3:N0D[WWHVU:.;!6*$-S*=!NX!B.7P;#DZ,]H_;O7]
M<=N99)[B'A!G"IKP!IUP25'\>N"#!PKYC+5RD)-:V^!L%[13D]GLW]*JD[;K
M> \03:8$WP.B!4<B7] M7(X;'7J&3AIX^WS.';!\,B H2>7Q0CR)GYB.8FP=
MQE*&[9:2<P:]!V0IQ/:"8+&UK3=7>F\5[GBX.7,/9+@M.7H^O5\II*'.DLIR
M3FP9OP<<;SE?LET,_30I'9+*<F+R*[L'; RO'!D>YOP"0<[5%3^C%,K5TF,L
ML3=)AXXBUU8@Q:B$Z2H]DQ,OR0#CQ*&.%%TRH?RWJ-P_W93PI(B%<??KIC5Y
MEWO(655Q=_2;0F1E7P6EQ_FX[2LE5M:P_#ZF=G;B7^+1SHX47=2XUKT'#.9U
MK[:NR$POW/FQBCV[!Y#42!'XM97]3@F+".;K -U?O%#:@BY/ZF^2;VP&\+3/
M$:$_G8C^7:"QU(H'IY^[Q@8@*@ZID\5?FV2G97LV6BG>:Y]C//POC$)?L_?
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M_1B,5X;$*#=4%\W2W;_K/4H$<RA)]NVSYA_LCJ)-7&4,E,U'@!5)#? PJ)*
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M^F6O\/A9M*<K#G95E1(/#!75VC1^) '&E +>$_*M>#)K=94Q^RUX.(DT@8N
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M?![)0E26)AW1>_VS[L\:J:[<\ZYXYQ[N*&QH8Y2I5&V@\^I(G#;OV4A)B4P
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MNJ\XQ;'#[4OF%)_US%?UKCN\)F G]H_*C, &A49E_BU M_;O54IV7=:M6OX
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M^ZDLKG-.&6@%Y7>N3!_3%BN$'R7XR#JUK#O>W,7,]5&*ZY-",SIBE>=80>T
M<*Z_<ZJI5[*<@NWWT ;W$!AAIC7)0\#1J'G*0\-YA.V4C9C:!Z&AHEU%6] L
MVX4S)N*=,V^OA75AI2:!%0H-#KCK1(RK8=NR/NZ*@N_JX_)$W@2C?@24^8?X
M:OO]61RA2>DWK9ZS8(1:NK"3'LA)BS<=P9ZLQC5S;APVQNY,1L;YB@.:0/N
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M36A=UEN\31@WR!]>MJ3K18*O%8G2@;C[.8#2-Z8 8#;>]3^_Y8LUNS[>YQN
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ML['O[L3^VZPX$15U,[.><_/FS7/S>5]ZWP"@R0"E@0 (" B X<<'\+X*$ /
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M&X&"3>4"R]AY^A,V)?LFU>4_J/T+LW^.6-#_$;/_G]C_X+4"0(*"^%@\*'2
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M^*&B)>)H2X:V.NJ$&R^NWZ8X!O0B\K.V9)>G6U7V$T5FG:!?%(YV(OQ4BP5
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MV[\Y@N@0VU;E!=?6#-;%[.!)\:CCR(.\G3W+SQ]D^;G> 6*PB>^ P)IW0#3
M5EGK'7"1Y.GP%HI,_PZ ,GD'X MM,ES\?47"UWR#'7QCAZB1^/BQ1WOSSQ,N
M>]4+<NR+Y3O@1UUOP,U7JV\/!"0/4[#]6+'O  2+T'? @>',GPM.H<N\-XQ)
MY'? 5'=!P(9MP+8PMELT-;*#PC/6Z!#(:VK\]Q"<JS-#Y!PQ:[#@<KG/.>#
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M4;9B[UVBB[B')OJ=[S5-)"X3;U_7&ZY7U@_OJGONDE3U=K?C-YK)J8R;,8K
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M022[I.F.:]Z7PNB'3Y=M<Q(AX$2_0GU^>?8O[D8.'&C%SD@JW 2R'Z[S0+*
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MX,8]L\D#K8R:<%$VV*Y.M3/\<4A6:0858"0.7"D._7'S&_"B:2GV%:G0!]M
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MI)Q]K)!-]^C")G(L)N<H=:TO)D,&\,^]V;7FW]#.0@E2#)L??Z:"M<:KT:,
MXU>)W"2T.RP"7H.2$@"-:O1(VCY9WB+NSV=_YV[7)_<U+#\4QVZ[ICGS;2R*
M3LH9*8:^'/^H%Y(S\Q-_6"@1?4DYLB/)@[3O5Z>NMC2A!U0J@,8[X <U\Q.N
M[X?+@KGRWM!^_SDPNB1Y0P*W1M!")?]O6,L5\3Q%^3XJ\J -F]:74$;.S3O9
MXC8*8TYNHS7BK0Z4:GY7A >?+258Z9G*:KA79VO AXZ"E_MV\_4A]AT ZR#Y
M0L82,-6[)?2"U^&&J03'_%^P9GH&]*"/>U5]672[N6H@3Y&7Z'98%W<&%V5V
M]C2^ S81(M]"2=#? 1OC1_MA.4D$DVAXQJX8UF93M: 6W]^ADL5#_,\:NP#G
M=\#%C_YW@!AJ^,<W\YN GL\XKTB"%.^ [K1%98G_9Q_?\$S!"]@DNR2A(#RR
MMP+#79@:($S#9F 7^?E-);7$)2J:*H0+M#PM*OZ+^/6ZH$!]\O]7\6OAY>[1
M[PZJ#=,VC-;VM[A:K=H&&21?>KR)<W[H^6/%5\+$ON,XA'I<!\;M:R;7LJU:
MD]CV#J!_F=C23-I<O[)5\4$-TJX1-1)H!)1NG#<#^E-WNI5N9-C<;="OB/OD
MHE9_JEXPQ20^!,7&8 ;R>FS-*MZJT,5=02BG<K]&ZL>*Y0MH#6!1QZMT<%WN
MOUJ.G2.5%]*)V5ID?90A,X6+X]X^CNCGG>/T();C6['<=]>O:+*^G9QZRSC.
M_\,9RN*]FPQ/K%*TZ^LTV,S]ICYAS6NJF5J?W%B)87EY56I_S382)YBNIJZ1
MW*K.UWRDZ.!$VGQ-(>)BY\B:J\19#7T1T.?ZI#&BM];]29:JK:\F1TEUC_#F
M*29+3I/"K)BCOHTZV9$Y63_8.(E["*Z0[Y7>Z$RB8$<*L\M$:0:8?^H+6FV@
M4YF9-)H04!2^B*ERMO,PD*-"ZI=-7-%"B9(\L%:;S6CHM?]#:]CWE1!+X'BB
M00!H@^P/R\K.Z?B5CF)78?=1D0CHDE7A[9]6+)A7 )QJK5@2::B)[FU]#G@J
MTU*;[]LM40!??6D_M59,QG-EX#_H?LY[[BD7-\X4F.8:TA3@P1S6H3VC! 4J
MB6CB[J(VWY0N%$_K%@L3Y;H3$FNC"A6X6ID0Z"U=W,3$2=M]@;.)SQ+3289?
M0BF"@:"\[W>9&JO6?QS:H2?J"LBR/E2/WT(><8YG/K"A:2[HF' ?5$T"O_26
MC/AVB&I@!W8!(%Z$8JW-4QI[==JF]R-M<>!- W]N)K2^B@A5X+32=:;>4=8U
M_.HY&JL"$RB<IK^I-44]#:3!%ECVCJ[5 H */3S$?9^?E.UDIZ-:$V^>OSH0
MF2;!C<4$%Q^F^['H_OUW%W=:E_H%8_=L_)!J9NI?W@$"K!ULNB3_KH>J0#RT
M^L.4T\5+UI/_1RZ9#FK'\"(^5K0<F[@2WY-0R8,3L %WL@<,"PG=OMJ] _)@
M/"MB0"Z\ C/-(<9BU34#>Z?:[.#PE319U4S#^--MY)=2&Q^Y:BKMVF5<(AM[
M>6)X8F;!(TZ&M$*GXU--G8EK91_+FP\EZM=M^LMYZ<ROY)FO4VUT7UJO*=^*
MDSYW7<^@DCSROI!_V\5;4\C%?>6TB^5MGU 2[P#&QG-"!.L$WQ<BMT&JFT?(
MKVVOY8%0-Y@/H"@55G);H.*AUQ&$>.I!(M#2P,=4!#-(0+'SYKH[)XZMBGLZ
M@^?40,@E].I=?-J<Y [S^TJZ[*OEU7I;?19Y%Q?+<=L!C#@YN+\Q:?N%.6=T
M2]^93U@Q2<B++W.$]XVZ@T)GWK>6T743H]L<$BZ@A>19<F[#\0N[9_;%W^"=
MMHAY_WGG%H#?'E&(D\KJFFCC_36B'= J?_6.RMA$D^:[\//2),G/RB.U-0S]
M"6UI!?D;2<F<PWLPZ4*:=LREN"&[DE396P$JV-Z[Y73)'VO^6!-*="II4A$@
MTP5,2P-EEBNZ@(L??-0;:YX%(ZKV#4!AB4K0?]< ?"C!A_K0K42_[JW<^.49
MBEF23&)'FFP4U%Q&#&YW/ MN,TYR]!GQM;'NOK[X:*IOGH>Q*;*M'TUBNI\&
M8Z)#I3_OM57P]>JX)[,-0XX\_Z2KD]*C]CZ=E"G:.L?JWXS40HV_7M,32L;_
M\MR9_Z3)[W@1U-[ F42NZAXHVY>LD2H?/ET.'W3F*5<:X>X5Z-G+9;M(88)I
M4PSEQ^!BL#PP<<T&'81T*WXK6&[=T%E2K'>4C--4XL"QODD.2T01(LG0]PX
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M.]3B!I(*.8 T9H#=%[YKZH)2?72]MFS<IY-8\340W820QCS%._W.ZF./V1D
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MV[^]D;U$**M+;%-?0.G*>8LI0V&9:X-9+L]7YO@R)^=-EY_SG$J1.N36Q5Y
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M#EVLTA='?R^PKAS+[Z04M<+M$WA_*,2[T<;Z"R.0;"DB ":S_4AD5/_$4CQ
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M63Z .QO2U=#4.GXJWN14MOB]F=^IX#+ KM\=0 BBGU;U'"+T%GD;?"C$RI'
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MR6&+^M7!O[: 3PVJZ;<56<G?*_Z6YI<=M)L$OLQ%DB\@[>0Y[B[.'#4#X;>
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M7%H(TF75S]C[H_8G5I@N+:[(/&8'O&N"SBP^'' D)YPQ'#KU6FXM9CP#B!P
M546^<TJ_V5C!&YZ-U2TUR5=9^ZKL\DE\MBRA?)\>&@ZQA79H#WS+/L@GR\WD
MJDU%:O%](&+68Y_BAN8DP$3+,DR_K%TZ.C/OZ' 9+MKK"AE9LUWSIS#%.>(W
MQ0S1[4#X_+&3_#G0ED!5!HYI7PJQX!!^#-8*U-)H05S:-!Z)PD7[1\1[0<&]
MD'Z T"MG4Y4V0AOX-<;'!=RT1<NP[9Q^_2")I>;[Z%9](9U$M\(N:Z>4DNM3
M8)XVIWF!C9E66.L6\O9&QJ8G3&@&H,/[U.AA6VYH?U"HR _W\=,H+T&"(SF%
MNK]/6_C!;^ #]S(60XPN7JMR;RYF(N8H//K?O:A/B61CEV*%=M>"1"9@Y.S6
MXRDT<<#/Q#N G4\J7/ZIOQH]Q]E!8O.A/*EF[)*+V]R'VNBY]!TFPG,B(J]Y
MG*TW]]WZ-DW'O:<+6UFWK)JXB9-ZOV/ZZF"5$V.'IG.$N-!_U4+6CD;V<$,=
MK5,SY.K"2E#>0;<;B?#@MO332/\I@)X&V&4/E,M?.$'(YF(%8(7<4+7@DPU>
M:B\UNX31,=1UH5B1ATW,X7NMLJ2Z]%WZ9Y8M\\,)3>OU>1*$E-1^SM<PH1#W
MBUEPRE-?5?Y^(T>:]XE  H ]@]3S\"]%/^SQ+W,<)]KVM8[66F#W92P2%4LJ
M.S.8.K[I3*1/RNQ;&O0",R8ZDT!EM9- W;&J+YKTO<H6=*3%B,Y49HV8G@92
MJ#?V#"0+F\CB*M@R.'LH6E5]D-@)WV?D[DO>!S/#+3@.*XKM%I!HHG]VJ<D*
M4L6XIW%$N90[X9%58=QF;GWX-+E[GB7^AGGCMD&.+1O3M]'RC<(SP')PL5ZX
MX!*?I]*9/G;L=DDHG*E>L-/E^Z,#DA</*4U,GMXF).)E=D\85#S3W81EQDO\
MC;'^RT#^]<C#=>!0!"A5O^,[6IU<I,N"1&+W1\8!)!"I=%N<2:9]*7NAIYQM
MNXM-J#4,.GF,Y3L6H$64##N<%K&*\AW:@83%.\9-M<F5Z8TRJZX%XPTZC)XS
MVW._(&HD[G=4NVW080U>(SBS YI1'?KAO*U,8-//5&[O7NH&JFGMH%#VMQVL
M4WT^!F_':=9+MDS>? I#K87$507W-S@%ZHNV-\>:8MR6Q&^&MDBW1:>9$OE-
M\FCXRO5!()QRUR+?LME[(!G&DQM3TLUJ9O);3=XZ^MQ)3E9FCXYRJN=7KZ7(
M8K;?;0_:KH1"8YL>_&!N:8DFT[RM1]K%U:?;'6PW$:_$D@1<Q*+]?KC[^ABR
M&HAC'TSB+0A[MD*H/L2T.V:)3/A3C!4 &WGKTS$*OB\;+AW!(XY70_V3Z)H8
MJZ\J'9;/S8GK<?!LS.93MLXC#T%'ALG))O3U]AXYCC4P04I/C3WN&H'K.]EI
M+8;3L5+*G!3"#OQ9^)O5.GS[1@&Z7\*@0G9[X=!2U!EX7:LMF.%=SI+O]R]+
MGVZZ+D4=]5G7Y-U)4.@5Y?E"R2T)1@UV_0OP4N4B1*0AAS[E_EH(;T1@NR_R
M_6POUT'9.]W3N4BQ,5VL?(4,J ?L])*VKB %SN!%>VT+6E4FO%!J3G,3<RJ,
MY$B6HZF%[1G'_0^J,4>2Y_M5_6>H7N4#R[I%:T0R[12#@&E@R*CW7^#,5GD4
MB$O<5MM<FZS8FBK-_YYX4]O^.Z1TT]41!+\GA_KX,#U8[72:!<](S3T#9*,W
M T6@=O[R#4!5$?LZ,[,L50)XH&%=:]NIH"(+2_J@QO7RA]=URG1)^DA 9LAE
M):VHR2Z([E?X@Q*&5&FC?$K808;V%#3FV%K=6&_;2Q4/AKITVHL,^N4XG+U^
MC&IMO%_[(5<8;6F.'5=%H'/?X?U:A?6)R&"@:%6=C?*(>$TQ(Y5RO:/^E-?B
M)!9A%O'LU"Q'2URARDOQ4-(AS8RD12&\<$\Y=B\$@J@Q=,BF$2/QG!R=<<:3
M=TKZ8*/]S5\X]1WLC'UK'(EI%-<"FWA*BO)877FKS*.2134+D.D:2W7[F]]7
M6F8G>,1Q]\"^C924<U@^N$>OL5/%-D6YN#+]2C^?G#@)"EQRPSY77$*#ZW<,
MTPO-&Y87:JD>,%H?T7>,K3,/.+*=KQT]8\=0:'GC ,(>TXO1Q<YYQH8%-(%,
MZS2;#5OH2IF-5!H*OQ$O><F"!"VS>RAI'8M8IUKL\0&;6<*V(0::(..E5!!/
M?!;==*7&/H6L/KN57,-RAWZ7C'JR]B5C5M"/JS#XG7<#H4X,^0LJ'C YYXX=
M\!X_@[0Z9WG%_I[ZYXP([WIZ,8AB(Q'!H"$+HG87W4\<+0LJ#?](=(919SW,
MLL=]O(PS7<12H1US92N:KM/0I\S\Q-_<V@3]( *FYJ##<G:12Q;UMSTC: 2#
MV0Z9.#7B4WICEZRP0X)4K\I+*^B3!PQEUCAP%U'CA7@,E!9BFH&06!5EJ_U3
MWSF-!.=IQ3,4[_>_!I\!>,,A#)/[4EX/ 3>EVK196P(73M:^)PA-]5FX5,UC
M,KD<N;#*@!N,LOFJTG]%J:FM68\.$_)@E8%Y8#,EHNKCM[-D9W#-Q4FDU"0L
M<2BFD"6.LT]EKU]XNA(9G;M4TJ+4XW:(L=A9R21[WC[V?9#> OS*U_SR8$5L
M9\A^C7C(G4@L8NY.MW!/P<2&_+/V7>T*[X!]H@-?-^CX@7==OU*^UZY%NIOG
MD2LX$ZQ_&VIHZ/5AS92@+B(%?.CGQ[N(_E(NB3NVBN?/H=?+KZ1'DB%[^O O
M/V;GWB\8].PL*W E[.1<B876'+=I!U_;HQ9_%E%A?]G-DR;=JG6?)0@K5)NN
M%_3<_3/7W<&2=FYZ-<>UQY42[)*!8ZY]1+,TJ)E\1.;= "H>N4_.Y\@L&6IB
M51TF?MJ/73%H+2S/MO$KM&'C^2*!@2B;U^5GJ!8=Z(-]?M#R&T.+X[C5OEA/
M/8.%/V@?BM?0/P,P">1]R,*S/WC+.>]_G9F(9Y:?<A\+R%I1Z#3%'^$*7L,_
MTU%]E*(O?@9T:_,_8GYD>09TB=2U%P@G#K+W;^(.I8],^T%&XU^L4E]2UG,H
M[/Q:8TI_^BQ.\ Q8S3,(!>.;-*ME$9Q)57ZT\(SR#WHO5Q?A>NT>A'IFO+4U
M6B?DDDBFR-:;;N4+6U(?W,DIK="X%M7J-?>I[RX-?)S>YY[1UFN3=$,FC/O[
M&.A;CJ?H=RY+$WMO:,X#6=;;+(NOI7^MR=7%-'(D@PQ@BK%-Y3CXP3!8A/BA
MX'^T=].? 1A**Y?,OE7/ %2\WV1_9!&&,Y>O?$6XUP4"VRVF[(%-T\!8'IDD
M$'UU)\"K-&-]?<HB'%B0+E<_*4,P\*^9.EPC(QE[1]Z18[QW:@.'_JC(P"?M
ML87;I-BH8#</T7RC153J@K#AD4].*#MQW[^-(P1/C GZVG35>+C9=Q=/V.7'
MM]2'B^'CGBE<,JF)Q,Z]GG^_]P@4*+<$\;7_4HVA_M"T)!?;AOX?$ F9NSON
M%PP$;'A#'':DMK1_'S&O<Z:?_WD]S=>$Q>8[)_J-^4]L)"7\Z2H4R\RR_W?_
M0PF2QI:ZL_(;M:I!1^OM.A?7"KK'"56S''($)\]PIGY=01L1?S]H(\(_*N<\
MGU6A!/Z'[]B: K13X2ACC@GSA(:\:_&V#XLE?D.$XN\,^$B 8D 1K@GL8O")
M(\-JQ),G0J=#^AXR?DX9!B!N[*!NIWR+4([I*T@+W2>\9M!H7:<_MOSJC71<
M24:RP5M6X#!:NC3&=^=(KIY(@I@<4(S0/,;<."WC%U*.67X&B+U>MIH8F[?@
M!BI5D;D&O#6M! @2  D)&^9\^-6Z2WDG-;E??'3/!VP4*P!J_TE]_W>!YM)<
M$FP[SZ0829WFIT-<D/'IAZI&D&MNK/!Z356@BFR4N1>8]X>14;Z\#H@(?=BH
MI70,XT_X.$+_R!A_L0]XIG202CO6D]@OBT.E$/M:;'9YZYCVJU-<)LR-+C$Q
M9,+JW$V"1%=H*8'G"10MDS7).#TH<$$2.T+E/$HD?C3%EQ^ 5D7.S=-JLBE%
MA^!VLF**7U>R]%X[F(;8IDT*B88@B([?7S-RN"#_?"E/5^1'?BF(#+A"?L67
MCE7+VVF/VC][_J? !K?:N#4)!,<6!>P'*0-L@SK.]2W?#.&"V3-IO8WNW&@S
MDJAZ]4KI%FK'.#T6>XFH%M,^9E+T#?>Q$JFR/$;>Y6XXNN94"A"G1@E0]=Q>
MJA8N#%JBIDL'IKOFL55J)]IU,G>&8@L,B.X+!Q%VSYX+#^0%U_5#\X;.6QN
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M7UYGM8$,8\HG*>*;Y)?DT')W?N>31AZDJ4F9MP#U_Q__%4C/"_\+4$L#!!0
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MPE_QP0OG)4+2.4QR/-*LR)--7"0S)HB5;SU;@Q'XB6+?<U H!<O:LJ"@SBE
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M(,+5K]Z%[>QKB5>QH(7NAKLF?]7["3/X1FQG'SNA[_9_%+R$"94>5%C#8N
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M"VFO!@ /NK<&<V7:;@"JD)2(E'5J<4'-]VNQNJZT\68QJT"4G&$UA-4DN_.
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MM4@!ZQ<CA,Z6-Y6#2$@ 9CH=]U11!\^LZ]PYQK: =?I.7<0>]AKQ_G5^?H.
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MW^YYO$EX$>=KP]A*.^*PS(G :H_ 5K3**=EN^/U/773:NL?046#[P1I892X
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M?L%Y=GV.5DC@+X#*S-$4#W=2XS3DF0/Y$%'J[<*L&VK"'N^V]K;BNJ%N!HI
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M(>HA\.O]Z'*'4-G"E8:96-&^"WAVR6X7TM\%;K_B0^'5=<.^86=9NN5UWNK
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MG:1=#F4[G*-K16!@R4@,RJZ#X@H\I!\*';"PZ7<9:VCL&VTY9)5GKD5L.#Y
MPJ4\>M11 W)F"KRE2O,M#78H,FFN^=_/)O^$0K28)8U<VI9S&V@/X[#^QCC@
MQE2L'-P,#4":U,M/8+C.("0#(0IS#\I+8TGOHNY[KTBG^=W\E/<8(<5H)+?/
MR?M&C'^M?/(C?BCY.-&N711.9N+U55@XJJ_ME@PM'0G#LMPY':K>R\N6F0O.
M4OUL^X#W*/]#I5FKE7UJ: E*&0FXCU/8W _QT\76?C-,&)N[@**)$_OWD=6
MD."''O5'/>^0[8>!0%,V<ILFKKOY.EP$1=R^/MF8O8.%(A@?15T?U-_F@SS=
M_(\Y3)K"<GABQE+9:W9<R^"?#@S#SGW*3PVAVPX)V"#205_?*-H]S1,'$:JX
M_ZOUW(K[YK]ZS]$+<\8#FP)RSY-&@*.'P=("11:D3C!(P+_#UHF 5?"[MA]/
M7'6EP#73F#VF*;N)EG\DR<Y['\C9;];$6KZ0*73_E1VL^OB5-I<#=5@.7>+0
MX)2.)FV!??FW2M\$Y2G90M9^MU ,[\M,5S&;F-58+4ID8H8@1<)0R3O\1F*U
MD^')+QJA_35HN JYI%K[U/M$D^LM/)6D+FT[!R^ HT)D!3:6D5.FOZWQT@03
M6F2"-(297"=_9\W6-I$64Z&7]<4[%+>W9>1>PT$D;@E<:%N?#,/+W>[7FEL:
M&PEDVFA;=#'@6),,#^Y5['\CBN!%=@'N].8$8;0D^PS7H *_]WF632F"X+!O
M5M&/B.A_"'8!^B;,.$OF$;/;WRLC8<;@$ARG,M%\3K1V5Y'[V_0]+%4HK5+A
M->N2LSQR(^#9XPR&_\M\YE'$O/*ATE*-+^*AW >^9821MSCL7[:L'_2J/8H$
M%NS*:RP/IY.P= V&2*'8VR>NB,\)64O/.KR+3:R5<_]ZRA!NN1)/ A':SG=[
MJ"W.8^N%SE >EAH,>-% WRJ=4T"GN.CJ'?(FME5&9(1-%BQ+P5:P$S.2Q6^A
M+>NR.-!G[QPHX7X(B6G-<B988HL>C-FR0W&^<B#E]VEWZBT%I-)-VTQA0LU)
M]=11PP5E!X"7>P3.O>,.Z@.Y3>'.&39V3 ]7'QLX,@G]]BE9%RMK%G<%DJ#X
MLVJ#-?3I,V8'-L*NF6:/)1T$?H=Z$5Q%&85('OM2]S:ZKZENK-SU.?[A.CH4
M@9R7E1 Y$2Z/($5):"'$<+U[RL?19!T$]LQM!#\B:6*+FXE8K8(K!E6_;+S;
M8_Q9XS5J/G?5:/^X4"P!ZNO9;KO?Q$R:YROH874B"@F(H&N[[SF%B$T8]X)G
M0.$.5")+/U_GW[W*1;Z-F:'G-WH!&%77M(.C]HY4T[$8BM%90F>MPE#>X%&E
ME76^C=G[\YE;9I?!(UT+_B?A+-2 @',H&?.$62#YBCX$Q&77A1P18WD'@T?\
M0-B:TE-;-AU./..]^9V8$WB"C#3XV757Q]^5E2V.T-KYO=INFXFW7#ST?LMN
M<J<E ZA04=;JC.PX*&\?R&F[6U&^'';EZ;EHD\_TNI4UMMP_XB_F@0X961.3
MN<_&"DG1*$F/D;['D])1%<FAH"M'XP_;:A'_*;0?M%0C0M1&-C7>&KISYOHQ
M"EL0,R'>I@S$\RNNLK]D<U/KHPK-BNCVC@&_&!(84GED0QY WQ(?1:,A40?
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MC612H#I&,. Y.15PR9.QJ-;*W&U"KFZ+7C%<BM;F9)[/O/_.A;W]-D99FUH
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MTE*K^Q3;/WGY\YRBLJO-&=<'_T[:U;B8BD.I-[D @.9>L>?Q+EU2&?>T=:4
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MTI\]Y<]SP@9("CMR8";MYBV'"J)>6[)?AKF_XYB;X1P1N\P$CK9]-XVCB?R
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M!YHH"'7?<VI-T:[4IB%\[43+0AE%PJ.W1(TS+Z%Y"ZA5>V]$5=I;(E5BBV'
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M;AHZAGD1$%:I,0A+\'/N,H]I;2A#O_UA6WYK(7U0,:$0!\X\N>ZGGO9H.@E
MY0YFJ6#BL$<3>>VXAJ1LI5Z)TUPEN *N<:0/MI'^Z@E0W.Z@JX-L]7\T*:BG
MI;G<^;YJHFNZ+*G)M#0_?66+*P \;(^OB,WF!%&/8\DA41!UN:+SWY86.M3(
M5(=8N%YLQ:MUE$KVVA"CC>@S/WF3&<S&M]1%VHC *]K1)PA0-?91;P/7T8,J
ME&@P9-H;0NV#0TI&OZ16MQ2T_+!B=HM5-B[@KG,U9Z7RW_+9MLR<20CHQPM
M(*\'SC_0H\@QK) '%IV?*(ZVMP34W&09D)35D26Y$P?IU82A=)M3C0W"_@3&
MJC!.ZJ9&+LR@@#C"=Z1X^!@,$R:C..JGG-B";QA.=FP:%PT<.<G2 R7!D^V-
M<F^ .)[8%S_P&^!7U(4QYB*^/ULY_O8'^F-+=7P#E&.>$SWEY^_E04>K8B\P
MJBP$P(H Y.1-400$?[PB1[4%Z?7KIQ.C%2."]>'\Z.[%KR:U.":?;IYVLT1&
M=JHG& R/R^KUYS7<^BP^Q3?,02>@,E\=-^F$HF ^C@BRS<93+OGMIF?U AFA
M+F<7XS0M6H.5/ <)MD@.%?0]=?7D "C*^$>QOM7.E5>?\GR_+:5_>V\S ^MJ
M!,NX$DIE5JG7H91_&;CK_[XBU.5C$(!Y Z#R(N+Z+&1@E'=Z*@TDE2>R;KMS
MQ"^UL_=O+U$JBE&?@Z/$PYI2=&@^!]-8F%U]7,S[5.42=@E<W[Y95\]E!FK.
MURM%A$4SQJPVY9G@RCI26R(SEEOP@PVG[9MU52K!$:Q$3WT3/'5CW2D.\2=,
M.[&;/*0)YW5D+='#W>17B1G:9 HIU*V7ZIS]M2QA"/FOWL6:NXC"DWGAJLGB
M[SUA-?$)]YZ=]$1("$@VO\DB.1N_.5V<'$/\^2#Z*\()E$82ER3Y0R;%1GN,
MD>0N%C8IO(NFEIQ94FOL2DZJ;950>V R3WMS:/-5^C#Q\TJQ&>,(EIR69N8/
MXS@'H1^;#/YG-;_48CE>J6*:2O25&WQF]XX/=D/NQMS4Y)RP(+06Q#'-=$"-
M>:_/+K*T!-%$2KYH4I]K\B$''U/=G_K#&;MEPFGTO?\2G\-_^,F2J1W_H.Z'
M>SF&)B-B_>>TD?X3BR-QFR.6445<H(G0U[QLIU5!JE:K,_,/\),5"AYXBY[5
M2^'SI64)>SA:FSH9HY.RK)SF\_*_X<]O[TH2O/Y.LC6-\@^Z6-3(?2FNB>L>
M7 XHO7*(^01D@@2J^&[6[C2ET,\B4D>AL[]NASQUP;NBJ^LN)E\T-#4V(4W5
M]&GNF#9:0TY.[0C&XT44L8D72EBJXMESAF@W!A=HE]>CP@]WO&2X>$=>=IAB
M?\Y6UE\9'LS.%I-8$61\$F3+?<K4<D^I,?I2#J'65J\[ZU(3"3ABU*3C=W.]
M;*V_;$]\2+;PD_UAKLTU)#HYT<JNBTTJ1K5891&'H, (_@;]P2WV0%4GLK )
M-X:P889EKV8+?NKOC+H3XZHLZVT2%1344^]R]G6]_,[^2HQ7RF?5:KEMA[V*
MS\4@(\^(A')M-$[EJ;\:+D9].OKZYL_-7Y>1ZI%.HC@RBPEZ7%K/*Y*21S)J
M,*OR9(5G(XK)^N=(E[U*-/.2]10/!X&663 Q,(HD]6VN^LTTD4X_16=4NB"?
M ]4H(9Q##\)/F-HLS(\8]2T4P:^[0BD@H498<4H^ M1#5*5LVBB[6J@&(*QQ
M9H.,:'HQ*[/D*G/?'\A#$@KP#2 ?A1,F\0:0NBPR@E."_C[YIRUQ8GYA $O;
M>KYIFKNSNKHYYCFW6SZ,95!TAKR&0RI" _^QN'Q?=%CT#<"#+8M HTU'IE=_
M6U7[O=$3"JP:HE_2ZC?2W3.^0LQ!/8!1 P\MP-3];$,HH-EA(GY33*06ST83
MI>\1Q=Z:HK@2A-2,NCV$HR=!*QUX]M O:MUHJB=G,&K].N6"D<$Y0#M4TR'&
MH2=>E=H-@4NV6N(UFL$FVQI5^"FNLV7;J+[$4_B38+#Q;^[(5+BL 048?=IJ
M,@RK/,T5Z>1IY4I=)!25$O++0J+G].9,LJQ$2F/U1YD5C#HRT (^5B_FKCRZ
MSD)9/3N9W-R&D+VKY65#]N@2%YJ*S&OV&]6J\&8HK_C@5NQ8_2MN$+@HLO-8
M@.XU,OQ/!4W&Z<KB)MPWQP>-;-EC.Z\-XV>?^]37WH2@_0@[@:3D6/9S^XNB
M<(?01@?$ATEJIW2=5,>5LKP \GXS%)C !_.U9F_X@^R9F/4R.],-)J84H'#9
M+K'OZT59GL)6J7Z;ZVG?Y]=3)5]?KPI-8P]JV]P[!H>$25W'V>7^\.U@:;?I
MF2,2/[67ZV_RE&J>^<-9O=.:,9QRE16G6$*QG- _-)/YOZ#@C.N5./[^ZOXQ
M7;_TC-QJGG!PD4EQJ).K+IHPIG\@O[INPC'4=;UPYF  U>H@=E>_#F1FK7!"
M)"-QH&XXZMG@&(N>5A'&X720X5"7J'?@X." E?]K^Q.1P*V8GA[_4=-D0X3_
M93<&D3X6KV>"^+((8WO,>+SCL5<_E%G$4,)"F:]4B-'J*,]-8])/?AEB*E ^
M805MQODPP_?&/C!-H_E> [VS5OT-84)[^/*P,-.>SWL;\09@0FQB.I31:\HH
MC3:\T\E> 1&;45O]G57O8YGX#9*R6X [$.X?'U:5<B<PC<0)%8IJ6@H6S:XK
M..WG*"[!/7,H=P=;RG["^A0:M(DZ62KEP(PV0$/D%89RJJ3=P?BD)^%_P3Q*
M]3E_/;'QHL@6V11GVX9DBQB*D"$F*N4-X%= /";7%'QGF,X\[O"A?%<+*@*8
M-IUXPW^BMKITF*+"W0");B7211!*/=)5WK5I*"<40-X3H O14EW9P!HXQH/>
M0>VZ!4P"-^O_\(MN7[95>3AA&?JH*_3^WDG+'J@]VPJ DA\E:5V.;>HSJ="N
MYNKWX=Y!F6SN"=YR1:\JL'WIL,F+\:!N<*V!4[GXP2H$O.5IY&--_9M*(J^R
M:+"\,+"->KAQ+HT3.UL9#*)M3 +T[EDLRN\]3NN-7ADM+[V *' R[>*Q;D3K
M-0R5/&#B\YPR3;6#G J^!!QU%#N^?EN7I';#B2O%X&N+^BT:\JA95D%[*$%R
M7",=_Z>GS/V6W'>: ^'LQIA"TH>1;XC80OW0>NZ,NO,R5=D2A!_>GZ'BG!_D
MCA2IJ,N1?V;&J*#?/J&W"IED,*-D]'"2 /5$G$BN%DR[#1+'H? G?M.Y-O \
MTZJH,)(K3-'T\:\CZQ@T9K_#%X&U4G;;6>%.O8C$DDR;(/L&!R=+<L2]9)/A
M0YCA\<VGDO4[B(MNA-?M!.PXO9M-%= B*Q[.]V!!1]X@PL1UTD.0R7P*<1[%
M'.!]IZO]W(Q90[A;G4F^Y0DPVBF:6U/\,7Q03TU%U*UJBZ':TZ+V:PL\;4LZ
MF0W2E8+=3H^Y,3/H4&AK,@^9+@E4#:9LQ?B4\,YWWSW+_AX,HAP/$J.4IW_0
M12-:S1%J[U]6E<0$(:0R[^=0/ LFZN?O5E$82BW2\*M65IIET\=/LZ44\@P5
MD578=,T..C&TL% Q$ F9M@)5EC SNQTBQ EZD@7&C^3_OE3R'0)@0. <7Y'Y
M=CZ:P_IY$$W&L11A5W1U!'R=W='X56G\HI'TGKF1TM[RT\^@--'VTFGY<X*_
M9?)I?55,Q)@O$T>*-G,NEK%?>[Q-Z:!<P#@J]\;.7IWQ--5K'Z4O'RH33#9\
M_0(8&6BL3V=((3Y$#67D G1KB^E6' F<$2BFXZ.MI[%W-A[X4?BU0L[.<-YT
MJZEUBBL_6.IP+8"M@0>R)"KNMI43IGP2'W'=AE*><K.\XZ20BQTF 8@68EXY
M\M*8EF1K4''('Q#YRTE&-<OE4PXO:$^ 1PG+EZ+)U'&*-.5>=L1E]O!K8\I&
MK;ZOW)WVT4)F].9B'BYQ03U9MG>/8<-@)YAH:@2%)A,<[>?;BMSFQNDQQ2H*
M!Y8\"5)(AD#^WDB\2_R9JB+O<![A,+)I)!T^I) [E+D6D^(*P(J?^-G45*4T
M_;3U!_YU@=#B!LE@Q5Z47W -OP^ @C<V6?RN(&%,IZVU->83PHG.QM=#\-&!
M:B^G3R[#29_LT?R,1?CBX<7T4N1OK8'--?<W0(R&YLQV9>BUYY<IZ:@-FI0%
M+T6,1>'N[KM1SADCG;G1IGF-4Q\*X8\'7Q(N9XF"JKNACR5^6#S]"FI7</QK
M'[S(Y$P.3Q&YTMQ98+V'784EH+_L%"V>V+.8^?/G3DW.-V?TTW%5(W#^&P!"
M"'YMWWH#_)7R!D=1:YQWE'S$;"ZW6H2O(;P-H'L5GQ6[.2-[#6:D7JH?R2\?
M3MX@1?;!ZVDQ"XA9P-0-+94Q'#4Z,Z)9;V!85Q2Y344F2L@K>5C\3^M<0?(X
MN/>563J/YCN$;K5"'\[/W2G.)9/5%MG%[M8\@>9)]*K5S%GNFC(_IFW!/^$3
M27-74$:#TV]>Z@P71Z#G*;F5R=/H=;%CA?VI1ON8M( 8+_]=":6Y?AZR$QLP
MW.*UGF0Y&J451C=%M='9('8@H_T:)^0$=U**FO?^05U(7!CI6\LPMO5? 2D"
MZFL<<V9C2YW+ZM:+)K;59X;9)T):*1E--5<#,VZ;)IP%+2UM%&D11HVQLYNT
MVWY9,W&N+NRU> //47(,PQ;(1,1"=4_\X'@%)ZV<S,)*DOR"!V(WO_!U2?8,
MS8ZQ*9T R:$&:''&$S9&X&0Z45D!I3P5<ZD7>V"E(GF'X4^A;JP9V+;:A4L\
MVX;JPEX==ME9L)]MD;@VCB"WIY*Q#]'.RY&7X?*AB[O1B^AO>6(?7^V(5Q/@
MF"Q%Y-#.7&<B7L&)^/6BQ-%A0\&=%G67*LFP6>"FN._ U:N<UN;K%M5O[O(6
MN)UP7=ID&M"._^^[> WB5^ZC<F'89%S#/&<M$1O*>.'J=D^K>QDS27RSP2X4
M:3[?)[5=G'JF7O[V!IF'7)8AT UU!;/DZ,+W,14SMH-1*1<_XH\/3,2@T;^P
MU- OL!HMI/ZAY;]JXLJA#MX <^4[:DN$TGB^"?UNI+_MK3#^&Q5G%=4&%ZSM
M4"CN3G$(4-S=BEMQE]+B[NY6* X)[L6A.(0$+\7=/1"@N%MQ2O_O7)W_W.Z[
MV;/6S/OL=\^DVT]O .VD6K%U/G6YCP*+R54@YY][*N>JS21F1++.2C9T+_I3
M^0L/2*S&3#M3N+AY"+]'2]+^W0Q,<;"_D8KIF>04(Y3L4/%JG&#2DV@_L+@3
M%(<[/'FK2>[4@ODL!5*O$;N!^NILY)"$O%@4M@J.M/U&-JJ;N3Q,!&+:0ZB8
M[Z5_3]\LH_Y=<@7#3$QJ$.3^VN2PL_O93T!;V\^9BV.O,\)(W%+A%P]T>JHX
M2CUSG27KI[,3["#-X[-N?).'"Y7O\%^F'9]_ $.&_#-I5:/*@FT,NI0S2E]0
MIRCC4D>^KJ5ZF6UT+EK;L\ IO.,G0N(.>2FWP]\TB]GEFKQIKYWIFV=HU](1
M#$Y%XYTZ\..G*'S^R)C,@"SS'FFA>\":ML!=FFK>':Z6+$AT8KD64D J I)M
M-_?#!J/5*;BYH1BZB"#(Z^=4.!\Q]9,.P.PYQ*Y3O<J'>*TFQHFI G=)5',*
MZ3;( -"%K(;KUB9;DX[3X$T)K*]+G5GV^W/!M:,N2PY+#I<U05'ZD#+[?XG/
M461HB];,[253CM\J\G24<X3]L'$GZ*6G, 6=Z-7WD/EJ9"X:Q8Z2#+ =<;_?
MY+64HW76-^8"!Y"NO!GSE,O/' X.%9@T&?AH]6VZ=XB'2#P/JJFM5V<)GCLG
M0G'V?:G+0?4XY%]KRB\/4;<@A\N>3DO0QT9P?6>-27TIBX(CUS$,<?Z9^P<0
M:.9FTOM2=?KS;^#P I<KPXV5EI6B* YAIL1K3KG:0&NTQ+BO#TA8;&2@2?35
M)R]7X,YUJ.63J:4H@;7XB(IPXF60+01$@'LH7 6H6O/D_XOC1>LDGVC6&R-H
MV#^T>^!63;-82GN>YM+:I]A<,!9.BJTI\K0$RN7/X%-?G@"3VTAY.)-X[UP)
MAHYK;[* /)K(+?">%]\6;4XT\ZFD=!9*8]K'^V_4YZ(:RZS%)EW_;)_4<PLJ
M :;-YE5=$44J2\9>J #?KAHS/:+I#YL,/EL[ZF.EMYFYH>R^<4"M83 CGQ,M
MTR/W)<?JG.N@-BHM6AD]M?]]3AHG5/:]Z08X-(?FC%D0]USLKGD5J&?@UW<,
M'".Q%*7V>%@XF(#?!RU6L[*7O//PM1&Q[$ZA\3ZBNX@><K+:-@\=_6UV^[J>
M)GW_^]WWT;M8]"^S%U3A[@KF#WJ1XM*$WT>QZD90-:6/Z:NS9_L>WBA$]9'J
M=+VQO]Z..'L>JH\/<$8B_-!<+(&_(B)MLO/",3^\U2VZ<STRD:WS,'WQ#@H^
M,EE<K4O\4"C72)D"=0">NH);Q_>/[1E]DO7A+)]J4I9J3#<4(W6@[A-8'E33
MUW:71_H[V4-@.7Q[1H_,WIV3W&J"9N4[!?=ME?[[S5=B]AL'ST?]5F'76T;)
M=1XL'_7Q_-+@TBO!/"_6R+.&.1L+9H)F_OQ S,#'S]8*4- "X8?Q-V'FCN*$
M!ON6A];V/,:^X/_Z3Q)&CPM9E6=9DNG&6A+$CPE!](YV@WXXIS"O!D_9@3,%
M_K(<0!)',2(KR1/"KO%*T8HBO*Q.W9G/!L]QKSPV+-=5PV!IQ2(9&_O5<TH(
M((/G>K:>YO \^+ Y"NL(5=@$W>R-/_=']-WUUI2<D\S_HJ<1\827?<X[QO/2
MK_?^*SNGN%E9)C-]GEC6@T[Q%"HH/N1:-Y' 1M9[0ZA#S'JA\_L4Y#!<C-2<
M8>M@8+V^A1^_>C*-5KFM7L \?[IGG:&=\XM!9B9(KU&.49DBLB0Q48G9+_!=
MH7(B:.>OD\N:VK5)6@;$V;>-8UG'(O_\4QM3UGM/=EZ;]+(9%0)O4*P!%=(A
M[U\G\[7K5\3L6?U'<[,D4/31(;]6'>0I>NY#B3^"C\+Z,TCOB4A7_1J:*G5:
M[GBYQC4<78+D"\D>^XM69X\C=7"Z=((2A##L@\1ZHGD51M'<!KKPIL+RZ#&'
MSW?QAU<6N:6UP!;$?KK ]Y[3$3?/F$LG63K"@3@+M1-D3C9N_L)L:!S^KF)+
M+GO_G2R=(DR"FU6K(]G^UNIJUHMF"BD ^2^.$>&TY6*7G\P^CRQKYYF2/VK]
MP!Q_>-+1"3+IGZ]I!WU98N?P0DL')C4;;R3S=,N0>)[HD2US4VF7MT((TF$1
M9)%BYRSMM?LQ[-]4[@-F_P'&!?0';,*&LB=16@+<R^*3KB%F!=D79G-9\LZE
M?KXJ5H$$F )D&LV>=MF)H9]Z,ES7AO#?O4?A_-HOX2\"/"!_A3PK6[B ^?D@
M=4D-!(]*SD]V)#:0ETWY&K9A2D);L,!S]>M48*ZG6>.^Y?Y"+KNRFW%"@ HV
MG>3$>1M!Y</5W/>V0H1/1O$-QM07I0])>[Z3]G\K%N<DI1:%'!KSQ=.Z?@:W
M^#&WU+MRT>H8G]66Q.V*FRFO,R1_HVFK=7^=4U^H*;]+<1,^>. >T+B?:2I7
M!)<U91A%UO\#L"D@];0ZHMHX/Q(22X=)BNZ&*,VU&(B69&\,TDY\QME_@7^K
M&E9=YP2"2!-$&,--':OJ#STWY5C7)X(4\[S*P/QF1=E6(A3/WWTK8OL^-:+J
M&Z59]"?BBOZ&N&3*IW9V:8^<W(_0\0Y3+3JD]H/$4;-$)Y381'>D(.4^[AKG
M0_*PCXP@><( T35CTWW:UPYOZ)(*!5C_P_1XC3*Q%8RFM9R-#&8(8N(L&+A_
M"?E1>M03TM5C[:C['6=S/O[KG._"W+V\3D@U0M0B1:C\ TYG9?5]I0)5FD2B
ME251*CD1"%YN9F3K,&![1,Z&/2"R(I6>XN)"/+BUGFA(8=[S^VO)4LF^PR%P
MZ?>1"6N/?F\_4GA(RT?<S:L#HJ'Z#RR.UB"-7&.M6OS'Y"D^\I2,D+@S%0Z^
MOSE<A()!T3M8BS_%'#D/H[UA[Z#W^*Z@<O(AM#$T@<SY=5-EX+-L*5(,?,3C
M0>].QPRR5^\\BX^K7SZE(?9*?+# >89ZXUK'?,I.D$'3OS#GL3?;V/V$\PZ"
MC590EK/O!<%Y]DK>_S$I'O<F)/O](2@&2/\T/SBGSJM"L8.\/V;A5;A:51)_
M= %<4UPDQRI$'"REYSEI#P+'>8P+SEAS<B*WE!8P=3%_$1"4>62*.N-6;B[E
MH7S,TE'AZ"QFCX ]][<J' 2T= R2#IY/.)ANX)9=N*!4TQ:$$X=L]THM.N%@
M5D5;8BW/M2RAM'WHA.Z"*U&\M*:_] FZS"FO/EZ[HQ77L;;:>*CP"JZ69_6]
M^]66&/#3*A\5.='9\6[R?_4W^Y"$3$#]IC^MSK-"+;YQOPV/G\*^YD:J5/[O
M[J+_\P#^(WYBW_6TW9QB2]DRH0_*-TA']+$R\/PDAL[#_,"<:,L@ZI6@6YH9
MCY>@(^3JA@8BYVD^=&KP7!+&)ZHE\!6P7O0/H/^)M/$Q@3NSY$L;3K*'AA9*
M[:.HLT=GO'7R#,9^[H?9J[UH#<,7)RMA7Z;6OO46+,^&/7!=6B+!LD!'A&_B
M+Y1QG/F4#5(*XA'.W=S9L, 1H[T"0P>!^Y@S:W%;)1U_0MP/=Q59[B??&TW5
MJ<;9'YT' :G(17D+F& %OLM3P.<NI%<?(CBEDC#I54N3&=\Y"UU@T&+5?. W
M@G0.OM[;%P<>NF@+>S3PK^5Y02P)SR)F>6O;PWJI6^..5HBI4+)+ZH"&R@8L
MU[$A"^@A7\6 ,0$F- K\,ON=@:(T48G81<"#[YIX\5NFA.N').;U<"/LF1GX
M.-=!$M";'($;)F;[2&A+HWR]Z$E+,0U]3\%H7N;.OB[',B'U!?5OY67E1WUZ
M+TP1.^1]621:U=B/%H/P."&2?P #LJ)ZL05"1]\ZHF_ZWF%9@!T/R1],@M1C
M6F[6IC"W9C@%4P!Y6MMC+>Y:=(-5#\2-CC?I&B/QC.70L8OOL4F*SXH*?70*
M0,VO?U8L=%G4XH*IH8VT^YP[N7"<1"*X[ %?)C!;V6A,IM/^KMW&^_04WQ#@
M#OK,*##690,:';&:?U/-\93/7Y7SFX!7'(EQ5_1ERC'Z?JW!A\4TQSI7I(D!
MB91XI^7=0;5VJY.C=U\FK+W];MOUU2VO"5W43B+?]X>3#TO.71SSWHAMDCOO
MH;KCD5AP5B-DRM+!]Q\ [TN@G?14,^>?,T;-S/T ZT\&MY^]&)KP&<-.A^'E
MGI:\5& M\S^=G*\A9%.#NGL+4&B66,$8UG",B,<H"S+MPK-!C5EL6;JQ7,N]
MZ=M^/(1*<O]S2=/@W[^_ NQ:KQ.DQ\9"M=!@CO6"HBZN_))CZXK3/613*$[S
MJ#_TZ+41/1L=GV\?CW:9R^ZX%0ME0K;83Q%;GNIB8\<8<NH4G@-G85IA?=4(
M/"@?NLM9W]]_ -%=.J)"O#JQ-?M?[5'3Z[MO8J140<M2B_,4P+,9#<Z:6V8>
MC]97'Y''.& 3FL3<T3+#CG:6T 5R%BM8ZC\.7M U:WU2(?>V)<<>@?O?3EOI
MNZ@/EG'],K B9VTL1#^;KF,1G*SHUP[N.'>:Y!/<9PZUD&"@H0XB?7&X"\R'
M9367@6KZ2K&U+J4*6V5<,[IR4IUO $FIJ89^#XOMYI2^?)-\\J=YOCQ;^JS0
M>_I?)DOO3EU&KPD*A=+?2L"661HKI]D5>%/'"&2]\)]S;J?K5+!3/Z^F$U;,
M=2,-?3AGZU B.8$D.,--><]9T*0U3TS8AXW^ 7I9E*[0F6-82Y)<QH84?Y>B
MV"W%9M#EU"V(*Y]:ZP>?.>??E;5U\1?'X'$6B@*R:;=I$+?EF&P6P'3E=>AU
MJ,U=N36BU'6DS-PPS_KNI \J>Y4[OO"GAIPATD&N8M704E'EEV1/1M4<TT)3
M[%@'Z\9^:L"P%N]2W!?0TJ$\8 V@R7^^.^?NIK&3V.XCFG?E@WOTA;X4\(.P
M$AD:VGV<SZ-6K;GW<1[I7<-D.-I2QWBGR(2%M?IVCRW[O9\5Q9.!D]&GNAH.
M6_ETKL]6KAO)1=%6;%S[ES]R*:I,I=.>P:B+].,[H$,GB@7%QE8(WU#\%N3'
M*OP/"0?I>)6;_Z?R=&P1--<YR9^J\VU0-5/_?KCR3*&OVVMH*R97$)D/-895
M05G$/865-U,$,L5]3>9]F%,<H1QM/NJALG-*G>5 G+<YXHA:.=6"N"AKYOPU
MH_CNO?=C]"%8Y3\NBRUZN'P#T4E;&--6DW6 S (]S#)TO?.%,U>F'Q8R)TXP
MN1[ZW"A3L4E>@N8'RH%_UPFE;L4+'BB0D_'JE-Q<),;QLFL@V*E=^"''N<NR
MW!45D8W&"]&_K(;Z?STMPK"-S51'DZL7WD4R"=WM3.M]I-V2P*RZSX0)TZ=W
M=6JLHS_0)GE[&5.]P +)@.TL?TV@01XF89AQ0N9,+-5+N]-_'V(:]YB-<G9R
MOO\Z) ([.6WSLFA<$0";Q.9W09%A'FB.&H9$22D"E]T+30]*ZD:G+W,QBL8P
M["$_F,S#TMG&@"&O[#W^* 1V85:U)HE1;]<G-%N$MZ;" 9VH-]U%&,@_KH2V
M+@^,C# FQC&P.!5V>IP8UN=2*K";I8_;X31D_P"FD7^$C;)LL<90IRE.$ZX%
M= 5/H%L=#1IDOE6(-_7'GJD/6PS#./?0KCWRC%E<7$!%D9H(L/9F!B<X(>3@
M>N,_5V;9Y5WGE,8MWO&G2I5YDW"5<DS]GIK<-A6@[5ISEPL\Z#;L:"U<-6;,
M4,KML8S1A32$*IF,<',$.DKP89B--Q&#PB6O)H4GB;_6L7CV*^RJ8*[+7V_M
M65-%O5Y6FDVH#@,YPHNR[AW?O K $[(>O\ 91KZZ^22F(GH7!NE)?R6:>QTP
M:9(4\;M\ME(C3)+Y R528VC([;2Q>YNDL!O2-@25MBNHI,O<R-1>!CWH968R
M6%_7,:;B=")$<7U3-!SFC_&'T;)L,(W.R%.S0RU#^%])?*%_T7LZ7$V?)4C!
M%0^P-MW]\#8^@ODC7<3Z$;\)/U/!8%GIU? ,YD'Y@DLILW'1F47I6B5E!J6D
M?4#/,F-K;[X[CQ@K30;;F3'=WM)9G@'!T?T9.OAQI1\<,6__$N(D=FWJ[YJ+
MI=8O=;_1;BIQ@  CR V$./UKZ]7>ZN^A53BJB:2O"W87E";MGDG@^^\^APKD
M/WYF7W"4=MSUTU$[Z&=3!]K2?3A@J!H/7LH"K0.V  %I13.!B^TH]15$UU#W
M@=>*:E43M2BTW*7&LW6SZRDTMW)YU_O =_90Q:^YY77P?I_ FXGXXEQA<;(5
M#[A@5,U)1V%Q$"/Z03QO=+R09JK7K,>O0:&MUOVJ;>U=F+BBOL<^P8HO,J+U
M'6+VMTV69\!/?D7@MAXN6JMB0TCDJ,F@&DI\WY1:Y_A0OCB^E46K&L&,WJ5R
M++Q.*Z#%@E2D='38.?#VS.3RP7=]K0SFDF"@N3$NMIMBK3TJ4M$ZE.7D1>P.
M-^-.;TL(8VH_B;A7M]" .$ZOSBW>'_:$E3PF05JM[YX$##X?B0W$J,#WA4H^
MOI4^XWGR)L'90U0+KA..N[AYH$MS9_I^_=/[YTTV8V1 J-5SW; GOQW.T6T=
M98"E%\V,$=U8D]D;R>JYOBJUPM+]HM"$6>^79ZA:&G]T9(UXS4>)560QM#7T
M/S61D_M$@SW*,*ZM$:G#4Z1SQX?K<Y0HS-X@;T%S5C>KMJ(S?OI8@-7[_")G
M0\?6\UN^SE80RJ[\U9OF,=4S^D#N]LI)-E.99L,-YZV8MVJD_S,<UV9\5A&
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MDUTG*% TWC.'L$++XL*@S'XC&2TT!(2V*GRE*UC>'W[[][$&W\%@=JC&706
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M&/$M/AEA;-7E4*:\MHYK(-K1M -"%$E"[$6Y?]A^%;I2G7NOS=R+Q,%C]+2
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M+#EPZXXD;?=KJA)V"P%CEK@5;89]:T]YM\&F>RKUJL\4_P+RD:&N4E<.>OY
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M[8=KWC/$#\F)>78B*FWD5#2VZ2.M3S+LZM2[+0J.B@:"7_?*_O2^>O_!")(
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M"@A6*9RTH,P37 XLY$0>EX*%I(S\^^^XGG^6@5#-28^R: #&<@+X024()8V
M5\K<I6+<Y<--OE]+:SA[4@F]38/H%9L;WK3\0Z&75,CXQ88+I]):V3$O9I4
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MO$P._9BBJV1+M?(<2F>X<;U6O(Z:8R2<H.$EC^R_V?O,Z:F8%D.<<JO)@ L
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M1CR4I NHAFEI)U\8:BJF&R&JI3Q(,#V30TE;FB^I!_;^%&60$#D-]A&--[P
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M35P&XD*B,6%X02-DDAP\9'SR._[R?5J:ZFW#"6^L>!J;S^27*N4DLO,U,ME
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MPPD4NQ4_NF]G!> PQW>[?RF)[@]'&0HG#6TC7[AP+.&01JG.JT'D%BP:1Q%
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M=ZP.H"(D+)JD38U]FV1^<X+]>CQSP)WZ,+>BD^/*Z.\YIE"Z+)GIGP1\1\&
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MPN(28N>-$%R\>)&2@I*)BHI)["K;5;'_\0??!%R^0*!"Z$M$< T@O$Q =)D
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MM<,P?ME]]?+R!:FRZ* J+?G">E_AA"M3<KY6\?)CUY82I^Y]Y,@\/D&RH)1
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MQ5RKK'3=P)+2FRW] 0K.Z)WJKVBU,%;LH=0XX&C\\$PJ<;V_P%8_<$!F,68
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MK!^ED0]4Q-#9I5'?8V]M_"AH]I @0IU#BYY4]><>H6^TBR(.>4LU>^W;L>[
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MO)#-^QYA(F5 P$/VBVV1BW?!R;J!P@/O]53J0/239OTAI'H<-,[)+/6<S/!
MN7Y."I@#<EM!7  /!!:LX@$)_5TD)O(4AG6'G%Z$F\*O_?DTI0L6BM7XVHSY
MR\I>QPK8,1_().1G/2O"KZ<=X_<0-P<RVU31Z,_#I"ZT@GZ85\X^ECJO)1VU
M /KFT6 \\  Q2W-"TP/B?>6\8NBW(%%+F;#_XLJ>+G+Q&5;#[NWO VC<F@XH
M$-HS_L<;P"924=G>.T(BS(^+C"7BE&6[[(C#U[-G'P6H2*_$/-BVCT5%11V<
MIB5X6#MZ\/]X+QAC2RFF5A<\:V%91<8>ZDU'4.Y,+),>,A>^S03G3OS]D/N-
MU?M(4#SJPX^\#[["+UZ/6686](>XY4Q+</?M.YI)LD7F6]R:'-G*X%9Z]V10
M28G(3XV>77HQ%LG'/1$^K\ YH4B:/^%DM==3UU H&3$1-O_B45>B9?7BS:VC
MSIV['!'*W$YCGI:>TGV/1J]ROD.HN]M?:NL7V9&\XR WQ^JCN65+NI6]F*(:
M=''=ANC;EVH!&)V]5VU#;CI3Y+/N)-KO-E;ZHCU+V\PN"+651NH  :.C%M=I
M.P89IQBN8./$I(#6J?*@-*/7(7H3U2G1;I%$=]GE_W'MK\19':4"+S*SU2 <
MK_<B+W:S9WOTZ&9H=^BC6:NW/ZL[21'HHB,_9ZZUHW"D;8C_LNYO',+G['?[
MW%W6 \VG)I,15I06"=^EL>,K= 1)\SLG])(TI\N0@ZMFBF08_U;<*2BST'WT
M()POS-P>,6FC9G)5,#=3=0:I#2Q^C<C>AOJJ8S$TEB8&G!WYOH%?U^3L_VM#
M9I &ELVXPA5L!RAC+AO#J&'+W&@0TB_@X3FX8RQT/4 0%NZE\\<BG1X9R-/:
M#:<W0(X-_';>XK74'0S1.<8J.8]+T:K"LMB1O&/HHL_C&,P;(=A&&4S4.% (
M;#_W#+MT;A$M#& =*J.XNO,6G/^^%IGS!\>F_(5C'ZT%LL/:P9F%]8 NF1:[
M0/]DT&[]L0)YFOS7)4AJYW;0)4S"&M-/+\'%!F"+XJ!P@%X&D[S?(-X.V^/O
M [W<E?,>+B>K8D(W(1OS$.P%_:H@/."5U+>G( N6%]C;+YC?F?,:)\P>G*>;
ML-B2]KD=3+ P\ES#6-&W>[_'J9BJXNHX%P5*C_U F1<!/P5I]+>ROQXC=@W3
MEYN'483_L<;ZLRK8,?_7)%/CL[P+U*YW=TR.8EYQ, *5"RM<-]A]AVI#D7+Z
MY<87+ 2N[*K?D5XN\]<H4"_POK<41T\^=2T(^6C$@#* O+IZ(&($6\>T7&T7
MVS24DIAXAY,:K"V=N>"L_P&32?I'L\;X%K+X?!!4UY#4AR6P#MA?PU57G(F6
M]R!'/KZXMUY@*6#,!N.AN/NUA4O^!.!+.TA'[\YTZ.N:C$%GVW^=^L((_[<;
M8AGE4Y@_\VMU#/V,W#1/N+V\BJ3JFXD"F*C_Z^K@":7GD.Z,:-6I@SLE,_]H
MX&)0Q<-#'%?WYAMU$M6X&7R&TB:-.ZN7/M$_^.;\P>I8&A2M2/H3Z&X$-&PY
M7KK[&4,81>D=)M.,R,592VXN-'W,[ 7>RHJ&X-4N]LG';*[&$@I&+9G XRPW
MHKA)CK$MT\N5N-'^GLKB%^$W'I=/A$G!!U\207+T!N6$OJP>.7J8/[^:FF0O
M'=>KRNZJD9%!%?Y_^ILQN9EY5<R;3=A&&,XC?4X$;32#?3U=H< #Z]#JPE6G
M8\G+,=RX(F,\\,UOM!1RP@A17,@!9UIZ^NJS].K A*U:&.:U(VPC'';5C.<_
M\9]_J"%*[=1?8;-<F4Z_Q(/$1^3O]';9#&'V<"']A&4;-JF!)=;/!$4S\RDL
M;A8%6C<\0(OY) Q.TVNWJT" <^,L2AV1"]LTIZO(;KWI\[CP>=P2C O]+:[_
M*NV\-,2"6O?H06!ZD7QC.%_)_M3Y*,@]-/V/-0(\D,DREHY3QYW+/+"@E.O=
M!I7YU2U%4.F!\T@2X8('0"<+>CEXU;E&'^B%32HLS._!C\9!'Z?L#%; CK[S
M7</S-?5D]/B>R#]'3KK/=[5.)R$_?H#:76DR? 4G_P(/O 05]6[@\ XC%+4F
MA75S7C*C&6^(A-OZQWR8AX:G]QW(P*_ VM-"0 !28/G[@B"+$"FL7SKV@JXS
M.,';<__S!?V.X?/)@I:OA5CW!ZKF@)I\@^/5O[5AY:H@D;8D7%%G'Z"Y13(H
M(<)FU?R--_#94S:8UPW N>]_M?>5 5%U[=J#I( B"-(A X(,(-TP(-(2THW2
MW2 ]A* @0THWTC!TIR#=TMTA(!W2?)OG+9_G?,][SO>>[YQ?[X_]8Z\=:_9:
M=US7?=]KC3;F5OZ[_=&RF0&+A]T#[/Q25N29B:5R)3DZK9_"76;]3G.0 0&'
MH\;#[JL36[<M"];N)#D$\FP-0%,XI7N:W9A3WJ*.ENH4%&-+U)X88_)M-UL:
M3&?J#7KU>T"SK\+3+6"/!2J#V(+$^9_2A*;Q(DA $#X=9*GDI]21\E6&D?PC
MV=HE'E=O\1PV+<2#0%TQ7TG(EB:D,J?"S>NHSEA7"QU\3@]5C^\Q=ZAZB\ L
M"%K?5*&&._AM"C+,XB/%-I)_&U>0.1JV&MK@VHY20K$BE9 7:6,&T Y5TX4-
M^C5<>JA@]M>@H09)0(49=H0F-&XME[AE?V*LP?9\_/*]M=#GVS#;NK%+7JRY
MM.//AB;V(G1QSJQEYO;0#YP03XD6O@2MW18&OQJ[R^?UM=/70HN &GR\W*J!
MG3UT2CE%/R3X.@7,Y,IM-#W)\[Z(IDJQ[I![Y<#'I7CSY#=$$H8Q:XZZ?^*N
M"N1);F,<#M<KL',,1--[Z"'N><<M,NL>N@%Y>!4="P*@["\AQY#B0EC[_,'3
M.=@7P*-J%3':&?2&*PERDQD7"Y@WU],Z=HN@9&$(>KW1>G,#@E,JVQLTS9K#
M_*\EHF]U%Z_\ECW=QL"G?DF?$<H!"I29??56_@I#=?PC;,4,$#%7V!&N3& C
MAEL*?S@,TRO_P.2_1!]'ADX?J/#WO)=-)_WP( #)+SA9?D2E>Y%3#%VCGB;G
M;$ OTRC60!</TTQWI\.:\'Y^5]:V@4S[ >146ELRY$6XK_)^8M!A$NFU:#3E
M\3XEX&GS1L0%<%QX (B9L7&J!@&L1^=; +X6?0#&\+&>6.28TY[0MWS=]3:[
M>U"3N'9RQ%G,Y9_F[JIW_XR(%D6TW( :H'%'''_/ZVDT;Z8<$-<#,P!\;V8^
MK#/JV957T;6?6@6G\9@-R]VS@8,\OB8*K$^PX4W J7 >UCR[A(_G\SO,G^$/
M7-*OWT:4P<RWE@CK<E/6X5KT_#=<GG/)_==VG;&,WW*$?PT]G0L]F4-O-80!
MU/GJ_N[O,H/=I\C78AO0K<6FL,*\FN*FYM"THZ-KE/^L('9<Q.3W%;'V?%^;
M<\U(4CZH#Z#6OK1B1E#7J%PHLTHJX431ZD6W^-Y%P3[LT/DU48C?)? L338/
MKBC+,%HDBGXH;:_NJ,^')^@VB%;\G57F;^6 P*$*0*K./O0KUUOYRC3[_>E?
MPBQK\WC0%8C1#4@;Y]I?60!\G0T @B+T?, C_-+N ;[^_%M[D3[L@-GK?4?/
MM<2S\2,6G!FH],GL/TK*\/Y#E4:C*.-IAB<7I;-&>E 1S-[RAW&U"K:!MK<<
MNV[!2AHA72G?,N&3B$VNI\SPY0ZZR%7Z@9ZDF77*[OJZ#LH#+AU8;<HY1N$7
MEV25\(P+!J,]UOI]0#MU[.:X>?=5@,\P AR;#N\3MI GY0V1#>'+=H*8GXK#
MU[5ZCHS@X.L7LC;7M1V7;?I:?T^T]=VV6OS6^N8?F38Z0" ]86"!IJNAE.S-
M 1L ?M7_1*$!27UG('7OM);!^$C>8.\/B\VEC>=1<RQE8+:+YB%0'3N8*$NM
M_E FZ0Q?IMM07,?_,2G-9KY!(8BXU0@ U10%0H_ 6FK0 _FC@?,+V%5\"6?1
MV?U-0(T P&IAOWXM=1('R)/\K5W)38)5>W:TKD)W*P0IUX(:_\OQR^J_QB]K
M[LU?N@+P5'OZ3.V=<]%;0$M" 4^TE0!CV L9_6'D+K/BD8UWJ7P-2QL]S;X6
M!)CCGMZ&J@" X!Z?-6W-W&+<U'VU2W=3V&T<,_OW^3G,IMW=D9_TNY0Q?XEC
MULS]OU,^^=#+(F[9PV#G;H$9W>YA?U'_J_F=.#DMH.N[[;+.HYUZ28I?U4=[
M3'].%9#X4FM55+3DM:=QQ4ZPWTMA-9YC_]F0@ZS4XJPP>6H_W%4>/] /-[1P
M-7;%?N%S %\)$ZQ&U*:E:\UIFJIRG;^;<UI1H)9]XE#CO0[ %-UCKU_*^O]I
M;5W^^[$@N/U*I5M(RD[0#L0?N)G3X9BR4^TC\)ZZCO$CD\\ <B( D!,^ *S>
M\6NTVWW:.@8\#:QCNPF@&&N0JICK%[,&6Y2'!*T:M[GFO[1NN)A<B_6L>4C<
MA@C[W,#I^T67<#7HSA]++?1=QJ_%\_]C"JS1/.9B^1B6N]UQFNT$P+MRIT3G
M,D^^S;*6(=9 R:E8E/OH.7F:23/C0O=&ZC>(6Z2(M)=]PC<4+9H.2&K.0U<8
M,M<O VNSKYP^G@6=718B)!)R:O@=!)]M.J^-+)3F1<CHZ@VN.,Z?84X"BNMX
M&T*T_#79!<^"=6H.7-=E _;?Y)>JC\PE&U^*[)85O9:4O,NXH4L^0.H #G2^
MV=1=I[G4^"OSLGU] _*AW,H]YFA$(?BR17E !$""PI2ANLT%I] S;  RCLMO
MZ%J[7Q*=7P<?EPXLR0SZ*0(R3W%XW1AYKL:4#NMT_[N;T9$#8#&UV/R5)]U1
MH9;H+=R\S03<O176\V0 688;>IE\M;LU_SV'S_Z4<]G-_6DF38_UMX09^\S?
M^5@_NAK03]O\E6.>6]-EH#UL_#<GX_"/UH[+0, \Z>7? M.SF9AK\:W1I)K=
MRR"3:_S7@-47M^*^KD- ?TF@;203 _TG -Z^<"GEEG(I_(5R'7G(UN-\ $#)
M[.K6.?D\@$%U(Z\;2<\P-_.C?HV(.KR!^5&*;FS\2P4J(P5-OY1E(Z1_J^3K
MV%>;0O=WXF5BIJNJ#IE<"9%D;;+/I<+VV]!N^L#Y,9+=U0T^<T=0(.&Q)<[N
MKN@# VLA?2'Y3WNB#Z=#A=.]>>Z1JC0)@4=?# GVK3CP?34X&5,*ID,B=D8E
MYK$:T36/SSXY\EFKKQSQ'ZV=,NLY%#_Y0=AGX!/0;MACXOMY?_=[ZGU(R_@X
M^V9MN6K5..$@(VL]D^,/94D9Z_O2?J2V;-X/0.@-IJ[Q\Y<T"F?1M2ZP4BGO
M*IQ@&_D32&9.+RYI5#6]P.ASGZ9)&CPH"STRGT62.0;-I\F)8C'&YS-"<F@N
M9PR4$'5W_^H#JP!Q9\_2ER8;9015&E,G!;44[]_FENN:3V<M)52NA_&=; F3
MC0<*L").?7>(#[.;5SO**"PJ70=^FM\#MY#,Q9 ?[ ZO7*C4O+\R@-?L_G1%
M)'&WJQ*&0;1QJ-7B)3^K!R893B 9J[[JAG^E\9G+%&(9*@U=7YK)WW56NU]8
M\+'*>&:=N2GV&)%,_3G[1\)/.>B/2VCER67C3_>R<"A.14/UA7C2\ 5@T%O'
MC=XPESIN655&"[M*LPQ7"T)G$!"L"RNY;OX>*8%.P_Z[BME482+H82(HK\]5
MXI<SGR=!#B#DK.\,2A+6+&"'6P#N] &(6*N*X*N*.(X-:JY*O08(A>I;GBYD
MJ,-<50Z"EH"GNL?8[-'23@C=-2[<!F0B#UC' 4"PE\P+JQ9F;=1'C1H..4ZK
M_$D%.GB^(!?.FQ]AKH<&9ERH+&<E@#>B%074")/-?0L^UGR0RY1XN<[[PYQ%
M^8UO9#2Y1E/*FC@7A!P56SS78OJ U4J %C'UG;#6^$JP<6ASSB3V!L3,.FU3
M80SU.<Y_P?U$"_W!]5Y>V6I)/WK/MD[[QSP]<[,U';-G1@_;2UO6C#R[W5DH
MG4I">,F.$>9.&Z*X4#,5G3BEKXK9J!@(W(2U+8F4T@G8 B#?^_BW4G+^UQ."
M3#%3:P>W5LV^(P5-4G<"-JFP%A.JUP\'NI01]8((K3E1(8Z3@U@RUZ)^Z +G
MQ#?M*%L.AA$5$](FM<$YHOCB]S2Z[Q-T7="UZAJK:PZ/C@\S3*8;^MD<0NO4
M,O>BJ^C>(QP1YRX'M&8" ZS7ENO!5C\1"/E6-3?K\DJ;++!F+,7"S%7&O9*L
MV77CF17K!9-$%02A2L/(H(Q#1D,BGGAI\^,X/?MD'^\+1#"9/>^6SO&67 /4
MY-4LA0Y9W3UQZPRP\>5DY\2IC.:W"HC,FL5=7VFTMK?$ Y2S/PL'>L=N0.MC
M %Z] ]B]#P@&2'(4O:*J+]\R 8&A\=FO@T X=9Q2?D9I4-K?=]$X>+H5[-E?
M421F^BJ*^V2F6(IRL@#M&))2#B6FW%%#OP%AKFMU7'J: ?Q^&'B8<Y,SU&F)
MU/WIL6$U?$R0:Y+9T*Y_8?H4>7SERL)</>A34>>V0^1#G[0@LS'X]J9#;94_
M9X,</\&][(X3=13H%ME.!ZRNC5MT[[IB\4K'D+K=0>"E'QX/5C"%W-1F><+V
M\V/#"Z]/8S2HAE<'G404,X[@ZHWOLF9JI&FR(R<(<^M<$<O@;T\JPA.TL &&
M(PF[IB[/2:_D^)<6U/V694<J5!=O(W0 2>?R=!WU.;"<9FVN2PX;!;5PCCAA
MQ3%]]EF[FB+JV6%<L <%)Z/S$HRH@D^59"V,?+R&23Z?E> G^03VL#]22K[+
M_.7<+^03$APGA*YFE+$ KW^.F%;UX=U,AXHQU< HZ33T*)J'/IT(_H&'=ZVW
M?Y13EIIS*S&&R$\)PPFXUAE3#V3HD><%<[<6R=F>6F56NO<8^T+I70F9$\;M
M8"DI"8Q2-,==^9JA[X^N7HJMT81UX5I%3$OJVQ*]"5 CPQW?.TK%MK ADG=R
M_8Q?#+>L$!9('_8Z\DB(72:US5Z]F!04SH]?*S$<*[(LE3266II)1X<ZB]&E
M'J%EZ6&:/76WL@V7SK=\E5[UD#NBX&.%EK%=&,_ ,:(697>P%X W?B]O0,D
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MWZ_/R&>JCP4C3]7:H)@[5Y(XC7#+,BK&55F:DI%9$0D*PM\ZM@4^4HM2N[^
M)E2]H>LI0/-&:>J)4WM$< TPHZ>2C@-G.X Q7+T!M82>2G+\XZS\>V&94C\G
M*3 :D+BTPPQX!K_&:WN<#94*&?^$ECXKLK?W6.O4)IA6^F<;O+;=+.TRGI9R
M3M704:RL7&=%:"SZ]1P:25YV8"0DD,8>(8^,WW^(A,U%M\5JU>#)R=FNXE+
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MQSTIU_C@*P$I+WOF$?*91U"R3_ZJ&* ZF".PW2' _RK#+*%7=RHH+XZ:+E5
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M.V'9L?'@%NQSF* WSK,GU^.8@[8-:JNB,M1WJ!THYS%O_W1-47"UP((X8HT
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M@L%DJVQ16URC]P*&(^F" C$"&8'[&P4Z*/6I^K5WWWQ6'A3#T>6$ DE'4+&
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M\&O6)^E'BK$&SF*(I/F,>$\EVBR;6L=R)UWQ.SO-5(5>-9USIY0.T^RWTY_
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M"63:VSH46 23:<@DX@:22'4B.XX GN"L0XF8M:\5=?9/C:Q%+E+;7)25#L;
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MB(9V[RG9_9"P/\7D5'<B4W$HG^%\MY] P:7F7*>!_@/M7\C^WP'S_[]"]C^
M_4]<BP J+,QK\& Q 1'@YIXNUQ>%<41-\3U&V&:W5.]<A3%GU#%5FH!N;^L+
MP&KBV=$2U;]2J]@S+/94S7HMG&UY65;"5-@$S]W6-4"E$6T]R*1!O 8@#1*O
MP3;E-GGHXZ?EE4 ^1-G?)_A+4-2$F6D,Q6+A)-P$_NDVI38R/^RSXZH*F>I>
MCWJO6+3?Z^3UWB 5+X9: KTE\4L041+!FD/GAJ\0>M@6ZZ,=2^H]2?XSZ331
MMUE<!WBP_2<-_%_2S!T&\-K.+K8P8X+?&!5#KR_:$Z?VM!(J*IYNK@T;DX8A
M)+,[2J2P6-T,W@9LI], ^GG8YE@/(Z;[$-,N]]MB'Y.TD3W$C!:33Z9V\B\
MRY'3+OY.V:$(%N5DG9#]$,E;I?;G;NGMCD18?(T\U^Z@N^3WG8(P6?&7V>@;
M89LLGMHE13W,/!*UDYF[\BV_>#X8NW;"NF-P))$Q!&T9Q,6 9U=R-AAU.?2J
M)T]BQE<Z.:N_2"\D^S)UZ.9GY6;) O.YC4]X&[A9E8MFL=I:NE+<%8)G^5CP
M&!@)+1Z\8X"!-TM>FX.6:0^:?&T4HES!_ %A*V%M SUUDOP;'9F:OW>N/T0E
MEW8+)R)K80YJU9/D-S,4Q:%CD3^O>>XSDPIITG-Y"3\R4WU,C&G_SA$WBJ"(
M6,@XSKK6.%,[\ +4U&E>7L=9AMO!V;7@]'^1+O]H+_ 5(0)G2X]TKM7<X\RI
M]1MND5W)P1P2A#DPGOHSKCUXK[A4UY]>0(:/B[MAX^Y8&/,P=<5OHR5"]F!1
M(X:VJ3[T0[T1 Q75AUX2Y(?A3%?:,.#*G7%$9-TP0G^#["=G!>G!ON5)X"ID
M(W-PXP*ENUF0X!TI$NVVB-YTZ,:3@:=8T(%<\5Q7 S\XE5J)O32KEM)8FHA
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M<L6#PK';>E$<U6#WMJD/'1!P9TR$JH=678K *%9(%>%?4<;DJ\6QUP_F_Y!
M%>N$239%K,/]=9")7],\TRJVX>;TEI>95#O>@W><B@6_U@,0L,6W$@@=V V(
M1B\,NWA2[X\0":X+B9W<E)]&#[8K7A"0(TJG=%E4F%-67;N_XN7MFV@U]3&O
M,F\@+#CN6?3TA@]7:P(#<B.MUG%D*U2<,(><:GJ!9?4-132G"S_9I&$_#_/+
M5N8;OU.-T?,J/&C_.)L'#<HSWZ!XN[=8-U-7$5\?PXE!K$&A$XAESSM@,U8
MN%?@](MMSA=./ KP:[0FW<]4+1K5:WY3XT)YF^C\!\ %7/B(G8KU-[ZE?0A+
MU))_VMZIM#;RG^7 =XI] Q?2\TL)')>^B:)8*/HZ,@&UMUDV OM6PH$E6HNK
MJSXF1*&>;=7+UC\PU]B8V(MV8$F?1!LJ7.\<6]J4!70QODY;7?[$*%X2G6#X
MPVWS!_U/TUM_6X%Q1",)6YX.[*.-)-4'A(AB"[5[G7?+NCJ06C%< DHLQHB_
MR'<R:QCK0O!6(QL//K?2V1/,S*D[.W*JK2)MTB^ XY$H _[V/;'?5)06L+=7
MB>Y#8J%&R@AE+I@-9]QWEPA;3LEUO6'X&3/(YQD- ;XBB!WZC9C/NS:?JHQ_
MGZEHY?/96N+W2I?AI&__H-OU7>ZQY 6(LA?6,X,MR6T]5+V-L7\F:YCFU&7>
MSG JF#Q9<P$G+TGCQ).L82T0:?-NO?=32.J_7F0>"[=QPIGAWI<KJNN-SU1A
M;LJ0&B90:&2^,,Z4&A8E#9:P5VL7#.;O.FB6OT[XD&3"FA^YUG=T1K+Z<7YD
M[#6I1&A,>*JS5%3*%,CEZ2P,DZ2[@,_EB$KS?_Y$!+UO/+9.@;712P'VS7+#
M +I7VWT!U@E>@/#@%P!9'R*R@_.4=JW/^)QZEW:S>]8G=*&)?+:#<43V;M_A
M@.4%6+QO32VWSR<G<C&15/*7]BI U#$5@G>^_(I(X+!6MBS5G73_XSJOJ+R!
MF4"&J78"U8 * 4)I8\.FC4]%;A16@M$MP;U"+U<AR_Y,61]$$%B7'4AN-I-D
MS[+9.;"6V1^7*7"PRVE#<NO1P\,F5J"KLW37^],^''GV R3]^2Q;H;]#C^Y-
M]5G$\4K3NJZ1TLQ&ZJDXWB=%AJEA[2@^;E2T79-QQ$JOTKQ'04W.-I:_!Z;<
MA"_ ];@=XJHPJ",I8LGKG,>TWFZQQ9T.-O+7V>=%O1K.69=Z6OE4:!7AVP@^
MXQ2"- <&N49#F4$"94GWRRY=5XQCGDRNQN=)R.OH<-6J/7B"G]*,F4F];\8R
M%OJ'ITBO%I1$B7M6<)IT73[/6#IQ^LL+SQVIE"<^&V1B??U%]G%^E5;/+C,H
MKI\4_07X.?REH5Y>5I??]0-+ Z8D2?UO3NM&:J]M>PY(@*Z$RO-D\(/QOK=N
M?R;S\T3'@ VC]7'C:D1+S2/?*%\VNH?<&:>6:22KX.>&<T'V'N65GKXWVC5(
M/6 B/IK6@DU8XJL1$_,7 .W$,>JMJ\.77W.8-I>,H29!)W)" \^&<;9LIY=Q
M#\MEXW39Z-R'?WS,6Z$5_=>)J[<R%;D-D"W3(PB%V<5-N^?)J+!>\DUEY=#J
MD3/N=4O#'1N31S5XS8@+IZ\ K;[ U "ZQ-G@\5@O31#CC)IQ@H 'H3:MT\E&
M5^S.Q&P[Z_"U?!0H I'K:N'1N\]FEUG'9"&P+PM;>AW=#)2GG0:1+38CAC)7
MU7DM5H40(C2WAD$L05O11F]Q3Y*)MW_;R[NXN-37TQ,M+TF]&:3L"9)$(9A?
M5_6(^U/J [DF.XM_ ;KXFEZ 6N_>Z^,687U&[[^[<Z\\/SHKR'"?%=HJ4"'A
M31XG(5>@\5?@<8K3$&9T/:)Q]*/#5-BN_MI)X N M*06G1"N"Y;<U,8T,>+_
M9?/1?VDK4M*=M.UPHI1HN)&)J9*5I0!3&](W.4SE^%DI5G$<!2AN_I"%L[68
MT!8!UJJ=B/?8KM=G:R31+B%&1SYB?-M-^G[&45Y1K:EC]KAJ?8:&8PS5&>']
M#LZW 1NV=AW6+RZ'ZK6*1*X^/>J,-H6K G^A;A/YLY-=/Z(>!G<83DD/,W.;
M48 -3AM@R;R!7\>%$*)KWLSF/&75/HH9_3N!U&CK=+%<](^^Y\2Z(@+HF:C5
MC18JT?:H_K[V)K#V5YP.VR@';;)=)(#_!Q86!S(A2OQ<L^XT\ZB^ONRXG)PF
M"?*G.+]!_EF,5^FM8T :5(W1[23/=K0VW17"I3Y=NTY3VJQU.KJ7XA#\2?-5
MI'E;MYJT--/!)J1U$\:OD,8I>K01%*9^FD*8A&EPI"+ZHF=BS[_5L*Z:MK[?
M\/OLUY23:=!#=RD4LC2&D4I"+1^)<D+2[- '[WPE.:Q6-\WJ]%;Z;8KE!PW3
MH34$NDJVP_-?V>A?'OE-)CD]\&8SU:?JH!6<Y]H14V1LJX: +_+J33"QUTKG
MS2I&YKV\.^Z,L_E]^:%K]5L#8_]]SU9>^_D?3_-WLA=Q(S;FF8P37!G?7P"9
MJ=-9CT,$>H=W$4%=Z$B# #<&(MPF%=<[:.;/^\*"@E[7"_W]<:[>WE9;Z;%J
M5QIO'1%!0X<Q$C-8=AMXG0-ALK:I.L8'FDR3T+7&J=IUFZU62P)M>(C=$LR6
MWV+EGC=1Q]35PPA(>1;^:6:YG/NDS))2^K'>X7PM+J C9W#4K1.PABSW.QCB
M;#"%$U<C?S/^% E#T*DR(-P?HS&[PC%Q4GCVJ#3(\N1.3U/]UW1'5?2XY:$5
M4Y3@_M3/I_Y1O.1@=5%8$=(JPA*Z[494;V._8NV"NLD+\;LJN3Q%]/(_[+IX
MZOC[W#6EU4VJ(/A8#NHX]>PXN'>8J\*9?@WU6.BC0-DA5$>CLU("5+ B:M#L
M=_2SJM8?O^\A:%*LGZ*Z$V?L-O@/QV*G3[&9BNQY[[KS> 534O#Z[ZH=W,-(
MMD@O4//_$^>4Q</L:-$&V:2.:9U=M<7C\G/G%+0JNCRE)TXR#_MGV6GOPL@(
M;OY"S.1B%2;QJI*>+!>IX_8*^)0EM7KM>7KQ7?KQK_4F$4=#^FYQ9<.#+-EQ
M7,&="ZEKPX/D"T#16M%2O^G-?3)VMLN[4_D5D1DQH#59D((,<N/3Q>_'L;5Y
MC._;_72:5.EQ[S&KY<GKX>&Q6S?[1?T<-'F8V$!F,N"W1?3%LJ7="1*M(.D
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M8@%@CW$&-9Z\;.$H29\'O0 0L1XRS[O*9ST>NYN!Y<R%?@OGZC70,&3$]$%
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MO+^:./'<VUP:.2:\%;EY4*I<!IX=\5!JQ]W9I%B>W1V$D%"I+5-.,(K(;-E
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MQ"!N7BM8?+X1"ASRSQ_=@L1:>!>^"+%)IT7T\^+L<=B=H?<_]R&+7"I5"9.
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M^5-NW-4*RH?3U31X\NPJ"W64>6%N._>[L</"K7^("E+< =P@P%D$!)CVTX<
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M9*W)8_3]?I#2>E+TWAN:N3=H/?[VNQ@\6>'9G'[;6>7-&\]F'OEE#J[+-Q#
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M*/7J:(,C(0B/1D6C^^!.5(OAPI%D3I @@A3%#1(?KL:9IS:E&^S'-C,8%%1
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M=017OF[=E*S>K*Q4/MC,04E59*J$QF$WHA8OC#Q*WH,:,,D0P?RN0D)-@A8
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M9L0FN8=D90!?W"IT,%Q0-RTNWGVO Y,QK)XVBE$:&PN\H.F#6^%8A83N@38
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MGHUP$0V38#]58FX4^^;FB>5#N_#%!CI'<PM:R,5X]2=H5I&?#'N<8\,.X@"
MY/Y,8E[-'X/DPITX OX>5;,*KYRY*ECV21%YK=5A@,SQ)[-$4[$HN?!8+];<
M#Y*62;*ZUC6K9ZT$?832]5A<&%SR5[36IB(J?8-]#B>5AAOBAC,%TR>O[$?9
M.-K]Z<^#="DWX7LB8S_7?A8$4Z0TVZA7B&Q<Q6AIRU\C[GMUL PTQDWGZY@@
M;C3<!4O@SH_*Z=OE&5@#\[EY >PAJ]29YN^=!,OI_#]RP9P29B-EM@%\0,F?
M-\6@=F9=D+GY"EPA-?R1\E3+-8@QKVJFK-O=4<P5H0R*,5ZE004>&D1GX6K
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M)_9*JB3HGG\/KM-D"=&DR$OU>E_;8$+*[\,:RLP4:LC,\+JJ/P&+3$?NSS
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M'[AZ*+8>(MG*43$',FT:PVH=)N\]-A-7M6J*#VS!-UX,!#0!1X.[73_PMI#
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M*9E# H-:J+@,0 (G&'*4/Y<H&_APO2>7EB<#R!5*@-LANE_EL#RR6 \G*\O
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MZKVP>=896AU& YU-8%$;YS>9T.HOZ;&(QHQ2X>5I1+I A;FB@*>-H>U#C"<
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MY?X]"0@-#0T3 Y,4"XN4^RGE4^[_XX9H!? >@]"0F,$@6@ )#P3& R$Z !H
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M[/K.F1 [@ ^^7Y)HO4C'MMU=>97I);]"(9A>73-:Q,:14]-H,2MK^8:I1.$
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MG>D-]ZT@U&](AY7SQ%]9@"7_8^*LKQE:".V!MB. \^-G\,\>P.R_KD$"9=D
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MST<?#&9L>>CZ1_G8_ZV $3/_ U!+ P04    " "81!!3-\%ZQR!M  !0<P
M%@   &<S9'EC:W(S=61T:# P,# R,RYJ<&?,NP547-VV-7@('@@6(+A;<'<-
MP8.[)TAP=P@4$B"X!0@$=R=(X>[N[DYP=ZF_\MUW[_O>?:^[_^XQND>?&GN4
M;#EGK;/W7'.NLPLR!UD#,&0E920!&!@8X"/T!4 6 7$ "0$!$0$>"1$1$1D9
MZ24J]BM4%!14?*S7Z-C$!*0DQ 1$1&14S+1D%(R41$1T/&\96=DX.3E):?F$
M>-D%F3DXV?\, H.,C(R*@HKWZA4>.SD1.?O_[0/2!F BP3"]"(&%H0!>8,+
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MHHIOD[^M9P+C%Q%R9>.Z\+!AK0._O;PYI[VW.E_1W#FZ72R68+*DRRBI*YA
M]CJM&N;@4C/,/5\;NGI@-@NKAQ4N]VIJN8UEI^ GJ_.])';AXTYP4+M<A+3=
M87'FW165FT'??'C&=QJ2O000*[U<D@:_LW=HM]%64/+^%E!"M)/ 5H+Y?Z'
MO7%=M0*["^YE+OM3!5XW1#LBB02+M_\6PQG4&UX?#;J^\5RI+1S=V4_$['4
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M,8D!4>5%3/I,,V<["OPK+(P E'A2%MNW#YKV-MGV>(C$=+"#$ #\J+F^:/6
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M2Q.YRHX=*4?CHX6:SO?=P\SO.URD4,$^,=H,].)0^QZ%LM\G(I,DFA?;<P_
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M;%P")V3F#[XIAP?DR]83?K-'\ &GYNTK6MB8F0JE_.[Z%I!BS%5U+8T, =3
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MC\K?YL-;>>B!ET!#.42(P(@Y*=V3C^CP,%(3RB%$V"$'CMQ] M9QICIV-YZ
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MZ+K0.'>8/J?W_YX;_9\6_@=02P,$%     @ F$004[W4/<G]AP  ')   !8
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MSQ-<6F8OB=IMN#,AX>!%06;5]K9A_=RPR[A"G=.R4-!01\Q(I'$.OS,.U3^
M -J5C&6 9]3]4/N7(AQJWGH5RL&4Y>3:/LX<6A&MCM[Z)@<,E$,Z,W$H>9G^
MD\!998Z-L9U; 4.)X7<;QK!,X0%$Y6 NN $":<*$Z)FI"6'"DX)U!62K!_6L
MP@/\+UPX38X,KN%'2[EJP#N4C!Y#"1'^K?29V;/5Z+E%\?7J+VF2DK)H#+\T
ML:<I@.Q@"@N86(<E[#)QP'Q?FSHCUZ?^D7=MX-%E.;F>A(_S/HL@;9<&KV/]
MFY?:>P/8.ZNA'F7KFT6.<NW\'TD-:CP#HYJH =%?I?!X=NO_9B,_TW^9JE,
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M^QY=)34CW3-SPF[W4+U:=W $);V?B%19K"DNKN7F%7#VI:[;BB*/,H["1I>
M+N[ #BOL>5?^.6^Y]$MI0'F!S>$'8$>$L,QI.:Y/IA&N-'B28#YU= =<+(TV
M."S"I_3 LOZV4_4:XKT%C7EO_L?^:46;YY>>=FPR';/(8\WG6YT'XAG&@D4]
MB):(I I8:NF4PA,_LV1ED4^*J4)*M@!W[Z1?J&EM_*905GWF(VVYM0'F_JW&
MD&D*14;T,NMY<],NV,*RHHM5>?XM(HC_SVZM8E/B21$GYY%&S%68Y-FG%_27
MB6=XP5^/0RGH28M+< =*%WNQ$2LQ]9<<'!4UVL+D<IF.PRM:,<H^(ZSZ31\6
M]M7QO6H7M?LPF3OI>'IU<\/%I!D_O#D.,GWT^;L"4 BX*6[FFMXR?QA"K^.<
MHD@':XF+14FKS):E?60=>^[SLZ4-I%,A*PL&6^1+Q1] 7]BM)ZDT0$,'=6Y-
M$W<063%;S"360T.A')[JLIPS5: \.8RPLP8W)*&1(\R8_ [3TD#HR6B H30G
M3#TQQ@V#.YY7NO1\G%PW(42.#O'G\4,Y3%X,7_[H?@I>ZN;\)D*23'&R@C@
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M$S^KHFZ@ZOI^:O'E $?72-10P$D )40('"/J/_:4.2CX=,XYHJ2*N:7U7X&
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MUN48]*S1]Y2LMR6(1+!1<9OP:@)HR468]&3V"_(LG9'OHZ6JO#7?Z)U\[S^
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M/GY@RUP1WT,L#(U+.>0=QM17>UH+/]Y1-*%MM2?6X]BE]OGHDA2#$(91)6:
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MYBA;>O<E0C1I5X RFA8MH!=/3E0& \NK/XW%I]H 1-?8R>*  G-(F>%AW<M
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M\5B=];($^L=#]KH%3D9%XXW3[V=G):>W<4[O].9-X_A?DXWNI2Y/^D*^8=>
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M71^:')+],N32(:?"K3,AJGONOJD>2,9G(;%UT=5=66MVKYE(ZV5[A[/4T['
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M "H 0$!&^'L#_D=#>(:(A/P<!?4%&OI3!S .\ P!$?$9$B(R,A+2TUV_I_L
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M<#!C)$VLK+3#(KG?\0/8Q(A ,:2U##QB/9%A%*C?D)VZ.6F<N;ZO%\$@T3.
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M<S<O?IDB%!\G9C_7S$97@"&O&>$GFT1VJ(9I<,#NVIX7-+'_KLZX?]&3CCW
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M_;JDRNOBV<&+)@/3S;R^?;9'\8AMD35C\J;!=98=,$;+M?$-=YI+#R5"3OM
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MF&[M0(P$R(;9\&R*!7=40$4I$F&/)JC7:"@]<]I81X$2]D3L+'PL-4 P8.I
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M8 ='(%-@ARSRC!'/4VG@"V@7R8R_E?V67-<S?G5%,#YP*'OB+] [BTT/2YI
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M_'J="H_.D5-]HP=7AY![S1+?<?1P7 ,GAJHI"+K*(H8AZ,4"WT U1#+SM>F
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M@Q0M YF%WD1MC)N)<7=2D?]P'TZS5YZ@J9_BXOOU*J3YLH,9,_T&26P_,SN
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M.*&U-K4ZF[[&OAF71AJB>T&$\/W&27]:@-+8RY%_;B-$WVA2%EW+6,<N;)"
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M3\&MXM?.^Q(XECA/P8@B6MZEJTTF3$>/MBCK"VD>Q/:Z_G(X L]OY.0J;_G
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M][^BFR2]Q>"R:=*HJK2)EO<Q&8+OKX+B^9"+YU898H>=3DS(7 LR\OVF(BG
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M=TL>U)Q<V ^I%CCRN3B;WQ&<[-ABC":Q?#TW&^$G3-*_3I)R=1#PZ8L>H0>
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M%:.Q+X'(M"P_3)6?]KNUTW(VS"URMR#E5Q^K18:X^3,75[*H!W$9^AC]R>P
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MH $$4@+ATHC>2T=-/*M4[J>2)Q$RCL!O89H<YF-Z@#) %H5V%=,(73*.1'$
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M65[>N;I$29NA:,,'=&*U:5_23UHSL-^E^K13X?:5=#'45KPY$>Z%2B@[R#X
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M1_!WJCV]N[;3Z+18@R9H+;8X4E9/3GGTA0VS^URYK1S))9_$V 1%O27 UX4
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M'T5$>F)J!._SA%5&"._?T]5B@5Q=48O%UYD$\1%%\,/<_P!02P,$%     @
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MF!V0!T:VKZ_%Y D8:T<3;/>,6DP%+X3:*-8I ,5D;.+-'<<8U2AVQZU2L(^
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M]LV:G*8217E[86RF%4$W"W]'7;;%QLA*!S,(U!1\'IZW\=Q9 Q[ V#-K\M1
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M^A=U0.<55,^= T=DDW_N0U>2D>[IXP^;*]HZ8^9F5H905RL[3]-4.,2-K>:
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MHF(6?,K&Q<W'QP=B$A87XA'CX.7C^3T)"C8V-BX.+AD>'AD/'14=S_]Z0_P
M"+%0"E$Z4%$> _<(45 )41"=  @ 4-!1_MB ?]U0[J&BH6-@8F'?QT$.J"8
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MK*/*!D0D5/OH(&Z%+#M":VRY23ZYRD3M4F$WG+.T(VF^8DWG9:55NL0Q1X9
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MQWPA1?'@0\[6TW%5U&>TM,&JDC^$D!TU272B_V4C?J71+.(6Y^U3P3=HASI
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M^BOS(-7OX'K3^F$!GV(RRJ'@:Y_[.IF#V-UFKS#F.ED7WU.:3_^(+[)V;"(
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MN7'P?@9\4(_:/>-!RT86 K!% !?6NVT0&C"X=S*F.WH%"18^^W^ Q=,$6;-
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M?AX!]*PM'F9LJHY/08ZO!&\VK\;Y=T%L[<A*3PI)LS&+;@D10.Q0$;+>WT4
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M"1NQXE-W[O# ILEFUF7H;<!!ZV[K&7%7,@3E-L;T,0+PC<FYC1[*R8"+KR$
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M>V0/@^6EPB(&!JQ%IL?7-8NO \A_S[3K$ NWQ<=M>UL^4P@':5^1Y)CML>^
MQ=*<6C^._4J>7)X)5AB^&D!4>M>!DGAQ]1GC'65Y$&HN=3F6&-[KRX'.F5V
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MVK*=4\+H5E<R'O\Q>C9YVP;A0#7OQF:H'L"#3.F ^ D[NUXDP.6J?(T7;XI
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M(I/QCLM8'INE4LR:> ZP^GA8.7'$3(FP#)FM58RE%7I$1M5N0"O%"W\^+UD
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M9C<S.W?^_:O[[>?[GI)3Y]2IJO><IZ$ST&4 ^[G<,SD !@8&,'G\ - Y0 9
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M*! #F'&OY[L;GS.W[)V*]+/$)Q3I[&E)G[ZLTP]S[I(IH#)WV].VQ5!7,D3
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MR>]$W!WN@;D,X_!AX@JLD]R^IZW:.9Q4D-5<$*_-C-^)<CV&N)AO?YZ06B%
M.$Z47?JDJ$!.7J2WR7@6+IH7JKUZE'N*&<49S/=1G9I%TC&,8OJS;0^B:2$D
MH2Y%*( \%0$%)+<E6(#)K(K6%9+1UFURI WY.UIO@7NXC$<N; VG%=H/!=X[
MR3WN8U?*RR%N?TSKU47I!E>1&K)7?@5PIJ%;59&8.TK9.E405R.;0+0?ZBD'
MQ"/-AG_;";!5U?4_BMA>.L-\]W"=_8#33/H06 ,%?M98AD?J#?REL4/K_>FC
M]*1'Z0Y0X$<2,-&;TWM.,+1M1#%.*5MC%R%,RX%YL#.R*.:B)_'[@!BUC[-D
M@E.FG5"-WF7E>< 9^F/H+LHCL/7?U==YAPX^"G+Y0]#Q7P2U_@@%QGO/\1TI
MLD]+G62/+A*GU#Z?S=3ZY9D(Y(MXI+@=A([^M5_M_;$DB4_"Q!M71V/5ZRFG
MOXX1^%_#!4J2Z"?<=IQF.T,!SS=NR8]VWOQIYSFGVV75O[P,.-U>,,$I_F<3
MHZFQX=Y!A\Q06M%@77= H'ZW9_'K63K63O%-9&I>1]?:^R7*HQ50I&-U[F/_
MP[_V1R,1F?XIR/OW45+_KNYQRAX_IVQ1=G^+#Y/=+-'4FDHZ?CMP/>5Q1]OP
M.%-V_Q\SCVNQ\&BP^-;+?17$**HSJGMF.U*EKZ$=!JWZ=J\0&CM02 E1]9^F
M]^3:?__EYM=-&JZDB":O.Z&O;VA(Z*NM#2/-L<>;. * &"6;*?'&[*%"OHC)
MU&]2?J^XDA"C!6@MGE=\A2?#]G%F@O4CU?F@5^FU!E8P#]4*]K2 <U5[JBFX
M=DPN19"M*XP(OI'-;4L#@3S<7E\*X+(<J!V \=T! &FLNN#WS&?Q@HM.F,PX
MR85.DG$JK<[DVWA+$V  &\EHLZI(0K<\765\D']S0H'< *U =&8.29#V!BP+
M*.89M62^(A^,[YYO>1TL^T;,@YGJP<VQ_(XOBQQ)*69A0S[&+H2#[+=D6NDM
M>E4?II(_\HRL&M.F8V5GM[HEI61&0^O%O=D#X<OIB5O@X&H[5KW1X=(;T*DT
M>RYDGI,U=9F5V=BI61+?=81PSE:[YNL]>!/-9WFS>U.2W\!A?1DN;BTZBILU
MNU3Y^5'<0NI48H+W>Y>9'9BN<+LGTR*!*N9"[9"<P ">B6G=_SQ?5*:J-4==
MPR+D%.W"W@>B5;UFLGP,'&($B\Z5M2J$TR)\3"J0AP:QD)UY:IVC4][PID%@
MN1V:M!(:^G<NIKCKT(ACU'GM*KV1;G-KR6!Y A<;6-;IC_P&;X+"^D#F[ <6
MP:_HW!L=%>4R');2&T [*2!#/\[?"7K7=/7%]S5N#.[#0]Z0O"0%]Z!0OMUG
MIMQ^^,X@?<TAS^2.F_A:+]OOAA _, ']_F&F%?@9-^<@0?"^6>9J *G+FH\@
M??38V*X=*8@04OH=B/(*(.AE9 R&7P8E[;3W]F[;138?^1V,+[4EO>>RN<F6
MIS\SQ35V#B =$%KF5!%"(B\J4R&0#@Q 1 #8?S?$I!N*ZZVKG9_XYHT-&8TL
M0)F,*ZEZ:'MOZIG^K'7*GJ:ZO!D\Z_M]O*@(A]OD[GTA/"PHA6(F WW[SLW)
ME4TV/EWTQ%!NC BBL\:U<H'MP=DWC_5BBV#*O91'[<CM,#>WP^3$!N<WAX<1
M:G!'8H*[U/O#_A1WH:VD?5HI_&=$=$$J]68QH#U)K/^9A/_3@&,UGIR3*0=?
MS5W7[''3=R"VA_(+/CV$H16?+9[S)]V):/Y!IV]MY*%HM7$W,_GV.A\.-:@"
M1E3K(M.R(3C9S7P+#836^9(GH@V<'N%<:XRU'%<U3CXHJ3?;8\$R9$^G2RL3
M)=F+ZGT#]E9!'#TV"J5OC"B33E98?*8HU^Z>V8&MT %X"@XS4Q\;18! 3O#:
M+\:4(][UO5D/HEO;&,;D";\H)FZA'!*;7!_;>PPX;8)]G(W(OH*ED8E'CJ*
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M-[KFB:&4=T@P @WK/BNR@#N^=M*.N.CD#_7!H:!13@,E7BZY[8M,. =+NI5
M%B2*:K[6L/,^7P*O4AGQ9#=>;+H24KTAY!>E.N;W:SM@)KA1IE(/@^,7WK)9
M7_257?SHL^>+5>0;30LVDJ.#^N"F"O6OH(#R@HV=\/-IYR[*1%/5KR^.?^"<
MN,2(E??V96"VA"Y7^9,9\'TB":ZL0<ZO]LFM5;1<1#S7! Y%*G1@VH9]M%(6
MN8,AYFDG0OL.\1 ;R[>;\R%2<E+M2$0BP5PI6R6 FX8VDZA_GEA#E7O"R;!Y
M#*T#OE2.EBQFV_+:891+4B5AN#U'*75H_]3- 073NHW).V?99@\JQ^7H@Q[B
M+L!50TL\>E41PU%#\2E?K5[N*%LB:K$"JA_IAJB/5M<_S+H3!#XR#G *(]C5
MY^,A;5/,L<4SSO:<VYWQ0YRY&6^M>V=OCX_T5=]]90J7&N?I@\Z_:Q(-=XHR
MY2 0/Y!U.5D7YADOT.4N8XX)W_=N+")3>X&&489=ANV4FC#RFINB^UR\3_HK
M0ZRX ^F"#3,3HX17--!- %;AM1Z!*5;ZYL-4!X+5/F0.#K2V$";3W$0.EY/H
M .%H2*K-FIB6.8,?R^+20 5AY>=#="F"L" C>>-/9"FO_5%-;&Q:4+^..V:G
MB83E6V_8Q.D4J!Q0QO>@9A?T4&050X%OK'F//R+W(37*E=<T6 *T0Q#,-Q>L
MN'/=D*!U["Z'/"GZLX0*W8!Q;OFXL,&%>,.9'G*6^(2UHN0EO#D(&Z-P7'53
MM SKJJ X%/A\:A8OXDE^/)<$[*P?@:,NE9V_\CKW>==6?++WBF'!)VW^JDR@
M-MX&<4LMK]9/KJG5I?',9LN0WV@Y!X+ZB,E/0!K5_OBV>D\_GELF$9F/%;NN
MU\^4^GY3Y%P#KYN5 999"3W"GTA 20[XW3M<\G%W[<A*R9=^0S,/9 =MHK&A
MV"1<5WA*H6B-%G4-3VK)J=$S9$\_7+^</R?O6PL=FSY#%I6QKIDFQ.LB8J01
MR^&DA<=NB\S<%=%R^N 6H:TV7?VI3E_F%9S\.E$.6QNO;4<-LM"PBT85%" W
MZ*=.NGW&[.1FQS[TM2IJB-7+'H[Y!>9+*:(AP-@8WJ;/-P'%S;<\IWR0_6[9
M[!2''U&(F-&19T@)M+S LJ<PSMOG>_'N930%7NNFB'\06 BI[H=.Y57H#Z/Z
M4?N20XG*DG/B/"SVIOZ3H @X>$8B>;H3(2K4]U>Q&M5'<D5,#;CSL[L8K\A/
M"S9$NY3Y I;C,$;L2P"G70KTL6HF#IHZ 02K9OWI.0;DU[#+H$L%(MHZAJSD
M=A)?R&!2/J3LB=6G@2KA9=QD9&)BB';-:Q%ML2^V-V4?#L\Q*#"T[#XQ6ZN=
MK+.*%2:IDYH'P"P[$N^D/W<L]R_><6]A&"]Q:TQX&*H)/F0M)*#09&_DXNJ6
M>(\-BL( W#S$\:N2E<<=3!J;JF.5E#D@JRA M+;C& K5N^@#%8FW]I0J^I5>
M_I'<S$FT_*H;$>Y%-7+/VHBWDK9-3"^.><AB M+[<[(+V,%O]MH;-#??O<H>
MVDJV(Y0/>;<RO-BY%B5%!5X>7SDJ26UI92B!'^\>Z]OL@SV8&:EU/$QN@&D3
M+($PP:&>?HL7B#%4VC+H H% Y-^3!&"RH@EMX];(A=^EK(^?E:'KVA#:N*$G
MX!H@Y\A[&3-('Y)_KKOM#(5D!0CMC2!#EFPQ0'SGU[5>8ZN*3WF)]'YK5W_+
M+00L8POFS5UQ=\^I@7<<R_0628,;@OMR$8ER[3<"NOT_1J&T#;FZJB )IZ&-
MTU95ULK7H]F@']$ZD7ZF'S[J(3OO/:/2O(U '=OKL)*.SKVEKGTRBW%Z &#6
M[779C$H2Z;4&.?#94']:,-(;(,.P'W&@4J=3"L\VIQ!$FLJH.3)*MRJDWVBZ
MY HHH*#2* Y2H3)]OB4()TA%IOU,%G!17O9C4&3UT?))C;](-X]XGVAAV+]2
M&=E$+(48[X0PLZB?>(XVL#?-V8>FR)M1CMD_NPQPJH+ "*Z?5! 1RMX?L ]5
M]KFYB=9L&I9N$(J;!@FA9KB2:6BE85:/.[)OEC>W!IF">3VU3'#]V5ZA':>E
MD)F)6C8\9X)+/4KXL"1=W1+C%N+H5)JV,L; %@W[1D,-U';CQM# \L_^%3?]
M+0G7EL>X-!FY/K$^[OIZ )U?[K6S6)%I*+!1=H>1-Y3?99.?HZ60 .NN3IE8
M@8T,4R'5-D)$2^"D=)26:I$K%M=_7S> $VQC1<S-L-HN]LE1D+S(.Q3HKSJ:
MBGC%/>3P"M^9]3KPFM%]H;%>S#W%,NAH*CSZ"T<JH,D5]^V,*T8E\@6NO_!D
M5@#/#UYVCH=S)X[]K*054VN/K[L1DPK;\HPE&H_T3D;R%G<VE9\'MCZ*V7)8
MH7U+:*>;)QRD[ZJ"@.RJQ#^G:G?%3ANZDX7]&2\\8QG==8U OJ,%;UQ4"/4^
MB<"G)(ABX\-@6[G$!\9JQU%)_*=GA@(:M=9/[5?C^4'4O>V+POSR5+<3-BL'
MU-0*VLH!TE%\#3VU&R<S&PGDF HEPDQP+-,=>GQIZ:!7B*FPD'DH4!H1_(,G
MW+=S/4W86VWNRD6^>IQQ/'-\15\Q_'HT2OES^@^\OKN??W*05?E"( <0P<;_
M"4(.G?T/4$L#!!0    ( )A$$%,&E<PV0C0  (8^   6    9S-D>6-K<C-U
M9'1H,# P,#,Q+FIP9^UZ=U04W[9F(2!90$ R*%D!0;)$$4DB04"B@ A(:!%)
MDFD0R;D16LF2<Y.;C +2(#E#DW,2:'+NGO:^>]\OW/N;>6_FO37SQQ1KKU6U
MNLXYM??9W][?5P5F'#,'4#Q64E4"<'!P@!?8/P S"2@ A%>O$ES%)R0@(" B
M(B0FI28C)2$AI;].14[-S,#*PLS Q'23XR[W338^=B8F'O';?(+W1$1$6+GO
MRT@(2=\5%A'Z-0D.$1$1*0DI'1D9G= MIEM"_^D#\Q6@),01P0G'Q6$#KE#B
MX%+B8-H 5@# P<?YVP'\_<"Y@HN'?Y6 D(B8!'M#%05P!0<7]PH>+CX^'A[V
M5Q_L[P >)?[U6_?DKU(]-2=@<Z06\H_]0LC^L.P;C?8 BD/XI=-[(N(;M'3T
M#)Q<W#RW[XB(BHE+W)=4>*2HI*RB^EA']YF>OH&AD86EU2MK&UL[9Q?7=V[N
M'IX!'P*#@D-"PR!Q'^,3H)\^)V9D9F7GY.;E%Y175%95PVMJZUI:V[ZW(SHZ
M?PP.#8^,CHU/(.<7%I>65U;7UC=V]_8/#H^.3T[/?OF% ^#B_./XEWY18OVZ
M@H>'BT?PRR^<*VZ_;J#$P[]U[^IU^:<$YHY4;$+^A-0/8[^4?2-B%]9&T;QT
M&B"^P2$RS[G[R[6_>?8?<^S]_Y9G_^[8;WXA 5)<'.SFX5("<L#Q&4^&'_$O
MN\WXKGTR<GQ11MB4#%1\$JTVDA[7AKXY=N!CO.4>M_4N0_V.+K]?GO[VDL5*
M'S6_B?^6\TP>C&V7/*2*5RTM-'CKN$DCC2S.*$OXI^#V V/S;Y-Q8V'3C;O;
MN5=A7-!,=Y]#LY^;/-NN]$;K%I;7ZM_GL:^\=D;Z3YZ=-W<?$/,BMJ5=87:)
MN?ZN_'=ZE7VT1[=FGZBEQ*K\$,P>CPH?D\@!S5[W5O6:MY?<>3QD4=Z GF*P
M.E!_>XU#CR[2F-6U%K_>8B9Z<[>T&39\),D;<!)08)? H!G$&6;+5_)&-$FB
M1)M(XE9%H_"T\^E"A:A#&$//!_0M+S.2[)&@0-=ED^>7I;=N(Z:UA8S3<A_+
MP;HNOAZ<\?H-HV]N1!:IY9Z 6B,+1;.S]-V22O">A-^<RLLD<*9921&/%G5>
MO#' [X*W9UX9=+3M%9X2-,-U/I='P"<%>'Q+OW84MC=+=F$98+)+$QF^CE*T
MS>O814J[A7-T*#FNM-]7'U],K,^]4*N!MM\P8D8G65,V[7]PG)PM.KZ!-N#P
MZ,BT2\#UH^LGR!@PM9W7#,MM2ZQ\*QJ9K#?(U[T!_5Q3M8<!5HN>%'C@GI!8
M-.JC=MH-1/LH#29DT_#T/".*:0H1[N4:'UR$VNX_&%\(S),AU\FHP0 A=<E(
MO?!<-;RQ>R*)Q94<DSW+$'J4O,1]LZ<SI571H74C@3LA@UVM1&[6Z3\R-N9F
M\"XGM-RQD8%5X].BFV%:,F)A2Q<F"YTB#D%COEQEX4(^\9S^EO3?XFRTE:OG
MP,2]_0V<"VJVE3W/+ASRIJ4"(6?(%1%W3FTA/5&ZB3Z%'N;7S'?=*O4_VARA
MV4X"N2H*86&P@Q![6'9E:54YDM*[>0'*OMJYI6N]^ZK9%870W"W?8%%'1SL-
MS$R&BLE[%YS340XYSD5[+U;1]O-Y\=.LRA+6[=Z%S6WV42F"R69R"U57C(SZ
M[HF-.FXC:7%KZ+F9(,!Q81IQ%;.F-FKD(+%Q?V8:4?#\H=6;3WJXQ%("Z5O*
MQOAG*2,TRV;458W:]G9CK4@6^&6\,]E'9,0^T0>KH\@R! 0<6O$=)-?FA*9
MS7S)&2=3T!TC;G6PXZ3,BR&?>6/1?_MJ8$&-:]GL@*GZ0A_#R>BL2O\,,YXM
M-&Z3Q-J1&D[\*/?^,R7$E*_3E 7+H31:=%A$1K^=MGQ2TY4EB3\8R3^SZJ3
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M-JYMHVA/3ZVD\WQU]]U^,<"<!O9+0P"RB)"V2D8!#3+7LL?UB]-(Z<$K#^A
M X2.;>V[T;?:55#CXFC.X".LJ'QXCYXVCR$Z(O-:O!&25:7<^Y/7D1;(>L7K
M<$^M6.@9Z6$IS_Y4_D&O*AJ-Z8P/5GTYO"-W"RD3I[7X88,4?K "^X.4W_R"
M7$ 0-V]KCDC6W1RZV-:$2&_T7$]+A?8)"VT&R&Z)#LSWJ7: VOR3^OFBY^/C
M2)+ CO<.6^2TEU2:RL$<NZ6ZO_3EC5[J.V )3D1D$YL\KWN Y56]LZ/M0RSE
M5C^3MM\$I^@F4+6!RC]:'QW=$Q%4"6U74K1)KRJ:4;#)_L[&42U%CTUSHM4^
M64-:?<3;\>5;+? +SU%I<E%J.(?%EZK4WE%#F.W]:0WE1^C<782\!HNB^8O
MXY7I7)4V@LNL;%M[I(R4E/GF)&NNSH<1#"=]=@AQO?I6GG9Q>\M[!0*_0?F]
MRTZ8[;;]GNX:1T7"U]-D? J6XHYXU_3G.U1OZ^V6>!DDYBPG9/T%^:6I\:US
M2=G53^CCIDZ'$D&1$'H5>J&RW'G3>5WP#DPC_ZCE';Y"+B+5T1A)H+&DX"QG
M_M'K!<9'=9_G1C-&WR(?<NQRK(@1JJA<<,$=X2S"GQ"UB#C@__9V,'X#+<1
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M=$(/<: GX_!B6+O1(;;RV?3%J##H6+1@>F*@=3EZ#<H_6F?0.Q#)8(V>'TD
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M. G:T[8P%2E \/_%?Z]#4#__'U!+ P04    " "81!!3<RLEW64X  !F1P
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M'%ZYR;0 GUQ86]%YM16DO%1J;^$OBYA&XH%08:$5N+:+<NH#[OB(2)7$[NT
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M 7)0AM;<BD@K0D^OK84$_F7"R5^/*<)#P;H?+D!L7F>UTD+#;E?M2^T#ZE"
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MS=8/HC3&W>M=2D=QVFJ&6IXO.%)BE?8T;#FLE^2]YG^28 R-WG3XL._OQHU
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M6LIZ,9^H9V,W+?Y6N/V^9HI]08/"W5LE=*L_&"1,6'CK*C?1CB?MF#OY,'6
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MG*+3TANW!OE*S!^<'C60AZIBQH[F&>V/R;L8MRK+KLL%3[THW4AWVU&BE^=
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M'TK+GC16QVW,6*5BZ_ JQ28]\0O1&D*15Q2'&4O_&+PO3XQ7V0!\E%#F_S1
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MVMPR$7]"D HQ*A_98&TW==,?YY]_]L6@"3Q=-2"SI[7<BK>#Z;L:R DVXJJ
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M';/3"0/90&DPR6+7^M!&:I7BN:G:^J:(+ Y^8:D[KV(_JF.BQ;PPNG@ZM:/
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MC.-#J#^N)\(BS\@8POTQ5_"YNT[IP96RM"^B4<';SVHPH7J7.+BA 2&W3[H
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M!;(9[<Z\] 0[NM"6^(H214%7LQBX7\HI&-OE&XJ24G5Y)-?CQ^8M..C!BI&
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M69;HAE'#MPJFRBZJ7 T@@;4/80R\%_8#G8A]:3G" 83MB:?O?I1*FV_^$-.
M.SRRJ%L"7_JXROYI4_:E0'\6_Q?[RPPMFXZVZBD.Z"^D\ /C*QQKOU&,!3LK
M?1N\PORWU\/#QC^0-@U1E8:</"'1?^NMM!4C47[;9)_NL-S=4T"U%8G% *]6
M7(_]!D@&"1FO(G0OUN917$.41?RLM4R9S=BPP3K<X=HO--;8L+I+*'93_^-;
M71G4:JNKE(K !SYV]\#5*]B,UY2U:R"=M3PULBC\>XR@LU8-LV5_5J>JI!\2
MS,U:RIBR"8*6,YLVO^WFBOAWX)_\X:T[UJJ)NN)]?KL_HN'1^"T'Q9<,/2#
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M E^^:19?XLTH3+50>W*-:9K&&O<X+:Q&;8)C6C@&=DS>8S5FB.%W XHSH<I
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M8*PX;TWD,8$NX/ DX D%M&RGO)]XME/Y E"V2CVW%;PJ#/M!#3%L7H +XJF
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M^$X-53WA=]>?@P/V^UB>X#4-\)>&DTE'&9]R;R)\!34+%P,#+D@]?S+#W-5
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MM- 3636*R,5HH%CL.QQLJB2L!H5K[!7%I8NN%'082YC;%(G2K@?A@C0P.E^
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M);UP_9'":Z%1EF';X6MHMF$X_R*#RSZ38W_H!6C1&2;+5] <PE26D"#M79$
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M+32P*AB=24?T3'SU6?Q.Q_^!(89<A#(GZUEG3P?.W5,('1@[>;]QG*E]$ R
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M.TETP-Z>&!_I>150YK__*;%? <?E#)5_U=B5_QNBU'^00+,ZGDISKT9?X9%
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MD>@@K*XUH1S_%-YO<R.\IC6-]>)[!OPVWHTF)E-A1^[;]Q?)9J5^QQ-5\N;
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MU!9YH_).NZU]>(,18[Y;25Q=>=%.?5"O(]R)=?@FDQC#5YT:UPG%/<1^<:\
MA;2SS(ZK'X21/'="[^I+$&_,XSIJRX(<#+TB7]+=4X7-MJ&V>Z>?-B75$CUZ
MUU._%OQ;RIO-NY",SAIE9!T,N6/X),.L8_ OT6IX#SU94K5KTX7DV$7U;Q8L
M1<5<0!J?W9J:NVB!SX\M[RRD0C,/Z^\<2P2(D1YJKUOJM5V.Y58(5D)NMX4O
M:7)UD&3(ZP$9J#" -S$TD &/UM7/H0$]PAOVJFS'DC6-@L<G!6V&$T5RN# 4
M+R#L=L D$FBS'YIPM<?OGBRVIEK@TA4= 2VQ(?I#?<44R3B.;N@H5B3$Q6H'
M,!QP)TCHH:\D'XRSF6[I7G[FGO""&.8(U!1?,297(6$$@#H&6I=,^U 2I)3)
M5&SJ;UAI-2R>V=C9J;%3(_,"J<04(#WYI]!G%84(Q.CCYCH9GO-5YBO:?P";
M"(V\N5U*[+2XPT7!H&[%L4"9?ST]E/I(%%HQWH \E,NRW#1(VE7,*35*8J6?
M8#IJSH@<!(OECV!#V;^AGZ$I0$U9%N,;,6)H+%L\H3X'O.LRU2Q@+'FM0F1Q
M&A^ZQ( Y$NWQ_F)=JVB[KKPLW",,PXP[J6JJMK1KY=^O30(5;Z0ZI.0#BRV3
MSN*:\++]E6)<^%%^SE';\UC^NR7;8.@/K;%SMG. VC'8R+TM[.CK[-X'KD:-
MR4Q6[^'FEJ2U$CKP&BM2AB36L<E=>8FO<[3W2.&:H[;XE$E/V!2]GV3V<T[2
MPHX!'93C"4B4W(=0?- 'OPVB5RX&\(1(*NHJ\2CN3FG"X09BS%G]C0NC:W&4
M/#BT.N*I1/VW"N>TPCP/+]U/U/K&ZX>%WV%L&V+F"P_<=*%W1B#]+<VDJ)[I
MOYBDCI:7@'_GE(2/E-?R)^7\EM"?QJ0;OTQC7JW:5.V//(X-;%(!/9SO<4/*
MJVWV81R8*5O7H1_1L]XQI/U YXG]0?VQ*/=+MR$Q;&S* -T!-)!=TEY68,JN
MK^P]3+JF/N;+(FMC.79(URJI[4P\Z\%. 3>>*W\Y\#FI:.-4:H?9VIQ^=.TY
M?M*SWS%E!7D3.Q5I!QN;??VO08HY%CB#$3<L_/2VYCS\(5%;CZXGXLP%SGPV
MM1@G+=@Z($L6:%-@Q_8(AR$0'YVYEA664;0ZG(_&-*/C%7@=4[0D+;R_R1*B
M(;D>RJC !GWP#<N6+3YAKC\&(TK)7@4J'9;JTYV(A=2V2Q'>A<*@QB&A1(2)
ML-H%M]^&?X(/X7F1S5@KUW!>LXG3IJ<J[2=@;P2-?P<00'-=Z2V) 3SNCKNL
M$@8Q/W&G[5PV"/S@1TSH_JX#H^IU-CZO VNWF8GEU@-&;)S#38N#\AN;KA<G
M<&ZG+K)PFH/4LT:7*PXE).4G';-9W6Y!]F,E;-3K%(7P]/NZFBJCWC$Y N@-
MDT@;VFSY5J1< B U=[F(@N(R ([=Z(-6;FF52V$N*Y5\ HOJ')W4T=8Q=2<V
M7<?GXY6L.BX)'MPV+E 9MA/>_/][3BA;BG013_X"#/;>]7&F5>5[V^!*M?Y:
MFD#)":96]=NF60M3<%K99N:J-LGSYT;"L4AY7>H[K*L)Y;^7 ;_I/K)(RG/U
M_<W/VH3W5%'"7BFO<5,5_HB115H?W!Y5IKVYQN9V0Q4: A*Z*O=1?$#)[Z6>
M]]>I^-N52%KU\B%FMB2O'+4X+:V:]!M\@6] &!8!V75C?F_5*43-4_L]>ZC-
MOAS@'W@X;\A\!&#B8JWV98P3L?%GC9WBW3UE,7WXHQ85("_\7X#A#BA;<7SB
MM?A2DWGWSN2%9K''TDJ6'<!G4VP7AFX,"I41H,R[>N99XRO_6% >W51Z?;D(
MB[7;P1TQO@/XM4*-3?';>HSB:L<@LG&Z8W(</ZGE<=L&OH0QKI+>#J]#O[VQ
MQGI,.&_"H5IVDK3.;A[I6Q1R)O2SHP%1Y,8<P.N*D\$BV_;MNHEOH7X K#V&
MS8[Z\HF=_3@IFUX1%AQ?DPH;@#!N)I:DD0YE+#"/56V#XZ44_I,.$;[<QA>/
M<&7[G3,VJSXBJQ=N3,-J^!VTDX.7T>OTYZ.OMAGJ"E*,L3,-E%91'4@EE=ST
MA<P2K4+YW$;/E ]ED-:I;F(F;TT,,L;%>&]&J:39BN%4E.8(;7Q'X3NSBSP;
M5TX3[7$ZIP0_6$?H''R6]=NRO5:@G>! $F2;:@/GC<@UQEQA!9XZM&& 3+AD
M3[M-P3A:J:-2Y^K*K#HT_6#B('>('E"KE3ZCPD: AS-9<&HX E"P.V\E5GNG
M_FNNHT:]?G[)8GT>$W,W:-:0*<CZZD;PT,0&1]*!/I(LS%/JI==T8<8D>,.P
M[82U+T"UQO3:ZK(4>7?L2WRMV<;6:EW&&TXO?O>&OCZFTPA:1/<]8::8^T=.
MFIV0>J9^I',S3JT+9?L<WDJ!J=1+Q VPRF+:TR**5?RL">)U.WR$8J7<DC;Q
M?LWZH:[IC@BWP(?;N/GN_D3;<*<A&3G.@(LX ^^<M$BB0]C1G2I:<I<FW$E\
MDY9DI)"I;GC\F1M\05="5#:CT2QC=I L7D6WM+&.>82_%*C5G2!G]HNTNT>-
MD(FBGIU1<$PL3 8*0G+J>S0U7>I+<QSL:&V)#U[0%V"I</Q20,QH'N=/)HE8
M#(%*N;^ 8C?W.TW_$NL$G1Q?@X^#XVSI&(%0G <W?7?9$^>^Y99%%,L,TS!_
MJ3/S;7$M6VO4PL'6"EDP$RDJ?KM:2-)!1V26AI"...2TYX!ZN"%_NQ,QENFP
M0%(VRYZ6Y9X\4V^ %'Z,%W?:O)K\=S^5KH!*IL4)$GOLWJ 8KWP#MK%4(Y8&
MQ1&^%JJ^:D(7+Q>T,:F##,FZLB)$ &1MNE1K@J)V5(A1Q"6RA+Y6,<=&+[.4
MQN:B2\&?<07YMT&E7G;L%\=/SZ(!0S(>#0,MA8@[Q$+?+EC;S-,IZT,):BY>
MG7MNPMGB7_LL+P*:R,ET:[AVNWY3;-Z5ZWJW:BQ%<[#4:2(^ WA*6C]VQJU;
M9KR2'ZKJ)X&9T%1PQI=[U8UFZ9)5N#8T,R.3!T/K L&O=U)SP.XR?:<,==;?
M! JJD:X;4P?JR9_N$)AV\C=90H]#L_7V>QP.(QWIQ:-"4^S:\JQ#Q>*SI/;<
ME(Z'\0E:Z*-I+8M]O(*C,0V/7%/H'F)TTV'&N$NE8"55TM0; .*PD=.-<FF$
M'R+#7P +BV$^^(?*'457IB3.Z3FU,--A$#@\YSEVUA"3%:(C/&0K%#>[4#>/
M,'PY@0?9;[3P=L-\T5^ )*LT,[N#;V;;J( $BY/9NBOBS*K?EW^^1T+:"3VR
MSTS@HJ36-OMYYY99LB4,1*2KA<V_X:E(PQGE<[9,R1A#!&$FC$-W)S2\M[PJ
M:6MJ8QNG 0;4D]WX;N:-&^TV->&&L0;[8Q$A/01#3(3-L6?==)&(4S.'P$V^
M -(#O>,K<L?ANX>SEYO:#B&7K"TL7,,G:;G%QXY2WA#C)3[#^]PZ/L5?@ 4M
M+?0,8)'1S&\%ARHYC<7,=Z<1LS,X-'YAO89$NZK! _/1,,:XA#Z<7#*#,0L
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M%[S**)HC$%$CT0>7#</G64L_3Y2-@^W*_-'661!OAK'00'+W"AD_?D4L5#,
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M@+I> &[AO%PE$R/4VE4Y^@C7,[68SY^+5?:!L:I<H.H)B-B'W.ZU#;5B!G'
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M\+E<_%3=FPM<]15-#":&';V QU9V]&!^\YU61@)E5/AGYWR(.?-#4:?!Z88
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M1EYABS]AG^,_8E])C'.1*BPG*@Y'Q,2$!\#,20;.*$(&,H?MK9';\O9_SS_
MB&7-.3=/#=$J./P=^VDDLHCR,P'7[N,@#U?_PRG/-HS]:$N"JLY0CBMU(>-=
M;&%P'"6NOA5F^D0Z^PEM"<O!QU$!I55OD$QSW9EP#6M95(Z#%-%7J;EV=,>^
M[?E$'PHWUZZI=*J6J=)[0ZPOM;N'+<7!06[213;*DN$"AT2JQ_<["&-FL)DY
M/,4A@^$RRGSQ3'.*%[&RQ:'&07P]F[$0/1\1&C 2-3+!E4XTQN33<6FIP'J
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M^DN<3BE?MX]N6\7]+U]M$+>,;!_YHBAZABAGB=0CX&Z2?)7N^02#N7K^U-[
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MB$?J[481)W!(F7J5YQ<5Z>%T.P;75ZB0Y\"0HPS??3(<6 8;^?^CD,_FLY\
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M.AT@\P#H@=^/@::KI9C3DN.3W;55A[I'&M'R4AM7U*E.9,7R_SG6_2O>I9^
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MC\V2DMNKO>R_7>O2_+3N8)GGM_7BP"X4N]-_AH-G]O_I=K_U)Q[8N]3E_L_
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MWTI9_BPIE<U>OZ@KB;RK28C']O]O @!02P,$%     @ F$004]>A:4^V/@
M>D8  !8   !G,V1Y8VMR,W5D=&@P,# P,S<N:G!GS;L%5!S;MC9:'=P3@GL"
M!((&=QK"QH,'=[?@KDT@N$. A  = @1O@CL$=PCN$"2XNW:_WON>\]^]]W_>
M>?>_[XTW;C'F&+U&5ZWJN=:<W_R^605B!O$3>*@@(R\#@$ @P 3Y!R#F 2D
M$QT= QT-$P,# PL+$QN7" \7!P>7G/ Q 1$U!2T--045%1T#!Q/=4S9Z*BIF
M@>=L+[AX>7EIF83$!+E%.7AXN7^?!(2%A86+@TN&AT?&_83J"??_\8'X#CS"
M!*$]0$,!/04>/ *A/ (A.@%:  "A@?XX@'\<H <HJ&CH&)A8V#C($ZH? @]
M*"@/4%'0T%!1D=\&(+\'4!^A$3[ADD1_K&:*\=2%B/MM8C8F_<OR-F+UT2,&
M'C/78"QL$E(R<@K&9TS,SUEX^?@%!(6$I7Z3EI&5DU?0>*VII:VCJV=N86EE
M;6-KY^;NX>GE[>,;\BXT+#PB,BHI^7U*:MJ'C^E?<G+SON87%!955%95U]36
MU3>T=W1V=??T]O6/C4],3DW/S,ZMK*ZM_]K8W-K>.3XY/3N_N+RZOOG=+Q"
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M:!(8A6P8:Z]&/6;XJAJPG-SL7:P%$EV<7(MHF.9*0ZI2P*PH"7(;07S,7Z*
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MXQVGA-37[O6<R0C2\@W.B5112?FU:HN*O1QP=_+I%,E,"-8T6[]506Y09Q#
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MX>*EL6M0CED4T//MZ%=6IH>U&U%RT]2H04_]3. YC%'>TA,@^-!@_:L]MA-
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MLU?1K' E][K@8!$!\".5KUOFRK]ICJ/+1I['\D@>[6_DE3R[Q0R.U# )F/_
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M,WY-PD/?A\XN7<[BZ)/5.DWD]J+E1KNN?0%NCTX^HK0'KTJCQ<1Q-SF#>LD
M$TUJ4KU)F(<-;^:+[1M?(T.[$=YH^[H-RE!I$V[TM<8DW_//!*]ZAWGZMA6-
M7'*]L]9TZH_X<]RLWUP*W!BNGS1TG18S1S_E@;[G$HTWU>0]I+E*5<$;625W
M_^K'E3L$^2B:(DD'2M2PB-G[L)C43S P+PC0Y,EA,@3)R*IM&WFMZL?:46-(
M0:[D5I-\//R(D_1M1+]IR9,&H]P/(\NLH'@U5?K]8FUD-9[XH,Z<DD^IE,7T
M!M7=ER'+A0XZG@P'@PS<N+IUE#&;,N'HKO2S;6MKHBFKE3M)_J3IL ?J.E-,
M$*[7 DNH#J)KKM]@R6USS1ME>4:4EW&*T6(O-_IR8_FQ4-6)\6*.Y!X$"5/\
MV^>?-<<R==3A%^_O:/4N%$Z3CY;VRI_" 2SX"NP.=ZOCT]PU#8V'++%V\L[T
MV&5EK3DV)Y&]E06&.A0M2#3J@IS2XLW5\ ]EUA'Z*S?O)%;**T&ZH[#F1Q/"
MW#0Q+UQDA-VMUO9"&'.B<O///^W:&R[7=VTC@(?):D=[%(/"MB]&+N34M)S=
M/(34?ED[+1KNIMW$6&@=Q)88&!LN;=^$YO*GAWZ036)VQ.U5.RT/(=88GB)C
M$3+NKBQM0LG5L[7-;V,<^ZU\GMG2 V]#?__DZXK+!EX15C>F*J9@:0"KK!+;
M".OBPM+BPD.KAOK9#4%:=U/BUZ#D(&!'15W)F68E[[^;[J_CXK]RHSKP#WZN
MN]71>/!3)>.Z61SNLSC-YQD%E+CO$J8QO]GO-^3?#3U)>TP%2EO;$ 3<9K##
MEJ7&V-W/Q_?/&IG?I'0&+XFXZW0$D_'_X$J0$#H')F^8'X1.1>8N]7A0+WVT
M%#:LJ.X?>/#M0P%(<=V_$^#*^D!T.>8^2Y\N,+Y/SN2>9&GS.I*<?]^*;#VV
M.-C7@288IB9!9#[J7N"ARZ=3-< [86E885B"S>C2@W:<_,-KC^5[50UIK#?[
M*JD26<3(-R=FK"=>'M\9,OS2TZ. '/'8O(4=U1V>[1K794EXT88<<6[\_10]
M_=$7,5*%<,UDS>A7E4HRFO.,<]^_:%,Y&Y.+802VEZE)$)><[5*+#K\IV=^/
M[?QJV_0A1;2/0.L-OLY-^AL]*RCJKB@__^C@UY<5#"QDY)BVF'201P!4G=MN
MD0CT+HND(MIX_%Q0IPT_TYZQ.B^&ZXL4R0G.-\":@27&&H4*O]IS7G)T[Y"#
MD]V]F(P#!GJL1-W VDN@VHD+[:YB_HQ;=3050I/V+#7]64:#?VG]OM8DZJO9
M805SU'7\Q2+;*D.6#9P(IG&V7V'K(:).#U+>!Q&1D*T' >1[:$9?@EAD\[9_
MM-FC:I$4XN4XUL2:JG[+>/2>[%J9+$[D\:[Z_)R^'ENT@Q,1*T,L:\0/CDWS
M5/.XW"SY0XT_O4WW/\!H$;/_%U!+ P04    " "81!!3!>DK'W)"  !I5
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ML7?7.OW*<CS#LAB55@.=E8J;2>N)C;.%,_4S#W%SI=B[Q!IS.PP*O' W2K1
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M[C*B<!<-03R]"]D8OI([(?4,[ VA EK^?PKXG^(8QJ?6$48"8947 5#8T<_
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MM@6@$$$*/6!K(9JA,-#QO??LDIKV\=%6IV).(;T2:DSNSS&-5VOX#.2; A)
M D]6TS_N\\^(! ==WZDC]U\Z/]'\2M%=,9KI$Q2V8IGS0@D)$$*Z'-M33\@4
M+YDJ"CU'%<OD69M7L;KP(R6/"J"_7!3=>OM(15+7/4C@I2<>)"3-%BU1X?/S
M\+N%S5*!3+<6Z*ISWG!(M@<6,$3[/S))2G8B55E+?,7^@>V9)0MGSE1,&[G$
M\T/[HQR!V.SJ*/Z(.FP,"CY#?YYPDW4>]>!YNY8/BE.*=631V.45C'Y5(4'H
M]]B%,3]E7N"GN%)KRO5OO^UPW%(9DD_2ZU"CLO%?(Q=H96,CXA9;&QG/NN!O
M  Y-*!C"V1<BXSE)A;_N-A7?"HQKQZN,DNB8J<O Q!SU'!;X8+Q+6\APE_J5
MA.:6/SB:_T68\,H,3NJDAXO4Q?7B[I7.78T@<46%AJ,-OBW*Q)>5+KOB5+?
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M$>^S)RJ6?GC28XGF?\]5AI#,&-7#<P9G?G)<=*SA*X;2=945:!Q:BKCP:J9
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M3*KVXS,<KXNW-CM+ZWDXP.0Q)O,&U&-[NU =%]?--$*PDP+?E[#/+W4\A\P
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M'E@]+:Y:O<#SQ3MBB0(KMM2N(H@BL9OI _%"OI9$/X$N,H<]R29!>/>@ !K
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MII&7WOAR;&T[UVV6$_@:C;?S*[:_2V9&)Y?HOKKO@02PBQHXW!B42AY2 6F
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M;ORW'M)8Z)&-8S'O(%40D2-[!A%R_O\ 4$L#!!0    ( )A$$%,<U'$7LT<
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MJ7)$],Y^!).8GFOYR?$?KOW%LW_.,=__*\_^S;%_]VL&P$:"3R$!$@$@"ER
MKR0W@ZQ836*7#6]91@E#7$)9J%]@S$BY,ISF-96^;]K,NH1B,\" E>UR&- ]
M90$#]#DA6W;J18 IY.TT9$CN\(Y4$09TC-S[F<  8;:F(T-1&$"B[:B$:G:!
M$W=W]@,&M'R$ 7=Z-#]Y#$Y';V$ ZD,8<.R4(_G_?0WN%%^?\[H]E'X^%O!S
MN=3S6.4!D1P[@!"M: D,0%O@#B?'+5Z]2($!H1FWJ'U0=P/(4BL$^KQ2>?25
M1OB7D0")9]V/OXF1I?Q6J^-O?9K\1H@0_WN_I'_OD[D<E_KQ=8QL5"J4X2W:
MAD5O[Q85*4=I-^T:@1A9TW^K:HLQ8O,D=A!!-<]D&Y+?EN<6DNBO?D3N4;!=
M;WO" #\,&'!5/Y;NS2GZZY1O_3X&10*,2)S_C\OC^IM$GO^U0,X6!X@WL'+:
MQ-F->I+'S"BZ/;>'8;(D.:#B@R ,>#SX!;X8HR!;B-Z<9PT85<QT+CP%N06-
MH[YE_41B#UX V.X(&J*ED?<H58IWZ#3+<LM-UX@,]\Z),$#J.U@)5?J"  :D
M5N?! !^D.T9HJ^@9\83H$2W$'SPB1D;S4QKJ.Y,#1<8[RKA%AP'#.JHPH-D'
M2E0B"1A##&ENL"Q3KO!%6R/WZ&" N-4;&("(=J7^G1 AZOXC9(LU'[(D!@,P
M?VE=^^S_;_%_H44FE)I$A:G*JSBEQH1GHTK;0CZ!O0C(=BU%.SU-," J4@8&
M.$/N4<R1-#^A*@+JCZ^&6@\Z--K=08;CGM4BHMJSM 1^W=S^#+YWK(SWFP%G
ML9M"TUU00H0,DP*+^N3#4DOB&ATIG>YX QI=\IQ<U]BNU^"L6JU+'2[9Y3?\
MIYR^_&O8/)X\"3%R1QO!:0,L]>HQ)B;TS1CD"T0OFQT'421RKSRY6=\Q3S]M
M?SF_'$O5M(N!_&SH/1KD=G?&FX(M.%VNZ3&5P,4J[],)XS IHDQ,39^ZEB6D
M08&0:8N,R+X' ADRLTKL+:R^ML)'>.N:L=34T6.*HZQKC:?995^'6+*%W/K5
M6OB&R-B2[YD6\E)_@A_.R+M1<,[T;$@'T"41^.T/ /+/\VQP<ZL?'(+(YXN)
M?G[P5_6>NPGS.^.6ACX88+AE+PGO'(Z% 1;F(&K++F][#2%;\1L"A6-BO_LZ
M*VR[N40+.GML'_O7KWFZDV<_G^_9>J@+3_G<79<062N)"_:P&'[\V#Z(^(G$
MJ]](M"W);L9; 'G*L2LX6V?7 3'[E/&+LT^#3;%[F"IH1>]1@OQ4:3I=/DOQ
M$KW_YQ<S#D.HY>M'846Y>OH=;J31H-&5)^;E:5\N@;D30>?S7)L/% X>D.=I
M3]:>KCB:KX>Q!!.H2ZHOZS[LQ<WYI&"^)9(#\LB;^2G$;$>K*.B,08NBIM+?
MGAP"K-T_"RZVX'A5GIUE;O1.36=0]X% 1%5BD3G'0E$AS_JK=Z,># S?0A\#
MI(AN+<J=[N1?/O U6=3%ESQ5%#"DU?3U9B=_BBL^-'>Q*ZV,=O=$G=IIE/0
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MO5)O>C=6M.SWMB;0V;:+P<%Y*!M<G)'JA,F8[OVKX9]Q)RXO7A,[EMR<A<(
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MHLUGAKVWLEP^)&N24;ST2\ZA/"_,F;!)+\/WK#_0B8?V+J?6@QZH641I97Q
M]*\QLFCN4@CXCF#%&KM='+OPR+8-AU&\,?*E^P7AST*6)>Q'E;XO]JA\I5 U
M[3&:=V6PP776[[G08SE=L*=(V,7K5Y3IHP*C5)-\I26Z)G.UKS+>Q$JIUU2]
MW:;_%#2JSI3''HE-R$Z_1.D-K&F\<;' .2^8U7V^M4@&+/GBBJ.5(2,IRKP+
M\XU*_X3>K82+T7,/QZ6SLHX?%7E#Q:CQ,^B/8F?8*164,T]=&?J<4 (4Z9?"
M,R.^C%RY'X#G'^D[+]+;]R% #O>B/O&ND'"G7@R#./J/.DW%7LJH6BNY+YT3
MSLK)O+>BJZJ1CY)ZD<$/ \X3D)7_(93D[RC/RV7I=;W;I5IMW45JDK3/L1"9
M[M!.]^:?9VA5=_Z!/G;'[UIXK-,<^BS +*S1+]:J5\)^6C3<>%M;OMC_F&W/
MW:U.SL+1^<MJ[(Z6N!V'MY<S']]9\4J=.@R(+B.Y]UZ$ =)%@)/J?\)Z_B-[
M]#O.,,O\B7X1 D,X,*";0'2W<O&&>U>[_ ,O#*!]!0.*QR!;4T66</ J@)AK
MN=6P>Q;C<4Q(Z+)]Y<2GHZVYE$(0&D9)8.:%/L AN66^?7.KW74K*N@U<>%_
M4I%DY&R7-/G17IH+Q*)00I%KXL2/C?<2STZ,D.N[/JNZE2Q?NB,/B97Y^O'I
M"\GW8<YMD;V5X+@CESNOJP)HFSUDZRLX]R]2[[]LY39PZF@T*CJ? @/$M2=_
M)RG>W+G_!%+_X]A1-T1U%0#!<F56F;3*T&*HD20((*.(]_65_F ]*%R0D9^0
M'6]69.%";IV&.&1AZ_\DO"'RC_/$3\-W1MS%H?D]1:&WB0,\>^)<!)I^'*AJ
MS"?M_:1O-^EJ]+^@^JTPVQ#<*7#.S"S.%@IPTK'N5XBUQW]>0]T1WBT:$1(U
M7+YZ&M$O.V3'D"@TUCL*8GZ+7<'+ "!<J<M!>C1#H<UPWS,FO07R_\2X?[?,
M;F$<@)5060SE+Z9J/T0(D!F_0DLS[4"T>N(,DN3@-XIWD=K9'6.R?W:&:+'C
M&_)21D6L!RFG2,-W>R/JTZQ,(NZDJ4DS'UK99?:7]K48T#G+B"1AR'^;V!.M
M":1\+$Z-7'D2$96C^[[>=U#&H2Z\#V> $7O1-5F*<Y%H=UP)+3*1(F5?<?\X
M4Q]B"&D5OR@IOP\[/('VK+LE*W!&<LX*[V8=%?NOZ-@@FCO;6EID*F(K;DH(
M?_WF;?:$Y!"G0765$OIE?D2,$LV?:U[%S>G<TSSSV+*<?E3"&O_U@JZ9UUR2
MK5@G)*">;4]> QJ  0,.NV$ >=[2X=7]L<9]P!H\'K^84I:+%0ZR;=*X;#I]
MT53&;7!#R@ #FNCNS*'M$Y"MMRG0N\CCHAG&]4ACZJ$!&+"D>-?_>WVBOQ0"
M.X?P&TVC59Q"KA[" $ZLVX=J,"#-%W)[(MH9^5NI^?0(S0OQO;M%*#(,Z&_]
MI;&,7PO5F&?$"G_R$(7O9!_14_YIKGOU4; S^5JTS>>GU 01@8LSE2(]^7_L
M"+8[%)H[-7D(M+P/^@,-ZCMA_X6_ZMD3FSKDHR,+GD4H"MLII]>OK](8PYMD
M)H$B1D*9*G.+W!;CYL*@);B',  Q[OJS8]Y&\LA 6T%W#(C,1"]U_QU"U[)&
M@: 4#(@$1][<PO>D%+?YR)L5H[;J;<D?+9*$JA0H_[82?S%C..AU=V5"&D2A
MOE5%6G _3MBW:0Z&X(NH" #_$W0'X0O;7;ASRODJ+S20R/+?;BOZ?MW:E=FT
MXH],L!&CQ;=<4W$-9*[\T\':'WEB^]R3/W12N)E6&T>\>^C*I&BJ),- -F.G
M)U<O30&B8TH/JV!O1AJ?"O\@&--2L:OMU&^_JVPY:M8]]CQL5&>&[Z7(2R7<
MA[0/%!":2V2.*PGT7)G5:U+VDU]7KS^Y)=0WGL7#J?(X3FGC0BBQ@)A!*$!F
M+BB]SV8&L'V:19(T!!9/U!_#@%+XSM@Z+X:T[!9!#,%*KA;[.(TNYO56!VDF
M:\&K/QLN62S]2^W32@5<.C2''[:#CODB'\AGR]DZFIY$I%#D^Y_&"=9$.Z3(
M F=,_P ,R-CBUD43:_J06!NRA7<Y7]6-':@[5T23F$35O*?TUEP]RJT*C=Q'
M292J,.!P(WD_E!*+(OSSY@:S>_B./]<"CWN]J/]!/]:K=TZ/],3/]^R9TPE7
M]Q8Y*[;<G,JX12J(%"A'-!KVM[=A ))#>7H%:U6N<9*.GM2%BW3F&UN*^\FM
MB1S-WN>"R?X"I;DE:';9K]!0QFE>C^5_KCZJSL P-Z+/B):-<--N &7R]52/
M;1'I7YFVKH9!]YN^"&SL+ S2L?;W$!I=?2ME_GS\/,TS;[OIF*FF@3C?@:7%
M^9"Z+8_&WT(V,2G.*)$BQ)]<96>_?/'F5!"%5+G+4GN#2X[*WHKID5N>O-7]
M^,EX3TVUYD8E9)FF.@8J4FQC[9E5^]Y+ C'X);L5OV>+'(%Z(6&&?,&EA9<&
MQ,=Y5[FB/#QY98/Q(NR3KO$]REMSZF>!JN.;5;>"[29/97K>KP&H>&FKW!6X
MH5FS,""_M 9MO!/C;D!]U%%>5+&Q(6%FCC[QPA<D*(70?+8V(3FJ%#VYH684
M]L72BBO#$Q[VPYNZ?Z:',".-_)<15;.>LL=JN4THL5KJ$G=6M:PY:@BP5RPM
ME%@M4EX[9;W#6<%X#P,V"^CMZJC3>=XN)N, SI5JPFPJD>ICJXTA%%^)3K U
M7GS-?(F+;B+,M/X7 F$/Q85OWT4BR$]KQ?N'.$Y$?5>"4-$/<+0QK!,]>\T]
MKH0@2?B;H:K_F *;86E6E<]C!,9:.ZS[^5V6#3*3[(O -W)*)"8,6'P#"7=R
MF&USH(D3 CTV$]0T-BV &%LLGJ["0YA7Q]L)R:>K5O(QV2N?2](&[W,Z8<#I
M\;+![8[-<<;OE3@:3).[W%W!AWFQ3/I"ZAL,$.&! 9=[RN[W<0MP#&&5;KB-
MNTXR+S].YPI@?2,6K#?=FUF^1,S/-U27=<L; =GB3(.7G8:T-M#LA0M"/UC!
MD?9GQBV= KP1"LCM!=-]-EW?S36IIP;6YOV'0<&]!3@K3!T,A $0$QB 2=1H
M9N& %Y]O'ET9IDS8Z,]9F9(8M@J<'8;L0<JY#J^/:^ (_R[78#L6PR,[?[H9
M:0Z_F7;-S=IR66!_.FOJY(RC2!H//4^R8=X+W-]_JQ@.GYW5UJ;+\<55Z9D/
M\,$0I2:" 3_@(I!\J^G?*XS\][X6VAB4WRY>4\5FS-_WW0VZ_#X^-!;'37=W
MKAK0F\0[<#JT>ZQILW,1>A\B^N]UA4[M_;B$BEL*+\XU]6]ZC:U"KJ^.2N[/
M>:]&+E+@,#34Y0\YS&OJA ?$OS= C-^]^@XA:\3_TKPECD-[K->CT;TJP_0^
M"_?1#)"Q\3R!9A^BBYVOE"CYKM<$W"?A%;A+'?;UZUF-U*Q'58U*G9_F%&TK
MI/(1NY&QQ0P7D9'T2'Z;R_F_SN6=:'_910'D^I#D_H+Q5JWI[C(4>DMD\$MO
M_MU%MK^,"TKN)<0>!G L/?*F]<6C#>G]]78+K$Q@)/E**3\#0&@FBOM5$$_N
M]G<DC/\3]-I$#EY*+^?>%1[ETSJT;9KZ;%B\KP0=QKCC?XE !@W)S&#^[(05
M0=<1#(O,M_G):\F,2+U"%!8KI'>*V61%C9)$-V20&K.FSU5);1:SZ]A+=[>R
M^TA(_"5Z)4^/J@(JDQF&S_JBK&Q$0F*JYEMWH!Z+]'6B.UY'V'LEL=O>:);G
M;O0R[]Q,G&1&Y#C9FY4$HLT1)GIK[KX$->VAPAT2MMS\>*=EM$HEL $#%"),
M:GSW]WV^V!I8XRX)XTKK6R;^8P+)]#7V</\'Z,0993&)<I6OX/-,&7OT)U7.
M><GW"'&N:+4O(5_DM1(6,BP,344F.+J^!XR,)^$K(B;1#= 'E2B_R=Z843\P
MSPC&Y_!%.$>FF2QG^)&B\FVOLF8FR'G(+>SCN>JYS? ;[-/=/:-*E\#7VT^:
ME[//5<^H<TZ*@EA7JGQH?;DCZ$G5E)L+R@-NH5*4H^T6).:7A]OKFY<NCZI*
M?7O']BZ:.P7B=MHOZ9.SO]F\M^KSNI'&!K49Y?$+HVC2(\1TT)I8A^$-3UK+
M'SAV?C8",VN&;(PN7#S$Z7_&8I9?.V#J&:H\QC^V<:M6"P/BP %K>!<&-^33
MZ?F<8(6/JFD8/ZQ2G)K.U\[X07=&)L1YA XZNITC!?1IGTU(5\/,DK_D7(0;
M*,%ATER]%0D&L)I19-)-HR$=<^M?MLWH#7XG&L]W*7V^VX#9SQX6LL6L-9@@
M%P7>L#/<6LEZEG\Z>J,C=6\P7Y9HE38CP9CL>>E"!]71I6KW1!._PJSPVHE]
M>/"V+KPL)F+"-"UIUKO)G!TA6:@?HMWUK<:-*C_,$(W<<HH^_,LPT=NV<<JQ
M?+[73T7G2'O-H%JK9'=,LC%J'I:/$#[G;4GAB.-\:7Q@$_*BT#TI(2D)T2[)
M755Y#D,W%X2*BV'2#'=*[H!Z0&ZANAV^\I'^B>#C]\KB8=O[HZ#^_$L4H<Z9
MNE,:,N' [[;:0^%55J!]U$0/U-A\;?ZG),K"!7*=8YM[3B9(_!+K9=W%J_(U
M)%[XM=4OZ%=L*CO?N3"5F\*Y%:6WNVGM//G!;EN> QQ<T?&"K*VMJPN+Z(_F
M7NVD^AN\**408\BE<DO%4Y1?T#Z@K4:5V9)_,TE7$2?50.YM9%I&D@@NIRHX
MI5;U%7 ?W7ZC/Y0C^3S-A.I+FQG/-N,G*<[F.0!Y=2RDYC%]6:7]XWH^IMXV
M6K]Q C%J89N,V"O/S#Z>.N+/,POI<1TVUD_,VTVT,FK4%] IG#<WR%J*2]JT
M%RKLEL(?'(*.[K\W)SP])3B<X7[-#N0YF9J\)R839I]LP'C/LEE![* M_B07
MX14;*2.PQ9/,ES>A1J!,R)3;#+Q%$*,,]#:N2X0^ +&Q1L^L5\5C?\K\\59B
MK:WY/3;T90/F^AT5#*#YP01G@',I-T_)=QC_YMS]MS/X?6FHZ%G)S;7H#>NN
M5$45S14,&&W:A6N4K9H".#. K!D&78F 3Z7""965K/^*60[4C*4361.5K(J@
MBH#CL^LLBT>QJSUSU$\5*"RV%+,8+KK"(%LJY3"@I1D&K*J-*XM1-OW^.U7(
M>]<NJ#\SVQTE'I1;#\ZWB2H&GA2R.6"V"=)RO"III#/Z1('$=]YA9O _2>3-
MKG;%ZX_Q D5Z3&-/Y:CZ>6E,Z^@E;>EL.WDO^(HP?KT5EO]9^+ZWX2OBRPCH
M.,(&.8F/DX?HPZWZ\/FL:#WZ2X& K-SV:S,W":99QDY91B9[U]60PP^2Z0Q!
ME:"S.NN<ZA#/A@5$7GST)V[(;U>1C:*B]!V68$!0PF352J@>QXH'.-@D_L>4
M&55BYZ3=M62IYJ4T J[7Q0'S9"Y2X-&0MT)*-MC=J\&16]!3XDWT\9L#  /Y
M825;OUTWI2W[ZU%'*DZQJ[0U"^=0&\IZ9L%<T_=1'!%K4RZZ!7\7ALD>5SQ"
M7Z>X;38M^,DUJA/\-+&?==:<=',F]RI40\ Z:65Z?*'V?MQU;F&3NHT[<-EC
MWD.E(IHK@3Z$9\7M'8O;#D"*6A-.)F#M03=0$)&#K6I./U=X 0,"!;5SG/)_
M:MG9N6!;W8].V_05J4+;.$\AN?-SF_EH)V,GNA"!.G"VYC2DJRJ3G>:0*0SJ
M:<F*TM!T?N\HX%;V8(9)I/CPP&##;GL5JTY(2H59G/[U@JQD&#_9TMH9]^CU
MS=ZB?>_H3_<!=H=K1FCE\07>?AOC+6_*.LK\R<&@(HWV6!'3>$!265G/Q[;)
MRN]9IN<>6I#$N]<II9:G>(L[*R_<BQH!KZ*$GJD/C,_W1Y5S=86ZQ5AM9UN0
M?9I7B2;5P+6FR<)1/>3/:+]U*TJD*+_!' V+T?X0;D=*SOV,KX??O1H&\'#*
MC8W)C1E6A/<%=2T(]_!SVR=2'_GU,QG4*?LH%&;.NIB9\$GA*X>4O\0GQ6_&
M=_=3VZ>3U& *P?O:1NN1$.OV"E\HBZHU;#]<COT&8;*BTE,;1WI0\W&=7G0W
M69;/)V-V9./+ =.IQOA\KUVI(D)E=5"<'6OJQ/(""5,$Q=KAER[+\4*LB7'1
MY2>5OL)JJR'F63%]^&FSE3E 5/)&S;;%, ADN;"LN< 8,FJ NTB1F^99?4)X
MJD1)E9,--JT0DN)<_O8&":KW!*[!Y?&L,'5B"]]5!TRHC_)E1!8_5LH0%5>W
M*#LFCS14R/Y(A"VZRP #BE-N&?.HB&5F>,G4D0EV<-Z:"^CY5^?D]R%CEDNZ
ME*&_<_8C-*/R!&5.YEIL#0:$%.&FF=EY.IC@C*OH:?MSMA9C2=>:N.!.4S$-
ML*/_&?1'A7%,KUR@DM^8H=_A0G48!= 8T78\ZJLJM'C26M423%5=P/OU"OD"
M^;*8_';%M"[+\FF;<M51Q_=1?&K428PHAV$KC"FT+)>%7\Y^IN+ ]=:?H4SC
M+%D3G:%N3EZ#3\:Y[C RHHSF'G_]EGD0+)ODRR'%B#3=]?A?S_EP#5H6CV]7
M2FYQ>F! NF%Q>AT$#=)U&-*TQ\L #0ZH_\<G?,R"RO!8?<\,_:$(#74?*0RW
MWJ%X5CD;&HQLF]4RU_XP<KYV7T.>EYE-M'NS R3U;2&8^SI#/P0N0SX6O((/
M@B]DD15*"&E52X<,BXL>QL*%@%=GSDE3;4J)(61SS>OL_8CFXM$7\Y0S?,7;
M]:;6RGWKU._5<J$6R%$BSJ54;AW/7MII1)=E"4F2%X]O))Y8Q"A+$J&V_%5"
M_0Z3X-]O;L3(_R]HZ1MV&7H3VA<JXG1\*Q4FOZ;+Y%5YL-5HY=_7'_1+/NXW
MKK(M;%&03<95/7OL+533+# 0FU9@$>FRLOA@#LQI/& BA!W;?ZL@?=-H124]
M\-.3>:+J54/,ZUHYK-RBY]/LA"==WXU$LNPY]0V6W9*%C5IO/M9/A6173[[N
M1"_A)LV*9")-C2(2;Z-E;;E60"A1&C^;%3:23U$<I]7:-],KEYINH0FDVV%$
MBCJJ"3XT&N-.*^:>GQA,S*6 /!=\>?F8@S#-,0@?A,:OSQYVF3EZ'L2=$B+R
MGOAR&/U,786-E=XG\C NU1:#>J4^G$)\[(S"S7!LV?@TDV. /IHKDFZ5S/0=
MB ^P]U 7_!UE"YPO"2I-&<*8^5Z28>PN%FD7"W:2[U\D>EBAU#-U^3R_T#V@
M/8.+D:HB<NO,:^6NB/8V',GQ;_MK3M&O8R<W=.*5B5#UAGJ9V?:G9FKZLM-J
MJH2M-_0U(:4YUPFFWW*J,[#) _([+;Y)9&+71K#<L#D<@.T#^]"L%I<(+KZ,
MVLR'WBX6;)],#1"R.MX*/Z-6KLN"G,=TRPFF.-P_FS'.O; ,_=:7Y)MI%*-A
MGFMO96E%+HMC;QXGEA[")/_Q9]W@2$H6JX.%C1L,P- 1<\)J S[JNIF:S$:O
M&1V8D5)QZCVA/R N50-WCRS/]6(@ Q "=?"W8Z>U27+[(>)T*X4SO625'W?U
MOFY4/MS<NJHT[(Z'_86.C"$A1&*8 @@2+]18V@&!:'=U77*_K^H4IIXO[2ZS
MF0C0QGTBFU7]Y,$!>+GRFU'=P5)T!FU-J\K[;I79)=>>,&#-H**ZBJI)='<\
M8N?\<"EV44'J4RF3V>"X0=J!UY>A*PFY<<.(Z_"6FC<N'$O ;5!4@WI-J)!R
MSI5@6XWVE[%6<M+@@+EN@FSKWKK+LQ+6*[OCZ%N-.*7RNJ.)^;G9A1WVK*XF
MA+EH4DYL0,<O86!9=2.'YZ#! @:@';.^HWR\C))Q6')^2=UQ(7=X@U%S?ZTM
MT@/OE3A<4#8QZRX=FP47BZZ.-0M$"%N76"W#@.FOHQ"+NY>UHG5'"Z'F>'=W
M.S:/:"[;G4K*(E/@VK-_:*:O[\!@32+/@CSQ:K!CTFION+>/G6\&0:$M1WN'
M_.1F DMWIO,XMP^$[?W6?;GL;K=92#GS@UK=59[EBI;*QDN<PHOGBR8A[#7.
MO,YD%'ZXGB?,4S'+U3'VN\^;W')W3W$A*X;VK\5N7]6*"9>"F5PUQZQ:Y0UN
M=BR$Y!)D08(0/>3ZJYQE01=SHQ_1)_L*.$6?687BSZ[%X1JCY4Y]X@Y<<B4Q
M,'K&O,\F*SUO.V";_*$G N$5O3]5IR??RO?8H=>E8_N215^^?/]>NR2)+1MZ
MC: + \*X^(R/]L^J<S_5B].]0$((&+N9&/^B*76L<8>>G=>K'E/6>877+O+B
M:-./573YZ1$T V+E.S(OP2$G(#VMSR%!Z0EJ0:+4T#$YYFU-^)AG@YI1?5Q+
M7-$YW)?R6H39 #2\5%D1N8]!.>;$(B5V05:@'1N:M4L, \S&*W=U:NV\8]J+
MT<;H0FAW!GFCUR&N\F_"BJ@@B#QQ*O5A05:K->J40N7&]V(&Q\5&;?54FQ<!
M=41]/80<LL/=(]T25",,M!'BF_SIN\OC[IZ5)ZZ*ZN-G.I_"WODR1U]T'#>S
M]]0BI+S62+JC'872ZEPMJGIJ':95S3[6YYXE44_R5O56( WSBYK=8=(GYTA(
M2K0B+,-EMPT!<7JTZ:,="Y>$/1ZO8OZF<2NRHZ+_*)<M$=T;NCED"*W3-/,9
M$]KX'M"H"*H]+KA[:6'R8]K"B78L(-NQFMK..]9PW?K^IU4_[RJ:F>5%[S9_
M^Y_#I07UWV1E,V^-W<>UL=D^CK5Y5DS3&^PBN"+-ISR7/+%9<[J=T!6TD:@Q
MW&A83/_F6<3X;%YE]7ND\) V%LZ>]U,9OV4)Z!(M^A]^4%P%STM()0R)$VMX
MR0^<?SZXU& !GN@AH*.BW\Y&R@+G(A.)*QA.C$*"N:",MDW+=_/0WD#*GLBX
M$BJWC<K\XJSL&<L;J\X43_2$R64>F8]14>>4D;FI>'PUQSQ-C\J':93JJB>S
M)T2Z7+@[&I];-==PXOB(2&$#+4)A*>(Z,WCA_5"\46Y6A<$;<&+M'']I6:S)
M7)A23"E57:>8Z&@)#&C%2H.8)K(Q+<78/@_OJ8O9I[;52[OK/QA<C"M18+91
M&-OG^B:PT-J)XCLYCRA)?J;$B/3U"&<&KB1:Y9PH':2B=SE>@%;,Y[PVJ/.;
M":ZF#'6;_)I6+SL,+BAB8,"K-KW_)#R^I89+)P2>2/%KY4IWO-[8$,16*VJ_
MD\)[/*BX$;0!'FTSR"O!N*TG.A1&-D^_N?>7=[O0O_7%*B/=')Z,DN_(6K])
MFC!.4^>(G82DU4G"PRBXYAZ)&^_V3+0S<M\9'K--TV" 5^#5Z(4]\RY7 Q1[
M-+UB>2):+K=H8?2 .$X0N\P;%U41(CN<9V<W-TI$IZS/ F<EDO[_L[<>%K(=
MCUTP=?.C"9W@,_[+%Z97IWH-1W#ZOYK<"=;Q" VMM5)?V3-E1"I%F8UJ)CL4
MH]99\DAA[IK1ZRD_6D^J3SE$YK&5,2-H5-BTWF!*Y2"T!UI(#_4/3NB5*Z,%
MTAG[."D!85 )ZQ$DA)L&_RH$G7Y<B)?0_<.I#HBUX5GMN S]!OV@,AZV@H(,
MWTI#).E SNR5G%*<ZMC:.,OD"_U1^N=CE.'YP#D?M!*A".QFY0DDCZY0!(&:
MHTEP<XZ)!GXYQ0(G'4EFYS@L#^C?RC14E$UR4W341J-6?-*9P<E'-I31ZS)?
M#W2O2YW=G80!#T.N?*&#)PX9[,%%;]E1#/CMT>G7-KR%4<O/P0,B##41!QL3
ME++%Q!:$^)Q3J%7,'Z_\5B"86R3DNNYKU;L.3]JMB5)/25_AT2]1LO(U"$:I
M"!VO"WY=BS"?E/FFST.F_N:3=%F.NLKN#<KW) X<#86 Z4]<QH-!#3*KE&>%
MLY%!4.QJ>M"*U8NH<6G;8LB3@<># 1MXE<TC;N4=21^.>29IPDU<W_%#RHUJ
M$PXV5D .,5R)90%TD;)K=W+'@6TS-H$'AUSQ9N//C937"YU'"]WH$>IZK9".
M;S2XCX968FN*+3@U9UWU/:5.)@*T,489OVA&\Y((46YFNZO\R! N#UD5&@J:
M\;ZVNA/-Z(1L9D;K=8NRAMZ,\OI5-;0T:!U/YN_.L]!%#(C$ S50X=>O0*LI
M."G!)1DX*FPUGE]UWK?,;@329^\9N=244+D6K])-_G!3]-?&O .9\O*Z))B+
MN%8[]_6N!\T8#\K&#+K# (&S7"]"5WT+Y!KM5^R,V]B<(#C#YCF 8&L(L>,G
M5@G+9[VTU4@.-.#)]I7 R:>([U*3:+W722VF6)'*R;$@%^+<O2E4OWPH4X!,
MT*E#*Q#;3)F$"Z^"?(H&2^@!*JH?.O4HG.EW:% =8RUU^GAF23AD0MJ+7>G5
MK!HRM8BF-3XI(IO1T4#3'8DD;[N<9@U;*_SN9RH$0B%!(M0UE;Y]8N BKZU4
MDT#YC]UNF\_GF)R@C]%S0FVH7 ,3"PH,L*=Y[\JK.@:FJ4\(RO"&:8JLKN3:
M>+SPCR:R0XWENA"_C98B9+ZSUX0^K=XU[Y!D+(H*RUP[&#22/R()K,S3/]QC
M4&JRE9C?P;L(3H$BWXOX(<:TN#^-R] QP.&5]>WK;_PJ^"K5&HL.A=(9*75;
MCV6T$+^QL+@W@_XQL=$94HSF E7=(M6XO(W+0XKX=6JGBD[,RH]AQ( C743E
M?J[N7'K(LZ#.!@O1Y6=C0?Y!Q)=(@H%"73K<H4[4A3-S)$H_9QKQ,Z-\IR2U
M_(@V*7!%#E]?%N6#-*WFF$DZ7&(O?E T::VCC\[*1/GB]3LGHUBI:F#1M?:0
MZI;2QO)U//A)5T<5/O]]/[_/BJF/9G[N1WKAV!NOQ044'&C/@$ "_@.@9PFS
M>V0]O*3*N_S9TTMO"NC7+NWB%CHSVD^IT80/%)<$)I^&.D?F6C)?Z-0V[J9P
M\,2.RHR7Q/KE*:'1CKJ0ES5($K[!#TPK7,2%XUM%%F0JT^ &**+[/2%."4GH
MU\23$K;CP, J>4ZMB:JST1R=9\^)0<6/CK%+;<C4L$?RCR-?)Z.X\Z1X)1CX
M%3N1$20+*CL),IT_TOOI<ZT19:E![G1^/75PQVSE?'&L8[!+-F%J'#D(F2^T
M^!;6\K(,V:@T%<^3ZJ]J\&_.W)C_.YDHV+.'U]@6!H=_Z-(!"W7K+**1^O*Z
M:N_7;YU9_%N/5"-R=J5GN15OD"/O, R.BBC=HFLV-^RETG/X3QD*]A8EI\E5
MU6W^_86,_?J<>T1I*'+)E<J%3=^A5(I6H!D,\.Z["V?Z[2]UP"H\SL':KWZN
M(?8E+=V8EA_^F@?CYWA0_%\.('K?2RO&B\*KSC-)E!Y@1+BVY='EH(5D_7JQ
M/HRJ5A+@B$6165<YPK7K$01=*]-.+[]8\HG2KE33DU;RDQO+^5%W*O15PP%]
M]7G73\:U%$,QXH(O-M?,!)"?.##@S'T"+IY=8VF(MN0*Q*VX*ZU8HM WF^W*
M>D\$';=5*5)"__K>,)J:OO QI)G<+)B[B$TY[DWLZ':(=G<!R5=LD\B!\;=A
M*44>. Y>=$=5U0U.R"<4':['T&RK@I;=L CI(B.]<:7OP@/FN?PS'F0WTKY"
M&!G;DZ79<9FR(YT%FW,2%#U/T1;>2=F[3\X]<'7O0YP1)"T;ZPF6AOHR[2<G
M6H#!A,JSQ01B_=Z<-'D'EC/I)?-*(KX?"[CK#1B@YA29R4/P<$I'HC9^=AO.
ML4+&"IW"#BY;B7ZX7BOT=LV(:/!.Z(3E U_UC$*X#0:+O@3!ST(Y?"QJD)"&
ME0O2W*S0,_:/-<<?U>])";1^4(Z*EIVM^SQ/-J^;*2)_SL]_FVIV7/A-8##]
M\NS$8--!4D 6;VX*KNK;B#^$R]J<U]@U-\W[<$#@P@93.5,[=IXWWG:A@M]F
M+,L@O>H"_U;[9L=L/V=,41Y7BBZU)"(^>J5?AE5-#;D/6M%/!YB55#E-:$K2
MS :?C(EH\L\(;!1.O DS\E)[9_9,=FYP&:X10JT+T\>$"N(QNP_))"GJ$"49
M?+;U4(BL&.J>596A)!WI:F=6#_T@OBV*&=I\,R+)_G?S.?[5_HG#).GE-2TN
M_(BTJ*PDCM)NN@$O'*7(Y4O_MY4!HSC4I$7I]22^I'TH%F+-+)RG",D(JS.5
M0G_*5V/*SG&R,\N>T]76 GG8D9L*FL\]BVK KD':L9PWVXUUJ8\(=C'+64S$
MRLMX1C4<Z18J+$-&N<JWX<W7-Q0<\W-;0Y'G"]Y%>'5N@G%4E^VH^/<8M[>[
M9.^(W,/CD=_5)^(]T)3/T%Q<V"%_3P..['\9][:S[3[@;5:@0FN98R3:KC9-
MP/[9=U&]RJK8&</'(-R4$]D7$AAJF4]Z&)R7>NU1=,N.4'UP?7(LM"-2K/)#
MB6RC%\0B[/?KNDE7Z<^HQQ%H?!D"-B /!Y#+^A[NJA!%\V 7"GUU)YBL[UT3
M0C$!Y] \F)[6Z;"QPJUXW(4M2Z3D]B()$- P^ _'_!_:_W">S:1JTPGW#&0J
M;/&&4JW@+TU0>D4N"<HTDC$$<D]$0!?D\JS)E.,1YI]%N2%3<S +BA_]"%TV
M".Z<?55._&DH@RN:,2K% >,STNG#F>^H_U$*)/>4_:H#6_UYM@2ZCW.@,Y4?
M]1=6PL(2N_F9%GBD(<";CADXY04UW)^^49:DC_YI55,+[VG[_T*BY/^+>/*_
MF-E80K/+FX#FRTTEU>([+T5 YZS7@E6?O4==.Y_26J]=XFD$SM,<,/% 5 0+
M$,8RD&'GE*7B"HH=H]S[745WWBWN[&;J=V%S2 )N:]+A.BA*@'.LT&J6B@C=
MUZM][L@KJ4;I"\DQ\O&4O8WYQMZB,>$7>-RS%N1/OZ7.<%?'6Y:^.C"&?*T0
MI"[L!]$?"21/I(E1EMPQ8," EXO!D"/-Q56EN;M7%14$%-^PVI4QC#4S%K-+
MY_9'I.N*6\L:)3.KBZ@3JUV7B1,^DKS7]5P*/(AT2  &8<#'9=$MG6,V*!;%
MG?EO3^#\=&]^@RN%AU#_I@<P8*FLJ;/@YYU,Z03+:F/IB)"X _BILQQQ4H<.
MLI]?<CO!E8:Q JJ\PP^488,V$;SR4?KZD.U4CA2!1_Y6HYS'9_.1K=[,<(5J
MFW+&>A4' U#"H5R07Y^X)^";P?PJ\NU,J,7JJV.,[YH?!] N'&P(8KQ_#KWV
M%<4L@P$8K9#AFA6#.V+>JXD@QZ>*02[ZM+>JDD_&C"IN^6@$OGRJ/LSA*P[Y
M<[?3ZJ\"S4P0DG?%CPG94=6>WX 18A^I.AW(T(0[$T6M>#XY+\*4H_]&^]3\
M"0=?-R*_BL2U/]UQ*O;0;[5$_O94_TD<\/OD3B#WYUE0VX/2_;3$H)O>2GY4
MJYEE;LR^W?^R/HDCV=UOLH%I4X@B/1RS3]EOOW2>(ES*H[_C#E%JCO V!/"#
M/OP( ])LVINN6&R.,WY[*LX/ =9H5JB27)2U?_BM/*F-UUH-VBZJF["K]4GV
ML]_<8?K=X<H2QS:[E>\,;T@(<BMKZH):O4ZOD_71;]Z+?GNOA,;\VT".:QC@
M%[%8/6EH&/X@B=+(J \R'OO*Q+@#&I+=W:7H2'#?I28:/XMQ(JI8U!'"H,_Q
M9V%/<0?Z0[M*Y1_(D00VRAS7!ZB3@]_Z#9_G_#ZA35EBK(ZA@H9,<FNM420*
M8:H(4==J]< Z9)E/\8;X3@X&^';"%4R)U3%UZX5<T+ZC(G[_Q:C;FWR+_M<V
MWL[)KGRT4.YI#>'E(HQ*3XEV$APGPE7E<>TM)ERC7J9]$1C "JC_MF(MH3$K
MDA,E.*4CYZ&O'T$X3@;2%=@[%;W<U><)@?\BORZR[#E:O/-Y^"_G'?I5N7_<
M)R,QZQVC9/L@XSE0M9_,@=;%;< $T5HZ*!$3U"$8(JU%%@E?LLNR9BUY.(*M
MK(T>O+KJ%+_8\RS ZW"7RG#)-7?_$8>M02*@UAY]GZ#UH8RI49ZL[>U2>#,4
MM8+%BPK2\2Q]6\-]H\B")P6+N3K.=9@EK,O!C$I,F%.,7/]/.69K4/(K-Y3Y
MJ2"B1M!*T(=PY1545N7Q;F1EJH&N_KE5$6]W]<L[9BR;&PHA QC@%PAG/\!!
M;C$)E,B_YAXGF0T&M+3! /]WKC'-3=.@K$0#(M?2Q")9+"U>RT';B)_OW6G<
M@7-M9G_X.X96<#0T@R/\D2T,6);^IVJU:>Y2TU.==RWH\-NK_WQ1MC^19(+O
MS;GCN84T8?XW[],<%;(V;;T_AD!Q:>X8D>K3&TO:J5&@_;4C#Q8[]%F8/7*S
M"F>KS/@D*,/LMNPS$F;^IE=B5!-$K7!T*:V&;YJ*#AAPQ0<YROA3,X"+JD8L
MO&LI,Y,:,;I7!1UI:>//B^*L"U?7(M0E]Z< !QW1/_>DUN!*G7CQC,<5+B70
M\*!$X857^)J6]3B5(DS'%A'0\]2OW[1Z,!]%=?(M'4C>FR.-;_WGWOU-G<LV
MB)#WYN].#N'.:LD/]&OJ:37/Q BPD4)W0H!S@7]N%DJ8)SY@7; 1F!/CPUT+
MH+@V!05/)'UZ\-3.;_83,_COC 46O&#K+#1@B 2.&LOPT8O\K5^$"/._WZQI
M+>*9U*8TUX/G%85.$1Y75M29O9=I)F:(MD4Q_X4G52(4_2G?\>\9ZF]42$OE
M3_\3YM_^5G4SA8AK2 0'#FS[),9M^3./9S,_2O9GL/0*)-EB;.L'2NM7_H5G
M^:\^.RNP0=]1V;6@3[#ON-U:82$7C_(GI3VQ%:5V+798?ME\HY[CB37=RE9\
M=YRC56U4II+*9->Y@JI#:3R5BH^GG" &; &I*']L\]ZR+/AP+(Q9<[D^ 9?9
M.5%G$ 2\^J*9<[/I?#MBFZ9QL+8.GC!/]\8\C0S#*QA8!A=0"#+7C,V,6E@?
ML,;;8Y9T?WR .^KV#H%/UZ5$.MV;0XB9>6"9]=&:KPSE=#NVO9%MJ\\@1I$[
M7 T?XAM!"09>DST-H]!"<'W,(5/WIC=W/6@'S7WY!Q$ZJ^D$USU[>L,HZW(U
MOB66<?4A\V?!J%+4DT;*9/%W>-S;JG\93+20G9<W>*$50USO-LYV)GT'9W2L
MVF>^'IU(,ZAAG#[T"]ND7=.H^F,XN^[D\"/19152K%P\Z(.MS"Z"7OGRF[SU
MN:9\^P""N<>X*T8V@QMLMCR .213*E\]6?91]URDT+.G1U1[!$Z0 HY#IA5Z
MH_D)RK!(%H4<#2"RQ_ 5V+/NZBNI&8 ;19,P3,<($II\8LWKN1OA1E<J,K'W
M+^FOB']SJE\9*:'U TX$H\QD84")3-,9@ACV;XA;P- &.4%6O-GGA8:[3_X+
MQTMKJ _I[/6H&_SY-CS+82N? R+^1I4DMLQ <TY; 2/$=88!J;ZTY1X'</ B
M/ Z]"M@NLJX\+.V_L-TAWF%X<!U[LFG!AP3&MN??X>>>F'JVK(@&6MZMKF\8
MESP;F9;(T2EO?CQM0RSKUS/7)92,AN2CIP<0]<.WT^YRP3>.Q5N>C>V2XG3O
M[HSW2H&V\69=NLDD>1?%"65"BLNG*\R"S';VM+?<=R2)(=;SZ[56WZ4X(RH1
M:N#>(VMP5!)7O/[4.$1.K!E#D>3S+4/(^*S8I4W_6=VDDYZ$[#A7F:&G"24G
MB-(%T02+EI[Y!1(N>_?-VR@]E#67!S^'J#+[4/HZ^P@+$UO9*=FICMPZ'/31
MCK(N/^X=L!8?[MM\V#S57V9-X,_^%%.W]FZ_]JP+B305M_R/1 "=CF36NJ..
MCGAH-R^/@TQ4(PPP5Q6<;RVTR\9P6:OF(T5+V '''IOYE]R]+C*O'ZD>>_Z8
M0$\[T<3>=K:F<QJ%IEI!.G7 "9,G%ZFTBPNHG'(*)YOW_=<D_['\Y*)L';"V
M_&2BVX9GP@8GI2\O8X>B<E1W*K8-NFLK#4FXNIR'M"\6<U-%YX%;O',!6B<J
M LXG878]5GOHPR-+5_5+S6_<% U5XPQ::F9?4OH07BY%*VRL'MIUHEGN, +%
MO.WZ N1LH2QG]#65K%P@YCF]N4K&Q)1WN8](K?F$92.23O6^V"\P'%7!@&"J
M?85*PY$#Y0<[_;/,[#.W%11K1 P 9<!%2RIN]A]'3T,$8&<HQ='Y19ECX=',
M*V.F[YIG@"<(,<]5NCVP_4:WQ@JGD96P\W&IKEM!,UI]'EKR1SSE3^(%7O3#
MJ<=L@6R5X#C7E8:@3CV!O!WT&WP<M:.AP)P1 ^6&'S]TYB64XTUJ8_D^9%XK
M*[_,5N!33G9[ZLV[]8?@X88!#\'DHD&.\P(XU*,'K"^7))"P1LN7GF]3YL2*
MJ9'US&_OZND9@=+(/IBA-CUI-O;MV']7\^Q2*XE3Q&&.D;3+<AJN;QKEBDH"
MA00]"JHJXQY/\+HI)Q&OX7[W'@3M(7 7:%$S#'<%"PFZ9";F5-^*&2RD#KYH
M*95VXFNA:GGL37N4$C04[#@;&E@E0U]=YV%VDOWPU;K=J=023M^0+JXX57['
MKTBO]H%AN?IH/GQ.1;>+*TZ#U7X76>0U^P-@EMQX7Y]S_ 14H/$_KX3_[H%(
M?VY6O&_N#JB9L*/6/^J;:5C^_0KI6PWVXQ>KRRE!3;N=BNNZ<;X_*(9P5@TL
MG;6%L^.=LN\3Y'"$LTSJYRL/XB!DI/N[8M19%WU&HRO4HK.$5YLA*A_JE(^G
MP$@A1P7"G,U0BN%&LWS+FR>-Q]J[;Z9U.@8U#3%?\2^9)5VL3:D=!;X^.O](
M[M^9DFM10UZUK56\?W8M(6D9+TBG'-/<LUF7BB>OH4&FCHW0TC+$E3CE-=#F
MQ5DCM#K9"&YSCRV,J[<.S[9\V<'-:J1YNG:B+G4_:ZV+NN66^^CXHG[F)3B=
M0BY<7(A7:#UVSKA>#_W2V*$2H3:7KSL5SSJ]T7FQR^NQWM-ET_&],(8WE970
M\3>4Z9/\&L_[E= '^5JV>,,GN >K(*+!'YZ*+K^0"^5I^.$+6@HW"G$@_Y!6
MSE-!N?]_=NKCO/!9#%^7E$YD7LP6?&'E"9-7'V.ECT7-!,UNO;T?OO&"[M)+
MZGO-YZ?UJ&Q66>KBM9R+0=Z0>?)MD=?],C^VO?:Y:JJRM]^OFE?H<J!9V]4(
MD_[=!:H[N9R^O#*R_,KPK4M+.G+?Q726)\EG>N/E9DJN7(&^ ).1'[V0CW)'
M:X<O8*M V<E]=3+J\5HX&Q$1P":8[_Y6G=R\],V[]V3O7K*EC=N5Y[TRDP/#
MQ+^7HZ\>_^/T8>_Q;ITMT1J+^5FLMIB+)Y\UG,C5QA/25_R9;\X%EL :MZ9:
MHV_/Y/E?YY<G6QTM7_YWKLN'=T$'3]SMW2%;'*J[3^/O9F]?K]L'_ZE,.^?R
M62RUR7:IX=R;]R_MDC4^%!7>OB7[M:[8Y9/F7D=O/DFOE%G'F);DN8X[\,/V
MGO;&/<8/5^?:W7MVZAZKU!JF+TZ7W]JX[F=_8OOQ^E*&LEWNO6^VUK/$5*RS
MMCZ1D]@56;-S J=L,LNDQ1:6!X^;+LU^Y*OV[-*ELOW;&M<MZ@MIRYP:4]F]
MTU'RE6N*[;R-JVNLKWPYW2MWW6?OM'/9T=4>>2P35VB$VB4P,,])EDG:<?I^
MVZ^M]R:O=U>=NF1ZN)5NZ]+%UBNU=;S;#_Z3<WB^3X/Y<G#T%LYJU2L3HYPS
M[2=].FN3Z'G \D3^]/5N![^M?'[5Y'=$XJQ'_ZY)+%-P^>2S:IV_[Y)Y]5P?
MGWSX^[V+;^&*S.AUB=L^JFQG%0KDOQ7^YJ5D2EG0SK#S@<UG,UT?\,9[;;L4
M:=+-&ZMTZ?FF28>>/7^RO3+E_L[(Z5./GRI@/.[%\.Y=3?)BY^(5D0?+1<]^
MFR=P)UIEQ9K=?>PZ3A_OS[-XY[ V[4I.T,^<J$]W\V[D1?"L?B;X2MQRO>ZU
M&N9U?O-4MF^]G".1->T:DV3R#*UC'T3OS4C<S<[2/.^PS=75YYFS@UZ;7U2=
M.WOIO>UR*V:=]NU<T.LU7T?/>(+(BH/'I+<R5.E([9M=7*#[]BNW9[K"1)%B
M;7-V]H;B@ZNG/KUEWE"J:_?X\'6W<]>L9_NF?7KW*B3U3N+DBKCJ#Z>/;ZWJ
MQ3Q&!>6$@&M;4RAL T=$]2U,75XQ[Y3WZ]W5$;?.I8;-"W7P^[&#919HY,,>
MV,Q_8;FL_D%,_6,'J2UAX7]4_LD#"]]G,_\S-!;^9^B5_S#Y1_V_YEGI_UB/
M_S-A7.V:6G_(']BJ_\67.?^'N/R/BX/8D"!7F8LF08M.2O. QK3O!#=P+6!@
M8&;@NSH=3:D[NET,L9,.G8NX9ZFK4%+^63;*P-G\>\>[VI>Z6WYKJZ5MW;R]
M8<-AB47<\]>Q!O]G:)D/[/E\D;EL_T'/_N/B?T+U_/\9+A3[_&<XL.,_P[$&
M_;5S5UGMBG9:LW1FA *+V.\CU?/^;9V>^[#7[OJ1X.S,9[/;M_W6<O$0=)4K
M%^AB..:O;KFR_J$ZL"3]RVYR_@]W/WCX#-F*!=PGDS-E5T<M7<.==_.,MP1'
M\?6^*6W'+AP5<;O&+.,B<>&804N)0MFJ>)3P0@VK"ZS'+[]9TF0A=^[NPIZG
MRH9,JVH=CHM\W[)MPHF4[9UG5HDYG>#[8,7\2JN=0"RL !TZRMS JCN$D@7Z
MD,VR^<(O)/XS3( ;:7VX19XGTT6F.5V,XS]# <80SK,2VWJW+9=MNN?&'9*<
M5-E\7/64MN;G^";.1UO0HHXYK.L4P11BFK%F_0_//_;_&1S/&O]G8'H,VJ<\
M:@["G*J219OVX\\3O%':VN@:^]$M9[@Z!,U!F6W.1$U?69.S;N4M?I2KJ5/*
M[;W,9<ZF@T8[ UN?-&0P+\*W?06*F?_?! !02P,$%     @ F$004SG_#<TL
M20  Z%<  !8   !G,V1Y8VMR,W5D=&@P,# P-#$N:G!GS+L%4%W;LBX\8:$)
MFN">X"[!78*%H GNP2$X! LL)+A[@KN[NSLA:'!W=Y>U'ME'[MFY?]U][_EO
MO7J+&E5S,&?+UZ.[1_<4Z#1T&<!X(R$M <# P !ZCW\ = X0 Y 0$! 1X)$0
M$1&1D9&>H&"AHCQ]BH+_[#DZ%C$!*0DQ 1$1&043-=E+!G(B(AHN6@865G9V
M=E)J'@%N-GZF5^QLOYC (",CHSQ%P4-%Q6-[0?2"[7_\@[8!F$C "6P4".8E
M (L) \*$@78!I    P_SQP_X^P\&%@0'CX"(A/SDZ>,%U1@ + P(! L'@H>'
M@WL\Z_YX'H##A'_V@E4$X;FB/N)+6RPVK\AT)'+1\G9LI=%CBE<?[+R1G^#@
MXN$34%)1T]#2L7-P<G'S\(J]%I>0E))^\^Z]LHJJFKJ&@:&1L8FIF;F]@^,G
M)V<75Y\OOG[^ 8%!4=$QL7'Q7[\E9&1F9>?DYN475%165=?4UM4W='1V=??T
M]O4/C(U/_)R<FIZ975E=6]_8W-K>V3TY/3N_N+RZOKG]A0L& ,'\X_?_B0OS
M$1<L'!P(#O$7+AA8IU\78,+!OV!%>":BB*AO^_PEFQ<2EFAD>GD[,ODKI6/L
M#W:C3W HV%<H3WY!^P/9?P^8][^%[)_ _@/7+( "@GE</! F( 1<W=)D>#[Y
MRU%T8-<QIS!F$K;+MALT1H.BBH*U?.R^#9((.@F6)0[W:F(MR5))"!++=<^!
M G(M#89WTG1%E$IV_-UTMG4&F_QA=Y]F6XI=U@K=BD'R?FI6_!QFW+433(N@
M9U45D:.DC".DN>^$2;Z)?][*-*_E'>X<1C.#N3 [9"PZ//H^^>ELGE?KYI2R
MY,'SODG*QOE&<NU 0RAP?9*]& TR)=-0YZ/D91CEG, 2U^45<?>5!$UR /T-
ML)U72A6U4F6!'D0Z4SO./KE=T4G_PRCBN7G1=V2*XZX4;N+RH'H#?0/K50&#
M-V,KM8FRT5)5=9P56A6B5XP4=?.=_'4*:LN'O3QIZ+(9==:^Z^+9>SAXIXO#
MRM\(D)8^X]P\Z>#6S!=&VD6D.$: MVTA.9$,8.1'#B9L-)1]U6EK[I+RG'Y@
M(V<@NL[FM4%*%<R!@^K7/9)74^>O\AF[%Y-ZZ-UY-RB=GT@BI=@3^MW4*R#8
MR9F['>'NQ6%:3)9KS2QJJ>FHB:,N1:BP,1$K1WH:G-'P+)\;I:%+9C2-W75[
MO!@O=IP+Y""DS1HI(:NQT#>K/@IF^"A%V*^T:#P!XB_E&28@\ ^NYA-ZIG7M
MKD+=XK:M,<%@" 72V3\>]J9(L;ZIOZ#M!IP<%O9:C5=:\>=2;/=TM/77CIX-
MKA2&8TAGLU9"^A.NV5,4Q&, Q7>&(?M?&:/:Y0?GN D$"=QZKU-=K:OIM44-
MTF93.6>9&5 &7[03)M93."R73GBZ8F.O)%0_0 '_<R%L<TL7NUN/0MN"F7*F
MWOU:6H86,=KA@2(8.:$ ZOR2MNO*KN?7<8>=LN.&<4\)&]U,H( 2.<T@(5\C
MNU=[9W+Z^_ 8Q_XVQ/0Q0Q-\_!Y;G7>K1YA[D=?V79-.3N'Z^>*6'$-IM2+E
M!V/"!2<#Q1'3AJA)1%L@;*<N@@M(^.K3RTI-9.O,RG$#7&M$YBWMIH^$B(=>
M??C+T<(DL>(NV<,ACH6H5FOB]0U^$L'*,N\<L6N'-SB^I7Y9"/$#3,9K+'*#
ME2<86DA;BHNUQ"S<B!/EV5LDSK\LIRBJ'?82(6Q->O*^H1]\>5(;2'$B/:(Z
M&%!]T43+L=!@?9KMYT3]T0YS$D.5@H@3Z4@U_<2JFB,LU7B*LUQ'OG1^1TFG
M2HA&ZFVNS=LU>Z2VO9"4Y#S0R,^?9^4^>LO+6XACR3KJ6;*\G\E/NC9W*.K4
M+YSNQ.MHBF8BCN3D$%R(DEP3_%5Q59:>,.7BS#I6CS=[HII\/G7Q',9X6,-2
MJN]'!"X$3$&3IJ4L+;X4DU4"U"K>/7-O&\(.UJNKFDQJZNL5O+G7(PJB3W'Y
MI-I[Q8*V^>&=/LY:E<)I:!%H3)NC?SR>6Z@Z]BZ7L/M2<*#%<B,,(DO)&D'4
M%7<>]N=7D PIKM[T?Z]V<6.E;\T[:>@5\WG2E[AG[*UM"FY^Q$DO@6M+?;&Y
M$*+UQ=%!'GE=_7CWK*0926\MW)9YV<>3B*>.?8)U $EV9-+CFG;CXX/(J=-*
M>2<O!A<(NPB*Y^F-7NW<6L9V#PU'GO7#I(BP] G TNKQ$5T,";V=*G$<)E27
MTJ^Z8^_/"Q5<[OSVC#L![PIA^$6BFUMH%<RVPQ=?? J8(QVQS.OQ=\?#?@R.
MQ"KGNFKSTGEM7+2OGL8DB#TQC(YH)Q8^./72]@]B8CKXC&IXF\09KQIN;T \
MT*0>[B9/4*X\C$<1.0SW!-C;+N6K/-%ING*U_'ZFP9$\%<#$'FT5@3&',51]
M976WU$!<_O9DC)A>1Y"JOJ;VY_F<IO.8#+EMQ>KH5>IB&R^.WC4YG8>BMZL"
M8N:HCH5+@8[Z\ F;#/ZT;E<D1\86 ^&^J<1/@;,?K).I#!J"_L=G"I--7':Y
M[R#=<?IV\93K7_>5C&RD%]M\;P+Z=GILA4G"Q9V;#\O1@G,6KNU0*5\V3:Q4
MJ-:-+6K64TG+!#[%2)\5#^+1='HW-=N0"M*:,_? _<E.^,WZ8'7<:G':!6)4
MM;H0X%R9Q'L?@DL-M\:SQ0ZS-*KEW['S90F5'8?-)8Q1U64A.L7U;BKIVDUI
MPM_GF=FB\D3Q9Q[*'O_JP4!""Y<*O8M8.006FRR#(P+@2H-^,*%79NRP"=ME
MY9-D2VMSH%5VV,JWDH.F^#.2=S_N;42L_(GIY;M;**<<'B2[,'=J<2(ZLTW[
M\V$8ZR.SW,<V[.OTI4+<1A!=I12CA$G.JS=FIP(X#*/.Y'XBI+KC+#!M8,U&
MY!DW3'?"AWTZ@)?>XL@F#;Y@/SYL7>6AKG*HL)CP?XNYXA_Q/=/^L)_:>*U7
MXK(?.-HN>=?!6].8KZ55DFO$\"D#+\O;K"G6R;[1^2E6&.=QUC/[_KV0*55A
M>"S%_YU!3M<0J_<DTAMI.4B#!L0&1C-U4M!HM\TT.^TT":^4N.Q3(7*81KH!
M/VE@9(S;7RAN$MW(Q,3W1MV H6 ZK(.+#DM*2 @"\O6SS68UL,;W&2TQ/+,M
M5]1Z$&P$%;CQA;[E6UHR%J6?6C*NU@;;<_9%O-P(I%AVHHAR'Y(5!XS4G4V$
MQZU2=CO%QBVM*)1*&7 B,\L$1,@,?600_:H(+3DM>5%QY8)Z/BTP5FAD]+ZX
M, (AIMT7*@4!I4;Z)CFSE,6A19PU.QWB</K8'IZV"I+I.YB:S4VNRD%B%+ S
M:YH.3T915ME8O5M??6[F$:SV" )Z)IM>Y>ZIY-"^E-)J0C$.XD!3P8<+^+(6
MV\</KK)521\Y3W1[98(6;T2<'_-67\8128M%;\[V,:%N33QI%0<44R7&#AUI
M'/'/YWBLTZ" LMTQO33I79&$^-M)'&N/^ ,SF":I[](V!B0?TGGH"//P#U1H
MTE#VW!$EJQKK&FO&BO3KZ^%-$O@<5&-(T@/PR??DQ\\MF:5#J!)S9M7SX(5K
MO0R YU'<)$T_=VE@DQKD$@5B)I5V+J,TY XHROCIE"0,ZH.96*3YHUQ3S.()
M<"*=\D3 ]MDSLBZ(MXF!9"I10K*/JNAF>+YZ>;SICSCWN9A07KYV7?N@1N0R
M9(OO^J8R>FKB=GQ*=.P91ZA#(49 9$\!XSB,@>5HJ5S0O-?T*;UH$- ^^9G:
MH%!;<\$S[HI5?JNR"+/N6U,E'AO"NSI?;L2\7BU;%0=+V''Q$8,Q<D9;J_2K
MFQ7Y;\W!G,(PPA0I ( &=)N/"N/'I1"-[/.7EF_/NM=_\0OI-@\N"YTF!WGS
M]T*!EKF)\4-VQI>[ Q;TH4P#FNK9KV1 <_F2$<G= VOP@5L"]AI8"O .995A
MDS*&55Z6&W#2&"%PGT.(POQ?YHFLR*-IS,[/SFT3O.>\$GX:D%D9JJ2 )JR'
M0(B88Z$3! R$=_+"\7YL<-"@2B0.*6Z1,:P6#YW#ZU=@D0.V9HMF=C0^)>M?
M/B5\JFDA: _'4B!A/[4!(KHJC%& -V._H[5,KXGZL;#L%9D1F*%4'G.7+<&"
MU-;#^Z%0?.4!!^F(W%^J+(QO_B%?909(%7 *^3S3O[>G\5X!GJ;*G0DIQ&9G
M,K)GY.F'?%A/??PND_ &+M+X7.K)9(3XW-F'Q/U+SK*'N%?8K?%/2F/\\97;
M;D1FN4E\QHI'A?%4(9ACUB_"\ [TJX,/3G:?,S;1I7S.<X*])EKWE-ZUU<3%
MJ;F*=%%5$.=WB[U\X^6W\2)F^0H.%OT#O(PX\)Y )PE.3TW#BVAS _#U4)>S
M)UOSXTMDG-H4K";^$9BM8XZQB\MKE#15!BZHBX(W(X<"C@%]A><*" X):*&<
M!0U%#;(^N_3>M98?_?2]O/Q[7&TGXP9%1L]G#JG+QHJ*C>IYDI=K7YN!%\GL
M)RXNBI_0@#@[.V>I8FOO^"3+JJ8WQ>\$*J@FR>%"T+)LSU>SZT?/!X>K'@KE
MJE(/I/)M-]N*M^B2\CZ'?X65@]E):!0'E,8=W%])>*V,G>_)X"775FBTE=-S
MO8U(,UQ^HG8>RHE5)56U]UKFI6Q!$1T</AX?]XTSA6U8M5T0\*-\A-V2:=>B
M6$BZO*KNZZ:Z7NUKI]L(-G.7JCG"N.3<BIK8DA>G5&ROBXS"4R,K>'2_U?';
MN9O_Q(*1TZ:631X<RIWMVS!0&GX2)<JY3A06-!\NUI?3FVEFL_M\%].LQLS-
MIM&X3@U+FNS<N$=^334O[0GOI^!L4XC3I7&BB=$6YX['$&QOTVT23$*S.!:@
M^&\--FF# !!Y :S-4R+#$=!VSI'V'1?J]8_YLW -1P!+45'2'JY2!L5>XK1#
M.!:[W9#"T(JX@F?3DS(CB ;X?W64(*ZFA%N4SEQ;2[<H34YIC$FL2"-^I5['
MW'8IN4U/&9O=2;<(=LXVI7C692B\J.DI;#0LYBTAF9^&3C;.+YX_;>Y!T=J"
MS%F=[NRV/T7C?$;A)ZUMQ.\^)2FY-A'VLS7#W(.UKF8"#Y=U*.?;_J&CM*6'
M9O0(C%4O*X;(C9\$;]+)TE-"CL:X?0UA)F,1HFBDGBO%41E',L.3H_?%3:QI
MZI).Q"6!N:+Q02H;!M7BSVF'T8 ;?VJ?75/0D*.VO.($_ZO<3(N$ZN2'U !&
MQE+4 4V7R%<5I,T$-Q_3.%?VDC@EL<$J4XZ6G*0$TOI.3[0U='<BVFTL,WF>
M,=9]N 9Y.-6^:^/'] H[=[87TWY1Y3MZ?I)3WE^%T[_Q/&D]AS7)TW[O'6=X
M=L7;T)R9F.3(['>PJZ)?IS7#WAQHF>2,AL7 ;/&F!CH^P*YUS3K,UC=RGIH-
M6=I-GA1%,GYOI%!@P5B&?5^VUF)1<JS_<[VB.5ZYN;Y!S&'0U.HUK @2 +OX
MQBO*B<3.-NQ;6V6ILTZO=DTD'F/5J0Q<*;_B"S,4YF;L4T%'Q/(+]A:2XWD2
M4DM1M4TSJM8D>5:D\K07V,![14^6S(GH14_.[8P@@.9_.-::!%,H'FN_[-T*
MY] /;G/<)1KL9:(8#0ADAN?XA<$YUP&#+\$=\E>LP]/D6T*A,LOR-]0I!%"@
M3+D4$J0Q7A6YX4(B]=VJ75K43A*K;0 R<(+[@ (%;EZ07D_H&DY>(D*!+PW,
MC%]?UDYG=+)RM_'LI=!GE0HTET4=*;0>GV.B<PZ855N(_E!7GD8(:%@G<AE[
M*[S-7W0LG(4PL5.@,;BAY3PVB\]":!A7EM^^;2-??E\@Q7#1F'<_",:59#,A
MS*P(]/-(FT2KMD4K/Q[L;EC_:.AW^V.E>#"'LR?R(]Y:A+JZUU$C>8CJY]V]
MIT\=0P0%%3HWAEMH0,_OZ+MTSU]!@?4OX#7%AW#-4WXH<"V3>0K>RIW.F+O9
MS#I.O2R]=.R]S%V\<]P<NJL]N'O;Z'%U?#!7^Y#TJ>@$7U;]GCOHS=/*?)H/
M4BS1FP9"%TLA#G.];X!:>Y/BF=DA1_O5KB DQ:PHR?(0.AI\BJ1S0)$CI]H:
M*>%1=:R/ ^GK%8$B#*)Y_0+29##S$?3?)AP)A\16+BL9IB9/\?F%/EVQN-QE
MJ_.7WFPJX%TF#ZCRV_"&3-94.[EGS6%Y0TR^)YBPP5.XQ%L0KH5QT?;P?>H&
M3+5F]CY]JM36NBY_Z8UE1A&Y;_ D"$&:6@# ?@Q4T3;,U1!O-J&1QPV$8.MB
MX0WA$>BZW&@BV!QS>A=ST*@.1%!0IY7#AK"0Q76"@!@A;LJ4_?FVN[NLN:8V
MBO#K,[S<U,$E3*G^CH]\5T9M>JXA-N]'$+S&[L4CA%:H]Z" '"84"&6^5 UH
MW7YLION1H$!/;?BBA@;0]J]N,?H0N\I\BP\%3D6%3HIO:4"@?UT)R3^3;Z>A
MH.^78H)'AJ% U"_VI#,Z+Z% >BH4H/B%8BG#DT6HHDD<"H@)0:0D(>S$S%W"
MSZ$ \A\SCE8ICYU;!03T2]V <BA _K=+P$;.P1 _\'U$^+W%9P?2-__+&OPK
M^\>:]4_81]A;,0VA0+?\"!08?I2E>>Y3Z&X*0OR_)?]WV\.&^Q]NMAXOQKO9
MM>?650:I/PF!_>Z9A#:?0(>.# 7Z$M.AP+0@^@-.E0)"]_]6U_(O@P@*> FM
MISB;0-I56F]I+3X(7=^F0D#WA:1MJ:?R_(\6T2O4?<"J+K3 \)/^@/(=BP8^
M3/Z-Z5-VGR.N%;F<\*8)3PU:TS2XC+@@X,T_#LSN!J_'QDB;6A_W8TJL*@58
MQ<<:ZX\#)=(&CYA=B;O<'6$D7O1L1E#:K=+(?YS^XX!L=TEW1RXGK/@"$@-4
M*8T*(XLS8@$Q?S^ B5P1NGGN('2'V X%,B:#^*FAP$LK_T<]KX7.-4:%";$4
MQ8%_#&SLSK<U8]4-#-%P5.P&GD-A, +U^>9/^XSJ*E*03"Q<#$-CJ12C\<G]
M0!,*B/3+"VY:$X[NNC*3OB$5:@'!\H9X$E'<E.D\U)3.6TL)9S<01N<@4O2]
MTQL58\CLE='7TQ_C2&Q6%"91<,;-I.T>& W'OD5QX26R>9HD2CQDKV>[HKZK
MNWRP[Z>8Q&I%/-]QL7SCOBB^SG/:*^ABD%IPQ)V&2GT=:F $)V1>W9C87UV;
MJEA?&X)7S/\3WFE]:\G3AO;T7G+\PT^-[H\<R+!+8).;/8(;8[O&6)&%Z#J'
MM3T%G7O.H.TA%(WF+AS5FLO+V]"&KMP#>J0G6:P;R"!$;/T64HU$'YJ66,G+
M>=<V!1^8R$\!D*]'PD0+_MW$*J="Z N<_C;DK1:CC%523^L"C-X\FV[;XNDE
MF[R^3LT<=,K5G-58TFH^J'(BDPC^.CIGVL?P%$.D3VL-*T&^,WN<:ES&?&P8
M)VD*;"SVI 3'=B ZQ<9^2*'A6M;:,<?,U7[WE- "3XDY808?HLK8P+5'2+0<
MF4(#"P6ZA+!TKFVV(V=U9\Q.EK397VDO2FB_5/#UZI&T#6O>C?,Y(3$[#VB9
M,:+*S)-UY.?,E V&W:4I_Q;#@Z?C[B+P2ENN<J70W4)QU&HSQBO[QSB#D1@R
MFR^+_<602*FS=K7,'*JD_ 3IVPF&V+4@TU5UK)XUE&QY8B^2+PH(NO<,#SB:
M"X*3/Q9/#XY>J$,!AR 4\^_O8HWA(D3Z%*2ZU8^G0HPFJT,]QDZ[B_3&K2##
M6&,1.'*(<%M'3KWIV-%YGZDJFLO*QL>58AD9#9#$VL)?6-[-OH[V(2RGIO!0
M+D?T8D#(+)3^/+HT;8Y+ZW3)%P!"RE%^6L?E 0\8FK5B?OM@>E1DQ71$-<',
M>/"A(H2X'Y%_/<QV,4L^T-4ZF2IMO(]]>#_O*(ZY$G)FWZ> .M>P%6)P4OB)
M%)WQ(\=3F;JC#2'C^L:Z]]. H'.[;L9EB?'P2N:\[BX!QX03<E9GMI@!_-[^
M GLP;;RS@CP0@21@*TS,=B\U;E0M_[(#8BE>DC!UQ\LA\96WY!+"6#?GDW15
MM""_RO%=(R7=#"W>T=H:(6 V:GX(08.S78@-APC%@%CZ<K-$\GB_W=*,L:;T
MTEUC<F,K[)*>YJ>'X^R[02+LWOP?;F-+G_DMIB(3M1N,Z\9T91I=,M5)'#]&
MW*S!X0SO"#]C[M+FQ0GB*3ZB#&*UBH\?[8!CD:;+5UCBE%S$[[&-3(@;7R7Y
MYE+2F\.8?.H2/[ZS9W=2&F,23!G/,TQ&1*0L+4C0,<9/6SA/E6@S>:HS$Q#_
MO/]9'J*3,N*'=;2Z Q7+%M(Y31U-K>+[K/8B^0+?:18-!1'YM&$-8-_TOU%^
M;?*#&'I7COSN!S]IF<6UORG[6!I3)Q2>S:=P0M3P<6Y<]*<U__;K+$U1PD%R
M@-XPY'GTS?L6N,>=P&4E]0Y> PIL9Q=_A0)KN^!K]--BLP$ZU1BK1N2DW>N.
MG6^MJ]%3GB#Z!KA!5RB BZUUO;HW/-V",77CGIT #]@(/ QO:/N2W0UITIWS
MCMVK%=TE%3B/K8KAZ3ZQZ&IQ.7T'@,(:\PU/8CM02K\TO;Z'!6K?;N'W+I44
M! E4H]]<7)=5'MKU]M@C&)%@G6"^< +W%BS?F;C+D 8=XH.X?"\F* SS_?C_
MH(@*DJLFB8$".#CN/]2<!PP8\C[3KI*1"[<EOK^IG/Y\07"]N)+\V$(S8_CJ
M==K6*('0>E%L>Z]5-<6%+,4@[AX,#'=)Z2?)([5GX)5G4_VSA-8128^@)WQZ
MX@5MQ%8>R<CY6GXTV:8>J:J+DRSZW]_>JZE?\3Q?T\S @P(=+U:)^^KG+AW7
M;T$-6;H$;R_[V:[ENR2=E._HO 7LGDXI>9P^F)E>3@AM3:UV#-</RJ[1KBB!
M5[!.4+Y(*00<Q"39GKD?)D%BXA?9&JJ^\'L\F]HT_I". S>,M^7'_[B%\>[F
MI:ND)30S=_NFVG\-[V'KI^^% D@]3=EOPBQC'!_WN'?Z)[%=B?8KLNXR#!_!
MH^.>2RK$K,.NNZ;9!WG@X=9?=#'R!%KLF'V+.%,PG^@D(]#FT9KMS]<2)$^*
M.WA]5BRMS<)=J##[SXD@_(]6#MJCR?U%6?J+,IR$JX6UI[?]=MOD(]9IO-U=
MBJW*AY//8UW?%_&F(L*>/"0C_WCU<+NS0WB8FHW6C%C]AYXQ/CU.41*)]^2E
M]'@^$2^T0#M1G0FQ_+HV^X6/NI<TU:/8C9#UH FU:G-OTZ1/9HY%W4T_VA1\
M_99ZP/*XIDE,L.>AP[L)E&2UTW^?%]_SJF>:!/L$I'??I4D%7-S=/]#G9<37
M9$(!P;^MNY9SQU;2M;PN*9/(*<;Z6>_2L+7<^>@:S]<.W(Z&FS,$\-H"PF*R
MW0*/4*SC>\5_@ON6VO.L$XB&8((Q.(5OQ"L,'\NG5D69-?4UYT?>7^2[4"F"
MI!2MD@SPMSSX(+$_1T6+1:SE3_1-YM<W3Y+G]46=Y;4_.0Z$4TK:3VR%Q: 3
M_$!&[/!X^4$T->JG5/_!((H'QZ02VJ_-_N&?3EV\QA>[]^A5!C;X&-0EZ">7
M^:K=9Q5]DKZ?16(H#/9/SD+ M4?:'%C-U:1_IT@]_C9_8R?UF7(5R(,AW=Z+
MOK;*$5\+7*\W?72C*3]<&WVKNGL/*U3'B7>7YW]WL[ZYZX&3#7UF/T?O+ 18
M&N40O6.0D9^<R,X#JC1UB-6'L%V)XYH:'(QNL%W]9T!"T,J?^O0Q]HA=49=F
M_HB(LI.8HN<DN%/?OC[WK15%0.,]RD[LP665+O],6RIT.+BA]]8D!+WYZ%95
M49S94A0*=/X*"K;?*A;)+X]5I^QC.;I/B@@)UJ"/R?P01),&&T3/I?YS7**V
MYMN*V>LK14T@"P4?CT9() $8^_.]@ZV2)MN5.?*\P LLL=R&7OOV&_R&)\"V
M:8GK6B\)<;7%1;QBJ&R(#,,]::QF[LU5\:!%0,E!1KU79R>=OP1Q^SH!$/>'
MO/_Y0'-KRQ1"NV=GDW!(U)&T7F"TT,@4I\@;8P])%S'>=2YQDQJ]5\XTK>'5
M;LG.E$:-;?ITTA2G=&@D_@2YJ^X'O#I."],SOH?6UX,&0MMVEU"@IJIMNU*6
MU*40L>\$? \%3,'7B,Q0@#AS'\+<+V0U<@,%<A_=_X",%V4T8>L^'/>QA+]\
MM*.G'10XF>7_;0YLOY*P2#WEUX4"0K.D$)A!*-!K^ML4E#:$7P+^3=J?IVEH
M/NS&]8^M2S<4.'MXK,:7B5KO/X7_>>K)%;ZHVY.<L 497KWWN7Q #[^UCX<"
M8:/KSJT0<)70/>C7; 11).&5%A2(7'WL!2"/*WZ,I@OAD_SS5)@8P73('B(9
M# 6V[L2@0-LOQ"1_G@(.^)D<PS<DC_JE'J!# 6#C,1=7N?PVAQDQCFS9N55!
M_$_R3EDO_^6R%G30CLS_8_;D11D7V6AI'2O[_)L6@L.K)ZGG!^BI?S/P_WV3
MADP)_6E1?UMB^-0_=VW*S03=5<WH\N.+(O0:<Y(@J<(J5N6G2?8AJT% HSB6
M @)I,+]$"LZ(X<3B_#SF2XGRHYFH7J(:-,1F?>=@C9J)*E+T >.:L-4]Q8IO
M>C*^$9&;8>_#FP2Z'7E_1)-4ZU^JUM?7O)A\G3!SV5"V$^(M!$L??4+J=UY,
M*G%\_VG2-KYRHFC5SP6+/?UMIQ"7CIW]1;ICW:NFDG>]*8+C_##98BY@K,I^
MFPTR;P8K.P3I_F68WBUM;9>I;O>G(B>4OLE^I53I<"?E<8MN?#S4<TD(<#3D
M*=QKV8"=T/%8@\G#TWCP-4;KBN0]>\DW*""ZL02!8[Y6?<'<$8Y&8Z*+L4>/
MAT]Y3NLGF(LM]OK:,FVW0;QY/^$RIYB,<I*8Q$S9A1S&LST-W?(8O?N O-<U
MIN&CBA..:H'?:VDUEDA)+<QYUP_-SYI,5OQ][EE7P,_<<R:/5)LGJ,2PF.US
M!N%L??K70PS7\CGV)P!5H56$T?-00<W$4#J^?&8JJ>XFFWRW;X$WB/S/EZC3
MX*9$U%TO@Q(V4VHV5V7,5F)-:NN"X3,B/?8 9X%VQ#PJSU?L%L&HQEL*%:TC
MSSJ50@WNE)MVHUPB4^O:X_UU8\(_5(]E,-@6F:8K2F +MX'&RJL$8+79#@\A
M4$ Q6G'"RCOSQVA 1\:6.5T8T$\]GS#W]R1IT= 3<MBN*"'#V@:;"-_%I5 T
M>2;)+CNZIM<&>>E)\3^\2PP"KO<Z@(C/RNG>O#YYXE"@6PG<X;0,!6X)SH7N
M\3H?_Z$L[V];E(IVSS\<!:Y<)G5^#!Z.DL3]$[ #%%B2^(J7>IQ\+03Q:WYT
M:026QX!Z_SL#E> YH:0.Y$4R)(9725N"S?1\;R?"<AUI:N[L-;K)>YB2R (7
MN6AV$9QL!CHIA04"\YWJN9RFA5;XCL$/J*ZD$!1]*+":]U@8'#WVY^<<V^!K
MUL?@#2J,LN LWYF<JHN-6R]H?U:B(Z$?D>:Z_'P*@)5NRT-KZ(>U&F>&S%$=
MQ'&'#[T0IDZ^8^&":?S$9IM@A/F[BHI0 'G)Y['RMO@5X0:/4+!5CJH3W3F?
MJC-E)GN,T_5@,*WA"\PA FA;W/G,'%(?2PXLLZ1G#@U/)S*>%=C(?W=%\U^:
M]:3Y;S!6/3+$&$38V0AY"U':[X&9'8I.S38:+/2QP(J+TID?M&^:[7Z6;O;3
M-EZ[BT97M%N2?,)(^Y*R=CH>\KP5$0J,3/U*:3VD$+KP:[E[4B@@IO-H#1\\
M\'5!9>X/YC$M>2>LLM9X!C9+].=Z1$2&)$@\<&&N$Z-Y">I1C"(+Z6 F<16X
MGCDQ8-$?)9?DB^M8XSZ3V:?_CN+RD+%JS%T[@8..4/9(NZR0' Q!,#99>#%!
M2CI.?,;2KM+\/-=TL<ZN%';\]^G"NA#798.QX);V(:;.OUS+?.9#_E"JU5.^
MX,#[;-2-USMU2>'QU" A)7BJ2G>2T*S%W>?:WP?-+"G'18L:9Q1E, 2NV0_O
M$-D;4?X3J\S?S52%+:QV/SB#G77G6>'MWF"O])#<NK4)OML&^]+_TJY']9[:
MXQ%?>NECYFX/$;I7)OW-HY5S+L?T+!N2[.?#CW.:GI$Q6%,^/0H_SC@JN\F>
M_O'7&E2C5B76-23B[41"L#@*JXP\IFR0(93ZD;>*3M//W4-:?U_'W\Q5^'KF
M^Q.LEKJU/#LD\E.B\98A)I[&1"'_ZW>6EX26'T.&_XI>?G_LJC'Q' H\T:V4
M#F/*W6;M>SQ6=?=]!*_[E^ S)FOAY09G0)\H0#M08"HWT8R[>V(MQ4[R^E%]
MK;%]H\=N["]]1Z/5Q/KF)A5R2[KREH7;4;=Z**X?%+;DB^ONDZ =LO17"-[.
MR?0P;9+4]UXKN2=\D)NK]Q<X-FW<)QK;-_YO20^UI!+4S/>Z(K^GA2^JWSS\
M(% NOJ2W&6_PZB^#:IQS;"NXOGPX=T7Z4KUUZU3W;S[=8_V7AJN!>0)#D63G
M;@IY,9E7^?PO)<W?[[A=I<%Y.UL5K]75QE)YOT<GBBPS<B0G\^8F"SM7T?US
M64\#^J.JKP\G O?QR4"!LN942*A&^1KI<[$5>739/,&>KY##!0K+@E,2SY3.
M>L&? WLDU 0U/BMLDU//I,%.!GQ:(I@6#M8L.$HWR^N803BUB.D[[(KB@$MO
M-QAAU_7*SWISE.D"H=7]6Z5FC5J62"?-VS4*^R.MU/94_X0'W^K]V_.$G&\P
MD:C-14Z,F,;X\]_3SOG1W/=&/2B=*[;:/9XT_-Q?EBX1RU+T1S2/XYYW][77
M18"0[[;P^BCYJ'HS5ZG'&*5@S984IR!=X#V8@B9^?]:U!J'8<?4K7M%'#6U<
M8'!B';0U]4>UQ>#/N]BW7<(K&O8C$$S/E2[4&LP=RIG6:O(0SQK K,U[D:IW
M5[_LML81['9"JNNOVM <,!/*-GFW[]>=*6B19_/E:!A-N@^O]TUT%QC#\8[1
M6L4-IR*H5SI"XG)<0F;8%Z6KQD-KZZF7]IMD'5WC.,C)CRWYQ.3F*@'CH*!)
M<-6LF UF]%"HKH4C/GY[OD7,]E^_[OH?@P?L3WHJ]UGH[YW:E%RO>5P[-WX;
MT13K\1I$>MC_'XN[2]O<CIT9(4U16AT#")Y&N$T)F%C;\<M15Y4UC!]D&5MD
M,N2-+'@CHQ+01Y76>:L51+&A.9/+*#?*:,:81)M;6BZ3S$GU7\)-J&@DH5R6
M'>(%4:K8V)]A$X&9?Y1&5MMJ=6E::J@Y&$,ZFX.TT0PX9RAKNZ=9^C$Q(VG;
M'S97FFC6$/%7>])-7,"%.[?S#8PG:HQ6C+/=)H'&@U^_LKX4]O\:T+/6_VXN
MK"Z"-X(6._:LVJN]O7W;G9XU*40#H=@==FYIF(#"%3R#GZ7+70^^\.?S@F#A
M\R<]EV])U))!134:.3PZ(G.(.S@P]%*URW\7SJ;,'QW!LY8_Y,@WJD;/@O)=
MU&?1AT'/L&'-:G^KMA@PLKA5O?R9W9R9Z<),>U93!O^^9R_U>QC/?2%%9V%O
MGMGLFAK'^F3<%(Z2R,>3PK<E)RRQ7!5YI T;:MYLMDDHYTY.BHQ)^Q6P*@*=
M*?4_A/A5#'D#_?A<V(@_UZ (+1O<$E0CC&AI8UMEM_PL82I>_%E"0*6&'],D
M4\:$ET_?2):"3,R3QQY*8DFM,Y$=MZO^7*'QU>L<V1GE6E]!*\'+=>M.;+!,
M@WIN79ST<Z;W:+9).'B0]W.-Z93;"DBFKPM<]DY!LIV+92&-0[RG:]W16:Q6
M90UJJ&M'(),8&69B.2C08#NM(E&^DOSFJG-V*'RF9+TITGJHDB("*8LM*YVM
M%[W/$8X$AOB3IT59>0QAH_\'7 >%%/D[JN)!)S@6EV&RTRNXA3D*3R$E.L/J
MLA_TW;P,8]LIY!5E5:$:[CCTII&<:6;($?#[B(K]:PG16F,<],6$W03FICV;
M;G=F\,5]<8SU%NY!_O8(*BA(RY:=H!1-0K8?E;(%3$<)7+Y(U+E':'3=S=MA
MAR<^A6)QT8*Y2+P_Z_C .J+UT?EF7*JNR8O;5AO5"3U\'^?8^2*][-INFMF(
MI>A<?9+T3 J59],,DU ,+PH(E$>3*=D: O';Y\:O<7/7$L:ZC7\F^[%<WO[4
MEBXWHIKLA$U&OQ--=?L4YR$F95/Q!B-5#IDTK\AM2%B:HR,*%J,P>5Y?*WDI
M5IN[9OPY5U8$.>!:8WN-,DKH$DD.!5Q$[G>S]]NTQ3#:*;52<\;#-Y3,OJ/Z
M5H#.&)"D;L,AU3(:6D8)$GH!/WJ?9%+<*;OM_:RL?>;5REAED&T2*KU9W60"
MA&'00(CB=(_9)PA5L8<<C9Q_3FRH&9*:^_'@'KQ[8=T0X++]*N''.//J&86T
MT?M5[DCUAK)WXS>C3B_=,S;$0EIG.I8O7O2SWQ#OXS(L[,+H-X4Q#K*SEB,2
MV3RF?BQZL68[+E7QS#AC=S]AL;.'#1WTB=4&M\*^8D-O+B'^4SB17?-<N7X*
MY.B?9NI^F>:9F12//5"O>4<#6R%]/@I;%DGKFUZ_'9USF<U ;()E;T)^U&H,
M59!)KD:8- Z>46QE-8Q!N/"K]]:.-"J$3J)R]PUEVZSMPZMF'-H23YU)9GX8
MI>!S>LT!:."C=%&?!N(A2KX8EFT)\ZKHS<,%@)N--\4=:^+5DD0-YE=#%8J>
M^G?CW$)Y!9Q7?-5&\/XQE%'"'NG^Y[EX5MWVK@E$^/@L=FFDPT(KZE!@MBQ[
MMWV3'ADEO)&G(T]WMR/#4OWU:<-:)$'!%L_-5PYF$[+Z4NE[L9VWM75AJQ2&
MCO.#46FG N+2[60^D6'5H"=\8^MZ1"$D?O'-@*&S/.3U CJD_1B\79T1_I^?
M6*KBKEH'?((03H:EW'Z.+K)%IHIY&UA+%H$MSV"3FSOFR7N7J.G61T#XU2"!
M"H]F%XEC\+IB;+%3=+28\864Y<I/ABCN$3VZ0%5 526,(E3;W@\("=ILLH4"
M9 ?,D(Y+\"V'*2CW5VM$V*V:0!SN5VIR0AKED/8UV4B[W6N;=3YZ'#OP>$GI
M6!L2;M."XD=#)BT$Q@C)]!-X:A*];WX4WO2RA>LXN2?$2K8J9)!":>V%MJNA
M$[;7<>%*]+V@-T2S<+VAJ8FN>(,6*:B^;2O*3A9PY?C3(U05B=*,>?/H7@K>
MQ<S<+]K9C/B E6OR@$L:NL 4O_RR&RF1+'L*7GWS1/$A#F>+-S:KRS4 *P/3
M9()/[K.8OW"]UI;0THB0GG<M=U."U=URJ(:5I7?J]Y83[56*2+?)GB!!U3@'
M?3/:7O>;&C:9K;?#9N0+H;TN"@.-R-37C:XJ@OX9FK+9&CL1UZ$OPI5>X[)J
MS;PQ\9V&-Q+%->L#X>\<:6:_V3UU\Q (T<PWR5@Z%@R!8X'#$%G'E-&ZC%P)
M//^V#+Z6<M3,TY<-MK89C2''P^\ ]4XV$+1-_X_>8>$'H:[="QVO^"U+XHTO
MS[/PW.!.3VEBL4EX6 12D(3@WL)H'76&WU +/M9099]);QDM<BE@HFP077-N
MD8D00XN9J2:+D9Q8\;X)OT4]B/J4JL.JYOHI<)7S+,U;HC9!/HEXB?;'4N]X
MPGGAM-*G*-&\59II;Y?V]AT9:[PS!D,BTLH(]VO=XY*^#TEF>5F^@_E;%BOR
MI#GI-JUSG$?F'T)H! B!9?MA1+C;2>W:+_=V#CF8YG.@Q7)GO*B-=B'.^RTK
MR3>7KL*PYX#AEI<&PUB!+HJK>^R(5L 9S3W]VO@G/UV,CA5<A[<?^D)/0E([
MPP2KDSZSGJ FJXRK8$AT.R&TSV?BWZ+YD/S<ZVR=C,OAB7U]-$AZ#X_XDM_]
M7![O=2VR4S[N-\HS946$GAM#NEQ^ Y]4V<ZQU(?DHMDNBHCOD3*DAVNA@72>
M7OVW*0*%/S=KPAPCM4B3]")OP!I!8Q@O0I8_GEX>]+:8#;+$Q)7K.OI$G':/
M.MY](PL;.-SD*9Y1X=+O(!$VN'G^MF'LLT3M<_Q2)AR]#?[KN?R50- <>:J!
M3G:N9G71%&92+*'-]%XWXX3YK6\%!LOH #KIX;C:#JW&X"':NQ_[5=88A.4$
M?9$RZ'&G\)0!2FA#,WMM/"1U!2S7NCVCFO/]#SE#!N2>C';2"Y%G,/="7/R?
M=%TO^%[/Y.F<S+*@\=Y7.P"\*$ZKN7MGH6,RF@YU=ID#5*/W(GQ]&KOJ<,][
M+S.XS::?84"!-DW$)6R4A$^ME)6]M [*B;XAG[/]T.QW7>X+1P_;U(]8@.&9
M8=*+D<D(7YC/GG.I8/+T'MJFCQEQP;=E=BGO6TA/WHYU<L1.Q97WH:E7^ADI
M(4$!AS6*NY$4S.NXD/0FF>?&XG:-8?.?T[QM4SMS22YV50:P<]MZC"@@HKE9
ME021HQ)"W+DW_B_YX^Y$3Y*X<&@+S%'S7]@-O-3ZR']!/-R:_9Z3*^ZXR>[F
MI)P22SKB,6W7]>WH].P6]749%AK)Y^(5%8N.D?-'8T;E$*'-]_<_F/42TPHH
MZ00MN"'2;JKRX@:^F" G"-V30U93Q%J+($S-)7+JUK9&=SZUD"(85W6D5!PA
MC?76#RKD*CB_ZCLO54P0XC3M9'IG@7 O_B:(7%P<3QD/-.O_=5ARH&5#;YT_
M"@ITMK"%OHA6G%#:Y3&9MUQ1*I(;>=4+MBZ&'7[?56I&L?W2X=G!9R[&L.1C
M[/![A&:S3$DZ;3%L'JU+CI2/OC6ICA'(K-$I]Z @'$&E6G;5!:-K1-J-D>W9
MA]7-8?-PME=X\9[=$1%+5[W8EE6IF&K((?$OC*5QI U#D@MT))!LEW(%7*>R
MYC1H7YK@]X6.IWQAHFV1GV4Z7/O!NEZ[;O] VV3AJJ[&(T_=ZJ.@.3-K]J9C
M-S&":ZB.KO9L6C#6[)YZS6ABS<R:_V+IJQ%SQTF[0#L^O]=B,W+1RAU"%N0-
M?X<HUT'_,O,U^D!M_B I3>DG^LU'+Z>]9UPK#*;D]2AZAC%'%MJ&2N ]\_%R
M&-R)U3OJV&A+^HU5)O!EI$)[^ (\68M])PL/S[FU^<7M$&=>PA?6Z#JIRO*^
MG;H2R3VE2N1JX[@4F5M(JLVZ9(),]G4<N25K8W0_*\][YH'E^\[4=S]89PN&
MTZZ]GS;F-L8[),*P5?F7$7J2MXJ%NUXD2TS+&"K G/K\X $A1"MZ$0QL:F>Z
M=E-Q7^A"JM_;GHXO:/C3;EBN'.%HSK6[V%,]\+,8U8;[!VR(EE_LW+R/NS4N
MI9@<G9-]J<,0EM?EITQN:]3[^<OP9+/Q*FF59D!_[_?B&PQPMDFO-1'N9"(N
M7#\KQ84 N"=^:H.R2/D!%'-J>@[&H_RNX%ZA6N<(!71P(T#>_?NOEL:Q;:O
M.+T%(C#Z1,>^<3+A35EQ>E@F/A&2)!G-KC0JG)]FZYG4B!R&-4(/5*1GIL'/
M6,A+!X?>?5]?+-=UNKA"?+%AXVS==86I11E3J;[(^[6[[>-+XDPZM_.YX;S\
M(G[*$V3BE[J8DI9P;X05XPC+7GF%1/;*^7#LGJ=V"<8F?#>G-,*['P-_M2,?
M9&JB/(&3"R<-B+;I.-):,Z43I@^Q[<<[%ZPFO2<'8T2IO[Y=&R0GDF2S0<+G
M(7/8\Z2?I#6%C.5;V/5" 1B1OI#?B@?%/[_F<S;(23_09(T=VAJNWYSXOD*Z
MZ:M_K&,VQ^R<?AA1'7< T87@MU+E4HIK'XXB'8J)9S+!P9)NW$*C42J*!?=;
MK,NTVVQL/%LI-'=2[OBSU\M=GZE9$C2[5.CX!UFV$,NMF3=GDDRP!Q?[2P=7
MK)$XOMLRYC>4W\G/?H/\W'3Q(3+ XR=Q*97Q)WGM+.ICVD&ZLI9M[\$-!2(^
MQ4,!?3>A!X*JRWJ^Z9W'GEB,.SR8N:3W^/2A26#KH92^:6[K.Z;)YER8?;B<
M;<(:%#"Y^2Q+E5B JK=0DT0L.#"E6=F:?.=D']YXD'#IRNOP]QO']+XM)S7%
MU@CI1>U9<X-I9F=-STFY@[]Q<DXY:%FV\2PG)2D@.HJ[;)1V,;[3&&?F6'C^
M6BQCVN0 ]E27:54VTWY?,18/L7ZS<<\BX/! OSX@FJBOX@4Y$6:D\+,I^!/%
MHRF)\M.$'8=.^U"18B=KY*J#'XNB5CVV!]H'V(KQ#-%8L>.2@7-#I>%^5SFS
ML@H[Y(HB1*E"LX+]7IL?J;=F&ENU3+#,GEM @>,OSC';8^;RN;3^^R5.56DF
M5Q!IZZ^AS0)G0>?#N-<1UP82,E\M?8<FSAB;FRAK\C_]X")I ^17WC?AKLZE
M8C0?Q*6;8%<_I/3H@^)"1Q\;4W+R=#B"N00Y-*V"J:7S<[:--^;\/RXAW[[?
MT[OE_+S KHRZE$41;IJ/IV/BLB]K%7(Z^O2#?F)[9RQH(.MF?</"E4"4OURQ
MN2.()H_FOUN^;+00@?MYCJ' @\\R%!BUT!:C,:)KPR:'PYRL2WTJO8H*ZK@U
MCA;R/<R.^S'+K;W66#O;_1Y60HO(5@,*S"4L/3Q17;K&M7RL_FF;VWZ:JN)B
M2A1X11.AH-DK=:5HL>9J!^$*B:B1JTWQ]UA?ORYU <"]"ZT?H<#X&Z?+R5HH
M(!I[!8&?@P(G \PCJ+?TH#L+32B0_N8."L >0('K#=(YC;_+L/XE Z:)[\',
M(I7@Q]](=6_N'@_68EK_=!4-R".H#3(["06VE5H>-]Q&,(1'\C=IP%+>+*79
MVM<M!WW/\RU\B'+@0W4Q%!C)=H<"7I^@P+U=^$&Q-<27_NC^Z1\BM%!'T@V-
MB=50(%B[6U"@QK%I"X+YS[._*R"QRF[&A$P4B>9R_D%<YTCKS'QVT!O]B[5+
M#WCLX,X!"L3%'/V9_UP=85XBUW)T??"[PK^V@IN[685$5,F45HC/#5'XA KF
MI&.+T&I4RQX4$/I#^_C?60#6HVI_9D/SFXF$"<]#TD<C_93]D 2Z]:" I07X
MG%87O*S="@6(,O\S/P ;-J\-!"C1@#8!0Z_H/37=/VN)4%F\!A'_)T"8Q@W)
MZBF]SB@UM/7QL[_69:Q BT>Q7@2X-2D]+6+^L[' ?](M#75+8;MOR=$/%51W
M543ZYTM]U"=OH$#0ORCN@$V8;I;A(?AVZP3[KU8=IE5<#_Q7AA@#8]RJH/_F
M8/('R=8\4.#+OPK&<BI"_R^!/-5Y#@4BN<3^WBF8YC<)6 B$^SD4RL3,V,(G
ML;[YAFA!!TA((D:* V:J8>:3BUR-+:T,#0/5Q=^C--@I.:7IN3'AH4#.&\^X
M83N+Z>W,XL[L(*[;XI30G(=:E8:@60J /\R&BZ3SI(@45UO$+</T2J4B:T2F
M8(;?[D6?GI$6AOE5\ &'VP'\\LAJI<6FX_25R5.\P\'3U$1B[B.MENHTSM0,
M9_T$]0/9[(L8JA["T,N;,TEJNJ<DKB<25ZA%?^H0\4C(3\*B5T0(S8MMB>S0
M*,(6%NR3 "D\N%M5&,<2YR=7!QJUJ8_F-VY:=/R.C-(QM(EWDVP;LHX2$I)D
MJ.JTVLP&.3AO?!!$*MD<M_I\9D*_K^XEVD3BY;?O[5SR_'V#]\]J_ OZ9LY>
M97<)5&'3(U8:%0Z O QOOG.S#\Z0$3"\!BL<6_;ZD;GU5]?%<2MSJ#%FQ.K%
ME-Y? @8YK_KZ]A+.P]'O18Z/ DK?R8\1[$J"2$^V=P-8(Z,DL#"XAS56GFN/
MWZM;%N@DSJ&RG;W'R;?,&7QAS=*UX9D(PK?[=#)B4.R40.E7[+@:Z+@@(^<O
MHVC,^&R6IZOXQ4)=(S:@YP JI<X&'!T4Q0'CO01L_X"JVO$+O)D58[1LO$)R
M4,2 )%E0\<KPDYU%/&_'BK.LA!4?>5M;JAL*,CW#6YB1)W,9R0M%]/3SCWE:
M[']R\_8)O>_Q0EAVL;/UFPGJ$Z;JR^!"/"9CS*HG7EG"O:#!9<.$GX^.:0<%
M('ZR3A"("!3HR9]&BPO:E/0_^KP0NJKM:,=&^+WVT7O[WC\ZKL3A8V2:3X&/
M\H2N?Y+Q\M(G/5);'4'\DNTAMSY0(%01"B M+#V@\FX]7"!" 8(TM+"@+:$5
MPL;'.,G5A@(M:8^N_MZGL_8M&[]R"09X]A>1 J*TN'WJ<>C"8_B-EX"7%, G
M!?^@T?H'#<SHJ-;6/;D3^)Q]+_5J@O3>//QOZIA-"?VA#N#@H,KSF_A,".9@
MZRV!X]+=+CJ$0YB8&/L'N(/+"0J(R=5# ?=?</-^0Z" */GO*2/)=!9^_>:_
M%$5"U"#P")MDR?7_GS9$?S;GOVN:QE^F&?XO]!4D:@0)'<?LM?[!U//7>@L2
M-8"HNS660:5#_S!PZ5]P^7<-O'R\,0,%OOT'SG]P;OP'9U!F1B4_ERW'DF]5
M<.(WE,HA(Y0HJ3;8[PK/G->B=Q[SXJ@X%J#*NA9^@V@&OL2M?*QJ"C4\7D[]
M^J[5L4#66J"CS;<I#Z.2M7=;8!BVC%\]?T[;C!?W*%/ZD(,0/PI$MN3S,B59
M%OCD\*]OTP\Y+T+<^23\I)C@$X:=L'!Q&V$X1UD[A?C1.JF]DJ9DM-R/0M/4
MK6JWI[@(B)MZ)O<4;E#,9V:77O!]@^&F)FFV%49>H>]UMU89)_^IJ3Y^H(0;
M="I:TD]NM8#IB/<1*-[ETILRT'+L#6)TX&%FK&I%EV>*S^%D+F'X^8P;#<0Y
ML5P/>$\3J6ICY?/3LK\EX<%B*]L662< W/_=CQ]J.Z' S;-STCLX=?!VNK:L
MW1(Z%%B7&0'O8QH]MAV^CNS3F-*0%J%,\)L-A\;7H_QB%:NSA($<^#FF'!0W
M.7KJ&Z?9:U_$;]ZOAP$=22:Y&%FJ=.\^J;'R? "G3J;5C)X/TL\<63KL23&5
M"$W)8STII;[[CB"_)H5F;$9A2=WQJ;1Q7]7I*?9,/Y ;24Y73@P3J6 _Q7TD
MG;=3QM2:L\WIZNACQJ:A-<B851C W\U"5]+VY&'*.AZP;ZRV[EX)A85Q>#%R
M/MV]3&_W;(QUR]M.[.0,Y7;"O_.6=7Q*GE?<J^+M0<T=FXM%I(]O#^\S&E#,
M!/-CU>9PAW3 F!.85JDYG5DKZ1AF%1&2MB&HNC>A-UF]7C.;Y4'\,_V,<XA?
M'L_8J,W08.#V<MW0H220<36@/(A"0@^$K?#*RRLUK6BN%?4:K"PE>QB<H\.@
M%_#],K*_['ET2!B;2QK2YS=7D7,:G"D!5Q_L-^A38VICJ5Y!P'1=KRLF.&2?
MRT<0-E/M_C@T\QW8&JY7"?PTP(O3*1-#'MHLJ,,G$<0YT\ AJ#[_3?$TR8!\
MW-N\>#$\1W=VT,(E5T-+<P!B&"D+V\ '=O9FD0>EF@/#H]B,A]5NFHJ00&O>
M(M;P>OS3B0KFM/Z=D6<>L3A>^;M<#3W-\/.$^M4M:ADW$S?FEFGN36@>)@:I
ME^6SM8R6C/N6!M55M4&+BR]JN-.% WQ&8-JPF5B3T)I-09$MXT6)JU0IH=9X
M8=ILIRX(" 3B<4MHDJ(2FUOSMY.&G&.FO!\;1&<T!7,W.AF<^M:?'D2]3MS2
MRRJ,DK!O)*<P@4.[*$YS\ZTS)3?[2< 1D<: &<"0=M%.5T]\+$!7'!>8;;;#
MIFX6IS+(GF(8C-I ]@F1+PR1FLQ>& ]GUB_7K'@7U_6@.+9B;J=#N,9)GIL.
MO__']CABF">!OTA3O&Q37:V;S$P),V/+O#YK!6X=''(LRA?F$TE/*2*"O?7J
MVF_!,G!RZJ)1?6C"/*"=%+,A%.N74B>%_"XTW2+T*6CH5C0@T#O=:IGTQ2%K
M6TNAV1&79WW(X70W<.18U///+XH:K_>M2)5;DS,)0E-R43!D&Y^)12.K35S
MG-;KA#9&V&M39:\<X&I$\7!HDW3<K!$JEA1'*66.X"!B&U7MX3;*U%366L0
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MIVSSQ7V3T:99US!B[<SE=G[.BVPV[Q#%9\4 M@D[2P?(7QN0P;;UY+BNNW$
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M>0#/^F\>\/J,QUKMA,!HD(=-K@Z>PE240D -1\8:(=FX$X+*6>I[#O8 /KM
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MP24^B@-"AI#<C6+\^>.2DL+MRFP&G\^;43QY:++'FE,I#%:92W=>7C#*QD>
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M@76FLS%H6HFS,R4"PG@+7M=U%&)XF()B!6!/9??"Q, C/]CE=\Y(LY%O^.@
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MG18S\?OADP_,<6U==<.R@1^F[CH/@Q\)VV!;4N8/T :3LL'9TSLQS"IU>B_
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M=1[L>FPS9&RT[%5E0-L&:]M^TY^]6%Y;GHUV762[#MH.15 $M.D$;+J 2W(
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M:UP:X=^V+P[QQ"9IQ3<M\;.-C>."HH+7=P_?R:_<F?$WW7)6L'75#P6N12C
M_SDC)A6TJ3&=^S'5YPU!6V<D=) /;+02.&PX6BY+Y__R7>;[KWPM"/8)(ITJ
MT!^^4_M/<F>RC^$,.&7-YA!(70CFLXBJ?G7%J@@)Q/_EC.N R@S#F5*5BWS^
M=PB!__<RYZF68="IPRYG#SZ3G[KFCB]EB0L@^ 6?-EV-O/B_S=&WIO.O"=Y<
M"]^Z*NG# !9_+XM>/+%9^*&X!^S98N1'GPS>)OS%11.49LC$E?Y6"U/:FRSL
M7QX/;)AMO#VPJ66[D8R-B,%0]\N9SD?'0UP^4<MXHH9AN4_6JU#C=K/6^+S)
M''_]Y&I[<6DWM@ C8%!V&6)<8#;;03+ _.M'YV'8>[CY-WGHW=\]#,G]CX?!
MC\[MD SO".?G(2=A(E?)W0.1ZQ^TC^3NF@Q_[Y$%ZI[3=J<[%"_+[6IM49J?
M F7_Y%O5UUFLF#Y[G$!ZUY9-W#$C?\WTE02A-.%Q-M-V\(JR2>OO_<_V@A ]
MMLY?:N*N+?[9L4;?WABUF7GV]9^>R4A5JNP84G73D*YU1Z7&O_FW7/-GG&BL
M)QZMFUE4%LR-,MP]Y)Q9MHLXC\Q2W1R[B2_518?'M*BEEA*UM/)&+<.'SNV@
M[Q,(<DM\;G'G&CLCEY%M3<CC^S_$M1;_+)!+[5H3T6)>S/U:YXZ36]03LR^W
MLYA<7S3ZGK_()CX9?# :?4GBTH)VO=HH:.:6:M:NU-),YK9',8UU_!_8LW^C
MJ.F*MCW1=&!(WYPQ)>*"4C(<,YM.=>942-]4+V)',D<N59W [#[T7JGJ$B$N
M8HW(NP )=<A@RE2Q*Z 1W22ZZY#NV ]^/Q;$+&*AM.U;0SZ*&_8%OWQ)/=?Z
M?$0(&,QE)=BH2ZO!1@R-!1Q^;%]R:*[["'%-L<WC0?^B-?^V8K_=E_W6M;3X
MJ9@?(SKBVZ:V]2)^4^1B5\R@/WE:=F"8B. M$?P&!S^DK_UPKS*X73H.V[=J
MYU6YW:Z+O;+MN(3Q9@XLS >BF>J**O$-A? XU>*!JDW^Q[-U1]/]_OF<-Q(@
M1+B3UQ<=AB\"^YF:^O_Q__Z8&U,^@9;T+QXN!A<DO&'5_O7))I^^+MLKN;4N
M/N;3S#+UA1N(K*-I-G.<\#\WNLGD:'ZPRE\F84-+(CI:DBM;?UDCJQTI6.N0
M42G11C7@?D:NB8:%B0?=N42^O57&7?[PSAY:/\UH$@YZ4J[*=\>"L2)M'8//
M"W?V/0]ZN)],.GX:LM?U@9+<N-Q,0U]Y*V;W%A>T\;_U:>2(]VNSKM2:&#4=
MR(>AO$5B/;6Y>>A3:A VN[R0/RUN+W0PA%@0&==*(M1R4XP0;^FW!GK9\WW!
MY3_^UE+DYF>'N,Q@TS'_##']Y*9"N.H8GE@P(#R7I-Q@-79)/FPW_:4M1\$2
M'?ZQZ,:NR+554_^X@R26=A5O+)4:]V(6<3*TAJR<B^\LZ')LI,77^D6UNOC%
M[4/L+U3E4,V.TM#WN^:)[2LKLYE&II[M>&*9T+4(?X<([8.YRLJ'IX_"XXD-
MC8[*ORGM53= &[ ;7;90$[*LE\Z"7I*_!>5G&;OU5"NR_'L;A5(PJHZ)RJ-/
M)PKIR;L%Z(]A*JH?W$R$N"+%10T]>(8MU!&;"DO,>BDIW2IHORCB0[20K_C:
MCQ[RZVP#SG>0[%4=B]M.B&62GV.=/_/.O(<D6QOJ@!8D+(21J7@S"6.VQZU+
M=01AM/,F*T\^:46+6T41 \?,<2WUSPKA1BD@\5A@$;](%_Z"CJCM(,[XR&TA
M^71YX!RO8YD--6^Y@F%)\T+^"R@B8NG"X/=.&70)O=AV+];8Y,5Z(9%$KH99
M6YH5E#1?E>69W2UU-/H7&0A/1\1Y"^:2FYON 4N#6U=Q<I45BROH5;$E^O1&
MU#'C0IB(#92?8^;OCXKDUWZOI?D@?R1CZI"1;O#<F1H&?U&4I(J4^B]/%PDU
MSZ.?6/@&_IUA3BUJ)BT[K)D,D^J%A'R&KTBTQ<NB9I)H_%7SV7_KU&8J\Q>.
M9(7XA>(.^<"_CT^/.!Z/*YRQ)0IZ9N6&[IBZJV/_29='*888?#B<P\<*H:9&
M/BC!')^XCO#7G_Z'ST"\WW\K_Y 81?@]HCK7\0?A#Y(Z+FE+1*-OS@4)O,+Z
MO[=[T0T;)%W/%O%P4/<KG*I+W:@E[?]F:SL/2^/A,;<Y4]U%S5NM@)X?0YGY
M._'!K^L3O+6.^?K:[(MSO=84S:J$MG%%F^BNRU63&5SA;,OD7V 8;X2],/N-
M](7+IZJ_W'Y%71K4EJX8W?MW+*YJ/7C\G36I'I;%>4:P?STX'Y(/ J/F9Z6J
M7(1O<,>ZPT=,IZ(Z+FT+#,8[-RSF?(QA-LJ&O=L%:0EAA5:$9E,LL^&:2HG!
M)\0(555N-C85NB\TR1:N?..S_,?,\PTO.'P$_$'(!4+/56O"!?I6$;S%OXP[
M>R&Z9_)L6S_=\>SE"TYCS!^9QD:ZZ1>]^QME8AM$D3YO&Y__LOQY]K:];]@^
MOMD;!7>%;]XRUMD[=3-P"CPW/%=F;+Q(P1=%+#"=?7X<Z*LL703+//N6'.3V
M136M<ZV96-F-4,D D06U"Y[P=>_@PS_2Q;;3/_F4S,Y,;GWZ]?I%*[4CSQL%
ML/%46J(""+GD0 G(%U(1-2"B'BC21:U5*#%TT"\<X1>4"UDINEN8+]FOT&HU
MJ%$ 0*NKD<<"=#Q,$,'RES/E;)=[;US4TG7O1P]1D2_JZ9K:\4.\:*9K#-M&
M>/BF4N$BO.U%N!L*8,5*@MWEKO[9LM^.7%SUO]#G"C7\0K'.>KLIY8I]XKSD
MY%+0H+.!06?9@\Y!L,01R&&^SA'\&:Y@H),H:02ZG=$V' _P%>F;Y^@F<Z)M
MEB30B M0V+$C=LO.<F(-*GW2BS6LU)DHUJC29X;B*%;JCA*SDS5?WMN\.P%&
MD0ZHZBE#6+Z=<I5URIUA^IL/:3= %%0/S)-D#0!]=:QA@32QDP2U.WSUOH*O
M9'9'XWUKYCOWHQU[Y.+@W\:-?7VTJ13&+X!A&O]ROW[%<X+]=3Z8H$7IANYR
MENW_EO$F?ORGSG^:_RPQ^70ML67^HCO^LI-)356GAMB.%ZURQ)O%K5X:M36'
MB//:NK;Y2!B1JQ_HQXU;Y9'K-;;[U>H&O_KZWOTQZ+5ZFNZ/I:PE<<;,,&9*
M2SYP5?1K.H*V8;LK)G94+OV;.3$K>[9K2FU#TBL&GQKQ;M61;;,^KIRI48AR
MIHY?"!1<S$+D1H4(F5?67=Z\Z_*U7[3&W8VX\]S'[L>C?[6)?\K".5LL>]N@
M L&I#;^4>>!_X,YS??_&'=T^E6B)+E4:4W4^=.?+6?_V>KE#L^E--,L-WW#V
MM=JJ5-MR16[49WHQ&_O7X$B(/W5UZ1C)^[F1V7F2]Q,D%6*]CW6M_&CY2-7F
MNUFBG(9.GX^/N/0EY=\9SW=LI_29G3_9C/YY3D<NLR^I\9.^<2W[=.S) RA-
M"=;=3B9-A?U"-VX.76&!INOL]FTQU-:_!09&E=U*%#_1-4T</IL9,E7_Y+&A
M9VKBVRS[\F_7_C]S*Y['Z;,G'GR\5CH?#(5 @J=F([B(?;HT4@K1N&C5-V81
MX73"LSOOT!QTV/)4&P4G0J.E7+24D\"Q.:-#+!:?^O8NR0">YH44ZY1^,H:R
MYH:/0BLN-/><^PY9CLT.I<"EG?8ZG319\+[S,"3]"W#6$#JK%)>5WF5WJO(?
M2L:V"//_)H3^V+_NWW9NN_W.S2,/Z^\>OG?$+08KT9'_]3R\#]N#7G+1,YYX
M\!\Y^SK_/%GX_#R(H0<>T<W,PT4_8>NW14KB@.T&WQ;!U%*EHG)YO&RDWG?9
MA,CH\T[J\_K#WO='^?'=Z?EWD'[OW0X'$7P>S]7XO,2R,7_D>P^_=/%ZOH;L
M-PP-#@!_^&%23]/YZQ_A>\42.3VYX/YN=XP-A6A R+K0'J][=WO5NQWTKA[Y
MH\'=3?^*.[RKQV^=&^X!>X^#WWN]2+Z/?*,&]W*,#,:,+2Q7H4]#GX8^#8RL
MR^C3WF.YQ[O[WD-G&,6M+81LUHC<35GP)G1PD!R<@@X.'1PZ..[@^/-_]![B
M.SB>N+XPV]7%!N ]_U%FB[X[0:<ST2S$?S2V#/X%3MBTG?3^\G3WC7RX8B-=
MU5W,9R&YQBJZ1G2-Z!J%:^P,?G^\/L(U4F=,K@WK)\9^D!Q<'1T<.K@2.+C;
MNV'O4;Y[^*USV__?_F[JXU5OT'WHW_N/O_T8]&][@\%C! =W:[E\\*ZU<8<"
MG1P@)]<HN).#N0NKX"[LZ7=AE<?OG=O.;V'0=M4?='\,!L+#\6=O_CWH#R+%
M<-^I29]]AS:_8NQ*=U3/<43)O,AH.R8UWAS=#_'>_:#8R@V."XGW/##',W %
M$+"#E-OH(3/PD%7TD*?WD-7'?_WHW [[/+7M_]$3?]S,'@MW>7,W^!'!0_Y+
M'%O4>=@GVH0+9\>?,&9_"U]I6(XGSN9TGBS/G5UW\* [?Z(#!.0 &T7? X'I
M &O;'.#B473T?@EZOYI8X!L^W-T,'N\?[KJ]JQ\/O8A%>JYM&8[OZ^YM2V6:
M<&_HS-"9@7!FV9VSP(,661RTZ-\]Q#QB<3?\O?>0K^,5)?)A>'H"3T^4Q)&%
MIR=N>K]U;H*@K'?5O_TM2E1VPYZI$81C_HU1&(]!\F6-HE>1 /5C'71D&3BR
MSN-#?_"?C]>=[O#N(8H3$XMBY)JJKF6C_T+_57K_A?NGF>R?_KA]Z/W6'PQ[
M#Z( KG/3&SSV_O6C/_SWXZ#7_?'0CW+^X8<9=!UC?ADP-8(>76'%[\)EO&(Q
M[8?C=RP*@SCT@* \8 T](.Z/EL,#5A^O>M>='S?#P>./^[M;[O5NQ2);Z/SZ
MD78+KMB(^J4?/Z;B_F-FZI:]X/?0QZ&/*[N/V[H%BCXNS5W0[_W;'H_NKGL\
MKIN5?43;"?W._\-CNA'CH=Q"H0?Z-/1I9?=I=?1II_=I]<?X6Z%^?_:^&72?
MYJ^B$T,G5G8GUD G=GHGUGCL_??O_6_]2,V3>J]C_4G',U>PO-;.0U>;+K+.
MSJ[:RD6[L'8UZ/]VVQE&3&X&'!'J8CX#S:B:J5^2==C$$KU)(W<_N:!CR_=S
MB)_T;X98'U3\422M1'KYKB7Q;_'9V9D[J.'U3SDJG[=TW]YZ+U($R+.:_,X6
MO6'9W\:#[&LW R6E_-G<"_/FC"GYC9F,#'G.2Z<Z<RH\\U4/GV8^E/W !J5;
M>BZO=B,MBFB^?M!-XHXMSZ&FQH%GKRJ;NL%]6/XF_/QV+,(%03\6:>:+';-3
MF54L3H5Q9U)V(6RC<='>%<,>"LC^(#;+D&-GQYOLA"]?--;2OE1DOV;UA][
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M4*:.!]\+M"H Z;I.C'V@8AGOUDX,CA((CM;N[3S! ?EZO5)-<)D!3^\5UV>
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M-,M[,AA1+LJ2, >+&L;[#<[^,7@'T#U .X*ITJ$%=2\A.O4N07?*4 H(DK_
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M(<MSJ*EQ/6"O*N/DZ_=K]==QY\V;"9<)_5BHJ?^8N=V/*<TJEG,-"=[G^S!
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M>IF?QAM!L06@*$2_'2"Q4 ,.,D=MMJ*!%-I 4J(&E#KJ/G@4D!R0'*#  -)
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M#01+>U#U2XH"<@-R Q080!H()@ZH^V5% <D!R0$*#" -!,D!=;^L*" Y(#E
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M(Q:KIE;67FU<-&LI-$"-K,Q@@M@TSWH4--C<*' ^$FX]7.*-,PC";UPHRBH
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MVZM%XCFW0ML-.KR< A=<#PG$VT&Z.1L*0$"\8HE, D[JOYCG(^FL!VM4U_C
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MX*%AK,%.0&"@\SPK8"2%\2,OIN_#+:OH(U5V$Z$&*6F96B)X'X-S )H[\ 0
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M8@="4:38D3P?# -L@@&E_>0$<:C: 4D]6V8<\A)EV2^AVC$_W_[SYDN]-3)
M5P2/HAP0(W)A/ [!Q .Y ;Y@"+X'Z/9G/W#M9\=FW*+Z;WQI_)V9;C0U<LUE
M> $;YW:#":_8 R,R5#N21()JY_+CB/2G:N<R5>.B1UZII-BIX!0VFSF68L>J
M*78>D:D6+M^$@<MGNC5N0'/WSD>'[Q$T3N"EW2?SP'G";V#.#<L^L&_1)8L;
MKX2WP38XN#9VZ9'YK]AS*X<'Q<Z3B5L$)EH;65S6<J_0MQ8UX8\F5GQB<H9(
M:($^WA13211+")6S[7B!JF*',NTG)_0#&5]1['3_CDWX7H2]\A3E5NMT<^:#
M'#*>ISZE,].V./9C[H=I20%9S?G0&)IMO(-.],QA0,*)?"I=)B-%L6>M*W8>
M]4PXQ<YCBMB8Z/'G=I.[:!B_F9[)FP+3^!HEZI. %M?2:0I?L2<+G1^*G4A&
M$YE'G3EJ'0ZCR(H=R>@H=J"F8N=1SG;!R+]B1S*>,5^#8Z,S=4B@2+G $Y6A
M:AU906&J:D!$48^Z8=RD.<P:IE]+=6G 9CC$X=D/_J04;-J(S\WL$C<'Z=87
M!<W2I4T=8=#*_XH#)[3EM\G8Q"R@Z\QHMIW0\Z).9#E!*[8BH$4Z,QV/4K$X
M+B_ 1&PF;693$X;6^EKKOWX+66;6%3L6=Q2I)4.4;0#39G+C,HT@):0H"7$"
M9J'ZPS)M+WDE)WR5B(2QF$%72^Q];+5(10'*J=0GP"RX([HB<Q4HHJ8W4SX2
M\H()[,F9 E3@%+%GL0!E3K9$Q0. .AZOWZ)^$_P1^M$\/X)WA%]YB4.,SRP+
M4TPA!2/S3^;)XF22:1$"@ 9I);\J9.6SR>&JO#Q.HW$FB^V&H^YS,&2Q3"^U
M=G!"4$Q1T#O?Q;J(\&#C'@<\<=YM3R9MLS^N#X:67>_:;%0?#MN#>M_J6?9H
MU.UVA]W*Q/D.;0!'&'1.8Y?:8H#C?3R;X2 ]K!#,5+FG #<DQ(V5Z.L4T/?)
M#)WP=K*$N@7_=Q_HV[[>[I30)[ @N+.S3<^\^OUANN7PX4PH<1ZP.>9V16LZ
MWA/M.-XPFE+C',PVRYF[\'@X7#"@_EU>?9:. /O=HX-0B6AHO'WSR]75W9MW
M-'^,8;T:]CN@^8G?38;*9FG^'OOAS, .C4\^_"<9KG-]=?\I:7@J_?YGWT[6
M2B<_N[K_G/R*VHO0('5F&9!D]8.4_8['ITUR!>#S.4&M9OW_\CKJ('(LE\$;
M2$S?>:$?_OR^_O_Q06,TT=,#:B/=BB6)H,_@'G!K'OOB'2^B^=^G#DDQ<\4I
M-ZZO/% FV#&$,^22T45PI/^3A-!P0J<P%)-ZF$Y+CAV8."Y\D(P;2!N<Z<1?
M?UA3=!_POF+B!2#O_NMGP)TO6R7XD*56KA>-VLYRATMGGM[P1\%IE6(F;>K+
MU$33Z#:4*X>\(5#3F6[ATO@:.#?0)V<4+,N, W([,C\ \\ "XP1E<-))9#I!
M=D04+T4=FR[6ZW%0+4<N"]/PN'&5>PQQ 2.<,JQU)2%4P!$.!+7A8M1WAS6#
M$C9E0*@94_\9>YMJ:(_8/N/;K>2SF^F8F67ZGOA^Q&?MB:)?XD?D4WJDI#:V
M?&+YP_;CSN'I_=C%MC^#ZD^XM/D7&&Y+DS#6&A<H6RKYHU1P39$Z&V5UD]6J
MM= TDAN3?7B%NDM;XQ$TZEVJ$H#:<K!Y!7HU-\Y2*HY-"%YRHYR-27.%<(8T
M'P"<I$\\GJ'#+!_J5/\9E>3OC?L&U6U1M[?#A,M#$4DGF>^,78D\GL+%/!\I
MQ])K8F\D6)?IE1;Y7SL>KP%'PFP85Z[+GU2.'H[2?AS.=XDLS*0B,3[DR:M9
M62K@W1GK\UNA>>7WD-U.OH*?A-IS57O\*^4P>'ZDF 0"KX"MN+EIRCGU%9Q3
ML$1)0PF5%6:CHA1O_),!NB6,R 8+PW@V%Q8<Q0JH[UV$3E$58'GD+.%)^#X3
MJL45"UZE<60GFP[X?! R/*F'I>(W4:[</Y_X7%)C5<=A?.Q7+EK*OT>F.-D<
MW-"8^6$N/;$"#A5:LL+(0OTJRPND\9Y@+3&6Q/1V.4\W,SMEGFW,Q5F6;\V0
MKU"9QQ$?]T-?% /+K<Q4V7<U^13<\6!)HP[@/<9>) X5$*H!Z';QI/@".S0"
M3F*.7=U]),&;SAC!Y\@]W7*#7L2W_R:87DACJ!K>Z ?PAX/+4DL\W!I/C^8;
M. =^0,^$AP$!CP8B7D%&YGDMCVB\DK%_.68!!XCX'G7]I(,2+">PXEE(;51A
M3=!,$G?CUC'RE#!JT1M&DP^X!X'YK]A^%(0Y]F-.PY89! M> 0=H?HE1^ W%
M1.D<%2?1.C12T?IS7.J+,CE(T-KECRL&(N!DZBC.U E@T [<.\!(XD?A\!'1
M6I/% J!%3M3FD4T^)SI@J0/&+\1(C<EN</I%'I.Y$Y0/[!"1R?+H9M*_)4:L
MDT>$SA]\F'"6[SWZLH4.9_7;\%CLR7>?<D%)&8C-I8/(Q03<BSG3,CLSR3V+
M;0!"/!^#N%C2*/SCL"J)8Z%3B$1)@V0S4B43"$C E VU(EF$H?2:\"Q.(%^Y
M/J[U(L>&4T^I%7Z>"GJ=T-U9ZVL,L2>FGN<;/%!0J4PJ:&8NX2$FT?..<SF)
MOBVY(>-6KF=;)P&3HJL'.N0'!J=X\ EWXXS1UP4=\-Q8&5#MYH<H?HH=UW[P
M[V,G^A6;/O;G]95%P;M-'@4?3OJVW>Y8==-J]^K=UM"NC\=L4!\U)X-AJVO9
M;;NYP=(CXJ(L:;4;O4$5V^0&XE1NMTOHK8(T-XG,(HCAG'4$LD%0WFA/6;_T
MX;8^^;ZYZ*:<5;!7V.,]HRR;OR=#*:58R22MYKM\@^XSC=I!79&R 3*.#%TF
MX2N"+JCT$M68F1^>7BL)Q<B=.Q@FG6$3LV"^='U">C/X^%]H8*/-!^9XF/\T
M<,(EBY!ZJT$%2R5A<D#4LE+C,081@'918O=GC\PMH24MB,YSP%MS,](G#K#P
M(4P[;J/%G+\4Q\X9VOGG$K;VC<?[LRTS9'EK0-@\9-R2?D-DX+H/%D2+&G4.
M\WYW? AN?Y9ZQ:^VFW=PQMV\&R4E5USH0'(=)9\R<FY%"_X)3X5HB,)5 7G@
M2Y!P0BX5O5J2GWPP)'/=FMCG RS/;7GZ:"PU6(@:C(MT?PP,F^QT>^$,X+'R
M!((40C(80(ZLR)BY8&+[0:.LFD09<!LT,5&D$;@6XIR6E:I+B@P=)2G'A1>9
MF4>"PAR'$M4)K+@_."O;DXUF66^$"7<>IVA,&7F6F!)!+<2]--02X=299VQ;
M_GC<Y:>;"(( +-D 6WO]&H^-Q-9.$VBJ;=C6<B05KI<I" C )XR%]@V/51Z@
M]HS&[V2.@?O-9U'EO+D<N';<!<01KLQZ<;!KDIV.[29NM:+<_-7])[G)XNK^
M=UJ-@Y_6F^T:-]!#X^V#/P>B&W;;8)AB;&]&V><:MQ\SMMNC&203@S*<2T9:
M(;Y*3$Z91C!)XSE%41/S#P4@8R%?]67YX&K^AZ=7LJ&HS+159'I^P:QTR R2
M%)^)X=@8Y#0>4:"0' +IVFK+$DP1,,E)[:5CTO*OPEDI4D:"F\XMO5_C3[;(
M)V=EU WT#YY+]"HFZ1=QKP2N(KQ$DRW3G4(R+2UE*P>RQR-9^?@Q[6MP/"I_
MXQLSDIQTJR=R_92C$JDO^2L$%O;6.CB3A\H.7KY2FP>KL2 O%!4;>:,^YHD.
MS%W)\'(Z6?C9YT.43&N*V&(.2?2WK7=\*1R54_ 6-P PS>OFKL;R$Q=7UI7&
M%M)4-)_'B7#E$$ZISI9A_O3)9>3-#%P@PXBO[PSXSY?O7T,_Z6V[^ !55\V,
M&;+E].QIX,>/--0].6==G#,M<R@V!6(,=L$H?BAB*#PT+$&<!"[CR''I49&3
M\*YTDAP.B3Y"&=RFV&6B>9>#DK223_RNS""J&'=4X2GEM&]U;6,A@W\?ST5G
MM^E^XLQ\C[R<[K,^7(7C4(P&&K=9QQJ.Z\->9U+O#MKMNMD;676;]<U.TVKW
M>_VS35A2J*(C2AP%? T"L)'.\%]=T-@MK'#X(E(QGW'ACIB>C(1YQ_,\5YY]
MBQ+ABH++^UU,?L;!6P&=- N3KC"2R2B1S)'%:G91]KXE0<EW+H;OWF\4EMOW
ML$7;><+_\&%W8VK!_]L;0)@%;AF8YC@T+WD]QPX:\3IWUO>X@.0#_W4=K##7
MG(?LO?SC P@_.YK"[8&)"/E10/]B7LZEV<K\69.KHJOP"(+8L^O"IKNF__D@
M3@!>RR0B4,@WOA.&FXU!+_/F \(K_]:G%*C\4/U^8S04QWHY-%2-$_$R.5A>
M>. ;)Z3:C'/S<V0K _M6H]\^'NBSDGLW3^&UH>&G#V"L1*R._([/]1R8\P\;
M!,PT$O: A'9C.%P#$9H_-']<)!)*=(4&NJ;\"T""U@S*HN;"^>-GX<@=W9W+
M^6[";94@IN"7P;_(@[V\)%*SRU&1PQ6VQLU:N(&C8![T;V_:;U00:QW2.*MP
MEZX!N!2\84</QUVG65L.V;WF!^>S-DXJ2BY<S9Z7\'[EF-"B6GF\R42Y$->M
M2Q/732VNS](K^GQ]W;S^?*PDUQY0H$S!U=T+S8G;,L3!,'*@<*8R"-G-B#D<
MV%-5B4 MU9/'D%W*X.DOZJ&HG;-HMD=31LD'>)A]Z'AE\+;YTL!6K@%/",SO
M0EY>>?:75%I^AGOBA5^<#;&\4["S:K&K7#?8>?.Q7QNT^H5U@^J1XG$,&66(
M2E6AK76EUI4*X$GKRO/$V^:ZLKUW7=ELM9?6<:^K*]NU;K^M=:5J1*50,E2[
M_6/?BT/UJ@.TW?**BS(T&O9>MJ1-C_:@4V9Z?$+Y=BAGO%5KC?9G8&BV?N5L
MK96:IO[+18-6:MLHM>Z62JW4:TXU5[<YTGI+->K0^7 %D" =8\<+8YRQR]2+
M%VD[0H?I+A<-VH[8QH[H+0^Q$'+N1HJY+7SDU)P8MG5.6CDB496!M?K2U'^Y
M:-#J:QOUU=]-?>V40QXVM6Y3C8)T#ED!)$A7.5F'$^$^$_7"2-K@T-&[RT6#
M-CBV,3@&97'WST+0/:"<V\EA;@V[.OZN&I6HRL%:?VGJOUPT:/VUC?X:[JB_
M7L@?C[I:?RE')0KEC_<P9>HU88;F@9\J:*3$7!)E4*%J7'B]2207+L_40%5[
M[<$QVFK9S&H9+8?Y,XL4/O,E 8>KY6ZV]F?3[$EFKR^PM6#0^O0"<:'UZ2M
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M(MSFOA<ZJ&8 *_ )2YIQ,OL:#5203Z21.4CP=\P"I>1+\-*T##NV #1XH1@
M[GB&Q8+(A/_BMYV)0PC#9T3DA,;;>(Y7<+PG.)OS2._"C3T@,SN('PUS/G?%
ME^O, VD/>A,(.K;A'._X-(XL3<"3+3^/Z;I&&(]#]N\8'Z/\V6ALY@SDM^4
MK_Y'4$[U$^,]"T_=* #ZV8&;@S#&C^$0UC0'W<SUZ:#&7W&-L637>LBLNO.C
M/G5LX,CWPH;JOOD8/?OU!9#Z7W_&KW\TYJ!U?!OL+Z2$61S%\,0+3NKP+L#"
M((#X06X;9RKZHJD9&<_ 2GF.&C,0#QZ"&Y!W!?3B&FAO-8PO<8#O(@C@02(
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M4/G1U$3;-XS0&Z5]5CSDX #<$,L4CTILZMTL@U,F!OYOS!@%BEN##^&K20N
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ML]VE,LS*6,!M(G?N>#+R ,2SVG'=D;1:38R(K8HH%$?A'BFBD"]!P&A!,5B
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M@2?-LET"HKO#71%-,9-]E3L,BAF[PY8[G N."^4.K<$+Y9FH)F,W<N9N6N:
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MERV?=&!6/9PH@0:M,[3.."U*:$Z5>GQQV?I"#1QHV:1ETTE1\O4'"RPGU.%
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M?7@1E?,X8#E$EN\5V<9NIW^P6@5.1$9L"!A#0(&\515KXA+BU-E;5] SG1)
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MY:L2O,-U$KRO#0L_'26GKG&P"@?MQG"X!AXT=VCNN$ <:#T!1CS:8QX%*!7
M2(?DU<6@1':HJ<<:ERV>JN;W7()#H2I.E$"#5AE*8.&RI9,:.-"NA:J8T=QQ
M>AQH/:%=BY.B1 R]4(\S+ELZ:<]"/9PH@0:M,93 PF5+)S5PH#T+53&CN>/T
M.-!Z0GL6)T4)=9H97\Q(.Q>*L89V+M3#B1)HT$I#*XW3HH0/9%>/,2Y;8:B!
M RV<M' Z*4JN<9@.3<U2CSDN6T"=S*+-F:_;K=A\Q0RCQJS0_M;;3R\--4JJ
MEW4V9EX,VOR)08VOX<D')EZRNM%23&74:"FF.MKF+.!B3$LQ!8WFU=MG#[9
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M EZU++^M+8?9K?1H)'M]SZ:1["],LF^9]-)(]L>7["7T]<>1[ ]VKIRV>GL
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MF>YP'B;H6;J5'$3 F#X8/W#K*8&:?(^>G(@L2.T(^2U)U0N!68(A,0=!;HD
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M4=-VH*:1G8C,LC%-=K#[;C3#5K;%* YY C2T%!4@F3)H@OM'52//[RS -*K
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MM9IH2[7:06^[AD<T59L$W<V.=:F<^+B,)J5C!RD=6Q6IU+Z@X8U8RL3'1JS
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MU-\ZSJB@J!UW?]2:)BE],:F88AKF3:B+JE.5[J47F6N0:D_,4;,:V\H3C9G
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MN-?#YO@ ,5 .\_SPZPA!NX4?E*"U,+D+.P=>^S";*HBVI;/(=)MS4'GZW=Y
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MO,Y!)(',:(06RZ$-Y+G;.N:!Z6;'^ZF;[:'A5A<'>F41Z\-+5RP9L9L.4UC
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MBP W$:!]=&-_D6),\QX#MD=7EQU^[JVJ^:00?X@@_@I4W4R:'L0G^%?5:,
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MP_LP>5ZX_0@74/&'=-'8@\4$I"&F(>"'X?KFH8TBF[Z792+'\C$^U1:C>UA
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M@"I.EK-34)8XGJY9AC51)@SG%6:QWJL96=W48 U$JIBT0Z%>$LW)5)-UIZ7
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M3X/PYGX+-]=YT#HX_,F<?E=-?\Y*30DPYS#Y J.FS;?2J+/SJA#\IU42>/]
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MO\$4-0$<H?:W GC653-31[H&IT0$2,_FG&0QMS<H -Y@LK ?DS%9;A5$X[^
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M8J1NF5$+'GD3<C+1D8+3%8[PS6$FM%7(2BCHZ6BPL?&JG6GE&5-WDUF2Q"3
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M)ATPQF5QO6\P)B4 4445LX"*SA?#Z(H8A$E:E@_A6BPX#E;A"K".*36NX*P
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M%(NZ9"F);\=5V."KB"D,XH.XL,+PK$@V2MF;HEF6Z#0/LOCN1P4UL[A-TB@
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MMW78;O-:5/B8IU\\!E,FK?1?SX=TA;,=WBPB )$8@_)@@55*5PFM<A6,",%
M](#[-Y(,/(%\F JQ0XQDZXKV'>YM?Y@DO.]JW-K)"#0.,. P(LF#/:IWOC+U
M4GU%URM2O+>D<6GR.%Q<'4]=J,Q^NX)XRUVXDEL=.,:N=61*/,@JP0 M0DF"
MPFC"%VUA>?F+]ZLX&Y@'!DW 2Y$</8Q[Z/=%2E'#2/-)4C@C@M>D1[,GV.:W
M3COFRU."WT+-DNK1Y!,,B(0QL_M?VC81$_%T4KBG/I69O+(M.:HN3=3!Q&/'
M,LG+YYX^&?\JSQOO]*E#!_LBPKM1/@^S)T_N"HD[$G'HFM3X6F?Z:T9HWB@!
M$.2+>\H'!/$L&&8T&):')T$17 @-4G/IX(1]1X2T:;9-Y'L8%?BS*BFZ^U-K
M(I!1[WIVFNB<HZ=;T31S6\YY7PF'1:26&RR'@X"/:\&*'+K[=L_D:8IAO8FA
MLTD[4@&9X>FJO]OS;KPP4N$=\V9,-WI7?(7HXYT?.]CGK["<JP9O&4@*DY6)
MGAA\;;#-9!6'=\LHF]IP&NF(.^$-H]&7N8$0K$(,=O[)/P'S72<+@5&P$V Z
M]42FI*H%5&#!4>-&3 !F!S)ZM51OZVWRC8MI[6Q*3.N\5\[$']V#T ^DJA,&
M_WAU?GWV^]?=K__ZX^3S]?GUR?7YO\_PET_JYP_G5Z>?+J[^>/4SA8GMME C
M 7# B[0;OM?_%^KJ\O</>K]FS@GYO7]G*+P,LV^+LO^6V(*&U%_-+OQS"=@M
MP\]!5[X$]=OI='L[7:4*GZDT%;Q*I Q)BE+-%70&C&,4-32CK.EGE((/H@*Y
MLI"N1TL?[95NP;VOIQ>?KR\O/EU]_7)Y<7KVX8_+LRNYZ?9:8/+'>9I$?.GQ
M!1-[ MQC/S*?=#EJW"?\#]4#[9(H3\Z\Q3[56E=S>#"H#U[CL5/8+8T42F#V
MP[&F!$K=.1E/1C94&:VJLZ&&& ?(1%7Q9&#%8%Z1H%!".;8A4WV3TF--:6>[
MFD9R269T9]?;Z>QOB]?T=&<_D+^5YG;E=+]V#1-84%JHD?8"K[ZA++'>A ^R
M-NI:SGLJ(8$6> %6E-#;Q'TH:5BG@,52?%0@53.<'$NPFB(B2Q")(NPUA4W@
MPJ3P).8L<##?4_+L::.G%M)8-2W#[8$L16D%EQ8O*NS;WFL)O2)X2'2]>0I.
M,#< "SU()QYN2^D&)-U9)2F5T6TP,PRRKTTKX@RF[=YKP^58Y@Z;VY]CU:@X
MRD.W.^;S1E%R2Q/%J@PPPVQ*/429I&E<\O21$F/%P'DJ,SF 3^>HRL9 %8F9
MY @VB*7#I]<;/*LI+7ZY?DY)ES20!Y7]7J5-4VHIE%'*NYA</6H[:D]WB365
M?/ *_@6OT:J6\!>\KM5L9K+\9N!NL5^+L$)E[F#V,*$,AD!C(%=J(,S$B<)O
M@D-$9[[@WH\^ZWTJSN,A>^P^@0F:JS3'V#F;EH'39V;-%8MS#%W/,.V-\"[0
MFUANP+LEF6L<!:K8 F/]MTP0F,S_'N>7Y2AA 8=O113)N6 X.HK\,?OG78JP
M5^*1_!.EC'39M=S+DJC(,<U5BTQT4?@ _S=Z+3!XRFDQO)-[_V'>9I2/7@9Q
MJX<'I%$M(<Q'!;E)^AB,S_<>'OW ,CL5\M3)4C*8E@/<"548DCROFHAA5I'L
M'#K_'YF.2.GZ51[U8'/V0[[H&R=91C[\>5.E='FI<<"7PY3S]5O.M(KY!#*V
M)R(@O]H+2RI&^.ORH,S7/'+3W*5$3>\(6'RY![1!62IE4N6J'2O"FD,MY]?D
M%GY(W2D5Q0D2&!%W)I9#47MA20H 2M]/,M'MWYB\LGS+(M(T2>6*X-=^ZA7!
M##ZON5.KNT9.K;FD7@\WUY>3R^NOY^<7EU_//W^\N/S]Y/K\XO.KG_%CY_Q<
MML2ZN/[U[-(Q'GB<OVK5:R:_2N?KI[-?3CZQ4^7LP_GG7Y17I=-R/H&=$+&'
M02!.+O2GK)&'#E$K*P@72?R "-=IX!&M>6RLV?E(87%H[:%$@?_JNX4>6JLW
M273#&C.^, &SU(^\<"1KI4T/)\43PG.B'TS!,",QE"LGA"R\ELC;8C7KLN2%
MQ^5@U/QGWX-X[*J0E60<QH;[Q)2".'2I(Y,GP"O)X048.:-$!NJ+^/V>S+YL
M@7:.IF2DW2<Y&+9 'ZP.-Y!7R*#9\*BQ'BT<C3T>#:C5$[Z'%;-0$1%]JCE%
MY3)%GD<L:DA^NR!8*(J'EU%1R5CMR(PT,E1/0$!L@NNS<_+U\OSJGU\_GIQ>
M7USJXWG2(J>Y\W'Q2AM[LS&WDN?J_(]J6Z-^:N #G,YOF30=]-6EB[?5E/Z9
M^' J08/G+%#>X=K$I.-2:C28N<YIJ^P9PHJ)?'+T>=>7Q##O@-/A0[^\)=9I
MP!6-7I7,XLUO>M"PY"/\E@^UL^PO;5JGLZ:U2U$9V9 6XP,V](M(E?Q5;DQY
MMF0B?X^QCVL)J&H!L#EEU(.Y1U6<@US+]-6IGL4_=7$,\_*\6NW"484N7&>Z
MQ$69*4UU393CX30987DMPH_I"AC.!1&.[M0]<V6@X">W[N+B+J]^=G+I'B13
MB-"N)T0\K[X(J=Q(EUI*DB+-K%D(7^V'PU?%W?#@(WC/TR6^AURQ$&?7 ZN7
MCIJ,,$*Y""9CZ/,9(!J,DQS]4>2PB=!IP8<I@H%D#=A*7=RJ8*J8NZ6X-LW.
M$05SH5FAB[S1G1T&]Z$(+G)*]YZ9,H</RMUR*Z0!M(A7^W>R:J^UO]LD-(R=
MDV( -K\,8N@JWS\NUZQ?YSF?$H_13)X[HP(DN>-PLU\+.-CTH/$W?6 C/-EI
MIA0:/$,P<G]6ZY*C?>+G75G0"/8PG.=_XY7KQ'GOQ=\X-"08@<K#N4^H? Q4
ML3R*[<\Q<5Q^V)\>5OY^,N!I4JR:K@I!3^-RHL3C.F'%&&>(L4&MJ>@@%2^L
MZ^V5H2X8(X>;3)8\E@7T:NA4'A"M78*5#/)$A="4)T-51L;8DGC@<=7E\F(B
MGXQEL"=N <^7VB6GR9>#UHT'%!TE>,0D2J*"^79-LNCY9"V9FS#_L-8<S35)
MS@ "[#T/ 9:=\E.CTX(ZP2N=UZ,2-]9BZ]TCC2.,?12B*7D41Z*,!P1!2BE?
MFY'M9>'%PHN%EQ\/+Q@\*QPJ^J1+P!':R!+FE(J1HAF/2KRT(LK\#%W,G;-8
M$FQ&@:8$]YSP8M9TT/S()Q:M&KQE+%I9M&H^6DD7%-5+]W(*U^]7'!868QK,
M:(LQ%F/6!F/(=9D.O#C\+]T D(Z3%CZC3DIN((LV#6:Y11N+-LU'&]D>RF5O
M<I\"Q"CV:YQDE41V;AQG$:?!;+>(8Q&G^8@S2#'=0,&*OLV*0L&!['1E9<&F
MZ1RW8&/!IOE@0[$A"FNXV699K-!"2S/Y:Z'%0DOSH07CRZ@I+P $9EP&9054
M"RS-Y*X%%@LLS0<6"LSDL$P==6S&^LE^PKJ>6.MAA4G7,J#UQ,&T.7_(M_NJ
M>F<E\)$#^#DF'R,GL0[:C6S]'(B^AQ^7M3QJ0C5;SDG-5RAUD2H!4J* $_;K
MHBG=NJ0;Z=$/JTDWKI$LX,H(")D%0&_03:UX0684M>R 9+X+4W'"5+6XYFJ8
M2489G?**T@B/9MI14F;9 !H64R#];H63P/_O(-%Y+,,OV$OHJ5IR5*SL7N1V
M*\'#O%@1R9R-0/B1)\- U 3-@&ZN)Q*.1B((N3-U4'#>$2R6LZYE,I7C#3#\
M-I>5@G7PL%GLE5P3LJ:,#"/&,E J(%H5MKQK/4EJ-+H2WT7JXP^<+0 '@6O2
MZ7;A/OR#=8AAV]4L<.&K*.E+C=/3<3&)&:6/M.@7=&O$7A47B[G*A&E<482T
M+CCKC")GU+ZK9L]X3HS!SQB$/8Y$,*@4?]^HH/F3W,'$9Z /Q<D'*?:?BYVM
MW7:K/=TU?6O/_+!2 K'(,'X=@^'+&L,I[C\.%9\?*4X@,Z!,[T+VLBLCPK$:
M<)9Q$AZC!7!NZZ RBURF'LIB0GW)S^I<5078U+OE"/?;Q!Q2!;2;6X"F0FGI
M0N&(,JW+\'2-8C*-3[^]N^CMU?7(EQO-G;#Y/.@!BI(G.@W .*IFS<PBUI4H
M8<]F_8D4$^IHE@DDY7SIX(;3+U XH)J5PX.<;VEV-*6-POT#\2&LOBE?CRN$
M[][*)N5B!-0BX%+TA17)O#)Y6)$T4X/(:KQ>1'GV= ;+[U!Y7P# U&?A8!0!
MP 0'RM+W*-N^*E#*%#>5QFDFWFS2@985;'5S>A$GQ6!HG%8RXZ@&*B4-X>Y@
M^@I9W\#(&C(KKJ(4I>)=I6PU2F*0D*0_*Q5D7@83M:UT.67#E45!.7\%& @3
MR7D>XQ2D81AS17M,@5&_P.& K^0PSHV(DK'*@2JWA8PAP/1?[#*$?UQ@"KSZ
MN5>$V-NSS&/V?_G]"^;J%ICJQE5_X"=&):E^8G\0<NW3 <N4K*/ET;3D[J8Z
MD6K&/HJY@*H=4Q:,/D:E (55]T4Z9QR8&VQA*HQR4=&M:G(UW07)FGPD>J)2
M7&@J!Q1U"-0'>(1-JU*QNT95*E;WRG5*..]^_>/SY=DOYU?79Y=G'[Y>G7PZ
MN_IZ]J\_SJ__W]>KL],_+L^O91)ZM^7\$7./,4H)O/)D/X$SKN@^E8K[!^O\
MLJ#$\U3G?)SP>.@IP)*#LA>]ID&%,C,$>8I:8HT1E)_A;ZT[DZ0-=\.35U%;
M$=M[KZ<W]1/LZ<:P]0*[DH]SSK?O[JI\>Y3KEV9CP2M5%5TG\5_M=,P.J,[V
MQQ#4I<])R]G=W=WI[AWM[Q^_YL[LTE(/C*I4(36>B+GI*BOSK$Z%Z,=0'242
M;$%!QI99BU#;Y!EVED#S0&?? I>.W?9^VP6RJG+[=2U-,,6W_%;,6@>W,8''
MMSH'^ZWCJ:+[F\3U:UG$()M7PT#E-8\C+\:B9+)XBR82-_^8S[!JA075T%)Z
MG<!RY7H.TP4F9?/=[AX<NNT]LZRN(66PN*39W@0WI+&%]WD+/T\AQQ5!D/_:
M.<<>.*GSI4B!0=D<";Q)6Y3ES?IK6KM?/YQ]//GCT_75US^^7'P&[>HSUB"3
M2M:YKG"^VW(^L$LT<_X8TYZ.L651R=TGTZ56Q=#<\(IL FOWOOY^_OD,E.>/
M9Z VJS8)E:+UOX/)">IB7\ Y-1HC6%8VC)7[7Z?K A(']U75H/.RW-+C>*=6
MRS.^?S7@&E;>1^[/NI37>R?J(C9.6;]&UG8Y93^]\\'#BKKTB>S0\535;?!6
M!8N3TDV?\8+JK5432]ZT6-/B?^?=-53JX6R'KU6OQ2IAIVXYM$X]!C406SJH
MNSERSY=%=8SKD&%*+M?IJE\=;LO(%/O-BPLOG3C\IZ[L,UFJ?;)S0=>=OOVH
MW"SH]Y<.RG(>TGDK>:CKH?-5B5.@2!YZLN@ND CS(')8HNSAPE:-]KIFU.L/
M*#A(O5'5,8QWGZEW*YL_\O(N_#S!9527)^N7\8>[Z[,T[H 0WLC%G<!6B.32
M=N72IIG]F-71_/4M4&\R_Q9(7J73K2:L275#U)M?EFA2.$&W>]6KO3"N5(::
M/1 _6+(OX9)< Q1'HIN]S>YWL8W]!:0/?O8ZGJ[&]-W@] G@6V_J8#IFR*R]
M]6:$E=>9?$?H@\P!TL#.GL@[<Q&4SYN&+9T.OFSKSXV96'_^:8JG5 5-:X>*
M!.4A4RUZ8?$HL9 LZ%O%C_Z\^LWYDB*47)(,B8H,#*/#_9^HBV/OM7/8:K=_
M0H93%\?1?#F6T3;1DZ)Z^RQ[IPZLEC]2CY" M > A!<;TMEDJ@]3E>WQ6E!@
MLV('](!\2"$X@)%1I/M6EZ)PZEW\J@-7-HS,>>\&/QY&GF-#&*R0UYI4A3$D
M=Q"6')VA1E=*/_+NF %)3I?97EZEPH^CL!C-,&EROW?MUKRK\^AWT9AQ4C,&
MA8\94@YO(B/S]8<MW.MFT!7^=DWP(;<U=A+V51N5,A:)8M P;**0$K&FYJ49
M F:>1Y[W)NVYNN**"K*I*"[W"37*\=Y2R)*^QRH?QF!*,OUDKT,=ZJ3#"HTV
M$_5Q?Y6ZIZ1%E$$#+F>WN68&BNM0Z:.4"F)CMJT*0AE7V*@J 9L1"'%0QIP;
MM;)1HTO#7L$%(3?L>GIO_:ZGU^1,+1V9O**S3>%P,N+5/."RB'<99FIV@NF#
MX8 ACU)V:^GL&NI".J7NZ0#8H<".T,(UHFMC#T-R/9\BCA=#B^O<A$FDVQP:
M"&($R:5)ENVH\%C"(OH$H_LB&91"@5\T,6,:)J:HV?>\^%M:C'-_(EO29-C)
M(/85B<HG0><.,W\(^Q'FH/KT9)5U8K!]$'+YM &8XQ@0RYU>9'!/?U8!=^>%
M/+O<5@&HB@P+1"1C4DE)^^QE@?<7+UZ6/.FK#C+4\$#-VJ>[$",.4><.@R&;
M8>=Y9@%,T->=_"@8$'8;SGR48+.<Z>TBHZRE9X4;8>-=V21!@QB;O);Z+1HB
M<F37,#U'&+6E[ZED:* 2ODIHXP3IM@P>_T^22MJ2]XB%/;U_- I9+AB&D;2#
M:4_!,E#ZNV6KG[\*VL5]#C'3UF\9,L9S*@>>FI>JG-TO4MIEY6S,H&OY)=-R
MJ]I9=QAR=P9HM^X.)U@#$$7P@H?$($%6\ZWHV(RNKZ--R(V7\!C1[3K32K6<
MY\-,=?XCW<P/FV=A&D"*EPT]U'+ZV W.GS7!3"<F1N>/)V4L;J@N9[W,.?L^
M#'LA:,OM5I<'N:MMWZ:I%OOKIUJL1S<FNG4Y^'KV?W\]?W]^?56G:JQ@:GSK
M<]!RSA3R-&)6? RS.^"PGO$'RU[S3\UUT;*>&!R%7)^#.@"W/<ZIG2BCSSE,
M_#LWM0NY\0_A$T@]$$]QF W+SB#DFF%00L/(3U+XA?KOXO4+ZD,&++;N;'/V
M'U HP_[D87W.B)X'3WU>YXTJ$_D>FAS,;W[K%7GR[HD2A7OS.C'+U^]@2C.M
M4WUP2;NJW3K<-SZ\1F)4/WI?4HQG=-AJ'_WT3BY;$90J!CO\5:<,7U]*.,WG
MB?Q5S[W*)/Q@F: AXN+1,D?MH>=*'IXGZ.&W+BO^7."%TIS\8%[>,^Y->306
M[T):R-C#]F[O:M.5'\.%1Q']2?.U%R32/SL?YF+$<:=UW+4@46'5A](6,?GU
M1N)Z(]$=:;PJKC4F.'*WU6G< >O\]$,P;34$7P]06_)L/!5^K<9B^+OG#$&'
M_\>K89Z/W[YY<WM[V\J$WQHD-V].4G^(R=%O1##PTC>!EWMO.D?M@]U.^PW0
MH=,YWNUT][OM[O[AT?[1F^#PZ.CP&*R+W4YKF(^FC%":4R#\A'VN;\F9%84P
MLU<_G\BD!_3#7(HL)QOC5*1@+H2^3$0XU_8'^GJV*^;(M'M&V3IPL)6W9CI6
MX93[PDY[78YV_FFD7L :=W:/]W</7L_T3*RS:-_/VZJ+UKY<\T4C)/^80_)?
ME_:K]W/CY<W+$B?=QD&;%2<K$R=66DQ)B[W#_8/]-\'Q[M%Q=P_%Q=Y3B(OW
MD\B[S986#%TK&*Q@^,$XU6FW.O^G<3#U'*+A@?<OC:++)L-WG@V]'?&]T^Y\
M[>X=WQ-^/PDL169<>@:$M3JI0"<<R(R.GLAO,2_VBQAX69$Y7R(/BZY\^G2J
M(\HE"%OD:BYR=2UR6>1J$')UOQ[O=N^+7(MRTQC%9O+?GB0M[6FRT"P\-A0>
MEU/V7_V\VR$%\*[2NQL"I8UAS]+%J"U&/R5&[W8Z7P_OB="ETU=&]'W1V3YG
MWP&T"2$O^O $E^^H%#S)G,ZNM]/9P_PGQ,_.?B!_JRU]HBWJ$R[=VSG>W2-
M/@F2,<H"<_PK65MGM]U5@8977MKS8I'M7'Q'/)>C=-OMK@7JAB+!/8"Z:X':
M O5+ >KNUX.G ^J/NB"H!6H+U,\,U%W0J/]FD=HB]<M ZF[GZWW=M0]6J3M'
MSA^MJ]9I2V-J9W>_?2?P'K</+/"N[<&^!_!V+?!:X'TQP-O]>O2C5&0+O!9X
MYP)OI]UIG7^^LLAKD??YD+<Q1/^_[R\_.>=8 0HCN#XD?D'YW#N$<J'Z/%"?
M!XG@3&]O/!9>JNINGR-:R,I['[S<<RB0JR=\#RMQ8ZXDO2?W!ESH"@.J@D!&
M=>DQ$-;Y0?4^"Z -VBKW ="KTU]?#( ^742#!;GGV;DFM%Q[WY,X&4W -L]%
M3%&>5_Y0C#P-?A9T&L2Z^X#.Z<DG"SH6=!JR<^\ G5,O\@M96^M3&'_K8<RG
MA: &,O(^$/3A[*.%( M!#=FY=T#0!VP-&EH$:CP?[X- GT[>6P2R"-20G7L'
M GWR>B*RX--H%MX'?+Y<GEGPL>#3D)U[!_A\,2H?6PQJ-">7QZ ]BS\6?QJR
M:T^3&PP\P/Y3]1=DV]RE+^?RQ:$!5ZJ2MQ?&7"VYK&W<>=VJP:8W5$H3/I65
M-35!JP7DKHQR2YHS\F^=DKIWDC\E(AT>M@X!B>Y9^%/-C-$*&2G+<SZP&.@3
M%0#EA_=:^WL_O;L=AKG8P7<CWV]3;UR[2Y$H]36AFX*5*YS'$ND=#Z#IDTWP
M7O#YD4J08/(I7EB7YX].W\S9V[@]7E^UWN[QGY>(SWP 35>SQRLTK<I0JGN-
MK3#,@#N.Y.B)$+M@Z,K661)A9P3L5.K[LJT"%;K^2]?AER6OQXL"\EAFR*@\
MS Z'5V'8B7P='4?L?P>#C!/97[SZU2,=JK=$GHO'!8^J[Y+]'N:6.^)^K+ ^
MF [.2KXO%0/*-<>4]]NAD&U/ B05ME7 4M_<F0L?QIQXPI6DCWV7!EX:1-@8
M"5M[P<@#$5-V>EBIS1?!&@J/N]Y3QPR>@"X07MV2]1BU_)8T%2Y&#E/>[_!'
M#U1&E[)@\K5HO7"P1JT7'F LUDUB5<T8KLY_^7QRS9W+RY\7M?6^>_>LO.W*
MEZD>G+)G8Z7?S9U05L4?9PC0%A0 N12'%U0Z#C"Z9; 'N(4!!NGUQ-"+^JI5
M'X5:RP>H\$:!@$?C>44^3%*@13"O"]\#V@00EVR?@-) WMO?9.NXH;5]7EZ(
M-<P.-89_O.J^:@#]]]N;S #5:>PS:)S+>)A'80 *H04?"SZ6YL^UT2W-+<@_
M,]'GP?NS<Z#$\B8U^ED-6SYXN7BKZP\></U!VX!IY7Q9X=VDE@"6"^\G;QLI
M)AK2 :LQ?'J3O7$N3YPKP17JS\\;(6>L&=&D<_-RS8@5VLO/%>)S1]N]']#/
MMZ&[W)0.^7*MQ)Y%-#2$2U8HK - 6:'PDFANA<+J/4N;C/D8PAX&JIW!Z3 4
M_=F:@S^NJ38O(\QA</])L>$>)-E>4'WQ]0N\<GE@N$BC#K4579LANBS-[;5(
M(RP3>RUBKT6:SA=[+=($+MAKD?7@$UZ+_-,;P;/.2>2-&B%EK/^K2:?FY1H1
M]E+D9?F_[*6(YI(5"<V')RL27A+-K4A8O5=IDQ&?+T%F^G^\V$N0DA)X173B
M^[#G<M@GB^Y$[DH6?J+DODU)_3UD$O:28$+4&^:C"'[X_U!+ P04    " "8
M1!!37][2&UT5   2WP  $0   '1S:&$M,C R,3 V,S N>'-D[5U9<^,XDG[?
MB/T/6#]L5,>6;,MVU92]73TA7SV>L"VOI>J9?>J 2$A"%$6J -"VYM=O)GA?
MXB&J3,6J'KIE DCD\3&1B8N__O5M89$7)B1W[*\'_</C \)LPS&Y/?MZX,H>
ME0;G!W_][=__[=?_Z/7(]>W=(QD8BK^P:RX-RY&N8!]&#[^0?UX^WY.1,6<+
M2JX=PUTP6Y$>F2NUO#@Z>GU]/32GW):.Y2KH2AX:SN*(]'H!X2O!*!:0:ZH8
MT?\NR,GQ2;]W_*77/QOWSR[Z_8N3T\,OYR=GQ_W/_W5\?'%\'"/PAR<#B?V[
M()\.CP_[AY_/OL0J/E'C.YTQ<G<=JWANL/.)T>\;IU_,L]//[,OQ\2?S_(R=
MF=/3X[/)>9Q39[D2?#97Y(/QBV81Y+5M9EEL16ZY36V#4XN, DD_DCO;."0#
MRR+/V$R29R:9>&'FH4_U39H7TM,<6,.6%S;0<Q=?#V+*>YL(Z] 1LR-3B2.U
M6K(CJ-2#6DQPX\!O9S(>-M(-)#,.9\[+$10< :?'O>-^[[0?5*_01Y(^X $?
MR[#5E,J);A&4Y/0BU5+D<X4ET*#_)=5 J*)NPJ*<?I2<T["%HBOX<Z;>-,[0
M2,>?3X_#'KA1P!$W<BAC%5,E6R W)P"2(Z\PQGLNUSE4064S2I>YNL2"/(-1
M;LA\SG41*O,O6=YYOI6!_=,C>"45()8%]0W'M958Y7?B%^9P9G'[^YI>L'A"
M9=C+6Z;^ZZFNW3\_/S_2I2%#KA#@D8HX\DMS6&)OQCR_$98D&E"E!)^XBMTZ
M8G'-IM2UP(RN_<.E%I]R9H)3M!AZM$2%6+&B8L;4(UTPN:0&JXA#>/'SE  J
MZQ_]\^'>\Z8'X"((T4Z"+Y:.4,3S%?>.H3WF&K7C7[W PCU\U.N?@,2'0.R
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M; 42\/P%8Z.)Q2 \F3(AL-PQOL.0K_\_=RR3"7GSPX7Q&F-5@ZO-T+-AEV5
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MT"[I;0T.AA.+SS3F_4UY42A6I\TN:0,-F[4K[M5,3 >B$W)6U,()U*']R#Q
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MZ[VC<-[7 J4Q9POZV_\!4$L#!!0    ( )A$$%.IT(X_OPD  %5]   5
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M_T@?(AQ*^X<%[5D5KLHHF)!K1A@:&I'7VP370P@1)N!?(T:$S^5",Z.)#*7
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M^,EUGI,@&B="/J)"?*<S8#P?>V@*1DTZ,5+AW"!V9ADHB:6II=K F]UZ+S
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MHJU+.UR_.0$H=QM<V^3.(;BQL;9OJB(J".O"*A<@'ZJ2>4A*>L75#!\BWUX
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M"53$"M:401;_(6,?WN(UPTA!+M#Y&_1?I\6OG=*/3L_>GWY_]NV7;/,-T08
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M/[[I^?)W=3'I[],9E?R-9D\P.?WTH$KL;^BQ81XIS/ A9=.MLD;SRGW_Q-D
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MTU/5O&JJZ04MW[?2^1$]?_;_!52\1,DX&./OA@6KJ"M$")"%]ATF,,\0(:.
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MUE[H?C*KOXBRYT6RH?^Y^L<A?HD0$2=;Y!=1FK[&R=-/$3HH5:PU"9ICH\3
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MATN)9W$6"@B-YD8WK'!KZT(%%;>P<*KCN0XO8H?K-@VL!EQ&UEZXN/2[RLT
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M!%1!Q)H:#1PPU,"*/2HJ844F2<%O[-L$XIGE^DTUK?IF!P6+RF8KQ:_M[N4
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M!#VM0*4(83(W@1F;JGHND-9BF\#SSR6>M[<7#LZGCSVF(F" <T &!'X$U9"
M8 ]*_D (X"R:?,1$'Q?1/LXCY":6:% T-#ME#E[B".,.UIQ]X$%$'UULIN-Y
M("F'#P[C10&CD]@Q\G!0RTA&"!E\(7#NYCQ)-QFKI6,769^U@_.@SY,,XH4U
M%!@P-BWG2<X]GB?Q.Q@T.(ZI5M4?8)0=4K$EOC_D*S+&Q1>UUX>':9@O[;IH
M>G@_ON($&"M >86QP!Y$!ZMJ+%0D4!\(X&?** 27N,2[*$YLG:*@XA8,3O47
MQVA@-. :LM;"Q6/ /3BKJ1WD/L[^?DWF,?GA-_WJK Y5=X!U<_%PNYOP I09
M>Z N3$=2P++'L8:T.1_<.AVO K'^W& @^=M=&J_A3V0EF;-%H[T;=A!TAV0K
M _?.=_5E#]=T05VQ"M,#^Q'L<;X>1<X"K4Z78SPEW)Q50(X'AQ]%M66YY3NC
M<?)TO"N[2#:K>*=_+-\9/\-UNR/^7HHO,NPQ@WU?24?WZ:-"OK9C&^R.:LYD
M#*%4X]JPL \ WX(1U3?):_92BM)ZB(':"Q?'OH(4E$9ZHFBEGN60>A:E>J9*
M;-@=47$[]39.X$T.=UI5J0X"YE-A*T$?5_#IY=CRNNS/E!5@O *YQ-R/#%92
M6) H($L 5$> =SN<,.+\8O#BD#_C-/ZGJU8&]=O*G!W(*+\3D#&.("I9CNS6
M*[C;XS1*7Z_^<2"1J*D '0<?)&5N9 .D_<"4D _R^!%!DOG +61=V?51&S,2
MJ(*)-34;.' B3I2\ &<FKOF#A2)*RH?<A#&,&#'<F:+%(&^R[.!G@'<=@XH9
M1V\#6A[R+">))\FJQAP5KMA:GUE,\1K"379-P@"%)R(A8KF5)K0?4YQI/&BG
M2,[T6)L2>3^'% 5K0 ,FLRO*G-U!J$W'3U2"$%:LFLAB Q5;-*NAE'@XN#RD
MQ([O8!KC#?>JC_ S^Y$C(.L^]2 '!K!AS&DC3L+=P1'%$>U37F$PLK2\HF"B
M\QHE*BL!?&B4)RB8LOL-?&@\LV>,W41[\9*L6)<4'#V]@,2E+Q%C3QF=T&>.
MT($&>7"0^Q/]ZO?OS_[MCV 39VM\H"_.%]W<R/=)J%+O2N2H:5F?*[,?\E9*
MV=47VFXMTUL2F%#W%)9:N7DX_GB@Q1EVA9>R!9AS!+!@&<9*P0)V;*_P^4&,
M9$_G_ $7 ' )BL4&_PTA!+@:1MW3W:PJQE]@1-B2A1%Q4ZV"70\1FRM"'42]
M+)S0\<;$%J<\RRLGW# \<A@RK*S%8.%IS0=J?&Q71-):N;[D6Z5D<GZ&Y?'M
MY9;\D 80NIFIO$(R)6_:Y=F(G9\VS]U%")!S::2[&EC(0WZ5"!3"@LK2,+ #
M1,R:EJLR;.YZN;?I8PZ^S;K),0#+WC7WQ6=EW)U&HFW?[=#X-?';^!^'>$/^
MLH+ISKU]-\C[-NX:NP L&Q7R +*@V<W*K-L-0]NF6Q"9X<1=V[S6L8"3QK3M
MH'_\A&I QQJH*O)\F2:DD.[T%7+P,VXC*L#/3&=A"D?SW.R586001^=V1E2#
MAPG"PB#HI##OP1L90"D'6/4J0'7#KF_,&AMU_62,-^CZR'K:F!L ((0\1!$U
MK*%&HT2YVJZY2_%]E$=W.*5J7&[+HX*\#*EL2!H4#6U*F8,7\[J1MM'V*3Y-
MB0!@SR6@GU5=-?GF? C6IH\R-M.UD0U22@\5)5X+5[:WCF^;'GUNH^;G-#SA
M!&1#$5O0(=A+/R)X6%=&=K#8T>W+>[BFIS/C;0PW*]PYN2O;AR950[O1XN+%
MGK@$]*6N4@3Z6,VZ.R4+P=+,,,?F6@\XCZG?=!C(GEV<VO _)-0<34=*9C^:
MD9."^JY@U5E89 2-F%X<*\K)F%T=+1IYP ))^:0-X4LOQD9 <*:?59IX&'@1
M2WEY]TQ^#F^2ZRA.?XK0@0W8O^76 ?Z(:1^Q[!G +WOZ2G!&$(4TO-)U/%O.
M;\"6" A>J(0T#?3@L!YSDV-S;DM-?)BQQT$A:30/DDV*TQ;VLD\PZ<MSQ.JH
MWAYIYP"S5(( 5F0\,FOZ7&=/,6:ZYSNIX9U'&:1/G=((PI*V19K2V,;.%9Z_
M5K\CSAHN/D?IQN:Q3UNF3MZ>M!/"\T.B[$ =XPQD\8 L'WW.4OY%(2-@0@;[
M^*@C@VM_JM0%IF_&N-!T=J42GU>?\>H9'[(HV:P^$_KBWM0-,:8DCU]H:VVG
M#ZG*OD;C8G%UJF1(&VTGME7OHU'Q8YS'@U*N$VA0-%Q#*G/P4A^@;Y[D@CW(
M&7^QMHQ+9/9$A!"J OKH8C,=SP/)VFEP^'G @0(=A B3U P+MH#S%46!>H!P
MU@'F:K='^!5"QJ3HRFD0'P;I&-K2 %TOL:#@*0) V0PW%/]7Q0SKZ#!D?&IM
MK IPN%N4C6295_R:WO9Y_^Z/5P]W=^RO9W_\C7TH&&6,2&%XKIS^@M:H$((;
M<6U"T]>[OFYZ=*N5G)_S>06KXII0".X\@ 964%. FJ\=?"G5+A@YJ'MZ%!UU
M2#U5)Z![F.5I3'OWL:#P*8GS[/[ADWYKPP%"YFO.7L(>^HB6[$289 S#*#*H
M@86U=!<T,*@/$W /'L G1XZ3I;GD-.1?38<A'_UM%>>T]G&3;.*7>'.(D&HS
M]YXOZ^N_DYB'.C=E0_=4*D;3>L(P"GA00<%I',G*7LK*=M*CW<RT_Q+GS_<0
ML>0F>X[W*WQ%EHCYJWJS=B.RCL#I9_.U.HHBIETNI*+4&>'7XW:4/9#YT]TM
M+H%^7_BNA1)_#;18E-&&E1>$V0'E49)K+YN4B)FF\@K$_2RIQ(.IL. L^FN4
MO(-88NG@B+55&CQFM<68 .RJ!IC$V,'B;+2!H:XQ+>IC4LA %</@ASB)=X>=
MRT$TCY<P!B.O,7\BZ7N</.F^?%3[FODR12+CWN %\3"6AVUZQCV*"$BGJ*;.
M:9XF$LSU7R-J?-%:K;Z2U!"-M?M=H19E!*79ILE.\UQ0QSD,=M""'U);)@;O
M!6F1M3A/HL[&PW$DROSTL7X"I#HE<E*>E28RA.$S)F!C"VW/"%@D8=IZ_(<=
M[9$0G:K@/JR9U6?LPV$ELCYQ+=E,Z+!$AKDX[#'86@[;T/:,@-5S6'IV)5R'
M)>R\S+$UPEZQK1A-Z;94BMDX;@OH>J[;U/FL -9T7\K>W=OJ@\.])N/1?6E=
MBZCIV]X:3/R\PL[PXKZXEO&*&%[%U:DMX1-";=4(:6RL[-F@:A1>J1 .7G0?
M?;!ZH89R=Q9I"#':[ON.B!UOZ 6&9'/Q',/MU1>X/M #L\OM-EY#W5BC2];0
M+O78>(DW0H03>OF-"\&W<*@8M(TVEX.V*J."A!!R#"''%CJ?$;RUDU(+\ !9
MGWMP<V,?6*88C@@M@C4H>?,M'F:D)7L@^ =R4L_ZA)[SDWFCG<AC 3_,(WG*
M1_&\',$;X^A=6*OP*L_INFYX:_*\I0MNSI=S&MP]99D#]RH'KE7>AO;6ID.;
M&E[Y:Z,W?_L93-S=FXYO#?$78<3U9^<O!?:\/2,_"LB>O2A>*/)43!E6!7WM
M"1(!Z >74:[^[()#CFX7[/H2C%RCD?SE\56\2<1_;R_\A9=QUI*88$/D#&%A
MY=[0!@H]IG :=="[@RF]0QL]D64*"0MX1V18WR3K%!*F5R\P??TKC-*;Y.A]
M8I)@P?0%;JYQ>GW(#RDL^CPI^Y,/UJ:]VIR+XJ=/;2DFC:]1(2B]CL\D!9"*
M"EZ)K.2SVI-]131.A< L%F^9R&5(#L';/-HC]@QVO_^Y64Y(,EU$^SB/D -O
MM"!N\62[+C,?O<<E_^ASC##2?G/LL;7:9X<SJD',2P""?]'3K9  $!$ EZ%\
M%G2**L'C<";PV,P$KK[LXY3],G\!4+M8X(:IY9K/A1!^-ZAJ>>H)[>DHF"MU
M-1RU,.#4C)KU 7=(O1F3D:L%CVK%@L:F)UO[5,*)QSR];7E.M5Q4]*VC1>";
M4X2S^I(L'KCL5558Q>W*V%4K,,Y93E"FK(LPU80U[%+!U[$[S,=%,;L-HS=B
M*L["CC15]0>=N9=?:NWU_=9>WJX2T9'^EEM0"@@*"0$3$5 9R6>@MG +=,%F
MXMCT_:Z, $3_/LJ\5V<X02B3!1AUSJ-OQ67,65G4"JN8X]: 7,Q\QSB]"6-Q
M-NLQT5CLHO^<2[P1;=I^3.F-_QNQ\/TQQ=DXYTKZV$]@7MWB^.A:T!.;1*M%
M\$0E&7I8(OB8I&!D+B+4$'IOT*"<1:^B72.7E&987%; A!T[FK&VT>Q)E4OV
M/@R7A:=YG9UE]2*6*0L+(S)C.<(1'/*WVGI$O,W##P_3OL"!Q!]+L\".L)BI
M"12Q@K=&YQ!S*0I?%^NHOG[*ZJ' ];FLCE :\<IK^9:7_^-:RH*,?8I+4;!
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MDN" 2@ZHZ*"0'=S/Z YP&QA77_:0]NR\I ^:PF0S:7!L%R80LVT3SGUP++B
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M#%UWXZ;]^^;XM=%S[ZB4RREE RB?$T YA>%]O7A@%3V%J'M4J;W4.E/Z-%L
MS8'J%_Z[*+A3OJ\B_WQ,O[NBWZ>K,!'H<8#!FKW:$J(]J52_'Z1 Q'#YT$?4
MR^+A(> E@Q),6%ESP4)22XL%'A4[P/A9;92,- [4/X2I[B:I);>ZR9P.5?,X
MJ\[%1Z-;*>4.8]HS@!*;*W,^L*$6Q(:64%,DD_+H]1/)MF^[P<A7 AFX"W5G
MC5W*"4_=K:;O*E&\._]P$>WC/$(_IOBPO[V]T$P2NPD89B-=!+TDAX09$-P
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MO?DHV(.8]BZE E '6(M-3?;V=PBU%WV0L9FJ^R]==9C@8K.)J6HC=(&3+-[
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MZ++BU3\.\9ZJY([H\ID:U"+9,/K+0[[<,AO;7(L*DK(9:%(UM!$M+EX,J)0
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M2\YUZIZ.3)X O"^:[(AM@@W,UFF\#Z<]H :0 YL$;2H-'[3^K0+.D:XA.<\
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M.N];C):+GIE_]Z#QJG"M\?PA]7KO4$^+70<JSQ!2;]4>*$*U#G*>TV'V 0#
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MSQ@P9/7&40K9B=DIT5 %5F[ZFMX.1OP*06#W'BYJ9F=] VZ4I/#:RX$ROF.
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M7<FF%:@DGP*J/N[A4(42WIR @SAP+=BHJ05'T?">?6I1S'<Z28'\8GC?;+5
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M<44\]::<5H)5OT@N3>-K)/='ZLWH"L'MU$^ IE)UU//[S-HIF'F@,&K3Z"6
M:F-FR@J9\TM44JA/B-DUCL9I:48US ]\@VR>_!>^55G,SR\BD'+\:EK0K.';
MF7$* H\*0K#X\"\8OOR1T9K$=+M***E!=4WAV?(+QWV*E04+?/]_S$V%;W-R
M+YD16M.?J^A#7<Y'];QL3H1/N H_@YMAJX,RNH+5@K<HBV(21R8SETF-K0(N
MP(Z!CR=%43-=ZJ2 !]*3X8]*'I* E#"#,"G\K$C&VT.3$/^JW-C[Z02Y%GA[
M5?,A_\5:V/L1^#'SJ6Y"DTRK+S8QBPJV1;5Z6O[Z7Z=P&&7IQ&Q7R<34L)HS
M&,\0OJ79$;)S'O74C"Y I)'\O.*;PUBYU0/\7I]@/XAI]8MYS2=<<N]5?YU<
MR=M45MQAZTW,&(M1<>IA/_!0LP)'"6=9A>()HT&Z(ESV>2:,OJ4Y1UI@7E^N
M-IEC\0MZF?#)>7%IRAP-"+@/;Y7TTLCR!5_R%9;DG3;.K#3\OI56T]C:'$<'
M7\)&@-G%^\+#+TF9P7TF$WP6M<&PUDQ1"B5Q\0=\R;?X(A/IJXWF2.^U5I8G
M"/S1;4NE?/:/>3J;&F<0A(^W%QG]G27"QZ.)2_2)QADY\X>&EAG5.FN[9(C"
MYDU4U.-KX9(<%@8!. &U\];)?6=2CJ!WJ-U63:F>":R:JZ!"FN]Q0A<D506V
MD(&I&F4)[!JX9.@T-*E:UK/^1:!<:I&>6U\U]L:7EBB+,Q;Q"-R+O%:-GXQJ
M4EIPOF;%PN &R-(1\C[B/\]1ERM!]B48L:;B>V.SL,'NR?VMUV!FZ:[]D[O.
M;V S?.Y;\ZO&]CUC;ZE(X>BL/!(+=\ 6[N#K6[BL ?]2.C<B,- ^S(>TU:5/
M$=MDM,*J/6-G-1*%7X6_Y9T0^W:D?$F]D/2*.*2"KXMS0QK%VC54)HMVC1@^
M] 5I'7H,6'ULDGE6@Z^@2)FAE3HV*$U)T\R=B.:7N^/M\ YZ5L#@^5DQ-SM"
M)HKVH0M?@N8#^^03";@8:&69CDG*Q\@QA>&;&*VT3[B-8$1X*S6/R*Q)TI)_
MA.,Y!>4,=C%,28\\"6M:@YL))]G8NTE6#.&-Y \8,8]0]QY.TG2>U>DVOU2D
M9A*=CD4QY;>TAMH$]F/Y0V^R]V9RL'O8/^X_VY=-UKD!]YK?P77XW5[_V>'Q
M\N^.Y;J]K[]Q/U+ "N7U75'![JF<5W=CUP8PH"I8%_!5X*]TE,YL X>9O9?;
M2[([KU)N55!+I,SM<_5A0;NS.^<:Z@P7@:'E&1*GLS+-HOX!1W/N[>>>@5Q.
M:8._-!GLN')!#=9<:*1166VGA7PK2J*@CN-)73$+\*JD"]R[NFF@ES71DJ%(
M&7;0V@-CX6/T(0.5*DXO=IR#^6:3U5#7HG0Z2[A1$>H#M$)L:P_[0L'%,%S0
M( FH -(@;*? C="Z2VTKMW$RA1.ZXKO"!ZRX>R.YM?;ZH!LGHY&9K184?$T[
M')[2RK^ 'H-7Z<P%B_.FJ%&%5=B.0_O5>?9]ZJV=;<PWYHF^8>&6R^CO8/#N
M]544*W?HH6.;T_W&<^,M-4;RR-/_K2A'!J[_PX"3O!7[7:>XY1YO+;NTV.6%
M!TM>;8EMEG)AN_1[5 53\K=9D8LM"J*G]\51S>9E-<<'T@$-3[EUJ/H#FF9P
MASW9(E%#@,#'FI>^=./L-?O=6:,/- I(YMCO&8CM4L)>75[+$_ WIC-40'"J
M38?P$D8?H_&BBT1T5E5,, J%IC XO_-2EDQ^KEV8Q$#A@YZN@Y7F0( G#7(*
MPC8JP24D#BW8D!5>-BK383.&Q$W)KB_2(;SJRRWK6S9&@T.>P&2E&"C!)0%'
MOC+.O% 9Y&W5F&?8B11'RO@ET+7%!C?P#2UV,%2\W#XHD)!?%]2<<K;0'>.>
M&>S>(4X1W(V>15$UWL^L4IJ[)2V]_9)8\VJ,,@W_I@'28\'_7Z"1%!B+X"U0
MO!&C@/#KV3P?76QG:07SC]$-/G#@@?B^<,G07A%::;3E0<9B*VS^!F +L;4-
M5+KM6Z,TI'QNY7-48W"ORR(-]]D[BF'!/6XUEQ(YI5NI O*[S"5@\]8U]:0;
MHC9#GN=L89MVPHOBM-QZPZH<:GZ)%#H\#_E!TI+<TE[?.UO:S4:5%<1<SU))
M/NA2XL>I4%%C,U X6 ;V7JZ9'LAUM\#(B;'G7V,G J]R2TN]^B8@ R!/0S J
M)9+3-%L#<>R9:SIUN*]I0X[P$N90T<.9YWWK)+HHK@PLBX26DS2;E_9UJ74I
MNRNZDM[%WC$ZQECVDOZM02=!\%[Q/ \U?B!@;W6SM(XGI]%F*H3=3[02[>TV
MF5)Z*Y=C"&T*GD&4DB+/T% I*FU\J'(^2Q8<%9I$?O_&5L?%Y0T;8:$2<I2B
MAM_2="D>#B;S$%GR;PTYX0SCENTBCTGLJ*_0B^\76_#=>YN>1[F_S&L<[.ZU
M/%'['7RY]+N]_N'2[_;W5GQWT/KN!AC$80<,XAO.[_Y.E_?\-9SL]RZ8OBXO
MOX2OZ]Z[IG^PLW>\?MM&$#C@-7_UQ7['QU]G3M^W^\"[-W""8J-@W]SCLU'C
M@^S1Q7 .3BDJ-S9C=45*ROX7DXDU:]"TME8$6&?(=8Y/P+-\[ ?_P$HXQPX'
MG/3$@R'% WL"KP$'LC.Y?H:_F#+=W61">>E&WBMXLC.DFE@ :W1@XTU$S\B/
M*"#@^KE0BM#+$%8)Y@,Q/P)WK]%J:"$E?!/0YJBT#[/G3=I@K'1X+L(!UNU;
MV>^UF[/SZB@#/S8S0Z+O7Q@Z59X1E(QQ6Z'Y6BG,06<V=M,#@Z:)F(($7;"M
MGXPOT0-JO3C8[&#!NA_"W&59V_QJW[L-R+#A<K9CK;^K+WS"$1<Z[^.5]R[$
M-Z&QC1,R4\FBHW'"+V'3Y6Q#MG^('U0&'4802/228?6QHZI<++] [Z(U&3H-
MWM@H#H"1!33309;X)M)CUAN(NZNZ9?^8P\_%%L9-A[_I/]T[/- ?)WF./_$>
M!NMD*,P6C>>>.1P\6:3,M;>%U[9AI>"W<;AG,'(D\]4RYT/WDQ50U9  G8D)
M9L[8#F],K<R*P3W2F@]T%5+0YTG)*H6@.LNU&^Z[5MR&[U^!=B;MYS?MI0]!
MQ^6&M(D;]Q?/(JS3"25IA-W!T4$K'>"=7F(X]89?__1Z"QYV0OX=>6(G[*6=
MM%PT/=Z^Q.KX[\%6]WJM5Z]_VWF7C>FIMM96;41_FL<_*19JV!7U8"E8;;8Z
M8!=%JP/VUKT0H(VM&@)I1146OM9KR(G+, Y-5EQM8:!FY;!MF^T>B-1HSM'7
M>86?K&H%CXJI\>BM[CP5ALZGR2<DS"5;9Y+@\68DJ:(*KJFB.("(JM9%4E1Q
M6FVY, EE/XB(5[,0GL9OG4TO^3M:R\Z[I+XRYB^< EXM,;%G'5!?< PF4U*.
MSG-W[*XR#_"H4;$+5MO8)%1SIG!6.(6U>EI2-ALEJ>6./1J3Y(K2/)BNWS"Y
M3P<$C@+^UP,'X++:162(V+;]^[8KZH=:I4&&S+>3CS*\<V>.Z:-G#]47IFN>
MZ11NCDGM)#<B9QG/$$-5(F@4\ZIJ+BYI5B_C8RQP0:'P6*?:.\;#)?+PG0W1
MHD@^)6"\4&#K%*\\J? L_!"1BS IDJ>*;SBD5$8AD560-CNUG9%(>N^I/*YA
M*'-F$(R8+CV$.B*Y3,!.T:QD>]<]BD.KC578WU?(^ZTC-D=B> QN>P!^%'3/
M?7+PC25M(O8H94)=C3EX/$XKROQ)&JZ1/7( &Q\M+X=4F%]@B:+M"TJT8KP0
M&*3L;]L]5UR!C5I=I+,X*GBDN(^8GQUQI;EFJ@(PZ-APNJE[+U>(8Z9/8<<0
M1 X.C!$V-:TXY535 K1 +]F0TA< ;P-;1SG%YU'4.Y4<RA6EY,F32#+"B>/8
M:'_G('ZP 2V #@UT2NK#O>BVYR4RSF.*SN2831CJH3V5#DPF/X?_M4:\-Q_!
M7&"H0C*^#6A5+P1K>8$'A"(5C*B P2*$5!Q2N_CP[V(RN?<[7%T4FE9"<GTV
M.!S\L#+E)?9,6RH.=WWGK6#QT+K&#[19*R/,<S"FZHJSTK+&F*0[B7J_RK)R
M9I>DH1+A0^Q\DE5>$<.RT2%P"Q$@]+]9PM:IN)O=@X8GOY G<]9ZPC 2EU2F
MY@0VX<:K*R4-28;!K'/4PK,4T=@P.##IYB7BP$L*53$TA1+7X&OS2<ZJ3%]!
M93OJN=G#29C76HZ%MF!KWV&F<8IK^D]K7R8$KS/EB!.IGJ 1+!P.IJ@D$^!2
M\G5DBLRP,F'L?KWH/@7Y'4;V6AZSA:HDA-RC<C1-);-@LVFM**HQ70<[]I)J
M4S1H "L[F8/Z@TN+*9AN6!)@,^C^:L2<.[,J!V-L&,DIQYC;V7UVPI4>L'WA
M:\:0%(3>GC#LA4H>0"8SFG?,"]NM[K\KSR=*JC.QXZ6S^\=\?"Z"5D57!F-^
ME1.)EBRE.:/V(YHKV-]BT:(I_CJYBJSM12B0>7:N2X$_",#_R1SDCX6:+?D0
M_N_=J5106C.-C%=1XPQ\87CZEQ&L6Z_GPRPGS#AK'3MN.%M',$U4$])[Z2D
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M!&^<SG/"D H;M%X _T5Y=32KDVN4QG'*Q,8<4!&$),>BE-5/?LDI1D=A.:S
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M#T*4(E13$F<E-0J>E\,PA]8,CR^)9<]1,J;)Z (=Q2@P?IKRP[LO4!C)9$(
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MO$.KX -%E.J@*HMK#)#9K<7G2CXDC'-6@H\<O'?'C6/MN/%E8-V"W[9GWJ/
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MA,:IX_5&V!Q\FE^F-?Y!_IX3+LK0!=V+81Q;;55UHXZ*K4)K:BO].T@<(;6
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M-%364BZP\&=6X=]PMMSZ'-';W_4D:5]W96N?/5 EPURU8W-7S:*:F]^KQMY
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M.$HS2WKD+0S&&T]J$G5@<Z4V(2(%ZU6? M:(A81+-7;0@)BQW%M'%L-!!2W
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M!V$ [H2FGV$:4&Y6'S+[AL4/1Y<1GBF\2K&7MX8D(P_)=(O2BO*6?'=BR#'
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M<]!H^59F\P'F+XT='UFS.#_=-FX2E^<WD"MOGFXE.T$IGH1GL)*;IF.)^7@
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M(I:(4FNVB1JH:.5*-FH&15QWGZN'<0Q84X>?HIAZ;H,,M @S7KJA'8X*VMH
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M/WBZ'SL77RZ\L\[Y__C>\?&!W]#>X)5^7T"-0V[)>(A&Q! 11T$OBJ.".2W
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M^=Z8#3Y&FJ[@[U;6?I]9C3.8?/G?Y7]?YK^S1HR>V^JSTI@75AKSG6 1V46
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MJ#BGV;NTF2.:W-4B#^,AIR?D5X,H"_L4]\[(9%(_W5+4&EE&LY3HGBF /<;
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M'DCLB&Q.FCM"3^7 ET;^'W] _M GX%E*O$<^X*F2^V!BP@-4S9?4&S\S'7(
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M>QKK]<B(B1"]$ "YZ=\3,:-L?@Q'7]_?5"7Q(Q-5$SN0+DV&5GMLKP41Q8.
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M^.%'[W@;V82'"8[@(H<#'HM7";3$.;^_P@Z@1@/_(:4F1'E"AQ3V1#3.$I"
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MQ)R43RU S=/A\=6T'/ <VC);;KY :X=O)XY%1_U1=9>>WKO;PLXZYA86RI@
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M"0)[O@0/;**4[D>@N3RLKGMR^"TY0*82'9F!8D&&;EOG>&"#<-'QJ/W0E8=
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M5WA;6'R[,&.%='%4]\N$K/+8'',B,A<*68/C*UWWMB H2?1QY=F(*A'C0,*
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M2K-I&,0/ A@KK+"01TI4%^+2S,9U[4 1V/\%<I.M,F2HBK@X-=6XP> 7=$5
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M-=!9:JP5J)8:5_\9#3-E+;NNH<^YX%L'MJ*MJZTK&'U6Q!P&QVYR KC&)Z7
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MIG2MQ]=IA<>(!X/*\_36C?HS6:6%Z[!NL51@AE%<2+:PW9069M*RS!+]H:F
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M (:''F<9 KHS%\&T\-Z"TAPE,[!7*8)Y;]TG'H2:W@Z'*;?#84K]>/FRN]H
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M%DX;YY&>]::#6I\DB[FH>+FS!O;MB(6++)*')ES#I,YJ"^,?IN1!R!R%S8?
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M%$5YQ227A]B IXG>8K/-WTZP'O_=YL<G,I_O;_AK+K:C'SQM]"2@W]WPUUQ
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M,+L"F^XCVH%CG!VUN%[LOJ3^SEX/;K"C8!AH)9,%A[S_-+L3\3#1N9:%E]4
M[R7/:]M!^B:O=>+YJH,X H.*+'9US!,2E7@5+Y;M0U]\AO..$]T=Q +;_ASE
MUD@ F<TIKI73[!ID;MS2TKMSAH-8T('0G\/5UZ:FQ0$3M&PO+J,7>\\WMW$^
M9%I[P_8DU6WX36.0UN/@)(@_7%.7=/*4[ C)"D:_2!XT=I<DSV ^$W;2R&*D
MYHSI= 9^?X7.1 V:*BNXU^.8GH!.#?X]P[M.LP)_AS.%'=F3 HW[K/BC+>1U
M:8>S7.-%9(_CWO9>%1L;T^*%%R<OW8:R+7CD(_6*)U3/CHI(54F%,8MQC>^<
M--)JDE2/N9\9*&WY)$_'W5;ML&+:I!+%J4Y5#<G.B%&)4-_*,>S[*B4GM4[3
M3\%9'XKHXQ)>)JPGJ2NRW>_D@<%_N(F\*X,LYR#D&=W1DV(4K-IMF,YC0H<0
M;IW/]?I;J2&*?$C[=1Q_0"9UC> MX,<BC %)]3:6J) :C$H885&@WUEC..&Z
M;'-LYJMW2R2(0A$G/G1:B>"EZ'E2IA1>+QN1-H-W-//CB$]_V*))S-!0;IJ<
M!6N,O+@@EO-N/^.[';]]S)>\0&"&Z9A,4_?&Q9@$P 2I^'25;WDD%$.@W;S"
M.!:\N)[__*XTIH53[ASZ="<]9C$<9K; S:J.%HJ.=7HK"JZ8X=G8BAT[]=VF
M6 F><_"+B(-Q.8;I;<]R<.C+"K=HC6%7CN=-Z$DUA[TP=%!XN_(VA_'>WD8R
M\.;F?2=4B@<S*.V9RATI9<?<$N7#N]NU=C 8^3FM1ARASB?/+M-\!N\SA=='
MS8#R2-H3E@"T.+8^-W%/[@P_;.#SCM;BJU>2OR2O<4VP'R^RC3C+8M6OM/@6
M0<ORK"$3 *Z!$T3/'EP-8SO2;TS0R,Q.-^3R_=OWYU[[XAV9U+JMKC(1?)[9
MQ)I9;A3MSB?D^\@([C[XC.!/Q^^/3\&C^GCZX3?P^C^\/[LG#W7K=A&B%1?G
M:ZO\7O:JH-PO]Y9]^7S9ER^6?;F_Z,L]^/+ELBN%LGE[=W/;$XL[D)X;)NC<
MV=T?R00#;8D?<GKQ%W1Z414>@=Y]#78:Z@6$A]]N$,&8R=*UZ1GG:#X4"24@
MX+0$JQ.$+[$&_G52478FK3F(OR@'N'3-T>_/,'6.>;,6?LT&#)BK<*YV;H=F
MM*K&CM.&*3/N#Z\>@9/"D[P5&M\U?%)C9L1[V;,RRM&=@OO;E!#\87[=30J"
MHTT6!E@WF'T;799X1N+VG!9TBKGY0QS14M&VB4CG.K9)-=:05?QZ<+=*DH K
M'A?\?'R$.WXV4Y&A%$XBRL4XETAF"I\$JNW2,1] ?02=8SW-]C8#:9]!W%U(
M25ZY:ZG[ -_'[H6EF][;*&YB:JDVL&*S5"_(4*Q,H4^0\>1YL !]]9W-[<WM
MC3&\;#J9X&>T.)IT>@.>?H%IMB.;?;J&P3<@D]SCBN;-64B8L NX1V'(@CNF
M&=IWKKB8)7-RR3.P9DE\^UL3I9M$B%U>]SN337.'PUO9[%9' F'X* -@1A?C
MU6[6,8N7RZ\\65+8U^CETORB(9M-9TG&V76QF2NV9.<+LN\QGF%JQ6I&W'T\
M>;_P4D8-B!5N]PZ'B.P-65.16S;IJ0FK>#![J $3/%]Y45#C;4:\F!^^S\7D
METKF4XX!L1(/3 7%*\JVT5MO1NMO'=V41'MA;)"=N[=!SMH1(@7*BO7705W#
MC-5W8D9T5)$GBT-8!GXB?*QXFF%:I).LL4 *;V@8FD-5"!N$!TE1GT1#6YMV
M-^+!07%X^EUW&Y2.*JC9T>V>>!BYD2!H#[&E:10^BU0["R)%.L#JT4715@YF
MX/W  Z=]2?>T:(3^O>LRY[@-.,$PK,&F,PQZ8_X]FSH:"HC-F#DVR0-B7(,<
M'@ZP(^:P9 Z^/LLKA8MIPD#]I1=P0=(P&D=BQABP&66SQ&")<H./PN_@2;'^
M31Y\6C<$$B'MR0,V[^Q9/KP2;(&("-0F0A9 AJ1B!G4@?JZQA3_ZG0U/?"M\
M5UX8?D.V>/2]'=P,C36L<9Y '%\/XGC^F $<W_BX^2I5GFC&!HP-1MG:3"@;
MOP*B&FS>R='1B8AVC(V4@I<7)85Q:^N5%65T?"5*[RB=)&W.WB AP>!<1;M.
M5:=8=WQ"9(2>-#HK!" 6>^XC@?Y F92Q_A!D%W& &":'R[.I8Z&FJM@I1;R1
M#*($U'J%=BGF7$&Y-WC^5(Y6AC\VAOB[*Q@]QHHG+47D\3AH!)\W3H<-?;Z^
MUA$8.[MW;^R<L.L]R4:T2'=OY5C8I& W2W7W)_,8UFV2%FS?7\*$\:$>>R>Z
MG' 9>BAHRY.#R")3HAB5$Q@\"50ZG>7E/,50?G+!./,$EAMVYKR.?>"R""UX
M1%F>D2--[CBY01*PP8T5\(2B#1P<'LT1GMT[6Z^_8M+AN3R2NU$1.)[MUP/8
MX=4T1Z=9\A@_1AO9@*T3U\J 0<#D(F(V3[*IF!LP'911("0'!C!XQG-8K"]^
MWT.Z_]V^(XU9LF*@ BH!HM@EYOQ/1H9H(;$& TB@+:<J'/TYE)W$ ;/XNHX1
M%AN9S&)>PA/)4 8W,RWPWQL6+-"Q7(_E)P/7%:_;">:FQP0R$$V,R3AT=A5V
MW9<2SB2">*(:1^-R NM37N-#$?T?LXE+T&-,-C8E2[T ?ZA P'MQQ0?)KM-*
M @_B;E_,W=6.AC=;3%]XDDK25"=G$+N7IEPZ@AX.RP7^]@?X2V:5MW:.T*&V
M3I=-A[&=+RJX%$UT$&Y*>)-WD>?@4D=3S.925KKO?)E<$JC63C;)1B<PS<E@
MJXF#_V!1$HVD\;=#V4?\)K$W"?3";'';<*>)53D)W*HM[@NA]Q#.L+V[/\/P
M$UR=8YAU6/U[\-3Q 5FM%DS*SS%.ND2F**J+8:].$+T7=EKGY7U^#_$8K)YR
MTMP?#9CL[E?Z.&%8%3\@$%3-,(I-XP'51QHU):B(*3*1*V'1-=&O%GH_84^!
M KUDG:7BQ=U+Q2$<4*G!,OK']=W+!1N"&,,:\7/AJ*::QQ2.23DR)YD-MP_S
MI/A4+W"<\)3&HJ.BL09)8H-Q$Q?*N<Y2L7_W4G$ 4SB>:NW?[U6&9OQKJ2=^
M#39$DUY4]^3IO"\Q18;@* S(ZD#0%IF68^-AZ;[W9(+L-(:.QQ3E! O^@LR8
M3HJ'2PQ-2J45#RETNRK-P4A+M22MK,:4,NP%5K6$TXM0,K"<PJ6:T-/0(-J=
M^$2G)M0!"1H\.UF>8["^Z@S_:@MT2*0@K[!@2RX=CMU\C9LD3"B<3 6M(,EL
M#8JU:K:.$]=UX@N+H,CBQ:$D5,S' 0-U0^$4F""+,P.O0)'ZMA10]_32^U"(
M50;&F$E"UD^3/\K*H+6<6(AK<GM"];N+/-:3!": DLKV1D[TIRCA)1B4.$6D
M&RZ_(O4XC6=+7M']T'^-TSP!)V^29'G+J?(*2T6KCGU3.1A?,:P572E5R@D[
MVXH^)5?9; <,?L]FN<D[:+U$Q<:O==]22586??'V-7,QUYMH;L&((TV:Q4)+
M)G 4C;(*[H3ALY&;*1RG]:C*AKS&6>."'DD$%"3,"5 M\G2JF9W;6C!E#8/(
MDTH"5O(79Q'0T:APC<13<Z?,V^<TZU-XF:GL2$Y X*\F;46/X3GHP1 [1X^)
M;HA%TN#ZVK,G&7*R!*V<EBJ9062;1J(P-2*?80NDDNG1G CC^BM[GSY<G2^P
M/XA9=6D$LP^4B1V4#"^$]S2GLL7B9H>:Z>F,/4B5$$U35+&@]<K MS[$7<HY
MKE*9<\] M"+KW0(5![C.@:/>+X;H@DYN^H4(I*DMR>=2 I2OLZGP\CX,R)90
MM2 ]]Y_<E>QG^AE.6ZU8PCJM=CID 1TYH^&T'Y9/4)!(,XT8@BC@>$2$;Y-Z
M5TC$%.XCX*=K! V8I^']0+VC@J"0$SX!-FP&DXC(9D5^-<DG@LU<D.+B:%*3
M8? #'IP^ O]U=0#"O@$@O+H/R;2%.G#&WY<WTTV=VP#]%-D3$C%T1OYH4,A.
M"K('Z&C:2) [8I*1<9;FY34"N80=!L$X[F]E%Z"!RT5*F/\Q/=TE#&A#[2:^
MAX=M-LY@O3CJ>J!A>SD:>ND!)Q/@9 JRX@KL6_KGK&PD2.I\&$@:H 4)VPRQ
MG#Z7Q 1,!JX 2,:@J]$'O*MH^:ES$L+8[C)LCN\0FQW.1Y(5!L\BO:.7$=DZ
MQNJA[&Y?9O":\H)$BE.:I5<_A=- E,RD?[*-KGP<%<D1N&O@:=7TUT19E7PH
MBB7848=)_20%9)15.,D0@FF E'96-]I0AI X$J*@.+PD<O"W=2IW&J*S!F9R
M67$R5JI3##PO/"OZ9G9R[">=.;)?N'/E3DWPE72BK%GI84)-H8H:.;B.H\'_
M^8_M%UNODUJ]#CH!J?0(/)LVE\(7T 2S,BV2V%K=5)H%MQC++52?N.,,Z!2Y
M:\F2X)%NF1$$UG656Z>?$^NSPR]:F%088&K?,917)%-1J\P,!T]6:,T2UX-R
MM9%3+1=,5$T&/.=9-7[&>3 ECG'D?[)([[H  J;6Z5U,SIJU+WJ'A%U[1\=(
MN-PZO6Y!G3KT)"/@PU+^D@IJ,\4$$XH)$9]H\"9TXB#$(BLV>6*C<Q&RK\G,
MFM/J3O7N-$T0*T(!0GL>2GGOF /))N7&C&RXWA9-6Q$BXPF'=5\XK!=/.*SO
M$X<UE (! A^1.8M599%79F)W').R@8K.\'O"1;#N$&-7RN7')9K <K2OHO)G
ME/&ED "Y7M;$->:MUHDK_KW$$WQ4XBL*6#0P A?!Z2?_21_(8XCK8^Z<*JK(
MX0Y769DOJ! 8*)N7O4O7&'?T]6L"8F4Z88$WU(-$GTXA3SJ$&(Q!D=7P9'2.
M@G&9<MCU4U%>VU)HYUX16Q"7V9 B?*1 94@:)776_;X]UF_=4<VIPWDES=X[
MAC?Y7F@[)G#'^;1L"9 P-4R?AAC"W2T3BME=X'D$IL@X:6!G-5PH#?=)\KF@
M8+@DG*+/E CSH%9M+6OI<9GJPH&$:H3?*43:C,X#83!8TBG:/S 8N@F<GG1*
M4I =0[F=@N _NQCXFT?)MK?N(:/6A?>\)7?JL*S%)59\T]W#7$^Z[)P.EP;3
MN%B0J%$DK(-$(0GR">/"C/KOUMEW>6DY^II>)5E.I"UL.X<X,) XY2IELVPE
M-)0RGNJ\&6"018 172D7RVF>@:\2IDZ#V<]L1%&&M+8Q.13K>R@T/E6JB+.T
M*2>3NX^Q]4AB*653F],R-O"A*F$ZUDZMCW63HG=9BKYO-U,KD5M+>U'3NY#;
MYA+S=@%)[H'M/TIS5GCJII^SFAED^1785M M1?2B3,G*5!G$G,*TH":2(&$D
MR1)3Q1*Q@Z(I@(_P[JP6F+&DX&(0R'(,/ZZ32?HI36<R'$EX]&H5:3/,'>>X
M]T,'IIG8L**-^PS$YB/9S!JS"VE)IGX0U6$6X3>@.AP&UFM_$H\:B:H&#4JL
MZ"'S;;D2(W-MF5(<C!B@"I E-Y0S;OF1%" HJ50^MS^3]W*J,QU66"XY'+>I
M>*+DBHM4)N/TWVTRFON9+V>56?+DG1VI\^?NO>55)&(]XD8\/?Y_OYZ<'@NQ
MI# X"JTD4B?^X_CT\.3LF$@/Y:H/R-'WR_$1LBL2(:(P]A%1'UPMI(T?WB$#
M)'),_/[SR>'/T=GQX:^G2,CX\W'TX<V[DY\.D!3R+(X^GIY\<!]&)(+Z.*2$
M/#L^__#V;>]99[_"78^./WXX@U_#Z7@*0^+A\0@^GG[X>(QTCG +AT$37A:^
M/7[SS^CO[S_\#@][]\\X^NW#NU_?GQ^<GKSC23HY/3W^[0-2</Z3R0F/UEK9
MWT-%YS%&LJNR +_JF&)6(O#W"!A#^_6:F-4D%I7J@V.-"<D7#&P)?4HDCD[D
M7FY(..1/: P3$5,60$B$2.19\X'%8"?#/$3(VF',1LM.##4<^M7V&ES#3KK1
M/JUT-!$3CC.,(Z:&*F.*#/:IB\BQA6EE6DD3532CT[&UPBP'V@T.D6?,I\ZC
MU&'7\[I)IQQ;)*6+L0 VE>).MP+2BK4EZ)ZPYB>+T])\403:'!IQD F0(N[4
M@P!9(7E80K[]:X'$5]/(D<!S%X%_,%K?;"INYGNH6#I,9LW]@']QSUZF"?.X
MM0;KY2=R*L9]&Q9^/,T1S];!"C%ZB<,0+G=7T!-=W_6_![3_(:(2JM9 ?\U$
MWH] */3"T-XF(PQ*@<MU84GZYDZ"SWB G"2Q1>(6.TBD^)5E@7"@30'YZ+C$
MJ-+H$&@+;%> J?IY&"/$A(PX65+?YK=[8=WMPXVUZ(;4K7O_DOV!M1;6>ZA=
M.$TY^%I?9K/[D<_*>4)W,3D'V"E?,/R#8R)5 (E6_N8EJ+.%VV)<DKY#)5>0
M5('GQ]UXYH2G&('WAK\MP+^$$<;1'\39BIX/G.S(.-"B(SO)QNV(/;'*QCSL
MBU%N<-PV @#!/D5C0O%9C!27MS&]S\2= @R=5U,-U<."%A?-);N&R9H?O_=0
M=W%.,?B//+WW :)?T!?)!B<DCBP\1GDFD#860;)U?T1@$:<I,+8M$'DETH@=
MHI-.0KVLN"<,AO,"T$L!(W.;FSKJL&OHN!S1RUSDAX-/LL0M'487X7%A9(MR
M*C%R6&H"*,C@(8.U8M>6%'&Q*-DAA3>L>5\E<%IG-& T\JTO=SFD$#8_K$H[
M,HG<FA"1867MW6:M=^$]U+E\3)HJ@P4"_^&>BN"43X>#EQB&FJ!0.S&BI$^]
M+<@9!EC+8?3KV4'T\>#\].3#.0XWQDV1.3 ?@UP")S&M8 %I([!;%\C=4I[*
M'XH!,DI6],R!"\:FYM;>2#QA]A Q@R9[3TH\:B\6MNSF3ER_-U"L/\:@:'F]
M*,F)^H'?9K[BXQ:4M'1F>,%>>D*)?#U*9/^IY=)#HC]>&:ZMA+:NCES$E[SW
MX/F2CX[?GKP_.5]GHN3MO?M@%SY"G'IV3]&C S=F%,XL8_S6!'C11=?@;H;X
MC&*,<-1Y_Z?39.[\D&S'&DM_^K\L*^>'C+F0,B'[6Q.1UF/0C3![7R'GAWY7
M$<6E*4/DVV$FL,7:-N]$G>5MI64E7.""3B=:$)RW;SVB7"SWQ P63-L0_+%/
M:<.<6@6"3KI-7@X6Q>5BJ8)4.A1IN$ZTNPPI-<T1[(\0E(FQOA_7M2&6PF![
M0N[NZ[_\[8"+'&06' E"@UWN(8401AYLT4>F+6+'8I)P\\ZQDOYJXU4"YB8,
M1+)97VG%R=*B8K0@S(X&%0^C%N@L0RX<KD($-%T+OL. B1[YND9'Z1 4RRK+
M2SQJ5HG<]2H_WI70@J7>(L0](B'+J:=I-I>QC/1F>5TXO=]RAS.)8F/F+UPQ
MO95#U4?W,-?B);7^F7/=!7_62ET"]M4U4 KC==@;6X^%[MPA9ZK3(B.F+,I_
M8CC#$+8YM5D:(^0*)440N@-&@345W3;F09W:BGD<?#9( !B"$EN9IG06/5XA
MO$A#2KZSPV>P9Z>H5AD\@GR*CW6Z_+S2ZE/V:&>LA4.[(IOK#$$-"XX<5%!7
MV1C[3>=8&T_SV.M(S1_@47Z:UF7.F(WKRY+N8A_$/9T0,!"TNAVX%U*6<'W;
M,0( :B[ ^7=+0#KX]S %BWSBQGX>[4)Z[2W\191**[30A0D!&4!L[:"4BM4&
MB0L[)2FH2QK:&'"4C 6%B##;K&SKG,& L8\&-+ ,M_.ZXLH#H3$XM,Y^>Z._
MP'^:,W<E_,:[%*DBN#TEO4G,+3SX!.&DJO;[V+CA?M,42R4+=S*$XE;[IE."
M:H[G+?8[E X7,H.CI!I+7?/H,AU]HG$PS)WO-H@M5P\Q =37R2PBMHP+9=<0
M&'Z*5+[@ U[B5_8%DMJK$J45I)(,_8& BTVPE;8H3*K9G2A:6$-@&3TX7\>I
M8VH@J3RIT9<(72^KKS6_3WMRV?0$#J>QB7F0:G/O\GCGLH0]UIDYKM#L'4-#
M_"DWHQ1;]1'/FG0)>K*';C=ACDU3?NJ<IWR2YGE(\N#'3BZL=HP90A^AVZ1-
MI E]1A#$)OD,%S1M17TD3'??;D6Q[;518TV7FT?.I$NNP_#FG%+,\J643_9T
M-VV>+)\,NF:M'.8753+E,P;V4')A@.J8!9S1\2I%W732M7[&[I%+D&\$!P1H
M>1"!,3&5O4&4C,M9XU K=[SFOLZ+-L@MSR8V;6N++ RM0^A>'UA<X T<JQQD
M8/0)^=[AMP.?G:@S)J=6948FH106]%L1"!+9N90"!M(%5@I=%M-^-YSH[I*C
M)!%BX)B\T2$\@$&B!5JGV(Z&4$NN_^ .@B^?X[@-)L7]7OO5B$NC4#MZ3JS3
MPEM*:/CHR?T&/38$LWAVLL:9E!@Q)D*9@:$3R[N8Z&^D:"YI&K@Y=1EB1 @5
M;YJ0GSM#&;<Z;M-8B5+%D@55D*?$6C4SI(6N2%+)B=_*D )+C*-5AX\=N3&:
MO3*I#+Q1:+U.V-R;,<J6=^3JEC,U&ABPP :(K%S-]\(/[MDC=4;>E] ZP;G5
M,>'D6^B\#-:Y?@/]!R()&;NKWVOJ)&2WA:69J_ _9=%?=.;VI(N9-MV=:(?9
MW&YRKP+-T,X;+D/WYB-<O5P*OXA&TIP03"KH_+A[3CQ!'KX>\O#R"?+P@.R&
MU2$/KP*0AP=@\"Q*NW?L'J?KYQ=EZN_Y16PP<YS,37J"$)/1&2K>,5+IGL')
MG,R9D(/^4<CIPKH/LR[$H'%?X,=O+JTK6KF'&&@[!KOR*LF=:CR=:>_R49F7
MU8__L47_@VO9;3>FE5P*$_4IY:IJB;RY!E-6URUWCFD+X[90;<=%FQ"'L.T#
M\VM!^:8S]*T,^0L#VTVPD?TN*;:%DXZP!=QC-V,T(4K&M*R$Q K)-#>V!]$\
M32J%K1.]!I>WC6 F:AK3:VNB8>@4:<"0V!FKW^0!\*2B7'1KJ:MN:@;E:[6)
MC!"?>0G+(&%$TR&&J7'PK4!Z$5H"YL7KZ&-96I_QE'Y>1S]593O#:?BE+,=S
M\_6)4BIJI"F&CT:;1//F11&=HYNF2<.CLD"KOR+^GBC@X'=%.H]X_:DA&&S3
M)D(F]"8"WS)MYL\F@L >44'XJ^=_-?:<^L):U^@0H'9E5"_Y1%T[/>;H49X0
MYPF16U["%%U<TILKGMQ&Y,002P>2X\7E "G,,WC.6)@IPRT#>FZ\_7$T*_-L
M1%656+EI:+1QM,>FP_)1P%SZ_A5.B!'GQ;:T:5]5&W&P'.;ND%/>P4 A=:ZS
M# "Q"Z:8&1<8?P_;0SZ_P.VB'V\HN9YTRJY2 VV2MD1UM+V+(HTRLKV'_Q*9
M.]: _L$(>X1KL1=R23$O(A-!2I7#AM9-@$;CL:-\,[DVUOW.3##'," 2>Z#>
M$)\H+\ 5%*2$RNLBK=QW<6* IRWX SSX9[L\?/SWC8NS]>KU<R>NT'G-,,8!
M^[^1VSI_AMO;[NN]5W\=<.^%ROA&W ,!W/4K!J/-**ND/!Q4Y"QQ<AOY<+'@
M&T[M%"I3\E:1ISGGJ$ ">W3@EH4,E7*!_;/>KL5@"I$SCO2PH)X'P@%68FF3
M>#ZP(%(SI=@V)L0!?82!";Z/X;)U&1S-Z!WHO,#UPSRC^._;/,OH5VR,4T0;
M^]VN[5Z/>F7H,NZJB<@H00CF_1:3E* M1=IVYC:5G&*<DGJ>68Y1[^9<42-T
M'%+EDI44Y6JNT_P*SY2=05\WL"8B+.$(E(,R,%)K!\&SP)'37!)/2[>]@R!.
M],] 7,U4NZ7F:)%NHL2(57)#=K.$(^SHP9N30BK$OX;I4)-2KRVE'2;+X:+.
M,&"U9!Q+'\KGQ22K8%W)=I4@ D];[!#!75-XT6X>Y"PQO%NTZ*L]\CH1YM,K
M"; Y[U2EL!,JY3&0$]:^:3*$B^QI34LLC''2&HS&OF",1GZ["[CB5!$KWI?-
MQDUK?^LY<99?.Q9^^RG2$C,>B9"#)[53!8?9>WGP_N9N[)^L1OKYH#-[ (X@
MB2W2,1U;SHK(]LW&PPI/B86G!YP9EW#FX$2:LP/#%P/32QUFEOEORK8Q+7=5
M,5(HV_STS&,4LN>&/1+ZH?JWDJ;WJY9X\O/HW[#6$NJT6@,F FZ !9&5PU;,
M?,D#L.)3#IZ.<C21I2,=<DB!=,CL\U]<JRN^CL<,N7ZFX:K6G]NJ-)SB=+M&
M/N)Y A]F! (*?B*8:!\YP[?85([,!>=T3A]P(1RW$$!;.RF2<<+6YG&++&%@
M/H'SS0DLXX?_'3;"&#N=_D\RP\UT %.(G9 2W-<G=96D^4"11^R&BM</C\0I
M/*K:"__9OVZ>;0XH#3/$AC+)"/>']?^QB]858GE^(I6&FP-'K]F:F"GHU7?D
M.N1HAD3IT78L_]AA G7Z]R[L2IF(!B>"F7?0/12@S/;K-UF9EQ?9J(9=.D**
M0'? .K5UFGXB$U:J0?ATR5 3CML1^P$2;Q=F&_Y&W,YH* ]1_ \WPB%<$>>1
M)>"0VJFIVZ&H:S'E_-C(V[)DQ<MS/,;.A[@XE,!]M"A2!,SWM8E+#71H(SOX
M8T-=1"1*4VK)12&BC&G;^$PDYD>P;*6YBW7T!8+!,2D$L^'Q4<)9G'0":8LK
MS_[R-P7?R<#CU:]$B\!<Y?,M&19?JB'(I)('?L.JE0]\K!Y@3O?(TC'YU%;<
MB4I+#1S5;*@@<FK[;)DA#I"!)>?PW5'6H93E.>\CI>PC+-L\DD'SO=Q;1:_$
M,F&KY\OG>?4+)5%F9YHBT&Z;*OPD]LD,3(59A^F#**X(5\E4D1H,HZPO%U=A
M(C45W<&NH-J L<>BT+%MX@YW-EH=2J+@M _$+L@T=5[8-;0Y?$%/HC_ GZO'
MF9BL/AU#8 O$!J^P*B@QL'UYK?%H6SI2V,4+=RC)%@_7>P/A8YEPNPWT[HR8
M.DNFD6:7RY:K<1:LF"Z7OU;*U.P^R6Z!NG][.X3':_48H0U#VQ7Y)#2G9,E+
M&$[8/22^;%P#&SF&]5]Y_Q\+!.- AO&T(&"3+:MB/)+,@OPH1B->0V[F,]@,
MAX101]4FGS[BF=5^DUV\F2T37OT>78^*/0-4;.>HC>F$M[_>J'L.Z!.4X^NA
M'*^>H!P/:!^N#.78W?J>H1P]C?JP\1SR<B,SZGLN?%];[$<PV[>S*Z+<^W(/
MOMQ;]"5>^?QV25S$FV8$_#S3YM<ZT\N>[?GH6"7-#)B1Z:"MJTXVOP'&2LD3
M+/+*)MS2MU3[[LV3?8>D^90'M%SR@2)ZOV"<W5E%_MB ORT;CX6.7UGUB[*)
M.P7L=$^*77+-:CH$7XX[36$N!-'9&?7K'N,'VFA:BOAL=T*/83\IE*AB="EH
M:OL#OX/5HI2%@U&*P<,<E]B1&U]',NC,IH%\@=0?F#(SX%>.U3>7[NW#N?NN
M9/OB^S+NQ9V%;"&[ $YFGG)BU>]73KV%,)-?)==%O[329-R5=<*?>.EAB"%1
MC$:X=\5 &"^'4_^(?2*HY<)<^Z2SYN:R2,L0XQ=-CI(9_SQ' AOG9V;I; ]#
M%"Y;7HD^&^&K.7P%OEY#&'6=,:4[G.3MJ&F5<LY_?.T,VM1G5HHQL^\ KOLH
MK5]'P[;1HRFX)70OF,99ANV=)8111**[# Q"9 &F7\M[>CROS-?#M.O!)VLX
MDS3DF,/.!B1AK^881C:EU)B]V)6Y=/$#4*CAUE2!@F^GCQ B/0( ?,ZF[=2V
MXD%GW!(O6[X("H8W[B"'+E$&SM$%1K(G">P7GOC&S@.>X<*KE I-LCY9,2:]
MR@P46+-IK7C5[8SX^QW)>M1J'LE%EI2UXBPJ!XG=F>2%D2V&QR_UA.)0+KG[
M&.O,-./-:6P6-A-^T4[7""OIQ BTZX 'SD&A2<=*5&SWJ??-\L?T(P^,$.X9
MRC;SS3A!AL.XE)LNFIA!7X;()=I ?2\;7HBNW)#WP"CA<-NAB)I;T3GU%#NY
MO3C/YASV"Q5[.G'"D?Y0HH2Q\TEBDW[>YU5Z8?)J'%:D;B!R##' 6>R(Z[(B
M; )7)Q&1-A?;$90+L4OT"PDH6X9EPI_5EXJ1MG]2$Q+Y$5M--E65Y'7I(&:Y
M$ SU-E?)/5YAZ)1XA56;#8,=C*_0;XD-VP5CA$R%F#4RL;^F[0:%^[E?1,R;
M^YXFWP?C/_2EZ)8.2-<M1+.GH:!$]_?+T2 [FSM@"#\"=_ZF:-7VK1QU600\
MG5B. \Y=W0[_$+"4P=YL;6YOP7S'[@X@'P(]-H0L@/TFG1HWL@%5 K [(?W1
ML%\I;R:LC^CM/DYEXO%Y#3?8Z2):Y:RDD@TZ(T,W\,!9C-G$84BX@&U#*9UT
M>N%:JFT+?[407MLME6MV\3I\4\3JBB%N.P0[=W7:WIM6E<:(MJ35B(93S+2I
MC*FEU6K*1@>^ Y4S^SV@0C_OU:KZO97&VO;.M"O!Q#$5A""LVF>?H9>1E^<5
MQM.'@2GP!O6$^@!(BV)DU_$Z+UM%*K-L/Q#+OK-2LR23,F]GM5:6B6MIH,?P
M(!DLOXI+9B1U8)U%1>_$NG&FKP9&M.8\CRBRN@RNOV%&RF1*B3A.!E!NHUB*
M1)6<](8KASJ8LNI?QR0_-K;9D2['LQ-)@8?W]H8SHX:WHG8$FLQ-\?Q,-ZW;
M"W-B97*!!'<D]_X%-S2G RQQ9EFVDCS@FG.KR&(C?)<([]S8[8H?1Y7Q.2 Q
M6D;N=06WW@2)4S')$#_C"%\94CDJDL1GWQ5",#I-3XNE AEM?#$HQLJ%;-T.
M#'B8DN_6.48ZK0FHUI)!XS"MU+R4&&1G5E'JU,G,L""9^7/G9,!Z9DSK8[9:
M$@HXSI**N4V(I)+?A2["0XDK;-B"EB..&X.>%'697U%PZ*-I>6R5VV5"_3RQ
MD8[VK6NH-3Q2XN+Z<M_4# &25*A072'N1YKMI @QL^B\DAH34!/"-.03LJTI
MM0IU!K9'8LA(N26)"2V6U07XF?_K-";!.K;$/6@MC4PE: B7$0$?_588;=3K
MA+EH*](:AV4U$X'Q53H#%C&"*=>"B]3F#'6RO!I8!\*-93CZBA' 9 3?? 5@
M2_2,)YBRE4,R:?LM7655T]JZI&MIC\1-4TS]IS9T,24W$D',1,/);64R5A$_
M1@ZAX[  T.I6#C%,R8S-/-Z<3F)J9-J<&^?&VZJL**;3MJ#0FY:Z^K"M"<4A
M&VMRA<INS;72.Y+CLA.XU?A"VHVP]J.#V"*A\.C #RW-$5<=>,/<*"74$9Z3
M ??[_H/83*ITUHZ95G"<U<D5MS'&?TY(H9HX52*D>@Y%'IW&-E7(3_<)SG$=
MO:/,:"!?UK(Z*&$VXNB:<CC%3E'J$[3BKJ$5NUN/&5;Q+=W2!X(B,'7>6*]+
MI59N"T;AT.&RI(S-I&18IY10*+()*M44; L)]/:-':^1[X+#96.)FRPFC[(C
MD=<FY@XW&#=64,>.+@.=B41MK6ND8^7 A1<57\JNK[P&]X\E6;.U"(,D7MXR
MPF2RM>$UN_DAMFACBGO.9&YMUP2IE>25/**<,E8$R_?<!27ZS/_;??YB+S8I
M(4Y FEU&BW_VVYM'LI:[N[=;RZP>MI+.%ES!LD7T[AY ]2P"\2C\YNCQUBUI
M<4L(MTM %2H_IO;7'MVD\N<Q4V#1$-:&XF):+=,A2*3,K4;4U&"MN3^R)N6U
M2X;>APY0N5[H:AC.TRI;@IYAZ/"!X4V]BVFP26V8#?F\DV'=3!+>(8QD2]L<
MM"^CG>U]]>>.TCRYQES?.VE7\<[ #P[%%3L8,0QF44,+# #C6IHGF7M2N8X2
M$15)7EX0$3>/HTD^P9GNQCZ<0*?7U3Y(&3JR+G:\K->&T]'7*6.GU5X_Q;7J
MCF$DD>4("F0RO+IV=,5"BR !Z46'"EL&4TZ[$U)J>)O[)*;@_%".,=Z?3O6^
M7$C1 JX=U:>SR>(B9R0Z)OXT<PFP+4-L*(:)XS(MGB'C?Y(1EV,EM5D&^X29
M-- 8;S'4@]BUV"O;PE$@B8JY7_<=.')%RYE:JA%\#82 U'5K2".[5ZZ?O 8!
MKKNW-)IXO1=BM3NT*+$OZRO3J*PXFK$W&H=8J:U-# V-O%7K4OXS6(U2%CDQ
M*$S:7&C$M(.M%XRBMG9EXRC6D=E(S+--J11*C*5:DMA8N!^%81Q2I?\TA87X
M!E0/"[=/F;?- 39*3P:P^<<@5'@8@2O7*/;IQG$_00!$L*=("C!RJ#J"PI!X
M7!X<V/98KV'"Z[" R-ELHM*@+BO&HFG\5:+L1QB!SSCJ?UCFX"1DR7U9G-_=
M.E5@HAQJ9FYIKP;*OMA^,0Z&C4[%E$#:"*CA[%HRXK4HO9^R YYQC)[@T^ ,
MD!DD^2"3GO4>:XAQ;%H.K@6[<\0IHX1S8V&VC/IIL4.X')^D\,N1.4VP%<6C
M#EH=:[>%0+@JS_5$,CT9_IQNGP%WBT8S!;<<GHED[I/L,]+1@?6+V.P:.\5?
M,J6#[<4$9Q]L;/L-\<95F#ROE/+<*QT0<@E1X=@LZ:*$VZR?/;BJ;)R>G!WT
MY8((><#I+>>@WTY!)U8<?3DI*'DM6&!V:&$NMU_M[\GR4D\H2L0^:LZ XRM)
M54K(?B5NJ9>/=[H<UL^P-#KP<_?'+'V[>Q2JH48!Q*R]9K.X.@YSYU8.W_%G
M4L;CZ#SYW.WYIR:QJRVUAW:#/X\RI:(D)$ W&&$02%Y]0=6%W.%EEVDN-41(
M2H7H%BKY0CR?XM9"=^-@2F@L,/2Z%7:\(J6Z*%1;&Y=@PET1_X:)C@R0:2DI
MX-"I4[X7*[(A?8@6Y@1UFGQ#O%_> PD#9-&7"1H?M8R50GD4I2QDAP_3YAK!
MBQY$45-Y3/LHT;J!H4#U<!/T6!/6P+9/#LV@\R3D%LYJ0^]-S_N!2IIL/%">
M*\S@VN;&M%/!?PI823OJ(+F/M%=)Q^&6-+$BDL:Z?/TO&(^!]AY.H-;:.*>T
M7) 6%\F%!+",W^URQ[HA3^2B9)3(N,\?I=U/1H,(J=\,9HBD#_9"4*BU:SV\
M!\T7/R10QKAL=DOF8H?E&J5U75:"@4*OOQ^^<Z_W3)8 G-(+]U)LMT?\S>3R
M7O^!Q:,D@0H,DS6KN8)!; 170C9*:=KE0I32P& 5Q,:*NZ8IR:6KRQ,PY8Y/
MBV>[VT_ E$<-3.%FZW$DO*]NA7F(GT\575<AZ1FC=0VJ""7[9BG"0)MVU0;J
MO2G51C:$?L2<0KI0R>!!DS@'C61E2WK( ^,.6:)'']A(EZGUT.I@'V)2T&-/
M0;,T;4://(RB&.6WU%_$QJN<2K).PESY*:@O$ H,WQ -%+"OJ!^F],3C$'(1
M,8,V%GRJA<+=3+P6AK1-.RSS.KC3%('?X"[-ZR:=:IDY&<+^'8=5^8EL: RC
MVLI//L +F#P6FI3[ASI%!UHYWWTB-1F&T>"R_;.L/L5:ND\26$F?0,RAU*7S
M1&>.(FVIE'@/Y*GKS-B_V[)Q6"?8VK&$]=Y\&;M3VH4+JAA#M\$Y44KQ"X[^
M&_;OFGC2M1'D.GN9#IIF?VL)><_^]K(O;^>+OC5-90UW#\B65O3W@P+H^YW]
M_NX,?U,AYN._ZZOAY@AIHCD_OG3$ ]L+G=T*TR0%N4%2K1HPS6@M(3_74AMT
MF5MK8W#:;C=[;F5$<$O-!+D RZ53U^, ?BQ"M[^$%&K_U9(O7RZ42/QR9]F7
MRUBJ7BYCJ7IY.Y:JMT3Q_Y&=XV5 -IT%-UYO8B)(GZX!>'8>QU([B&5%EOU"
MM2,'92ON6P)'OG'.01YG558@9TH>S7)"%8VJEE/,Y-9A!Q4#\$B3*L_0UT/S
M; 2..]Z FUZYCM\OW EM3MD<RY>NH]>>KZ+-EZYSO\IVZ<IS#5U2>RT2;+WV
M]N8V-56JY-_I( X_7H6%P-UP$N9I98J:@DZN5N/!)]WH+V4-:;8J90:N'? :
M%WFE@P4#$<%4%F.%:6MG,4N?LDQR62NFV%E"78#DX@*A"Y2OSBY(*JTD^"0^
M@9>ELI:E^T$,!=-AR-5ZO3W2P8H0Y!:L:UH^+;SB5D/X'M3  ]OD2O<.M RH
M- [.A?W-YUM_?;R]++I0IV!4MPL<20QLJL.G_6>@2;Z?.;T)/H)](2V Q(!B
MN45H (3R>)'&;Z5N^*CO/)D>JV[P,NDWS5:&L(5A60NOYR[Q6E3CNQ>/5ZC_
MP;T.DU#*#5=@(E)OX)I:X<@<-&.3S?"JA=##$N($GPYK1$S/= [,VFI$C5'(
MP,4H19K3L807)Z:NWCF$>M!/ZL0G/\0V$&O9V7+%E?SIX.!C?PG!*T'?-I_;
M]C:R.:B%#)_TB)G %C;83/'24 7.LL+P3($74\!%H]28B_B3 WNGC_9.;[37
M'?UDFE;9B O;I9\J0MZX^RL,YB-3(LB=L"^E)8;@9RU^O'46G8%H\UHSCJK3
M=L&Y]=!S_I3#L5:\I=M^+2&,)O$\X"JD%UJ%[*@;GM%RDM9<5B!*J_)BA I0
MSJI1.\6H MF,/H<(M6-PK3R%R5QDG*7C! ]F1$,O?EB.N;4NP0GV=F*POA*J
M /9JYV^^5I*"6OJO"<Y*!C  DQ\6AXE!Q%.85:F$9 :=(#,^F-A3N>9:[NE0
M( ZBZ[+-QXQT]=+#C30KHS2KME_C>S4.10OU1*,%M<\)W!_>*F7V&/>^8$K/
M4FF&S)=[O2M3C?05@O"EY]PXA8]7&['>@6T/\W*1@>0'.JLYP#/14RA$^OL;
M(&CA1*<$5^X/GQ;3J.&U4HH0H2?UD5M^(+,PM9"+%6I 3@J;TLEG+)O" &-L
M4]WV>RD3K6/'.383$=LS5[D"M76O>XSJ"0IOE$MVO2[9G]/Q24.2C%%V>:8M
MTA2OP$2_=E)FJ:'+83Q[5IBQ()=,9>F.J7DPOKER=E OZLS'Z07@?I^H9S>U
MJN%1PCI.P9,3 (;::*1<JG8FE+KRD$'LA3#LPTDO\<OB%,F<"J<&-NY>OXUI
MO?"CW_YUN+WS\L6M E(^_P6=?(M:W1"Q#)4@,4W&_^K&D*LPDD'0C9R;V#G@
MFE@X.&*W 3Q5RY)A+S=R>2X1 9I+;1]'4&/J/26-XH?:)(U4M4OAS!8J'_^:
MSL0+\0T6=?2[H1#P9]A9S>4(3_2/]!IKZ SWQ*@7A;T)?7:[NM[P4H0%KS ,
M0!?FJMBON.#%1]W3$.J^;H>F_-20G5*)W 77[23NZH/0M3P4^L A$\)FMC&S
MU:#LH@H$-Y*R77X1)$*HJA&CKAA-!49#_(1ON7M\R\X3ON51XUMR/"7RA/?7
M'Z"VT16,T=0B!>YL7O0#G*:DS%@G>6&NR9HQ+8!PX?6TBX4=FS"(%A6 R35Y
MYCW+,J$],"3(_9; ?%^51W#P5&4[BWXA!,7R(C,M:7#;=*_?P;_JM'$[@[+/
MUNM20=BL=Q+)%=29=9)<E90LE'S08Y_&!8:.TS-BXG$7"W\%NKNV34;=:QS<
M[QM,\2RNC$#5R"T[XFA*L0I&8QLWCOI3Y!0S6<<ZBA57R#'VWR77"^HB8&E\
M;@V_>2K'45/+7 FOEUP8!L/+LJ98%IQ+L&,0J31";[]QF[YV?X<X*_X9.\S1
M,,O)/T(MI; 5VH%RO]Z U!N>D*MO7M+>V+K1""AWW'?\4Z-]CEN--Y))+<IG
ME.O6:>* ")<Q8,,!3 $CE0BXA3PG>$L6WKG<V@S3F0$)!CAOZCP[#K_%#!Z
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MZ[GN!U<<0/.X>0F\>(JL**X<'(95"'"@"!<[!%SXZ2-NQO.F\=8_,OI[2O'
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MDQ%K A&-" ])*-MD#6@LZ_Q2O+;]R:":NW;-*186_S ,1C9\^#]02P,$%
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MRQ#DC;5DD>O%N4?@QDG?3Q3RRIK/=*V_2&H#-7CW&GK1/G3QE[L91/8VA,=
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MQSZ?4K%IB/V-\^]5$H9W]+J>]_V_^%.!U5^Q''KI?\H<>NE_U_P/4$L#!!0
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M(CBS$#*41/ $R@@RICX4*2(C<$2-='(; C'SF=94+5 DHE<,QEWK4T-9 ,K
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MD1/3R^BQ1_>WAYFZ3(/2P ?65[^?0XH81O@TT0]O@O[\B 'QI".Y"$$F"CH
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MRR2V]R2IP/[&D?@J^<,[>EU/ _]?_(>!U?]E.?+2?S!SY*7_R.9_4$L#!!0
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MBLZ0PS,3X5E)H'YMBR#C*? ;6\GVBA4NZ&M%724U^.]J]="0V@HWO"AS,7R
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M4]!3"A]GQ' ^7\" IE)ID&,(R0(3!QQ202&<4D521K,M.!*1 QNFTYM7[X+
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M=&@P,# P,#$N:G!G4$L! A0#%     @ F$004YDR9E1$'P  ;RT  !8
M         ( !^XT  &<S9'EC:W(S=61T:# P,# P,BYJ<&=02P$"% ,4
M" "81!!36REU-U(P  "80@  %@              @ %SK0  9S-D>6-K<C-U
M9'1H,# P,# S+FIP9U!+ 0(4 Q0    ( )A$$%.O9*&FT2H  .\Q   6
M          "  ?G=  !G,V1Y8VMR,W5D=&@P,# P,#0N:G!G4$L! A0#%
M  @ F$004P@"I^ @0   ;E$  !8              ( !_@@! &<S9'EC:W(S
M=61T:# P,# P-2YJ<&=02P$"% ,4    " "81!!3'F&<,8BB  #%J   %@
M            @ %220$ 9S-D>6-K<C-U9'1H,# P,# V+FIP9U!+ 0(4 Q0
M   ( )A$$%-$-O/-&2<  )0O   6              "  0[L 0!G,V1Y8VMR
M,W5D=&@P,# P,#<N:G!G4$L! A0#%     @ F$004_] C,6,]P  K_H  !8
M             ( !6Q," &<S9'EC:W(S=61T:# P,# P."YJ<&=02P$"% ,4
M    " "81!!3R9MA)1\U  "%.P  %@              @ $;"P, 9S-D>6-K
M<C-U9'1H,# P,# Y+FIP9U!+ 0(4 Q0    ( )A$$%.6EJ_0)D   '-'   6
M              "  6Y  P!G,V1Y8VMR,W5D=&@P,# P,3 N:G!G4$L! A0#
M%     @ F$004TO/,[Q870  QG   !8              ( !R( # &<S9'EC
M:W(S=61T:# P,# Q,2YJ<&=02P$"% ,4    " "81!!3!H@H]R,R  !%.
M%@              @ %4W@, 9S-D>6-K<C-U9'1H,# P,#$R+FIP9U!+ 0(4
M Q0    ( )A$$%,30!'FWVP  %2'   6              "  :L0! !G,V1Y
M8VMR,W5D=&@P,# P,3,N:G!G4$L! A0#%     @ F$004^@%%"_YJ0  "[,
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M,V1Y8VMR,W5D=&@P,# P,3DN:G!G4$L! A0#%     @ F$004]73-@.V@@
MEI8  !8              ( !T,<' &<S9'EC:W(S=61T:# P,# R,"YJ<&=0
M2P$"% ,4    " "81!!3:DS$_^DJ   Q,0  %@              @ &Z2@@
M9S-D>6-K<C-U9'1H,# P,#(Q+FIP9U!+ 0(4 Q0    ( )A$$%-NJ28OAC
M #8X   6              "  ==U" !G,V1Y8VMR,W5D=&@P,# P,C(N:G!G
M4$L! A0#%     @ F$004S?!>L<@;0  4',  !8              ( !D:8(
M &<S9'EC:W(S=61T:# P,# R,RYJ<&=02P$"% ,4    " "81!!3O=0]R?V'
M   <D   %@              @ 'E$PD 9S-D>6-K<C-U9'1H,# P,#(T+FIP
M9U!+ 0(4 Q0    ( )A$$%-33!/;XCH  *M!   6              "  1:<
M"0!G,V1Y8VMR,W5D=&@P,# P,C4N:G!G4$L! A0#%     @ F$004QCQ9R16
M50  EW0  !8              ( !+-<) &<S9'EC:W(S=61T:# P,# R-BYJ
M<&=02P$"% ,4    " "81!!3!<0W]8UE  #I?   %@              @ &V
M+ H 9S-D>6-K<C-U9'1H,# P,#(W+FIP9U!+ 0(4 Q0    ( )A$$%.E@A02
M23T  ,Q-   6              "  7>2"@!G,V1Y8VMR,W5D=&@P,# P,C@N
M:G!G4$L! A0#%     @ F$004T96>/&>4@  LUP  !8              ( !
M],\* &<S9'EC:W(S=61T:# P,# R.2YJ<&=02P$"% ,4    " "81!!3Q"Y>
M.BTI  !&,   %@              @ '&(@L 9S-D>6-K<C-U9'1H,# P,#,P
M+FIP9U!+ 0(4 Q0    ( )A$$%,&E<PV0C0  (8^   6              "
M 2=,"P!G,V1Y8VMR,W5D=&@P,# P,S$N:G!G4$L! A0#%     @ F$004THH
M;A^:.0  WT0  !8              ( !G8 + &<S9'EC:W(S=61T:# P,# S
M,BYJ<&=02P$"% ,4    " "81!!3<RLEW64X  !F1P  %@
M@ %KN@L 9S-D>6-K<C-U9'1H,# P,#,S+FIP9U!+ 0(4 Q0    ( )A$$%-%
M@ 9;N4X  .YE   6              "  03S"P!G,V1Y8VMR,W5D=&@P,# P
M,S0N:G!G4$L! A0#%     @ F$004Y)TPR@V6@  ]%T  !8
M ( !\4$, &<S9'EC:W(S=61T:# P,# S-2YJ<&=02P$"% ,4    " "81!!3
M)V?H+5F%  "ZC@  %@              @ %;G P 9S-D>6-K<C-U9'1H,# P
M,#,V+FIP9U!+ 0(4 Q0    ( )A$$%/7H6E/MCX  'I&   6
M  "  >@A#0!G,V1Y8VMR,W5D=&@P,# P,S<N:G!G4$L! A0#%     @ F$00
M4P7I*Q]R0@  :50  !8              ( !TF - &<S9'EC:W(S=61T:# P
M,# S."YJ<&=02P$"% ,4    " "81!!3/OD+9G@S  #=0   %@
M    @ %XHPT 9S-D>6-K<C-U9'1H,# P,#,Y+FIP9U!+ 0(4 Q0    ( )A$
M$%,<U'$7LT<  ,Y9   6              "  237#0!G,V1Y8VMR,W5D=&@P
M,# P-# N:G!G4$L! A0#%     @ F$004SG_#<TL20  Z%<  !8
M     ( !"Q\. &<S9'EC:W(S=61T:# P,# T,2YJ<&=02P$"% ,4    " "8
M1!!3Q"6M!$I   "+1P  %@              @ %K: X 9S-D>6-K<C-U9'1H
M,# P,#0R+FIP9U!+ 0(4 Q0    ( )A$$%-U5RY31ZL! #F=&P 5
M      "  >FH#@!T<VAA+3$P<5\R,#(Q,#8S,"YH=&U02P$"% ,4    " "8
M1!!37][2&UT5   2WP  $0              @ %C5!  ='-H82TR,#(Q,#8S
M,"YX<V102P$"% ,4    " "81!!3J="./[\)  !5?0  %0
M@ 'O:1  ='-H82TR,#(Q,#8S,%]C86PN>&UL4$L! A0#%     @ F$004WQ3
MR$]L+0  ZD$# !4              ( !X7,0 '1S:&$M,C R,3 V,S!?9&5F
M+GAM;%!+ 0(4 Q0    ( )A$$%/G:TX5EFT  -V4!@ 5              "
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M82UE>#,Q,5\W+FAT;5!+ 0(4 Q0    ( )A$$%.B6YDC;P@  #E'   0
M          "  1B2$P!T<VAA+65X,S$R7S8N:'1M4$L! A0#%     @ F$00
M4["M3))"!0  [B4  !               ( !M9H3 '1S:&$M97@S,C%?.2YH
M=&U02P$"% ,4    " "81!!3A?=%<D,%  #])0  $               @ $E
IH!, ='-H82UE>#,R,E\X+FAT;5!+!08     -@ V "X.  "6I1,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
